Citrus Sinensis ID: 015672

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400---
Protein Sequence
MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccccccccccccccEEEEEEEcccccccccEEEEEEEEEEEccccEEEEEEEEcccccEEEEEEccccccHHHHHHHHHHHcccccEEEEcEEEEcccccccEEEEEEEEcccccHHHHHHHHccccccccHHHHHHHHHHHHHHHHHHHHccccEEcccccccEEEcccccEEEEEEccccccHHHcccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHcccccHHHHHHHccccccccccccccccccccccccccHHHHHHHHHHccccccccccHHHHHccccccccccccccccccccccccccccccccccccHHHHHHccHHHHHHHcHHHcccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccccHHcccHHHHHccccccccccccccccccccccccccccEEEEEEEccccccccEEEEEEEEEEEEEcccEEEEEEEEcccccEEEEEEEEEccccccHHHHHHcccccccEccEEEEEEEccccccEEEEEEEEcccEEHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHHcEEcccccHHHEcccccccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHHHHHcHHHccccccccccccHHHHccccccHHHHHHHHccccccHHHcccHHHHHHcHHHHHHHccccEcccccEccccccccHHHHcccHHHHHHHHcHHHHHHHcccccccc
Coil and Loop (DISEMBL)
masaslgnggvgssrsvngfksssSSVDWLGREMLEMRLRdqvdndedrdsepdiidgvgaetGHVIRttiggrngnskqKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLdhpnivalkhcffsttDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCigichrdikpqnllvkgepnvsyicsryyrapelifgateyttaIDIWSTGCVMAELllgqplfpgesgVDQLVEIIKVLGtptreeikcmnpnytefkfpqikphpwhkvfqkrlppeaVDLVCRffqyspnlrctaleacvhpffdelrdpntrlpngrplpplfnfkppelsgippetinrlipEHARKQNLFMALHS
Flexible Loop (DISEMBL)
masaslgnggvgssrsvngfksssSSVDWLGREMLEMRLRdqvdndedrdsepdiidgvgaetghvirttiggrngnskQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVaikkvlqdkrYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNysrihqrmpLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS
Low Complexity Region (SEG)
MASAslgnggvgssrsvngfksssssVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKeelylnlvleyvpeTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS
Disordered region (IsUnstruct)
*******************************************************IDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR**************************************************
Disordered Region (DISOPRED)
*****************************************************************VIRTTIGG**GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQN*******
Disordered Region (DISEMBL)
**************RSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS
Disordered Region (DISPRO)
*************************************************************ETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLF*****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	403	2.2.26 [Sep-21-2011]
Q39019	421	Shaggy-related protein ki	yes	no	0.997	0.954	0.836	0.0
Q9FVS6	420	Shaggy-related protein ki	no	no	0.990	0.95	0.823	0.0
P51138	411	Glycogen synthase kinase-	N/A	no	0.965	0.946	0.701	1e-174
Q8VZD5	410	Shaggy-related protein ki	no	no	0.960	0.943	0.706	1e-174
P51139	411	Glycogen synthase kinase-	N/A	no	0.952	0.934	0.714	1e-173
P43288	405	Shaggy-related protein ki	no	no	0.925	0.920	0.728	1e-173
P51137	411	Glycogen synthase kinase-	N/A	no	0.970	0.951	0.707	1e-173
P43289	409	Shaggy-related protein ki	no	no	0.967	0.953	0.693	1e-173
Q40518	409	Shaggy-related protein ki	N/A	no	0.925	0.911	0.728	1e-172
Q96287	472	Shaggy-related protein ki	no	no	0.908	0.775	0.707	1e-166

>sp|Q39019|KSG10_ARATH Shaggy-related protein kinase kappa OS=Arabidopsis thaliana GN=ASK10 PE=2 SV=2

 Score =  741 bits (1912), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 353/422 (83%), Positives = 378/422 (89%), Gaps = 20/422 (4%)

Query: 1   MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
           MAS+ LGNG VG+SRS  G KSSSSSVDWL R++ E R+RD+V+ D++RDSEPDIIDG G
Sbjct: 1   MASSGLGNG-VGTSRSAKGLKSSSSSVDWLTRDLAETRIRDKVETDDERDSEPDIIDGAG 59

Query: 61  AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
           AE GHVIRTT+ GRNG S+Q VSYI+EHVVGTGSFG+VFQAKCRETGE+VAIKKVLQDKR
Sbjct: 60  AEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKR 119

Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
           YKNRELQIMQMLDHPN VALKH FFS TD EE+YLNLVLE+VPETVNR+AR+YSR +Q M
Sbjct: 120 YKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLM 179

Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV-------------------KGEP 221
           PLIYVKLYTYQICRALAYIHN  G+CHRDIKPQNLLV                   KGEP
Sbjct: 180 PLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEP 239

Query: 222 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 281
           NVSYICSRYYRAPELIFGA+EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 240 NVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 299

Query: 282 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 341
           LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL+CRFFQYSPNLRCTAL
Sbjct: 300 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTAL 359

Query: 342 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 401
           EAC+HP FDELRDPNTRLPNGRPLPPLFNFKP ELSGIPPE +NRL+PEHARKQNLFMAL
Sbjct: 360 EACIHPLFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPEIVNRLVPEHARKQNLFMAL 419

Query: 402 HS 403
           HS
Sbjct: 420 HS 421

May mediate extracellular signals to regulate transcription in differentiating cells.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FVS6|KSG4_ARATH Shaggy-related protein kinase delta OS=Arabidopsis thaliana GN=ASK4 PE=2 SV=1

 Score =  726 bits (1873), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 345/419 (82%), Positives = 375/419 (89%), Gaps = 20/419 (4%)

Query: 4   ASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAET 63
           + LGNG VGSSRS    K++SSSVDWL R+MLEM++RD+ + DE+RDSEPDIIDGVGAE 
Sbjct: 3   SHLGNG-VGSSRSAKNTKNTSSSVDWLSRDMLEMKIRDKTEADEERDSEPDIIDGVGAEP 61

Query: 64  GHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN 123
           GHVI TT+ GRNG S+Q VSYIAEHVVGTGSFG+VFQAKCRETGE+VAIKKVLQDKRYKN
Sbjct: 62  GHVITTTLPGRNGQSRQTVSYIAEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKRYKN 121

Query: 124 RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI 183
           RELQIMQMLDHPN+V LKH F+S T+ EE+YLNLVLE+VPETVNR AR+YSR++Q MPLI
Sbjct: 122 RELQIMQMLDHPNVVCLKHSFYSRTENEEVYLNLVLEFVPETVNRTARSYSRMNQLMPLI 181

Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV-------------------KGEPNVS 224
           YVKLYTYQICR LAY+HNC G+CHRDIKPQNLLV                   KGEPN+S
Sbjct: 182 YVKLYTYQICRGLAYLHNCCGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNIS 241

Query: 225 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 284
           YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT
Sbjct: 242 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 301

Query: 285 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 344
           PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL+CRFFQYSPNLRCTA+EAC
Sbjct: 302 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTAVEAC 361

Query: 345 VHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS 403
           +HPFFDELRDPN RLPNGRPLPPLFNFKP ELSGIPPET++RL+PEHARKQN FMALHS
Sbjct: 362 IHPFFDELRDPNARLPNGRPLPPLFNFKPQELSGIPPETVDRLVPEHARKQNHFMALHS 420

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1

 Score =  610 bits (1572), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 292/416 (70%), Positives = 336/416 (80%), Gaps = 27/416 (6%)

Query: 6   LGNGGVGSSRSVNGFKSSSS-SVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETG 64
           +   GV  +  +    +SS+ +VD L  E+L MR++D      D++ E  ++DG   E G
Sbjct: 1   MATAGVAPASGIVDVNASSAIAVDKLPDEILGMRIKD------DKEMEAHVVDGNSTEAG 54

Query: 65  HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR 124
           HVI TTIGG+NG  KQ +SY+AE  VG GSFGVVFQAKC ETGE VAIKKVLQDKRYKNR
Sbjct: 55  HVIVTTIGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR 114

Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY 184
           ELQ M++LDHPN+V LKHCFFSTT+K+ELYLNLVLE+VPETV+R+ R+YS+++QRMPLIY
Sbjct: 115 ELQTMRLLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPETVHRVIRHYSKMNQRMPLIY 174

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLV-------------------KGEPNVSY 225
           VKLY+YQICR+LAYIHNC+G+ HRDIKPQNLLV                   KGEPN+SY
Sbjct: 175 VKLYSYQICRSLAYIHNCVGVSHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 234

Query: 226 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 285
           ICSRYYRAPELIFGATEYT+AIDIWS GCV+ ELLLGQPLFPG SGVDQLVEIIKVLGTP
Sbjct: 235 ICSRYYRAPELIFGATEYTSAIDIWSAGCVLGELLLGQPLFPGASGVDQLVEIIKVLGTP 294

Query: 286 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 345
           TREEIKCMNPNYTEFKFPQIK HPWHK+F+KR+PPEAVDLV R  QYSPNLR TALEA V
Sbjct: 295 TREEIKCMNPNYTEFKFPQIKAHPWHKIFRKRMPPEAVDLVSRLLQYSPNLRSTALEALV 354

Query: 346 HPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQ-NLFMA 400
           HPFFDELRDPNTRLPNGR LPPLFNFK  EL G+P E + +L+P HARKQ +LF +
Sbjct: 355 HPFFDELRDPNTRLPNGRHLPPLFNFKANELKGVPAEMLVKLVPSHARKQCSLFAS 410

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1

 Score =  609 bits (1571), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 291/412 (70%), Positives = 333/412 (80%), Gaps = 25/412 (6%)

Query: 9   GGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIR 68
           G + +S       ++S   + L   + EM+++D      D++ E  ++DG G ETGH+I 
Sbjct: 5   GTLPASSMATKQSNASICAEKLPEGINEMKIKD------DKEMEAAVVDGNGTETGHIIV 58

Query: 69  TTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQI 128
           TTIGG+NG  KQ +SY+AE +VG GSFG+VFQAKC ETGE VAIKKVLQDKRYKNRELQ 
Sbjct: 59  TTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT 118

Query: 129 MQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY 188
           M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV R++++YSR +QRMP+IYVKLY
Sbjct: 119 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLY 178

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLV-------------------KGEPNVSYICSR 229
           TYQICRALAYIH  +G+CHRDIKPQNLLV                   KGEPN+SYICSR
Sbjct: 179 TYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 238

Query: 230 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 289
           YYRAPELIFGATEYTT IDIWS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPTREE
Sbjct: 239 YYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 298

Query: 290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           IKCMNPNYTEFKFPQIK HPWHK+F KR PPEAVDLV R  QYSPNLR TA+EA VHPFF
Sbjct: 299 IKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAMEAIVHPFF 358

Query: 350 DELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 401
           DELRDPNTRLPNGR LPPLFNFKP EL G   E +++LIP+HARKQ  F+AL
Sbjct: 359 DELRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPDHARKQCSFLAL 410

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2

 Score =  609 bits (1570), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 293/410 (71%), Positives = 335/410 (81%), Gaps = 26/410 (6%)

Query: 6   LGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEP-DIIDGVGAETG 64
           + +GGV  +       +SS  V+ L  EM +M++RD      D++ E   I+DG G ETG
Sbjct: 1   MASGGVAPASGFIDKNASSVGVEKLPEEMNDMKIRD------DKEMEAATIVDGNGTETG 54

Query: 65  HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR 124
           H+I TTIGG+NG  KQ +SY+AE VVG GSFGVVFQAKC ETGE VAIKKVLQDKRYKNR
Sbjct: 55  HIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR 114

Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY 184
           ELQ M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV+R+ R+Y++++QRMP+IY
Sbjct: 115 ELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVSRVIRHYNKMNQRMPMIY 174

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLV-------------------KGEPNVSY 225
           VKLY+YQICRALAYIHN IG+CHRDIKPQNLLV                   KGEPN+SY
Sbjct: 175 VKLYSYQICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNISY 234

Query: 226 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 285
           ICSRYYRAPELIFGATEYTTAIDIWS GCV+ ELLLGQPLFPGESGVDQLVEIIKVLGTP
Sbjct: 235 ICSRYYRAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLFPGESGVDQLVEIIKVLGTP 294

Query: 286 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 345
           TREEIKCMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDLV R  QYSPNLR TALEA V
Sbjct: 295 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEALV 354

Query: 346 HPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQ 395
           HPF+D++RDPNTRLPNGR LPPLFNFK  EL G+P E + +L+P HARKQ
Sbjct: 355 HPFYDDVRDPNTRLPNGRFLPPLFNFKVNELKGVPAEMLVKLVPPHARKQ 404

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3

 Score =  607 bits (1566), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 290/398 (72%), Positives = 330/398 (82%), Gaps = 25/398 (6%)

Query: 23  SSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKV 82
            S+ VD L  EM +M++RD      D++ E  ++DG G ETGH+I TTIGGRNG  KQ +
Sbjct: 14  DSTGVDKLPEEMNDMKIRD------DKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTI 67

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKH 142
           SY+AE VVG GSFGVVFQAKC ETGE VAIKKVLQD+RYKNRELQ M++LDHPN+V+LKH
Sbjct: 68  SYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKH 127

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           CFFSTT+K+ELYLNLVLEYVPETV+R+ ++Y++++QRMPLIYVKLYTYQI RAL+YIH C
Sbjct: 128 CFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRC 187

Query: 203 IGICHRDIKPQNLLV-------------------KGEPNVSYICSRYYRAPELIFGATEY 243
           IG+CHRDIKPQNLLV                   KGEPN+SYICSRYYRAPELIFGATEY
Sbjct: 188 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 247

Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 303
           TTAID+WS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP
Sbjct: 248 TTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 307

Query: 304 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGR 363
           QIK HPWHK+F KR+PPEAVDLV R  QYSPNLR  AL+  VHPFFDELRDPN RLPNGR
Sbjct: 308 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFFDELRDPNARLPNGR 367

Query: 364 PLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 401
            LPPLFNFKP EL G+P E + +L+PEHARKQ  ++ L
Sbjct: 368 FLPPLFNFKPHELKGVPLEMVAKLVPEHARKQCPWLGL 405

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1

 Score =  606 bits (1563), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 295/417 (70%), Positives = 332/417 (79%), Gaps = 26/417 (6%)

Query: 4   ASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAET 63
           AS+G       R V G        D L  EM +M++RD      DR+ E  ++DG G ET
Sbjct: 2   ASVGVAPTSGFREVLG-DGEIGVDDILPEEMSDMKIRD------DREMEATVVDGNGTET 54

Query: 64  GHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN 123
           GH+I TTIGGRNG  KQ +SY+AE VVG GSFGVVFQAKC ETGE VAIKKVLQDKRYKN
Sbjct: 55  GHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKN 114

Query: 124 RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI 183
           RELQ M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV+R+ ++YS+++QRMP+I
Sbjct: 115 RELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYSKLNQRMPMI 174

Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV-------------------KGEPNVS 224
           YVKLYTYQI RAL+YIH CIG+CHRDIKPQNLLV                   KGEPN+S
Sbjct: 175 YVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 234

Query: 225 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 284
           YICSRYYRAPELIFGATEYTTAID+WS GCV+AELLLGQPLFPGE GVDQLVEIIKVLGT
Sbjct: 235 YICSRYYRAPELIFGATEYTTAIDVWSVGCVLAELLLGQPLFPGERGVDQLVEIIKVLGT 294

Query: 285 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 344
           PTREEIKCMNPNYTEFKFPQIK HPWHK+F KR+P EAVDLV R  QYSPNLRC AL+  
Sbjct: 295 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPAEAVDLVSRLLQYSPNLRCQALDCL 354

Query: 345 VHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 401
            HPFFDELRDPN RLP GR LPPLFNFKP EL G+P ET+ +L+PEHARKQ  F+ L
Sbjct: 355 THPFFDELRDPNARLPTGRFLPPLFNFKPHELKGVPVETLMKLVPEHARKQCPFLGL 411

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1

 Score =  606 bits (1563), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 288/415 (69%), Positives = 338/415 (81%), Gaps = 25/415 (6%)

Query: 6   LGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGH 65
           + + G+  S +V     + +  D L  EM +M+++D      D++ E  I++G   ETGH
Sbjct: 1   MASVGIEPSAAVRESTGNVTDADRLPEEMKDMKIQD------DKEMEATIVNGNVTETGH 54

Query: 66  VIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE 125
           +I TTIGGRNG  KQ +SY+AE VVG GSFGVVFQAKC ETGE VAIKKVLQD+RYKNRE
Sbjct: 55  IIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRE 114

Query: 126 LQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYV 185
           LQ M++LDHPN+V+LKHCFFSTT+K+ELYLNLVLEYVPETV+R+ ++Y++++QRMPL+YV
Sbjct: 115 LQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYV 174

Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLV-------------------KGEPNVSYI 226
           KLYTYQI R+L+YIH CIG+CHRDIKPQNLLV                   KGEPN+SYI
Sbjct: 175 KLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 234

Query: 227 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 286
           CSRYYRAPELIFGATEYTTAID+WS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPT
Sbjct: 235 CSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 294

Query: 287 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 346
           REEIKCMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDLV R  QYSPNLRC AL++ VH
Sbjct: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCAALDSLVH 354

Query: 347 PFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 401
           PFFDELRDPN RLPNGR LPPLFNFKP EL G+P E + +L+PEHARKQ  +++L
Sbjct: 355 PFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVPEHARKQCPWLSL 409

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1

 Score =  603 bits (1555), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 292/401 (72%), Positives = 329/401 (82%), Gaps = 28/401 (6%)

Query: 17  VNGFKSSSS---SVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGG 73
           V+G + SSS    VD L  EM +MR+RD      D++ E  I+DG G ETGH+I TTIGG
Sbjct: 9   VSGLRESSSHSVGVDRLPEEMNDMRIRD------DKEIEAAIVDGNGTETGHIIVTTIGG 62

Query: 74  RNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLD 133
           R+G  KQ +SY+AE +VG GSFGVVFQAKC ETGE VAIKKVLQDKRYKNRELQ M++LD
Sbjct: 63  RHGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLD 122

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           HPN+V LKHCFFSTT+K+E+YLNLVLEYVPETV+R+ ++Y++++QRMPLI VKLYTYQI 
Sbjct: 123 HPNVVCLKHCFFSTTEKDEVYLNLVLEYVPETVHRVIKHYNKLNQRMPLILVKLYTYQIF 182

Query: 194 RALAYIHNCIGICHRDIKPQNLLV-------------------KGEPNVSYICSRYYRAP 234
           RAL+YIH+ IG+CHRDIKPQNLLV                   KGEPN+SYICSRYYRAP
Sbjct: 183 RALSYIHHTIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242

Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
           ELIFGATEYTTAIDIWS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN
Sbjct: 243 ELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 302

Query: 295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 354
           PNY EFKFPQIK HPWHK+F KR+PPEAVDLV R  QYSPNLRCTALEA  H FFDELRD
Sbjct: 303 PNYNEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAVTHAFFDELRD 362

Query: 355 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQ 395
           PNTRLPNGR LPPLFNFK  EL G+  E + +L+PEHARKQ
Sbjct: 363 PNTRLPNGRVLPPLFNFKAHELKGVSAENLLKLVPEHARKQ 403

May mediate extracellular signals to regulate transcription in differentiating cells.

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q96287|KSG8_ARATH Shaggy-related protein kinase theta OS=Arabidopsis thaliana GN=ASK8 PE=2 SV=3

 Score =  583 bits (1504), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 273/386 (70%), Positives = 315/386 (81%), Gaps = 20/386 (5%)

Query: 28  DWLGREMLEMRLRDQVD-NDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIA 86
           D L   M+EM++RD+ + N ED+D E  +++G G ETG VI TT+GGR+G  KQ +SY+A
Sbjct: 81  DQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETGQVITTTVGGRDGKPKQTISYMA 140

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFS 146
           + VVGTGSFGVVFQAKC ETGE VAIKKVLQDKRYKNRELQIM++ DHPN+V L+H FFS
Sbjct: 141 QRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHSFFS 200

Query: 147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
           TTDK+ELYLNLVLEYVPETV R +++Y++++Q MP+I+V+LYTYQICRAL Y+H  +G+C
Sbjct: 201 TTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIFVQLYTYQICRALNYLHRVVGVC 260

Query: 207 HRDIKPQNLLVK-------------------GEPNVSYICSRYYRAPELIFGATEYTTAI 247
           HRDIKPQNLLV                    GEPN+SYICSRYYRAPELIFGATEYT AI
Sbjct: 261 HRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTNAI 320

Query: 248 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 307
           D+WS GCVMAELLLGQPLFPGESG+DQLVEIIK+LGTPTREEI+CMNPNYTEFKFPQIK 
Sbjct: 321 DMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQIKA 380

Query: 308 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPP 367
           HPWHK+F KR+PPEAVDLV R  QYSPNLRCTALEAC HPFFD+LRDPN  LPNGR LPP
Sbjct: 381 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACAHPFFDDLRDPNVSLPNGRALPP 440

Query: 368 LFNFKPPELSGIPPETINRLIPEHAR 393
           LFNF   EL+G   E   RLIP H +
Sbjct: 441 LFNFTAQELAGASTELRQRLIPAHCQ 466

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	403
449460309	428	PREDICTED: shaggy-related protein kinase	1.0	0.941	0.909	0.0
224119932	422	predicted protein [Populus trichocarpa]	1.0	0.954	0.902	0.0
224129720	422	predicted protein [Populus trichocarpa]	1.0	0.954	0.902	0.0
225465185	422	PREDICTED: shaggy-related protein kinase	1.0	0.954	0.902	0.0
359806970	420	uncharacterized protein LOC100799387 [Gl	0.947	0.909	0.900	0.0
359806021	420	uncharacterized protein LOC100820098 [Gl	0.947	0.909	0.888	0.0
116787454	424	unknown [Picea sitchensis]	1.0	0.950	0.837	0.0
15218288	421	Shaggy-related protein kinase kappa [Ara	0.997	0.954	0.836	0.0
297849298	421	hypothetical protein ARALYDRAFT_471093 [	0.997	0.954	0.834	0.0
357445263	428	Glycogen synthase kinase-3-like protein	1.0	0.941	0.864	0.0

>gi|449460309|ref|XP_004147888.1| PREDICTED: shaggy-related protein kinase kappa-like [Cucumis sativus]

 Score =  802 bits (2071), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 384/422 (90%), Positives = 395/422 (93%), Gaps = 19/422 (4%)

Query: 1   MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
           MASASLGNGGVGSSRS+NGFK SSSSVDWLGREMLEMRLRD+ D DEDRDSEPDIIDGVG
Sbjct: 7   MASASLGNGGVGSSRSINGFKGSSSSVDWLGREMLEMRLRDKTDTDEDRDSEPDIIDGVG 66

Query: 61  AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
           AE GHVIRTTIGGRNG SKQ +SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR
Sbjct: 67  AEAGHVIRTTIGGRNGQSKQNISYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 126

Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
           YKNRELQIMQMLDHPNIV+LKHCFFSTTDKEE+YLNLVLE+VPETVNRIARNYSRI QRM
Sbjct: 127 YKNRELQIMQMLDHPNIVSLKHCFFSTTDKEEVYLNLVLEFVPETVNRIARNYSRISQRM 186

Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL-------------------LVKGEP 221
           PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL                   LVKGEP
Sbjct: 187 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 246

Query: 222 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 281
           NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG+PLFPGESGVDQLVEIIKV
Sbjct: 247 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGKPLFPGESGVDQLVEIIKV 306

Query: 282 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 341
           LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL
Sbjct: 307 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 366

Query: 342 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 401
           EACVHPFFDELRDPNTRLPNGRPLPPLFNFKP EL+GIPP+T+NRLIPEHARKQNLFMAL
Sbjct: 367 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKPQELAGIPPDTVNRLIPEHARKQNLFMAL 426

Query: 402 HS 403
           H+
Sbjct: 427 HT 428

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224119932|ref|XP_002331098.1| predicted protein [Populus trichocarpa] gi|222872826|gb|EEF09957.1| predicted protein [Populus trichocarpa]

 Score =  789 bits (2038), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 381/422 (90%), Positives = 393/422 (93%), Gaps = 19/422 (4%)

Query: 1   MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
           M+SASLGNGGVGSSRSVNGFKSSSSS+DWLGREMLEMRLRD+VD+DEDRDSEPDIIDGVG
Sbjct: 1   MSSASLGNGGVGSSRSVNGFKSSSSSMDWLGREMLEMRLRDKVDHDEDRDSEPDIIDGVG 60

Query: 61  AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
           AE GHVIRTTIGGRNG S+Q VSYIAEHVVGTGSFGVV QAKCRETGEIVAIKKVLQDKR
Sbjct: 61  AEAGHVIRTTIGGRNGQSRQTVSYIAEHVVGTGSFGVVVQAKCRETGEIVAIKKVLQDKR 120

Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
           YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSR + RM
Sbjct: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRNNPRM 180

Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL-------------------LVKGEP 221
           PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL                   LVKGEP
Sbjct: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPSTHQLKLCDFGSAKVLVKGEP 240

Query: 222 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 281
           NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300

Query: 282 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 341
           LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL
Sbjct: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360

Query: 342 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 401
           EAC+HPFFDELRDP TRLPNGRPLPPLFNFKP ELSGIP + +NRLIP++ARKQNLFMAL
Sbjct: 361 EACIHPFFDELRDPATRLPNGRPLPPLFNFKPQELSGIPTDIVNRLIPDYARKQNLFMAL 420

Query: 402 HS 403
           H+
Sbjct: 421 HT 422

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224129720|ref|XP_002328786.1| predicted protein [Populus trichocarpa] gi|222839084|gb|EEE77435.1| predicted protein [Populus trichocarpa]

 Score =  789 bits (2037), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 381/422 (90%), Positives = 391/422 (92%), Gaps = 19/422 (4%)

Query: 1   MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
           M+SASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRD+VD+DEDRDSEPDIIDGVG
Sbjct: 1   MSSASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDKVDHDEDRDSEPDIIDGVG 60

Query: 61  AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
           AE GHVIRTTIGGRNG S+Q +SYIAEHVVGTGSFGVV QAKCRETGEIVAIKKVLQDKR
Sbjct: 61  AEAGHVIRTTIGGRNGQSRQTISYIAEHVVGTGSFGVVVQAKCRETGEIVAIKKVLQDKR 120

Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
           YKNRELQIMQMLDHPNIVALKH FFSTTDKEELYLNLVLEYVP+TVNRIARNYSR  QRM
Sbjct: 121 YKNRELQIMQMLDHPNIVALKHSFFSTTDKEELYLNLVLEYVPDTVNRIARNYSRNSQRM 180

Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL-------------------LVKGEP 221
           PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL                   LVKGEP
Sbjct: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPSTHQLKLCDFGSAKVLVKGEP 240

Query: 222 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 281
           NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300

Query: 282 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 341
           LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL
Sbjct: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360

Query: 342 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 401
           EACVHPFFDELRDP TRLPNGRPLPPLFNFK  ELSGIP + +NRLIPE+ARKQNLFMAL
Sbjct: 361 EACVHPFFDELRDPTTRLPNGRPLPPLFNFKSQELSGIPTDIVNRLIPEYARKQNLFMAL 420

Query: 402 HS 403
           H+
Sbjct: 421 HT 422

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225465185|ref|XP_002263398.1| PREDICTED: shaggy-related protein kinase kappa [Vitis vinifera] gi|297739515|emb|CBI29697.3| unnamed protein product [Vitis vinifera]

 Score =  763 bits (1969), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 381/422 (90%), Positives = 391/422 (92%), Gaps = 19/422 (4%)

Query: 1   MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
           MASASLG+GGVGSSR+ NGFK SSSSVDWLGREMLEMRLRD+VD D+DRDSEPDIIDGVG
Sbjct: 1   MASASLGHGGVGSSRTANGFKGSSSSVDWLGREMLEMRLRDRVDQDDDRDSEPDIIDGVG 60

Query: 61  AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
           AE GHVIRTT GGRNG SKQ VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR
Sbjct: 61  AEAGHVIRTTFGGRNGQSKQTVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120

Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
           YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE+VPETVNRIARNYSRI+QRM
Sbjct: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEFVPETVNRIARNYSRINQRM 180

Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL-------------------LVKGEP 221
           PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL                   LVKGEP
Sbjct: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 240

Query: 222 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 281
           NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 241 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 300

Query: 282 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 341
           LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL
Sbjct: 301 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 360

Query: 342 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 401
           EAC+HPFFDELRDP+TRLPNGRPLPPLFNFKP ELSGIP +   RLIPEHARKQNLFMAL
Sbjct: 361 EACIHPFFDELRDPSTRLPNGRPLPPLFNFKPQELSGIPSDIRTRLIPEHARKQNLFMAL 420

Query: 402 HS 403
           H+
Sbjct: 421 HT 422

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359806970|ref|NP_001241073.1| uncharacterized protein LOC100799387 [Glycine max] gi|255641011|gb|ACU20785.1| unknown [Glycine max]

 Score =  753 bits (1943), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 364/404 (90%), Positives = 374/404 (92%), Gaps = 22/404 (5%)

Query: 19  GFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNS 78
           GF+ SSSSVDWLGREMLEMRLRD  D   DRDSEPDIIDGVGAETGHVIRT+IGGRNG S
Sbjct: 20  GFRGSSSSVDWLGREMLEMRLRDHED---DRDSEPDIIDGVGAETGHVIRTSIGGRNGQS 76

Query: 79  KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV 138
           KQ VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV
Sbjct: 77  KQNVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV 136

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           AL+HCFFSTTDKEE+YLNLVLEYVPETVNRIAR+YSRI+QRMPLIYVKLYTYQICRALAY
Sbjct: 137 ALRHCFFSTTDKEEVYLNLVLEYVPETVNRIARSYSRINQRMPLIYVKLYTYQICRALAY 196

Query: 199 IHNCIGICHRDIKPQNLLV-------------------KGEPNVSYICSRYYRAPELIFG 239
           IHNCIGICHRDIKPQNLLV                   KGEPNVSYICSRYYRAPELIFG
Sbjct: 197 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 256

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 299
           ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE
Sbjct: 257 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 316

Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 359
           FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC+HPFFDELRDPNTRL
Sbjct: 317 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACIHPFFDELRDPNTRL 376

Query: 360 PNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS 403
           PN RPLPPLFNFKP ELSG+PP+ INRLIPEHARKQNLFMALH+
Sbjct: 377 PNARPLPPLFNFKPQELSGVPPDVINRLIPEHARKQNLFMALHT 420

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359806021|ref|NP_001240918.1| uncharacterized protein LOC100820098 [Glycine max] gi|255639602|gb|ACU20095.1| unknown [Glycine max]

 Score =  745 bits (1923), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 359/404 (88%), Positives = 373/404 (92%), Gaps = 22/404 (5%)

Query: 19  GFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNS 78
           GF+ SSSSVDWLGREMLEM LRD  D    RDSEPDIIDG+GAETGHVIRT++GGRNG S
Sbjct: 20  GFRGSSSSVDWLGREMLEMSLRDHEDV---RDSEPDIIDGLGAETGHVIRTSVGGRNGQS 76

Query: 79  KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV 138
           KQ VSYI+EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV
Sbjct: 77  KQNVSYISEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIV 136

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           AL+HCF+STTDKEE+YLNLVLEYVPETVNRIAR+YSRI+QRMPLIYVKLYTYQICRALAY
Sbjct: 137 ALRHCFYSTTDKEEVYLNLVLEYVPETVNRIARSYSRINQRMPLIYVKLYTYQICRALAY 196

Query: 199 IHNCIGICHRDIKPQNLLV-------------------KGEPNVSYICSRYYRAPELIFG 239
           IHNCIGICHRDIKPQNLLV                   KGEPNVSYICSRYYRAPELIFG
Sbjct: 197 IHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNVSYICSRYYRAPELIFG 256

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 299
           ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE
Sbjct: 257 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 316

Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 359
           FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC+HPFFDELRDPNTRL
Sbjct: 317 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACIHPFFDELRDPNTRL 376

Query: 360 PNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALHS 403
           PNGRPLPPLFNFKP ELSG+PP+ INRLIPEHARKQNLFMALH+
Sbjct: 377 PNGRPLPPLFNFKPQELSGVPPDVINRLIPEHARKQNLFMALHT 420

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|116787454|gb|ABK24513.1| unknown [Picea sitchensis]

 Score =  741 bits (1913), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 355/424 (83%), Positives = 384/424 (90%), Gaps = 21/424 (4%)

Query: 1   MASASLG-NGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRD-QVDNDEDRDSEPDIIDG 58
           MASASLG +GGVGSSR++N  K   +SVDWLGREMLEMR+RD ++D D+++D EP I+DG
Sbjct: 1   MASASLGHSGGVGSSRTINRLKGPVNSVDWLGREMLEMRIRDNKLDVDDEKDIEPAIVDG 60

Query: 59  VGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD 118
           +GAE+GH+I TTIGGRNG  KQ +SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD
Sbjct: 61  MGAESGHIIATTIGGRNGQPKQTISYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD 120

Query: 119 KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ 178
           KRYKNRELQIM MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIAR+Y+R++Q
Sbjct: 121 KRYKNRELQIMHMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARHYNRMNQ 180

Query: 179 RMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV-------------------KG 219
           RMPLIYVKLY+YQICR+LAYIHNC+GICHRDIKPQNLLV                   KG
Sbjct: 181 RMPLIYVKLYSYQICRSLAYIHNCVGICHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 240

Query: 220 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
           EPN+SYICSRYYRAPELIFGATEYTTAID+WSTGCVMAELLLGQPLFPGESGVDQLVEII
Sbjct: 241 EPNISYICSRYYRAPELIFGATEYTTAIDMWSTGCVMAELLLGQPLFPGESGVDQLVEII 300

Query: 280 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT 339
           KVLGTPTREEIKCMNPNYTEFKFPQIK HPWHKVFQKRLPPEAVDLV R  QYSPNLRCT
Sbjct: 301 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKVFQKRLPPEAVDLVSRLLQYSPNLRCT 360

Query: 340 ALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFM 399
           ALEAC+HPFFDELRDPNTRLPNGRPLPPLFNFKP EL+GIPP+T+ RLIPEHARKQNLFM
Sbjct: 361 ALEACIHPFFDELRDPNTRLPNGRPLPPLFNFKPQELAGIPPDTLERLIPEHARKQNLFM 420

Query: 400 ALHS 403
           ALH+
Sbjct: 421 ALHT 424

Source: Picea sitchensis

Species: Picea sitchensis

Genus: Picea

Family: Pinaceae

Order: Coniferales

Class: Coniferopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15218288|ref|NP_172455.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|30681397|ref|NP_849627.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|42571421|ref|NP_973801.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|79317477|ref|NP_001031013.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|145323818|ref|NP_001077498.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|145323820|ref|NP_001077499.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|38503402|sp|Q39019.2|KSG10_ARATH RecName: Full=Shaggy-related protein kinase kappa; AltName: Full=ASK-kappa; Short=AtK-1 gi|20260176|gb|AAM12986.1| shaggy-like protien kinase, kappa [Arabidopsis thaliana] gi|23197848|gb|AAN15451.1| shaggy-like protien kinase, kappa [Arabidopsis thaliana] gi|332190380|gb|AEE28501.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|332190381|gb|AEE28502.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|332190382|gb|AEE28503.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|332190383|gb|AEE28504.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|332190384|gb|AEE28505.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana] gi|332190385|gb|AEE28506.1| Shaggy-related protein kinase kappa [Arabidopsis thaliana]

 Score =  741 bits (1912), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 353/422 (83%), Positives = 378/422 (89%), Gaps = 20/422 (4%)

Query: 1   MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
           MAS+ LGNG VG+SRS  G KSSSSSVDWL R++ E R+RD+V+ D++RDSEPDIIDG G
Sbjct: 1   MASSGLGNG-VGTSRSAKGLKSSSSSVDWLTRDLAETRIRDKVETDDERDSEPDIIDGAG 59

Query: 61  AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
           AE GHVIRTT+ GRNG S+Q VSYI+EHVVGTGSFG+VFQAKCRETGE+VAIKKVLQDKR
Sbjct: 60  AEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKR 119

Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
           YKNRELQIMQMLDHPN VALKH FFS TD EE+YLNLVLE+VPETVNR+AR+YSR +Q M
Sbjct: 120 YKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLM 179

Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV-------------------KGEP 221
           PLIYVKLYTYQICRALAYIHN  G+CHRDIKPQNLLV                   KGEP
Sbjct: 180 PLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEP 239

Query: 222 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 281
           NVSYICSRYYRAPELIFGA+EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 240 NVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 299

Query: 282 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 341
           LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL+CRFFQYSPNLRCTAL
Sbjct: 300 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTAL 359

Query: 342 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 401
           EAC+HP FDELRDPNTRLPNGRPLPPLFNFKP ELSGIPPE +NRL+PEHARKQNLFMAL
Sbjct: 360 EACIHPLFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPEIVNRLVPEHARKQNLFMAL 419

Query: 402 HS 403
           HS
Sbjct: 420 HS 421

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297849298|ref|XP_002892530.1| hypothetical protein ARALYDRAFT_471093 [Arabidopsis lyrata subsp. lyrata] gi|297338372|gb|EFH68789.1| hypothetical protein ARALYDRAFT_471093 [Arabidopsis lyrata subsp. lyrata]

 Score =  741 bits (1912), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 352/422 (83%), Positives = 379/422 (89%), Gaps = 20/422 (4%)

Query: 1   MASASLGNGGVGSSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVG 60
           MAS+ LGNG VG+SRS  G KSSSSSVDWL R++ E R+RD+V+ D++RDSEPDIIDG G
Sbjct: 1   MASSGLGNG-VGTSRSAKGLKSSSSSVDWLTRDLAETRIRDKVETDDERDSEPDIIDGAG 59

Query: 61  AETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR 120
           AE GHVIRTT+ GRNG S+Q VSYI+EHVVGTGSFG+VFQAKCRETGE+VAIKKVLQDKR
Sbjct: 60  AEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKR 119

Query: 121 YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM 180
           YKNRELQIMQMLDHPN+VALKH FFS TD EE+YLNLVLE+VPETVNR+AR+YSR +Q M
Sbjct: 120 YKNRELQIMQMLDHPNVVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLM 179

Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV-------------------KGEP 221
           PLIYVKLYTYQICRALAYIHN  G+CHRDIKPQNLLV                   KGEP
Sbjct: 180 PLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEP 239

Query: 222 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 281
           NVSYICSRYYRAPELIFGA+EY+TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV
Sbjct: 240 NVSYICSRYYRAPELIFGASEYSTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 299

Query: 282 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 341
           LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL+CRFFQYSPNLRCTAL
Sbjct: 300 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTAL 359

Query: 342 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNLFMAL 401
           EAC+HP FDELRDPNTRLPNGRPLPPLFNFKP ELSGIPPE +NRL+PEHARKQNLFMAL
Sbjct: 360 EACIHPLFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPEIVNRLVPEHARKQNLFMAL 419

Query: 402 HS 403
           HS
Sbjct: 420 HS 421

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357445263|ref|XP_003592909.1| Glycogen synthase kinase-3-like protein [Medicago truncatula] gi|92893880|gb|ABE91930.1| Protein kinase [Medicago truncatula] gi|355481957|gb|AES63160.1| Glycogen synthase kinase-3-like protein [Medicago truncatula]

 Score =  737 bits (1903), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 370/428 (86%), Positives = 381/428 (89%), Gaps = 25/428 (5%)

Query: 1   MASASLGNGGVGSSRSVNGFKSSSSS-VDWLGREMLEMRLR-----DQVDNDEDRDSEPD 54
           MASASLGNGG+GSS        ++SS VDWLGREML M L      D  D D+ R+SEPD
Sbjct: 1   MASASLGNGGIGSSSRSAAALRAASSSVDWLGREMLHMNLNRDHDHDDDDEDDARESEPD 60

Query: 55  IIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK 114
           IIDGVGAETGHVIRT+I  RNG SKQ VSYIAEHVVGTGSFG VFQAKCRETGEIVAIKK
Sbjct: 61  IIDGVGAETGHVIRTSIAARNGQSKQNVSYIAEHVVGTGSFGTVFQAKCRETGEIVAIKK 120

Query: 115 VLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYS 174
           VLQDKRYKNRELQIMQMLDHPNIVAL+HCFFSTTDKEELYLNLVLEYVPETVNRIARNYS
Sbjct: 121 VLQDKRYKNRELQIMQMLDHPNIVALRHCFFSTTDKEELYLNLVLEYVPETVNRIARNYS 180

Query: 175 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV----------------- 217
           RI+QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV                 
Sbjct: 181 RINQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVNPHTHQLKLCDFGSAKV 240

Query: 218 --KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 275
             KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL
Sbjct: 241 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 300

Query: 276 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 335
           VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN
Sbjct: 301 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 360

Query: 336 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQ 395
           LRCTALEAC+HPFFDELRDPNTRLPNGRPLPPLFNFKP ELSGIPP+ INRLIPEHARKQ
Sbjct: 361 LRCTALEACIHPFFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPDVINRLIPEHARKQ 420

Query: 396 NLFMALHS 403
           NLFMALH+
Sbjct: 421 NLFMALHT 428

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	403
TAIR|locus:2832141	405	SK 11 "AT5G26751" [Arabidopsis	0.488	0.486	0.783	3.5e-152
TAIR|locus:2222642	410	SK13 "shaggy-like kinase 13" [	0.488	0.480	0.804	1.5e-151
TAIR|locus:2126993	472	SK32 "shaggy-like protein kina	0.464	0.396	0.783	3.3e-145
TAIR|locus:2202255	407	GSK1 "GSK3/SHAGGY-like protein	0.471	0.466	0.777	1e-141
TAIR|locus:2124082	380	BIN2 "BRASSINOSTEROID-INSENSIT	0.471	0.5	0.740	3.9e-140
TAIR|locus:2098896	438	AT3G61160 [Arabidopsis thalian	0.471	0.433	0.708	2.9e-131
UNIPROTKB|E2R4Y4	420	GSK3B "Uncharacterized protein	0.441	0.423	0.740	3.4e-113
UNIPROTKB|P49841	420	GSK3B "Glycogen synthase kinas	0.441	0.423	0.740	3.4e-113
UNIPROTKB|F1SPD2	395	GSK3B "Uncharacterized protein	0.441	0.450	0.740	3.4e-113
UNIPROTKB|Q5YJC2	420	GSK3B "Glycogen synthase kinas	0.441	0.423	0.740	3.4e-113

TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)]

 Score = 852 (305.0 bits), Expect = 3.5e-152, Sum P(2) = 3.5e-152
 Identities = 156/199 (78%), Positives = 171/199 (85%)

Query:   203 IGICHRDIKPQNLLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 262
             + +C  D     +LVKGEPN+SYICSRYYRAPELIFGATEYTTAID+WS GCV+AELLLG
Sbjct:   209 VKLC--DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLG 266

Query:   263 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEA 322
             QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F KR+PPEA
Sbjct:   267 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA 326

Query:   323 VDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPE 382
             VDLV R  QYSPNLR  AL+  VHPFFDELRDPN RLPNGR LPPLFNFKP EL G+P E
Sbjct:   327 VDLVSRLLQYSPNLRSAALDTLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPLE 386

Query:   383 TINRLIPEHARKQNLFMAL 401
              + +L+PEHARKQ  ++ L
Sbjct:   387 MVAKLVPEHARKQCPWLGL 405

GO:0004672 "protein kinase activity" evidence=ISS;IDA

GO:0005634 "nucleus" evidence=ISM

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0016310 "phosphorylation" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 863 (308.9 bits), Expect = 1.5e-151, Sum P(2) = 1.5e-151
 Identities = 160/199 (80%), Positives = 172/199 (86%)

Query:   203 IGICHRDIKPQNLLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 262
             + +C  D     +LVKGEPN+SYICSRYYRAPELIFGATEYTT IDIWS GCV+AELLLG
Sbjct:   214 VKLC--DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLG 271

Query:   263 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEA 322
             QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F KR PPEA
Sbjct:   272 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEA 331

Query:   323 VDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPE 382
             VDLV R  QYSPNLR TA+EA VHPFFDELRDPNTRLPNGR LPPLFNFKP EL G   E
Sbjct:   332 VDLVSRLLQYSPNLRSTAMEAIVHPFFDELRDPNTRLPNGRALPPLFNFKPQELKGASLE 391

Query:   383 TINRLIPEHARKQNLFMAL 401
              +++LIP+HARKQ  F+AL
Sbjct:   392 LLSKLIPDHARKQCSFLAL 410

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006972 "hyperosmotic response" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)]

 Score = 812 (290.9 bits), Expect = 3.3e-145, Sum P(2) = 3.3e-145
 Identities = 148/189 (78%), Positives = 159/189 (84%)

Query:   205 ICHRDIKPQNLLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQP 264
             IC  D     +LV GEPN+SYICSRYYRAPELIFGATEYT AID+WS GCVMAELLLGQP
Sbjct:   280 IC--DFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQP 337

Query:   265 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVD 324
             LFPGESG+DQLVEIIK+LGTPTREEI+CMNPNYTEFKFPQIK HPWHK+F KR+PPEAVD
Sbjct:   338 LFPGESGIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVD 397

Query:   325 LVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETI 384
             LV R  QYSPNLRCTALEAC HPFFD+LRDPN  LPNGR LPPLFNF   EL+G   E  
Sbjct:   398 LVSRLLQYSPNLRCTALEACAHPFFDDLRDPNVSLPNGRALPPLFNFTAQELAGASTELR 457

Query:   385 NRLIPEHAR 393
              RLIP H +
Sbjct:   458 QRLIPAHCQ 466

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0009741 "response to brassinosteroid stimulus" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 827 (296.2 bits), Expect = 1.0e-141, Sum P(2) = 1.0e-141
 Identities = 150/193 (77%), Positives = 166/193 (86%)

Query:   203 IGICHRDIKPQNLLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 262
             + +C  D     +LVKGEPN+SYICSRYYRAPELIFGATEYT +IDIWS GCV+AELLLG
Sbjct:   210 VKLC--DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLG 267

Query:   263 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEA 322
             QPLFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIK HPWHKVF KR+PPEA
Sbjct:   268 QPLFPGENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEA 327

Query:   323 VDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPE 382
             +DL  R  QYSP+LRCTALEAC HPFF+ELR+PN RLPNGRPLPPLFNFK  EL G   E
Sbjct:   328 IDLASRLLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQ-ELGGASME 386

Query:   383 TINRLIPEHARKQ 395
              INRLIPEH R+Q
Sbjct:   387 LINRLIPEHVRRQ 399

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051049 "regulation of transport" evidence=RCA

TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 805 (288.4 bits), Expect = 3.9e-140, Sum P(2) = 3.9e-140
 Identities = 143/193 (74%), Positives = 165/193 (85%)

Query:   203 IGICHRDIKPQNLLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 262
             + IC  D      LVKGE N+SYICSR+YRAPELIFGATEYTT+IDIWS GCV+AELLLG
Sbjct:   180 VKIC--DFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 237

Query:   263 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEA 322
             QPLFPGE+ VDQLVEIIKVLGTPTREEI+CMNP+YT+F+FPQIK HPWHK+F KR+PPEA
Sbjct:   238 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEA 297

Query:   323 VDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPE 382
             +D   R  QYSP+LRCTALEAC HPFFDELR+PN RLPNGRP PPLFNFK  E++G  PE
Sbjct:   298 IDFASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQ-EVAGSSPE 356

Query:   383 TINRLIPEHARKQ 395
              +N+LIP+H ++Q
Sbjct:   357 LVNKLIPDHIKRQ 369

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IPI

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0009825 "multidimensional cell growth" evidence=IMP

GO:0009965 "leaf morphogenesis" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0005886 "plasma membrane" evidence=IDA

GO:0046827 "positive regulation of protein export from nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0006096 "glycolysis" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006972 "hyperosmotic response" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)]

 Score = 748 (268.4 bits), Expect = 2.9e-131, Sum P(2) = 2.9e-131
 Identities = 136/192 (70%), Positives = 155/192 (80%)

Query:   203 IGICHRDIKPQNLLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 262
             + IC  D     +L+ GEPN+SYICSRYYRAPELIFGATEYT+AID+WS GCVMAEL LG
Sbjct:   249 VKIC--DFGSAKMLIPGEPNISYICSRYYRAPELIFGATEYTSAIDMWSVGCVMAELFLG 306

Query:   263 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEA 322
              PLFPGE+ VDQLVEIIK+LGTP REEIK MNP Y +FKFPQIK  PWHK+F++++ PEA
Sbjct:   307 HPLFPGETSVDQLVEIIKILGTPAREEIKNMNPRYNDFKFPQIKAQPWHKIFRRQVSPEA 366

Query:   323 VDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPE 382
             +DL  R  QYSPNLRCTALEAC HPFFD+LRDP   LPNGR LPPLF+F   EL+G   E
Sbjct:   367 MDLASRLLQYSPNLRCTALEACAHPFFDDLRDPRASLPNGRALPPLFDFTAQELAGASVE 426

Query:   383 TINRLIPEHARK 394
               +RLIPEHARK
Sbjct:   427 LRHRLIPEHARK 438

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

UNIPROTKB|E2R4Y4 GSK3B "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 712 (255.7 bits), Expect = 3.4e-113, Sum P(2) = 3.4e-113
 Identities = 134/181 (74%), Positives = 149/181 (82%)

Query:   216 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 275
             LV+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQL
Sbjct:   207 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 266

Query:   276 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 335
             VEIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P 
Sbjct:   267 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 326

Query:   336 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARK 394
              R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR 
Sbjct:   327 ARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARI 384

Query:   395 Q 395
             Q
Sbjct:   385 Q 385

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|P49841 GSK3B "Glycogen synthase kinase-3 beta" [Homo sapiens (taxid:9606)]

 Score = 712 (255.7 bits), Expect = 3.4e-113, Sum P(2) = 3.4e-113
 Identities = 134/181 (74%), Positives = 149/181 (82%)

Query:   216 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 275
             LV+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQL
Sbjct:   207 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 266

Query:   276 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 335
             VEIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P 
Sbjct:   267 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 326

Query:   336 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARK 394
              R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR 
Sbjct:   327 ARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARI 384

Query:   395 Q 395
             Q
Sbjct:   385 Q 385

GO:0010226 "response to lithium ion" evidence=IEA

GO:0010800 "positive regulation of peptidyl-threonine phosphorylation" evidence=IEA

GO:0016477 "cell migration" evidence=IEA

GO:0030010 "establishment of cell polarity" evidence=IEA

GO:0030426 "growth cone" evidence=IEA

GO:0030529 "ribonucleoprotein complex" evidence=IEA

GO:0033138 "positive regulation of peptidyl-serine phosphorylation" evidence=IEA

GO:0035255 "ionotropic glutamate receptor binding" evidence=IEA

GO:0035372 "protein localization to microtubule" evidence=IEA

GO:0042493 "response to drug" evidence=IEA

GO:0043025 "neuronal cell body" evidence=IEA

GO:0043197 "dendritic spine" evidence=IEA

GO:0043198 "dendritic shaft" evidence=IEA

GO:0043407 "negative regulation of MAP kinase activity" evidence=IEA

GO:0044027 "hypermethylation of CpG island" evidence=IEA

GO:0044337 "canonical Wnt receptor signaling pathway involved in positive regulation of apoptotic process" evidence=IEA

GO:0045121 "membrane raft" evidence=IEA

GO:0045444 "fat cell differentiation" evidence=IEA

GO:0045892 "negative regulation of transcription, DNA-dependent" evidence=IEA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0048156 "tau protein binding" evidence=IEA

GO:0048168 "regulation of neuronal synaptic plasticity" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0050774 "negative regulation of dendrite morphogenesis" evidence=IEA

GO:2000738 "positive regulation of stem cell differentiation" evidence=IEA

GO:0000320 "re-entry into mitotic cell cycle" evidence=IEA

GO:0005178 "integrin binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006349 "regulation of gene expression by genetic imprinting" evidence=IEA

GO:0006611 "protein export from nucleus" evidence=IEA

GO:0007520 "myoblast fusion" evidence=IEA

GO:0009887 "organ morphogenesis" evidence=IEA

GO:0051059 "NF-kappaB binding" evidence=IPI

GO:0030877 "beta-catenin destruction complex" evidence=IDA;TAS

GO:0060070 "canonical Wnt receptor signaling pathway" evidence=IC;IDA

GO:0001085 "RNA polymerase II transcription factor binding" evidence=IPI

GO:0005515 "protein binding" evidence=IPI

GO:0016301 "kinase activity" evidence=IDA;TAS

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0001837 "epithelial to mesenchymal transition" evidence=IMP

GO:0045719 "negative regulation of glycogen biosynthetic process" evidence=TAS

GO:0090090 "negative regulation of canonical Wnt receptor signaling pathway" evidence=TAS

GO:2000077 "negative regulation of type B pancreatic cell development" evidence=TAS

GO:2000466 "negative regulation of glycogen (starch) synthase activity" evidence=TAS

GO:0051534 "negative regulation of NFAT protein import into nucleus" evidence=IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS;IDA

GO:0050321 "tau-protein kinase activity" evidence=IDA

GO:0005813 "centrosome" evidence=IDA

GO:0032886 "regulation of microtubule-based process" evidence=IMP

GO:0019901 "protein kinase binding" evidence=IPI

GO:0005886 "plasma membrane" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0032092 "positive regulation of protein binding" evidence=ISS

GO:0007623 "circadian rhythm" evidence=ISS

GO:0002039 "p53 binding" evidence=IDA

GO:0006983 "ER overload response" evidence=IDA

GO:0018105 "peptidyl-serine phosphorylation" evidence=IDA

GO:0035556 "intracellular signal transduction" evidence=IDA

GO:0043066 "negative regulation of apoptotic process" evidence=IDA

GO:0046827 "positive regulation of protein export from nucleus" evidence=IDA

GO:0005829 "cytosol" evidence=TAS

GO:0007173 "epidermal growth factor receptor signaling pathway" evidence=TAS

GO:0007411 "axon guidance" evidence=TAS

GO:0008543 "fibroblast growth factor receptor signaling pathway" evidence=TAS

GO:0048011 "neurotrophin TRK receptor signaling pathway" evidence=TAS

GO:0048015 "phosphatidylinositol-mediated signaling" evidence=TAS

GO:0034236 "protein kinase A catalytic subunit binding" evidence=IPI

GO:0031334 "positive regulation of protein complex assembly" evidence=IDA

GO:0005977 "glycogen metabolic process" evidence=IDA

GO:0008013 "beta-catenin binding" evidence=IPI

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0032091 "negative regulation of protein binding" evidence=IDA

GO:0045732 "positive regulation of protein catabolic process" evidence=IC

GO:0031333 "negative regulation of protein complex assembly" evidence=IMP

GO:0001954 "positive regulation of cell-matrix adhesion" evidence=IMP

GO:0032855 "positive regulation of Rac GTPase activity" evidence=IMP

GO:0021766 "hippocampus development" evidence=IMP

GO:0071109 "superior temporal gyrus development" evidence=IMP

GO:0005730 "nucleolus" evidence=IDA

UNIPROTKB|F1SPD2 GSK3B "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 712 (255.7 bits), Expect = 3.4e-113, Sum P(2) = 3.4e-113
 Identities = 134/181 (74%), Positives = 149/181 (82%)

Query:   216 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 275
             LV+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQL
Sbjct:   182 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 241

Query:   276 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 335
             VEIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P 
Sbjct:   242 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 301

Query:   336 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARK 394
              R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR 
Sbjct:   302 ARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARI 359

Query:   395 Q 395
             Q
Sbjct:   360 Q 360

GO:2000738 "positive regulation of stem cell differentiation" evidence=IEA

GO:0071109 "superior temporal gyrus development" evidence=IEA

GO:0051534 "negative regulation of NFAT protein import into nucleus" evidence=IEA

GO:0051059 "NF-kappaB binding" evidence=IEA

GO:0050321 "tau-protein kinase activity" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0046827 "positive regulation of protein export from nucleus" evidence=IEA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0045444 "fat cell differentiation" evidence=IEA

GO:0044337 "canonical Wnt receptor signaling pathway involved in positive regulation of apoptotic process" evidence=IEA

GO:0044027 "hypermethylation of CpG island" evidence=IEA

GO:0043198 "dendritic shaft" evidence=IEA

GO:0043066 "negative regulation of apoptotic process" evidence=IEA

GO:0043025 "neuronal cell body" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0035372 "protein localization to microtubule" evidence=IEA

GO:0034236 "protein kinase A catalytic subunit binding" evidence=IEA

GO:0033138 "positive regulation of peptidyl-serine phosphorylation" evidence=IEA

GO:0032886 "regulation of microtubule-based process" evidence=IEA

GO:0032855 "positive regulation of Rac GTPase activity" evidence=IEA

GO:0032092 "positive regulation of protein binding" evidence=IEA

GO:0032091 "negative regulation of protein binding" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IEA

GO:0031334 "positive regulation of protein complex assembly" evidence=IEA

GO:0031333 "negative regulation of protein complex assembly" evidence=IEA

GO:0030877 "beta-catenin destruction complex" evidence=IEA

GO:0030529 "ribonucleoprotein complex" evidence=IEA

GO:0030426 "growth cone" evidence=IEA

GO:0021766 "hippocampus development" evidence=IEA

GO:0018105 "peptidyl-serine phosphorylation" evidence=IEA

GO:0016477 "cell migration" evidence=IEA

GO:0010800 "positive regulation of peptidyl-threonine phosphorylation" evidence=IEA

GO:0009887 "organ morphogenesis" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IEA

GO:0007520 "myoblast fusion" evidence=IEA

GO:0007409 "axonogenesis" evidence=IEA

GO:0006983 "ER overload response" evidence=IEA

GO:0006611 "protein export from nucleus" evidence=IEA

GO:0006349 "regulation of gene expression by genetic imprinting" evidence=IEA

GO:0005977 "glycogen metabolic process" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0005829 "cytosol" evidence=IEA

GO:0005813 "centrosome" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0002039 "p53 binding" evidence=IEA

GO:0001954 "positive regulation of cell-matrix adhesion" evidence=IEA

GO:0001837 "epithelial to mesenchymal transition" evidence=IEA

GO:0001085 "RNA polymerase II transcription factor binding" evidence=IEA

GO:0000320 "re-entry into mitotic cell cycle" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|Q5YJC2 GSK3B "Glycogen synthase kinase-3 beta" [Spermophilus citellus (taxid:9997)]

 Score = 712 (255.7 bits), Expect = 3.4e-113, Sum P(2) = 3.4e-113
 Identities = 134/181 (74%), Positives = 149/181 (82%)

Query:   216 LVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 275
             LV+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQL
Sbjct:   207 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 266

Query:   276 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 335
             VEIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P 
Sbjct:   267 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 326

Query:   336 LRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARK 394
              R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR 
Sbjct:   327 ARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARI 384

Query:   395 Q 395
             Q
Sbjct:   385 Q 385

GO:0001837 "epithelial to mesenchymal transition" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005634 "nucleus" evidence=ISS

GO:0005737 "cytoplasm" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0016020 "membrane" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0032092 "positive regulation of protein binding" evidence=ISS

GO:0032886 "regulation of microtubule-based process" evidence=ISS

GO:0050321 "tau-protein kinase activity" evidence=ISS

GO:0051534 "negative regulation of NFAT protein import into nucleus" evidence=ISS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P43288	KSG1_ARATH	2, ., 7, ., 1, 1, ., 1	0.7286	0.9255	0.9209	no	no
Q10452	GSK3_SCHPO	2, ., 7, ., 1, 1, ., 1	0.5965	0.7990	0.8320	yes	no
Q39012	KSG9_ARATH	2, ., 7, ., 1, 1, ., 1	0.7021	0.8833	0.8746	no	no
Q39010	KSG6_ARATH	2, ., 7, ., 1, 1, ., 1	0.7074	0.8833	0.8640	no	no
Q39019	KSG10_ARATH	2, ., 7, ., 1, 1, ., 1	0.8364	0.9975	0.9548	yes	no
P38615	RIM11_YEAST	2, ., 7, ., 1, 1, ., 1	0.5436	0.6799	0.7405	yes	no
Q9U2Q9	GSK3_CAEEL	2, ., 7, ., 1, 1, ., 2, 6	0.6315	0.7493	0.8342	yes	no
Q9FVS6	KSG4_ARATH	2, ., 7, ., 1, 1, ., 1	0.8233	0.9900	0.95	no	no
Q40518	MSK1_TOBAC	2, ., 7, ., 1, 1, ., 1	0.7281	0.9255	0.9119	N/A	no
Q9WV60	GSK3B_MOUSE	2, ., 7, ., 1, 1, ., 1	0.6444	0.8287	0.7952	yes	no
P51136	GSK3_DICDI	2, ., 7, ., 1, 1, ., 2, 6	0.6197	0.7741	0.6680	yes	no
P51137	MSK1_MEDSA	2, ., 7, ., 1, 1, ., 1	0.7074	0.9702	0.9513	N/A	no
P51138	MSK2_MEDSA	2, ., 7, ., 1, 1, ., 1	0.7019	0.9652	0.9464	N/A	no
P51139	MSK3_MEDSA	2, ., 7, ., 1, 1, ., 1	0.7146	0.9528	0.9343	N/A	no
O04160	KSGT_BRANA	2, ., 7, ., 1, 1, ., 1	0.6798	0.9503	0.8183	N/A	no
P18266	GSK3B_RAT	2, ., 7, ., 1, 1, ., 1	0.6444	0.8287	0.7952	yes	no
Q8VZD5	KSG5_ARATH	2, ., 7, ., 1, 1, ., 1	0.7063	0.9602	0.9439	no	no
P49841	GSK3B_HUMAN	2, ., 7, ., 1, 1, ., 1	0.6444	0.8287	0.7952	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.994
3rd Layer	2.7.11	0.998

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: grail3.0150004202 hypothetical protein (422 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	403
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-119
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-82
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-79
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	7e-77
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-75
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-74
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-71
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-71
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-69
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-68
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-67
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-64
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-61
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	8e-61
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-60
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-58
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-57
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-56
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-55
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-55
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-55
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	9e-54
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-53
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-53
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-52
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-51
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-51
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-50
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-49
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-49
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-49
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-48
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-48
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	9e-47
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-46
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-46
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-46
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-45
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-45
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	8e-45
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-44
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-43
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-43
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-43
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-43
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-42
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-42
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-42
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	9e-42
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-40
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-40
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-39
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-38
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-37
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-35
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	9e-35
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-33
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-33
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-32
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	9e-32
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-31
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	8e-31
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-30
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-29
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-29
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-28
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-28
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-27
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-27
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-27
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-27
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-27
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-27
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-26
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-25
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-25
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-25
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-24
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-24
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-24
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-24
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-23
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-23
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-23
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-22
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-21
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	9e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-20
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-18
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-18
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-18
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-18
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-17
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-17
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-16
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-16
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-15
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-15
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-15
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-15
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-15
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	9e-15
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	9e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-14
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-14
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-14
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-14
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-14
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	9e-14
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-13
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-13
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-13
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-13
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	9e-13
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-12
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-12
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-12
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-12
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-11
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-11
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-11
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-11
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-11
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	8e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-10
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	9e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-10
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-09
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-09
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-09
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-09
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	7e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-08
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-08
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-08
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-08
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-08
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	8e-08
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	9e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-07
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-07
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-07
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-07
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-07
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-07
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	5e-07
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	7e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	9e-07
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	9e-07
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-06
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-06
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-06
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-06
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-06
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-06
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-06
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-06
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	5e-06
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	8e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	8e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-05
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-05
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-05
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-05
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-05
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-04
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-04
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-04
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-04
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-04
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-04
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-04
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	6e-04
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	6e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	7e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	7e-04
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-04
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	0.001
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.002
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	0.002
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	0.002
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	0.002
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	0.002
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	0.003
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	0.003
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	0.003
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.004

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  354 bits (909), Expect = e-119
 Identities = 162/337 (48%), Positives = 228/337 (67%), Gaps = 24/337 (7%)

Query: 77  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPN 136
           N     SY   +++G GSFGVV++A C +T E VAIKKVLQD +YKNREL IM+ L+H N
Sbjct: 61  NRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHIN 120

Query: 137 IVALKHCFFSTT---DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           I+ LK  +++     +++ ++LN+V+E++P+TV++  ++Y+R +  +PL  VKLY+YQ+C
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC 180

Query: 194 RALAYIHNCIGICHRDIKPQNLLVK-------------------GEPNVSYICSRYYRAP 234
           RALAYIH+   ICHRD+KPQNLL+                    G+ +VSYICSR+YRAP
Sbjct: 181 RALAYIHSKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAP 239

Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
           EL+ GAT YTT ID+WS GC++AE++LG P+F G+S VDQLV II+VLGTPT +++K MN
Sbjct: 240 ELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN 299

Query: 295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 354
           PNY + KFP +KP    KVF K  P +A++ + +F +Y P  R   +EA   PFFD+LRD
Sbjct: 300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359

Query: 355 PNTRLPNG-RPLPPLFNFKPPELSGIPPETINRLIPE 390
           P  +LP     LP LFNF   E+  +      ++IP+
Sbjct: 360 PCIKLPKYIDKLPDLFNFCDAEIKEMSDACRRKIIPK 396

Length = 440

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  253 bits (650), Expect = 5e-82
 Identities = 109/329 (33%), Positives = 168/329 (51%), Gaps = 46/329 (13%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y     +G+G++GVV  A  + TG  VAIKK+      L D +   RE+++++ L H NI
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 138 VALKHCF--FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQIC 193
           + L       S  D  ++Y+  V E +   ++++      I    PL   +++ + YQI 
Sbjct: 62  IGLLDILRPPSPEDFNDVYI--VTELMETDLHKV------IKSPQPLTDDHIQYFLYQIL 113

Query: 194 RALAYIHNCIGICHRDIKPQNLLVKGEPNV----------------------SYICSRYY 231
           R L Y+H+   + HRD+KP N+LV    ++                       Y+ +R+Y
Sbjct: 114 RGLKYLHSA-NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWY 172

Query: 232 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 291
           RAPEL+  ++ YT AIDIWS GC+ AELL  +PLFPG   +DQL  I++VLGTP+ E++K
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232

Query: 292 CM-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
            + +     +    P+    P  K+F     PEA+DL+ +   + P  R TA EA  HP+
Sbjct: 233 FITSEKARNYLKSLPKKPKKPLSKLFPG-ASPEAIDLLEKMLVFDPKKRITADEALAHPY 291

Query: 349 FDELRDPNTRLPNGRPLPPLFNFKPPELS 377
             +L DP    P  +P      F   EL+
Sbjct: 292 LAQLHDPE-DEPVAKPPFDFDFFDDDELT 319

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  245 bits (629), Expect = 2e-79
 Identities = 107/300 (35%), Positives = 161/300 (53%), Gaps = 52/300 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHP 135
           Y     +G G++GVV++A+ ++TGEIVA+KK+  D   +         RE+ +++ L HP
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHP 58

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNY-SRIHQRMPLIYVKLYTYQICR 194
           NIV L     +   + +LYL  V EY    +    + Y  +    +    +K   YQ+ R
Sbjct: 59  NIVKLLDVIHT---ERKLYL--VFEYCDMDL----KKYLDKRPGPLSPNLIKSIMYQLLR 109

Query: 195 ALAYIHNCIGICHRDIKPQNLLVKGEPNVSYIC----SR----------------YYRAP 234
            LAY H    I HRD+KPQN+L+  +  +  +     +R                +YRAP
Sbjct: 110 GLAYCH-SHRILHRDLKPQNILINRDGVLK-LADFGLARAFGIPLRTYTHEVVTLWYRAP 167

Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
           E++ G+  Y+TA+DIWS GC+ AE++ G+PLFPG+S +DQL +I ++LGTPT E      
Sbjct: 168 EILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW---- 223

Query: 295 PNYTEFK-----FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           P  T+       FP+  P    KV   RL PE +DL+ +  QY+P  R +A EA  HP+F
Sbjct: 224 PGVTKLPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  239 bits (611), Expect = 7e-77
 Identities = 109/297 (36%), Positives = 163/297 (54%), Gaps = 42/297 (14%)

Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKN---RELQIMQMLD 133
           QK+  I     G G++GVV++A+ + TGEIVAIKK+              RE+++++ L+
Sbjct: 2   QKLGKI-----GEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN 56

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           HPNI+ L   F     K +LYL  V E++   + ++ ++  R    +P   +K Y YQ+ 
Sbjct: 57  HPNIIKLLDVFR---HKGDLYL--VFEFMDTDLYKLIKDRQRG---LPESLIKSYLYQLL 108

Query: 194 RALAYIHNCIGICHRDIKPQNLLVKGE-------------------PNVSYICSRYYRAP 234
           + LA+ H+  GI HRD+KP+NLL+  E                   P   Y+ +R+YRAP
Sbjct: 109 QGLAFCHSH-GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAP 167

Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
           EL+ G   Y+T +DIWS GC+ AELL  +PLFPG+S +DQL +I + LGTP  E      
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFT 227

Query: 295 PN--YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
                 +F FP+    P  K+F     P+A+DL+ +   Y P+ R TA +A  HP+F
Sbjct: 228 SLARNYKFSFPKKAGMPLPKLFPN-ASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  235 bits (601), Expect = 3e-75
 Identities = 105/289 (36%), Positives = 155/289 (53%), Gaps = 40/289 (13%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G+ G+VF+AK RETGE VA+KKV   +          RE++ +Q   HP +V L   
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           F          L  V+EY+P  ++ + R+  R    +P   VK Y   + + +AY+H   
Sbjct: 68  F---PHGSGFVL--VMEYMPSDLSEVLRDEER---PLPEAQVKSYMRMLLKGVAYMHA-N 118

Query: 204 GICHRDIKPQNLLV-----------------KGEPNVSY---ICSRYYRAPELIFGATEY 243
           GI HRD+KP NLL+                   E    Y   + +R+YRAPEL++GA +Y
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178

Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYTEF 300
              +D+W+ GC+ AELL G PLFPGE+ ++QL  + + LGTP  E    +  + P+Y + 
Sbjct: 179 DPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL-PDYNKI 237

Query: 301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
            FP+ KP P  ++F     PEA+DL+     Y P+ R +A EA  HP+F
Sbjct: 238 TFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  234 bits (598), Expect = 1e-74
 Identities = 106/296 (35%), Positives = 155/296 (52%), Gaps = 42/296 (14%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDH 134
           Y     +G G++ VV++A+ +ETG IVAIKK+   +R +          RE++++Q L H
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           PNI+ L   F          +NLV E++   + ++ ++ S +        +K Y     R
Sbjct: 62  PNIIGLLDVF--GHKS---NINLVFEFMETDLEKVIKDKSIVLT---PADIKSYMLMTLR 113

Query: 195 ALAYIHNCIGICHRDIKPQNLL------VK----------GEPNVSYIC---SRYYRAPE 235
            L Y+H+   I HRD+KP NLL      +K          G PN        +R+YRAPE
Sbjct: 114 GLEYLHSN-WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPE 172

Query: 236 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN- 294
           L+FGA  Y   +D+WS GC+ AELLL  P  PG+S +DQL +I + LGTPT E    +  
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232

Query: 295 -PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
            P+Y EFK     P P  ++F      +A+DL+ R    +PN R TA +A  HP+F
Sbjct: 233 LPDYVEFKP--FPPTPLKQIF-PAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  224 bits (574), Expect = 1e-71
 Identities = 96/291 (32%), Positives = 145/291 (49%), Gaps = 62/291 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIV 138
           Y     +G GSFG V+ A+ ++TG++VAIK +      +D+    RE++I++ L HPNIV
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
            L   F    D+++LYL  V+EY    +  + + +       R+     + Y  QI  AL
Sbjct: 61  RLYDVF---EDEDKLYL--VMEYCEGGDLFDLLKK-----RGRLSEDEARFYLRQILSAL 110

Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV------------------SYICSRYYRAPELIF 238
            Y+H+  GI HRD+KP+N+L+  + +V                  +++ +  Y APE++ 
Sbjct: 111 EYLHSK-GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL 169

Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 298
           G   Y  A+DIWS G ++ ELL G+P FPG+   DQL+E+ K +G P             
Sbjct: 170 G-KGYGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPK------------ 213

Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
               P   P  W       + PEA DL+ +     P  R TA EA  HPFF
Sbjct: 214 ----PPFPPPEW------DISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  223 bits (571), Expect = 8e-71
 Identities = 105/290 (36%), Positives = 163/290 (56%), Gaps = 43/290 (14%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQ-IMQMLDHPNIVALK 141
           +G G+FG V+ A+ +ETGE+VAIKK+ +  ++ +       RE++ + ++ +HPNIV LK
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVKLK 64

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F    + +ELY   V EY+   + ++ +   R  +      ++   YQI + LA+IH 
Sbjct: 65  EVF---RENDELYF--VFEYMEGNLYQLMK--DRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 202 CIGICHRDIKPQNLLVKGEPNV------------------SYICSRYYRAPELIFGATEY 243
             G  HRD+KP+NLLV G   V                   Y+ +R+YRAPE++  +T Y
Sbjct: 118 H-GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSY 176

Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMNPNYTE 299
           ++ +DIW+ GC+MAEL   +PLFPG S +DQL +I  VLGTPT+++     K  +     
Sbjct: 177 SSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK--LG 234

Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           F+FPQ  P   H++      PEA+DL+    ++ P  R TA +A  HP+F
Sbjct: 235 FRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  220 bits (563), Expect = 2e-69
 Identities = 106/291 (36%), Positives = 153/291 (52%), Gaps = 38/291 (13%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKN---RELQIMQMLDHPNIVALK 141
            VVG G++GVV + + + TGEIVAIKK  +   D+  K    RE+++++ L H NIV LK
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F     K  LYL  V EYV  T+  +          +P   V+ Y +Q+ +A+AY H+
Sbjct: 67  EAFRR---KGRLYL--VFEYVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHS 118

Query: 202 CIGICHRDIKPQNLLVK--------------------GEPNVSYICSRYYRAPELIFGAT 241
              I HRDIKP+N+LV                       P   Y+ +R+YRAPEL+ G T
Sbjct: 119 -HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177

Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNYTE 299
            Y   +D+W+ GC+MAELL G+PLFPG+S +DQL  I K LG   P+ +E+   NP +  
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237

Query: 300 FKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
             FP+   P    + +  ++   A+D +    +  P  R T  E   HP+F
Sbjct: 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  217 bits (554), Expect = 2e-68
 Identities = 91/291 (31%), Positives = 136/291 (46%), Gaps = 56/291 (19%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y     +G+GSFG V++AK + TG+IVA+K + +            RE++I++ L HPNI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L   F    DK+ LYL  V+EY          +Y      +     K    QI R L 
Sbjct: 61  VRLIDAF---EDKDHLYL--VMEYCEGGDLF---DYLSRGGPLSEDEAKKIALQILRGLE 112

Query: 198 YIHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIF 238
           Y+H+  GI HRD+KP+N+L+     V                   +++ + +Y APE++ 
Sbjct: 113 YLHSN-GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLL 171

Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 298
           G   Y   +D+WS G ++ ELL G+P F GE+ +DQL  I ++LG P             
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL------------ 219

Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
             +F + K              EA DL+ +     P+ R TA E   HP+F
Sbjct: 220 --EFDEPKWSS--------GSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  213 bits (545), Expect = 8e-67
 Identities = 88/290 (30%), Positives = 148/290 (51%), Gaps = 39/290 (13%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
           +G G++G V++A+ ++TGE+VA+KK+  +   K        RE++++Q L HPNIV LK 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRME-NEKEGFPITAIREIKLLQKLRHPNIVRLKE 65

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              S   K  +Y+  V EY+   +  +  +      +     +K Y  Q+   L Y+H+ 
Sbjct: 66  IVTSK-GKGSIYM--VFEYMDHDLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN 119

Query: 203 IGICHRDIKPQNLLV-----------------KGEPNVSY---ICSRYYRAPELIFGATE 242
            GI HRDIK  N+L+                     +  Y   + + +YR PEL+ GAT 
Sbjct: 120 -GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATR 178

Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYTE 299
           Y   +D+WS GC++AEL LG+P+F G + ++QL +I ++ G+PT E    +  + P +  
Sbjct: 179 YGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL-PWFEN 237

Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
            K  +       + F+  + P A+DL+ +     P  R +A +A  H +F
Sbjct: 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  208 bits (533), Expect = 2e-64
 Identities = 100/304 (32%), Positives = 165/304 (54%), Gaps = 52/304 (17%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIM---QMLDHPNIVAL 140
           +G G++G+V++A  R T E+VA+KK+        D +   RE  IM   ++ DHPNIV L
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFRE--IMFLQELGDHPNIVKL 72

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARN--YSRIHQRMPLIYVKLYTYQICRALAY 198
            +   +  DK+ +YL  V EY+   ++ + R      +H+R    Y+    YQ+ +AL Y
Sbjct: 73  LNVIKAENDKD-IYL--VFEYMETDLHAVIRANILEDVHKR----YI---MYQLLKALKY 122

Query: 199 IHNCIGICHRDIKPQNLLVKGEPNVS------------------------YICSRYYRAP 234
           IH+   + HRD+KP N+L+  +  V                         Y+ +R+YRAP
Sbjct: 123 IHSG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181

Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
           E++ G+T YT  +D+WS GC++ E+LLG+PLFPG S ++QL +II+V+G P+ E+I+ + 
Sbjct: 182 EILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241

Query: 295 PNYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 351
             +        P     P  ++   +   +A+DL+ +   ++PN R TA EA  HP+  +
Sbjct: 242 SPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300

Query: 352 LRDP 355
             +P
Sbjct: 301 FHNP 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  201 bits (513), Expect = 2e-61
 Identities = 103/308 (33%), Positives = 157/308 (50%), Gaps = 45/308 (14%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKK------VLQDKRYKNRELQIMQMLDHPN 136
            Y     +G+G++GVV  A    +G+ VAIKK      V    +   REL+I++   H N
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI--YVKLYTYQICR 194
           I+A++         +   + +V++ +   ++ I      IH   PL   +++ + YQ+ R
Sbjct: 66  IIAIRD-ILRPPGADFKDVYVVMDLMESDLHHI------IHSDQPLTEEHIRYFLYQLLR 118

Query: 195 ALAYIHNCIGICHRDIKPQNLLVKG-----------------EPNV------SYICSRYY 231
            L YIH+   + HRD+KP NLLV                    P         Y+ +R+Y
Sbjct: 119 GLKYIHSA-NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWY 177

Query: 232 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 291
           RAPEL+    EYTTAID+WS GC+ AE+L  + LFPG++ V QL  I+ VLG+P+ E + 
Sbjct: 178 RAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237

Query: 292 CMNP----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 347
            +       Y +   P+ +P PW K+F K   PEA+DL+ +  Q+ P  R T  +A  HP
Sbjct: 238 RIGSDRVRKYIQ-NLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERITVEQALQHP 295

Query: 348 FFDELRDP 355
           F  +  DP
Sbjct: 296 FLAQYHDP 303

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  199 bits (509), Expect = 8e-61
 Identities = 101/302 (33%), Positives = 155/302 (51%), Gaps = 39/302 (12%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 135
           Y     VG+G++G V  A   +TG  VAIKK+ +        KR Y  REL++++ +DH 
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74

Query: 136 NIVALKHCFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           N++ L   F   +  E+   + LV   +   +N I +      Q++   +++   YQI R
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK-----CQKLSDDHIQFLVYQILR 129

Query: 195 ALAYIHNCIGICHRDIKPQNLLVKGEPNV----------------SYICSRYYRAPELIF 238
            L YIH+  GI HRD+KP N+ V  +  +                 Y+ +R+YRAPE++ 
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIML 188

Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--- 295
               Y   +DIWS GC+MAELL G+ LFPG   +DQL  I+ ++GTP  E ++ ++    
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248

Query: 296 -NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 354
            NY +   PQ+    + +VF     P A+DL+ +     P+ R TA EA  HP+  E  D
Sbjct: 249 RNYIQ-SLPQMPKKDFKEVFS-GANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306

Query: 355 PN 356
           P 
Sbjct: 307 PE 308

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  195 bits (498), Expect = 6e-60
 Identities = 97/290 (33%), Positives = 155/290 (53%), Gaps = 43/290 (14%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGEIVA+KK+  +   +       RE+ +++ L+HPNIV L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNY--SRIHQRMPLIYVKLYTYQICRALAYIHN 201
             S     +LYL  V E++    +   + Y  S     +    +K Y YQ+ + +AY H+
Sbjct: 67  VHSEN---KLYL--VFEFL----DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117

Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYRAPELIFGATE 242
              + HRD+KPQNLL+                 G P  +Y   + + +YRAPE++ G+ +
Sbjct: 118 H-RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQ 176

Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYTE 299
           Y+T +DIWS GC+ AE++  +PLFPG+S +DQL  I + LGTP  +    +  + P+Y  
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL-PDYKP 235

Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
             FP+       KV    L  + +DL+ +   Y P  R +A  A  HP+F
Sbjct: 236 -TFPKWARQDLSKVVP-NLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  191 bits (488), Expect = 2e-58
 Identities = 98/293 (33%), Positives = 154/293 (52%), Gaps = 38/293 (12%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDH-PNIVALKH 142
           +G G++G V++A+ + TG++VA+KK   +   +       RE+ ++QML     IV L  
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNR-IARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                    +  L LV EY+   + + +  N     + +P   +K + YQ+ + +A+ H 
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128

Query: 202 CIGICHRDIKPQNLLVKGEPNV-----------------SY---ICSRYYRAPELIFGAT 241
             G+ HRD+KPQNLLV  +  +                 SY   I + +YRAPE++ G+T
Sbjct: 129 -HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGST 187

Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            Y+T +DIWS GC+ AE+   QPLFPG+S + QL+ I K+LGTPT +      P  ++ +
Sbjct: 188 HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW----PGVSKLR 243

Query: 302 ----FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
               FPQ KP    +     L PE +DL+ +  +Y P  R +A  A  HP+FD
Sbjct: 244 DWHEFPQWKPQDLSRAVPD-LSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  188 bits (480), Expect = 4e-57
 Identities = 107/303 (35%), Positives = 159/303 (52%), Gaps = 50/303 (16%)

Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLD 133
           +K++ I E     G++GVV++A+ ++TGEIVA+KK+  +K  +       RE+ I+  L 
Sbjct: 8   EKLNRIEE-----GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ 62

Query: 134 HPNIVALKHCFF-STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 192
           HPNIV +K     S  DK  +Y+  V+EYV   +  +      + Q      VK    Q+
Sbjct: 63  HPNIVTVKEVVVGSNLDK--IYM--VMEYVEHDLKSL---METMKQPFLQSEVKCLMLQL 115

Query: 193 CRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYRA 233
              +A++H+   I HRD+K  NLL+                 G P   Y   + + +YRA
Sbjct: 116 LSGVAHLHD-NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRA 174

Query: 234 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 293
           PEL+ GA EY+TAID+WS GC+ AELL  +PLFPG+S +DQL +I K+LGTPT +     
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW--- 231

Query: 294 NPNYTEFKFPQIKPHPWHKVFQ--KRLPP-----EAVDLVCRFFQYSPNLRCTALEACVH 346
            P ++E    + K    +   Q  K+ P         DL+ R   Y P  R +A +A  H
Sbjct: 232 -PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290

Query: 347 PFF 349
           P+F
Sbjct: 291 PYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  185 bits (472), Expect = 5e-56
 Identities = 96/285 (33%), Positives = 145/285 (50%), Gaps = 36/285 (12%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQML-DHPNIVALKH 142
           G G+F  V +A+ R+TG+  AIK +   K +K+       RE+Q ++ L  HPNI+ L  
Sbjct: 8   GEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
             F   D++   L LV E +   +  + +      + +P   VK Y YQ+ ++L ++H  
Sbjct: 66  VLF---DRKTGRLALVFELMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN 119

Query: 203 IGICHRDIKPQNLLVKGE-----------------PNVSYICSRYYRAPELIFGATEYTT 245
            GI HRDIKP+N+L+K +                 P   YI +R+YRAPE +     Y  
Sbjct: 120 -GIFHRDIKPENILIKDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGP 178

Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-NYTEFKFPQ 304
            +DIW+ GCV  E+L   PLFPG + +DQ+ +I  VLGTP  E +K      +  + FP 
Sbjct: 179 KMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPS 238

Query: 305 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
            K     K+       E +DL+ +   Y P+ R TA +A  HP+F
Sbjct: 239 KKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  184 bits (469), Expect = 1e-55
 Identities = 108/290 (37%), Positives = 161/290 (55%), Gaps = 40/290 (13%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKN---RELQIMQMLDHPNIVALKH 142
           +VG GS+G+V + K +ETG+IVAIKK L+   DK  K    RE+++++ L H N+V L  
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 143 CFFSTTDKEELYLNLVLEYVPETV-NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F     K+ LYL  V E+V  TV + + +  + + +      V+ Y +QI R + + H+
Sbjct: 68  VF---RRKKRLYL--VFEFVDHTVLDDLEKYPNGLDESR----VRKYLFQILRGIEFCHS 118

Query: 202 CIGICHRDIKPQNLLVK-------------------GEPNVSYICSRYYRAPELIFGATE 242
              I HRDIKP+N+LV                    GE    Y+ +R+YRAPEL+ G T+
Sbjct: 119 H-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177

Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEIKCMNPNYTEF 300
           Y  A+DIW+ GC++ E+L G+PLFPG+S +DQL  IIK LG   P  +EI   NP +   
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237

Query: 301 KFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           + P++K   P  K F K L    +DL  +  +  P+ R ++ +   H FF
Sbjct: 238 RLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  185 bits (471), Expect = 3e-55
 Identities = 98/324 (30%), Positives = 164/324 (50%), Gaps = 45/324 (13%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y     +G G++G+V  A  + TG  VAIKK+         +R   RE++I++   H NI
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQR-TLREIKILRRFKHENI 65

Query: 138 VALKHCFFSTTDKE--ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           + +       + +   ++Y+  V E +   + ++ +      Q +   +++ + YQI R 
Sbjct: 66  IGILDIIRPPSFESFNDVYI--VQELMETDLYKLIKT-----QHLSNDHIQYFLYQILRG 118

Query: 196 LAYIHNCIGICHRDIKPQNLLV------------------KGEPN----VSYICSRYYRA 233
           L YIH+   + HRD+KP NLL+                      +      Y+ +R+YRA
Sbjct: 119 LKYIHSA-NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177

Query: 234 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 293
           PE++  +  YT AIDIWS GC++AE+L  +PLFPG+  + QL  I+ VLGTP++E++ C+
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237

Query: 294 -NP---NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
            +    NY +   P     PW+K+F     P+A+DL+ +   ++P+ R T  EA  HP+ 
Sbjct: 238 ISLRARNYIK-SLPFKPKVPWNKLFPN-ADPKALDLLDKMLTFNPHKRITVEEALAHPYL 295

Query: 350 DELRDPNTRLPNGRPLPPLFNFKP 373
           ++  DP+       P P  F    
Sbjct: 296 EQYHDPSDEPVAEEPFPFDFELFD 319

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  184 bits (470), Expect = 3e-55
 Identities = 107/329 (32%), Positives = 170/329 (51%), Gaps = 43/329 (13%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           +G G++G+V  AK  ET E VAIKK+        D +   RE+++++ LDH N++A+K  
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 144 FFSTTDK--EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 +   ++Y+  V E +   +++I R+     Q +   + + + YQ+ R L YIH+
Sbjct: 73  MPPPHREAFNDVYI--VYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHS 126

Query: 202 CIGICHRDIKPQNLLV-------------------KGEPNVSYICSRYYRAPELIFGATE 242
              + HRD+KP NLL+                   KG+    Y+ +R+YRAPEL+   +E
Sbjct: 127 A-NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSE 185

Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-NPNYTEF- 300
           YTTAID+WS GC+ AELL  +PLFPG+  V QL  I ++LG+P+ E++  + N     + 
Sbjct: 186 YTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYI 245

Query: 301 -KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 359
              P      + ++F     P A+DL+ +   + P+ R T  EA  HP+   L DP+   
Sbjct: 246 RSLPYTPRQSFARLF-PHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEP 304

Query: 360 PNGRPLPPLFNFKPPELSGIPPETINRLI 388
               P    F+F+   L+    E I  LI
Sbjct: 305 VCQTPFS--FDFEEDALT---EEDIKELI 328

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  179 bits (456), Expect = 9e-54
 Identities = 99/289 (34%), Positives = 159/289 (55%), Gaps = 41/289 (14%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHCF 144
           +G G++  V++ + R TGEIVA+K++  D          RE+ +M+ L H NIV L H  
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR---MPLIYVKLYTYQICRALAYIHN 201
             T +K    L LV EY+ + + +    Y   H     +    VK +TYQ+ + +A+ H 
Sbjct: 67  IHTENK----LMLVFEYMDKDLKK----YMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 202 CIGICHRDIKPQNLLV--KGEPNV-----------------SYICSRYYRAPELIFGATE 242
              + HRD+KPQNLL+  +GE  +                 + + + +YRAP+++ G+  
Sbjct: 119 N-RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177

Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEF 300
           Y+T+IDIWS GC+MAE++ G+PLFPG +  DQL++I +++GTPT      ++  P Y + 
Sbjct: 178 YSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY-KP 236

Query: 301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
            FP+  P    ++F     P  +DL+ R  Q +P LR +A +A  HP+F
Sbjct: 237 TFPRYPPQDLQQLF-PHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  177 bits (452), Expect = 4e-53
 Identities = 100/291 (34%), Positives = 152/291 (52%), Gaps = 44/291 (15%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHC 143
           +G GS+GVVF+ + RETG+IVAIKK ++       K+   RE+++++ L HPN+V L   
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 144 FFSTTDKEELYLNLVLEYVPETV-NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH-- 200
           F     + +  L+LV EY   TV N + +N     + +P   +K   +Q  +A+ + H  
Sbjct: 69  F-----RRKRKLHLVFEYCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH 119

Query: 201 NCIGICHRDIKPQNLLVKGEPNVS-------------------YICSRYYRAPELIFGAT 241
           NCI   HRD+KP+N+L+  +  +                    Y+ +R+YRAPEL+ G T
Sbjct: 120 NCI---HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176

Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNYTE 299
           +Y   +D+W+ GCV AELL GQPL+PG+S VDQL  I K LG   P  ++I   N  +  
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236

Query: 300 FKFPQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
              P+ +   P    F   +   A+  +    Q  P  R +  E   HP+F
Sbjct: 237 LSIPEPETREPLESKFPN-ISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  177 bits (452), Expect = 5e-53
 Identities = 97/295 (32%), Positives = 154/295 (52%), Gaps = 37/295 (12%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKR----YKNRELQIMQMLDHPNI 137
           +Y     +G GS+  V++ + + TG++VA+K++ L+ +        RE  +++ L H NI
Sbjct: 6   TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L H    T       L LV EY+   + +   +       + +  V+L+ +Q+ R LA
Sbjct: 66  VTL-HDIIHTKKT----LTLVFEYLDTDLKQYMDDCGGG---LSMHNVRLFLFQLLRGLA 117

Query: 198 YIHNCIGICHRDIKPQNLLV--KGE--------------PNVSY---ICSRYYRAPELIF 238
           Y H    + HRD+KPQNLL+  +GE              P+ +Y   + + +YR P+++ 
Sbjct: 118 YCHQ-RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLL 176

Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIK--CMNP 295
           G+TEY+T++D+W  GC+  E+  G+PLFPG + V DQL +I +VLGTPT E       NP
Sbjct: 177 GSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236

Query: 296 NYTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
            +  + FP   P P      +    P   +L  +F QY P  R +A EA  HP+F
Sbjct: 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  175 bits (445), Expect = 4e-52
 Identities = 103/303 (33%), Positives = 157/303 (51%), Gaps = 54/303 (17%)

Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLD 133
           QKV  I E     G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+
Sbjct: 3   QKVEKIGE-----GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 57

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           HPNIV L     +   + +LYL  V E++ + + +           +PLI  K Y +Q+ 
Sbjct: 58  HPNIVKLLDVIHT---ENKLYL--VFEFLHQDLKKFMDASPLSGIPLPLI--KSYLFQLL 110

Query: 194 RALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYRAP 234
           + LA+ H+   + HRD+KPQNLL+                 G P  +Y   + + +YRAP
Sbjct: 111 QGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 169

Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
           E++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP       + 
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV----VW 225

Query: 295 PNYTEFK-----FPQIKPHPWHKVFQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           P  T        FP+         F K +PP   +  DL+ +   Y PN R +A  A  H
Sbjct: 226 PGVTSLPDYKPSFPKWARQD----FSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281

Query: 347 PFF 349
           PFF
Sbjct: 282 PFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  174 bits (442), Expect = 3e-51
 Identities = 105/323 (32%), Positives = 150/323 (46%), Gaps = 65/323 (20%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALK 141
           + +G G++G+V++A+   +GEIVA+KKV  D           RE+ ++  L HPNIV LK
Sbjct: 13  NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH- 200
                   K    + LV+EY  + +  +  N            VK    Q+ R L Y+H 
Sbjct: 73  EV---VVGKHLDSIFLVMEYCEQDLASLLDNMPT---PFSESQVKCLMLQLLRGLQYLHE 126

Query: 201 NCIGICHRDIKPQNLLV--KGE-----------------PNVSYICSRYYRAPELIFGAT 241
           N I   HRD+K  NLL+  KG                  P    + + +YRAPEL+ G T
Sbjct: 127 NFI--IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCT 184

Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 299
            YTTAID+W+ GC++AELL  +PL PG+S ++QL  II++LGTP        +  P   +
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244

Query: 300 FKFPQ-----IKPH-PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 353
           F  P+     +K   PW       L    + L+     Y P  R TA EA    +F E  
Sbjct: 245 FTLPKQPYNNLKHKFPW-------LSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE-- 295

Query: 354 DPNTRLPNGRPLPPLFNFKPPEL 376
                    +PLP       PE+
Sbjct: 296 ---------KPLP-----CEPEM 304

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  174 bits (442), Expect = 4e-51
 Identities = 96/291 (32%), Positives = 159/291 (54%), Gaps = 36/291 (12%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHC 143
           VG G+FG+V  A+ + TG+ VAIKK+++        +   REL++++ L H NI++L   
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           F S    E++Y   V E +   ++R+  +     + +   +++ + YQI R L Y+H+  
Sbjct: 78  FISP--LEDIYF--VTELLGTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA- 127

Query: 204 GICHRDIKPQNLLVK---------------GEPNVS-YICSRYYRAPELIFGATEYTTAI 247
           G+ HRD+KP N+L+                 +P ++ Y+ +RYYRAPE++    +Y   +
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEV 187

Query: 248 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-NPNYTEF--KFPQ 304
           DIWS GC+ AE+L G+PLFPG+  V+Q   I  +LGTP  + I  + + N   F    P+
Sbjct: 188 DIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPK 247

Query: 305 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 355
            +P P+ + F+    P A+DL+ +   + P  R +A EA  HP+     DP
Sbjct: 248 REPVPFSEKFKN-ADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  170 bits (433), Expect = 3e-50
 Identities = 102/293 (34%), Positives = 149/293 (50%), Gaps = 49/293 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++G VF+AK RET EIVA+K+V  D   +       RE+ +++ L H NIV L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
             S  DK+   L LV EY  + + +    +   +  +    VK + +Q+ + LA+ H+  
Sbjct: 68  LHS--DKK---LTLVFEYCDQDLKKY---FDSCNGDIDPEIVKSFMFQLLKGLAFCHSH- 118

Query: 204 GICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYRAPELIFGATEYT 244
            + HRD+KPQNLL+                 G P   Y   + + +YR P+++FGA  Y+
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 178

Query: 245 TAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 303
           T+ID+WS GC+ AEL   G+PLFPG    DQL  I ++LGTPT E      P  +  K P
Sbjct: 179 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESW----PGVS--KLP 232

Query: 304 QIKPHP-------WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
             KP+P          V   +L     DL+      +P  R +A EA  HP+F
Sbjct: 233 DYKPYPMYPATTSLVNVV-PKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  169 bits (429), Expect = 5e-49
 Identities = 101/298 (33%), Positives = 157/298 (52%), Gaps = 43/298 (14%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A  R TG  VAIKK+       L  KR   REL++++ + H N++ L  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR-AYRELRLLKHMKHENVIGLLD 81

Query: 143 CFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F      +  +   LV+ ++   + ++ +     H+++    ++   YQ+ + L YIH 
Sbjct: 82  VFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHA 136

Query: 202 CIGICHRDIKPQNLLVKGEPNVS----------------YICSRYYRAPELIFGATEYTT 245
             GI HRD+KP NL V  +  +                 Y+ +R+YRAPE+I     YT 
Sbjct: 137 A-GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQ 195

Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAE+L G+PLF G   +DQL+EI+KV GTP++E ++ +      NY + K
Sbjct: 196 TVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVK-K 254

Query: 302 FPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
            P+ +     K F+  LP   P AV+++ +        R TA EA  HP+F+E  DP 
Sbjct: 255 LPRFR----KKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  167 bits (424), Expect = 6e-49
 Identities = 93/291 (31%), Positives = 152/291 (52%), Gaps = 44/291 (15%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLDHPNIVA 139
           +G G++GVV++ + ++TG+IVA+KK+    R ++          RE+ +++ L HPNIV 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L+         +E  L L+ E++   + +   +     Q M    VK Y YQI + + + 
Sbjct: 64  LQDVLM-----QESRLYLIFEFLSMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFC 117

Query: 200 HNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYRAPELIFGA 240
           H+   + HRD+KPQNLL+                 G P   Y   + + +YRAPE++ G+
Sbjct: 118 HS-RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGS 176

Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYT 298
             Y+T +DIWS G + AE+   +PLF G+S +DQL  I ++LGTPT +    +   P+Y 
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236

Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
              FP+ K     +   K L  + +DL+ +   Y P  R +A +A  HP+F
Sbjct: 237 N-TFPKWKK-GSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  166 bits (422), Expect = 6e-49
 Identities = 89/290 (30%), Positives = 132/290 (45%), Gaps = 63/290 (21%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----RELQIMQMLDHPNIVALK 141
            ++G GSFG V+ A  ++TGE++A+K V L     +      RE++I+  L HPNIV   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62

Query: 142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             + S  D+E+  LN+ LEYV   +++ + + + ++ + +    ++ YT QI   LAY+H
Sbjct: 63  RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV----IRKYTRQILEGLAYLH 118

Query: 201 NCIGICHRDIKPQNLLV---------------------KGEPNVSYICSRYYRAPELIFG 239
           +  GI HRDIK  N+LV                      GE   S   + Y+ APE+I G
Sbjct: 119 SN-GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 299
             EY  A DIWS GC + E+  G+P +         +  I   G P              
Sbjct: 178 -EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP-------------- 222

Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
              P+I  H         L  EA D + +  +  P  R TA E   HPF 
Sbjct: 223 ---PEIPEH---------LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  165 bits (420), Expect = 3e-48
 Identities = 97/296 (32%), Positives = 160/296 (54%), Gaps = 44/296 (14%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ R T E +A+KK+  ++  +       RE+ +++ + H NIV L+  
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 144 FFSTTDKEELYLNLVLEYVPETVNR---IARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             S     E  L LV EY+   + +    + ++++ + R+    +K Y YQI R +AY H
Sbjct: 70  VHS-----EKRLYLVFEYLDLDLKKHMDSSPDFAK-NPRL----IKTYLYQILRGIAYCH 119

Query: 201 NCIGICHRDIKPQNLLVK-----------------GEPNVSY---ICSRYYRAPELIFGA 240
           +   + HRD+KPQNLL+                  G P  ++   + + +YRAPE++ G+
Sbjct: 120 SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGS 178

Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYT 298
             Y+T +DIWS GC+ AE++  +PLFPG+S +D+L +I ++LGTP  E    +   P+Y 
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238

Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 354
              FP+  P     V    L P  VDL+ +  +  P+ R TA  A  H +F +L D
Sbjct: 239 S-AFPKWPPKDLATVVPT-LEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292

Length = 294

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  166 bits (423), Expect = 3e-48
 Identities = 111/332 (33%), Positives = 170/332 (51%), Gaps = 50/332 (15%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y  + V+G GS+GVV  A    TGE VAIKK+      + D     RE++++++L HP+I
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIAR---NYSRIHQRMPLIYVKLYTYQICR 194
           V +KH     + +E   + +V E +   ++++ +   + +  H        + + YQ+ R
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHH-------QFFLYQLLR 114

Query: 195 ALAYIHNCIGICHRDIKPQNLLVK----------GEPNVS------------YICSRYYR 232
           AL YIH    + HRD+KP+N+L            G   V+            Y+ +R+YR
Sbjct: 115 ALKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173

Query: 233 APELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 290
           APEL  G+  ++YT AIDIWS GC+ AE+L G+PLFPG++ V QL  I  +LGTP+ E I
Sbjct: 174 APELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232

Query: 291 -KCMNPNYTEFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALEACVH 346
            +  N     +     K  P    F ++ P   P A+ L+ R   + P  R TA EA   
Sbjct: 233 SRVRNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290

Query: 347 PFFDELRDPNTRLPNGRPLPPL-FNFKPPELS 377
           P+F  L     R P+ +P+  L F F+   L+
Sbjct: 291 PYFKGLAKVE-REPSAQPITKLEFEFERRRLT 321

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  162 bits (411), Expect = 9e-47
 Identities = 94/303 (31%), Positives = 138/303 (45%), Gaps = 52/303 (17%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKHC 143
           G G+FG V++A+  +TG +VA+KK+L     K+       RE++I++ L HPN+V L   
Sbjct: 17  GEGTFGEVYKARQIKTGRVVALKKILM-HNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 144 FFSTTDKE-----ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
                DK       +Y  +V  Y+   ++ +  N   +      I  K Y  Q+   + Y
Sbjct: 76  AVERPDKSKRKRGSVY--MVTPYMDHDLSGLLEN-PSVKLTESQI--KCYMLQLLEGINY 130

Query: 199 IHNCIGICHRDIKPQNLLV--KG----------------EPNVSY------------ICS 228
           +H    I HRDIK  N+L+  +G                 PN               + +
Sbjct: 131 LH-ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVT 189

Query: 229 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 288
           R+YR PEL+ G   YTTA+DIW  GCV AE+   +P+  G+S +DQL  I K+ GTPT E
Sbjct: 190 RWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEE 249

Query: 289 EIKCMN--PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 346
                   P           P    + F K   PE +DL+ +     P  R TA +A  H
Sbjct: 250 TWPGWRSLPGCEGVHSFTNYPRTLEERFGKLG-PEGLDLLSKLLSLDPYKRLTASDALEH 308

Query: 347 PFF 349
           P+F
Sbjct: 309 PYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  162 bits (412), Expect = 1e-46
 Identities = 98/299 (32%), Positives = 150/299 (50%), Gaps = 34/299 (11%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNI 137
           Y +   VG+G++G V  A  + TGE VAIKK+    Q + +  R   EL +++ + H N+
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 138 VALKHCFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           + L   F S    +E     LV+ Y+   + +I      +   +    V+   YQ+   L
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKI------MGHPLSEDKVQYLVYQMLCGL 130

Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNVS----------------YICSRYYRAPELIFGA 240
            YIH+  GI HRD+KP NL V  +  +                 Y+ +R+YRAPE+I   
Sbjct: 131 KYIHSA-GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILNW 189

Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
             Y   +DIWS GC+MAE+L G+ LF G+  +DQL +I+KV G P  E ++ +     + 
Sbjct: 190 MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK- 248

Query: 301 KFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
            + +  P    K F    P   P+AVDL+ +  +   + R TA EA  HP+FD  RD +
Sbjct: 249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  162 bits (411), Expect = 2e-46
 Identities = 99/312 (31%), Positives = 148/312 (47%), Gaps = 62/312 (19%)

Query: 90  VGTGSFGVVFQAKCRET--GEIVAIKKV-------LQDKRYKNRELQIMQML-DHPNIVA 139
           +G G++G+V  A+  ET   E VAIKK+       +  KR   REL++++    H NI  
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKR-ALRELKLLRHFRGHKNITC 66

Query: 140 LKHCFFSTTDK-EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           L            ELYL    E +   +++I R+     Q +   + + + YQI   L Y
Sbjct: 67  LYDMDIVFPGNFNELYL--YEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKY 120

Query: 199 IHNCIGICHRDIKPQNLLV----------------------KGEPNVS-YICSRYYRAPE 235
           IH+   + HRD+KP NLLV                      +    ++ Y+ +R+YRAPE
Sbjct: 121 IHSA-NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179

Query: 236 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE------E 289
           ++     YT AID+WS GC++AELL  +P+F G+  VDQL +I++VLGTP  E       
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239

Query: 290 IKCMN-----PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 344
            K  N     PN  +  F  I P+           P A+DL+ +   + P  R +  EA 
Sbjct: 240 PKAQNYIRSLPNIPKKPFESIFPNA---------NPLALDLLEKLLAFDPTKRISVEEAL 290

Query: 345 VHPFFDELRDPN 356
            HP+     DP+
Sbjct: 291 EHPYLAIWHDPD 302

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  161 bits (408), Expect = 5e-46
 Identities = 99/328 (30%), Positives = 148/328 (45%), Gaps = 71/328 (21%)

Query: 77  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------------- 123
           +  ++      H+ G G++G V +A    TG+IVAIKKV +     N             
Sbjct: 5   SISERYIQKGAHL-GEGTYGKVEKAYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVGMCG 62

Query: 124 ------RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH 177
                 REL+IM  + H NI+ L   +      E  ++NLV++ +   + ++     +I 
Sbjct: 63  IHFTTLRELKIMNEIKHENIMGLVDVYV-----EGDFINLVMDIMASDLKKVVD--RKI- 114

Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV--KGEPNV-------SYICS 228
            R+    VK    QI   L  +H      HRD+ P N+ +  KG   +        Y   
Sbjct: 115 -RLTESQVKCILLQILNGLNVLHKWY-FMHRDLSPANIFINSKGICKIADFGLARRYGYP 172

Query: 229 RY------------------------YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQP 264
            Y                        YRAPEL+ GA +Y  A+D+WS GC+ AELL G+P
Sbjct: 173 PYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232

Query: 265 LFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPE 321
           LFPGE+ +DQL  I ++LGTP  +   + K + P YTEF     KP     +F      +
Sbjct: 233 LFPGENEIDQLGRIFELLGTPNEDNWPQAKKL-PLYTEFTP--RKPKDLKTIFPNA-SDD 288

Query: 322 AVDLVCRFFQYSPNLRCTALEACVHPFF 349
           A+DL+    + +P  R +A EA  H +F
Sbjct: 289 AIDLLQSLLKLNPLERISAKEALKHEYF 316

Length = 335

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  159 bits (405), Expect = 1e-45
 Identities = 101/322 (31%), Positives = 143/322 (44%), Gaps = 75/322 (23%)

Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVAL 140
           +G G++G V++AK +    G+  AIKK   DK           RE+ +++ L H N+V+L
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSR-----IHQRMPLIYVKLYTYQICRA 195
              F    DK    + L+ +Y    + +I + + +     I   M    VK   +QI   
Sbjct: 68  VEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSM----VKSLLWQILNG 120

Query: 196 LAYIH-NCIGICHRDIKPQNLLVKGE-----------------------------PNVSY 225
           + Y+H N +   HRD+KP N+LV GE                             P V  
Sbjct: 121 VHYLHSNWV--LHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVT 178

Query: 226 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---------VDQLV 276
           I   +YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F G             DQL 
Sbjct: 179 I---WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235

Query: 277 EIIKVLGTPTREE---IKCMNPNYTEFKFPQIKPHPW----HKVFQKRLP--PEAVDLVC 327
            I +VLGTPT ++   IK M P Y                  K  +K      +  DL+ 
Sbjct: 236 RIFEVLGTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLR 294

Query: 328 RFFQYSPNLRCTALEACVHPFF 349
           +  +Y P  R TA EA  HP+F
Sbjct: 295 KLLEYDPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  158 bits (402), Expect = 1e-45
 Identities = 92/294 (31%), Positives = 142/294 (48%), Gaps = 47/294 (15%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLD---HPN 136
           +G G++G V++A+   TG  VA+KKV    R             RE+ +++ L+   HPN
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV L           EL L LV E+V + +        +    +P   +K    Q+ R +
Sbjct: 63  IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPK--PGLPPETIKDLMRQLLRGV 120

Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV------------------SYICSRYYRAPELIF 238
            ++H    I HRD+KPQN+LV  +  V                  S + + +YRAPE++ 
Sbjct: 121 DFLH-SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLL 179

Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 298
            ++ Y T +D+WS GC+ AEL   +PLF G S  DQL +I  V+G P+ EE    N +  
Sbjct: 180 QSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP-RNVSLP 237

Query: 299 EFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
              FP   P      F+  +P    E +DL+ +   ++P+ R +A EA  HP+F
Sbjct: 238 RSSFPSYTPRS----FKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  157 bits (397), Expect = 8e-45
 Identities = 99/296 (33%), Positives = 156/296 (52%), Gaps = 36/296 (12%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
           +YI    +G G++  VF+ + + T  +VA+K++  +          RE+ +++ L H NI
Sbjct: 7   TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L       TDK    L LV EY+ + + +   +   I   M +  VK++ YQI R LA
Sbjct: 67  VTLHDIVH--TDKS---LTLVFEYLDKDLKQYMDDCGNI---MSMHNVKIFLYQILRGLA 118

Query: 198 YIHNCIGICHRDIKPQNLLV--KGE--------------PNVSY---ICSRYYRAPELIF 238
           Y H    + HRD+KPQNLL+  +GE              P  +Y   + + +YR P+++ 
Sbjct: 119 YCHR-RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL 177

Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-- 296
           G++EY+T ID+W  GC+  E+  G+PLFPG +  D+L  I ++LGTPT E    ++ N  
Sbjct: 178 GSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237

Query: 297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
           +  + FP+ KP P       RL  E ++L+ +F QY    R +A EA  H +F  L
Sbjct: 238 FKNYNFPKYKPQPLIN-HAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  156 bits (395), Expect = 3e-44
 Identities = 95/301 (31%), Positives = 148/301 (49%), Gaps = 34/301 (11%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           VG+G++G V  A      + VA+KK+      L   R   REL++++ + H N++ L   
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 144 FFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           F   T  E    + LV   +   +N I +      Q++   +V+   YQ+ R L YIH+ 
Sbjct: 83  FTPATSIENFNEVYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA 137

Query: 203 IGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTTA 246
            GI HRD+KP N+ V                  +    Y+ +R+YRAPE++     Y   
Sbjct: 138 -GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQT 196

Query: 247 IDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 306
           +DIWS GC+MAELL G+ LFPG   +DQL  I++V+GTP+ E +K ++  +       + 
Sbjct: 197 VDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLP 256

Query: 307 PHPWH---KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGR 363
             P     K+F +   P A+DL+ +      + R +A EA  HP+F +  DP    P   
Sbjct: 257 HMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDE-PEAE 314

Query: 364 P 364
           P
Sbjct: 315 P 315

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  150 bits (382), Expect = 1e-43
 Identities = 61/247 (24%), Positives = 108/247 (43%), Gaps = 59/247 (23%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHCF 144
           +G G FG V+ A+ ++TG+ VAIK + ++          RE++I++ L+HPNIV L   F
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
                ++E +L LV+EY    ++  + +       ++    +     QI   L Y+H+  
Sbjct: 61  -----EDENHLYLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQILEGLEYLHSN- 111

Query: 204 GICHRDIKPQNLLVKGEPNVSYIC--------------------SRYYRAPELIFGATEY 243
           GI HRD+KP+N+L+  +     +                     +  Y APE++ G   Y
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171

Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKF 302
           +   DIWS G ++ EL              +L ++I+          K +  +  +    
Sbjct: 172 SEKSDIWSLGVILYEL-------------PELKDLIR----------KMLQKDPEKRPSA 208

Query: 303 PQIKPHP 309
            +I  H 
Sbjct: 209 KEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  152 bits (386), Expect = 3e-43
 Identities = 91/305 (29%), Positives = 156/305 (51%), Gaps = 36/305 (11%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
           +YI    +G G++  V++ + + T  +VA+K++  +          RE+ +++ L H NI
Sbjct: 7   TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L H    T    E  L LV EY+ + + +   +       + +  VKL+ +Q+ R L 
Sbjct: 67  VTL-HDIIHT----EKSLTLVFEYLDKDLKQYLDDCGNS---INMHNVKLFLFQLLRGLN 118

Query: 198 YIHNCIGICHRDIKPQNLLV--KGE--------------PNVSY---ICSRYYRAPELIF 238
           Y H    + HRD+KPQNLL+  +GE              P  +Y   + + +YR P+++ 
Sbjct: 119 YCHR-RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILL 177

Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NPN 296
           G+T+Y+T ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E    +  N  
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237

Query: 297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
           +  + +P+ +    H     RL  +  +L+ +  Q+    R +A EA  HP+F  L +  
Sbjct: 238 FKSYNYPKYRADCLHN-HAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERI 296

Query: 357 TRLPN 361
            +LP+
Sbjct: 297 HKLPD 301

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  154 bits (389), Expect = 3e-43
 Identities = 97/295 (32%), Positives = 148/295 (50%), Gaps = 37/295 (12%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 83

Query: 143 CFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F      EE   + LV   +   +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 138

Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 139 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 197

Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 198 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 256

Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 257 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  151 bits (383), Expect = 6e-43
 Identities = 103/298 (34%), Positives = 155/298 (52%), Gaps = 43/298 (14%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN 136
           SY+    +G GS+  V++   R  G++VA+K V+  K  +       RE  +++ L H N
Sbjct: 6   SYLNLEKLGEGSYATVYKGISRINGQLVALK-VISMKTEEGVPFTAIREASLLKGLKHAN 64

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYV-PETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           IV L H    T +     L  V EY+  +    + ++   +H       V+L+ +Q+ R 
Sbjct: 65  IVLL-HDIIHTKET----LTFVFEYMHTDLAQYMIQHPGGLHPY----NVRLFMFQLLRG 115

Query: 196 LAYIHNCIGICHRDIKPQNLLV----------------KGEPNVSY---ICSRYYRAPEL 236
           LAYIH    I HRD+KPQNLL+                K  P+ +Y   + + +YR P++
Sbjct: 116 LAYIHG-QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDV 174

Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMN- 294
           + GAT+Y++A+DIW  GC+  E+L GQP FPG S V +QL +I  VLG PT +    ++ 
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234

Query: 295 -PNYTEFKFPQIKPHPWHKVFQKRL--PPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
            PNY    F   KP     V+ KRL  PP+A DL  +     P  R +A +A +HP+F
Sbjct: 235 LPNYKPEWFLPCKPQQLRVVW-KRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  152 bits (387), Expect = 1e-42
 Identities = 100/303 (33%), Positives = 146/303 (48%), Gaps = 54/303 (17%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK---VLQD----KRYKNRELQIMQMLDHPNIV---- 138
           +G G+FGVV+       G+ VA+KK   V Q+    KR   REL+++    H N++    
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLSALD 66

Query: 139 ----ALKHCFFSTTDKEELYLNLVLEYVPETVNR-IARNYSRIHQRMPLIYVKLYTYQIC 193
                    F      EE+Y+  V E +   +++ I        Q +   +VK++ YQI 
Sbjct: 67  ILQPPHIDPF------EEIYV--VTELMQSDLHKIIVSP-----QPLSSDHVKVFLYQIL 113

Query: 194 RALAYIHNCIGICHRDIKPQNLLV---------------KGEPNVSY-----ICSRYYRA 233
           R L Y+H+  GI HRDIKP NLLV                 EP+ S      + ++YYRA
Sbjct: 114 RGLKYLHSA-GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172

Query: 234 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 293
           PE++ G+  YT+A+DIWS GC+ AELL  + LF  +S + QL  I  +LGTP+ E ++  
Sbjct: 173 PEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232

Query: 294 NPNYTEFKFPQIKPHPWHKVFQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
                          P   V          EAV L+CR   + P+ R +A +A  HP+ D
Sbjct: 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD 292

Query: 351 ELR 353
           E R
Sbjct: 293 EGR 295

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  150 bits (379), Expect = 2e-42
 Identities = 105/294 (35%), Positives = 149/294 (50%), Gaps = 47/294 (15%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKH 142
           VVG G++GVV + + +ET EIVAIKK          K    REL++++ L   NIV LK 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL----IYVKLYTYQICRALAY 198
            F     + +LYL  V EYV        +N   + + MP       V+ Y YQ+ +A+ +
Sbjct: 68  AF---RRRGKLYL--VFEYV-------EKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115

Query: 199 IHNCIGICHRDIKPQNLLVKGEP-----------NVS---------YICSRYYRAPELIF 238
            H    I HRDIKP+NLL+               N+S         Y+ +R+YR+PEL+ 
Sbjct: 116 CHKN-DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL 174

Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NPN 296
           GA  Y  A+D+WS GC++ EL  GQPLFPGES +DQL  I KVLG    E++K    NP 
Sbjct: 175 GAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233

Query: 297 YTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           +   +FP +  P    + +   L    +DL+    + +P  R    +   HP F
Sbjct: 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  149 bits (376), Expect = 5e-42
 Identities = 91/293 (31%), Positives = 148/293 (50%), Gaps = 36/293 (12%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
           +Y+    +G G++  VF+ + + T  +VA+K++  +          RE+ +++ L H NI
Sbjct: 6   TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L H    T    E  L LV EY+   + +   N   +   M +  VK++ +Q+ R L+
Sbjct: 66  VTL-HDIIHT----ERCLTLVFEYLDSDLKQYLDNCGNL---MSMHNVKIFMFQLLRGLS 117

Query: 198 YIHNCIGICHRDIKPQNLLV--KGE--------------PNVSY---ICSRYYRAPELIF 238
           Y H    I HRD+KPQNLL+  KGE              P  +Y   + + +YR P+++ 
Sbjct: 118 YCHK-RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL 176

Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK--CMNPN 296
           G+TEY+T ID+W  GC++ E+  G+P+FPG +  ++L  I ++LGTPT E       N  
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236

Query: 297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           +  + FPQ +  P       RL  + +DL+     Y    R +A  A  H +F
Sbjct: 237 FRSYLFPQYRAQPL-INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  149 bits (379), Expect = 9e-42
 Identities = 86/304 (28%), Positives = 147/304 (48%), Gaps = 57/304 (18%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-VLQDKR---YKNRELQIMQMLDHPNIVALKHCFF 145
           +G GS G+VF A   +  + VA+KK VL D +   +  RE++I++ LDH NIV +     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 146 S-----TTDKEELY----LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
                 T D   L     + +V EY+   +  +          +   + +L+ YQ+ R L
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGL 127

Query: 197 AYIHNCIGICHRDIKPQNLLVKGE----------------PNVSY-------ICSRYYRA 233
            YIH+   + HRD+KP N+ +  E                P+ S+       + +++YR+
Sbjct: 128 KYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRS 186

Query: 234 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL---VEIIKVLGTPTREEI 290
           P L+     YT AID+W+ GC+ AE+L G+PLF G   ++Q+   +E + V+    R E+
Sbjct: 187 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNEL 246

Query: 291 KCMNPNYTEFKFPQIKPHPW--HKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALEACV 345
             + P++       ++       +  +  LP   PEA+D + +   ++P  R TA EA +
Sbjct: 247 LNVIPSF-------VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299

Query: 346 HPFF 349
           HP+ 
Sbjct: 300 HPYM 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  146 bits (367), Expect = 6e-40
 Identities = 83/334 (24%), Positives = 127/334 (38%), Gaps = 67/334 (20%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHP 135
           SY     +G GSFG V+ A+ R+   +VA+K + +    K+       RE+QI+  L+HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 136 -NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
            NIV L   F     ++E  L LV+EYV                 +          QI  
Sbjct: 58  PNIVKLYDFF-----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 195 ALAYIHNCIGICHRDIKPQNLLVKGEPNV--------------------------SYICS 228
           AL Y+H+  GI HRDIKP+N+L+  +  V                          + + +
Sbjct: 113 ALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171

Query: 229 RYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLG 283
             Y APE++ G +    +++ DIWS G  + ELL G P F GE       Q ++II  L 
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231

Query: 284 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 343
           TP                       P      + +   A DL+ +     P  R ++   
Sbjct: 232 TP-------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSD 272

Query: 344 CVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELS 377
             H     L+   + L +          +     
Sbjct: 273 LSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPP 306

Length = 384

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  142 bits (360), Expect = 6e-40
 Identities = 73/284 (25%), Positives = 119/284 (41%), Gaps = 59/284 (20%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQMLDHPNIVALKHC 143
             +G G FG V++A+ + TG+ VAIK + L+ K  K     E+QI++   HPNIV     
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 144 FFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           +     K+EL+  +V+E+    ++  + ++    +Q +    +     ++ + L Y+H+ 
Sbjct: 66  YL---KKDELW--IVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHS- 116

Query: 203 IGICHRDIKPQNLLV------------------KGEPNVSYICSRYYRAPELIFGATEYT 244
            GI HRDIK  N+L+                    +   + + + Y+ APE+I G   Y 
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPYD 175

Query: 245 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 304
              DIWS G    EL  G+P +  E    + +  I   G P                   
Sbjct: 176 YKADIWSLGITAIELAEGKPPY-SELPPMKALFKIATNGPP---------------GLR- 218

Query: 305 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
             P  W          E  D + +  Q +P  R TA +   HPF
Sbjct: 219 -NPEKW--------SDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  142 bits (360), Expect = 6e-39
 Identities = 99/318 (31%), Positives = 156/318 (49%), Gaps = 61/318 (19%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKR-YKNRELQIMQMLDHP 135
           Y     +G+G+ G+V  A    TG+ VAIKK       V   KR Y  REL +M++++H 
Sbjct: 18  YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY--RELVLMKLVNHK 75

Query: 136 NIVALKHCFFSTTDK-----EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 190
           NI+ L + F  T  K     +++YL  V+E +   + ++       H+RM  +      Y
Sbjct: 76  NIIGLLNVF--TPQKSLEEFQDVYL--VMELMDANLCQVI-QMDLDHERMSYL-----LY 125

Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVKGE-------------PNVS-----YICSRYYR 232
           Q+   + ++H+  GI HRD+KP N++VK +                S     Y+ +RYYR
Sbjct: 126 QMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 184

Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE+I G   Y   +DIWS GC+M E++ G  LFPG   +DQ  +II+ LGTP+ E +  
Sbjct: 185 APEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243

Query: 293 MNP---NYTEFKFPQIKPHPWHKVF------------QKRLPPEAVDLVCRFFQYSPNLR 337
           + P   NY E + P+   + + ++F             K    +A DL+ +     P  R
Sbjct: 244 LQPTVRNYVENR-PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKR 302

Query: 338 CTALEACVHPFFDELRDP 355
            +  +A  HP+ +   DP
Sbjct: 303 ISVDDALQHPYINVWYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  138 bits (349), Expect = 6e-38
 Identities = 90/309 (29%), Positives = 140/309 (45%), Gaps = 70/309 (22%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKH 142
            +G G++G V++A+ ++TGE+VA+KKV  D   +       RE++I++ L+H NIV LK 
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73

Query: 143 CFFSTTD-----KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY------- 190
                 D     K++    LV EY+              H  M L+   L  +       
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYMD-------------HDLMGLLESGLVHFSEDHIKS 120

Query: 191 ---QICRALAYIHNCIGICHRDIKPQNLLV--KGE------------------PNVSYIC 227
              Q+   L Y H      HRDIK  N+L+  KG+                  P  + + 
Sbjct: 121 FMKQLLEGLNYCHK-KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179

Query: 228 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 287
           + +YR PEL+ G   Y  AID+WS GC++ EL   +P+F     + QL  I ++ G+P  
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC- 238

Query: 288 EEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRL-------PPEAVDLVCRFFQYSPNLRCT 339
                + P+  +   F  +KP    K +++RL       P  A+DL+       P+ RCT
Sbjct: 239 ---PAVWPDVIKLPYFNTMKP---KKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCT 292

Query: 340 ALEACVHPF 348
           A EA   P+
Sbjct: 293 AEEALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  135 bits (342), Expect = 3e-37
 Identities = 82/291 (28%), Positives = 125/291 (42%), Gaps = 72/291 (24%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALKH 142
           +G GSFG V   + ++TG++ A+K     K+++ K   +   E  I+  ++HP IV L H
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-H 59

Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             F T +K    L LVLEY P  E  + +++       R      + Y  +I  AL Y+H
Sbjct: 60  YAFQTEEK----LYLVLEYAPGGELFSHLSK-----EGRFSEERARFYAAEIVLALEYLH 110

Query: 201 NCIGICHRDIKPQNLL------------------VKGEPNVSYIC-SRYYRAPELIFGAT 241
           +  GI +RD+KP+N+L                         +  C +  Y APE++ G  
Sbjct: 111 SL-GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK- 168

Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            Y  A+D WS G ++ E+L G+P F  E    ++ E I                     +
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYEKIL----------------KDPLR 211

Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA-CV--HPFF 349
           FP            + L PEA DL+    Q  P  R  +  A  +  HPFF
Sbjct: 212 FP------------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  132 bits (334), Expect = 1e-35
 Identities = 86/301 (28%), Positives = 133/301 (44%), Gaps = 51/301 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKH- 142
           +G G+FG VF+A+ ++T +IVA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 143 CFFSTT----DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           C    T     K   YL  V E+     + +A   S  + +  L  +K     +   L Y
Sbjct: 80  CRTKATPYNRYKGSFYL--VFEFCE---HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134

Query: 199 IHNCIGICHRDIKPQNLLV---------------------KGEPN--VSYICSRYYRAPE 235
           IH    I HRD+K  N+L+                       +PN   + + + +YR PE
Sbjct: 135 IHRN-KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193

Query: 236 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI-KCMN 294
           L+ G  +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E       
Sbjct: 194 LLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDK 253

Query: 295 -PNYTEFKFPQ-----IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
              + + + PQ     +K      V      P A+DL+ +     P  R  A  A  H F
Sbjct: 254 LELFKKMELPQGQKRKVKERLKPYVKD----PHALDLIDKLLVLDPAKRIDADTALNHDF 309

Query: 349 F 349
           F
Sbjct: 310 F 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  129 bits (326), Expect = 9e-35
 Identities = 90/295 (30%), Positives = 139/295 (47%), Gaps = 49/295 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-------------LQIMQMLDHPN 136
           +G G++G V++A+   +G  VA+K V    R +  E             L+ ++  DHPN
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSV----RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63

Query: 137 IVALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNY-SRIHQR-MPLIYVKLYTYQIC 193
           IV L   C  S TD+E   + LV E+V + +    R Y  ++    +P   +K    Q  
Sbjct: 64  IVRLMDVCATSRTDRE-TKVTLVFEHVDQDL----RTYLDKVPPPGLPAETIKDLMRQFL 118

Query: 194 RALAYIH-NCIGICHRDIKPQNLLVKGEPNVS---------YIC---------SRYYRAP 234
           R L ++H NCI   HRD+KP+N+LV     V          Y C         + +YRAP
Sbjct: 119 RGLDFLHANCI--VHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAP 176

Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
           E++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    +
Sbjct: 177 EVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RD 234

Query: 295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
                  F    P P   V  + +      L+     ++P+ R +A  A  HPFF
Sbjct: 235 VTLPRGAFSPRGPRPVQSVVPE-IEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  124 bits (314), Expect = 3e-33
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 33/213 (15%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y     +G GSFG V+  + +  G++  +K++       +++     E++I++ L+HPNI
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +     F     +E+  L +V+EY     +++  +   +  +  P   +  +  Q+C AL
Sbjct: 62  IKYYESF-----EEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116

Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELI 237
            Y+H+   I HRDIKPQN+ +     V                   + + + YY +PEL 
Sbjct: 117 KYLHS-RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC 175

Query: 238 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 270
                Y    DIWS GCV+ EL   +  F GE+
Sbjct: 176 QNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  124 bits (313), Expect = 9e-33
 Identities = 93/299 (31%), Positives = 147/299 (49%), Gaps = 39/299 (13%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKR----YKNRELQIMQMLDHPNI 137
           SY     +G GS+  V++ K +  G++VA+K + LQ++        RE  +++ L H NI
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65

Query: 138 VALKHCFFSTTDKEELYLNLVLEYV-PETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           V L H    T +     L LV EYV  +    + ++   +H       VKL+ +Q+ R L
Sbjct: 66  VLL-HDIIHTKET----LTLVFEYVHTDLCQYMDKHPGGLHPE----NVKLFLFQLLRGL 116

Query: 197 AYIHNCIGICHRDIKPQNLLV----------------KGEPNVSY---ICSRYYRAPELI 237
           +YIH    I HRD+KPQNLL+                K  P+ +Y   + + +YR P+++
Sbjct: 117 SYIHQRY-ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL 175

Query: 238 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMN-- 294
            G+TEY+T +D+W  GC+  E++ G   FPG   + DQL  I  VLGTP  +    ++  
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235

Query: 295 PNYTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
           P++   +F    P    + + K      A DL  +  Q  P  R +A  A  H +F +L
Sbjct: 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  122 bits (309), Expect = 1e-32
 Identities = 81/287 (28%), Positives = 130/287 (45%), Gaps = 65/287 (22%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----RELQIMQMLDHPNIVALKH 142
           ++G G+FGVV++    ETG+ VAIK++ L+  + +      +E+ +++ L HPNIV    
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                  +    L ++LEY    ++ +I + +    + +    V +Y YQ+ + LAY+H 
Sbjct: 67  SI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAYLHE 117

Query: 202 CIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGATE 242
             G+ HRDIK  N+L   +  V                   S + + Y+ APE+I   + 
Sbjct: 118 -QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-SG 175

Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 302
            +TA DIWS GC + ELL G P +                          +NP    F+ 
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPPYYD------------------------LNPMAALFRI 211

Query: 303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
            Q   HP      + + PE  D + + FQ  PNLR TA +   HP+ 
Sbjct: 212 VQ-DDHP---PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  123 bits (309), Expect = 9e-32
 Identities = 93/304 (30%), Positives = 149/304 (49%), Gaps = 46/304 (15%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84

Query: 144 FFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           F      EE   + LV+E +   + ++ +     H+RM  +      YQ+   + ++H+ 
Sbjct: 85  FTPQKSLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGIKHLHSA 138

Query: 203 IGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFGATEYT 244
            GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G   Y 
Sbjct: 139 -GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YK 196

Query: 245 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE-- 299
             +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E  
Sbjct: 197 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256

Query: 300 -----FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 351
                  FP++ P    P      K    +A DL+ +     P  R +  EA  HP+ + 
Sbjct: 257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316

Query: 352 LRDP 355
             DP
Sbjct: 317 WYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  122 bits (308), Expect = 1e-31
 Identities = 90/304 (29%), Positives = 149/304 (49%), Gaps = 46/304 (15%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A     G  VA+KK+    Q++ +  R   EL +++ ++H NI++L + 
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88

Query: 144 FFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           F      EE   + LV+E +   + ++  +    H+RM  +      YQ+   + ++H+ 
Sbjct: 89  FTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL-----YQMLCGIKHLHSA 142

Query: 203 IGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFGATEYT 244
            GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G   Y 
Sbjct: 143 -GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILG-MGYK 200

Query: 245 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEFK 301
             +DIWS GC+M EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P   NY E +
Sbjct: 201 ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENR 260

Query: 302 -------FPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 351
                  F ++ P    P      K    +A DL+ +     P+ R +  EA  HP+   
Sbjct: 261 PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320

Query: 352 LRDP 355
             DP
Sbjct: 321 WYDP 324

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  120 bits (303), Expect = 8e-31
 Identities = 91/305 (29%), Positives = 150/305 (49%), Gaps = 48/305 (15%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91

Query: 144 FFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           F      EE   + +V+E +   + ++ +     H+RM  +      YQ+   + ++H+ 
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGIKHLHSA 145

Query: 203 IGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFGATEYT 244
            GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G   Y 
Sbjct: 146 -GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YK 203

Query: 245 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEFK 301
             +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E +
Sbjct: 204 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 263

Query: 302 FPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
            P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+ +
Sbjct: 264 -PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322

Query: 351 ELRDP 355
              DP
Sbjct: 323 VWYDP 327

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  117 bits (294), Expect = 2e-30
 Identities = 83/286 (29%), Positives = 124/286 (43%), Gaps = 63/286 (22%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL---QDKRYK------NRELQIMQMLDHPNIVAL 140
           +G+GSFG V++    + G+  A+K+V      +  +       +E+ ++  L HPNIV  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ- 66

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
               +  T++EE  L + LE VP     +A+   + +   P   ++LYT QI   L Y+H
Sbjct: 67  ----YLGTEREEDNLYIFLELVPG--GSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLH 119

Query: 201 NCIGICHRDIKPQNLLV--KGEPNV----------------SYICSRYYRAPELIFGATE 242
           +     HRDIK  N+LV   G   +                S+  S Y+ APE+I     
Sbjct: 120 D-RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGG 178

Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 302
           Y  A DIWS GC + E+  G+P +    GV  + +I +    P                 
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP----------------- 221

Query: 303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
               P P H      L  EA D + +  Q  P+LR TA E   HPF
Sbjct: 222 ----PIPDH------LSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  114 bits (287), Expect = 3e-29
 Identities = 70/240 (29%), Positives = 118/240 (49%), Gaps = 38/240 (15%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYK-NRELQIMQMLDHPNIVALKH 142
            V+G GS GVV++ + + TG+I A+KK+     ++ R +  REL+ ++  + P +V    
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F+      E  +++VLEY+   ++  + +       ++P   +     QI + L Y+H 
Sbjct: 67  AFYK-----EGEISIVLEYMDGGSLADLLK----KVGKIPEPVLAYIARQILKGLDYLHT 117

Query: 202 CIGICHRDIKPQNLLV--KGEPNVS------------YICSRY-----YRAPELIFGATE 242
              I HRDIKP NLL+  KGE  ++              C+ +     Y +PE I G + 
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGES- 176

Query: 243 YTTAIDIWSTGCVMAELLLGQ-P-LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
           Y+ A DIWS G  + E  LG+ P L PG+    +L++ I   G P     +  +P + +F
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI-CDGPPPSLPAEEFSPEFRDF 235

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  113 bits (284), Expect = 6e-29
 Identities = 78/293 (26%), Positives = 126/293 (43%), Gaps = 67/293 (22%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----RELQIMQMLDHPNIVALK 141
           + +G G+FG V+ A   +TGE++A+K++ +QD   K       E++++++L HPN+V   
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK-- 63

Query: 142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             +     +E++Y+   +EY    T+  +   + RI   +    +++YT Q+   LAY+H
Sbjct: 64  -YYGVEVHREKVYI--FMEYCSGGTLEELLE-HGRI---LDEHVIRVYTLQLLEGLAYLH 116

Query: 201 NCIGICHRDIKPQNLL-----------------------VKGEPNVSYICSRYYRAPELI 237
           +  GI HRDIKP N+                          GE   S   +  Y APE+I
Sbjct: 117 SH-GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175

Query: 238 FGAT--EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 295
            G     +  A DIWS GCV+ E+  G+  +       Q++  +     P          
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPP--------- 226

Query: 296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                  P             +L PE  D + R  +  P  R TA E   HPF
Sbjct: 227 ------IPDS----------LQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  113 bits (284), Expect = 1e-28
 Identities = 79/319 (24%), Positives = 125/319 (39%), Gaps = 94/319 (29%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLD-HP 135
           +    ++G GSF  V  AK +ET +  AIK     +++++K+  Y   E +++  L+ HP
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
            I+ L + F    D+E LY   VLEY P   N     Y R +  +     + Y  +I  A
Sbjct: 63  GIIKLYYTF---QDEENLY--FVLEYAP---NGELLQYIRKYGSLDEKCTRFYAAEILLA 114

Query: 196 LAYIHNCIGICHRDIKPQNLLVK----------------------GEPNVSYICSRY--- 230
           L Y+H+  GI HRD+KP+N+L+                                      
Sbjct: 115 LEYLHSK-GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 231 --------------YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 276
                         Y +PEL+        + D+W+ GC++ ++L G+P F G +  + L 
Sbjct: 174 KNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN--EYLT 230

Query: 277 --EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 334
             +I+K                  E+ FP               PP+A DL+ +     P
Sbjct: 231 FQKILK-----------------LEYSFPPN------------FPPDAKDLIEKLLVLDP 261

Query: 335 NLRCTALEACV----HPFF 349
             R    E       HPFF
Sbjct: 262 QDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  111 bits (280), Expect = 3e-28
 Identities = 74/270 (27%), Positives = 122/270 (45%), Gaps = 62/270 (22%)

Query: 93  GSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNR------ELQIMQMLDHPNIVALKHCFF 145
           G++G VF AK + TG+I AIK +   D   KN+      E  I+     P +V L   ++
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL---YY 60

Query: 146 STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           S   K+ LYL  V+EY+P   +  +  N   + + +     ++Y  +I  AL Y+H+  G
Sbjct: 61  SFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLHSN-G 113

Query: 205 ICHRDIKPQNLLVKGE---------------------------PNVSYICSRYYRAPELI 237
           I HRD+KP N+L+                               +   + +  Y APE+I
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173

Query: 238 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII--KVLGTPTREEI----- 290
            G   ++  +D WS GC++ E L+G P F GE+  +++ + I    +  P   E+     
Sbjct: 174 LG-QGHSKTVDWWSLGCILYEFLVGIPPFHGET-PEEIFQNILNGKIEWPEDVEVSDEAI 231

Query: 291 ----KCMNPNYTE---FK-FPQIKPHPWHK 312
               K + P+  +    K   +IK HP+ K
Sbjct: 232 DLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  109 bits (274), Expect = 1e-27
 Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 49/229 (21%)

Query: 87  EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
              +G G+FG V++   +         VA+K + +D   +      RE +IM+ LDHPNI
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRA 195
           V L       T++E L   +V+EY+P        +Y R ++   L    L  +  QI R 
Sbjct: 64  VKLLGV---CTEEEPLM--IVMEYMP---GGDLLDYLRKNRPKELSLSDLLSFALQIARG 115

Query: 196 LAYIH--NCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YYR----------- 232
           + Y+   N I   HRD+  +N LV     V  I     SR      YY+           
Sbjct: 116 MEYLESKNFI---HRDLAARNCLVGENLVVK-ISDFGLSRDLYDDDYYKVKGGKLPIRWM 171

Query: 233 APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIK 280
           APE +    ++T+  D+WS G ++ E+  LG+  +PG S   +++E +K
Sbjct: 172 APESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS-NAEVLEYLK 218

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  109 bits (273), Expect = 3e-27
 Identities = 86/303 (28%), Positives = 144/303 (47%), Gaps = 46/303 (15%)

Query: 80  QKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN------RELQIMQML 132
           Q+   +AE  +G G++G VF+A+  +  G  VA+K+V      +       RE+ +++ L
Sbjct: 1   QQYECVAE--IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 58

Query: 133 D---HPNIVAL-KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY 188
           +   HPN+V L   C  S TD+E   L LV E+V + +             +P   +K  
Sbjct: 59  ETFEHPNVVRLFDVCTVSRTDRET-KLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDM 115

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV------------------SYICSRY 230
            +Q+ R L ++H+   + HRD+KPQN+LV     +                  S + + +
Sbjct: 116 MFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW 174

Query: 231 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 290
           YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  E+ 
Sbjct: 175 YRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233

Query: 291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPE----AVDLVCRFFQYSPNLRCTALEACVH 346
               P                 +  ++   +      DL+ +   ++P  R +A  A  H
Sbjct: 234 ----PRDVALPRQAFHSKSAQPI--EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287

Query: 347 PFF 349
           P+F
Sbjct: 288 PYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  109 bits (274), Expect = 4e-27
 Identities = 62/203 (30%), Positives = 102/203 (50%), Gaps = 37/203 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALK 141
            +GTGSFG V   + + +G+  A+K     K+++ K+ +    E +I+Q + HP +V L 
Sbjct: 8   TLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLY 67

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
             F     +++  L LV+EYVP  E  + + ++      R P    + Y  Q+  AL Y+
Sbjct: 68  GSF-----QDDSNLYLVMEYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYL 117

Query: 200 HNCIGICHRDIKPQNLLV--------------KGEPNVSY-IC-SRYYRAPELIFGATEY 243
           H+   I +RD+KP+NLL+              K     +Y +C +  Y APE+I     Y
Sbjct: 118 HSL-DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPEYLAPEIILS-KGY 175

Query: 244 TTAIDIWSTGCVMAELLLGQPLF 266
             A+D W+ G ++ E+L G P F
Sbjct: 176 GKAVDWWALGILIYEMLAGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  108 bits (271), Expect = 4e-27
 Identities = 68/228 (29%), Positives = 111/228 (48%), Gaps = 48/228 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRE----TGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
              +G G+FG V++ K +         VA+K + +D   +      RE +IM+ LDHPN+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
           V L       T++E LY  +V+EY+         +Y R ++ ++ L  +  +  QI R +
Sbjct: 64  VKLLGV---CTEEEPLY--IVMEYME---GGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115

Query: 197 AYIH--NCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YYR-----------A 233
            Y+   N I   HRD+  +N LV GE  V  I     SR      YYR           A
Sbjct: 116 EYLESKNFI---HRDLAARNCLV-GENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMA 171

Query: 234 PELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIK 280
           PE +    ++T+  D+WS G ++ E+  LG+  +PG S  ++++E +K
Sbjct: 172 PESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS-NEEVLEYLK 217

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  108 bits (272), Expect = 4e-27
 Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 35/222 (15%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKH 142
            +G GSFG V + + +  G+I+  K++       ++K+    E+ I++ L HPNIV    
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 D+    L +V+EY     + ++ +   +  + +   ++     Q+  AL   HN
Sbjct: 67  RII---DRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 202 CIG----ICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIF 238
                  + HRD+KP N+ +    NV                   +Y+ + YY +PE + 
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLN 183

Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 280
             + Y    DIWS GC++ EL    P F       QL   IK
Sbjct: 184 HMS-YDEKSDIWSLGCLIYELCALSPPFTA-RNQLQLASKIK 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  107 bits (270), Expect = 7e-27
 Identities = 86/304 (28%), Positives = 133/304 (43%), Gaps = 70/304 (23%)

Query: 82  VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--------LQDKRYK------NRELQ 127
             ++   ++G G++G V+ A    TGE++A+K+V          D R K        E++
Sbjct: 1   FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60

Query: 128 IMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVK 186
            ++ LDH NIV          +  E YL++ LEYVP  ++    R Y R  +++    V+
Sbjct: 61  TLKDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VR 111

Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE---------------------PNVSY 225
            +T Q+   LAY+H+  GI HRD+K  NLLV  +                      N+S 
Sbjct: 112 FFTEQVLEGLAYLHS-KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170

Query: 226 ICSRYYRAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 284
             S ++ APE+I   ++ Y+  +DIWS GCV+ E+  G+  +  E               
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE--------------- 215

Query: 285 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 344
              E I  M     +   P I P          L P A+D +   F  +P+ R TA E  
Sbjct: 216 ---EAIAAMFKLGNKRSAPPIPPD-----VSMNLSPVALDFLNACFTINPDNRPTARELL 267

Query: 345 VHPF 348
            HPF
Sbjct: 268 QHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  106 bits (266), Expect = 2e-26
 Identities = 88/304 (28%), Positives = 131/304 (43%), Gaps = 78/304 (25%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-------QDKRYKN------RELQIMQ 130
           +I   ++G+GSFG V+      +GE++A+K+V           R ++      RE+ +++
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 131 MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYT 189
            L H NIV               +LN+ LEYVP  +V  +  NY    + +    V+ + 
Sbjct: 62  ELQHENIVQYLGSSLDAD-----HLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFV 112

Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLV---------------KGEPNV----------S 224
            QI + L Y+HN  GI HRDIK  N+LV               K E N           S
Sbjct: 113 RQILKGLNYLHN-RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS 171

Query: 225 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 284
              S ++ APE++   T YT   DIWS GC++ E+L G+  FP      QL  I K+   
Sbjct: 172 LQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFKI--- 224

Query: 285 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 344
                         E   P+I  +         +  EA+D + + F+   N R TA E  
Sbjct: 225 -------------GENASPEIPSN---------ISSEAIDFLEKTFEIDHNKRPTAAELL 262

Query: 345 VHPF 348
            HPF
Sbjct: 263 KHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  103 bits (259), Expect = 2e-25
 Identities = 67/288 (23%), Positives = 116/288 (40%), Gaps = 62/288 (21%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVL--QDKRYKN---RELQIMQMLDHPNIVALKHC 143
            +G G+ GVV +   R TG+I+A+K +    ++  +    REL I+   + P IV     
Sbjct: 8   ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           F++  D     +++ +EY+      + +    +  R+P   +      + + L Y+H   
Sbjct: 68  FYNNGD-----ISICMEYMDGG--SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH 120

Query: 204 GICHRDIKPQNLLV--KGEPNV---------------SYICSRYYRAPELIFGATEYTTA 246
            I HRD+KP N+LV  +G+  +               +++ +  Y APE I G  +Y+  
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQG-NDYSVK 179

Query: 247 IDIWSTGCVMAELLLGQPLFPGESG-----VDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            DIWS G  + EL  G+  +P E+       + L  I+               P      
Sbjct: 180 SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN------------EPP------ 221

Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
            P++    +         P+  D V       P  R +  E   HPF 
Sbjct: 222 -PRLPSGKF--------SPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  103 bits (258), Expect = 3e-25
 Identities = 75/285 (26%), Positives = 118/285 (41%), Gaps = 62/285 (21%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCFFS 146
            +G GS+G V++A  +ETG++VAIK V  ++  +   +E+ I++  D P IV     +F 
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69

Query: 147 TTDKEELYLNLVLEY-VPETVNRI--ARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
            TD     L +V+EY    +V+ I    N +   + +  I      YQ  + L Y+H+  
Sbjct: 70  NTD-----LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAI-----LYQTLKGLEYLHS-N 118

Query: 204 GICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGATEYT 244
              HRDIK  N+L+  E                      + I + ++ APE+I     Y 
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYN 177

Query: 245 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 304
              DIWS G    E+  G+P                    P  +    ++P    F  P 
Sbjct: 178 NKADIWSLGITAIEMAEGKP--------------------PYSD----IHPMRAIFMIPN 213

Query: 305 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
            KP P      ++  PE  D V +     P  R +A++   HPF 
Sbjct: 214 -KPPPTLSD-PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  102 bits (256), Expect = 5e-25
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 34/213 (15%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNR---ELQIMQMLDHPN 136
           +  E  +G G F VV++A C   G +VA+KKV    + D + +     E+ +++ LDHPN
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           ++     F      E   LN+VLE      ++R+ +++ +  + +P   +  Y  Q+C A
Sbjct: 64  VIKYLASFI-----ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 196 LAYIHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPEL 236
           L ++H+   I HRDIKP N+ +     V                   S + + YY +PE 
Sbjct: 119 LEHMHS-KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 269
           I     Y    DIWS GC++ E+   Q  F G+
Sbjct: 178 IHENG-YNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  100 bits (251), Expect = 2e-24
 Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 48/220 (21%)

Query: 89  VVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVA 139
            +G G+FG V++   +  GE     VA+K + +    +       E  IM+ L HPNIV 
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
           L       T  E LY  +V EY+P        ++ R H +++ L  +     QI + + Y
Sbjct: 66  LLGVC---TQGEPLY--IVTEYMP---GGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117

Query: 199 IH--NCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YYR------------AP 234
           +   N +   HRD+  +N LV  E  V  I     SR      YYR            AP
Sbjct: 118 LESKNFV---HRDLAARNCLV-TENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAP 173

Query: 235 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 273
           E +    ++T+  D+WS G ++ E+  LG+  +PG S  +
Sbjct: 174 ESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 212

Length = 258

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  101 bits (252), Expect = 4e-24
 Identities = 93/317 (29%), Positives = 150/317 (47%), Gaps = 65/317 (20%)

Query: 90  VGTGSFGVVFQAKCRETGEI---VAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCF 144
           VG G++G V++AK R+ G+     A+K++          RE+ +++ L HPN+++L+  F
Sbjct: 9   VGRGTYGHVYKAK-RKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNY--SRIHQR---MPLIYVKLYTYQICRALAYI 199
            S  D++   + L+ +Y    +  I + +  S+ +++   +P   VK   YQI   + Y+
Sbjct: 68  LSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 200 HNCIGICHRDIKPQNLLVKGE---------PNVSY-----------------ICSRYYRA 233
           H    + HRD+KP N+LV GE          ++ +                 + + +YRA
Sbjct: 125 H-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 234 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLF---------PGESGVDQLVEIIKVLGT 284
           PEL+ GA  YT AIDIW+ GC+ AELL  +P+F               DQL  I  V+G 
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243

Query: 285 PTR---EEIKCMNPNYTEFK-FPQ--------IKPHPWHKVFQKRLPPEAVDLVCRFFQY 332
           P     E+IK M  + T  K F +        IK    HKV   +   +A  L+ +    
Sbjct: 244 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV---KPDSKAFHLLQKLLTM 300

Query: 333 SPNLRCTALEACVHPFF 349
            P  R T+ +A   P+F
Sbjct: 301 DPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  100 bits (251), Expect = 5e-24
 Identities = 90/315 (28%), Positives = 148/315 (46%), Gaps = 61/315 (19%)

Query: 90  VGTGSFGVVFQAKCRETGEI---VAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCF 144
           VG G++G V++AK R+ G+     A+K++          RE+ +++ L HPN++AL+  F
Sbjct: 9   VGRGTYGHVYKAK-RKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 145 FSTTDKEELYLNLVLEYVPETVNRI-----ARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
            S +D++   + L+ +Y    +  I     A   ++   ++P   VK   YQI   + Y+
Sbjct: 68  LSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 200 HNCIGICHRDIKPQNLLVKGE---------PNVSY-----------------ICSRYYRA 233
           H    + HRD+KP N+LV GE          ++ +                 + + +YRA
Sbjct: 125 H-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 234 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLF---------PGESGVDQLVEIIKVLGT 284
           PEL+ GA  YT AIDIW+ GC+ AELL  +P+F               DQL  I  V+G 
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243

Query: 285 PTR---EEIKCMNPNY----TEFKFPQIKPHPWHKVFQK-RLPPEA--VDLVCRFFQYSP 334
           P     E+I+ M P Y     +F+          K  +K ++ P++    L+ +     P
Sbjct: 244 PADKDWEDIRKM-PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDP 302

Query: 335 NLRCTALEACVHPFF 349
             R T+ +A   P+F
Sbjct: 303 TKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 99.1 bits (248), Expect = 8e-24
 Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 49/219 (22%)

Query: 89  VVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVAL 140
            +G G+FG V++ K +        VA+K + +D   + R     E ++M+ L HPN+V L
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKL--YTYQICR 194
                  T++E LY  LVLEY+         R +R      ++  L    L  +  QI +
Sbjct: 62  LGV---CTEEEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116

Query: 195 ALAYIH--NCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YYR---------- 232
            + Y+     +   HRD+  +N LV  +  V  I     SR      YYR          
Sbjct: 117 GMEYLASKKFV---HRDLAARNCLVGEDLVVK-ISDFGLSRDVYDDDYYRKKTGGKLPIR 172

Query: 233 --APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 268
             APE +     +T+  D+WS G ++ E+  LG   +PG
Sbjct: 173 WMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 97.6 bits (243), Expect = 3e-23
 Identities = 78/286 (27%), Positives = 118/286 (41%), Gaps = 67/286 (23%)

Query: 93  GSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQ---IMQMLDHPNIVALKHCF 144
           G+FG V+ AK R TG+  AIK      ++   +  N + +   +M   + P +  L   +
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL---Y 63

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM---PLIYVKLYTYQICRALAYIHN 201
           +S   K+  YL LV+EY+         + + + + +   P  + K Y  ++   +  +H 
Sbjct: 64  YSFQSKD--YLYLVMEYLN------GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ 115

Query: 202 CIGICHRDIKPQNLLVK---------------GEPNVSYICSRYYRAPELIFGATEYTTA 246
             GI HRDIKP+NLL+                G  N  ++ +  Y APE I G  +    
Sbjct: 116 -RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILGVGD-DKM 173

Query: 247 IDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 306
            D WS GCV+ E L G P F  E+  D + + I          I                
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHAET-PDAVFDNI------LSRRIN--------------- 211

Query: 307 PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA---LEACVHPFF 349
              W +  ++   PEAVDL+ R     P  R  A    E   HPFF
Sbjct: 212 ---WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 97.7 bits (244), Expect = 4e-23
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 75/293 (25%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
             +G G+ G V++A  R TG+ VAIKK+ L+ +  +    E+ IM+   HPNIV     +
Sbjct: 25  EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSY 84

Query: 145 FSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
                 +EL++  V+EY+         T N +  N  +I       YV     ++ + L 
Sbjct: 85  L---VGDELWV--VMEYMDGGSLTDIITQNFVRMNEPQI------AYVCR---EVLQGLE 130

Query: 198 YIH--NCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPEL 236
           Y+H  N I   HRDIK  N+L+  + +V                   S + + Y+ APE+
Sbjct: 131 YLHSQNVI---HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEV 187

Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 296
           I    +Y   +DIWS G +  E+  G+P +  E  +  L  I    G P    +K     
Sbjct: 188 IKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIP---PLK----- 237

Query: 297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
                     P  W   F+        D + +     P  R +A E   HPF 
Sbjct: 238 ---------NPEKWSPEFK--------DFLNKCLVKDPEKRPSAEELLQHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 98.5 bits (246), Expect = 6e-23
 Identities = 89/348 (25%), Positives = 134/348 (38%), Gaps = 104/348 (29%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
           V+G G+FG V+  + ++TG++ A+K + +    K  ++        I+   D P IV L 
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
             ++S  D+E LYL  V+EY+P  + +N + R         P    + Y  ++  AL  +
Sbjct: 67  --YYSFQDEEHLYL--VMEYMPGGDLMNLLIR-----KDVFPEETARFYIAELVLALDSV 117

Query: 200 HNCIGICHRDIKPQNL-----------------------------------------LVK 218
           H  +G  HRDIKP N+                                         LV+
Sbjct: 118 HK-LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176

Query: 219 GEPNVSYICSRY-------YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 271
              +               Y APE++ G T Y    D WS G ++ E+L G P F  ++ 
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT- 234

Query: 272 VDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 330
              L E        T  +I     N+ E  +FP   P          + PEA+DL+CR  
Sbjct: 235 ---LQE--------TYNKII----NWKESLRFPPDPP----------VSPEAIDLICRLL 269

Query: 331 QYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSG 378
               +   +  E   HPFF           N R   P F    PELS 
Sbjct: 270 CDPEDRLGSFEEIKSHPFF-----KGIDWENLRETKPPF---VPELSS 309

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 95.1 bits (237), Expect = 2e-22
 Identities = 72/294 (24%), Positives = 118/294 (40%), Gaps = 65/294 (22%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLDHPN 136
           +    V+G G+FG V   + R+T ++ A+K     K ++    +N   E +I+Q L+HP 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
           +V L   ++S  D+E +YL  V++ +     R    Y    + +     VK +  +I  A
Sbjct: 62  LVNL---WYSFQDEENMYL--VVDLLLGGDLR----YHLSQKVKFSEEQVKFWICEIVLA 112

Query: 196 LAYIHNCIGICHRDIKPQNLLV------------------KGEPNVSYICSRYYRAPELI 237
           L Y+H+  GI HRDIKP N+L+                        S   +  Y APE++
Sbjct: 113 LEYLHS-KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVL 171

Query: 238 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 297
                Y+ A+D WS G    E L G+  + G S                R++I       
Sbjct: 172 CRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RTIRDQI------- 210

Query: 298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--CTALEACVHPFF 349
              K            +      EA+D + +  +  P  R      +   HP+F
Sbjct: 211 -RAKQETADVL-----YPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 78/295 (26%), Positives = 116/295 (39%), Gaps = 72/295 (24%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAI----KKVLQDKRYKNRELQ---IMQMLDHPNIVALKH 142
           VG G +G VF AK ++TGEIVA+    K +L         L    I+       +V L +
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHN 201
            F    D E LY  L +EYVP    R   N   +  +     + + Y  ++  A+  +H 
Sbjct: 69  AF---QDDEYLY--LAMEYVPGGDFRTLLNNLGVLSED----HARFYMAEMFEAVDALHE 119

Query: 202 CIGICHRDIKPQNLLVKGEPNV----------------SYICSRYYRAPELIFGATEYTT 245
            +G  HRD+KP+N L+    ++                S + S  Y APE++ G   Y  
Sbjct: 120 -LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRG-KGYDF 177

Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D WS GC++ E L G P F G                          PN T   +  +
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFSGS------------------------TPNET---WENL 210

Query: 306 KPHPWHKVFQK--------RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
           K   W +  Q+         L  EA DL+ +          +  +   HPFF E+
Sbjct: 211 K--YWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 91.8 bits (228), Expect = 9e-21
 Identities = 95/341 (27%), Positives = 141/341 (41%), Gaps = 72/341 (21%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALKH 142
           +GTGSFG V  AK + TGE  AIK     ++L+ K+ +   +E  I+  L HP IV +  
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F    D+  +Y   +LE+V   V      + R   R P    K Y  ++  A  Y+H+ 
Sbjct: 86  SF---QDENRVY--FLLEFV---VGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK 137

Query: 203 IGICHRDIKPQNLLVKGEPNVSY---------------IC-SRYYRAPELIFGATEYTTA 246
             I +RD+KP+NLL+  + +V                 +C +  Y APE+I  +  +  A
Sbjct: 138 -DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVI-QSKGHGKA 195

Query: 247 IDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 306
           +D W+ G ++ E + G P F  +              TP R   K +       KFP   
Sbjct: 196 VDWWTMGVLLYEFIAGYPPFFDD--------------TPFRIYEKILA---GRLKFPN-- 236

Query: 307 PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-----HPFFDELRDPNTRLPN 361
              W   F  R    A DLV    Q     R   L+  V     HP+F    + +     
Sbjct: 237 ---W---FDGR----ARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA-NWDKLYAR 285

Query: 362 GRPLP-PLFNFKPPELSGI---PPETINRLIPEHARKQNLF 398
             P P P+    P + S     P   ++RL P  A +Q  F
Sbjct: 286 YYPAPIPVRVKSPGDTSNFEKYPDSPVDRLPPLTAAQQAEF 326

Length = 329

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 88.4 bits (219), Expect = 6e-20
 Identities = 73/296 (24%), Positives = 125/296 (42%), Gaps = 70/296 (23%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV--------LQDKRYKN--RELQIMQMLDHPNIV 138
            +GTG+F   +QA+  +TG ++A+K+V         Q++  +   +E+++M  L+HP+I+
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
                  +T   E+ + NL +E++   +V+ +   Y    +    + +  YT Q+ R L+
Sbjct: 67  ---RMLGAT--CEDSHFNLFVEWMAGGSVSHLLSKYGAFKEA---VIIN-YTEQLLRGLS 117

Query: 198 YIHNCIGICHRDIKPQNLLVK------------------------GEPNVSYICSRYYRA 233
           Y+H    I HRD+K  NLL+                         GE     + +  + A
Sbjct: 118 YLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176

Query: 234 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 293
           PE++ G  +Y  + D+WS GCV+ E+   +P +  E   + L  I K         I   
Sbjct: 177 PEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK---------IASA 226

Query: 294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
                    P I  H         L P   D+  R  +  P  R  + E   HP F
Sbjct: 227 TTA------PSIPEH---------LSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 70/295 (23%), Positives = 116/295 (39%), Gaps = 73/295 (24%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G G FG V   K +      A+K V          + +   E +I++  +HP IV L +
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59

Query: 143 CFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
             F    K++ Y+ +++EY       T+ R    +     R        Y   +  A  Y
Sbjct: 60  RTF----KDKKYIYMLMEYCLGGELWTILRDRGLFDEYTAR-------FYIACVVLAFEY 108

Query: 199 IHNCIGICHRDIKPQNLLV------------------KGEPNVSYICSRYYRAPELIFGA 240
           +HN  GI +RD+KP+NLL+                   G+   ++  +  Y APE+I   
Sbjct: 109 LHN-RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNK 167

Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
             Y  ++D WS G ++ ELL G+P F GE   D +             +I   N      
Sbjct: 168 G-YDFSVDYWSLGILLYELLTGRPPF-GEDDEDPME---------IYNDILKGNGKL--- 213

Query: 301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-----HPFFD 350
           +FP              +   A DL+ +  + +P  R   L+  +     H +F+
Sbjct: 214 EFPNY------------IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 5e-19
 Identities = 75/291 (25%), Positives = 117/291 (40%), Gaps = 67/291 (23%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDK---RYKNRELQIMQMLDHPNIVALKHC 143
             +G+G++G V++A+   TGE+VAIK + L+         +E+ +++   HPNIVA    
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI-YVKLYTYQICRALAYIHNC 202
           +          L +V+EY      +     +R       I YV   T +    LAY+H  
Sbjct: 69  YLRRD-----KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLK---GLAYLHE- 119

Query: 203 IGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGATE- 242
            G  HRDIK  N+L+  + +V                   S+I + Y+ APE+   A E 
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA--AVER 177

Query: 243 ---YTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 298
              Y    DIW+ G    EL   Q P+F         +  ++ L   ++           
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPPMFD--------LHPMRALFLISKS---------- 219

Query: 299 EFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
            F  P++K    W  VF         D + +     P  R TA +   HPF
Sbjct: 220 NFPPPKLKDKEKWSPVFH--------DFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 84.8 bits (210), Expect = 1e-18
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 40/214 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDH---PNIVAL 140
           ++G G++G V++ K   TG +VA+K +  D    +     RE+ ++  L     PNI   
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
              +          L +++EY      R       I ++    Y+ +   ++  AL YIH
Sbjct: 68  YGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEK----YISVIIREVLVALKYIH 118

Query: 201 NCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGAT 241
             +G+ HRDIK  N+LV    NV                   +++ + Y+ APE+I    
Sbjct: 119 K-VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGK 177

Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL 275
            Y T  DIWS G  + E+  G P +   S VD  
Sbjct: 178 YYDTKADIWSLGITIYEMATGNPPY---SDVDAF 208

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 85.2 bits (211), Expect = 2e-18
 Identities = 78/289 (26%), Positives = 117/289 (40%), Gaps = 78/289 (26%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIM-------QMLDHPNIVA 139
           V+G GSFG V  AK +  G+  A+ KVLQ K    K  +  IM       + + HP +V 
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           L H  F T DK  LY   VL+YV   E    + R      +  P    + Y  +I  AL 
Sbjct: 61  L-HYSFQTADK--LY--FVLDYVNGGELFFHLQR-----ERSFPEPRARFYAAEIASALG 110

Query: 198 YIHNCIGICHRDIKPQNLL------------------VKGEPNVSYIC-SRYYRAPELIF 238
           Y+H+ + I +RD+KP+N+L                  ++     S  C +  Y APE++ 
Sbjct: 111 YLHS-LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLR 169

Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 298
               Y   +D W  G V+ E+L G P F       ++ +   +L  P R     + PN +
Sbjct: 170 -KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-TAEMYD--NILNKPLR-----LKPNIS 220

Query: 299 ---------------------EFKFPQIKPHP------WHKVFQKRLPP 320
                                +  F +IK H       W  +  K++ P
Sbjct: 221 VSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITP 269

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 79/297 (26%), Positives = 129/297 (43%), Gaps = 66/297 (22%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 143
           +G GS G+V  A  + TG  VA+KK+  D R + R      E+ IM+   HPNIV +   
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81

Query: 144 FFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           + S    +EL++  V+E++    +  I       H RM    +      + +AL+++H  
Sbjct: 82  YSSYLVGDELWV--VMEFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALSFLHA- 133

Query: 203 IGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGATEY 243
            G+ HRDIK  ++L+  +  V                   S + + Y+ APE+I     Y
Sbjct: 134 QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SRLPY 192

Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 303
            T +DIWS G ++ E++ G+P +  E  +  +            + I+   P       P
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------------KRIRDNLP-------P 233

Query: 304 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 360
           ++K    HKV      P     + R     P  R TA E   HPF  +   P++ +P
Sbjct: 234 KLKNL--HKV-----SPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 83.4 bits (207), Expect = 3e-18
 Identities = 68/289 (23%), Positives = 110/289 (38%), Gaps = 62/289 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIV 138
           +     +G GSFG V++A  + T ++VAIK +       +     +E+Q +     P I 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
                F   +      L +++EY          +  +   ++   Y+     ++   L Y
Sbjct: 63  KYYGSFLKGSK-----LWIIMEYCG---GGSCLDLLKP-GKLDETYIAFILREVLLGLEY 113

Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV------------SYICSR-------YYRAPELIFG 239
           +H   G  HRDIK  N+L+  E +V            S +  R       ++ APE+I  
Sbjct: 114 LHE-EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ 172

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 299
            + Y    DIWS G    EL  G+P  P  S +  +    +VL        K  NP    
Sbjct: 173 -SGYDEKADIWSLGITAIELAKGEP--P-LSDLHPM----RVL----FLIPKN-NP---- 215

Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
              P ++ + + K F+        D V       P  R +A E   H F
Sbjct: 216 ---PSLEGNKFSKPFK--------DFVSLCLNKDPKERPSAKELLKHKF 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 83.9 bits (207), Expect = 5e-18
 Identities = 77/281 (27%), Positives = 127/281 (45%), Gaps = 48/281 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
           ++  H +G GSFG V+ A    T E+VA+KK+    +  N       +E++ +Q L HPN
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICR 194
            +  K C+      +E    LV+EY   +    A +   +H++ PL  V++   T+   +
Sbjct: 83  TIEYKGCYL-----KEHTAWLVMEYCLGS----ASDLLEVHKK-PLQEVEIAAITHGALQ 132

Query: 195 ALAYIHNCIGICHRDIKPQNLLV---------------KGEPNVSYICSRYYRAPELIFG 239
            LAY+H+   I HRDIK  N+L+               K  P  S++ + Y+ APE+I  
Sbjct: 133 GLAYLHSHNMI-HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILA 191

Query: 240 ATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 295
             E  Y   +D+WS G    EL   +P     + +  L  I +   +PT +  +  +   
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPTLQSNEWTDSFR 250

Query: 296 ---NYTEFKFPQIKPHPW----HKVFQKRLPPEA-VDLVCR 328
              +Y   K PQ +P       H   ++  P    +DL+ R
Sbjct: 251 GFVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQR 291

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 82.5 bits (204), Expect = 5e-18
 Identities = 66/204 (32%), Positives = 94/204 (46%), Gaps = 37/204 (18%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNR-----ELQIMQMLDHPNI 137
           YI   V+G G+FG     +  E   +V  K+V L     K R     E+ I+ +L HPNI
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           +A  + F      ++  L + +EY       ++I R   +  Q      V  Y +QI  A
Sbjct: 62  IAYYNHFM-----DDNTLLIEMEYANGGTLYDKIVR---QKGQLFEEEMVLWYLFQIVSA 113

Query: 196 LAYIHNCIGICHRDIKPQNL------LVK-GEPNVSYICSR------------YYRAPEL 236
           ++YIH   GI HRDIK  N+      L+K G+  +S I               YY +PEL
Sbjct: 114 VSYIHK-AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPEL 172

Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
             G  +Y    DIW+ GCV+ ELL
Sbjct: 173 CQGV-KYNFKSDIWALGCVLYELL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 83.7 bits (207), Expect = 5e-18
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 38/206 (18%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVAL 140
             +G GSFG V+ A+   T E+VAIKK+    +  N       +E++ +Q L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 198
           K C+       E    LV+EY   +    A +   +H++ PL  V++    +   + LAY
Sbjct: 81  KGCYL-----REHTAWLVMEYCLGS----ASDILEVHKK-PLQEVEIAAICHGALQGLAY 130

Query: 199 IHNCIGICHRDIKPQNLL------VK---------GEPNVSYICSRYYRAPELIFGATE- 242
           +H+   I HRDIK  N+L      VK           P  S++ + Y+ APE+I    E 
Sbjct: 131 LHSHERI-HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMDEG 189

Query: 243 -YTTAIDIWSTGCVMAELLLGQ-PLF 266
            Y   +D+WS G    EL   + PLF
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLF 215

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.9 bits (205), Expect = 5e-18
 Identities = 73/291 (25%), Positives = 117/291 (40%), Gaps = 68/291 (23%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR------ELQIMQMLDHPNIVAL 140
           +G G+FG V+     +TG  +A+K+V         K        E+Q+++ L H  IV  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             C     D E L +   +EY+P       ++  + +  +     + YT QI   + Y+H
Sbjct: 70  YGCL---RDDETLSI--FMEYMP---GGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH 121

Query: 201 NCIGICHRDIKPQNLLVKGEPNVSY-----------ICSR-----------YYRAPELIF 238
           + + I HRDIK  N+L     NV             ICS            Y+ +PE+I 
Sbjct: 122 SNM-IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180

Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 298
           G   Y    D+WS GC + E+L  +P +   +  + +  I K+   PT            
Sbjct: 181 GEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN----------- 225

Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
               PQ+  H         + P+A + + R F  +   R +A E   H F 
Sbjct: 226 ----PQLPSH---------VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 81.6 bits (201), Expect = 1e-17
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 34/210 (16%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN---RELQIMQMLDHPNIVA 139
           E  +G G F  V++A C   G  VA+KKV    L D + +    +E+ +++ L+HPN++ 
Sbjct: 7   EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 66

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
               F      E+  LN+VLE      ++R+ +++ +  + +P   V  Y  Q+C AL +
Sbjct: 67  YYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121

Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFG 239
           +H+   + HRDIKP N+ +     V                   S + + YY +PE I  
Sbjct: 122 MHS-RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH- 179

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGE 269
              Y    DIWS GC++ E+   Q  F G+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 46/213 (21%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQML-DHPNIVALKH 142
           V+G G++G V++A+ ++TG++VAIK  + D           E  I++   +HPNI     
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIK--IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70

Query: 143 CFF---STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            F       + ++L+  LV+E     +V  + +   +  +R+   ++     +  R LAY
Sbjct: 71  AFIKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY 128

Query: 199 IH--NCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELI 237
           +H    I   HRDIK QN+L+     V                   ++I + Y+ APE+I
Sbjct: 129 LHENKVI---HRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVI 185

Query: 238 FGATE------YTTAIDIWSTGCVMAELLLGQP 264
             A +      Y    D+WS G    EL  G+P
Sbjct: 186 --ACDEQPDASYDARSDVWSLGITAIELADGKP 216

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 80.2 bits (198), Expect = 5e-17
 Identities = 58/206 (28%), Positives = 105/206 (50%), Gaps = 37/206 (17%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           VGTG+FG V   + R +    A+K +       L+ +++ + E ++++ + HP I+ L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66

Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            F++  D+  LY+  ++EYVP  E  + + RN  R      L     Y  +I  AL Y+H
Sbjct: 67  -FWTEHDQRFLYM--LMEYVPGGELFSYL-RNSGRFSNSTGL----FYASEIVCALEYLH 118

Query: 201 NCIGICHRDIKPQNLLVKGEPNVSY---------------IC-SRYYRAPELIFGATEYT 244
           +   I +RD+KP+N+L+  E ++                 +C +  Y APE+I  +  + 
Sbjct: 119 S-KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVI-QSKGHN 176

Query: 245 TAIDIWSTGCVMAELLLGQPLFPGES 270
            A+D W+ G ++ E+L+G P F  ++
Sbjct: 177 KAVDWWALGILIYEMLVGYPPFFDDN 202

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 78.6 bits (194), Expect = 1e-16
 Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 37/217 (17%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
           G GS+G V++ K     +  A+K+V L     K R     E++I+  ++HPNI++ K  F
Sbjct: 9   GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68

Query: 145 FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIH 200
               D  +L +  V+EY P  +    I++   R  +R  +   +++    Q+ R L  +H
Sbjct: 69  L---DGNKLCI--VMEYAPFGDLSKAISK---RKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 201 NCIGICHRDIKPQNLLVK-------GEPNVSYICSR----------YYRAPELIFGATEY 243
               I HRD+K  N+L+        G+  +S +  +          +Y APE ++    Y
Sbjct: 121 E-QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPE-VWKGRPY 178

Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 280
           +   DIWS GC++ E+    P F   S  D   ++ +
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 75/298 (25%), Positives = 119/298 (39%), Gaps = 75/298 (25%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKK-----VLQDKRYK--NRELQIMQML-DHPNIVAL 140
           V+G GSFG V  A+ + T E+ A+K      +LQD   +    E +++ +   HP +  L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAY 198
            H  F T D+    L  V+EY    VN     +  I +  R      + Y  +I   L +
Sbjct: 62  -HSCFQTKDR----LFFVMEY----VNGGDLMF-HIQRSGRFDEPRARFYAAEIVLGLQF 111

Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV------------------SYIC-SRYYRAPELIFG 239
           +H   GI +RD+K  N+L+  E ++                  S  C +  Y APE++  
Sbjct: 112 LHE-RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY 170

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 299
              Y  A+D W+ G ++ E+L GQ  F G+   D+L + I             +      
Sbjct: 171 -QPYGPAVDWWALGVLLYEMLAGQSPFEGD-DEDELFQSI-------------LEDEV-- 213

Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-----HPFFDEL 352
                         + + L  EA  ++  F   +P  R   L         HPFF E+
Sbjct: 214 -------------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 82/320 (25%), Positives = 124/320 (38%), Gaps = 78/320 (24%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVALK 141
           +G G FG V   + + TG++ A KK L  KR K R        E +I++ +    IV+L 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59

Query: 142 HCFFSTTDKEELYLNLV----LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           + F  T D   L + L+    L+Y    V       +R            Y  QI   L 
Sbjct: 60  YAF-ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEAR---------AIFYAAQIICGLE 109

Query: 198 YIHNCIGICHRDIKPQNLLVKGEPNV------------------SYICSRYYRAPELIFG 239
           ++H    I +RD+KP+N+L+    NV                      +  Y APE++ G
Sbjct: 110 HLHQ-RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG 168

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 299
              Y  ++D ++ GC + E++ G+  F       Q  E ++      +EE+K        
Sbjct: 169 E-VYDFSVDWFALGCTLYEMIAGRSPF------RQRKEKVE------KEELKRRTLE-MA 214

Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD 354
            ++P             +  PEA DL     Q  P  R      +A E   HP F +L  
Sbjct: 215 VEYPD------------KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW 262

Query: 355 PNTRLPNGRPLPPLFNFKPP 374
              RL  G   PP   F P 
Sbjct: 263 R--RLEAGMLEPP---FIPD 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 77.2 bits (190), Expect = 5e-16
 Identities = 79/287 (27%), Positives = 119/287 (41%), Gaps = 61/287 (21%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYK---NRELQIMQMLDHPNIVALKHCF 144
           V+G G++G+V+ A+   T   +AIK++  +D RY    + E+ +   L H NIV      
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQ----- 69

Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           +  +D E  +  + +E VP  +++ + R+ +  +      I    YT QI   L Y+H+ 
Sbjct: 70  YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--IFYTKQILEGLKYLHD- 126

Query: 203 IGICHRDIKPQNLLVKGEPNVSYI-----CSRY---------------YRAPELI-FGAT 241
             I HRDIK  N+LV     V  I       R                Y APE+I  G  
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPR 186

Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            Y    DIWS GC + E+  G+P F                       I+   P    FK
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPF-----------------------IELGEPQAAMFK 223

Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
               K HP      + L  EA + + R F+  P+ R +A +    PF
Sbjct: 224 VGMFKIHP---EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 77.0 bits (190), Expect = 6e-16
 Identities = 69/295 (23%), Positives = 117/295 (39%), Gaps = 69/295 (23%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHC 143
           V+G G+  VV+ A C    E VAIK++  +K   +     +E+Q M   +HPN+V   + 
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YT 66

Query: 144 FFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F     +EL+  LV+ Y+     ++ +  +Y R      +I   L   ++ + L Y+H+
Sbjct: 67  SF--VVGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLHS 120

Query: 202 CIGICHRDIKPQNLLVKGEPNV-----------------------SYICSRYYRAPELIF 238
             G  HRDIK  N+L+  + +V                       +++ +  + APE++ 
Sbjct: 121 N-GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179

Query: 239 GATEYTTAIDIWSTGCVMAELLLGQP----LFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
               Y    DIWS G    EL  G        P +     L+  ++             N
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV----LMLTLQ-------------N 222

Query: 295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
                   P ++    +K + K        ++    Q  P+ R TA E   H FF
Sbjct: 223 D------PPSLETGADYKKYSKSFR----KMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 76.9 bits (189), Expect = 7e-16
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 52/214 (24%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------KRYK--NRELQIMQMLDHPNIV 138
           V+G G++G V+       G+++A+K+V  D        K Y+    E+ +++ L H NIV
Sbjct: 7   VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
                 +  T  ++  +++ +E+VP     I+   +R       ++ K YT QI   +AY
Sbjct: 66  Q-----YLGTCLDDNTISIFMEFVPG--GSISSILNRFGPLPEPVFCK-YTKQILDGVAY 117

Query: 199 IH-NCIGICHRDIKPQNLLVKGEPN-----VSYICSR----------------------Y 230
           +H NC+   HRDIK  N+++   PN     + + C+R                      Y
Sbjct: 118 LHNNCV--VHRDIKGNNVMLM--PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173

Query: 231 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQP 264
           + APE+I   + Y    DIWS GC + E+  G+P
Sbjct: 174 WMAPEVI-NESGYGRKSDIWSIGCTVFEMATGKP 206

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 33/199 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
           +G GSFG V+ A+     E+VAIKK+    +  N       +E++ +Q L HPN +  + 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           C+       E    LV+EY   + + +   + +  Q + +  V   T+   + LAY+H+ 
Sbjct: 83  CYL-----REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLHSH 134

Query: 203 IGICHRDIKPQNLLVKG---------------EPNVSYICSRYYRAPELIFGATE--YTT 245
             + HRD+K  N+L+                  P   ++ + Y+ APE+I    E  Y  
Sbjct: 135 -NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDG 193

Query: 246 AIDIWSTGCVMAELLLGQP 264
            +D+WS G    EL   +P
Sbjct: 194 KVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 75.9 bits (186), Expect = 2e-15
 Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 37/201 (18%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
           +G GSFG V+ A+   T E+VAIKK+    +  N       +E++ +Q + HPN +  K 
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIH 200
           C+       E    LV+EY   +    A +   +H++ PL  + +   T+   + LAY+H
Sbjct: 93  CYL-----REHTAWLVMEYCLGS----ASDLLEVHKK-PLQEVEIAAITHGALQGLAYLH 142

Query: 201 NCIGICHRDIKPQNLLVK---------------GEPNVSYICSRYYRAPELIFGATE--Y 243
           +   I HRDIK  N+L+                  P  S++ + Y+ APE+I    E  Y
Sbjct: 143 SHNMI-HRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQY 201

Query: 244 TTAIDIWSTGCVMAELLLGQP 264
              +D+WS G    EL   +P
Sbjct: 202 DGKVDVWSLGITCIELAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 74.9 bits (184), Expect = 3e-15
 Identities = 54/223 (24%), Positives = 99/223 (44%), Gaps = 35/223 (15%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQ--DKRYKN---RELQIMQMLDHPNI 137
           +   + +G GSFGVVF+   +    + A+K++ L   ++R +     E +++  LD   I
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +     F      ++  LN+V+EY     ++++ +      + +P   V  +  QI   L
Sbjct: 62  IRYYESFL-----DKGKLNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGL 114

Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELI 237
           A++H+   I HRDIK  NL +    NV                   + + + YY +PEL 
Sbjct: 115 AHLHS-KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELC 173

Query: 238 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 280
                Y    D+W+ G V+ E   G+  F   +    +++II+
Sbjct: 174 -EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 75.7 bits (186), Expect = 3e-15
 Identities = 84/319 (26%), Positives = 129/319 (40%), Gaps = 73/319 (22%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALKH 142
           +G GSFG V Q + R+T  I A+K + +       E+        ++  ++ P IV LK 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
             FS    E+LYL L      E  + + R       R  L   + YT ++  AL  +H  
Sbjct: 60  --FSFQSPEKLYLVLAFINGGELFHHLQR-----EGRFDLSRARFYTAELLCALENLHK- 111

Query: 203 IGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGATEY 243
             + +RD+KP+N+L+  + ++                   ++  +  Y APEL+ G   Y
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG-Y 170

Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 303
           T A+D W+ G ++ E+L G P F  E+ V+++    K+L  P R                
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYR--KILQEPLR---------------- 211

Query: 304 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFFDELRDPNTRLP 360
                     F      +A DL+       P  R     A E   HPFF +L     +L 
Sbjct: 212 ----------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS--WKKLL 259

Query: 361 NGRPLPPLFNFKPPELSGI 379
                PP   FKP   S I
Sbjct: 260 MKGIQPP---FKPAVSSAI 275

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 74.7 bits (183), Expect = 3e-15
 Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 34/214 (15%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN---RELQIMQMLDHP 135
           ++  E  +G G F  V++A C    + VA+KKV    + D + +    +E+ +++ L+HP
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           N++     F    +     LN+VLE      ++++ + + +  + +P   V  Y  Q+C 
Sbjct: 63  NVIKYLDSFIEDNE-----LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117

Query: 195 ALAYIHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPE 235
           A+ ++H+   + HRDIKP N+ +     V                   S + + YY +PE
Sbjct: 118 AVEHMHS-RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 236 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 269
            I     Y    DIWS GC++ E+   Q  F G+
Sbjct: 177 RIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 75.4 bits (185), Expect = 4e-15
 Identities = 81/281 (28%), Positives = 122/281 (43%), Gaps = 62/281 (22%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ---------IMQMLDHPNIVA 139
           V+G GSFG V  AK +  G+  A+ KVLQ K   NR+ Q         +++ + HP +V 
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAV-KVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           L H  F TT+K    L  VL++V   E    + R  S      P    + Y  +I  AL 
Sbjct: 61  L-HYSFQTTEK----LYFVLDFVNGGELFFHLQRERS-----FPEPRARFYAAEIASALG 110

Query: 198 YIHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIF 238
           Y+H+ I I +RD+KP+N+L+  + +V                   ++  +  Y APE+I 
Sbjct: 111 YLHS-INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI- 168

Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII-KVL----GTPT------R 287
               Y   +D W  G V+ E+L G P F      +    I+ K L    G          
Sbjct: 169 RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILE 228

Query: 288 EEIKCMNPNYTEFK--FPQIKPHP------WHKVFQKRLPP 320
           E ++         K  F +I+ HP      W  + QK++PP
Sbjct: 229 ELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPP 269

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 74.0 bits (182), Expect = 9e-15
 Identities = 73/309 (23%), Positives = 127/309 (41%), Gaps = 82/309 (26%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNR------ELQIMQMLDHPNIVALK 141
           ++  G++G V+  + +ET +  A+KK+  Q+   +N+      E  I+   ++P +V++ 
Sbjct: 8   LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM- 66

Query: 142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            C F T    + +L +V+EYV       + +N       +P+   ++Y  +   AL Y+H
Sbjct: 67  FCSFET----KRHLCMVMEYVEGGDCATLLKNIGA----LPVDMARMYFAETVLALEYLH 118

Query: 201 NCIGICHRDIKPQNLLVKGEPNVSY---------------------------------IC 227
           N  GI HRD+KP NLL+    ++                                   +C
Sbjct: 119 N-YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177

Query: 228 -SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 286
            +  Y APE+I     Y   +D W+ G ++ E L+G   F G++  +   ++I       
Sbjct: 178 GTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS------ 230

Query: 287 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEA 343
            ++I    P   E                  LP +A DL+ R  + +P  R     A E 
Sbjct: 231 -DDI--EWPEGDE-----------------ALPADAQDLISRLLRQNPLERLGTGGAFEV 270

Query: 344 CVHPFFDEL 352
             H FF  L
Sbjct: 271 KQHRFFLGL 279

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 73.6 bits (181), Expect = 9e-15
 Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 44/205 (21%)

Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKK-----VLQDKRYKNRELQIMQMLDHPNIV 138
           +G G FG V    CR       TGE VA+K        Q +    RE++I++ LDH NIV
Sbjct: 12  LGEGHFGKVE--LCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 197
             K             L L++EY+P    R    Y + H+ ++ L  + L++ QIC+ + 
Sbjct: 70  KYKGV---CEKPGGRSLRLIMEYLPSGSLRD---YLQRHRDQINLKRLLLFSSQICKGMD 123

Query: 198 YIHNCIGICHRDIKPQNLLVKGEPNVSY----------ICSRYYR------------APE 235
           Y+ +     HRD+  +N+LV+ E  V                YY             APE
Sbjct: 124 YLGS-QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182

Query: 236 LIFGATEYTTAIDIWSTGCVMAELL 260
            +  +  +++A D+WS G  + EL 
Sbjct: 183 CLRTSK-FSSASDVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 71/303 (23%), Positives = 113/303 (37%), Gaps = 85/303 (28%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           G G+FG V++A+ +ETG   A K +       L+D      E+ I+    HPNIV L   
Sbjct: 14  GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV---EIDILSECKHPNIVGLYEA 70

Query: 144 FFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLI--YVKLYTYQICRALAYIH 200
           +F         L +++E+     ++ I     R      L    ++    Q+  AL ++H
Sbjct: 71  YFYENK-----LWILIEFCDGGALDSIMLELER-----GLTEPQIRYVCRQMLEALNFLH 120

Query: 201 NCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELI---- 237
           +   + HRD+K  N+L+  + +V                   ++I + Y+ APE++    
Sbjct: 121 SHK-VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179

Query: 238 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 297
           F    Y    DIWS G  + EL   +P                    P  E    +NP  
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEP--------------------PHHE----LNPMR 215

Query: 298 TEFKFPQ------IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 351
              K  +       +P  W   F         D +       P+ R TA E   HPF  +
Sbjct: 216 VLLKILKSEPPTLDQPSKWSSSFN--------DFLKSCLVKDPDDRPTAAELLKHPFVSD 267

Query: 352 LRD 354
             D
Sbjct: 268 QSD 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 79/307 (25%), Positives = 126/307 (41%), Gaps = 78/307 (25%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 141
           V+G G+FG V   + + + ++ A+K + + +  K         E  IM   +   IV L 
Sbjct: 50  VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL- 108

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           H  F    +++ YL +V+EY+P  + VN ++ NY      +P  + + YT ++  AL  I
Sbjct: 109 HYAF----QDDKYLYMVMEYMPGGDLVNLMS-NYD-----IPEKWARFYTAEVVLALDAI 158

Query: 200 HNCIGICHRDIKPQNLL---------------VKGEPNVSYICSRY-----YRAPELIF- 238
           H+ +G  HRD+KP N+L               +K + N    C        Y +PE++  
Sbjct: 159 HS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS 217

Query: 239 --GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 296
             G   Y    D WS G  + E+L+G   F  +S V          GT +    K M+ +
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----------GTYS----KIMD-H 262

Query: 297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFF----- 349
                FP              +  +A DL+C F         R    E   HPFF     
Sbjct: 263 KNSLTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW 312

Query: 350 --DELRD 354
             D +R+
Sbjct: 313 TFDNIRE 319

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 49/206 (23%)

Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 12  LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNR--IARNYSRIHQRMPLIYVKLYTYQICRALA 197
            K   +S   +    L LV+EY+P    R  + ++  R+  R  L    LY  QIC+ + 
Sbjct: 70  YKGVCYSAGRRN---LRLVMEYLPYGSLRDYLQKHRERLDHRKLL----LYASQICKGME 122

Query: 198 YI--HNCIGICHRDIKPQNLLVKGEPNV---------------SYICSR-------YYRA 233
           Y+     +   HRD+  +N+LV+ E  V                Y   R       ++ A
Sbjct: 123 YLGSKRYV---HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179

Query: 234 PELIFGATEYTTAIDIWSTGCVMAEL 259
           PE +   ++++ A D+WS G V+ EL
Sbjct: 180 PESL-TESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 79/302 (26%), Positives = 125/302 (41%), Gaps = 74/302 (24%)

Query: 89  VVGTGSFGVVFQAKCR---ETGEIVAIK-----KVLQDKRYKNRELQIMQMLDH----PN 136
           V+GTG++G VF  +     + G++ A+K      ++Q  +         Q+L+     P 
Sbjct: 7   VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           +V L H  F T  K    L+L+L+YV   E    +   Y R  +      V++Y  +I  
Sbjct: 67  LVTL-HYAFQTDTK----LHLILDYVNGGELFTHL---YQR--EHFTESEVRVYIAEIVL 116

Query: 195 ALAYIHNCIGICHRDIKPQNLLVKGEPNV--------------------SYICSRYYRAP 234
           AL ++H  +GI +RDIK +N+L+  E +V                    S+  +  Y AP
Sbjct: 117 ALDHLHQ-LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175

Query: 235 ELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 293
           E+I G +  +  A+D WS G +  ELL G   F  +   +   EI       +R  +K  
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI-------SRRILKSK 228

Query: 294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFFD 350
            P                  F K +  EA D + +  +  P  R     A E   HPFF 
Sbjct: 229 PP------------------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270

Query: 351 EL 352
            +
Sbjct: 271 GI 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 73.4 bits (180), Expect = 2e-14
 Identities = 86/304 (28%), Positives = 132/304 (43%), Gaps = 77/304 (25%)

Query: 89  VVGTGSFGVVF---QAKCRETGEIVAIKKVLQD----KRYKNRELQIM--QMLDH----P 135
           V+GTG++G VF   +    +TG++ A+K VLQ     ++ K  E       +L+H    P
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMK-VLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR--MPLIYVKLYTYQIC 193
            +V L H  F T  K    L+L+L+YV          ++ ++QR       V+ Y+ +I 
Sbjct: 66  FLVTL-HYAFQTEAK----LHLILDYVSG-----GEMFTHLYQRDNFSEDEVRFYSGEII 115

Query: 194 RALAYIHNCIGICHRDIKPQNLLVKGEPNV--------------------SYICSRYYRA 233
            AL ++H  +GI +RDIK +N+L+  E +V                    S+  +  Y A
Sbjct: 116 LALEHLHK-LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174

Query: 234 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 293
           PE+I G   +  A+D WS G ++ ELL G   F  E   +   E+       +R  +KC 
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV-------SRRILKCD 227

Query: 294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPF 348
            P                  F   + PEA DL+ +  +  P  R       A E   HPF
Sbjct: 228 PP------------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269

Query: 349 FDEL 352
           F  L
Sbjct: 270 FKGL 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 72/294 (24%), Positives = 119/294 (40%), Gaps = 74/294 (25%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG+  A+K + ++      E+       +++Q   HP + ALK
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F  T D     L  V+EY    E    ++R       R      + Y  +I  AL Y+
Sbjct: 62  YSF-QTHD----RLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSALGYL 111

Query: 200 HNCIGICHRDIKPQNLLVK-------------------GEPNVSYICSRYYRAPELIFGA 240
           H+C  + +RD+K +NL++                    G    ++  +  Y APE +   
Sbjct: 112 HSC-DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLED 169

Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
            +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+         
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR--------- 213

Query: 301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 349
                        F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 214 -------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 67/275 (24%), Positives = 112/275 (40%), Gaps = 57/275 (20%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFF 145
           G G+ G V + + + TG I A+K +  D     ++   REL+I +    P IV     F 
Sbjct: 10  GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF- 68

Query: 146 STTDKEELYLNLVLEY-----VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
              D+    + + +EY     +     ++ +   RI ++  L  +      + + L+Y+H
Sbjct: 69  --LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEK-VLGKI---AESVLKGLSYLH 122

Query: 201 NCIGICHRDIKPQNLLVKGEPNV-----------------SYICSRYYRAPELIFGATEY 243
           +   I HRDIKP N+L+  +  V                 ++  + +Y APE I G   Y
Sbjct: 123 S-RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKP-Y 180

Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGES----GVDQLVEIIKVLGTPT-----------RE 288
           +   D+WS G  + E+   +  FP E     G  +L+  I  +  P             E
Sbjct: 181 SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSE 240

Query: 289 EIK-----CMNPNYTEFKFP-QIKPHPWHKVFQKR 317
           E K     C+  + T    P  +  HPW K   K+
Sbjct: 241 EFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 71/303 (23%), Positives = 118/303 (38%), Gaps = 70/303 (23%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQI-MQMLDHPNIVALKHCF 144
           G G++GVV + +   TG I+A+K++   +  +  K    +L I M+ +D P  V      
Sbjct: 10  GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL 69

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           F   D     + + +E +  ++++  +        +P   +      I +AL Y+H+ + 
Sbjct: 70  FREGD-----VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124

Query: 205 ICHRDIKPQNLLVKGEPNVSYIC-------------------SRYYRAPELIFGATE--- 242
           + HRD+KP N+L+     V  +C                    + Y APE I        
Sbjct: 125 VIHRDVKPSNVLINRNGQVK-LCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKG 183

Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 302
           Y    D+WS G  M EL  G+  FP +S             TP                F
Sbjct: 184 YDVKSDVWSLGITMIELATGR--FPYDS-----------WKTP----------------F 214

Query: 303 PQIK-----PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 357
            Q+K     P P  ++  ++  PE  D V +  + +   R    E   HPFF+     NT
Sbjct: 215 QQLKQVVEEPSP--QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNT 272

Query: 358 RLP 360
            + 
Sbjct: 273 DVA 275

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 71.4 bits (175), Expect = 4e-14
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 35/208 (16%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKH 142
           VVG G+FG+V   + +   ++V IK++  ++  K+       E Q++++L HPNI+    
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F      E+  L +V+EY P  T+    +   R +  +    +  +  QI  AL ++H 
Sbjct: 67  NFL-----EDKALMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILLALHHVHT 119

Query: 202 CIGICHRDIKPQNLLVK--------GEPNVSYICSRY-----------YRAPELIFGATE 242
            + I HRD+K QN+L+         G+  +S I S             Y +PEL  G   
Sbjct: 120 KL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEG-KP 177

Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGES 270
           Y    DIW+ GCV+ EL   +  F   +
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFEAAN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 71.5 bits (175), Expect = 4e-14
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 39/216 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKH 142
            +G GSFG ++ AK +   E   IK++      +++K    +E+ ++  + HPNIV    
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVT--- 63

Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            FF++  +E   L +V+EY    + + RI R    +     ++    +  QI   L +IH
Sbjct: 64  -FFASF-QENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQIL---SWFVQISLGLKHIH 118

Query: 201 NCIGICHRDIKPQNLLVKGEPNVS------------------YIC--SRYYRAPELIFGA 240
           +   I HRDIK QN+ +     V+                  Y C  + YY +PE I   
Sbjct: 119 D-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPE-ICQN 176

Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 276
             Y    DIWS GCV+ EL   +  F G + + QLV
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLV 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 71.7 bits (176), Expect = 7e-14
 Identities = 77/299 (25%), Positives = 129/299 (43%), Gaps = 54/299 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDK-RYKN---RELQIMQMLDHPNIVALKHC 143
            +G G+ GVV +   R +G I+A K + L+ K   +N   REL+++   + P IV     
Sbjct: 8   ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67

Query: 144 FFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           F+S  D E   +++ +E++   +++++ +   RI    P   +   +  + R L Y+   
Sbjct: 68  FYS--DGE---ISICMEHMDGGSLDQVLKKAGRI----PENILGKISIAVLRGLTYLREK 118

Query: 203 IGICHRDIKPQNLLV--KGEPNV---------------SYICSRYYRAPELIFGATEYTT 245
             I HRD+KP N+LV  +GE  +               S++ +R Y +PE + G T YT 
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQG-THYTV 177

Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
             DIWS G  + E+ +G+   P         E+  + G P   E +    +      P  
Sbjct: 178 QSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMFGRPV-SEGEAKESHRPVSGHPPD 232

Query: 306 KPHPWHKVFQ----------KRLP-----PEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
            P P   +F+           +LP      E  D V +  + +P  R    E   HPF 
Sbjct: 233 SPRPM-AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 71.0 bits (174), Expect = 9e-14
 Identities = 79/309 (25%), Positives = 127/309 (41%), Gaps = 64/309 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCF---- 144
           V+G GSFG V  A+ + T E  AIK + +D   ++ +++   +      +A +H F    
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           F T   +E +L  V+EY+      +  +      R      + Y  +I   L ++H   G
Sbjct: 62  FCTFQTKE-HLFFVMEYL--NGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKK-G 116

Query: 205 ICHRDIKPQNLL------------------VKGEPNVSYIC-SRYYRAPELIFGATEYTT 245
           I +RD+K  N+L                  + GE   S  C +  Y APE++ G  +Y  
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG-QKYNE 175

Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
           ++D WS G ++ E+L+GQ  F GE   D+L + I         +                
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGE-DEDELFDSI-------LNDR--------------- 212

Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-TALEACVHPFFDELRDPNTRLPNGRP 364
              P    F + +  EA D + + F+  P  R     +   HPFF   R  +      R 
Sbjct: 213 ---PH---FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF---RGIDWERLEKRE 263

Query: 365 LPPLFNFKP 373
           +PP   FKP
Sbjct: 264 IPP--PFKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 83/299 (27%), Positives = 124/299 (41%), Gaps = 80/299 (26%)

Query: 89  VVGTGSFGVVFQAK---CRETGEIVAIKKVLQ---------DKRYKNRELQIMQMLDHPN 136
           V+G G +G VFQ +     +TG+I A+K VL+         D  +   E  I++ + HP 
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           IV L    F T  K  LYL  +LEY+   E    + R    +           Y  +I  
Sbjct: 62  IVDL-IYAFQTGGK--LYL--ILEYLSGGELFMHLEREGIFMEDT-----ACFYLSEISL 111

Query: 195 ALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----ICSRY---------------YRAPE 235
           AL ++H   GI +RD+KP+N+L+  + +V      +C                  Y APE
Sbjct: 112 ALEHLHQ-QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPE 170

Query: 236 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 295
            I   + +  A+D WS G +M ++L G P F  E+    + +I+K          K   P
Sbjct: 171 -ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG---------KLNLP 220

Query: 296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 349
            Y                    L PEA DL+ +  + +P+ R       A E   HPFF
Sbjct: 221 PY--------------------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 79/284 (27%), Positives = 128/284 (45%), Gaps = 66/284 (23%)

Query: 89  VVGTGSFGVVF---QAKCRETGEIVAIK-------KVLQDKRYKNRELQIMQMLDHPNIV 138
           V+G GSFG VF   +    + G++ A+K       KV    R K  E  I+  ++HP IV
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFIV 61

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY--VKLYTYQICRAL 196
            L H  F T  K    L L+L+++     R    ++R+ + +      VK Y  ++  AL
Sbjct: 62  KL-HYAFQTEGK----LYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 111

Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELI 237
            ++H+ +GI +RD+KP+N+L+  E ++                   S+  +  Y APE++
Sbjct: 112 DHLHS-LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 170

Query: 238 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTPT---------- 286
                +T + D WS G +M E+L G   F G+   + +  I+K  LG P           
Sbjct: 171 -NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLL 229

Query: 287 REEIKCMNPNYTEFKFPQ----IKPHP------WHKVFQKRLPP 320
           R   K  NP       P     IK HP      W+K++++ + P
Sbjct: 230 RALFK-RNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 58/238 (24%), Positives = 101/238 (42%), Gaps = 65/238 (27%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNR----ELQIMQMLDHPNIVALK 141
           ++G G  G VF  + + TG++ A+K   K    KR K +    E +I+  LDHP +  L 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 142 HCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             F + T     YL LV++Y P   + R+ +   +  + +     + Y  ++  AL Y+H
Sbjct: 68  ASFQTET-----YLCLVMDYCPGGELFRLLQ--RQPGKCLSEEVARFYAAEVLLALEYLH 120

Query: 201 NCIGICHRDIKPQNLLVK------------------------------------------ 218
             +GI +RD+KP+N+L+                                           
Sbjct: 121 -LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179

Query: 219 ------GEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 270
                    + S++ +  Y APE+I G   + +A+D W+ G ++ E+L G   F G +
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSN 236

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 68/284 (23%), Positives = 109/284 (38%), Gaps = 51/284 (17%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHCF 144
           +G G+ G V + K   TG ++A K V    +        RELQIM     P IV+    F
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
            +  +     + + +E++   +++RI +    I    P+  +      +   L Y++N  
Sbjct: 73  LNENN-----ICMCMEFMDCGSLDRIYKKGGPI----PVEILGKIAVAVVEGLTYLYNVH 123

Query: 204 GICHRDIKPQNLLVKGEPNV-----------------SYICSRYYRAPELIFGATEYTTA 246
            I HRDIKP N+LV     +                 +++ +  Y +PE I G  +YT  
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGG-KYTVK 182

Query: 247 IDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            D+WS G  + EL LG+ P        D   + + +L                     QI
Sbjct: 183 SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-----------------LQQI 225

Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
              P  ++     P +  D V       P  R T  + C  P F
Sbjct: 226 VQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 61/234 (26%), Positives = 107/234 (45%), Gaps = 44/234 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---------ELQIMQMLDHPNIVA 139
           ++G G+FG V+     +TG  +A+K+V  D   +           E+Q+++ L H  IV 
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
              C     D EE  L++ +EY+P  ++    + Y  + + +     + YT QI + ++Y
Sbjct: 69  YYGCL---RDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVSY 121

Query: 199 IHNCIGICHRDIKPQNLLVKGEPNVSY-----------IC-----------SRYYRAPEL 236
           +H+ + I HRDIK  N+L     NV             IC           + Y+ +PE+
Sbjct: 122 LHSNM-IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180

Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 290
           I G   Y    D+WS  C + E+L  +P +   +  + +  I K+   PT+  +
Sbjct: 181 ISGEG-YGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPML 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 68.9 bits (168), Expect = 4e-13
 Identities = 77/296 (26%), Positives = 123/296 (41%), Gaps = 78/296 (26%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---------ELQIMQMLDHPNIVA 139
           ++G G+FG V+     +TG  +A+K+V  D               E+Q+++ L H  IV 
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
              C     D  E  L++ +E++P  ++    ++Y  + + +     + YT QI   ++Y
Sbjct: 69  YYGCL---RDPMERTLSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVSY 121

Query: 199 IHNCIGICHRDIKPQNLLVKGEPNVSY-----------IC-----------SRYYRAPEL 236
           +H+ + I HRDIK  N+L     NV             IC           + Y+ +PE+
Sbjct: 122 LHSNM-IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180

Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 296
           I G   Y    DIWS GC + E+L  +P +   +  + +  I K+   PT       NP 
Sbjct: 181 ISGEG-YGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPT-------NP- 228

Query: 297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
                                LPP   D  CR F     L+   +EA + P  DEL
Sbjct: 229 --------------------VLPPHVSDH-CRDF-----LKRIFVEAKLRPSADEL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 68.7 bits (168), Expect = 4e-13
 Identities = 68/298 (22%), Positives = 120/298 (40%), Gaps = 65/298 (21%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
           +G G++G V++   R TG  +A+K++   L + ++     EL I+     P IV     F
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           F      E  + + +EY+   +++++        + +P   ++  TY + + L ++    
Sbjct: 69  F-----IEGAVYMCMEYMDAGSLDKLYAGGVAT-EGIPEDVLRRITYAVVKGLKFLKEEH 122

Query: 204 GICHRDIKPQNLLVKGEPNV-----------------SYICSRYYRAPELI-----FGAT 241
            I HRD+KP N+LV G   V                 + I  + Y APE I         
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNP 182

Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVD---QLVEIIKVLGTPTREEIKCMNPNYT 298
            YT   D+WS G  + E+ LG+  +P E+  +   QL  I+   G P       +   Y+
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT-----LPSGYS 235

Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
                                 +A D V +     PN R T  +   HP+  + ++ +
Sbjct: 236 ---------------------DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 69.1 bits (169), Expect = 5e-13
 Identities = 83/300 (27%), Positives = 127/300 (42%), Gaps = 77/300 (25%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNR--ELQIMQM-LDHPNIVAL 140
           V+G GSFG V  A+ + T E+ AIK      +LQD        E +I+ +   HP + AL
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            HC F T D+    L  V+EYV   + + +I R+      R      + Y  ++  AL +
Sbjct: 62  -HCCFQTKDR----LFFVMEYVNGGDLMFQIQRSRKFDEPR-----SRFYAAEVTLALMF 111

Query: 199 IHNCIGICHRDIKPQNLLV-------------------KGEPNVSYICSRYYRAPELIFG 239
           +H   G+ +RD+K  N+L+                    G    ++  +  Y APE I  
Sbjct: 112 LHRH-GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPE-ILQ 169

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 299
             EY  ++D W+ G +M E++ GQP F  ++  D L E I                 + +
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESIL----------------HDD 212

Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--CTALEAC-----VHPFFDEL 352
             +P      W       L  EAV ++  F   +PN R  C A +        HPFF E+
Sbjct: 213 VLYPV-----W-------LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 68.9 bits (168), Expect = 5e-13
 Identities = 65/208 (31%), Positives = 93/208 (44%), Gaps = 43/208 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY--KNRELQIM-------QMLDHPNIVA 139
           V+G GSFG V  A+ +   +  A+K VLQ K    K  E  IM       + + HP +V 
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVK-VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           L H  F T DK    L  VL+Y+   E    + R    +  R      + Y  +I  AL 
Sbjct: 61  L-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASALG 110

Query: 198 YIHNCIGICHRDIKPQNLLVKG----------------EPN--VSYIC-SRYYRAPELIF 238
           Y+H+ + I +RD+KP+N+L+                  E N   S  C +  Y APE++ 
Sbjct: 111 YLHS-LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLH 169

Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLF 266
               Y   +D W  G V+ E+L G P F
Sbjct: 170 -KQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 68.2 bits (166), Expect = 5e-13
 Identities = 75/292 (25%), Positives = 119/292 (40%), Gaps = 69/292 (23%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---------ELQIMQMLDHPNIVA 139
           ++G G+FG V+     +TG  +A K+V  D               E+Q+++ L H  IV 
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
              C     D+ E  L + +EY+P  +V    + Y  + + +     + YT QI   ++Y
Sbjct: 69  YYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV----TRKYTRQILEGMSY 121

Query: 199 IHNCIGICHRDIKPQNLLVKGEPNVSY-----------IC-----------SRYYRAPEL 236
           +H+ + I HRDIK  N+L     NV             IC           + Y+ +PE+
Sbjct: 122 LHSNM-IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180

Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 296
           I G   Y    D+WS GC + E+L  +P +   +  + +  I K+   PT       NP 
Sbjct: 181 ISGEG-YGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPT-------NP- 228

Query: 297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       P H     R      D +   F  + + R +A E   HPF
Sbjct: 229 ----------QLPSHISEHAR------DFLGCIFVEARH-RPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 68.5 bits (168), Expect = 6e-13
 Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 47/232 (20%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNRELQ----IMQMLDHPNIVALKHC 143
           +G G+FG V +   + +G I+A+K++    D++ + R L     +M+  D P IV     
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVK---- 67

Query: 144 FFSTTDKE-------ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           F+    +E       EL +++ L+   + V      Y  +   +P   +        +AL
Sbjct: 68  FYGALFREGDCWICMEL-MDISLDKFYKYV------YEVLKSVIPEEILGKIAVATVKAL 120

Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNVSY----ICS--------------RYYRAPELI- 237
            Y+   + I HRD+KP N+L+    N+      I                R Y APE I 
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 180

Query: 238 -FGATEYTTAIDIWSTGCVMAELLLGQPLFPG-ESGVDQLVEIIKVLGTPTR 287
                 Y    D+WS G  + E+  G+  +P   S  DQL +++K  G P  
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPI 230

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 68.5 bits (167), Expect = 6e-13
 Identities = 76/301 (25%), Positives = 127/301 (42%), Gaps = 74/301 (24%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 143
           +G GS G+V  A+ + +G  VA+K  + D R + R      E+ IM+   H N+V +   
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHQNVVEM--- 83

Query: 144 FFSTTDKEELYLNLVLEYV-----PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           + S    EEL++  ++E++      + V++   N  +I               + +AL Y
Sbjct: 84  YKSYLVGEELWV--LMEFLQGGALTDIVSQTRLNEEQI---------ATVCESVLQALCY 132

Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFG 239
           +H+  G+ HRDIK  ++L+  +  V                   S + + Y+ APE+I  
Sbjct: 133 LHS-QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI-S 190

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 299
            T Y T +DIWS G ++ E++ G+P +  +S V  +  +        R+           
Sbjct: 191 RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDS---------- 232

Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 359
                  P P  K   K + P   D + R     P  R TA E   HPF  +   P   +
Sbjct: 233 -------PPPKLKNAHK-ISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLV 284

Query: 360 P 360
           P
Sbjct: 285 P 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 67.5 bits (165), Expect = 8e-13
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 41/206 (19%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN--RELQIMQMLDHPNI 137
           Y+    +G GSFG     K +E G+   IK++    +  K  +   +E+ ++  + HPNI
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY----VKLYTYQIC 193
           V  +  F     +E   L +V++Y           Y +I+ +  +++    +  +  QIC
Sbjct: 62  VQYQESF-----EENGNLYIVMDYCEG-----GDLYKKINAQRGVLFPEDQILDWFVQIC 111

Query: 194 RALAYIHNCIGICHRDIKPQNL-LVKG------------------EPNVSYICSRYYRAP 234
            AL ++H+   I HRDIK QN+ L K                   E   + I + YY +P
Sbjct: 112 LALKHVHD-RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSP 170

Query: 235 ELIFGATEYTTAIDIWSTGCVMAELL 260
           E I     Y    DIW+ GCV+ E+ 
Sbjct: 171 E-ICENRPYNNKSDIWALGCVLYEMC 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 68.1 bits (166), Expect = 9e-13
 Identities = 79/313 (25%), Positives = 129/313 (41%), Gaps = 72/313 (23%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 140
           ++G GSFG VF A+ + T +  AIK + +D    + +++   +         +HP +  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            +C F T  KE L+   V+EY+      +  +    H +  L     Y  +I   L ++H
Sbjct: 62  -YCTFQT--KENLFF--VMEYL--NGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH 113

Query: 201 NCIGICHRDIKPQNLLVK------------------GEPNVSYIC-SRYYRAPELIFGAT 241
           +  GI +RD+K  N+L+                   G+      C +  Y APE++ G  
Sbjct: 114 S-KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG-Q 171

Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
           +Y T++D WS G ++ E+L+GQ  F G    +              + I+  NP Y  + 
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF------------QSIRMDNPCYPRW- 218

Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELRDPNTRLP 360
                           L  EA D++ + F   P  R     +   HPFF E+    + L 
Sbjct: 219 ----------------LTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID--WSALE 260

Query: 361 NGRPLPPLFNFKP 373
                PP   FKP
Sbjct: 261 EREIEPP---FKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 40/203 (19%)

Query: 89  VVGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVA 139
           V+G G FG V    +      TGE+VA+K + ++   +N      E+ I++ L H NIV 
Sbjct: 11  VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
            K C    +++    L L++EYVP       R+Y   H ++ L  + L+  QIC  +AY+
Sbjct: 71  YKGC---CSEQGGKGLQLIMEYVPLGS---LRDYLPKH-KLNLAQLLLFAQQICEGMAYL 123

Query: 200 HNCIGICHRDIKPQNLLVKGEPNVSYICS-----------RYYRAPE-----LIFGATE- 242
           H+   I HRD+  +N+L+  +  +  I              YYR  E     + + A E 
Sbjct: 124 HSQHYI-HRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181

Query: 243 -----YTTAIDIWSTGCVMAELL 260
                ++ A D+WS G  + ELL
Sbjct: 182 LKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 43/208 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ---------IMQMLDHPNIVA 139
           V+G GSFG V  AK +  G   A+ KVLQ K    ++ Q         +++ L HP +V 
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAV-KVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           L + F +    E+LY   VL+YV   E    + R    +  R      + Y  ++  A+ 
Sbjct: 61  LHYSFQTA---EKLY--FVLDYVNGGELFFHLQRERCFLEPR-----ARFYAAEVASAIG 110

Query: 198 YIHNCIGICHRDIKPQNLL------------------VKGEPNVSYIC-SRYYRAPELIF 238
           Y+H+ + I +RD+KP+N+L                  V+ E   S  C +  Y APE + 
Sbjct: 111 YLHS-LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPE-VL 168

Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLF 266
               Y   +D W  G V+ E+L G P F
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 39/204 (19%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
           +G G+FG V++AK +ETG  +A  KV++ K  +       E++I+   +HP IV L   F
Sbjct: 20  LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 145 FSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           +      +  L +++E+ P   V+ I     R     P I  ++   Q+  AL Y+H+ +
Sbjct: 79  Y-----WDGKLWIMIEFCPGGAVDAIMLELDRGLTE-PQI--QVICRQMLEALQYLHS-M 129

Query: 204 GICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGAT--- 241
            I HRD+K  N+L+  + ++                   S+I + Y+ APE++   T   
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189

Query: 242 -EYTTAIDIWSTGCVMAELLLGQP 264
             Y    DIWS G  + E+   +P
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEP 213

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 66.1 bits (161), Expect = 3e-12
 Identities = 61/244 (25%), Positives = 105/244 (43%), Gaps = 54/244 (22%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVALK 141
           +G G FG V   + + TG++ A KK L  KR K +        E +I++ ++ P IV L 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59

Query: 142 HCFFSTTDKEELYLNLV--------LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + F S T     +L LV        L+Y    V        R+      I+   Y+ QI 
Sbjct: 60  YAFESKT-----HLCLVMSLMNGGDLKYHIYNVGERGLEMERV------IH---YSAQIT 105

Query: 194 RALAYIHNCIGICHRDIKPQNLLV------------------KGEPNVSYICSRYYRAPE 235
             + ++H+ + I +RD+KP+N+L+                   G+       +  Y APE
Sbjct: 106 CGILHLHS-MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPE 164

Query: 236 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 295
            I     Y+  +D ++ GC + E++ G+  F       + V   ++      +E+K  + 
Sbjct: 165 -ILKEEPYSYPVDWFAMGCSIYEMVAGRTPF---KDHKEKVAKEELKRRTLEDEVKFEHQ 220

Query: 296 NYTE 299
           N+TE
Sbjct: 221 NFTE 224

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 66.5 bits (162), Expect = 4e-12
 Identities = 78/315 (24%), Positives = 132/315 (41%), Gaps = 76/315 (24%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 140
           V+G GSFG V  A+ +  GE  A+K + +D    + +++   +         ++P +  L
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            +C F T +    +L  V+E++   + +  I         R  L     Y  +I   L +
Sbjct: 62  -YCTFQTKE----HLFFVMEFLNGGDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQF 111

Query: 199 IHNCIGICHRDIKPQNLL------------------VKGEPNVSYIC-SRYYRAPELIFG 239
           +H+  GI +RD+K  N++                  V G+   S  C +  Y APE++ G
Sbjct: 112 LHS-KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG 170

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 299
             +YT ++D WS G ++ E+L+GQ  F G+   D+L E I+V                  
Sbjct: 171 -LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV------------------ 210

Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELRDPNTR 358
                  PH     + + +  E+ D++ + F+  P  R   +     HPFF  +   N  
Sbjct: 211 -----DTPH-----YPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI---NWT 257

Query: 359 LPNGRPLPPLFNFKP 373
               R L P   FKP
Sbjct: 258 ALEKRELDP--PFKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 76/296 (25%), Positives = 126/296 (42%), Gaps = 64/296 (21%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 143
           +G GS G+V  A  + +G++VA+KK+  D R + R      E+ IM+   H N+V + + 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           +      +EL+  +V+E++       A      H RM    +      + +AL+ +H   
Sbjct: 86  YLV---GDELW--VVMEFLEGG----ALTDIVTHTRMNEEQIAAVCLAVLKALSVLH-AQ 135

Query: 204 GICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGATEYT 244
           G+ HRDIK  ++L+  +  V                   S + + Y+ APELI     Y 
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI-SRLPYG 194

Query: 245 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 304
             +DIWS G ++ E++ G+P +  E               P  + +K +  N      P+
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNLP----PK 235

Query: 305 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 360
           +K    HKV      P     + R     P  R TA E   HPF  +   P+  +P
Sbjct: 236 LK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVP 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 66.0 bits (161), Expect = 6e-12
 Identities = 71/292 (24%), Positives = 128/292 (43%), Gaps = 72/292 (24%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 140
           V+G GS+  V   + ++T  I A+K + ++    + ++  +Q          +HP +V L
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
             CF     + E  L  V+E+V   + +  + R      +++P  + + Y+ +I  AL +
Sbjct: 62  HSCF-----QTESRLFFVIEFVSGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNF 111

Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV------------------SYIC-SRYYRAPELIFG 239
           +H   GI +RD+K  N+L+  E ++                  S  C +  Y APE++ G
Sbjct: 112 LHE-RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG 170

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLF--------PGESGVDQLVEII--KVLGTPTREE 289
             +Y  ++D W+ G +M E++ G+  F        P ++  D L ++I  K +  P    
Sbjct: 171 -EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLS 229

Query: 290 IKC-------MNPNYTE-------FKFPQIKPHP------WHKVFQKR-LPP 320
           +K        +N +  E         F  IK HP      W  + QK+ LPP
Sbjct: 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPP 281

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 65.1 bits (159), Expect = 6e-12
 Identities = 56/232 (24%), Positives = 92/232 (39%), Gaps = 46/232 (19%)

Query: 90  VGTGSFGVVFQAKCRETG--EI-VAIK-----KVLQDKRYKNRELQIMQMLDHPNIVALK 141
           +G G+FG V +         E+ VA+K      +   K+   RE  +M  LDHP IV L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61

Query: 142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
                    E L   LV+E  P   + +    Y +  + +P+  +K   +Q+   +AY+ 
Sbjct: 62  ---IGVCKGEPLM--LVMELAPLGPLLK----YLKKRREIPVSDLKELAHQVAMGMAYLE 112

Query: 201 NCIGICHRDIKPQNLLVKGEPNVS---YICSR-------YYR------------APELIF 238
           +     HRD+  +N+L+          +  SR       YYR            APE I 
Sbjct: 113 SK-HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171

Query: 239 GATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVEIIKVLGTPTR 287
               +++  D+WS G  + E    G   +    G +   ++E  + L  P  
Sbjct: 172 YGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEE 222

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 64.6 bits (157), Expect = 9e-12
 Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 36/202 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           Y    VVG GSFG     +   + +  A+K++   K         +E  ++  + HPNIV
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           A K  F     + + +L +V+EY    + + +I     ++    P   +  +  Q+C  +
Sbjct: 62  AFKESF-----EADGHLYIVMEYCDGGDLMQKIKLQRGKL---FPEDTILQWFVQMCLGV 113

Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELI 237
            +IH    + HRDIK +N+ +     V                   +Y+ + YY  PE I
Sbjct: 114 QHIHE-KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE-I 171

Query: 238 FGATEYTTAIDIWSTGCVMAEL 259
           +    Y    DIWS GC++ EL
Sbjct: 172 WENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 65.4 bits (159), Expect = 9e-12
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 38/218 (17%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNR--ELQIMQMLDHPNIVALK 141
           V+G GSFG V  A+ + T E+ AIK      V+QD   +    E +++ + D P  +   
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYIH 200
           H  F T D+    L  V+EYV      +  +  ++ + + P      Y  +I   L ++H
Sbjct: 67  HSCFQTVDR----LYFVMEYV--NGGDLMYHIQQVGKFKEP--QAVFYAAEISVGLFFLH 118

Query: 201 NCIGICHRDIKPQNLLVKGEPNVSY-------------ICSRY------YRAPELIFGAT 241
              GI +RD+K  N+++  E ++               + +R       Y APE+I    
Sbjct: 119 R-RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII-AYQ 176

Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
            Y  ++D W+ G ++ E+L GQP F GE   D+L + I
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 38/205 (18%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 143
           +G GS G+V  A  + TG+ VA+KK+  D R + R      E+ IM+   H N+V + + 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           +      +EL++  V+E++       A      H RM    +      + RAL+Y+HN  
Sbjct: 88  YLV---GDELWV--VMEFLEGG----ALTDIVTHTRMNEEQIATVCLSVLRALSYLHN-Q 137

Query: 204 GICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGATEYT 244
           G+ HRDIK  ++L+  +  +                   S + + Y+ APE+I     Y 
Sbjct: 138 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVI-SRLPYG 196

Query: 245 TAIDIWSTGCVMAELLLGQPLFPGE 269
           T +DIWS G ++ E++ G+P +  E
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPYFNE 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 71/284 (25%), Positives = 112/284 (39%), Gaps = 66/284 (23%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----------RYKNRELQIMQMLDHPNI 137
           V+G G FG V  A+ ++TGE+ AIK  L+               + R  +      HP +
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIK-ALKKGDIIARDEVESLMCEKRIFETANSERHPFL 64

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           V L  CF     + E ++  V+EY    + +  I  +               Y   +   
Sbjct: 65  VNLFACF-----QTEDHVCFVMEYAAGGDLMMHIHTD------VFSEPRAVFYAACVVLG 113

Query: 196 LAYIHNCIGICHRDIKPQNLLVKGEPNV------------------SYIC-SRYYRAPEL 236
           L Y+H    I +RD+K  NLL+  E  V                  S  C +  + APE+
Sbjct: 114 LQYLHEN-KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEV 172

Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPG---ESGVDQLV-EIIKVLGTPTREEIKC 292
           +   T YT A+D W  G ++ E+L+G+  FPG   E   D +V + ++     +RE I  
Sbjct: 173 LTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISI 231

Query: 293 M------NPN----YTEFKFPQIKPHP------WHKVFQKRLPP 320
           M      NP       E     +K  P      W  +  +++ P
Sbjct: 232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKP 275

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 60/234 (25%), Positives = 109/234 (46%), Gaps = 49/234 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDH--------PNIVAL 140
           V+G GS+  V   + ++  +I A+K V ++  + + ++  +Q   H        P +V L
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
             CF +T+      L LV+EYV   + +  + R      +++P  + + Y  +IC AL +
Sbjct: 62  HSCFQTTSR-----LFLVIEYVNGGDLMFHMQR-----QRKLPEEHARFYAAEICIALNF 111

Query: 199 IHNCIGICHRDIKPQNLLVK-------------------GEPNVSYICSRYYRAPELIFG 239
           +H   GI +RD+K  N+L+                    G+   ++  +  Y APE++ G
Sbjct: 112 LHE-RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG 170

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLF------PGESGVDQLVEIIKVLGTPTR 287
             EY  ++D W+ G +M E++ G+  F      P  +  D L ++I  L  P R
Sbjct: 171 E-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKPIR 221

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 60/244 (24%), Positives = 111/244 (45%), Gaps = 48/244 (19%)

Query: 85  IAEHVVGTGSFGVVFQAKCRETGE-IVAIKKVL-------QDKRYKNRELQ--------I 128
           + EH+ G+G+FG V++ + +  G+ ++A+K++        +DKR +++ +         I
Sbjct: 4   VLEHL-GSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTII 62

Query: 129 MQMLDHPNIVALKHCFFSTTDKEELYLNLVL-EYVP--ETVNRIARNYSRI-HQRMPLIY 184
            + L HPNIV     F    + + LY+ + L E  P  E  N +     R   +R+  I+
Sbjct: 63  KEQLRHPNIVRYYKTF---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV--------------SYICSR- 229
           V     Q+  AL Y+H    I HRD+ P N+++  +  V              S + S  
Sbjct: 120 V-----QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV 174

Query: 230 ---YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 286
               Y  PE++     Y    D+W+ GC++ ++   QP F   + +    +I++ +  P 
Sbjct: 175 GTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL 233

Query: 287 REEI 290
            E +
Sbjct: 234 PEGM 237

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 66/283 (23%), Positives = 116/283 (40%), Gaps = 64/283 (22%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE----------LQIMQMLDHPNIVA 139
           +G G+FG V+Q + ++T  I A+K + + +    +E          L    + + P IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           LK  F + +D     L LV +Y+   E    + +       R      K Y  ++  AL 
Sbjct: 61  LKFSFQTDSD-----LYLVTDYMSGGELFWHLQKE-----GRFSEDRAKFYIAELVLALE 110

Query: 198 YIHNCIGICHRDIKPQNLLVKG------------EPNVS-------YICSRYYRAPELIF 238
           ++H    I +RD+KP+N+L+              + N++       +  +  Y APE++ 
Sbjct: 111 HLHK-YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLL 169

Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII---------KVLGTPTREE 289
               YT  +D WS G ++ E+  G   F  E    Q+   I          VL    R+ 
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-TQQMYRNIAFGKVRFPKNVLSDEGRQF 228

Query: 290 IKCM---NPNY---TEFKFPQIKPHP------WHKVFQKRLPP 320
           +K +   NP +         ++K HP      W  + +K++ P
Sbjct: 229 VKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITP 271

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 60/222 (27%), Positives = 111/222 (50%), Gaps = 43/222 (19%)

Query: 90  VGTGSFGVVFQAKCRETGEIVA-------IKKVLQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G G+ GVV + + + +G I+A       IK  ++++    RELQ++   + P IV    
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F+S  D E   +++ +E++   +++++ +   RI + +    +   +  + R LAY+  
Sbjct: 71  AFYS--DGE---ISICMEHMDGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLAYLRE 121

Query: 202 CIGICHRDIKPQNLLV--KGEPNV---------------SYICSRYYRAPELIFGATEYT 244
              I HRD+KP N+LV  +GE  +               S++ +R Y +PE + G T Y+
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQG-THYS 180

Query: 245 TAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTP 285
              DIWS G  + EL +G+ P+ P ++      E+  + G P
Sbjct: 181 VQSDIWSMGLSLVELAIGRYPIPPPDAK-----ELEAIFGRP 217

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 39/209 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
           V+G GSFG V  A+ + T E+ AIK + +D   ++ +++       ++ +   P  +   
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAYI 199
           H  F T D+        L +V E VN     Y  I Q  +    +   Y  +I   L ++
Sbjct: 67  HSCFQTMDR--------LYFVMEYVNGGDLMY-HIQQVGKFKEPHAVFYAAEIAIGLFFL 117

Query: 200 HNCIGICHRDIKPQNLLVKGEPNVSY----ICSRY---------------YRAPELIFGA 240
           H+  GI +RD+K  N+++  E ++      +C                  Y APE+I   
Sbjct: 118 HS-KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-AY 175

Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGE 269
             Y  ++D W+ G ++ E+L GQP F GE
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 71/295 (24%), Positives = 123/295 (41%), Gaps = 79/295 (26%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVL-------QDKRYKNRELQIM-QMLDHPNIVAL 140
           V+G GS+  V   + ++T  I A+K V        +D  +   E  +  Q  +HP +V L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
             CF     + E  L  V+EYV   + +  + R      +++P  + + Y+ +I  AL Y
Sbjct: 62  HSCF-----QTESRLFFVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNY 111

Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV------------------SYIC-SRYYRAPELIFG 239
           +H   GI +RD+K  N+L+  E ++                  S  C +  Y APE++ G
Sbjct: 112 LHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 170

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLF--------PGESGVDQLVEII------------ 279
             +Y  ++D W+ G +M E++ G+  F        P ++  D L ++I            
Sbjct: 171 -EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 229

Query: 280 --------KVLGTPTREEIKCMNPNYTEFKFPQIKPHP------WHKVFQKRLPP 320
                     L    +E + C      +  F  I+ HP      W  + QK++ P
Sbjct: 230 VKAASVLKSFLNKDPKERLGCH----PQTGFADIQGHPFFRNVDWDLMEQKQVVP 280

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 61/228 (26%), Positives = 105/228 (46%), Gaps = 44/228 (19%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPN 136
           Y    V+G G+FG V   + + + ++ A+K + +       D  +   E  IM   + P 
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           +V L  C F    +++ YL +V+EY+P  + VN ++ NY      +P  + K YT ++  
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWAKFYTAEVVL 153

Query: 195 ALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----ICSRY----------------YRAP 234
           AL  IH+ +G+ HRD+KP N+L+    ++       C +                 Y +P
Sbjct: 154 ALDAIHS-MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISP 212

Query: 235 ELIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
           E++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 74/304 (24%), Positives = 128/304 (42%), Gaps = 76/304 (25%)

Query: 89  VVGTGSFGVVF---QAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDH----PN 136
           V+GTG++G VF   +    ++G++ A+K      ++Q  +         Q+L+H    P 
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY--VKLYTYQICR 194
           +V L + F + T      L+L+L+Y+          ++ + QR       V++Y+ +I  
Sbjct: 67  LVTLHYAFQTDTK-----LHLILDYING-----GELFTHLSQRERFKEQEVQIYSGEIVL 116

Query: 195 ALAYIHNCIGICHRDIKPQNLLVKGEPNV--------------------SYICSRYYRAP 234
           AL ++H  +GI +RDIK +N+L+    +V                    S+  +  Y AP
Sbjct: 117 ALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175

Query: 235 ELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 293
           +++ G    +  A+D WS G +M ELL G   F  +   +   EI       +R  +K  
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI-------SRRILKSE 228

Query: 294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPF 348
            P      +PQ             +   A D++ R     P  R       A E   HPF
Sbjct: 229 PP------YPQ------------EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPF 270

Query: 349 FDEL 352
           F ++
Sbjct: 271 FQKI 274

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 62.8 bits (153), Expect = 4e-11
 Identities = 60/203 (29%), Positives = 88/203 (43%), Gaps = 44/203 (21%)

Query: 89  VVGTGSFGVVFQA--KCRETGEI-VAIKKVLQDKRYKNREL-----QIMQMLDHPNIVAL 140
            +G G FG V+Q      E  +I VA+K          RE       IM+  DHP+IV L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYI 199
                      E  + +V+E  P       R+Y ++++  + L  + LY+YQ+  ALAY+
Sbjct: 73  IGVI------TENPVWIVMELAPLGE---LRSYLQVNKYSLDLASLILYSYQLSTALAYL 123

Query: 200 H--NCIGICHRDIKPQNLLVKGEPNVS---YICSR------YYRA-----------PELI 237
                +   HRDI  +N+LV     V    +  SR      YY+A           PE I
Sbjct: 124 ESKRFV---HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESI 180

Query: 238 FGATEYTTAIDIWSTGCVMAELL 260
                +T+A D+W  G  M E+L
Sbjct: 181 -NFRRFTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 60/227 (26%), Positives = 113/227 (49%), Gaps = 38/227 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVA-------IKKVLQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G G+ GVVF+   + +G I+A       IK  ++++    RELQ++   + P IV    
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F+S  D E   +++ +E++   +++++ +   RI +++    +   +  + + L Y+  
Sbjct: 71  AFYS--DGE---ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE 121

Query: 202 CIGICHRDIKPQNLLV--KGEPNV---------------SYICSRYYRAPELIFGATEYT 244
              I HRD+KP N+LV  +GE  +               S++ +R Y +PE + G T Y+
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQG-THYS 180

Query: 245 TAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEI 290
              DIWS G  + E+ +G+ P+ P ++   +L+    V G P   E 
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 63.0 bits (153), Expect = 4e-11
 Identities = 65/257 (25%), Positives = 116/257 (45%), Gaps = 55/257 (21%)

Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
           G+ K+K  Y     +G G+ G V+ A    TG+ VAIK++ LQ +  K     E+ +M+ 
Sbjct: 15  GDPKKK--YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVK 186
             HPNIV     +      +EL++  V+EY+      + V     +  +I          
Sbjct: 73  NKHPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQIAA-------- 119

Query: 187 LYTYQICR----ALAYIHNCIGICHRDIKPQNLLVKGEPNV------------------- 223
                +CR    AL ++H+   + HRDIK  N+L+  + +V                   
Sbjct: 120 -----VCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173

Query: 224 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 283
           + + + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   G
Sbjct: 174 TMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNG 231

Query: 284 TPTREEIKCMNPNYTEF 300
           TP  +  + ++  + +F
Sbjct: 232 TPELQNPEKLSAIFRDF 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 63.2 bits (154), Expect = 4e-11
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 37/207 (17%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKN----RELQIMQM-LDHPNIVALKHC 143
           +G+G+ G V++ + ++TG ++A+K++ +   + +N     +L ++    D P IV     
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMP-LIYVKLYTYQICRALAYIHNC 202
           F + +D     + + +E +   ++++ +   RI   +P  I  K+ T  I +AL Y+   
Sbjct: 83  FITDSD-----VFICMELMSTCLDKLLK---RIQGPIPEDILGKM-TVAIVKALHYLKEK 133

Query: 203 IGICHRDIKPQNLLVKGEPNVSY----ICSRY--------------YRAPELIFGAT--- 241
            G+ HRD+KP N+L+    NV      I  R               Y APE I       
Sbjct: 134 HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNP 193

Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPG 268
           +Y    D+WS G  + EL  GQ  +  
Sbjct: 194 KYDIRADVWSLGISLVELATGQFPYKN 220

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 63.4 bits (154), Expect = 4e-11
 Identities = 83/314 (26%), Positives = 131/314 (41%), Gaps = 75/314 (23%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKK-----VLQDKRYK--NRELQIMQML-DHPNIVAL 140
           V+G GSFG V  A+ +E+G + A+K      +LQD   +    E +I+ +  +HP +  L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            +C F T D+    L  V+E+V           SR   R      + Y  +I  AL ++H
Sbjct: 62  -YCCFQTPDR----LFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEITSALMFLH 113

Query: 201 NCIGICHRDIKPQNLLV-------------------KGEPNVSYICSRYYRAPELIFGAT 241
           +  GI +RD+K  N+L+                    G+   ++  +  Y APE I    
Sbjct: 114 D-KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE-ILQEM 171

Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            Y  ++D W+ G ++ E+L G   F  E+  D L E I        +E+           
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI------LNDEV----------- 213

Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--CTAL--EACV--HPFFDELRDP 355
                      V+   L  +AVD++  F   +P +R     L  E  +  HPFF EL   
Sbjct: 214 -----------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL--- 259

Query: 356 NTRLPNGRPLPPLF 369
           +    N R + P F
Sbjct: 260 DWEKLNRRQIEPPF 273

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 62.6 bits (152), Expect = 5e-11
 Identities = 64/288 (22%), Positives = 113/288 (39%), Gaps = 71/288 (24%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 137
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 138 VALKHCFFSTTDKEELYLNLV----LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           V + + F  T DK    L+L+    L Y       ++++       M     + Y  +I 
Sbjct: 60  VCMSYAF-HTPDKLSFILDLMNGGDLHY------HLSQHGVFSEAEM-----RFYAAEII 107

Query: 194 RALAYIHNCIGICHRDIKPQNLLV------------------KGEPNVSYICSRYYRAPE 235
             L ++HN   + +RD+KP N+L+                  K +P+ S + +  Y APE
Sbjct: 108 LGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPE 165

Query: 236 LIFGATEYTTAIDIWSTGCVMAELLLGQ----------------------PLFPGESGVD 273
           ++     Y ++ D +S GC++ +LL G                          P     +
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 225

Query: 274 QLVEIIKVLGTPTREEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRLPP 320
               +  +L       + C+     E K  P  +   W  VF ++ PP
Sbjct: 226 LRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPP 273

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 59/223 (26%), Positives = 103/223 (46%), Gaps = 44/223 (19%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPNIVALK 141
           V+G G+FG V   + + T ++ A+K + +       D  +   E  IM   + P +V L 
Sbjct: 50  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F     +++ YL +V+EY+P  + VN ++ NY      +P  + + YT ++  AL  I
Sbjct: 110 YAF-----QDDRYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWARFYTAEVVLALDAI 158

Query: 200 HNCIGICHRDIKPQNLLVKGEPNVSY----ICSRY----------------YRAPELIF- 238
           H+ +G  HRD+KP N+L+    ++       C +                 Y +PE++  
Sbjct: 159 HS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 217

Query: 239 --GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
             G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 62.3 bits (151), Expect = 5e-11
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 32/202 (15%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPN 136
           +Y    VVG GS+G V   + R  G+   IKK+       ++++   +E Q++  L HPN
Sbjct: 1   AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IVA +  +    + E+  L +V+ +  E  +   +   +  + +P   V  +  QI  AL
Sbjct: 61  IVAYRESW----EGEDGLLYIVMGFC-EGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115

Query: 197 AYIHNCIGICHRDIKPQNLLVK-------GEPNV------------SYICSRYYRAPELI 237
            Y+H    I HRD+K QN+ +        G+  +            + I + YY +PEL 
Sbjct: 116 QYLHE-KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL- 173

Query: 238 FGATEYTTAIDIWSTGCVMAEL 259
           F    Y    D+W+ GC + E+
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 62.9 bits (153), Expect = 6e-11
 Identities = 81/338 (23%), Positives = 131/338 (38%), Gaps = 98/338 (28%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKK----VLQDKR---YKNRELQIMQMLDHPNIVALK 141
           +VG G FG V   + + TG+I A+K     VL  +    +   E  I+ + + P I  L+
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F    DK+ LYL  V+EY P  + ++ + R   +  + M     + Y  ++  A+  +
Sbjct: 68  YAF---QDKDNLYL--VMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVLAIHSV 118

Query: 200 HNCIGICHRDIKPQNLLV--------------------KGEPNVSYICSRYYRAPELI-- 237
           H  +G  HRDIKP+N+L+                    K   +   + +  Y APE++  
Sbjct: 119 HQ-MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177

Query: 238 ---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
               G   Y    D WS G +  E++ G+  F   +       I+               
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM--------------- 222

Query: 295 PNYTEF-KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA------CVHP 347
            N+  F KFP+            ++  + +DL+        +L C   E       C HP
Sbjct: 223 -NFQRFLKFPE----------DPKVSSDFLDLI-------QSLLCGQKERLGYEGLCCHP 264

Query: 348 FFDELRDPNTRLPNGRPLPPLF----------NFKPPE 375
           FF ++   N R      LPP            NF  PE
Sbjct: 265 FFSKIDWNNIR----NSLPPFVPTLKSDDDTSNFDEPE 298

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 62.2 bits (151), Expect = 7e-11
 Identities = 80/325 (24%), Positives = 124/325 (38%), Gaps = 88/325 (27%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 140
           V+G G FG V   + R TG++ A KK L+ KR K R        E QI++ ++   +V+L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65

Query: 141 KHCFFSTTDKEELYLNLV----LEYVPETVNRIARNYSRIHQRMPLIY----VKLYTYQI 192
            + +  T D   L L L+    L++              I+      +       Y  +I
Sbjct: 66  AYAY-ETKDALCLVLTLMNGGDLKF-------------HIYNMGNPGFDEERAVFYAAEI 111

Query: 193 CRALAYIHNCIGICHRDIKPQNLLV------------------KGEPNVSYICSRYYRAP 234
              L  +H    I +RD+KP+N+L+                  +GE     + +  Y AP
Sbjct: 112 TCGLEDLHR-ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAP 170

Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
           E++     YT + D W  GC++ E++ G+  F          E +K      REE++   
Sbjct: 171 EVV-KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK------EKVK------REEVERRV 217

Query: 295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--C---TALEACVHPFF 349
               E              + ++    A  +  +     P  R  C    A E   HPFF
Sbjct: 218 KEDQE-------------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFF 264

Query: 350 DELRDPN-TRLPNGRPLPPLFNFKP 373
              R  N  RL  G   PP   F P
Sbjct: 265 ---RTANFKRLEAGMLEPP---FCP 283

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 62.0 bits (150), Expect = 8e-11
 Identities = 67/257 (26%), Positives = 117/257 (45%), Gaps = 55/257 (21%)

Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR----ELQIMQM 131
           G+ K+K  Y     +G G+ G VF A    TG+ VAIK++   K+ K      E+ +M+ 
Sbjct: 15  GDPKKK--YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72

Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVK 186
           L +PNIV     F      +EL++  V+EY+      + V     + ++I          
Sbjct: 73  LKNPNIVNFLDSFLV---GDELFV--VMEYLAGGSLTDVVTETCMDEAQIAA-------- 119

Query: 187 LYTYQICR----ALAYIHNCIGICHRDIKPQNLLVKGEPNV------------------- 223
                +CR    AL ++H    + HRDIK  N+L+  + +V                   
Sbjct: 120 -----VCRECLQALEFLH-ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173

Query: 224 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 283
           + + + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   G
Sbjct: 174 TMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNG 231

Query: 284 TPTREEIKCMNPNYTEF 300
           TP  +  + ++P + +F
Sbjct: 232 TPELQNPEKLSPIFRDF 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 61/242 (25%), Positives = 107/242 (44%), Gaps = 44/242 (18%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
           +G G+FG V++A+ +ETG ++A  KV+  K  +       E+ I+   DHPNIV L   F
Sbjct: 13  LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 145 FSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLI--YVKLYTYQICRALAYIHN 201
           +   +     L +++E+     V+ +     R     PL    +++   Q   AL Y+H 
Sbjct: 72  YYENN-----LWILIEFCAGGAVDAVMLELER-----PLTEPQIRVVCKQTLEALNYLHE 121

Query: 202 CIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGATE 242
              I HRD+K  N+L   + ++                   S+I + Y+ APE++   T 
Sbjct: 122 N-KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180

Query: 243 ----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 298
               Y    D+WS G  + E+   +P     + +  L++I K    PT  +    +  + 
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPTLAQPSRWSSEFK 239

Query: 299 EF 300
           +F
Sbjct: 240 DF 241

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 58/203 (28%), Positives = 78/203 (38%), Gaps = 47/203 (23%)

Query: 105 ETGEIVAIKKVLQD--------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156
            TG  VAIK +  D         R++ RE  +   L HPNIVAL      + +     L 
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFR-RETALCARLYHPNIVAL----LDSGEAPPGLLF 55

Query: 157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL 216
            V EYVP    R  R        +P         Q+  ALA  HN  GI HRD+KPQN++
Sbjct: 56  AVFEYVP---GRTLREVLAADGALPAGETGRLMLQVLDALACAHNQ-GIVHRDLKPQNIM 111

Query: 217 VK---GEPNV--------------------------SYICSRYYRAPELIFGATEYTTAI 247
           V      P+                             + +  Y APE + G    T   
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV-TPNS 170

Query: 248 DIWSTGCVMAELLLGQPLFPGES 270
           D+++ G +  E L GQ +  G S
Sbjct: 171 DLYAWGLIFLECLTGQRVVQGAS 193

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 60/201 (29%), Positives = 92/201 (45%), Gaps = 34/201 (16%)

Query: 90  VGTGSFGVVFQAKCR-ETGEIVAIKKVLQDKRYKNR-------ELQIMQMLDHPNIVALK 141
           +GTGSFG V  A  + E    VAIK+  + K  K +       E +I+  ++HP  V L 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F     K+E YL LVLE+V   +      + R ++R P      Y  QI     Y+ +
Sbjct: 98  GSF-----KDESYLYLVLEFV---IGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149

Query: 202 CIGICHRDIKPQNLLVKG---------------EPNVSYIC-SRYYRAPELIFGATEYTT 245
            + I +RD+KP+NLL+                 +     +C +  Y APE++     +  
Sbjct: 150 -LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVG-HGK 207

Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A D W+ G  + E+L+G P F
Sbjct: 208 AADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 60.9 bits (147), Expect = 6e-10
 Identities = 61/242 (25%), Positives = 105/242 (43%), Gaps = 56/242 (23%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ---DKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G G FG VF  K + T E    K +      +R K++   E+ +M+ L H NIV     
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLI---YVKLYTYQICRALAYIH 200
           F +  +++   L +++E+       ++RN  + ++    I    +   T Q+  ALAY H
Sbjct: 81  FLNKANQK---LYILMEFC--DAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH 135

Query: 201 NCIG------ICHRDIKPQNLL-----------------VKGEP---------------- 221
           N         + HRD+KPQN+                  + G P                
Sbjct: 136 NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE 195

Query: 222 NVSYIC--SRYYRAPELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEI 278
           ++++ C  + YY +PEL+   T+ Y    D+W+ GC++ EL  G+  F   +   QL+  
Sbjct: 196 SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISE 255

Query: 279 IK 280
           +K
Sbjct: 256 LK 257

Length = 1021

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 59.3 bits (144), Expect = 9e-10
 Identities = 70/321 (21%), Positives = 112/321 (34%), Gaps = 79/321 (24%)

Query: 96  GVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHCFFSTTD 149
            +V  AK + T  +VA+KK+  D   K        E+   + L HPNI+     F     
Sbjct: 14  MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF---IV 70

Query: 150 KEELYL-----------NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
             ELY+           +L+  + PE               +P + +      +  AL Y
Sbjct: 71  DSELYVVSPLMAYGSCEDLLKTHFPEG--------------LPELAIAFILKDVLNALDY 116

Query: 199 IHNCIGICHRDIKPQNLLVKGE-----PNVSYICS---------------------RYYR 232
           IH+  G  HR +K  ++L+ G+       + Y  S                       + 
Sbjct: 117 IHS-KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL 175

Query: 233 APELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR---- 287
           +PE++    + Y    DI+S G    EL  G   F        L+E  KV GT       
Sbjct: 176 SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTVPCLLDK 233

Query: 288 ----EEIKCMNPNYTEFKFPQIK---PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 340
                    M+ + +  + P  +    HP+ + F           V    Q  P  R +A
Sbjct: 234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFS----EHFHQFVELCLQRDPESRPSA 289

Query: 341 LEACVHPFFDELRDPNTRLPN 361
            +   H FF + +  NT L +
Sbjct: 290 SQLLNHSFFKQCKRRNTSLLD 310

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 59.0 bits (143), Expect = 9e-10
 Identities = 64/242 (26%), Positives = 101/242 (41%), Gaps = 60/242 (24%)

Query: 88  HVVGTGSFGVVFQAK-----CRETGEIVAIKKVLQDKRYKN-----RELQIMQML-DHPN 136
             +G G+FG V +A+            VA+K +  D   K+      E+++M+M+  H N
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPE-------TVNR-IARNYSRIHQRMPLIYVKLY 188
           I+ L       T +  LY  +V+EY             R      S    R P   +   
Sbjct: 78  IINLLGV---CTQEGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132

Query: 189 -----TYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YY 231
                 YQ+ R + ++    CI   HRD+  +N+LV  E +V  I     +R      YY
Sbjct: 133 DLVSFAYQVARGMEFLASKKCI---HRDLAARNVLV-TEDHVMKIADFGLARDIHHIDYY 188

Query: 232 R------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 278
           R            APE +F    YT   D+WS G ++ E+  LG   +PG   V++L ++
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEELFKL 246

Query: 279 IK 280
           +K
Sbjct: 247 LK 248

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 86/336 (25%), Positives = 127/336 (37%), Gaps = 86/336 (25%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKN----RELQIMQMLDHPNIVALK 141
           V+G G+FG V   K + TG++ A+K   K    KR +      E  ++   D   I  L 
Sbjct: 8   VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F     ++E  L LV++Y       +    S+   R+P    + Y  ++  A+  +H 
Sbjct: 68  YAF-----QDENNLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120

Query: 202 CIGICHRDIKPQNLLVK----------------------------GEPNVSYICSRYYRA 233
            +G  HRDIKP N+L+                             G P+  YI     +A
Sbjct: 121 -LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD--YISPEILQA 177

Query: 234 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 293
            E   G   Y    D WS G  M E+L G+  F  ES V+   +I+              
Sbjct: 178 ME--DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM-------------- 221

Query: 294 NPNYTE-FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFF 349
             N+ E F+FP              +  EA DL+ R    SP  R       +   HPFF
Sbjct: 222 --NHKEHFQFPPDVTD---------VSEEAKDLIRRLI-CSPETRLGRNGLQDFKDHPFF 269

Query: 350 DELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETIN 385
           + +   N R        P      PE+S  P +T N
Sbjct: 270 EGIDWDNIRNST----APYV----PEVSS-PTDTSN 296

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 45/207 (21%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCF 144
           +G+G+ G V++   R TG + A+K +  +     +R   RE++I++ ++HPN+V   H  
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKC-HDM 140

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           F    +    + ++LE++    +  +   + I     L  V     QI   +AY+H    
Sbjct: 141 FDHNGE----IQVLLEFM----DGGSLEGTHIADEQFLADV---ARQILSGIAYLHR-RH 188

Query: 205 ICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELI-----FGA 240
           I HRDIKP NLL+    NV                   S + +  Y +PE I      GA
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGA 248

Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFP 267
            +   A DIWS G  + E  LG+  FP
Sbjct: 249 YD-GYAGDIWSLGVSILEFYLGR--FP 272

Length = 353

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 65/297 (21%), Positives = 117/297 (39%), Gaps = 53/297 (17%)

Query: 93  GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152
           GS G VF A  +       + K+ Q K     E  ++Q ++HP+++ +K    S      
Sbjct: 77  GSEGRVFVAT-KPGQPDPVVLKIGQ-KGTTLIEAMLLQNVNHPSVIRMKDTLVS----GA 130

Query: 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP 212
           +   ++  Y  +    + +    +     LI  K    QI   L Y+H    I HRD+K 
Sbjct: 131 ITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEK----QILEGLRYLHA-QRIIHRDVKT 185

Query: 213 QNLLVKGEPNVSYIC------SRY---------------YRAPELIFGATEYTTAIDIWS 251
           +N+ +    +V  +C      +++                 APE +    +Y +  DIWS
Sbjct: 186 ENIFIN---DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLARDKYNSKADIWS 241

Query: 252 TGCVMAELLL----------GQPLFPGESGVDQLVEIIKVLGT-----PTREEIKCMNPN 296
            G V+ E+L             P    +S    L++II  L       P     + +   
Sbjct: 242 AGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR-LVRG 300

Query: 297 YTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
           + E+   + +P+  +  FQ+  LP +   LV +   +   +R +A E   +P F +L
Sbjct: 301 FIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357

Length = 357

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 62/291 (21%), Positives = 112/291 (38%), Gaps = 56/291 (19%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHC 143
           ++G G+ G V++A    T  I+A+K +  D     ++    EL+I+   D P I+     
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           FF      E  +++  E++             +++++P   +      + + L Y+ + +
Sbjct: 68  FFV-----ENRISICTEFMDG-------GSLDVYRKIPEHVLGRIAVAVVKGLTYLWS-L 114

Query: 204 GICHRDIKPQNLLVKGEPNV-----------------SYICSRYYRAPELIFGATEYTTA 246
            I HRD+KP N+LV     V                 +Y+ +  Y APE I G  +Y   
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISG-EQYGIH 173

Query: 247 IDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 306
            D+WS G    EL LG+  +P        +  +++L     E+             P + 
Sbjct: 174 SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP------------PVLP 221

Query: 307 PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 357
              + + F        V  + +  +  P  R        HPF  +  D N 
Sbjct: 222 VGQFSEKF--------VHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 83/316 (26%), Positives = 124/316 (39%), Gaps = 70/316 (22%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 140
           V+G G FG V   + R TG++ A KK L+ KR K R        E QI++ ++   +V+L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            + + +   K+ L L L L    +    I   Y              Y  +IC  L  +H
Sbjct: 66  AYAYET---KDALCLVLTLMNGGDLKFHI---YHMGEAGFEEGRAVFYAAEICCGLEDLH 119

Query: 201 NCIGICHRDIKPQNLLVKGE--------------PNVSYICSRY----YRAPELIFGATE 242
               I +RD+KP+N+L+                 P    I  R     Y APE++     
Sbjct: 120 Q-ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-KNER 177

Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 302
           YT + D W+ GC++ E++ GQ  F       Q  + IK      REE++ +     E   
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERLVKEVQE--- 222

Query: 303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPNT 357
                      + ++  P+A  L        P  R       A E   HP F ++     
Sbjct: 223 ----------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN--FK 270

Query: 358 RLPNGRPLPPLFNFKP 373
           RL  G   PP   FKP
Sbjct: 271 RLEAGMLEPP---FKP 283

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 55/207 (26%), Positives = 86/207 (41%), Gaps = 43/207 (20%)

Query: 89  VVGTGSFGVVFQAK----CRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIV 138
            +G G FG VF AK      E GE + + K LQ  + +N      REL + + L H N+V
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP----ETVNRIARNYSRIHQRMPLIYVKLYT--YQI 192
            L        + E  Y+  +LEY      +   R  ++     +  PL   +      QI
Sbjct: 72  RL---LGLCREAEPHYM--ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126

Query: 193 CRALAYIHNCIGICHRDIKPQNLLVKGE--PNVSYIC-------SRYYR----------- 232
              + ++ N     HRD+  +N LV  +    VS +        S YY+           
Sbjct: 127 ALGMDHLSN-ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWL 185

Query: 233 APELIFGATEYTTAIDIWSTGCVMAEL 259
           APE +    +++T  D+WS G +M E+
Sbjct: 186 APEAVQ-EDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 56.7 bits (137), Expect = 4e-09
 Identities = 69/260 (26%), Positives = 108/260 (41%), Gaps = 65/260 (25%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-----VLQDKRYKNRELQIMQMLDHPNIVALKHCF 144
           +G G+FG V++   +   E VA+K          KR   +E +I++  DHPNIV L    
Sbjct: 3   IGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL---I 58

Query: 145 FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH-- 200
                K+ +Y  +V+E VP    +  + +  +    R+ +  +   +      + Y+   
Sbjct: 59  GVCVQKQPIY--IVMELVPGGSLLTFLRKKKN----RLTVKKLLQMSLDAAAGMEYLESK 112

Query: 201 NCIGICHRDIKPQNLLVKGEPNVSYIC----SR------------------YYRAPE-LI 237
           NCI   HRD+  +N LV GE NV  I     SR                   + APE L 
Sbjct: 113 NCI---HRDLAARNCLV-GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALN 168

Query: 238 FGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 296
           +G   YT+  D+WS G ++ E   LG   +PG S               TRE I+     
Sbjct: 169 YG--RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------------TRERIE---SG 211

Query: 297 YTEFKFPQIKPHPWHKVFQK 316
           Y     PQ+ P   +++  +
Sbjct: 212 Y-RMPAPQLCPEEIYRLMLQ 230

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 39/205 (19%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 145
           +G+G++G V++A+   TGE+ AIK +     +D     +E+ +M+   H NIVA    F 
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73

Query: 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
           S   +++L++   +E+      +   + +       + YV   T Q    L Y+H+  G 
Sbjct: 74  SYLRRDKLWIC--MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ---GLYYLHS-KGK 127

Query: 206 CHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGATE---- 242
            HRDIK  N+L+    +V                   S+I + Y+ APE+   A E    
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKGG 185

Query: 243 YTTAIDIWSTGCVMAELL-LGQPLF 266
           Y    DIW+ G    EL  L  P+F
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMF 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 71/294 (24%), Positives = 120/294 (40%), Gaps = 73/294 (24%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F  T D+    L  V+EY    E    ++R       R      + Y  +I  AL Y+
Sbjct: 62  YSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSALDYL 111

Query: 200 HNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGA 240
           H+   + +RD+K +NL++  + ++                   ++  +  Y APE +   
Sbjct: 112 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLED 170

Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
            +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+         
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR--------- 214

Query: 301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 349
                        F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 215 -------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 56.2 bits (135), Expect = 6e-09
 Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 48/211 (22%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 137
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 138 VALKHCFFSTTDKEELYLNLV----LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           V + + F  T DK    L+L+    L Y           +   H       ++ Y  +I 
Sbjct: 60  VCMTYAF-HTPDKLCFILDLMNGGDLHY-----------HLSQHGVFSEKEMRFYATEII 107

Query: 194 RALAYIHNCIGICHRDIKPQNLLV------------------KGEPNVSYICSRYYRAPE 235
             L ++HN   + +RD+KP N+L+                  K +P+ S + +  Y APE
Sbjct: 108 LGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPE 165

Query: 236 LIFGATEYTTAIDIWSTGCVMAELLLGQPLF 266
           ++   T Y ++ D +S GC++ +LL G   F
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 56.0 bits (136), Expect = 7e-09
 Identities = 65/280 (23%), Positives = 109/280 (38%), Gaps = 64/280 (22%)

Query: 93  GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQ-MLDHPNIVALKHCFFSTTDKE 151
           G FG V   K + T + + ++K+++ K +   E  + Q M D+PN + L +    TT K 
Sbjct: 27  GKFGKVSVLKHKPTQK-LFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSV--TTLKG 83

Query: 152 ELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            +   L+++Y+      + +        +   ++    VK    Q+  AL  +H    I 
Sbjct: 84  HV---LIMDYIKDGDLFDLL--------KKEGKLSEAEVKKIIRQLVEALNDLHK-HNII 131

Query: 207 HRDIKPQNLLVKGEPNVSYIC-----------SRY-----YRAPELIFGATEYTTAIDIW 250
           H DIK +N+L     +  Y+C           S Y     Y +PE I G   Y  + D W
Sbjct: 132 HNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYFSPEKIKGHN-YDVSFDWW 190

Query: 251 STGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPW 310
           + G +  ELL G+   P +   D   E +         +++ +                 
Sbjct: 191 AVGVLTYELLTGK--HPFKEDED---EEL---------DLESLLKRQQ-----------K 225

Query: 311 HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-HPFF 349
              F K +   A D V    +Y+ N R T     + HPF 
Sbjct: 226 KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 56.1 bits (135), Expect = 7e-09
 Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 35/206 (16%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 140
           V+G G FG V   + R TG++ A K+ L+ KR K R        E QI++ ++   +V L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            + + +   K+ L L L +    +    I   Y+  +          Y  +I   L  +H
Sbjct: 66  AYAYET---KDALCLVLTIMNGGDLKFHI---YNMGNPGFEEERALFYAAEILCGLEDLH 119

Query: 201 NCIGICHRDIKPQNLLV------------------KGEPNVSYICSRYYRAPELIFGATE 242
                 +RD+KP+N+L+                  +GE     + +  Y APE++     
Sbjct: 120 R-ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL-NNQR 177

Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPG 268
           YT + D W  GC++ E++ GQ  F G
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQSPFRG 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 77/318 (24%), Positives = 131/318 (41%), Gaps = 79/318 (24%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F  T D+    L  V+EY    E    ++R      +R      + Y  +I  AL Y+
Sbjct: 62  YAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEYL 111

Query: 200 HNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGA 240
           H+   + +RDIK +NL++  + ++                   ++  +  Y APE +   
Sbjct: 112 HS-RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLED 169

Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
            +Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+         
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR--------- 213

Query: 301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDP 355
                        F + L PEA  L+    +  P  R       A E   H FF  +   
Sbjct: 214 -------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 260

Query: 356 NTRLPNGRPLPPLFNFKP 373
           +  +   + LPP   FKP
Sbjct: 261 D--VVQKKLLPP---FKP 273

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 40/219 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNR--ELQIMQMLDHPNIVALK 141
           V+G GSFG V  A+ + T E+ AIK      V+QD   +    E +++ +   P  +   
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAYI 199
           H  F T D+        L +V E VN     Y +I Q  R    +   Y  +I   L ++
Sbjct: 67  HSCFQTMDR--------LYFVMEYVNGGDLMY-QIQQVGRFKEPHAVFYAAEIAIGLFFL 117

Query: 200 HNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGA 240
           H+  GI +RD+K  N+++  E ++                   ++  +  Y APE+I   
Sbjct: 118 HS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-AY 175

Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
             Y  ++D W+ G ++ E+L GQ  F GE   D+L + I
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 82/341 (24%), Positives = 143/341 (41%), Gaps = 75/341 (21%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---ELQIMQML------DHPNIVA 139
           ++G G+FG V +A  R+  E  A+K V    +Y      E+Q M+ +      D   ++ 
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195

Query: 140 LKHCFFSTTDKEELYLNLVL-EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           ++  F      E  ++ +V+ +Y P  ++ I ++    H+ +  I      +Q   AL Y
Sbjct: 196 IQRYF----QNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQI-----IFQTGVALDY 246

Query: 199 IHNCIGICHRDIKPQNLLVKG---------------EPNVSYIC---------------- 227
            H  + + H D+KP+N+L++                +P    IC                
Sbjct: 247 FHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIV 306

Query: 228 -SRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT- 284
            +R+YR+PE++ G    Y+T  D+WS GC++ EL  G+ L+     ++ L  + K LG  
Sbjct: 307 STRHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL 364

Query: 285 PTREEIKCMNPNYTEF--KFPQIKP--HPWH--KVFQKRLPPEAV------DLVCRFFQY 332
           P+    +C             Q++P   P H  ++ + R   E +      DL+     Y
Sbjct: 365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY 424

Query: 333 SPNLRCTALEACVHP----FFDELRD-PNTRLPNGRP-LPP 367
               R  A +   HP    ++ E R  PN   P+ R  L P
Sbjct: 425 DRQKRLNARQMTTHPYVLKYYPECRQHPNY--PDNRSMLRP 463

Length = 467

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 80/326 (24%), Positives = 123/326 (37%), Gaps = 100/326 (30%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVA------LKH 142
           V+G G+FG V   + ++TG I A+K +L+      +E Q+  +    +I+       +  
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMK-ILRKADMLEKE-QVAHIRAERDILVEADGAWVVK 65

Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            F+S  DK  LYL  ++E++P  + +  + +  +   +       + Y  +   A+  IH
Sbjct: 66  MFYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEA-----TQFYIAETVLAIDAIH 118

Query: 201 NCIGICHRDIKPQNLLVKGEPNVSY----IC--------SRYYR---------------- 232
             +G  HRDIKP NLL+  + +V      +C        + +YR                
Sbjct: 119 Q-LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177

Query: 233 --------------------------APELIFGATEYTTAIDIWSTGCVMAELLLGQPLF 266
                                     APE +F  T Y    D WS G +M E+L+G P F
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 267 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLV 326
             E              TP     K MN   T   FP   P          +  +A DL+
Sbjct: 237 CSE--------------TPQETYRKVMNWKET-LVFPPEVP----------ISEKAKDLI 271

Query: 327 CRFFQYSPNL--RCTALEACVHPFFD 350
            RF   S N        E   HPFF+
Sbjct: 272 LRFCTDSENRIGSNGVEEIKSHPFFE 297

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 54/227 (23%), Positives = 88/227 (38%), Gaps = 54/227 (23%)

Query: 90  VGTGSFGVVFQAKCRE-TGEI--VAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALK 141
           +G GSFGVV + +     G++  VA+K +  DK         +E  IM  LDH N++ L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR----MPLIYVKLYTYQICRALA 197
               +        L +V E  P     +     R+ +       +  +  Y  QI   + 
Sbjct: 63  GVVLTHP------LMMVTELAP-----LGSLLDRLRKDALGHFLISTLCDYAVQIANGMR 111

Query: 198 YIH--NCIGICHRDIKPQNLLVKGEPNVSYIC----SR-------YYR------------ 232
           Y+     I   HRD+  +N+L+    +   I      R       +Y             
Sbjct: 112 YLESKRFI---HRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWC 167

Query: 233 APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 278
           APE +   T ++ A D+W  G  + E+   G+  + G SG   L +I
Sbjct: 168 APESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 31/204 (15%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----IMQML-DHPNIVALKHCF 144
           +G G++G V++   ++ G + A+K +L      + E++    I+Q L +HPN+V     F
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           +         L LVLE     +V  + +      QR+    +    Y     L ++HN  
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN- 147

Query: 204 GICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGATEYT 244
            I HRD+K  N+L+  E  V                   + + + ++ APE+I    +Y 
Sbjct: 148 RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYD 207

Query: 245 TA----IDIWSTGCVMAELLLGQP 264
            +     D+WS G    EL  G P
Sbjct: 208 YSYDARCDVWSLGITAIELGDGDP 231

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 38/202 (18%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 145
           VG+G++G V++A+   TGE+ A+K +      D     +E+ +++   H NIVA    F 
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY---FG 73

Query: 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
           S   +E+L+  + +EY      +   + +     + + YV   T Q    LAY+H+  G 
Sbjct: 74  SYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ---GLAYLHS-KGK 127

Query: 206 CHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGATE---- 242
            HRDIK  N+L+    +V                   S+I + Y+ APE+   A E    
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV--AAVEKNGG 185

Query: 243 YTTAIDIWSTGCVMAELLLGQP 264
           Y    DIW+ G    EL   QP
Sbjct: 186 YNQLCDIWAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 53.8 bits (129), Expect = 4e-08
 Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 42/204 (20%)

Query: 90  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVAL 140
           +G G FG V    +  +   TGE VA+K +  +    +     +E++I++ L H NIV  
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNR--IARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           K      T+     + L++E++P    +  + RN ++I+ +  L     Y  QIC+ + Y
Sbjct: 72  KGI---CTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQL----KYAVQICKGMDY 124

Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV---------------SYICSR-------YYRAPEL 236
           + +   + HRD+  +N+LV+ E  V                Y   +       ++ APE 
Sbjct: 125 LGSRQYV-HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183

Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           +  +  Y  A D+WS G  + ELL
Sbjct: 184 LIQSKFYI-ASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 70/300 (23%), Positives = 115/300 (38%), Gaps = 54/300 (18%)

Query: 93  GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152
           G+ G  F     +T E V IK     +     E  I++ ++HP+I+ LK  F        
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKA--GQRGGTATEAHILRAINHPSIIQLKGTF-------- 152

Query: 153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP 212
            Y       +P     +   Y    + + +  +      + RA+ Y+H    I HRDIK 
Sbjct: 153 TYNKFTCLILPRYKTDL-YCYLAAKRNIAICDILAIERSVLRAIQYLHEN-RIIHRDIKA 210

Query: 213 QNLLVKGEPNVSY-----IC-------SRYY--------RAPELIFGATEYTTAIDIWST 252
           +N+ +    +V        C       ++YY         APEL+     Y  A+DIWS 
Sbjct: 211 ENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELL-ARDPYGPAVDIWSA 269

Query: 253 GCVMAELLLGQPLFPGESGVD-------QLVEIIKVLGTPTRE----------EIKCMNP 295
           G V+ E+         + G+D       Q+  II+  GT   E          EI     
Sbjct: 270 GIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLA 329

Query: 296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 355
             +  K P  +P  W  +++  LP +   L+C+   +  + R +A        F ++ DP
Sbjct: 330 KKSSRK-PGSRP-LWTNLYE--LPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385

Length = 391

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 53.3 bits (128), Expect = 5e-08
 Identities = 62/236 (26%), Positives = 97/236 (41%), Gaps = 65/236 (27%)

Query: 90  VGTGSFGVVFQAKCRE-----TGEI-VAIKK-----VLQDKRYKNRELQIMQMLDHPNIV 138
           +G+G+FG V++    +     +G I VA+K        Q+K+   +E  +M   +HPNIV
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 139 A-LKHCFFSTTDKEELYLNL-------VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 190
             L  C       E  Y+ +       +L Y+ +   R+ R    +     L+ + L   
Sbjct: 63  KLLGVCL----LNEPQYIIMELMEGGDLLSYLRDA--RVERFGPPLLTLKELLDICLDVA 116

Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYICSR-----------------YYR- 232
           + C  L  +H      HRD+  +N LV  +    Y   R                 YYR 
Sbjct: 117 KGCVYLEQMH----FIHRDLAARNCLVSEK---GYDADRVVKIGDFGLARDIYKSDYYRK 169

Query: 233 -----------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQL 275
                      APE L+ G   +TT  D+WS G +M E+L LGQ  +P  +  + L
Sbjct: 170 EGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 53.0 bits (127), Expect = 6e-08
 Identities = 52/225 (23%), Positives = 93/225 (41%), Gaps = 35/225 (15%)

Query: 84  YIAEHVVGTGSFGVVF---QAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDH 134
           YI +  +G GSFG V+     K      +  +K++        +    N+E Q++  LDH
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61

Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           P IV     F      E     ++ EY     ++          + +    V  +  Q+ 
Sbjct: 62  PAIVKFHASFL-----ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116

Query: 194 RALAYIHNCIGICHRDIKPQNLLVK------GEPNVS------------YICSRYYRAPE 235
             + Y+H    I HRD+K +N+ +K      G+  VS            +  + YY +PE
Sbjct: 117 LGVHYMHQ-RRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE 175

Query: 236 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 280
            +     Y +  DIWS GC++ E+      F G++ +  ++ I++
Sbjct: 176 AL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.3 bits (128), Expect = 8e-08
 Identities = 37/137 (27%), Positives = 71/137 (51%), Gaps = 18/137 (13%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           V+G G+FG V   + ++TG+I A+K +L+ + +K  +L        ++   D P +V+L 
Sbjct: 8   VIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLY 67

Query: 142 HCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           + F     ++  YL L++E++P   +  +   Y    + +     + Y  +   A+  +H
Sbjct: 68  YSF-----QDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMAECVLAIEAVH 118

Query: 201 NCIGICHRDIKPQNLLV 217
             +G  HRDIKP N+L+
Sbjct: 119 K-LGFIHRDIKPDNILI 134

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 52.8 bits (127), Expect = 9e-08
 Identities = 56/227 (24%), Positives = 90/227 (39%), Gaps = 61/227 (26%)

Query: 89  VVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNI 137
            +G G+FG VF  +C         E+VA+ K L++      ++   RE +++    H NI
Sbjct: 12  ELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRM--------PLIYVKLY 188
           V         T+ +     +V EY+    +N+  R++      +         L   +L 
Sbjct: 71  VKFYGV---CTEGDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125

Query: 189 --TYQICRALAYI---HNCIGICHRDIKPQN------LLVK-GEPNVS---YICSRYYR- 232
               QI   + Y+   H      HRD+  +N      L+VK G+  +S   Y    YYR 
Sbjct: 126 QIAVQIASGMVYLASQH----FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD-YYRV 180

Query: 233 -----------APELIFGATEYTTAIDIWSTGCVMAELLL--GQPLF 266
                       PE I     +TT  D+WS G V+ E+     QP +
Sbjct: 181 GGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 36/199 (18%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVALK 141
           +G G FG V   + R TG++ A KK L  KR K R        E +I+  +    IV+L 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKK-LNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRI-ARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           + F + TD     L LV+  +     R    N    +   P      YT QI   L ++H
Sbjct: 60  YAFQTKTD-----LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH 114

Query: 201 NCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGAT 241
               I +RD+KP+N+L+  + NV                    Y  +  + APEL+ G  
Sbjct: 115 Q-RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-E 172

Query: 242 EYTTAIDIWSTGCVMAELL 260
           EY  ++D ++ G  + E++
Sbjct: 173 EYDFSVDYFALGVTLYEMI 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 52.4 bits (125), Expect = 1e-07
 Identities = 64/257 (24%), Positives = 116/257 (45%), Gaps = 55/257 (21%)

Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 16  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVK 186
             +PNIV     +      +EL++  V+EY+      + V     +  +I          
Sbjct: 74  NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQIAA-------- 120

Query: 187 LYTYQICR----ALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----ICSR--------- 229
                +CR    AL ++H+   + HRDIK  N+L+  + +V       C++         
Sbjct: 121 -----VCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174

Query: 230 ------YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 283
                 Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   G
Sbjct: 175 TMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNG 232

Query: 284 TPTREEIKCMNPNYTEF 300
           TP  +  + ++  + +F
Sbjct: 233 TPELQNPEKLSAIFRDF 249

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 56/195 (28%), Positives = 89/195 (45%), Gaps = 37/195 (18%)

Query: 90  VGTGSFGVVFQAKCRETGEI-VAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 145
           +G+G FGVV   K R  G+I VAIK + +    ++    E ++M  L HPN+V L   + 
Sbjct: 12  LGSGQFGVVHLGKWR--GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL---YG 66

Query: 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRALAYIHNCIG 204
             T +  +++  V EY+    N    NY R  +        L     +C A+ Y+ +  G
Sbjct: 67  VCTKQRPIFI--VTEYM---ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN-G 120

Query: 205 ICHRDIKPQNLLVKGEPNV---------------SYICSRYYR-----APELIFGATEYT 244
             HRD+  +N LV GE NV                Y  S+  +     AP  +F  + ++
Sbjct: 121 FIHRDLAARNCLV-GEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179

Query: 245 TAIDIWSTGCVMAEL 259
           +  D+WS G +M E+
Sbjct: 180 SKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 52.4 bits (125), Expect = 1e-07
 Identities = 75/306 (24%), Positives = 127/306 (41%), Gaps = 80/306 (26%)

Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
           G+ K+K  Y     +G G+ G V+ A    TG+ VAIK++ LQ +  K     E+ +M+ 
Sbjct: 15  GDPKKK--YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIYVK 186
             +PNIV     +      +EL++  V+EY+      + V     +  +I          
Sbjct: 73  NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQIAA-------- 119

Query: 187 LYTYQICR----ALAYIHNCIGICHRDIKPQNLLVKGEPNV------------------- 223
                +CR    AL ++H+   + HRDIK  N+L+  + +V                   
Sbjct: 120 -----VCRECLQALDFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173

Query: 224 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 283
           + + + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   G
Sbjct: 174 TMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNG 231

Query: 284 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 343
           TP     +  NP                    +RL     D + R  +   + R +A E 
Sbjct: 232 TP-----ELQNP--------------------ERLSAVFRDFLNRCLEMDVDRRGSAKEL 266

Query: 344 CVHPFF 349
             HPF 
Sbjct: 267 LQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 31/204 (15%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----IMQML-DHPNIVALKHCF 144
           +G G++G VF+   ++ G   A+K +L      + E++    I++ L DHPN+V     +
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 145 FSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           +    K    L LVLE     +V  + + + +  +RM    +    ++    L ++H   
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK 144

Query: 204 GICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGA---- 240
            I HRD+K  N+L+  E  V                   + + + ++ APE+I       
Sbjct: 145 TI-HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLD 203

Query: 241 TEYTTAIDIWSTGCVMAELLLGQP 264
           + Y    D+WS G    EL  G P
Sbjct: 204 STYDARCDVWSLGITAIELGDGDP 227

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 33/219 (15%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT 148
           V+G G+FG V   K + T  I A+K + + +  K  E    +  +  N++    C + TT
Sbjct: 8   VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNGDCQWITT 65

Query: 149 ----DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
                ++E YL LV++Y       +    S+   R+P    + Y  ++  A+  IH  + 
Sbjct: 66  LHYAFQDENYLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ-LH 122

Query: 205 ICHRDIKPQNLLVKGEPNVSY--------------------ICSRYYRAPELIF----GA 240
             HRDIKP N+L+    ++                      + +  Y +PE++     G 
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182

Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
            +Y    D WS G  M E+L G+  F  ES V+   +I+
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 53/219 (24%), Positives = 101/219 (46%), Gaps = 41/219 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + +G+  A+K + ++      E+       ++++   HP + +LK
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           +  F T D+    L  V+EYV   E    ++R       R      + Y  +I  AL Y+
Sbjct: 62  YS-FQTKDR----LCFVMEYVNGGELFFHLSRERVFSEDR-----TRFYGAEIVSALDYL 111

Query: 200 HNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGA 240
           H+   I +RD+K +NL++  + ++                   ++  +  Y APE +   
Sbjct: 112 HSG-KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPE-VLED 169

Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
            +Y  A+D W  G VM E++ G+  F  +   ++L E+I
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 55/234 (23%), Positives = 90/234 (38%), Gaps = 67/234 (28%)

Query: 89  VVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVA 139
           V+G+G+FG V++      GE     VAIK + ++   K       E  +M  +DHP++V 
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 140 L-------KHCFFSTTDKEELYLNLVLEYVPETVNRIAR----NYSRIHQRMPLIYVKLY 188
           L       +    +    + + L  +L+YV    + I      N+               
Sbjct: 74  LLGICLSSQVQLIT----QLMPLGCLLDYVRNHKDNIGSQYLLNWCV------------- 116

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYIC-----------SRYYR----- 232
             QI + ++Y+     + HRD+  +N+LVK  P    I             + Y      
Sbjct: 117 --QIAKGMSYLEE-KRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLDVDEKEYHAEGGK 172

Query: 233 ------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 277
                 A E I     YT   D+WS G  + EL+  G   + G   V+   L+E
Sbjct: 173 VPIKWMALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 50.6 bits (121), Expect = 4e-07
 Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 39/216 (18%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
           +G+G FGVV   K R   + VAIK + +    +     E ++M  L HP +V L   +  
Sbjct: 12  LGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQL---YGV 67

Query: 147 TTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            T ++ LY+  V E++     +N + +   ++ + M L   +     +C  + Y+     
Sbjct: 68  CTQQKPLYI--VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQ----DVCEGMEYLERN-S 120

Query: 205 ICHRDIKPQNLLVKGEPNVS---YICSRY-----------------YRAPELIFGATEYT 244
             HRD+  +N LV     V    +  +RY                 +  PE +F  ++Y+
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPE-VFNFSKYS 179

Query: 245 TAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEII 279
           +  D+WS G +M E+   G+  F  +S   ++VE+I
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEMI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 39/206 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 140
           V+G G FG V   + R TG++ A KK L+ KR K R        E +I++ ++   +V+L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAY 198
            + + +   K+ L L L +    +    I    N     QR        Y  ++C  L  
Sbjct: 66  AYAYET---KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQR-----AIFYAAELCCGLED 117

Query: 199 IHNCIGICHRDIKPQNLLV------------------KGEPNVSYICSRYYRAPELIFGA 240
           +     I +RD+KP+N+L+                  +GE     + +  Y APE+I   
Sbjct: 118 LQR-ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI-NN 175

Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLF 266
            +YT + D W  GC++ E++ GQ  F
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 73/304 (24%), Positives = 116/304 (38%), Gaps = 100/304 (32%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           V+G G+FG V   + ++TG + A+K      +L+ ++  +   E  I+   D   +V + 
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM- 66

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
             F+S  DK  LYL  ++E++P  + +  + +  +   +       + Y  +   A+  I
Sbjct: 67  --FYSFQDKLNLYL--IMEFLPGGDMMTLLMKKDTLTEEE-----TQFYIAETVLAIDSI 117

Query: 200 HNCIGICHRDIKPQNLLVKGEPNVSY----IC--------SRYYR--------------- 232
           H  +G  HRDIKP NLL+  + +V      +C        + +YR               
Sbjct: 118 HQ-LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176

Query: 233 ---------------------------APELIFGATEYTTAIDIWSTGCVMAELLLGQPL 265
                                      APE +F  T Y    D WS G +M E+L+G P 
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Query: 266 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL 325
           F  E              TP     K MN   T   FP   P          +  +A DL
Sbjct: 236 FCSE--------------TPQETYKKVMNWKET-LIFPPEVP----------ISEKAKDL 270

Query: 326 VCRF 329
           + RF
Sbjct: 271 ILRF 274

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 81/341 (23%), Positives = 129/341 (37%), Gaps = 104/341 (30%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHP 135
           ++    +G G+FG V  A   +T  + A+K  L+ K   NR        E  I+   D+ 
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNE 61

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVP------------------------------ET 165
            +V L   ++S  DK+ LY   V++Y+P                              E+
Sbjct: 62  WVVKL---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIES 116

Query: 166 VNRIARNYSRIHQRMPLI----YVKLYTYQICRALAYIHNC------IGICHRDIKPQNL 215
           V+++   +  I     LI    ++KL  + +C    + HN         I    ++P +L
Sbjct: 117 VHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176

Query: 216 ------------LVKGEPNV----------SYICSRYYRAPELIFGATEYTTAIDIWSTG 253
                       L   E             S + +  Y APE++     YT   D WS G
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVG 235

Query: 254 CVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKV 313
            ++ E+L+GQP F              +  TPT  ++K +N   T    PQ+K       
Sbjct: 236 VILFEMLVGQPPF--------------LAPTPTETQLKVINWENTLHIPPQVK------- 274

Query: 314 FQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDEL 352
               L PEAVDL+ +    +     R  A +   HPFF E+
Sbjct: 275 ----LSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 49.9 bits (119), Expect = 6e-07
 Identities = 51/194 (26%), Positives = 85/194 (43%), Gaps = 35/194 (18%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
           +GTG FGVV   K R   + VAIK + +    ++    E ++M  L H  +V L   +  
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL---YGV 67

Query: 147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRALAYIHNCIGI 205
            T +  +Y  +V EY+    N    NY R H +       L     +C  +AY+ +   I
Sbjct: 68  CTKQRPIY--IVTEYMS---NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI 122

Query: 206 CHRDIKPQNLLVKGEPNVS---YICSRY-----------------YRAPELIFGATEYTT 245
            HRD+  +N LV  +  V    +  SRY                 +  PE +   +++++
Sbjct: 123 -HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE-VLLYSKFSS 180

Query: 246 AIDIWSTGCVMAEL 259
             D+W+ G +M E+
Sbjct: 181 KSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 50.6 bits (121), Expect = 7e-07
 Identities = 36/139 (25%), Positives = 63/139 (45%), Gaps = 24/139 (17%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVALK 141
           +G G+FG V   +  +T  + A+K  L+      R        E  I+   D+  +V L 
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKT-LRKADVLMRNQAAHVKAERDILAEADNEWVVKL- 66

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM---PLIYVKLYTYQICRALAY 198
             ++S  DK+ LY   V++Y+P        +   +  R+        + Y  ++  A+  
Sbjct: 67  --YYSFQDKDNLYF--VMDYIP------GGDMMSLLIRLGIFEEDLARFYIAELTCAIES 116

Query: 199 IHNCIGICHRDIKPQNLLV 217
           +H  +G  HRDIKP N+L+
Sbjct: 117 VHK-MGFIHRDIKPDNILI 134

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 50.4 bits (120), Expect = 9e-07
 Identities = 64/224 (28%), Positives = 95/224 (42%), Gaps = 40/224 (17%)

Query: 77  NSKQKVSYIAEHVVGTGSFGVVFQA-KCRETGEIVAIKKV-LQDKR---YKNRELQIMQM 131
           N+ ++  Y+   +VG       F A +  +  E V  K V L D+R   Y   EL  +  
Sbjct: 62  NNPREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAA 121

Query: 132 LDHPNIVALKHCF-FSTTDKEELYLNLVLEY-VPETVNRIARNYSRIHQRMPL--IYVKL 187
            DH  IV  KH   F + DK    L L++EY     +N+  +   R+ + +P     V L
Sbjct: 122 CDHFGIV--KHFDDFKSDDK----LLLIMEYGSGGDLNKQIKQ--RLKEHLPFQEYEVGL 173

Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLL---------------------VKGEPNVSYI 226
             YQI  AL  +H+   + HRD+K  N+                      V  +   S+ 
Sbjct: 174 LFYQIVLALDEVHS-RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232

Query: 227 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 270
            + YY APEL +    Y+   D+WS G ++ ELL     F G S
Sbjct: 233 GTPYYLAPEL-WERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275

Length = 478

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 49.7 bits (118), Expect = 9e-07
 Identities = 51/201 (25%), Positives = 89/201 (44%), Gaps = 39/201 (19%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYK----NRELQIMQMLDHPNIVALKHCF 144
           +G GSFG V++     T E+VAIK + L++   +     +E+ ++   D P I      +
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIHNC 202
              T      L +++EY+         +   + +  PL   Y+     +I + L Y+H+ 
Sbjct: 72  LKGTK-----LWIIMEYLG------GGSALDLLKPGPLEETYIATILREILKGLDYLHSE 120

Query: 203 IGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGATEY 243
             I HRDIK  N+L+  + +V                   +++ + ++ APE+I   + Y
Sbjct: 121 RKI-HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAY 178

Query: 244 TTAIDIWSTGCVMAELLLGQP 264
               DIWS G    EL  G+P
Sbjct: 179 DFKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 45/208 (21%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFST 147
           G G FG V+      T + VA+K +           +E QIM+ L H  +V L   +   
Sbjct: 15  GAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQL---YAVC 70

Query: 148 TDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMP-LIYVKLYTYQICRALAYIH--NCI 203
           +++E +Y  +V EY+ + ++    ++      R+P L+ +     QI   +AY+   N I
Sbjct: 71  SEEEPIY--IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM---AAQIAEGMAYLESRNYI 125

Query: 204 GICHRDIKPQNLLVKGEPNVSYIC------------------SRY---YRAPELI-FGAT 241
              HRD+  +N+LV GE  V  I                   +++   + APE   +G  
Sbjct: 126 ---HRDLAARNILV-GENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYG-- 179

Query: 242 EYTTAIDIWSTGCVMAELL-LGQPLFPG 268
            +T   D+WS G ++ E++  G+  +PG
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGRVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 31/89 (34%), Positives = 44/89 (49%), Gaps = 23/89 (25%)

Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-------------SYICSRYY------ 231
           Q+  A+ YIH   GI HRDIK +N+LV G  ++             S+    +Y      
Sbjct: 268 QLLSAIDYIH-GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326

Query: 232 --RAPELIFGATEYTTAIDIWSTGCVMAE 258
              APE++ G   YT ++DIWS G V+ E
Sbjct: 327 DTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 58/227 (25%), Positives = 91/227 (40%), Gaps = 43/227 (18%)

Query: 80  QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLD 133
           Q   Y    V+G+G+ G V  AK    GE  A+K V        DK     E+  +   D
Sbjct: 30  QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCD 89

Query: 134 HPNIVALKHCFFSTTDKEE---LYLNLVLEYV------PETVNRIARNYSRIHQRMPLIY 184
             +IV     F     +     L + LVL+Y        E  +R   N +       L++
Sbjct: 90  FFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLF 149

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLL---------------------VKGEPNV 223
           +     Q+  A+ ++H+   I HRDIK  N+L                     V  +   
Sbjct: 150 I-----QVLLAVHHVHSKHMI-HRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGR 203

Query: 224 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 270
           ++  + YY APE I+    Y+   D++S G ++ ELL  +  F GE+
Sbjct: 204 TFCGTPYYVAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249

Length = 496

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 41/137 (29%), Positives = 69/137 (50%), Gaps = 20/137 (14%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNR------ELQIMQMLDHPNIVALK 141
           V+G G+FG V   + ++TG I A+KK+ + +   K +      E  I+   D+P +V L 
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F     ++E YL L++EY+P  + +  + +      +     Y+     +   A+  I
Sbjct: 68  YSF-----QDENYLYLIMEYLPGGDMMTLLMK-KDTFTEEETRFYIA----ETILAIDSI 117

Query: 200 HNCIGICHRDIKPQNLL 216
           H  +G  HRDIKP NLL
Sbjct: 118 HK-LGYIHRDIKPDNLL 133

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 30/99 (30%), Positives = 39/99 (39%), Gaps = 26/99 (26%)

Query: 231 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 290
           Y APE +F  T Y    D WS G +M E+L+G P F  +               P     
Sbjct: 205 YIAPE-VFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSD--------------NPQETYR 249

Query: 291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF 329
           K +N   T  +FP           +  L PEA DL+ R 
Sbjct: 250 KIINWKET-LQFPD----------EVPLSPEAKDLIKRL 277

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 32/205 (15%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYK-NRELQIMQMLDHPNIVALKHCFF 145
           VVG G++G V++ +  +TG++ AIK   V +D+  +   E+ +++   H   +A  +  F
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82

Query: 146 --STTDKEELYLNLVLEYV-PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              +    +  L LV+E+    +V  + +N       +   ++     +I R LA++H  
Sbjct: 83  IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLH-A 139

Query: 203 IGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIF----G 239
             + HRDIK QN+L+     V                   ++I + Y+ APE+I      
Sbjct: 140 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENP 199

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQP 264
              Y    DIWS G    E+  G P
Sbjct: 200 DATYDYRSDIWSLGITAIEMAEGAP 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 39/201 (19%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYK----NRELQIMQMLDHPNIVALKHCF 144
           +G GSFG VF+     T ++VAIK + L++   +     +E+ ++   D P +      +
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIHNC 202
              T      L +++EY+         +   + +  PL   ++ T   +I + L Y+H+ 
Sbjct: 72  LKDTK-----LWIIMEYLG------GGSALDLLEPGPLDETQIATILREILKGLDYLHSE 120

Query: 203 IGICHRDIKPQNLLVK--GEPNVS-----------------YICSRYYRAPELIFGATEY 243
             I HRDIK  N+L+   GE  ++                 ++ + ++ APE+I   + Y
Sbjct: 121 KKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAY 178

Query: 244 TTAIDIWSTGCVMAELLLGQP 264
            +  DIWS G    EL  G+P
Sbjct: 179 DSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 51/218 (23%)

Query: 89  VVGTGSFGVVFQAKC----RETGEI-VAIKKVLQDKRYKNR-----ELQIMQML-DHPNI 137
            +G G+FG V +A      +    + VA+K +        R     EL+IM  L +H NI
Sbjct: 42  TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101

Query: 138 VALKHCFFSTTDKEELYLNLVLEYV--PETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           V L     + T    + +  + EY    + +N + R          L+    ++YQ+ + 
Sbjct: 102 VNL---LGACTIGGPILV--ITEYCCYGDLLNFLRRKRESFLTLEDLLS---FSYQVAKG 153

Query: 196 LAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC-----------SRY-----------Y 231
           +A++   NCI   HRD+  +N+L+     +  IC           S Y           +
Sbjct: 154 MAFLASKNCI---HRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKW 209

Query: 232 RAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 268
            APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 210 MAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 49/201 (24%), Positives = 90/201 (44%), Gaps = 39/201 (19%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYK----NRELQIMQMLDHPNIVALKHCF 144
           +G GSFG VF+     T ++VAIK + L++   +     +E+ ++   D P +      +
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIHNC 202
              T      L +++EY+         +   + +  P    ++ T   +I + L Y+H+ 
Sbjct: 72  LKGTK-----LWIIMEYLG------GGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE 120

Query: 203 IGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGATEY 243
             I HRDIK  N+L+  + +V                   +++ + ++ APE+I   + Y
Sbjct: 121 KKI-HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAY 178

Query: 244 TTAIDIWSTGCVMAELLLGQP 264
            +  DIWS G    EL  G+P
Sbjct: 179 DSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 53/209 (25%), Positives = 86/209 (41%), Gaps = 50/209 (23%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIKKV---LQDKRYKN--RELQIMQMLDHPNIV 138
           E V+G G FG V + + +  G+    VAIK +     DK+  +   E  IM   DHPNI+
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH--QRMPLIYVKLYTYQICRAL 196
            L+     +       + ++ EY+    N     + R +  +      V +    I   +
Sbjct: 69  RLEGVVTKSRP-----VMIITEYM---ENGSLDKFLRENDGKFTVGQLVGM-LRGIASGM 119

Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNVSYIC-------SRYYR----------------- 232
            Y+   +   HRD+  +N+LV    N + +C       SR                    
Sbjct: 120 KYLSE-MNYVHRDLAARNILV----NSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW 174

Query: 233 -APELIFGATEYTTAIDIWSTGCVMAELL 260
            APE I    ++T+A D+WS G VM E++
Sbjct: 175 TAPEAI-AYRKFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 74/279 (26%), Positives = 114/279 (40%), Gaps = 69/279 (24%)

Query: 90  VGTGSFGVVFQAKC-------RETGEIVAIKKVLQDKRYKN-----RELQIMQML-DHPN 136
           +G G FG V  A+         +    VA+K +  D   K+      E+++M+M+  H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNR--------IARNYSRIHQRMP---LIYV 185
           I+ L     + T    LY+  ++EY  +   R            YS    R+P   + + 
Sbjct: 83  IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137

Query: 186 KLY--TYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYICS----------RYY 231
            L   TYQ+ R + Y+    CI   HRD+  +N+LV  E NV  I             YY
Sbjct: 138 DLVSCTYQVARGMEYLASQKCI---HRDLAARNVLVT-ENNVMKIADFGLARDVNNIDYY 193

Query: 232 R------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 278
           +            APE +F    YT   D+WS G +M E+  LG   +PG   V++L ++
Sbjct: 194 KKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKL 251

Query: 279 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 317
           +K  G    +   C N  Y   +        WH +   R
Sbjct: 252 LKE-GHRMDKPANCTNELYMMMR------DCWHAIPSHR 283

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 47.6 bits (113), Expect = 4e-06
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 41/205 (20%)

Query: 87  EHVVGTGSFGVVFQAKCRETG--EI-VAIKKV---LQDKRYKN--RELQIMQMLDHPNIV 138
           E V+G G FG V   + +  G  EI VAIK +     +K+ ++   E  IM   DHPNI+
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 197
            L+     T  K  +   +V EY+    N     + R H  +  +I +      I   + 
Sbjct: 69  HLEGVV--TKSKPVM---IVTEYME---NGSLDAFLRKHDGQFTVIQLVGMLRGIASGMK 120

Query: 198 YIHNCIGICHRDIKPQNLLVKG-----------------EPNVSYICSR-----YYRAPE 235
           Y+ + +G  HRD+  +N+LV                   +P  +Y          + APE
Sbjct: 121 YLSD-MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179

Query: 236 LIFGATEYTTAIDIWSTGCVMAELL 260
            I    ++T+A D+WS G VM E++
Sbjct: 180 AI-AYRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 84/389 (21%), Positives = 140/389 (35%), Gaps = 125/389 (32%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNR------ELQIMQMLDHPNIVALKH 142
           +G G+FG V  A+  +T  + A+K + + D   +N+      E  I+   D+  +V L  
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL-- 66

Query: 143 CFFSTTDKEELYLNLVLEYVP------------------------------ETVNRIARN 172
            ++S  DK+ LY   V++Y+P                              E+V+++   
Sbjct: 67  -YYSFQDKDNLYF--VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFI 123

Query: 173 YSRIHQRMPLI----YVKLYTYQICRALAYIH--------------------------NC 202
           +  I     LI    ++KL  + +C    + H                          NC
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANC 183

Query: 203 IGICHRDIKP---------QNLLVK---GEPNVSYICSRYYRAPELIFGATEYTTAIDIW 250
              C   +KP         Q  L     G PN        Y APE++   T YT   D W
Sbjct: 184 R--CGDRLKPLERRAARQHQRCLAHSLVGTPN--------YIAPEVLL-RTGYTQLCDWW 232

Query: 251 STGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPW 310
           S G ++ E+L+GQP F  ++ ++  +++I    +                          
Sbjct: 233 SVGVILYEMLVGQPPFLAQTPLETQMKVINWQTS-------------------------L 267

Query: 311 HKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFFDELRDPNTRLPNGRPLPP 367
           H   Q +L PEA DL+ +  +  P  R     A E   HPFF  +   +       P  P
Sbjct: 268 HIPPQAKLSPEASDLIIKLCR-GPEDRLGKNGADEIKAHPFFKTIDFSSDLRQQSAPYIP 326

Query: 368 LFNFKPPELSGIPPETINRLIPEHARKQN 396
                P + S   P   ++L  +  ++ N
Sbjct: 327 KIT-HPTDTSNFDPVDPDKLWSDDDKEGN 354

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 47.0 bits (112), Expect = 5e-06
 Identities = 46/190 (24%), Positives = 76/190 (40%), Gaps = 31/190 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---ELQIMQMLDHPNIVALKHCFFS 146
           +G G FG V     R  G+ VA+K +  D         E  +M  L HPN+V L      
Sbjct: 14  IGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL- 70

Query: 147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
                 LY  +V EY+    + +    SR    + L     +   +C  + Y+       
Sbjct: 71  --QGNPLY--IVTEYM-AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE-KNFV 124

Query: 207 HRDIKPQNLLVKGEPNVSYIC-------SRY----------YRAPELIFGATEYTTAIDI 249
           HRD+  +N+LV  E  V+ +        +            + APE +    +++T  D+
Sbjct: 125 HRDLAARNVLVS-EDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEAL-REKKFSTKSDV 182

Query: 250 WSTGCVMAEL 259
           WS G ++ E+
Sbjct: 183 WSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 46.4 bits (110), Expect = 8e-06
 Identities = 60/239 (25%), Positives = 92/239 (38%), Gaps = 70/239 (29%)

Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ--RMPLIYVKLYTYQI 192
           PN+V L     S     E  + LVL++         + +S I +   +P   VK +  ++
Sbjct: 45  PNMVCLHKYIVS-----EDSVFLVLQHAEG-----GKLWSHISKFLNIPEECVKRWAAEM 94

Query: 193 CRALAYIHNCIGICHRDIKPQNLLV--KGEPNVSYIC--------------SRYYRAPEL 236
             AL  +H   GI  RD+ P N+L+  +G   ++Y                   Y APE 
Sbjct: 95  VVALDALHR-EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPE- 152

Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIKCMNP 295
           + G +E T A D WS G ++ ELL G+ L     SG++                      
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT--------------------- 191

Query: 296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-----HPFF 349
            +T    P+             +  EA  L+ +  Q++P  R  A  A V     HPFF
Sbjct: 192 -HTTLNIPEW------------VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 47.0 bits (111), Expect = 8e-06
 Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 39/222 (17%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 141
           V+G G+FG V   K +   ++ A+K + + +  K         E  ++   D+  I  L 
Sbjct: 8   VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F    D+  LYL  V++Y       +    S+   R+P    + Y  ++  A+  +H 
Sbjct: 68  YAF---QDENNLYL--VMDYY--VGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 202 CIGICHRDIKPQNLLVKGEPNVSY--------------------ICSRYYRAPELIF--- 238
            +   HRDIKP N+L+    ++                      + +  Y +PE++    
Sbjct: 121 -LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 179

Query: 239 -GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
            G  +Y    D WS G  M E+L G+  F  ES V+   +I+
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 49/205 (23%), Positives = 91/205 (44%), Gaps = 32/205 (15%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYK-NRELQIMQMLDHPNIVALKHCFF 145
           +VG G++G V++ +  +TG++ AIK   V  D+  +  +E+ +++   H   +A  +  F
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 146 STTDKEEL--YLNLVLEYV-PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              +   +   L LV+E+    +V  + +N       +   ++     +I R L+++H  
Sbjct: 73  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH 130

Query: 203 IGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIF----G 239
             + HRDIK QN+L+     V                   ++I + Y+ APE+I      
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENP 189

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQP 264
              Y    D+WS G    E+  G P
Sbjct: 190 DATYDFKSDLWSLGITAIEMAEGAP 214

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 41/149 (27%), Positives = 63/149 (42%), Gaps = 37/149 (24%)

Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYICS-----------RYYR-- 232
           Y++Q+ + + ++    CI   HRD+  +N+L+  E NV  IC             Y R  
Sbjct: 184 YSFQVAKGMEFLASRKCI---HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKG 239

Query: 233 ---------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVL 282
                    APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +  
Sbjct: 240 DARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEF 291

Query: 283 GTPTREEIKCMNPNYTEFKFPQIKPHPWH 311
               +E  +   P+YT  +  Q     WH
Sbjct: 292 CRRLKEGTRMRAPDYTTPEMYQTMLDCWH 320

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 52/214 (24%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNR---ELQIMQMLDHPNIVALKHC 143
           ++G G+FG VF+   ++    VA+K   +D  +  K +   E +I++  DHPNIV L   
Sbjct: 2   LLGKGNFGEVFKGTLKDKTP-VAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57

Query: 144 FFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
               T ++ +Y  +V+E VP     +  R  ++  +  Q +       +       +AY+
Sbjct: 58  IGVCTQRQPIY--IVMELVPGGDFLSFLRKKKDELKTKQLVK------FALDAAAGMAYL 109

Query: 200 H--NCIGICHRDIKPQNLLVKGEPNVSYIC----SRY-----------------YRAPE- 235
              NCI   HRD+  +N LV GE NV  I     SR                  + APE 
Sbjct: 110 ESKNCI---HRDLAARNCLV-GENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEA 165

Query: 236 LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 268
           L +G   Y++  D+WS G ++ E   LG   +PG
Sbjct: 166 LNYG--RYSSESDVWSYGILLWETFSLGVCPYPG 197

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 36/138 (26%), Positives = 68/138 (49%), Gaps = 16/138 (11%)

Query: 93  GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALK------HCFFS 146
           G+FG V+  + +   ++ A+K V++     N+ + + Q+    + +AL       H ++S
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVK-VVKKADMINKNM-VHQVQAERDALALSKSPFIVHLYYS 72

Query: 147 TTDKEELYLNLVLEY-VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
                 +YL  V+EY +   V  +   Y    + M + Y+     ++  AL Y+H   GI
Sbjct: 73  LQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLHRH-GI 125

Query: 206 CHRDIKPQNLLVKGEPNV 223
            HRD+KP N+L+  E ++
Sbjct: 126 IHRDLKPDNMLISNEGHI 143

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 65/302 (21%), Positives = 113/302 (37%), Gaps = 94/302 (31%)

Query: 90  VGTGSFGVVFQ--AKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVA 139
           +G GSFG+V++  AK    GE    VAIK V ++   + R     E  +M+  +  ++V 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETV--NRIA----RNYSRIHQ--------RMPLIYV 185
           L              L +V    P  V    +A    ++Y R  +          P    
Sbjct: 74  L--------------LGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119

Query: 186 KLYTY--QICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYIC----------SRYYR- 232
           K      +I   +AY+       HRD+  +N +V  +  V  I           + YYR 
Sbjct: 120 KFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVAEDLTVK-IGDFGMTRDIYETDYYRK 177

Query: 233 -----------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIK 280
                      APE +     +TT  D+WS G V+ E+  L +  + G S  +++++ + 
Sbjct: 178 GGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSN-EEVLKFVI 235

Query: 281 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 340
                   +   ++        P+  P    ++ +              +QY+P +R T 
Sbjct: 236 --------DGGHLDL-------PENCPDKLLELMR------------MCWQYNPKMRPTF 268

Query: 341 LE 342
           LE
Sbjct: 269 LE 270

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 55/217 (25%), Positives = 90/217 (41%), Gaps = 52/217 (23%)

Query: 82  VSYIA-EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQML 132
           VS +  E V+G G FG V + + +  G+    VAIK +      K R     E  IM   
Sbjct: 3   VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 62

Query: 133 DHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQ 191
           DHPNI+ L+     T  +  + +   +E      N    ++ R +  +  +I +      
Sbjct: 63  DHPNIIHLEGVV--TKSRPVMIITEFME------NGALDSFLRQNDGQFTVIQLVGMLRG 114

Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYIC-------SRY-------------- 230
           I   + Y+   +   HRD+  +N+LV    N + +C       SR+              
Sbjct: 115 IAAGMKYLSE-MNYVHRDLAARNILV----NSNLVCKVSDFGLSRFLEDDTSDPTYTSSL 169

Query: 231 -------YRAPELIFGATEYTTAIDIWSTGCVMAELL 260
                  + APE I    ++T+A D+WS G VM E++
Sbjct: 170 GGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 44.4 bits (105), Expect = 5e-05
 Identities = 55/226 (24%), Positives = 86/226 (38%), Gaps = 49/226 (21%)

Query: 79  KQKVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKV-----LQDKRYKNRELQI 128
           +  + Y+ +  +G G+FG VFQA+       E   +VA+K +        +    RE  +
Sbjct: 4   RNNIEYVRD--IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 61

Query: 129 MQMLDHPNIVAL--------KHC----FFSTTDKEELYLNLVLEYVPETVNRIARNYSRI 176
           M   DHPNIV L          C    + +  D  E   +          +  +      
Sbjct: 62  MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121

Query: 177 HQRMPLIYVKLY--TYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS---YICSR-- 229
              +PL   +      Q+   +AY+     + HRD+  +N LV     V    +  SR  
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFV-HRDLATRNCLVGENMVVKIADFGLSRNI 180

Query: 230 ----YYRA------------PELIFGATEYTTAIDIWSTGCVMAEL 259
               YY+A            PE IF    YTT  D+W+ G V+ E+
Sbjct: 181 YSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 45.1 bits (107), Expect = 5e-05
 Identities = 37/148 (25%), Positives = 66/148 (44%), Gaps = 31/148 (20%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNR---ELQIMQMLDHPNIVALKH 142
           +G G  G V+ A        VA+KK+ +D       K R   E +I   L HP IV +  
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV-- 67

Query: 143 CFFSTTDKEELYLNLVLEYVP-ETVNRIARNY-------SRIHQRMPL-----IYVKLYT 189
            +   +D + +Y  +   Y+   T+  + ++          + ++  +     I+ K   
Sbjct: 68  -YSICSDGDPVYYTM--PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK--- 121

Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLV 217
             IC  + Y+H+  G+ HRD+KP N+L+
Sbjct: 122 --ICATIEYVHS-KGVLHRDLKPDNILL 146

Length = 932

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 50/197 (25%), Positives = 87/197 (44%), Gaps = 41/197 (20%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVALKHCFF 145
           +G+G FG+V+     E  + VAIK +    + ++ +   E Q+M  L HP +V L     
Sbjct: 12  IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI-EEAQVMMKLSHPKLVQLYGVCT 69

Query: 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYIHNCI 203
             +      + LV E++    +    +Y R  QR       L      +C  +AY+ +  
Sbjct: 70  ERSP-----ICLVFEFME---HGCLSDYLR-AQRGKFSQETLLGMCLDVCEGMAYLESSN 120

Query: 204 GICHRDIKPQNLLVKGEPNVSYIC----SRY-----------------YRAPELIFGATE 242
            I HRD+  +N LV GE  V  +     +R+                 + +PE +F  ++
Sbjct: 121 VI-HRDLAARNCLV-GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPE-VFSFSK 177

Query: 243 YTTAIDIWSTGCVMAEL 259
           Y++  D+WS G +M E+
Sbjct: 178 YSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 34/106 (32%), Positives = 49/106 (46%), Gaps = 30/106 (28%)

Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYICS-----------RYYR-- 232
           Y++Q+ R + ++    CI   HRD+  +N+L+  E NV  IC             Y R  
Sbjct: 179 YSFQVARGMEFLASRKCI---HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKG 234

Query: 233 ---------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 268
                    APE IF    YTT  D+WS G ++ E+  LG   +PG
Sbjct: 235 SARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG 279

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 53/214 (24%), Positives = 87/214 (40%), Gaps = 51/214 (23%)

Query: 90  VGTGSFGVVFQAKC--------RETGEIVAIKKVLQDKRYK-NRELQIMQMLDHPNIVAL 140
           +G G+FG VF A+C        +    + A+K+  +  R    RE +++ +L H +IV  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71

Query: 141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNY---------SRIHQRMPLIYVKLY-- 188
              F+    +    L +V EY+    +NR  R++                 L   ++   
Sbjct: 72  ---FYGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----------CSRYYRA----- 233
             QI   + Y+ + +   HRD+  +N LV G+  V  I           + YYR      
Sbjct: 128 ASQIASGMVYLAS-LHFVHRDLATRNCLV-GQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185

Query: 234 -------PELIFGATEYTTAIDIWSTGCVMAELL 260
                  PE I    ++TT  DIWS G V+ E+ 
Sbjct: 186 LPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 53/222 (23%), Positives = 83/222 (37%), Gaps = 64/222 (28%)

Query: 89  VVGTGSFGVVFQAKCRETG----EIVAIKKVLQDKRYKNRELQIMQML---------DHP 135
           ++  G+FG +F     +      E V +K V         E+Q+  +L          H 
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS----EIQVTLLLQESCLLYGLSHQ 68

Query: 136 NIVALKH-CFFSTTDKEELY-------LNLVLE---YVPETVNRIARNYSRIHQRMPLIY 184
           NI+ + H C         LY       L L L+          +       +H  M +  
Sbjct: 69  NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH--MAI-- 124

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYIC----SR------Y---- 230
                 QI   ++Y+H   G+ H+DI  +N ++  E  V  I     SR      Y    
Sbjct: 125 ------QIACGMSYLHK-RGVIHKDIAARNCVIDEELQVK-ITDNALSRDLFPMDYHCLG 176

Query: 231 ---YR-----APELIFGATEYTTAIDIWSTGCVMAELL-LGQ 263
               R     A E +    EY++A D+WS G ++ EL+ LGQ
Sbjct: 177 DNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQ 217

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 56/267 (20%), Positives = 100/267 (37%), Gaps = 40/267 (14%)

Query: 112 IKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIAR 171
           I K +   +   RE+ I++ + H  I+ L H +         + + V   +P+    +  
Sbjct: 123 IVKAVTGGKTPGREIDILKTISHRAIINLIHAY--------RWKSTVCMVMPKYKCDLF- 173

Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-------- 223
            Y      +PL        ++  ALAY+H   GI HRD+K +N+ +    N         
Sbjct: 174 TYVDRSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDEPENAVLGDFGAA 232

Query: 224 -------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGE 269
                         +  +    +PEL+     Y    DIWS G V+ E+ +    LF  +
Sbjct: 233 CKLDAHPDTPQCYGWSGTLETNSPELL-ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291

Query: 270 --SGVDQLVEIIKVLGTPTREEIKCMNPN----YTEFKFPQIKPHPWHKVFQKRLPPEAV 323
             S   QL  II+ +     E  +  + N    + ++      P+    V +K      V
Sbjct: 292 VKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDV 351

Query: 324 D-LVCRFFQYSPNLRCTALEACVHPFF 349
           + L+ +   +    R +A +    P F
Sbjct: 352 EYLIAKMLTFDQEFRPSAQDILSLPLF 378

Length = 392

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 35/214 (16%)

Query: 89  VVGTGSFGVVFQAKCR-ETGEI--VAIKKVLQDKRYKN------RELQIMQMLDHPNIVA 139
           ++G G FG V + +   + G    VA+K +  D    +       E   M+  DHPN++ 
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 140 LKHCFFSTTDKEELYLNLV-LEYVPETVNRIARNYSRIH---QRMPLIYVKLYTYQICRA 195
           L    F  +  +++   +V L ++          YSR+    +++PL  +  +   I   
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 196 LAYIHNCIGICHRDIKPQNLLVKGEPNV---SYICSR------YYRAPELI-----FGAT 241
           + Y+ N   I HRD+  +N +++ +  V    +  S+      YYR   +      + A 
Sbjct: 126 MEYLSNRNFI-HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 184

Query: 242 E------YTTAIDIWSTGCVMAELL-LGQPLFPG 268
           E      YT+  D+W+ G  M E+   GQ  +PG
Sbjct: 185 ESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 51/236 (21%), Positives = 93/236 (39%), Gaps = 66/236 (27%)

Query: 89  VVGTGSFGVV-----FQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIV 138
            +G G FG V     F+ K R     VA+K + ++      R    E  +++ ++HP+++
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL----------- 187
            L   + + +    L L  ++EY         R++ R  +++   Y+             
Sbjct: 67  KL---YGACSQDGPLLL--IVEYAKYGS---LRSFLRESRKVGPSYLGSDGNRNSSYLDN 118

Query: 188 -------------YTYQICRALAYIHNCIGICHRDIKPQNLLVK----------GEPNVS 224
                        + +QI R + Y+   + + HRD+  +N+LV           G     
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177

Query: 225 YICSRYYR-----------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 268
           Y    Y +           A E +F    YTT  D+WS G ++ E++ LG   +PG
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 55/224 (24%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFFS 146
           +G G FG V++     T   VA+K +            E QIM+ L HP ++ L   +  
Sbjct: 14  LGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL---YAV 69

Query: 147 TTDKEELYL-------NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
            T +E +Y+         +LEY    +   A    ++ Q + +        Q+   +AY+
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEY----LQGGAGRALKLPQLIDM------AAQVASGMAYL 119

Query: 200 --HNCIGICHRDIKPQNLLVKGEPNVSYIC----SRYYR-----------------APEL 236
              N I   HRD+  +N+LV GE N+  +     +R  +                 APE 
Sbjct: 120 EAQNYI---HRDLAARNVLV-GENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEA 175

Query: 237 IFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVE 277
                 ++   D+WS G ++ E++  G+  +PG +   V Q V+
Sbjct: 176 AL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 82/313 (26%), Positives = 125/313 (39%), Gaps = 86/313 (27%)

Query: 90  VGTGSFGVVFQAKC-------RETGEIVAIKKVLQDKRYKN-----RELQIMQML-DHPN 136
           +G G FG V  A+              VA+K +  D   K+      E+++M+M+  H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNR---IAR-----NYSRIHQRMP---LIYV 185
           I+ L     + T    LY+  ++EY  +   R    AR     +YS    ++P   L + 
Sbjct: 80  IINL---LGACTQDGPLYV--LVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134

Query: 186 KLYT--YQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYICS----------RYY 231
            L +  YQ+ R + Y+    CI   HRD+  +N+LV  E NV  I             YY
Sbjct: 135 DLVSCAYQVARGMEYLASQKCI---HRDLAARNVLVT-EDNVMKIADFGLARDVHNIDYY 190

Query: 232 R------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 278
           +            APE +F    YT   D+WS G ++ E+  LG   +PG   V++L ++
Sbjct: 191 KKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEELFKL 248

Query: 279 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR-----------------LPPE 321
           +K       E  +   P     +   I    WH V  +R                    E
Sbjct: 249 LK-------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDE 301

Query: 322 AVDLVCRFFQYSP 334
            +DL   F QYSP
Sbjct: 302 YLDLSVPFEQYSP 314

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 76/314 (24%), Positives = 127/314 (40%), Gaps = 87/314 (27%)

Query: 90  VGTGSFGVVFQAKC-------RETGEIVAIKKVLQDKRYKN-----RELQIMQMLD-HPN 136
           +G G FG V +A+         +    VA+K +  +   K+      E+++M+++  H N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNR------------IARNYSRIHQRMPLIY 184
           I+ L       T +  LY+  ++EY  +   R               + +++ +   L +
Sbjct: 80  IINL---LGVCTQEGPLYV--IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE-QLSF 133

Query: 185 VKLYT--YQICRALAYIHN--CIGICHRDIKPQNLLVKGEPNVSYICS----------RY 230
             L +  YQ+ R + Y+ +  CI   HRD+  +N+LV  E NV  I             Y
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCI---HRDLAARNVLVT-EDNVMKIADFGLARGVHDIDY 189

Query: 231 YR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVE 277
           Y+            APE +F    YT   D+WS G +M E+  LG   +PG      + E
Sbjct: 190 YKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIP----VEE 244

Query: 278 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR----------------LPPE 321
           + K+L    RE  +   P+    +   +    WH V  +R                +  E
Sbjct: 245 LFKLL----REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEE 300

Query: 322 AVDLVCRFFQYSPN 335
            +DL   F QYSP+
Sbjct: 301 YLDLSMPFEQYSPS 314

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 34/106 (32%), Positives = 49/106 (46%), Gaps = 30/106 (28%)

Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYICS-----------RYYR-- 232
           Y++Q+ R + ++    CI   HRD+  +N+L+  E NV  IC             Y R  
Sbjct: 178 YSFQVARGMEFLASRKCI---HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKG 233

Query: 233 ---------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 268
                    APE IF    YTT  D+WS G ++ E+  LG   +PG
Sbjct: 234 DARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG 278

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 71/334 (21%), Positives = 125/334 (37%), Gaps = 78/334 (23%)

Query: 89  VVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVAL 140
           V+G G      V  A+ + TGE V ++++  +        +   EL + ++ +HPNIV  
Sbjct: 5   VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPY 64

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           +  F    D E   +   + Y     + I  ++      + + Y+      + +AL YIH
Sbjct: 65  RATFI--ADNELWVVTSFMAY-GSAKDLICTHFMDGMSELAIAYILQ---GVLKALDYIH 118

Query: 201 NCIGICHRDIKPQNLLVKGE---------PNVSYIC-----------SRY------YRAP 234
           + +G  HR +K  ++L+  +          N+S I             +Y      + +P
Sbjct: 119 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSP 177

Query: 235 ELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT--------- 284
           E++    + Y    DI+S G    EL  G   F        L+E  K+ GT         
Sbjct: 178 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE--KLNGTVPCLLDTTT 235

Query: 285 ---------PTR--------EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVC 327
                    P+R        E      P  +     +   HP+++ F     P     V 
Sbjct: 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSN---GESSSHPYNRTFS----PHFHHFVE 288

Query: 328 RFFQYSPNLRCTALEACVHPFFDEL-RDPNTRLP 360
           +  Q +P+ R +A     H FF ++ R  +  LP
Sbjct: 289 QCLQRNPDARPSASTLLNHSFFKQIKRRASEALP 322

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 41.1 bits (96), Expect = 6e-04
 Identities = 52/206 (25%), Positives = 80/206 (38%), Gaps = 43/206 (20%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + V+G G FG VF+   +  G     VAIK +      K R     E  IM    H NI+
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH--QRMPLIYVKLYTYQICRAL 196
            L+               ++ EY+    N     Y R H  +      V +    I   +
Sbjct: 70  RLEGVVTKFKP-----AMIITEYME---NGALDKYLRDHDGEFSSYQLVGMLR-GIAAGM 120

Query: 197 AYIHNCIGICHRDIKPQNLLVKG-----------------EPNVSYICSR-----YYRAP 234
            Y+ + +   HRD+  +N+LV                   +P  +Y  S       + AP
Sbjct: 121 KYLSD-MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179

Query: 235 ELIFGATEYTTAIDIWSTGCVMAELL 260
           E I    ++T+A D+WS G VM E++
Sbjct: 180 EAI-AYRKFTSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 40.7 bits (95), Expect = 7e-04
 Identities = 43/170 (25%), Positives = 63/170 (37%), Gaps = 43/170 (25%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRE----TGEIVA----------------------IKKVLQ 117
           +  + ++G G FG V++ +C        + VA                      I K+  
Sbjct: 14  WKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIAL 73

Query: 118 DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH 177
            K   N        +DH  I     C      +   Y  ++LE + E    I   + RI 
Sbjct: 74  WKNIHN--------IDHLGIPKYYGCGSFKRCRM-YYRFILLEKLVENTKEI---FKRIK 121

Query: 178 QR-MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI 226
            +   LI  K     +   L YIH   GI H DIKP+N++V G  N  YI
Sbjct: 122 CKNKKLI--KNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDGN-NRGYI 167

Length = 294

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 41.2 bits (96), Expect = 7e-04
 Identities = 32/106 (30%), Positives = 50/106 (47%), Gaps = 30/106 (28%)

Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC-----------SRY---- 230
           +TYQ+ R + ++   NC+   HRD+  +N+L+  +  +  IC           S Y    
Sbjct: 242 FTYQVARGMEFLASKNCV---HRDLAARNVLL-AQGKIVKICDFGLARDIMHDSNYVSKG 297

Query: 231 -------YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 268
                  + APE IF    YTT  D+WS G ++ E+  LG   +PG
Sbjct: 298 STFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 40.7 bits (95), Expect = 7e-04
 Identities = 50/204 (24%), Positives = 87/204 (42%), Gaps = 44/204 (21%)

Query: 89  VVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYK-NREL----QIMQMLDHPNIVA 139
           V+G+G+FG V++      GE     VAIK++ +    K N+E+     +M  +D+P++  
Sbjct: 14  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73

Query: 140 LKH-CFFSTTD--KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           L   C  ST     + +    +L+YV E  + I              Y+  +  QI + +
Sbjct: 74  LLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQ-----------YLLNWCVQIAKGM 122

Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNVS---YICSRYYRAPELIFGAT------------ 241
            Y+     + HRD+  +N+LVK   +V    +  ++   A E  + A             
Sbjct: 123 NYLEE-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALE 181

Query: 242 -----EYTTAIDIWSTGCVMAELL 260
                 YT   D+WS G  + EL+
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.0 bits (96), Expect = 9e-04
 Identities = 30/106 (28%), Positives = 50/106 (47%), Gaps = 30/106 (28%)

Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC-----------SRY---- 230
           ++ Q+ + + ++   NCI   HRD+  +N+L+  +  V+ IC           S Y    
Sbjct: 217 FSSQVAQGMDFLASKNCI---HRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKG 272

Query: 231 -------YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 268
                  + APE IF    YT   D+WS G ++ E+  LG+  +PG
Sbjct: 273 NARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 73/315 (23%), Positives = 115/315 (36%), Gaps = 96/315 (30%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK---KVLQDKRYKNRELQ------IMQMLDHPNIVA 139
           V+G+G+FG V++      GE V I    K+L +       ++      IM  +DHP++V 
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 140 LKHCFFSTTDKEELYL---NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           L     S T +    L     +L+YV E  + I               +  +  QI + +
Sbjct: 74  LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQ-----------LLLNWCVQIAKGM 122

Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNVS---YICSRYYRAPELIFGAT------------ 241
            Y+     + HRD+  +N+LVK   +V    +  +R     E  + A             
Sbjct: 123 MYLEE-RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 181

Query: 242 -----EYTTAIDIWSTGCVMAELLL--GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
                ++T   D+WS G  + EL+   G+P                  G PTRE      
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD----------------GIPTREI----- 220

Query: 295 PNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
           P+  E   + PQ              PP     +C    Y   ++C  ++A   P F EL
Sbjct: 221 PDLLEKGERLPQ--------------PP-----ICTIDVYMVMVKCWMIDADSRPKFKEL 261

Query: 353 --------RDPNTRL 359
                   RDP   L
Sbjct: 262 AAEFSRMARDPQRYL 276

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 39.9 bits (93), Expect = 0.002
 Identities = 30/106 (28%), Positives = 50/106 (47%), Gaps = 30/106 (28%)

Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC-----------SRY---- 230
           ++YQ+ + ++++   NCI   HRD+  +N+L+     ++ IC           S Y    
Sbjct: 219 FSYQVAKGMSFLASKNCI---HRDLAARNILLT-HGRITKICDFGLARDIRNDSNYVVKG 274

Query: 231 -------YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 268
                  + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 275 NARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPG 319

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 55/212 (25%), Positives = 87/212 (41%), Gaps = 34/212 (16%)

Query: 90  VGTGSFGVVFQAKCRETGEI--VAIK--KVLQDKRYKN----RELQIMQMLDHPNIVALK 141
           +G G FG V + +  +   I  VA+K  K+    R +      E   M+  DHPN++ L 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 142 HCFFSTTDKEELYLNLV-LEYVPETVNRIARNYSRIH---QRMPLIYVKLYTYQICRALA 197
                T + E     +V L ++          YSR+    Q +P   +  +   I   + 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 198 YIHNCIGICHRDIKPQNLLVKGEPNVS---YICSR------YYRAPELI-----FGATE- 242
           Y+ +   I HRD+  +N ++    NV    +  S+      YYR   +      + A E 
Sbjct: 127 YLSSKSFI-HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIES 185

Query: 243 -----YTTAIDIWSTGCVMAELLL-GQPLFPG 268
                YTT  D+WS G  M E+   GQ  +PG
Sbjct: 186 LADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 35/214 (16%)

Query: 89  VVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVA 139
           ++G G FG V +A+ +    + + VA+K +  D    +      RE   M+  DHPN++ 
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 140 LKHCFFSTTDKEELYLNLV-LEYVPETVNRIARNYSRIHQR---MPLIYVKLYTYQICRA 195
           L      +  K  L + +V L ++           SRI +    +PL  +  +   I   
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 196 LAYIHNCIGICHRDIKPQNLLVKGEPNVS---YICSR------YYR---APELIFG--AT 241
           + Y+ +     HRD+  +N ++     V    +  S+      YYR   A +L     A 
Sbjct: 126 MEYLSS-KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLAL 184

Query: 242 E------YTTAIDIWSTGCVMAELL-LGQPLFPG 268
           E      YTT  D+W+ G  M E++  GQ  + G
Sbjct: 185 ESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 60/234 (25%), Positives = 88/234 (37%), Gaps = 69/234 (29%)

Query: 78  SKQKVSYIAEHVVGTGSFGVV-----FQAKCRETGEIVAIK--------KVLQDKRYKNR 124
               V ++ E  +G G+FG V          R +   VAIK        KV Q+ R   +
Sbjct: 3   PLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR---Q 57

Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--------------ETVNRIA 170
           E ++M  L HPNIV    C      KE+    L  EY+                 V   +
Sbjct: 58  EAELMSDLQHPNIV----CLLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAES 112

Query: 171 RNYSRIHQRMPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC- 227
            + +         ++ +   QI   + Y+  H+     HRD+  +N LV GE     I  
Sbjct: 113 GDETVKSSLDCSDFLHI-AIQIAAGMEYLSSHH---FVHRDLAARNCLV-GEGLTVKISD 167

Query: 228 ---------SRYYR------------APELI-FGATEYTTAIDIWSTGCVMAEL 259
                    + YYR             PE I +G  ++TT  DIWS G V+ E+
Sbjct: 168 FGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 39.0 bits (91), Expect = 0.002
 Identities = 52/214 (24%), Positives = 90/214 (42%), Gaps = 55/214 (25%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR----ELQIMQMLDHPNIVALKHCFF 145
           +G+G FG V++   +     VAIK +  D   K +    E+Q ++ L H ++++L   F 
Sbjct: 14  LGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL---FA 69

Query: 146 STTDKEELYL--------NLVLEYV--PETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
             +  E +Y+        +L L ++  PE          ++     LI +     Q+   
Sbjct: 70  VCSVGEPVYIITELMEKGSL-LAFLRSPE---------GQVLPVASLIDM---ACQVAEG 116

Query: 196 LAYIHNCIGICHRDIKPQNLLVKGEPNVS---------------YICSRY-----YRAPE 235
           +AY+       HRD+  +N+LV GE  V                Y+ S       + APE
Sbjct: 117 MAYLEE-QNSIHRDLAARNILV-GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPE 174

Query: 236 LIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPG 268
                  ++T  D+WS G ++ E+   GQ  +PG
Sbjct: 175 AA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 70/279 (25%), Positives = 112/279 (40%), Gaps = 69/279 (24%)

Query: 90  VGTGSFGVVFQAKC-----RETGEI--VAIKKVLQDKRYKN-----RELQIMQML-DHPN 136
           +G G FG V  A+       +   +  VA+K +  D   K+      E+++M+M+  H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNR----------IARNYSRIHQRMPLIYVK 186
           I+ L     + T    LY+  ++EY  +   R          +   Y+        +  K
Sbjct: 86  IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 187 LY---TYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYICS----------RYY 231
                 YQ+ R + Y+    CI   HRD+  +N+LV  E NV  I             YY
Sbjct: 141 DLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYY 196

Query: 232 R------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 278
           +            APE +F    YT   D+WS G ++ E+  LG   +PG   V++L ++
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKL 254

Query: 279 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 317
           +K  G    +   C N  Y   +        WH V  +R
Sbjct: 255 LKE-GHRMDKPSNCTNELYMMMR------DCWHAVPSQR 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 55/214 (25%), Positives = 89/214 (41%), Gaps = 48/214 (22%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIV--AIKKVLQ-----DKRYKNRELQIMQML-DHPNIV 138
           + V+G G+FG V +A+ ++ G  +  AIK++ +     D R    EL+++  L  HPNI+
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 139 -ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVK----------- 186
             L  C      +   YL L +EY P          SR+ +  P   +            
Sbjct: 72  NLLGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125

Query: 187 --LYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYICS-RYYRAPELIFGATE- 242
              +   + R + Y+     I HRD+  +N+LV GE  V+ I      R  E+    T  
Sbjct: 126 LLHFAADVARGMDYLSQKQFI-HRDLAARNILV-GENYVAKIADFGLSRGQEVYVKKTMG 183

Query: 243 ----------------YTTAIDIWSTGCVMAELL 260
                           YTT  D+WS G ++ E++
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 39.1 bits (91), Expect = 0.003
 Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 46/215 (21%)

Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL- 140
             +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN+V L 
Sbjct: 9   TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68

Query: 141 -----KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
                +  F+  T+    Y NL L+Y+ E  NR         Q +  + +     QI  A
Sbjct: 69  GVCTREPPFYIITEFMT-YGNL-LDYLREC-NR---------QEVNAVVLLYMATQISSA 116

Query: 196 LAYIHNCIGICHRDIKPQNLLVKGEPNVSYIC----SRYYR-----------------AP 234
           + Y+     I HRD+  +N LV GE ++  +     SR                    AP
Sbjct: 117 MEYLEKKNFI-HRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 174

Query: 235 ELIFGATEYTTAIDIWSTGCVMAEL-LLGQPLFPG 268
           E +    +++   D+W+ G ++ E+   G   +PG
Sbjct: 175 ESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 38.7 bits (90), Expect = 0.004
 Identities = 38/122 (31%), Positives = 46/122 (37%), Gaps = 30/122 (24%)

Query: 231 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 290
           Y APE IF    Y    D WS G +M E L+G P F  E+  +   +II           
Sbjct: 214 YIAPE-IFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKII----------- 261

Query: 291 KCMNPNYTE-FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHP 347
                N+ E   FP              L  EA DL+ R    + N   R  A E   HP
Sbjct: 262 -----NWRETLYFPD----------DIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHP 306

Query: 348 FF 349
           FF
Sbjct: 307 FF 308

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	403
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.98
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.96
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.96
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.91
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.89
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.88
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.88
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.87
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.86
PRK09188	365	serine/threonine protein kinase; Provisional	99.85
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.84
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.83
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.8
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.79
PRK10345	210	hypothetical protein; Provisional	99.76
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.75
PRK12274	218	serine/threonine protein kinase; Provisional	99.74
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.7
smart00090	237	RIO RIO-like kinase.	99.68
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.66
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.62
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.59
PRK14879	211	serine/threonine protein kinase; Provisional	99.57
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.55
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.53
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.53
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.51
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.49
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.47
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.46
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.41
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.35
KOG1243	690	consensus Protein kinase [General function predict	99.27
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.21
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.11
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.02
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.02
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.0
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.94
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.93
COG4248	637	Uncharacterized protein with protein kinase and he	98.63
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.55
KOG3087	229	consensus Serine/threonine protein kinase [General	98.54
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.48
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.47
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.34
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.34
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.28
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.17
PRK09902	216	hypothetical protein; Provisional	98.09
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.86
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.8
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.72
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.62
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.57
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.35
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.33
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.33
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.13
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.04
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.38
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	96.18
KOG2270	520	consensus Serine/threonine protein kinase involved	96.12
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	96.08
PLN02876	822	acyl-CoA dehydrogenase	95.87
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	95.58
PF01636	239	APH: Phosphotransferase enzyme family This family	95.53
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	95.1
KOG2268	465	consensus Serine/threonine protein kinase [Signal	95.01
PLN02756	418	S-methyl-5-thioribose kinase	94.99
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	94.98
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	94.83
PRK05231	319	homoserine kinase; Provisional	94.59
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	94.35
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	94.33
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	93.88
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	93.46
PRK10593	297	hypothetical protein; Provisional	93.31
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	92.34
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	91.89
PLN02236	344	choline kinase	90.8
KOG1236	565	consensus Predicted unusual protein kinase [Genera	90.65
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	90.45
PHA03111	444	Ser/Thr kinase; Provisional	89.04
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	88.28
PRK09550	401	mtnK methylthioribose kinase; Reviewed	87.16
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	86.28
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	86.25
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	84.09
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	81.2

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.6e-67  Score=475.85  Aligned_cols=336  Identities=73%  Similarity=1.182  Sum_probs=309.6

Q ss_pred             ceeEecccCCCCCCcccccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccccHHHHHHHHHhcCCCCccccceEE
Q 015672           65 HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCF  144 (403)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  144 (403)
                      +.....+.+.....+....|...+++|.|+||.||+|....+++.||||++..+++..++|+++|++++|||||++..+|
T Consensus         7 ~~~~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f   86 (364)
T KOG0658|consen    7 HVIQTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFF   86 (364)
T ss_pred             eEEEEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEE
Confidence            34444555565666677889999999999999999999999999999999999999999999999999999999999988


Q ss_pred             eecCCCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCC----
Q 015672          145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----  220 (403)
Q Consensus       145 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~----  220 (403)
                      +...+.+..++.+||||++.+|.+.++.+...+.+++...++.++.||++||.|||+ .||+||||||.|+|+|.+    
T Consensus        87 ~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~-~~IcHRDIKPqNlLvD~~tg~L  165 (364)
T KOG0658|consen   87 SSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS-HGICHRDIKPQNLLVDPDTGVL  165 (364)
T ss_pred             EecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh-cCcccCCCChheEEEcCCCCeE
Confidence            877766678999999999999999999888888999999999999999999999999 899999999999999744    


Q ss_pred             ---------------CCceeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 015672          221 ---------------PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  285 (403)
Q Consensus       221 ---------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~  285 (403)
                                     .+++++||++|+|||++++...|+.+.||||.||++.||+-|++.|+|.+..+++..|++.+|+|
T Consensus       166 KicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~P  245 (364)
T KOG0658|consen  166 KICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTP  245 (364)
T ss_pred             EeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCC
Confidence                           44578899999999999999999999999999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCCCCCCCCCC
Q 015672          286 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPL  365 (403)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~~~~~~~~~  365 (403)
                      +.+++.++++++.++.+|++...+|...+....++++.||+.++|+++|.+|.++.|+|.||||.+++++...++++..+
T Consensus       246 t~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~l  325 (364)
T KOG0658|consen  246 TREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRPL  325 (364)
T ss_pred             CHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCcC
Confidence            99999999999999999999999999888889999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCCCChHHHhhcCcHHHHhhhhhhhhc
Q 015672          366 PPLFNFKPPELSGIPPETINRLIPEHARKQNLFMALH  402 (403)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (403)
                      |++++|.+.. ..+.++..+.++|++.+.++-.-.+|
T Consensus       326 p~lf~f~~~e-~~~~~~~~~~l~p~~~~~~~~~~~~~  361 (364)
T KOG0658|consen  326 PPLFNFKRAE-LGISPELVNVLIPEHLREQEKDKILC  361 (364)
T ss_pred             CCccCchHHH-hccchHHHHhhccHhhhhhccccccc
Confidence            9999999874 45788899999999999887655443

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-55  Score=410.63  Aligned_cols=263  Identities=37%  Similarity=0.679  Sum_probs=231.3

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc-----cHHHHHHHHHhcC-CCCccccceEEeecCCCCceEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      .+|.+.++||.|+||.||+|+.+.++..||||++++...     ...||+..|++|+ |||||++.+++...    ...+
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~----~~~L   85 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDN----DRIL   85 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhcc----CceE
Confidence            459999999999999999999999999999999865432     2348999999999 99999999988422    2279


Q ss_pred             EEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc------------
Q 015672          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV------------  223 (403)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~------------  223 (403)
                      ++|||||+.+|+++++..   ...+++..++.|+.||+.||+|+|. +|+.||||||||||+.+...+            
T Consensus        86 ~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk-~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   86 YFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHK-HGFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHh-cCcccccCChhheEecccceeEecccccccccc
Confidence            999999999999888764   5789999999999999999999999 899999999999999854333            


Q ss_pred             ------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--c
Q 015672          224 ------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--P  295 (403)
Q Consensus       224 ------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~  295 (403)
                            .++.|++|+|||+++....|+.++||||+|||++|+++-++.|+|.++.+++.+|++.+|+|....|....  .
T Consensus       162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La  241 (538)
T KOG0661|consen  162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA  241 (538)
T ss_pred             cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence                  45679999999999988899999999999999999999999999999999999999999999988775321  1


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                      ..-.+.+|+..+.++..+++. .+.++.+||.+||.|||.+||||.++|+||||+...
T Consensus       242 ~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  242 SAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             HHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence            223568899999998888866 999999999999999999999999999999998643

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.7e-54  Score=386.49  Aligned_cols=275  Identities=34%  Similarity=0.563  Sum_probs=236.1

Q ss_pred             CCCCcccccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc------cHHHHHHHHHhcCCCCccccceEEeecC
Q 015672           75 NGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTT  148 (403)
Q Consensus        75 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~  148 (403)
                      .+..+....|+.+..|++|+||.||+|+++.|++.||+|+++-++.      ...+||.+|.+++|||||.+.++.....
T Consensus        69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~  148 (419)
T KOG0663|consen   69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN  148 (419)
T ss_pred             ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence            3344566679999999999999999999999999999999965432      2358999999999999999999875433


Q ss_pred             CCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---
Q 015672          149 DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---  225 (403)
Q Consensus       149 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---  225 (403)
                         -..+|||||||+.+|..++...   .+++...+++.++.|++.||+|||. +.|+||||||+|+|++..|.+++   
T Consensus       149 ---~d~iy~VMe~~EhDLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~-~wilHRDLK~SNLLm~~~G~lKiaDF  221 (419)
T KOG0663|consen  149 ---MDKIYIVMEYVEHDLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHD-NWILHRDLKTSNLLLSHKGILKIADF  221 (419)
T ss_pred             ---cceeeeeHHHHHhhHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhh-ceeEecccchhheeeccCCcEEeccc
Confidence               2338899999999988887764   3789999999999999999999999 79999999999999998877654   


Q ss_pred             ----------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          226 ----------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       226 ----------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                      +.|.+|+|||++++...|++++||||+|||+.||+++++.|+|..+.+++..|.+.+|+|....
T Consensus       222 GLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~i  301 (419)
T KOG0663|consen  222 GLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAI  301 (419)
T ss_pred             chhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcccc
Confidence                            3588999999999999999999999999999999999999999999999999999999999998


Q ss_pred             HhhcC--cCccccCCCCCCCCCcccccccC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCC
Q 015672          290 IKCMN--PNYTEFKFPQIKPHPWHKVFQKR-LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  356 (403)
Q Consensus       290 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~  356 (403)
                      |+...  +......++..+...+...+... +++...+|+.++|.+||.+|.||.|.|+|+||.+...|.
T Consensus       302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~  371 (419)
T KOG0663|consen  302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPI  371 (419)
T ss_pred             CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCC
Confidence            87544  22223556666666666656544 789999999999999999999999999999999976544

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.9e-55  Score=385.30  Aligned_cols=260  Identities=36%  Similarity=0.657  Sum_probs=224.3

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc------cHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      .|+.+.++|+|+||+||+|+++.||+.||||++.....      ...+|+++|++|+|+|+|.++++|     .....++
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrklh   77 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKLH   77 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----HhcceeE
Confidence            48889999999999999999999999999999864332      335899999999999999999998     6666699


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      +|+|||+.++.+.+..   ...+++...++.++.|++.|+.|+|+ ++||||||||+||||+..+.++.           
T Consensus        78 LVFE~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk-~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~  153 (396)
T KOG0593|consen   78 LVFEYCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHK-NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA  153 (396)
T ss_pred             EEeeecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhh-cCeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence            9999999766444443   45789999999999999999999999 89999999999999987766543           


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh--hcCc
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK--CMNP  295 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~--~~~~  295 (403)
                              +.|++|+|||++.+...|+.++||||+||++.||++|.+.|+|.++.+++..|.+.+|.-.+..+.  ..++
T Consensus       154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence                    458999999999998899999999999999999999999999999999999999999977666544  4566


Q ss_pred             CccccCCCCCCCC-CcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          296 NYTEFKFPQIKPH-PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       296 ~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                      .+....+|..... ++...+ ..++.-+.||+++||+.||.+|++.+|+|.||||...
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~  290 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF  290 (396)
T ss_pred             ceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence            6777788876543 333333 4677889999999999999999999999999999754

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.2e-54  Score=373.98  Aligned_cols=261  Identities=38%  Similarity=0.727  Sum_probs=225.7

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|...++||+|.||+||+|++..+|+.||||+++..+      ....+|+..|+.++|+||+.++++|-     ....+.
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~-----~~~~l~   77 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFP-----HKSNLS   77 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhcc-----CCCceE
Confidence            4889999999999999999999999999999996432      23458999999999999999999993     333488


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      ||+||++.+|..+++..   ...++...++.|+.++++||+|||+ +.|+||||||.|+|++.++.+++           
T Consensus        78 lVfEfm~tdLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~-~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~  153 (318)
T KOG0659|consen   78 LVFEFMPTDLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHS-KWILHRDLKPNNLLISSDGQLKIADFGLARFFGS  153 (318)
T ss_pred             EEEEeccccHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHh-hhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence            99999999998887653   3568899999999999999999999 89999999999999998877654           


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--c
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--P  295 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~  295 (403)
                              +.|++|+|||+++|...|+..+||||.|||+.||+.|.+.|+|.++.+++..|.+.+|+|..+.|+.+.  +
T Consensus       154 p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  154 PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence                    348899999999999999999999999999999999999999999999999999999999999998775  3


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                      +|..++  +.+..+....+ ...+.++.||+.+||.+||.+|+|+.|+|+|+||+....|
T Consensus       234 dY~~~~--~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p  290 (318)
T KOG0659|consen  234 DYVKIQ--QFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP  290 (318)
T ss_pred             cHHHHh--cCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence            444433  33334444334 4568888999999999999999999999999999986543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-54  Score=395.53  Aligned_cols=239  Identities=33%  Similarity=0.499  Sum_probs=191.8

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----------ccHHHHHHHHHhcCCCCccccceEEeecC
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----------RYKNRELQIMQMLDHPNIVALKHCFFSTT  148 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  148 (403)
                      ....|.+.+.||+|+||.|-+|..+.||+.||||++.+.+           ....+|++||++|+|||||+++++|    
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f----  245 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF----  245 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee----
Confidence            4456999999999999999999999999999999985432           1235899999999999999999998    


Q ss_pred             CCCceEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC-----
Q 015672          149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN-----  222 (403)
Q Consensus       149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~-----  222 (403)
                       ....+.||||||++| .|.+.+-    .++.+.+...+.+++|++.||.|||+ +||+||||||+|||+..+..     
T Consensus       246 -~~~ds~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~-~GI~HRDiKPeNILl~~~~e~~llK  319 (475)
T KOG0615|consen  246 -EVPDSSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHS-QGIIHRDIKPENILLSNDAEDCLLK  319 (475)
T ss_pred             -ecCCceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHH-cCcccccCCcceEEeccCCcceEEE
Confidence             444457999999985 4433322    24678888889999999999999999 89999999999999975511     


Q ss_pred             ----------------ceeeccccccchhhhhCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhC
Q 015672          223 ----------------VSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD-QLVEIIKVLG  283 (403)
Q Consensus       223 ----------------~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~-~~~~i~~~~~  283 (403)
                                      -++||||.|.|||++.+.  ..+..++||||+||+||.+++|.+||.+..... ....|.+.  
T Consensus       320 ItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G--  397 (475)
T KOG0615|consen  320 ITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG--  397 (475)
T ss_pred             ecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC--
Confidence                            146899999999999543  335669999999999999999999998765443 33333321  


Q ss_pred             CCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          284 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                                     .+.+        ....+..+++++.+||.+||..||++|||++|+|+||||+...
T Consensus       398 ---------------~y~f--------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  398 ---------------RYAF--------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             ---------------cccc--------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence                           1111        1112356899999999999999999999999999999999754

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4.4e-52  Score=411.09  Aligned_cols=308  Identities=52%  Similarity=0.975  Sum_probs=259.6

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccccHHHHHHHHHhcCCCCccccceEEeecC---CCCceEEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT---DKEELYLNLV  158 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~~~~lv  158 (403)
                      ..|.+.++||+|+||.||+|.+..+++.||||++..+.....+|+.+|+.++|+||++++++|+...   .....++++|
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lv  145 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV  145 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEE
Confidence            3599999999999999999999999999999998776666778999999999999999998875432   2334578899


Q ss_pred             eeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC-c--------------
Q 015672          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN-V--------------  223 (403)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~-~--------------  223 (403)
                      |||+++++..++..+......+++..++.++.||+.||.|||+ .||+||||||+|||++.++. +              
T Consensus       146 mE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~-~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  224 (440)
T PTZ00036        146 MEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG  224 (440)
T ss_pred             EecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCcCHHHEEEcCCCCceeeeccccchhccCC
Confidence            9999998877776655556779999999999999999999999 89999999999999975432 2              


Q ss_pred             ----eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 015672          224 ----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  299 (403)
Q Consensus       224 ----~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  299 (403)
                          ..+||+.|+|||++.+...|+.++|||||||++|||++|.+||.+.+..+.+..+.+.++.|..+.+...++.+..
T Consensus       225 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~  304 (440)
T PTZ00036        225 QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYAD  304 (440)
T ss_pred             CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhc
Confidence                2356889999999877667999999999999999999999999999999999999999999999988888888888


Q ss_pred             cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCCCCCC-CCCCCCCCCCCCCCCCC
Q 015672          300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPN-GRPLPPLFNFKPPELSG  378 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  378 (403)
                      ..++......+...++...++++.+||.+||++||.+|||+.|+|+||||+++.++...++. ...+|.++++....+..
T Consensus       305 ~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (440)
T PTZ00036        305 IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFNFCDAEIKE  384 (440)
T ss_pred             ccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcccccCCCCCCCCCCCcCCCHHHHhh
Confidence            88888877778777888889999999999999999999999999999999998876655444 24455566665544444


Q ss_pred             CChHHHhhcCcH
Q 015672          379 IPPETINRLIPE  390 (403)
Q Consensus       379 ~~~~~~~~~~~~  390 (403)
                      +.+....+++|.
T Consensus       385 ~~~~~~~~~~~~  396 (440)
T PTZ00036        385 MSDACRRKIIPK  396 (440)
T ss_pred             CCHHHHHHHhhH
Confidence            555555555554

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-53  Score=382.95  Aligned_cols=271  Identities=38%  Similarity=0.693  Sum_probs=235.6

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccc------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      .|...+.||.|+||.|+.+.++.+|+.||||++..-      .....+|+.+|+.++|+||+.+++.+......+-.-+|
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            377789999999999999999999999999998532      12335899999999999999999988653334455689


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc-------------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-------------  223 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~-------------  223 (403)
                      +|+|+|+.+|.++++.    ...++...++.+++||+.||+|+|+ .+|+||||||.|+|++.+...             
T Consensus       103 iV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHS-AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~  177 (359)
T KOG0660|consen  103 LVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHS-ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK  177 (359)
T ss_pred             EehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhc-ccccccccchhheeeccCCCEEeccccceeeccc
Confidence            9999999888887765    3449999999999999999999999 899999999999999755333             


Q ss_pred             --------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          224 --------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       224 --------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                              .++.|.+|+|||++.....|+.++||||+|||+.||++|++.|+|.+..+++..|...+|+|..+.+.....
T Consensus       178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s  257 (359)
T KOG0660|consen  178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS  257 (359)
T ss_pred             cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence                    345689999999998888899999999999999999999999999999999999999999999998876652


Q ss_pred             C---ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCCCC
Q 015672          296 N---YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL  359 (403)
Q Consensus       296 ~---~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~~~  359 (403)
                      .   ..-.++|..++.+|...++ +.++.+.||+.+||.+||.+|+|++|+|+||||....+|....
T Consensus       258 ~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP  323 (359)
T KOG0660|consen  258 EKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP  323 (359)
T ss_pred             HHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence            2   1223678888899988886 8899999999999999999999999999999999999888654

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-52  Score=392.54  Aligned_cols=266  Identities=35%  Similarity=0.580  Sum_probs=222.4

Q ss_pred             cccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        79 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      +....|+.+++||+|.||.||+|++..+|+.||+|+++.+.      ....+||.||++|+|||||++.+.....   ..
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~  190 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LS  190 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CC
Confidence            45567999999999999999999999999999999996543      2346899999999999999999987543   23


Q ss_pred             eEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------
Q 015672          153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------  225 (403)
Q Consensus       153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------  225 (403)
                      ..+|||+|||+.+|..++...   .-.|++.+++.|+.||+.||+|||+ +||+|||||.+||||++++..++       
T Consensus       191 ~siYlVFeYMdhDL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~-~gvlHRDIK~SNiLidn~G~LKiaDFGLAr  266 (560)
T KOG0600|consen  191 GSIYLVFEYMDHDLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHS-RGVLHRDIKGSNILIDNNGVLKIADFGLAR  266 (560)
T ss_pred             ceEEEEEecccchhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhh-cCeeeccccccceEEcCCCCEEecccccee
Confidence            458999999998887776542   3579999999999999999999999 89999999999999998876643       


Q ss_pred             -------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          226 -------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       226 -------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                                   +.|.+|+|||+++|...|+.++|+||+||||.||++|++.|+|.++.+++..|.+.+|.|..+.|..
T Consensus       267 ~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~  346 (560)
T KOG0600|consen  267 FYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPV  346 (560)
T ss_pred             eccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccc
Confidence                         4689999999999999999999999999999999999999999999999999999999999998862


Q ss_pred             cC-cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          293 MN-PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       293 ~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                      .+ +.+..+.-...-...+... -..+++.+.+|+.+||..||.+|.||.++|+|+||..-
T Consensus       347 ~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~  406 (560)
T KOG0600|consen  347 SKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE  406 (560)
T ss_pred             ccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence            22 1111111111111112222 25689999999999999999999999999999999543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.9e-52  Score=395.91  Aligned_cols=231  Identities=31%  Similarity=0.516  Sum_probs=201.2

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ..|...+.||+|+|+.||.+++..+|+.||+|++.+.       .....+||+|.+.|+|||||+++++|     ++..+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence            5599999999999999999999999999999999652       22335799999999999999999999     66667


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc----------
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV----------  223 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~----------  223 (403)
                      +|||+|+|. ++|..+++    ....+++.+++.+++||+.||.|||+ ++|||||||..|+||+++-++          
T Consensus        93 VYivLELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~-~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~  167 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHS-LGIIHRDLKLGNLFLNENMNVKIGDFGLATQ  167 (592)
T ss_pred             eEEEEEecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHh-cCceecccchhheeecCcCcEEecccceeee
Confidence            999999999 56655554    35789999999999999999999999 899999999999999866443          


Q ss_pred             ---------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          224 ---------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       224 ---------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                               +++|||.|.|||++.. ..++..+||||+||+||.|++|+|||...+-.+.+..|...             
T Consensus       168 le~~~Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~-------------  233 (592)
T KOG0575|consen  168 LEYDGERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN-------------  233 (592)
T ss_pred             ecCcccccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc-------------
Confidence                     5689999999999974 45999999999999999999999999988877877777652             


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                          ++.+            |..+|.+++|||.+||+.||.+|||++++|.|+||..-
T Consensus       234 ----~Y~~------------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g  275 (592)
T KOG0575|consen  234 ----EYSM------------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG  275 (592)
T ss_pred             ----Cccc------------ccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence                2333            35789999999999999999999999999999999543

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-52  Score=391.40  Aligned_cols=239  Identities=30%  Similarity=0.566  Sum_probs=208.7

Q ss_pred             CcccccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-------cccHHHHHHHHHhc-CCCCccccceEEeecCC
Q 015672           78 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (403)
Q Consensus        78 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  149 (403)
                      .+...+|.+++.||+|+|++|++|+.+.+++.||||++.+.       ..+..+|..+|.+| .||.|++++..|     
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----  143 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----  143 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----
Confidence            34456799999999999999999999999999999988542       23456799999999 899999998887     


Q ss_pred             CCceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc-----
Q 015672          150 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-----  223 (403)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~-----  223 (403)
                      .+...+|+|+||++ |+|..++..+    +.+.+..++.|+.||+.||+|||+ +||||||||||||||+.++++     
T Consensus       144 QD~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~-~GIIHRDlKPENILLd~dmhikITDF  218 (604)
T KOG0592|consen  144 QDEESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHS-NGIIHRDLKPENILLDKDGHIKITDF  218 (604)
T ss_pred             ecccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeEcCCCcEEEeec
Confidence            44555999999998 6776666653    779999999999999999999999 899999999999999876554     


Q ss_pred             ---------------------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 015672          224 ---------------------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV  276 (403)
Q Consensus       224 ---------------------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~  276 (403)
                                                 +++||-.|.+||++.. ...+..+|||+||||||+|+.|.+||.+.++.-.++
T Consensus       219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq  297 (604)
T KOG0592|consen  219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ  297 (604)
T ss_pred             cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH
Confidence                                       4689999999999954 458999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCC
Q 015672          277 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  356 (403)
Q Consensus       277 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~  356 (403)
                      +|+..                 .+.            +++.+++.+.|||.++|..||.+|+|+.+|.+||||.++.+.+
T Consensus       298 kI~~l-----------------~y~------------fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  298 KIQAL-----------------DYE------------FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             HHHHh-----------------ccc------------CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence            99875                 222            3367899999999999999999999999999999999997655

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-51  Score=369.45  Aligned_cols=236  Identities=33%  Similarity=0.516  Sum_probs=202.4

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ...|+++++||+|+||+||+++.+.+++.||+|++++.+       .....|..||..++||.||+++..|     ++..
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt~~   98 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QTEE   98 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----ccCC
Confidence            456999999999999999999999999999999986543       2334699999999999999999888     5555


Q ss_pred             EEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc---------
Q 015672          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV---------  223 (403)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~---------  223 (403)
                      .+|||+||+.| .|...+..    .+.+++..++.|+..|+.||.|||+ +|||||||||+||||+..|++         
T Consensus        99 kLylVld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~-~gIiyRDlKPENILLd~~GHi~LtDFgL~k  173 (357)
T KOG0598|consen   99 KLYLVLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHS-KGIIYRDLKPENILLDEQGHIKLTDFGLCK  173 (357)
T ss_pred             eEEEEEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHeeecCCCcEEEeccccch
Confidence            69999999985 55444433    5789999999999999999999999 899999999999999987765         


Q ss_pred             ----------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015672          224 ----------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       224 ----------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  293 (403)
                                +++||+.|||||++.+. .|+.++|+|||||++|||++|.+||.+.+.......|.+.-           
T Consensus       174 ~~~~~~~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-----------  241 (357)
T KOG0598|consen  174 EDLKDGDATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-----------  241 (357)
T ss_pred             hcccCCCccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-----------
Confidence                      45799999999999876 59999999999999999999999999999887777776521           


Q ss_pred             CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC----CHHHHhcCCCcccCCCC
Q 015672          294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC----TALEACVHPFFDELRDP  355 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp----ta~e~l~hp~f~~~~~~  355 (403)
                              .         ...+..++.+++|||+++|+.||++|.    .+.++-+||||..+++.
T Consensus       242 --------~---------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~  290 (357)
T KOG0598|consen  242 --------L---------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWE  290 (357)
T ss_pred             --------C---------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHH
Confidence                    0         001244899999999999999999996    68999999999998753

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.7e-50  Score=389.67  Aligned_cols=263  Identities=37%  Similarity=0.617  Sum_probs=216.0

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccccccHH---HHHHHHHhcC-C-----CCccccceEEeecCCCCce
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLD-H-----PNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~~~  153 (403)
                      +|.+.+.||+|+||.|.+|.+..|++.||||+++..+.+..   .|+.+|..|+ |     -|+|+++++|     ....
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-----~fr~  261 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-----YFRN  261 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-----cccc
Confidence            68999999999999999999999999999999987776554   5889999996 3     5899999999     4455


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC-----------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN-----------  222 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~-----------  222 (403)
                      |+|||+|.+..+|.++++....  .+++...++.++.||+.||.+||+ .||||+|||||||||..-+.           
T Consensus       262 HlciVfELL~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~-l~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  262 HLCIVFELLSTNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHE-LGIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             ceeeeehhhhhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCChhheeeccCCcCceeEEecccc
Confidence            6999999999999999887553  569999999999999999999999 89999999999999964322           


Q ss_pred             -------ceeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          223 -------VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       223 -------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                             ..++.+++|+|||+++|.+ |+.+.||||||||++||++|.+.|+|.++.+++..|++.+|.|+...+.....
T Consensus       339 c~~~q~vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~  417 (586)
T KOG0667|consen  339 CFESQRVYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK  417 (586)
T ss_pred             cccCCcceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence                   2456789999999999875 99999999999999999999999999999999999999999999987753322


Q ss_pred             CccccCC----C--------------------------CC----CCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHH
Q 015672          296 NYTEFKF----P--------------------------QI----KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL  341 (403)
Q Consensus       296 ~~~~~~~----~--------------------------~~----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~  341 (403)
                      ....+.-    +                          ..    ...++...+...-...+.|||.+||.+||.+|+|+.
T Consensus       418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~  497 (586)
T KOG0667|consen  418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA  497 (586)
T ss_pred             cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence            1111100    0                          00    011122222223345689999999999999999999


Q ss_pred             HHhcCCCcccCCC
Q 015672          342 EACVHPFFDELRD  354 (403)
Q Consensus       342 e~l~hp~f~~~~~  354 (403)
                      ++|+||||.....
T Consensus       498 qal~Hpfl~~~~~  510 (586)
T KOG0667|consen  498 QALNHPFLTGTSL  510 (586)
T ss_pred             HHhcCcccccccc
Confidence            9999999996543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-50  Score=367.42  Aligned_cols=239  Identities=30%  Similarity=0.537  Sum_probs=199.7

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-----cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      .+.+.++.||+|..|+||+|+++.|++.+|+|++..+     .++..+|+++++..+||+||.+|++|+....    .++
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~is  154 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EIS  154 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEE
Confidence            4577889999999999999999999999999999432     2344589999999999999999999976442    388


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-----------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-----------  224 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-----------  224 (403)
                      |+||||+ |+|..++..    .+++++.....++.+|++||.|||+.++||||||||+|||++..+.++           
T Consensus       155 I~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv  230 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV  230 (364)
T ss_pred             eehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence            9999999 678777665    377999999999999999999999547999999999999999888775           


Q ss_pred             ------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-----CcHHHHHHHHHHhCCCCHHHHhhc
Q 015672          225 ------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-----SGVDQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       225 ------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~  293 (403)
                            ++||..|||||.+.+. .|+.++||||||++++|+++|+.||...     +-.+.+..|+.  +.|+.      
T Consensus       231 nS~a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~--~ppP~------  301 (364)
T KOG0581|consen  231 NSIANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD--EPPPR------  301 (364)
T ss_pred             hhhcccccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc--CCCCC------
Confidence                  4589999999999765 5999999999999999999999999774     22344444432  11111      


Q ss_pred             CcCccccCCCCCCCCCccccccc-CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCC
Q 015672          294 NPNYTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  357 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~  357 (403)
                                          ++. .+|+++++||..||++||.+|+|+.|+++|||+++...+..
T Consensus       302 --------------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~v  346 (364)
T KOG0581|consen  302 --------------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNV  346 (364)
T ss_pred             --------------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccccc
Confidence                                223 38999999999999999999999999999999998766554

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-49  Score=361.54  Aligned_cols=273  Identities=34%  Similarity=0.710  Sum_probs=228.5

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc------cHHHHHHHHHhcCCCC-ccccceEEeecCC-CCce
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPN-IVALKHCFFSTTD-KEEL  153 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~-~~~~  153 (403)
                      ..|...++||+|+||+||+|+.+.+|+.||+|++.-+..      ...+|+.+|+.|+|+| ||.+++++.+... ....
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            348888999999999999999999999999999965432      2368999999999999 9999999866442 2234


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee--------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY--------  225 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~--------  225 (403)
                      .+++|+||+..+|..+++........++...++.+++||+.||+|||+ ++|+||||||+||||+..+.++.        
T Consensus        91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~-~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra  169 (323)
T KOG0594|consen   91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS-HGILHRDLKPQNLLISSSGVLKLADFGLARA  169 (323)
T ss_pred             eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCcceEEECCCCcEeeeccchHHH
Confidence            588999999998888877654333567888999999999999999999 89999999999999998877654        


Q ss_pred             -----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          226 -----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       226 -----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                 ++|.+|+|||++.+...|+..+||||+|||++||+++++.|++.++.+++..|.+.+|+|..+.|+...
T Consensus       170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~  249 (323)
T KOG0594|consen  170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS  249 (323)
T ss_pred             hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence                       468899999999999889999999999999999999999999999999999999999999998887543


Q ss_pred             --cCccccCCCCCC-CCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCC
Q 015672          295 --PNYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  357 (403)
Q Consensus       295 --~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~  357 (403)
                        ++|.. .++... +.++.... ...+++..+|+.+||+++|.+|.||..+|.||||..+..+..
T Consensus       250 ~~~~~k~-~f~~~~~~~~l~~~~-~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~  313 (323)
T KOG0594|consen  250 SLPDYKA-PFPKWPGPKDLSSIL-PKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSS  313 (323)
T ss_pred             ccccccc-cCcCCCCccchHHhc-cccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchh
Confidence              22222 344433 33333333 345579999999999999999999999999999999865443

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=7.6e-50  Score=377.08  Aligned_cols=242  Identities=32%  Similarity=0.551  Sum_probs=205.5

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccccc-------HHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-------KNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      ...+|+++.+||+|+||.||+|+.+.||..+|+|++++..-.       ...|-.+|...++++||+++..|     .+.
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~  213 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK  213 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence            345699999999999999999999999999999999764322       23588899999999999999988     677


Q ss_pred             eEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc--------
Q 015672          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV--------  223 (403)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~--------  223 (403)
                      .++||||||++| ++..++..    .+.+++.+++.|+.+++.|++.||+ .|+|||||||+|+||+..|++        
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~-~gyIHRDIKPdNlLiD~~GHiKLSDFGLs  288 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQ-LGYIHRDIKPDNLLIDAKGHIKLSDFGLS  288 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHH-cCcccccCChhheeecCCCCEeecccccc
Confidence            789999999994 66555554    4789999999999999999999999 899999999999999865544        


Q ss_pred             ----------------------------------------------------------eeeccccccchhhhhCCCCCCc
Q 015672          224 ----------------------------------------------------------SYICSRYYRAPELIFGATEYTT  245 (403)
Q Consensus       224 ----------------------------------------------------------~~~~t~~y~aPE~~~~~~~~~~  245 (403)
                                                                                +.+|||-|||||++.+.. |+.
T Consensus       289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~  367 (550)
T KOG0605|consen  289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGK  367 (550)
T ss_pred             chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCc
Confidence                                                                      235899999999998765 999


Q ss_pred             hhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHH
Q 015672          246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDL  325 (403)
Q Consensus       246 ~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  325 (403)
                      .+|+||||||+||||.|.+||.+.+..+...+|+..-.               .+.+|.          ...++++++||
T Consensus       368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~---------------~l~fP~----------~~~~s~eA~DL  422 (550)
T KOG0605|consen  368 ECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE---------------TLKFPE----------EVDLSDEAKDL  422 (550)
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh---------------hccCCC----------cCcccHHHHHH
Confidence            99999999999999999999999999999888876410               112221          13578999999


Q ss_pred             HHHhcccCCCCCCC---HHHHhcCCCcccCCCCCCC
Q 015672          326 VCRFFQYSPNLRCT---ALEACVHPFFDELRDPNTR  358 (403)
Q Consensus       326 i~~~L~~dP~~Rpt---a~e~l~hp~f~~~~~~~~~  358 (403)
                      |.+||+ ||++|..   ++||.+||||+++.+....
T Consensus       423 I~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~  457 (550)
T KOG0605|consen  423 ITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLR  457 (550)
T ss_pred             HHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhh
Confidence            999999 9999985   8999999999999765443

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-49  Score=381.99  Aligned_cols=263  Identities=30%  Similarity=0.487  Sum_probs=215.8

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      -|.+++.||.|+-|.|-+|++..||+.+|||++.+.       .....+|+.+|+.+.||||+++|++|     .+..++
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~~l   87 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQHL   87 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCceE
Confidence            389999999999999999999999999999999765       33457899999999999999999999     566679


Q ss_pred             EEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce----------
Q 015672          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS----------  224 (403)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~----------  224 (403)
                      |+|+||+++ .|.+++.    .++++++.++.+++.||+.|+.|+|. .+|+||||||+|+||+..++++          
T Consensus        88 ylvlEyv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~-~~icHRDLKpENlLLd~~~nIKIADFGMAsLe  162 (786)
T KOG0588|consen   88 YLVLEYVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHA-FNICHRDLKPENLLLDVKNNIKIADFGMASLE  162 (786)
T ss_pred             EEEEEecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhh-hcceeccCCchhhhhhcccCEeeeccceeecc
Confidence            999999984 4443333    25889999999999999999999999 8999999999999999887764          


Q ss_pred             --------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          225 --------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       225 --------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                              .||+|.|.|||++.|.++.+.++||||+|||||.|+||+.||.+++-...+.++.+                
T Consensus       163 ~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~----------------  226 (786)
T KOG0588|consen  163 VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR----------------  226 (786)
T ss_pred             cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc----------------
Confidence                    36899999999999998889999999999999999999999987765555555544                


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCCCCCCCCC-CCCCCCCCCCC
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRP-LPPLFNFKPPE  375 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~~~~~~~~-~~~~~~~~~~~  375 (403)
                       +.|.+|            ..+++++++||++||..||++|+|.+||++|||+..............+ ..++  ..-+.
T Consensus       227 -G~f~MP------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~~~~~~~~i--~s~ps  291 (786)
T KOG0588|consen  227 -GVFEMP------------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSSKSLRPPVSVPI--LSIPS  291 (786)
T ss_pred             -CcccCC------------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChhhhcCCCcccce--eecCC
Confidence             344444            5799999999999999999999999999999999987654432111111 0111  11244


Q ss_pred             CCCCChHHHhh
Q 015672          376 LSGIPPETINR  386 (403)
Q Consensus       376 ~~~~~~~~~~~  386 (403)
                      .+.|+|.+++.
T Consensus       292 ~~~IDp~Il~~  302 (786)
T KOG0588|consen  292 IQEIDPLILQH  302 (786)
T ss_pred             cccCCHHHHhh
Confidence            55678777764

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7e-49  Score=359.70  Aligned_cols=236  Identities=31%  Similarity=0.529  Sum_probs=198.3

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ...+|.+.+.||+|+||+||+|+++.++..||||.+.+.+      +....|+.+|+.++|||||.+++++     ....
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~   82 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDD   82 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCC
Confidence            3456999999999999999999999999999999986543      2235799999999999999999998     4445


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCC-CC-----c---
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE-PN-----V---  223 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~-~~-----~---  223 (403)
                      ++|||||||. |+|..+++.    .+.+++..++.++.||+.||++||+ ++||||||||+||||+.. ..     .   
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~-~~IiHRDLKPQNiLLs~~~~~~~~~~LKIA  157 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHE-NNIIHRDLKPQNILLSTTARNDTSPVLKIA  157 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCcceEEeccCCCCCCCceEEec
Confidence            6999999999 788777665    4689999999999999999999999 899999999999999864 11     1   


Q ss_pred             ---------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015672          224 ---------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  288 (403)
Q Consensus       224 ---------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~  288 (403)
                                     +.+|+|.|||||++.. ..|+.|+|+||+|+|+|+|++|++||...+..+.+..+.+.-.     
T Consensus       158 DFGfAR~L~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~-----  231 (429)
T KOG0595|consen  158 DFGFARFLQPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE-----  231 (429)
T ss_pred             ccchhhhCCchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc-----
Confidence                           3468999999999954 4599999999999999999999999999888887765443210     


Q ss_pred             HHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                                  ..         ..++..++....+|+...|+.||.+|.+..+-+.|+++..-
T Consensus       232 ------------~~---------~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~  274 (429)
T KOG0595|consen  232 ------------IV---------PVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN  274 (429)
T ss_pred             ------------cc---------CchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence                        01         11224567788899999999999999999999999998764

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-48  Score=357.46  Aligned_cols=255  Identities=28%  Similarity=0.498  Sum_probs=211.0

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ...|.+++.||.|.-|+||+|+.+.++..+|+|++.+..       ...+.|.+||+.++||.+..+|..|     ....
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~~  150 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETDK  150 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----eccc
Confidence            345889999999999999999999999999999985432       2234689999999999999999998     5566


Q ss_pred             EEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc---------
Q 015672          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV---------  223 (403)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~---------  223 (403)
                      +.|++||||+| +|..+.+.  ..+..+++..++.|+.+|+.||+|||- .|||.||||||||||..+|++         
T Consensus       151 ~~cl~meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHm-lGivYRDLKPENILvredGHIMLsDFDLS~  227 (459)
T KOG0610|consen  151 YSCLVMEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHM-LGIVYRDLKPENILVREDGHIMLSDFDLSL  227 (459)
T ss_pred             eeEEEEecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHh-hceeeccCCcceeEEecCCcEEeeeccccc
Confidence            79999999995 66655543  335789999999999999999999998 899999999999998544332         


Q ss_pred             ------------------------------------------------------------------eeeccccccchhhh
Q 015672          224 ------------------------------------------------------------------SYICSRYYRAPELI  237 (403)
Q Consensus       224 ------------------------------------------------------------------~~~~t~~y~aPE~~  237 (403)
                                                                                        +++||-.|.|||++
T Consensus       228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI  307 (459)
T KOG0610|consen  228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI  307 (459)
T ss_pred             cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence                                                                              24578889999999


Q ss_pred             hCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccC
Q 015672          238 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR  317 (403)
Q Consensus       238 ~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (403)
                      .|.. .+.++|+|+|||++|||+.|..||.|.+..+.+.+|+..                 ...||..          ..
T Consensus       308 ~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-----------------~l~Fp~~----------~~  359 (459)
T KOG0610|consen  308 RGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-----------------PLKFPEE----------PE  359 (459)
T ss_pred             ecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-----------------CCcCCCC----------Cc
Confidence            7764 899999999999999999999999999999999888752                 2233332          25


Q ss_pred             CCHHHHHHHHHhcccCCCCCCC----HHHHhcCCCcccCCCCCCCCCCCCCCCCCCCC
Q 015672          318 LPPEAVDLVCRFFQYSPNLRCT----ALEACVHPFFDELRDPNTRLPNGRPLPPLFNF  371 (403)
Q Consensus       318 ~s~~~~~li~~~L~~dP~~Rpt----a~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~  371 (403)
                      ++..++|||+++|.+||.+|..    |.||.+||||+++++.-.+...+..+|.....
T Consensus       360 vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~  417 (459)
T KOG0610|consen  360 VSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDG  417 (459)
T ss_pred             chhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCcccc
Confidence            7889999999999999999998    99999999999998875554444444443333

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-49  Score=345.27  Aligned_cols=235  Identities=28%  Similarity=0.479  Sum_probs=203.9

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc-------cHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..+|+..+.||.|+||.|.+++.+.+|..+|+|++.+.+-       ...+|..+|+.+.||+++++++.|     .+..
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~  117 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNS  117 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCC
Confidence            4569999999999999999999999999999999865432       224699999999999999999887     6666


Q ss_pred             EEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc---------
Q 015672          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV---------  223 (403)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~---------  223 (403)
                      +++|||||++| .|..+++.    .+++++..++.|+.||+.||+|||+ ++|++||||||||||+.+|.+         
T Consensus       118 ~lymvmeyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~-~~iiYRDLKPENiLlD~~G~iKitDFGFAK  192 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHS-LDIIYRDLKPENLLLDQNGHIKITDFGFAK  192 (355)
T ss_pred             eEEEEEeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHh-cCeeeccCChHHeeeccCCcEEEEeccceE
Confidence            79999999985 45444443    5789999999999999999999999 899999999999999988765         


Q ss_pred             -------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          224 -------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       224 -------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                             ++||||.|+|||++... .|+.++|.|||||++|||+.|.+||.+.+......+|.+.               
T Consensus       193 ~v~~rT~TlCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~---------------  256 (355)
T KOG0616|consen  193 RVSGRTWTLCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG---------------  256 (355)
T ss_pred             EecCcEEEecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC---------------
Confidence                   45799999999999654 5999999999999999999999999999998888888763               


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCCCC
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDP  355 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~~~  355 (403)
                        ...|            |..++.+++|||.++|+.|-.+|.     ...++.+||||+++.+.
T Consensus       257 --~v~f------------P~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~  306 (355)
T KOG0616|consen  257 --KVKF------------PSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWE  306 (355)
T ss_pred             --cccC------------CcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHH
Confidence              3333            356899999999999999999994     57899999999988653

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.8e-49  Score=375.13  Aligned_cols=254  Identities=30%  Similarity=0.468  Sum_probs=207.9

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccccc------HHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY------KNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+..+.      ..+|++|++.|+|||||.+++.|     +...++|
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~~   77 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHLW   77 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceEE
Confidence            599999999999999999999999999999998654332      45899999999999999999998     5555699


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----------  226 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----------  226 (403)
                      +|.|||.|+|..++..    .+.++++.++.++.|++.||.|||+ .+|+|||+||.|||++..+.++++          
T Consensus        78 vVte~a~g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs-~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~  152 (808)
T KOG0597|consen   78 VVTEYAVGDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHS-NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST  152 (808)
T ss_pred             EEehhhhhhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh-cCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence            9999999988887765    5789999999999999999999999 899999999999999988776543          


Q ss_pred             ---------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          227 ---------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       227 ---------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                               |||.|||||++.+ ..|+..+|+||+|||+||+++|++||...+-......|...   |.           
T Consensus       153 ~t~vltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d---~v-----------  217 (808)
T KOG0597|consen  153 NTSVLTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD---PV-----------  217 (808)
T ss_pred             CceeeeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC---CC-----------
Confidence                     7999999999965 46999999999999999999999999876655554444431   10           


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCCCCCCCCCCCCCCCCCCCCC
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPEL  376 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (403)
                                 .    .+..++..+.+||..+|.+||.+|.|+.+++.|||.++-..-...........++.+..||+.
T Consensus       218 -----------~----~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~spftn~~Ppe~  281 (808)
T KOG0597|consen  218 -----------K----PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDSPFTNNTPPEY  281 (808)
T ss_pred             -----------C----CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccCccccCCChHH
Confidence                       0    124689999999999999999999999999999999864322221122223344455445544

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.1e-47  Score=355.20  Aligned_cols=258  Identities=32%  Similarity=0.654  Sum_probs=213.0

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      .+|++.+.||.|+||.||+|++..+++.||+|++....     ....+|+++++.++|+||+++++++.     ...+.+
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~   79 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIH-----TERCLT   79 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEc-----CCCeEE
Confidence            45999999999999999999999999999999885321     23457999999999999999999873     334588


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      +||||+++++...+...   ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+++           
T Consensus        80 lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~  155 (288)
T cd07871          80 LVFEYLDSDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHK-RKILHRDLKPQNLLINEKGELKLADFGLARAKSV  155 (288)
T ss_pred             EEEeCCCcCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence            99999998876665432   3457888999999999999999999 89999999999999987655432           


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc--
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--  295 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--  295 (403)
                              .+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.++.+.+.....  
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07871         156 PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE  235 (288)
T ss_pred             CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence                    3577899999987666689999999999999999999999999988888999999999998887765432  


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                      .+..+.++.....++... ...+++++.|||.+||++||.+|||++|+++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         236 EFRSYLFPQYRAQPLINH-APRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hhhccccCccCCCchHHh-CCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            233333444433343332 24578999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-47  Score=356.00  Aligned_cols=245  Identities=29%  Similarity=0.461  Sum_probs=203.9

Q ss_pred             CCCCCCcccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------------------ccHHHHHHHHHhcCC
Q 015672           73 GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------------RYKNRELQIMQMLDH  134 (403)
Q Consensus        73 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------------~~~~~E~~~l~~l~h  134 (403)
                      ......++.++|++.+.||+|.||+|-+|++..+++.||||++.+.+                  +...+||.||++++|
T Consensus        88 ~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H  167 (576)
T KOG0585|consen   88 DDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH  167 (576)
T ss_pred             cCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC
Confidence            34444567788999999999999999999999999999999985422                  123479999999999


Q ss_pred             CCccccceEEeecCCCCceEEEEEeeccCCcHHHHHHHhhhhcCC-CCHHHHHHHHHHHHHHHHHHHhcCCccccccccc
Q 015672          135 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR-MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ  213 (403)
Q Consensus       135 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~-l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~  213 (403)
                      +|||+++++.   ++.+..++|||+|||...-  +.  +...... +.+.+++.|+++++.||+|||. +|||||||||+
T Consensus       168 ~nVV~LiEvL---DDP~s~~~YlVley~s~G~--v~--w~p~d~~els~~~Ar~ylrDvv~GLEYLH~-QgiiHRDIKPs  239 (576)
T KOG0585|consen  168 PNVVKLIEVL---DDPESDKLYLVLEYCSKGE--VK--WCPPDKPELSEQQARKYLRDVVLGLEYLHY-QGIIHRDIKPS  239 (576)
T ss_pred             cCeeEEEEee---cCcccCceEEEEEeccCCc--cc--cCCCCcccccHHHHHHHHHHHHHHHHHHHh-cCeeccccchh
Confidence            9999999987   4566777999999998421  11  1122233 8899999999999999999999 89999999999


Q ss_pred             cceecCCCCcee------------------------eccccccchhhhhC---CCCCCchhHHHHHHHHHHHHHhCCCCC
Q 015672          214 NLLVKGEPNVSY------------------------ICSRYYRAPELIFG---ATEYTTAIDIWSTGCVMAELLLGQPLF  266 (403)
Q Consensus       214 NILl~~~~~~~~------------------------~~t~~y~aPE~~~~---~~~~~~~~DiwSlGvil~el~tg~~pf  266 (403)
                      |+||+.++.+++                        +|||.|+|||.+.+   ....+.+.||||+||+||.|+.|+.||
T Consensus       240 NLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF  319 (576)
T KOG0585|consen  240 NLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF  319 (576)
T ss_pred             heEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence            999998887743                        58999999999976   334678999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          267 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       267 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      .+....+.+.+|+..                 ...||..          +.+.+.++|||.+||++||++|++..++..|
T Consensus       320 ~~~~~~~l~~KIvn~-----------------pL~fP~~----------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  320 FDDFELELFDKIVND-----------------PLEFPEN----------PEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             ccchHHHHHHHHhcC-----------------cccCCCc----------ccccHHHHHHHHHHhhcChhheeehhhheec
Confidence            999888888888752                 3333332          3478999999999999999999999999999


Q ss_pred             CCcccC
Q 015672          347 PFFDEL  352 (403)
Q Consensus       347 p~f~~~  352 (403)
                      ||...-
T Consensus       373 pwvt~~  378 (576)
T KOG0585|consen  373 PWVTRD  378 (576)
T ss_pred             ceeccC
Confidence            999764

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-47  Score=365.68  Aligned_cols=232  Identities=36%  Similarity=0.537  Sum_probs=196.9

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc---------cccHHHHHHHHHhcC-CCCccccceEEeecCCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDK  150 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  150 (403)
                      ...|.+.+.||+|+||+|++|.+..++..||+|++.+.         .....+|+.+++.+. ||||+++++++.+.   
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~---   92 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP---   92 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC---
Confidence            44699999999999999999999999999999977543         122347999999999 99999999998433   


Q ss_pred             CceEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCC-CCce----
Q 015672          151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE-PNVS----  224 (403)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~-~~~~----  224 (403)
                        ..+++|||||.+ .|.+.+..    .+++.+..++.+++||+.|++|||+ +||+||||||+|||++.+ ++++    
T Consensus        93 --~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~-~gi~HRDLK~ENilld~~~~~~Kl~DF  165 (370)
T KOG0583|consen   93 --TKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHS-RGIVHRDLKPENILLDGNEGNLKLSDF  165 (370)
T ss_pred             --CeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEecCCCCCEEEecc
Confidence              338999999996 55554443    5789999999999999999999999 899999999999999987 6553    


Q ss_pred             ---------------eeccccccchhhhhCCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015672          225 ---------------YICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  288 (403)
Q Consensus       225 ---------------~~~t~~y~aPE~~~~~~-~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~  288 (403)
                                     .+||+.|+|||++.+.. +.+.++||||+||+||.|++|+.||...+....+..|.+        
T Consensus       166 G~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~--------  237 (370)
T KOG0583|consen  166 GLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK--------  237 (370)
T ss_pred             ccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc--------
Confidence                           46899999999998766 557999999999999999999999998776666666543        


Q ss_pred             HHhhcCcCccccCCCCCCCCCcccccccCC-CHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRL-PPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                               ..+.+|            ..+ |+++++||.+||..||.+|+|+.++++||||+.
T Consensus       238 ---------~~~~~p------------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  238 ---------GEFKIP------------SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             ---------CCccCC------------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                     223333            345 999999999999999999999999999999997

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-49  Score=338.75  Aligned_cols=235  Identities=31%  Similarity=0.467  Sum_probs=195.4

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccc------ccccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ....|.+.+.||+|.|+.|++|.+..+|+.+|+|++..      +.+..++|+.|.+.|+||||+++.+.+     ....
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~   83 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES   83 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccc
Confidence            44569999999999999999999999999999998742      223456899999999999999999887     6667


Q ss_pred             EEEEEeeccCCc-H-HHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC---------
Q 015672          154 YLNLVLEYVPET-V-NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN---------  222 (403)
Q Consensus       154 ~~~lv~e~~~~~-l-~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~---------  222 (403)
                      +.|||+|++.|. + .++...     ..+++..+-.+++||++||.|+|. +||||||+||+|+|+....+         
T Consensus        84 ~~ylvFe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~-n~IvHRDvkP~nllLASK~~~A~vKL~~F  157 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHS-NGIVHRDLKPENLLLASKAKGAAVKLADF  157 (355)
T ss_pred             eeEEEEecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeeeeccCCCceeeccc
Confidence            789999999863 2 122222     346788899999999999999999 79999999999999954321         


Q ss_pred             ------------ceeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          223 ------------VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       223 ------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                  ..++|||.|||||++... +|+..+|||+.|||||-|+.|.+||++.+....+..|++.         
T Consensus       158 GvAi~l~~g~~~~G~~GtP~fmaPEvvrkd-py~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g---------  227 (355)
T KOG0033|consen  158 GLAIEVNDGEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG---------  227 (355)
T ss_pred             ceEEEeCCccccccccCCCcccCHHHhhcC-CCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc---------
Confidence                        135689999999999655 5999999999999999999999999998888888877763         


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                              .++++.   ..     ...+++++++||++||..||.+|+|+.|+|+|||+.+
T Consensus       228 --------~yd~~~---~~-----w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  228 --------AYDYPS---PE-----WDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             --------ccCCCC---cc-----cCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence                    222221   11     2568999999999999999999999999999999976

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.7e-49  Score=343.69  Aligned_cols=238  Identities=27%  Similarity=0.480  Sum_probs=196.6

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc------cccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ....|+++++||+|+||.||++.+..+|+.+|.|.+.-+      +.....|+.+|++|+|||||++++.-+.   .+..
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~e   93 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNE   93 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccch
Confidence            345699999999999999999999999999999988522      2233479999999999999999873221   3333


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh--cC-CccccccccccceecCCCCc------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN--CI-GICHRDIKPQNLLVKGEPNV------  223 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~--~~-~ivHrDlKp~NILl~~~~~~------  223 (403)
                      .++||||||+ |+|.+++..+...++.+++..++.++.|++.||.++|+  .. -|+||||||.||+|+..+.+      
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence            4789999998 89999999998888999999999999999999999997  21 39999999999999988766      


Q ss_pred             -------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          224 -------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       224 -------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                   +++|||+||+||.+.+. .|+.++||||+||++|||+.-++||.+.+-.+.-.+|.+.--+|.+   
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~-~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p---  249 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIHES-GYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP---  249 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHhcC-CCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc---
Confidence                         35799999999999655 5999999999999999999999999999766655555543111110   


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                                              ....|.++..||..|+..||+.||+.     +|++.++.
T Consensus       250 ------------------------~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~  283 (375)
T KOG0591|consen  250 ------------------------DEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQ  283 (375)
T ss_pred             ------------------------HHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHH
Confidence                                    14578999999999999999999986     56666554

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=8e-46  Score=349.62  Aligned_cols=263  Identities=32%  Similarity=0.571  Sum_probs=203.9

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      .+|++.+.||+|+||.||+|++..+++.||||++....     ....+|+.+++.++|+||+++++++.     ...+.+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~   79 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH-----TKETLT   79 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe-----cCCeEE
Confidence            46999999999999999999999999999999985322     23457999999999999999999873     334589


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      +||||+++++...+...   ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+++           
T Consensus        80 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          80 LVFEYVHTDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQ-RYILHRDLKPQNLLISDTGELKLADFGLARAKSV  155 (303)
T ss_pred             EEEECCCcCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence            99999998876655432   3568889999999999999999999 89999999999999987665432           


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHHhhcCc-
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNP-  295 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~-  295 (403)
                              .+|+.|+|||++.+...++.++|||||||++|+|++|..||.+..+. +.+..+...++.+....+..... 
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence                    35778999999876666899999999999999999999999876543 55666666667766554432211 


Q ss_pred             -CccccCCCCCCCCCcccccc-cCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          296 -NYTEFKFPQIKPHPWHKVFQ-KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       296 -~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                       .+....+....+..+...+. ...++++.+||.+||++||++|||+.|+++||||+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence             11111111111111111111 23567899999999999999999999999999998863

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8.8e-46  Score=354.44  Aligned_cols=267  Identities=36%  Similarity=0.655  Sum_probs=210.7

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccc------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|++.+.||+|+||.||+|++..+++.||||++...      .....+|+++++.++||||+++++++..........+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            489999999999999999999999999999988532      11245799999999999999999987654444445689


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce------------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS------------  224 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~------------  224 (403)
                      +|||||++++...+..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.++            
T Consensus        81 lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELMESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecCCCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999999888766543    3568999999999999999999999 8999999999999998765442            


Q ss_pred             ----------eeccccccchhhhhCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015672          225 ----------YICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       225 ----------~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  293 (403)
                                .++|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+...++.++...+...
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV  235 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence                      2467889999998542 45899999999999999999999999998888888888888888877655432


Q ss_pred             CcCcc-cc--CCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          294 NPNYT-EF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       294 ~~~~~-~~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                      ..... .+  .+....+.++...+ ..+++++.+||.+||+.||++|||++|+++||||+.+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~  299 (338)
T cd07859         236 RNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKV  299 (338)
T ss_pred             hhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcc
Confidence            21100 00  01111111111112 3468899999999999999999999999999999987653

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-47  Score=349.51  Aligned_cols=239  Identities=33%  Similarity=0.540  Sum_probs=191.7

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc----cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      .+|...+.||+|+||.||++.+..+|..+|||.+...    .....+|+.+|.+|+|||||++++.......   ..+++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeEe
Confidence            4588899999999999999999999999999998655    3335789999999999999999886422221   46889


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecC-CCCc------------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKG-EPNV------------  223 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~-~~~~------------  223 (403)
                      +|||++ |++.+++..+.   +.+++..++.+++||++||.|||+ +|||||||||+|||++. ++.+            
T Consensus        94 ~mEy~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs-~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHS-KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             eeeccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            999998 57877766532   379999999999999999999998 89999999999999987 3333            


Q ss_pred             ----------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHHhCCCCHHHHhh
Q 015672          224 ----------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       224 ----------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                                .+.||+.|||||++........++|||||||++.||+||++||... ...+.+..+...           
T Consensus       170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~-----------  238 (313)
T KOG0198|consen  170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE-----------  238 (313)
T ss_pred             cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc-----------
Confidence                      2458999999999964222335999999999999999999999763 322322222211           


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCC
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  354 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  354 (403)
                             ...|         .++..+|+++++||.+||++||++||||.++|+|||.+....
T Consensus       239 -------~~~P---------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  239 -------DSLP---------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             -------CCCC---------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence                   0111         134679999999999999999999999999999999987543

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-46  Score=342.42  Aligned_cols=248  Identities=26%  Similarity=0.448  Sum_probs=204.7

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ....|++..+||.|.-++||+|++..++..||||++.-++     ....+|++.|+.++||||++++..|.....     
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~-----   98 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE-----   98 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce-----
Confidence            4456999999999999999999999999999999985433     344689999999999999999998855443     


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce---------
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS---------  224 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~---------  224 (403)
                      +|+||.||. |++.+++..+..  ..+.+..+..+++++++||.|||. +|.||||||+.||||+.+|.++         
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~-~G~IHRdvKAgnILi~~dG~VkLadFgvsa~  175 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQ-NGHIHRDVKAGNILIDSDGTVKLADFGVSAS  175 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHh-cCceecccccccEEEcCCCcEEEcCceeeee
Confidence            999999998 788888876653  569999999999999999999999 8999999999999999888763         


Q ss_pred             --------------eeccccccchhhh-hCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          225 --------------YICSRYYRAPELI-FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       225 --------------~~~t~~y~aPE~~-~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                    ++||++|||||++ .....|+.|+||||||++..||++|..||........+....+  +.|+...
T Consensus       176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--n~pp~~~  253 (516)
T KOG0582|consen  176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--NDPPTLL  253 (516)
T ss_pred             ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--CCCCCcc
Confidence                          3679999999994 4445699999999999999999999999988877766544333  3333211


Q ss_pred             HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCC
Q 015672          290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  354 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  354 (403)
                      ....                 .......++..++.+|..||++||.+||||.++|+|+||+....
T Consensus       254 t~~~-----------------~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  254 TSGL-----------------DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             cccC-----------------ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence            1100                 00112456789999999999999999999999999999998754

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-47  Score=358.54  Aligned_cols=234  Identities=29%  Similarity=0.481  Sum_probs=199.7

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc----cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ...|....+||+|+.|.||.|+...+++.||||.+...    ++...+|+.+|+..+|+|||.+++.|...+.     +|
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de-----LW  346 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE-----LW  346 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccce-----eE
Confidence            34588889999999999999999999999999998533    3445689999999999999999999865533     99


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-----------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-----------  224 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-----------  224 (403)
                      +||||++ |+|.++...     ..+++.++..++++++.||+|||. +||+|||||.+|||++.++.++           
T Consensus       347 VVMEym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~-~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~  420 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHA-RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS  420 (550)
T ss_pred             EEEeecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHh-cceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence            9999998 456555543     458999999999999999999999 8999999999999998777653           


Q ss_pred             --------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          225 --------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       225 --------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                              .+|||+|||||++.. ..|++++||||||++++||+-|++||..++....++.|... |+|...        
T Consensus       421 ~~~~KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~lk--------  490 (550)
T KOG0578|consen  421 EEQSKRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKLK--------  490 (550)
T ss_pred             cccCccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCcC--------
Confidence                    468999999999954 56999999999999999999999999988887777776543 332211        


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                                       .+..+|++++|||.+||+.|+.+|++|.|+|+||||+..
T Consensus       491 -----------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  491 -----------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             -----------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence                             236799999999999999999999999999999999543

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.8e-45  Score=345.93  Aligned_cols=263  Identities=35%  Similarity=0.679  Sum_probs=214.2

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ..|.+.+.||+|+||.||+|++..+++.||+|.+....     ....+|+++++.++|+||+++++++..     ..+.+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT-----DKSLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee-----CCeEE
Confidence            45999999999999999999999999999999885322     234579999999999999999998733     34588


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      +||||+++++...+...   ...++...++.++.||+.||.|||+ .||+||||||+|||++.++.+++           
T Consensus        81 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  156 (309)
T cd07872          81 LVFEYLDKDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHR-RKVLHRDLKPQNLLINERGELKLADFGLARAKSV  156 (309)
T ss_pred             EEEeCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence            99999998776655432   3457888999999999999999999 89999999999999987665432           


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC-
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-  296 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-  296 (403)
                              .+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.+....+...... 
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07872         157 PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND  236 (309)
T ss_pred             CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence                    34778999999876666899999999999999999999999998888888889999998888776544321 


Q ss_pred             -ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCC
Q 015672          297 -YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  354 (403)
Q Consensus       297 -~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  354 (403)
                       +..+.++.....++.... ..+++++.+||.+||++||.+|||+.|+++||||+.+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  294 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHA-PRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT  294 (309)
T ss_pred             hhhhhhcCccCCCchhhhc-cCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence             222333433333332222 457899999999999999999999999999999998753

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-46  Score=362.43  Aligned_cols=235  Identities=29%  Similarity=0.478  Sum_probs=200.8

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc-------cHHHHHHHHHhcC-CCCccccceEEeecCCCC
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQMLD-HPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  151 (403)
                      ...+|.++++||+|+||+|+++..+.+++.||||+++++.-       ....|.+|+.... ||.++.++.+|     ..
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----QT  440 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----QT  440 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----cc
Confidence            45579999999999999999999999999999999976532       2235777777774 99999999998     55


Q ss_pred             ceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc--------
Q 015672          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV--------  223 (403)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~--------  223 (403)
                      ..++|+||||+.|+.  +..  ....+.+++..++.|+..|+.||+|||+ +|||+||||.+|||||.+|++        
T Consensus       441 ~~~l~fvmey~~Ggd--m~~--~~~~~~F~e~rarfyaAev~l~L~fLH~-~~IIYRDlKLdNiLLD~eGh~kiADFGlc  515 (694)
T KOG0694|consen  441 KEHLFFVMEYVAGGD--LMH--HIHTDVFSEPRARFYAAEVVLGLQFLHE-NGIIYRDLKLDNLLLDTEGHVKIADFGLC  515 (694)
T ss_pred             CCeEEEEEEecCCCc--EEE--EEecccccHHHHHHHHHHHHHHHHHHHh-cCceeeecchhheEEcccCcEEecccccc
Confidence            567999999998743  111  1123679999999999999999999999 899999999999999988766        


Q ss_pred             -----------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          224 -----------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       224 -----------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                                 +++|||.|||||++.+. .|+.++|.|||||+||||+.|..||.++++.+.+..|...           
T Consensus       516 Ke~m~~g~~TsTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d-----------  583 (694)
T KOG0694|consen  516 KEGMGQGDRTSTFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND-----------  583 (694)
T ss_pred             cccCCCCCccccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-----------
Confidence                       46799999999999765 5999999999999999999999999999999999888752           


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCcccCCC
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  354 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~e~l~hp~f~~~~~  354 (403)
                            +..            +|..+|.++.++|+++|..||++|..     +++|.+||||+.+.+
T Consensus       584 ------~~~------------yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w  632 (694)
T KOG0694|consen  584 ------EVR------------YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDW  632 (694)
T ss_pred             ------CCC------------CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCH
Confidence                  111            33568999999999999999999995     588999999999874

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-46  Score=307.49  Aligned_cols=261  Identities=34%  Similarity=0.643  Sum_probs=220.5

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|...++||+|.||+||+|+++.+++.||+|.++-+.      ....+|+.+++.|+|.|||+++++..+     +..+.
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-----dkklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-----CceeE
Confidence            3777889999999999999999999999999986432      234689999999999999999998733     33488


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      +|+|||...|..+..   ..++.+....++.++.|++.||.|+|+ +++.||||||.|+||+.++..+.           
T Consensus        78 lvfe~cdqdlkkyfd---slng~~d~~~~rsfmlqllrgl~fchs-hnvlhrdlkpqnllin~ngelkladfglarafgi  153 (292)
T KOG0662|consen   78 LVFEFCDQDLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHS-HNVLHRDLKPQNLLINRNGELKLADFGLARAFGI  153 (292)
T ss_pred             EeHHHhhHHHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhh-hhhhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence            999999977655544   456889999999999999999999999 89999999999999998887654           


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                              +.|.+|++|.++++..-|++..|+||.|||+.|+.. |++.|++.+-.+++..|.+.+|.|.++.|+.+..-
T Consensus       154 pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l  233 (292)
T KOG0662|consen  154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL  233 (292)
T ss_pred             ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence                    248899999999999889999999999999999986 89999999999999999999999999999876533


Q ss_pred             ccccCCCCCCCC-CcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          297 YTEFKFPQIKPH-PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       297 ~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                      .+-.-+|.+.+. .|.... ++++..-+||++++|..+|.+|++|+++++||||.+..
T Consensus       234 pdyk~yp~ypattswsqiv-p~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  234 PDYKPYPIYPATTSWSQIV-PKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             CCCcccCCccccchHHHHh-hhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence            333334444332 344433 46777889999999999999999999999999998753

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6.8e-45  Score=340.36  Aligned_cols=257  Identities=38%  Similarity=0.694  Sum_probs=203.4

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|.+.+.||+|+||.||+|+++.+++.||+|++....      ....+|+++++.++|+||+++++++     ....+++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   76 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKLY   76 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEEE
Confidence            5999999999999999999999999999999885431      2335799999999999999999887     3344689


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce------------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS------------  224 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~------------  224 (403)
                      +||||+++++...+..   ....+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.++            
T Consensus        77 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  152 (287)
T cd07848          77 LVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK-NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE  152 (287)
T ss_pred             EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence            9999999766544332   23568899999999999999999999 8999999999999998765442            


Q ss_pred             --------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--
Q 015672          225 --------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--  294 (403)
Q Consensus       225 --------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--  294 (403)
                              ..||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+....+..+.+.+....  
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07848         153 GSNANYTEYVATRWYRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN  231 (287)
T ss_pred             cccccccccccccccCCcHHHcCC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence                    2467889999999655 48999999999999999999999999988888777777777776665543221  


Q ss_pred             cCccccCCCCCC-CCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          295 PNYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       295 ~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                      +.+....++... ...+.......++.++.+||++||++||++|||++++|+||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            111111122111 1112222234578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-45  Score=338.97  Aligned_cols=291  Identities=27%  Similarity=0.440  Sum_probs=233.3

Q ss_pred             CCCCCCCCceeEecccCCCCCCcccccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccccH---HHHHHHHHhcC
Q 015672           57 DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLD  133 (403)
Q Consensus        57 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~E~~~l~~l~  133 (403)
                      +...+..|.++++.+|+.+...+    |.+.++||-|.|++||+|.+..+.+.||+|+++....+.   ..||.+|+.+.
T Consensus        57 ~~~dY~kGGYHpV~IGD~F~~gR----Y~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~  132 (590)
T KOG1290|consen   57 DPEDYRKGGYHPVRIGDVFNGGR----YHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVR  132 (590)
T ss_pred             ChhhhhcCCCceeeccccccCce----EEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHH
Confidence            34567889999999998877655    999999999999999999999999999999987654443   46999999983


Q ss_pred             -----C---CCccccceEEeecCCCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCc
Q 015672          134 -----H---PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI  205 (403)
Q Consensus       134 -----h---~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~i  205 (403)
                           |   .+||++++.|- ....++.|+|||+|+++.+|..++....  .+.++...++.|++||+.||.|||...||
T Consensus       133 ~~Dp~~~~~~~VV~LlD~Fk-hsGpNG~HVCMVfEvLGdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ecgI  209 (590)
T KOG1290|consen  133 EGDPNDPGKKCVVQLLDHFK-HSGPNGQHVCMVFEVLGDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHRECGI  209 (590)
T ss_pred             hcCCCCCCCceeeeeeccce-ecCCCCcEEEEEehhhhhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhcCc
Confidence                 2   47999999874 4558899999999999988887776543  57899999999999999999999987799


Q ss_pred             cccccccccceecCC-----------------------------------------------------------------
Q 015672          206 CHRDIKPQNLLVKGE-----------------------------------------------------------------  220 (403)
Q Consensus       206 vHrDlKp~NILl~~~-----------------------------------------------------------------  220 (403)
                      ||-||||+|||+...                                                                 
T Consensus       210 IHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~  289 (590)
T KOG1290|consen  210 IHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLA  289 (590)
T ss_pred             cccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhc
Confidence            999999999998100                                                                 


Q ss_pred             ---------------------CC---c--------------------e--------------------------------
Q 015672          221 ---------------------PN---V--------------------S--------------------------------  224 (403)
Q Consensus       221 ---------------------~~---~--------------------~--------------------------------  224 (403)
                                           ..   +                    +                                
T Consensus       290 ~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~  369 (590)
T KOG1290|consen  290 GLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPS  369 (590)
T ss_pred             ccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcC
Confidence                                 00   0                    0                                


Q ss_pred             -----------------------------------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCC
Q 015672          225 -----------------------------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ  263 (403)
Q Consensus       225 -----------------------------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~  263 (403)
                                                               -+.|+.|+|||++.+.. |++.+||||++|++|||+||.
T Consensus       370 s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGD  448 (590)
T KOG1290|consen  370 SPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGD  448 (590)
T ss_pred             CccccccccccCCCCCCCccceeEEEeeccchhhhhhhhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCc
Confidence                                                     01267799999999875 999999999999999999999


Q ss_pred             CCCCCC------CcHHHHHHHHHHhCCCCHHHHhh-------cCcCccccCCCCCCCCCccccccc------CCCHHHHH
Q 015672          264 PLFPGE------SGVDQLVEIIKVLGTPTREEIKC-------MNPNYTEFKFPQIKPHPWHKVFQK------RLPPEAVD  324 (403)
Q Consensus       264 ~pf~~~------~~~~~~~~i~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~------~~s~~~~~  324 (403)
                      ..|...      .+.++++.|++.+|..+......       .+....-..+...+.+++...+..      .-..++.|
T Consensus       449 yLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsd  528 (590)
T KOG1290|consen  449 YLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSD  528 (590)
T ss_pred             eeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHH
Confidence            998532      35689999999999988876542       222222234455566665554432      23467899


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          325 LVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       325 li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                      ||.-||+++|++|+||.++|+|||+..+..+
T Consensus       529 FL~PmLef~PeKR~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  529 FLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             HHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence            9999999999999999999999999987655

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.4e-44  Score=338.67  Aligned_cols=261  Identities=31%  Similarity=0.568  Sum_probs=203.4

Q ss_pred             cEeeeceecccCceEEEEEEECC-CCcEEEEEEccccc------ccHHHHHHHHHhc---CCCCccccceEEeecCCCCc
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDK------RYKNRELQIMQML---DHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~  152 (403)
                      +|++.+.||+|+||+||+|++.. +++.||+|.+....      ....+|+.+++.+   +||||+++++++........
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            59999999999999999999854 46889999875321      1234677777766   69999999998754333345


Q ss_pred             eEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------
Q 015672          153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------  225 (403)
Q Consensus       153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------  225 (403)
                      ..+++||||+++++..++....  ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+++       
T Consensus        82 ~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~-~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          82 TKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             CcEEEEEccCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            5688999999988877665422  2458889999999999999999999 89999999999999987665432       


Q ss_pred             -----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          226 -----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       226 -----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                 .||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..+....+.+....+....
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (290)
T cd07862         159 IYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV  237 (290)
T ss_pred             eccCCcccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence                       357889999998654 58999999999999999999999999999889998998888777665443211


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                      . .....+......++... ...+++.+.+||.+||+.||++|||+.++|+||||
T Consensus       238 ~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         238 A-LPRQAFHSKSAQPIEKF-VTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             c-ccchhccCCCCCCHHHH-ccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            0 11111111222222222 24578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.2e-43  Score=354.11  Aligned_cols=264  Identities=23%  Similarity=0.378  Sum_probs=198.8

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCC------CccccceEEeecCCCCc
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHP------NIVALKHCFFSTTDKEE  152 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~~~  152 (403)
                      .+|.+.++||+|+||+||+|.+..+++.||||++....   .....|+++++.++|.      ++++++++|.    .+.
T Consensus       129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~----~~~  204 (467)
T PTZ00284        129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ----NET  204 (467)
T ss_pred             CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE----cCC
Confidence            56999999999999999999999999999999985422   2335688888888655      4777777663    223


Q ss_pred             eEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC----------
Q 015672          153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN----------  222 (403)
Q Consensus       153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~----------  222 (403)
                      .++|+|||++++++...+..    ...+++..++.++.||+.||.|||+..|||||||||+|||++.++.          
T Consensus       205 ~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~  280 (467)
T PTZ00284        205 GHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL  280 (467)
T ss_pred             ceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence            46889999998887666543    3568999999999999999999996249999999999999975432          


Q ss_pred             ------c----------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 015672          223 ------V----------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK  280 (403)
Q Consensus       223 ------~----------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~  280 (403)
                            +                ..+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..+.+
T Consensus       281 ~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~  359 (467)
T PTZ00284        281 PPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK  359 (467)
T ss_pred             CCCCceEEECCCCccccCccccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence                  1                24578999999999765 589999999999999999999999999988888888888


Q ss_pred             HhCCCCHHHHhhcCcC-----cccc--CCCCCCCCCccccc------ccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 015672          281 VLGTPTREEIKCMNPN-----YTEF--KFPQIKPHPWHKVF------QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  347 (403)
Q Consensus       281 ~~~~~~~~~~~~~~~~-----~~~~--~~~~~~~~~~~~~~------~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp  347 (403)
                      .++.++..........     +...  ..+...+..+....      ....++.+.|||.+||++||++|||++|+|+||
T Consensus       360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp  439 (467)
T PTZ00284        360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP  439 (467)
T ss_pred             HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence            8887765543211100     0000  00000000000000      001246788999999999999999999999999


Q ss_pred             CcccCCC
Q 015672          348 FFDELRD  354 (403)
Q Consensus       348 ~f~~~~~  354 (403)
                      ||.+...
T Consensus       440 ~~~~~~~  446 (467)
T PTZ00284        440 YVLKYYP  446 (467)
T ss_pred             cccccCC
Confidence            9987543

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.3e-44  Score=336.84  Aligned_cols=267  Identities=30%  Similarity=0.620  Sum_probs=213.1

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ..|++.+.||+|+||.||+|++..+++.||+|.+....     ....+|+.+++.++|+||+++++++.     ...+++
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~~~   80 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT   80 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCeEE
Confidence            45999999999999999999999999999999885322     23457999999999999999999883     334588


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      +||||+++++...+...   ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.++.           
T Consensus        81 lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  156 (301)
T cd07873          81 LVFEYLDKDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHR-RKVLHRDLKPQNLLINERGELKLADFGLARAKSI  156 (301)
T ss_pred             EEEeccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence            99999998876665432   3467888999999999999999999 89999999999999987765433           


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc--
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--  295 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--  295 (403)
                              .+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....|.....  
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence                    2467899999987666688999999999999999999999999888888888888888877766543321  


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCCC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  358 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~~  358 (403)
                      .+..+.++....... ......+++++++||.+||+.||.+|||+.|+++||||+.+...-++
T Consensus       237 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~~~  298 (301)
T cd07873         237 EFKSYNYPKYRADCL-HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIHK  298 (301)
T ss_pred             cccccccCccccccH-HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchhhc
Confidence            122222232211111 11234678999999999999999999999999999999987654433

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.1e-44  Score=351.66  Aligned_cols=266  Identities=34%  Similarity=0.569  Sum_probs=209.4

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|++.+.||+|+||.||+|.+..+++.||||++....      ....+|+.+++.++|+||+++++++.........++|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            3788999999999999999999999999999885421      2235799999999999999999987543322223689


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      +||||+.+++...+..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+++           
T Consensus        81 lv~e~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQSDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHS-AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccccCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999999877655432    3568999999999999999999999 89999999999999987765532           


Q ss_pred             ---------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          226 ---------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       226 ---------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                               .+|+.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++..+...++.++.+.+......
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  235 (372)
T cd07853         156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG  235 (372)
T ss_pred             CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence                     34778999999977666899999999999999999999999999989999999999998887665432111


Q ss_pred             cccc--CCCCCCC-CCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          297 YTEF--KFPQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       297 ~~~~--~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                      ....  ..+...+ ......+....++++.+||.+||++||++|||+.|+|+||||++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence            0000  0000000 0000012245688999999999999999999999999999998853

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=9.2e-44  Score=344.24  Aligned_cols=269  Identities=31%  Similarity=0.541  Sum_probs=209.2

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCC-CCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  153 (403)
                      ..+|.+.+.||+|+||.||+|++..+++.||||++....      ....+|+.+++.++|+||+++++++..... ....
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            346999999999999999999999999999999985421      223479999999999999999987743221 2234


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee--------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY--------  225 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~--------  225 (403)
                      .+|+||||+++++...+.      ..++...+..++.|++.||.|||+ +||+||||||+|||++.++.+++        
T Consensus       103 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  175 (364)
T cd07875         103 DVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLART  175 (364)
T ss_pred             eEEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence            578999999988765543      347788889999999999999999 89999999999999987665432        


Q ss_pred             ----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          226 ----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       226 ----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                .+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...++.|..+.+....+
T Consensus       176 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (364)
T cd07875         176 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  254 (364)
T ss_pred             cCCCCcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence                      467889999999654 589999999999999999999999999998888888888888887765443321


Q ss_pred             C----------ccccCCCCCC---CCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCC
Q 015672          296 N----------YTEFKFPQIK---PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  357 (403)
Q Consensus       296 ~----------~~~~~~~~~~---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~  357 (403)
                      .          +..+.+....   ..++........+.++++||.+||+.||.+|||+.++|+||||....++..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~  329 (364)
T cd07875         255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSE  329 (364)
T ss_pred             HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCccc
Confidence            1          1111110000   011111112234678999999999999999999999999999987665543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-45  Score=314.53  Aligned_cols=235  Identities=29%  Similarity=0.461  Sum_probs=200.4

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      ...+|++++.||+|.||.||+|+.+.++-.||+|++.+..       ....+|++|...|+||||+++|++|     .+.
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-----hd~   94 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-----HDS   94 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----ecc
Confidence            3456999999999999999999999999999999986542       3345899999999999999999999     444


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc--------
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV--------  223 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~--------  223 (403)
                      ..+|+++||.+ |.+...+...  ...++.+..+..|+.|++.||.|+|. ++||||||||+|+|++..+..        
T Consensus        95 ~riyLilEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~-k~VIhRdiKpenlLlg~~~~lkiAdfGws  171 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHL-KRVIHRDIKPENLLLGSAGELKIADFGWS  171 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhcc-CCcccCCCCHHHhccCCCCCeeccCCCce
Confidence            55999999998 5665555422  24668888999999999999999999 899999999999999765543        


Q ss_pred             ---------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          224 ---------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       224 ---------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                               +.+||.-|.+||+..+. .++..+|+|++|++.||++.|.+||...+..+.+..|.+.             
T Consensus       172 V~~p~~kR~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-------------  237 (281)
T KOG0580|consen  172 VHAPSNKRKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-------------  237 (281)
T ss_pred             eecCCCCceeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-------------
Confidence                     56789999999999655 5899999999999999999999999998877888877763             


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                          ++.            ++..++.+++|||.+||..+|.+|.+..|++.|||+...
T Consensus       238 ----~~~------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  238 ----DLK------------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             ----ccc------------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence                122            235689999999999999999999999999999998764

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-44  Score=352.12  Aligned_cols=260  Identities=24%  Similarity=0.365  Sum_probs=198.9

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      ...+|.+.+.||+|+||.||+|.+..+++.||+|....  ....+|+++++.|+||||++++++|..     ..+.++||
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~lv~  162 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--GGTATEAHILRAINHPSIIQLKGTFTY-----NKFTCLIL  162 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--hhhHHHHHHHHhCCCCCCCCEeEEEEE-----CCeeEEEE
Confidence            34569999999999999999999999999999997643  345689999999999999999998733     34588999


Q ss_pred             eccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce---------------
Q 015672          160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS---------------  224 (403)
Q Consensus       160 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~---------------  224 (403)
                      |++.+++...+..    ...+++..++.++.||+.||.|||+ +|||||||||+|||++..+.++               
T Consensus       163 e~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~-~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        163 PRYKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             ecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence            9999877665543    3568899999999999999999999 8999999999999997655432               


Q ss_pred             -----eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHHHHhCCCCHHHHhh
Q 015672          225 -----YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-------GVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       225 -----~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                           ..||+.|+|||++.+. .++.++|||||||++|||++|..||....       ...++..+....+.++.+....
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             cccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence                 2478999999998654 58999999999999999999998875432       3456667777777654332100


Q ss_pred             cCcC----c-----cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          293 MNPN----Y-----TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       293 ~~~~----~-----~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                      ....    +     .....+.. ...|...  ..++.++.+||.+||++||++||||.|+|+||||+++..|
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGS-RPLWTNL--YELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCC-CCCHHHH--hhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence            0000    0     00000000 0111111  2357789999999999999999999999999999887543

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.1e-44  Score=333.95  Aligned_cols=261  Identities=30%  Similarity=0.556  Sum_probs=204.5

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhc---CCCCccccceEEeecCCCCce
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQML---DHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~  153 (403)
                      +|++.+.||+|+||+||+|+++.+++.||+|.+....      ....+|+++++.+   +|+||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4899999999999999999999999999999885321      1234677777766   799999999987654444556


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee--------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY--------  225 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~--------  225 (403)
                      .++++|||+.+++..++....  ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+++        
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~~~kl~dfg~~~~  157 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGGQVKLADFGLARI  157 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence            789999999988766655422  2458999999999999999999999 89999999999999987765533        


Q ss_pred             ----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          226 ----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       226 ----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                .+|..|+|||++.+. .++.++|||||||++|+|++|.+||.+....+.+..+....+.+....+.... 
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  235 (288)
T cd07863         158 YSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV-  235 (288)
T ss_pred             ccCcccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc-
Confidence                      357789999998654 58999999999999999999999999888888888888877776655443110 


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                      ......+......++.. ....++..+.+||.+||++||++|||+.|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 TLPRGAFSPRGPRPVQS-VVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccccccCCCCCCchHH-hCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            00011111111222222 224578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.1e-44  Score=346.03  Aligned_cols=268  Identities=31%  Similarity=0.551  Sum_probs=206.4

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc------cccHHHHHHHHHhcCCCCccccceEEeecCC-CCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  153 (403)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++...      .....+|+.+++.++||||+++++++..... ....
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            34699999999999999999999999999999998532      1223479999999999999999998743321 1223


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee--------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY--------  225 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~--------  225 (403)
                      .+|+||||+++++...+.      ..++...+..++.||+.||.|||+ +||+||||||+|||++.++.+++        
T Consensus       100 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~  172 (359)
T cd07876         100 DVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLART  172 (359)
T ss_pred             eeEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence            578999999987655432      347888899999999999999999 89999999999999987765533        


Q ss_pred             ----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC-
Q 015672          226 ----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-  294 (403)
Q Consensus       226 ----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-  294 (403)
                                .+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+....+.... 
T Consensus       173 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (359)
T cd07876         173 ACTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP  251 (359)
T ss_pred             cccCccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence                      357889999998654 58999999999999999999999999998888888888888887765432211 


Q ss_pred             ---------cCccccCCCCCCC---CCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCC
Q 015672          295 ---------PNYTEFKFPQIKP---HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  356 (403)
Q Consensus       295 ---------~~~~~~~~~~~~~---~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~  356 (403)
                               +.+....+....+   .+.........++++++||.+||++||++|||+.|+|+||||.....+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~  325 (359)
T cd07876         252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPA  325 (359)
T ss_pred             HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCcc
Confidence                     1111111000000   0000011233578899999999999999999999999999998755443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.9e-44  Score=342.04  Aligned_cols=233  Identities=30%  Similarity=0.431  Sum_probs=191.8

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..+|.+.+.||+|+||.||+|+++.+++.||+|++....       ....+|+.+++.++||||+++++++.     ...
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~   91 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ-----DEN   91 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----cCC
Confidence            356999999999999999999999999999999885421       22457999999999999999999883     344


Q ss_pred             EEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------
Q 015672          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------  225 (403)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------  225 (403)
                      ++++||||+.+ +|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+++       
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  166 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHS-KDIIYRDLKPENLLLDNKGHVKVTDFGFAK  166 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEECCCCCEEEeeccCce
Confidence            58999999974 56555443    3568899999999999999999999 89999999999999987765533       


Q ss_pred             ---------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          226 ---------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       226 ---------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                               .||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...               
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~---------------  230 (329)
T PTZ00263        167 KVPDRTFTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG---------------  230 (329)
T ss_pred             EcCCCcceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---------------
Confidence                     468899999998654 4899999999999999999999999877665544443321               


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCcccCC
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELR  353 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~e~l~hp~f~~~~  353 (403)
                        ...            ++..++..+++||.+||+.||.+|++     ++++++||||++..
T Consensus       231 --~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~  278 (329)
T PTZ00263        231 --RLK------------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN  278 (329)
T ss_pred             --CcC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence              011            12347889999999999999999997     79999999998754

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-44  Score=343.25  Aligned_cols=236  Identities=31%  Similarity=0.551  Sum_probs=197.3

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc-------cHHHHHHHHHhcC-CCCccccceEEeecCCCCc
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQMLD-HPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~  152 (403)
                      ...|++.+.||.|.||.||+|+.+.+|+.+|+|.+.+...       ...+|+++|+++. |||||.+++.|.     ..
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e-----~~  108 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE-----DP  108 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE-----cC
Confidence            4459999999999999999999999999999999965432       5578999999998 999999999994     33


Q ss_pred             eEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC----Cc----
Q 015672          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP----NV----  223 (403)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~----~~----  223 (403)
                      ..+++|||+|.| .|.+.+...     .+++..+..++.||+.|+.|||+ .||+||||||+|+|+....    .+    
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~-~gvvHrDlKpEN~L~~~~~~~~~~ik~~D  182 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS-LGVVHRDLKPENLLLASKDEGSGRIKLID  182 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCHHHeeeccccCCCCcEEEee
Confidence            458999999984 444333322     39999999999999999999999 8999999999999996442    12    


Q ss_pred             --------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          224 --------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       224 --------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                    ..+||+.|+|||++.. ..|+..+||||+||++|.|++|.+||.+.+.......+.+.        
T Consensus       183 FGla~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~--------  253 (382)
T KOG0032|consen  183 FGLAKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG--------  253 (382)
T ss_pred             CCCceEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC--------
Confidence                          3468999999999954 46999999999999999999999999999988877766542        


Q ss_pred             HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                               .+   .+...+|     ..++..+++||++||..||.+|+||.++|+|||++...
T Consensus       254 ---------~~---~f~~~~w-----~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~  300 (382)
T KOG0032|consen  254 ---------DF---DFTSEPW-----DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG  300 (382)
T ss_pred             ---------CC---CCCCCCc-----cccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence                     11   1222333     56899999999999999999999999999999988753

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.2e-44  Score=342.65  Aligned_cols=268  Identities=34%  Similarity=0.613  Sum_probs=211.4

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCC-CCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  154 (403)
                      .+|++.+.||+|+||+||+|.+..+++.||||++....      ....+|+.+++.++|+||+++++++..... .....
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            45999999999999999999999999999999986432      123479999999999999999987743221 22245


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      .|++++++++++..++.     ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+++         
T Consensus        95 ~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  168 (343)
T cd07878          95 VYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHS-AGIIHRDLKPSNVAVNEDCELRILDFGLARQA  168 (343)
T ss_pred             EEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCChhhEEECCCCCEEEcCCccceec
Confidence            78999999888866553     2568999999999999999999999 89999999999999987765533         


Q ss_pred             -------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 015672          226 -------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  298 (403)
Q Consensus       226 -------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  298 (403)
                             ++|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+..+.+........
T Consensus       169 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07878         169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHA  248 (343)
T ss_pred             CCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhH
Confidence                   4688999999987655689999999999999999999999998888888888888877777665443322111


Q ss_pred             cc---CCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCC
Q 015672          299 EF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  356 (403)
Q Consensus       299 ~~---~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~  356 (403)
                      ..   .++......+...+ ...++.+.+||.+||+.||++|||+.|+|+||||.....+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~  308 (343)
T cd07878         249 RKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE  308 (343)
T ss_pred             HHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCc
Confidence            00   11222222222212 34678899999999999999999999999999999876554

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-44  Score=336.14  Aligned_cols=232  Identities=26%  Similarity=0.407  Sum_probs=192.6

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      +|++.+.||+|+||.||+|++..+++.||+|++....       ....+|+++++.++||||+++++.+     .+..++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~   76 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRFL   76 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCeE
Confidence            5899999999999999999999999999999985321       2245799999999999999998876     344568


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      ++||||++ ++|.+++..    ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+++         
T Consensus        77 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~  151 (291)
T cd05612          77 YMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHS-KEIVYRDLKPENILLDKEGHIKLTDFGFAKKL  151 (291)
T ss_pred             EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCCCEEEEecCcchhc
Confidence            99999997 466655543    3568899999999999999999999 89999999999999987765533         


Q ss_pred             -------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 015672          226 -------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  298 (403)
Q Consensus       226 -------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  298 (403)
                             .||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...                 
T Consensus       152 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~-----------------  213 (291)
T cd05612         152 RDRTWTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-----------------  213 (291)
T ss_pred             cCCcccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------
Confidence                   468899999998654 5899999999999999999999999887766555554431                 


Q ss_pred             ccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCcccCCC
Q 015672          299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  354 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~e~l~hp~f~~~~~  354 (403)
                      ...            ++..+++.+++||.+||+.||.+|++     ++++++||||+.+..
T Consensus       214 ~~~------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  262 (291)
T cd05612         214 KLE------------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW  262 (291)
T ss_pred             CcC------------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence            001            22456889999999999999999995     999999999987654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.1e-46  Score=323.87  Aligned_cols=236  Identities=27%  Similarity=0.486  Sum_probs=196.3

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------------ccHHHHHHHHHhc-CCCCccccceEEeecCC
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  149 (403)
                      .|.-.++||.|..++|.+|.++.+++.+|+|++....            +...+|+.||+++ .||+|+++.+.|     
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y-----   92 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY-----   92 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec-----
Confidence            4888899999999999999999999999999984211            1223699999998 699999999998     


Q ss_pred             CCceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce----
Q 015672          150 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS----  224 (403)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~----  224 (403)
                      ....++++|+|.|+ |.|.+++..    ...+++...+.+++|++.|+.|||. ++||||||||+|||++++-+++    
T Consensus        93 es~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa-~~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHA-RNIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHH-hhhhhcccChhheeeccccceEEecc
Confidence            55556899999998 666555543    4679999999999999999999999 8999999999999999876653    


Q ss_pred             --------------eeccccccchhhhh-----CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 015672          225 --------------YICSRYYRAPELIF-----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  285 (403)
Q Consensus       225 --------------~~~t~~y~aPE~~~-----~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~  285 (403)
                                    .+|||.|.|||.+.     +.+.|+..+|+||+|||||.|+.|.+||+.....-.+..|++.    
T Consensus       168 GFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG----  243 (411)
T KOG0599|consen  168 GFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG----  243 (411)
T ss_pred             ceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc----
Confidence                          47899999999873     4456999999999999999999999999877666666666652    


Q ss_pred             CHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          286 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                                   .++|.   ...|     .+++.+.+|||.+||+.||.+|+|++|+|+||||..+.
T Consensus       244 -------------kyqF~---speW-----adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~  290 (411)
T KOG0599|consen  244 -------------KYQFR---SPEW-----ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA  290 (411)
T ss_pred             -------------ccccC---Ccch-----hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence                         22221   1122     56899999999999999999999999999999997754

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.6e-43  Score=335.91  Aligned_cols=259  Identities=30%  Similarity=0.541  Sum_probs=193.7

Q ss_pred             eceecccCceEEEEEEEC--CCCcEEEEEEccccc--ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeecc
Q 015672           87 EHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (403)
Q Consensus        87 ~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  162 (403)
                      .++||+|+||+||+|+++  .+++.||+|.+....  ....+|+++++.++||||+++++.+...   ...++|++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEecc
Confidence            467999999999999975  467899999886432  2346899999999999999999887532   334688999999


Q ss_pred             CCcHHHHHHHhhh-----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecC----CCCc----------
Q 015672          163 PETVNRIARNYSR-----IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKG----EPNV----------  223 (403)
Q Consensus       163 ~~~l~~~~~~~~~-----~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~----~~~~----------  223 (403)
                      ++++..++.....     ....+++..++.++.||+.||.|||+ .||+||||||+|||+..    .+.+          
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            9888776653221     12358889999999999999999999 89999999999999942    1222          


Q ss_pred             ------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHHHh
Q 015672          224 ------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---------VDQLVEIIKVL  282 (403)
Q Consensus       224 ------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~---------~~~~~~i~~~~  282 (403)
                                  ..++|+.|+|||++.+...++.++||||+||++|+|++|++||.+...         ..++..+...+
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM  241 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence                        234688899999997766689999999999999999999999975432         35667778888


Q ss_pred             CCCCHHHHhhcCcCcc------cc---CCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          283 GTPTREEIKCMNPNYT------EF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       283 ~~~~~~~~~~~~~~~~------~~---~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                      +.|....+........      .+   .........+........+.++.+||.+||++||.+|||++|+|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            8877766543221000      00   0000000000011112346779999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.8e-45  Score=323.06  Aligned_cols=268  Identities=35%  Similarity=0.626  Sum_probs=212.5

Q ss_pred             ccEeeeceecccCceEEEEEEECCCC----cEEEEEEcccccc------cHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETG----EIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      ..|++...||+|.||.||+|..++++    +.+|||+++.++.      ..-+|+.+++.|+|+|++.+..+|...    
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~----   99 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH----   99 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----
Confidence            35999999999999999999766543    3789999976532      234899999999999999999988653    


Q ss_pred             ceEEEEEeeccCCcHHHHHHHhhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCC----CCcee-
Q 015672          152 ELYLNLVLEYVPETVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----PNVSY-  225 (403)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~----~~~~~-  225 (403)
                      +..+++++||.+.+|..++...... ...++...++.++.||+.|+.|||+ +=|+||||||.|||+..+    +.+++ 
T Consensus       100 d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~-NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  100 DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS-NWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh-hheeeccCCcceEEEeccCCccCeeEee
Confidence            3459999999999999988765432 3468899999999999999999999 689999999999999877    44432 


Q ss_pred             ---------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---------cHHHH
Q 015672          226 ---------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES---------GVDQL  275 (403)
Q Consensus       226 ---------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~---------~~~~~  275 (403)
                                           +.|.+|+|||+++|...|+.++||||+|||+.||+|-++.|.+..         ..+++
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence                                 458899999999999999999999999999999999999997653         24788


Q ss_pred             HHHHHHhCCCCHHHHhhcC--cCccccCCCCCCCCCcc-----ccc--ccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          276 VEIIKVLGTPTREEIKCMN--PNYTEFKFPQIKPHPWH-----KVF--QKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       276 ~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~-----~~~--~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      ..|.+.+|.|+...|+.+.  +++.. .+..++.+.+.     ..+  ...-++...+|+.+||++||-+|.|++++|+|
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~-~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQT-LLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHH-HHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            9999999999998886543  11100 00011111111     111  12235669999999999999999999999999


Q ss_pred             CCcccCCCC
Q 015672          347 PFFDELRDP  355 (403)
Q Consensus       347 p~f~~~~~~  355 (403)
                      +||.+-..|
T Consensus       338 ~yF~~d~lp  346 (438)
T KOG0666|consen  338 PYFTEDPLP  346 (438)
T ss_pred             cccccCCCC
Confidence            999986444

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.8e-43  Score=339.70  Aligned_cols=267  Identities=32%  Similarity=0.562  Sum_probs=207.9

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCC-CCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  153 (403)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++....      ....+|+.+++.++|+||+++++++..... ....
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            346999999999999999999999999999999886432      123469999999999999999998753322 2234


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee--------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY--------  225 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~--------  225 (403)
                      ..++||||+++++...+.      ..++...+..++.|++.||.|||+ .||+||||||+|||++.++.+++        
T Consensus        96 ~~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~Nill~~~~~~kl~Dfg~~~~  168 (355)
T cd07874          96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_pred             eeEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence            578999999987755443      347888889999999999999999 89999999999999987665432        


Q ss_pred             ----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          226 ----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       226 ----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                .+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+..+.+....+
T Consensus       169 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (355)
T cd07874         169 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_pred             CCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence                      467889999998654 589999999999999999999999999888888888888888877765543322


Q ss_pred             C----------ccccCCCCCCC---CCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          296 N----------YTEFKFPQIKP---HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       296 ~----------~~~~~~~~~~~---~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                      .          +....++....   .+.........+.++++||.+||+.||++|||+.|+|+||||....++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~  320 (355)
T cd07874         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP  320 (355)
T ss_pred             HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence            1          11111111111   011111223456789999999999999999999999999999866544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-46  Score=341.82  Aligned_cols=232  Identities=26%  Similarity=0.450  Sum_probs=191.8

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ..|...+.||+|+||.||+|.+..+++.||+|++..+.     ...++|+.+|..++++||.++|+.|+....     +|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~-----Lw   87 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK-----LW   87 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc-----HH
Confidence            34888899999999999999999999999999985432     345689999999999999999999965544     99


Q ss_pred             EEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc------------
Q 015672          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV------------  223 (403)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~------------  223 (403)
                      ++||||.| ++.+++..    +..+.+..+..++++++.||.|||. .+.+|||||+.|||+..++.+            
T Consensus        88 iiMey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~-~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~  162 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHS-EKKIHRDIKAANILLSESGDVKLADFGVAGQLT  162 (467)
T ss_pred             HHHHHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhh-cceecccccccceeEeccCcEEEEecceeeeee
Confidence            99999984 55444443    3445788888899999999999999 899999999999999876554            


Q ss_pred             -------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          224 -------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       224 -------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                             +++|||+|||||++. ...|+.++||||||++.+||++|.+|+........+..|                  
T Consensus       163 ~~~~rr~tfvGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI------------------  223 (467)
T KOG0201|consen  163 NTVKRRKTFVGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI------------------  223 (467)
T ss_pred             chhhccccccccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec------------------
Confidence                   467999999999997 446999999999999999999999999776653322222                  


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                            |...+.    .+...+++.+++||..||.+||+.||+|.++|+|+|++..
T Consensus       224 ------pk~~PP----~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  224 ------PKSAPP----RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             ------cCCCCC----ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence                  211111    1234689999999999999999999999999999999874

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.4e-43  Score=331.51  Aligned_cols=237  Identities=23%  Similarity=0.372  Sum_probs=188.6

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      |.+.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++|+||+++++++     ....+++
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~~   76 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDALC   76 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeEE
Confidence            888999999999999999999999999999875321       1234799999999999999998887     3334689


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-----------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-----------  224 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-----------  224 (403)
                      +||||++ ++|...+...  ....+++..+..++.|++.||.|||+ .||+||||||+|||++.++.++           
T Consensus        77 lv~e~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05631          77 LVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQR-ERIVYRDLKPENILLDDRGHIRISDLGLAVQIP  153 (285)
T ss_pred             EEEEecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcC
Confidence            9999998 4565444321  12468889999999999999999999 8999999999999998665443           


Q ss_pred             -------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          225 -------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       225 -------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                             ..||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...+....           
T Consensus       154 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------  221 (285)
T cd05631         154 EGETVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ-----------  221 (285)
T ss_pred             CCCeecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc-----------
Confidence                   2368899999999654 589999999999999999999999987654333222222111100           


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCcccCCC
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  354 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~e~l~hp~f~~~~~  354 (403)
                                    ..++..+++++.+||.+||+.||.+||+     ++++++||||.++..
T Consensus       222 --------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05631         222 --------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF  269 (285)
T ss_pred             --------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence                          0122457899999999999999999997     899999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1e-43  Score=338.36  Aligned_cols=226  Identities=27%  Similarity=0.454  Sum_probs=184.9

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEee
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  160 (403)
                      +.||+|+||.||+|++..+++.||||++....       ....+|+.+++.++||||+++++++     ....++|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence            46999999999999999999999999886431       1234689999999999999999887     33446899999


Q ss_pred             ccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce---------------
Q 015672          161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS---------------  224 (403)
Q Consensus       161 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~---------------  224 (403)
                      |+++ +|...+..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++.++               
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  150 (323)
T cd05571          76 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHS-CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA  150 (323)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC
Confidence            9984 55444432    4578999999999999999999999 8999999999999998765442               


Q ss_pred             ----eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccc
Q 015672          225 ----YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  300 (403)
Q Consensus       225 ----~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  300 (403)
                          .+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+.......+...                 ..
T Consensus       151 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-----------------~~  212 (323)
T cd05571         151 TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------EI  212 (323)
T ss_pred             cccceecCccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-----------------CC
Confidence                3478899999998654 5899999999999999999999999877655444333211                 01


Q ss_pred             CCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCC
Q 015672          301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  353 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~  353 (403)
                      .            ++..+++++.+||.+||+.||++||     ++.++++||||..+.
T Consensus       213 ~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~  258 (323)
T cd05571         213 R------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN  258 (323)
T ss_pred             C------------CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            1            2246789999999999999999999     899999999998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-44  Score=336.52  Aligned_cols=235  Identities=28%  Similarity=0.401  Sum_probs=202.9

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccccc------HHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY------KNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      -|.+.+.||+|.|++|-+|++.-||..||||++.+.+..      .-+|+++|+.++|||||++|++.-+     ...+|
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT-----QTKly   93 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT-----QTKLY   93 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc-----cceEE
Confidence            499999999999999999999999999999999765432      3479999999999999999998733     33489


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCC---------------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE---------------  220 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~---------------  220 (403)
                      ||+|+-+ |+|.+++-..   ..++.+..++.|+.||+.|+.|+|+ ..+|||||||+||.+-..               
T Consensus        94 LiLELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHq-LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   94 LILELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQ-LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             EEEEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhh-hhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence            9999987 4777666543   4679999999999999999999999 899999999999986321               


Q ss_pred             ----CCceeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          221 ----PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       221 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                          .-.+.+|+..|.|||++++..+..+++||||||||||.|++|++||...++.+.+..|+.+-              
T Consensus       170 ~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK--------------  235 (864)
T KOG4717|consen  170 QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK--------------  235 (864)
T ss_pred             CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc--------------
Confidence                12256789999999999999877899999999999999999999999999999998887641              


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                         +.            +|..++.+++|||..||+.||++|.+.+++..|+|++.+..+
T Consensus       236 ---Yt------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~  279 (864)
T KOG4717|consen  236 ---YT------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG  279 (864)
T ss_pred             ---cc------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence               11            236789999999999999999999999999999999987654

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.4e-43  Score=340.25  Aligned_cols=260  Identities=22%  Similarity=0.336  Sum_probs=197.0

Q ss_pred             cccEeeeceecccCceEEEEEEEC--CCCcEEEEEEcccccccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      ..+|.+.+.||+|+||.||+|...  .+++.||+|.+... ....+|+++++.++|+||+++++.+     ....++|++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAY-----RWKSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeE-----eeCCEEEEE
Confidence            346999999999999999999764  35678999988654 3456899999999999999999887     334458999


Q ss_pred             eeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------------
Q 015672          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------------  224 (403)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------------  224 (403)
                      ||++.+++..++..    ...+++..++.++.||+.||.|||+ +|||||||||+|||++.++.++              
T Consensus       165 ~e~~~~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        165 MPKYKCDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             ehhcCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            99999887666532    4678999999999999999999999 8999999999999998665432              


Q ss_pred             -------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          225 -------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES---GVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       225 -------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                             ..||+.|+|||++.+. .++.++|||||||++|||++|+.||.+..   ....+..+.+.++..+.+......
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             ccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence                   3478899999998654 58999999999999999999999997654   345666677666654432111000


Q ss_pred             c----CccccCCCCCCCCCcccc-cccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          295 P----NYTEFKFPQIKPHPWHKV-FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       295 ~----~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                      .    .+..+.........+... ....++.++.+||.+||++||++|||+.|+|+||||.+.
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence            0    000111111111111111 113467889999999999999999999999999999874

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=7.2e-43  Score=326.03  Aligned_cols=258  Identities=34%  Similarity=0.568  Sum_probs=201.6

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|++.+.||+|+||.||+|++..+|+.||+|.+....      ....+|+++++.++|+||+++++++.     +..+++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH-----SDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc-----cCCceE
Confidence            3889999999999999999999999999999885321      23457999999999999999999873     344589


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      +++||+++++...+..   ....+++..++.++.||+.||.|||+ .||+||||||+||+++.++.+++           
T Consensus        76 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  151 (284)
T cd07839          76 LVFEYCDQDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHS-HNVLHRDLKPQNLLINKNGELKLADFGLARAFGI  151 (284)
T ss_pred             EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence            9999999877665443   23568999999999999999999999 89999999999999987765543           


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                              .+++.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+.++.+....+......
T Consensus       152 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         152 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             CCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence                    2467899999987766689999999999999999998877 4555666777777777777776655432211


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                      .....++..............+++++.+||.+||..||.+|||++++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            11111111111111111224578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-43  Score=342.57  Aligned_cols=235  Identities=31%  Similarity=0.516  Sum_probs=190.7

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      +|++.+.||+|+||+||+|++..+++.||||++....       ....+|+.+++.++|+||+++++++     ....++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~   76 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENYL   76 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCeE
Confidence            5999999999999999999999999999999986421       1234799999999999999999888     344568


Q ss_pred             EEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce----------
Q 015672          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS----------  224 (403)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~----------  224 (403)
                      |+|||||++ +|.+++..    ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++.++          
T Consensus        77 ~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  151 (364)
T cd05599          77 YLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHK-LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL  151 (364)
T ss_pred             EEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence            999999974 56555443    3568999999999999999999999 8999999999999998665432          


Q ss_pred             -----------------------------------------------eeccccccchhhhhCCCCCCchhHHHHHHHHHH
Q 015672          225 -----------------------------------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMA  257 (403)
Q Consensus       225 -----------------------------------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~  257 (403)
                                                                     .+||+.|+|||++.+. .++.++|||||||++|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~  230 (364)
T cd05599         152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIMY  230 (364)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHHH
Confidence                                                           2478999999998654 5899999999999999


Q ss_pred             HHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCC
Q 015672          258 ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR  337 (403)
Q Consensus       258 el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R  337 (403)
                      +|++|..||.+.+..+....+....               ....++.          ...+++++.+||.+||. ||.+|
T Consensus       231 el~~G~~Pf~~~~~~~~~~~i~~~~---------------~~~~~~~----------~~~~s~~~~~li~~ll~-~p~~R  284 (364)
T cd05599         231 EMLVGYPPFCSDNPQETYRKIINWK---------------ETLQFPD----------EVPLSPEAKDLIKRLCC-EAERR  284 (364)
T ss_pred             HhhcCCCCCCCCCHHHHHHHHHcCC---------------CccCCCC----------CCCCCHHHHHHHHHHcc-CHhhc
Confidence            9999999998877665554443210               0001110          12468999999999997 99999


Q ss_pred             CC---HHHHhcCCCcccCCC
Q 015672          338 CT---ALEACVHPFFDELRD  354 (403)
Q Consensus       338 pt---a~e~l~hp~f~~~~~  354 (403)
                      ++   +.++++||||+....
T Consensus       285 ~~~~~~~~ll~h~~~~~~~~  304 (364)
T cd05599         285 LGNNGVNEIKSHPFFKGVDW  304 (364)
T ss_pred             CCCCCHHHHhcCCCcCCCCH
Confidence            98   999999999988643

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-43  Score=344.62  Aligned_cols=234  Identities=29%  Similarity=0.504  Sum_probs=188.8

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      +|.+.+.||+|+||+||+|++..+++.||||++.+..       ....+|+++++.++||||+++++++     .+..++
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~   76 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQYL   76 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCee
Confidence            5999999999999999999999999999999885432       2235699999999999999999988     344568


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce----------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS----------  224 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~----------  224 (403)
                      |+||||++ ++|..++..    ...+++..++.++.|++.||+|||+ .||+||||||+|||++.++.++          
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~-~givHrDlkp~NIll~~~~~~kl~DfGla~~~  151 (377)
T cd05629          77 YLIMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHK-LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF  151 (377)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCCCEEEeeccccccc
Confidence            99999997 566655543    3568899999999999999999999 8999999999999997654332          


Q ss_pred             --------------------------------------------------------eeccccccchhhhhCCCCCCchhH
Q 015672          225 --------------------------------------------------------YICSRYYRAPELIFGATEYTTAID  248 (403)
Q Consensus       225 --------------------------------------------------------~~~t~~y~aPE~~~~~~~~~~~~D  248 (403)
                                                                              .+||+.|+|||++.+. .++.++|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~D  230 (377)
T cd05629         152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQECD  230 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCcee
Confidence                                                                    2478899999998654 5899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHH
Q 015672          249 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR  328 (403)
Q Consensus       249 iwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  328 (403)
                      ||||||++|||++|.+||.+.+..+.+..+....               ....++.          ...++.++.+||.+
T Consensus       231 iwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------------~~~~~p~----------~~~~s~~~~dli~~  285 (377)
T cd05629         231 WWSLGAIMFECLIGWPPFCSENSHETYRKIINWR---------------ETLYFPD----------DIHLSVEAEDLIRR  285 (377)
T ss_pred             eEecchhhhhhhcCCCCCCCCCHHHHHHHHHccC---------------CccCCCC----------CCCCCHHHHHHHHH
Confidence            9999999999999999998877666555444310               0011111          12478999999999


Q ss_pred             hcccCCCCC---CCHHHHhcCCCcccCC
Q 015672          329 FFQYSPNLR---CTALEACVHPFFDELR  353 (403)
Q Consensus       329 ~L~~dP~~R---pta~e~l~hp~f~~~~  353 (403)
                      ||. +|.+|   +|+.++++||||+++.
T Consensus       286 lL~-~~~~r~~r~~~~~~l~hp~~~~~~  312 (377)
T cd05629         286 LIT-NAENRLGRGGAHEIKSHPFFRGVD  312 (377)
T ss_pred             Hhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence            998 77775   5999999999998764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=9.9e-43  Score=325.16  Aligned_cols=259  Identities=34%  Similarity=0.645  Sum_probs=202.4

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|.+.+.||+|+||.||+|++..+++.||+|++....      ....+|+.+++.++|+||+++++++.     ...+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence            4889999999999999999999999999999875321      23457999999999999999999884     334589


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      +||||+.+++..++..... ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+++           
T Consensus        76 ~v~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  153 (285)
T cd07861          76 LIFEFLSMDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHS-RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI  153 (285)
T ss_pred             EEEecCCCCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence            9999999877666543221 3568899999999999999999999 89999999999999987765532           


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                              .+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+....+.+.++.+....+.......
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         154 PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence                    236789999998766668899999999999999999999999888777777777777766555443211000


Q ss_pred             c-ccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          298 T-EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       298 ~-~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                      . ...++....... ......+++++.+||.+||+.||++|||+.++++||||
T Consensus       234 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         234 DYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            0 001111111111 11124578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.2e-43  Score=340.25  Aligned_cols=235  Identities=26%  Similarity=0.441  Sum_probs=188.9

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      +|++.+.||+|+||+||+|++..+++.||||++.+..       ....+|+.++..++|+||+++++.+     .+..++
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~~   76 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLNL   76 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCeE
Confidence            5899999999999999999999999999999986421       2234699999999999999999887     344568


Q ss_pred             EEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce----------
Q 015672          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS----------  224 (403)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~----------  224 (403)
                      |+|||||++ +|..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.++          
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~-~givHrDlKp~NILi~~~~~vkL~DFGla~~~  151 (363)
T cd05628          77 YLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQ-LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL  151 (363)
T ss_pred             EEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence            999999984 66555543    4678999999999999999999999 8999999999999997654331          


Q ss_pred             --------------------------------------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHH
Q 015672          225 --------------------------------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL  260 (403)
Q Consensus       225 --------------------------------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~  260 (403)
                                                                  .+||+.|+|||++.+. .++.++|||||||++|||+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell  230 (363)
T cd05628         152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEML  230 (363)
T ss_pred             cccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHHH
Confidence                                                        3578899999998654 5899999999999999999


Q ss_pred             hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCC---C
Q 015672          261 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL---R  337 (403)
Q Consensus       261 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~---R  337 (403)
                      +|+.||.+.+..+....+.....               ...+|.          ...+++++++||.+|+. +|.+   |
T Consensus       231 ~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~~li~~l~~-~~~~r~~r  284 (363)
T cd05628         231 IGYPPFCSETPQETYKKVMNWKE---------------TLIFPP----------EVPISEKAKDLILRFCC-EWEHRIGA  284 (363)
T ss_pred             hCCCCCCCCCHHHHHHHHHcCcC---------------cccCCC----------cCCCCHHHHHHHHHHcC-ChhhcCCC
Confidence            99999988876666655543110               011111          02368999999999875 4554   5


Q ss_pred             CCHHHHhcCCCcccCCC
Q 015672          338 CTALEACVHPFFDELRD  354 (403)
Q Consensus       338 pta~e~l~hp~f~~~~~  354 (403)
                      |+++|+++||||+++..
T Consensus       285 ~~~~ei~~hp~f~~~~~  301 (363)
T cd05628         285 PGVEEIKTNPFFEGVDW  301 (363)
T ss_pred             CCHHHHhCCCCCCCCCH
Confidence            89999999999998743

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.8e-43  Score=341.92  Aligned_cols=236  Identities=28%  Similarity=0.482  Sum_probs=188.0

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      .|++++.||+|+||+||+|++..+++.||||++....       ....+|+.+++.++|+||+++++++.     +..++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-----cCCEE
Confidence            4899999999999999999999999999999985432       12357999999999999999999883     34468


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce----------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS----------  224 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~----------  224 (403)
                      ++||||++ ++|..++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.++          
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHK-MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            99999997 466555543    3568899999999999999999999 8999999999999997554321          


Q ss_pred             --------------------------------------------------------eeccccccchhhhhCCCCCCchhH
Q 015672          225 --------------------------------------------------------YICSRYYRAPELIFGATEYTTAID  248 (403)
Q Consensus       225 --------------------------------------------------------~~~t~~y~aPE~~~~~~~~~~~~D  248 (403)
                                                                              .+||+.|+|||++.+. .++.++|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~D  230 (381)
T cd05626         152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLCD  230 (381)
T ss_pred             ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCccc
Confidence                                                                    3578899999998654 5899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHH
Q 015672          249 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR  328 (403)
Q Consensus       249 iwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  328 (403)
                      ||||||++|||++|..||...+..+....+.....               ...++.          ...+++++++||.+
T Consensus       231 iwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~----------~~~~s~~~~dli~~  285 (381)
T cd05626         231 WWSVGVILFEMLVGQPPFLAPTPTETQLKVINWEN---------------TLHIPP----------QVKLSPEAVDLITK  285 (381)
T ss_pred             eeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccc---------------ccCCCC----------CCCCCHHHHHHHHH
Confidence            99999999999999999988776554444432100               001110          13578999999999


Q ss_pred             hcccC--CCCCCCHHHHhcCCCcccCCC
Q 015672          329 FFQYS--PNLRCTALEACVHPFFDELRD  354 (403)
Q Consensus       329 ~L~~d--P~~Rpta~e~l~hp~f~~~~~  354 (403)
                      ||..+  |..|++++++++||||+++..
T Consensus       286 ll~~~~~~~~R~~~~~~l~hp~f~~~~~  313 (381)
T cd05626         286 LCCSAEERLGRNGADDIKAHPFFSEVDF  313 (381)
T ss_pred             HccCcccccCCCCHHHHhcCcccCCCCh
Confidence            76554  445999999999999988643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-42  Score=335.97  Aligned_cols=259  Identities=23%  Similarity=0.347  Sum_probs=190.4

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeec
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY  161 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  161 (403)
                      .+|.+.+.||+|+||.||+|++..+++.||+|+....  ....|+.+++.++|+||+++++++..     ..+.++||||
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~  138 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTLVS-----GAITCMVLPH  138 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheEEe-----CCeeEEEEEc
Confidence            3599999999999999999999999999999975432  34579999999999999999998843     3458899999


Q ss_pred             cCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-----------------
Q 015672          162 VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-----------------  224 (403)
Q Consensus       162 ~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-----------------  224 (403)
                      +.+++..++..   ....+++..++.++.||+.||.|||+ +|||||||||+|||++..+.++                 
T Consensus       139 ~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  214 (357)
T PHA03209        139 YSSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL  214 (357)
T ss_pred             cCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEEecCccccccccCcccc
Confidence            99888766543   23568999999999999999999999 8999999999999998765442                 


Q ss_pred             -eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCC-CCCCCCCc---------HHHHHHHHHHhCCCCHHHHhhc
Q 015672          225 -YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESG---------VDQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       225 -~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~-~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~  293 (403)
                       ..||+.|+|||++.+. .++.++|||||||++|||+++. ++|.....         ...+..+...++..+.......
T Consensus       215 ~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  293 (357)
T PHA03209        215 GLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDP  293 (357)
T ss_pred             cccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCC
Confidence             3468899999998654 5899999999999999999855 44443221         2234444444443332211000


Q ss_pred             CcCc--cccCCCCCCCCC---cccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          294 NPNY--TEFKFPQIKPHP---WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       294 ~~~~--~~~~~~~~~~~~---~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                      ....  ...........+   +.......++.++.+||.+||++||++|||+.|+|+||||+++
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        294 GSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             ccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            0000  000000000001   1111123567889999999999999999999999999999864

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.7e-43  Score=343.19  Aligned_cols=235  Identities=28%  Similarity=0.498  Sum_probs=189.8

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      .|+++++||+|+||+||+|++..+++.||+|++.+..       ....+|+.+++.++|+||+++++.+.     +..++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCEE
Confidence            4899999999999999999999999999999986432       23457999999999999999999883     34468


Q ss_pred             EEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce----------
Q 015672          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS----------  224 (403)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~----------  224 (403)
                      |+|||||++ +|..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.++          
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~-~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~  151 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (382)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence            999999984 66555543    3568899999999999999999999 8999999999999997654332          


Q ss_pred             --------------------------------------------------------eeccccccchhhhhCCCCCCchhH
Q 015672          225 --------------------------------------------------------YICSRYYRAPELIFGATEYTTAID  248 (403)
Q Consensus       225 --------------------------------------------------------~~~t~~y~aPE~~~~~~~~~~~~D  248 (403)
                                                                              .+||+.|+|||++.+. .++.++|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~D  230 (382)
T cd05625         152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCD  230 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCeee
Confidence                                                                    2478889999998654 5899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHH
Q 015672          249 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR  328 (403)
Q Consensus       249 iwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  328 (403)
                      ||||||++|||++|++||.+.+..+....+......               ..+|          ....+++++.+||.+
T Consensus       231 iwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p----------~~~~~s~~~~~li~~  285 (382)
T cd05625         231 WWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTS---------------LHIP----------PQAKLSPEASDLIIK  285 (382)
T ss_pred             EEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCC---------------cCCC----------CcccCCHHHHHHHHH
Confidence            999999999999999999887766555444321100               0111          013578999999999


Q ss_pred             hcccCCCCCCC---HHHHhcCCCcccCCC
Q 015672          329 FFQYSPNLRCT---ALEACVHPFFDELRD  354 (403)
Q Consensus       329 ~L~~dP~~Rpt---a~e~l~hp~f~~~~~  354 (403)
                      |+ .||.+|++   ++++++||||+.+..
T Consensus       286 l~-~~p~~R~~~~~~~ei~~hp~f~~~~~  313 (382)
T cd05625         286 LC-RGPEDRLGKNGADEIKAHPFFKTIDF  313 (382)
T ss_pred             Hc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence            86 59999997   999999999988653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5e-43  Score=335.62  Aligned_cols=234  Identities=28%  Similarity=0.413  Sum_probs=191.1

Q ss_pred             cccEeeeceecccCceEEEEEEECCCC-cEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      ..+|.+.+.||+|+||.||+|.+..++ ..||+|++....       ....+|+.+++.++||||+++++++.     ..
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~  103 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK-----DE  103 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE-----eC
Confidence            446999999999999999999876655 689999885321       22346999999999999999999883     34


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-------
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-------  224 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-------  224 (403)
                      .++++||||+. ++|..++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.++       
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~ikL~DFG~a  178 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQS-LNIVYRDLKPENLLLDKDGFIKMTDFGFA  178 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCCCEEEecCCCC
Confidence            46899999997 566655543    3568899999999999999999999 8999999999999998776553       


Q ss_pred             ---------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          225 ---------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       225 ---------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                               ..||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+.......+....             
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~-------------  244 (340)
T PTZ00426        179 KVVDTRTYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI-------------  244 (340)
T ss_pred             eecCCCcceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC-------------
Confidence                     3478899999999654 48999999999999999999999998877655544443210             


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCCC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  354 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~~  354 (403)
                          ..            ++..+++++.+||++||+.||.+|+     +++++++||||+.+..
T Consensus       245 ----~~------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~  292 (340)
T PTZ00426        245 ----IY------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW  292 (340)
T ss_pred             ----CC------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence                01            1245788999999999999999996     8999999999998653

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-43  Score=333.10  Aligned_cols=240  Identities=29%  Similarity=0.480  Sum_probs=194.4

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      +|++.+.||+|+||.||+|++..+++.||||++....       ....+|+.++..++|+||+++++++     ....++
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~~   76 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEYL   76 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCEE
Confidence            5999999999999999999999999999999986431       2234699999999999999999887     334468


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      |+||||++ ++|..++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+++         
T Consensus        77 ~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~  151 (333)
T cd05600          77 YLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHE-LGYIHRDLKPENFLIDASGHIKLTDFGLSKGI  151 (333)
T ss_pred             EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence            99999997 577666543    3568899999999999999999999 89999999999999987765543         


Q ss_pred             -------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 015672          226 -------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  298 (403)
Q Consensus       226 -------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  298 (403)
                             +||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+....+......              
T Consensus       152 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--------------  216 (333)
T cd05600         152 VTYANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET--------------  216 (333)
T ss_pred             ccccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc--------------
Confidence                   468899999998665 5899999999999999999999999887766655544331100              


Q ss_pred             ccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCC
Q 015672          299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  354 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  354 (403)
                       ...+....      ....+++++.+||.+||..+|.+||++.++++||||.++..
T Consensus       217 -~~~~~~~~------~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~  265 (333)
T cd05600         217 -LQRPVYDD------PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW  265 (333)
T ss_pred             -ccCCCCCc------cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence             00010000      01357899999999999999999999999999999998643

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-42  Score=328.85  Aligned_cols=268  Identities=33%  Similarity=0.639  Sum_probs=210.7

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      .+|.+.+.||+|+||.||+|++..+++.||+|.+....     ....+|+.+++.++|+||+++++++.........+++
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            45999999999999999999999999999999885321     1234699999999999999999877544434445689


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      +++||+++++...+.     ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+++           
T Consensus        85 lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~-~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  158 (336)
T cd07849          85 IVQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP  158 (336)
T ss_pred             EEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence            999999987765543     2568999999999999999999999 89999999999999987654432           


Q ss_pred             -----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          226 -----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       226 -----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                 .+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+...++.+..+.+....
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
T cd07849         159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII  238 (336)
T ss_pred             cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence                       357789999987665568999999999999999999999999888777888888888877766554322


Q ss_pred             cCccc-c--CCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCC
Q 015672          295 PNYTE-F--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  356 (403)
Q Consensus       295 ~~~~~-~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~  356 (403)
                      ..... +  ..+.....++... ....++++.+||.+||+.||++|||+.++++||||+...++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~  302 (336)
T cd07849         239 SLRARNYIKSLPFKPKVPWNKL-FPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPS  302 (336)
T ss_pred             chhhhhHHhhcCcCCcccHHHH-hcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCC
Confidence            11100 0  1111112222211 134688999999999999999999999999999999887653

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.1e-43  Score=342.01  Aligned_cols=234  Identities=26%  Similarity=0.477  Sum_probs=189.6

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      .|++.+.||+|+||.||+|++..+++.||||++.+.       .....+|+.+|+.++|+||+++++.+     .+..++
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~   76 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL   76 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCEE
Confidence            499999999999999999999999999999988532       12245799999999999999999887     334468


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce----------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS----------  224 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~----------  224 (403)
                      |+|||||+ ++|.+++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.++          
T Consensus        77 ~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~  151 (376)
T cd05598          77 YFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (376)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence            99999997 567666543    3568889999999999999999999 8999999999999997655432          


Q ss_pred             ----------------------------------------------------eeccccccchhhhhCCCCCCchhHHHHH
Q 015672          225 ----------------------------------------------------YICSRYYRAPELIFGATEYTTAIDIWST  252 (403)
Q Consensus       225 ----------------------------------------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSl  252 (403)
                                                                          .+||+.|+|||++.+. .++.++|||||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSl  230 (376)
T cd05598         152 RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSV  230 (376)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeeec
Confidence                                                                2578899999998654 58999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhccc
Q 015672          253 GCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQY  332 (403)
Q Consensus       253 Gvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  332 (403)
                      ||++|+|++|+.||.+.+..+....+.....               ...++          ....+++++.+||.+|+ .
T Consensus       231 Gvilyell~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~----------~~~~~s~~~~~li~~l~-~  284 (376)
T cd05598         231 GVILYEMLVGQPPFLADTPAETQLKVINWET---------------TLHIP----------SQAKLSREASDLILRLC-C  284 (376)
T ss_pred             cceeeehhhCCCCCCCCCHHHHHHHHhccCc---------------cccCC----------CCCCCCHHHHHHHHHHh-c
Confidence            9999999999999988776555444322100               00011          01357899999999976 5


Q ss_pred             CCCCCC---CHHHHhcCCCcccCC
Q 015672          333 SPNLRC---TALEACVHPFFDELR  353 (403)
Q Consensus       333 dP~~Rp---ta~e~l~hp~f~~~~  353 (403)
                      +|.+|+   |+.++++||||+.+.
T Consensus       285 ~p~~R~~~~t~~ell~h~~~~~~~  308 (376)
T cd05598         285 GAEDRLGKNGADEIKAHPFFKGID  308 (376)
T ss_pred             CHhhcCCCCCHHHHhCCCCcCCCC
Confidence            999999   999999999998764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-43  Score=323.45  Aligned_cols=232  Identities=25%  Similarity=0.434  Sum_probs=201.4

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc-------cHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      .+-+|++.+.||+|.||+|-+|+....|+.||||.+++++-       ...+|++||..|+||||+++|++|     .+.
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENk  125 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENK  125 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCC
Confidence            44569999999999999999999999999999999876532       235899999999999999999999     556


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc--------
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV--------  223 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~--------  223 (403)
                      ..+.|||||.. |.|++++..    .+.+++.+++.+++||+.|+.|+|. ++++|||||.+|||++.++++        
T Consensus       126 dKIvivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHk-nrVvHRDLKLENILLD~N~NiKIADFGLS  200 (668)
T KOG0611|consen  126 DKIVIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHK-NRVVHRDLKLENILLDQNNNIKIADFGLS  200 (668)
T ss_pred             ceEEEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhh-ccceecccchhheeecCCCCeeeeccchh
Confidence            66999999987 677776655    5789999999999999999999999 799999999999999988776        


Q ss_pred             ----------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015672          224 ----------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       224 ----------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  293 (403)
                                ++||+|.|.+||++.+.++-++.+|-|||||+||.|+.|..||.|.+....+..|.+.            
T Consensus       201 Nly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G------------  268 (668)
T KOG0611|consen  201 NLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG------------  268 (668)
T ss_pred             hhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc------------
Confidence                      4578999999999998887889999999999999999999999999987777766542            


Q ss_pred             CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                           .+.             ....+.++..||+.||..||++|.|++++-.|=|++-
T Consensus       269 -----aYr-------------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw  308 (668)
T KOG0611|consen  269 -----AYR-------------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVNW  308 (668)
T ss_pred             -----ccc-------------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence                 111             1234677899999999999999999999999977754

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=6.5e-42  Score=323.80  Aligned_cols=267  Identities=34%  Similarity=0.551  Sum_probs=210.2

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|.+....      ....+|+.++++++|+||+++++++...   ....
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLDS   82 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCCe
Confidence            346999999999999999999999999999999885321      1234799999999999999999987432   2234


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee--------
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI--------  226 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~--------  226 (403)
                      +++||||+.+++..++...   ...+++..+..++.||+.||.|||+ .|++||||||+||+++.++.++++        
T Consensus        83 ~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          83 IFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHE-NFIIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence            7899999998877666542   2568899999999999999999999 899999999999999877655432        


Q ss_pred             -----------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          227 -----------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       227 -----------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                 +++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....+.....
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07845         159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD  238 (309)
T ss_pred             CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence                       356699999987666689999999999999999999999999998888888888888777665443221


Q ss_pred             --CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          296 --NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       296 --~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                        ....+..+......+... ....++++.+||.+||++||++|||+.++++||||++..-+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         239 LPLVGKFTLPKQPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             ccccccccccCCCCCchHHh-ccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence              111122221111111111 12368899999999999999999999999999999876444

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-42  Score=329.35  Aligned_cols=224  Identities=30%  Similarity=0.515  Sum_probs=183.2

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeecc
Q 015672           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (403)
Q Consensus        90 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  162 (403)
                      ||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++.     ...++++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ-----SPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe-----cCCeEEEEEcCC
Confidence            799999999999999999999999885421       12346999999999999999988873     344589999999


Q ss_pred             C-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-----------------
Q 015672          163 P-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-----------------  224 (403)
Q Consensus       163 ~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-----------------  224 (403)
                      + ++|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++                 
T Consensus        76 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  150 (312)
T cd05585          76 NGGELFHHLQR----EGRFDLSRARFYTAELLCALENLHK-FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKT  150 (312)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcc
Confidence            8 456554433    4568999999999999999999999 8999999999999998765442                 


Q ss_pred             --eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCC
Q 015672          225 --YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  302 (403)
Q Consensus       225 --~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  302 (403)
                        .+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...                 ... 
T Consensus       151 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-----------------~~~-  211 (312)
T cd05585         151 NTFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-----------------PLR-  211 (312)
T ss_pred             ccccCCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-----------------CCC-
Confidence              2478899999999654 5899999999999999999999999887655544443321                 001 


Q ss_pred             CCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCCcccCC
Q 015672          303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFFDELR  353 (403)
Q Consensus       303 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---ta~e~l~hp~f~~~~  353 (403)
                                 ++..+++++.+||.+||+.||.+||   ++.++++||||.+..
T Consensus       212 -----------~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~  254 (312)
T cd05585         212 -----------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS  254 (312)
T ss_pred             -----------CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence                       2245789999999999999999997   589999999999863

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=322.61  Aligned_cols=264  Identities=27%  Similarity=0.510  Sum_probs=205.2

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc---cccHHHHHHHHHhcCC--C----CccccceEEeecCCCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDH--P----NIVALKHCFFSTTDKE  151 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h--~----niv~~~~~~~~~~~~~  151 (403)
                      ..+|.+...+|+|.||.|-.|.+..++..||||+++.-   .+...-|+++|+++.+  |    -+|++.++|     ..
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----dy  162 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----DY  162 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----hc
Confidence            34599999999999999999999999999999998643   3334569999999943  2    255666666     55


Q ss_pred             ceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC---------
Q 015672          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN---------  222 (403)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~---------  222 (403)
                      ..++|||+|.++-++.+++....  ...++...++.++.|++.+++|||+ .+++|-||||+|||+.+...         
T Consensus       163 rghiCivfellG~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~-~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  163 RGHICIVFELLGLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHD-LKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             cCceEEEEeccChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHh-cceeecCCChheEEEeccceEEEeccCCc
Confidence            66799999999878877776533  3568999999999999999999999 89999999999999843211         


Q ss_pred             ---------------------------ceeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHH
Q 015672          223 ---------------------------VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL  275 (403)
Q Consensus       223 ---------------------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~  275 (403)
                                                 ..++.|..|+|||++++-+ ++.++||||+||||+|+++|...|++.++.+++
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL  318 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLEHL  318 (415)
T ss_pred             cceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence                                       1335689999999998764 999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCHHHHhhcC-cCcc---ccCCCCCC-----------CCCcccccc--cCCCHHHHHHHHHhcccCCCCCC
Q 015672          276 VEIIKVLGTPTREEIKCMN-PNYT---EFKFPQIK-----------PHPWHKVFQ--KRLPPEAVDLVCRFFQYSPNLRC  338 (403)
Q Consensus       276 ~~i~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~-----------~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rp  338 (403)
                      +.+.+.+|+.+...+.... ..|.   ..+++...           ..|+.....  ..-..++.|||++||.+||.+|+
T Consensus       319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri  398 (415)
T KOG0671|consen  319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI  398 (415)
T ss_pred             HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence            9999999988877665441 1110   11111110           111111110  11124589999999999999999


Q ss_pred             CHHHHhcCCCcccCC
Q 015672          339 TALEACVHPFFDELR  353 (403)
Q Consensus       339 ta~e~l~hp~f~~~~  353 (403)
                      |+.|+|.||||+.+.
T Consensus       399 Tl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  399 TLREALSHPFFARLT  413 (415)
T ss_pred             cHHHHhcCHHhhcCC
Confidence            999999999998864

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=7.6e-42  Score=320.87  Aligned_cols=266  Identities=36%  Similarity=0.634  Sum_probs=207.2

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcC-CCCccccceEEeecCCCCceEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+.+++.+. |+||+++++++..........+
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            4999999999999999999999999999999875332      23457999999995 6999999988755443344568


Q ss_pred             EEEeeccCCcHHHHHHHhhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecC-CCCcee--------
Q 015672          156 NLVLEYVPETVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKG-EPNVSY--------  225 (403)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~-~~~~~~--------  225 (403)
                      +++|||+++++..++...... ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+++        
T Consensus        82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            899999998887766543322 3468899999999999999999999 89999999999999987 443322        


Q ss_pred             -----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          226 -----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       226 -----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                 .+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..+.+.++.+....+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T cd07837         161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS  240 (295)
T ss_pred             cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence                       235679999998665568999999999999999999999999988888888888877777655443221


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  350 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~  350 (403)
                      .......++...+..... ....+++++.+||.+||..||.+|||+.|++.||||+
T Consensus       241 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         241 KLRDWHEFPQWKPQDLSR-AVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hccchhhcCcccchhHHH-hccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            111111122221111111 1235789999999999999999999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.2e-42  Score=322.50  Aligned_cols=233  Identities=24%  Similarity=0.357  Sum_probs=183.4

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeecc
Q 015672           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (403)
Q Consensus        90 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  162 (403)
                      ||+|+||+||+|.+..+++.||+|++....       .....|+++++.++|+||+++.+++     ....++++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence            799999999999999999999999985422       1234699999999999999998877     3344589999999


Q ss_pred             C-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------------
Q 015672          163 P-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------------  225 (403)
Q Consensus       163 ~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------------  225 (403)
                      + ++|...+.........+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+++                
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  154 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT  154 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccc
Confidence            7 46655554333334568999999999999999999999 89999999999999987655432                


Q ss_pred             ---eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCC
Q 015672          226 ---ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  302 (403)
Q Consensus       226 ---~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  302 (403)
                         .||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+........                
T Consensus       155 ~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------  217 (280)
T cd05608         155 KGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS----------------  217 (280)
T ss_pred             cccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC----------------
Confidence               367889999999654 589999999999999999999999976543322222221110000                


Q ss_pred             CCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCCC
Q 015672          303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  354 (403)
Q Consensus       303 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~~  354 (403)
                               ..++..+++++.+|+.+||+.||++||     |++++++||||++..+
T Consensus       218 ---------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~  265 (280)
T cd05608         218 ---------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNW  265 (280)
T ss_pred             ---------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCH
Confidence                     012245789999999999999999999     8899999999998653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-43  Score=335.08  Aligned_cols=235  Identities=31%  Similarity=0.549  Sum_probs=191.7

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      +|.+.+.||+|+||+||+|++..+++.||||++....       ....+|+.++..++|+||+++++++     .+..++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEHL   76 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCeE
Confidence            5999999999999999999999999999999985421       2345799999999999999999887     344568


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce----------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS----------  224 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~----------  224 (403)
                      |+||||++ ++|..++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.++          
T Consensus        77 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  151 (350)
T cd05573          77 YLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHK-LGFIHRDIKPDNILIDADGHIKLADFGLCKKM  151 (350)
T ss_pred             EEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCCCEEeecCCCCccC
Confidence            99999997 566665543    2578999999999999999999999 8999999999999997665432          


Q ss_pred             --------------------------------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 015672          225 --------------------------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF  266 (403)
Q Consensus       225 --------------------------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf  266 (403)
                                                            ..||+.|+|||++.+. .++.++|||||||++|+|++|+.||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf  230 (350)
T cd05573         152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPF  230 (350)
T ss_pred             cccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCC
Confidence                                                  2368889999999655 5899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-HHHHhc
Q 015672          267 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-ALEACV  345 (403)
Q Consensus       267 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-a~e~l~  345 (403)
                      .+.+.......+.....               ...++.          ...+++++.+||.+||. ||.+|++ ++++++
T Consensus       231 ~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         231 YSDTLQETYNKIINWKE---------------SLRFPP----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             CCCCHHHHHHHHhccCC---------------cccCCC----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            88776555544443100               011111          12368999999999997 9999999 999999


Q ss_pred             CCCcccCCC
Q 015672          346 HPFFDELRD  354 (403)
Q Consensus       346 hp~f~~~~~  354 (403)
                      ||||+++..
T Consensus       285 hp~~~~~~~  293 (350)
T cd05573         285 HPFFKGIDW  293 (350)
T ss_pred             CCCcCCCCH
Confidence            999998754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=7.2e-42  Score=324.45  Aligned_cols=259  Identities=31%  Similarity=0.545  Sum_probs=190.7

Q ss_pred             eceecccCceEEEEEEECC--CCcEEEEEEccccc--ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeecc
Q 015672           87 EHVVGTGSFGVVFQAKCRE--TGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (403)
Q Consensus        87 ~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  162 (403)
                      ..+||+|+||.||+|+.+.  ++..||+|.+....  ....+|+++++.++||||+++++++...   ...++++||||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEeee
Confidence            3679999999999999754  56889999886543  2345799999999999999999987542   334588999999


Q ss_pred             CCcHHHHHHHhhh-----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecC----CCCce---------
Q 015672          163 PETVNRIARNYSR-----IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKG----EPNVS---------  224 (403)
Q Consensus       163 ~~~l~~~~~~~~~-----~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~----~~~~~---------  224 (403)
                      ++++..++.....     ....+++..++.++.||+.||.|||+ .||+||||||+|||+..    .+.++         
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            9888776643211     12347888899999999999999999 89999999999999942    22221         


Q ss_pred             -------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHHHh
Q 015672          225 -------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---------VDQLVEIIKVL  282 (403)
Q Consensus       225 -------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~---------~~~~~~i~~~~  282 (403)
                                   ..+|+.|+|||++.+...++.++|||||||++|||+||++||.....         ...+..+...+
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM  241 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence                         24577899999987666689999999999999999999999975432         24556677777


Q ss_pred             CCCCHHHHhhcCcC--ccc----cCCCCCCCCCc---ccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          283 GTPTREEIKCMNPN--YTE----FKFPQIKPHPW---HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       283 ~~~~~~~~~~~~~~--~~~----~~~~~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                      +.+..+.|......  +..    +..........   ........+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            77766555432111  000    00000000000   001112346779999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.6e-42  Score=335.96  Aligned_cols=237  Identities=27%  Similarity=0.486  Sum_probs=192.2

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++.+..       ....+|+.+++.++||||+++++++     ....
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~~  116 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDDK  116 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCC
Confidence            346999999999999999999999999999999985321       2234799999999999999999887     3445


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------  224 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------  224 (403)
                      ++++||||++ ++|..++..     ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.++        
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~kL~DfG~~~  190 (370)
T cd05596         117 YLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEcCCCCEEEEecccee
Confidence            6999999997 567665543     458889999999999999999999 8999999999999998765442        


Q ss_pred             ------------eeccccccchhhhhCC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          225 ------------YICSRYYRAPELIFGA---TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       225 ------------~~~t~~y~aPE~~~~~---~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                  .+||+.|+|||++.+.   ..++.++|||||||++|||++|++||.+.+....+..+.....      
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~------  264 (370)
T cd05596         191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN------  264 (370)
T ss_pred             eccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC------
Confidence                        2468899999998543   2478999999999999999999999998876665555543100      


Q ss_pred             HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCcccCC
Q 015672          290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELR  353 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpta~e~l~hp~f~~~~  353 (403)
                               ...++.          ...++.++.+||.+||+.+|.+  |+|++++++||||+...
T Consensus       265 ---------~~~~~~----------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~  311 (370)
T cd05596         265 ---------SLTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ  311 (370)
T ss_pred             ---------cCCCCC----------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence                     011111          1247899999999999999998  99999999999998754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.4e-42  Score=328.84  Aligned_cols=226  Identities=27%  Similarity=0.444  Sum_probs=184.6

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEee
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  160 (403)
                      +.||+|+||.||+|++..+|+.||+|++....       ....+|+.+++.++||||+++++++.     ...++|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCEEEEEEe
Confidence            46999999999999999999999999986431       12246899999999999999998873     3345899999


Q ss_pred             ccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce---------------
Q 015672          161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS---------------  224 (403)
Q Consensus       161 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~---------------  224 (403)
                      |+++ +|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++               
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  150 (323)
T cd05595          76 YANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  150 (323)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC
Confidence            9984 55444332    3568999999999999999999999 8999999999999998765443               


Q ss_pred             ----eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccc
Q 015672          225 ----YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  300 (403)
Q Consensus       225 ----~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  300 (403)
                          ..||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...                 ..
T Consensus       151 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-----------------~~  212 (323)
T cd05595         151 TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----------------EI  212 (323)
T ss_pred             ccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------CC
Confidence                2468899999998654 5899999999999999999999999877655544443321                 01


Q ss_pred             CCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCC
Q 015672          301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  353 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~  353 (403)
                      .            ++..+++++.+||.+||+.||++|+     ++.++++||||....
T Consensus       213 ~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         213 R------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             C------------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            1            2245789999999999999999998     899999999998765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.3e-42  Score=329.71  Aligned_cols=226  Identities=26%  Similarity=0.433  Sum_probs=183.5

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEee
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  160 (403)
                      +.||+|+||.||+|++..+++.||+|++.+..       ....+|+++++.++||||+++++.+     ....++|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence            46999999999999999999999999986431       1234689999999999999998887     33445899999


Q ss_pred             ccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce---------------
Q 015672          161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS---------------  224 (403)
Q Consensus       161 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~---------------  224 (403)
                      |+++ +|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++               
T Consensus        76 y~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~  150 (328)
T cd05593          76 YVNGGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHS-GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA  150 (328)
T ss_pred             CCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc
Confidence            9984 55443332    3568999999999999999999999 8999999999999998765443               


Q ss_pred             ----eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccc
Q 015672          225 ----YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  300 (403)
Q Consensus       225 ----~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  300 (403)
                          .+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...                 ..
T Consensus       151 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-----------------~~  212 (328)
T cd05593         151 TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------DI  212 (328)
T ss_pred             ccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-----------------Cc
Confidence                2468899999998654 5899999999999999999999999877654443332210                 01


Q ss_pred             CCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCC
Q 015672          301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  353 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~  353 (403)
                      .            ++..+++++.+||.+||+.||++|+     ++.++++||||....
T Consensus       213 ~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~  258 (328)
T cd05593         213 K------------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVN  258 (328)
T ss_pred             c------------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            1            2246789999999999999999997     899999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.2e-42  Score=335.82  Aligned_cols=235  Identities=27%  Similarity=0.460  Sum_probs=189.2

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      +|++.+.||+|+||.||+|++..+++.||||++....       ....+|+.++..++|+||+++++.+     .+..++
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~~   76 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRNL   76 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence            4899999999999999999999999999999985321       2234689999999999999999887     344568


Q ss_pred             EEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce----------
Q 015672          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS----------  224 (403)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~----------  224 (403)
                      |+||||+++ +|..++..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++          
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~-~givHrDLkp~NIli~~~~~vkL~DfG~~~~~  151 (360)
T cd05627          77 YLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQ-LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL  151 (360)
T ss_pred             EEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence            999999984 66555543    3568999999999999999999999 8999999999999997655432          


Q ss_pred             --------------------------------------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHH
Q 015672          225 --------------------------------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL  260 (403)
Q Consensus       225 --------------------------------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~  260 (403)
                                                                  .+||+.|+|||++.+. .++.++|||||||++|||+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel~  230 (360)
T cd05627         152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEML  230 (360)
T ss_pred             ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeecc
Confidence                                                        2478899999998654 5899999999999999999


Q ss_pred             hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC--
Q 015672          261 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC--  338 (403)
Q Consensus       261 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp--  338 (403)
                      +|++||.+.+.......+.....               ...++.          ...+++++++||.+|+ .||.+|+  
T Consensus       231 tG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~~li~~l~-~~p~~R~~~  284 (360)
T cd05627         231 IGYPPFCSETPQETYRKVMNWKE---------------TLVFPP----------EVPISEKAKDLILRFC-TDSENRIGS  284 (360)
T ss_pred             cCCCCCCCCCHHHHHHHHHcCCC---------------ceecCC----------CCCCCHHHHHHHHHhc-cChhhcCCC
Confidence            99999988776665554432100               001110          0236889999999987 4999998  


Q ss_pred             -CHHHHhcCCCcccCCC
Q 015672          339 -TALEACVHPFFDELRD  354 (403)
Q Consensus       339 -ta~e~l~hp~f~~~~~  354 (403)
                       ++.++++||||+++..
T Consensus       285 ~~~~ei~~hp~f~~~~~  301 (360)
T cd05627         285 NGVEEIKSHPFFEGVDW  301 (360)
T ss_pred             CCHHHHhcCCCCCCCCH
Confidence             4899999999998753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=6.5e-42  Score=327.02  Aligned_cols=258  Identities=24%  Similarity=0.398  Sum_probs=190.5

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      .+|++.+.||+|+||.||++++..++..||+|.+....     ....+|+++++.++|+||+++++++..     ...++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   79 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEIS   79 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCEEE
Confidence            46999999999999999999999999999999886432     234579999999999999999998843     33588


Q ss_pred             EEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------
Q 015672          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------  225 (403)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------  225 (403)
                      +||||+++ +|.+++..    ...+++..+..++.|++.||.|||+..+|+||||||+|||++.++.+++          
T Consensus        80 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  155 (331)
T cd06649          80 ICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (331)
T ss_pred             EEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence            99999984 77666543    3568899999999999999999997336999999999999987765432          


Q ss_pred             -------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh----hcC
Q 015672          226 -------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK----CMN  294 (403)
Q Consensus       226 -------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~----~~~  294 (403)
                             .||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.. .+   ++.+......    ...
T Consensus       156 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~~  230 (331)
T cd06649         156 DSMANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE-AI---FGRPVVDGEEGEPHSIS  230 (331)
T ss_pred             ccccccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HH---hcccccccccCCccccC
Confidence                   368899999998654 5899999999999999999999999776544322 21   2211110000    000


Q ss_pred             cCc----cc---cCCCCCC------------CCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          295 PNY----TE---FKFPQIK------------PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       295 ~~~----~~---~~~~~~~------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                      +..    ..   .......            ...........+++++++||.+||++||++|||+.++++||||+...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence            000    00   0000000            00000000124688999999999999999999999999999998753

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.3e-42  Score=331.70  Aligned_cols=237  Identities=25%  Similarity=0.480  Sum_probs=192.0

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      +|.+.+.||+|+||+||+|++..+++.||+|++....       ....+|+.+++.++|+||+++++++     .+..++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~~   76 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDNL   76 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeE
Confidence            5999999999999999999999999999999986432       2345789999999999999998887     334468


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      ++||||++ ++|..++...   ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+++         
T Consensus        77 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~-~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~  152 (330)
T cd05601          77 YLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQ-MGYVHRDIKPENVLIDRTGHIKLADFGSAARL  152 (330)
T ss_pred             EEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEcccCchHheEECCCCCEEeccCCCCeEC
Confidence            99999997 5776665542   2568999999999999999999999 89999999999999987655432         


Q ss_pred             -----------eccccccchhhhhC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          226 -----------ICSRYYRAPELIFG-----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       226 -----------~~t~~y~aPE~~~~-----~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                 .||+.|+|||++..     ...++.++|||||||++|+|++|..||...+....+..+.....      
T Consensus       153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~------  226 (330)
T cd05601         153 TANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR------  226 (330)
T ss_pred             CCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC------
Confidence                       36888999999852     34578999999999999999999999988776655554433100      


Q ss_pred             HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCC
Q 015672          290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  354 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  354 (403)
                               ...++.          ...++.++.+||.+||+ ||.+|||++++++||||..+..
T Consensus       227 ---------~~~~~~----------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~  271 (330)
T cd05601         227 ---------FLKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW  271 (330)
T ss_pred             ---------ccCCCC----------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence                     001111          13478999999999998 9999999999999999998653

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.4e-42  Score=327.41  Aligned_cols=227  Identities=30%  Similarity=0.499  Sum_probs=183.9

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhc-CCCCccccceEEeecCCCCceEEEEEe
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      +.||+|+||+||+|+++.+++.||||++.+..       .....|..++..+ +||||+++++++.     ...++|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~-----~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ-----TPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE-----cCCEEEEEE
Confidence            46999999999999999999999999986431       1223577788776 6999999999873     334589999


Q ss_pred             eccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------------
Q 015672          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------------  225 (403)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------------  225 (403)
                      ||+++ +|...+..    ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+++             
T Consensus        76 Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~-~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~  150 (320)
T cd05590          76 EFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHD-KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG  150 (320)
T ss_pred             cCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC
Confidence            99984 55444432    4578999999999999999999999 89999999999999987655432             


Q ss_pred             ------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 015672          226 ------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  299 (403)
Q Consensus       226 ------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  299 (403)
                            .||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...                 .
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~-----------------~  212 (320)
T cd05590         151 KTTSTFCGTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-----------------E  212 (320)
T ss_pred             CcccccccCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence                  368899999998654 5899999999999999999999999888766655544321                 0


Q ss_pred             cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCCCcccCCC
Q 015672          300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDELRD  354 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta------~e~l~hp~f~~~~~  354 (403)
                      ..            ++..++.++.+||.+||+.||++|+++      +++++||||..+..
T Consensus       213 ~~------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~  261 (320)
T cd05590         213 VV------------YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW  261 (320)
T ss_pred             CC------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence            00            123478999999999999999999998      99999999988753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.1e-42  Score=327.44  Aligned_cols=229  Identities=28%  Similarity=0.482  Sum_probs=185.1

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHH---HhcCCCCccccceEEeecCCCCce
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIM---QMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      |.+.+.||+|+||.||+|.+..+++.||||++.+..       ....+|+.++   +.++||||+++++++.     ...
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-----~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ-----TED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE-----cCC
Confidence            678999999999999999999999999999986431       1123455544   5668999999999883     344


Q ss_pred             EEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------
Q 015672          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------  224 (403)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------  224 (403)
                      ++|+||||+++ +|...+.     ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++        
T Consensus        76 ~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~  149 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHE-NKIVYRDLKLDNLLLDTEGFVKIADFGLCK  149 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCCcEEeCcccCCc
Confidence            58999999985 4433322     3568999999999999999999999 8999999999999998766543        


Q ss_pred             -----------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015672          225 -----------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       225 -----------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  293 (403)
                                 .+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...            
T Consensus       150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------------  216 (324)
T cd05589         150 EGMGFGDRTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND------------  216 (324)
T ss_pred             cCCCCCCcccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence                       2468899999998654 5899999999999999999999999887766655544331            


Q ss_pred             CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCC
Q 015672          294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  353 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~  353 (403)
                           ...            ++..+++++.+||.+||+.||.+||     ++.++++||||+.+.
T Consensus       217 -----~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~  264 (324)
T cd05589         217 -----EVR------------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN  264 (324)
T ss_pred             -----CCC------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence                 000            2245789999999999999999999     799999999998864

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.9e-43  Score=330.27  Aligned_cols=234  Identities=26%  Similarity=0.448  Sum_probs=203.4

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      ..|.+++++|+|+||.+++++++..++.|++|++.-.      ++...+|+.++++++|||||.+++.|+    .++.++
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~l   79 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQLL   79 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCceE
Confidence            3599999999999999999999999999999998532      334568999999999999999999984    444569


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc-----------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-----------  223 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~-----------  223 (403)
                      ||||+||+ |++.+.+....  +..+++..+..|+.|++.|+.|||+ ++|+|||||+.||+++.++.+           
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~-~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l  156 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE-NRVLHRDLKCANIFLTKDKKVKLGDFGLAKIL  156 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh-hhhhcccchhhhhhccccCceeecchhhhhhc
Confidence            99999998 56766666543  4679999999999999999999998 899999999999999876554           


Q ss_pred             --------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          224 --------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       224 --------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                              +.+|||.||+||++.+. +|+.|+|||||||++|||++-+++|.+.+....+.+|.+....|          
T Consensus       157 ~~~~~~a~tvvGTp~YmcPEil~d~-pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P----------  225 (426)
T KOG0589|consen  157 NPEDSLASTVVGTPYYMCPEILSDI-PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP----------  225 (426)
T ss_pred             CCchhhhheecCCCcccCHHHhCCC-CCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC----------
Confidence                    45799999999999654 59999999999999999999999999999888888888764333          


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                                        ++...+.+++.||..||..+|..||++.++|.+|....
T Consensus       226 ------------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  226 ------------------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             ------------------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence                              23567899999999999999999999999999998874

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-44  Score=317.56  Aligned_cols=236  Identities=28%  Similarity=0.443  Sum_probs=197.3

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc--ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      ..-|.++.+||+|+||.||+|.++.+|+.+|||.+..+.  ....+|+.||++.+.+++|++|+.||...+     +|+|
T Consensus        32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LWIV  106 (502)
T KOG0574|consen   32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LWIV  106 (502)
T ss_pred             HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eEee
Confidence            345889999999999999999999999999999986543  344589999999999999999999987766     9999


Q ss_pred             eeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc--------------
Q 015672          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV--------------  223 (403)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~--------------  223 (403)
                      ||||+ |+..++++..   ...+.+.++..+++..++||+|||. ..-||||||..|||++.++..              
T Consensus       107 MEYCGAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~-~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT  182 (502)
T KOG0574|consen  107 MEYCGAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHD-LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT  182 (502)
T ss_pred             hhhcCCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHH-HHHHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence            99998 7777776643   4679999999999999999999999 788999999999999877654              


Q ss_pred             -----eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 015672          224 -----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  298 (403)
Q Consensus       224 -----~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  298 (403)
                           +.+|||+|||||++..- .|+.++||||||++..||..|++||.+-.....+..                     
T Consensus       183 MAKRNTVIGTPFWMAPEVI~EI-GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM---------------------  240 (502)
T KOG0574|consen  183 MAKRNTVIGTPFWMAPEVIEEI-GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM---------------------  240 (502)
T ss_pred             HHhhCccccCcccccHHHHHHh-ccchhhhHhhhcchhhhhhcCCCCcccccccceeEe---------------------
Confidence                 45799999999999654 599999999999999999999999976554333221                     


Q ss_pred             ccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                         +|.-++..+.  -++..|.++.|||++||..+|++|-||.++++|||++..
T Consensus       241 ---IPT~PPPTF~--KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  241 ---IPTKPPPTFK--KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             ---ccCCCCCCCC--ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence               1211111111  124568899999999999999999999999999999864

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.7e-41  Score=316.88  Aligned_cols=258  Identities=40%  Similarity=0.756  Sum_probs=208.8

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|++.+.||+|+||.||+|++..+++.||+|++....      ....+|+.+++.++|+||+++++++.     ...+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP-----HGSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCeeE
Confidence            4899999999999999999999999999999885432      23457999999999999999999873     345689


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce------------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS------------  224 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~------------  224 (403)
                      +||||++++|..++...   ...+++..++.++.||+.||.|||+ .||+|+||||+||+++.++.+.            
T Consensus        76 ~v~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~  151 (286)
T cd07832          76 LVMEYMPSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHA-NGIMHRDLKPANLLISADGVLKIADFGLARLFSE  151 (286)
T ss_pred             EEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence            99999987887765542   2568899999999999999999999 8999999999999998655432            


Q ss_pred             --------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--
Q 015672          225 --------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--  294 (403)
Q Consensus       225 --------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--  294 (403)
                              ..++..|+|||++.+...++.++|||||||++|+|++|.+||.+.++...+..+...++.+....+....  
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07832         152 EEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL  231 (286)
T ss_pred             CCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCc
Confidence                    2356789999998666667999999999999999999999999888888888888888888776654332  


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  350 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~  350 (403)
                      ..+....++.....++...+ ...+.++.+||.+||..||++|||++++++||||.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         232 PDYNKITFPESKPIPLEEIF-PDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             chhhcccCCCCCcchHHHhC-CCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            12223333333333333322 35678999999999999999999999999999994

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-43  Score=339.36  Aligned_cols=237  Identities=25%  Similarity=0.393  Sum_probs=197.4

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      .|.++..||.|+||+||+|..+.++-..|.|+|.-..    ....-||+||...+||+||++++.||..+.     +||+
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-----Lwil  107 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-----LWIL  107 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-----eEEE
Confidence            4788899999999999999999999888999884322    233469999999999999999999876554     9999


Q ss_pred             eeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc---------------
Q 015672          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV---------------  223 (403)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~---------------  223 (403)
                      .|||+|+--+.+  ....+..+.+.+++.+++|++.||.|||+ ++|||||||..|||++-+|.+               
T Consensus       108 iEFC~GGAVDai--mlEL~r~LtE~QIqvvc~q~ldALn~LHs-~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~  184 (1187)
T KOG0579|consen  108 IEFCGGGAVDAI--MLELGRVLTEDQIQVVCYQVLDALNWLHS-QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR  184 (1187)
T ss_pred             EeecCCchHhHH--HHHhccccchHHHHHHHHHHHHHHHHHhh-cchhhhhccccceEEEecCcEeeecccccccchhHH
Confidence            999997543322  23346789999999999999999999999 899999999999999877665               


Q ss_pred             ----eeeccccccchhhhh----CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          224 ----SYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       224 ----~~~~t~~y~aPE~~~----~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                          +++|||+|||||+..    ...+|+.++||||||++|.||..+.+|...-+....+..|.+. .+|+         
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS-ePPT---------  254 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPT---------  254 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc-CCCc---------
Confidence                468999999999973    4456999999999999999999999999888888777776552 1111         


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                                      -..|...+..+.||+.+||..||..||+++++|+||||+.+.
T Consensus       255 ----------------LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  255 ----------------LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             ----------------ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence                            112345678899999999999999999999999999998653

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.6e-42  Score=333.33  Aligned_cols=237  Identities=28%  Similarity=0.492  Sum_probs=190.7

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      .+|++.+.||+|+||.||+|++..+++.||+|++.+.       .....+|+.+++.++||||+++++++     .+..+
T Consensus        43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~~~  117 (370)
T cd05621          43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDDKY  117 (370)
T ss_pred             HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence            4699999999999999999999999999999988532       12245799999999999999999988     34456


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce---------
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS---------  224 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~---------  224 (403)
                      +|+|||||+ ++|..++..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++.++         
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~-~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~  191 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHS-MGLIHRDVKPDNMLLDKHGHLKLADFGTCMK  191 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence            899999997 567666543     358889999999999999999999 8999999999999998765443         


Q ss_pred             -----------eeccccccchhhhhCCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          225 -----------YICSRYYRAPELIFGAT---EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       225 -----------~~~t~~y~aPE~~~~~~---~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                 .+||+.|+|||++.+..   .++.++|||||||++|+|++|+.||.+.+....+..+.....       
T Consensus       192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~-------  264 (370)
T cd05621         192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN-------  264 (370)
T ss_pred             cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-------
Confidence                       24788999999986432   378899999999999999999999988876666655543211       


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCcccCCC
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRD  354 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpta~e~l~hp~f~~~~~  354 (403)
                              ...++.          ...++..+++||.+||+.++.+  |+|+.++++||||+....
T Consensus       265 --------~~~~p~----------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~  312 (370)
T cd05621         265 --------SLNFPE----------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW  312 (370)
T ss_pred             --------ccCCCC----------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence                    011111          1246899999999999866544  889999999999987543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.4e-42  Score=326.13  Aligned_cols=232  Identities=27%  Similarity=0.430  Sum_probs=187.3

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCC-CccccceEEeecCCCCceE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHP-NIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~  154 (403)
                      +|++.+.||+|+||.||+|++..+++.||||++.+..       .....|++++..+.|+ +|+.+++++.     ...+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----TMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE-----cCCE
Confidence            4899999999999999999999999999999986431       1234688889999775 5777777763     3345


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce---------
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS---------  224 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~---------  224 (403)
                      +|+||||++ ++|...+..    ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.++         
T Consensus        76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDAEGHIKIADFGMCKE  150 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEcCCCCEEEeecCccee
Confidence            899999997 466544433    3568899999999999999999999 8999999999999998765543         


Q ss_pred             ----------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          225 ----------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       225 ----------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                .+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....            
T Consensus       151 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~------------  217 (324)
T cd05587         151 NIFGGKTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN------------  217 (324)
T ss_pred             cCCCCCceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------------
Confidence                      2368899999999654 48999999999999999999999998877666555543210            


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCcccCCC
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRD  354 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta-----~e~l~hp~f~~~~~  354 (403)
                           ..            ++..+++++.+||.+||..||.+|+++     .++++||||+.+..
T Consensus       218 -----~~------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~  265 (324)
T cd05587         218 -----VS------------YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW  265 (324)
T ss_pred             -----CC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                 00            224578999999999999999999976     89999999988643

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=336.47  Aligned_cols=246  Identities=26%  Similarity=0.382  Sum_probs=207.0

Q ss_pred             ccCCCCCCcccccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc-------cHHHHHHHHHhcCCCCccccceE
Q 015672           71 IGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQMLDHPNIVALKHC  143 (403)
Q Consensus        71 ~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~h~niv~~~~~  143 (403)
                      +...+.......-|.-++.||.|+||.||-|++..+.+.||||++.-..+       .+.+|+..|++|.|||+|.+.+|
T Consensus        15 iA~LF~k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgC   94 (948)
T KOG0577|consen   15 IADLFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGC   94 (948)
T ss_pred             HHHHHccCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccce
Confidence            33344444445568889999999999999999999999999999853322       23479999999999999999999


Q ss_pred             EeecCCCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc
Q 015672          144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV  223 (403)
Q Consensus       144 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~  223 (403)
                      |.....     .|||||||-|+-.+++.-.   ..++.+.++..|+.+.+.||.|||+ ++.||||||..|||++..+.+
T Consensus        95 yLre~T-----aWLVMEYClGSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS-~~~IHRDiKAGNILLse~g~V  165 (948)
T KOG0577|consen   95 YLREHT-----AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHS-HNRIHRDIKAGNILLSEPGLV  165 (948)
T ss_pred             eeccch-----HHHHHHHHhccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHH-hhHHhhhccccceEecCCCee
Confidence            965544     8999999999887777654   3678999999999999999999999 899999999999999887665


Q ss_pred             ---------------eeeccccccchhhhhC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015672          224 ---------------SYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  286 (403)
Q Consensus       224 ---------------~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~  286 (403)
                                     +++|||+|||||+++.  .+.|+-++||||||++..||...++|+...+....++.|.+.-.   
T Consensus       166 KLaDFGSAsi~~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes---  242 (948)
T KOG0577|consen  166 KLADFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES---  242 (948)
T ss_pred             eeccccchhhcCchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC---
Confidence                           5689999999999853  34699999999999999999999999999999999988876311   


Q ss_pred             HHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          287 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                                      |...        ....|..+..|+..||+.=|.+|||++++|+|+|+..-
T Consensus       243 ----------------PtLq--------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~  284 (948)
T KOG0577|consen  243 ----------------PTLQ--------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE  284 (948)
T ss_pred             ----------------CCCC--------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence                            1111        13457889999999999999999999999999998764

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3e-41  Score=317.38  Aligned_cols=264  Identities=37%  Similarity=0.657  Sum_probs=207.3

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc---------cHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      +|.+.+.||+|+||.||+|.+..+++.||||.+.....         ....|+++++.++|+||+++++++.     +..
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG-----HKS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee-----cCC
Confidence            38889999999999999999998999999999864321         1246899999999999999999883     345


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee-------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-------  226 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~-------  226 (403)
                      ++++||||+.++|..++...   ...+++..+..++.||+.||.|||+ +||+||||||+||+++.++.+++.       
T Consensus        76 ~~~lv~e~~~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nill~~~~~~~l~dfg~~~~  151 (298)
T cd07841          76 NINLVFEFMETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHS-NWILHRDLKPNNLLIASDGVLKLADFGLARS  151 (298)
T ss_pred             EEEEEEcccCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCChhhEEEcCCCCEEEccceeeee
Confidence            68999999988877766532   1368899999999999999999999 899999999999999887665432       


Q ss_pred             ------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          227 ------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       227 ------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                  +++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....+....
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         152 FGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT  231 (298)
T ss_pred             ccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence                        34569999998665668999999999999999999999999888888787777777777665543221


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCC
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  356 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~  356 (403)
                      ..............+... .....+.++.+||.+||++||++|||+.|+++||||++...+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQ-IFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             cccccccccccCCcchhh-hcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence            111111111111112111 2245688999999999999999999999999999999865443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-42  Score=319.48  Aligned_cols=238  Identities=24%  Similarity=0.368  Sum_probs=189.8

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      |++.++||+|+||.||++.+..+++.||+|++....       ....+|+.+++.++|+||+++++.+     ....+++
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   76 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeEE
Confidence            889999999999999999999999999999885421       2234699999999999999998887     3344689


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-----------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-----------  224 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-----------  224 (403)
                      +||||+. ++|...+...  ....+++..+..++.|++.||.|||+ .||+||||||+||+++..+.++           
T Consensus        77 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05605          77 LVLTLMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHR-ERIVYRDLKPENILLDDYGHIRISDLGLAVEIP  153 (285)
T ss_pred             EEEeccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            9999997 4665444321  23468999999999999999999999 8999999999999998765443           


Q ss_pred             -------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          225 -------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       225 -------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                             .+|++.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.......+...+....           
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------  221 (285)
T cd05605         154 EGETIRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ-----------  221 (285)
T ss_pred             CCCccccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc-----------
Confidence                   2457889999998654 589999999999999999999999987665443333322211000           


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCCCC
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDP  355 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~~~  355 (403)
                                    ..++..+++.+.+||.+||..||++||     +++++++||||......
T Consensus       222 --------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05605         222 --------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK  270 (285)
T ss_pred             --------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence                          001245789999999999999999999     99999999999886443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.5e-42  Score=328.26  Aligned_cols=236  Identities=30%  Similarity=0.468  Sum_probs=184.1

Q ss_pred             cEeeeceecccCceEEEEEEEC---CCCcEEEEEEccccc--------ccHHHHHHHHHhc-CCCCccccceEEeecCCC
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  150 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  150 (403)
                      +|++.+.||+|+||.||+|+..   .+++.||+|++.+..        ....+|+.+++.+ +|+||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence            3899999999999999999864   478999999885321        1234689999999 589999998877     3


Q ss_pred             CceEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-----
Q 015672          151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-----  224 (403)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-----  224 (403)
                      ....+++||||+++ +|...+..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.++     
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nili~~~~~~kl~DfG  150 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHK-LGIVYRDIKLENILLDSEGHVVLTDFG  150 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHeEECCCCCEEEeeCc
Confidence            34458899999984 66554432    3568999999999999999999999 8999999999999998765442     


Q ss_pred             ---------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          225 ---------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       225 ---------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                     ..||+.|+|||++.+...++.++|||||||++|+|++|..||...........+...+..     
T Consensus       151 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-----  225 (332)
T cd05614         151 LSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-----  225 (332)
T ss_pred             CCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc-----
Confidence                           246889999999976555889999999999999999999999754322111111111000     


Q ss_pred             HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCC
Q 015672          290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  353 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~  353 (403)
                         .                 ...++..+++.+.+||.+||+.||++||     +++++++||||++..
T Consensus       226 ---~-----------------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~  274 (332)
T cd05614         226 ---C-----------------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD  274 (332)
T ss_pred             ---C-----------------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence               0                 0012245789999999999999999999     888999999998764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.4e-41  Score=317.33  Aligned_cols=258  Identities=36%  Similarity=0.664  Sum_probs=202.6

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|++.+.||.|+||.||+|++..+++.||||.+..+.      ....+|++++++++|+||+++++++.     +....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc-----cCCcEE
Confidence            3889999999999999999999999999999885322      23457999999999999999999873     344588


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----------  226 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----------  226 (403)
                      +||||+.+++...+....  ...+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++..          
T Consensus        76 ~v~e~~~~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~  152 (284)
T cd07860          76 LVFEFLHQDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV  152 (284)
T ss_pred             EEeeccccCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence            999999877766554321  3568899999999999999999999 899999999999999877655432          


Q ss_pred             ---------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC-
Q 015672          227 ---------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-  296 (403)
Q Consensus       227 ---------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-  296 (403)
                               +++.|+|||++.+...++.++|||||||++|+|+||+.||.+.+..+.+..+.+..+.+....+.....- 
T Consensus       153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         153 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             CccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence                     3567999998866555788999999999999999999999988888888888888777765443221100 


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                      .....++.......... ...+++++.+||.+||+.||.+|||++++++||||
T Consensus       233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         233 DYKPSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHhhcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            00001222211111111 23578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=8e-42  Score=324.32  Aligned_cols=226  Identities=31%  Similarity=0.463  Sum_probs=183.6

Q ss_pred             EeeeceecccCceEEEEEEECCCCcE-EEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEI-VAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~-vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ..+.+.||+|+||+||+|.++  |+. ||+|++....      ..+.+|+.+|.+++|||||++++++.....    .++
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~~~  116 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----SLC  116 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----ceE
Confidence            445566999999999999987  555 9999986432      256789999999999999999999843221    488


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC-ccccccccccceecCCC-Cce---------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-ICHRDIKPQNLLVKGEP-NVS---------  224 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~-ivHrDlKp~NILl~~~~-~~~---------  224 (403)
                      |||||++ |+|..++...  ....++...+..++.||+.||.|||+ .+ ||||||||+|||++.+. .++         
T Consensus       117 iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~-~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS-EGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE  193 (362)
T ss_pred             EEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc-CCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence            9999998 6777776553  34779999999999999999999999 79 99999999999999875 443         


Q ss_pred             ----------eeccccccchhhhhC-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015672          225 ----------YICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       225 ----------~~~t~~y~aPE~~~~-~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  293 (403)
                                ..||+.|||||++.+ ...|+.++||||||++||||+||+.||.+.........+......|+       
T Consensus       194 ~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~-------  266 (362)
T KOG0192|consen  194 KVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP-------  266 (362)
T ss_pred             eccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-------
Confidence                      247889999999974 34699999999999999999999999998887444444433221111       


Q ss_pred             CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                          ++..+++.+..||.+||..||.+||+..+++.
T Consensus       267 --------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  267 --------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             --------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence                                22457899999999999999999999998864

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.5e-41  Score=324.81  Aligned_cols=267  Identities=32%  Similarity=0.579  Sum_probs=206.5

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCC-CCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  154 (403)
                      .+|.+.+.||+|+||.||+|++..+++.||||.+.+..      ....+|+.+++.++|+||++++++|..... .+..+
T Consensus        16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   95 (353)
T cd07850          16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD   95 (353)
T ss_pred             cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence            45999999999999999999999999999999885421      123469999999999999999998753321 22345


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      .|+||||+.+++...+..      .++...+..++.|++.||.|||+ .||+||||||+|||++.++.+++         
T Consensus        96 ~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  168 (353)
T cd07850          96 VYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  168 (353)
T ss_pred             EEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence            789999999877665432      37888899999999999999999 89999999999999987765433         


Q ss_pred             ---------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          226 ---------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       226 ---------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                               .+++.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+...++.|+.+.+......
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
T cd07850         169 GTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT  247 (353)
T ss_pred             CCCCCCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence                     356789999998654 5899999999999999999999999998888888888888888877654432211


Q ss_pred             cccc--CCCCCCCCCccccc------------ccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCC
Q 015672          297 YTEF--KFPQIKPHPWHKVF------------QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  356 (403)
Q Consensus       297 ~~~~--~~~~~~~~~~~~~~------------~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~  356 (403)
                      ...+  ..+.....++...+            +...++.+.+||.+||+.||++|||+.|+|+||||+....+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~  321 (353)
T cd07850         248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPS  321 (353)
T ss_pred             hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCc
Confidence            1110  00000111111110            123567799999999999999999999999999998655443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.4e-41  Score=323.53  Aligned_cols=237  Identities=25%  Similarity=0.348  Sum_probs=182.2

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ...+|+..++||+|+||.||+|++..+++.||||++....     ....+|+++++.++|+||+++++++     .....
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~  146 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGE  146 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCe
Confidence            3456899999999999999999999999999999985432     2345799999999999999999987     33445


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      +++||||+.+..   +..    .....+..+..++.||+.||.|||+ +||+||||||+|||++.++.+++         
T Consensus       147 ~~lv~e~~~~~~---L~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~  218 (353)
T PLN00034        147 IQVLLEFMDGGS---LEG----THIADEQFLADVARQILSGIAYLHR-RHIVHRDIKPSNLLINSAKNVKIADFGVSRIL  218 (353)
T ss_pred             EEEEEecCCCCc---ccc----cccCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCEEEcccccceec
Confidence            889999998532   111    1235667788899999999999999 89999999999999987665432         


Q ss_pred             ----------eccccccchhhhhC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015672          226 ----------ICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       226 ----------~~t~~y~aPE~~~~----~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  291 (403)
                                .||..|+|||++..    ....+.++|||||||++|||++|+.||......+....+.......      
T Consensus       219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~------  292 (353)
T PLN00034        219 AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ------  292 (353)
T ss_pred             ccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC------
Confidence                      46788999998742    2234568999999999999999999997433222111111100000      


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCC
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  354 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  354 (403)
                                .         ...+..++.++.+||.+||..||++|||+.|+++||||.+-..
T Consensus       293 ----------~---------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~  336 (353)
T PLN00034        293 ----------P---------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP  336 (353)
T ss_pred             ----------C---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence                      0         0012457899999999999999999999999999999988543

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-41  Score=315.20  Aligned_cols=258  Identities=34%  Similarity=0.682  Sum_probs=202.2

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ..|++.+.||+|+||.||+|.++.+++.||||.+....     ....+|+++++.++|+||+++++++.     ...+.+
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   79 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH-----TKKTLT   79 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe-----cCCeEE
Confidence            46999999999999999999999899999999885432     22357999999999999999999873     344689


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      +||||++++|..++...   ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+++           
T Consensus        80 lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  155 (291)
T cd07844          80 LVFEYLDTDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQ-RRVLHRDLKPQNLLISERGELKLADFGLARAKSV  155 (291)
T ss_pred             EEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence            99999998877665432   3468889999999999999999999 89999999999999987765433           


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHHHHhhcCc-
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCMNP-  295 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~-  295 (403)
                              .++..|+|||++.+...++.++|||||||++|+|++|+.||.+.. ..+.+..+.+.++.+....+..... 
T Consensus       156 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         156 PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             CCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence                    235679999998765568999999999999999999999997766 4566666777777776665543322 


Q ss_pred             -CccccCCCCCCCCCcccccccCCC--HHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          296 -NYTEFKFPQIKPHPWHKVFQKRLP--PEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       296 -~~~~~~~~~~~~~~~~~~~~~~~s--~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                       .+....++.....+..... ..++  .++.++|.+||+.||++|||+.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHA-PRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccccccCChhHHHhC-cCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence             1122222222222221111 1234  889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=7.7e-42  Score=325.13  Aligned_cols=226  Identities=30%  Similarity=0.498  Sum_probs=184.2

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhc-CCCCccccceEEeecCCCCceEEEEEe
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      ++||+|+||.||+|++..+++.||||++..+.       .....|.+++..+ +||||+++++++.     ...++|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~-----~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ-----TKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCeEEEEE
Confidence            46999999999999999999999999986431       1223578888766 7999999999883     334589999


Q ss_pred             eccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------------
Q 015672          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------------  225 (403)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------------  225 (403)
                      ||+++ +|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+++             
T Consensus        76 E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~  150 (321)
T cd05591          76 EYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHR-HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG  150 (321)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCCCEEEeecccceecccCC
Confidence            99984 55444432    3568899999999999999999999 89999999999999987765432             


Q ss_pred             ------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 015672          226 ------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  299 (403)
Q Consensus       226 ------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  299 (403)
                            .||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...                 .
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~-----------------~  212 (321)
T cd05591         151 VTTTTFCGTPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD-----------------D  212 (321)
T ss_pred             ccccccccCccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence                  368889999998654 5899999999999999999999999988776666554431                 0


Q ss_pred             cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-------CHHHHhcCCCcccCC
Q 015672          300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-------TALEACVHPFFDELR  353 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-------ta~e~l~hp~f~~~~  353 (403)
                      ..            ++..++.++.+||.+||+.||++|+       ++.++++||||..+.
T Consensus       213 ~~------------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~  261 (321)
T cd05591         213 VL------------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEID  261 (321)
T ss_pred             CC------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence            00            1234789999999999999999999       999999999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.6e-41  Score=323.33  Aligned_cols=231  Identities=27%  Similarity=0.424  Sum_probs=187.1

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc-------cHHHHHHHHHhc-CCCCccccceEEeecCCCCceE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      +|.+.+.||+|+||.||+|++..+++.||||++.+...       ....|..++..+ +|++|+++++++     ....+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence            38899999999999999999999999999999864321       123467777776 578888888877     33345


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce---------
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS---------  224 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~---------  224 (403)
                      +++||||++ ++|...+..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++         
T Consensus        76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~  150 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEecCCCHHHeEECCCCcEEEccCCCcee
Confidence            899999997 466544432    3568899999999999999999999 8999999999999998765543         


Q ss_pred             ----------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          225 ----------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       225 ----------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                ..||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+....            
T Consensus       151 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~------------  217 (323)
T cd05616         151 NMWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN------------  217 (323)
T ss_pred             cCCCCCccccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------
Confidence                      2368899999999654 58999999999999999999999998887666655554310            


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCcccCC
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELR  353 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~e~l~hp~f~~~~  353 (403)
                           ..            ++..++.++.+||.+||+.||.+|++     ..++++||||+.+.
T Consensus       218 -----~~------------~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~  264 (323)
T cd05616         218 -----VA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  264 (323)
T ss_pred             -----CC------------CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence                 00            22457899999999999999999997     48999999998765

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.6e-41  Score=324.68  Aligned_cols=269  Identities=35%  Similarity=0.658  Sum_probs=214.4

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      .+|++.+.||+|+||.||+|.+..+++.||+|++....      ....+|+.+++.++|+||+++++++.... ....++
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence            46999999999999999999999999999999886432      12346999999999999999998764332 344578


Q ss_pred             EEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------
Q 015672          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------  225 (403)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------  225 (403)
                      ++||||+.+++..++..    ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++.+++          
T Consensus        84 ~lv~e~~~~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          84 YVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEehhhhhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            99999998876555432    3568999999999999999999999 89999999999999987765432          


Q ss_pred             -------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          226 -------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       226 -------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                                   .++..|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+...++.|+...+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~  238 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR  238 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence                         3567899999986655689999999999999999999999999888888888888888887766543


Q ss_pred             cCcCccc---cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCC
Q 015672          293 MNPNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  357 (403)
Q Consensus       293 ~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~  357 (403)
                      .......   ..++.....+|... ....++++.+||.+||+.||++|||+++++.||||++...+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~  305 (334)
T cd07855         239 IGSDRVRKYIQNLPRKQPVPWSKI-FPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD  305 (334)
T ss_pred             hchhhHHHHHhhcccCCCCCHHHH-cccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcc
Confidence            2211100   01222222333322 2457899999999999999999999999999999998876654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.4e-41  Score=322.62  Aligned_cols=226  Identities=27%  Similarity=0.498  Sum_probs=181.5

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHh-cCCCCccccceEEeecCCCCceEEEEEe
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      +.||+|+||.||+|+++.+++.||+|++....       .....|..++.. ++|+||+++++++     ....++|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence            46999999999999999999999999986432       123357777765 4899999999887     3345689999


Q ss_pred             eccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------------
Q 015672          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------------  224 (403)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------------  224 (403)
                      ||+.+ +|...+..    ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++.++              
T Consensus        76 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  150 (316)
T cd05620          76 EFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHS-KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD  150 (316)
T ss_pred             CCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC
Confidence            99984 55544432    3568899999999999999999999 8999999999999998765442              


Q ss_pred             -----eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 015672          225 -----YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  299 (403)
Q Consensus       225 -----~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  299 (403)
                           ..||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...  .+              
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~--------------  213 (316)
T cd05620         151 NRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TP--------------  213 (316)
T ss_pred             CceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC--------------
Confidence                 2468899999999654 5899999999999999999999999877765544433211  00              


Q ss_pred             cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH-HHHhcCCCcccCC
Q 015672          300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-LEACVHPFFDELR  353 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta-~e~l~hp~f~~~~  353 (403)
                                   .++..++.++++||.+||+.||++|+++ +++++||||+.+.
T Consensus       214 -------------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         214 -------------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             -------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence                         0123478899999999999999999997 5889999998864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.3e-41  Score=322.84  Aligned_cols=227  Identities=29%  Similarity=0.517  Sum_probs=181.9

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHh-cCCCCccccceEEeecCCCCceEEEEEe
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      +.||+|+||+||+|++..+++.||||++....       .....|..++.. ++||||+++++++.     ...++++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEEEE
Confidence            46999999999999999999999999886431       122357777775 49999999998873     334589999


Q ss_pred             eccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------------
Q 015672          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------------  224 (403)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------------  224 (403)
                      ||++ ++|...+..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++              
T Consensus        76 ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~-~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  150 (316)
T cd05619          76 EYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHS-KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD  150 (316)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC
Confidence            9997 566555443    3568889999999999999999999 8999999999999998765442              


Q ss_pred             -----eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 015672          225 -----YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  299 (403)
Q Consensus       225 -----~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  299 (403)
                           ..||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+...  .+              
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~--------------  213 (316)
T cd05619         151 AKTCTFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NP--------------  213 (316)
T ss_pred             CceeeecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC--------------
Confidence                 2368889999998654 5899999999999999999999999887755544433210  00              


Q ss_pred             cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHH-HHhcCCCcccCCC
Q 015672          300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELRD  354 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~-e~l~hp~f~~~~~  354 (403)
                                   .++..++.++.+||.+||+.||++||++. ++++||||+.+..
T Consensus       214 -------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05619         214 -------------CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW  256 (316)
T ss_pred             -------------CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence                         01234788999999999999999999996 8999999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.7e-42  Score=326.32  Aligned_cols=227  Identities=28%  Similarity=0.469  Sum_probs=180.8

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEcccccc-------cHHHHH-HHHHhcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNREL-QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      +.||+|+||+||+|++..+++.||||++.....       ....|. .+++.++||||+++++.+.     ....+++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-----~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-----eCCEEEEEE
Confidence            469999999999999999999999999854321       112233 3567899999999998873     334588999


Q ss_pred             eccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------------
Q 015672          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------------  224 (403)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------------  224 (403)
                      ||+.+ +|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++              
T Consensus        76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  150 (323)
T cd05575          76 DYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHS-LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS  150 (323)
T ss_pred             cCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC
Confidence            99984 55444432    4568899999999999999999999 8999999999999998765543              


Q ss_pred             -----eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 015672          225 -----YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  299 (403)
Q Consensus       225 -----~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  299 (403)
                           .+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...   +              
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~--------------  212 (323)
T cd05575         151 KTTSTFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK---P--------------  212 (323)
T ss_pred             CccccccCChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC---C--------------
Confidence                 2468889999998654 5899999999999999999999999887765554444321   0              


Q ss_pred             cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCcccCCC
Q 015672          300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELRD  354 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta----~e~l~hp~f~~~~~  354 (403)
                      ..            ++..+++++.+||.+||+.||.+||++    .++++||||..+..
T Consensus       213 ~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         213 LR------------LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             CC------------CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            00            124578999999999999999999987    69999999987643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.7e-42  Score=327.89  Aligned_cols=228  Identities=27%  Similarity=0.429  Sum_probs=183.6

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEee
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  160 (403)
                      +.||+|+||.||+|++..+++.||+|++....       ....+|+++++.++|+||+++++++     ....++|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence            46999999999999999999999999986431       1224688999999999999998887     33446899999


Q ss_pred             ccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce---------------
Q 015672          161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS---------------  224 (403)
Q Consensus       161 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~---------------  224 (403)
                      |+++ +|...+..    ...+++..++.++.||+.||.|||+..||+||||||+|||++.++.++               
T Consensus        76 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~  151 (325)
T cd05594          76 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA  151 (325)
T ss_pred             CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence            9985 45443332    456899999999999999999999625999999999999998765443               


Q ss_pred             ----eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccc
Q 015672          225 ----YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  300 (403)
Q Consensus       225 ----~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  300 (403)
                          ..||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+...                 ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-----------------~~  213 (325)
T cd05594         152 TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------EI  213 (325)
T ss_pred             ccccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-----------------CC
Confidence                2468899999998654 5899999999999999999999999877655444333210                 01


Q ss_pred             CCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCCC
Q 015672          301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  354 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~~  354 (403)
                      .            ++..+++++.+||.+||+.||++|+     ++.++++||||..+..
T Consensus       214 ~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~  260 (325)
T cd05594         214 R------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVW  260 (325)
T ss_pred             C------------CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence            1            2245789999999999999999997     9999999999997643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.2e-41  Score=323.40  Aligned_cols=227  Identities=29%  Similarity=0.494  Sum_probs=184.1

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhc-CCCCccccceEEeecCCCCceEEEEEe
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      +.||+|+||+||+|++..+++.||||++.+..       ....+|+.++..+ +||||+++++++.     ...++|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-----~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-----TKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence            46999999999999999999999999986431       1234688888887 7999999999873     334589999


Q ss_pred             eccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------------
Q 015672          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------------  224 (403)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------------  224 (403)
                      ||+++ +|...+..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++              
T Consensus        76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  150 (318)
T cd05570          76 EYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG  150 (318)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC
Confidence            99974 55444432    3578999999999999999999999 8999999999999998765442              


Q ss_pred             -----eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 015672          225 -----YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  299 (403)
Q Consensus       225 -----~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  299 (403)
                           .+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...                 .
T Consensus       151 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-----------------~  212 (318)
T cd05570         151 VTTSTFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-----------------E  212 (318)
T ss_pred             CcccceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence                 2468889999999654 5899999999999999999999999877755544443321                 0


Q ss_pred             cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCcccCCC
Q 015672          300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRD  354 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta-----~e~l~hp~f~~~~~  354 (403)
                      ..            ++..++.++.+||.+||+.||++|||+     .++++||||+....
T Consensus       213 ~~------------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         213 VR------------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             CC------------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            00            224578999999999999999999999     99999999988643

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-41  Score=324.85  Aligned_cols=238  Identities=27%  Similarity=0.440  Sum_probs=188.6

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      +|++.+.||+|+||+||++++..+++.||+|++.+.       .....+|+.++..++|+||+++++++     ....++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENNL   76 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCeE
Confidence            599999999999999999999999999999998532       12235688999999999999999887     334568


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce----------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS----------  224 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~----------  224 (403)
                      |+||||++ ++|..++..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++.++          
T Consensus        77 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  152 (331)
T cd05597          77 YLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQ-LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRL  152 (331)
T ss_pred             EEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEECCCCHHHEEECCCCCEEEEECCceeec
Confidence            99999997 566665543   23568999999999999999999999 8999999999999997665442          


Q ss_pred             ----------eeccccccchhhhhC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          225 ----------YICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       225 ----------~~~t~~y~aPE~~~~----~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                ..||+.|+|||++.+    ...++.++|||||||++|+|++|+.||.+.+..+....+....        
T Consensus       153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~--------  224 (331)
T cd05597         153 LADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--------  224 (331)
T ss_pred             CCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCC--------
Confidence                      246889999999853    2347889999999999999999999998877655554443210        


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCcccCC
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELR  353 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpta~e~l~hp~f~~~~  353 (403)
                             ..+.++.         ....+++++++||.+||..++++  |+++.++++||||..+.
T Consensus       225 -------~~~~~~~---------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~  273 (331)
T cd05597         225 -------EHFQFPP---------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID  273 (331)
T ss_pred             -------CcccCCC---------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence                   0011111         01347899999999999765544  78999999999998764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.1e-40  Score=311.32  Aligned_cols=257  Identities=35%  Similarity=0.632  Sum_probs=196.7

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|++.+.||+|+||.||+|+++.+++.||+|++....      ....+|+.+++.++|+||+++++++.     ...+.+
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~   76 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKRKLH   76 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCCEEE
Confidence            5999999999999999999999999999999875322      22357999999999999999999883     334588


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      +||||+++.+...+   ......+++..++.++.||+.||.|||+ .||+||||||+||+++.++.+++           
T Consensus        77 ~v~e~~~~~~l~~~---~~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07847          77 LVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHK-HNCIHRDVKPENILITKQGQIKLCDFGFARILTG  152 (286)
T ss_pred             EEEeccCccHHHHH---HhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence            99999997553322   2223468999999999999999999999 89999999999999987665432           


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc--
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--  295 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--  295 (403)
                              .++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++............  
T Consensus       153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         153 PGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             CcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence                    2456799999987656688999999999999999999999998887777776666555433322111110  


Q ss_pred             CccccCCCCCCC-CCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          296 NYTEFKFPQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       296 ~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                      .+.....+.... .++.. ....++..+.+||.+||+.||++|||+.|++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         233 FFKGLSIPEPETREPLES-KFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccccccCCCcccccCHHH-HhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            011111111111 11111 123578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4e-41  Score=332.50  Aligned_cols=257  Identities=25%  Similarity=0.339  Sum_probs=190.8

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEee
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  160 (403)
                      ...|.+.+.||+|+||.||+|++..+++.||||...  .....+|+++|++|+|+|||++++++..     ....++|||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--~~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--YASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--ccCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEEEEEE
Confidence            446999999999999999999999999999999643  2335689999999999999999998743     334789999


Q ss_pred             ccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce----------------
Q 015672          161 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS----------------  224 (403)
Q Consensus       161 ~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~----------------  224 (403)
                      ++.+++...+...   ...+++..++.++.||+.||.|||+ +|||||||||+||||+.++.++                
T Consensus       241 ~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        241 KYRSDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             ccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            9988876665432   2468999999999999999999999 8999999999999998654432                


Q ss_pred             -----eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHHHHhCCCCHHHH--
Q 015672          225 -----YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-------GVDQLVEIIKVLGTPTREEI--  290 (403)
Q Consensus       225 -----~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~--  290 (403)
                           ..||+.|+|||++.+. .++.++|||||||++|||++|..++....       ...++..+++..+....+..  
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence                 2478899999999665 58999999999999999999876543221       12345555544332211100  


Q ss_pred             ------hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          291 ------KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       291 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                            ............+......|...  ..++.++.+||.+||++||++|||+.|+|+||||+.
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRY--YKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhh--ccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                  00000000011111122223222  246778999999999999999999999999999964

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4e-41  Score=322.42  Aligned_cols=270  Identities=34%  Similarity=0.643  Sum_probs=210.8

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      .+|.+.+.||+|+||+||+|++..+++.||||.+...      .....+|+.+++.++|+||+++++++.........++
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            3599999999999999999999999999999987532      1123469999999999999999987754333333458


Q ss_pred             EEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------
Q 015672          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------  225 (403)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------  225 (403)
                      ++++||+++++...+..    ...+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+++          
T Consensus        85 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  159 (337)
T cd07858          85 YIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS  159 (337)
T ss_pred             EEEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence            99999999877665543    3568999999999999999999999 89999999999999987654432          


Q ss_pred             ---------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          226 ---------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       226 ---------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                               .++..|+|||++.....++.++|||||||++|+|++|++||.+.+....+..+....+.+..+.+......
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07858         160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE  239 (337)
T ss_pred             CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence                     35678999999865445899999999999999999999999988877777788888887776655322111


Q ss_pred             ccc-c--CCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCC
Q 015672          297 YTE-F--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  357 (403)
Q Consensus       297 ~~~-~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~  357 (403)
                      ... +  ..+.....++.. ....+++++.+||.+||+.||++|||+.++++||||..+.++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~  302 (337)
T cd07858         240 KARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSD  302 (337)
T ss_pred             hhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCccc
Confidence            000 0  011111111111 12457899999999999999999999999999999998876653

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.5e-41  Score=315.53  Aligned_cols=261  Identities=37%  Similarity=0.610  Sum_probs=206.8

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      .+|++.+.||.|+||.||+|.+..+++.+|+|.+....      ....+|+.+++.++||||+++++++...   +..++
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCcE
Confidence            35999999999999999999999999999999885322      1234799999999999999999987543   22458


Q ss_pred             EEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------
Q 015672          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------  225 (403)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------  225 (403)
                      |+||||+++++..++...   ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+++          
T Consensus        82 ~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          82 YMVMEYVEHDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHD-NWILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             EEEehhcCcCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            899999998877666542   2358999999999999999999999 89999999999999987765533          


Q ss_pred             ---------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc-
Q 015672          226 ---------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-  295 (403)
Q Consensus       226 ---------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-  295 (403)
                               .+++.|+|||.+.+...++.++|||||||++|+|++|.+||...+..+.+..+....+.+....+..... 
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence                     2466799999987655578999999999999999999999999888888888888888777766543321 


Q ss_pred             -CccccCCCCCCCCCcccccccC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          296 -NYTEFKFPQIKPHPWHKVFQKR-LPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       296 -~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                       ......+.......+...++.. +++.+.+||.+||+.||++|||+.|+++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence             0111111111122222333333 68899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=6.5e-41  Score=312.73  Aligned_cols=258  Identities=35%  Similarity=0.680  Sum_probs=205.6

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      +|++.+.||.|++|.||+|++..+++.||||++....     ....+|+++++.++|+||+++++++..     ..+.++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-----ENKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-----CCcEEE
Confidence            4899999999999999999999999999999885432     233479999999999999999998843     334889


Q ss_pred             EeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------------
Q 015672          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------------  225 (403)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------------  225 (403)
                      ||||+++++..++..... ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++.++.            
T Consensus        76 v~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~  153 (284)
T cd07836          76 VFEYMDKDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP  153 (284)
T ss_pred             EEecCCccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence            999999887766554221 2458899999999999999999998 89999999999999987765533            


Q ss_pred             -------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 015672          226 -------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  298 (403)
Q Consensus       226 -------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  298 (403)
                             .++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+....|....+.... ...
T Consensus       154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  232 (284)
T cd07836         154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QLP  232 (284)
T ss_pred             ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cCc
Confidence                   246779999998766667899999999999999999999999988888888888877777766554332 111


Q ss_pred             c--cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          299 E--FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       299 ~--~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                      .  ..++......... +...++.++.++|.+||+.||.+||++.++++||||
T Consensus       233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         233 EYKPTFPRYPPQDLQQ-LFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hhcccccCCChHHHHH-HhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            1  1222222212211 223568899999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-41  Score=317.08  Aligned_cols=263  Identities=36%  Similarity=0.630  Sum_probs=199.5

Q ss_pred             cEeeeceecccCceEEEEEEECC--CCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRE--TGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      +|.+.+.||+|+||.||+|.+..  +++.||+|.+....       ....+|+.+++.++||||+++++++..   .+..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE---HADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC---CCCc
Confidence            38899999999999999999988  89999999986532       233579999999999999999998843   2235


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecC----CCCcee---
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKG----EPNVSY---  225 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~----~~~~~~---  225 (403)
                      .+++||||+++++..++....... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.    ++.+++   
T Consensus        78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS-NWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            689999999988777665443322 368899999999999999999999 89999999999999987    443322   


Q ss_pred             -------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcH---------HHHHH
Q 015672          226 -------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---------DQLVE  277 (403)
Q Consensus       226 -------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~---------~~~~~  277 (403)
                                         .+++.|+|||++.+...++.++|||||||++|+|++|++||.+....         ..+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence                               34667999999876666899999999999999999999999765432         34556


Q ss_pred             HHHHhCCCCHHHHhhcCc--Cccc----cCCCCCCCCCccccccc--CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          278 IIKVLGTPTREEIKCMNP--NYTE----FKFPQIKPHPWHKVFQK--RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       278 i~~~~~~~~~~~~~~~~~--~~~~----~~~~~~~~~~~~~~~~~--~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                      +...++.+....+.....  .+..    .................  ..+.++.++|.+||+.||++|||+.|+++||||
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            666777666554432111  1111    00000000111111112  567899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.2e-41  Score=322.79  Aligned_cols=259  Identities=22%  Similarity=0.378  Sum_probs=186.1

Q ss_pred             eeceeccc--CceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           86 AEHVVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        86 ~~~~lG~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      ++++||+|  +|++||+++++.+|+.||+|.+..+.      ....+|+++++.++||||+++++++...     .+.++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEEE
Confidence            56789999  78899999999999999999986432      2345799999999999999999988432     34889


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      ||||++ +++.+++....  ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+..           
T Consensus        77 v~e~~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~  153 (327)
T cd08227          77 VTSFMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMIN  153 (327)
T ss_pred             EEeccCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence            999998 56666654322  2458889999999999999999999 89999999999999986654321           


Q ss_pred             ---------------eccccccchhhhhCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC-----
Q 015672          226 ---------------ICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT-----  284 (403)
Q Consensus       226 ---------------~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~-----  284 (403)
                                     .++..|+|||++.+. ..++.++|||||||++|+|++|+.||..................     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (327)
T cd08227         154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  233 (327)
T ss_pred             ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccc
Confidence                           234569999998653 35889999999999999999999999866544433322211000     


Q ss_pred             --CCHHHHhhcCcC-------cccc-CCCCCC---CCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          285 --PTREEIKCMNPN-------YTEF-KFPQIK---PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       285 --~~~~~~~~~~~~-------~~~~-~~~~~~---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                        .+.+.+. ....       .... ......   ...........+++++.+||.+||++||++|||++++++||||++
T Consensus       234 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~  312 (327)
T cd08227         234 TTIPAEELT-MKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  312 (327)
T ss_pred             cchhhhhcc-cCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence              0000000 0000       0000 000000   000001122456789999999999999999999999999999988


Q ss_pred             CC
Q 015672          352 LR  353 (403)
Q Consensus       352 ~~  353 (403)
                      +.
T Consensus       313 ~~  314 (327)
T cd08227         313 IK  314 (327)
T ss_pred             cc
Confidence            64

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.3e-41  Score=321.13  Aligned_cols=226  Identities=29%  Similarity=0.509  Sum_probs=180.9

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHh-cCCCCccccceEEeecCCCCceEEEEEe
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      +.||+|+||+||+|++..+++.||||++..+.       .....|..++.. .+||||+++++++     ....++++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            46999999999999999999999999886432       112346666654 4899999999887     3344689999


Q ss_pred             eccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------------
Q 015672          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------------  224 (403)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------------  224 (403)
                      ||++ ++|...+..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++              
T Consensus        76 e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  150 (316)
T cd05592          76 EYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHK-KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE  150 (316)
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC
Confidence            9997 455544433    3578999999999999999999999 8999999999999998765543              


Q ss_pred             -----eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 015672          225 -----YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  299 (403)
Q Consensus       225 -----~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  299 (403)
                           .+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...  .               
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~---------------  212 (316)
T cd05592         151 GKASTFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--R---------------  212 (316)
T ss_pred             CccccccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--C---------------
Confidence                 2468899999998654 4899999999999999999999999988765555444321  0               


Q ss_pred             cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH-HHHhcCCCcccCC
Q 015672          300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-LEACVHPFFDELR  353 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta-~e~l~hp~f~~~~  353 (403)
                         +         .++..++.++.+||.+||..||.+||++ .++++||||..+.
T Consensus       213 ---~---------~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05592         213 ---P---------HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID  255 (316)
T ss_pred             ---C---------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence               0         0224578899999999999999999986 5888999998864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-43  Score=306.36  Aligned_cols=267  Identities=31%  Similarity=0.513  Sum_probs=216.1

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccc--cc----ccHHHHHHHHHhcCCCCccccceEEee---cCCCCc
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DK----RYKNRELQIMQMLDHPNIVALKHCFFS---TTDKEE  152 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~--~~----~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~  152 (403)
                      ..|+...+||+|.||.||+|+.+++|+.||+|++.-  ++    ....+|+.+|..|+|+|++.+++.+-+   ......
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            358888999999999999999999999999997642  22    223589999999999999998887643   333445


Q ss_pred             eEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------
Q 015672          153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------  225 (403)
Q Consensus       153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------  225 (403)
                      ..+|+||++|+.+|..++.+.   ..+++...++.++.+++.||.|+|+ ..|+|||+||+|+||+.++.+++       
T Consensus        97 ~t~ylVf~~cehDLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr-~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   97 ATFYLVFDFCEHDLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHR-NKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ceeeeeHHHhhhhHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHH-hhHHhhcccHhhEEEcCCceEEeecccccc
Confidence            568999999998887776643   3679999999999999999999999 79999999999999998765432       


Q ss_pred             ----------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          226 ----------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       226 ----------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                      +.|.+|++||.+++...|+++.|||+.|||+.||+||.+.|.+.++..++..|...+|..+.+.
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence                            3488999999999999999999999999999999999999999999999999999999999998


Q ss_pred             HhhcCc--CccccCCCCCCCCCcccc---c-ccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          290 IKCMNP--NYTEFKFPQIKPHPWHKV---F-QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       290 ~~~~~~--~~~~~~~~~~~~~~~~~~---~-~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                      |+.++.  -+.....+..........   . +-.-++++.||+.++|.+||.+|++++++++|.||..=
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd  321 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD  321 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence            876542  122222221111111110   0 11125689999999999999999999999999999763

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.6e-41  Score=322.59  Aligned_cols=228  Identities=26%  Similarity=0.489  Sum_probs=179.8

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhc-CCCCccccceEEeecCCCCceEEEEEe
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      ++||+|+||.||+|++..+++.||+|++.+..       ....+|+.++..+ +||||+++++++.     ...++|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~-----~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ-----TESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE-----cCCEEEEEE
Confidence            46999999999999999999999999986431       1234688888888 7999999999873     334589999


Q ss_pred             eccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------------
Q 015672          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------------  224 (403)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------------  224 (403)
                      ||+++ +|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++              
T Consensus        76 e~~~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  150 (329)
T cd05588          76 EFVSGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHE-RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG  150 (329)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCCCEEECcCccccccccCC
Confidence            99984 55444432    4679999999999999999999999 8999999999999998765442              


Q ss_pred             -----eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc--------HHHHHHHHHHhCCCCHHHHh
Q 015672          225 -----YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--------VDQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       225 -----~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~~  291 (403)
                           .+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....        .+.+...+..          
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~----------  219 (329)
T cd05588         151 DTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE----------  219 (329)
T ss_pred             CccccccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc----------
Confidence                 3468889999999654 589999999999999999999999963211        1111111110          


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC------HHHHhcCCCcccCCC
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT------ALEACVHPFFDELRD  354 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt------a~e~l~hp~f~~~~~  354 (403)
                            ....            ++..++.++.+||.+||+.||.+|+|      ++++++||||..+..
T Consensus       220 ------~~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~  270 (329)
T cd05588         220 ------KQIR------------IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW  270 (329)
T ss_pred             ------CCCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence                  0001            23457899999999999999999987      789999999987643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.3e-41  Score=322.12  Aligned_cols=226  Identities=31%  Similarity=0.489  Sum_probs=182.7

Q ss_pred             ceecccCceEEEEEEEC---CCCcEEEEEEccccc--------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           88 HVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +.||+|+||.||+|+..   .+++.||+|++....        ....+|+.+++.++||||+++++++.     ...++|
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-----TGGKLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-----cCCeEE
Confidence            67999999999999864   478899999885421        12346999999999999999998873     334588


Q ss_pred             EEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------
Q 015672          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------  225 (403)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------  225 (403)
                      +||||+++ +|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+++          
T Consensus        77 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  151 (323)
T cd05584          77 LILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQ-QGIIYRDLKPENILLDAQGHVKLTDFGLCKESI  151 (323)
T ss_pred             EEEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence            99999985 55444432    4567888899999999999999999 89999999999999987665432          


Q ss_pred             ---------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          226 ---------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       226 ---------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                               .||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+....+..+...               
T Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~---------------  215 (323)
T cd05584         152 HEGTVTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG---------------  215 (323)
T ss_pred             cCCCcccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---------------
Confidence                     368889999998654 4889999999999999999999999887765555444321               


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCC
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  353 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~  353 (403)
                        ...            ++..+++++.+||.+||+.||++||     +++++++||||....
T Consensus       216 --~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~  263 (323)
T cd05584         216 --KLN------------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN  263 (323)
T ss_pred             --CCC------------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence              001            2245789999999999999999999     899999999998753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.7e-41  Score=327.43  Aligned_cols=237  Identities=28%  Similarity=0.488  Sum_probs=189.6

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-------cccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..+|++.+.||+|+||.||+|+++.+++.||+|++.+.       .....+|+.+++.++||||+++++.+     ....
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~~  116 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDDR  116 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcCC
Confidence            35699999999999999999999999999999988532       12234789999999999999999887     3345


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------  224 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------  224 (403)
                      ++++||||++ ++|..++..     ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++        
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence            6899999997 567665543     458888999999999999999999 8999999999999998765542        


Q ss_pred             ------------eeccccccchhhhhCCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          225 ------------YICSRYYRAPELIFGAT---EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       225 ------------~~~t~~y~aPE~~~~~~---~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                  .+||+.|+|||++.+..   .++.++|||||||++|||++|..||.+.+.......+.....      
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~------  264 (371)
T cd05622         191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN------  264 (371)
T ss_pred             EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------
Confidence                        24788999999986432   378999999999999999999999998876665555543110      


Q ss_pred             HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCcccCC
Q 015672          290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELR  353 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpta~e~l~hp~f~~~~  353 (403)
                               ...++.          ...++..+++||.+||..++.+  |++++++++||||++..
T Consensus       265 ---------~~~~~~----------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         265 ---------SLTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             ---------cccCCC----------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence                     011111          1357899999999999844433  78999999999998754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.5e-40  Score=319.05  Aligned_cols=267  Identities=29%  Similarity=0.526  Sum_probs=199.1

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCC-------
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK-------  150 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-------  150 (403)
                      .+|.+.+.||.|+||.||+|.+..+++.||+|++....    ....+|+++++.++|+||+++++++......       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            45999999999999999999999999999999885432    2345799999999999999998876432211       


Q ss_pred             --CceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC-ce---
Q 015672          151 --EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN-VS---  224 (403)
Q Consensus       151 --~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~-~~---  224 (403)
                        .....++||||+++++..++.     ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++. ++   
T Consensus        85 ~~~~~~~~lv~e~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~-~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          85 LTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccceEEEEeecccccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCceEEECC
Confidence              123578999999987765543     2468899999999999999999999 89999999999999974432 11   


Q ss_pred             -------------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 015672          225 -------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  285 (403)
Q Consensus       225 -------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~  285 (403)
                                         ..++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....+......+
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence                               1346789999988665568899999999999999999999998888777666665544333


Q ss_pred             CHHHHhhcCcCccc-cC-CCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          286 TREEIKCMNPNYTE-FK-FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       286 ~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                      .............. .. .......++.. +...++.++.+||.+||+.||++|||+.++++||||+....|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~  309 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLRD-LLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP  309 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHHH-HccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCC
Confidence            33221111000000 00 00011111111 124578999999999999999999999999999999876443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-42  Score=349.68  Aligned_cols=241  Identities=29%  Similarity=0.501  Sum_probs=204.8

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccc-------ccccHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      ...+|.++++||+|+||.|.+++++.+++.||+|++.+       +...+..|-.+|..-+.+-|++++..|     .+.
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~  147 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDE  147 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCc
Confidence            34569999999999999999999999999999998854       234456788999999999999999888     777


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------  225 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------  225 (403)
                      .|+|+||||++ |+|..++..+    .++++.++++|+..|+.||+-||+ .|+|||||||+||||+..|+++.      
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~-mgyVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHS-MGYVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHh-ccceeccCCcceeEecccCcEeeccchhH
Confidence            88999999998 5666666553    379999999999999999999999 89999999999999998887743      


Q ss_pred             --------------eccccccchhhhh----CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015672          226 --------------ICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  287 (403)
Q Consensus       226 --------------~~t~~y~aPE~~~----~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~  287 (403)
                                    +|||-|.+||++.    +...|+..+|+||+||++|||+.|..||+.++-.+.+-+|+..      
T Consensus       223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h------  296 (1317)
T KOG0612|consen  223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH------  296 (1317)
T ss_pred             HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch------
Confidence                          5899999999984    2246999999999999999999999999999888888887753      


Q ss_pred             HHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCcccCCCCC
Q 015672          288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVHPFFDELRDPN  356 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---a~e~l~hp~f~~~~~~~  356 (403)
                               -..+.||..          ..+|+++++||+++++ +|+.|..   ++++..||||.++.+..
T Consensus       297 ---------k~~l~FP~~----------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~  348 (1317)
T KOG0612|consen  297 ---------KESLSFPDE----------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDN  348 (1317)
T ss_pred             ---------hhhcCCCcc----------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhh
Confidence                     123344421          3489999999999885 6889988   99999999999987743

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.7e-41  Score=334.97  Aligned_cols=241  Identities=23%  Similarity=0.315  Sum_probs=195.3

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCC---CCc
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD---KEE  152 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~  152 (403)
                      .+|.+.+.||+|+||+||+|++..+++.||||++....      ....+|+.++..++|+||+++++.+.....   ...
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            46999999999999999999999999999999985432      223578999999999999998877643322   222


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-------
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-------  224 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-------  224 (403)
                      ..+++||||+. ++|.+.+.........+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++       
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~-~~IiHrDLKP~NILl~~~~~vkL~DFGls  190 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLCSNGLVKLGDFGFS  190 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEeCCCCEEEEecccC
Confidence            35789999998 57877766544445678999999999999999999999 8999999999999998765443       


Q ss_pred             --------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          225 --------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       225 --------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                    .+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+.....       
T Consensus       191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~-------  262 (496)
T PTZ00283        191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY-------  262 (496)
T ss_pred             eeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC-------
Confidence                          2468899999999654 589999999999999999999999988765555444332100       


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                                           ..++..+++++.+||.+||+.||.+||++.++++|||++..
T Consensus       263 ---------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        263 ---------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence                                 00224678999999999999999999999999999998764

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.9e-40  Score=309.14  Aligned_cols=257  Identities=36%  Similarity=0.620  Sum_probs=200.4

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEcccccc-----cHHHHHHHHHhcC-CCCccccceEEeecCCCCceEEEE
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      |.+.+.||+|+||.||+|.+..+++.||+|++.....     ...+|+.++.++. |+||+++++++...   ...++++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence            6788999999999999999999999999998864321     1236888888885 99999999987532   2235889


Q ss_pred             EeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------------
Q 015672          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------------  225 (403)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------------  225 (403)
                      ||||+++++...+...   ...+++..+..++.||+.||.|||+ .||+||||||+||+++. +.+++            
T Consensus        78 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          78 VFELMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             EEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            9999998776655432   2468899999999999999999999 89999999999999987 54432            


Q ss_pred             ------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC-cc
Q 015672          226 ------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-YT  298 (403)
Q Consensus       226 ------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~  298 (403)
                            .++..|+|||++.....++.++|||||||++|||++|.+||.+.+..+.+..+...++.+........... ..
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07831         153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM  232 (282)
T ss_pred             CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence                  35678999998765556789999999999999999999999998888888888887777766543222111 11


Q ss_pred             ccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                      .+.++......... ....++.++.+||.+||..||++|||+.++++||||
T Consensus       233 ~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         233 NYNFPSKKGTGLRK-LLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccCcccccccHHH-HcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            12222222211111 124578999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.8e-40  Score=311.59  Aligned_cols=262  Identities=34%  Similarity=0.638  Sum_probs=202.5

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|++.+.||+|++|.||+|++..+++.||+|.+....      ....+|+++++.++|+||+++++++.     ...+.+
T Consensus         3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   77 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRLY   77 (294)
T ss_pred             ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeEE
Confidence            5999999999999999999999999999999885321      23457999999999999999999883     334689


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC-Ccee----------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP-NVSY----------  225 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~-~~~~----------  225 (403)
                      +||||+++++...+....  ...+++..+..++.||+.||+|||+ ++|+||||||+||+++..+ .+++          
T Consensus        78 lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         78 LVFEYLDLDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             EEEecccccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            999999887765543321  2235778888999999999999999 8999999999999997533 2221          


Q ss_pred             ---------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          226 ---------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       226 ---------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                               .+++.|+|||++.+...++.++|||||||++|+|++|.+||...+..+.+.++...++.+....|......
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             CCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence                     23577999999876556889999999999999999999999988888888888887777766554321110


Q ss_pred             cc-ccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          297 YT-EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       297 ~~-~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                      .. ...++....... ......+++++.++|.+||+.||++||++.++++||||.++.
T Consensus       235 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        235 PDYKSAFPKWPPKDL-ATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             hhhhhhcccCCCCCH-HHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence            00 001111111111 112245788999999999999999999999999999999864

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.8e-41  Score=345.96  Aligned_cols=242  Identities=27%  Similarity=0.428  Sum_probs=194.0

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      ..|++++.||+|+||+||+|++..+++.||+|.+....      ..+..|+.+++.|+|||||+++++|+..   ....+
T Consensus        13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---~~~~l   89 (1021)
T PTZ00266         13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---ANQKL   89 (1021)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---CCCEE
Confidence            46999999999999999999999999999999885321      2245799999999999999999987543   23458


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC-------ccccccccccceecCCC------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-------ICHRDIKPQNLLVKGEP------  221 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~-------ivHrDlKp~NILl~~~~------  221 (403)
                      ||||||++ ++|..++.........+++..++.|+.||+.||.|||+ .+       ||||||||+||||+...      
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs-~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHN-LKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-cccccccCCceeccCcHHHeEeecCccccccc
Confidence            89999998 57877776554445679999999999999999999997 44       99999999999996421      


Q ss_pred             -----------Cc------------------eeeccccccchhhhhCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCc
Q 015672          222 -----------NV------------------SYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESG  271 (403)
Q Consensus       222 -----------~~------------------~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~tg~~pf~~~~~  271 (403)
                                 .+                  ..+||+.|+|||++.+. ..++.++||||||||||+|++|..||...+.
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~  248 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN  248 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence                       11                  12478999999998643 3488999999999999999999999987766


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          272 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       272 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                      ...+...+...  +.               ++           ....+.++.+||.+||..||.+||++.|+|.||||..
T Consensus       249 ~~qli~~lk~~--p~---------------lp-----------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~  300 (1021)
T PTZ00266        249 FSQLISELKRG--PD---------------LP-----------IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN  300 (1021)
T ss_pred             HHHHHHHHhcC--CC---------------CC-----------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence            55444333210  00               00           0245789999999999999999999999999999988


Q ss_pred             CCCC
Q 015672          352 LRDP  355 (403)
Q Consensus       352 ~~~~  355 (403)
                      +..+
T Consensus       301 i~~p  304 (1021)
T PTZ00266        301 VGPP  304 (1021)
T ss_pred             cCCC
Confidence            7654

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=5.9e-41  Score=320.55  Aligned_cols=239  Identities=25%  Similarity=0.411  Sum_probs=189.8

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      +|.+.++||+|+||.||+++++.+++.||+|++.+..       ....+|+.++..++|+||+++++++     .+..++
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENNL   76 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCEE
Confidence            5999999999999999999999999999999885321       1235688899999999999999887     334468


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce----------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS----------  224 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~----------  224 (403)
                      ++||||+. ++|..++...   ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++          
T Consensus        77 ~lv~ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~-~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~  152 (332)
T cd05623          77 YLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNGHIRLADFGSCLKL  152 (332)
T ss_pred             EEEEeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCCCEEEeecchheec
Confidence            99999997 5776665432   3568899999999999999999999 8999999999999998665442          


Q ss_pred             ----------eeccccccchhhhhC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          225 ----------YICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       225 ----------~~~t~~y~aPE~~~~----~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                .+||+.|+|||++.+    ...++.++|||||||++|||++|+.||.+.+..+.+..+....        
T Consensus       153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--------  224 (332)
T cd05623         153 MEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--------  224 (332)
T ss_pred             ccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC--------
Confidence                      247889999999852    3357899999999999999999999998877666555543210        


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCcccCCC
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRD  354 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpta~e~l~hp~f~~~~~  354 (403)
                             ..+.++.         ....+++++++||.+||..++.+  |++++++++||||..+..
T Consensus       225 -------~~~~~p~---------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~  274 (332)
T cd05623         225 -------ERFQFPA---------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW  274 (332)
T ss_pred             -------ccccCCC---------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence                   0011111         11357899999999999776555  689999999999998653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.1e-40  Score=318.65  Aligned_cols=262  Identities=24%  Similarity=0.388  Sum_probs=189.4

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      .+|++.++||+|+||.||+|.+..++..+|+|.+....     ....+|+++++.++|+||+++++++..     ..+++
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   79 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEIS   79 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCEEE
Confidence            46999999999999999999999999999999875432     234579999999999999999998843     33589


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------  225 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------  225 (403)
                      +||||+. ++|.+++..    ...+++..+..++.|++.||.|||+..+|+||||||+|||++.++.+++          
T Consensus        80 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          80 ICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             EEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence            9999997 577666543    3568888999999999999999997347999999999999987765533          


Q ss_pred             -------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH-HhCCCCHHHHhh-cC--
Q 015672          226 -------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK-VLGTPTREEIKC-MN--  294 (403)
Q Consensus       226 -------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~-~~--  294 (403)
                             .+|..|+|||++.+. .++.++|||||||++|+|++|+.||...........+.. ..+.+....... ..  
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (333)
T cd06650         156 DSMANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP  234 (333)
T ss_pred             hhccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence                   367789999998654 589999999999999999999999976654322211110 001110000000 00  


Q ss_pred             ----cCccccCCCCC---------CCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          295 ----PNYTEFKFPQI---------KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       295 ----~~~~~~~~~~~---------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                          ..+.....+..         ............++.++++||.+||++||++|||+.|+++||||+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                00000000000         000000000123578899999999999999999999999999998753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4e-40  Score=311.17  Aligned_cols=265  Identities=29%  Similarity=0.492  Sum_probs=200.5

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCC---CC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD---KE  151 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~  151 (403)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||.+....      ....+|+++++.++||||+++++++.....   ..
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            345999999999999999999999999999999885321      122469999999999999999998754322   22


Q ss_pred             ceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------
Q 015672          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------  225 (403)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------  225 (403)
                      ....++||||+++++...+..   ....+++..++.++.||+.||.|||+ .||+||||||+||+++.++.+++      
T Consensus        91 ~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          91 KGSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHR-NKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             CceEEEEEcCCCcCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence            346789999999877665543   12468999999999999999999999 89999999999999987665432      


Q ss_pred             -----------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015672          226 -----------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  288 (403)
Q Consensus       226 -----------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~  288 (403)
                                       .++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+....+..+.+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence                             235669999998665557899999999999999999999999888777777777766665554


Q ss_pred             HHhhcCc--CccccCCCCCCCCCcccc-cccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          289 EIKCMNP--NYTEFKFPQIKPHPWHKV-FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       289 ~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                      .+.....  .+....++.......... .....+..+.+||.+||..||.+|||++++++||||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            3322110  011111111111111110 111246788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8.7e-41  Score=318.93  Aligned_cols=227  Identities=28%  Similarity=0.505  Sum_probs=177.8

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhc-CCCCccccceEEeecCCCCceEEEEEe
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      +.||+|+||+||+|++..+++.||+|++.+..       ....+|+.++..+ +||||+++++++..     ..++++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----ESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-----CCEEEEEE
Confidence            46999999999999999999999999986431       1234677887776 89999999998733     34589999


Q ss_pred             eccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------------
Q 015672          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------------  224 (403)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------------  224 (403)
                      ||+++ +|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++              
T Consensus        76 E~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~  150 (329)
T cd05618          76 EYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  150 (329)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC
Confidence            99984 55443332    3578999999999999999999999 8999999999999998765543              


Q ss_pred             -----eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--------cHHHHHHHHHHhCCCCHHHHh
Q 015672          225 -----YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES--------GVDQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       225 -----~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~--------~~~~~~~i~~~~~~~~~~~~~  291 (403)
                           ..||+.|+|||++.+. .++.++|||||||++|+|++|+.||....        ....+...+..          
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~----------  219 (329)
T cd05618         151 DTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE----------  219 (329)
T ss_pred             CccccccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc----------
Confidence                 2468899999999654 58999999999999999999999995311        11111111110          


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC------HHHHhcCCCcccCC
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT------ALEACVHPFFDELR  353 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt------a~e~l~hp~f~~~~  353 (403)
                            ...            .++..++.++.+||.+||+.||++|+|      +.++++||||+.+.
T Consensus       220 ------~~~------------~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  269 (329)
T cd05618         220 ------KQI------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  269 (329)
T ss_pred             ------CCC------------CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence                  000            123567899999999999999999998      57999999998764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.9e-40  Score=308.18  Aligned_cols=259  Identities=35%  Similarity=0.631  Sum_probs=195.9

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ..|.+.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+++++.++|+||+++++++.     ...+.|
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~~~   79 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKETLT   79 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCeEE
Confidence            45999999999999999999999999999999885321     13457999999999999999999873     334588


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      +||||+.+++...+...   ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.++.           
T Consensus        80 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  155 (291)
T cd07870          80 FVFEYMHTDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHG-QHILHRDLKPQNLLISYLGELKLADFGLARAKSI  155 (291)
T ss_pred             EEEecccCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence            99999998775544321   2457788889999999999999999 89999999999999987665433           


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHhhcC--
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMN--  294 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~--  294 (403)
                              .+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+. .+.+..+...++.|....+....  
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07870         156 PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL  235 (291)
T ss_pred             CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence                    2467799999986655688999999999999999999999976554 35566666666766655432211  


Q ss_pred             cCccccCCCCCCCCCcccccc-cCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQ-KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                      +.+....++............ ...+.++.+||.+||+.||++|||+.|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            111111111111111111000 1236789999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-40  Score=308.56  Aligned_cols=257  Identities=35%  Similarity=0.653  Sum_probs=202.1

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      |++.+.||.|++|.||+|.+..+|..||+|++..+.      ....+|+++++.++|+||+++++++.     +..+.++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence            677889999999999999999999999999885332      23457999999999999999999873     3356899


Q ss_pred             EeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------------
Q 015672          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------------  225 (403)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------------  225 (403)
                      +|||+++++..++....  ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++.            
T Consensus        76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~-~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~  152 (283)
T cd07835          76 VFEFLDLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHS-HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP  152 (283)
T ss_pred             EEeccCcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC
Confidence            99999887766654322  1358899999999999999999999 89999999999999987655432            


Q ss_pred             -------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 015672          226 -------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  298 (403)
Q Consensus       226 -------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  298 (403)
                             .++..|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+.+..+.+....+........
T Consensus       153 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07835         153 VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD  232 (283)
T ss_pred             ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence                   2366799999886655578999999999999999999999998888888888888877777665432211000


Q ss_pred             -ccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          299 -EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       299 -~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                       ...++......... ....++.++.++|.+||+.||++|||+.|+++||||
T Consensus       233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         233 YKPTFPKWARQDLSK-VVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhhhcccccccchhh-hcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence             00111111111111 234678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=9.4e-41  Score=307.19  Aligned_cols=234  Identities=34%  Similarity=0.566  Sum_probs=188.0

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEcccccccH------HHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK------NRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      |++.+.||+|+||+||++++..+++.||+|++.......      .+|+.+++.++|+||+++++++..     ..++++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence            889999999999999999999999999999986543211      248999999999999999998844     445889


Q ss_pred             EeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      +|||+.+ +|..++..    ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+.+           
T Consensus        76 v~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~-~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~  150 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHS-KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE  150 (260)
T ss_dssp             EEEEETTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHH-TTEEESSBSGGGEEESTTSEEEESSGTTTEESTS
T ss_pred             cccccccccccccccc----ccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccc
Confidence            9999997 88777662    4678999999999999999999999 89999999999999986654432           


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                              .+|..|+|||++.....++.++||||||+++|+|++|..||......+....+.+...........      
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------  224 (260)
T PF00069_consen  151 NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ------  224 (260)
T ss_dssp             TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc------
Confidence                    357789999998634568999999999999999999999998774444444333322211111000      


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                                      .....+.++.++|.+||+.||++||++.++++||||
T Consensus       225 ----------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  225 ----------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             ----------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             ----------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                            001124789999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.7e-40  Score=316.19  Aligned_cols=230  Identities=28%  Similarity=0.440  Sum_probs=185.4

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCC-CCccccceEEeecCCCCceEE
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~  155 (403)
                      |...+.||+|+||.||+|+++.+++.||+|++.++.       .....|+.++..+.| ++|+++++++.     ....+
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~~   76 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ-----TVDRL   76 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe-----cCCEE
Confidence            778899999999999999999999999999886432       123457888888865 66777877763     33458


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      |+||||++ ++|...+..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++         
T Consensus        77 ~lv~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~-~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~  151 (323)
T cd05615          77 YFVMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEH  151 (323)
T ss_pred             EEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCCCEEEecccccccc
Confidence            99999997 466544432    3568999999999999999999999 89999999999999987655432         


Q ss_pred             ----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          226 ----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       226 ----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                .||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.......+....             
T Consensus       152 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-------------  217 (323)
T cd05615         152 MVDGVTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-------------  217 (323)
T ss_pred             CCCCccccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence                      368889999998654 58999999999999999999999998877665555544310             


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCcccCC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELR  353 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~e~l~hp~f~~~~  353 (403)
                          ..            ++..++.++.+|+.+||+.||.+|++     ..++++||||+.+.
T Consensus       218 ----~~------------~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~  264 (323)
T cd05615         218 ----VS------------YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID  264 (323)
T ss_pred             ----CC------------CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence                00            12457889999999999999999997     57999999999875

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.7e-40  Score=307.93  Aligned_cols=258  Identities=36%  Similarity=0.639  Sum_probs=196.2

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+++++.++|+||+++++++     ....+.+
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   76 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRLY   76 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeEE
Confidence            5999999999999999999999899999999875322      2235799999999999999999988     3445689


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      +||||+++.....+   ......+++..++.++.||+.||.|||+ .||+||||+|+||+++.++.+++           
T Consensus        77 lv~e~~~~~~l~~~---~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          77 LVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHS-HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             EEEecCCccHHHHH---HhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence            99999996543222   2223458899999999999999999999 89999999999999987665432           


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC-
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-  296 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-  296 (403)
                              .++..|+|||++.+...++.++|||||||++|+|++|++||...+..+....+....+............. 
T Consensus       153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         153 PGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             CccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence                    35667999999876556789999999999999999999999888777777776666554332211111100 


Q ss_pred             -ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          297 -YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       297 -~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                       ......+..............++..+.+|+.+||..||++|||+.++++||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence             01111111111111111124678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.8e-41  Score=320.85  Aligned_cols=226  Identities=30%  Similarity=0.483  Sum_probs=183.1

Q ss_pred             ceecccCceEEEEEEE---CCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           88 HVVGTGSFGVVFQAKC---RETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~---~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      +.||+|+||.||++++   ..+|+.||+|++....      ....+|++++++++||||+++++++.     ...++|+|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-----TEGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCEEEEE
Confidence            5799999999999986   3578999999986422      22346999999999999999998873     33458899


Q ss_pred             eeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-------------
Q 015672          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-------------  224 (403)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-------------  224 (403)
                      |||+. ++|...+..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.++             
T Consensus        77 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  151 (318)
T cd05582          77 LDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  151 (318)
T ss_pred             EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence            99997 566554432    3568999999999999999999999 8999999999999998765543             


Q ss_pred             ------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 015672          225 ------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  298 (403)
Q Consensus       225 ------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  298 (403)
                            ..||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+.                 
T Consensus       152 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~-----------------  213 (318)
T cd05582         152 EKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA-----------------  213 (318)
T ss_pred             CCceecccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC-----------------
Confidence                  2367889999998654 5789999999999999999999999887766555444321                 


Q ss_pred             ccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCcccCC
Q 015672          299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELR  353 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~e~l~hp~f~~~~  353 (403)
                      ...            ++..+++++.+||.+||+.||++||+     +.+++.||||..+.
T Consensus       214 ~~~------------~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~  261 (318)
T cd05582         214 KLG------------MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID  261 (318)
T ss_pred             CCC------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence            011            12457899999999999999999999     67899999998764

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=6.2e-40  Score=310.00  Aligned_cols=264  Identities=33%  Similarity=0.562  Sum_probs=203.4

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCC---CC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD---KE  151 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~  151 (403)
                      ..+|.+.+.||+|+||.||+|.+..+++.+|+|.+....      ....+|+++++.++|+||+++++++.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            456999999999999999999999999999999874321      234579999999999999999987754332   23


Q ss_pred             ceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------
Q 015672          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------  225 (403)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------  225 (403)
                      ...+++||||+.+++...+..   ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+++      
T Consensus        87 ~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHE-NHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEECcCccc
Confidence            446889999999876554432   23568999999999999999999999 89999999999999987654432      


Q ss_pred             ------------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 015672          226 ------------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV  281 (403)
Q Consensus       226 ------------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~  281 (403)
                                              .+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~  242 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL  242 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence                                    23566999999876656899999999999999999999999998888888888877


Q ss_pred             hCCCCHHHHhhcCcCc--cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          282 LGTPTREEIKCMNPNY--TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       282 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                      .+.+....+.....-.  .........+..+... ...+++++.+||.+||+.||.+|||+.+++.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER-FGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHHHH-cccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            7766655443221100  0000000001111111 13456889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1e-40  Score=333.48  Aligned_cols=235  Identities=26%  Similarity=0.340  Sum_probs=191.5

Q ss_pred             cEeeeceecccCceEEEEEEECCC-CcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRET-GEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~-~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      .|.+.+.||+|+||.||+|....+ ++.||+|.+....    ....+|+.+++.++||||+++++++.     ...++|+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~~~l  142 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDKLLL  142 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCEEEE
Confidence            499999999999999999998877 7889999764322    23457999999999999999999883     3345899


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce------------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS------------  224 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~------------  224 (403)
                      ||||++ ++|...+.........+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.++            
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS-RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            999997 57777665444334568899999999999999999999 8999999999999998765442            


Q ss_pred             ---------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          225 ---------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       225 ---------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                               .+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......           
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-----------  289 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-----------  289 (478)
T ss_pred             ccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence                     237889999999865 45899999999999999999999999887765555444321000           


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                                       .++..++.++.+||.+||..||++||++.+++.|||++.+
T Consensus       290 -----------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        290 -----------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             -----------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence                             0124578899999999999999999999999999998643

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.5e-40  Score=310.93  Aligned_cols=237  Identities=24%  Similarity=0.398  Sum_probs=186.2

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      |++.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++|+||+.+++.+.     ...++|
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~   76 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-----TKDALC   76 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-----cCCEEE
Confidence            778899999999999999999999999999875421       12346999999999999999988873     334689


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-----------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-----------  224 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-----------  224 (403)
                      +||||+. ++|...+....  ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++           
T Consensus        77 lv~e~~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05630          77 LVLTLMNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQ-ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP  153 (285)
T ss_pred             EEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence            9999997 56765553321  2458889999999999999999999 8999999999999998665442           


Q ss_pred             -------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          225 -------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       225 -------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                             ..||..|+|||++.+. .++.++|||||||++|+|++|+.||...................            
T Consensus       154 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~------------  220 (285)
T cd05630         154 EGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV------------  220 (285)
T ss_pred             CCccccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh------------
Confidence                   2467889999999654 58999999999999999999999997654321111111100000            


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCcccCCC
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  354 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~e~l~hp~f~~~~~  354 (403)
                                   ...++..+++++.+||.+||+.||++|||     +.|+++||||+++..
T Consensus       221 -------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05630         221 -------------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF  269 (285)
T ss_pred             -------------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence                         00122457889999999999999999999     999999999988643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-40  Score=316.16  Aligned_cols=270  Identities=35%  Similarity=0.648  Sum_probs=213.6

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|.+.+.||.|+||.||+|++..+++.||||++....      ....+|+.+++.++|+||+++++++..........+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            3899999999999999999998899999999885432      2345799999999999999999987544323334689


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      ++|||+++++..++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+++           
T Consensus        81 lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~-~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHS-ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchhhhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            9999999766555442    3478899999999999999999999 89999999999999987755433           


Q ss_pred             -----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          226 -----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       226 -----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                 .+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.++...+....
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  235 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT  235 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence                       346779999998765468999999999999999999999999999888888888888888766554211


Q ss_pred             cCc-ccc--CCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCCC
Q 015672          295 PNY-TEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  358 (403)
Q Consensus       295 ~~~-~~~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~~  358 (403)
                      ... ..+  ..+.....++... ...++.++.+||.+||++||++|||+.++++||||+++..+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~  301 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSKL-FPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDE  301 (330)
T ss_pred             ccchhhHHhhcccCCcchhHHh-cccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccC
Confidence            110 000  1111122222222 24578999999999999999999999999999999998776544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-40  Score=312.17  Aligned_cols=241  Identities=29%  Similarity=0.504  Sum_probs=194.2

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc-------cHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+.....       ....|+++++.++|+||+++++.+     ....+.
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   76 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETYL   76 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCEE
Confidence            59999999999999999999999999999998864321       234689999999999999999887     344568


Q ss_pred             EEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      |+||||+.+ +|.+++...  ....+++..++.++.||+.||.|||+ .|++||||||+||+++.++.+.+         
T Consensus        77 ~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  153 (316)
T cd05574          77 CLVMDYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHL-LGIVYRDLKPENILLHESGHIMLSDFDLSKQS  153 (316)
T ss_pred             EEEEEecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence            999999974 776665432  23568899999999999999999999 89999999999999986644321         


Q ss_pred             ---------------------------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 015672          226 ---------------------------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF  266 (403)
Q Consensus       226 ---------------------------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf  266 (403)
                                                             +||..|+|||++.+. .++.++|||||||++|+|++|..||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf  232 (316)
T cd05574         154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTPF  232 (316)
T ss_pred             cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCCC
Confidence                                                   356779999998654 4899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC----HHH
Q 015672          267 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT----ALE  342 (403)
Q Consensus       267 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt----a~e  342 (403)
                      .+.+....+..+...                 ...++.          ...++.++.+||.+||..||++|||    +++
T Consensus       233 ~~~~~~~~~~~~~~~-----------------~~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~  285 (316)
T cd05574         233 KGSNRDETFSNILKK-----------------EVTFPG----------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAE  285 (316)
T ss_pred             CCCchHHHHHHHhcC-----------------CccCCC----------ccccCHHHHHHHHHHccCCHhHCCCchhhHHH
Confidence            887766555444321                 000110          0236899999999999999999999    999


Q ss_pred             HhcCCCcccCCCCCCCC
Q 015672          343 ACVHPFFDELRDPNTRL  359 (403)
Q Consensus       343 ~l~hp~f~~~~~~~~~~  359 (403)
                      +++||||+....+..+.
T Consensus       286 ll~~~~~~~~~~~~~~~  302 (316)
T cd05574         286 IKQHPFFRGVNWALIRH  302 (316)
T ss_pred             HHcCchhhcCChhhccc
Confidence            99999999876555443

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-41  Score=322.64  Aligned_cols=226  Identities=28%  Similarity=0.469  Sum_probs=179.3

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEcccccc-------cHHHHHHHHHhc---CCCCccccceEEeecCCCCceEEEEEe
Q 015672           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQML---DHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        90 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      ||+|+||+||+|++..+++.||||++.+...       ....|..++..+   +||||+++++.+     ....++|+||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence            7999999999999999999999999854221       112355666655   699999999887     3344589999


Q ss_pred             eccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------------
Q 015672          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------------  224 (403)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------------  224 (403)
                      ||+.+ +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.++              
T Consensus        76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~-~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  150 (330)
T cd05586          76 DYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHK-YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN  150 (330)
T ss_pred             cCCCCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC
Confidence            99974 55444432    4678999999999999999999999 8999999999999998765442              


Q ss_pred             -----eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 015672          225 -----YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  299 (403)
Q Consensus       225 -----~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  299 (403)
                           .+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+...                 .
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~-----------------~  213 (330)
T cd05586         151 KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG-----------------K  213 (330)
T ss_pred             CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence                 246889999999876556899999999999999999999999887755544443221                 0


Q ss_pred             cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC----CHHHHhcCCCcccCC
Q 015672          300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC----TALEACVHPFFDELR  353 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp----ta~e~l~hp~f~~~~  353 (403)
                      ..++           ...+++++.+||.+||..||++||    ++.++++||||....
T Consensus       214 ~~~~-----------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         214 VRFP-----------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             CCCC-----------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence            1111           124688999999999999999998    799999999998754

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.5e-40  Score=309.68  Aligned_cols=233  Identities=25%  Similarity=0.398  Sum_probs=179.8

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeecc
Q 015672           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (403)
Q Consensus        90 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  162 (403)
                      ||+|+||.||+++.+.+|+.||+|.+....       .....|+++++.++||||+++++.+     ....++++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence            799999999999999999999999885321       1224599999999999999998887     3345689999999


Q ss_pred             C-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------------
Q 015672          163 P-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------------  225 (403)
Q Consensus       163 ~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------------  225 (403)
                      + ++|...+...  ....+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++                
T Consensus        76 ~g~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  152 (277)
T cd05607          76 NGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHS-MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTIT  152 (277)
T ss_pred             CCCCHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHH-CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceee
Confidence            7 4665544322  12357888888999999999999999 89999999999999987665432                


Q ss_pred             --eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCC
Q 015672          226 --ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  303 (403)
Q Consensus       226 --~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  303 (403)
                        .+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.........+......             ....+ 
T Consensus       153 ~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-------------~~~~~-  217 (277)
T cd05607         153 QRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE-------------DEVKF-  217 (277)
T ss_pred             ccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc-------------ccccc-
Confidence              3578899999986654 899999999999999999999999765432221122111000             00000 


Q ss_pred             CCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCcccCCCC
Q 015672          304 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELRDP  355 (403)
Q Consensus       304 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta----~e~l~hp~f~~~~~~  355 (403)
                                ....+++++.+||.+||+.||++||++    .++++||||+.+..+
T Consensus       218 ----------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~  263 (277)
T cd05607         218 ----------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFP  263 (277)
T ss_pred             ----------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHH
Confidence                      013478899999999999999999999    678899999987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=8.2e-40  Score=312.66  Aligned_cols=268  Identities=34%  Similarity=0.584  Sum_probs=208.8

Q ss_pred             cEeeeceecccCceEEEEEEECCC--CcEEEEEEccccc------ccHHHHHHHHHhc-CCCCccccceEEeecCCCCce
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRET--GEIVAIKKVLQDK------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~--~~~vaiK~~~~~~------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  153 (403)
                      +|.+.+.||+|+||.||++++..+  +..||+|.+....      ....+|+++++.+ +|+||+++++...... ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence            388999999999999999999888  8999999875321      1234699999999 5999999988654322 2234


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce---------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS---------  224 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~---------  224 (403)
                      .++++++|++++|...+..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.++         
T Consensus        80 ~~~~~~e~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givH~dlkp~Nili~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          80 ELYLYEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHS-ANVLHRDLKPGNLLVNADCELKICDFGLARG  154 (332)
T ss_pred             cEEEEEecccCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence            5789999999887665543    4568899999999999999999999 8999999999999998665432         


Q ss_pred             --------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          225 --------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       225 --------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                    ..+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+...++.++.+.+
T Consensus       155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL  234 (332)
T ss_pred             cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence                          246778999998866556899999999999999999999999998888889999999998887654


Q ss_pred             hhcCcCcc-c--cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCC
Q 015672          291 KCMNPNYT-E--FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  357 (403)
Q Consensus       291 ~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~  357 (403)
                      ........ .  ..+......++.. .....+..+.+||.+||+.||++|||+.+++.||||++..++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~  303 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDD  303 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccc
Confidence            43221100 0  0111111111111 12346889999999999999999999999999999998876543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-41  Score=335.13  Aligned_cols=229  Identities=24%  Similarity=0.405  Sum_probs=187.2

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcC-CCCccccce-EEeecCCCC-ceEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLD-HPNIVALKH-CFFSTTDKE-ELYL  155 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~-h~niv~~~~-~~~~~~~~~-~~~~  155 (403)
                      ++++.+.|.+|||+.||+|.+...|..||+|++....    ....+||++|+.|+ |+|||.|++ ........+ ..-+
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            4889999999999999999998888999999885432    23458999999997 999999999 443333333 3457


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--ccccccccccceecCCCCceee------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVKGEPNVSYI------  226 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~--ivHrDlKp~NILl~~~~~~~~~------  226 (403)
                      .|+||||. ++|.+++....  ..+|++.++++|+.|+++|+.+||. ..  |||||||-|||||+.++..++|      
T Consensus       118 llLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             EeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            78999999 68888877644  4569999999999999999999998 67  9999999999999999877665      


Q ss_pred             ----------------------ccccccchhhhh--CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 015672          227 ----------------------CSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL  282 (403)
Q Consensus       227 ----------------------~t~~y~aPE~~~--~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~  282 (403)
                                            .|+.|+|||++.  ....+++|+|||||||+||.|+....||........    +.  
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI----ln--  268 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI----LN--  268 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE----Ee--
Confidence                                  288899999983  344589999999999999999999999976532211    11  


Q ss_pred             CCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          283 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                     ..|.+|..          ...+..+++||+.||+.||++||++.+++.
T Consensus       269 ---------------g~Y~~P~~----------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~  306 (738)
T KOG1989|consen  269 ---------------GNYSFPPF----------PNYSDRLKDLIRTMLQPNPDERPNIYQVLE  306 (738)
T ss_pred             ---------------ccccCCCC----------ccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence                           23344432          357899999999999999999999999875

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=328.51  Aligned_cols=229  Identities=31%  Similarity=0.488  Sum_probs=184.8

Q ss_pred             eecccCceEEEEEEECCCCcEEEEEEcccccc----cHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeeccC-
Q 015672           89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-  163 (403)
Q Consensus        89 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-  163 (403)
                      +||+|.||+||-|++..+....|||.+.....    -...|+.+.+.|+|.|||++++++     .++.++-|+||-++ 
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence            59999999999999999999999999854322    234799999999999999999987     55667889999998 


Q ss_pred             CcHHHHHHHhhhhcCCC--CHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC-------------------
Q 015672          164 ETVNRIARNYSRIHQRM--PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN-------------------  222 (403)
Q Consensus       164 ~~l~~~~~~~~~~~~~l--~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~-------------------  222 (403)
                      |+|..+++...   +++  .+..+-.|.+||++||.|||. +.|||||||-+|||++.-..                   
T Consensus       657 GSLSsLLrskW---GPlKDNEstm~fYtkQILeGLkYLHe-n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~  732 (1226)
T KOG4279|consen  657 GSLSSLLRSKW---GPLKDNESTMNFYTKQILEGLKYLHE-NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC  732 (1226)
T ss_pred             CcHHHHHHhcc---CCCccchhHHHHHHHHHHHHhhhhhh-cceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence            57777766532   455  677888999999999999999 89999999999999963211                   


Q ss_pred             -ceeeccccccchhhhh-CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccc
Q 015672          223 -VSYICSRYYRAPELIF-GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  300 (403)
Q Consensus       223 -~~~~~t~~y~aPE~~~-~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  300 (403)
                       -++.||..|||||++. |...|+.++|||||||++.||.||++||..........  .+                    
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM--Fk--------------------  790 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM--FK--------------------  790 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh--hh--------------------
Confidence             1456899999999995 44569999999999999999999999997554333221  11                    


Q ss_pred             CCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                       ..-++.+|   .+|..++.+++.||.+|+..||.+||+|.++|..||++.-
T Consensus       791 -VGmyKvHP---~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  791 -VGMYKVHP---PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             -hcceecCC---CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence             11111111   1346789999999999999999999999999999999865

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.1e-40  Score=318.66  Aligned_cols=239  Identities=27%  Similarity=0.415  Sum_probs=188.9

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      +|.+.+.||+|+||.||++++..+++.||+|++.+..       ....+|+.++..++|+||+++++++     ....++
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~~   76 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENYL   76 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence            5999999999999999999999999999999885421       1234688899999999999999887     344568


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce----------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS----------  224 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~----------  224 (403)
                      |+||||+. ++|..++...   ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++.++          
T Consensus        77 ~lv~Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~-~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~  152 (331)
T cd05624          77 YLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQ-LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKM  152 (331)
T ss_pred             EEEEeCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCchHHEEEcCCCCEEEEeccceeec
Confidence            99999997 5676665432   3568899999999999999999999 8999999999999998765542          


Q ss_pred             ----------eeccccccchhhhhCC----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          225 ----------YICSRYYRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       225 ----------~~~t~~y~aPE~~~~~----~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                ..||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....       
T Consensus       153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-------  225 (331)
T cd05624         153 NQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE-------  225 (331)
T ss_pred             cCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCC-------
Confidence                      2478899999998542    3478899999999999999999999988776555544432100       


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCcccCCC
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRD  354 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpta~e~l~hp~f~~~~~  354 (403)
                              .+.++.         ....+++++++||.+||..++++  |++++++++||||+.+..
T Consensus       226 --------~~~~p~---------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~  274 (331)
T cd05624         226 --------RFQFPS---------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDW  274 (331)
T ss_pred             --------cccCCC---------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence                    011111         01347899999999999976655  569999999999987643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6.6e-41  Score=319.28  Aligned_cols=226  Identities=29%  Similarity=0.459  Sum_probs=179.6

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEcccccc-------cHHHHH-HHHHhcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNREL-QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      +.||+|+||+||+|++..+|+.||+|++.+...       ....|. .+++.++||||+++++.+.     ....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~-----~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----cCCEEEEEE
Confidence            469999999999999999999999999854311       112343 3577899999999988873     334588999


Q ss_pred             eccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------------
Q 015672          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------------  224 (403)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------------  224 (403)
                      ||+.+ ++...+.    ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.++              
T Consensus        76 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~-~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~  150 (325)
T cd05604          76 DFVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS  150 (325)
T ss_pred             cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC
Confidence            99985 5544333    24578999999999999999999999 8999999999999998765543              


Q ss_pred             -----eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 015672          225 -----YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  299 (403)
Q Consensus       225 -----~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  299 (403)
                           .+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...                 .
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~-----------------~  212 (325)
T cd05604         151 DTTTTFCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK-----------------P  212 (325)
T ss_pred             CCcccccCChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence                 2468889999998654 5899999999999999999999999887765554444321                 0


Q ss_pred             cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCcccCC
Q 015672          300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELR  353 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta----~e~l~hp~f~~~~  353 (403)
                      .            .+....+..+.++|.+||+.||.+||++    .++++||||....
T Consensus       213 ~------------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~  258 (325)
T cd05604         213 L------------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS  258 (325)
T ss_pred             c------------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence            0            0113478899999999999999999976    5999999998764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=7.4e-40  Score=313.29  Aligned_cols=258  Identities=35%  Similarity=0.586  Sum_probs=202.5

Q ss_pred             ccEe-eeceecccCceEEEEEEECCCCcEEEEEEcccccc------------------cHHHHHHHHHhcCCCCccccce
Q 015672           82 VSYI-AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------------------YKNRELQIMQMLDHPNIVALKH  142 (403)
Q Consensus        82 ~~y~-~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------~~~~E~~~l~~l~h~niv~~~~  142 (403)
                      .+|. +.+.||.|+||+||+|.+..+++.||||++.....                  ...+|+++++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3465 45789999999999999999999999998753211                  2347999999999999999999


Q ss_pred             EEeecCCCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC
Q 015672          143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN  222 (403)
Q Consensus       143 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~  222 (403)
                      ++.     ...+.+++|||+.+++...+..    ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++.
T Consensus        88 ~~~-----~~~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~dl~~~nill~~~~~  157 (335)
T PTZ00024         88 VYV-----EGDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHK-WYFMHRDLSPANIFINSKGI  157 (335)
T ss_pred             EEe-----cCCcEEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHeEECCCCC
Confidence            873     3346899999999887766543    3568899999999999999999999 89999999999999987654


Q ss_pred             cee---------------------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 015672          223 VSY---------------------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE  269 (403)
Q Consensus       223 ~~~---------------------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~  269 (403)
                      +++                                 .+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            432                                 13567999999876556799999999999999999999999999


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCc--CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 015672          270 SGVDQLVEIIKVLGTPTREEIKCMNP--NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  347 (403)
Q Consensus       270 ~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp  347 (403)
                      +..+.+..+...++.+....+.....  .+..+  ....+..... .....+.++.+||.+||+.||++|||++|++.||
T Consensus       238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~  314 (335)
T PTZ00024        238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEF--TPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALKHE  314 (335)
T ss_pred             CHHHHHHHHHHHhCCCchhhCcchhhccccccc--CcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence            88888888888887776654432210  01110  0001111111 1235688999999999999999999999999999


Q ss_pred             CcccC
Q 015672          348 FFDEL  352 (403)
Q Consensus       348 ~f~~~  352 (403)
                      ||+..
T Consensus       315 ~~~~~  319 (335)
T PTZ00024        315 YFKSD  319 (335)
T ss_pred             ccCCC
Confidence            99865

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-42  Score=301.26  Aligned_cols=241  Identities=29%  Similarity=0.474  Sum_probs=188.5

Q ss_pred             ccEeee-ceecccCceEEEEEEECCCCcEEEEEEcccccccHHHHHHHHHhc-CCCCccccceEEeecCCCCceEEEEEe
Q 015672           82 VSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        82 ~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      .+|.+. ++||-|-.|+|..|.++.|++.+|+|++... ....+|+++.-+. .|+|||.++++|.... .+...+.+||
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-~KARrEVeLHw~~s~h~~iV~IidVyeNs~-~~rkcLLiVm  138 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-PKARREVELHWMASGHPHIVSIIDVYENSY-QGRKCLLIVM  138 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-HHHHhHhhhhhhhcCCCceEEeehhhhhhc-cCceeeEeee
Confidence            346653 6799999999999999999999999987543 3456899876665 6999999999874332 4566788999


Q ss_pred             eccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC----------------
Q 015672          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN----------------  222 (403)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~----------------  222 (403)
                      |.++| .|..-+.  ......+++.++..|++||..|+.|||+ .+|.||||||+|+|......                
T Consensus       139 E~meGGeLfsriq--~~g~~afTErea~eI~~qI~~Av~~lH~-~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~  215 (400)
T KOG0604|consen  139 ECMEGGELFSRIQ--DRGDQAFTEREASEIMKQIGLAVRYLHS-MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ  215 (400)
T ss_pred             ecccchHHHHHHH--HcccccchHHHHHHHHHHHHHHHHHHHh-cchhhccCChhheeeecCCCCcceEecccccccccC
Confidence            99986 3322222  2334569999999999999999999999 89999999999999864321                


Q ss_pred             -----ceeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHHHhCCCCHHHHhhc
Q 015672          223 -----VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD----QLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       223 -----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~  293 (403)
                           .+-+.||+|.|||++ +...|+..+|+||+||++|-|++|.+||+......    .-..|..             
T Consensus       216 ~~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~-------------  281 (400)
T KOG0604|consen  216 EPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT-------------  281 (400)
T ss_pred             CCccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc-------------
Confidence                 133579999999998 66679999999999999999999999998765421    1222221             


Q ss_pred             CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                          ..+.||.   ..|     ..+|++++|+|+++|..+|.+|.|+.++++|||+.+..
T Consensus       282 ----gqy~FP~---pEW-----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  282 ----GQYEFPE---PEW-----SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             ----cCccCCC---hhH-----hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence                1223332   122     46899999999999999999999999999999998753

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.6e-40  Score=315.42  Aligned_cols=227  Identities=26%  Similarity=0.492  Sum_probs=179.5

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhc-CCCCccccceEEeecCCCCceEEEEEe
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      +.||+|+||+||+|++..+++.||+|++.+..       ....+|+.++..+ +|+||+++++++.     ...++|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ-----TTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE-----eCCEEEEEE
Confidence            46999999999999999999999999986432       1234688888888 6999999999873     334589999


Q ss_pred             eccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------------
Q 015672          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------------  224 (403)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------------  224 (403)
                      ||+++ +|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++              
T Consensus        76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  150 (327)
T cd05617          76 EYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHE-RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG  150 (327)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC
Confidence            99974 55444432    3579999999999999999999999 8999999999999998665442              


Q ss_pred             -----eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc------HHHHHHHHHHhCCCCHHHHhhc
Q 015672          225 -----YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       225 -----~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~  293 (403)
                           .+||+.|+|||++.+. .++.++|||||||++|+|++|..||.....      .+.+......  .         
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~---------  218 (327)
T cd05617         151 DTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--K---------  218 (327)
T ss_pred             CceecccCCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--C---------
Confidence                 3468899999998654 589999999999999999999999964221      1222221110  0         


Q ss_pred             CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC------HHHHhcCCCcccCC
Q 015672          294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT------ALEACVHPFFDELR  353 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt------a~e~l~hp~f~~~~  353 (403)
                           ...            ++..++..+.++|.+||..||++|++      +.++++||||+.+.
T Consensus       219 -----~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~  267 (327)
T cd05617         219 -----PIR------------IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID  267 (327)
T ss_pred             -----CCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence                 000            23457899999999999999999998      57999999999875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.4e-40  Score=316.95  Aligned_cols=226  Identities=26%  Similarity=0.448  Sum_probs=180.1

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEcccccc-------cHHHH-HHHHHhcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRE-LQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E-~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      +.||+|+||+||+|++..+++.||+|++.+...       ....| ..+++.++|+||+++++++.     ....+++||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~-----~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE-----cCCeEEEEE
Confidence            469999999999999999999999999854221       11123 33567889999999998873     334588999


Q ss_pred             eccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------------
Q 015672          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------------  224 (403)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------------  224 (403)
                      ||+.+ +|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++              
T Consensus        76 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~-~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~  150 (325)
T cd05602          76 DYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  150 (325)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC
Confidence            99985 55554433    3568888999999999999999999 8999999999999998665443              


Q ss_pred             -----eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 015672          225 -----YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  299 (403)
Q Consensus       225 -----~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  299 (403)
                           .+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+...   +              
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~--------------  212 (325)
T cd05602         151 GTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK---P--------------  212 (325)
T ss_pred             CCcccccCCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC---C--------------
Confidence                 2478899999998654 5899999999999999999999999887766655544321   0              


Q ss_pred             cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHH----HHhcCCCcccCC
Q 015672          300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL----EACVHPFFDELR  353 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~----e~l~hp~f~~~~  353 (403)
                      ..            ++..++..+.+||.+||+.||.+|+++.    ++++|+||....
T Consensus       213 ~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~  258 (325)
T cd05602         213 LQ------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN  258 (325)
T ss_pred             cC------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence            00            1245789999999999999999999876    899999997654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.7e-40  Score=313.78  Aligned_cols=270  Identities=34%  Similarity=0.567  Sum_probs=209.1

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCC-CCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  154 (403)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|++....      ....+|+.+++.++|+||+++++++..... .....
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            45999999999999999999999999999999885432      223469999999999999999987743221 12234


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      .+++++++++++..++..     ..+++..++.++.||+.||.|||+ .||+||||||+||+++.++.+++         
T Consensus        97 ~~lv~~~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~  170 (345)
T cd07877          97 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHT  170 (345)
T ss_pred             EEEEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence            789999998877665542     468899999999999999999999 89999999999999988766543         


Q ss_pred             -------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 015672          226 -------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  298 (403)
Q Consensus       226 -------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  298 (403)
                             .++..|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+....+.+.............
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (345)
T cd07877         171 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  250 (345)
T ss_pred             cccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhH
Confidence                   3577899999986655688999999999999999999999988887777777777777766655433321110


Q ss_pred             cc---CCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCCC
Q 015672          299 EF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  358 (403)
Q Consensus       299 ~~---~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~~  358 (403)
                      ..   ..+......+... ....++++.+||.+||+.||.+|||+.+++.||||++...|...
T Consensus       251 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~  312 (345)
T cd07877         251 RNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE  312 (345)
T ss_pred             HHHHHHhcccCCcchhhh-cCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCcc
Confidence            00   0111111111111 12468899999999999999999999999999999987765543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-39  Score=312.63  Aligned_cols=266  Identities=35%  Similarity=0.615  Sum_probs=206.2

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCC-CCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  154 (403)
                      .+|.+.+.||+|+||.||+|++..+++.||+|++....      ....+|+.+++.++|+||+++++++..... .....
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            45999999999999999999999999999999885421      123579999999999999999998753321 12234


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      .++|+||+..++....      ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++.         
T Consensus        95 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~  167 (342)
T cd07879          95 FYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHS-AGIIHRDLKPGNLAVNEDCELKILDFGLARHA  167 (342)
T ss_pred             EEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence            6899999987654332      2468889999999999999999999 89999999999999987765543         


Q ss_pred             -------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 015672          226 -------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  298 (403)
Q Consensus       226 -------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  298 (403)
                             .+++.|+|||++.+...++.++|||||||++|||++|+.||.+.+....+..+....+.+.............
T Consensus       168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (342)
T cd07879         168 DAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA  247 (342)
T ss_pred             CCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccch
Confidence                   3577899999986645588999999999999999999999998887777777877777776655433221100


Q ss_pred             ---ccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          299 ---EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       299 ---~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                         ....+......+...+ ...++++.+||.+||+.||++||++++++.||||+...+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         248 KSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             HHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence               0011222222222211 3468889999999999999999999999999999998653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.4e-40  Score=306.68  Aligned_cols=237  Identities=24%  Similarity=0.368  Sum_probs=189.0

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      |+..+.||+|+||+||+|.+..+++.||+|.+....       ....+|+++++.++|+||+.+++.+.     ...+++
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~   76 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE-----TKDALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe-----cCCEEE
Confidence            778899999999999999999999999999885421       12356999999999999999988873     334589


Q ss_pred             EEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-----------
Q 015672          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-----------  224 (403)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-----------  224 (403)
                      ++|||+.+ ++...+...  ....+++..+..++.|++.||.|||+ .||+||||||+||+++.++.++           
T Consensus        77 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~-~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05632          77 LVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHR-ENTVYRDLKPENILLDDYGHIRISDLGLAVKIP  153 (285)
T ss_pred             EEEEeccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence            99999985 554444321  13468999999999999999999999 8999999999999998665442           


Q ss_pred             -------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          225 -------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       225 -------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                             ..|+..|+|||++.+. .++.++|+|||||++|+|++|..||.+.........+........           
T Consensus       154 ~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~-----------  221 (285)
T cd05632         154 EGESIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE-----------  221 (285)
T ss_pred             CCCcccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc-----------
Confidence                   2357889999998654 589999999999999999999999987665444333332211100           


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCcccCCC
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  354 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~e~l~hp~f~~~~~  354 (403)
                                    ..++..+++++.+|+.+||+.||++|||     ++++++||||+....
T Consensus       222 --------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~  269 (285)
T cd05632         222 --------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF  269 (285)
T ss_pred             --------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence                          0012457889999999999999999999     899999999998744

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-42  Score=303.94  Aligned_cols=235  Identities=27%  Similarity=0.428  Sum_probs=197.7

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccccH-------HHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ++|..+++||+|.||+|-+|+.+.+++.||||+++++--..       ..|-++|+..+||.+..+...|     ....+
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~dr  242 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQDR  242 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccCce
Confidence            46889999999999999999999999999999987653222       2477899999999999887777     44455


Q ss_pred             EEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce---------
Q 015672          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS---------  224 (403)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~---------  224 (403)
                      +|+||||+.| .|...+..    ...+++..++.+...|+.||.|||+ .+||.||||.+|+|++.+++++         
T Consensus       243 lCFVMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs-~~ivYRDlKLENLlLDkDGHIKitDFGLCKE  317 (516)
T KOG0690|consen  243 LCFVMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHS-RNIVYRDLKLENLLLDKDGHIKITDFGLCKE  317 (516)
T ss_pred             EEEEEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhh-CCeeeeechhhhheeccCCceEeeecccchh
Confidence            9999999985 33221221    4568999999999999999999999 8999999999999999988763         


Q ss_pred             ----------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          225 ----------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       225 ----------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                ++|||.|.|||++.. ..|+.++|.|.+||++|||++|+.||+..+....+..|.-.             
T Consensus       318 ~I~~g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-------------  383 (516)
T KOG0690|consen  318 EIKYGDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-------------  383 (516)
T ss_pred             cccccceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-------------
Confidence                      578999999999954 46999999999999999999999999998887777666532             


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCCCCC
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPN  356 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~~~~  356 (403)
                          +.+            +|..++++++.|+..+|..||.+|.     .|.|+.+|+||..+.+..
T Consensus       384 ----d~k------------FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~  434 (516)
T KOG0690|consen  384 ----DLK------------FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA  434 (516)
T ss_pred             ----hcc------------CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence                222            3467999999999999999999998     488999999999987643

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=5.1e-40  Score=314.71  Aligned_cols=269  Identities=35%  Similarity=0.685  Sum_probs=208.3

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhc-CCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..+|++.+.||+|+||.||+|.+..+++.+|+|++....      ....+|+.+++.+ +|+||+++++++..   .+..
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~~   82 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---ENDK   82 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCCc
Confidence            346999999999999999999998899999999874321      2234699999999 99999999988732   2344


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee--------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY--------  225 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~--------  225 (403)
                      .+++||||++++|...+..     ..+.+..++.++.||+.||.|||+ .||+||||||+||+++.++.+++        
T Consensus        83 ~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          83 DIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHS-GNVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             eEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            5889999999877655542     267788888899999999999999 89999999999999987664432        


Q ss_pred             ----------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          226 ----------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       226 ----------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                      .+|+.|+|||++.+...++.++|||||||++|+|++|++||.+....+....+....+.+....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence                            3566799999886656688999999999999999999999998888888888877777776554


Q ss_pred             HhhcCcCcccc---CCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCCCC
Q 015672          290 IKCMNPNYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL  359 (403)
Q Consensus       290 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~~~  359 (403)
                      +..+.......   ........+..... ..++.++.+||.+||+.||++|||+.++++||||++...+....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~  308 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEP  308 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCC
Confidence            43222111100   01111111111222 34789999999999999999999999999999999986655443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=313.47  Aligned_cols=242  Identities=26%  Similarity=0.368  Sum_probs=194.8

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-------cccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ...|..-++||+|+||.||-|+.+.||+.||+|++.+.       .....+|.++|.+++.+.||.+-..|.+     ..
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT-----kd  258 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET-----KD  258 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC-----CC
Confidence            34578889999999999999999999999999987432       1233479999999999999999777743     33


Q ss_pred             EEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------
Q 015672          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------  225 (403)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------  225 (403)
                      .+|+||..|.| +|..-+.+  .....+++..++.|+.+|+.||++||+ .+||.|||||+|||||+.+++.+       
T Consensus       259 ~LClVLtlMNGGDLkfHiyn--~g~~gF~e~ra~FYAAEi~cGLehlH~-~~iVYRDLKPeNILLDd~GhvRISDLGLAv  335 (591)
T KOG0986|consen  259 ALCLVLTLMNGGDLKFHIYN--HGNPGFDEQRARFYAAEIICGLEHLHR-RRIVYRDLKPENILLDDHGHVRISDLGLAV  335 (591)
T ss_pred             ceEEEEEeecCCceeEEeec--cCCCCCchHHHHHHHHHHHhhHHHHHh-cceeeccCChhheeeccCCCeEeeccceEE
Confidence            49999999985 44322222  223579999999999999999999999 89999999999999999888743       


Q ss_pred             -----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          226 -----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       226 -----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                 +||.+|||||++.+.. |+..+|.|||||++|||+.|+.||........-.++-+.....+.       
T Consensus       336 ei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~-------  407 (591)
T KOG0986|consen  336 EIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPE-------  407 (591)
T ss_pred             ecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchh-------
Confidence                       6899999999997665 999999999999999999999999766544333333332211111       


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCCCCC
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDPN  356 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~~~~  356 (403)
                                        .++..+|+++++|...+|+.||.+|.     +++++.+||||++++.+.
T Consensus       408 ------------------ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r  456 (591)
T KOG0986|consen  408 ------------------EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR  456 (591)
T ss_pred             ------------------hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence                              13367899999999999999999998     578999999999987543

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-39  Score=311.35  Aligned_cols=268  Identities=34%  Similarity=0.633  Sum_probs=206.8

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCC-Cce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~  153 (403)
                      ..+|++.+.||+|+||.||+|.+..++..||||++....      ....+|+++++.++|+||+++++++...... ...
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            345999999999999999999999999999999885321      1234799999999999999999987433221 123


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee--------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY--------  225 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~--------  225 (403)
                      .+++||||+++++..+..     ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++.+++        
T Consensus        94 ~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~-~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~  167 (343)
T cd07880          94 DFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLARQ  167 (343)
T ss_pred             eEEEEEecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence            568999999887766553     2568999999999999999999999 89999999999999987766543        


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                              .+++.|+|||++.+...++.++|+|||||++|++++|.+||.+.+....+..+....+.++.+.........
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (343)
T cd07880         168 TDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED  247 (343)
T ss_pred             cccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchh
Confidence                    357789999998654558899999999999999999999999888777777777766655544332221110


Q ss_pred             c---ccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          298 T---EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       298 ~---~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                      .   ....+......+. .+...+++++.++|.+||+.||++|||+.+++.||||+....+
T Consensus       248 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~  307 (343)
T cd07880         248 AKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP  307 (343)
T ss_pred             HHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence            0   0011111111111 1224678899999999999999999999999999999987654

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-39  Score=313.24  Aligned_cols=269  Identities=35%  Similarity=0.621  Sum_probs=209.8

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCC-CCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  153 (403)
                      ..+|.+.+.||+|+||.||+|++..+++.||+|++....      ....+|+.+++.++|+||+++++++..... ....
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            345999999999999999999999999999999875421      123469999999999999999887643322 2334


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee--------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY--------  225 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~--------  225 (403)
                      .+++|+||++++|..++..     ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+++        
T Consensus        94 ~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~  167 (343)
T cd07851          94 DVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDCELKILDFGLARH  167 (343)
T ss_pred             cEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence            5889999999888766543     568999999999999999999999 89999999999999987665543        


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                              .++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.++...+.......
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  247 (343)
T cd07851         168 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES  247 (343)
T ss_pred             ccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence                    357789999998655568899999999999999999999999888888888888877777665443322111


Q ss_pred             cc---cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCC
Q 015672          298 TE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  356 (403)
Q Consensus       298 ~~---~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~  356 (403)
                      ..   ...+......+... ....++++.+||.+||..||++|||+.++++||||++...+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~-~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~  308 (343)
T cd07851         248 ARNYIQSLPQMPKKDFKEV-FSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE  308 (343)
T ss_pred             HHHHHHhccccCCCCHHHH-hccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence            00   01111111111111 134689999999999999999999999999999999876554

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-40  Score=301.31  Aligned_cols=229  Identities=28%  Similarity=0.460  Sum_probs=185.2

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      .|.+.+.||+|+||.||+|.+..+++.||+|.+....         ....+|+++++.++|+||+++++++.     ...
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~   77 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-----DDE   77 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-----cCC
Confidence            4899999999999999999999999999999875321         12356999999999999999999883     334


Q ss_pred             EEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee------
Q 015672          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI------  226 (403)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~------  226 (403)
                      .+++++||+++ ++.+.+..    ...+++..++.++.|++.||.|||+ .||+||||||+||+++.++.++++      
T Consensus        78 ~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nilv~~~~~~~l~dfg~~~  152 (263)
T cd06625          78 TLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHS-NMIVHRDIKGANILRDSAGNVKLGDFGASK  152 (263)
T ss_pred             eEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEeecccce
Confidence            68999999974 66555443    3468888999999999999999999 899999999999999876654332      


Q ss_pred             ----------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          227 ----------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       227 ----------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                      ++..|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+.....       
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------  224 (263)
T cd06625         153 RLQTICSSGTGMKSVTGTPYWMSPEVISGE-GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT-------  224 (263)
T ss_pred             eccccccccccccCCCcCccccCcceeccC-CCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC-------
Confidence                            45679999998664 489999999999999999999999977655444333221100       


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                                          ...++..++.++.+||.+||..||.+|||+.++++||||
T Consensus       225 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         225 --------------------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             --------------------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                                001234578899999999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.8e-39  Score=304.36  Aligned_cols=243  Identities=24%  Similarity=0.379  Sum_probs=191.6

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhc-CCCCccccceEEeecCCCCceEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ..+|.+.+.||+|+||.||+|....+++.+|+|.+....   ....+|+.+++.+ +|+|++++++++...........+
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~  100 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW  100 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence            445999999999999999999999999999999885432   2335789999998 899999999988654433445688


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------  225 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------  225 (403)
                      +||||++ ++|..++.........+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+++          
T Consensus       101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~  179 (291)
T cd06639         101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  179 (291)
T ss_pred             EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence            9999997 47766665443334678899999999999999999999 89999999999999987665433          


Q ss_pred             ---------eccccccchhhhhCCC----CCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          226 ---------ICSRYYRAPELIFGAT----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       226 ---------~~t~~y~aPE~~~~~~----~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                               .++..|+|||++....    .++.++|||||||++|+|++|++||...+....+..+.+.   +.      
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~------  250 (291)
T cd06639         180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN---PP------  250 (291)
T ss_pred             cccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC---CC------
Confidence                     2456799999875332    2678999999999999999999999876654444333221   00      


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  350 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~  350 (403)
                                +..       ..+...+..+.+||.+||+.||++||++.++++||||+
T Consensus       251 ----------~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         251 ----------PTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             ----------CCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence                      000       01134567899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1e-39  Score=304.29  Aligned_cols=256  Identities=39%  Similarity=0.728  Sum_probs=204.8

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEcccccc------cHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      |.+.+.||+|++|.||+|.+..+++.+|+|.+.....      ...+|+++++.++|+||+++++.+.     ....+++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR-----HKGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc-----cCCCEEE
Confidence            5677899999999999999988999999998854322      2457999999999999999999873     3345889


Q ss_pred             EeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------------
Q 015672          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------------  225 (403)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------------  225 (403)
                      ++||+++++...+...   ...+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++.+++            
T Consensus        76 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~  151 (283)
T cd05118          76 VFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHS-HGILHRDLKPENLLINTEGVLKLADFGLARSFGSP  151 (283)
T ss_pred             EEeccCCCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence            9999998876665542   2578899999999999999999999 89999999999999987665533            


Q ss_pred             -------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc--C
Q 015672          226 -------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--N  296 (403)
Q Consensus       226 -------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~  296 (403)
                             .++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+....+.....  .
T Consensus       152 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05118         152 VRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR  231 (283)
T ss_pred             cccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence                   2456799999987654689999999999999999999999999888888888888877776665543322  1


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                      .....++......... ....++.++.+||.+||+.||.+||++.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         232 NYKFSFPKKAGMPLPK-LFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhhhccccccCHHH-hhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            1222333222222211 224578999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.9e-40  Score=314.30  Aligned_cols=226  Identities=27%  Similarity=0.443  Sum_probs=178.6

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEcccccc-------cHHHHH-HHHHhcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNREL-QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      ++||+|+||.||+|++..+++.||+|++.+...       ...+|. .+++.++|+||+++++.+.     ....+++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~-----~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ-----TAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCEEEEEE
Confidence            469999999999999999999999999854211       112333 4678899999999998873     334588999


Q ss_pred             eccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------------
Q 015672          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------------  225 (403)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------------  225 (403)
                      ||+++ +|...+..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+++             
T Consensus        76 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  150 (321)
T cd05603          76 DYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHS-LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE  150 (321)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC
Confidence            99985 55443332    3568889999999999999999999 89999999999999987665432             


Q ss_pred             ------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 015672          226 ------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  299 (403)
Q Consensus       226 ------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  299 (403)
                            +||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+...   +              
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~--------------  212 (321)
T cd05603         151 ETTSTFCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---P--------------  212 (321)
T ss_pred             CccccccCCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---C--------------
Confidence                  367889999998654 5899999999999999999999999887655444333221   0              


Q ss_pred             cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCcccCC
Q 015672          300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELR  353 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta----~e~l~hp~f~~~~  353 (403)
                      ..            ++...+.++.++|.+||+.||.+|+++    .++++||||..+.
T Consensus       213 ~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~  258 (321)
T cd05603         213 LQ------------LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPIN  258 (321)
T ss_pred             CC------------CCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence            00            124567899999999999999999975    5999999998754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-41  Score=296.67  Aligned_cols=239  Identities=26%  Similarity=0.431  Sum_probs=187.3

Q ss_pred             ccEee-eceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhc-CCCCccccceEEeecCCCCceEE
Q 015672           82 VSYIA-EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        82 ~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      .-|.+ .+.||+|+|+.|-.|....++..||||++.+..    ...-+|++++.+. .|+||++++++|     .++..+
T Consensus        77 d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~F  151 (463)
T KOG0607|consen   77 DMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRF  151 (463)
T ss_pred             HHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceE
Confidence            33544 578999999999999999999999999996542    2334799999998 599999999998     555669


Q ss_pred             EEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc-----------
Q 015672          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-----------  223 (403)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~-----------  223 (403)
                      |||||-+.| .+..-+..    ...+++.++.++..+|+.||+|||. +||.||||||+|||-.....+           
T Consensus       152 YLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~-kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLg  226 (463)
T KOG0607|consen  152 YLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHT-KGIAHRDLKPENILCESPNKVSPVKICDFDLG  226 (463)
T ss_pred             EEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhh-cCcccccCCccceeecCCCCcCceeeeccccc
Confidence            999999985 44333322    4679999999999999999999999 899999999999997544332           


Q ss_pred             ------------------eeeccccccchhhhh----CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcH---------
Q 015672          224 ------------------SYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---------  272 (403)
Q Consensus       224 ------------------~~~~t~~y~aPE~~~----~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~---------  272 (403)
                                        +-+|+..|||||++.    ....|+.++|.||||||||-|+.|.+||.|....         
T Consensus       227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~  306 (463)
T KOG0607|consen  227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEV  306 (463)
T ss_pred             cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCc
Confidence                              224566799999872    2346999999999999999999999999765321         


Q ss_pred             ------HHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          273 ------DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       273 ------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                            ..+..|.+                 ..+.||   ...|     ..+|.+++|||+++|..|+.+|.+|.++++|
T Consensus       307 Cr~CQ~~LFesIQE-----------------GkYeFP---dkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  307 CRVCQNKLFESIQE-----------------GKYEFP---DKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             cHHHHHHHHHHHhc-----------------cCCcCC---hhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence                  11222221                 222333   2233     4689999999999999999999999999999


Q ss_pred             CCcccCCCC
Q 015672          347 PFFDELRDP  355 (403)
Q Consensus       347 p~f~~~~~~  355 (403)
                      ||++.+...
T Consensus       362 Pw~~~~~~e  370 (463)
T KOG0607|consen  362 PWVQRCAPE  370 (463)
T ss_pred             ccccccchh
Confidence            999987533

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-39  Score=303.34  Aligned_cols=258  Identities=38%  Similarity=0.678  Sum_probs=201.5

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccc------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+...      .....+|+++++.++|+||+++++++..     ....+
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   76 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRLY   76 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEEE
Confidence            599999999999999999999999999999987532      1234579999999999999999998843     33588


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      ++|||+++++...+..   ....+++..+..++.||+.||.|||+ .+|+||||+|+||+++.++.+++           
T Consensus        77 iv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~  152 (288)
T cd07833          77 LVFEYVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS-HNIIHRDIKPENILVSESGVLKLCDFGFARALRA  152 (288)
T ss_pred             EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence            9999999766543322   23458899999999999999999999 89999999999999987665533           


Q ss_pred             ---------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--
Q 015672          226 ---------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--  294 (403)
Q Consensus       226 ---------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--  294 (403)
                               .++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++...........  
T Consensus       153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07833         153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN  232 (288)
T ss_pred             CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence                     346679999999766468999999999999999999999999888777777776666655544332221  


Q ss_pred             cCccccCCCCCC-CCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          295 PNYTEFKFPQIK-PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       295 ~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                      ..+....++... ...+...++..++.++.+||.+||..||++|||+.++++||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            112222222211 1112222334568999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.2e-39  Score=302.30  Aligned_cols=238  Identities=24%  Similarity=0.379  Sum_probs=186.1

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhc-CCCCccccceEEeecCCC-CceEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTDK-EELYLN  156 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~-~~~~~~  156 (403)
                      ..|.+.+.||+|+||.||+|....+++.||+|.+....   ....+|+.+++++ +|+||+++++.+...... ...+++
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW   85 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence            34889999999999999999999999999999885432   2345789999998 799999999988654322 235688


Q ss_pred             EEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-----------
Q 015672          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-----------  224 (403)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-----------  224 (403)
                      ++|||+++ ++..++...  ....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++           
T Consensus        86 iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~  162 (272)
T cd06637          86 LVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  162 (272)
T ss_pred             EEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence            99999984 666655432  23468889999999999999999999 8999999999999998765442           


Q ss_pred             --------eeccccccchhhhhC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          225 --------YICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       225 --------~~~t~~y~aPE~~~~----~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                              ..|++.|+|||++.+    ...++.++|||||||++|+|++|..||...........+...   +       
T Consensus       163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~-------  232 (272)
T cd06637         163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P-------  232 (272)
T ss_pred             cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---C-------
Confidence                    235778999999853    234788999999999999999999999765433322221110   0       


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                               .        .......++.++.+||.+||..||.+|||+.++++||||
T Consensus       233 ---------~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         233 ---------A--------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             ---------C--------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                     0        000123467899999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.7e-39  Score=303.55  Aligned_cols=242  Identities=24%  Similarity=0.352  Sum_probs=190.2

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhc-CCCCccccceEEeecCCCCceEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ..+|++.+.||+|+||.||+|.+..+++.+|+|++....   ....+|+.+++.+ +|+||+++++++.........+++
T Consensus        17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~   96 (286)
T cd06638          17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLW   96 (286)
T ss_pred             ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEE
Confidence            446999999999999999999999999999999875422   2345789999999 699999999987654444556789


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------  225 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------  225 (403)
                      +||||++ ++|..++.........+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++.          
T Consensus        97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  175 (286)
T cd06638          97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV-NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  175 (286)
T ss_pred             EEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence            9999997 57776665443344668888999999999999999999 89999999999999987654422          


Q ss_pred             ---------eccccccchhhhhC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          226 ---------ICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       226 ---------~~t~~y~aPE~~~~----~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                               .|++.|+|||++..    ...++.++|||||||++|+|++|+.||...+....+..+...  .+       
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~-------  246 (286)
T cd06638         176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--PP-------  246 (286)
T ss_pred             cCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--CC-------
Confidence                     35678999998742    234788999999999999999999999766543332221110  00       


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                                +       ....+...+.++.+||.+||+.||++|||+.++++|+||
T Consensus       247 ----------~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         247 ----------P-------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ----------C-------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence                      0       000123457889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4e-39  Score=307.32  Aligned_cols=266  Identities=35%  Similarity=0.700  Sum_probs=207.9

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ..+|++.+.||.|+||.||+|.+..+++.||+|++.+.      .....+|+++++.++||||++++++|...    ...
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----~~~   84 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP----LED   84 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----CCc
Confidence            34599999999999999999999999999999987432      12345799999999999999999887432    224


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      .+++|||+++++..++.     ...++...+..++.||+.||.|||+ .+|+||||||+|||++..+.+++         
T Consensus        85 ~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~-~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          85 IYFVTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHS-AGVVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEEEeehhccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            78999999887766554     2457888888999999999999999 89999999999999987655433         


Q ss_pred             -------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc-
Q 015672          226 -------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY-  297 (403)
Q Consensus       226 -------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-  297 (403)
                             .++..|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+.+.++.++.+......... 
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd07856         159 DPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT  238 (328)
T ss_pred             CCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence                   356789999987654568999999999999999999999999888777777778888887766543221110 


Q ss_pred             ccc--CCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCC
Q 015672          298 TEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  357 (403)
Q Consensus       298 ~~~--~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~  357 (403)
                      ..+  ..+.....+..... ..+++++.++|.+||+.||++|||+++++.||||.....|..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~  299 (328)
T cd07856         239 LRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTD  299 (328)
T ss_pred             HHHHhhccccCCCcHHHHc-CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCcc
Confidence            000  11111112222211 357889999999999999999999999999999998776643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.4e-39  Score=303.52  Aligned_cols=238  Identities=25%  Similarity=0.377  Sum_probs=186.4

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc-----cHHHHHHH-HHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQI-MQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|++.+.||+|+||.||+|++..+|+.||+|.+.....     ....|+.+ ++.++|+||+++++++..     ...++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-----~~~~~   76 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-----EGDVW   76 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-----CCcEE
Confidence            58999999999999999999999999999998864321     12235544 667799999999998843     23488


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-CccccccccccceecCCCCcee----------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVKGEPNVSY----------  225 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~-~ivHrDlKp~NILl~~~~~~~~----------  225 (403)
                      ++|||+++++..++.........+++..+..++.||+.||.|||+ + +++||||||+|||++.++.+++          
T Consensus        77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             EEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            999999998887776544444678999999999999999999998 6 9999999999999987665433          


Q ss_pred             --------eccccccchhhhhCC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHHHHhhc
Q 015672          226 --------ICSRYYRAPELIFGA---TEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~---~~~~~~~DiwSlGvil~el~tg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~  293 (403)
                              .++..|+|||++.+.   ..++.++|+|||||++|+|++|+.||.... ..+.+..+...  ..        
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~--------  225 (283)
T cd06617         156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE--PS--------  225 (283)
T ss_pred             cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc--CC--------
Confidence                    356779999988542   346889999999999999999999996432 22333222211  00        


Q ss_pred             CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                            ..+           ....++.++.+||.+||..||.+|||+.++++||||....
T Consensus       226 ------~~~-----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         226 ------PQL-----------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             ------CCC-----------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence                  000           0134688999999999999999999999999999998854

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.5e-39  Score=295.78  Aligned_cols=231  Identities=27%  Similarity=0.437  Sum_probs=185.7

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|++.+.||+|++|.||++.+..+++.||+|.+..+.      ....+|+++++.++|+|++++++.+.    .....++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence            4999999999999999999999999999999885322      23456899999999999999987662    2234588


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------  225 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------  225 (403)
                      ++|||++ +++.+.+...  ....+++..++.++.|++.||.|||+ .||+||||||+||+++.++.++.          
T Consensus        77 lv~e~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~-~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~  153 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHE-KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE  153 (257)
T ss_pred             EEecccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCchhEEEecCCcEEEecccceEEec
Confidence            9999997 4665555432  23458899999999999999999999 89999999999999987654432          


Q ss_pred             ---------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          226 ---------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       226 ---------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                               .+++.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+....              
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~--------------  218 (257)
T cd08223         154 NQCDMASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK--------------  218 (257)
T ss_pred             ccCCccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--------------
Confidence                     357789999998654 58899999999999999999999998766544433332210              


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                           .+         ..+..+++++.+||.+||+.||++|||+.++++||||
T Consensus       219 -----~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         219 -----LP---------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             -----CC---------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                 00         0124578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=2.9e-41  Score=287.41  Aligned_cols=265  Identities=31%  Similarity=0.586  Sum_probs=209.0

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-cccHHHHHHHHHhcC-CCCccccceEEeecCCCCceEEEE
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      ...+|++.+++|+|.|+.||.|....+++.++||+++.- +....+|+.||+.|. ||||+++++....   .......+
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~D---p~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKD---PESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcC---ccccCchh
Confidence            345699999999999999999999999999999998643 445679999999997 9999999998733   33334668


Q ss_pred             EeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc--------------
Q 015672          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV--------------  223 (403)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~--------------  223 (403)
                      |+||+...-  +    ......++...++.++.|++.||.|+|+ +||+|||+||.|++|+....-              
T Consensus       113 iFE~v~n~D--f----k~ly~tl~d~dIryY~~elLkALdyCHS-~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  113 IFEYVNNTD--F----KQLYPTLTDYDIRYYIYELLKALDYCHS-MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             Hhhhhcccc--H----HHHhhhhchhhHHHHHHHHHHHHhHHHh-cCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            999998521  1    1223567778899999999999999999 899999999999999864321              


Q ss_pred             -----eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCHHHH-h----h
Q 015672          224 -----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEI-K----C  292 (403)
Q Consensus       224 -----~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~-~----~  292 (403)
                           -.+.+++|.-||++.....|+.+-|+|||||+|..|+..+-| |.|.++.+++..|.+.+|+.....- .    .
T Consensus       186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~  265 (338)
T KOG0668|consen  186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID  265 (338)
T ss_pred             CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence                 234688999999998888899999999999999999997755 5788999999999999998654321 1    1


Q ss_pred             cCcCccccCCCCCCCCCccccccc----CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQK----RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~----~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                      +++.+... +......+|....+.    -.++++.|||.++|.+|..+|+||.|++.||||..+...
T Consensus       266 Ldp~~~~i-~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~  331 (338)
T KOG0668|consen  266 LDPQFEDI-LGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA  331 (338)
T ss_pred             CChhHhhH-hhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence            22322221 223334556554432    357999999999999999999999999999999876543

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=286.31  Aligned_cols=240  Identities=25%  Similarity=0.346  Sum_probs=187.2

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc----cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ..+|.+.+.||+|||+.||+++...++..||+|++.-.    .+...+|++..++++|||+++++++............|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            34599999999999999999999999999999998533    23345899999999999999998876544433455688


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--ccccccccccceecCCCCcee--------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVKGEPNVSY--------  225 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~--ivHrDlKp~NILl~~~~~~~~--------  225 (403)
                      |+++|.. |++.+.+......+..+++..+..|+.+|++||++||+ ..  ++||||||.|||+.+.+....        
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecCCCceEEEeccCccc
Confidence            9999887 77888887766666789999999999999999999998 77  999999999999987654422        


Q ss_pred             --------------------eccccccchhhhhC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 015672          226 --------------------ICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG  283 (403)
Q Consensus       226 --------------------~~t~~y~aPE~~~~--~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~  283 (403)
                                          .||..|+|||++.-  ....++++|||||||+||.|+.|..||...-         +.-+
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~---------~~Gg  249 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY---------QQGG  249 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh---------hcCC
Confidence                                26888999998832  2236889999999999999999999994211         1000


Q ss_pred             CCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          284 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      .-..      .-....+.+|..          ...|+.+.+||+.||+.||.+||++.+++.+
T Consensus       250 SlaL------Av~n~q~s~P~~----------~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  250 SLAL------AVQNAQISIPNS----------SRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             eEEE------eeeccccccCCC----------CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            0000      000011222221          3478999999999999999999999999864

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-39  Score=327.66  Aligned_cols=265  Identities=20%  Similarity=0.269  Sum_probs=181.5

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCc-EEEEE------------------Ecccc---cccHHHHHHHHHhcCCCCcc
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGE-IVAIK------------------KVLQD---KRYKNRELQIMQMLDHPNIV  138 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-~vaiK------------------~~~~~---~~~~~~E~~~l~~l~h~niv  138 (403)
                      ..+|.+.+.||+|+||+||+|..+.... .+++|                  .+...   .....+|+.+|+.++|+||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            3569999999999999999987653221 12222                  11111   12235799999999999999


Q ss_pred             ccceEEeecCCCCceEEEEEeeccCCcHHHHHHHhh-hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccccccee
Q 015672          139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYS-RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV  217 (403)
Q Consensus       139 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl  217 (403)
                      ++++++..     ..+.|++++++.+++..++.... ..........++.++.||+.||.|||+ +|||||||||+|||+
T Consensus       227 ~l~~~~~~-----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~-~gIiHrDLKP~NILl  300 (501)
T PHA03210        227 KIEEILRS-----EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD-KKLIHRDIKLENIFL  300 (501)
T ss_pred             cEeEEEEE-----CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence            99998843     33478999999877766543221 112334456778899999999999999 899999999999999


Q ss_pred             cCCCCce--------------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCC-CCCC--CcHHH
Q 015672          218 KGEPNVS--------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGE--SGVDQ  274 (403)
Q Consensus       218 ~~~~~~~--------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~p-f~~~--~~~~~  274 (403)
                      +.++.++                    .+||+.|+|||++.+. .++.++|||||||++|||++|..+ |...  +....
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            8765442                    3478999999998654 589999999999999999998754 4322  33455


Q ss_pred             HHHHHHHhCCCCHHHHhhcCc---CccccCCCCCCCCCccccc-ccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 015672          275 LVEIIKVLGTPTREEIKCMNP---NYTEFKFPQIKPHPWHKVF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  350 (403)
Q Consensus       275 ~~~i~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~  350 (403)
                      +..++..++.+..+.......   ......+... .......+ ...++.++.++|.+||++||++|||+.|+|.||||.
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~  458 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHA-GHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS  458 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccC-ccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence            556655554332221000000   0000000000 01111111 124678899999999999999999999999999998


Q ss_pred             cCC
Q 015672          351 ELR  353 (403)
Q Consensus       351 ~~~  353 (403)
                      ...
T Consensus       459 ~~~  461 (501)
T PHA03210        459 AEE  461 (501)
T ss_pred             cCC
Confidence            754

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-39  Score=302.71  Aligned_cols=259  Identities=32%  Similarity=0.614  Sum_probs=200.6

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      |.+.+.||+|+||.||+|++..+++.+|+|.+....      ....+|+++++.++|+|++++++++...   .....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence            678899999999999999999899999999986542      1234799999999999999999987432   1245889


Q ss_pred             EeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------------
Q 015672          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------------  225 (403)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------------  225 (403)
                      ||||+++++..++...   ...+++..+..++.||+.||+|||+ .|++|+||||+||+++.++.+++            
T Consensus        78 v~e~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~-~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          78 VFEYMDHDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHS-NGILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             EeccccccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9999998776555432   2468899999999999999999999 89999999999999997765543            


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC-
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-  296 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-  296 (403)
                              .++..|+|||.+.+...++.++|||||||++|+|++|+.||...+....+..+....+.++...+...... 
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence                    23567999998766556889999999999999999999999988887777777777777665544322110 


Q ss_pred             -ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          297 -YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       297 -~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                       .................+...+++++.++|.+||..||.+||++.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence             00000000000111112222348999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-39  Score=299.08  Aligned_cols=242  Identities=26%  Similarity=0.421  Sum_probs=191.4

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhc-CCCCccccceEEeecCC-CCceEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTD-KEELYL  155 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~~~~~  155 (403)
                      ..+|++.+.||+|+||.||+|.+..+++.+|+|++....   ....+|+.+++++ +|+||+++++++..... ....++
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL   84 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence            356999999999999999999999899999999886432   3346799999999 79999999998865443 345678


Q ss_pred             EEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      ++||||+++ +|.+++.........+++..+..++.|++.||.|||+ .+|+|+||+|+||+++.++.+++         
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~  163 (275)
T cd06608          85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE-NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL  163 (275)
T ss_pred             EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence            999999984 6666665433334678999999999999999999999 89999999999999987765533         


Q ss_pred             ----------eccccccchhhhhCC----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015672          226 ----------ICSRYYRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       226 ----------~~t~~y~aPE~~~~~----~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  291 (403)
                                .++..|+|||++...    ..++.++|||||||++|+|++|..||........+..+...   +.     
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~-----  235 (275)
T cd06608         164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN---PP-----  235 (275)
T ss_pred             ccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc---CC-----
Confidence                      246779999987432    34678999999999999999999999766544444333221   00     


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                                 +..       ..+...+.++.+||.+||..||++|||+.++++|||+
T Consensus       236 -----------~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         236 -----------PTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             -----------CCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                       000       0112367899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.2e-39  Score=312.32  Aligned_cols=231  Identities=23%  Similarity=0.363  Sum_probs=177.1

Q ss_pred             ccEeeeceecccCceEEEEEEEC-----CCCcEEEEEEccccc-----ccHHHHHHHHHhc-CCCCccccceEEeecCCC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  150 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  150 (403)
                      .+|++.++||+|+||.||+|.+.     .++..||+|++....     ....+|+.++..+ +||||+++++++...   
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---   83 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP---   83 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC---
Confidence            45999999999999999999752     345689999986432     2345799999999 899999999877422   


Q ss_pred             CceEEEEEeeccC-CcHHHHHHHhhh------------------------------------------------------
Q 015672          151 EELYLNLVLEYVP-ETVNRIARNYSR------------------------------------------------------  175 (403)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~------------------------------------------------------  175 (403)
                       ...++++|||++ ++|.+++.....                                                      
T Consensus        84 -~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          84 -NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             -CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence             234789999998 577666653211                                                      


Q ss_pred             ----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee---------------------cccc
Q 015672          176 ----IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI---------------------CSRY  230 (403)
Q Consensus       176 ----~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~---------------------~t~~  230 (403)
                          ....+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++++                     +++.
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence                01347778888999999999999999 899999999999999876654332                     2457


Q ss_pred             ccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCC
Q 015672          231 YRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHP  309 (403)
Q Consensus       231 y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (403)
                      |+|||++.+. .++.++|||||||++|||++ |..||.+....+.+...... +.              ..         
T Consensus       242 y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~--------------~~---------  296 (338)
T cd05102         242 WMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GT--------------RM---------  296 (338)
T ss_pred             ccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CC--------------CC---------
Confidence            9999998654 58999999999999999997 99999876544333322211 00              00         


Q ss_pred             cccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          310 WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       310 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                         ..+..+++++.+||.+||+.||++|||+.++++
T Consensus       297 ---~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         297 ---RAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             ---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence               012457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.6e-39  Score=303.53  Aligned_cols=239  Identities=27%  Similarity=0.428  Sum_probs=187.9

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc----cHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      ..|++.+.||.|+||.||+|++..+++.+|+|.+.....    ...+|+.+++.++|+||+++++.+..     ..++++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-----DGKLWI   86 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-----CCeEEE
Confidence            459999999999999999999999999999999864322    23468999999999999999998743     335899


Q ss_pred             EeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      ||||+++ ++..++..   ....+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+++           
T Consensus        87 v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          87 MIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHS-MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             EEecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhc-CCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            9999985 44333322   23468899999999999999999999 89999999999999986654432           


Q ss_pred             --------eccccccchhhhhC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015672          226 --------ICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~----~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  293 (403)
                              .+++.|+|||++.+    ...++.++|||||||++|+|++|.+||...+.......+... ..+.       
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~-------  234 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPT-------  234 (292)
T ss_pred             cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC-CCcc-------
Confidence                    24678999998842    234688999999999999999999999776644433332211 0000       


Q ss_pred             CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                                        ...+..++.++.+||.+||+.||++||+++++++||||..+..+
T Consensus       235 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  278 (292)
T cd06644         235 ------------------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN  278 (292)
T ss_pred             ------------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence                              00123567899999999999999999999999999999887543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=6.1e-39  Score=302.19  Aligned_cols=264  Identities=30%  Similarity=0.498  Sum_probs=202.3

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCC-----
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-----  149 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----  149 (403)
                      ..+|++.+.||+|+||.||+|.++.+++.||+|.+....      ....+|+++++.++||||+++++++....+     
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            346999999999999999999999999999999885321      123479999999999999999988744321     


Q ss_pred             CCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----
Q 015672          150 KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----  225 (403)
Q Consensus       150 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----  225 (403)
                      ....++++|+||+++++...+...   ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+++    
T Consensus        86 ~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~~~kl~dfg  161 (302)
T cd07864          86 KDKGAFYLVFEYMDHDLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHK-KNFLHRDIKCSNILLNNKGQIKLADFG  161 (302)
T ss_pred             ccCCcEEEEEcccCccHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCcEEeCccc
Confidence            122368999999998776554431   3468899999999999999999999 89999999999999987765533    


Q ss_pred             ----------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          226 ----------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       226 ----------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                      .++..|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..+.+..+.+....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (302)
T cd07864         162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV  241 (302)
T ss_pred             ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence                            2355699999886555578999999999999999999999998888888878777777666544


Q ss_pred             HhhcCcC--ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          290 IKCMNPN--YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       290 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                      +......  +............+.. ....++..+.+||.+||..||.+|||+.+++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         242 WPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             cccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            3322110  0000000000011111 123568999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=8.5e-40  Score=312.04  Aligned_cols=259  Identities=22%  Similarity=0.344  Sum_probs=184.8

Q ss_pred             ceeccc--CceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           88 HVVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        88 ~~lG~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      ..||+|  +||+||++++..+++.||+|++....      ....+|+.+++.++|+||++++++|.     ...+.++||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-----~~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-----TGSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-----cCCceEEEE
Confidence            456666  99999999999999999999985432      23357889999999999999999883     334588999


Q ss_pred             eccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee------------
Q 015672          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI------------  226 (403)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~------------  226 (403)
                      ||+. +++..++....  ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++.++..            
T Consensus        79 e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~  155 (328)
T cd08226          79 PFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG  155 (328)
T ss_pred             ecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccC
Confidence            9998 47766655432  2458888999999999999999999 899999999999999876544321            


Q ss_pred             --------------ccccccchhhhhCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH---
Q 015672          227 --------------CSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---  288 (403)
Q Consensus       227 --------------~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~---  288 (403)
                                    ++..|+|||++.+. ..++.++|||||||++|+|++|.+||.+......+..+.......+..   
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd08226         156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT  235 (328)
T ss_pred             ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccc
Confidence                          23459999998653 347899999999999999999999998776554443333211110100   


Q ss_pred             ------HHhhcCcCcc----ccCCC-----CCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          289 ------EIKCMNPNYT----EFKFP-----QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       289 ------~~~~~~~~~~----~~~~~-----~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                            .+........    .....     ......+.......+++.+.+||++||++||++|||++++++||||+.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence                  0000000000    00000     00000111111234678899999999999999999999999999998875


Q ss_pred             C
Q 015672          354 D  354 (403)
Q Consensus       354 ~  354 (403)
                      .
T Consensus       316 ~  316 (328)
T cd08226         316 E  316 (328)
T ss_pred             H
Confidence            4

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.6e-39  Score=302.33  Aligned_cols=232  Identities=30%  Similarity=0.502  Sum_probs=190.9

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      +|++.+.||+|+||.||++.+..+++.||+|++....       ....+|+++++.++|+||+++++++.     +..++
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   76 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-----DDSNL   76 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCeE
Confidence            5999999999999999999999999999999885421       22346999999999999999999883     34458


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      ++||||++ ++|...+..    ...+++..+..++.||+.||.|||+ .||+||||+|+|||++.++.+++         
T Consensus        77 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~-~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~  151 (290)
T cd05580          77 YLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHS-LDIVYRDLKPENLLLDSDGYIKITDFGFAKRV  151 (290)
T ss_pred             EEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCCCEEEeeCCCcccc
Confidence            89999995 677665543    3578999999999999999999999 89999999999999988766543         


Q ss_pred             -------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 015672          226 -------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  298 (403)
Q Consensus       226 -------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  298 (403)
                             .+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+.......+...  .              
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~--------------  214 (290)
T cd05580         152 KGRTYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--K--------------  214 (290)
T ss_pred             CCCCCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C--------------
Confidence                   357789999998654 5789999999999999999999999877644443333211  0              


Q ss_pred             ccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCCC
Q 015672          299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  354 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~~  354 (403)
                       ..            ++..++..++++|.+||..||.+|+     +++|+++||||+.+..
T Consensus       215 -~~------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  262 (290)
T cd05580         215 -VR------------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDW  262 (290)
T ss_pred             -cc------------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCH
Confidence             00            1245688999999999999999999     9999999999988764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.6e-39  Score=301.79  Aligned_cols=238  Identities=26%  Similarity=0.384  Sum_probs=186.5

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhc-CCCCccccceEEeecCC-CCceEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTD-KEELYLN  156 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~~~~~~  156 (403)
                      ..|++.+.||.|+||.||+|++..+++.+|+|.+....   .....|+.+++++ +|+||++++++++.... ....+++
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   95 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW   95 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence            35999999999999999999999999999999875432   2345688888888 79999999998754322 2345789


Q ss_pred             EEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------
Q 015672          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------  225 (403)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------  225 (403)
                      ++|||+++ ++..++....  ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+++          
T Consensus        96 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~  172 (282)
T cd06636          96 LVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHA-HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  172 (282)
T ss_pred             EEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence            99999984 7766665422  3457888889999999999999999 89999999999999987665432          


Q ss_pred             ---------eccccccchhhhhC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          226 ---------ICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       226 ---------~~t~~y~aPE~~~~----~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                               .+++.|+|||++..    ...++.++|||||||++|+|++|..||...........+...   ..      
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~------  243 (282)
T cd06636         173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PP------  243 (282)
T ss_pred             ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---CC------
Confidence                     35677999998752    234788999999999999999999999765543333222110   00      


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                                        .......++.++.+||.+||+.||.+|||+.|+++||||
T Consensus       244 ------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         244 ------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             ------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                              000113578899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.9e-39  Score=303.31  Aligned_cols=242  Identities=25%  Similarity=0.428  Sum_probs=188.7

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.++++++|+||+++++.+..     ..++++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~l   76 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-----EGAVYM   76 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-----CCeEEE
Confidence            4889999999999999999999999999999875432     234479999999999999999998743     345889


Q ss_pred             EeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      ||||+++ ++..++... .....+++..+..++.||+.||.|||+..+|+||||||+||+++.++.+++           
T Consensus        77 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  155 (286)
T cd06622          77 CMEYMDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA  155 (286)
T ss_pred             EEeecCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence            9999985 565554431 112468999999999999999999996259999999999999987665533           


Q ss_pred             ------eccccccchhhhhCCC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          226 ------ICSRYYRAPELIFGAT-----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       226 ------~~t~~y~aPE~~~~~~-----~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                            .+++.|+|||++.+..     .++.++|||||||++|+|++|..||...........+......+.        
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------  227 (286)
T cd06622         156 SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP--------  227 (286)
T ss_pred             CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC--------
Confidence                  2456799999984332     357899999999999999999999976554333322222111100        


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                                       ..++..+++++.+||.+||+.||++||+++++++||||.....+
T Consensus       228 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         228 -----------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             -----------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence                             00224578999999999999999999999999999999886544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-40  Score=287.90  Aligned_cols=250  Identities=25%  Similarity=0.405  Sum_probs=194.7

Q ss_pred             cccCCCCCCcccccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccccH-----HHHHHHHHhc-CCCCccccceE
Q 015672           70 TIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQML-DHPNIVALKHC  143 (403)
Q Consensus        70 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~E~~~l~~l-~h~niv~~~~~  143 (403)
                      ++++.....-..++.+.+..||.|+-|+||+++.+.+|...|||.+.+.....     ...+.++.+- +.|.||+.+++
T Consensus        80 ti~~g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~Gy  159 (391)
T KOG0983|consen   80 TIGGGQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGY  159 (391)
T ss_pred             EecCCcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeE
Confidence            34433333334455677888999999999999999999999999997543221     1233333333 47999999999


Q ss_pred             EeecCCCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc
Q 015672          144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV  223 (403)
Q Consensus       144 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~  223 (403)
                      |++..+     .++.||.|...+..++..   ..+.+++..+-++...++.||.||...++|||||+||+|||++..+++
T Consensus       160 Fi~n~d-----V~IcMelMs~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gni  231 (391)
T KOG0983|consen  160 FITNTD-----VFICMELMSTCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNI  231 (391)
T ss_pred             EeeCch-----HHHHHHHHHHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCE
Confidence            987665     778999987655555554   357799999999999999999999987899999999999999999988


Q ss_pred             eee------------------ccccccchhhhh--CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHh
Q 015672          224 SYI------------------CSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVDQLVEIIKVL  282 (403)
Q Consensus       224 ~~~------------------~t~~y~aPE~~~--~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~-~~~~~~~i~~~~  282 (403)
                      +++                  |.+.|||||-+.  ....|+..+||||||++++||+||+.||.+.+ +.+.+..+....
T Consensus       232 KlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e  311 (391)
T KOG0983|consen  232 KLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE  311 (391)
T ss_pred             EeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC
Confidence            765                  567899999984  23458999999999999999999999998854 446665555421


Q ss_pred             CCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          283 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                        |+.              ++          ....+|+.+.+|+..||+.|+.+||...++|+|||+....
T Consensus       312 --PP~--------------L~----------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  312 --PPL--------------LP----------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             --CCC--------------CC----------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence              110              00          0134899999999999999999999999999999987654

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.3e-39  Score=302.76  Aligned_cols=234  Identities=26%  Similarity=0.400  Sum_probs=187.7

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ..+|.+.+.||+|+||.||+|++..+++.||+|.+....    ....+|+.+++.++|+||+++++.+..     ..+.|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~   93 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW   93 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEE
Confidence            346999999999999999999999999999999885432    234579999999999999999998743     33589


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-----------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-----------  224 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-----------  224 (403)
                      +||||++ ++|..++..     ..++...+..++.|++.||.|||+ .||+||||||+|||++.++.++           
T Consensus        94 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~-~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~  167 (296)
T cd06654          94 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (296)
T ss_pred             EeecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence            9999997 466665532     457888899999999999999999 8999999999999998665432           


Q ss_pred             --------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          225 --------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       225 --------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                              ..+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+... +.+.          
T Consensus       168 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~----------  235 (296)
T cd06654         168 PEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPE----------  235 (296)
T ss_pred             ccccccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCC----------
Confidence                    245678999999865 44789999999999999999999999876654433322210 0000          


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                                     ...+..++..+.+||.+||..||++|||+.++++||||...
T Consensus       236 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         236 ---------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             ---------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence                           00124578899999999999999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-39  Score=299.09  Aligned_cols=256  Identities=40%  Similarity=0.728  Sum_probs=207.1

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      |++.+.||+|+||.||+|+...+++.||+|.+....      .....|+.+++.++|+||+++++++..     ..+.++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-----ERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-----CCceEE
Confidence            567889999999999999999999999999886432      123469999999999999999998733     345889


Q ss_pred             EeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee-----------
Q 015672          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-----------  226 (403)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~-----------  226 (403)
                      ||||+++++..++....   ..+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.+++.           
T Consensus        76 v~e~~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~  151 (282)
T cd07829          76 VFEYCDMDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHS-HRILHRDLKPQNILINRDGVLKLADFGLARAFGIP  151 (282)
T ss_pred             EecCcCcCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence            99999988877665421   468899999999999999999999 899999999999999886655432           


Q ss_pred             --------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC-c
Q 015672          227 --------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-Y  297 (403)
Q Consensus       227 --------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~  297 (403)
                              .+..|+|||.+.+...++.++|||||||++|++++|.+||.+.+..+.+..+.+.++.+....+...... +
T Consensus       152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07829         152 LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD  231 (282)
T ss_pred             ccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence                    2456999999876546899999999999999999999999998888888888888888887766543322 1


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                      ....++..........+ ..++.++.++|.+||..||++||++.+++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         232 YKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            22233333333332222 3458899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-40  Score=312.54  Aligned_cols=224  Identities=25%  Similarity=0.350  Sum_probs=188.0

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccc---cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      .+.+++.||+|.||.||+|.+.. ...||+|.++..   ...+.+|+++|++|+|+|||++++++....     -++|||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piyIVt  280 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIYIVT  280 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceEEEE
Confidence            35677889999999999999963 347999988642   244568999999999999999999984433     389999


Q ss_pred             eccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceeec-----------
Q 015672          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYIC-----------  227 (403)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~~-----------  227 (403)
                      ||++ |+|.++++.  ..+..+.......++.||++|++||.+ +++|||||...||||+.+..+++..           
T Consensus       281 E~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes-~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLES-KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE  357 (468)
T ss_pred             EecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHh-CCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence            9998 788888776  235678888999999999999999999 8999999999999999887665431           


Q ss_pred             ---------cccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          228 ---------SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       228 ---------t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                               ...|.|||.+.. ..++.++|||||||+||||+| |+.||.+.+..+.+..+.+....|.           
T Consensus       358 Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~-----------  425 (468)
T KOG0197|consen  358 YTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR-----------  425 (468)
T ss_pred             eeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC-----------
Confidence                     234999999954 459999999999999999998 9999999999998888776433332           


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  344 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l  344 (403)
                                       |..+|+++.+++..||..+|++|||++.+.
T Consensus       426 -----------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  426 -----------------PEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             -----------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence                             367999999999999999999999998765

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-39  Score=300.27  Aligned_cols=257  Identities=40%  Similarity=0.699  Sum_probs=202.7

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEcccccc-----cHHHHHHHHHhcC-CCCccccceEEeecCCCCceEEEE
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      |++.+.||+|+||+||+|+...+++.||||.+.....     ...+|+..++.++ |+||+++++++..     ....++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence            6788999999999999999988999999998754321     2346889999999 9999999998743     445889


Q ss_pred             EeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------------
Q 015672          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------------  225 (403)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------------  225 (403)
                      ||||+++++...+....  ...++...+..++.|++.||.|||+ +|++|+||||+||+++.++.+++            
T Consensus        76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~  152 (283)
T cd07830          76 VFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHK-HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR  152 (283)
T ss_pred             EEecCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence            99999888866654422  2468899999999999999999999 89999999999999987655433            


Q ss_pred             ------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC--c
Q 015672          226 ------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN--Y  297 (403)
Q Consensus       226 ------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~  297 (403)
                            .++..|+|||++.+...++.++|+|||||++|+|++|++||...+..+.+..+...++.+....+......  .
T Consensus       153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         153 PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence                  35677999998865556889999999999999999999999999888888888888888776554322111  1


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                      ....++........... ...+.++.+||.+||+.||++|||+.|++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         233 LGFRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccccHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            11122222222222222 2337889999999999999999999999999998

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-39  Score=301.99  Aligned_cols=237  Identities=27%  Similarity=0.417  Sum_probs=188.8

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      .+|++.+.||.|+||.||+|.+..+++.+|+|.+....    ....+|+++++.++|+||+++++.+..     ...+++
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   79 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-----ENKLWI   79 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-----CCeEEE
Confidence            34999999999999999999998899999999885432    224479999999999999999998843     345889


Q ss_pred             EeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      ||||+++ ++..++...   ...+++..++.++.|++.||.|||+ .||+||||||+||+++.++.+++           
T Consensus        80 v~e~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          80 LIEFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             EeeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            9999985 665554432   3468999999999999999999999 89999999999999986654432           


Q ss_pred             --------eccccccchhhhhC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015672          226 --------ICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~----~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  293 (403)
                              .+++.|+|||++..    ...++.++|||||||++|+|++|++||.+.+....+..+...  .+        
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~--------  225 (280)
T cd06611         156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--EP--------  225 (280)
T ss_pred             cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--CC--------
Confidence                    35778999999742    234678999999999999999999999876654443333211  00        


Q ss_pred             CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                               +..       ..+..++.++.+||.+||+.||.+||++.++++||||....
T Consensus       226 ---------~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         226 ---------PTL-------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             ---------CCc-------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence                     000       01235688999999999999999999999999999998763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.7e-39  Score=303.32  Aligned_cols=236  Identities=27%  Similarity=0.413  Sum_probs=187.8

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      ...+|.+.+.||+|+||.||+|.+..+++.||+|.+....    ....+|+.+++.++|+||+++++.+.     ...+.
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~   91 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDEL   91 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEE
Confidence            3456999999999999999999999999999999885432    23356899999999999999999883     34458


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      ++||||++ +++..++..     ..+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+++         
T Consensus        92 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~-~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~  165 (297)
T cd06656          92 WVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  165 (297)
T ss_pred             EEeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEECcCccceEc
Confidence            89999997 466555432     457888899999999999999999 89999999999999986654432         


Q ss_pred             ----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          226 ----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       226 ----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                .+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+....+..+.. .+.+.         
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~---------  234 (297)
T cd06656         166 TPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE---------  234 (297)
T ss_pred             cCCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCC---------
Confidence                      35678999999865 4588999999999999999999999977654332221111 00000         


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                                      ...+..++..+.+||.+||..||++||++.++++||||+...
T Consensus       235 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         235 ----------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             ----------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence                            001245788899999999999999999999999999998864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.4e-39  Score=304.40  Aligned_cols=259  Identities=24%  Similarity=0.371  Sum_probs=187.2

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      +|++.+.||+|+||.||++.+..++..+|+|.+..+.     ....+|+++++.++||||+++++++..     ..++++
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   76 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-----DGEISI   76 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCEEEE
Confidence            4999999999999999999999999999999875431     223479999999999999999998843     345899


Q ss_pred             EeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      ||||+++ +|..++..    ...+++..+..++.||+.||.|||+..+|+||||||+|||++.++.+++           
T Consensus        77 v~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (308)
T cd06615          77 CMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  152 (308)
T ss_pred             EeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence            9999984 67666543    3568899999999999999999996348999999999999987654432           


Q ss_pred             ------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 015672          226 ------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  299 (403)
Q Consensus       226 ------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  299 (403)
                            .+++.|+|||++.+. .++.++|||||||++|+|++|+.||...+... ...+.....................
T Consensus       153 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         153 SMANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             cccccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccccccCCcccccCCC
Confidence                  357789999998654 58899999999999999999999997665332 2222111000000000000000000


Q ss_pred             cCCCC----------CCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          300 FKFPQ----------IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       300 ~~~~~----------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                      ...+.          .........-...++.++++||.+||..||++|||+.++++||||...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence            00000          000000000012367889999999999999999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=7.2e-39  Score=301.24  Aligned_cols=234  Identities=29%  Similarity=0.445  Sum_probs=188.5

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      ..|++.+.||.|+||.||+|.+..+++.||+|.+....    ....+|+.+++.++|+||+++++.+.     ....+++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l   93 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDELFV   93 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceEEE
Confidence            45999999999999999999999999999999885322    23356999999999999999999873     3345889


Q ss_pred             EeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      |+||+.+ +|..++.     ...+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+++           
T Consensus        94 v~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~-~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          94 VMEYLAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHA-NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             EEEecCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            9999984 5555443     2458899999999999999999999 89999999999999987654432           


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                              .++..|+|||.+.+. .++.++|||||||++|+|++|..||.+.+.......+... ..+.           
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~-----------  234 (296)
T cd06655         168 EQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE-----------  234 (296)
T ss_pred             ccccCCCcCCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc-----------
Confidence                    346679999998644 4889999999999999999999999887765544333221 0000           


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                                    ...+..+++.+.+||.+||..||.+|||+.++++||||+...
T Consensus       235 --------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         235 --------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             --------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence                          001245788999999999999999999999999999998653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.3e-39  Score=296.62  Aligned_cols=227  Identities=33%  Similarity=0.555  Sum_probs=183.1

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------------ccHHHHHHHHHhcCCCCccccceEEeecCCC
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  150 (403)
                      |.+...||.|+||.||+|.+..+++.+|+|.+....             ....+|+.+++.++|+||+++++++..    
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----   77 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD----   77 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe----
Confidence            788899999999999999998899999999875321             123478999999999999999998733    


Q ss_pred             CceEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----
Q 015672          151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----  225 (403)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----  225 (403)
                       ..+.+++|||+++ +|..++..    ...+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+++    
T Consensus        78 -~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~-~~ivH~di~p~nil~~~~~~~~l~dfg  151 (267)
T cd06628          78 -ADHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHN-RGIIHRDIKGANILVDNKGGIKISDFG  151 (267)
T ss_pred             -CCccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHh-cCcccccCCHHHEEEcCCCCEEecccC
Confidence             3458899999974 66665543    3567888899999999999999999 89999999999999986654432    


Q ss_pred             ---------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 015672          226 ---------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  284 (403)
Q Consensus       226 ---------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~  284 (403)
                                           .++..|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+....+..+....  
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--  228 (267)
T cd06628         152 ISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA--  228 (267)
T ss_pred             CCcccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC--
Confidence                                 246679999998654 48899999999999999999999998765444333222100  


Q ss_pred             CCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          285 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                                       .+         .++..++.++.++|.+||+.||.+||++.++++||||
T Consensus       229 -----------------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         229 -----------------SP---------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             -----------------CC---------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                             00         0224578899999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3e-39  Score=301.18  Aligned_cols=235  Identities=25%  Similarity=0.418  Sum_probs=182.0

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      +|++.++||+|+||.||+|++..+++.||+|.+..+.     ....+|++++++++||||+++++.+..     ..+.++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   76 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRISI   76 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEEE
Confidence            4888999999999999999999999999999885432     223469999999999999999998843     334789


Q ss_pred             EeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------------
Q 015672          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------------  225 (403)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------------  225 (403)
                      ||||+++.....   +    ..+++..+..++.|++.||.|||+ .||+|+||||+|||++.++.+++            
T Consensus        77 v~e~~~~~~l~~---~----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~  148 (279)
T cd06619          77 CTEFMDGGSLDV---Y----RKIPEHVLGRIAVAVVKGLTYLWS-LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS  148 (279)
T ss_pred             EEecCCCCChHH---h----hcCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence            999999643221   1    346788889999999999999999 89999999999999987655432            


Q ss_pred             -----eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCCHHHHhhcCcCc
Q 015672          226 -----ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ---LVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       226 -----~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                           .+|..|+|||++.+. .++.++|||||||++|+|++|+.||........   ............           
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----------  216 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----------  216 (279)
T ss_pred             cccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----------
Confidence                 457789999998654 489999999999999999999999965322110   001111100000           


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCC
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  354 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  354 (403)
                          .+.        ......++++.+||.+||+.||++||+++++++||||+....
T Consensus       217 ----~~~--------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~  261 (279)
T cd06619         217 ----PPV--------LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND  261 (279)
T ss_pred             ----CCC--------CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence                000        011346789999999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3e-39  Score=298.87  Aligned_cols=233  Identities=25%  Similarity=0.365  Sum_probs=183.5

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      .+|.+.+.||+|+||.||+|++..+++.||+|.+....    ....+|+.+++.++||||+++++.+..     ....++
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-----~~~~~l   83 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-----RDKLWI   83 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----CCEEEE
Confidence            36999999999999999999999999999999885432    223579999999999999999998743     345889


Q ss_pred             EeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      +|||+++ +|.+++..    .+.+++..++.++.|++.||.|||+ .||+||||||+||+++.++.+++           
T Consensus        84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06645          84 CMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHS-KGKMHRDIKGANILLTDNGHVKLADFGVSAQITA  158 (267)
T ss_pred             EEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence            9999984 66665543    3578999999999999999999999 89999999999999987654422           


Q ss_pred             --------eccccccchhhhh--CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          226 --------ICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       226 --------~~t~~y~aPE~~~--~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                              .|+..|+|||++.  ....++.++|||||||++|+|++|..||........+.......             
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~-------------  225 (267)
T cd06645         159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSN-------------  225 (267)
T ss_pred             cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccC-------------
Confidence                    3678899999874  23347889999999999999999999997655433322221110             


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  348 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~  348 (403)
                          +..+     .+..  ...++..+.+||.+||+.||++|||++++++|||
T Consensus       226 ----~~~~-----~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         226 ----FQPP-----KLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             ----CCCC-----cccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                0000     0000  1246788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.3e-38  Score=292.50  Aligned_cols=230  Identities=25%  Similarity=0.403  Sum_probs=186.4

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccc------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+...      .....+|+++++.++|+||+++++++.     .....+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence            388899999999999999999999999999987532      223346899999999999999999873     334588


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------  225 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------  225 (403)
                      +||||++ ++|..++....  ...++...+..++.|++.||.|||+ .||+||||||+||+++.++.+++          
T Consensus        76 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~-~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~  152 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHS-KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS  152 (256)
T ss_pred             EEEEeCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEeCCCCEEEcccccceecc
Confidence            9999997 57766665421  3568888899999999999999999 89999999999999987655433          


Q ss_pred             ---------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          226 ---------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       226 ---------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                               .+++.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+.+..              
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------------  217 (256)
T cd08529         153 DNTNFANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV--------------  217 (256)
T ss_pred             CccchhhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------------
Confidence                     356779999998654 48899999999999999999999998777544443332210              


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                           ++.         ++..++.++.++|.+||+.+|++||++.++++|||+
T Consensus       218 -----~~~---------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         218 -----FPP---------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             -----CCC---------CccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                 000         113468899999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1e-38  Score=294.98  Aligned_cols=229  Identities=27%  Similarity=0.477  Sum_probs=182.4

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----------ccHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      +|++.+.||.|+||.||+|.. .+++.+|+|.+....          ....+|+++++.++|+||+++++++.     ..
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-----DD   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-----cC
Confidence            388899999999999999986 578899999875321          12457999999999999999999873     33


Q ss_pred             eEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------
Q 015672          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------  225 (403)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------  225 (403)
                      .+++++|||+++ +|..++..    ...+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++.      
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~  149 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHN-NCVVHRDIKGNNVMLMPNGIIKLIDFGCA  149 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHhEEECCCCeEEeccchhh
Confidence            568999999974 66655543    3568889999999999999999999 89999999999999986654432      


Q ss_pred             -------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015672          226 -------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  286 (403)
Q Consensus       226 -------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~  286 (403)
                                         .++..|+|||++.+. .++.++|||||||++|+|++|..||...+.......+....+.  
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--  226 (265)
T cd06631         150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL--  226 (265)
T ss_pred             HhhhhccccccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC--
Confidence                               246679999998654 5889999999999999999999999776544433322221000  


Q ss_pred             HHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          287 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                                     .+         .++..++.++.+||.+||+.||.+|||+.++++||||
T Consensus       227 ---------------~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         227 ---------------MP---------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             ---------------CC---------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                           00         1224578999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.5e-39  Score=296.66  Aligned_cols=231  Identities=28%  Similarity=0.471  Sum_probs=181.7

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      +|++.+.||+|+||.||+|.+..++..||+|.+....         ....+|+.+++.++|+||+++++++..   ....
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   79 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAEK   79 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCCC
Confidence            5899999999999999999999999999999875321         124569999999999999999987643   2234


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------  225 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------  225 (403)
                      .+++++||++ ++|...+..    ...++....+.++.|++.||.|||+ .+|+||||||+||+++.++.+++       
T Consensus        80 ~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~-~~i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          80 TLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHS-NMIVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            5789999997 466655543    3457888889999999999999998 89999999999999986654322       


Q ss_pred             ---------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          226 ---------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       226 ---------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                     .++..|+|||.+.+. .++.++|||||||++|+|++|+.||...+.......+...   +.    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~---~~----  226 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ---PT----  226 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC---CC----
Confidence                           246679999998654 5889999999999999999999999766544333222110   00    


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  350 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~  350 (403)
                                          ...++..+++.+++|| +||..||++||+++|+++||||+
T Consensus       227 --------------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         227 --------------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             --------------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                                0012234678899999 67778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-39  Score=298.11  Aligned_cols=231  Identities=26%  Similarity=0.412  Sum_probs=187.0

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      +|.+.+.||.|+||.||+|++..+++.||+|.+....     ....+|+++++.++|+||+++++.+..     ..++++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~~   76 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-----GSKLWI   76 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-----CCeEEE
Confidence            4889999999999999999999999999999885432     234579999999999999999998743     346899


Q ss_pred             EeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      |+||+++ ++...+..     ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+.+           
T Consensus        77 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  150 (274)
T cd06609          77 IMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHE-EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS  150 (274)
T ss_pred             EEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence            9999985 56555442     378899999999999999999999 89999999999999987654432           


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                              .+++.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+....               
T Consensus       151 ~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---------------  214 (274)
T cd06609         151 TMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN---------------  214 (274)
T ss_pred             cccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC---------------
Confidence                    3466799999986554 8999999999999999999999997665443333222210               


Q ss_pred             cccCCCCCCCCCcccccccC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          298 TEFKFPQIKPHPWHKVFQKR-LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                          .+.         .... +++++.++|.+||..||++|||++++++||||++..
T Consensus       215 ----~~~---------~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         215 ----PPS---------LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             ----CCC---------CcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence                000         1122 688999999999999999999999999999998754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5.4e-39  Score=299.76  Aligned_cols=235  Identities=26%  Similarity=0.399  Sum_probs=186.7

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      -|++.+.||+|+||.||+|.+..++..+|+|.+....    ....+|+++++.++|+||+++++.+..     ....++|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~v   80 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWIL   80 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEEE
Confidence            3788999999999999999999999999999885432    223469999999999999999998743     3458899


Q ss_pred             eeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------------
Q 015672          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------------  225 (403)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------------  225 (403)
                      |||+++ ++..++..   ....+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++            
T Consensus        81 ~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  156 (282)
T cd06643          81 IEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHE-NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  156 (282)
T ss_pred             EEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEccCCCEEEcccccccccccc
Confidence            999985 44333322   23568899999999999999999999 89999999999999987665432            


Q ss_pred             -------eccccccchhhhh----CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          226 -------ICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       226 -------~~t~~y~aPE~~~----~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                             .+++.|+|||++.    ....++.++|||||||++|+|++|.+||...+..+....+......          
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~----------  226 (282)
T cd06643         157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP----------  226 (282)
T ss_pred             ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC----------
Confidence                   3567899999874    2234778999999999999999999999877655554444321100          


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                               .       ...+..++.++.+||.+||..||.+|||++++++||||...
T Consensus       227 ---------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         227 ---------T-------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             ---------C-------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence                     0       00123468899999999999999999999999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=314.37  Aligned_cols=217  Identities=24%  Similarity=0.398  Sum_probs=178.8

Q ss_pred             eceecccCceEEEEEEECCCCcEEEEEEcccccccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeeccC-Cc
Q 015672           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ET  165 (403)
Q Consensus        87 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~  165 (403)
                      ++.||+|+.|.||+|+.+  ++.||||+++.   ..+.+|.-|++|+|+|||.+.++|     .....+|||||||. |-
T Consensus       129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e---lkETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE---LKETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhccCcccceeeeecc--CceehhHHHhh---hhhhhHHHHHhccCcceeeEeeee-----cCCceeEEeeecccccc
Confidence            567999999999999976  88999998753   345689999999999999999999     55566999999998 66


Q ss_pred             HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc------------------eeec
Q 015672          166 VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV------------------SYIC  227 (403)
Q Consensus       166 l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~------------------~~~~  227 (403)
                      |..+++.    ...+.......|..+|+.|+.|||. ++|||||||.-||||..+..+                  .++|
T Consensus       199 L~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~-hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaG  273 (904)
T KOG4721|consen  199 LYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHL-HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAG  273 (904)
T ss_pred             HHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHH-hhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhh
Confidence            7666654    5678888888999999999999999 799999999999999866544                  4568


Q ss_pred             cccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCC
Q 015672          228 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP  307 (403)
Q Consensus       228 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (403)
                      |..|||||++.+. +.+.|+|||||||+||||+||..||.+.+....+.-    .|.                       
T Consensus       274 TVaWMAPEvIrne-PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG----VGs-----------------------  325 (904)
T KOG4721|consen  274 TVAWMAPEVIRNE-PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG----VGS-----------------------  325 (904)
T ss_pred             hHhhhCHHHhhcC-CcccccceehhHHHHHHHHhcCCCccccchheeEEe----ccC-----------------------
Confidence            9999999999655 599999999999999999999999976553322110    011                       


Q ss_pred             CCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          308 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       308 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      ..+.-..+..+++.++-||+.||+-.|..||++.++|.|
T Consensus       326 NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  326 NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence            011112346788999999999999999999999999998

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5e-39  Score=300.82  Aligned_cols=243  Identities=21%  Similarity=0.340  Sum_probs=186.4

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcC-CCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|...+.||+|+||.||++.+..+++.||+|.+....     ....+|+.++.++. |+||+++++++...     ...+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-----~~~~   79 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-----GDCW   79 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-----CcEE
Confidence            4677889999999999999999999999999886432     22346888999996 99999999987432     3377


Q ss_pred             EEeeccCCcHHHHHHHh-hhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------
Q 015672          157 LVLEYVPETVNRIARNY-SRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------  225 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~-~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------  225 (403)
                      ++|||+..++..+.... ......+++..+..++.|++.||+|||+..+|+||||||+|||++.++.+++          
T Consensus        80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            99999987766654332 2223668999999999999999999997349999999999999987654432          


Q ss_pred             --------eccccccchhhhhCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          226 --------ICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~--~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                              .+++.|+|||++.+.  ..++.++|||||||++|+|++|+.||.....  ....+.+.....          
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~----------  227 (288)
T cd06616         160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGD----------  227 (288)
T ss_pred             cCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCC----------
Confidence                    356789999998654  3589999999999999999999999976541  222222211100          


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                            .+...     ...+..++.++.+||.+||+.||++|||++++++||||+...
T Consensus       228 ------~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         228 ------PPILS-----NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             ------CCcCC-----CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence                  00000     001134788999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.5e-39  Score=297.67  Aligned_cols=233  Identities=26%  Similarity=0.365  Sum_probs=181.6

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      .+|++.+.||+|+||.||+|++..+++.||+|++....    ....+|+.+++.++|+||+++++.+..     ....++
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-----~~~~~i   83 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-----REKLWI   83 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-----CCEEEE
Confidence            35999999999999999999999999999999885432    234579999999999999999988743     335889


Q ss_pred             EeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      ||||+++ +|..++..    ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+++           
T Consensus        84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          84 CMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHS-KGKMHRDIKGANILLTDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence            9999984 66555432    3568899999999999999999999 89999999999999987654432           


Q ss_pred             --------eccccccchhhhhC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          226 --------ICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~--~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                              .+++.|+|||.+..  ...++.++|||||||++|+|++|..||...+..+....+...              
T Consensus       159 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~--------------  224 (267)
T cd06646         159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS--------------  224 (267)
T ss_pred             cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC--------------
Confidence                    35678999998742  334778999999999999999999999654432221111110              


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  348 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~  348 (403)
                         .+..+     .+.  ....++..+.+||++||..||++|||++++++|+|
T Consensus       225 ---~~~~~-----~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         225 ---NFQPP-----KLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             ---CCCCC-----CCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence               00000     000  11346889999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-39  Score=304.88  Aligned_cols=237  Identities=26%  Similarity=0.418  Sum_probs=179.2

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcC-CCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~  153 (403)
                      ...|++++.||+||.+.||++.. .+.+.||+|++....      ....+|+..|.+|+ |.+||+++++-.+     +.
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-----d~  433 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-----DG  433 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-----Cc
Confidence            34699999999999999999987 445667777664221      22357999999994 8999999997633     56


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCC-------------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE-------------  220 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~-------------  220 (403)
                      ++||||||-+.+|..++....   ..++..+++.|..|++.|+.++|. .||||.||||.|+|+-..             
T Consensus       434 ~lYmvmE~Gd~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~-~gIVHSDLKPANFLlVkG~LKLIDFGIA~aI  509 (677)
T KOG0596|consen  434 YLYMVMECGDIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQ-HGIVHSDLKPANFLLVKGRLKLIDFGIANAI  509 (677)
T ss_pred             eEEEEeecccccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHH-hceeecCCCcccEEEEeeeEEeeeechhccc
Confidence            799999999989988887643   234445889999999999999999 899999999999997421             


Q ss_pred             --CC-----ceeeccccccchhhhhCCC----------CCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 015672          221 --PN-----VSYICSRYYRAPELIFGAT----------EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG  283 (403)
Q Consensus       221 --~~-----~~~~~t~~y~aPE~~~~~~----------~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~  283 (403)
                        ..     -..+||+.||+||.+....          ..+.++||||||||||+|+.|++||....+  .+ ..+..+.
T Consensus       510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--~~-aKl~aI~  586 (677)
T KOG0596|consen  510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--QI-AKLHAIT  586 (677)
T ss_pred             CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--HH-HHHHhhc
Confidence              11     1346999999999984221          256799999999999999999999953321  11 2222222


Q ss_pred             CCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          284 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                      .|.           .++.||.+..           ..++.++++.||.+||++|||..++|+|||++-.
T Consensus       587 ~P~-----------~~Iefp~~~~-----------~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  587 DPN-----------HEIEFPDIPE-----------NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             CCC-----------ccccccCCCC-----------chHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence            222           1223333221           2239999999999999999999999999999764

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.1e-38  Score=295.04  Aligned_cols=232  Identities=28%  Similarity=0.500  Sum_probs=183.4

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEccccc----------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      |+..+.||+|+||.||++.+..+++.||+|++....          ....+|+.+++.++|+||+++++.+     .+..
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~   76 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CEDS   76 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccCC
Confidence            788899999999999999999999999999885422          2335799999999999999999987     3444


Q ss_pred             EEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC-ce-------
Q 015672          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN-VS-------  224 (403)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~-~~-------  224 (403)
                      .+++||||+.+ +|.+++..    ...+++..+..++.||+.||.|||+ +|++||||||+||+++.++. ++       
T Consensus        77 ~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~-~~i~H~~i~~~nil~~~~~~~~~l~dfg~~  151 (268)
T cd06630          77 HFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGAA  151 (268)
T ss_pred             eEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEcccccc
Confidence            58899999984 66666543    3568889999999999999999999 89999999999999976543 21       


Q ss_pred             ----------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015672          225 ----------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  288 (403)
Q Consensus       225 ----------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~  288 (403)
                                      ..+|..|+|||++.+. .++.++|||||||++|+|++|..||...........+.+....    
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----  226 (268)
T cd06630         152 ARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA----  226 (268)
T ss_pred             cccccccccCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc----
Confidence                            1346679999998654 5889999999999999999999999755433222222211000    


Q ss_pred             HHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 015672          289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  350 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~  350 (403)
                                 ..         ...++..+++++.+++.+||..||.+|||+.++++||||+
T Consensus       227 -----------~~---------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         227 -----------TT---------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             -----------CC---------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                       00         0012245789999999999999999999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.9e-38  Score=291.53  Aligned_cols=230  Identities=26%  Similarity=0.456  Sum_probs=186.4

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccc------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|++.+.||+|+||.||++++..+++.||+|.+...      .....+|+.+++.++|+||+++++++     ....+.+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence            489999999999999999999999999999987532      12345799999999999999999887     3445689


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------  225 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------  225 (403)
                      +||||+. +++...+...  ....+++..+..++.|++.||.|||+ .+++|+||+|+|||++.++.++.          
T Consensus        76 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~  152 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN  152 (256)
T ss_pred             EEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence            9999997 4665554431  12357888899999999999999999 89999999999999987655432          


Q ss_pred             ---------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          226 ---------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       226 ---------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                               .+++.|+|||++.+. .++.++|+|||||++|+|++|..||...+..+....+....              
T Consensus       153 ~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~--------------  217 (256)
T cd08218         153 STVELARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS--------------  217 (256)
T ss_pred             cchhhhhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC--------------
Confidence                     256779999998654 48889999999999999999999998766555544443210              


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                           .+         ..+..++.++.++|.+||+.||.+||++.++++||||
T Consensus       218 -----~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         218 -----YP---------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             -----CC---------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                 00         0124578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.3e-38  Score=290.72  Aligned_cols=234  Identities=25%  Similarity=0.418  Sum_probs=188.6

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|++.+.||.|+||.||+|.+..+++.||+|.+....      .....|+++++.++|+||+++++.+..   .....++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence            4889999999999999999999999999999875322      123468999999999999999887643   2344578


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH-----hcCCccccccccccceecCCCCcee-----
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH-----NCIGICHRDIKPQNLLVKGEPNVSY-----  225 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH-----~~~~ivHrDlKp~NILl~~~~~~~~-----  225 (403)
                      ++|||++ ++|..++.........+++..+..++.||+.||.|||     + .+|+|+||||+||+++.++.+++     
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-~~i~h~dl~p~nili~~~~~~kl~d~g~  156 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG-NTVLHRDLKPANIFLDANNNVKLGDFGL  156 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc-CcceecCCCHHHEEEecCCCEEEecccc
Confidence            9999997 5777777654444567899999999999999999999     8 79999999999999987665432     


Q ss_pred             --------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015672          226 --------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       226 --------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  291 (403)
                                    .+++.|+|||++.+. .++.++|+|||||++|+|++|..||...+.......+...          
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------  225 (265)
T cd08217         157 AKILGHDSSFAKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG----------  225 (265)
T ss_pred             cccccCCcccccccccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC----------
Confidence                          457789999998654 4889999999999999999999999877643333222110          


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                               ..+         .++...+.++.+|+.+||..||++|||+.++++|||+
T Consensus       226 ---------~~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         226 ---------KFR---------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ---------CCC---------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                     000         1224578899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.6e-38  Score=293.46  Aligned_cols=237  Identities=27%  Similarity=0.386  Sum_probs=187.2

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      +|++.+.||.|+||+||+|....++..+|+|++....     ....+|+++++.++|+||+++++.+.     .....++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~i   76 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV-----VGDELWL   76 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe-----eCCEEEE
Confidence            5999999999999999999998899999999885432     23457999999999999999988773     3345889


Q ss_pred             EeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      +||++++ ++..++..... ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+++           
T Consensus        77 v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~-~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          77 VMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHS-NGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD  154 (267)
T ss_pred             EEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence            9999974 66555543211 2468889999999999999999999 89999999999999987654422           


Q ss_pred             ------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015672          226 ------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       226 ------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  293 (403)
                                  .++..|+|||++.....++.++|+|||||++|+|++|+.||...+....+..+...  .+.       
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~-------  225 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN--DPP-------  225 (267)
T ss_pred             CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC--CCC-------
Confidence                        35677999999866546899999999999999999999999876655444333321  000       


Q ss_pred             CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                           .  ++.   ..    ....+++++.+||.+||..||++|||+.++++||||
T Consensus       226 -----~--~~~---~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         226 -----S--LET---GA----DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             -----C--cCC---cc----ccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence                 0  000   00    013578999999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.9e-38  Score=295.82  Aligned_cols=228  Identities=24%  Similarity=0.375  Sum_probs=175.0

Q ss_pred             eecccCceEEEEEEECCCCcEEEEEEcccccc-------cHHHHHHHHH---hcCCCCccccceEEeecCCCCceEEEEE
Q 015672           89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQ---MLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        89 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~---~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      .||+|+||.||++.+..+++.+|+|.+.+...       ...+|..+++   ..+|+||+.+++.+..     ....++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCeEEEE
Confidence            48999999999999999999999998854321       1223443333   3479999999887733     3348899


Q ss_pred             eeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------------
Q 015672          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------------  225 (403)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------------  225 (403)
                      |||++ ++|...+..    ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++.            
T Consensus        76 ~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~  150 (279)
T cd05633          76 LDLMNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (279)
T ss_pred             EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCCCCCHHHEEECCCCCEEEccCCcceecccc
Confidence            99998 455544432    3568999999999999999999999 89999999999999986654432            


Q ss_pred             -----eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCCHHHHhhcCcCcc
Q 015672          226 -----ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD--QLVEIIKVLGTPTREEIKCMNPNYT  298 (403)
Q Consensus       226 -----~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~  298 (403)
                           .+|+.|+|||++.+...++.++|||||||++|+|++|..||.......  .+......                 
T Consensus       151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-----------------  213 (279)
T cd05633         151 KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-----------------  213 (279)
T ss_pred             CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc-----------------
Confidence                 368889999998644558999999999999999999999997543221  11111100                 


Q ss_pred             ccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCCC
Q 015672          299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  354 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~~  354 (403)
                                 ....++..++.++.+||.+||..||.+|+     |+.++++||||+++..
T Consensus       214 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~  263 (279)
T cd05633         214 -----------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW  263 (279)
T ss_pred             -----------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence                       00012345789999999999999999999     6999999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-38  Score=293.37  Aligned_cols=260  Identities=34%  Similarity=0.612  Sum_probs=199.0

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhc---CCCCccccceEEeecCCCCceE
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQML---DHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      |.+.+.||+|+||.||+|+++.+++.||+|.+....      ....+|+.+++++   +|+||+++++++..........
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            678899999999999999998889999999985321      1234577777666   5999999999986654444556


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee--------
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI--------  226 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~--------  226 (403)
                      ++++|||+.+++..++....  ...+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.+++.        
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~-~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~  157 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHS-HRIVHRDLKPQNILVTSDGQVKIADFGLARIY  157 (287)
T ss_pred             eEEEehhcccCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence            89999999987766654322  2358899999999999999999999 899999999999999887665432        


Q ss_pred             ----------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          227 ----------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       227 ----------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                                ++..|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+.... .
T Consensus       158 ~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  235 (287)
T cd07838         158 SFEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV-S  235 (287)
T ss_pred             cCCcccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc-c
Confidence                      45679999998654 48899999999999999999999999988888888887766554433221110 0


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                      .....++......+. .....+++.+.+||.+||+.||.+||++.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         236 LPRSSFPSYTPRSFK-SFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             cchhhcccccccchh-hhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            000111111111111 1123567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.7e-38  Score=290.29  Aligned_cols=230  Identities=27%  Similarity=0.433  Sum_probs=185.9

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+....      ....+|+++++.++|+||+++++.+.     .....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL-----EDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe-----cCCEEE
Confidence            4899999999999999999999999999999885432      23457999999999999999998773     344588


Q ss_pred             EEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc-e----------
Q 015672          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-S----------  224 (403)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~-~----------  224 (403)
                      +||||+++ +|.+++....  ...+++..+..++.|++.||.|||+ +||+||||||+||+++.++.. +          
T Consensus        76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             EEEecCCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            99999974 7766665422  3457888999999999999999999 899999999999999755432 1          


Q ss_pred             --------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          225 --------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       225 --------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                              ..++..|+|||.+.+. .++.++|||||||++|+|++|..||.+.+.......+......            
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~------------  219 (256)
T cd08220         153 SSKSKAYTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA------------  219 (256)
T ss_pred             CCCccccccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC------------
Confidence                    2356789999998654 4789999999999999999999999877655544443321000            


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                                      .++..++.++.++|.+||..||++|||+.|+++||||
T Consensus       220 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         220 ----------------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             ----------------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                            0123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.1e-38  Score=299.40  Aligned_cols=236  Identities=28%  Similarity=0.432  Sum_probs=187.7

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      .|.....||+|+||.||++.+..++..||||.+....    ....+|+.+++.++|+||+++++.+.     ...+.++|
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~lv   97 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWVV   97 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEEE
Confidence            3566778999999999999998899999999875322    23457999999999999999999873     33458999


Q ss_pred             eeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-------------
Q 015672          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-------------  224 (403)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-------------  224 (403)
                      |||+++ ++..++.     ...+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.++             
T Consensus        98 ~e~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~  171 (292)
T cd06658          98 MEFLEGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHN-QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE  171 (292)
T ss_pred             EeCCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence            999985 4544432     2468889999999999999999999 8999999999999998765443             


Q ss_pred             ------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 015672          225 ------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  298 (403)
Q Consensus       225 ------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  298 (403)
                            ..++..|+|||++.+. .++.++|||||||++|||++|..||.+.+....+..+.......             
T Consensus       172 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------------  237 (292)
T cd06658         172 VPKRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR-------------  237 (292)
T ss_pred             cccCceeecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc-------------
Confidence                  2357789999998554 58899999999999999999999998776555443332211000             


Q ss_pred             ccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCC
Q 015672          299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  356 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~  356 (403)
                         ++          ....++..+.+||.+||..||.+|||++++++||||+....|.
T Consensus       238 ---~~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         238 ---VK----------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             ---cc----------cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence               00          0124688999999999999999999999999999999865543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2e-38  Score=293.51  Aligned_cols=226  Identities=21%  Similarity=0.283  Sum_probs=178.6

Q ss_pred             ccEeeeceecccCceEEEEEEEC---CCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      .+|.+.+.||+|+||.||+|.++   ..+..||+|.+....     ....+|+.+++.++||||+++++++..     ..
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~   79 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-----GN   79 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-----CC
Confidence            35999999999999999999865   346689999886432     133479999999999999999998732     33


Q ss_pred             EEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee------
Q 015672          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI------  226 (403)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~------  226 (403)
                      +.++||||+++ +|..++...   ...+++..+..++.||+.||+|||+ .|++||||||+|||++.++..+..      
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~-~~iiH~dikp~nili~~~~~~~l~dfg~~~  155 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSE-MGYVHKGLAAHKVLVNSDLVCKISGFRRLQ  155 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeeccccHhhEEEcCCCcEEECCCcccc
Confidence            58899999985 565555432   2468899999999999999999999 899999999999999876544321      


Q ss_pred             --------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015672          227 --------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       227 --------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  291 (403)
                                    ++..|+|||++.+. .++.++|||||||++||+++ |..||.+.+..+.+..+.....        
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~--------  226 (266)
T cd05064         156 EDKSEAIYTTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR--------  226 (266)
T ss_pred             cccccchhcccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC--------
Confidence                          24579999998654 58999999999999999775 9999988776555444322100        


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                .+          .+..++..+.+++.+||+.||.+||++.++++
T Consensus       227 ----------~~----------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         227 ----------LP----------APRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             ----------CC----------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                      00          12457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-39  Score=311.83  Aligned_cols=229  Identities=29%  Similarity=0.445  Sum_probs=186.3

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccccHHHHHHHHHhc-CCCCccccceEEeecCCCCceEEEEE
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      ....|.+...+|.|+|+.|-.|.+..+++.+++|++.+......+|+.++... +|+||+++++.+     .+..+.|+|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~~~v  394 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEIYLV  394 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCceeeee
Confidence            45579999999999999999999999999999999987766677888776665 799999999988     666679999


Q ss_pred             eeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccccccee-cCCCCceee-----------
Q 015672          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV-KGEPNVSYI-----------  226 (403)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl-~~~~~~~~~-----------  226 (403)
                      ||++.|...  ++...  ..+.....+..|+.||+.|+.|||+ +|||||||||+|||+ +..+++.++           
T Consensus       395 ~e~l~g~el--l~ri~--~~~~~~~e~~~w~~~lv~Av~~LH~-~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  395 MELLDGGEL--LRRIR--SKPEFCSEASQWAAELVSAVDYLHE-QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             ehhccccHH--HHHHH--hcchhHHHHHHHHHHHHHHHHHHHh-cCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            999986331  22211  1223336777899999999999999 899999999999999 466655432           


Q ss_pred             -----ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccC
Q 015672          227 -----CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  301 (403)
Q Consensus       227 -----~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  301 (403)
                           -|..|.|||++. ...|+.+|||||||++||+|++|+.||......   ..+...++.+..              
T Consensus       470 ~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~--------------  531 (612)
T KOG0603|consen  470 CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKF--------------  531 (612)
T ss_pred             hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCcc--------------
Confidence                 266799999996 556999999999999999999999999876655   233333333321              


Q ss_pred             CCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       302 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                                   ...+|.+++|||++||+.||.+|+++.+++.||||
T Consensus       532 -------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  532 -------------SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             -------------ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                         14689999999999999999999999999999999

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.3e-38  Score=297.17  Aligned_cols=235  Identities=28%  Similarity=0.505  Sum_probs=188.0

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      +|++.+.||+|+||.||++.+..+++.||+|.+....       ....+|+++++.++|+||+++++.+     ....++
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRHL   76 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCEE
Confidence            5899999999999999999999999999999885432       1234689999999999999999887     334468


Q ss_pred             EEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      ++||||+++ +|..++..    ...+++..+..++.|++.||.|||+ .+|+||||||+||+++..+.++.         
T Consensus        77 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~  151 (305)
T cd05609          77 CMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHN-YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIG  151 (305)
T ss_pred             EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHEEECCCCCEEEeeCCCcccc
Confidence            999999984 66666543    3568889999999999999999999 89999999999999986654322         


Q ss_pred             -------------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 015672          226 -------------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK  280 (403)
Q Consensus       226 -------------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~  280 (403)
                                               .++..|+|||.+.+. .++.++|||||||++|+|++|..||.+.+..+.+..+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~  230 (305)
T cd05609         152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS  230 (305)
T ss_pred             CcCccccccccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence                                     245679999998654 589999999999999999999999987765544444332


Q ss_pred             HhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCcccCCC
Q 015672          281 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVHPFFDELRD  354 (403)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---a~e~l~hp~f~~~~~  354 (403)
                      ..                 ...+.         ....++.++.+||.+||+.||++||+   +.++++||||.....
T Consensus       231 ~~-----------------~~~~~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~  281 (305)
T cd05609         231 DD-----------------IEWPE---------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW  281 (305)
T ss_pred             cc-----------------cCCCC---------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence            10                 00000         01247889999999999999999997   799999999977543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-39  Score=310.17  Aligned_cols=237  Identities=28%  Similarity=0.409  Sum_probs=196.2

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccccc------HHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY------KNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ....|.+.+.||+|.|++|.+|++..++..||||.+.+....      ..+|+++|+.|+|||||+++.+..+...    
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~----  129 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT----  129 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce----
Confidence            344599999999999999999999999999999998654322      3579999999999999999999855444    


Q ss_pred             EEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc---------
Q 015672          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV---------  223 (403)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~---------  223 (403)
                       +|+||||+.+ .+.+++.    .++++.+..++.++.|++.|++|||+ ++|||||||++||||+.+.++         
T Consensus       130 -lylV~eya~~ge~~~yl~----~~gr~~e~~ar~~F~q~vsaveYcH~-k~ivHrdLk~eNilL~~~mnikIaDfgfS~  203 (596)
T KOG0586|consen  130 -LYLVMEYASGGELFDYLV----KHGRMKEKEARAKFRQIVSAVEYCHS-KNIVHRDLKAENILLDENMNIKIADFGFST  203 (596)
T ss_pred             -eEEEEEeccCchhHHHHH----hcccchhhhhhhhhHHHHHHHHHHhh-cceeccccchhhcccccccceeeeccccce
Confidence             9999999984 4444433    35778889999999999999999999 899999999999999877655         


Q ss_pred             ---------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          224 ---------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       224 ---------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                               +++|++.|.|||++.+..+.++.+|+||+|+++|-|+.|..||.+.+-.+.-...+.              
T Consensus       204 ~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~--------------  269 (596)
T KOG0586|consen  204 FFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR--------------  269 (596)
T ss_pred             eecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee--------------
Confidence                     346899999999999888889999999999999999999999988764332211111              


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                         ..+.            ++-.++.++.+||+++|..+|.+|++.+++++|.|.......
T Consensus       270 ---gk~r------------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  270 ---GKYR------------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             ---eeec------------ccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence               1111            224578999999999999999999999999999999876544

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.4e-38  Score=291.61  Aligned_cols=231  Identities=29%  Similarity=0.469  Sum_probs=182.0

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      +|.+.+.||+|+||.||+|.+..+++.||||.+..+.         ....+|+++++.++|+||+++++++..   ....
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~   79 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PMER   79 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCCc
Confidence            5999999999999999999999999999999874321         123469999999999999999987632   2234


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------  225 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------  225 (403)
                      .++++|||++ ++|.+.+..    ...+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.+++       
T Consensus        80 ~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          80 TLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHS-NMIVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             eEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecCCCCEEECcCcccc
Confidence            5789999997 466655443    3457888899999999999999999 89999999999999986654322       


Q ss_pred             ---------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          226 ---------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       226 ---------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                     .++..|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+..   .+.    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~----  226 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT----  226 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCC----
Confidence                           356679999998654 588999999999999999999999976644433322211   110    


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  350 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~  350 (403)
                                          ....+..++..+.++|.+|| .+|++||+++++++|||++
T Consensus       227 --------------------~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         227 --------------------NPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRHTFVH  265 (265)
T ss_pred             --------------------CCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcCcccC
Confidence                                00122456788999999999 4999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.5e-38  Score=290.55  Aligned_cols=232  Identities=29%  Similarity=0.466  Sum_probs=185.9

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc--ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      .+|++.+.||+|+||.||+|....+++.+|+|.+....  ....+|+++++.++|+||+++++.+..     ..++|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK-----NTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCcEEEEE
Confidence            45999999999999999999999889999999886442  345689999999999999999998843     34588999


Q ss_pred             eccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------------
Q 015672          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------------  225 (403)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------------  225 (403)
                      ||+++ +|.+++..   ....+++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.+++             
T Consensus        78 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (256)
T cd06612          78 EYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHS-NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM  153 (256)
T ss_pred             ecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence            99984 66555432   23568899999999999999999999 89999999999999987765432             


Q ss_pred             ------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 015672          226 ------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  299 (403)
Q Consensus       226 ------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  299 (403)
                            .++..|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+...   .              
T Consensus       154 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~--------------  215 (256)
T cd06612         154 AKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---P--------------  215 (256)
T ss_pred             cccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---C--------------
Confidence                  246689999998654 5899999999999999999999999765543322211110   0              


Q ss_pred             cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                             ...+  ..+..++.++.+||.+||+.||++|||+.|+++||||
T Consensus       216 -------~~~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         216 -------PPTL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             -------CCCC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence                   0000  0123467899999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-39  Score=294.76  Aligned_cols=233  Identities=28%  Similarity=0.442  Sum_probs=195.1

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc-------cHHHHHHHHHhc-CCCCccccceEEeecCCCCce
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  153 (403)
                      .+|..+.+||+|+||+|.+|..+.+.+.||||+++++--       ....|.++|... +-|.+++++.+|.+.     .
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm-----D  423 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM-----D  423 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh-----h
Confidence            458899999999999999999999999999999876421       123577777766 457788888877332     3


Q ss_pred             EEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------
Q 015672          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------  224 (403)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------  224 (403)
                      .+|+||||+.| +|-.-+++    -+++.+..+..|+..|+-||-|||+ +|||.||||.+||||+.+++++        
T Consensus       424 RLyFVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~-kgIiYRDLKLDNvmLd~eGHiKi~DFGmcK  498 (683)
T KOG0696|consen  424 RLYFVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCK  498 (683)
T ss_pred             heeeEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhc-CCeeeeeccccceEeccCCceEeeeccccc
Confidence            38999999985 44333333    3678888999999999999999999 8999999999999999988763        


Q ss_pred             -----------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015672          225 -----------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       225 -----------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  293 (403)
                                 ++|||-|+|||++. ..+|+.++|.||+||+||||+.|++||.++++.+.++.|...-           
T Consensus       499 Eni~~~~TTkTFCGTPdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn-----------  566 (683)
T KOG0696|consen  499 ENIFDGVTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN-----------  566 (683)
T ss_pred             ccccCCcceeeecCCCcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc-----------
Confidence                       56899999999985 4569999999999999999999999999999999999887631           


Q ss_pred             CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCcccCCC
Q 015672          294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRD  354 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta-----~e~l~hp~f~~~~~  354 (403)
                                        ..++..+|.++.+++..+|...|.+|..+     .++-.||||+.+.+
T Consensus       567 ------------------vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW  614 (683)
T KOG0696|consen  567 ------------------VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW  614 (683)
T ss_pred             ------------------CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence                              12446799999999999999999999854     67999999998865

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.4e-38  Score=292.95  Aligned_cols=247  Identities=24%  Similarity=0.398  Sum_probs=187.4

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      +|...+.||.|++|.||+|.+..+++.+|+|.+....     ....+|+++++.++|+||+++++++..   .....+++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~l   78 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIGI   78 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEEE
Confidence            4899999999999999999999999999999886432     234579999999999999999988743   22345789


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      ||||++ ++|.+++.........+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++.+++           
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS-RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999997 47766655443334568888999999999999999999 89999999999999987665433           


Q ss_pred             ------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          226 ------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--VDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       226 ------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                            .++..|+|||.+.+. .++.++|||||||++|+|++|..||.....  .... .....+......         
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~---------  226 (287)
T cd06621         158 SLAGTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI-ELLSYIVNMPNP---------  226 (287)
T ss_pred             cccccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChH-HHHHHHhcCCch---------
Confidence                  246679999998554 589999999999999999999999976522  0001 111111100000         


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                         .++..   +   ......++.+.+||.+||..||.+|||+.|+++||||+...
T Consensus       227 ---~~~~~---~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         227 ---ELKDE---P---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             ---hhccC---C---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence               00000   0   00023467899999999999999999999999999997654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.5e-38  Score=299.03  Aligned_cols=235  Identities=26%  Similarity=0.389  Sum_probs=188.6

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ..|.+.+.||+|+||.||+|....+++.||+|++....       ....+|+++++.++||||+++++++...     ..
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-----~~   89 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-----HT   89 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-----Ce
Confidence            34999999999999999999999899999999875321       1234799999999999999999988532     34


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      .++||||+.+++..++...   ...+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+++         
T Consensus        90 ~~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~-~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~  165 (307)
T cd06607          90 AWLVMEYCLGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHS-HERIHRDIKAGNILLTEPGTVKLADFGSASLV  165 (307)
T ss_pred             EEEEHHhhCCCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEECCCCCEEEeecCcceec
Confidence            7899999998876655432   3468899999999999999999999 89999999999999988766543         


Q ss_pred             ------eccccccchhhhhC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          226 ------ICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       226 ------~~t~~y~aPE~~~~--~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                            .+++.|+|||++.+  ...++.++|||||||++|+|++|.+||.+.+.......+...  .+            
T Consensus       166 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~------------  231 (307)
T cd06607         166 SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DS------------  231 (307)
T ss_pred             CCCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CC------------
Confidence                  35678999998742  345788999999999999999999999877655443333211  00            


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                           +..        .....+..+.+||.+||..||++||++.+++.||||..-
T Consensus       232 -----~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         232 -----PTL--------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             -----CCC--------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence                 000        012357889999999999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.9e-38  Score=291.57  Aligned_cols=234  Identities=32%  Similarity=0.541  Sum_probs=182.7

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc--------------ccHHHHHHHHHhcCCCCccccceEEeecC
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------------RYKNRELQIMQMLDHPNIVALKHCFFSTT  148 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  148 (403)
                      +|.+.+.||.|+||.||+|.+..+++.||+|.+....              ....+|+.+++.++|+||+++++++.   
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---   78 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET---   78 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec---
Confidence            4899999999999999999998899999999874211              12346899999999999999998773   


Q ss_pred             CCCceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee--
Q 015672          149 DKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY--  225 (403)
Q Consensus       149 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~--  225 (403)
                        ....+++||||++ ++|...+..    ...++...++.++.||+.||.|||+ .+++||||||+||+++.++.+++  
T Consensus        79 --~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~~~nil~~~~~~~~l~d  151 (272)
T cd06629          79 --TEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHS-KGILHRDLKADNLLVDADGICKISD  151 (272)
T ss_pred             --cCCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCeeecCCChhhEEEcCCCeEEEee
Confidence              3345889999997 466655543    2568888999999999999999999 89999999999999986654432  


Q ss_pred             -------------------eccccccchhhhhCCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 015672          226 -------------------ICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP  285 (403)
Q Consensus       226 -------------------~~t~~y~aPE~~~~~~-~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~  285 (403)
                                         .++..|+|||++.... .++.++|+|||||++|++++|..||...+..+.+..+...... 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-  230 (272)
T cd06629         152 FGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA-  230 (272)
T ss_pred             ccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccC-
Confidence                               2466799999986543 4789999999999999999999999765544333222110000 


Q ss_pred             CHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          286 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                                            ..+.......++.++.+||.+||..||.+|||++++++||||
T Consensus       231 ----------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         231 ----------------------PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             ----------------------CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                                  000011123578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-38  Score=289.41  Aligned_cols=234  Identities=28%  Similarity=0.413  Sum_probs=185.5

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      .+|++.+.||.|+||.||+|.+..+++.+|+|++....    ....+|+++++.++|+||+++++.+..     ...+|+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-----RDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-----CCEEEE
Confidence            45999999999999999999999899999999886432    234579999999999999999988733     345899


Q ss_pred             EeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      +|||+++ ++..++...   ...+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.+++           
T Consensus        78 ~~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          78 VMEYCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHE-TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             EEeCCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            9999985 555544331   2568899999999999999999999 89999999999999997665433           


Q ss_pred             --------eccccccchhhhhCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          226 --------ICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~--~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                              .++..|+|||.+.+.  ..++.++|||||||++|+|++|.+||...+.......+....-.+.         
T Consensus       154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~---------  224 (262)
T cd06613         154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP---------  224 (262)
T ss_pred             hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc---------
Confidence                    346679999998543  2578899999999999999999999987765544433322100000         


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  348 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~  348 (403)
                              ..       ......+.++.+||.+||..||.+|||+.+++.|||
T Consensus       225 --------~~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         225 --------KL-------KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             --------cc-------cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                    00       011345778999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=7e-38  Score=287.74  Aligned_cols=229  Identities=34%  Similarity=0.551  Sum_probs=183.3

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEccccc---------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      |+..+.||+|+||+||+|....+++.||+|.+....         ....+|+++++.++|+||+++++++     .....
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~   76 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REEDN   76 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCCe
Confidence            778899999999999999998899999999875322         2245799999999999999999877     33345


Q ss_pred             EEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee--------
Q 015672          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY--------  225 (403)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~--------  225 (403)
                      +++++||+++ +|..++..    ...+++..+..++.||+.||.|||+ .||+|+||+|+||+++.++.+++        
T Consensus        77 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~  151 (258)
T cd06632          77 LYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHD-RNTVHRDIKGANILVDTNGVVKLADFGMAKQ  151 (258)
T ss_pred             EEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEccCcccee
Confidence            8899999984 66655543    3457888899999999999999999 89999999999999987665433        


Q ss_pred             ----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          226 ----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       226 ----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                .++..|+|||.+.....++.++|+|||||++|+|++|..||...........+.....            
T Consensus       152 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~------------  219 (258)
T cd06632         152 VVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE------------  219 (258)
T ss_pred             ccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc------------
Confidence                      2567799999985443378999999999999999999999976654333333221100            


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                            .+         .++..+++++.+|+.+||+.||.+|||+.+++.|||+
T Consensus       220 ------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         220 ------LP---------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             ------CC---------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                  00         0224578999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.5e-38  Score=293.35  Aligned_cols=224  Identities=16%  Similarity=0.188  Sum_probs=177.9

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEee
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  160 (403)
                      ..||+|++|.||+|..  +|+.||||.+....       ....+|+.+|++++||||+++++++.... ....++++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence            5699999999999997  58899999986432       22348999999999999999999875421 22345889999


Q ss_pred             ccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee--------------
Q 015672          161 YVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY--------------  225 (403)
Q Consensus       161 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~--------------  225 (403)
                      |+.+ +|.+++..    ...++......++.|++.||.|||+..+++||||||+|||++.++.++.              
T Consensus       103 y~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~  178 (283)
T PHA02988        103 YCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPF  178 (283)
T ss_pred             eCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccccc
Confidence            9994 67666543    3567888889999999999999997348999999999999998765543              


Q ss_pred             --eccccccchhhhhCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCC
Q 015672          226 --ICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  302 (403)
Q Consensus       226 --~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  302 (403)
                        ++|..|+|||++.+. ..++.++|||||||++|||++|+.||.+.+..+....+......+               . 
T Consensus       179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~---------------~-  242 (283)
T PHA02988        179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL---------------K-  242 (283)
T ss_pred             cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC---------------C-
Confidence              357789999998542 458999999999999999999999998877655554443311110               0 


Q ss_pred             CCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       303 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                 ++...++++.+||.+||+.||++|||+.++++
T Consensus       243 -----------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        243 -----------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             -----------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                       12346889999999999999999999999985

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-40  Score=307.11  Aligned_cols=232  Identities=30%  Similarity=0.514  Sum_probs=190.7

Q ss_pred             Eee--eceecccCceEEEEEEECCCCcEEEEEEcccc------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           84 YIA--EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        84 y~~--~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      |++  .++||+|.||+||-|+++++|+.||||++.+.      ......|+.||+.+.||.||.+.-.|.+     ...+
T Consensus       564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET-----~erv  638 (888)
T KOG4236|consen  564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET-----PERV  638 (888)
T ss_pred             HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC-----CceE
Confidence            544  57899999999999999999999999998532      2345679999999999999998777633     3348


Q ss_pred             EEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC-------------
Q 015672          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN-------------  222 (403)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~-------------  222 (403)
                      +.|||.+.|++...+...  ..+++++...+.++.||+.||.|||. ++|+|+||||+|||+.....             
T Consensus       639 FVVMEKl~GDMLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~-knIvHCDLKPENVLLas~~~FPQvKlCDFGfAR  715 (888)
T KOG4236|consen  639 FVVMEKLHGDMLEMILSS--EKGRLPERITKFLVTQILVALRYLHF-KNIVHCDLKPENVLLASASPFPQVKLCDFGFAR  715 (888)
T ss_pred             EEEehhhcchHHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhh-cceeeccCCchheeeccCCCCCceeecccccee
Confidence            899999999877665433  35789999999999999999999998 89999999999999965422             


Q ss_pred             --------ceeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHHhhc
Q 015672          223 --------VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       223 --------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~  293 (403)
                              -+.+|||.|.|||++.+. .|+..-||||.|||+|.-+.|..||..+.+. +++++.               
T Consensus       716 iIgEksFRrsVVGTPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNA---------------  779 (888)
T KOG4236|consen  716 IIGEKSFRRSVVGTPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNA---------------  779 (888)
T ss_pred             ecchhhhhhhhcCCccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccchhHHhhcc---------------
Confidence                    135689999999999654 5999999999999999999999999654432 333321               


Q ss_pred             CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                           .|-   +++.||     ..+++++.|||.++|+..-++|.+.+..|.|||+++.
T Consensus       780 -----aFM---yPp~PW-----~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  780 -----AFM---YPPNPW-----SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             -----ccc---cCCCch-----hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence                 122   234566     4689999999999999999999999999999999875

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=7.6e-38  Score=287.46  Aligned_cols=230  Identities=27%  Similarity=0.431  Sum_probs=184.1

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccc------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|.+.+.||+|+||.||+|.++.++..+|+|.+...      .....+|+++++.++|+||+++++.+     ....+.+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence            388999999999999999999999999999988532      22345799999999999999999887     3344689


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc-e----------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-S----------  224 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~-~----------  224 (403)
                      +|+||++ ++|.+.+...  ....+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.. +          
T Consensus        76 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             EEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            9999997 4665555432  12357888999999999999999999 899999999999999866432 1          


Q ss_pred             ---------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          225 ---------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       225 ---------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                               ..+++.|+|||++.+. .++.++|+|||||++|+|++|..||...+..+....+....             
T Consensus       153 ~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  218 (257)
T cd08225         153 NDSMELAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY-------------  218 (257)
T ss_pred             cCCcccccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-------------
Confidence                     1356779999988554 48899999999999999999999997765444433322110             


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                            ++.         ....++.++.++|.+||..+|++|||+.++++||||
T Consensus       219 ------~~~---------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         219 ------FAP---------ISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             ------CCC---------CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                  000         113467899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.2e-38  Score=299.15  Aligned_cols=263  Identities=21%  Similarity=0.319  Sum_probs=181.0

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      |.+.+.+|.|  |.||+++...+++.||||++....      ....+|+++++.++|+||+++++++..     ....++
T Consensus         4 ~~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-----~~~~~~   76 (314)
T cd08216           4 TLIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-----DSELYV   76 (314)
T ss_pred             hhhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-----CCeEEE
Confidence            3344444444  556666666789999999985431      234579999999999999999998843     344889


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      +|||++ +++..++....  ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.++.           
T Consensus        77 ~~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~-~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~  153 (314)
T cd08216          77 VSPLMAYGSCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHS-KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIK  153 (314)
T ss_pred             EEeccCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCcceEEEecCCceEEecCccceeecc
Confidence            999998 56666655432  3458889999999999999999999 89999999999999987554432           


Q ss_pred             ---------------eccccccchhhhhCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH-
Q 015672          226 ---------------ICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE-  288 (403)
Q Consensus       226 ---------------~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~-  288 (403)
                                     .++..|+|||++.+. ..++.++|||||||++|+|++|..||........+............. 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (314)
T cd08216         154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDK  233 (314)
T ss_pred             ccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcccccc
Confidence                           234569999998543 347899999999999999999999998765544332222111000000 


Q ss_pred             -HHhhcCcCccc----cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCC
Q 015672          289 -EIKCMNPNYTE----FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  357 (403)
Q Consensus       289 -~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~  357 (403)
                       ...........    ...+. ............++.++.+||.+||++||++|||+.++|+||||+.+..+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~~  306 (314)
T cd08216         234 STYPLYEDSMSQSRSSNEHPN-NRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNT  306 (314)
T ss_pred             CchhhhcCCcCcccccccccc-hhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccch
Confidence             00000000000    00000 0001111122345678999999999999999999999999999998864443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.6e-38  Score=290.19  Aligned_cols=228  Identities=30%  Similarity=0.482  Sum_probs=184.7

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      +|++.+.||.|+||.||+|++..+++.||+|.+.+..       ....+|++++++++||||+++++++     .+..+.
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence            3899999999999999999999899999999885432       2335799999999999999999887     444568


Q ss_pred             EEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee--------
Q 015672          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI--------  226 (403)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~--------  226 (403)
                      ++|+||+.+ +|...+..    ...+++..+..++.||+.||.|||+ ++|+|+||||+||+++.++.++++        
T Consensus        76 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~  150 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHS-KGIIHRDIKPDNILLDEQGHVHITDFNIATKV  150 (258)
T ss_pred             EEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEEcCCCCEEEeeccccccc
Confidence            999999974 56555443    2578899999999999999999999 899999999999999877665432        


Q ss_pred             ----------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCCHHHHhhcC
Q 015672          227 ----------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV--DQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       227 ----------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                ++..|+|||++.+. .++.++|+|||||++|+|++|..||...+..  +.+.....   ..         
T Consensus       151 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~---------  217 (258)
T cd05578         151 TPDTLTTSTSGTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE---TA---------  217 (258)
T ss_pred             CCCccccccCCChhhcCHHHHccc-CCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc---cc---------
Confidence                      45679999998654 4899999999999999999999999876642  22211111   00         


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH--HHHhcCCCc
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA--LEACVHPFF  349 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta--~e~l~hp~f  349 (403)
                                      ....+..++.++.++|.+||+.||.+||++  .|+++||||
T Consensus       218 ----------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         218 ----------------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ----------------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                            001224578999999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.4e-37  Score=285.76  Aligned_cols=230  Identities=31%  Similarity=0.480  Sum_probs=187.7

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      .|++.+.||.|+||.||.++...+++.+++|.+....      ....+|++++++++|+||+++++++..     ...++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-----DNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-----CCeEE
Confidence            3899999999999999999999999999999875321      224579999999999999999998843     34589


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------  225 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------  225 (403)
                      ++|||++ ++|...+....  ...+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+++          
T Consensus        76 ~~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~  152 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHK-AGILHRDIKTLNIFLTKAGLIKLGDFGISKILG  152 (256)
T ss_pred             EEEEecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence            9999997 57766654321  3458888999999999999999999 89999999999999987665432          


Q ss_pred             ---------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          226 ---------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       226 ---------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                               .+++.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+...  ...          
T Consensus       153 ~~~~~~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~----------  219 (256)
T cd08221         153 SEYSMAETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYT----------  219 (256)
T ss_pred             cccccccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCC----------
Confidence                     357889999998654 4788999999999999999999999877665555444321  000          


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                             .         .+..++.++.++|.+||..||.+||++.++++|||+
T Consensus       220 -------~---------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         220 -------P---------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             -------C---------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                   0         113468899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.1e-38  Score=293.00  Aligned_cols=238  Identities=27%  Similarity=0.422  Sum_probs=184.6

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      .+|++.+.||+|+||+||++.+..+++.||+|++....     ....+|+++++.++|+||+++++.+..     ..+++
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~   79 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-----ENNIC   79 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-----CCEEE
Confidence            45999999999999999999999999999999875432     234579999999999999999998843     34589


Q ss_pred             EEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-----------
Q 015672          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-----------  224 (403)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-----------  224 (403)
                      +||||+++ +|..++..    .+.++...+..++.|++.||.|||+..+|+||||||+||+++.++.+.           
T Consensus        80 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~  155 (284)
T cd06620          80 MCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI  155 (284)
T ss_pred             EEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence            99999984 55554433    356889999999999999999999635899999999999998765442           


Q ss_pred             ------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHH-------HHHHHHHhCCCCHHHHh
Q 015672          225 ------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-------LVEIIKVLGTPTREEIK  291 (403)
Q Consensus       225 ------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~-------~~~i~~~~~~~~~~~~~  291 (403)
                            ..++..|+|||++.+. .++.++|||||||++|+|++|..||......+.       +..........      
T Consensus       156 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------  228 (284)
T cd06620         156 NSIADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE------  228 (284)
T ss_pred             hhccCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc------
Confidence                  2467789999998654 588999999999999999999999976543210       11111110000      


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                               ..+.+        ....++.++.+||.+||+.||++|||+.|+++||||.+.
T Consensus       229 ---------~~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         229 ---------PPPRL--------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             ---------cCCCC--------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence                     00000        002367889999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.2e-37  Score=295.28  Aligned_cols=235  Identities=27%  Similarity=0.428  Sum_probs=188.7

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      .-|...+.||+|+||+||+|++..+++.||+|++....       ....+|+++++.++|+|++++++++..     ...
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~   95 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----EHT   95 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCE
Confidence            34777888999999999999999999999999885321       123468999999999999999998843     345


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      .|+||||+.+++..++...   ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++.++.         
T Consensus        96 ~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~  171 (313)
T cd06633          96 AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPGQVKLADFGSASKS  171 (313)
T ss_pred             EEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChhhEEECCCCCEEEeecCCCccc
Confidence            8899999998876655432   3568888999999999999999999 89999999999999987765543         


Q ss_pred             ------eccccccchhhhhC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          226 ------ICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       226 ------~~t~~y~aPE~~~~--~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                            .++..|+|||++..  ...++.++|||||||++|+|++|.+||...+.......+... ..             
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~~-------------  237 (313)
T cd06633         172 SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DS-------------  237 (313)
T ss_pred             CCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-CC-------------
Confidence                  35678999999742  245788999999999999999999999877655555443321 00             


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                           +..        ....++..+.+||.+||+.+|.+||++.+++.||||+..
T Consensus       238 -----~~~--------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         238 -----PTL--------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             -----CCC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence                 000        113457789999999999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=9.1e-38  Score=296.63  Aligned_cols=234  Identities=26%  Similarity=0.392  Sum_probs=188.6

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ..|...+.||+|+||.||++++..++..||+|.+....       ....+|+++++.++|+|++++++++..     ...
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~   99 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----EHT   99 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CCe
Confidence            34889999999999999999999999999999885321       123468999999999999999998843     334


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      .++||||+.+++.+.+...   ...+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+++         
T Consensus       100 ~~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~  175 (317)
T cd06635         100 AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPGQVKLADFGSASIA  175 (317)
T ss_pred             EEEEEeCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcccEEECCCCCEEEecCCCcccc
Confidence            7899999998876655432   3568889999999999999999999 89999999999999987765543         


Q ss_pred             ------eccccccchhhhhC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          226 ------ICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       226 ------~~t~~y~aPE~~~~--~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                            .+++.|+|||++..  ...++.++|||||||++|+|++|..||...+....+..+......+            
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------  243 (317)
T cd06635         176 SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT------------  243 (317)
T ss_pred             CCcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC------------
Confidence                  35778999999742  2347889999999999999999999998776555554443311100            


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                                     ......++.+.+||.+||+.||.+||++.++++|+|+..
T Consensus       244 ---------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         244 ---------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             ---------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence                           011346788999999999999999999999999999965

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.7e-38  Score=292.17  Aligned_cols=231  Identities=24%  Similarity=0.365  Sum_probs=185.5

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      .|+..+.||.|+||.||+|.+..++..||+|.+....     ....+|+.+++.+.|+||+++++++.     +..+.++
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKLWI   79 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEEE
Confidence            4888999999999999999999899999999875432     12357999999999999999999884     3345899


Q ss_pred             EeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      ||||+++ +|.+.+.     ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+..           
T Consensus        80 v~e~~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~-~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06640          80 IMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHS-EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             EEecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence            9999985 6655543     2468888899999999999999999 89999999999999987654432           


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                              .++..|+|||++.+. .++.++|+|||||++|+|++|..||...+.......+... .              
T Consensus       154 ~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-~--------------  217 (277)
T cd06640         154 TQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN-N--------------  217 (277)
T ss_pred             CccccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC-C--------------
Confidence                    246679999998654 4899999999999999999999999776544333221110 0              


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                          .         ..+...++.++.+||.+||+.||++||++.++++||||....
T Consensus       218 ----~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         218 ----P---------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             ----C---------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence                0         011234678899999999999999999999999999997753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=9e-38  Score=290.81  Aligned_cols=232  Identities=27%  Similarity=0.407  Sum_probs=181.4

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeecc
Q 015672           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (403)
Q Consensus        90 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  162 (403)
                      ||+|+||+||+|.+..+++.||+|.+....       ....+|+++++.++||||+++++.+     ....+.|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence            699999999999999999999999885321       1234699999999999999998887     3334589999999


Q ss_pred             C-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------------
Q 015672          163 P-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------------  225 (403)
Q Consensus       163 ~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------------  225 (403)
                      + ++|...+....  ...+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.+++                
T Consensus        76 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  152 (277)
T cd05577          76 NGGDLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQ-RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIK  152 (277)
T ss_pred             CCCcHHHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccc
Confidence            8 46665554322  2368899999999999999999999 89999999999999987765533                


Q ss_pred             --eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCC
Q 015672          226 --ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  303 (403)
Q Consensus       226 --~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  303 (403)
                        .++..|+|||++.+.. ++.++|||||||++|+|++|+.||...........+......                 . 
T Consensus       153 ~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------------~-  213 (277)
T cd05577         153 GRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE-----------------M-  213 (277)
T ss_pred             cccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc-----------------c-
Confidence              2456799999986554 899999999999999999999999765532111111111000                 0 


Q ss_pred             CCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCCCC
Q 015672          304 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDP  355 (403)
Q Consensus       304 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~~~  355 (403)
                             ....+..+++++.+||.+||+.||.+||     ++.++++||||..+...
T Consensus       214 -------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~  263 (277)
T cd05577         214 -------AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR  263 (277)
T ss_pred             -------cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence                   0012245789999999999999999999     99999999999887643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=8.6e-38  Score=288.57  Aligned_cols=236  Identities=28%  Similarity=0.499  Sum_probs=186.1

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      +|++.+.||+|+||.||+|.++.+++.+|+|.+....     ....+|+++++.++|+||+++++.+..     ....++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~l   76 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-----NGDISI   76 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-----CCEEEE
Confidence            4888899999999999999999999999999886442     123579999999999999999998743     345889


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      ++||++ ++|..++....   ..+++..+..++.|++.||.|||+..|++||||||+||+++.++.+++           
T Consensus        77 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~  153 (265)
T cd06605          77 CMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN  153 (265)
T ss_pred             EEEecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence            999999 67776665422   578889999999999999999997359999999999999998765433           


Q ss_pred             ------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHH-hCCCCHHHHhhcCcCc
Q 015672          226 ------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKV-LGTPTREEIKCMNPNY  297 (403)
Q Consensus       226 ------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~-~~~~~~i~~~-~~~~~~~~~~~~~~~~  297 (403)
                            .++..|+|||.+.+. .++.++|||||||++|+|++|..||...+. .+......+. ...+.           
T Consensus       154 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----------  221 (265)
T cd06605         154 SLAKTFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-----------  221 (265)
T ss_pred             HHhhcccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC-----------
Confidence                  356789999998654 589999999999999999999999975521 1111111111 10000           


Q ss_pred             cccCCCCCCCCCccccccc-CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          298 TEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~-~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                           +.         .+. .++.++.+||.+||..||++|||+.+++.||||+..
T Consensus       222 -----~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         222 -----PR---------LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             -----CC---------CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence                 00         111 278899999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-40  Score=335.51  Aligned_cols=237  Identities=28%  Similarity=0.476  Sum_probs=194.0

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccc------ccccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      .+++-...||.|.||.||.|.+..+|...|+|-++-      ......+|..++..|+|||+|++|++-.....     +
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek-----v 1309 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK-----V 1309 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH-----H
Confidence            357788899999999999999999999999997742      12334589999999999999999987644332     7


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      +|.||||. |+|.+++..    ++-.++...+.+..|++.|+.|||+ .|||||||||+||+|+.++.+++         
T Consensus      1310 ~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~-~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHE-HGIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred             HHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHh-cCceecCCCccceeeecCCcEEeecccceeEe
Confidence            79999998 577666654    3456777788889999999999999 89999999999999998776543         


Q ss_pred             --------------eccccccchhhhhCCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          226 --------------ICSRYYRAPELIFGAT--EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       226 --------------~~t~~y~aPE~~~~~~--~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                    .||+.|||||++.+..  ....+.|||||||++.||+||+.||...++.-++...+.....|    
T Consensus      1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P---- 1460 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP---- 1460 (1509)
T ss_pred             cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC----
Confidence                          4899999999996543  35679999999999999999999998877666655544432222    


Q ss_pred             HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                                    +         +|..+|.+.+|||.+||+.||++|.++.|+++|-|-+...+.
T Consensus      1461 --------------q---------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~ 1503 (1509)
T KOG4645|consen 1461 --------------Q---------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDE 1503 (1509)
T ss_pred             --------------C---------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccccc
Confidence                          2         335689999999999999999999999999999987765443

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.1e-37  Score=288.79  Aligned_cols=230  Identities=25%  Similarity=0.338  Sum_probs=176.7

Q ss_pred             cEeeecee--cccCceEEEEEEECCCCcEEEEEEcccccccHHHHHHHHHhc-CCCCccccceEEeecCCCCceEEEEEe
Q 015672           83 SYIAEHVV--GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        83 ~y~~~~~l--G~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      .|.+.+.+  |+|+||.||+++.+.++..+|+|.+..... ...|+.+...+ +|+||+++++.+..     ....++||
T Consensus        15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~e~~~~~~~~~h~~iv~~~~~~~~-----~~~~~iv~   88 (267)
T PHA03390         15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF-NAIEPMVHQLMKDNPNFIKLYYSVTT-----LKGHVLIM   88 (267)
T ss_pred             hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc-chhhHHHHHHhhcCCCEEEEEEEEec-----CCeeEEEE
Confidence            35665555  999999999999999999999998854321 12244444333 79999999998843     33589999


Q ss_pred             eccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC-Ccee------------
Q 015672          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP-NVSY------------  225 (403)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~-~~~~------------  225 (403)
                      ||++ ++|..++..    ...+++..+..++.||+.||.|||+ .|++||||||+||+++.++ .+.+            
T Consensus        89 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  163 (267)
T PHA03390         89 DYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP  163 (267)
T ss_pred             EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence            9997 577666543    2478999999999999999999999 8999999999999998776 4332            


Q ss_pred             ---eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCHHHHhhcCcCccccC
Q 015672          226 ---ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMNPNYTEFK  301 (403)
Q Consensus       226 ---~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~  301 (403)
                         .++..|+|||++.+. .++.++|||||||++|+|++|..||........ ...+......+                
T Consensus       164 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------  226 (267)
T PHA03390        164 SCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK----------------  226 (267)
T ss_pred             ccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhccc----------------
Confidence               357789999998654 489999999999999999999999975543321 11111110000                


Q ss_pred             CCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCCCcc
Q 015672          302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-ALEACVHPFFD  350 (403)
Q Consensus       302 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-a~e~l~hp~f~  350 (403)
                                ......+++.+.+||.+||+.||.+|++ ++++|+||||.
T Consensus       227 ----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        227 ----------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             ----------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence                      0012357899999999999999999996 59999999996

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-38  Score=291.39  Aligned_cols=233  Identities=27%  Similarity=0.461  Sum_probs=184.4

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcC---CCCccccceEEeecCCCCceE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~  154 (403)
                      .|.+.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++   |+|++++++++.     ...+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence            3888899999999999999999999999999875421     23457899999996   999999999874     3345


Q ss_pred             EEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee--------
Q 015672          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY--------  225 (403)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~--------  225 (403)
                      .+++|||+++ +|..++..     ..+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.+++        
T Consensus        77 ~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  150 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHK-VGVIHRDIKAANILVTNTGNVKLCDFGVAAL  150 (277)
T ss_pred             EEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHHEEEcCCCCEEEccCCceee
Confidence            8899999975 66555432     368889999999999999999999 89999999999999987655432        


Q ss_pred             -----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          226 -----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       226 -----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                 .|+..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+.......+...             
T Consensus       151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-------------  217 (277)
T cd06917         151 LNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-------------  217 (277)
T ss_pred             cCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-------------
Confidence                       35667999999865555789999999999999999999999765533222111000             


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                            ..+..        .....+.++.++|.+||+.||++|||+.++++||||++..
T Consensus       218 ------~~~~~--------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         218 ------KPPRL--------EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             ------CCCCC--------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence                  00000        0123678999999999999999999999999999998754

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=287.28  Aligned_cols=230  Identities=32%  Similarity=0.523  Sum_probs=179.2

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEcccccc-------cHHHHHHH-HHhcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQI-MQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      +.||+|+||.||+|.+..+++.||+|.+.+...       ....|..+ ...++|+||+++++++.     ...++++||
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence            569999999999999999999999998854321       11234333 34558999999998883     334589999


Q ss_pred             eccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------------
Q 015672          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------------  225 (403)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------------  225 (403)
                      ||++ ++|..++..    ...+++..+..++.||+.||.|||+ .+|+||||+|+||+++.++.+++             
T Consensus        77 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  151 (260)
T cd05611          77 EYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQ-RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK  151 (260)
T ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCcEEEeecccceeccccc
Confidence            9997 467666543    3568899999999999999999999 89999999999999987765543             


Q ss_pred             --eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCC
Q 015672          226 --ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  303 (403)
Q Consensus       226 --~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  303 (403)
                        .+++.|+|||.+.+.. ++.++|||||||++|+|++|..||...+.......+....                 ..  
T Consensus       152 ~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------~~--  211 (260)
T cd05611         152 KFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR-----------------IN--  211 (260)
T ss_pred             cCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc-----------------cC--
Confidence              3577899999986654 8999999999999999999999998776554443332210                 00  


Q ss_pred             CCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH---HHHhcCCCcccCC
Q 015672          304 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA---LEACVHPFFDELR  353 (403)
Q Consensus       304 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta---~e~l~hp~f~~~~  353 (403)
                            +.......+++++.++|.+||+.||++|||+   +|++.||||+++.
T Consensus       212 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         212 ------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             ------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence                  0011123578999999999999999999955   7999999998864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.3e-37  Score=289.45  Aligned_cols=235  Identities=29%  Similarity=0.455  Sum_probs=187.3

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      .|...+.||+|++|.||++.+..+++.+|+|++....    ....+|+.+++.++|+||+++++++..     ..+.+++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCeEEEE
Confidence            4666689999999999999998899999999874322    223578999999999999999998743     3458899


Q ss_pred             eeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------------
Q 015672          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------------  225 (403)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------------  225 (403)
                      +||+. ++|...+..     ..++...+..++.|++.||.|||+ +||+||||||+||+++.++.+++            
T Consensus        95 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~  168 (285)
T cd06648          95 MEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA-QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE  168 (285)
T ss_pred             EeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence            99997 466555443     468888999999999999999999 89999999999999987665432            


Q ss_pred             -------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 015672          226 -------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  298 (403)
Q Consensus       226 -------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  298 (403)
                             .+++.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+... ..+             
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~-------------  233 (285)
T cd06648         169 VPRRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPP-------------  233 (285)
T ss_pred             CcccccccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCC-------------
Confidence                   356789999998654 4899999999999999999999999876655444333221 000             


Q ss_pred             ccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                           ..       ..+..++..+.+||.+||..||++|||+.++++||||+...++
T Consensus       234 -----~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  278 (285)
T cd06648         234 -----KL-------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP  278 (285)
T ss_pred             -----CC-------cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCc
Confidence                 00       0012367899999999999999999999999999999987644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=9.9e-38  Score=293.64  Aligned_cols=234  Identities=27%  Similarity=0.450  Sum_probs=185.6

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      |.....||+|+||.||+|.+..+++.||+|.+....    ....+|+.+++.++||||+++++.+..     ....+++|
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~iv~   97 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----GEELWVLM   97 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-----CCeEEEEE
Confidence            555668999999999999998899999999885321    234578999999999999999998743     34588999


Q ss_pred             eccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------------
Q 015672          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------------  225 (403)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------------  225 (403)
                      ||+++ ++..++.     ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+++             
T Consensus        98 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~  171 (297)
T cd06659          98 EFLQGGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHS-QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV  171 (297)
T ss_pred             ecCCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence            99984 5544432     2468889999999999999999999 89999999999999987654432             


Q ss_pred             ------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 015672          226 ------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  299 (403)
Q Consensus       226 ------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  299 (403)
                            .++..|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+..+...   +.             
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~-------------  234 (297)
T cd06659         172 PKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PP-------------  234 (297)
T ss_pred             ccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CC-------------
Confidence                  357789999998654 5899999999999999999999999876655544332210   00             


Q ss_pred             cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                         +     .+  .....++..+.++|.+||+.||++||++.++++||||.+...|
T Consensus       235 ---~-----~~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~  280 (297)
T cd06659         235 ---P-----KL--KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLP  280 (297)
T ss_pred             ---C-----Cc--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCc
Confidence               0     00  0113467899999999999999999999999999999876443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.3e-38  Score=304.73  Aligned_cols=231  Identities=22%  Similarity=0.279  Sum_probs=176.6

Q ss_pred             cccEeeeceecccCceEEEEEEECCC-----CcEEEEEEccccc-----ccHHHHHHHHHhc-CCCCccccceEEeecCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  149 (403)
                      ..+|++.+.||+|+||.||+|++..+     +..||+|.+....     ....+|+++++.+ +|+||+++++++.    
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~----  112 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT----  112 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec----
Confidence            44699999999999999999986543     3579999986432     2245799999999 8999999999873    


Q ss_pred             CCceEEEEEeeccC-CcHHHHHHHhhh-----------------------------------------------------
Q 015672          150 KEELYLNLVLEYVP-ETVNRIARNYSR-----------------------------------------------------  175 (403)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~-----------------------------------------------------  175 (403)
                       ....+++|||||+ ++|.+++.....                                                     
T Consensus       113 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         113 -HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             -CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence             3334889999998 577666543210                                                     


Q ss_pred             -------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----------------
Q 015672          176 -------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----------------  226 (403)
Q Consensus       176 -------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----------------  226 (403)
                                   ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+++.                
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                         01246778889999999999999999 899999999999999866544321                


Q ss_pred             -----ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccc
Q 015672          227 -----CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  300 (403)
Q Consensus       227 -----~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  300 (403)
                           ++..|+|||++.+. .++.++|||||||++|+|++ |+.||........+.........+               
T Consensus       271 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~---------------  334 (374)
T cd05106         271 KGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM---------------  334 (374)
T ss_pred             ccCCCCccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc---------------
Confidence                 23469999998654 58999999999999999997 999998765443333332210000               


Q ss_pred             CCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                  ..+..+++++.++|.+||+.||++|||+.++++
T Consensus       335 ------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         335 ------------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             ------------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                        011346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.2e-37  Score=286.28  Aligned_cols=227  Identities=26%  Similarity=0.413  Sum_probs=181.0

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+....     ....+|+.+++.++|+||+++++.+.     ...++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFE-----ADGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----ECCEEEE
Confidence            4889999999999999999999999999999875322     23356899999999999999999873     3446899


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce------------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS------------  224 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~------------  224 (403)
                      +|||++ +++...+...  ....+++..+..++.||+.||.|||+ +||+|+||||+||+++.++.+.            
T Consensus        76 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  152 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS  152 (255)
T ss_pred             EEeeCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence            999997 4665554321  23457889999999999999999999 8999999999999998765443            


Q ss_pred             -------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          225 -------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       225 -------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                             ..+++.|+|||++.+. .++.++|+|||||++|+|++|..||...+.......+....               
T Consensus       153 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~---------------  216 (255)
T cd08219         153 PGAYACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS---------------  216 (255)
T ss_pred             cccccccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCC---------------
Confidence                   2356779999998654 48999999999999999999999998766444433332210               


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                          .+         ..+..++..+.+||.+||..||++|||+.+++.-
T Consensus       217 ----~~---------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 ----YK---------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ----CC---------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                00         0124568889999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.9e-37  Score=287.08  Aligned_cols=228  Identities=29%  Similarity=0.459  Sum_probs=175.7

Q ss_pred             eceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeecc
Q 015672           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (403)
Q Consensus        87 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  162 (403)
                      ...||+|+||.||+|++..++..||+|.+....    ....+|+.+++.++|+||+++++++.     ...++++++||+
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~   87 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----ENGFFKIFMEQV   87 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cCCEEEEEEecC
Confidence            357999999999999999999999999875432    23457999999999999999999873     334688999999


Q ss_pred             C-CcHHHHHHHhhhhcCCC--CHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCC-CCce--------------
Q 015672          163 P-ETVNRIARNYSRIHQRM--PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE-PNVS--------------  224 (403)
Q Consensus       163 ~-~~l~~~~~~~~~~~~~l--~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~-~~~~--------------  224 (403)
                      + ++|...+....   ..+  +...+..++.||+.||.|||+ .||+||||||+||+++.+ +.++              
T Consensus        88 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~  163 (268)
T cd06624          88 PGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHD-NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN  163 (268)
T ss_pred             CCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence            7 57766655321   234  677788899999999999999 899999999999999752 2221              


Q ss_pred             -----eeccccccchhhhhCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 015672          225 -----YICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  298 (403)
Q Consensus       225 -----~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  298 (403)
                           ..+++.|+|||++.+. ..++.++|||||||++|+|++|..||..................              
T Consensus       164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------  229 (268)
T cd06624         164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI--------------  229 (268)
T ss_pred             CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhcc--------------
Confidence                 2357789999998543 23789999999999999999999999754332211111000000              


Q ss_pred             ccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                                  ...++..+++++.+|+.+||..+|.+|||+.+++.||||
T Consensus       230 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         230 ------------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             ------------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                        001234578899999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.2e-37  Score=290.37  Aligned_cols=230  Identities=25%  Similarity=0.375  Sum_probs=175.9

Q ss_pred             eecccCceEEEEEEECCCCcEEEEEEcccccc-------cHHHHH---HHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNREL---QIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        89 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~---~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      .||+|+||.||+|++..+++.||+|.+.+...       ....|.   ..++...|+||+.+++.+.     ....+++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----TPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCEEEEE
Confidence            48999999999999999999999998854321       112233   3445568999999988873     33458899


Q ss_pred             eeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-------------
Q 015672          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-------------  224 (403)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-------------  224 (403)
                      |||+.+ +|...+..    ...+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.++             
T Consensus        76 ~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~  150 (278)
T cd05606          76 LDLMNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (278)
T ss_pred             EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc
Confidence            999984 55444432    4568999999999999999999999 8999999999999998765542             


Q ss_pred             ----eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccc
Q 015672          225 ----YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  300 (403)
Q Consensus       225 ----~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  300 (403)
                          ..|+..|+|||++.+...++.++||||+||++|+|++|+.||.+................              . 
T Consensus       151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------~-  215 (278)
T cd05606         151 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--------------A-  215 (278)
T ss_pred             CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc--------------C-
Confidence                246888999999865545899999999999999999999999765322111100000000              0 


Q ss_pred             CCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCCC
Q 015672          301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  354 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~~  354 (403)
                                 ..++..++.++.++|.+||..||.+||     ++.++++||||++...
T Consensus       216 -----------~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~  263 (278)
T cd05606         216 -----------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW  263 (278)
T ss_pred             -----------CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCc
Confidence                       002244689999999999999999999     9999999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.2e-38  Score=293.80  Aligned_cols=231  Identities=25%  Similarity=0.377  Sum_probs=184.5

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      .|...+.||+|+||.||+|.+..+++.||+|.+....     ....+|+++++.++|+||+++++.+.     ...+.++
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKLWI   79 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCceEE
Confidence            4788899999999999999998899999999875332     13457999999999999999999873     3345889


Q ss_pred             EeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      ||||+++ ++...+.     ...+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++.++.           
T Consensus        80 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06642          80 IMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             EEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhc-CCeeccCCChheEEEeCCCCEEEccccccccccC
Confidence            9999985 5544432     2568888999999999999999999 89999999999999987665432           


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                              .++..|+|||++.+. .++.++|||||||++|+|++|..||...........+...                
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~----------------  216 (277)
T cd06642         154 TQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN----------------  216 (277)
T ss_pred             cchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC----------------
Confidence                    246679999998654 5889999999999999999999999755433322211110                


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                         ..         ..+...++.++.++|.+||+.+|++|||+.++++||||....
T Consensus       217 ---~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         217 ---SP---------PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             ---CC---------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence               00         001234678899999999999999999999999999998753

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.5e-37  Score=286.62  Aligned_cols=226  Identities=28%  Similarity=0.467  Sum_probs=180.5

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeecc
Q 015672           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (403)
Q Consensus        90 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  162 (403)
                      ||.|+||.||+|++..+++.||+|++....       ....+|+.+++.++|+||+++++.+.     +..+++++|||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecC
Confidence            699999999999999999999999885432       23457999999999999999999873     334588999998


Q ss_pred             C-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------------
Q 015672          163 P-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------------  225 (403)
Q Consensus       163 ~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------------  225 (403)
                      + ++|.+++..    ...++...+..++.||+.||.|||+ .+++|+||||+||+++.++.+++                
T Consensus        76 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~  150 (262)
T cd05572          76 LGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW  150 (262)
T ss_pred             CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccc
Confidence            7 567665543    2458888999999999999999999 89999999999999987765533                


Q ss_pred             --eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHHHhCCCCHHHHhhcCcCccccC
Q 015672          226 --ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES--GVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  301 (403)
Q Consensus       226 --~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  301 (403)
                        .+++.|+|||.+.+. .++.++|+|||||++|+|++|..||....  ..+....+....               ....
T Consensus       151 ~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------~~~~  214 (262)
T cd05572         151 TFCGTPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN---------------GKLE  214 (262)
T ss_pred             cccCCcCccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC---------------CCCC
Confidence              346789999998544 58999999999999999999999997766  223332222100               0001


Q ss_pred             CCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCcccCC
Q 015672          302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELR  353 (403)
Q Consensus       302 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~e~l~hp~f~~~~  353 (403)
                                  ++...++++.++|.+||..||++|||     ++|+++||||++..
T Consensus       215 ------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  259 (262)
T cd05572         215 ------------FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD  259 (262)
T ss_pred             ------------CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence                        12345789999999999999999999     99999999998764

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.1e-37  Score=286.07  Aligned_cols=227  Identities=22%  Similarity=0.340  Sum_probs=181.1

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc---cHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|.+..+..   ...+|+++++.++|+||+++++++.     ....++++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv   80 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYII   80 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCcEEE
Confidence            359999999999999999999999999999998865432   2457999999999999999998873     23347899


Q ss_pred             eeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee-----------
Q 015672          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-----------  226 (403)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~-----------  226 (403)
                      |||++ ++|.+++....  ...++...+..++.|++.||.|||+ .|++||||||+|||++.++.+++.           
T Consensus        81 ~e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          81 TEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EEeCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            99997 56766554321  2457888889999999999999999 899999999999999876655332           


Q ss_pred             ---------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          227 ---------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       227 ---------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                               ++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+....              
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--------------  222 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY--------------  222 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC--------------
Confidence                     13469999988654 58899999999999999998 999998776544433332110              


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                          .          ...+..++.++.++|.+||..||++|||+.++++
T Consensus       223 ----~----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         223 ----R----------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             ----C----------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                0          0012457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.7e-37  Score=285.71  Aligned_cols=231  Identities=26%  Similarity=0.429  Sum_probs=181.3

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      +|++.+.||+|+||.||+|++..+++.||||.+....       ....+|+++++.++||||+++++++..     ..+.
T Consensus         3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   77 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNEL   77 (267)
T ss_pred             ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCeE
Confidence            5999999999999999999999999999999774311       123569999999999999999998743     2358


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      +++|||++ +++..++.........+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+++         
T Consensus        78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~  156 (267)
T cd08228          78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-RRVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence            89999998 47776665544334568888999999999999999999 89999999999999987665432         


Q ss_pred             ----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHHhhcC
Q 015672          226 ----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       226 ----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                .+++.|+|||.+.+. .++.++|||||||++|+|++|..||...... ..+.......+.++        
T Consensus       157 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------  227 (267)
T cd08228         157 SSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP--------  227 (267)
T ss_pred             cchhHHHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC--------
Confidence                      356789999998654 4889999999999999999999999654321 12222221111110        


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                .        .....+..+.+||.+||..||++||++.++++.
T Consensus       228 ----------~--------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         228 ----------L--------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             ----------C--------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence                      0        113467889999999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=9.7e-38  Score=293.12  Aligned_cols=235  Identities=27%  Similarity=0.422  Sum_probs=185.9

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ..+|.+.+.||+|+||.||++....+++.||+|.+....    ....+|+.+++.++||||+++++.+..     ....+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-----GDELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-----CCcEE
Confidence            356999999999999999999998899999999875322    233568999999999999999998743     33488


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------  225 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------  225 (403)
                      +|+||++ +++..++..     ..++...+..++.|++.||.|||+ +|++||||||+||+++.++.++.          
T Consensus        93 lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~-~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~  166 (293)
T cd06647          93 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (293)
T ss_pred             EEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCEeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence            9999997 466555432     457888899999999999999999 89999999999999987654432          


Q ss_pred             ---------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          226 ---------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       226 ---------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                               .+++.|+|||.+.+. .++.++|||||||++|++++|+.||...+....+..+.. .+.+           
T Consensus       167 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~-----------  233 (293)
T cd06647         167 PEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP-----------  233 (293)
T ss_pred             ccccccccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCC-----------
Confidence                     356679999998654 588999999999999999999999987654433221111 0000           


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                             .     +  ..+..++..+.+||.+||..||++||++.+++.||||+..+
T Consensus       234 -------~-----~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         234 -------E-----L--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             -------C-----C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence                   0     0  01134678899999999999999999999999999998753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.4e-37  Score=291.90  Aligned_cols=236  Identities=19%  Similarity=0.250  Sum_probs=176.3

Q ss_pred             ccEeeeceecccCceEEEEEEECC----------------CCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCcccc
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRE----------------TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVAL  140 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~  140 (403)
                      ..|++.++||+|+||.||+|.+..                ++..||+|.+....     ....+|++++..++|+||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            459999999999999999998532                34479999886432     234579999999999999999


Q ss_pred             ceEEeecCCCCceEEEEEeeccC-CcHHHHHHHhhhh---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 015672          141 KHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRI---------------HQRMPLIYVKLYTYQICRALAYIHNCIG  204 (403)
Q Consensus       141 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~---------------~~~l~~~~~~~~~~qi~~~L~~LH~~~~  204 (403)
                      ++++...     ...++||||+. ++|.+++......               ...++...+..++.||+.||.|||+ .|
T Consensus        85 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~  158 (304)
T cd05096          85 LGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS-LN  158 (304)
T ss_pred             EEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-CC
Confidence            9988432     34889999997 5777665432110               1235667788999999999999999 89


Q ss_pred             ccccccccccceecCCCCceee---------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh--
Q 015672          205 ICHRDIKPQNLLVKGEPNVSYI---------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--  261 (403)
Q Consensus       205 ivHrDlKp~NILl~~~~~~~~~---------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t--  261 (403)
                      |+||||||+|||++.++.++++                     ++..|+|||++.+. .++.++|||||||++|+|++  
T Consensus       159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~  237 (304)
T cd05096         159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILMLC  237 (304)
T ss_pred             ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHHcc
Confidence            9999999999999877654331                     24579999998654 58999999999999999987  


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHH
Q 015672          262 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL  341 (403)
Q Consensus       262 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~  341 (403)
                      +..||.+.+..+.+..+...+.....            ...         ...+..++..+.+||.+||+.||++|||+.
T Consensus       238 ~~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~  296 (304)
T cd05096         238 KEQPYGELTDEQVIENAGEFFRDQGR------------QVY---------LFRPPPCPQGLYELMLQCWSRDCRERPSFS  296 (304)
T ss_pred             CCCCCCcCCHHHHHHHHHHHhhhccc------------ccc---------ccCCCCCCHHHHHHHHHHccCCchhCcCHH
Confidence            56788776655544443322110000            000         001235688999999999999999999999


Q ss_pred             HHhc
Q 015672          342 EACV  345 (403)
Q Consensus       342 e~l~  345 (403)
                      ++.+
T Consensus       297 ~i~~  300 (304)
T cd05096         297 DIHA  300 (304)
T ss_pred             HHHH
Confidence            9943

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=8.9e-39  Score=299.90  Aligned_cols=261  Identities=30%  Similarity=0.517  Sum_probs=207.3

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccccc---HHHHHHHHHhcC------CCCccccceEEeecCCCCce
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY---KNRELQIMQMLD------HPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~E~~~l~~l~------h~niv~~~~~~~~~~~~~~~  153 (403)
                      .|.+....|+|-|++|..|.+...|+.||||+|..+...   -.+|++||++|+      --|+++++..|     ....
T Consensus       433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-----~hkn  507 (752)
T KOG0670|consen  433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-----KHKN  507 (752)
T ss_pred             eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----hhcc
Confidence            588888999999999999999999999999999765433   347999999995      34788888777     5566


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee-------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-------  226 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~-------  226 (403)
                      |+|||+|-+.-+|..++..+.. ..++.+..++.|+.|+..||..|-. .||+|.||||+|||++....+-.+       
T Consensus       508 HLClVFE~LslNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~  585 (752)
T KOG0670|consen  508 HLCLVFEPLSLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDFGSAS  585 (752)
T ss_pred             eeEEEehhhhchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEeccCcceeeeccCcccc
Confidence            7999999999899998888765 4568889999999999999999998 699999999999999877655332       


Q ss_pred             -----------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc--
Q 015672          227 -----------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--  293 (403)
Q Consensus       227 -----------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--  293 (403)
                                 .+.+|+|||+++|.+ |+...|+||+||+||||+||+..|+|.++...+...+.+-|..+...+...  
T Consensus       586 ~~~eneitPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF  664 (752)
T KOG0670|consen  586 FASENEITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQF  664 (752)
T ss_pred             ccccccccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcch
Confidence                       256799999999875 999999999999999999999999999999999999998888877665421  


Q ss_pred             -CcCccc-cC-----------------CCCCCC-CCccccccc--CC-------CHHHHHHHHHhcccCCCCCCCHHHHh
Q 015672          294 -NPNYTE-FK-----------------FPQIKP-HPWHKVFQK--RL-------PPEAVDLVCRFFQYSPNLRCTALEAC  344 (403)
Q Consensus       294 -~~~~~~-~~-----------------~~~~~~-~~~~~~~~~--~~-------s~~~~~li~~~L~~dP~~Rpta~e~l  344 (403)
                       +..|+. ++                 +....+ ..+...+-.  .+       -..+++||.+||.+||++|.|..++|
T Consensus       665 ~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL  744 (752)
T KOG0670|consen  665 KDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQAL  744 (752)
T ss_pred             hhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHh
Confidence             111100 00                 111111 111111100  12       24689999999999999999999999


Q ss_pred             cCCCccc
Q 015672          345 VHPFFDE  351 (403)
Q Consensus       345 ~hp~f~~  351 (403)
                      +||||.+
T Consensus       745 ~HpFi~~  751 (752)
T KOG0670|consen  745 KHPFITE  751 (752)
T ss_pred             cCCcccC
Confidence            9999975

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.2e-37  Score=292.78  Aligned_cols=235  Identities=26%  Similarity=0.388  Sum_probs=187.5

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      .|...+.||+|+||.||+|++..+++.+|+|.+....       ....+|+++++.++|+|++++++++..     ....
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   90 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTA   90 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCee
Confidence            4888899999999999999999999999999875321       123469999999999999999998843     2348


Q ss_pred             EEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------
Q 015672          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------  225 (403)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------  225 (403)
                      ++||||+.+++...+...   ...+++..+..++.|++.||.|||+ .+++||||||+|||++.++.++.          
T Consensus        91 ~lv~e~~~~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  166 (308)
T cd06634          91 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (308)
T ss_pred             EEEEEccCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence            899999998776655432   3458888999999999999999999 89999999999999987765432          


Q ss_pred             -----eccccccchhhhhC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 015672          226 -----ICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  298 (403)
Q Consensus       226 -----~~t~~y~aPE~~~~--~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  298 (403)
                           .+++.|+|||++.+  ...++.++|||||||++|+|++|..||...+..+....+.....               
T Consensus       167 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---------------  231 (308)
T cd06634         167 PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES---------------  231 (308)
T ss_pred             CcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC---------------
Confidence                 35788999999742  23478899999999999999999999977655444433332100               


Q ss_pred             ccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                          +.        ......+..+.+||.+||..+|++||++.++++|||+....
T Consensus       232 ----~~--------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         232 ----PA--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             ----CC--------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence                00        01134678899999999999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.9e-37  Score=289.35  Aligned_cols=230  Identities=23%  Similarity=0.293  Sum_probs=181.1

Q ss_pred             ccEeeeceecccCceEEEEEEECCCC-----cEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      .+|++.+.||+|+||.||+|.....+     ..||+|.+....     ....+|++++..++|+||+++++++.     .
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~   79 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----K   79 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----C
Confidence            35899999999999999999876554     679999886432     22457999999999999999998873     2


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceec
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVK  218 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~  218 (403)
                      ....+++|||++ ++|.+++.....            ....++...+..++.||+.||.|||+ .||+||||||+||+++
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nil~~  158 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLVG  158 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccccceEEEc
Confidence            334889999997 577666654311            11457888899999999999999999 8999999999999998


Q ss_pred             CCCCceee---------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 015672          219 GEPNVSYI---------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLV  276 (403)
Q Consensus       219 ~~~~~~~~---------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~  276 (403)
                      .++.+++.                     +++.|+|||.+.+. .++.++|||||||++|||++ |..||.+.+..+...
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE  237 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            76654321                     25669999998654 58999999999999999998 999998877655443


Q ss_pred             HHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          277 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       277 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      .+.....                   +         ..+..+++++.+|+.+||+.||++||++.+++++
T Consensus       238 ~i~~~~~-------------------~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         238 MIRSRQL-------------------L---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHcCCc-------------------C---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            3322100                   0         0124578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.7e-37  Score=301.45  Aligned_cols=232  Identities=22%  Similarity=0.318  Sum_probs=176.8

Q ss_pred             cccEeeeceecccCceEEEEEEE-----CCCCcEEEEEEccccc-----ccHHHHHHHHHhc-CCCCccccceEEeecCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  149 (403)
                      ..+|.+.+.||+|+||.||+|++     ..++..||||++....     ....+|+.++..+ +||||+++++++.    
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~----  109 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT----  109 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec----
Confidence            34699999999999999999974     3456789999986432     2235799999999 8999999999873    


Q ss_pred             CCceEEEEEeeccC-CcHHHHHHHhhh-----------------------------------------------------
Q 015672          150 KEELYLNLVLEYVP-ETVNRIARNYSR-----------------------------------------------------  175 (403)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~-----------------------------------------------------  175 (403)
                       .....++|||||+ |+|..++.....                                                     
T Consensus       110 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         110 -VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             -cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence             3334789999998 566665543110                                                     


Q ss_pred             ------------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee-----------
Q 015672          176 ------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-----------  226 (403)
Q Consensus       176 ------------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~-----------  226 (403)
                                        ....+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++++           
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS-KNCIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                              01246777888999999999999999 899999999999999876544321           


Q ss_pred             ----------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          227 ----------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       227 ----------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                ++..|+|||++.+. .++.++|||||||++|+|++ |..||........+.......             
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-------------  333 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG-------------  333 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC-------------
Confidence                      13459999998654 58999999999999999998 899998765444433332210             


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                          ...          ..+...+.++.+||.+||+.||++|||+.++++.
T Consensus       334 ----~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         334 ----YRM----------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             ----ccC----------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                000          0113457899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-37  Score=283.19  Aligned_cols=230  Identities=28%  Similarity=0.469  Sum_probs=182.8

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      +|.+.+.||+|+||.||+|++..+++.||+|.+....         ....+|+++++.++|+||+++++++..   ....
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~~   79 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEEK   79 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCCC
Confidence            5999999999999999999999999999999874211         123479999999999999999987633   2234


Q ss_pred             EEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------
Q 015672          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------  224 (403)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------  224 (403)
                      .++++|||+++ +|.+.+..    ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++..+        
T Consensus        80 ~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          80 KLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHS-NMIVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             EEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCEEECcccccc
Confidence            57799999974 66555443    2457888899999999999999999 8999999999999998665432        


Q ss_pred             --------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          225 --------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       225 --------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                    ..++..|+|||++.+. .++.++|||||||++|+|++|+.||...........+.   ..+.    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~----  226 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQPT----  226 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cCCC----
Confidence                          2356789999998654 47899999999999999999999997665444333222   1111    


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                                          ...++..+++++.++|.+||+ +|.+|||+.+++.|||.
T Consensus       227 --------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         227 --------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             --------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                                011335688999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-38  Score=302.52  Aligned_cols=225  Identities=19%  Similarity=0.283  Sum_probs=177.4

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEcccc------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      ..+...||+|.||+||+|++.+   .||||++..+      ...+++|+.++++-+|.||+-+.+++     .+.. +.|
T Consensus       394 v~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~-----~~p~-~AI  464 (678)
T KOG0193|consen  394 VLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC-----MNPP-LAI  464 (678)
T ss_pred             hhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh-----cCCc-eee
Confidence            5678899999999999999853   5999998643      24457899999999999999999988     3333 379


Q ss_pred             EeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----------
Q 015672          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----------  226 (403)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----------  226 (403)
                      |+-+|+| +|+..+...   ..++.....+.|++||+.|+.|||. ++|||||||..||++.+++.+++.          
T Consensus       465 iTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHA-K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~  540 (678)
T KOG0193|consen  465 ITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHA-KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR  540 (678)
T ss_pred             eehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhh-hhhhhhhccccceEEccCCcEEEecccceeeeee
Confidence            9999996 565555432   3568888899999999999999999 899999999999999988776542          


Q ss_pred             -----------ccccccchhhhh--CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015672          227 -----------CSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       227 -----------~t~~y~aPE~~~--~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  293 (403)
                                 |...|||||++.  ...+|+..+|||||||++|||++|..||...+....+..+-+....|....    
T Consensus       541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~----  616 (678)
T KOG0193|consen  541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSK----  616 (678)
T ss_pred             eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchh----
Confidence                       356699999984  234699999999999999999999999985443333333322222222111    


Q ss_pred             CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                          ...+.+.++++|+..||.+++++||++.+||.
T Consensus       617 --------------------~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  617 --------------------IRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             --------------------hhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                                11456789999999999999999999999986

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=6.8e-37  Score=286.55  Aligned_cols=237  Identities=24%  Similarity=0.316  Sum_probs=181.9

Q ss_pred             ccEeeeceecccCceEEEEEEECC-----CCcEEEEEEcccccc-----cHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      .+|++.+.||+|+||.||+|..+.     .+..||+|.+.....     ...+|+.+++.++|+||+++++++.     .
T Consensus         6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~   80 (288)
T cd05061           6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS-----K   80 (288)
T ss_pred             HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc-----C
Confidence            469999999999999999997652     345799998754322     2346889999999999999998873     2


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhhh------cCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS  224 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~------~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~  224 (403)
                      ....++||||++ ++|.+++......      ........+..++.||+.||.|||+ ++|+||||||+|||++.++.++
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCCChheEEEcCCCcEE
Confidence            234789999997 6787776543211      1234556778899999999999999 8999999999999998766543


Q ss_pred             ee---------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHh
Q 015672          225 YI---------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVL  282 (403)
Q Consensus       225 ~~---------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~  282 (403)
                      ..                     ++..|+|||.+.+. .++.++|||||||++|||++ |..||.+.+..+....+... 
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-  237 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG-  237 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-
Confidence            21                     24469999998654 48999999999999999998 78899876654443332210 


Q ss_pred             CCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc------CCCcccCC
Q 015672          283 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV------HPFFDELR  353 (403)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~------hp~f~~~~  353 (403)
                      +.                  +         ..+...++.+.+++.+||+.||++|||+.++++      ||||+++.
T Consensus       238 ~~------------------~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  287 (288)
T cd05061         238 GY------------------L---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS  287 (288)
T ss_pred             CC------------------C---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence            00                  0         012346789999999999999999999999987      99998864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.8e-37  Score=287.46  Aligned_cols=231  Identities=24%  Similarity=0.386  Sum_probs=185.1

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      -|.+.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++|+||+++++.+.     ...+.++
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l   79 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLWI   79 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEEE
Confidence            3888999999999999999998899999999875322     23457999999999999999999883     3345889


Q ss_pred             EeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      ||||+++ ++..++.     ...++...+..++.|++.||.|||+ .|++|+||||+||+++.++.++.           
T Consensus        80 v~e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          80 IMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             EEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHcc-CCeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence            9999985 5554443     2468889999999999999999999 89999999999999987765432           


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                              .++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+... ..             
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~-------------  218 (277)
T cd06641         154 TQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-NP-------------  218 (277)
T ss_pred             chhhhccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-CC-------------
Confidence                    34677999999854 35788999999999999999999999765543333222110 00             


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                           +         .+...++.++.++|.+||+.||.+||++.++++||||.+..
T Consensus       219 -----~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~  260 (277)
T cd06641         219 -----P---------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA  260 (277)
T ss_pred             -----C---------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence                 0         01245788999999999999999999999999999998753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=5.3e-37  Score=281.35  Aligned_cols=232  Identities=29%  Similarity=0.498  Sum_probs=188.2

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|.+.+.||.|+||.||++.+..+++.||+|++....      ....+|+++++.++|+|++++.+.+..     ..+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-----KGKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-----CCEEE
Confidence            4889999999999999999999899999999986432      234579999999999999999988743     25688


Q ss_pred             EEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------
Q 015672          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------  225 (403)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------  225 (403)
                      +++||+++ +|...+.........++...+..++.|++.||.|||+ .|++|+||+|+||+++.++.+++          
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  154 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS  154 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHHeEEcCCCcEEECCccceeecc
Confidence            99999984 7766665543234678999999999999999999999 89999999999999987655432          


Q ss_pred             ---------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          226 ---------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       226 ---------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                               .+++.|+|||.+.+. .++.++||||+|+++|+|++|..||...+..+.........              
T Consensus       155 ~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--------------  219 (258)
T cd08215         155 STVDLAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ--------------  219 (258)
T ss_pred             cCcceecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC--------------
Confidence                     356789999988654 48899999999999999999999997766444333322110              


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                           .+.         ++..++.++.+++.+||..||++|||+.++|+||||
T Consensus       220 -----~~~---------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         220 -----YPP---------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             -----CCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                 000         123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.5e-37  Score=289.22  Aligned_cols=234  Identities=28%  Similarity=0.452  Sum_probs=185.6

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      |....+||+|+||.||++....+++.||||++....    ....+|+.+++.++|+||+++++.+.     ...+.+++|
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~   96 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWVVM   96 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE-----eCCEEEEEE
Confidence            555678999999999999999999999999874322    22456999999999999999999883     334588999


Q ss_pred             eccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------------
Q 015672          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------------  225 (403)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------------  225 (403)
                      ||+++ ++..+..     ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+++             
T Consensus        97 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~-~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~  170 (292)
T cd06657          97 EFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHA-QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  170 (292)
T ss_pred             ecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEEcccccceeccccc
Confidence            99985 4544332     2467888999999999999999999 89999999999999987654432             


Q ss_pred             ------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 015672          226 ------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  299 (403)
Q Consensus       226 ------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  299 (403)
                            .+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+....+......               
T Consensus       171 ~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~---------------  234 (292)
T cd06657         171 PRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP---------------  234 (292)
T ss_pred             ccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc---------------
Confidence                  35677999998854 45789999999999999999999999877655544433221100               


Q ss_pred             cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                       .+.          ....+++.+.++|.+||+.||.+||++.++++||||.....|
T Consensus       235 -~~~----------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~  279 (292)
T cd06657         235 -KLK----------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP  279 (292)
T ss_pred             -ccC----------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCC
Confidence             000          013468889999999999999999999999999999987643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.3e-37  Score=288.17  Aligned_cols=229  Identities=23%  Similarity=0.341  Sum_probs=180.0

Q ss_pred             ccEeeeceecccCceEEEEEEECC-----CCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      ..|.+.+.||+|+||.||+|.+..     +++.||+|.+....     ....+|+++++.++|+||+++++++...    
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----   80 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG----   80 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC----
Confidence            459999999999999999998753     46789999986432     2345799999999999999999988433    


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhh----------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCC
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYS----------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE  220 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~----------~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~  220 (403)
                       ...+++|||++ ++|..++....          .....+++..+..++.|++.||.|||+ +||+||||||+||+++.+
T Consensus        81 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~h~dlkp~nili~~~  158 (280)
T cd05049          81 -DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS-QHFVHRDLATRNCLVGYD  158 (280)
T ss_pred             -CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeeccccccceEEEcCC
Confidence             44899999997 56766665431          112347788889999999999999999 899999999999999876


Q ss_pred             CCceee---------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 015672          221 PNVSYI---------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEI  278 (403)
Q Consensus       221 ~~~~~~---------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i  278 (403)
                      +.+++.                     +++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus       159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05049         159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI  237 (280)
T ss_pred             CeEEECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            554321                     24569999998654 58999999999999999998 99999877665544433


Q ss_pred             HHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          279 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      ...  .                 .+         ..+..++..+.+||.+||+.||++|||+.|+++
T Consensus       238 ~~~--~-----------------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         238 TQG--R-----------------LL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HcC--C-----------------cC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            211  0                 00         011357889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=3.4e-37  Score=283.95  Aligned_cols=226  Identities=32%  Similarity=0.580  Sum_probs=181.7

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEcccccc-------cHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeecc
Q 015672           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (403)
Q Consensus        90 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  162 (403)
                      ||.|+||.||+|++..+++.+|+|.+.....       ...+|+++++.++|+||+++++.+     .....+|++|||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence            6899999999999998999999998854322       234689999999999999998877     3345589999999


Q ss_pred             C-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------------
Q 015672          163 P-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------------  225 (403)
Q Consensus       163 ~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------------  225 (403)
                      . ++|..++..    ...+++..+..++.||+.||.|||+ .+++||||+|+||+++.++.++.                
T Consensus        76 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  150 (265)
T cd05579          76 PGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHS-NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN  150 (265)
T ss_pred             CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc
Confidence            7 477666553    2468899999999999999999999 89999999999999987765533                


Q ss_pred             -----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          226 -----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       226 -----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                 .++..|+|||.+.... ++.++|||||||++|++++|..||......+....+...             
T Consensus       151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-------------  216 (265)
T cd05579         151 LNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG-------------  216 (265)
T ss_pred             cccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-------------
Confidence                       2455799999986544 889999999999999999999999877655544333220             


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH---HHHhcCCCcccCC
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA---LEACVHPFFDELR  353 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta---~e~l~hp~f~~~~  353 (403)
                          ...++.          ...++..+.+||.+||+.||.+|||+   .++++||||+++.
T Consensus       217 ----~~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~  264 (265)
T cd05579         217 ----KIEWPE----------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID  264 (265)
T ss_pred             ----CcCCCc----------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence                000110          01258899999999999999999999   9999999998764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=6.3e-37  Score=282.35  Aligned_cols=233  Identities=31%  Similarity=0.502  Sum_probs=187.9

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      +|++.+.||+|++|.||+|++..+++.||+|++....     ....+|+.++..++|+||+++++++..     ....++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~l   76 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK-----EGEISI   76 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-----CCeEEE
Confidence            4889999999999999999999999999999886542     234579999999999999999998843     355889


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      +|||++ ++|..++..    ...+++..+..++.|++.||.|||+..+++||||+|+||+++.++.++.           
T Consensus        77 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~  152 (264)
T cd06623          77 VLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN  152 (264)
T ss_pred             EEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999 677666554    2668999999999999999999996249999999999999987765433           


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--cH-HHHHHHHHHhCCCCHHHHhhcC
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES--GV-DQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~--~~-~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                              .++..|+|||.+.+. .++.++|+|||||++|+|++|..||....  .. +....+..   ..         
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~---------  219 (264)
T cd06623         153 TLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GP---------  219 (264)
T ss_pred             CCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CC---------
Confidence                    356789999998654 58899999999999999999999997764  22 22222111   00         


Q ss_pred             cCccccCCCCCCCCCcccccccC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKR-LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                             .+.         .+.. ++..+.++|.+||..+|++|||+.++++||||+...
T Consensus       220 -------~~~---------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         220 -------PPS---------LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             -------CCC---------CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence                   000         1133 788999999999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=282.59  Aligned_cols=260  Identities=33%  Similarity=0.585  Sum_probs=206.1

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc------cccHHHHHHHHHhcCCCCccccceEEeecCCC-CceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~~  154 (403)
                      .+|.-++.+|.|.- .|..+-+.-.++.||+|++...      .+...+|..++..++|+||++++.+|...... ...-
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            35889999999998 7778888888999999987432      22345899999999999999999987432211 1223


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc-----------
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-----------  223 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~-----------  223 (403)
                      +|+|||++..++..+...      .+.-..+..++.|+++|++|||+ .||+||||||+||++..+...           
T Consensus        96 ~y~v~e~m~~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs-~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   96 VYLVMELMDANLCQVILM------ELDHETISYILYQMLCGIKHLHS-AGIIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             HHHHHHhhhhHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHh-cceeecccCcccceecchhheeeccchhhccc
Confidence            789999999888776652      35566788999999999999999 899999999999999765443           


Q ss_pred             -------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--
Q 015672          224 -------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--  294 (403)
Q Consensus       224 -------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--  294 (403)
                             .++.|++|+|||++.+.. |...+||||+||++.||++|...|+|.+..+++.++.+.+|.|..+....+.  
T Consensus       169 ~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~  247 (369)
T KOG0665|consen  169 DTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT  247 (369)
T ss_pred             CcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence                   345688999999998876 9999999999999999999999999999999999999999999998775443  


Q ss_pred             --------cCccccCCCCCCC-CCcccccc--cCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 015672          295 --------PNYTEFKFPQIKP-HPWHKVFQ--KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  350 (403)
Q Consensus       295 --------~~~~~~~~~~~~~-~~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~  350 (403)
                              +.+..+.+....+ .-|.....  +.-+..++||+.+||..||++|.+++++|+||||+
T Consensus       248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                    2222233332222 11222111  12245689999999999999999999999999998

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=7.7e-37  Score=281.06  Aligned_cols=225  Identities=22%  Similarity=0.299  Sum_probs=177.9

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      .+|++.+.||+|+||.||++..+ .+..+|+|.+....   ....+|+++++.++||||+++++++.     .....++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEEE
Confidence            35889999999999999999875 45679999876432   23457999999999999999998873     33448899


Q ss_pred             eeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee-----------
Q 015672          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-----------  226 (403)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~-----------  226 (403)
                      |||++ ++|.+.+...   ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++.++..           
T Consensus        78 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05114          78 TEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLER-NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD  153 (256)
T ss_pred             EEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence            99997 5666554431   2357888899999999999999999 899999999999999876544322           


Q ss_pred             ---------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          227 ---------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       227 ---------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                               ++..|+|||++.+. .++.++|||||||++|+|++ |+.||...+..+.+..+.+....            
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~------------  220 (256)
T cd05114         154 EYTSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL------------  220 (256)
T ss_pred             ceeccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC------------
Confidence                     23469999998644 58999999999999999999 99999887766655554331000            


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                      ..+...+.++.+|+.+||..||++||+++++++
T Consensus       221 ----------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         221 ----------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             ----------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                            011335788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1e-36  Score=281.15  Aligned_cols=232  Identities=29%  Similarity=0.511  Sum_probs=182.0

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc------cHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+.....      ....|+++++.++|+||+++++.+.     ....++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV-----HREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe-----cCCEEE
Confidence            48899999999999999999988999999999864332      2357999999999999999998763     334588


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------  225 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------  225 (403)
                      +|+||++ ++|.+++..    ...+++..++.++.|++.||.|||+ .||+|+||+|+||+++.++.+++          
T Consensus        76 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~  150 (264)
T cd06626          76 IFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHS-HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK  150 (264)
T ss_pred             EEEecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEcccccccccC
Confidence            9999998 566555443    3457888899999999999999999 89999999999999987654432          


Q ss_pred             -------------eccccccchhhhhCCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          226 -------------ICSRYYRAPELIFGAT--EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       226 -------------~~t~~y~aPE~~~~~~--~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                   .+++.|+|||++.+..  .++.++|||||||++|++++|..||...+........... +..+    
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~----  225 (264)
T cd06626         151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKP----  225 (264)
T ss_pred             CCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCC----
Confidence                         2456799999985432  2788999999999999999999999765433322222111 1000    


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                                .++.          ...+++.+.+||.+||+.||.+|||+.+++.|||+
T Consensus       226 ----------~~~~----------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         226 ----------PIPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             ----------CCCc----------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                      0010          12358899999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=7.3e-37  Score=286.37  Aligned_cols=230  Identities=24%  Similarity=0.341  Sum_probs=179.7

Q ss_pred             cccEeeeceecccCceEEEEEEEC-----CCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      +.+|.+.+.||+|+||.||++...     .++..+|+|.+....    ....+|++++++++|+||+++++++.     .
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~   78 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----E   78 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----c
Confidence            456999999999999999999853     345679999886432    23457999999999999999999873     3


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhh---------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSR---------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP  221 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~---------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~  221 (403)
                      ..+++++|||++ ++|..++.....         ....+++..+..++.||+.||+|||+ .||+||||||+|||++.++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~-~~i~H~dlkp~Nili~~~~  157 (288)
T cd05093          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGENL  157 (288)
T ss_pred             CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEccCC
Confidence            345889999997 577666653221         11348899999999999999999999 8999999999999998776


Q ss_pred             Cceee---------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 015672          222 NVSYI---------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEII  279 (403)
Q Consensus       222 ~~~~~---------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~  279 (403)
                      .++..                     ++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+.+..+.
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~  236 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  236 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            54332                     2456999999865 458999999999999999998 999998776555444443


Q ss_pred             HHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          280 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      ...                   ..         ..+..++.++.+|+.+||+.||.+|||+.++++
T Consensus       237 ~~~-------------------~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         237 QGR-------------------VL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             cCC-------------------cC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            210                   00         012356889999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.3e-37  Score=295.10  Aligned_cols=232  Identities=23%  Similarity=0.330  Sum_probs=177.8

Q ss_pred             ccEeeeceecccCceEEEEEEECC-----CCcEEEEEEccccc-----ccHHHHHHHHHhc-CCCCccccceEEeecCCC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  150 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  150 (403)
                      .+|++.+.||+|+||.||+|+...     +++.||+|++....     ....+|++++.++ +|+||+++++++...   
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~---   83 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP---   83 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC---
Confidence            359999999999999999997543     45789999886432     1234699999999 899999999977432   


Q ss_pred             CceEEEEEeeccC-CcHHHHHHHhhh------------------------------------------------------
Q 015672          151 EELYLNLVLEYVP-ETVNRIARNYSR------------------------------------------------------  175 (403)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~------------------------------------------------------  175 (403)
                       ...++++|||++ ++|..++.....                                                      
T Consensus        84 -~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          84 -GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             -CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence             235789999998 466665542110                                                      


Q ss_pred             ---hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee---------------------ccccc
Q 015672          176 ---IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI---------------------CSRYY  231 (403)
Q Consensus       176 ---~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~---------------------~t~~y  231 (403)
                         ....++...+..++.||+.||.|||+ .||+||||||+|||++.++.+++.                     ++..|
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLAS-RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence               12367888899999999999999999 899999999999999876655332                     24569


Q ss_pred             cchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCc
Q 015672          232 RAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPW  310 (403)
Q Consensus       232 ~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (403)
                      +|||++.+. .++.++|||||||++|+|++ |..||.+....+.+.........                  +       
T Consensus       242 ~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------------------~-------  295 (337)
T cd05054         242 MAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR------------------M-------  295 (337)
T ss_pred             cCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC------------------C-------
Confidence            999998664 58999999999999999998 99999875544433332221000                  0       


Q ss_pred             ccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          311 HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       311 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                        ..+...++++.+++.+||+.+|++||++.++++|
T Consensus       296 --~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         296 --RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             --CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence              0123467899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.2e-37  Score=291.89  Aligned_cols=227  Identities=22%  Similarity=0.365  Sum_probs=176.0

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcE----EEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEI----VAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~----vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      ..+|++.+.||+|+||.||+|++..++..    ||+|.+....     ....+|+.+++.++|+||+++++++...    
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~----   81 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----   81 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC----
Confidence            34599999999999999999998766654    8999885332     2334689999999999999999987432    


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----  226 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----  226 (403)
                        ..++++||+. +++.+++...   ...++...+..++.||+.||+|||+ .||+||||||+|||++.++.+++.    
T Consensus        82 --~~~~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiH~dlkp~Nill~~~~~~kl~DfG~  155 (316)
T cd05108          82 --TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEE-RRLVHRDLAARNVLVKTPQHVKITDFGL  155 (316)
T ss_pred             --CceeeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEecCCCcEEEccccc
Confidence              1568999987 5666655432   2457888889999999999999999 899999999999999877655432    


Q ss_pred             -----------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015672          227 -----------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  288 (403)
Q Consensus       227 -----------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~  288 (403)
                                       ++..|+|||++.+. .++.++|||||||++|||++ |..||.+....+ +..+.....     
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~-----  228 (316)
T cd05108         156 AKLLGADEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGE-----  228 (316)
T ss_pred             cccccCCCcceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhCCC-----
Confidence                             13469999998654 58999999999999999997 999997765433 222222100     


Q ss_pred             HHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                  ..+          .+..++.++.+++.+||..||.+|||+.+++.+
T Consensus       229 ------------~~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         229 ------------RLP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             ------------CCC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                        000          113467889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=7.3e-37  Score=284.39  Aligned_cols=227  Identities=32%  Similarity=0.587  Sum_probs=186.1

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcC-CCCccccceEEeecCCCCceE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  154 (403)
                      +|.+.+.||+|+||.||+|....+++.||+|++....       ....+|+++++.+. |+||+++++.+     .....
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~   76 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEEN   76 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCce
Confidence            5999999999999999999999999999999885421       23356889999998 99999999887     33445


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee--------
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY--------  225 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~--------  225 (403)
                      ++++|||+. ++|.+++..    ...++...+..++.|++.||.|||+ .|++|+||||+||+++.++.+..        
T Consensus        77 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~-~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~  151 (280)
T cd05581          77 LYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHS-KGIIHRDLKPENILLDKDMHIKITDFGTAKV  151 (280)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCCCEEecCCccccc
Confidence            889999994 677666654    3478999999999999999999999 89999999999999986654322        


Q ss_pred             -------------------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHH
Q 015672          226 -------------------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ  274 (403)
Q Consensus       226 -------------------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~  274 (403)
                                                     .++..|+|||++.+. .++.++|||||||++|++++|..||...+....
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  230 (280)
T cd05581         152 LDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT  230 (280)
T ss_pred             cCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence                                           245779999988554 488999999999999999999999987765444


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCc
Q 015672          275 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFF  349 (403)
Q Consensus       275 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta----~e~l~hp~f  349 (403)
                      +..+...                 ...            ++..+++.+.+||.+||+.||.+|||+    +++++||||
T Consensus       231 ~~~~~~~-----------------~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         231 FQKILKL-----------------EYS------------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHHHhc-----------------CCC------------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            4433321                 000            124568899999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1e-36  Score=286.54  Aligned_cols=239  Identities=23%  Similarity=0.378  Sum_probs=183.0

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc-----cHHHHHHHHHhc-CCCCccccceEEeecCCCCceE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||.+.....     ...+|+.++.++ .|+||+++++++..     ...
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~   88 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-----DSD   88 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-----CCe
Confidence            3469999999999999999999998899999999864321     123466666666 49999999998843     335


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee--------
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI--------  226 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~--------  226 (403)
                      ++++|||+++.+..+....   ...+++..+..++.||+.||.|||+..||+||||+|+||+++.++.+++.        
T Consensus        89 ~~~v~e~~~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          89 VFICMELMSTCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             EEEEeeccCcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            8999999988776665442   34788888899999999999999962499999999999999876654332        


Q ss_pred             ----------ccccccchhhhhCC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHHhh
Q 015672          227 ----------CSRYYRAPELIFGA---TEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       227 ----------~t~~y~aPE~~~~~---~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~  292 (403)
                                ++..|+|||.+.+.   ..++.++|||||||++|+|++|+.||...... +.+..+...   .       
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~-------  235 (296)
T cd06618         166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE---E-------  235 (296)
T ss_pred             cCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC---C-------
Confidence                      35679999998543   23788999999999999999999999654322 222222110   0       


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                               .+..   +    ....++.++.+||.+||..||.+||+++++++||||....
T Consensus       236 ---------~~~~---~----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         236 ---------PPSL---P----PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             ---------CCCC---C----CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence                     0000   0    0124678999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1e-36  Score=283.65  Aligned_cols=231  Identities=21%  Similarity=0.289  Sum_probs=177.7

Q ss_pred             cccEeeeceecccCceEEEEEEECC-----CCcEEEEEEcccccc-----cHHHHHHHHHhcCCCCccccceEEeecCCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  150 (403)
                      ..+|++.+.||+|+||.||+|.+..     ++..||+|++.....     ...+|+.+++.++|+||+++++++     .
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~   79 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S   79 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----c
Confidence            3469999999999999999998653     356799998754321     234789999999999999999887     3


Q ss_pred             CceEEEEEeeccC-CcHHHHHHHhhhh------cCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc
Q 015672          151 EELYLNLVLEYVP-ETVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV  223 (403)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~------~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~  223 (403)
                      ...+.++||||++ ++|.+++......      ...++...+..++.|++.||.|||+ .|++||||||+|||++.++.+
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~vH~dlkp~Nil~~~~~~~  158 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDFTV  158 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCcchheEEEcCCCCE
Confidence            3345889999998 5777666542211      1234667788889999999999999 899999999999999977655


Q ss_pred             eee---------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 015672          224 SYI---------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKV  281 (403)
Q Consensus       224 ~~~---------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~  281 (403)
                      +.+                     +++.|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+.+..+...
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~  237 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG  237 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            332                     24569999998654 58999999999999999999 78999877655444333221


Q ss_pred             hCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          282 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                       ..                  +         ..+..++..+.+|+.+||+.||++|||+.|++++
T Consensus       238 -~~------------------~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         238 -GL------------------L---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             -Cc------------------C---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             00                  0         0124567899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-39  Score=280.74  Aligned_cols=267  Identities=32%  Similarity=0.516  Sum_probs=207.6

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccc------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +.+-.+.||.|+||+||.+.+..+|+.||+|++..-      ....-+|+.+|..++|.|++..++.........-.-+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            345568899999999999999999999999988532      12234799999999999999988875322211111256


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----------  226 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----------  226 (403)
                      .++|++..+|..++-    ..+.++.+.++.+++||+.||+|||+ .+|.||||||.|+|++.+--.+++          
T Consensus       134 V~TELmQSDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHs-A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  134 VLTELMQSDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHT-ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHHHhhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhh-cchhhccCCCccEEeccCceEEecccccccccch
Confidence            677777766554433    25678899999999999999999999 899999999999999877554443          


Q ss_pred             ----------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          227 ----------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       227 ----------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                                .|.+|+|||++.+...|+.++||||.|||+.|++..+..|...+..+++..|...+|+|..+.++...+.
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG  288 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG  288 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence                      3788999999999999999999999999999999999999999999999999999999999988755433


Q ss_pred             ccccCCCCC-CCCCcccc----cccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCC
Q 015672          297 YTEFKFPQI-KPHPWHKV----FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  354 (403)
Q Consensus       297 ~~~~~~~~~-~~~~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  354 (403)
                      -...-+..- ++..+..+    -+..-..+..+++.++|..||++|.+.++++.|++..+.+-
T Consensus       289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~  351 (449)
T KOG0664|consen  289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL  351 (449)
T ss_pred             hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence            221111111 11111111    11233467889999999999999999999999999988653

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=9.1e-37  Score=315.60  Aligned_cols=127  Identities=24%  Similarity=0.409  Sum_probs=108.5

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      .+|.+.++||+|+||+||+|++..+++.||||++....       .....|+.+++.++|+||+++++.+     ....+
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~   78 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSANN   78 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECCE
Confidence            45999999999999999999999999999999986432       3445789999999999999998877     33446


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceec
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVK  218 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~  218 (403)
                      +|+||||+. ++|..++..    ...+++..++.++.||+.||.|||. .+||||||||+||||+
T Consensus        79 ~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKP~NILl~  138 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHR-HGIIHRDLKPDNMLIS  138 (669)
T ss_pred             EEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCccHHHEEEc
Confidence            899999996 577666543    3468888999999999999999999 8999999999999984

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=5.1e-37  Score=282.81  Aligned_cols=231  Identities=24%  Similarity=0.433  Sum_probs=181.1

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccc---------cccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      +|.+.+.||+|+||.||++++..++..+++|+++..         ......|+.+++.++||||+++++.+..     ..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-----RD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-----CC
Confidence            389999999999999999999877777777765321         1123468899999999999999988733     23


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc---------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV---------  223 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~---------  223 (403)
                      ..++||||++ +++..++.........+++..++.++.|++.||.|||+ .|++|+||||+||+++.+. +         
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~~l~~~nili~~~~-~~l~d~g~~~  153 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-RRILHRDLKAKNIFLKNNL-LKIGDFGVSR  153 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-cCccccCCChhheEeecCC-EeecccCcee
Confidence            4889999998 47766665544445678999999999999999999999 8999999999999997431 1         


Q ss_pred             ----------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015672          224 ----------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       224 ----------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  293 (403)
                                ...+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+...  .         
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~---------  221 (260)
T cd08222         154 LLMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--P---------  221 (260)
T ss_pred             ecCCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--C---------
Confidence                      1235678999998854 44788999999999999999999999765544433332210  0         


Q ss_pred             CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                              .+         ..+..++.++.++|.+||..||++||++.++++||||
T Consensus       222 --------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         222 --------TP---------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             --------CC---------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                    00         0124567899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1e-36  Score=284.93  Aligned_cols=236  Identities=30%  Similarity=0.464  Sum_probs=190.9

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      ...|++.+.||+|+||.||+|.+..++..||+|++....   ....+|+++++.++|+||+++++.+...     ...++
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l   92 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG-----DELWV   92 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEEEE
Confidence            345999999999999999999998889999999986543   2345799999999999999999988443     45889


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----------  226 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----------  226 (403)
                      ++||++ ++|.+++....   ..++...+..++.|++.||.|||+ .||+|+||||+||+++.++.++++          
T Consensus        93 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~-~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          93 VMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHS-QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             EEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence            999999 67777765422   368889999999999999999999 899999999999999877655332          


Q ss_pred             ---------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          227 ---------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       227 ---------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                               ++..|+|||++.+. .++.++|||||||++|+|++|..||...+.......+... ..+.           
T Consensus       169 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~-----------  235 (286)
T cd06614         169 EKSKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP-----------  235 (286)
T ss_pred             chhhhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCC-----------
Confidence                     45679999998654 4899999999999999999999999876655443333221 0000           


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                             .     .  ....++.++.+||.+||+.||.+|||+.++++||||++.
T Consensus       236 -------~-----~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         236 -------L-----K--NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             -------C-----c--chhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence                   0     0  012367899999999999999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1e-36  Score=314.83  Aligned_cols=231  Identities=22%  Similarity=0.359  Sum_probs=177.6

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      +|++.++||+|+||.||+|++..+++.||+|++..+.       ....+|+++++.++||||+++++++.     +....
T Consensus         3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~l   77 (932)
T PRK13184          3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDPV   77 (932)
T ss_pred             CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCEE
Confidence            5999999999999999999999999999999986431       12347999999999999999998873     33458


Q ss_pred             EEEeeccC-CcHHHHHHHhhh-------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce---
Q 015672          156 NLVLEYVP-ETVNRIARNYSR-------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS---  224 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~-------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~---  224 (403)
                      +++|||++ ++|..++.....       ....++...+..++.||+.||+|||+ .||+||||||+|||++.++.++   
T Consensus        78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs-~GIIHRDLKPeNILLd~dg~vKLiD  156 (932)
T PRK13184         78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS-KGVLHRDLKPDNILLGLFGEVVILD  156 (932)
T ss_pred             EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH-CCccccCCchheEEEcCCCCEEEEe
Confidence            89999998 577776654211       12335566778899999999999999 8999999999999997654321   


Q ss_pred             ----------------------------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015672          225 ----------------------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES  270 (403)
Q Consensus       225 ----------------------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~  270 (403)
                                                        .+||+.|+|||++.+. .++.++|||||||++|||++|..||...+
T Consensus       157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~~~  235 (932)
T PRK13184        157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRRKK  235 (932)
T ss_pred             cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence                                              2478999999998654 48999999999999999999999997754


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          271 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       271 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      .......  .....|..              .     .+     ...+++.+.+++.+||..||++|++..+.+.+
T Consensus       236 ~~ki~~~--~~i~~P~~--------------~-----~p-----~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        236 GRKISYR--DVILSPIE--------------V-----AP-----YREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhhhhh--hhccChhh--------------c-----cc-----cccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            3322111  11000000              0     00     13578899999999999999999987666543

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6.8e-37  Score=283.00  Aligned_cols=230  Identities=28%  Similarity=0.459  Sum_probs=179.8

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      +|.+.+.||+|+||.||+|++..+++.+|||.+....       ....+|+.+++.++|+||+++++++..     ..+.
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~   77 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNEL   77 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----CCeE
Confidence            5889999999999999999999999999999875321       223469999999999999999998843     3358


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      +++|||++ ++|..++.........+++..+..++.||+.||.|||+ .||+|+||||+||+++.++.++.         
T Consensus        78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd08229          78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence            89999998 47777666444334568899999999999999999999 89999999999999987665432         


Q ss_pred             ----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHHhhcC
Q 015672          226 ----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       226 ----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                .++..|+|||.+.+. .++.++|||||||++|+|++|..||.+.... ..........            
T Consensus       157 ~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------  223 (267)
T cd08229         157 SSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC------------  223 (267)
T ss_pred             ccCCcccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC------------
Confidence                      356789999998654 4889999999999999999999999765432 1111111100            


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                            ..+..        ....+++++.+||.+||..||.+|||+.++++
T Consensus       224 ------~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         224 ------DYPPL--------PSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             ------CCCCC--------CcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence                  00000        11346889999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.5e-36  Score=279.81  Aligned_cols=227  Identities=22%  Similarity=0.307  Sum_probs=178.5

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      ..+|++.++||+|+||.||+|... ++..||+|.+....   ....+|+.+++.++|+||+++++.+.     .....++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   78 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT-----KEEPIYI   78 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCCcEE
Confidence            346999999999999999999864 56789999876432   23457999999999999999988773     3344789


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----------  226 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----------  226 (403)
                      +|||++ ++|.+++...  ....++...+..++.|++.||.|||+ .+++||||||+||+++.++.++..          
T Consensus        79 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          79 ITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             EEecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence            999997 5776665432  23457888888999999999999999 899999999999999876654321          


Q ss_pred             ----------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          227 ----------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       227 ----------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                ++..|+|||++.+. .++.++|||||||++|+|++ |..||......+....+.....            
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~------------  222 (261)
T cd05072         156 NEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR------------  222 (261)
T ss_pred             CceeccCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC------------
Confidence                      23469999998654 58899999999999999998 9999987765554444332110            


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                            .+          ....++.++.+|+.+||..||++|||++++++
T Consensus       223 ------~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         223 ------MP----------RMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             ------CC----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                  00          11347889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.2e-37  Score=288.62  Aligned_cols=230  Identities=23%  Similarity=0.345  Sum_probs=178.2

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcE--EEEEEccccc-----ccHHHHHHHHHhc-CCCCccccceEEeecCCCCce
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  153 (403)
                      .+|++.+.||+|+||.||+|.+..++..  +|+|.+....     ....+|++++.++ +|+||+++++++     ....
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~~   81 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRG   81 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCCC
Confidence            4599999999999999999998877754  5777664321     2234699999999 899999999987     3334


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCC
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE  220 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~  220 (403)
                      ++++||||++ ++|.+++.....            ....+++..++.++.||+.||+|||+ +||+||||||+|||++.+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dlkp~Nili~~~  160 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGEN  160 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEecCC
Confidence            5889999997 577776654321            12357888999999999999999999 899999999999999877


Q ss_pred             CCceee------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 015672          221 PNVSYI------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKV  281 (403)
Q Consensus       221 ~~~~~~------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~  281 (403)
                      +.+++.                  ++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  239 (303)
T cd05088         161 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  239 (303)
T ss_pred             CcEEeCccccCcccchhhhcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence            655432                  13469999988554 58899999999999999998 99999876654433322110


Q ss_pred             hCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          282 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                        ...          ..+..+++++.+||.+||+.||++||++++++.+
T Consensus       240 ------------------~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         240 ------------------YRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             ------------------CcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                              000          0113467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.1e-36  Score=297.24  Aligned_cols=231  Identities=23%  Similarity=0.343  Sum_probs=176.3

Q ss_pred             cccEeeeceecccCceEEEEEEECCC-----CcEEEEEEccccc-----ccHHHHHHHHHhcC-CCCccccceEEeecCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDK-----RYKNRELQIMQMLD-HPNIVALKHCFFSTTD  149 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  149 (403)
                      ..+|++.+.||+|+||.||+|++...     +..||||++....     ....+|+++++.+. ||||+++++++.    
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~----  111 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT----  111 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc----
Confidence            44699999999999999999987433     3479999986432     23357999999996 999999999883    


Q ss_pred             CCceEEEEEeeccC-CcHHHHHHHhhh-----------------------------------------------------
Q 015672          150 KEELYLNLVLEYVP-ETVNRIARNYSR-----------------------------------------------------  175 (403)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~-----------------------------------------------------  175 (403)
                       ....+|||||||+ ++|.+++.....                                                     
T Consensus       112 -~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         112 -KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             -cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence             3345899999998 567665543210                                                     


Q ss_pred             ---------------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccce
Q 015672          176 ---------------------------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL  216 (403)
Q Consensus       176 ---------------------------------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NIL  216 (403)
                                                             ....+++..+..++.||+.||.|||+ .+|+||||||+|||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dikp~Nil  269 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS-KNCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHhEE
Confidence                                                   01246777888999999999999999 89999999999999


Q ss_pred             ecCCCCcee---------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 015672          217 VKGEPNVSY---------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQ  274 (403)
Q Consensus       217 l~~~~~~~~---------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~  274 (403)
                      ++.++.+++                     .++..|+|||++.+. .++.++|||||||++|+|++ |..||........
T Consensus       270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~  348 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST  348 (400)
T ss_pred             EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence            987654432                     234569999998654 58999999999999999997 9999977544333


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          275 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       275 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      +.......                 ...+          .+..++.++.++|.+||+.||++|||+.++.+
T Consensus       349 ~~~~~~~~-----------------~~~~----------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         349 FYNKIKSG-----------------YRMA----------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHHHhcC-----------------CCCC----------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            33322210                 0000          12457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=9.3e-37  Score=279.75  Aligned_cols=220  Identities=22%  Similarity=0.294  Sum_probs=172.0

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeecc
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  162 (403)
                      +.||+|+||.||+|++..+++.||+|.+....     ....+|+++++.++|+||+++++++..     ....++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCCeEEEEeec
Confidence            46999999999999999999999999875432     234579999999999999999998733     33488999999


Q ss_pred             CC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceeec--------------
Q 015672          163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYIC--------------  227 (403)
Q Consensus       163 ~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~~--------------  227 (403)
                      ++ ++.+++..   ....+++..+..++.|++.||.|||+ .||+||||||+|||++.++.++...              
T Consensus        76 ~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  151 (252)
T cd05084          76 QGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLES-KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS  151 (252)
T ss_pred             cCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEEcCCCcEEECccccCcccccccccc
Confidence            74 66555432   23457888999999999999999999 8999999999999998776553321              


Q ss_pred             -------cccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 015672          228 -------SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  299 (403)
Q Consensus       228 -------t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  299 (403)
                             +..|+|||.+.+. .++.++|||||||++|+|++ |..||...........+......               
T Consensus       152 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~---------------  215 (252)
T cd05084         152 TGGMKQIPVKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL---------------  215 (252)
T ss_pred             cCCCCCCceeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC---------------
Confidence                   2349999998654 48999999999999999998 88999765543332222211000               


Q ss_pred             cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                   ..+...+..+.+|+.+||+.||++|||+.++++
T Consensus       216 -------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         216 -------------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             -------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                         012356889999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.7e-36  Score=276.80  Aligned_cols=232  Identities=26%  Similarity=0.425  Sum_probs=186.6

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+....      ....+|+++++.++|+||+++++++..     ....+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-----GNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-----CCEEE
Confidence            3889999999999999999999999999999875421      123468999999999999999988743     35588


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------  225 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------  225 (403)
                      +||||++ ++|...+.........+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++.          
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~-~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~  154 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-QKILHRDLKSANILLVANDLVKIGDLGISKVLK  154 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEEecCCcEEEeeccchhhhc
Confidence            9999997 46766665543334568888999999999999999999 89999999999999987665533          


Q ss_pred             -------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 015672          226 -------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  298 (403)
Q Consensus       226 -------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  298 (403)
                             .+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+...                 
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-----------------  216 (256)
T cd08530         155 KNMAKTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG-----------------  216 (256)
T ss_pred             cCCcccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------
Confidence                   256789999998654 5888999999999999999999999877654433322210                 


Q ss_pred             ccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                        .++.         .+...+.++.++|.+||+.+|++|||+.++++||++
T Consensus       217 --~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         217 --KYPP---------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             --CCCC---------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence              0110         113467899999999999999999999999999984

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.5e-36  Score=279.37  Aligned_cols=226  Identities=20%  Similarity=0.265  Sum_probs=177.8

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      .+|.+.+.||+|+||.||+|.+.. +..+|+|.+....   ....+|+.++++++||||+++++++.     ....++++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCCcEEE
Confidence            459999999999999999998753 4569999886432   23457999999999999999999873     23347899


Q ss_pred             eeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee-----------
Q 015672          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-----------  226 (403)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~-----------  226 (403)
                      |||+. +++.+++...   ...+++..+..++.||+.||.|||+ .||+|+||||+||+++.++.++..           
T Consensus        78 ~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05113          78 TEYMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLES-KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD  153 (256)
T ss_pred             EEcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence            99997 4666655432   2368889999999999999999999 899999999999999876654332           


Q ss_pred             ---------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          227 ---------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       227 ---------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                               ++..|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+......+           
T Consensus       154 ~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-----------  221 (256)
T cd05113         154 EYTSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY-----------  221 (256)
T ss_pred             ceeecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC-----------
Confidence                     23469999998654 48999999999999999998 999998766554444433211000           


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                       .+...+..+.+++.+||+.||.+|||+.+++++
T Consensus       222 -----------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         222 -----------------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             -----------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                             113457899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.3e-36  Score=282.98  Aligned_cols=230  Identities=20%  Similarity=0.283  Sum_probs=179.2

Q ss_pred             ccEeeeceecccCceEEEEEEECC-----CCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      .+|.+.+.||+|+||.||+|.+..     ++..||+|.+....     ..+.+|+.+++.++|+||+++++++...    
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----   81 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER----   81 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC----
Confidence            459999999999999999999977     77889999875332     2345689999999999999999987432    


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhh---hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC---ce
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSR---IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN---VS  224 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~---~~  224 (403)
                       ...++||||+. ++|..++.....   ....+++..+..++.||+.||.|||+ .+++||||||+|||++..+.   ++
T Consensus        82 -~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          82 -LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NHFIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             -CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchheEEEeccCCCcceE
Confidence             23679999996 577776654321   11257888899999999999999999 89999999999999975431   11


Q ss_pred             ee---------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHh
Q 015672          225 YI---------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVL  282 (403)
Q Consensus       225 ~~---------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~  282 (403)
                      ..                     .+..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+... 
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-  237 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-  237 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-
Confidence            11                     12459999998654 48999999999999999997 99999877655443322211 


Q ss_pred             CCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          283 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      ..               .            ..+..++..+.+++.+||+.||++|||+.++++|
T Consensus       238 ~~---------------~------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         238 GR---------------L------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             Cc---------------C------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            00               0            0124578899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.4e-36  Score=284.51  Aligned_cols=237  Identities=27%  Similarity=0.461  Sum_probs=183.8

Q ss_pred             cEeeeceecccCceEEEEEEEC---CCCcEEEEEEccccc--------ccHHHHHHHHHhc-CCCCccccceEEeecCCC
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  150 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  150 (403)
                      .|++.+.||.|+||.||+|+..   .+|+.||+|.+....        ....+|+++++.+ +|+||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence            3889999999999999999874   478999999885421        2235699999999 589999998887     3


Q ss_pred             CceEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----
Q 015672          151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----  225 (403)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----  225 (403)
                      ....+++||||+++ +|...+..    ...+++..+..++.||+.||.|||+ .|++||||||+|||++.++.+++    
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg  150 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFG  150 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEECCCCCEEEeeCc
Confidence            34468899999984 55554432    3568888999999999999999999 89999999999999987665432    


Q ss_pred             ----------------eccccccchhhhhCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015672          226 ----------------ICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  288 (403)
Q Consensus       226 ----------------~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~  288 (403)
                                      .++..|+|||.+.+. ..++.++|||||||++|+|++|..||...........+.+.....   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---  227 (290)
T cd05613         151 LSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS---  227 (290)
T ss_pred             cceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc---
Confidence                            256789999998542 246789999999999999999999997543322222222211000   


Q ss_pred             HHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCCC
Q 015672          289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  354 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~~  354 (403)
                                   .+         .++..+++.+.+|+.+||..||++||     ++++++.||||+...+
T Consensus       228 -------------~~---------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  276 (290)
T cd05613         228 -------------EP---------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW  276 (290)
T ss_pred             -------------CC---------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence                         00         01245788999999999999999997     8999999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=7e-37  Score=281.94  Aligned_cols=227  Identities=21%  Similarity=0.323  Sum_probs=182.7

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc----cHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ..+|++.++||.|+||.||+|.+.. ++.+|+|.+.....    ...+|+++++.++|+||+++++++.     ...+++
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   78 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPVY   78 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCeE
Confidence            4569999999999999999999977 88999999864432    3457999999999999999988773     333488


Q ss_pred             EEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee---------
Q 015672          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI---------  226 (403)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~---------  226 (403)
                      +||||+++ +|.+++....  ...++...+..++.||+.||.|||+ .||+||||||+||+++.++.+++.         
T Consensus        79 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~-~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~  155 (261)
T cd05148          79 IITELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEE-QNSIHRDLAARNILVGEDLVCKVADFGLARLIK  155 (261)
T ss_pred             EEEeecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccCcceEEEcCCceEEEccccchhhcC
Confidence            99999984 7776665422  3457888899999999999999999 899999999999999887665442         


Q ss_pred             ----------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          227 ----------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       227 ----------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                ++..|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+.+..+......+          
T Consensus       156 ~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----------  224 (261)
T cd05148         156 EDVYLSSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP----------  224 (261)
T ss_pred             CccccccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCC----------
Confidence                      23569999998654 58899999999999999998 899998777555554443211000          


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                        .+..+++.+.++|.+||+.||.+|||+.++++
T Consensus       225 ------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         225 ------------------CPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             ------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                              12457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=297.17  Aligned_cols=235  Identities=25%  Similarity=0.399  Sum_probs=200.5

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      .+..++..||-|+||.|-++........+|+|++++..       +....|..||...+.+.||++|..|     .+..|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~ky  494 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKY  494 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchh
Confidence            34667888999999999999887666668999886432       2233689999999999999999988     77888


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc----------
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV----------  223 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~----------  223 (403)
                      +||+||-|- |.++.+++.    .+.+....++.++..+++|++|||+ +|||.|||||+|+|++.++.+          
T Consensus       495 vYmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~-k~iIYRDLKPENllLd~~Gy~KLVDFGFAKk  569 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHR-KGIIYRDLKPENLLLDNRGYLKLVDFGFAKK  569 (732)
T ss_pred             hhhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHh-cCceeccCChhheeeccCCceEEeehhhHHH
Confidence            999999886 677777665    5778999999999999999999999 899999999999999877654          


Q ss_pred             --------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          224 --------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       224 --------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                              +++|||.|.|||++++. ..+.++|.||||+++|||++|.+||.+.+....+..|.+.+.            
T Consensus       570 i~~g~KTwTFcGTpEYVAPEIILnK-GHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid------------  636 (732)
T KOG0614|consen  570 IGSGRKTWTFCGTPEYVAPEIILNK-GHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID------------  636 (732)
T ss_pred             hccCCceeeecCCcccccchhhhcc-CcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh------------
Confidence                    56799999999999865 489999999999999999999999999999988888877531            


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCcccCCC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  354 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~e~l~hp~f~~~~~  354 (403)
                         .+.            +|+.++..+.+||+++...+|.+|..     +.++.+|-||....+
T Consensus       637 ---~i~------------~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw  685 (732)
T KOG0614|consen  637 ---KIE------------FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW  685 (732)
T ss_pred             ---hhh------------cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence               112            33678899999999999999999985     899999999998764

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.8e-36  Score=278.66  Aligned_cols=229  Identities=31%  Similarity=0.510  Sum_probs=180.2

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+...       .....+|++++++++|+||+++++.+..     ....
T Consensus         3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~~   77 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNEL   77 (267)
T ss_pred             ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCeE
Confidence            599999999999999999999989999999987421       2234579999999999999999998843     3458


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      +++|||++ ++|..++.........+++..+..++.|++.||.|||+ .||+||||||+||+++.++.++.         
T Consensus        78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~  156 (267)
T cd08224          78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS-KRIMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence            89999998 57777766543334568889999999999999999999 89999999999999987654432         


Q ss_pred             ----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCCHHHHhhc
Q 015672          226 ----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV--DQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       226 ----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~  293 (403)
                                .+++.|+|||.+.+. .++.++|||||||++|+|++|+.||......  +....+...            
T Consensus       157 ~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------  223 (267)
T cd08224         157 SSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC------------  223 (267)
T ss_pred             cCCCcccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC------------
Confidence                      356779999998654 4899999999999999999999999654321  111111110            


Q ss_pred             CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                             .++.   .+     ....+.++.++|.+||..+|++|||+.++++
T Consensus       224 -------~~~~---~~-----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         224 -------DYPP---LP-----ADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             -------CCCC---CC-----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                   0000   00     1246789999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.7e-36  Score=285.19  Aligned_cols=229  Identities=22%  Similarity=0.311  Sum_probs=178.1

Q ss_pred             cEeeeceecccCceEEEEEEECCCCc--EEEEEEccccc-----ccHHHHHHHHHhc-CCCCccccceEEeecCCCCceE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGE--IVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~--~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      +|++.+.||+|+||.||+|....++.  .+|+|.+....     ....+|++++.++ +||||+++++++.     ....
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~~   77 (297)
T cd05089           3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE-----NRGY   77 (297)
T ss_pred             cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-----cCCc
Confidence            59999999999999999999877664  46888775321     2345799999999 7999999999873     3334


Q ss_pred             EEEEeeccC-CcHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC
Q 015672          155 LNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP  221 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~  221 (403)
                      ++++|||++ ++|.+++.....            ....+++..+..++.||+.||+|||+ .||+||||||+|||++.++
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~  156 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE-KQFIHRDLAARNVLVGENL  156 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCcCCcceEEECCCC
Confidence            889999997 577766644211            11347888999999999999999999 8999999999999998765


Q ss_pred             Cceee------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHh
Q 015672          222 NVSYI------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVL  282 (403)
Q Consensus       222 ~~~~~------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~  282 (403)
                      .+++.                  .+..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~  235 (297)
T cd05089         157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  235 (297)
T ss_pred             eEEECCcCCCccccceeccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence            54332                  13359999998654 48999999999999999997 999998776555444332210


Q ss_pred             CCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          283 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      ..                            ..+..++.++.+||.+||..||.+|||++++++.
T Consensus       236 ~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         236 RM----------------------------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            00                            0124578899999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-36  Score=281.07  Aligned_cols=233  Identities=20%  Similarity=0.290  Sum_probs=179.2

Q ss_pred             EeeeceecccCceEEEEEEECCC---CcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCC-CCce
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL  153 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  153 (403)
                      |.+.+.||+|+||.||+|....+   +..||+|.+..+.      ....+|+++++.++|+||+++++.+..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            56789999999999999987653   4789999886432      123579999999999999999987754332 2334


Q ss_pred             EEEEEeeccC-CcHHHHHHHhh--hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----
Q 015672          154 YLNLVLEYVP-ETVNRIARNYS--RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----  226 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----  226 (403)
                      +.+++|||++ +++..++....  .....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++.+    
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchheEEECCCCeEEECCccc
Confidence            5789999998 56666654322  112468888999999999999999999 899999999999999876554322    


Q ss_pred             -----------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015672          227 -----------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  288 (403)
Q Consensus       227 -----------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~  288 (403)
                                       ++..|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+.+..+....      
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~------  232 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN------  232 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------
Confidence                             2346999998854 458999999999999999999 899998776555443332210      


Q ss_pred             HHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                ..            ..+..++.++.+++.+||+.||++|||+.+++++
T Consensus       233 ----------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         233 ----------RL------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             ----------CC------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                      00            0124578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.2e-36  Score=283.95  Aligned_cols=230  Identities=21%  Similarity=0.299  Sum_probs=177.5

Q ss_pred             ccEeeeceecccCceEEEEEEEC----CCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      ..|++.+.||+|+||+||+|...    .+++.||+|.+....     ....+|+++++.++|+||+++++++..     .
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-----E   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-----C
Confidence            35889999999999999999853    456789999886422     234579999999999999999998733     3


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhh-------------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceec
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYS-------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVK  218 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~-------------~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~  218 (403)
                      ...|++|||++ ++|.+++....             .....+++..+..++.|++.||.|||+ +||+||||||+|||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~nili~  158 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS-HFFVHKDLAARNILIG  158 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-cCeehhccccceEEEc
Confidence            34889999998 56766653211             012346788888999999999999999 8999999999999998


Q ss_pred             CCCCceee---------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 015672          219 GEPNVSYI---------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLV  276 (403)
Q Consensus       219 ~~~~~~~~---------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~  276 (403)
                      .++.+++.                     ++..|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+...
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE  237 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            77654332                     23459999998654 48999999999999999998 999998766544333


Q ss_pred             HHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          277 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       277 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      .+... ..+                           ..+..+++.+.+++.+||+.||++||++.+++++
T Consensus       238 ~~~~~-~~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         238 MVRKR-QLL---------------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHcC-CcC---------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            32211 000                           0124578899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-37  Score=299.30  Aligned_cols=231  Identities=27%  Similarity=0.436  Sum_probs=186.2

Q ss_pred             eeeceecccCceEEEEEEECCCCcEEEEEEcc-----cc---cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-----QD---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        85 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~-----~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ....+||+|+|-+||+|.+..+|..||.-.++     +.   ...+..|+.+|+.|+|+|||++|+.|.....   ..+.
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in  119 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTIN  119 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceee
Confidence            34577999999999999999999999854332     11   1344579999999999999999999865443   5588


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc-CCccccccccccceecCCC-Cc----------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-IGICHRDIKPQNLLVKGEP-NV----------  223 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~-~~ivHrDlKp~NILl~~~~-~~----------  223 (403)
                      +|+|++. |+|..+...    .+++....++.|++||++||.|||+. .-|||||||.+||+|++.. .+          
T Consensus       120 ~iTEL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  120 FITELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL  195 (632)
T ss_pred             eeeecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence            9999997 666555444    57788999999999999999999982 2499999999999998652 22          


Q ss_pred             -------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          224 -------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       224 -------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                             ..+|||.|||||++.  ..|+..+||||||+.+.||+|+..||....+..++++.+-. |..|..        
T Consensus       196 ~r~s~aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S-GiKP~s--------  264 (632)
T KOG0584|consen  196 LRKSHAKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS-GIKPAA--------  264 (632)
T ss_pred             hhccccceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc-CCCHHH--------
Confidence                   357999999999985  35999999999999999999999999888877776655432 222211        


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                                       +..--.+++++||.+||.. ..+|+|+.|+|+||||+.
T Consensus       265 -----------------l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~  301 (632)
T KOG0584|consen  265 -----------------LSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE  301 (632)
T ss_pred             -----------------hhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence                             1122368999999999999 999999999999999986

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.3e-36  Score=280.25  Aligned_cols=232  Identities=19%  Similarity=0.254  Sum_probs=175.3

Q ss_pred             eeeceecccCceEEEEEEECCCCc--EEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCC-CCceEE
Q 015672           85 IAEHVVGTGSFGVVFQAKCRETGE--IVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYL  155 (403)
Q Consensus        85 ~~~~~lG~G~~g~V~~~~~~~~~~--~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~  155 (403)
                      .+.+.||+|+||.||+|++..++.  .+|+|.+....      ....+|+++++.++|+||+++++.++.... ......
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            467889999999999999877765  68999875321      223468999999999999999987654322 122357


Q ss_pred             EEEeeccC-CcHHHHHHHhh--hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee------
Q 015672          156 NLVLEYVP-ETVNRIARNYS--RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI------  226 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~------  226 (403)
                      +++|||+. +++...+....  .....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.++++      
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhheEEcCCCCEEECCCCccc
Confidence            89999998 56665543221  112347888899999999999999999 899999999999999866544321      


Q ss_pred             ---------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          227 ---------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       227 ---------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                     +++.|+|||.+.+. .++.++|||||||++|+|++ |+.||.+....+....+.... .      
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~------  232 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN-R------  232 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-C------
Confidence                           24569999998554 58999999999999999999 899998766544333322100 0      


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                 .          ..+..++..+.++|.+||+.||++|||+.+++++
T Consensus       233 -----------~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         233 -----------L----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             -----------C----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                       0          0123567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-36  Score=280.75  Aligned_cols=230  Identities=23%  Similarity=0.308  Sum_probs=179.7

Q ss_pred             cccEeeeceecccCceEEEEEEECCC-----CcEEEEEEcccccc-----cHHHHHHHHHhcCCCCccccceEEeecCCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  150 (403)
                      ..+|++.+.||+|+||.||+|.++..     +..||+|.+.....     ...+|+.+++.++|+||+++++++.     
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----   79 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-----   79 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc-----
Confidence            34699999999999999999998643     37899999854322     2347899999999999999999873     


Q ss_pred             CceEEEEEeeccC-CcHHHHHHHhhhh------cCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc
Q 015672          151 EELYLNLVLEYVP-ETVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV  223 (403)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~------~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~  223 (403)
                      ...+.++||||++ ++|.+++......      ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~di~p~nill~~~~~~  158 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVAEDLTV  158 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccChheEEEcCCCCE
Confidence            3345889999997 6777776543211      2246778888999999999999999 899999999999999877655


Q ss_pred             eee---------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 015672          224 SYI---------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKV  281 (403)
Q Consensus       224 ~~~---------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~  281 (403)
                      ++.                     ++..|+|||.+.+. .++.++|||||||++||+++ |..||.+.+..+....+...
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  237 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG  237 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC
Confidence            432                     24579999998644 48999999999999999998 99999876655444333210


Q ss_pred             hCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          282 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                       ..+               .            .+...+.++.+||.+||+.+|++|||+.++++
T Consensus       238 -~~~---------------~------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         238 -GHL---------------D------------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             -CCC---------------C------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence             000               0            12346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=5.4e-36  Score=274.62  Aligned_cols=232  Identities=34%  Similarity=0.535  Sum_probs=183.8

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|.+.+.||+|++|.||+|.+..+++.|++|++....      ....+|+.++++++|+||+++++.+....   ....+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence            3888999999999999999999899999999886443      23457999999999999999998874321   24588


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------  225 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------  225 (403)
                      +++||++ +++.+++..    ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+++          
T Consensus        78 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~  152 (260)
T cd06606          78 IFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHS-NGIVHRDIKGANILVDSDGVVKLADFGCAKRLG  152 (260)
T ss_pred             EEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence            9999995 566666554    2378899999999999999999999 89999999999999987655432          


Q ss_pred             -----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          226 -----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       226 -----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                 .++..|+|||.+.+. .++.++|||||||++|+|++|..||...+.....  ......           
T Consensus       153 ~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~-----------  218 (260)
T cd06606         153 DIETGEGTGSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA--LYKIGS-----------  218 (260)
T ss_pred             cccccccccCCCCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH--HHhccc-----------
Confidence                       245679999998554 4899999999999999999999999776522211  111100           


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                          ....         ..++..++..+.+||.+||+.||++||++.++++||||
T Consensus       219 ----~~~~---------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         219 ----SGEP---------PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             ----cCCC---------cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                0000         01224568999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-36  Score=274.64  Aligned_cols=228  Identities=35%  Similarity=0.599  Sum_probs=185.0

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc------cHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|.+.+.||+|++|.||++++..+++.||+|.+.....      ...+|++++.+++|+|++++++++..     ....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-----SDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-----CCEEE
Confidence            38899999999999999999998999999999865432      24579999999999999999888733     34588


Q ss_pred             EEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------
Q 015672          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------  225 (403)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------  225 (403)
                      ++|||+++ +|.+++..    ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+++          
T Consensus        76 ~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  150 (254)
T cd06627          76 IILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHE-QGVIHRDIKAANILTTKDGVVKLADFGVATKLN  150 (254)
T ss_pred             EEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEECCCCCEEEeccccceecC
Confidence            99999985 66555443    2568999999999999999999999 89999999999999987655432          


Q ss_pred             ---------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          226 ---------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       226 ---------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                               .++..|+|||.+.+. .++.++||||||+++|+|++|..||...+.......+...               
T Consensus       151 ~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------------  214 (254)
T cd06627         151 DVSKDDASVVGTPYWMAPEVIEMS-GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD---------------  214 (254)
T ss_pred             CCcccccccccchhhcCHhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc---------------
Confidence                     346679999998654 4889999999999999999999999776644333332210               


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                          ..+         .++..++..+.++|.+||..||++|||+.+++.||||
T Consensus       215 ----~~~---------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         215 ----DHP---------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             ----CCC---------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                000         1224578899999999999999999999999999998

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-36  Score=278.23  Aligned_cols=226  Identities=22%  Similarity=0.300  Sum_probs=179.0

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      ..|.+.+.||+|+||.||+|.+. +++.||+|.+....   ....+|+.++++++|+||+++++++.     .....+++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv   79 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT-----LEEPIYIV   79 (261)
T ss_pred             hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEe-----cCCCeeee
Confidence            45999999999999999999974 45789999986533   23457999999999999999998773     23347899


Q ss_pred             eeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceeec----------
Q 015672          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYIC----------  227 (403)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~~----------  227 (403)
                      |||++ ++|.+++....  ...++...+..++.|++.||.|||+ .||+||||||+||+++.++.++++.          
T Consensus        80 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          80 TELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             eecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            99995 67766654321  3468889999999999999999999 8999999999999998877654321          


Q ss_pred             ----------cccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          228 ----------SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       228 ----------t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                                +..|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+....+..+.+....            
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------------  223 (261)
T cd05068         157 IYEAREGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM------------  223 (261)
T ss_pred             cccccCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence                      2359999988654 58999999999999999999 99999877655544443321000            


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                            +          .+...+..+.+++.+||+.||++||++.++++
T Consensus       224 ------~----------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         224 ------P----------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             ------C----------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                  0          11346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.5e-36  Score=283.30  Aligned_cols=229  Identities=21%  Similarity=0.271  Sum_probs=177.6

Q ss_pred             cEeeeceecccCceEEEEEEECCC-----CcEEEEEEcccccc-----cHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      .|.+.+.||+|+||.||+|.+..+     ++.||+|++.....     ...+|+.++..++|+||+++++++..     .
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~   80 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK-----E   80 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-----C
Confidence            488899999999999999987543     57899999864322     24578999999999999999998732     2


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecC
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKG  219 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~------------~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~  219 (403)
                      ...++++||+. +++..++....            .....++...+..++.|++.||.|||+ .||+||||||+|||++.
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~-~gi~H~dlkp~Nil~~~  159 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-HHVVHKDLATRNVLVFD  159 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-cCccccccchhheEecC
Confidence            34789999987 45655553210            112347788889999999999999999 89999999999999987


Q ss_pred             CCCceee---------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 015672          220 EPNVSYI---------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVE  277 (403)
Q Consensus       220 ~~~~~~~---------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~  277 (403)
                      ++.+++.                     +++.|+|||++.+. .++.++|||||||++|||++ |..||.+....+.+..
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM  238 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            6544322                     24579999998654 48999999999999999998 8889987766555444


Q ss_pred             HHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          278 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       278 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      +......                            ..+..++.++.+|+.+||+.||++||++.+++..
T Consensus       239 i~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         239 IRNRQVL----------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHcCCcC----------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            4321000                            0124578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.4e-36  Score=273.49  Aligned_cols=230  Identities=29%  Similarity=0.490  Sum_probs=184.6

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      .|.+.+.||+|++|.||++.+..+++.+++|++....    ....+|+++++.++|+||+++++.+...     ...+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEE
Confidence            3888999999999999999998899999999986543    3456799999999999999999987433     448899


Q ss_pred             eeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------------
Q 015672          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------------  225 (403)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------------  225 (403)
                      +||++ ++|.+++...   ...++...+..++.|++.||.|||+ .|++||||+|+||+++.++.+++            
T Consensus        76 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122          76 MEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHS-NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             EecCCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhc-CCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence            99999 6666655432   2568899999999999999999999 89999999999999987655432            


Q ss_pred             ------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 015672          226 ------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  299 (403)
Q Consensus       226 ------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  299 (403)
                            .++..|+|||.+.+. .++.++|||||||++|+|++|..||...+.......+... ..               
T Consensus       152 ~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~---------------  214 (253)
T cd05122         152 KARNTMVGTPYWMAPEVINGK-PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GP---------------  214 (253)
T ss_pred             ccccceecCCcccCHHHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CC---------------
Confidence                  346679999998654 4889999999999999999999999876544443332221 00               


Q ss_pred             cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 015672          300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  348 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~  348 (403)
                         +..   +    ....++..+.++|.+||+.||++|||+.++++|||
T Consensus       215 ---~~~---~----~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         215 ---PGL---R----NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ---CCc---C----cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence               000   0    01224789999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-37  Score=296.74  Aligned_cols=237  Identities=27%  Similarity=0.468  Sum_probs=189.2

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccccc-------HHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-------KNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      +.-|..++.||-|+||+|.+++...|...||+|.+++....       .+.|..||..-+++-||++|..|     .+..
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkd  702 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKD  702 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCC
Confidence            34588999999999999999999999999999998653222       23588899999999999998887     4455


Q ss_pred             EEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------
Q 015672          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------  224 (403)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------  224 (403)
                      .+|+||+|++| ++-.++-.    .+-|.+..+++|+..+.+|+++.|. .|+|||||||+|||||.+++++        
T Consensus       703 nLYFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHk-mGFIHRDiKPDNILIDrdGHIKLTDFGLCT  777 (1034)
T KOG0608|consen  703 NLYFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCT  777 (1034)
T ss_pred             ceEEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHh-ccceecccCccceEEccCCceeeeeccccc
Confidence            59999999985 55444433    3668999999999999999999999 8999999999999999777652        


Q ss_pred             -----------------------------------------------------eeccccccchhhhhCCCCCCchhHHHH
Q 015672          225 -----------------------------------------------------YICSRYYRAPELIFGATEYTTAIDIWS  251 (403)
Q Consensus       225 -----------------------------------------------------~~~t~~y~aPE~~~~~~~~~~~~DiwS  251 (403)
                                                                           ++||+.|+|||++.. ..|+..||+||
T Consensus       778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws  856 (1034)
T KOG0608|consen  778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWS  856 (1034)
T ss_pred             cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhH
Confidence                                                                 357999999999965 45999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcc
Q 015672          252 TGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ  331 (403)
Q Consensus       252 lGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  331 (403)
                      .|||||||+.|++||......+.-.+++.+-               ..+.++          ...++|+++.+||.++. 
T Consensus       857 ~gvil~em~~g~~pf~~~tp~~tq~kv~nw~---------------~~l~~~----------~~~~ls~e~~~li~kLc-  910 (1034)
T KOG0608|consen  857 VGVILYEMLVGQPPFLADTPGETQYKVINWR---------------NFLHIP----------YQGNLSKEALDLIQKLC-  910 (1034)
T ss_pred             hhHHHHHHhhCCCCccCCCCCcceeeeeehh---------------hccccc----------cccccCHHHHHHHHHHh-
Confidence            9999999999999998776544333332210               000111          22578999999999864 


Q ss_pred             cCCCCCC---CHHHHhcCCCcccCCC
Q 015672          332 YSPNLRC---TALEACVHPFFDELRD  354 (403)
Q Consensus       332 ~dP~~Rp---ta~e~l~hp~f~~~~~  354 (403)
                      .+++.|+   .++++..||||+.+..
T Consensus       911 ~sad~RLGkng~d~vKaHpfFkgIDf  936 (1034)
T KOG0608|consen  911 CSADSRLGKNGADQVKAHPFFKGIDF  936 (1034)
T ss_pred             cChhhhhcccchhhhhcCccccccch
Confidence            6788998   4788999999998864

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.9e-36  Score=282.78  Aligned_cols=229  Identities=24%  Similarity=0.329  Sum_probs=178.6

Q ss_pred             ccEeeeceecccCceEEEEEEECC-----CCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      .+|.+.+.||+|+||.||+|++..     ++..+|+|.+....    ....+|+++++.++|+||+++++++.     ..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DG   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----cC
Confidence            459999999999999999998543     45679999875432    23567999999999999999999873     33


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecC
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKG  219 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~  219 (403)
                      .+.++||||++ ++|.+++.....            ....+++..+..++.||+.||.|||+ +||+||||||+|||++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nil~~~  158 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLATRNCLVGA  158 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEcc
Confidence            45889999997 677766654221            12347888899999999999999999 89999999999999987


Q ss_pred             CCCceee---------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 015672          220 EPNVSYI---------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVE  277 (403)
Q Consensus       220 ~~~~~~~---------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~  277 (403)
                      ++.+++.                     ++..|+|||++.+. .++.++|||||||++|+|++ |..||...+..+.+..
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  237 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC  237 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            6654322                     24579999998654 58899999999999999998 9999977665544333


Q ss_pred             HHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          278 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       278 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      +...  .                 .+         ..+...+..+.+|+.+||+.||++|||+.++++
T Consensus       238 ~~~~--~-----------------~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         238 ITQG--R-----------------VL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HhCC--C-----------------CC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            2210  0                 00         011346789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-36  Score=277.68  Aligned_cols=227  Identities=24%  Similarity=0.315  Sum_probs=178.0

Q ss_pred             ccEeeeceecccCceEEEEEEECCC---CcEEEEEEcccccc-----cHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      .+|.+.+.||+|+||+||+|++..+   ...||+|.+.....     ...+|+.+++.++|+||+++++.+.     ...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   78 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----KSR   78 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----cCC
Confidence            4599999999999999999998644   45799998854321     2346999999999999999999873     233


Q ss_pred             EEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee------
Q 015672          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI------  226 (403)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~------  226 (403)
                      ..+++|||+++ +|.+++...   ...++...+..++.|++.||.|||+ .+|+||||||+|||++.++.++..      
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~di~p~nili~~~~~~~l~dfg~~~  154 (266)
T cd05033          79 PVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSE-MNYVHRDLAARNILVNSNLVCKVSDFGLSR  154 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCCCEEECccchhh
Confidence            48899999974 676665432   2468899999999999999999999 899999999999999877654322      


Q ss_pred             ---------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          227 ---------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       227 ---------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                     ++..|+|||.+.+. .++.++|||||||++|+|++ |..||......+....+......      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------  227 (266)
T cd05033         155 RLEDSEATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL------  227 (266)
T ss_pred             cccccccceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC------
Confidence                           13569999998644 58999999999999999998 99999776654443333221000      


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                  +          .+...++.+.+|+.+||+.||++||++.+++++
T Consensus       228 ------------~----------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         228 ------------P----------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             ------------C----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                        0          113568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-36  Score=277.44  Aligned_cols=225  Identities=22%  Similarity=0.311  Sum_probs=177.1

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      +|++.+.||+|+||.||+|.++ ++..+|+|.+....   ....+|+++++.++|+||+++++++     ....+.++||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~   78 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFIVT   78 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEEEE
Confidence            4889999999999999999885 56789999875432   2345799999999999999998877     3334588999


Q ss_pred             eccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee------------
Q 015672          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI------------  226 (403)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~------------  226 (403)
                      ||++ ++|.+++...   ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+++.            
T Consensus        79 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          79 EYMANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLES-NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             ecCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence            9997 4666555432   2367888999999999999999999 899999999999999877654332            


Q ss_pred             -----c---cccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          227 -----C---SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       227 -----~---t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                           +   +..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+.....              
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------------  219 (256)
T cd05059         155 YTSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR--------------  219 (256)
T ss_pred             ccccCCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc--------------
Confidence                 1   2359999998654 58999999999999999999 8999987665544433321100              


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                          .          ..+...+.++.+++.+||..+|++|||+.++++.
T Consensus       220 ----~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         220 ----L----------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             ----C----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                0          0113468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.3e-36  Score=283.51  Aligned_cols=230  Identities=22%  Similarity=0.334  Sum_probs=179.0

Q ss_pred             ccEeeeceecccCceEEEEEEECCCC-----cEEEEEEcccccc-----cHHHHHHHHHhc-CCCCccccceEEeecCCC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQDKR-----YKNRELQIMQML-DHPNIVALKHCFFSTTDK  150 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~-----~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  150 (403)
                      .+|.+.+.||+|+||.||++......     ..+|+|.+.....     ...+|+++++++ +|+||+++++++.     
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-----   86 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT-----   86 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc-----
Confidence            45999999999999999999876443     6899998864322     234799999999 8999999998873     


Q ss_pred             CceEEEEEeeccC-CcHHHHHHHhh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccccccee
Q 015672          151 EELYLNLVLEYVP-ETVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV  217 (403)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~------------~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl  217 (403)
                      ....++++|||++ ++|..++....            .....+++..+..++.|++.||.|||+ .+|+||||||+|||+
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~Nil~  165 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS-KKCIHRDLAARNVLV  165 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCccccccceeeEEE
Confidence            2334889999987 57766665321            223568888999999999999999999 899999999999999


Q ss_pred             cCCCCceee---------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 015672          218 KGEPNVSYI---------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQL  275 (403)
Q Consensus       218 ~~~~~~~~~---------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~  275 (403)
                      +.++.++..                     ++..|+|||++.+. .++.++|||||||++|+|++ |..||.+....+..
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  244 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF  244 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence            877654321                     23469999988544 58999999999999999997 99999877655444


Q ss_pred             HHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          276 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       276 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      ..+.....                .            ..+...+.++.+|+.+||..||++|||+.+++++
T Consensus       245 ~~~~~~~~----------------~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         245 KLLKEGYR----------------M------------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHcCCc----------------C------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            33321100                0            0123467899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6.3e-36  Score=276.19  Aligned_cols=225  Identities=25%  Similarity=0.353  Sum_probs=175.8

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      ..|.+.++||+|+||.||+|++..+ ..||+|++....   ....+|+++++.++|+||+++++.+.     . .+.++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~~~lv   78 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPIYIV   78 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-----C-CCcEEE
Confidence            4599999999999999999988655 469999986532   23467999999999999999987651     1 236799


Q ss_pred             eeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee-----------
Q 015672          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-----------  226 (403)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~-----------  226 (403)
                      |||++ +++.+++...  ....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+++.           
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          79 TEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             EEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            99998 4776665432  12457888899999999999999999 899999999999999876654322           


Q ss_pred             ---------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          227 ---------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       227 ---------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                               ++..|+|||+..+. .++.++|||||||++|+|++ |..||.+....+....+.....             
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-------------  221 (262)
T cd05071         156 EYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-------------  221 (262)
T ss_pred             ccccccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC-------------
Confidence                     23469999988544 48999999999999999999 8889987765554433321100             


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                           .+          ....++..+.+||.+||+.||++||++.++++
T Consensus       222 -----~~----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         222 -----MP----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             -----CC----------CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                 00          11346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=5e-37  Score=312.87  Aligned_cols=242  Identities=28%  Similarity=0.429  Sum_probs=180.6

Q ss_pred             CcccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeec-----
Q 015672           78 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFST-----  147 (403)
Q Consensus        78 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~-----  147 (403)
                      ++...+|+.++.||+||||.||+|+++-+|+.||||+|.-..     ....+|+.+|.+|+|||||+|+..|...     
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            567778999999999999999999999999999999996442     2234799999999999999998776310     


Q ss_pred             -------------------------------------------------C----------------------C-------
Q 015672          148 -------------------------------------------------T----------------------D-------  149 (403)
Q Consensus       148 -------------------------------------------------~----------------------~-------  149 (403)
                                                                       .                      .       
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                             0                      0       


Q ss_pred             ------------------------CC-------ceEEEEEeeccCCcHHHHHHHhhhhcCCC-CHHHHHHHHHHHHHHHH
Q 015672          150 ------------------------KE-------ELYLNLVLEYVPETVNRIARNYSRIHQRM-PLIYVKLYTYQICRALA  197 (403)
Q Consensus       150 ------------------------~~-------~~~~~lv~e~~~~~l~~~~~~~~~~~~~l-~~~~~~~~~~qi~~~L~  197 (403)
                                              .+       ..++||-||||+.++.+.+-...   ... ....++++++||++||.
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N---~~~~~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN---HFNSQRDEAWRLFREILEGLA  711 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc---ccchhhHHHHHHHHHHHHHHH
Confidence                                    00       16789999999965543322211   111 46778999999999999


Q ss_pred             HHHhcCCccccccccccceecCCCCc-------------------------------------eeeccccccchhhhhCC
Q 015672          198 YIHNCIGICHRDIKPQNLLVKGEPNV-------------------------------------SYICSRYYRAPELIFGA  240 (403)
Q Consensus       198 ~LH~~~~ivHrDlKp~NILl~~~~~~-------------------------------------~~~~t~~y~aPE~~~~~  240 (403)
                      |+|+ +|||||||||.||+++....+                                     ..+||..|+|||++.+.
T Consensus       712 YIH~-~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  712 YIHD-QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HHHh-CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            9999 899999999999999865544                                     34688999999999666


Q ss_pred             C--CCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCC
Q 015672          241 T--EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRL  318 (403)
Q Consensus       241 ~--~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (403)
                      .  .|+.|+||||||||||||+.   ||...  ++... +...+..+               .+|.    +  ..+...-
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~-iL~~LR~g---------------~iP~----~--~~f~~~~  843 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTS--MERAS-ILTNLRKG---------------SIPE----P--ADFFDPE  843 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCch--HHHHH-HHHhcccC---------------CCCC----C--ccccccc
Confidence            5  69999999999999999984   46433  22222 22222111               1111    1  0111223


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 015672          319 PPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  350 (403)
Q Consensus       319 s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~  350 (403)
                      -+....+|+.||+.||.+||||.|+|++.||-
T Consensus       844 ~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  844 HPEEASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             chHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            35667899999999999999999999999997

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.3e-36  Score=276.66  Aligned_cols=212  Identities=26%  Similarity=0.329  Sum_probs=167.6

Q ss_pred             cCceEEEEEEECCCCcEEEEEEcccccccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeeccC-CcHHHHHH
Q 015672           93 GSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIAR  171 (403)
Q Consensus        93 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~  171 (403)
                      |.||.||+|++..+++.||+|.+.... ...+|...+....||||+++++++.     ...+.+++|||++ ++|.+.+.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-EYSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-hhhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCCHHHHHH
Confidence            889999999999999999999986543 2345666666678999999999873     3345889999998 46666554


Q ss_pred             HhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----------------ccccccchh
Q 015672          172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----------------CSRYYRAPE  235 (403)
Q Consensus       172 ~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----------------~t~~y~aPE  235 (403)
                      .    ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++..+..                ++..|+|||
T Consensus        78 ~----~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE  152 (237)
T cd05576          78 K----FLNIPEECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPE  152 (237)
T ss_pred             H----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCc
Confidence            3    2458899999999999999999999 899999999999999887655432                355699999


Q ss_pred             hhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccc
Q 015672          236 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQ  315 (403)
Q Consensus       236 ~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (403)
                      .+.+ ..++.++||||+||++|+|++|..||.......     ..                ...+            .++
T Consensus       153 ~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----~~----------------~~~~------------~~~  198 (237)
T cd05576         153 VGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSGI-----NT----------------HTTL------------NIP  198 (237)
T ss_pred             ccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----cc----------------cccc------------CCc
Confidence            8854 347899999999999999999998874322100     00                0000            022


Q ss_pred             cCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCc
Q 015672          316 KRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFF  349 (403)
Q Consensus       316 ~~~s~~~~~li~~~L~~dP~~Rpta-----~e~l~hp~f  349 (403)
                      ..+++.+++||.+||+.||++|+|+     +++++||||
T Consensus       199 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         199 EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             ccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            4578899999999999999999986     999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=8.2e-36  Score=281.28  Aligned_cols=229  Identities=24%  Similarity=0.345  Sum_probs=177.7

Q ss_pred             cccEeeeceecccCceEEEEEEEC-----CCCcEEEEEEcccccc-----cHHHHHHHHHhc-CCCCccccceEEeecCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDKR-----YKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  149 (403)
                      ..+|.+.+.||+|+||.||+|.+.     .++..||+|.+.....     ...+|+.+++++ +|+||+++++++..   
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~---  110 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI---  110 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec---
Confidence            346999999999999999999752     3456899998864321     245799999999 79999999998733   


Q ss_pred             CCceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---
Q 015672          150 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---  225 (403)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---  225 (403)
                        ....+++|||+. ++|..++....  ...+++..+..++.||+.||.|||+ ++|+|+||||+|||++.++.++.   
T Consensus       111 --~~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~l~df  185 (302)
T cd05055         111 --GGPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNVLLTHGKIVKICDF  185 (302)
T ss_pred             --CCceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeehhhhccceEEEcCCCeEEECCC
Confidence              234889999997 56766654321  2337889999999999999999999 89999999999999986654322   


Q ss_pred             ------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 015672          226 ------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  286 (403)
Q Consensus       226 ------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~  286 (403)
                                        .++..|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+.......    
T Consensus       186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~----  260 (302)
T cd05055         186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG----  260 (302)
T ss_pred             cccccccCCCceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC----
Confidence                              124569999998654 48999999999999999998 999998776555443333210    


Q ss_pred             HHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          287 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                   ...          ..+...++++.+|+.+||..||++|||+.++++
T Consensus       261 -------------~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         261 -------------YRM----------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             -------------CcC----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                         000          011346789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=6.5e-36  Score=282.56  Aligned_cols=230  Identities=21%  Similarity=0.312  Sum_probs=176.8

Q ss_pred             ccEeeeceecccCceEEEEEEECC-------CCcEEEEEEcccccc-----cHHHHHHHHHhc-CCCCccccceEEeecC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQDKR-----YKNRELQIMQML-DHPNIVALKHCFFSTT  148 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~-----~~~~E~~~l~~l-~h~niv~~~~~~~~~~  148 (403)
                      .+|.+.+.||+|+||.||+|++..       +...+|+|.+..+..     ...+|+.+++.+ +|+||+++++++.   
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~---   94 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT---   94 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe---
Confidence            459999999999999999998643       235799998864321     234689999999 7999999999873   


Q ss_pred             CCCceEEEEEeeccC-CcHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccc
Q 015672          149 DKEELYLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL  215 (403)
Q Consensus       149 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NI  215 (403)
                        .....++||||++ ++|.+++.....            ....++...+..++.|++.||+|||+ .|++||||||+||
T Consensus        95 --~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~Ni  171 (307)
T cd05098          95 --QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNV  171 (307)
T ss_pred             --cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHHhe
Confidence              3335889999998 577776654221            12347888899999999999999999 8999999999999


Q ss_pred             eecCCCCceee---------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 015672          216 LVKGEPNVSYI---------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVD  273 (403)
Q Consensus       216 Ll~~~~~~~~~---------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~  273 (403)
                      |++.++.+++.                     ++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+
T Consensus       172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~  250 (307)
T cd05098         172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  250 (307)
T ss_pred             EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence            99876654332                     12469999998654 48999999999999999998 889997665433


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          274 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       274 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      ....+... ..                           ...+..++.++.+||.+||..+|++|||+.+++++
T Consensus       251 ~~~~~~~~-~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         251 LFKLLKEG-HR---------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHcC-CC---------------------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            33222110 00                           00124578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=7.4e-36  Score=275.16  Aligned_cols=226  Identities=22%  Similarity=0.311  Sum_probs=177.7

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      ...|++.++||+|+||.||+|... +++.||+|.+....   ....+|+.+++.++|+||+++++++ ..     .+.++
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~-----~~~~~   77 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV-TQ-----EPIYI   77 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEE-cc-----CCcEE
Confidence            346999999999999999999864 57889999886543   2345799999999999999998765 11     23789


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----------  226 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----------  226 (403)
                      +|||+. +++.+.+...  ....++...+..++.|++.||+|||+ .|++||||||+||+++.++.+.+.          
T Consensus        78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05067          78 ITEYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIER-KNYIHRDLRAANILVSETLCCKIADFGLARLIED  154 (260)
T ss_pred             EEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence            999997 5676655432  23467888899999999999999998 899999999999999876554321          


Q ss_pred             ----------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          227 ----------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       227 ----------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                ++..|+|||++.+. .++.++|||||||++|++++ |++||.+.+..+....+......+          
T Consensus       155 ~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----------  223 (260)
T cd05067         155 NEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP----------  223 (260)
T ss_pred             CCcccccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC----------
Confidence                      23469999998544 48899999999999999999 999998776555444332211000          


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                        .+...+.++.++|.+||..||++|||++++++
T Consensus       224 ------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         224 ------------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             ------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                              12346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-36  Score=279.62  Aligned_cols=220  Identities=19%  Similarity=0.268  Sum_probs=166.8

Q ss_pred             ceecccCceEEEEEEECCCCc-------EEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           88 HVVGTGSFGVVFQAKCRETGE-------IVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~-------~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +.||+|+||.||+|.+..++.       .+|+|.+....    .....|+.+++.++|+||+++++.+...     ...+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CCcE
Confidence            469999999999999865543       48888775432    2234688999999999999999988543     2378


Q ss_pred             EEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc--------e---
Q 015672          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV--------S---  224 (403)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~--------~---  224 (403)
                      +||||+++ +|..++...   ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++..        +   
T Consensus        76 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d  151 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLED-KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD  151 (258)
T ss_pred             EEEecCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccceEEEecccccccCCCceEEecc
Confidence            99999984 666555432   2357888899999999999999999 899999999999999765432        1   


Q ss_pred             ------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015672          225 ------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       225 ------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~  291 (403)
                                  ..++..|+|||++.+...++.++|||||||++|+|++|. +||...+...... ....          
T Consensus       152 ~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~----------  220 (258)
T cd05078         152 PGISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED----------  220 (258)
T ss_pred             cccccccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc----------
Confidence                        235678999999876556899999999999999999984 6665544332221 1110          


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                             ...            ++...+.++.+||.+||+.||++|||++++++.
T Consensus       221 -------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         221 -------RHQ------------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             -------ccc------------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                   000            113356789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.3e-36  Score=277.82  Aligned_cols=231  Identities=24%  Similarity=0.354  Sum_probs=178.8

Q ss_pred             ccEeeeceecccCceEEEEEEECC-----CCcEEEEEEcccccc-----cHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      .+|++.+.||+|+||.||+|+.+.     +.+.||+|.+.....     ...+|++++++++|+||+++++++     .+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence            469999999999999999999754     346799998754332     246799999999999999999877     33


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSRIH-----QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY  225 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~  225 (403)
                      ..+.++||||++ ++|.+++.......     ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.++.
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dlkp~Nili~~~~~~~l  158 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN-ARFVHRDLAARNCLVSSQREVKV  158 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh-cCcccCcCccceEEEeCCCcEEE
Confidence            345889999998 57777665432111     158899999999999999999999 89999999999999987665432


Q ss_pred             --------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 015672          226 --------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT  284 (403)
Q Consensus       226 --------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~  284 (403)
                                          .++..|+|||.+.+. .++.++|||||||++|+|++ |..||........+..+...   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~---  234 (275)
T cd05046         159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG---  234 (275)
T ss_pred             cccccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC---
Confidence                                234569999988654 47899999999999999998 88899765544433332210   


Q ss_pred             CCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          285 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                    ...++          .+..++..+.+++.+||+.||.+|||+.+++++
T Consensus       235 --------------~~~~~----------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         235 --------------KLELP----------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             --------------CcCCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence                          00000          123578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=7.4e-36  Score=275.16  Aligned_cols=225  Identities=22%  Similarity=0.302  Sum_probs=176.4

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      .+|++.+.||+|+||.||+|.+. .+..+|+|.+....   ....+|+.++++++|+||+++++++.    .  ...+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~----~--~~~~lv   78 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS----E--EPIYIV   78 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC----C--CCcEEE
Confidence            45999999999999999999875 56779999886432   23458999999999999999988651    1  126799


Q ss_pred             eeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee-----------
Q 015672          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-----------  226 (403)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~-----------  226 (403)
                      |||++ ++|.+++...  ....+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+++.           
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          79 TEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIER-MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence            99997 4676665432  13457888999999999999999999 899999999999999876554321           


Q ss_pred             ---------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          227 ---------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       227 ---------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                               ++..|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+....+......            
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------  222 (260)
T cd05070         156 EYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM------------  222 (260)
T ss_pred             ccccccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence                     23459999988654 58899999999999999999 89999877655554443321000            


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                      ..+...+..+.+|+.+||..||++|||++++.+
T Consensus       223 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         223 ----------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             ----------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                            012356789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=6.9e-36  Score=278.61  Aligned_cols=229  Identities=24%  Similarity=0.355  Sum_probs=177.5

Q ss_pred             ccEeeeceecccCceEEEEEEEC-----CCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      .+|++.++||+|+||.||++...     .++..+|+|.+....    ....+|+++++.++|+||+++++++..     .
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE-----G   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-----C
Confidence            35889999999999999999743     346689999875432    234579999999999999999887732     3


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhh-----------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCC
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSR-----------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE  220 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~-----------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~  220 (403)
                      ...+++|||++ ++|..++.....           ....+++..+..++.||+.||.|||+ .||+||||||+|||++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~nil~~~~  158 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS-LHFVHRDLATRNCLVGQG  158 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH-CCeecccccHhhEEEcCC
Confidence            34789999997 577666654211           01347888899999999999999999 899999999999999876


Q ss_pred             CCceee---------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 015672          221 PNVSYI---------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEI  278 (403)
Q Consensus       221 ~~~~~~---------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i  278 (403)
                      +.+++.                     +++.|+|||++.+. .++.++|||||||++|+|++ |.+||......+.+..+
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI  237 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            654332                     24569999998654 48999999999999999998 99999776655544333


Q ss_pred             HHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          279 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      ....  +.                          ..+..+++.+.+||.+||+.||.+||++.++++
T Consensus       238 ~~~~--~~--------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         238 TQGR--EL--------------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HcCc--cC--------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            2210  00                          012457889999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=7.4e-36  Score=280.34  Aligned_cols=236  Identities=18%  Similarity=0.240  Sum_probs=178.6

Q ss_pred             ccEeeeceecccCceEEEEEEECCCC----------------cEEEEEEccccc-----ccHHHHHHHHHhcCCCCcccc
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETG----------------EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVAL  140 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~  140 (403)
                      .+|++.+.||+|+||.||+|.+..++                ..||+|.+....     ....+|+++++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            45999999999999999999876543                468999886432     223469999999999999999


Q ss_pred             ceEEeecCCCCceEEEEEeeccC-CcHHHHHHHhhh-------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccc
Q 015672          141 KHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSR-------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP  212 (403)
Q Consensus       141 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp  212 (403)
                      ++++..     ..+.+++|||+. ++|..++.....       ....+++..+..++.|++.||.|||+ .||+||||||
T Consensus        85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~i~H~dlkp  158 (296)
T cd05051          85 LGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES-LNFVHRDLAT  158 (296)
T ss_pred             EEEEec-----CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccccch
Confidence            988732     345889999997 567666654321       11258889999999999999999999 8999999999


Q ss_pred             ccceecCCCCcee---------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh--CCCCCCCC
Q 015672          213 QNLLVKGEPNVSY---------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPGE  269 (403)
Q Consensus       213 ~NILl~~~~~~~~---------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t--g~~pf~~~  269 (403)
                      +||+++.++.+++                     .+++.|+|||++.+. .++.++|||||||++|+|++  |..||...
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  237 (296)
T cd05051         159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEHL  237 (296)
T ss_pred             hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence            9999987654432                     124579999998654 58999999999999999998  77888776


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          270 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       270 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      +..+.+...........               .....      ..+...+.++.+||.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~---------------~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         238 TDQQVIENAGHFFRDDG---------------RQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             ChHHHHHHHHhcccccc---------------ccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            65555444433211000               00000      012346789999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1e-35  Score=275.37  Aligned_cols=225  Identities=23%  Similarity=0.322  Sum_probs=177.1

Q ss_pred             cEeeeceecccCceEEEEEEECCCCc---EEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      .|+..+.||+|+||.||+|+...++.   .+|+|.+....     ....+|+++++.++|+||+++.+++.     ...+
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   80 (268)
T cd05063           6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----KFKP   80 (268)
T ss_pred             HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----cCCC
Confidence            58899999999999999999876554   79999885432     22346899999999999999998873     3334


Q ss_pred             EEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee-------
Q 015672          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-------  226 (403)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~-------  226 (403)
                      .++||||+++ +|..++..   ....+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+++.       
T Consensus        81 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~  156 (268)
T cd05063          81 AMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSD-MNYVHRDLAARNILVNSNLECKVSDFGLSRV  156 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEEcCCCcEEECCCcccee
Confidence            7899999984 66555433   23568888999999999999999999 899999999999999876654332       


Q ss_pred             ---------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          227 ---------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       227 ---------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                     .+..|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+......+     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~-----  230 (268)
T cd05063         157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP-----  230 (268)
T ss_pred             cccccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC-----
Confidence                           12359999998654 58999999999999999997 999998776555444443211100     


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                             ....++.++.+|+.+||+.||++||++.++++
T Consensus       231 -----------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         231 -----------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             -----------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                   01346789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-36  Score=272.49  Aligned_cols=220  Identities=35%  Similarity=0.594  Sum_probs=178.5

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeecc
Q 015672           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (403)
Q Consensus        90 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  162 (403)
                      ||.|+||.||++.+..+++.+|+|.+....       .....|+.+++.++|+||+++++.+     ....+++++|||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence            699999999999998889999999885432       1345789999999999999999887     4455689999999


Q ss_pred             C-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------------
Q 015672          163 P-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------------  225 (403)
Q Consensus       163 ~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------------  225 (403)
                      + ++|.+.+..    ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+.+                
T Consensus        76 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~  150 (250)
T cd05123          76 PGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHS-LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT  150 (250)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcc
Confidence            4 677665543    2468899999999999999999999 89999999999999987655432                


Q ss_pred             ---eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCC
Q 015672          226 ---ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  302 (403)
Q Consensus       226 ---~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  302 (403)
                         .++..|+|||.+.+. ..+.++|+|||||++|++++|..||...+.......+...                 ... 
T Consensus       151 ~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-----------------~~~-  211 (250)
T cd05123         151 NTFCGTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD-----------------PLR-  211 (250)
T ss_pred             cCCcCCccccChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC-----------------CCC-
Confidence               346679999998654 4788999999999999999999999776653333332210                 001 


Q ss_pred             CCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH---HHHhcCCCc
Q 015672          303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA---LEACVHPFF  349 (403)
Q Consensus       303 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta---~e~l~hp~f  349 (403)
                                 ++..++.++.++|.+||..||++|||+   +++++||||
T Consensus       212 -----------~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         212 -----------FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             -----------CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence                       224568899999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.5e-36  Score=276.66  Aligned_cols=220  Identities=17%  Similarity=0.201  Sum_probs=163.6

Q ss_pred             ceecccCceEEEEEEECCC------------CcEEEEEEcccccc----cHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           88 HVVGTGSFGVVFQAKCRET------------GEIVAIKKVLQDKR----YKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~------------~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      +.||+|+||.||+|+....            ...+|+|.+.....    ...+|+.+++.++||||+++++++...    
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~----   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD----   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence            3689999999999985322            23588898754322    234678899999999999999987432    


Q ss_pred             ceEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC-------c
Q 015672          152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN-------V  223 (403)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~-------~  223 (403)
                       ...+++|||+++ .+..++..   ....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.       +
T Consensus        77 -~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~~~~~~~~  151 (262)
T cd05077          77 -VENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLED-KDLVHGNVCTKNILLAREGIDGECGPFI  151 (262)
T ss_pred             -CCCEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhh-CCeECCCCCcccEEEecCCccCCCCcee
Confidence             236799999985 44444332   13468899999999999999999999 89999999999999975432       1


Q ss_pred             e---------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015672          224 S---------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTR  287 (403)
Q Consensus       224 ~---------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~-tg~~pf~~~~~~~~~~~i~~~~~~~~~  287 (403)
                      +               ..++..|+|||++.....++.++|||||||++|+|+ +|..||......+.. .....      
T Consensus       152 ~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~------  224 (262)
T cd05077         152 KLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEG------  224 (262)
T ss_pred             EeCCCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhc------
Confidence            1               135677999998865556899999999999999997 588888765432221 11100      


Q ss_pred             HHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                 .  ..          .....++++.+||.+||+.||++||++.+++++
T Consensus       225 -----------~--~~----------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         225 -----------Q--CM----------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             -----------C--cc----------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                       0  00          002245789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-36  Score=273.61  Aligned_cols=224  Identities=27%  Similarity=0.382  Sum_probs=179.4

Q ss_pred             ceecccCceEEEEEEECCC---CcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           88 HVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      +.||+|+||.||+|.+...   +..||+|.+....     ....+|+++++.++|+||+++++++..     ...++++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence            4699999999999999866   8899999986532     234579999999999999999988743     44588999


Q ss_pred             eccC-CcHHHHHHHhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee--------
Q 015672          160 EYVP-ETVNRIARNYSRI-----HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY--------  225 (403)
Q Consensus       160 e~~~-~~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~--------  225 (403)
                      ||++ ++|..++......     ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+++        
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~nili~~~~~~~l~dfg~~~~  154 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS-KKFVHRDLAARNCLVGEDLVVKISDFGLSRD  154 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc-CCcccCccCcceEEECCCCcEEEcccccccc
Confidence            9995 6777766553211     3678999999999999999999999 89999999999999988765533        


Q ss_pred             -------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015672          226 -------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       226 -------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  291 (403)
                                   .++..|+|||.+... .++.++|||||||++|+|++ |..||...+..+....+....         
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---------  224 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY---------  224 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------
Confidence                         246679999998654 58999999999999999999 699998876554444333210         


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                         ....+..++.++.+++.+||+.||.+|||+.+++++
T Consensus       225 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         225 -------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             -------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                               001124568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.5e-36  Score=279.12  Aligned_cols=219  Identities=17%  Similarity=0.248  Sum_probs=164.8

Q ss_pred             eecccCceEEEEEEECCC------------------------CcEEEEEEcccccc----cHHHHHHHHHhcCCCCcccc
Q 015672           89 VVGTGSFGVVFQAKCRET------------------------GEIVAIKKVLQDKR----YKNRELQIMQMLDHPNIVAL  140 (403)
Q Consensus        89 ~lG~G~~g~V~~~~~~~~------------------------~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~niv~~  140 (403)
                      .||+|+||.||+|....+                        ...||+|++.....    ...+|+.+++.++|+||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            599999999999975321                        23588898754322    23468889999999999999


Q ss_pred             ceEEeecCCCCceEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecC
Q 015672          141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKG  219 (403)
Q Consensus       141 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~  219 (403)
                      ++++...     .+.++||||+++ +|..++..   ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.
T Consensus        82 ~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~Nill~~  152 (274)
T cd05076          82 HGVCVRG-----SENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLED-KNLVHGNVCAKNILLAR  152 (274)
T ss_pred             EEEEEeC-----CceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHc-CCccCCCCCcccEEEec
Confidence            9987432     347899999985 45444432   23568899999999999999999999 89999999999999975


Q ss_pred             CCC-------ce---------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHH-hCCCCCCCCCcHHHHH
Q 015672          220 EPN-------VS---------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLV  276 (403)
Q Consensus       220 ~~~-------~~---------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~-tg~~pf~~~~~~~~~~  276 (403)
                      .+.       ++               ..++..|+|||.+.+...++.++|||||||++|||+ +|..||.+....+...
T Consensus       153 ~~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  232 (274)
T cd05076         153 LGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER  232 (274)
T ss_pred             cCcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence            321       11               124677999998865556899999999999999995 6999997665433221


Q ss_pred             HHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          277 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       277 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                       ....                 ...            .+...++++.++|.+||+.||++|||+.+++++
T Consensus       233 -~~~~-----------------~~~------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         233 -FYEK-----------------KHR------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             -HHHh-----------------ccC------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence             1110                 000            112345789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=7.6e-36  Score=279.70  Aligned_cols=228  Identities=21%  Similarity=0.356  Sum_probs=175.5

Q ss_pred             cEeeeceecccCceEEEEEEECC-----CCcEEEEEEcccccc-----cHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      +|++.+.||+|+||.||+|+...     ....+|+|.+.....     ...+|+.+++.++||||+++++.+.     ..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence            37889999999999999998753     235689998764332     2457999999999999999998873     23


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhh--------------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccc
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSR--------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIK  211 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~--------------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlK  211 (403)
                      ...+++|||+. ++|..++.....                    ....++...+..++.|++.||.|||+ .+|+|||||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dik  154 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLA  154 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH-CCeehhhhh
Confidence            34789999998 677666543211                    12347788889999999999999999 899999999


Q ss_pred             cccceecCCCCceee---------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 015672          212 PQNLLVKGEPNVSYI---------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGE  269 (403)
Q Consensus       212 p~NILl~~~~~~~~~---------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~  269 (403)
                      |+|||++.++.+++.                     ++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.
T Consensus       155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~  233 (290)
T cd05045         155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGI  233 (290)
T ss_pred             hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence            999999877655432                     24579999988654 58999999999999999998 99999776


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          270 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       270 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      ...+....+...                  +..          ..+..++.++.+|+.+||+.||++||++.++++
T Consensus       234 ~~~~~~~~~~~~------------------~~~----------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         234 APERLFNLLKTG------------------YRM----------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CHHHHHHHHhCC------------------CCC----------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            544433222110                  000          012457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.2e-35  Score=276.64  Aligned_cols=226  Identities=20%  Similarity=0.309  Sum_probs=174.9

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCc----EEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      ..+|++.++||+|+||+||+|++..++.    .||+|.+....     ....+|+.+++.++|+||+++++++...    
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----   81 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS----   81 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC----
Confidence            3469999999999999999999877776    48999875432     2234688999999999999999877421    


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----  226 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----  226 (403)
                        ..++++||++ +++.+++...   ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.++++    
T Consensus        82 --~~~l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~-~~iiH~dlkp~Nil~~~~~~~kL~dfG~  155 (279)
T cd05109          82 --TVQLVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEE-VRLVHRDLAARNVLVKSPNHVKITDFGL  155 (279)
T ss_pred             --CcEEEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceEEEcCCCcEEECCCCc
Confidence              2568999997 5665555432   3468899999999999999999999 899999999999999876654321    


Q ss_pred             -----------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015672          227 -----------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  288 (403)
Q Consensus       227 -----------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~  288 (403)
                                       +++.|+|||.+.+. .++.++|||||||++|||++ |..||......... ........++  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~--  231 (279)
T cd05109         156 ARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-DLLEKGERLP--  231 (279)
T ss_pred             eeecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCcCC--
Confidence                             13569999998654 58999999999999999998 89999765543322 2222110000  


Q ss_pred             HHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                               .+...+.++.++|.+||..||++||++.+++.
T Consensus       232 -------------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         232 -------------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             -------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                     11346789999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.4e-35  Score=272.72  Aligned_cols=226  Identities=22%  Similarity=0.324  Sum_probs=177.8

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc--cHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      .+|++.+.||+|+||.||++...  +..||+|.+..+..  ...+|+.+++.++|+|+++++++++..    ....+++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~lv~   79 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYIVT   79 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCceEEEE
Confidence            35999999999999999999864  78899998865432  345799999999999999999876432    23478999


Q ss_pred             eccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee------------
Q 015672          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI------------  226 (403)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~------------  226 (403)
                      ||++ ++|.+++....  ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++.++++            
T Consensus        80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          80 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEA-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             ECCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            9998 47766654321  2347888899999999999999999 899999999999999887765543            


Q ss_pred             ----ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccC
Q 015672          227 ----CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  301 (403)
Q Consensus       227 ----~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  301 (403)
                          ++..|+|||++.+. .++.++|||||||++|+|++ |+.||...+..+....+.+..                   
T Consensus       157 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-------------------  216 (256)
T cd05082         157 DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-------------------  216 (256)
T ss_pred             CCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-------------------
Confidence                23469999998544 58899999999999999997 999998765444433332110                   


Q ss_pred             CCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       302 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                               ....+..+++.+.++|.+||+.||++|||+.++++
T Consensus       217 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         217 ---------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                     00012457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.5e-35  Score=276.08  Aligned_cols=231  Identities=19%  Similarity=0.276  Sum_probs=178.5

Q ss_pred             cccEeeeceecccCceEEEEEEECC----CCcEEEEEEcccccc-----cHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRE----TGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      ..+|++.+.||+|+||.||+|.+..    ++..||+|.+.....     ...+|+.+++.++|+||++++++++..    
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED----   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence            3469999999999999999999875    357899998864322     234799999999999999999876432    


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSRI----HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI  226 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~  226 (403)
                      ....+++++|++ +++..++......    ...+++..+..++.||+.||+|||+ .+++||||||+||+++.++.+++.
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK-RGVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCHhhEEEcCCCcEEEC
Confidence            233678999987 6776666543221    1458889999999999999999999 899999999999999876655432


Q ss_pred             ---------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 015672          227 ---------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT  284 (403)
Q Consensus       227 ---------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~  284 (403)
                                           ++..|+|||++.+. .++.++|||||||++|++++ |+.||...+..+....+...   
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---  235 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG---  235 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC---
Confidence                                 23459999998654 48999999999999999999 99999876544432222210   


Q ss_pred             CCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          285 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                     +..+          .+..+++++.+++.+||..||++|||+.++++
T Consensus       236 ---------------~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         236 ---------------YRLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             ---------------CCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                           0000          11346789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.1e-35  Score=275.31  Aligned_cols=226  Identities=26%  Similarity=0.357  Sum_probs=176.8

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCc---EEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      .+|.+.+.||+|+||.||+|+++.++.   .+|+|.+....     ....+|+.+++.++||||+++++++.     ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   78 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSK   78 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCC
Confidence            358999999999999999999865443   79999885432     23457999999999999999998873     233


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI------  226 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~------  226 (403)
                      +.++||||++ ++|..++...   ...++...+..++.|++.||.|||+ .+++||||||+|||++.++.++..      
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~h~dlkp~nili~~~~~~~l~dfg~~~  154 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILVNSNLVCKVSDFGLSR  154 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeehhhchhcEEECCCCeEEeCCCCccc
Confidence            5889999997 4676665432   2457888899999999999999999 899999999999999876554321      


Q ss_pred             ----------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          227 ----------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       227 ----------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                      ++..|+|||++.+. .++.++|+|||||++|++++ |..||...+..+....+.+...      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~------  227 (267)
T cd05066         155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR------  227 (267)
T ss_pred             ccccccceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc------
Confidence                            13469999998654 58999999999999999886 9999987665544443332110      


Q ss_pred             HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                  .+          .+..+++.+.+++.+||+.+|.+||++.++++
T Consensus       228 ------------~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         228 ------------LP----------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             ------------CC----------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                        00          11346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-35  Score=272.34  Aligned_cols=227  Identities=24%  Similarity=0.322  Sum_probs=180.5

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      ..+|++.++||+|+||.||+|.+. .++.||||.+....   ....+|+.+++.++|+||+++++++.     .....++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~   78 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEPIYI   78 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCceEE
Confidence            346999999999999999999975 55789999886432   23457999999999999999998773     2334889


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceeec---------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYIC---------  227 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~~---------  227 (403)
                      +|||++ ++|.+++...  ....++...+..++.||+.||.|||+ +||+|+||||+||+++.++.+++..         
T Consensus        79 v~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~-~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          79 VTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLES-RNYIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             EEeccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence            999997 4676655432  12468888999999999999999999 8999999999999998877664431         


Q ss_pred             -----------cccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          228 -----------SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       228 -----------t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                 +..|+|||.+.+. .++.++|||||||++|++++ |+.||.+.+....+..+......+          
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~----------  224 (261)
T cd05034         156 DEYTAREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP----------  224 (261)
T ss_pred             hhhhhhhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----------
Confidence                       2469999998654 58999999999999999998 999998777665555443311100          


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                        .+...+.++.+++.+||+.||++||+++++++
T Consensus       225 ------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         225 ------------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             ------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                              11345789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=8.3e-36  Score=286.26  Aligned_cols=232  Identities=23%  Similarity=0.331  Sum_probs=175.7

Q ss_pred             ccEeeeceecccCceEEEEEEEC-----CCCcEEEEEEccccc-----ccHHHHHHHHHhc-CCCCccccceEEeecCCC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  150 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  150 (403)
                      .+|.+.+.||+|+||+||+|.+.     .+++.||||.+..+.     ....+|+.++..+ +|+||+++++++...   
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---   83 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---   83 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC---
Confidence            45999999999999999999853     467889999986432     1234799999999 689999999877432   


Q ss_pred             CceEEEEEeeccC-CcHHHHHHHhhh------------------------------------------------------
Q 015672          151 EELYLNLVLEYVP-ETVNRIARNYSR------------------------------------------------------  175 (403)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~------------------------------------------------------  175 (403)
                       ...++++||||+ ++|.+++.....                                                      
T Consensus        84 -~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          84 -GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             -CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence             234789999998 577666543210                                                      


Q ss_pred             ---------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee--------------------
Q 015672          176 ---------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI--------------------  226 (403)
Q Consensus       176 ---------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~--------------------  226 (403)
                               ....++...+..++.||+.||.|||+ +||+||||||+|||++.++.+++.                    
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                     01236777788899999999999999 899999999999999876655432                    


Q ss_pred             -ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCC
Q 015672          227 -CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ  304 (403)
Q Consensus       227 -~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (403)
                       ++..|+|||++.+. .++.++|||||||++|+|++ |..||.+......+.........                 .  
T Consensus       242 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-----------------~--  301 (343)
T cd05103         242 RLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-----------------M--  301 (343)
T ss_pred             CCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC-----------------C--
Confidence             13469999998654 58999999999999999997 99999775443332222211000                 0  


Q ss_pred             CCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          305 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       305 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                              ..+...++++.+++.+||+.||++|||+.++++|
T Consensus       302 --------~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         302 --------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             --------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                    0113357889999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.4e-35  Score=272.99  Aligned_cols=217  Identities=24%  Similarity=0.329  Sum_probs=169.7

Q ss_pred             eecccCceEEEEEEE--CCCCcEEEEEEcccccc------cHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEee
Q 015672           89 VVGTGSFGVVFQAKC--RETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (403)
Q Consensus        89 ~lG~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  160 (403)
                      .||+|+||.||+|.+  ..++..+|+|++.....      ...+|+.+++.++|+||+++++++.     . ...++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~-~~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-----A-ESWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----C-CCcEEEEe
Confidence            589999999999965  45678999998854321      2356899999999999999988651     1 13679999


Q ss_pred             ccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee-------------
Q 015672          161 YVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-------------  226 (403)
Q Consensus       161 ~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~-------------  226 (403)
                      |++ ++|..++..    ...+++..+..++.|++.||.|||+ +||+||||||.|||++.++.+++.             
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~  150 (257)
T cd05116          76 LAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEE-TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN  150 (257)
T ss_pred             cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchhhEEEcCCCeEEECCCccccccCCCCC
Confidence            998 456665543    3468889999999999999999999 899999999999999876544321             


Q ss_pred             ---------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          227 ---------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       227 ---------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                               ++..|+|||.+.. ..++.++|||||||++|||++ |..||.+.+..+....+.+.. .+           
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~-~~-----------  217 (257)
T cd05116         151 YYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE-RM-----------  217 (257)
T ss_pred             eeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-CC-----------
Confidence                     1357999998854 458899999999999999998 999998776555444332210 00           


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                      ..+..+++++.+||.+||+.||++||++++|..
T Consensus       218 ----------------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         218 ----------------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             ----------------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                            012457899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.2e-35  Score=278.10  Aligned_cols=229  Identities=24%  Similarity=0.298  Sum_probs=177.7

Q ss_pred             ccEeeeceecccCceEEEEEEECC-----CCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      .+|.+.+.||+|+||.||+|.+..     ++..||+|.+....     ....+|+.+++.++|+||+++++++.     .
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~-----~   79 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA-----V   79 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc-----C
Confidence            459999999999999999998753     67889999886432     23457999999999999999998773     3


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhh------------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccc
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSR------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP  212 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~------------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp  212 (403)
                      ....+++|||++ ++|..++.....                  ....+++..+..++.||+.||.|||+ .+++||||||
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~-~~i~H~dl~p  158 (288)
T cd05050          80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE-RKFVHRDLAT  158 (288)
T ss_pred             CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCeecccccH
Confidence            334789999998 577776653211                  11246778889999999999999999 8999999999


Q ss_pred             ccceecCCCCceee---------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 015672          213 QNLLVKGEPNVSYI---------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGES  270 (403)
Q Consensus       213 ~NILl~~~~~~~~~---------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~  270 (403)
                      +|||++.++.++..                     ++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+
T Consensus       159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~~~  237 (288)
T cd05050         159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYGMA  237 (288)
T ss_pred             hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999876654332                     13459999998654 58999999999999999997 888998766


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          271 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       271 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      ..+....+....                   ..         ..+..++.++.+||.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~-------------------~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         238 HEEVIYYVRDGN-------------------VL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHHHhcCC-------------------CC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            555443332110                   00         012356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=9.2e-36  Score=301.22  Aligned_cols=261  Identities=20%  Similarity=0.252  Sum_probs=166.4

Q ss_pred             ccccEeeeceecccCceEEEEEEECCC----CcEEEEEEcccccccHHHHHHHHHhc---CCCCccccceEEeecCC-CC
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRET----GEIVAIKKVLQDKRYKNRELQIMQML---DHPNIVALKHCFFSTTD-KE  151 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~-~~  151 (403)
                      ...+|.+.+.||+|+||.||+|++..+    +..||+|++.....   .|+.+...+   .+.+++.+...+..... ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~  206 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNERVRRACPNSCADFVYGFLEPVSSKK  206 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHHHHHhhchhhHHHHHHhhhccccccc
Confidence            456799999999999999999999988    89999998754321   233322332   33344443333322111 34


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhhh----------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccccc
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSRI----------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~----------------~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~N  214 (403)
                      ...+++||||++ ++|.+++......                ........+..++.||+.||.|||+ .+|+||||||+|
T Consensus       207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHRDLKP~N  285 (566)
T PLN03225        207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHRDVKPQN  285 (566)
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeCcCCHHH
Confidence            455889999998 4566655431100                0011234466789999999999999 899999999999


Q ss_pred             ceecCC-CCce--------------------eeccccccchhhhhCCC---------------------CCCchhHHHHH
Q 015672          215 LLVKGE-PNVS--------------------YICSRYYRAPELIFGAT---------------------EYTTAIDIWST  252 (403)
Q Consensus       215 ILl~~~-~~~~--------------------~~~t~~y~aPE~~~~~~---------------------~~~~~~DiwSl  252 (403)
                      ||++.+ +.++                    +++|+.|+|||.+....                     .++.++|||||
T Consensus       286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl  365 (566)
T PLN03225        286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA  365 (566)
T ss_pred             EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence            999853 3332                    34678899999763221                     23456799999


Q ss_pred             HHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhccc
Q 015672          253 GCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQY  332 (403)
Q Consensus       253 Gvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  332 (403)
                      ||+||||+++..++  .+....+..+....+... ..|.......   ..+.. . .... ..........|||.+||++
T Consensus       366 GviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~-~~~~~~~~~~---~~~~~-~-~~~~-~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        366 GLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDL-VAWRKLVEPR---ASPDL-R-RGFE-VLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             HHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcH-HHHHHhhccc---cchhh-h-hhhh-hccccchHHHHHHHHHccC
Confidence            99999999876543  344444444444333221 1121110000   00000 0 0000 0012345677999999999


Q ss_pred             CCCCCCCHHHHhcCCCcccCC
Q 015672          333 SPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       333 dP~~Rpta~e~l~hp~f~~~~  353 (403)
                      ||++|||+.++|+||||+...
T Consensus       437 dP~kR~ta~e~L~Hpff~~~~  457 (566)
T PLN03225        437 KGRQRISAKAALAHPYFDREG  457 (566)
T ss_pred             CcccCCCHHHHhCCcCcCCCC
Confidence            999999999999999998754

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.1e-36  Score=302.72  Aligned_cols=227  Identities=26%  Similarity=0.336  Sum_probs=187.8

Q ss_pred             cEeeeceecccCceEEEEEEECC-----CCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      +.+..+.||+|.||+||+|+...     ....||||.++...     ..+++|++++..|+|||||++++++.     ++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~-----~~  561 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR-----EG  561 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc-----cC
Confidence            45678899999999999998643     34679999987543     34679999999999999999999994     44


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhhh------cC----CCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSRI------HQ----RMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP  221 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~------~~----~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~  221 (403)
                      .-+|||+|||. |+|..+++.....      +.    .++..+...|+.||+.|++||-+ +.+|||||...|+||..+-
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~-~~FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS-HHFVHRDLATRNCLVGENL  640 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-Ccccccchhhhhceeccce
Confidence            44899999998 8999988764321      12    27788899999999999999998 8999999999999998776


Q ss_pred             Cceeec---------------------cccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 015672          222 NVSYIC---------------------SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEII  279 (403)
Q Consensus       222 ~~~~~~---------------------t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~  279 (403)
                      .+++..                     ...|||||.|... .|++++|||||||+|||+++ |+.||.+..+.+.+..+.
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~  719 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR  719 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence            665421                     3459999999754 59999999999999999998 999999999999888776


Q ss_pred             HHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 015672          280 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  344 (403)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l  344 (403)
                      +.--                  +          ..+++++.++.+|+..||+.+|.+||++.||-
T Consensus       720 ~g~l------------------L----------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  720 AGQL------------------L----------SCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             cCCc------------------c----------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            5210                  0          02368999999999999999999999999873

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.4e-35  Score=271.86  Aligned_cols=225  Identities=23%  Similarity=0.303  Sum_probs=176.3

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc---cHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      .+|.+.+.||+|+||.||+|.+..+ ..+|+|.+.....   ...+|+++++.++|+|++++++++.    .  ...+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----~--~~~~~v   78 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS----E--EPIYIV   78 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc----C--CCcEEE
Confidence            4599999999999999999988654 4699998764332   3457999999999999999987651    1  236799


Q ss_pred             eeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee-----------
Q 015672          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-----------  226 (403)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~-----------  226 (403)
                      |||+.+ +|.+++....  ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+++.           
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05069          79 TEFMGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIER-MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEcCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence            999984 7766665321  2347888899999999999999999 899999999999999876654321           


Q ss_pred             ---------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          227 ---------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       227 ---------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                               ++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+....+......            
T Consensus       156 ~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------------  222 (260)
T cd05069         156 EYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM------------  222 (260)
T ss_pred             cccccCCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence                     23469999988654 48999999999999999999 99999887665544433221000            


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                      ..+...+..+.+|+.+||..||++||+++++++
T Consensus       223 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         223 ----------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             ----------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                            012356889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.4e-35  Score=279.83  Aligned_cols=231  Identities=23%  Similarity=0.326  Sum_probs=177.9

Q ss_pred             cccEeeeceecccCceEEEEEEEC-------CCCcEEEEEEccccc-----ccHHHHHHHHHhc-CCCCccccceEEeec
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCR-------ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFST  147 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~  147 (403)
                      ..+|.+.+.||+|+||.||+|++.       .++..||+|.+....     ....+|+.+++.+ +|+||+++++.+.  
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--   91 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--   91 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe--
Confidence            456999999999999999999753       234579999875432     2245799999999 8999999999873  


Q ss_pred             CCCCceEEEEEeeccC-CcHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccccc
Q 015672          148 TDKEELYLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (403)
Q Consensus       148 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~N  214 (403)
                         ....++++|||++ ++|..++.....            ....++...+..++.||+.||.|||+ +||+||||||+|
T Consensus        92 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~N  167 (304)
T cd05101          92 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLAARN  167 (304)
T ss_pred             ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH-CCeeecccccce
Confidence               2345889999997 577776654321            12346777888999999999999999 899999999999


Q ss_pred             ceecCCCCceee---------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcH
Q 015672          215 LLVKGEPNVSYI---------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGV  272 (403)
Q Consensus       215 ILl~~~~~~~~~---------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~  272 (403)
                      ||++.++.++++                     +++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  246 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  246 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence            999876654332                     23569999998654 58999999999999999998 88899876654


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          273 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       273 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      +....+.... .                 .          ..+..++.++.+||.+||..+|.+|||+.++++.
T Consensus       247 ~~~~~~~~~~-~-----------------~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         247 ELFKLLKEGH-R-----------------M----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHcCC-c-----------------C----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            4443332110 0                 0          0123578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-35  Score=272.06  Aligned_cols=218  Identities=24%  Similarity=0.337  Sum_probs=171.2

Q ss_pred             ceecccCceEEEEEEECCCC---cEEEEEEcccccc-----cHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           88 HVVGTGSFGVVFQAKCRETG---EIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      ++||+|+||.||+|.+..++   ..+|+|.+.....     ...+|+++++.++|+||+++++++.      ....++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence            46999999999999876554   7899998865433     3357899999999999999988652      12368999


Q ss_pred             eccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee------------
Q 015672          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI------------  226 (403)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~------------  226 (403)
                      ||+. ++|.+++..    ...+++..+..++.|++.||.|||. .+++||||||+|||++.++.+++.            
T Consensus        75 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~  149 (257)
T cd05060          75 ELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLES-KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS  149 (257)
T ss_pred             EeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhh-cCeeccCcccceEEEcCCCcEEeccccccceeecCC
Confidence            9987 567666543    2468899999999999999999999 899999999999999877655432            


Q ss_pred             ----------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          227 ----------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       227 ----------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                ++..|+|||.+.+. .++.++|||||||++|+|++ |.+||...+..+....+... ..           
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~-~~-----------  216 (257)
T cd05060         150 DYYRATTAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-ER-----------  216 (257)
T ss_pred             cccccccCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-Cc-----------
Confidence                      12469999998554 58999999999999999998 99999776654433333211 00           


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                            .          ..+..++..+.++|.+||..||++||++.++++
T Consensus       217 ------~----------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         217 ------L----------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             ------C----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                  0          012457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-38  Score=271.53  Aligned_cols=243  Identities=23%  Similarity=0.331  Sum_probs=190.5

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEcccccc-----cHHHHHHH-HHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQI-MQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      .+-+..||.|+||+|++..++.+|+..|||.++....     ....|.+. ++.-+.||||++|+..|...+     .||
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-----cWi  140 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-----CWI  140 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-----eee
Confidence            4456779999999999999999999999999964332     22245543 444478999999999876655     899


Q ss_pred             EeeccCCcHHHHHHH-hhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----------
Q 015672          158 VLEYVPETVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----------  226 (403)
Q Consensus       158 v~e~~~~~l~~~~~~-~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----------  226 (403)
                      .||+|+-++..+... +......+++..+-.+....+.||.||-...+|||||+||+|||++..+.++++          
T Consensus       141 CMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  141 CMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             eHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            999999887765433 344467799998888888899999999987899999999999999999988764          


Q ss_pred             --------ccccccchhhhhCCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          227 --------CSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       227 --------~t~~y~aPE~~~~~~-~~~~~~DiwSlGvil~el~tg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                              |...|||||-+.... .|+.++||||||++|||++||+.|+.+.+. .+++..+..  |.|+.-...     
T Consensus       221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp~l~~~-----  293 (361)
T KOG1006|consen  221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPPILLFD-----  293 (361)
T ss_pred             HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCCCeecCc-----
Confidence                    456799999985443 389999999999999999999999987654 234333322  333221000     


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCC
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  354 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  354 (403)
                                      .-..+.+..+..||.-||.+|-.+||...+++++||++....
T Consensus       294 ----------------~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~  335 (361)
T KOG1006|consen  294 ----------------KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV  335 (361)
T ss_pred             ----------------ccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence                            001247889999999999999999999999999999987544

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-36  Score=298.13  Aligned_cols=241  Identities=26%  Similarity=0.392  Sum_probs=201.0

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhc-CCCCccccceEEeecCCCCceEEEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      .|++.++||.|.+|.||+++.+.+++..|+|+...+.   ...+.|.++|+.+ +|||++.++++|+.........+|||
T Consensus        20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV   99 (953)
T KOG0587|consen   20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV   99 (953)
T ss_pred             ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence            3999999999999999999999999999999875432   3344577888887 69999999999988777778889999


Q ss_pred             eeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------------
Q 015672          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------------  225 (403)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------------  225 (403)
                      ||||+ |+..++.....  +.++.+..+..|++.++.||.+||. ..++|||||-.|||++.++.++.            
T Consensus       100 MEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~-nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT  176 (953)
T KOG0587|consen  100 MEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN-NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST  176 (953)
T ss_pred             eeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh-cceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence            99998 67777777665  7889999999999999999999998 79999999999999998887744            


Q ss_pred             -------eccccccchhhhhCCC----CCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          226 -------ICSRYYRAPELIFGAT----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       226 -------~~t~~y~aPE~~~~~~----~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                             +|||+|||||++....    .|+..+|+||||++..||.-|.+|+.+......+..|.+   .|+        
T Consensus       177 ~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---NPP--------  245 (953)
T KOG0587|consen  177 VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPP--------  245 (953)
T ss_pred             cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC---CCC--------
Confidence                   5799999999995332    378899999999999999999999987766554433322   111        


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                                     ....-+...+.++.+||..||..|-.+||+..++|+|||+.+.
T Consensus       246 ---------------PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  246 ---------------PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             ---------------ccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence                           1111235678999999999999999999999999999999854

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-35  Score=278.14  Aligned_cols=237  Identities=20%  Similarity=0.243  Sum_probs=176.6

Q ss_pred             cccEeeeceecccCceEEEEEEECCC--------------CcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccc
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRET--------------GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALK  141 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~--------------~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~  141 (403)
                      ..+|++.+.||+|+||.||+|++..+              ...||+|.+....     ....+|+++++.++|+||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            34699999999999999999987543              2358999886432     1245799999999999999999


Q ss_pred             eEEeecCCCCceEEEEEeeccC-CcHHHHHHHhhh--------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccc
Q 015672          142 HCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSR--------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP  212 (403)
Q Consensus       142 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp  212 (403)
                      +++..     ....++||||++ ++|.+++.....        ....++...+..++.|++.||.|||+ .|++||||||
T Consensus        84 ~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp  157 (295)
T cd05097          84 GVCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLAT  157 (295)
T ss_pred             EEEcC-----CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh-cCeeccccCh
Confidence            98733     334889999998 467666543210        01236777888999999999999999 8999999999


Q ss_pred             ccceecCCCCceee---------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh--CCCCCCCC
Q 015672          213 QNLLVKGEPNVSYI---------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPGE  269 (403)
Q Consensus       213 ~NILl~~~~~~~~~---------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t--g~~pf~~~  269 (403)
                      +|||++.++.+++.                     ++..|+|||++.+. .++.++|||||||++|+|++  |..||...
T Consensus       158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~~  236 (295)
T cd05097         158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence            99999876544331                     14579999998654 48999999999999999988  66788776


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          270 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       270 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      +..+.+..+.+......               ....      ...+...++.+.+|+.+||+.||++||+++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~---------------~~~~------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         237 SDEQVIENTGEFFRNQG---------------RQIY------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             ChHHHHHHHHHhhhhcc---------------cccc------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            65554444332110000               0000      0012346789999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.9e-35  Score=273.76  Aligned_cols=226  Identities=25%  Similarity=0.352  Sum_probs=177.0

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCc---EEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..|.+.+.||+|+||.||+|.+..+++   .||||.+....     .....|+.+++.++||||+++++++.     ...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSR   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC-----CCC
Confidence            348999999999999999999877665   59999886432     23346999999999999999998873     334


Q ss_pred             EEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceeec-----
Q 015672          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYIC-----  227 (403)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~~-----  227 (403)
                      ..++||||+++ +|..++...   ...++...+..++.|++.||.|||+ .|++||||||+||+++.++.++...     
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~-~g~~H~dl~p~nili~~~~~~kl~dfg~~~  154 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSE-MNYVHRDLAARNILVNSNLVCKVSDFGLSR  154 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccChheEEEcCCCcEEECCCcccc
Confidence            47899999984 666555432   3457888999999999999999999 8999999999999998765543211     


Q ss_pred             -------------------cccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015672          228 -------------------SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  287 (403)
Q Consensus       228 -------------------t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~  287 (403)
                                         +..|+|||.+.+ ..++.++|||||||++||+++ |..||...+..+....+....     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~-----  228 (269)
T cd05065         155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY-----  228 (269)
T ss_pred             ccccCccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-----
Confidence                               235999999854 458999999999999999886 999998766554444332210     


Q ss_pred             HHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                   ..+          .+..++..+.+++.+||..||.+||++.+++.
T Consensus       229 -------------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         229 -------------RLP----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             -------------cCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                         001          11346788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.4e-35  Score=277.46  Aligned_cols=237  Identities=29%  Similarity=0.469  Sum_probs=180.3

Q ss_pred             EeeeceecccCceEEEEEEEC---CCCcEEEEEEccccc--------ccHHHHHHHHHhc-CCCCccccceEEeecCCCC
Q 015672           84 YIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  151 (403)
                      |.+.+.||+|+||.||+++..   .++..||||.+....        ....+|++++..+ +|+||+++++.+     ..
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~~   76 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----QT   76 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----ec
Confidence            889999999999999999864   467889999885321        1234699999999 599999999887     33


Q ss_pred             ceEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce------
Q 015672          152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS------  224 (403)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~------  224 (403)
                      ...+++||||+.+ +|...+..    ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++      
T Consensus        77 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~H~dl~p~nil~~~~~~~~l~dfg~  151 (288)
T cd05583          77 DTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQ-LGIIYRDIKLENILLDSEGHVVLTDFGL  151 (288)
T ss_pred             CCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCCCEEEEECcc
Confidence            3458899999984 55444432    3568888999999999999999999 8999999999999998765432      


Q ss_pred             --------------eeccccccchhhhhCCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          225 --------------YICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       225 --------------~~~t~~y~aPE~~~~~~-~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                    ..++..|+|||.+.+.. ..+.++||||||+++|+|++|..||...........+.+....     
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-----  226 (288)
T cd05583         152 SKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK-----  226 (288)
T ss_pred             ccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-----
Confidence                          23577899999985432 3678999999999999999999999654322222222111000     


Q ss_pred             HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCCCcccCCCC
Q 015672          290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVHPFFDELRDP  355 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---a~e~l~hp~f~~~~~~  355 (403)
                              ..   +         ..+..++..+.++|.+||+.||++|||   +.++|+||||+.+.++
T Consensus       227 --------~~---~---------~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~  275 (288)
T cd05583         227 --------SK---P---------PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD  275 (288)
T ss_pred             --------cC---C---------CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence                    00   0         012346889999999999999999998   5677999999988643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.6e-35  Score=275.88  Aligned_cols=236  Identities=20%  Similarity=0.209  Sum_probs=170.4

Q ss_pred             ccEeeeceecccCceEEEEEEECCC---CcEEEEEEcccccccHH---------------HHHHHHHhcCCCCccccceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDKRYKN---------------RELQIMQMLDHPNIVALKHC  143 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~---------------~E~~~l~~l~h~niv~~~~~  143 (403)
                      .+|.+.++||+|+||+||+|.+..+   +..+|+|+.........               .+...+..+.|+||++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            3599999999999999999998877   66778886432222211               12233455689999999887


Q ss_pred             EeecCCCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc
Q 015672          144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV  223 (403)
Q Consensus       144 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~  223 (403)
                      ..... ....+.+++++++..++..++...    ...++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+
T Consensus        92 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~-~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         92 GSFKR-CRMYYRFILLEKLVENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeEec-CCceEEEEEEehhccCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCcE
Confidence            64332 233456789998877766555432    335677888999999999999999 899999999999999754332


Q ss_pred             e--------------------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 015672          224 S--------------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE  277 (403)
Q Consensus       224 ~--------------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~  277 (403)
                      +                          ..||+.|+|||++.+. .++.++|||||||++|||++|+.||.+......+..
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~  244 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH  244 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence            1                          2478999999998654 589999999999999999999999987743332222


Q ss_pred             HHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          278 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       278 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      ....      +.+.....  ...             .....++++.+++..|+..+|++||++.++++
T Consensus       245 ~~~~------~~~~~~~~--~~~-------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        245 AAKC------DFIKRLHE--GKI-------------KIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HhHH------HHHHHhhh--hhh-------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            1110      00000000  000             01345788999999999999999999999875

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.8e-35  Score=276.13  Aligned_cols=238  Identities=26%  Similarity=0.352  Sum_probs=173.3

Q ss_pred             EeeeceecccCceEEEEEEE----CCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           84 YIAEHVVGTGSFGVVFQAKC----RETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      |.+.+.||+|+||+||++..    ..+++.||+|.+....     ....+|+++++.++|+||+++++++..   .....
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~   82 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGGKG   82 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCCce
Confidence            48999999999999988753    3567899999886432     233579999999999999999987643   23345


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee-------
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-------  226 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~-------  226 (403)
                      ++++|||+. +++..++..     ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.++..       
T Consensus        83 ~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHS-QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             EEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccChheEEEcCCCcEEEeecccccc
Confidence            889999998 466555432     458999999999999999999999 899999999999999876654322       


Q ss_pred             ---------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH-hCCCCHHHH
Q 015672          227 ---------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTPTREEI  290 (403)
Q Consensus       227 ---------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~-~~~~~~~~~  290 (403)
                                     ++..|+|||.+.+. .++.++|||||||++|+|++|..||......  +...... .+......+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~  233 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRL  233 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhh
Confidence                           24459999998654 5899999999999999999999998654321  1111100 000000000


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      ...            .........+..++.++.+++.+||+.||++|||+.++++
T Consensus       234 ~~~------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         234 IEL------------LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhh------------hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            000            0000000122457889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-35  Score=270.20  Aligned_cols=225  Identities=23%  Similarity=0.359  Sum_probs=178.7

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc---cHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      .+|++.+.||.|+||.||+|...  ++.||+|.+.....   ...+|+.+++.++|+||+++++++..     ....++|
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v   78 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLYIV   78 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeEEE
Confidence            35899999999999999999874  88999999875543   34579999999999999999998743     3348899


Q ss_pred             eeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee-----------
Q 015672          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-----------  226 (403)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~-----------  226 (403)
                      |||++ ++|.+++....  ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++..+..           
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          79 TEYMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEE-KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             EEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence            99998 57766655422  2358899999999999999999999 899999999999999877665432           


Q ss_pred             -----ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccc
Q 015672          227 -----CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  300 (403)
Q Consensus       227 -----~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  300 (403)
                           .+..|+|||.+... .++.++|||||||++|++++ |..||...+..+....+...                  +
T Consensus       156 ~~~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~------------------~  216 (256)
T cd05039         156 QDSGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG------------------Y  216 (256)
T ss_pred             cccCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC------------------C
Confidence                 23459999998644 58899999999999999997 99999776544433222210                  0


Q ss_pred             CCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      .          ...+...++++.++|.+||..+|++|||+.++++
T Consensus       217 ~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         217 R----------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             C----------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            0          0012356889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-35  Score=274.30  Aligned_cols=224  Identities=25%  Similarity=0.376  Sum_probs=172.1

Q ss_pred             eeeceecccCceEEEEEEEC----CCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           85 IAEHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        85 ~~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      .+.+.||.|.||.||+|.+.    ..+..|+||.+....     ..+.+|++.+++++||||+++++++.....     .
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-----~   76 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-----L   76 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-----E
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc-----c
Confidence            46788999999999999987    346789999985421     334579999999999999999999863222     7


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee--------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI--------  226 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~--------  226 (403)
                      ++|+||++ ++|.+++...  ....++......++.||+.||.|||+ .+|+|+||+++|||++.++.+++.        
T Consensus        77 ~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~  153 (259)
T PF07714_consen   77 FLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHS-NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPI  153 (259)
T ss_dssp             EEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred             ccccccccccccccccccc--cccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccc
Confidence            89999998 6788777653  13568899999999999999999999 899999999999999987665432        


Q ss_pred             -------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          227 -------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       227 -------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                                   +...|+|||.+.... ++.++||||||+++||+++ |+.||...+..+....+.+....        
T Consensus       154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~--------  224 (259)
T PF07714_consen  154 SEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRL--------  224 (259)
T ss_dssp             TTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEET--------
T ss_pred             cccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccc--------
Confidence                         244699999986554 8999999999999999999 78999887665555444221000        


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                          ..+..++..+.++|.+||..||++|||+.++++
T Consensus       225 --------------------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  225 --------------------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             --------------------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             --------------------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                                012457899999999999999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-36  Score=267.84  Aligned_cols=235  Identities=26%  Similarity=0.475  Sum_probs=187.1

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhc-CCCCccccceEEeecCCCC
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  151 (403)
                      ...+|.++++||+|+|++|.+++.++|.+.||+|+++++.       ...+.|..+...- +||.+|-++.+|     ..
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf-----qt  322 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF-----QT  322 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-----cc
Confidence            3456999999999999999999999999999999986532       2234566666665 799999999988     34


Q ss_pred             ceEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc-------
Q 015672          152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-------  223 (403)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~-------  223 (403)
                      ...+++|.||++| +|-.-    .....++++..++.|...|+.||.|||+ .|||.||||.+|+|++.++++       
T Consensus       323 esrlffvieyv~ggdlmfh----mqrqrklpeeharfys~ei~lal~flh~-rgiiyrdlkldnvlldaeghikltdygm  397 (593)
T KOG0695|consen  323 ESRLFFVIEYVNGGDLMFH----MQRQRKLPEEHARFYSAEICLALNFLHE-RGIIYRDLKLDNVLLDAEGHIKLTDYGM  397 (593)
T ss_pred             cceEEEEEEEecCcceeee----hhhhhcCcHHHhhhhhHHHHHHHHHHhh-cCeeeeeccccceEEccCCceeecccch
Confidence            4458899999985 33211    1224679999999999999999999999 899999999999999987765       


Q ss_pred             ------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCC-------CCcHHHHHHH-HHHhC
Q 015672          224 ------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG-------ESGVDQLVEI-IKVLG  283 (403)
Q Consensus       224 ------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~-------~~~~~~~~~i-~~~~~  283 (403)
                                  +++|||.|.|||++.+. .|+..+|.|+|||+++||+.|+.||.-       .+..+-+..+ .+.  
T Consensus       398 cke~l~~gd~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek--  474 (593)
T KOG0695|consen  398 CKEGLGPGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK--  474 (593)
T ss_pred             hhcCCCCCcccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh--
Confidence                        46789999999999765 599999999999999999999999952       1222222222 221  


Q ss_pred             CCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC------CHHHHhcCCCcccCCC
Q 015672          284 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC------TALEACVHPFFDELRD  354 (403)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp------ta~e~l~hp~f~~~~~  354 (403)
                                     .+            .+++.+|-.+..+++..|.+||.+|.      ...++..|+||+.+.+
T Consensus       475 ---------------qi------------riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw  524 (593)
T KOG0695|consen  475 ---------------QI------------RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW  524 (593)
T ss_pred             ---------------cc------------cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence                           00            13467888899999999999999997      4689999999997754

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.2e-35  Score=278.79  Aligned_cols=230  Identities=22%  Similarity=0.330  Sum_probs=177.6

Q ss_pred             cccEeeeceecccCceEEEEEEECC-------CCcEEEEEEcccccc-----cHHHHHHHHHhc-CCCCccccceEEeec
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQDKR-----YKNRELQIMQML-DHPNIVALKHCFFST  147 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~-----~~~~E~~~l~~l-~h~niv~~~~~~~~~  147 (403)
                      ..+|.+.+.||+|+||.||+|++..       ....+|+|.+.....     ...+|+++++.+ +|+||+++++++.  
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--   88 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT--   88 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc--
Confidence            3469999999999999999998642       345799998764322     234799999999 6999999999873  


Q ss_pred             CCCCceEEEEEeeccC-CcHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccccc
Q 015672          148 TDKEELYLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (403)
Q Consensus       148 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~N  214 (403)
                         ...+++++|||++ ++|..++.....            ....++...+..++.||+.||.|||+ .||+||||||+|
T Consensus        89 ---~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~N  164 (314)
T cd05099          89 ---QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES-RRCIHRDLAARN  164 (314)
T ss_pred             ---cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeecccccee
Confidence               2345889999997 577777654321            12347888889999999999999999 899999999999


Q ss_pred             ceecCCCCceee---------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcH
Q 015672          215 LLVKGEPNVSYI---------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGV  272 (403)
Q Consensus       215 ILl~~~~~~~~~---------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~  272 (403)
                      ||++.++.++..                     ++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~  243 (314)
T cd05099         165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE  243 (314)
T ss_pred             EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence            999877655432                     12469999998654 58999999999999999999 89999876654


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          273 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       273 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      +.+..+....                ..            ..+..++.++.+||.+||..||++|||+.++++
T Consensus       244 ~~~~~~~~~~----------------~~------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         244 ELFKLLREGH----------------RM------------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHHHcCC----------------CC------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            4443332110                00            012456789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4e-35  Score=269.45  Aligned_cols=225  Identities=21%  Similarity=0.305  Sum_probs=176.3

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      +|++.+.||+|+||.||+|.+. .+..+|+|.+....   ....+|+++++.++|+||+++++++.     ...+.+++|
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~   78 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT-----ERSPICLVF   78 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEc-----cCCceEEEE
Confidence            5899999999999999999875 46789999886432   24567999999999999999998873     334588999


Q ss_pred             eccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee------------
Q 015672          160 EYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI------------  226 (403)
Q Consensus       160 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~------------  226 (403)
                      ||+.+ +|...+..   ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++++            
T Consensus        79 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          79 EFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLES-SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             EcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence            99984 55544432   12457888899999999999999999 899999999999999876544321            


Q ss_pred             --------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          227 --------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       227 --------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                              ++..|+|||++.+. .++.++|||||||++|+|++ |..||......+.+..+.....              
T Consensus       155 ~~~~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--------------  219 (256)
T cd05112         155 YTSSTGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR--------------  219 (256)
T ss_pred             ccccCCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC--------------
Confidence                    23469999998654 58899999999999999998 9999987665544443321100              


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                    ...+...+..+.+|+.+||+.||++|||+.+++++
T Consensus       220 --------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         220 --------------LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             --------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence                          00113357899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-35  Score=273.64  Aligned_cols=223  Identities=24%  Similarity=0.353  Sum_probs=171.6

Q ss_pred             ceecccCceEEEEEEECCCCc--EEEEEEccccc-----ccHHHHHHHHHhc-CCCCccccceEEeecCCCCceEEEEEe
Q 015672           88 HVVGTGSFGVVFQAKCRETGE--IVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~--~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      +.||+|+||.||+|++..++.  .+|+|.+....     ....+|++++.++ +||||+++++++..     ...++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-----CCCceEEE
Confidence            368999999999999987775  46888775321     2334699999999 89999999998733     33478999


Q ss_pred             eccC-CcHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee
Q 015672          160 EYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI  226 (403)
Q Consensus       160 e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~  226 (403)
                      ||++ ++|.+++.....            ....+++..+..++.|++.||+|||+ .|++||||||+|||++.++.+++.
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nili~~~~~~kl~  154 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENYVAKIA  154 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccccceEEEcCCCeEEEC
Confidence            9997 577776654221            11347888899999999999999999 899999999999999877655432


Q ss_pred             ------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015672          227 ------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  287 (403)
Q Consensus       227 ------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~  287 (403)
                                        .+..|+|||++.. ..++.++|||||||++|+|++ |..||.+.+..+....+...      
T Consensus       155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~------  227 (270)
T cd05047         155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG------  227 (270)
T ss_pred             CCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC------
Confidence                              1345999999854 458999999999999999997 99999776654443332210      


Q ss_pred             HHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                  ...          ..+..++.++.+|+.+||..||.+|||+.++++
T Consensus       228 ------------~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         228 ------------YRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             ------------CCC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                        000          011346789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.9e-35  Score=271.00  Aligned_cols=218  Identities=23%  Similarity=0.288  Sum_probs=169.2

Q ss_pred             eecccCceEEEEEEEC--CCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeec
Q 015672           89 VVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY  161 (403)
Q Consensus        89 ~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  161 (403)
                      .||+|+||.||+|.+.  .++..||+|++....     ....+|+.++++++|+||+++++++.     . ...++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-----~-~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-----A-EALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-----C-CCeEEEEEe
Confidence            3899999999999765  445679999886432     22457999999999999999998762     1 237899999


Q ss_pred             cC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee--------------
Q 015672          162 VP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI--------------  226 (403)
Q Consensus       162 ~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~--------------  226 (403)
                      ++ ++|.+++..   ....+++..+..++.||+.||.|||+ +|++||||||+|||++.++.+++.              
T Consensus        76 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  151 (257)
T cd05115          76 ASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEG-KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY  151 (257)
T ss_pred             CCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecccchheEEEcCCCcEEeccCCccccccCCccc
Confidence            97 566655442   13468999999999999999999999 899999999999999876544321              


Q ss_pred             --------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          227 --------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       227 --------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                              ++..|+|||++... .++.++|||||||++|++++ |..||.+....+....+.+.. .+            
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~------------  217 (257)
T cd05115         152 YKARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-RL------------  217 (257)
T ss_pred             eeccCCCCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-CC------------
Confidence                    13569999998654 48999999999999999996 999998776555443332210 00            


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                     ..+...++++.++|.+||..||++||++.++.+
T Consensus       218 ---------------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         218 ---------------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             ---------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                           012456899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.5e-35  Score=287.58  Aligned_cols=232  Identities=22%  Similarity=0.328  Sum_probs=177.3

Q ss_pred             cccEeeeceecccCceEEEEEEEC-----CCCcEEEEEEcccccc-----cHHHHHHHHHhcC-CCCccccceEEeecCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDKR-----YKNRELQIMQMLD-HPNIVALKHCFFSTTD  149 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  149 (403)
                      ..+|.+.+.||+|+||.||+|++.     .+++.||+|++.....     ...+|+.+|..+. |+||+++++++..   
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~---  112 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK---  112 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc---
Confidence            345889999999999999999864     3456899999864321     2347999999997 9999999998843   


Q ss_pred             CCceEEEEEeeccC-CcHHHHHHHhhh-----------------------------------------------------
Q 015672          150 KEELYLNLVLEYVP-ETVNRIARNYSR-----------------------------------------------------  175 (403)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~-----------------------------------------------------  175 (403)
                        ...+++|||||. ++|.+++.....                                                     
T Consensus       113 --~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         113 --GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             --CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence              234889999998 577776643210                                                     


Q ss_pred             -----------------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccccc
Q 015672          176 -----------------------------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (403)
Q Consensus       176 -----------------------------------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~N  214 (403)
                                                               ....+++..+..++.||+.||.|||+ .+|+||||||+|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrdlkp~N  269 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS-KNCVHRDLAARN  269 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcCcccCCcce
Confidence                                                     01235666778899999999999999 899999999999


Q ss_pred             ceecCCCCcee---------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcH
Q 015672          215 LLVKGEPNVSY---------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGV  272 (403)
Q Consensus       215 ILl~~~~~~~~---------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~  272 (403)
                      ||++..+.+++                     .++..|+|||++.+. .++.++|||||||++|||++ |..||......
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            99986543322                     234669999998654 48999999999999999998 89999776655


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          273 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       273 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      +.+...... +.                ..          ..+..++.++.+||.+||..||.+||++.++++.
T Consensus       349 ~~~~~~~~~-~~----------------~~----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         349 EQFYNAIKR-GY----------------RM----------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHHHc-CC----------------CC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            544333221 00                00          0123568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.9e-35  Score=281.53  Aligned_cols=230  Identities=21%  Similarity=0.315  Sum_probs=177.0

Q ss_pred             ccEeeeceecccCceEEEEEEECCC-------CcEEEEEEccccc-----ccHHHHHHHHHhc-CCCCccccceEEeecC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRET-------GEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTT  148 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  148 (403)
                      .+|.+.+.||+|+||.||+|++...       +..||+|.+....     ....+|+++++++ +|+||+++++.+.   
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~---   88 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT---   88 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc---
Confidence            3599999999999999999986432       2368999876432     2345799999999 8999999999873   


Q ss_pred             CCCceEEEEEeeccC-CcHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccc
Q 015672          149 DKEELYLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL  215 (403)
Q Consensus       149 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NI  215 (403)
                        ....++++|||++ ++|.+++.....            ....++...+..++.||+.||.|||+ +||+||||||+||
T Consensus        89 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~Ni  165 (334)
T cd05100          89 --QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS-QKCIHRDLAARNV  165 (334)
T ss_pred             --cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceE
Confidence              3335889999997 577776654211            12346777888899999999999999 8999999999999


Q ss_pred             eecCCCCceee---------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 015672          216 LVKGEPNVSYI---------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVD  273 (403)
Q Consensus       216 Ll~~~~~~~~~---------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~  273 (403)
                      |++.++.+++.                     ++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  244 (334)
T cd05100         166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  244 (334)
T ss_pred             EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            99876554332                     12459999998654 58999999999999999998 889998776555


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          274 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       274 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      ....+.....                  .          ..+..++.++.+||.+||..+|++|||+.+++++
T Consensus       245 ~~~~~~~~~~------------------~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         245 LFKLLKEGHR------------------M----------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHcCCC------------------C----------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            4433321100                  0          0123567899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.2e-35  Score=269.46  Aligned_cols=221  Identities=25%  Similarity=0.330  Sum_probs=173.5

Q ss_pred             ceecccCceEEEEEEECC-CC--cEEEEEEcccccc-----cHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           88 HVVGTGSFGVVFQAKCRE-TG--EIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      +.||+|+||.||+|.+.. .+  ..||||.+.....     ...+|++++++++|+||+++++.+..      ...+++|
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence            468999999999999865 33  3699999865443     34579999999999999999988743      4588999


Q ss_pred             eccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee------------
Q 015672          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI------------  226 (403)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~------------  226 (403)
                      ||++ ++|...+.....  ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+++.            
T Consensus        75 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~  151 (257)
T cd05040          75 ELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES-KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE  151 (257)
T ss_pred             EecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh-CCccccccCcccEEEecCCEEEeccccccccccccc
Confidence            9996 577666554221  467888999999999999999999 899999999999999876654332            


Q ss_pred             ----------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          227 ----------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       227 ----------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                ++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+.....            
T Consensus       152 ~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------------  218 (257)
T cd05040         152 DHYVMEEHLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE------------  218 (257)
T ss_pred             cceecccCCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC------------
Confidence                      34579999998544 58999999999999999998 9999987766554444432100            


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                         .  .          ..+...+..+.+++.+||+.+|++|||+.++++
T Consensus       219 ---~--~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         219 ---R--L----------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             ---c--C----------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence               0  0          011346789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4e-35  Score=273.38  Aligned_cols=226  Identities=21%  Similarity=0.281  Sum_probs=172.5

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCc----EEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      .+|++.+.||+|+||+||+|.+..+++    .+|+|.+....     .....|+.+++.++|+||+++++++.     . 
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-----~-   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-----G-   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-----C-
Confidence            458999999999999999999877776    47777764321     12235677889999999999998762     1 


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee-----
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-----  226 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~-----  226 (403)
                      ...++++||++ ++|.+++...   ...+++..+..++.||+.||.|||+ .+++||||||+|||++.++.++..     
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~kl~Dfg~~  156 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEE-HRMVHRNLAARNILLKSDSIVQIADFGVA  156 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCCcEEEcCCccc
Confidence            12568899987 6776665432   3468889999999999999999999 899999999999999876554321     


Q ss_pred             ----------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          227 ----------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       227 ----------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                      ++..|+|||.+.+. .++.++|||||||++||+++ |..||.+...... ..+......+    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~----  230 (279)
T cd05111         157 DLLYPDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERL----  230 (279)
T ss_pred             eeccCCCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcC----
Confidence                            34579999998654 58999999999999999998 9999987654332 2222210000    


Q ss_pred             HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                   +          .+...+.++.+++.+||..||++|||+.|+++.
T Consensus       231 -------------~----------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~  264 (279)
T cd05111         231 -------------A----------QPQICTIDVYMVMVKCWMIDENVRPTFKELANE  264 (279)
T ss_pred             -------------C----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                         0          012356788999999999999999999999773

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=5.9e-35  Score=270.52  Aligned_cols=228  Identities=21%  Similarity=0.316  Sum_probs=169.0

Q ss_pred             ceecccCceEEEEEEECC--CCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEee
Q 015672           88 HVVGTGSFGVVFQAKCRE--TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  160 (403)
                      +.||+|+||.||+|....  ....+|+|.+....     ....+|+++++.++|+||+++++.+.     .....++|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEE
Confidence            359999999999997533  34578899775332     12347899999999999999999873     3334889999


Q ss_pred             ccC-CcHHHHHHHhhh-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee------------
Q 015672          161 YVP-ETVNRIARNYSR-IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI------------  226 (403)
Q Consensus       161 ~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~------------  226 (403)
                      |++ ++|.+++..... .....++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+++.            
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED  154 (269)
T ss_pred             eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh-cCEecccccHhheEecCCCcEEEeccccccccccch
Confidence            998 577777655322 12334567788999999999999999 899999999999999877655332            


Q ss_pred             ---------ccccccchhhhhC------CCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          227 ---------CSRYYRAPELIFG------ATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       227 ---------~t~~y~aPE~~~~------~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                               ++..|+|||++..      ...++.++|||||||++|||++ |..||......+.+..+......      
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~------  228 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI------  228 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCc------
Confidence                     2345999999742      2346889999999999999999 78899877665555444332110      


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                .++.       ...+..++..+.+++..|+ .||++|||++++++
T Consensus       229 ----------~~~~-------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         229 ----------KLPK-------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ----------cCCC-------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                      0000       0122457888999999998 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-37  Score=297.90  Aligned_cols=183  Identities=27%  Similarity=0.425  Sum_probs=150.1

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecC-CCCceEEEE
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTT-DKEELYLNL  157 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~l  157 (403)
                      |...+.||+|+||.||+++++.+|+.||||.+....     ...-+|+++|++|+|+|||++.++-.+.. ..-.....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            778899999999999999999999999999986532     22247999999999999999876531111 000234679


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecC-----------------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKG-----------------  219 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~-----------------  219 (403)
                      |||||. |+|...+..... ..++++.++..++..++.||.|||+ +|||||||||+||++-.                 
T Consensus        95 vmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrE-n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar  172 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLRE-NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR  172 (732)
T ss_pred             EEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence            999998 677777765443 5679999999999999999999999 79999999999999731                 


Q ss_pred             -----CCCceeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015672          220 -----EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG  268 (403)
Q Consensus       220 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~  268 (403)
                           ....+++||+.|.+||++.....|+.-+|.|||||++|+++||..||..
T Consensus       173 el~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  173 ELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             cCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence                 1223678999999999996556799999999999999999999999954

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5e-35  Score=273.18  Aligned_cols=237  Identities=26%  Similarity=0.445  Sum_probs=174.2

Q ss_pred             cEeeeceecccCceEEEEEEE----CCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKC----RETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~----~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      .|.+.+.||+|+||.||+|..    ..+++.||+|.+....    ....+|+++++.++|+||++++++++..   +...
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~   81 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRRN   81 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCCc
Confidence            589999999999999999984    4578899999985432    2345799999999999999998876442   2234


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee-------
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-------  226 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~-------  226 (403)
                      +++||||++ ++|..++...   ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+++.       
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~-~~i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGS-KRYVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHhhEEECCCCeEEECCCccccc
Confidence            789999997 5777665432   2457888999999999999999999 899999999999999876654321       


Q ss_pred             ---------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC-----
Q 015672          227 ---------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT-----  286 (403)
Q Consensus       227 ---------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~-----  286 (403)
                                     ++..|+|||++.+. .++.++|||||||++|||++|..++..... ...    +..+...     
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~----~~~~~~~~~~~~  231 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFM----RMMGNDKQGQMI  231 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhh----hhcccccccccc
Confidence                           12349999998654 589999999999999999999877643321 111    1111000     


Q ss_pred             HHHH-hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          287 REEI-KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       287 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      ...+ .....   ....+          .+..++.++.+||.+||..||++|||+.++++
T Consensus       232 ~~~~~~~~~~---~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         232 VYHLIELLKN---NGRLP----------APPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             hHHHHHHHhc---CCcCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            0000 00000   00000          12457889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5.3e-35  Score=270.76  Aligned_cols=231  Identities=21%  Similarity=0.396  Sum_probs=178.2

Q ss_pred             cEeeeceecccCceEEEEEEECC-CCcEEEEEEccccc--------------ccHHHHHHHHHh-cCCCCccccceEEee
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDK--------------RYKNRELQIMQM-LDHPNIVALKHCFFS  146 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~--------------~~~~~E~~~l~~-l~h~niv~~~~~~~~  146 (403)
                      .|++.+.||+|+||.||+|.+.. +++.+|+|.+....              ....+|+.++.+ ++|+||+++++.+. 
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-   79 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL-   79 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence            38889999999999999999987 67899999874211              112357777764 79999999999873 


Q ss_pred             cCCCCceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee
Q 015672          147 TTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY  225 (403)
Q Consensus       147 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~  225 (403)
                          ...+.+++|||++ +++.+++.........+++..++.++.|++.||.|||+..+|+||||||+||+++.++.++.
T Consensus        80 ----~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l  155 (269)
T cd08528          80 ----ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI  155 (269)
T ss_pred             ----cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEE
Confidence                3446899999997 47766665443334568899999999999999999995258999999999999987665432


Q ss_pred             ------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015672          226 ------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  287 (403)
Q Consensus       226 ------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~  287 (403)
                                        .++..|+|||++.+. .++.++|||||||++|+|++|++||...+.......+......+. 
T Consensus       156 ~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-  233 (269)
T cd08528         156 TDFGLAKQKQPESKLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL-  233 (269)
T ss_pred             ecccceeecccccccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC-
Confidence                              356779999998654 489999999999999999999999976654443333322110000 


Q ss_pred             HHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                                .....++++.+||.+||+.||++||++.|+..+
T Consensus       234 --------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         234 --------------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             --------------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                                      012467899999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.8e-35  Score=275.86  Aligned_cols=236  Identities=19%  Similarity=0.270  Sum_probs=174.9

Q ss_pred             ccEeeeceecccCceEEEEEEECC----------------CCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCcccc
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRE----------------TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVAL  140 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~  140 (403)
                      .+|++.+.||+|+||.||+|++..                ++..+|+|.+....     ....+|+++++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            459999999999999999986532                34579999886432     234579999999999999999


Q ss_pred             ceEEeecCCCCceEEEEEeeccC-CcHHHHHHHhhhh-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccc
Q 015672          141 KHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRI-------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP  212 (403)
Q Consensus       141 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~-------~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp  212 (403)
                      ++++..     ....+++|||++ ++|..++......       ...+++..+..++.||+.||+|||+ .||+||||||
T Consensus        85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dlkp  158 (296)
T cd05095          85 LAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS-LNFVHRDLAT  158 (296)
T ss_pred             EEEEec-----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCh
Confidence            998743     234789999997 5777666543211       1236677899999999999999999 8999999999


Q ss_pred             ccceecCCCCceee---------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh--CCCCCCCC
Q 015672          213 QNLLVKGEPNVSYI---------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPGE  269 (403)
Q Consensus       213 ~NILl~~~~~~~~~---------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t--g~~pf~~~  269 (403)
                      +|||++.++.++..                     .+..|+|||+..+. .++.++|||||||++|||++  |..||...
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            99999866544321                     13569999987654 48999999999999999998  77899766


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          270 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       270 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      +..+.+.........           .......+          .+..+++.+.+|+.+||+.||++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~-----------~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         238 SDEQVIENTGEFFRD-----------QGRQVYLP----------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             ChHHHHHHHHHHHhh-----------ccccccCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            554443322211000           00000000          11346789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=6.1e-35  Score=270.58  Aligned_cols=226  Identities=27%  Similarity=0.372  Sum_probs=176.9

Q ss_pred             ccEeeeceecccCceEEEEEEECCC---CcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      .+|.+.+.||+|+||.||+|.+...   ...||||......     ....+|+.+++.++|+||+++++++..      .
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------~   79 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------N   79 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------C
Confidence            4589999999999999999987544   3568999875432     234579999999999999999987631      1


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI------  226 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~------  226 (403)
                      ..++||||++ ++|.+++...   ...++...+..++.|++.||.|||+ .|++||||||+|||++..+.+++.      
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~H~dl~p~nili~~~~~~~l~d~g~~~  155 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLES-KRFVHRDIAARNVLVSSPDCVKLGDFGLSR  155 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccChheEEEecCCCeEEccCceee
Confidence            2579999997 5676665432   2357888999999999999999999 899999999999999876655332      


Q ss_pred             --------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015672          227 --------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       227 --------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  291 (403)
                                    ++..|+|||.+.. ..++.++|||||||++|++++ |..||.+.+..+....+.....        
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~--------  226 (270)
T cd05056         156 YLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER--------  226 (270)
T ss_pred             ecccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc--------
Confidence                          1246999998854 458999999999999999986 9999987776555444322100        


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                .          ..+..++..+.++|.+||..+|++|||+.+++..
T Consensus       227 ----------~----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         227 ----------L----------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             ----------C----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                      0          0124578899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=6e-35  Score=269.19  Aligned_cols=225  Identities=23%  Similarity=0.341  Sum_probs=176.0

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      .+|.+.+.||+|+||.||++... .+..+|+|.+....   ....+|+++++.++|+||+++++.+..      ...+++
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~v   78 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYII   78 (260)
T ss_pred             cceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEEE
Confidence            45999999999999999999864 45679999886533   234579999999999999999887632      237899


Q ss_pred             eeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee-----------
Q 015672          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-----------  226 (403)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~-----------  226 (403)
                      |||++ +++.+++...  ....++...+..++.||+.||.|||+ .|++||||||+||+++..+.+++.           
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          79 TEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             EEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            99997 5776665432  13457778888999999999999999 899999999999999877655432           


Q ss_pred             ---------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          227 ---------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       227 ---------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                               ++..|+|||++.. ..++.++|||||||++|++++ |..||.+.+..+....+....              
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~--------------  220 (260)
T cd05073         156 EYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY--------------  220 (260)
T ss_pred             CcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC--------------
Confidence                     1345999999864 458899999999999999998 999998776554443332210              


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                          ..+          .+...+.++.+++.+||+.||++||++.++++
T Consensus       221 ----~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         221 ----RMP----------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             ----CCC----------CcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                000          11356789999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=9e-35  Score=266.89  Aligned_cols=224  Identities=27%  Similarity=0.383  Sum_probs=177.5

Q ss_pred             eeeceecccCceEEEEEEECCCC----cEEEEEEcccccc-----cHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           85 IAEHVVGTGSFGVVFQAKCRETG----EIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        85 ~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      ++.+.||.|+||.||+|++..++    ..||+|.+.....     ....|+.+++.++|+||+++++.+...     ...
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~   76 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----EPL   76 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----Cee
Confidence            56788999999999999998766    8999999864432     345799999999999999999987432     458


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee--------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI--------  226 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~--------  226 (403)
                      +++|||++ +++..++....  ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++++        
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~  153 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLES-KNFIHRDLAARNCLVGENLVVKISDFGLSRDL  153 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhc-CCeeecccccceEEEccCCeEEEcccCCceec
Confidence            89999997 46666654322  1228999999999999999999999 899999999999999887654332        


Q ss_pred             ------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015672          227 ------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       227 ------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  293 (403)
                                  +++.|+|||.+. ...++.++|||||||++|+|++ |.+||...+.......+.....          
T Consensus       154 ~~~~~~~~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------  222 (258)
T smart00219      154 YDDDYYKKKGGKLPIRWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR----------  222 (258)
T ss_pred             ccccccccccCCCcccccChHHhc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC----------
Confidence                        346799999984 4458999999999999999998 8899987665554444332100          


Q ss_pred             CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                               +         ..+...+.++.+++.+||..||++|||+.++++
T Consensus       223 ---------~---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      223 ---------L---------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             ---------C---------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                     0         011347889999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.6e-35  Score=270.27  Aligned_cols=228  Identities=21%  Similarity=0.256  Sum_probs=167.3

Q ss_pred             ceecccCceEEEEEEEC--CCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEee
Q 015672           88 HVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  160 (403)
                      +.||+|+||.||+|...  .++..+|+|.+....     ....+|+.+++.++||||+++++++.     .....++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEEE
Confidence            36899999999999864  345679999886432     23456999999999999999998873     3334789999


Q ss_pred             ccC-CcHHHHHHHhhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee------------
Q 015672          161 YVP-ETVNRIARNYSRI-HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI------------  226 (403)
Q Consensus       161 ~~~-~~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~------------  226 (403)
                      |++ ++|.+++...... ....+...++.++.|++.||.|||+ .+++||||||+||+++.++.+++.            
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence            998 6777666543221 1235566778899999999999999 899999999999999876544322            


Q ss_pred             ---------ccccccchhhhhCC------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          227 ---------CSRYYRAPELIFGA------TEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       227 ---------~t~~y~aPE~~~~~------~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                               ++..|+|||++.+.      ..++.++|||||||++|||++ |..||......+...........      
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------  228 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL------  228 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC------
Confidence                     34569999998532      135789999999999999996 99999876655443322211000      


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                .++    .+   ......++.+.+++.+|+ .||++|||+++++.
T Consensus       229 ----------~~~----~~---~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         229 ----------KLP----KP---RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             ----------CCC----CC---ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                      000    00   011246788999999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7.7e-35  Score=266.62  Aligned_cols=219  Identities=23%  Similarity=0.354  Sum_probs=170.4

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEcccccc-----cHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeecc
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  162 (403)
                      ++||+|+||.||+|.. .++..+|+|.+.....     ...+|+++++.++|+||+++++.+..     ....++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEECC
Confidence            3689999999999986 4688999998754321     24579999999999999999998733     23488999999


Q ss_pred             C-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee---------------
Q 015672          163 P-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI---------------  226 (403)
Q Consensus       163 ~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~---------------  226 (403)
                      + +++...+..   ....+.+..+..++.|++.||.|||+ .|++||||||+||+++.++.++..               
T Consensus        75 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  150 (250)
T cd05085          75 PGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLES-KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS  150 (250)
T ss_pred             CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccChheEEEcCCCeEEECCCccceecccccccc
Confidence            7 556554432   12457888899999999999999999 899999999999999876654332               


Q ss_pred             -----ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccc
Q 015672          227 -----CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  300 (403)
Q Consensus       227 -----~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  300 (403)
                           ++..|+|||++.+ ..++.++|||||||++|++++ |..||.+.........+....                . 
T Consensus       151 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~----------------~-  212 (250)
T cd05085         151 SGLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY----------------R-  212 (250)
T ss_pred             CCCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC----------------C-
Confidence                 1345999999854 458899999999999999998 999998776544333322110                0 


Q ss_pred             CCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                 ...+..++.++.+|+.+||..||++||++.++++
T Consensus       213 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         213 -----------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                       0012357889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-35  Score=267.51  Aligned_cols=219  Identities=24%  Similarity=0.358  Sum_probs=171.3

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeecc
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  162 (403)
                      ++||+|+||.||+|.+.. ++.||+|.+....     ....+|+++++.++|+||+++++++..     ..+.++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-----KQPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec-----CCCeEEEEEcC
Confidence            469999999999999877 9999999876432     234579999999999999999988743     33488999999


Q ss_pred             C-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceeec--------------
Q 015672          163 P-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYIC--------------  227 (403)
Q Consensus       163 ~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~~--------------  227 (403)
                      . +++.+.+..   ....++...+..++.|++.||.|||+ ++++||||||+|||++.++.++++.              
T Consensus        75 ~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~-~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  150 (251)
T cd05041          75 PGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLES-KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV  150 (251)
T ss_pred             CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee
Confidence            7 456555433   13457888889999999999999999 8999999999999998776554321              


Q ss_pred             -------cccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 015672          228 -------SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  299 (403)
Q Consensus       228 -------t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  299 (403)
                             +..|+|||.+.+. .++.++|||||||++|+|++ |..||...........+.....                
T Consensus       151 ~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~----------------  213 (251)
T cd05041         151 SDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR----------------  213 (251)
T ss_pred             ccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC----------------
Confidence                   2349999998654 58999999999999999999 8899977664433332221000                


Q ss_pred             cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                        .          ..+..++.++.+|+.+||+.+|.+|||+.|+++
T Consensus       214 --~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         214 --M----------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             --C----------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence              0          012356889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-34  Score=269.97  Aligned_cols=225  Identities=24%  Similarity=0.347  Sum_probs=176.7

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCc----EEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      .+|++.+.||+|+||+||+|.++.++.    .+|+|.+....     ....+|+.+++.++|+||+++++++..      
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   80 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------   80 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence            459999999999999999999876665    58999876443     223479999999999999999998753      


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee-----
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-----  226 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~-----  226 (403)
                      ...+++|||++ +++.+.+...   ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.++..     
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~di~p~nil~~~~~~~kL~dfg~~  156 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEE-KRLVHRDLAARNVLVKTPQHVKITDFGLA  156 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecccCcceEEEcCCCeEEECCCccc
Confidence            23789999997 5666655432   3458899999999999999999999 899999999999999876654332     


Q ss_pred             ----------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          227 ----------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       227 ----------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                      ++..|+|||.+.. ..++.++|||||||++||+++ |+.||.+....+....+... ..     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~-----  229 (279)
T cd05057         157 KLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-ER-----  229 (279)
T ss_pred             ccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-CC-----
Confidence                            1346999998854 458899999999999999998 99999877654433333211 00     


Q ss_pred             HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                  .+          .+...+.++.+++.+||..||.+|||+.++++
T Consensus       230 ------------~~----------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         230 ------------LP----------QPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             ------------CC----------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                        00          11346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.4e-35  Score=273.08  Aligned_cols=238  Identities=23%  Similarity=0.373  Sum_probs=173.2

Q ss_pred             cEeeeceecccCceEEEEEEE----CCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           83 SYIAEHVVGTGSFGVVFQAKC----RETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      -|++.+.||+|+||.||+|+.    ..++..||+|.+....     ....+|+++++.++|+||+++++++..   .+..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCCC
Confidence            378999999999999999984    4568899999985332     234579999999999999999887743   2234


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------  225 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------  225 (403)
                      ..++||||++ ++|..++...   ...+++..+..++.||+.||+|||+ .||+||||||+||+++.++.+++       
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~-~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccchheEEEcCCCCEEECCCcccc
Confidence            5789999997 5676655431   2357888999999999999999999 89999999999999987655432       


Q ss_pred             ---------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH--
Q 015672          226 ---------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--  288 (403)
Q Consensus       226 ---------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~--  288 (403)
                                     .++..|+|||++.+. .++.++|||||||++|+|+++..|+.....  ...   ...+....+  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~~---~~~~~~~~~~~  231 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMT--LFL---KMIGPTHGQMT  231 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccc--hhh---hhccccccccc
Confidence                           124469999998654 588999999999999999998776532211  110   111100000  


Q ss_pred             ---HHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          289 ---EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       289 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                         .......   ....          ..+..++..+.+||.+||+.||++|||+.+++++
T Consensus       232 ~~~~~~~~~~---~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         232 VTRLVRVLEE---GKRL----------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HHHHHHHHHc---CccC----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence               0000000   0000          0124578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.8e-35  Score=270.92  Aligned_cols=223  Identities=22%  Similarity=0.325  Sum_probs=171.1

Q ss_pred             ceecccCceEEEEEEECCCC------cEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           88 HVVGTGSFGVVFQAKCRETG------EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~------~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +.||+|+||.||+|+.....      +.+|+|.+....     ....+|+++++.++|+||+++++++..     ....+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-----NEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-----CCCeE
Confidence            36999999999999976543      689999875432     233579999999999999999988733     23488


Q ss_pred             EEeeccC-CcHHHHHHHhhh---hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC-----Cceee-
Q 015672          157 LVLEYVP-ETVNRIARNYSR---IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP-----NVSYI-  226 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~-----~~~~~-  226 (403)
                      ++|||++ ++|...+.....   ....+++..+..++.||+.||.|||+ .+++|+||||+||+++.++     .+++. 
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ-MHFIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh-CCcccCCCChheEEEecCCCCCCcceEECC
Confidence            9999997 577666654321   12347788889999999999999998 8999999999999998755     33221 


Q ss_pred             --------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 015672          227 --------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTP  285 (403)
Q Consensus       227 --------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~  285 (403)
                                          ++..|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+... .  
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~--  230 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-G--  230 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-C--
Confidence                                24579999998654 58999999999999999998 99999876655443332210 0  


Q ss_pred             CHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          286 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                   ..            ..+..++..+.+||.+||..+|.+||++.++++
T Consensus       231 -------------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         231 -------------RL------------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             -------------cc------------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                         00            012456889999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.5e-34  Score=266.59  Aligned_cols=222  Identities=21%  Similarity=0.332  Sum_probs=165.7

Q ss_pred             ceecccCceEEEEEEECC---CCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           88 HVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      +.||+|+||.||+|.+..   .+..||+|.+....     ....+|+.+++.++||||+++++.+...    ....+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEEE
Confidence            468999999999998653   34579999875322     2334689999999999999999866432    22367999


Q ss_pred             eccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee------------
Q 015672          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI------------  226 (403)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~------------  226 (403)
                      ||+. ++|.+++...   ........+..++.||+.||.|||+ .+|+||||||+|||++.++.+++.            
T Consensus        77 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~  152 (262)
T cd05058          77 PYMKHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLAS-KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE  152 (262)
T ss_pred             ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence            9987 5776665432   2345666778888999999999999 899999999999999876554321            


Q ss_pred             -----------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          227 -----------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       227 -----------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                 ++..|+|||.+.+. .++.++|||||||++|||++ |.+||...+..+....+...  .+         
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~~---------  220 (262)
T cd05058         153 YYSVHNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--RR---------  220 (262)
T ss_pred             ceeecccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CC---------
Confidence                       24469999988654 58999999999999999999 56777665544433222110  00         


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                             .          ..+..+++.+.+++.+||..||++||++.++++.
T Consensus       221 -------~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         221 -------L----------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             -------C----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                   0          0113467889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.4e-34  Score=272.88  Aligned_cols=227  Identities=22%  Similarity=0.331  Sum_probs=174.3

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCc----EEEEEEcccccc-----cHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      ..+|+..+.||+|+||.||+|.+..++.    .||+|.+.....     ...+|+.+++.++|+||+++++.+...    
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~----   81 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP----   81 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC----
Confidence            3458899999999999999999877776    478887754322     235789999999999999999987421    


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----  226 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----  226 (403)
                        ..++++||++ +++.+.+...   ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++++    
T Consensus        82 --~~~~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dikp~Nill~~~~~~kL~Dfg~  155 (303)
T cd05110          82 --TIQLVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEE-RRLVHRDLAARNVLVKSPNHVKITDFGL  155 (303)
T ss_pred             --CceeeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhh-cCeeccccccceeeecCCCceEEccccc
Confidence              1468999998 5666554431   2457888899999999999999999 899999999999999876554322    


Q ss_pred             -----------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015672          227 -----------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  288 (403)
Q Consensus       227 -----------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~  288 (403)
                                       ++..|+|||++.+. .++.++|||||||++|||++ |..||.+....+ ...+......    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~----  229 (303)
T cd05110         156 ARLLEGDEKEYNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGER----  229 (303)
T ss_pred             cccccCcccccccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCCC----
Confidence                             24579999998654 58999999999999999997 899997765333 2222221000    


Q ss_pred             HHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                   .+          .+...+.++.+++.+||..||++||++.++++.
T Consensus       230 -------------~~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         230 -------------LP----------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             -------------CC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                         00          013357789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.4e-34  Score=265.64  Aligned_cols=224  Identities=21%  Similarity=0.347  Sum_probs=176.4

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc--ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      .+|++.+.||+|+||.||++..  +++.||+|.+..+.  ....+|+.+++.++|+||+++++++..    +  ..+++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~--~~~~v~   77 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH----N--GLYIVM   77 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC----C--CcEEEE
Confidence            4599999999999999999874  68889999886432  234579999999999999999987632    1  167999


Q ss_pred             eccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee------------
Q 015672          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI------------  226 (403)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~------------  226 (403)
                      ||+. ++|..++....  ...+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+++.            
T Consensus        78 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~-~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~  154 (254)
T cd05083          78 ELMSKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLES-KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV  154 (254)
T ss_pred             ECCCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence            9998 57776665422  2357888889999999999999999 899999999999999877665432            


Q ss_pred             ----ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccC
Q 015672          227 ----CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  301 (403)
Q Consensus       227 ----~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  301 (403)
                          .+..|+|||.+.+. .++.++|||||||++|+|++ |++||...+..+....+.+..                  .
T Consensus       155 ~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------------------~  215 (254)
T cd05083         155 DNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY------------------R  215 (254)
T ss_pred             CCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC------------------C
Confidence                23469999988544 58999999999999999997 999998776544333322110                  0


Q ss_pred             CCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       302 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      ..          .+..++..+.+|+.+||..+|++||++++++.
T Consensus       216 ~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         216 ME----------PPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             CC----------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            00          11357889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.1e-34  Score=264.89  Aligned_cols=218  Identities=20%  Similarity=0.230  Sum_probs=165.7

Q ss_pred             ceecccCceEEEEEEECCCC----------cEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           88 HVVGTGSFGVVFQAKCRETG----------EIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~----------~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      +.||+|+||.||+|.+..++          ..+++|.+....   ....+|+.+++.++|+||+++++++.. .     .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~-----~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-D-----E   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-C-----C
Confidence            46999999999999998766          358888765433   244578999999999999999998744 2     2


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC-------Ccee-
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP-------NVSY-  225 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~-------~~~~-  225 (403)
                      .++||||++ ++|..++...   ...++...+..++.||+.||.|||+ .||+||||||+|||++.++       .+++ 
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLED-KKLVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhh-CCeecccCccceEEEecCccccCCceeEEeC
Confidence            679999998 4665555432   2268888899999999999999999 8999999999999998766       2222 


Q ss_pred             --------------eccccccchhhhhCC-CCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          226 --------------ICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       226 --------------~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                    .++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+..+.......         
T Consensus       151 Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~---------  221 (259)
T cd05037         151 DPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD---------  221 (259)
T ss_pred             CCCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc---------
Confidence                          246679999998654 358999999999999999999 5778866542221111110         


Q ss_pred             HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                   ...        .+......+.+||.+||..||.+|||+.++++
T Consensus       222 -------------~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         222 -------------QHR--------LPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             -------------CCC--------CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                         000        00112378999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.7e-34  Score=265.23  Aligned_cols=227  Identities=20%  Similarity=0.255  Sum_probs=165.9

Q ss_pred             eecccCceEEEEEEECCC--CcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeec
Q 015672           89 VVGTGSFGVVFQAKCRET--GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY  161 (403)
Q Consensus        89 ~lG~G~~g~V~~~~~~~~--~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  161 (403)
                      .||+|+||.||+|+....  ...+++|.+....     ....+|+.+++.++||||+++++.+.     ...+.++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e~   76 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFEY   76 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEec
Confidence            599999999999975433  3356677664322     23457888999999999999999873     33458899999


Q ss_pred             cC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------------
Q 015672          162 VP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------------  225 (403)
Q Consensus       162 ~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------------  225 (403)
                      ++ ++|..++..........+...++.++.||+.||+|||+ .+|+||||||+|||++.++.++.               
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence            98 57776665432223446677788899999999999999 89999999999999986654422               


Q ss_pred             ------eccccccchhhhhCC------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          226 ------ICSRYYRAPELIFGA------TEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       226 ------~~t~~y~aPE~~~~~------~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                            .++..|+|||++...      ..++.++|||||||++|||++ |..||...+..+.+..+......        
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~--------  227 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV--------  227 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccc--------
Confidence                  245679999987421      135789999999999999997 57788776665555544321100        


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                              ..+       ...+...+++.+.+++..|| .||++||+++++++
T Consensus       228 --------~~~-------~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         228 --------KLF-------KPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             --------ccC-------CCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence                    000       00111346788999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3e-34  Score=266.16  Aligned_cols=233  Identities=21%  Similarity=0.316  Sum_probs=174.8

Q ss_pred             EeeeceecccCceEEEEEEEC---CCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCc-e
Q 015672           84 YIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE-L  153 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~-~  153 (403)
                      |.+.+.||+|+||.||+|...   .+++.||||.+..+.      ....+|+++++.++||||+++++++........ .
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999864   357899999886432      123479999999999999999987754332222 2


Q ss_pred             EEEEEeeccC-CcHHHHHHHhh--hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----
Q 015672          154 YLNLVLEYVP-ETVNRIARNYS--RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----  226 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----  226 (403)
                      ..+++++|+. +++..++....  .....++...++.++.||+.||+|||+ .||+||||||+||+++.++.++..    
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccchhhEEEcCCCCEEECcccc
Confidence            3567889887 56655543211  111247888899999999999999999 899999999999999876655432    


Q ss_pred             -----------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015672          227 -----------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  288 (403)
Q Consensus       227 -----------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~  288 (403)
                                       +++.|++||.+.+. .++.++|||||||++|+|++ |++||.+.+..+....+... .     
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~-----  232 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-N-----  232 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-C-----
Confidence                             13569999998654 58899999999999999999 89999876654433333221 0     


Q ss_pred             HHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                ...            .+...+..+.+++.+||..+|++||++.+++++
T Consensus       233 ----------~~~------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         233 ----------RLK------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             ----------cCC------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                      000            113467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-35  Score=279.99  Aligned_cols=229  Identities=23%  Similarity=0.379  Sum_probs=181.3

Q ss_pred             eeeceecccCceEEEEEEECCCCc---E-EEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           85 IAEHVVGTGSFGVVFQAKCRETGE---I-VAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        85 ~~~~~lG~G~~g~V~~~~~~~~~~---~-vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      .+.++||+|+||.||+|+.+..+.   . ||+|....+.       ..+-+|.++|+.++|||||++||+.....     
T Consensus       160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~-----  234 (474)
T KOG0194|consen  160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE-----  234 (474)
T ss_pred             cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC-----
Confidence            456899999999999999875432   3 8999876422       12237999999999999999999874433     


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI------  226 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~------  226 (403)
                      .+++|||+|. |+|.+++...   ...++..+...++.+.+.||+|||+ +++|||||-.+|+|++.++.+++.      
T Consensus       235 Pl~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~-k~~IHRDIAARNcL~~~~~~vKISDFGLs~  310 (474)
T KOG0194|consen  235 PLMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHS-KNCIHRDIAARNCLYSKKGVVKISDFGLSR  310 (474)
T ss_pred             ccEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHH-CCCcchhHhHHHheecCCCeEEeCcccccc
Confidence            3889999998 4777776653   2358899999999999999999999 899999999999999876554322      


Q ss_pred             -c------------cccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          227 -C------------SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       227 -~------------t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                       |            ...|+|||.+... .|+.++|||||||++||+++ |..||.+....+....+....          
T Consensus       311 ~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~----------  379 (474)
T KOG0194|consen  311 AGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNG----------  379 (474)
T ss_pred             CCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcC----------
Confidence             1            2459999999655 69999999999999999998 889999999887777774421          


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                             +..          ..+...+.++..++.+|+..||++|||+.++.+  +++.+
T Consensus       380 -------~r~----------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~--~l~~~  420 (474)
T KOG0194|consen  380 -------YRM----------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK--KLEAL  420 (474)
T ss_pred             -------ccC----------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHH--HHHHH
Confidence                   111          122356788999999999999999999999865  34443

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-34  Score=274.77  Aligned_cols=243  Identities=26%  Similarity=0.366  Sum_probs=174.7

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      ++|.-.++||+|+||.||+|... ++..||||++....    ..+.+|+.++.+++|||+|+++++|.....    ..+|
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~~L  149 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HRLL  149 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eEEE
Confidence            35777789999999999999985 44899999885432    347799999999999999999999953321    4789


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CccccccccccceecCCCCcee---------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--GICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      |+||++ |+|.+.+......  .+++.....|+.+++.||+|||...  .|||||||++|||||.+...++         
T Consensus       150 VYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~  227 (361)
T KOG1187|consen  150 VYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG  227 (361)
T ss_pred             EEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence            999999 6887665542211  7889999999999999999999833  3999999999999996544321         


Q ss_pred             -----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHH-HHhCCCCHHHHh
Q 015672          226 -----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES--GVDQLVEII-KVLGTPTREEIK  291 (403)
Q Consensus       226 -----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~--~~~~~~~i~-~~~~~~~~~~~~  291 (403)
                                 .||..|+|||++.. ...+.++|||||||+|.|++||+.+.....  ....+..+. ..+...      
T Consensus       228 ~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~------  300 (361)
T KOG1187|consen  228 PEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG------  300 (361)
T ss_pred             CccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc------
Confidence                       68889999999854 458999999999999999999998876432  111122222 111111      


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                          ...++--+.+.......   ...-..+..+..+|++.+|.+||++.|+++
T Consensus       301 ----~~~eiiD~~l~~~~~~~---~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  301 ----KLREIVDPRLKEGEYPD---EKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             ----chhheeCCCccCCCCCh---HHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence                01111111111000000   011233678889999999999999999754

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.4e-34  Score=264.83  Aligned_cols=241  Identities=24%  Similarity=0.361  Sum_probs=174.9

Q ss_pred             cEeeeceecccCceEEEEEEEC----CCCcEEEEEEcccccc-----cHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      .|.+.+.||+|+||.||+|+..    .+++.||+|.+.....     ...+|+++++.++|+||+++++++..   ....
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~~   81 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGGR   81 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCCC
Confidence            4788899999999999999864    3478999999865433     34679999999999999999887633   2244


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI------  226 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~------  226 (403)
                      +.+++|||++ +++..++...   ...++...+..++.||+.||.|||+ .||+||||||+||+++.++.+++.      
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGS-QRYIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCCCEEEccccccc
Confidence            5889999997 5776665432   2358888999999999999999999 899999999999999877655432      


Q ss_pred             ----------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH-HhCCCCHHH
Q 015672          227 ----------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK-VLGTPTREE  289 (403)
Q Consensus       227 ----------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~-~~~~~~~~~  289 (403)
                                      ++..|+|||.+.+. .++.++|||||||++|+|++|..||.........  +.. ..+......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~  234 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR--MIGIAQGQMIVTR  234 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhcc--ccccccccccHHH
Confidence                            12359999998654 5889999999999999999999998654321100  000 000000000


Q ss_pred             HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      +......  ....+          .+..++.++.+|+.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~--~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         235 LLELLKE--GERLP----------RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHHHHc--CCcCC----------CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            0000000  00000          11346788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=273.23  Aligned_cols=237  Identities=29%  Similarity=0.429  Sum_probs=184.0

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccccc-----------HHHHHHHHHhcCCCCccccceEEeecCCC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-----------KNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----------~~~E~~~l~~l~h~niv~~~~~~~~~~~~  150 (403)
                      .+|.+++.||+|+|+.||+|.+....+.||||+-..++..           .-+|..|.+.|+||-||++|++|--.++ 
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd-  541 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD-  541 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc-
Confidence            4599999999999999999999988999999976432221           1269999999999999999998844333 


Q ss_pred             CceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc-CCccccccccccceecCCCCc------
Q 015672          151 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-IGICHRDIKPQNLLVKGEPNV------  223 (403)
Q Consensus       151 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~-~~ivHrDlKp~NILl~~~~~~------  223 (403)
                         .+|-|+|||+|+-.++   |.+-+..+++.+++.|+.||+.||.||... ..|||-||||.||||.+...+      
T Consensus       542 ---sFCTVLEYceGNDLDF---YLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT  615 (775)
T KOG1151|consen  542 ---SFCTVLEYCEGNDLDF---YLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT  615 (775)
T ss_pred             ---cceeeeeecCCCchhH---HHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee
Confidence               3899999999744332   233356799999999999999999999972 249999999999998533211      


Q ss_pred             -----------------------eeeccccccchhhhhC---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcH-HHHH
Q 015672          224 -----------------------SYICSRYYRAPELIFG---ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLV  276 (403)
Q Consensus       224 -----------------------~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~-~~~~  276 (403)
                                             ...||-+|.+||.+.-   .+.++.++||||+|||+|.++.|+.||...-.. +.+.
T Consensus       616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq  695 (775)
T KOG1151|consen  616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ  695 (775)
T ss_pred             ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence                                   1247999999998742   345889999999999999999999999654332 2221


Q ss_pred             H--HHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          277 E--IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       277 ~--i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                      .  |++.                .+..||.-          +.++.++++||++||.+.-++|....++-.||||.-
T Consensus       696 eNTIlkA----------------tEVqFP~K----------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  696 ENTILKA----------------TEVQFPPK----------PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             hhchhcc----------------eeccCCCC----------CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            1  1111                22333321          358999999999999999999999999999999964

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-34  Score=292.54  Aligned_cols=230  Identities=20%  Similarity=0.327  Sum_probs=187.5

Q ss_pred             cccEeeeceecccCceEEEEEEECCCC-----cEEEEEEcccc-----cccHHHHHHHHHhcCCCCccccceEEeecCCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  150 (403)
                      ...-++.+.||+|.||.||.|....-.     ..||||.+.+.     ...+.+|..+|+.++|||||+++++++.... 
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~-  769 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP-  769 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC-
Confidence            344778899999999999999876432     24999998654     2344589999999999999999999976433 


Q ss_pred             CceEEEEEeeccC-CcHHHHHHHhhhh---cCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee
Q 015672          151 EELYLNLVLEYVP-ETVNRIARNYSRI---HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI  226 (403)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~  226 (403)
                          .+|++|||. |+|..+++.....   ...++......++.||++|+.||++ +++|||||..+|+||+....+++.
T Consensus       770 ----~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~-~~fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  770 ----PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES-KHFVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             ----cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh-CCCcCcchhhhheeecccCcEEEc
Confidence                779999998 6888887764211   3457888889999999999999999 899999999999999987666543


Q ss_pred             c---------------------cccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 015672          227 C---------------------SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT  284 (403)
Q Consensus       227 ~---------------------t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~  284 (403)
                      .                     ...|||||.+.. ..++.++|||||||+|||++| |..||.+.++.+.+....+.-. 
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggR-  922 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGR-  922 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCc-
Confidence            1                     235999999965 469999999999999999998 8999999998887765554211 


Q ss_pred             CCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          285 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                       ++          .+..++..+.++|..||+.+|++||++..+++
T Consensus       923 -----------------L~----------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  923 -----------------LD----------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             -----------------cC----------CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence                             11          23678999999999999999999999999987

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=1.3e-34  Score=266.91  Aligned_cols=261  Identities=29%  Similarity=0.485  Sum_probs=193.3

Q ss_pred             cccEeeeceecccCceEEEEEEECC---CCcEEEEEEcccc--cccHHHHHHHHHhc-CCCCccccceEEeecCCCCceE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQD--KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ...|.++++||+|+|++||++.+..   ..+.||+|.+...  ......|+++|..+ .+.||+++.+++     .++..
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----rnnd~  109 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----RNNDQ  109 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----ccCCe
Confidence            3458999999999999999999877   7889999988543  33456899999998 589999999988     56666


Q ss_pred             EEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC------------
Q 015672          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP------------  221 (403)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~------------  221 (403)
                      .++||||++. ...++.       ..++...++.|++.++.||.++|. +|||||||||.|+|.+...            
T Consensus       110 v~ivlp~~~H~~f~~l~-------~~l~~~~i~~Yl~~ll~Al~~~h~-~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLY-------RSLSLAEIRWYLRNLLKALAHLHK-NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             eEEEecccCccCHHHHH-------hcCCHHHHHHHHHHHHHHhhhhhc-cCccccCCCccccccccccCCceEEechhHH
Confidence            8999999984 332222       346788899999999999999999 8999999999999974110            


Q ss_pred             ----------------------------------------------------CceeeccccccchhhhhCCCCCCchhHH
Q 015672          222 ----------------------------------------------------NVSYICSRYYRAPELIFGATEYTTAIDI  249 (403)
Q Consensus       222 ----------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~Di  249 (403)
                                                                          .....||++|+|||+++..+.-++++||
T Consensus       182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi  261 (418)
T KOG1167|consen  182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI  261 (418)
T ss_pred             HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence                                                                0023479999999999988888999999


Q ss_pred             HHHHHHHHHHHhCCCCCCC-CCcHHHHHHHHHHhCCCCHHHHhhcC------------------cCccccCCCCCCC--C
Q 015672          250 WSTGCVMAELLLGQPLFPG-ESGVDQLVEIIKVLGTPTREEIKCMN------------------PNYTEFKFPQIKP--H  308 (403)
Q Consensus       250 wSlGvil~el~tg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~--~  308 (403)
                      ||.|||+.-+++++.||.. .++.+.+.++...+|...........                  ..+.......+..  .
T Consensus       262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q  341 (418)
T KOG1167|consen  262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ  341 (418)
T ss_pred             eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence            9999999999999988754 45556677666655543222111100                  0011110000000  0


Q ss_pred             --CcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCC
Q 015672          309 --PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  354 (403)
Q Consensus       309 --~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  354 (403)
                        -+........+..+.||+.+||..||.+|.||+++|+||||.+...
T Consensus       342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~  389 (418)
T KOG1167|consen  342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR  389 (418)
T ss_pred             cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence              0111122345668999999999999999999999999999997654

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.6e-34  Score=310.12  Aligned_cols=242  Identities=21%  Similarity=0.301  Sum_probs=176.1

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccccccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeecc
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  162 (403)
                      .|...++||+|+||.||+|++..++..||||.+.........|++++++++|||||++++++...     ...++||||+
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~lv~Ey~  765 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSE-----KGAYLIHEYI  765 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcC-----CCCEEEEeCC
Confidence            35667889999999999999988999999999876555556789999999999999999988433     2378999999


Q ss_pred             C-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCccccccccccceecCCCCce--------------
Q 015672          163 P-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH---NCIGICHRDIKPQNLLVKGEPNVS--------------  224 (403)
Q Consensus       163 ~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~~ivHrDlKp~NILl~~~~~~~--------------  224 (403)
                      + ++|.+++.       .+++.....++.||+.||+|||   + .+|+||||||+||+++.+...+              
T Consensus       766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH~dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~  837 (968)
T PLN00113        766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCS-PAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTK  837 (968)
T ss_pred             CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCC-CCeecCCCCHHhEEECCCCceEEEeccccccccCCC
Confidence            8 56766553       3677888999999999999999   5 6999999999999998765432              


Q ss_pred             eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHhhcCcCccccCCC
Q 015672          225 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  303 (403)
Q Consensus       225 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  303 (403)
                      ..+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ...+..+.+.......         ...+.-+
T Consensus       838 ~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~  907 (968)
T PLN00113        838 CFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCH---------LDMWIDP  907 (968)
T ss_pred             ccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccc---------hhheeCc
Confidence            235688999999865 4589999999999999999999999953321 1111122111100000         0000001


Q ss_pred             CCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          304 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       304 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                      ......   ..+.....++.+++.+||+.||++|||+.|+++.  ++++
T Consensus       908 ~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~--L~~~  951 (968)
T PLN00113        908 SIRGDV---SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT--LESA  951 (968)
T ss_pred             cccCCC---CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH--HHHh
Confidence            000000   0001123467899999999999999999999875  4444

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=285.42  Aligned_cols=231  Identities=27%  Similarity=0.422  Sum_probs=173.7

Q ss_pred             cEeeeceecccCceE-EEEEEECCCCcEEEEEEcccccc-cHHHHHHHHHhc-CCCCccccceEEeecCCCCceEEEEEe
Q 015672           83 SYIAEHVVGTGSFGV-VFQAKCRETGEIVAIKKVLQDKR-YKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~-V~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      -|.-.+++|.|+.|+ ||+|...  |+.||||.+..+.. ..++|+..|+.- +|||||++++.-     .+..++||..
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIal  582 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIAL  582 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEEe
Confidence            366678899999995 7999975  88999998866543 678999999988 699999986543     6677899999


Q ss_pred             eccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCC---CCc-------------
Q 015672          160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE---PNV-------------  223 (403)
Q Consensus       160 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~---~~~-------------  223 (403)
                      |.|..+|.+++.................++.|++.||++||+ .+||||||||.||||+..   +..             
T Consensus       583 ELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  583 ELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            999999999887631101111113456678899999999999 899999999999999752   221             


Q ss_pred             -----------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015672          224 -----------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       224 -----------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  291 (403)
                                 ...||-+|+|||++.... -+.++||+||||++|+.++| ..||...-  +.-.+|...          
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~----------  728 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTG----------  728 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcC----------
Confidence                       123788999999997654 57799999999999999986 89995432  222233321          


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  350 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~  350 (403)
                             .+..-.+.         .....++.|||.+||..||..||+|.++|.||||=
T Consensus       729 -------~~~L~~L~---------~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW  771 (903)
T KOG1027|consen  729 -------NYTLVHLE---------PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW  771 (903)
T ss_pred             -------ccceeeec---------cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence                   11111110         11122899999999999999999999999999994

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-34  Score=271.53  Aligned_cols=223  Identities=30%  Similarity=0.464  Sum_probs=178.2

Q ss_pred             cEeeeceecccCceEEEEEEECCC--C--cEEEEEEcccc-----cccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRET--G--EIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~--~--~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..++.++||.|.||.||+|.+..-  |  -.||||..+.+     .+.+..|..+|+.++|||||++++++.. .     
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~-----  463 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q-----  463 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c-----
Confidence            345678899999999999987532  2  35899988653     2334579999999999999999998732 1     


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceeec-----
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYIC-----  227 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~~-----  227 (403)
                      ..|||||+++ |.|..++...   ...++......|+.||+.||.|||+ .++|||||...|||+.....++...     
T Consensus       464 P~WivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeS-krfVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLES-KRFVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             ceeEEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHh-hchhhhhhhhhheeecCcceeeecccchhh
Confidence            2899999998 6676666543   4678888899999999999999999 8999999999999998877665431     


Q ss_pred             ---------------cccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015672          228 ---------------SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       228 ---------------t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  291 (403)
                                     ..-|||||.+. ...++.++|||-|||.+||++. |..||.+-.+.+.+..+.+.-..|      
T Consensus       540 ~~ed~~yYkaS~~kLPIKWmaPESIN-fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP------  612 (974)
T KOG4257|consen  540 YLEDDAYYKASRGKLPIKWMAPESIN-FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP------  612 (974)
T ss_pred             hccccchhhccccccceeecCccccc-hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC------
Confidence                           23499999984 5569999999999999999976 999999887766554443321111      


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  344 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l  344 (403)
                                            .|+++++.+..|+.+||.+||.+||++.++.
T Consensus       613 ----------------------~P~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  613 ----------------------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             ----------------------CCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence                                  3468999999999999999999999987764

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.1e-32  Score=272.72  Aligned_cols=255  Identities=20%  Similarity=0.282  Sum_probs=168.0

Q ss_pred             ccccEeeeceecccCceEEEEEEEC----------------CCCcEEEEEEcccccc------------------cHHHH
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCR----------------ETGEIVAIKKVLQDKR------------------YKNRE  125 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~------------------~~~~E  125 (403)
                      ...+|.+.++||+|+||+||+|...                ..++.||||.+.....                  ....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4567999999999999999999752                2356799999753221                  11246


Q ss_pred             HHHHHhcCCCCc-----cccceEEeecCC---CCceEEEEEeeccC-CcHHHHHHHhh-----------h---------h
Q 015672          126 LQIMQMLDHPNI-----VALKHCFFSTTD---KEELYLNLVLEYVP-ETVNRIARNYS-----------R---------I  176 (403)
Q Consensus       126 ~~~l~~l~h~ni-----v~~~~~~~~~~~---~~~~~~~lv~e~~~-~~l~~~~~~~~-----------~---------~  176 (403)
                      +.++.+++|.++     ++++++|.....   ......++||||++ ++|.+++....           .         .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            677777877655     556665532111   11234789999998 56666654211           0         0


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee--------------------ccccccchhh
Q 015672          177 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI--------------------CSRYYRAPEL  236 (403)
Q Consensus       177 ~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~--------------------~t~~y~aPE~  236 (403)
                      ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+++.                    +|+.|+|||+
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~-~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~  381 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE  381 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence            1224566788899999999999999 899999999999999876554332                    2678999998


Q ss_pred             hhCCCC-------------------C--CchhHHHHHHHHHHHHHhCCC-CCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          237 IFGATE-------------------Y--TTAIDIWSTGCVMAELLLGQP-LFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       237 ~~~~~~-------------------~--~~~~DiwSlGvil~el~tg~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                      +.....                   |  ..+.||||+||++|+|++|.. ||.+.......   .+.. ......|....
T Consensus       382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~---~~~~-~~~~~~~r~~~  457 (507)
T PLN03224        382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE---LRQY-DNDLNRWRMYK  457 (507)
T ss_pred             hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH---Hhhc-cchHHHHHhhc
Confidence            743211                   1  234799999999999999875 77543211110   0000 00000011000


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCC---CCCCCHHHHhcCCCccc
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP---NLRCTALEACVHPFFDE  351 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP---~~Rpta~e~l~hp~f~~  351 (403)
                      .  ..+.++          .....++..+||+.+||..+|   .+|+|++|+|+||||..
T Consensus       458 ~--~~~~~~----------~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        458 G--QKYDFS----------LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             c--cCCCcc----------cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            0  011111          124578999999999999876   68999999999999953

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-33  Score=263.96  Aligned_cols=233  Identities=21%  Similarity=0.272  Sum_probs=184.5

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ....+.++||+|.||.|.+|... .+..||+|+++.+.     ..+.+|+++|.+|+|||||.++++|...+.     +|
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP-----ic  611 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP-----LC  611 (807)
T ss_pred             hheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-----hH
Confidence            34678999999999999999874 36899999996532     345689999999999999999999976555     89


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceeec--------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYIC--------  227 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~~--------  227 (403)
                      +|+||++ |+|.+++.....  ..+.......++.||+.|++||.+ .++|||||.+.|+|++++.++++..        
T Consensus       612 mI~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes-~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLES-LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHh-hchhhccccccceeecCcccEEecCcccccccc
Confidence            9999998 788888776432  113344556789999999999999 8999999999999999998887642        


Q ss_pred             -------------cccccchhhhhCCCCCCchhHHHHHHHHHHHHHh--CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          228 -------------SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--GQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       228 -------------t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                                   ...|||+|.++.. .+++++|+|+||+++||+++  ...||....+.+...+....+..+...    
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~----  763 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQ----  763 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcc----
Confidence                         3469999998755 59999999999999999865  778998777666555544433222111    


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                       .....|.-++..+.+||.+||..|-.+||+++++-.
T Consensus       764 -----------------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  764 -----------------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             -----------------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence                             011123568899999999999999999999999844

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6e-34  Score=278.76  Aligned_cols=231  Identities=26%  Similarity=0.371  Sum_probs=192.8

Q ss_pred             EeeeceecccCceEEEEEEECCCCc---EEEEEEcccc-----cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      ..+.++||.|.||.|++|+.+..++   .||||.++..     +..+..|..||.+++||||+++.++..     ...-+
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT-----ks~Pv  705 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT-----KSKPV  705 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe-----cCcee
Confidence            4688999999999999999887664   6999999643     445567999999999999999999873     33347


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee--------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI--------  226 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~--------  226 (403)
                      .||.|||+ |+|+.+++...   +.+...+..-+++.|+.|++||-+ +|+|||||...|||++.+-.++..        
T Consensus       706 MIiTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsd-m~YVHRDLAARNILVNsnLvCKVsDFGLSRvl  781 (996)
T KOG0196|consen  706 MIITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSD-MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  781 (996)
T ss_pred             EEEhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhh-cCchhhhhhhhheeeccceEEEeccccceeec
Confidence            89999998 78888887653   568888888899999999999999 899999999999999865433321        


Q ss_pred             ------------c--cccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015672          227 ------------C--SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       227 ------------~--t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  291 (403)
                                  |  ...|.|||.+. ...++.++||||+|++|||.++ |..||.+.++.+.+..|.+..+.|++    
T Consensus       782 edd~~~~ytt~GGKIPiRWTAPEAIa-~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP----  856 (996)
T KOG0196|consen  782 EDDPEAAYTTLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP----  856 (996)
T ss_pred             ccCCCccccccCCccceeecChhHhh-hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC----
Confidence                        1  24599999995 4569999999999999999765 99999999999999999886655543    


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCC
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  354 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  354 (403)
                                              ..++..+..|+..||++|-.+||++.|++.+  |.++..
T Consensus       857 ------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~--lDklIr  893 (996)
T KOG0196|consen  857 ------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVST--LDKLIR  893 (996)
T ss_pred             ------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH--HHHHhc
Confidence                                    5689999999999999999999999999986  555433

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-32  Score=263.84  Aligned_cols=226  Identities=22%  Similarity=0.359  Sum_probs=181.7

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      .+.+..++||-|.||.||.|.+++-...||||.++.+.   ..+.+|..+|+.++|||+|+++++|..     ...+|||
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~-----EpPFYIi  341 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-----EPPFYII  341 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhcc-----CCCeEEE
Confidence            34667789999999999999999999999999987653   345689999999999999999999833     3348899


Q ss_pred             eeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceeec----------
Q 015672          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYIC----------  227 (403)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~~----------  227 (403)
                      +|||. |+|.++++...+  ..++.-....++.||..|++||.. +++|||||...|+|+..+.-+++..          
T Consensus       342 TEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEk-knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD  418 (1157)
T KOG4278|consen  342 TEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD  418 (1157)
T ss_pred             EecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHH-hhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence            99987 788777776442  446666777888999999999998 8999999999999998776554421          


Q ss_pred             ----------cccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          228 ----------SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       228 ----------t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                                ..-|.|||-+. ...++.++|||+|||+|||+.| |-.||++.+....+....+.               
T Consensus       419 TYTAHAGAKFPIKWTAPEsLA-yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg---------------  482 (1157)
T KOG4278|consen  419 TYTAHAGAKFPIKWTAPESLA-YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG---------------  482 (1157)
T ss_pred             ceecccCccCcccccCccccc-ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc---------------
Confidence                      23499999884 4458999999999999999998 88999998754433322221               


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  344 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l  344 (403)
                         +.+          .-+..+++.+.+|++.||+|+|.+||+++|+-
T Consensus       483 ---yRM----------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  483 ---YRM----------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             ---ccc----------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence               111          12367999999999999999999999998873

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.1e-31  Score=243.22  Aligned_cols=220  Identities=39%  Similarity=0.659  Sum_probs=173.7

Q ss_pred             CceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeeccCC-cHH
Q 015672           94 SFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVN  167 (403)
Q Consensus        94 ~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~  167 (403)
                      +||.||+|.+..+++.+|+|++....     ....+|++.++.++|+||+++++.+..     ....++++||+++ +|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence            58999999999889999999986432     345689999999999999999988743     2458899999986 776


Q ss_pred             HHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------------------eccc
Q 015672          168 RIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------------------ICSR  229 (403)
Q Consensus       168 ~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------------------~~t~  229 (403)
                      .++...    ..++...+..++.+++.+|.|||+ .+|+|+||+|.||+++.++.+.+                  .++.
T Consensus        76 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  150 (244)
T smart00220       76 DLLKKR----GRLSEDEARFYARQILSALEYLHS-NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTP  150 (244)
T ss_pred             HHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCc
Confidence            665432    237888899999999999999999 79999999999999987755432                  3466


Q ss_pred             cccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCC
Q 015672          230 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHP  309 (403)
Q Consensus       230 ~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (403)
                      .|++||.+.+ ..++.++||||||+++|++++|..||...................                ...     
T Consensus       151 ~~~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~----------------~~~-----  208 (244)
T smart00220      151 EYMAPEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP----------------FPP-----  208 (244)
T ss_pred             CCCCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC----------------Ccc-----
Confidence            8999999864 457889999999999999999999997744444333332210000                000     


Q ss_pred             cccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          310 WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       310 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                          ....++.++.+++.+||..||++||++.++++||||
T Consensus       209 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      209 ----PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             ----ccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence                001177899999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-33  Score=268.91  Aligned_cols=232  Identities=23%  Similarity=0.300  Sum_probs=185.8

Q ss_pred             cEeeeceecccCceEEEEEEECCCC---cEEEEEEcccccc-----cHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      +..+.++||+|+||+|++|.+...+   ..||||.+..+..     .+.+|+.+|.+|+|+|+|++|++....      -
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q------p  184 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ------P  184 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc------h
Confidence            3567789999999999999987532   3699999976543     456899999999999999999998541      2


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceeec------
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYIC------  227 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~~------  227 (403)
                      +.||||+++ |+|.+-+..  .....|.......|+.||+.|+.||.+ +++|||||...|+||-....++++.      
T Consensus       185 ~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLes-krlvHRDLAARNlllasprtVKI~DFGLmRa  261 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLES-KRLVHRDLAARNLLLASPRTVKICDFGLMRA  261 (1039)
T ss_pred             hhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhhhheecccceeeeecccceec
Confidence            679999998 677655554  234567788889999999999999999 8999999999999998766655431      


Q ss_pred             ----------------cccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          228 ----------------SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       228 ----------------t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                      ...|+|||.+. ...++.++|||+|||++|||++ |+-||.|......+..|-+.-.       
T Consensus       262 Lg~ned~Yvm~p~rkvPfAWCaPEsLr-h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er-------  333 (1039)
T KOG0199|consen  262 LGENEDMYVMAPQRKVPFAWCAPESLR-HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER-------  333 (1039)
T ss_pred             cCCCCcceEecCCCcCcccccCHhHhc-cccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc-------
Confidence                            23499999985 4569999999999999999998 8899999998877766643110       


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                                 ++          .++.+++++.+++.+||..+|++|||+..|.+.-+..+.
T Consensus       334 -----------Lp----------RPk~csedIY~imk~cWah~paDRptFsair~~~~l~ea  374 (1039)
T KOG0199|consen  334 -----------LP----------RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA  374 (1039)
T ss_pred             -----------CC----------CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence                       00          125689999999999999999999999998765454443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.98  E-value=1.2e-33  Score=272.54  Aligned_cols=238  Identities=26%  Similarity=0.390  Sum_probs=192.4

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc----cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +.+|.++..+|.|+||.||+++++.+++..|+|+++-+    ....++|+-+++..+|+|||.+++.|....     .+|
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d-----klw   88 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-----KLW   88 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc-----CcE
Confidence            34599999999999999999999999999999998643    344568999999999999999999985443     399


Q ss_pred             EEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc------------
Q 015672          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV------------  223 (403)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~------------  223 (403)
                      ++||||++ +|.++.    ...+.+++.++.++.+..+.||+|||+ +|-+|||||-.|||+++.+.+            
T Consensus        89 icMEycgggslQdiy----~~TgplselqiayvcRetl~gl~ylhs-~gk~hRdiKGanilltd~gDvklaDfgvsaqit  163 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIY----HVTGPLSELQIAYVCRETLQGLKYLHS-QGKIHRDIKGANILLTDEGDVKLADFGVSAQIT  163 (829)
T ss_pred             EEEEecCCCccccee----eecccchhHHHHHHHhhhhccchhhhc-CCcccccccccceeecccCceeecccCchhhhh
Confidence            99999994 554432    235788999999999999999999999 899999999999999877655            


Q ss_pred             -------eeeccccccchhhhh--CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          224 -------SYICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       224 -------~~~~t~~y~aPE~~~--~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                             +++||++|||||+..  ....|+..+|||++|++..|+..-++|...-.....+..+.+..-.|+.       
T Consensus       164 ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~-------  236 (829)
T KOG0576|consen  164 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT-------  236 (829)
T ss_pred             hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc-------
Confidence                   467999999999862  2345999999999999999999888887665555555544442222211       


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                                .+.       ....++.+.+|++.+|..+|++|||++.+|.|||...-
T Consensus       237 ----------lkD-------k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  237 ----------LKD-------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             ----------ccC-------CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence                      110       13457889999999999999999999999999998653

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=225.56  Aligned_cols=194  Identities=23%  Similarity=0.411  Sum_probs=159.5

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc-----cHHHHHHHH-HhcCCCCccccceEEeecCCCCceEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIM-QMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      +....+..||+|+||.|-+.++..+|...|+|.+...-.     ...+|+.+. +....|.+|.+|+.++...+     +
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd-----v  120 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD-----V  120 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc-----E
Confidence            345567789999999999999999999999999864322     112455543 33468999999998865544     9


Q ss_pred             EEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee---------
Q 015672          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI---------  226 (403)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~---------  226 (403)
                      |+.||.|..++..+.......++.+++..+-+++..+++||.|||+...|||||+||+||||+.++.++.+         
T Consensus       121 wIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~  200 (282)
T KOG0984|consen  121 WICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV  200 (282)
T ss_pred             EEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence            99999999999888887777788999999999999999999999997789999999999999999998765         


Q ss_pred             ---------ccccccchhhhh---CCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHH
Q 015672          227 ---------CSRYYRAPELIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGE-SGVDQLVEIIK  280 (403)
Q Consensus       227 ---------~t~~y~aPE~~~---~~~~~~~~~DiwSlGvil~el~tg~~pf~~~-~~~~~~~~i~~  280 (403)
                               |...|||||.+.   +...|+.++||||||+++.||.+++.||... +..+++..+++
T Consensus       201 dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  201 DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence                     345699999984   2335899999999999999999999999654 55667766654

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=5.9e-32  Score=257.06  Aligned_cols=183  Identities=27%  Similarity=0.429  Sum_probs=157.4

Q ss_pred             CcccccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccccH------------HHHHHHHHhcC---CCCccccce
Q 015672           78 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK------------NRELQIMQMLD---HPNIVALKH  142 (403)
Q Consensus        78 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~E~~~l~~l~---h~niv~~~~  142 (403)
                      .++...|...+.||+|+||.|++|.++.....|+||.+.+++-..            -.|++||..|+   |+||+++++
T Consensus       557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd  636 (772)
T KOG1152|consen  557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD  636 (772)
T ss_pred             ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence            345567999999999999999999999999999999987654322            25999999997   999999999


Q ss_pred             EEeecCCCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC
Q 015672          143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN  222 (403)
Q Consensus       143 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~  222 (403)
                      +|     ++..++||+||--+.++ ++. .+...+..+.+.+++.|++||+.|+++||+ +||||||||-+|+.+++++.
T Consensus       637 fF-----Eddd~yyl~te~hg~gI-DLF-d~IE~kp~m~E~eAk~IFkQV~agi~hlh~-~~ivhrdikdenvivd~~g~  708 (772)
T KOG1152|consen  637 FF-----EDDDYYYLETEVHGEGI-DLF-DFIEFKPRMDEPEAKLIFKQVVAGIKHLHD-QGIVHRDIKDENVIVDSNGF  708 (772)
T ss_pred             ee-----ecCCeeEEEecCCCCCc-chh-hhhhccCccchHHHHHHHHHHHhccccccc-cCceecccccccEEEecCCe
Confidence            98     66777999999877542 222 233446789999999999999999999999 89999999999999998887


Q ss_pred             ce-----------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 015672          223 VS-----------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG  268 (403)
Q Consensus       223 ~~-----------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~  268 (403)
                      ++                 ++||..|.|||++-|..+.+..-|||++|++||.++....||+.
T Consensus       709 ~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  709 VKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             EEEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            64                 45899999999998888789999999999999999999999864

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.7e-31  Score=243.91  Aligned_cols=234  Identities=25%  Similarity=0.322  Sum_probs=169.4

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-cccHHHHHHHHH--hcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQ--MLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~--~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      +.++.+.||+|.||.||+|+++  |+.||||++... ...-.+|.+|.+  .|+|+||+.++..=.... .....+|||.
T Consensus       212 qI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~TQLwLvT  288 (513)
T KOG2052|consen  212 QIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWTQLWLVT  288 (513)
T ss_pred             eeEEEEEecCccccceeecccc--CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceEEEEEee
Confidence            4789999999999999999997  899999998643 333346666655  569999999877643332 4456799999


Q ss_pred             eccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc-------CCccccccccccceecCCCCc--------
Q 015672          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-------IGICHRDIKPQNLLVKGEPNV--------  223 (403)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~-------~~ivHrDlKp~NILl~~~~~~--------  223 (403)
                      +|.+ |+|.+++..     ..++.....+++..++.||+|||..       ..|.|||||..|||+..++.+        
T Consensus       289 dYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA  363 (513)
T KOG2052|consen  289 DYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  363 (513)
T ss_pred             ecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence            9998 899888765     5688888999999999999999951       349999999999999876654        


Q ss_pred             ---------------eeeccccccchhhhhCCCCC-----CchhHHHHHHHHHHHHHhC----------CCCCCCCC---
Q 015672          224 ---------------SYICSRYYRAPELIFGATEY-----TTAIDIWSTGCVMAELLLG----------QPLFPGES---  270 (403)
Q Consensus       224 ---------------~~~~t~~y~aPE~~~~~~~~-----~~~~DiwSlGvil~el~tg----------~~pf~~~~---  270 (403)
                                     ..+||..|||||++...-..     =..+||||||.++||++..          ++||.+.-   
T Consensus       364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D  443 (513)
T KOG2052|consen  364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD  443 (513)
T ss_pred             EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence                           24689999999999543221     1258999999999999863          47775432   


Q ss_pred             -cHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          271 -GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       271 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                       ..+.+.+++-.                  .++....+..|..   ...-..+..+++.||..||.-|.||-.+.+
T Consensus       444 Ps~eeMrkVVCv------------------~~~RP~ipnrW~s---~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  444 PSFEEMRKVVCV------------------QKLRPNIPNRWKS---DPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             CCHHHHhcceee------------------cccCCCCCccccc---CHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence             22222222111                  0111111222321   112245778999999999999999987764

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1e-29  Score=237.23  Aligned_cols=247  Identities=25%  Similarity=0.323  Sum_probs=170.5

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccc-ccccHHHHHHHHHh--cCCCCccccceEEeecCCCCceEEEEEe
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNRELQIMQM--LDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      ..++.++||+|.||.||+|...  ++.||||++.. ++.....|.+|...  ++|+||+++++.--..+ ....-++||+
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~eywLVt  287 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEYWLVT  287 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc--CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccceeEEe
Confidence            3678899999999999999875  69999999863 34455667766654  68999999876542222 2244578999


Q ss_pred             eccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CCccccccccccceecCCCCc-------
Q 015672          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC--------IGICHRDIKPQNLLVKGEPNV-------  223 (403)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~--------~~ivHrDlKp~NILl~~~~~~-------  223 (403)
                      +|.+ |+|.+++..     ..+++....+++..++.||+|||+.        ..|+|||||..||||.++..+       
T Consensus       288 ~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             eeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            9998 788888775     4588899999999999999999962        369999999999999877554       


Q ss_pred             --------------eeeccccccchhhhhCCCCCC-----chhHHHHHHHHHHHHHhCCCCCC-CCCcHHHHHHHHHHhC
Q 015672          224 --------------SYICSRYYRAPELIFGATEYT-----TAIDIWSTGCVMAELLLGQPLFP-GESGVDQLVEIIKVLG  283 (403)
Q Consensus       224 --------------~~~~t~~y~aPE~~~~~~~~~-----~~~DiwSlGvil~el~tg~~pf~-~~~~~~~~~~i~~~~~  283 (403)
                                    .-+||..|||||++.+...+.     .+.||||+|.+||||++....+. +....-++.--.+.-.
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence                          236899999999997765554     36899999999999998754442 2211111111111222


Q ss_pred             CCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 015672          284 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA  343 (403)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~  343 (403)
                      .|..+.+...-.  .....|.+ +..|..   ..-..-+.+.+..||..||+.|.||.=+
T Consensus       443 hPt~e~mq~~VV--~kK~RP~~-p~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  443 HPTLEEMQELVV--RKKQRPKI-PDAWRK---HAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             CCCHHHHHHHHH--hhccCCCC-hhhhhc---CccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence            344333321100  00011111 111221   1123568899999999999999998533

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-28  Score=249.28  Aligned_cols=227  Identities=25%  Similarity=0.383  Sum_probs=174.1

Q ss_pred             eeeceecccCceEEEEEEECC-------CCcEEEEEEcccc-----cccHHHHHHHHHhc-CCCCccccceEEeecCCCC
Q 015672           85 IAEHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        85 ~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  151 (403)
                      .+.+.||+|.||.|++|....       ....||||.++..     ......|+++|+.+ +|+||+.+++++..     
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~-----  373 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ-----  373 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc-----
Confidence            556699999999999997431       1457999988643     23445799999998 59999999998843     


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhh---hhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceec
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYS---RIH---------QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVK  218 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~---~~~---------~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~  218 (403)
                      ...+++|+|||. |+|..+++...   ...         ..+.......++.||+.|++||++ .++|||||-..|||+.
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~-~~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS-VPCVHRDLAARNVLIT  452 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh-CCccchhhhhhhEEec
Confidence            445889999998 78877776644   111         128888899999999999999999 8999999999999998


Q ss_pred             CCCCceee-----------------c-----cccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 015672          219 GEPNVSYI-----------------C-----SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQL  275 (403)
Q Consensus       219 ~~~~~~~~-----------------~-----t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~  275 (403)
                      .+..+++.                 +     ...|||||.+.. ..|+.++|||||||+|||+++ |..||++......+
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l  531 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL  531 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence            76444321                 1     123999999976 569999999999999999998 89999885523222


Q ss_pred             HHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          276 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       276 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      .+..+..                 ...          ..|..+++++.++++.||..+|++||++.++.+
T Consensus       532 ~~~l~~G-----------------~r~----------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  532 LEFLKEG-----------------NRM----------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHhcC-----------------CCC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            2222210                 000          123567999999999999999999999998875

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=8.7e-29  Score=243.61  Aligned_cols=223  Identities=25%  Similarity=0.330  Sum_probs=174.0

Q ss_pred             EeeeceecccCceEEEEEEECCCCc----EEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ....++||+|+||+||+|.+...|+    +||||++....     .....|+-+|..|+|||++++++++....      
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence            4566889999999999999876664    68999875432     23346889999999999999999885433      


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceeec------
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYIC------  227 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~~------  227 (403)
                      +.||++|++ |.|.++++..   ...+.......|..||++|+.|||. +++|||||-..|||+.....+++..      
T Consensus       772 ~qlvtq~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~-qrlVHrdLaaRNVLVksP~hvkitdfgla~l  847 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEE-QRLVHRDLAARNVLVKSPNHVKITDFGLAKL  847 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHh-cchhhhhhhhhheeecCCCeEEEEecchhhc
Confidence            568999999 6777766653   4678888899999999999999999 8999999999999998766654321      


Q ss_pred             ---------------cccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015672          228 ---------------SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       228 ---------------t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  291 (403)
                                     .+-|||=|.+.. ..|+.++|||||||++||++| |..|+.+....+.-..+..    ..     
T Consensus       848 l~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~----ge-----  917 (1177)
T KOG1025|consen  848 LAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK----GE-----  917 (1177)
T ss_pred             cCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc----cc-----
Confidence                           234888888754 469999999999999999998 9999988765443221111    10     


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                               .++          .+...+-++.-++.+||..|++.||++.++..
T Consensus       918 ---------RLs----------qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  918 ---------RLS----------QPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             ---------cCC----------CCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence                     011          12457889999999999999999999988753

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=5.4e-29  Score=263.46  Aligned_cols=189  Identities=16%  Similarity=0.186  Sum_probs=136.1

Q ss_pred             HhcCC-CCccccceEEeecC--CCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcc
Q 015672          130 QMLDH-PNIVALKHCFFSTT--DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC  206 (403)
Q Consensus       130 ~~l~h-~niv~~~~~~~~~~--~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~iv  206 (403)
                      +.++| .||+++++.|-...  ......++++|||++++|..++...   ...+++..++.++.||+.||.|||+ +|||
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~-~gIv  102 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHS-QGIV  102 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHh-CCee
Confidence            34555 57777777652211  1122347788999998888776532   3558999999999999999999999 8999


Q ss_pred             ccccccccceecCCCCc------------------------------------------------------eeecccccc
Q 015672          207 HRDIKPQNLLVKGEPNV------------------------------------------------------SYICSRYYR  232 (403)
Q Consensus       207 HrDlKp~NILl~~~~~~------------------------------------------------------~~~~t~~y~  232 (403)
                      ||||||+||||+..+.+                                                      ..+||++||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            99999999999531110                                                      124678899


Q ss_pred             chhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCccc
Q 015672          233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHK  312 (403)
Q Consensus       233 aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (403)
                      |||++.+. .|+.++|||||||+||||++|.+||....  ..+..+.... .++.                         
T Consensus       183 APE~~~~~-~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~~-------------------------  233 (793)
T PLN00181        183 SPEEDNGS-SSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPPQ-------------------------  233 (793)
T ss_pred             ChhhhccC-CCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cChh-------------------------
Confidence            99998765 48999999999999999999998875321  1111111110 0000                         


Q ss_pred             ccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          313 VFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       313 ~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                       . ....+...+++.+||+.||.+||++.|+++||||.+..
T Consensus       234 -~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~  272 (793)
T PLN00181        234 -I-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR  272 (793)
T ss_pred             -h-hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence             0 01134567899999999999999999999999998753

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=1.2e-26  Score=205.04  Aligned_cols=189  Identities=35%  Similarity=0.578  Sum_probs=158.6

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEcccccc-----cHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeeccC-
Q 015672           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-  163 (403)
Q Consensus        90 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-  163 (403)
                      ||+|++|.||++....+++.+++|++.....     ...+|+++++.++|++|+++++++..     ....++++|+++ 
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-----ENHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-----CCeEEEEEecCCC
Confidence            6899999999999988899999999876543     46789999999999999999988733     245889999999 


Q ss_pred             CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecC-CCCceee----------------
Q 015672          164 ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKG-EPNVSYI----------------  226 (403)
Q Consensus       164 ~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~-~~~~~~~----------------  226 (403)
                      +++..++....   ..++...+..++.+++.+|.+||+ .|++|+||+|.||+++. ++...++                
T Consensus        76 ~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~-~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~  151 (215)
T cd00180          76 GSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHS-NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK  151 (215)
T ss_pred             CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhh
Confidence            67766655421   357888999999999999999999 89999999999999998 5544322                


Q ss_pred             ---ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCC
Q 015672          227 ---CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  303 (403)
Q Consensus       227 ---~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  303 (403)
                         +...|++||.+.....++.+.|+|++|++++++                                            
T Consensus       152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------  187 (215)
T cd00180         152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------  187 (215)
T ss_pred             cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence               456799999985543578999999999999999                                            


Q ss_pred             CCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 015672          304 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  347 (403)
Q Consensus       304 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp  347 (403)
                                      ..+.+++.+||..||.+||++.++++|+
T Consensus       188 ----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ----------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                            1356899999999999999999999885

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=9.2e-29  Score=216.00  Aligned_cols=241  Identities=22%  Similarity=0.275  Sum_probs=175.8

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhc-CCCCccccceEEeecCCCCceEE
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      ....|.+.+.||+|.||.+.+|+++.++..+++|.+.+..   ..+.+|...--.| .|.||+..|++-+...+    +.
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d----~Y   97 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD----AY   97 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc----eE
Confidence            4456999999999999999999999999999999886542   3445666554445 58999998887655433    57


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC--Cceee------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP--NVSYI------  226 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~--~~~~~------  226 (403)
                      ++++||++ |+|.....     ..++.+...++++.|++.||.|||+ +++||||||.+||||-...  .++.+      
T Consensus        98 vF~qE~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHs-knlVHRdlK~eNiLif~~df~rvKlcDFG~t~  171 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHS-KNLVHRDLKAENILIFDADFYRVKLCDFGLTR  171 (378)
T ss_pred             EEeeccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhc-cchhhcccccceEEEecCCccEEEeeeccccc
Confidence            79999999 55533222     2567888899999999999999999 8999999999999985332  22222      


Q ss_pred             --c--------cccccchhhhhCC----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHHh
Q 015672          227 --C--------SRYYRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       227 --~--------t~~y~aPE~~~~~----~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~  291 (403)
                        |        +..|.|||++...    -...+.+|||.||+++|.++||.+||+...-. ....+..+.++.....   
T Consensus       172 k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~---  248 (378)
T KOG1345|consen  172 KVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPA---  248 (378)
T ss_pred             ccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCcc---
Confidence              2        3459999987422    12567899999999999999999999754322 2233333332221110   


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCCCcccC
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR---CTALEACVHPFFDEL  352 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R---pta~e~l~hp~f~~~  352 (403)
                                .|        . .-..+++.+..+.++-|..+|++|   -++..-...-|....
T Consensus       249 ----------~P--------~-~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~  293 (378)
T KOG1345|consen  249 ----------LP--------K-KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL  293 (378)
T ss_pred             ----------Cc--------h-hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence                      00        0 114578999999999999999999   677777777787643

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.95  E-value=2.4e-27  Score=216.56  Aligned_cols=232  Identities=18%  Similarity=0.259  Sum_probs=175.2

Q ss_pred             ccccEeeeceecccCceEEEEEEECCC-----CcEEEEEEcccccccH-----HHHHHHHHhcCCCCccccceEEeecCC
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKHCFFSTTD  149 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~-----~~E~~~l~~l~h~niv~~~~~~~~~~~  149 (403)
                      .+.++++...+-+|.||.||.|.++..     .+.|-+|.++......     ..|...+..+.|||+..+.++..... 
T Consensus       282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~-  360 (563)
T KOG1024|consen  282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY-  360 (563)
T ss_pred             hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc-
Confidence            344588889999999999999976542     2446667665443322     25777777889999999988875422 


Q ss_pred             CCceEEEEEeeccC-CcHHHHHHHhhh----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce
Q 015672          150 KEELYLNLVLEYVP-ETVNRIARNYSR----IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS  224 (403)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~----~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~  224 (403)
                         ...+.++.+.+ ++|..++.....    ..+.+...+...++.|++.|++|||+ .||||.||...|.+|++.-.++
T Consensus       361 ---~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~-~~ViHkDiAaRNCvIdd~LqVk  436 (563)
T KOG1024|consen  361 ---ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN-HGVIHKDIAARNCVIDDQLQVK  436 (563)
T ss_pred             ---CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh-cCcccchhhhhcceehhheeEE
Confidence               23556777777 778777763321    12345666777889999999999999 8999999999999998765554


Q ss_pred             eec---------------------cccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHh
Q 015672          225 YIC---------------------SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVL  282 (403)
Q Consensus       225 ~~~---------------------t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~  282 (403)
                      ...                     ...||+||.+.+. .|+.++|+|||||+||||+| |+.|+..-+..+....+... 
T Consensus       437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~-~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG-  514 (563)
T KOG1024|consen  437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS-HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG-  514 (563)
T ss_pred             eccchhccccCcccccccCCCCCCcccccCHHHHhhh-hhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc-
Confidence            432                     2359999999654 59999999999999999998 99999888877765544431 


Q ss_pred             CCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          283 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                       +.+.          .|-++++++..++.-||..+|++||+.+|+..
T Consensus       515 -----------------yRla----------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  515 -----------------YRLA----------QPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             -----------------ceec----------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence                             1111          13578999999999999999999999999864

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=2.7e-25  Score=199.32  Aligned_cols=179  Identities=36%  Similarity=0.597  Sum_probs=146.6

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEcccc-----cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      |.+.+.||.|++|.||++....+++.+|+|.+...     .....+|++.++.++|+|++++++.+..     ....+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-----PEPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-----CCceEEE
Confidence            56778999999999999999888999999998653     2344579999999999999999988733     2348899


Q ss_pred             eeccCC-cHHHHHHHhhhhcCC-CCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce------------
Q 015672          159 LEYVPE-TVNRIARNYSRIHQR-MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS------------  224 (403)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~-l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~------------  224 (403)
                      +|++++ +|..++...    .. +++..+..++.|++.+|.|||+ .+++|+||+|.||+++.++.+.            
T Consensus        76 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~  150 (225)
T smart00221       76 MEYCEGGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHS-LGIVHRDLKPENILLGMDGLVKLADFGLARFIHR  150 (225)
T ss_pred             EeccCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecC
Confidence            999986 776665542    23 7888899999999999999999 7999999999999998654432            


Q ss_pred             --------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCC-CCcH
Q 015672          225 --------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG-ESGV  272 (403)
Q Consensus       225 --------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~-~~~~  272 (403)
                              ..++..|++||.+.+...++.++|||+||+++|+|++|+.||.. .+..
T Consensus       151 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~  207 (225)
T smart00221      151 DLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT  207 (225)
T ss_pred             cccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence                    23455699999874344578899999999999999999999977 4444

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.93  E-value=2.5e-26  Score=199.03  Aligned_cols=155  Identities=20%  Similarity=0.171  Sum_probs=113.6

Q ss_pred             CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------------eccccc
Q 015672          164 ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------------ICSRYY  231 (403)
Q Consensus       164 ~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------------~~t~~y  231 (403)
                      |+|.+++...   +..+++..++.++.||+.||.|||+ .+      ||+|||++.++.++.            .||+.|
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~-~~------kp~Nil~~~~~~~~~fG~~~~~~~~~~~g~~~y   70 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHR-QA------KSGNILLTWDGLLKLDGSVAFKTPEQSRVDPYF   70 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh-cC------CcccEeEcCccceeeccceEeeccccCCCcccc
Confidence            3555555432   3569999999999999999999998 66      999999987665432            468899


Q ss_pred             cchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCc
Q 015672          232 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPW  310 (403)
Q Consensus       232 ~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (403)
                      +|||++.+. .++.++|||||||++|||++|+.||........ +..+........                +..  .+ 
T Consensus        71 ~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------------~~~--~~-  130 (176)
T smart00750       71 MAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD----------------PRD--RS-  130 (176)
T ss_pred             cChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC----------------ccc--cc-
Confidence            999999654 589999999999999999999999976543322 222222110000                000  00 


Q ss_pred             ccccccCCCH--HHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          311 HKVFQKRLPP--EAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       311 ~~~~~~~~s~--~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                         .+..++.  ++.+||.+||..||.+|||+.++++|+|+..
T Consensus       131 ---~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      131 ---NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             ---cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence               0012333  6999999999999999999999999999753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=9.4e-26  Score=227.98  Aligned_cols=238  Identities=23%  Similarity=0.338  Sum_probs=171.4

Q ss_pred             eeeceecccCceEEEEEEECCCCcEEEEEEcc----ccccc------HHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRY------KNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        85 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~----~~~~~------~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ....++|.|++|.|+.+......+.++.|...    .....      ...|+.+-..|.|+|++.....++....     
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-----  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-----  395 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-----
Confidence            35678999999988888877766666666543    11100      1245666677899999877665532221     


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce----------
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS----------  224 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~----------  224 (403)
                      ..-+||||+.+|..++..    ...+....+..++.|++.||+|||. .||.||||||+|+++...+.++          
T Consensus       396 ~~~~mE~~~~Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~-~GiahrdlK~enll~~~~g~lki~Dfg~~~vf  470 (601)
T KOG0590|consen  396 ILQSMEYCPYDLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHS-MGLAHRDLKLENLLVTENGILKIIDFGAASVF  470 (601)
T ss_pred             chhhhhcccHHHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHh-cCceeccCccccEEEecCCceEEeecCcceee
Confidence            223399999855444432    2467888899999999999999999 8999999999999998765443          


Q ss_pred             -------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHH-HHHHHhCCCCHHHH
Q 015672          225 -------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV-EIIKVLGTPTREEI  290 (403)
Q Consensus       225 -------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~-~i~~~~~~~~~~~~  290 (403)
                                   ++|+..|+|||++.+..+....+||||.|++++.|.+|+.||......+... ...           
T Consensus       471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~-----------  539 (601)
T KOG0590|consen  471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN-----------  539 (601)
T ss_pred             ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc-----------
Confidence                         3578889999999877766778999999999999999999996544332211 000           


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                           ....++.   ...++  .+...++.+.+.+|.+||++||.+|.|+++|++.+||+.+.
T Consensus       540 -----~~~~~~~---~~~~~--~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  540 -----YSDQRNI---FEGPN--RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             -----ccccccc---ccChH--HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence                 0000000   00111  12245788999999999999999999999999999999874

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.89  E-value=1.3e-23  Score=213.19  Aligned_cols=208  Identities=27%  Similarity=0.485  Sum_probs=154.9

Q ss_pred             cccccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        79 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      ....+|..++.|..|+||.||+++++.+.+.+|+| +.++.....+   ++.....|.+                    |
T Consensus        80 p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn---ilt~a~npfv--------------------v  135 (1205)
T KOG0606|consen   80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN---ILTFAGNPFV--------------------V  135 (1205)
T ss_pred             CCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc---cccccCCcce--------------------e
Confidence            34567999999999999999999999999999995 4433322111   2222222222                    2


Q ss_pred             eeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc---------------
Q 015672          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV---------------  223 (403)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~---------------  223 (403)
                           |+-..++..    -+.++.        +++.+++|||+ .||+|||+||+|.||+.-+++               
T Consensus       136 -----gDc~tllk~----~g~lPv--------dmvla~Eylh~-ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 -----GDCATLLKN----IGPLPV--------DMVLAVEYLHS-YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             -----chhhhhccc----CCCCcc--------hhhHHhHhhcc-CCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence                 211122222    234443        34789999998 899999999999999754443               


Q ss_pred             -------------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 015672          224 -------------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  284 (403)
Q Consensus       224 -------------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~  284 (403)
                                         ..+|||.|+|||++... .|+..+|+|++|+|+||++.|..||.++...+.+...+.....
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq-gygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~  276 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE  276 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhhh-ccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence                               23689999999999754 5999999999999999999999999999988888776653222


Q ss_pred             CCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCCCcccCCCC
Q 015672          285 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC---TALEACVHPFFDELRDP  355 (403)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---ta~e~l~hp~f~~~~~~  355 (403)
                      .+++                          ...++++++++|.++|+.+|..|.   .+.++.+|+||+.+.+.
T Consensus       277 wpE~--------------------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  277 WPEE--------------------------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             cccc--------------------------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            1111                          245789999999999999999997   57788999999988654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=5.7e-22  Score=170.91  Aligned_cols=184  Identities=23%  Similarity=0.301  Sum_probs=145.8

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc--cccHHHHHHHHHhcCC-CCccccceEEeecCCCCceEEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      .+|.++++||+|+||.+|+|....+|..||||+-...  ......|..+.+.|++ ..|..+..+.     .+..|-.+|
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~ynvlV   89 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYNVLV   89 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----cccccceee
Confidence            3599999999999999999999999999999976543  2344579999999976 4555555444     556667899


Q ss_pred             eeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc---------------
Q 015672          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV---------------  223 (403)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~---------------  223 (403)
                      |++++.+|.+++...   ...++...+..++-|++.-++|+|. +++|||||||+|.|+.-...+               
T Consensus        90 MdLLGPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~-r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   90 MDLLGPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHL-RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eeccCccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHh-hccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            999999998876543   4678899999999999999999998 899999999999998533221               


Q ss_pred             --------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHH
Q 015672          224 --------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL  275 (403)
Q Consensus       224 --------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~  275 (403)
                                    ...||..|.+--...+. .-+..-|+=|+|.+|.++..|..||++-......
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~-eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~  230 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGI-EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK  230 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhh-hhhhhhhhhhhcceeeeeecCCCcccccchhhHH
Confidence                          34577778776554433 2567889999999999999999999987654433

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=8.6e-21  Score=178.58  Aligned_cols=241  Identities=33%  Similarity=0.508  Sum_probs=176.6

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCC-CccccceEEeecCCCCceEE
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHP-NIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~  155 (403)
                      |.+.+.||.|+||.||++.+.   ..+|+|.+....       ....+|+.++..+.|+ +|+++++.+..     ....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD-----EGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec-----CCEE
Confidence            778899999999999999986   788999885432       2345789999999988 79999988722     2227


Q ss_pred             EEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC------------
Q 015672          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN------------  222 (403)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~------------  222 (403)
                      +++++++.+ .+..+....... ..+....+..++.|++.++.|+|+ .+++|||+||+||+++....            
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~-~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~  151 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHS-KGIIHRDIKPENILLDRDGRVVKLIDFGLAKL  151 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence            899999985 443232221100 268889999999999999999999 89999999999999975541            


Q ss_pred             --------------ceeeccccccchhhhhCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhC
Q 015672          223 --------------VSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLG  283 (403)
Q Consensus       223 --------------~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlGvil~el~tg~~pf~~~~~---~~~~~~i~~~~~  283 (403)
                                    ....+|..|+|||.+.+.  ..+....|+||+|++++++++|..||.....   ............
T Consensus       152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  231 (384)
T COG0515         152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP  231 (384)
T ss_pred             cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence                          233567889999999663  4688999999999999999999999877664   333333333222


Q ss_pred             CCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          284 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                      .+.             .....      ...........+.+++.+++..+|..|.+..+...++|.....
T Consensus       232 ~~~-------------~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~  282 (384)
T COG0515         232 TPS-------------LASPL------SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK  282 (384)
T ss_pred             Ccc-------------ccccc------CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence            110             00000      0000011236789999999999999999999999987766543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2.2e-23  Score=202.07  Aligned_cols=222  Identities=28%  Similarity=0.430  Sum_probs=171.9

Q ss_pred             eecccCceEEEEEEE---CCCCcEEEEEEcccc------cccHHHHHHHHHhcC-CCCccccceEEeecCCCCceEEEEE
Q 015672           89 VVGTGSFGVVFQAKC---RETGEIVAIKKVLQD------KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        89 ~lG~G~~g~V~~~~~---~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      ++|+|+||.|++++.   ...+..+|+|+..+.      +.....|..++...+ ||.+|+++..|.+...     ++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~k-----l~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGK-----LYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccc-----hhHh
Confidence            479999999998753   345778999977432      112335888888887 9999999888744333     7889


Q ss_pred             eeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------------
Q 015672          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------------  224 (403)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------------  224 (403)
                      +++..+..  +.. .......+.+...+.+...++.|++++|+ .+|+|||+|++||+++.+|.++              
T Consensus        76 ld~~rgg~--lft-~l~~~~~f~~~~~~~~~aelaLald~lh~-l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~  151 (612)
T KOG0603|consen   76 LDFLRGGD--LFT-RLSKEVMFDELDVAFYLAELALALDHLHK-LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK  151 (612)
T ss_pred             hhhcccch--hhh-ccccCCchHHHHHHHHHHHHHHHHhhcch-hHHHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence            99987522  111 12223557777888888999999999999 8999999999999999888652              


Q ss_pred             -eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCC
Q 015672          225 -YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  303 (403)
Q Consensus       225 -~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  303 (403)
                       .+||..|||||++.   ....++|.||||+++|+|+||..||.+    +....|.+.-                 ..  
T Consensus       152 ~~cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~-----------------~~--  205 (612)
T KOG0603|consen  152 IACGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE-----------------LE--  205 (612)
T ss_pred             hcccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc-----------------cC--
Confidence             26799999999985   367899999999999999999999987    4444444310                 01  


Q ss_pred             CCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCcccCCCC
Q 015672          304 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRDP  355 (403)
Q Consensus       304 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~e~l~hp~f~~~~~~  355 (403)
                                .+..++..+.+++..++..+|..|..     +.++++|+||+.+.+.
T Consensus       206 ----------~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  206 ----------MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             ----------CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence                      23567889999999999999999985     4799999999988654

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2.1e-22  Score=184.89  Aligned_cols=188  Identities=22%  Similarity=0.328  Sum_probs=133.7

Q ss_pred             CCCCccccceEEeecC----------------------CCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHH
Q 015672          133 DHPNIVALKHCFFSTT----------------------DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY  190 (403)
Q Consensus       133 ~h~niv~~~~~~~~~~----------------------~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~  190 (403)
                      +|||||++...|....                      -.....+|+||.-++.+|..++..     ...+......++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-----CCCchHHHHHHHH
Confidence            6999999988874321                      123446899999888888776654     4456667778889


Q ss_pred             HHHHHHHHHHhcCCccccccccccceecCCC-----------------------------CceeeccccccchhhhhCCC
Q 015672          191 QICRALAYIHNCIGICHRDIKPQNLLVKGEP-----------------------------NVSYICSRYYRAPELIFGAT  241 (403)
Q Consensus       191 qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~-----------------------------~~~~~~t~~y~aPE~~~~~~  241 (403)
                      |+++|+.|||. +||.|||+|.+|||+.-+.                             .+...|.-.-||||+....+
T Consensus       349 QlLEav~hL~~-hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  349 QLLEAVTHLHK-HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHHH-ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            99999999999 8999999999999984221                             11223556689999875432


Q ss_pred             C-----CCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCccccccc
Q 015672          242 E-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK  316 (403)
Q Consensus       242 ~-----~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (403)
                      .     .-.++|.|+.|.+.||+++...||++..+...-.                  ..|.+-++|.         ++.
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~------------------r~Yqe~qLPa---------lp~  480 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT------------------RTYQESQLPA---------LPS  480 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchheech------------------hhhhhhhCCC---------Ccc
Confidence            1     1248999999999999999999998744221100                  0112222222         346


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCH---HHHhc------CCCcccCC
Q 015672          317 RLPPEAVDLVCRFFQYSPNLRCTA---LEACV------HPFFDELR  353 (403)
Q Consensus       317 ~~s~~~~~li~~~L~~dP~~Rpta---~e~l~------hp~f~~~~  353 (403)
                      .+++.+++|+..+|+.||.+|+++   +.+|+      |.|++...
T Consensus       481 ~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~vka~~  526 (598)
T KOG4158|consen  481 RVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGEDVKAMM  526 (598)
T ss_pred             cCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCchHHHHhc
Confidence            789999999999999999999984   45554      55555543

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=1.1e-20  Score=179.61  Aligned_cols=232  Identities=19%  Similarity=0.167  Sum_probs=173.0

Q ss_pred             cEeeeceecccCceEEEEEEECCCC-cEEEEEEccccc----ccHHHHHHHHHhcCC----CCccccceEEeecCCCCce
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDK----RYKNRELQIMQMLDH----PNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~~~~~~----~~~~~E~~~l~~l~h----~niv~~~~~~~~~~~~~~~  153 (403)
                      .|.+.+.||+|+||.||+|.+..++ ..+|+|......    .....|+.++..+..    .++..+++...    ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            5999999999999999999987764 678898765421    145679999999973    56777665541    3455


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC----C-------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP----N-------  222 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~----~-------  222 (403)
                      +-++||+.++.+|.++.....  .+.++...+..++.|++.+|++||+ .|++||||||+|+++....    .       
T Consensus        95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~-~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS-KGFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh-cCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            678999999999988776544  5789999999999999999999999 8999999999999986432    0       


Q ss_pred             -----------------------ceeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 015672          223 -----------------------VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII  279 (403)
Q Consensus       223 -----------------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~  279 (403)
                                             ..+.||..|+++.+-.+. ..+.+.|+||++.++.+++.|..||.+...........
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI-EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC-ccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence                                   012378889999987654 47899999999999999999999997765443333322


Q ss_pred             HHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          280 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      +......               ...         .....+.++.++...+-..+...+|....+...
T Consensus       251 ~~~~~~~---------------~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  251 KDPRKLL---------------TDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             HHhhhhc---------------ccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            2110000               000         112345677788877777899999988777654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.86  E-value=1.6e-21  Score=178.09  Aligned_cols=221  Identities=23%  Similarity=0.309  Sum_probs=133.8

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccccccH-------HHHHHHHHhcC----------CCCccccceEEe
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLD----------HPNIVALKHCFF  145 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~E~~~l~~l~----------h~niv~~~~~~~  145 (403)
                      .+...+.||.|+++.||.+++..|++.+|+|+........       ++|.-....+.          |-.++.-++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4778899999999999999999999999999874322221       12221111111          111111122211


Q ss_pred             --------ecCCC-Cce---EEEEEeeccCCcHHHHHHHhhhhcCC---CCHHHHHHHHHHHHHHHHHHHhcCCcccccc
Q 015672          146 --------STTDK-EEL---YLNLVLEYVPETVNRIARNYSRIHQR---MPLIYVKLYTYQICRALAYIHNCIGICHRDI  210 (403)
Q Consensus       146 --------~~~~~-~~~---~~~lv~e~~~~~l~~~~~~~~~~~~~---l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDl  210 (403)
                              ..... ...   ..+++|+-+.++|..+..........   +....-..+..|++..+++||+ .||||+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS-YGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-cceEeccc
Confidence                    11111 111   24678888888888876543332222   1122223445899999999999 89999999


Q ss_pred             ccccceecCCCCceee----------------ccccccchhhhhCC-------CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 015672          211 KPQNLLVKGEPNVSYI----------------CSRYYRAPELIFGA-------TEYTTAIDIWSTGCVMAELLLGQPLFP  267 (403)
Q Consensus       211 Kp~NILl~~~~~~~~~----------------~t~~y~aPE~~~~~-------~~~~~~~DiwSlGvil~el~tg~~pf~  267 (403)
                      ||+|++++.+|.+...                .+..|.+||.....       ..++.+.|.|+||+++|.|++|..||.
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~  251 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFG  251 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STC
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCC
Confidence            9999999988776332                24569999987432       237889999999999999999999997


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCC
Q 015672          268 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR  337 (403)
Q Consensus       268 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R  337 (403)
                      ........                       ..        .|. .. .++++.+++||.++|++||.+|
T Consensus       252 ~~~~~~~~-----------------------~~--------~f~-~C-~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  252 LSSPEADP-----------------------EW--------DFS-RC-RDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             CCGGGSTS-----------------------GG--------GGT-TS-S---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCccccc-----------------------cc--------cch-hc-CCcCHHHHHHHHHHccCCcccC
Confidence            54321000                       00        010 01 2578999999999999999988

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=3.4e-21  Score=183.33  Aligned_cols=150  Identities=19%  Similarity=0.278  Sum_probs=108.3

Q ss_pred             ccEeeeceecccCceEEEEEEECC-CCcEEEEEEcccc---------cccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      ..|.+.+.||+|+||+||+|+++. +++.+|||++...         ...+.+|+++|+.++|+||+..+..+   .   
T Consensus        18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~---   91 (365)
T PRK09188         18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G---   91 (365)
T ss_pred             CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C---
Confidence            349999999999999999999876 6778899986422         12356899999999999998533221   1   


Q ss_pred             ceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccc-ccccceecCCCCcee-----
Q 015672          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDI-KPQNLLVKGEPNVSY-----  225 (403)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDl-Kp~NILl~~~~~~~~-----  225 (403)
                        ..++||||++|......       ....   ...++.|++.||.|||+ .||+|||| ||+|||++.++.+++     
T Consensus        92 --~~~LVmE~~~G~~L~~~-------~~~~---~~~~~~~i~~aL~~lH~-~gIiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         92 --KDGLVRGWTEGVPLHLA-------RPHG---DPAWFRSAHRALRDLHR-AGITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             --CcEEEEEccCCCCHHHh-------Cccc---hHHHHHHHHHHHHHHHH-CCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence              26899999986322211       1111   14567899999999999 89999999 999999976655432     


Q ss_pred             ----------------------eccccccchhhhhCC-----CCCCchhHHH
Q 015672          226 ----------------------ICSRYYRAPELIFGA-----TEYTTAIDIW  250 (403)
Q Consensus       226 ----------------------~~t~~y~aPE~~~~~-----~~~~~~~Diw  250 (403)
                                            .+++.|+|||.+...     ...+...|-|
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence                                  245668999987322     1233456777

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=3.5e-20  Score=166.78  Aligned_cols=178  Identities=24%  Similarity=0.297  Sum_probs=145.3

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccc--cccHHHHHHHHHhcC-CCCccccceEEeecCCCCceEEEEEe
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      .|.++++||+|+||++|+|++.-+++.||||.-...  ......|....+.|. .++|..+|.+-     ..+.|-.|||
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~NiLVi  103 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYNILVI  103 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec-----cccchhhhhh
Confidence            499999999999999999999999999999965332  334457899888885 47787765322     5566677999


Q ss_pred             eccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc----------------
Q 015672          160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV----------------  223 (403)
Q Consensus       160 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~----------------  223 (403)
                      |+++.+|.++++.   .+++++...+..++.|++.-++|+|+ +.+|.|||||+|.||...+.-                
T Consensus       104 dLLGPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~-k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  104 DLLGPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHE-KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             hhhCcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHh-cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            9999999888764   35789999999999999999999999 899999999999999643221                


Q ss_pred             ---------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015672          224 ---------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES  270 (403)
Q Consensus       224 ---------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~  270 (403)
                                     ++.||..||+=-.-++.. -+..-|+=|||-++++++.|..||.|-.
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCcccccc
Confidence                           334777888866655543 6778999999999999999999998753

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.84  E-value=1.4e-21  Score=198.64  Aligned_cols=223  Identities=27%  Similarity=0.401  Sum_probs=152.6

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc-----cH---HHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YK---NRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~---~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      .|...+.||++.|=+|.+|++. .|. |+||++.+...     ..   .+|++ ...++|||.+.+....     .....
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence            4888899999999999999985 344 88998854331     11   23444 5667999999876543     22223


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC------------
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN------------  222 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~------------  222 (403)
                      .|||=+|+..+|++-+..    ..-+...+.+-|+.||+.||.-+|. .||+|+|||.|||||+.=+-            
T Consensus        96 AylvRqyvkhnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~-~gVcHGDIKsENILiTSWNW~~LtDFAsFKPt  170 (1431)
T KOG1240|consen   96 AYLVRQYVKHNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHK-LGVCHGDIKSENILITSWNWLYLTDFASFKPT  170 (1431)
T ss_pred             HHHHHHHHhhhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHH-cCccccccccceEEEeeechhhhhcccccCCc
Confidence            556777777666554432    2335666778889999999999999 89999999999999963110            


Q ss_pred             ----------ceeecc----ccccchhhhhCCC----------CCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 015672          223 ----------VSYICS----RYYRAPELIFGAT----------EYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVE  277 (403)
Q Consensus       223 ----------~~~~~t----~~y~aPE~~~~~~----------~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~  277 (403)
                                .-+..|    ..|.|||-+....          ..+++-||||+||+++||++ |++||.    ..++..
T Consensus       171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~a  246 (1431)
T KOG1240|consen  171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLA  246 (1431)
T ss_pred             cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHh
Confidence                      011222    2599999885421          15678999999999999987 799993    222222


Q ss_pred             HHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          278 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       278 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      ....- ....+..                       +..--+..++.||..|++.||.+|.+|++.|+-
T Consensus       247 Yr~~~-~~~~e~~-----------------------Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  247 YRSGN-ADDPEQL-----------------------LEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HhccC-ccCHHHH-----------------------HHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            21110 1111100                       001124578999999999999999999999975

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.83  E-value=7.6e-21  Score=166.70  Aligned_cols=225  Identities=15%  Similarity=0.186  Sum_probs=168.9

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEccc------ccccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      ..+.-+|.+...|..|+|++.  |..+++|++..      ..+.++.|.-.|+.+.||||..+++.+-     ....+.+
T Consensus       192 lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacn-----sppnlv~  264 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACN-----SPPNLVI  264 (448)
T ss_pred             hhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhcc-----CCCCceE
Confidence            445667899999999999986  55566776632      2345667888899999999999999983     3345889


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccc-cccccccceecCCCCce-----------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH-RDIKPQNLLVKGEPNVS-----------  224 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH-rDlKp~NILl~~~~~~~-----------  224 (403)
                      +..|++ ++|..++....  ..-....++.+++.+|+.|+.|||+-..++- --|....++|+.+-..+           
T Consensus       265 isq~mp~gslynvlhe~t--~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq  342 (448)
T KOG0195|consen  265 ISQYMPFGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ  342 (448)
T ss_pred             eeeeccchHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee
Confidence            999999 77877765432  2235667888999999999999998323443 36778889998764322           


Q ss_pred             ---eeccccccchhhhhCCCCC--CchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 015672          225 ---YICSRYYRAPELIFGATEY--TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  299 (403)
Q Consensus       225 ---~~~t~~y~aPE~~~~~~~~--~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  299 (403)
                         ..-.|.||+||.+...+..  -.++|+|||.+++||+.|...||..-...+.-.+|.-.                  
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale------------------  404 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE------------------  404 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc------------------
Confidence               1247889999999654432  35899999999999999999999887776655444321                  


Q ss_pred             cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 015672          300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  344 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l  344 (403)
                               .+...+++.++..+..|+.-|+.-||.+||.++.++
T Consensus       405 ---------glrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  405 ---------GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             ---------cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence                     112224567899999999999999999999987664

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.80  E-value=1.4e-19  Score=160.63  Aligned_cols=163  Identities=13%  Similarity=0.104  Sum_probs=116.4

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----cc---------HHHHHHHHHhcCCCCccccceEEeecC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RY---------KNRELQIMQMLDHPNIVALKHCFFSTT  148 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~---------~~~E~~~l~~l~h~niv~~~~~~~~~~  148 (403)
                      .+|.+.++||.|+||.||++..  ++..+|||++....    ..         ..+|++.+.++.|++|..+.+++....
T Consensus        31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            4599999999999999999765  46689999985321    11         457888999999999999988765322


Q ss_pred             CC---CceEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce
Q 015672          149 DK---EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS  224 (403)
Q Consensus       149 ~~---~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~  224 (403)
                      ..   .....+|+|||++| +|.++.        .+++    ....+++.+|..||+ .|++|||+||+||+++.++ +.
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~-~gi~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQ-HGMVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHH-cCCccCCCChHHEEEeCCC-EE
Confidence            11   12347899999997 443331        1222    235699999999999 8999999999999998877 65


Q ss_pred             eecc---cccc---chhhhhCCCCCCchhHHHHHHHHHHHHH
Q 015672          225 YICS---RYYR---APELIFGATEYTTAIDIWSTGCVMAELL  260 (403)
Q Consensus       225 ~~~t---~~y~---aPE~~~~~~~~~~~~DiwSlGvil~el~  260 (403)
                      ++..   ..+.   |-+.+.-...|+.++|+||||+++..+.
T Consensus       175 liDfg~~~~~~e~~a~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        175 IIDLSGKRCTAQRKAKDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEECCCcccccchhhHHHHHHHhHhcccccccceeEeehHHH
Confidence            5432   2221   1222222334778999999999877653

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.79  E-value=3.3e-19  Score=156.05  Aligned_cols=127  Identities=18%  Similarity=0.224  Sum_probs=93.6

Q ss_pred             eceecccCceEEEEEEECCCCcEEEEEEcccccc------------------------------cHHHHHHHHHhcCCCC
Q 015672           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------------------------------YKNRELQIMQMLDHPN  136 (403)
Q Consensus        87 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------------------~~~~E~~~l~~l~h~n  136 (403)
                      ...||+|+||.||+|.+. +|+.||||+++....                              ...+|++++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999986 899999999854311                              1124999999998888


Q ss_pred             ccccceEEeecCCCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHH-HhcCCccccccccccc
Q 015672          137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI-HNCIGICHRDIKPQNL  215 (403)
Q Consensus       137 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~L-H~~~~ivHrDlKp~NI  215 (403)
                      +.......  ..   .  .+|||||+++.......   .....++...+..++.|++.+|.|+ |+ .||+||||||+||
T Consensus        81 v~~p~~~~--~~---~--~~iVmE~i~g~~l~~~~---~~~~~~~~~~~~~i~~qi~~~L~~l~H~-~giiHrDlkP~NI  149 (190)
T cd05147          81 IPCPEPIL--LK---S--HVLVMEFIGDDGWAAPR---LKDAPLSESKARELYLQVIQIMRILYQD-CRLVHADLSEYNL  149 (190)
T ss_pred             CCCCcEEE--ec---C--CEEEEEEeCCCCCcchh---hhcCCCCHHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHE
Confidence            75433221  11   1  26999999964211110   1135688889999999999999999 67 7999999999999


Q ss_pred             eecCCCCceee
Q 015672          216 LVKGEPNVSYI  226 (403)
Q Consensus       216 Ll~~~~~~~~~  226 (403)
                      |++. +.+.++
T Consensus       150 li~~-~~v~Li  159 (190)
T cd05147         150 LYHD-GKLYII  159 (190)
T ss_pred             EEEC-CcEEEE
Confidence            9984 445443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10345 hypothetical protein; Provisional

Probab=99.76  E-value=5.3e-18  Score=149.99  Aligned_cols=122  Identities=20%  Similarity=0.259  Sum_probs=92.3

Q ss_pred             eeceecccCceEEEEEEECCCCcEEEEEEcccc----cccHHHHHHHHHhc-----CCCCccccceEEeecCCCCceEEE
Q 015672           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQML-----DHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        86 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      -.+.||+|+||.||.  +..++.. +||++...    .....+|+.+++.+     .||||+++++++.+... .+..+.
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g-~g~v~~   81 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG-TGYVYD   81 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC-CeEEEE
Confidence            347799999999995  6666666 69987643    33456899999999     67999999998855321 223345


Q ss_pred             EEeeccC---CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHH-HHHHhcCCccccccccccceecC
Q 015672          157 LVLEYVP---ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL-AYIHNCIGICHRDIKPQNLLVKG  219 (403)
Q Consensus       157 lv~e~~~---~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L-~~LH~~~~ivHrDlKp~NILl~~  219 (403)
                      +||||++   ++|.+++..     ..+++.  ..++.|++.++ +|||+ ++||||||||+|||++.
T Consensus        82 ~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~-~~IvhrDlKp~NILl~~  140 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLD-NRIVTMELKPQNILCQR  140 (210)
T ss_pred             EEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEec
Confidence            8999955   577777653     235544  35577888888 89999 89999999999999974

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.75  E-value=5.7e-18  Score=148.54  Aligned_cols=126  Identities=17%  Similarity=0.236  Sum_probs=95.2

Q ss_pred             eceecccCceEEEEEEECCCCcEEEEEEcccccc------------------------------cHHHHHHHHHhcCCCC
Q 015672           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------------------------------YKNRELQIMQMLDHPN  136 (403)
Q Consensus        87 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------------------~~~~E~~~l~~l~h~n  136 (403)
                      ...||+|+||.||+|++. +|+.||||++.....                              ...+|.+.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            467999999999999987 899999999864311                              1236889999999998


Q ss_pred             ccccceEEeecCCCCceEEEEEeeccCCc-HH-HHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccccc
Q 015672          137 IVALKHCFFSTTDKEELYLNLVLEYVPET-VN-RIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (403)
Q Consensus       137 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~-~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~N  214 (403)
                      |.....+...   .    .+|||||+++. +. ..+.     ...++...+..++.|++.+|.+||+..||+||||||+|
T Consensus        81 i~~p~~~~~~---~----~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~N  148 (190)
T cd05145          81 VPVPEPILLK---K----NVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYN  148 (190)
T ss_pred             CCCceEEEec---C----CEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhh
Confidence            8554433311   1    36999999874 21 1121     24577788899999999999999973599999999999


Q ss_pred             ceecCCCCceee
Q 015672          215 LLVKGEPNVSYI  226 (403)
Q Consensus       215 ILl~~~~~~~~~  226 (403)
                      ||++ ++.+.++
T Consensus       149 Ill~-~~~~~li  159 (190)
T cd05145         149 ILYH-DGKPYII  159 (190)
T ss_pred             EEEE-CCCEEEE
Confidence            9998 5555544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=5.7e-17  Score=141.16  Aligned_cols=164  Identities=17%  Similarity=0.153  Sum_probs=116.8

Q ss_pred             eeeceecccCceEEEEEEECCCCcEEEEEEcccccc--------cHHHHHHHHHhcCC-CCccccceEEeecCCCCceEE
Q 015672           85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------YKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        85 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~  155 (403)
                      .+...|++|+||+|+++..  .+..++.+.+.....        .+.+|+++|++|.| ++|.+++++.    .     .
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~----~-----~   73 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD----G-----R   73 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc----C-----E
Confidence            3567899999999998765  577788776643322        35689999999954 7788876631    1     5


Q ss_pred             EEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccc-ccccceecCCCCceee--------
Q 015672          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDI-KPQNLLVKGEPNVSYI--------  226 (403)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDl-Kp~NILl~~~~~~~~~--------  226 (403)
                      +++|||+.|...   ...      .+.. ...++.|++.+|.++|+ .||+|||| ||+|||++.++.+.++        
T Consensus        74 ~lvmeyI~G~~L---~~~------~~~~-~~~~~~qi~~~L~~lH~-~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~  142 (218)
T PRK12274         74 HLDRSYLAGAAM---YQR------PPRG-DLAYFRAARRLLQQLHR-CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRG  142 (218)
T ss_pred             EEEEeeecCccH---Hhh------hhhh-hHHHHHHHHHHHHHHHH-CcCccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence            799999986431   111      0111 13467899999999999 89999999 7999999877665433        


Q ss_pred             ------------------------ccccccchhhhhCCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCC
Q 015672          227 ------------------------CSRYYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGES  270 (403)
Q Consensus       227 ------------------------~t~~y~aPE~~~~~~~~~-~~~DiwSlGvil~el~tg~~pf~~~~  270 (403)
                                              .++.|++|+.-.-....+ ...+.++.|+-+|.++|+..++.+++
T Consensus       143 ~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        143 NPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             CCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence                                    255567776542221233 45677799999999999999886654

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=9.6e-17  Score=166.31  Aligned_cols=173  Identities=25%  Similarity=0.391  Sum_probs=131.8

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc-cHHHHHHHHHhcC---CCCccccceEEeecCCCCceEE
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-YKNRELQIMQMLD---HPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      ....|.|.+.||+|+||+||+|.... |+.||+|+-+.... .+.--.+++.+|+   -+.|+.+..++...+.     -
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~-----S  769 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA-----S  769 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCc-----c
Confidence            34469999999999999999999876 99999997644321 1222345556665   2345555544433232     5


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc-----------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-----------  223 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~-----------  223 (403)
                      ++|+||.+ |+|.+++.    ..+.+++..+..+..|++.-++.||. .+|||+||||+|.||......           
T Consensus       770 ~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~-~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHA-MGIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             eeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHh-cceecccCCcceeEeecccCCCCcccceEEEe
Confidence            68999998 77777665    34678888999999999999999999 899999999999998532111           


Q ss_pred             -----------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCC
Q 015672          224 -----------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQP  264 (403)
Q Consensus       224 -----------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~  264 (403)
                                       ..++|..+-.+|+..|. .++..+|.|.|..+++.|+.|+.
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr-pWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR-PWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCC-CCchhhhhHHHHHHHHHHHHHHH
Confidence                             22457789999999665 59999999999999999999973

>smart00090 RIO RIO-like kinase

Probab=99.68  E-value=1.3e-16  Score=144.34  Aligned_cols=131  Identities=18%  Similarity=0.145  Sum_probs=95.0

Q ss_pred             cEeeeceecccCceEEEEEE-ECCCCcEEEEEEccccc----------------------------ccHHHHHHHHHhcC
Q 015672           83 SYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDK----------------------------RYKNRELQIMQMLD  133 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~-~~~~~~~vaiK~~~~~~----------------------------~~~~~E~~~l~~l~  133 (403)
                      .|.+.+.||+|+||.||+|. +..+|+.||||++....                            ....+|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999998 66789999999885321                            01246999999997


Q ss_pred             CCCccccceEEeecCCCCceEEEEEeeccCCc-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC-ccccccc
Q 015672          134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-ICHRDIK  211 (403)
Q Consensus       134 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~-ivHrDlK  211 (403)
                      +.+ +.+...+.. .   .  .++||||+++. +....    .....+....+..++.||+.+|.+||. .| |+|||||
T Consensus       109 ~~~-i~~p~~~~~-~---~--~~lV~E~~~g~~L~~~~----~~~~~~~~~~~~~i~~qi~~~l~~LH~-~g~iiH~Dik  176 (237)
T smart00090      109 EAG-VPVPKPIAW-R---R--NVLVMEFIGGDGLPAPR----LKDVEPEEEEEFELYDDILEEMRKLYK-EGELVHGDLS  176 (237)
T ss_pred             hcC-CCCCeeeEe-c---C--ceEEEEEecCCcccccc----cccCCcchHHHHHHHHHHHHHHHHHHh-cCCEEeCCCC
Confidence            643 333333311 1   1  36999999973 22211    112334555677889999999999999 79 9999999


Q ss_pred             cccceecCCCCceee
Q 015672          212 PQNLLVKGEPNVSYI  226 (403)
Q Consensus       212 p~NILl~~~~~~~~~  226 (403)
                      |+||+++ ++.++++
T Consensus       177 p~NIli~-~~~i~Li  190 (237)
T smart00090      177 EYNILVH-DGKVVII  190 (237)
T ss_pred             hhhEEEE-CCCEEEE
Confidence            9999998 5555443

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.66  E-value=3.4e-16  Score=149.63  Aligned_cols=161  Identities=29%  Similarity=0.494  Sum_probs=113.0

Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC--------
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN--------  222 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~--------  222 (403)
                      ..|+||.|++|. .+|.+.+.. .......+....+.++.|++.|++|    ++.+|||+||.||+...+..        
T Consensus       328 ~~~lyI~Mn~c~~~tledWl~r-r~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  328 KVYLYIQMNLCEKETLEDWLRR-RRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             ccchhhhhhhhhhhhHHHHhhC-CCcccccchhHHHHHHHhhccchhh----ccchhhhccccccccccchhhhhhhhhh
Confidence            447899999998 455555432 2223456677788999999999999    48999999999999854432        


Q ss_pred             -----------------ceeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 015672          223 -----------------VSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT  284 (403)
Q Consensus       223 -----------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~  284 (403)
                                       ...+||..||+||.+.+. .|+.++||||||+||||++. =...|...   ..+..+..  + 
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-~y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~r~--g-  475 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-QYSEKVDIYALGLILAELLIQFSTQFERI---ATLTDIRD--G-  475 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhh-hhhhhcchhhHHHHHHHHHHHhccHHHHH---Hhhhhhhc--C-
Confidence                             234689999999999765 49999999999999999997 23333111   11111111  0 


Q ss_pred             CCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          285 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                                      .+|        ..+..+ -++-.+|+..||...|.+||++.+.--|+|.
T Consensus       476 ----------------~ip--------~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  476 ----------------IIP--------PEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             ----------------CCC--------hHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence                            111        000011 2456799999999999999988888778775

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=3.5e-17  Score=165.88  Aligned_cols=238  Identities=23%  Similarity=0.301  Sum_probs=173.0

Q ss_pred             ccEeeeceecccCceEEEEEEECC-CCcEEEEEEccccc---cc---HHHHHHHHHhcC-CCCccccceEEeecCCCCce
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDK---RY---KNRELQIMQMLD-HPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~---~~---~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..|.+.+.||+|+|+.|-.+.... ....+|+|.+....   ..   ...|..+-+.+. |.|++.+++..     .+..
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~~   94 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSPR   94 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCCc
Confidence            348888999999999998887643 34557777664321   11   224777777777 99999998876     5555


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcC-CCCHHHHHHHHHHHHHHHHHHH-hcCCccccccccccceecCCC-Cc-------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYIH-NCIGICHRDIKPQNLLVKGEP-NV-------  223 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~-~l~~~~~~~~~~qi~~~L~~LH-~~~~ivHrDlKp~NILl~~~~-~~-------  223 (403)
                      +.+++++|..+.-  .......... ..+...+..++.|+..++.|+| . .++.||||||+|.+++..+ ..       
T Consensus        95 ~~~~~~~~s~g~~--~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~-~~~~h~~ikP~n~~l~~s~~~l~~~df~~  171 (601)
T KOG0590|consen   95 SYLLSLSYSDGGS--LFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE-NGVTHRDIKPSNSLLDESGSALKIADFGL  171 (601)
T ss_pred             ccccccCcccccc--cccccccCCccCCCCcchhhhhhhhccCccccCcc-cccccCCCCCccchhccCCCcccCCCchh
Confidence            6889999976421  1111101122 5667778899999999999999 7 7999999999999998766 32       


Q ss_pred             ---------------eeec-cccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015672          224 ---------------SYIC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  287 (403)
Q Consensus       224 ---------------~~~~-t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~  287 (403)
                                     ..+| ++.|+|||...+..+.....|+||+|+++.-+++|..|+.........            
T Consensus       172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~------------  239 (601)
T KOG0590|consen  172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR------------  239 (601)
T ss_pred             hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc------------
Confidence                           2357 899999999877556788999999999999999999998654432210            


Q ss_pred             HHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                               +..  +.... ..........++....+++.++|..+|..|.+..++..+||+..
T Consensus       240 ---------~~~--~~~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  240 ---------YSS--WKSNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ---------cee--ecccc-cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                     000  00000 00001122567889999999999999999999999999999988

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.59  E-value=4.7e-15  Score=144.24  Aligned_cols=187  Identities=25%  Similarity=0.343  Sum_probs=133.2

Q ss_pred             HHhcCCCCccccceEEeecCCCCceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 015672          129 MQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH  207 (403)
Q Consensus       129 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivH  207 (403)
                      |+.+.|.|+.++++.++..     ..+++|.+||. |+|.+.+..   ....++......++++|+.||.|||......|
T Consensus         1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~h   72 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSPIGYH   72 (484)
T ss_pred             CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCcceee
Confidence            4678999999999998654     34889999998 788777765   23556777777888999999999998433499


Q ss_pred             cccccccceecCCCCceee-------c--------------cccccchhhhhCCC--C----CCchhHHHHHHHHHHHHH
Q 015672          208 RDIKPQNLLVKGEPNVSYI-------C--------------SRYYRAPELIFGAT--E----YTTAIDIWSTGCVMAELL  260 (403)
Q Consensus       208 rDlKp~NILl~~~~~~~~~-------~--------------t~~y~aPE~~~~~~--~----~~~~~DiwSlGvil~el~  260 (403)
                      +.++..|.+++....++..       .              ...|.|||++.+..  .    .+.+.||||||++++|++
T Consensus        73 g~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~  152 (484)
T KOG1023|consen   73 GALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL  152 (484)
T ss_pred             eeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence            9999999999866544321       1              22489999985431  1    366799999999999999


Q ss_pred             hCCCCCCCCCcH----HHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCC
Q 015672          261 LGQPLFPGESGV----DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL  336 (403)
Q Consensus       261 tg~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~  336 (403)
                      +...||......    +.+..+.+....+.                     .|.-... ..+.+++..++..||.-+|.+
T Consensus       153 ~r~~~~~~~~~~~~~~eii~~~~~~~~~~~---------------------rP~i~~~-~e~~~~l~~l~~~cw~e~P~~  210 (484)
T KOG1023|consen  153 FRSGPFDLRNLVEDPDEIILRVKKGGSNPF---------------------RPSIELL-NELPPELLLLVARCWEEIPEK  210 (484)
T ss_pred             hccCccccccccCChHHHHHHHHhcCCCCc---------------------Ccchhhh-hhcchHHHHHHHHhcccChhh
Confidence            999999764322    22222211000000                     1110001 145668999999999999999


Q ss_pred             CCCHHHHhc
Q 015672          337 RCTALEACV  345 (403)
Q Consensus       337 Rpta~e~l~  345 (403)
                      ||+++++-.
T Consensus       211 rPs~~~i~~  219 (484)
T KOG1023|consen  211 RPSIEQIRS  219 (484)
T ss_pred             CccHHHHHh
Confidence            999998853

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.57  E-value=3.4e-14  Score=126.69  Aligned_cols=121  Identities=17%  Similarity=0.289  Sum_probs=90.7

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEccccc------------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      +.||+|++|.||+|.+  .+..+++|+.....            ....+|+.++..+.|++|.....++....     ..
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-----NF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-----CC
Confidence            5799999999999987  57789999754221            12346899999999999876655543322     26


Q ss_pred             EEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee
Q 015672          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY  225 (403)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~  225 (403)
                      +++|||++| ++.+++...       .. ....++.+++.+|.+||+ .+++|||++|+|||++ ++.+.+
T Consensus        75 ~lv~e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~-~~i~H~Dl~p~Nil~~-~~~~~l  135 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHS-AGIIHGDLTTSNMILS-GGKIYL  135 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHh-CCcccCCCCcccEEEE-CCCEEE
Confidence            789999985 665554321       11 567788999999999999 8999999999999998 444443

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.55  E-value=6e-15  Score=133.21  Aligned_cols=224  Identities=21%  Similarity=0.230  Sum_probs=155.5

Q ss_pred             EEEEEEECCCCcEEEEEEcc----ccc--ccHHHH--HHHHHhcCCCCccccceEEeecCCCCceEEEEEeeccC-CcHH
Q 015672           97 VVFQAKCRETGEIVAIKKVL----QDK--RYKNRE--LQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVN  167 (403)
Q Consensus        97 ~V~~~~~~~~~~~vaiK~~~----~~~--~~~~~E--~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~  167 (403)
                      .||++.+...|.+|+--.+.    ++.  +...++  ..-|-++.|.|||+++.+|......+.....++.||+. +++.
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~  160 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK  160 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence            46677666666665432221    110  001112  23455678999999998886555556667889999998 7888


Q ss_pred             HHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc-CCccccccccccceecCCCCceee--------------------
Q 015672          168 RIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC-IGICHRDIKPQNLLVKGEPNVSYI--------------------  226 (403)
Q Consensus       168 ~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~-~~ivHrDlKp~NILl~~~~~~~~~--------------------  226 (403)
                      .+++........+.....++|+.||+.||.|||++ .-|+|+++..+-|++..++-++..                    
T Consensus       161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~  240 (458)
T KOG1266|consen  161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKS  240 (458)
T ss_pred             HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhh
Confidence            88888877778888999999999999999999984 349999999999999866655432                    


Q ss_pred             ---ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCC
Q 015672          227 ---CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  302 (403)
Q Consensus       227 ---~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  302 (403)
                         +-++|.|||.=. ....+.++|||+||....+|..+..- -.+.+....-..+...+-                   
T Consensus       241 ~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~-------------------  300 (458)
T KOG1266|consen  241 VNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVII-------------------  300 (458)
T ss_pred             ccccCCccccCCcCc-ccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhee-------------------
Confidence               346789998642 23467799999999999999888742 222222221111111100                   


Q ss_pred             CCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       303 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                                   ..-..--++++.+||+-.|..||++.+++.||..-++.
T Consensus       301 -------------~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh  338 (458)
T KOG1266|consen  301 -------------GLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH  338 (458)
T ss_pred             -------------eccCccccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence                         00012235789999999999999999999999976654

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.53  E-value=2.9e-14  Score=125.86  Aligned_cols=125  Identities=19%  Similarity=0.203  Sum_probs=90.3

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc--------------------------ccHHHHHHHHHhcCCCC
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------------------------RYKNRELQIMQMLDHPN  136 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------------------~~~~~E~~~l~~l~h~n  136 (403)
                      .|.+.+.||+|+||.||+|... +|+.||||++....                          ....+|+.++..+.|.+
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            3888899999999999999874 79999999864321                          01346888899998875


Q ss_pred             ccccceEEeecCCCCceEEEEEeeccCCc-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccc
Q 015672          137 IVALKHCFFSTTDKEELYLNLVLEYVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL  215 (403)
Q Consensus       137 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NI  215 (403)
                      +. +...+ ...     ..+++|||+++. +..+.       .   ......++.+++.++.++|+ .||+||||||+||
T Consensus        95 i~-v~~~~-~~~-----~~~lv~e~~~g~~L~~~~-------~---~~~~~~~~~~i~~~l~~lh~-~gi~H~Dl~p~Ni  156 (198)
T cd05144          95 FP-VPKPI-DWN-----RHAVVMEYIDGVELYRVR-------V---LEDPEEVLDEILEEIVKAYK-HGIIHGDLSEFNI  156 (198)
T ss_pred             CC-CCcee-ecC-----CceEEEEEeCCcchhhcc-------c---cccHHHHHHHHHHHHHHHHH-CCCCcCCCCcccE
Confidence            32 11122 111     147999999863 32211       0   12345678899999999999 8999999999999


Q ss_pred             eecCCCCceee
Q 015672          216 LVKGEPNVSYI  226 (403)
Q Consensus       216 Ll~~~~~~~~~  226 (403)
                      +++.++.++++
T Consensus       157 ll~~~~~~~li  167 (198)
T cd05144         157 LVDDDEKIYII  167 (198)
T ss_pred             EEcCCCcEEEE
Confidence            99887766554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.53  E-value=8.2e-14  Score=123.03  Aligned_cols=118  Identities=15%  Similarity=0.290  Sum_probs=84.6

Q ss_pred             eecccCceEEEEEEECCCCcEEEEEEccccc------------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        89 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      .||+|+||.||+|..  ++..+++|......            ....+|++++..+.|+++.....++....     ..+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD-----NKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC-----CCE
Confidence            489999999999985  57889999854221            12246999999999887654443332221     256


Q ss_pred             EEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee
Q 015672          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI  226 (403)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~  226 (403)
                      ++|||++| ++..++...    . .      .++.|++.+|.+||+ .|++|||++|+||+++ ++.+.++
T Consensus        74 lv~e~~~g~~l~~~~~~~----~-~------~~~~~i~~~l~~lH~-~gi~H~Dl~~~Nil~~-~~~~~li  131 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEG----N-D------ELLREIGRLVGKLHK-AGIVHGDLTTSNIIVR-DDKLYLI  131 (199)
T ss_pred             EEEEEECCccHHHHHhhc----H-H------HHHHHHHHHHHHHHH-CCeecCCCCcceEEEE-CCcEEEE
Confidence            99999985 444433211    0 0      667899999999999 8999999999999998 5555544

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.51  E-value=1.3e-13  Score=139.86  Aligned_cols=122  Identities=16%  Similarity=0.259  Sum_probs=87.9

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEcc-cc-----------cccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QD-----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~-~~-----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      |...+.||+|+||+||++.+...  .+++|+.. +.           .....+|+++++.++|++++....+.....   
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~---  409 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE---  409 (535)
T ss_pred             cCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC---
Confidence            56789999999999999987533  34444321 11           112357999999999999887655443321   


Q ss_pred             ceEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee
Q 015672          152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI  226 (403)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~  226 (403)
                        ..++||||+++ +|.+.+.            ....++.|++.+|.|||+ .||+||||||+|||++ ++.+.++
T Consensus       410 --~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~-~giiHrDlkp~NILl~-~~~~~li  469 (535)
T PRK09605        410 --EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK-AGIVHGDLTTSNFIVR-DDRLYLI  469 (535)
T ss_pred             --CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh-CCCccCCCChHHEEEE-CCcEEEE
Confidence              25699999985 5544332            245678899999999999 8999999999999994 4444443

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.49  E-value=2.3e-13  Score=132.66  Aligned_cols=232  Identities=24%  Similarity=0.238  Sum_probs=169.5

Q ss_pred             cccccEeeeceecc--cCceEEEEEEE--CCCCcEEEEEEcc------cccccHHHHHHHHHhc-CCCCccccceEEeec
Q 015672           79 KQKVSYIAEHVVGT--GSFGVVFQAKC--RETGEIVAIKKVL------QDKRYKNRELQIMQML-DHPNIVALKHCFFST  147 (403)
Q Consensus        79 ~~~~~y~~~~~lG~--G~~g~V~~~~~--~~~~~~vaiK~~~------~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  147 (403)
                      -....+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-.      .......+|+.-.+.+ .|+|.++.+..+   
T Consensus       111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~---  187 (524)
T KOG0601|consen  111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW---  187 (524)
T ss_pred             hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc---
Confidence            34445778889999  99999999998  8889999999732      1222334677766666 489999977777   


Q ss_pred             CCCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHH----HHHHHHhcCCccccccccccceecCCCCc
Q 015672          148 TDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR----ALAYIHNCIGICHRDIKPQNLLVKGEPNV  223 (403)
Q Consensus       148 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~----~L~~LH~~~~ivHrDlKp~NILl~~~~~~  223 (403)
                        .....+++-+|+|+.++..+...   ...-++...++..+.+...    ||.++|+ .+|+|-|+||+||++..+...
T Consensus       188 --e~~~~lfiqtE~~~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs-~~~~~~~~kp~~i~~~~~~~s  261 (524)
T KOG0601|consen  188 --EGSGILFIQTELCGESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHS-NNIVHDDLKPANIFTTSDWTS  261 (524)
T ss_pred             --ccCCcceeeeccccchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCC-Ccccccccchhheecccccce
Confidence              44455889999999766544332   2334788888888889988    9999999 799999999999999766211


Q ss_pred             e---------e----------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC--CcHHHHH
Q 015672          224 S---------Y----------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE--SGVDQLV  276 (403)
Q Consensus       224 ~---------~----------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~--~~~~~~~  276 (403)
                      .         .                -+...|++||+..+  -++.+.||+|+|.++.+..++..++...  +...++.
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            0         0                24556999999854  4899999999999999999987666433  2111111


Q ss_pred             HHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          277 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       277 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                      .+.                              ....+-...+.++...+..|+..+|..|+++..+++|+++..
T Consensus       340 ~~~------------------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  340 QGY------------------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             ccc------------------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            100                              001111344566667999999999999999999999999875

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.47  E-value=2.4e-14  Score=146.44  Aligned_cols=238  Identities=24%  Similarity=0.293  Sum_probs=168.3

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ..+.+.+-+-+|+++.++.+.-..+|...++|+....       .+....+-.++-...+|-++.....+     .-...
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~rsP  878 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCRSP  878 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCCCC
Confidence            3477777899999999999988778877777654321       11122233333334556665443222     12223


Q ss_pred             EEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc----------
Q 015672          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV----------  223 (403)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~----------  223 (403)
                      .+++++|+.+ ++...+..    ....+..-++.+...+..+++|||. ..++|||++|.|+|+...+..          
T Consensus       879 ~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s-~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~  953 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHS-SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSK  953 (1205)
T ss_pred             cchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhcccc-chhhcccccccchhhcccCCcccCccccccc
Confidence            7799999863 44333332    2345556677777889999999998 579999999999997422211          


Q ss_pred             ----------------------------------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCC
Q 015672          224 ----------------------------------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ  263 (403)
Q Consensus       224 ----------------------------------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~  263 (403)
                                                              ...+|+.|.+||...+.. ....+|+|++|++++|.++|.
T Consensus       954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen  954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred             cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCC
Confidence                                                    234688999999987654 788999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHH--
Q 015672          264 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL--  341 (403)
Q Consensus       264 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~--  341 (403)
                      +||........+..|...                         ..+|.. -+...+.++++++.++|..+|.+|..+.  
T Consensus      1033 pp~na~tpq~~f~ni~~~-------------------------~~~~p~-g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~ 1086 (1205)
T KOG0606|consen 1033 PPFNAETPQQIFENILNR-------------------------DIPWPE-GPEEGSYEAQDLINRLLTEEPTQRLGAKGA 1086 (1205)
T ss_pred             CCCCCcchhhhhhccccC-------------------------CCCCCC-CccccChhhhhhhhhhhccCchhccCcccc
Confidence            999888776666554432                         111211 2246789999999999999999999877  


Q ss_pred             -HHhcCCCcccCCCCC
Q 015672          342 -EACVHPFFDELRDPN  356 (403)
Q Consensus       342 -e~l~hp~f~~~~~~~  356 (403)
                       ++-.||||+.+.+..
T Consensus      1087 ~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1087 AEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred             cccccCCccCCCCccc
Confidence             899999999886544

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.46  E-value=2.9e-13  Score=118.26  Aligned_cols=123  Identities=21%  Similarity=0.204  Sum_probs=81.6

Q ss_pred             eceecccCceEEEEEEECCCCcEEEEEEcccccccH----------------------------HHHHHHHHhcCCCC--
Q 015672           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK----------------------------NRELQIMQMLDHPN--  136 (403)
Q Consensus        87 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------------------------~~E~~~l~~l~h~n--  136 (403)
                      .+.||+|+||+||+|.+. +++.||||++.......                            ..|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999986 89999999875432110                            13444555554433  


Q ss_pred             ccccceEEeecCCCCceEEEEEeeccCCcHH--HHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccccc
Q 015672          137 IVALKHCFFSTTDKEELYLNLVLEYVPETVN--RIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (403)
Q Consensus       137 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~--~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~N  214 (403)
                      +.+.+.+    .     ..+++|||+++...  ..+....     . ...+..++.+++.++.++|...+|+||||||+|
T Consensus        81 ~~~~~~~----~-----~~~lv~e~~~g~~~~~~~l~~~~-----~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~N  145 (187)
T cd05119          81 VPKPIDL----N-----RHVLVMEFIGGDGIPAPRLKDVR-----L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYN  145 (187)
T ss_pred             CCceEec----C-----CCEEEEEEeCCCCccChhhhhhh-----h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhh
Confidence            2222211    1     15799999986210  1111111     1 145778889999999999973599999999999


Q ss_pred             ceecCCCCceee
Q 015672          215 LLVKGEPNVSYI  226 (403)
Q Consensus       215 ILl~~~~~~~~~  226 (403)
                      |+++ ++.+.++
T Consensus       146 ili~-~~~~~li  156 (187)
T cd05119         146 ILVD-DGKVYII  156 (187)
T ss_pred             EEEE-CCcEEEE
Confidence            9998 5555443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.41  E-value=2.7e-12  Score=116.46  Aligned_cols=126  Identities=13%  Similarity=0.190  Sum_probs=87.2

Q ss_pred             ceec-ccCceEEEEEEECCCCcEEEEEEcccc-----------------cccHHHHHHHHHhcCCCCc--cccceEEeec
Q 015672           88 HVVG-TGSFGVVFQAKCRETGEIVAIKKVLQD-----------------KRYKNRELQIMQMLDHPNI--VALKHCFFST  147 (403)
Q Consensus        88 ~~lG-~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------------~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~  147 (403)
                      ..|| .|+.|+||.+...  +..++||.+...                 .....+|++++..|.|++|  +..+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4576 7888888888764  778899876321                 1123469999999999886  4455443221


Q ss_pred             CCCCceEEEEEeeccCC--cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee
Q 015672          148 TDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY  225 (403)
Q Consensus       148 ~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~  225 (403)
                      . ......++|||++++  ++..++..     ..++..    .+.||+.+|.+||+ .||+||||||+|||++.++.+.+
T Consensus       115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~-~GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 H-GLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHD-AGVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             c-CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHH-CCCCCCCCCchhEEEcCCCCEEE
Confidence            1 112234699999985  56555432     334443    25689999999999 89999999999999988776655


Q ss_pred             e
Q 015672          226 I  226 (403)
Q Consensus       226 ~  226 (403)
                      +
T Consensus       184 I  184 (239)
T PRK01723        184 I  184 (239)
T ss_pred             E
Confidence            4

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.35  E-value=3.6e-12  Score=106.48  Aligned_cols=124  Identities=19%  Similarity=0.250  Sum_probs=91.4

Q ss_pred             eeceecccCceEEEEEEECCCCcEEEEEEcccccc--cHHHHHHHHHhcCC--CCccccceEEeecCCCCceEEEEEeec
Q 015672           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKNRELQIMQMLDH--PNIVALKHCFFSTTDKEELYLNLVLEY  161 (403)
Q Consensus        86 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~  161 (403)
                      +.+.||.|.++.||++...  +..+++|.......  ...+|+.+++.+.|  .++.+++..+.     .....+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~-----~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGE-----SDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcC-----CCCccEEEEEe
Confidence            3577999999999999975  37899998865442  46789999999977  47777766542     22447899999


Q ss_pred             cCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc--CCccccccccccceecCCCCceee
Q 015672          162 VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC--IGICHRDIKPQNLLVKGEPNVSYI  226 (403)
Q Consensus       162 ~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~--~~ivHrDlKp~NILl~~~~~~~~~  226 (403)
                      +.+....          .++......++.+++.+|.+||..  .+++|+|++|+|||++..+.+.++
T Consensus        75 ~~g~~~~----------~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~  131 (155)
T cd05120          75 IEGETLD----------EVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGII  131 (155)
T ss_pred             cCCeecc----------cCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEE
Confidence            9863211          013344566778999999999972  269999999999999875555443

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.27  E-value=8.7e-11  Score=116.03  Aligned_cols=161  Identities=22%  Similarity=0.314  Sum_probs=115.1

Q ss_pred             EeeeceecccCceEEE-EEEECCCCcEEEEEEcccccc----cHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           84 YIAEHVVGTGSFGVVF-QAKCRETGEIVAIKKVLQDKR----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~-~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      |.+ ...+-++.+ +| .|..+.++.+|.|........    ...+-++-|+.|+||||+++++.+     .....+|+|
T Consensus        15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~ylv   87 (690)
T KOG1243|consen   15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYLV   87 (690)
T ss_pred             ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEEE
Confidence            555 444444444 34 466777888888887754333    245678889999999999999987     334469999


Q ss_pred             eeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceeec---------cc
Q 015672          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYIC---------SR  229 (403)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~~---------t~  229 (403)
                      +|-+.. +...+..       +....+...+.||+.||.|||...+++|++|.-+.|+++..+..++.|         +.
T Consensus        88 TErV~P-l~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~  159 (690)
T KOG1243|consen   88 TERVRP-LETVLKE-------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFN  159 (690)
T ss_pred             eecccc-HHHHHHH-------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCC
Confidence            998864 2222332       224556677889999999998547899999999999999998887654         11


Q ss_pred             ----------cccchhhhhCCCCCCchhHHHHHHHHHHHHHhC
Q 015672          230 ----------YYRAPELIFGATEYTTAIDIWSTGCVMAELLLG  262 (403)
Q Consensus       230 ----------~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg  262 (403)
                                .|..|+.+..   -+-..|.|-|||++++++.|
T Consensus       160 ~~~~~~~~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  160 APAKSLYLIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cccccchhhhcccChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence                      1445554311   12357999999999999999

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.21  E-value=7.7e-12  Score=122.10  Aligned_cols=233  Identities=21%  Similarity=0.178  Sum_probs=161.7

Q ss_pred             cccccEeeeceecccCceEEEEEEEC-CCCcEEEEEEcccccccH------HHHHHHHHhc-CCCCccccceEEeecCCC
Q 015672           79 KQKVSYIAEHVVGTGSFGVVFQAKCR-ETGEIVAIKKVLQDKRYK------NRELQIMQML-DHPNIVALKHCFFSTTDK  150 (403)
Q Consensus        79 ~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~------~~E~~~l~~l-~h~niv~~~~~~~~~~~~  150 (403)
                      ....+|..+..||.|.|+.|+.+... .++..|++|.+.+.....      ..|+.+...+ .|.+++.++..|..... 
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~-  340 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ-  340 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc-
Confidence            44556889999999999999998765 678899999775433222      2466665555 58888888777743332 


Q ss_pred             CceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----
Q 015672          151 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----  225 (403)
Q Consensus       151 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----  225 (403)
                          .++-.|||.+....+..   .....+.+...+++..|++.|+.++|+ +.++|+|+||+||++..++....     
T Consensus       341 ----~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s-~~~~~~d~~psni~i~~~~~~~~~~~~~  412 (524)
T KOG0601|consen  341 ----GYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHS-KLFVHLDVKPSNILISNDGFFSKLGDFG  412 (524)
T ss_pred             ----ccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccc-hhhhcccccccceeeccchhhhhccccc
Confidence                56888999753322222   223456777788889999999999998 89999999999999987532111     


Q ss_pred             ------------ecccccc-chhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          226 ------------ICSRYYR-APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       226 ------------~~t~~y~-aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                                  .....+. .+|++.....+..++|++|||..+.+.++|.+.-.....   ...+...           
T Consensus       413 ~~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~-----------  478 (524)
T KOG0601|consen  413 CWTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSG-----------  478 (524)
T ss_pred             cccccceecccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeecc-----------
Confidence                        1122344 356665666688999999999999999999754322211   1111100           


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                              ..+          .......++..+...++..|+..|+.+.++..|.-|...
T Consensus       479 --------~~p----------~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  479 --------DTP----------NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             --------ccc----------CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence                    000          012234678889999999999999999999998877654

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.11  E-value=2.6e-09  Score=102.73  Aligned_cols=209  Identities=18%  Similarity=0.224  Sum_probs=143.1

Q ss_pred             ceEEEEEEECCCCcEEEEEEcccccccH----HHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeeccCC--cHHH
Q 015672           95 FGVVFQAKCRETGEIVAIKKVLQDKRYK----NRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE--TVNR  168 (403)
Q Consensus        95 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~  168 (403)
                      -.+.|+|....+|..|++|.+..++...    ..-++.++++.|.|||++.++|.+.. -...-+++|++|.++  +|.+
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHHH
Confidence            3477999999999999999984333221    24688999999999999999986443 345568999999985  4443


Q ss_pred             HHHHhh-----------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceeecccc----ccc
Q 015672          169 IARNYS-----------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYICSRY----YRA  233 (403)
Q Consensus       169 ~~~~~~-----------~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~~t~~----y~a  233 (403)
                      +.....           ..+...++..++.|+.|+..||.++|+ .|+.-+-|.|.+||++++..+.+.|...    .--
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs-sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS-SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh-cCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            321111           112357788999999999999999999 7998899999999999987766554222    112


Q ss_pred             h-hhhhCCCCCCchhHHHHHHHHHHHHHhCCCC-CCCCCcHHH-HHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCc
Q 015672          234 P-ELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQ-LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPW  310 (403)
Q Consensus       234 P-E~~~~~~~~~~~~DiwSlGvil~el~tg~~p-f~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (403)
                      | |.+.+    -.+-|.=.||.++..|.||..- +........ +..|.                               
T Consensus       447 ~~~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-------------------------------  491 (655)
T KOG3741|consen  447 PTEPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-------------------------------  491 (655)
T ss_pred             CCcchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-------------------------------
Confidence            2 22322    2356999999999999999532 222221111 22221                               


Q ss_pred             ccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          311 HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       311 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                           ...+.+++++|.-+...++++ -+..+++.|
T Consensus       492 -----~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  492 -----TTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             -----hhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                 346777788888777777775 456666543

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.02  E-value=3.2e-10  Score=113.29  Aligned_cols=125  Identities=18%  Similarity=0.255  Sum_probs=74.5

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc------------------------------------------
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------------------------------------------  120 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------------------------------  120 (403)
                      .|.. +.||+|++|.||+|+.+.+|+.||||++...-.                                          
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            3555 789999999999999988899999999854310                                          


Q ss_pred             --cHHHHHHHHHhc----CCCCccccceEEeecCCCCceEEEEEeeccCC-cHHHHHHHhhhhc---CCCCHHHHHHHHH
Q 015672          121 --YKNRELQIMQML----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIH---QRMPLIYVKLYTY  190 (403)
Q Consensus       121 --~~~~E~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~---~~l~~~~~~~~~~  190 (403)
                        ...+|...+.++    .+.+.+.+-.+|...    ...-+|||||+.| .+.++.. ....+   ..+....+..++.
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~----st~~VLvmE~i~G~~l~d~~~-l~~~g~d~~~la~~~v~~~~~  274 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDY----CSETVMVMERMYGIPVSDVAA-LRAAGTDMKLLAERGVEVFFT  274 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeeccc----CCCceEEEeeecCccHHhHHH-HHhcCCCHHHHHHHHHHHHHH
Confidence              001233333333    233333333333111    1125699999986 3333211 11101   1233444455555


Q ss_pred             HHHHHHHHHHhcCCccccccccccceecCCC
Q 015672          191 QICRALAYIHNCIGICHRDIKPQNLLVKGEP  221 (403)
Q Consensus       191 qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~  221 (403)
                      |++       . .|++|+|+||.||+++.++
T Consensus       275 Qif-------~-~GffHaDpHPGNIlv~~~g  297 (537)
T PRK04750        275 QVF-------R-DGFFHADMHPGNIFVSYDP  297 (537)
T ss_pred             HHH-------h-CCeeeCCCChHHeEEecCC
Confidence            554       4 6999999999999998776

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.02  E-value=2.1e-09  Score=92.14  Aligned_cols=118  Identities=14%  Similarity=0.170  Sum_probs=81.2

Q ss_pred             eceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeeccC
Q 015672           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP  163 (403)
Q Consensus        87 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~  163 (403)
                      .+.|+.|.++.||+++..  +..|++|......   ....+|+.+++.+.+.+++.-.-.+ .   ...  -++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~-~---~~~--~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYF-D---PET--GVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEE-e---CCC--CeEEEEecC
Confidence            356899999999999864  7889999875443   3456899999999766655332222 1   111  358999999


Q ss_pred             CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCc-----cccccccccceecCCCCcee
Q 015672          164 ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI-----CHRDIKPQNLLVKGEPNVSY  225 (403)
Q Consensus       164 ~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~i-----vHrDlKp~NILl~~~~~~~~  225 (403)
                      |....  ..      ..   ....++.+++.+|..||. .++     +|+|++|.||+++ ++.+.+
T Consensus        75 G~~l~--~~------~~---~~~~~~~~l~~~l~~LH~-~~~~~~~~~HgD~~~~Nil~~-~~~~~l  128 (170)
T cd05151          75 GSELL--TE------DF---SDPENLEKIAKLLKKLHS-SPLPDLVPCHNDLLPGNFLLD-DGRLWL  128 (170)
T ss_pred             CCccc--cc------cc---cCHHHHHHHHHHHHHHhC-CCCCCceeecCCCCcCcEEEE-CCeEEE
Confidence            73210  00      01   112345799999999998 675     9999999999998 444443

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.00  E-value=9.6e-11  Score=116.16  Aligned_cols=137  Identities=20%  Similarity=0.382  Sum_probs=102.3

Q ss_pred             HHHHHHHHHHhcCCccccccccccceecCCCCceeec----------------------------cccccchhhhhCCCC
Q 015672          191 QICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYIC----------------------------SRYYRAPELIFGATE  242 (403)
Q Consensus       191 qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~~----------------------------t~~y~aPE~~~~~~~  242 (403)
                      +++.||.|+|.+.++||++|.|++|.++..+.++..|                            ...|.|||++.+ ..
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~  185 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT  185 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence            4558999999878999999999999999888776554                            224999999976 45


Q ss_pred             CCchhHHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHH
Q 015672          243 YTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPE  321 (403)
Q Consensus       243 ~~~~~DiwSlGvil~el~-tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  321 (403)
                      .+.++|++|+||++|.+. .|+..+......... ......                 .+....       ....+++.+
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~~-----------------~~~~~~-------~~s~~~p~e  240 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRNL-----------------LNAGAF-------GYSNNLPSE  240 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchh-hhhhcc-----------------cccccc-------cccccCcHH
Confidence            789999999999999998 566666544322111 111100                 000000       012568999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          322 AVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       322 ~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                      +++=|.++|..|+..||++.+++..|||.+..
T Consensus       241 l~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~  272 (700)
T KOG2137|consen  241 LRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG  272 (700)
T ss_pred             HHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence            99999999999999999999999999998753

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.94  E-value=5.6e-09  Score=91.00  Aligned_cols=125  Identities=18%  Similarity=0.219  Sum_probs=83.5

Q ss_pred             ceecccCceEEEEEEECC------CCcEEEEEEccc--------------ccc------------c----HHHHHHHHHh
Q 015672           88 HVVGTGSFGVVFQAKCRE------TGEIVAIKKVLQ--------------DKR------------Y----KNRELQIMQM  131 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~------~~~~vaiK~~~~--------------~~~------------~----~~~E~~~l~~  131 (403)
                      ..||.|--+.||.|....      .+..+|||+.+-              +.+            .    .++|+..|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998643      357899997621              100            0    1268999999


Q ss_pred             cCCC--CccccceEEeecCCCCceEEEEEeeccCCcHH--HHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHH-HhcCCcc
Q 015672          132 LDHP--NIVALKHCFFSTTDKEELYLNLVLEYVPETVN--RIARNYSRIHQRMPLIYVKLYTYQICRALAYI-HNCIGIC  206 (403)
Q Consensus       132 l~h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~--~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~L-H~~~~iv  206 (403)
                      +...  ++.+.+.+    ..     -+|||||+++...  ..+..     ..++...+..+..|++.+|..| |. .|||
T Consensus        83 l~~~Gv~vP~pi~~----~~-----~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~-~glV  147 (197)
T cd05146          83 MQKAGIPCPEVVVL----KK-----HVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKE-CNLV  147 (197)
T ss_pred             HHHcCCCCCeEEEe----cC-----CEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHh-CCee
Confidence            8643  44444432    11     4589999986311  11111     2344455667788999999998 88 7999


Q ss_pred             ccccccccceecCCCCceeecc
Q 015672          207 HRDIKPQNLLVKGEPNVSYICS  228 (403)
Q Consensus       207 HrDlKp~NILl~~~~~~~~~~t  228 (403)
                      |+||++.|||+.. +.+.++.-
T Consensus       148 HGDLs~~NIL~~~-~~v~iIDF  168 (197)
T cd05146         148 HADLSEYNMLWHD-GKVWFIDV  168 (197)
T ss_pred             cCCCCHHHEEEEC-CcEEEEEC
Confidence            9999999999974 44555543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.93  E-value=5.9e-09  Score=102.83  Aligned_cols=128  Identities=20%  Similarity=0.258  Sum_probs=77.9

Q ss_pred             eceecccCceEEEEEEECCCCcEEEEEEccccc-cc-------------------------------------------H
Q 015672           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RY-------------------------------------------K  122 (403)
Q Consensus        87 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~-------------------------------------------~  122 (403)
                      .+.||.|++|.||+|+.+ +|+.||||+....- ..                                           .
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            467999999999999974 79999999874321 00                                           1


Q ss_pred             HHHHHHHHhc----CCCCccccceEEeecCCCCceEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHH-HH
Q 015672          123 NRELQIMQML----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICR-AL  196 (403)
Q Consensus       123 ~~E~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~-~L  196 (403)
                      .+|.+.+.++    +|.+-+.+-..+.....    ..+|||||++| .+.++....   .....   ...++.+++. .+
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~----~~vLvmE~i~G~~L~~~~~~~---~~~~~---~~~ia~~~~~~~l  270 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTS----ERVLTMEWIDGIPLSDIAALD---EAGLD---RKALAENLARSFL  270 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcC----CceEEEEeECCcccccHHHHH---hcCCC---HHHHHHHHHHHHH
Confidence            1244444443    23333333333321111    15699999986 333332211   01122   2334455554 46


Q ss_pred             HHHHhcCCccccccccccceecCCCCceee
Q 015672          197 AYIHNCIGICHRDIKPQNLLVKGEPNVSYI  226 (403)
Q Consensus       197 ~~LH~~~~ivHrDlKp~NILl~~~~~~~~~  226 (403)
                      ..+|. .|++|+|+||.||+++.++.+.++
T Consensus       271 ~ql~~-~g~~H~D~hPgNilv~~~g~i~li  299 (437)
T TIGR01982       271 NQVLR-DGFFHADLHPGNIFVLKDGKIIAL  299 (437)
T ss_pred             HHHHh-CCceeCCCCcccEEECCCCcEEEE
Confidence            78898 799999999999999888776554

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.63  E-value=1.6e-06  Score=82.02  Aligned_cols=236  Identities=17%  Similarity=0.195  Sum_probs=136.8

Q ss_pred             eeceecccCceEEEEEEECCCCcEEEEEEcccccccH-HHHHHHHHhc-CCCCccc-c---ceEEeecCCCCceEEEEEe
Q 015672           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-NRELQIMQML-DHPNIVA-L---KHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        86 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~E~~~l~~l-~h~niv~-~---~~~~~~~~~~~~~~~~lv~  159 (403)
                      ..+.||+|+-+.+|-.-..  + ..+.|+.....-.. .+-+..|... .||-+.. +   ....+.  ......+.++|
T Consensus        15 ~gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G--~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHG--GRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecchh--h-chhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhC--CCccceeEEec
Confidence            4577999999999865432  1 23456654322111 1222223322 4554322 0   011111  12233377888


Q ss_pred             eccCCc--HHHHHHHh--hhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee---------
Q 015672          160 EYVPET--VNRIARNY--SRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI---------  226 (403)
Q Consensus       160 e~~~~~--l~~~~~~~--~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~---------  226 (403)
                      ..+.+-  ...++.-.  ...........+.+..+.++.+..-||. .|.+-+|+.++|+|++++..+..+         
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~-~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~  168 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE-HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINA  168 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh-cCCcccccCccceeeecCceEEEEcccceeecc
Confidence            887752  22221110  1112235667888999999999999999 799999999999999887776544         


Q ss_pred             ---------ccccccchhhhh----CCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCC-HH-HH
Q 015672          227 ---------CSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPT-RE-EI  290 (403)
Q Consensus       227 ---------~t~~y~aPE~~~----~~~~~~~~~DiwSlGvil~el~tg-~~pf~~~~~~~~~~~i~~~~~~~~-~~-~~  290 (403)
                               |...|.+||.-.    ..-.-+...|.|.|||++|+++.| +.||.|-...         ...|. .+ .+
T Consensus       169 ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~---------~~ap~p~E~~I  239 (637)
T COG4248         169 NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLI---------SDAPNPLETDI  239 (637)
T ss_pred             CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccccc---------CCCCCcchhhh
Confidence                     456799999752    111246678999999999999886 9999764210         00011 11 11


Q ss_pred             hhcCcCccc----cCCCCCCCCCcccccccCCCHHHHHHHHHhccc--CCCCCCCHH
Q 015672          291 KCMNPNYTE----FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQY--SPNLRCTAL  341 (403)
Q Consensus       291 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~--dP~~Rpta~  341 (403)
                      ....-.|..    -..+.....||     ..+++++..|..+|+..  ++.-|||++
T Consensus       240 a~g~f~ya~~~~~g~~p~P~~~P~-----~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         240 AHGRFAYASDQRRGLKPPPRSIPL-----SMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             hcceeeechhccCCCCCCCCCCCh-----hhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence            100000000    11111122233     35789999999999985  356899874

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.55  E-value=8.5e-07  Score=79.21  Aligned_cols=74  Identities=11%  Similarity=0.087  Sum_probs=50.8

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEcccc-----cccHHHHHHHHHhcCCCC--ccccceEEeecCCCCceEEEEEee
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPN--IVALKHCFFSTTDKEELYLNLVLE  160 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e  160 (403)
                      +.|+.|.++.||++... +|+.+++|.....     .....+|+++++.+.+.+  +.+++....  ........++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~--~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCE--DPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECC--CCCccCCceEEEE
Confidence            56899999999999874 3678999987543     234578999999997644  445544321  1111123579999


Q ss_pred             ccCC
Q 015672          161 YVPE  164 (403)
Q Consensus       161 ~~~~  164 (403)
                      |++|
T Consensus        81 ~i~G   84 (223)
T cd05154          81 RVDG   84 (223)
T ss_pred             EeCC
Confidence            9985

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.54  E-value=1.2e-06  Score=74.14  Aligned_cols=128  Identities=16%  Similarity=0.227  Sum_probs=84.9

Q ss_pred             eeceecccCceEEEEEEECCCCcEEEEEEcccc------------cccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        86 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ....|-+|+-+.|+++.+.  |+.+.||.-...            +....+|+++|.++.--.|..-.-+|..   .+. 
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D---~~~-   84 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID---TYG-   84 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe---cCC-
Confidence            4567889999999999874  888888854221            1222468999888865444322222222   122 


Q ss_pred             EEEEEeeccCC--cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc
Q 015672          154 YLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV  223 (403)
Q Consensus       154 ~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~  223 (403)
                       -+|+|||++|  ++.+++.....  ..........++.+|-..+.-||. .+|||+||..+||+|..++.-
T Consensus        85 -~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~-ndiiHGDLTTSNill~~~~~~  152 (229)
T KOG3087|consen   85 -GQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHD-NDIIHGDLTTSNILLRSDGNQ  152 (229)
T ss_pred             -CeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhh-CCeecccccccceEEecCCCc
Confidence             3489999997  56555544322  122222225677888889999999 799999999999999876543

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.48  E-value=1.2e-06  Score=78.74  Aligned_cols=132  Identities=19%  Similarity=0.128  Sum_probs=89.8

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEccc----------c----------------cccHHHHHHHHHhcCCC--
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ----------D----------------KRYKNRELQIMQMLDHP--  135 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----------~----------------~~~~~~E~~~l~~l~h~--  135 (403)
                      +.+...||-|--+.||.|.+. .|.++|||.-+-          .                ....++|.++|.+|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            557789999999999999984 789999995321          0                11234799999999755  


Q ss_pred             CccccceEEeecCCCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccc
Q 015672          136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNL  215 (403)
Q Consensus       136 niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NI  215 (403)
                      .+.+-++         ...-++||||++|..   +..     -++.......++..|+.-+.-+-. .||||+|+.+=||
T Consensus       172 ~VP~P~~---------~nRHaVvMe~ieG~e---L~~-----~r~~~en~~~il~~il~~~~~~~~-~GiVHGDlSefNI  233 (304)
T COG0478         172 KVPKPIA---------WNRHAVVMEYIEGVE---LYR-----LRLDVENPDEILDKILEEVRKAYR-RGIVHGDLSEFNI  233 (304)
T ss_pred             CCCCccc---------cccceeeeehcccce---eec-----ccCcccCHHHHHHHHHHHHHHHHH-cCccccCCchheE
Confidence            4444332         122558999998732   111     111223333344445544444335 6999999999999


Q ss_pred             eecCCCCceeeccccccch
Q 015672          216 LVKGEPNVSYICSRYYRAP  234 (403)
Q Consensus       216 Ll~~~~~~~~~~t~~y~aP  234 (403)
                      |++.++.+.++.-|.|.+.
T Consensus       234 lV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         234 LVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             EEecCCCEEEEeCcccccC
Confidence            9999999999988888753

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.47  E-value=3.4e-06  Score=77.58  Aligned_cols=95  Identities=12%  Similarity=0.144  Sum_probs=66.0

Q ss_pred             HHHHHHHHHhcCCCCcccc--ceEEeecCCCCceEEEEEeeccCC--cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHH
Q 015672          122 KNRELQIMQMLDHPNIVAL--KHCFFSTTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA  197 (403)
Q Consensus       122 ~~~E~~~l~~l~h~niv~~--~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~  197 (403)
                      ..+|...+.+|...+|...  ..+.....+.....-++|||++++  ++.+++....  ...........++.+++..+.
T Consensus        75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~  152 (268)
T PRK15123         75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVR  152 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHH
Confidence            5689998888865554433  222222122212346799999996  5666654322  134455667788999999999


Q ss_pred             HHHhcCCccccccccccceecC
Q 015672          198 YIHNCIGICHRDIKPQNLLVKG  219 (403)
Q Consensus       198 ~LH~~~~ivHrDlKp~NILl~~  219 (403)
                      -||. .||+|+|+++.|||++.
T Consensus       153 ~LH~-~Gi~HgDL~~~NiLl~~  173 (268)
T PRK15123        153 DMHA-AGINHRDCYICHFLLHL  173 (268)
T ss_pred             HHHH-CcCccCCCChhhEEEec
Confidence            9999 89999999999999985

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.34  E-value=2.2e-06  Score=74.43  Aligned_cols=114  Identities=21%  Similarity=0.233  Sum_probs=68.0

Q ss_pred             EEEEEEECCCCcEEEEEEcccc--------------c----------------ccHHHHHHHHHhcCCCC--ccccceEE
Q 015672           97 VVFQAKCRETGEIVAIKKVLQD--------------K----------------RYKNRELQIMQMLDHPN--IVALKHCF  144 (403)
Q Consensus        97 ~V~~~~~~~~~~~vaiK~~~~~--------------~----------------~~~~~E~~~l~~l~h~n--iv~~~~~~  144 (403)
                      .||.|.. ..|..+|||+.+..              .                ....+|.+.|.++...+  +.+.+.+.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4888887 46789999976311              0                11236999999998764  44444321


Q ss_pred             eecCCCCceEEEEEeeccC--CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHH-HHhcCCccccccccccceecCCC
Q 015672          145 FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY-IHNCIGICHRDIKPQNLLVKGEP  221 (403)
Q Consensus       145 ~~~~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~-LH~~~~ivHrDlKp~NILl~~~~  221 (403)
                           .    -+|||||++  |.....+...     .+.......++.+++..+.. +|. .||||+||.+.|||++.+ 
T Consensus        80 -----~----~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~~~-  143 (188)
T PF01163_consen   80 -----R----NVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVDDG-  143 (188)
T ss_dssp             -----T----TEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEETT-
T ss_pred             -----C----CEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEeecc-
Confidence                 1    248999998  5222112221     11123345667788886665 577 899999999999999877 


Q ss_pred             Cceeec
Q 015672          222 NVSYIC  227 (403)
Q Consensus       222 ~~~~~~  227 (403)
                      .+.++.
T Consensus       144 ~~~iID  149 (188)
T PF01163_consen  144 KVYIID  149 (188)
T ss_dssp             CEEE--
T ss_pred             eEEEEe
Confidence            555554

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.34  E-value=5.1e-06  Score=70.58  Aligned_cols=115  Identities=15%  Similarity=0.271  Sum_probs=73.4

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEcccc------------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      ..+++|+-+.++.+.+.  |..+++|.-.+.            .....+|+.++.++.--.|..-.=+.+.   .+.  .
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD---~~~--~   74 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD---PDN--G   74 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc---CCC--C
Confidence            35788999999998764  445667743211            1122369999998865444322212221   222  4


Q ss_pred             EEEeeccCCcHH-HHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC
Q 015672          156 NLVLEYVPETVN-RIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP  221 (403)
Q Consensus       156 ~lv~e~~~~~l~-~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~  221 (403)
                      .|+|||++|.+. +.+..    .   .    ..++..|-.-+.-||. .||||+||.++||++.+.+
T Consensus        75 ~I~me~I~G~~lkd~l~~----~---~----~~~~r~vG~~vg~lH~-~givHGDLTtsNiIl~~~~  129 (204)
T COG3642          75 LIVMEYIEGELLKDALEE----A---R----PDLLREVGRLVGKLHK-AGIVHGDLTTSNIILSGGR  129 (204)
T ss_pred             EEEEEEeCChhHHHHHHh----c---c----hHHHHHHHHHHHHHHh-cCeecCCCccceEEEeCCc
Confidence            589999998542 23322    1   1    2345566667788998 8999999999999998765

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.28  E-value=1.5e-07  Score=93.03  Aligned_cols=230  Identities=17%  Similarity=0.135  Sum_probs=144.3

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccccccHHHHHHHHHhcCCCC-ccccceEEeecCCCCceEEEEEeec
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPN-IVALKHCFFSTTDKEELYLNLVLEY  161 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~~~lv~e~  161 (403)
                      .|...+-+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++.     ...+.+.++.+++
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~d-----~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLED-----YDGEDYLWIPMRI  315 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCccccccc-----CCcccccchhhhh
Confidence            4667788999999999999876655554 6766544 34456899999999999 4444333     2566789999999


Q ss_pred             cCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC-----------------Cce
Q 015672          162 VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP-----------------NVS  224 (403)
Q Consensus       162 ~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~-----------------~~~  224 (403)
                      +.+.-.. ..........+..-....+.+.-.++|+++|+ .-=+|||    ||+..++.                 ...
T Consensus       316 ~s~~rs~-~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~-~~~~~~d----~~l~s~~~~~~~~~~v~~~L~~~~~~~t  389 (829)
T KOG0576|consen  316 CSTGRSS-ALEMTVSEIALEQYQFAYPLRKETRPLAELHS-SYKVHRD----NILGSEEEVKLLDFAVPPQLTRTMKPRT  389 (829)
T ss_pred             hcCCccc-cccCChhhHhhhhhhhhhhhhhhccccccccc-ccccCcc----cccccccccccccccCCcccCccccccc
Confidence            9853000 00000000112222233444556778999997 4458998    77765432                 123


Q ss_pred             eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCC
Q 015672          225 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ  304 (403)
Q Consensus       225 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (403)
                      ..+|+.++|||+.... .+....|.|++|+--.++.-|.+|-....  ....    ..|.              ..+.+.
T Consensus       390 ~~~~~~~~~pev~~~~-~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~----~~g~--------------~p~s~~  448 (829)
T KOG0576|consen  390 AIGTPEPLAPEVIQEN-TIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLP----MIGN--------------GPNSPM  448 (829)
T ss_pred             CCCCCCCCCchhhccc-ccccCCCccCCCcchhhcCCCCCCCCCCc--cccC----CCCC--------------CCCccc
Confidence            5688999999998654 48999999999988778888877764311  0000    0000              000111


Q ss_pred             CCC-CCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          305 IKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       305 ~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                      ... .-|...       .-.++...|+..-|..|++...++.|.+|....
T Consensus       449 L~~~~aw~~~-------~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp  491 (829)
T KOG0576|consen  449 LTDKSAWSPV-------FHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP  491 (829)
T ss_pred             cchhhhcCcc-------cccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence            111 111111       112577889999999999999999999998753

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.17  E-value=3.8e-05  Score=68.11  Aligned_cols=94  Identities=20%  Similarity=0.285  Sum_probs=66.2

Q ss_pred             HHHHHHHHHhcCCCCcc--ccceEEeecCCCCceEEEEEeeccCC--cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHH
Q 015672          122 KNRELQIMQMLDHPNIV--ALKHCFFSTTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA  197 (403)
Q Consensus       122 ~~~E~~~l~~l~h~niv--~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~  197 (403)
                      ..+|...+..|...+|.  +.+.+........ ...++|+|++++  +|..++....    ..+......++.+++..+.
T Consensus        58 a~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   58 AKREWRNLQRLREAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLIA  132 (206)
T ss_pred             HHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHHH
Confidence            45788888888654443  3333332222222 456799999986  4555554422    2555567788899999999


Q ss_pred             HHHhcCCccccccccccceecCCC
Q 015672          198 YIHNCIGICHRDIKPQNLLVKGEP  221 (403)
Q Consensus       198 ~LH~~~~ivHrDlKp~NILl~~~~  221 (403)
                      -||. .||+|+|+++.|||++.+.
T Consensus       133 ~lH~-~gi~H~Dl~~~NILv~~~~  155 (206)
T PF06293_consen  133 KLHD-AGIYHGDLNPSNILVDPDD  155 (206)
T ss_pred             HHHH-CcCCCCCCCcccEEEeCCC
Confidence            9999 8999999999999999876

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.09  E-value=0.00014  Score=63.91  Aligned_cols=127  Identities=13%  Similarity=0.088  Sum_probs=84.9

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEccc----------ccccHHHHHHHHHhcCCCCcc--ccceEEeecCCCCceEEEE
Q 015672           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQ----------DKRYKNRELQIMQMLDHPNIV--ALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        90 lG~G~~g~V~~~~~~~~~~~vaiK~~~~----------~~~~~~~E~~~l~~l~h~niv--~~~~~~~~~~~~~~~~~~l  157 (403)
                      -|+||.+-|+.....  |+.+=+|.-..          ....+.+|+..+..|...+|.  +.. ++-.........-+|
T Consensus        26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            356788888877653  44677775431          223456899999998654443  332 111122233455779


Q ss_pred             EeeccC--CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC
Q 015672          158 VLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN  222 (403)
Q Consensus       158 v~e~~~--~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~  222 (403)
                      |+|-++  .+|.+++....  -.+.+......++.+++..+.-||. .|+.|+|+-+.|||++.++.
T Consensus       103 VTe~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~-~Gv~Hgdly~khIll~~~g~  166 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHS-VNRQHGCCYVRHIYVKTEGK  166 (216)
T ss_pred             EEEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHhheeecCCCC
Confidence            999888  46665554321  1234556667888999999999999 89999999999999986554

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.86  E-value=0.00032  Score=61.91  Aligned_cols=132  Identities=17%  Similarity=0.203  Sum_probs=78.0

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccccccH-------------HHHHHHHHhcCCCCccccce---EEee
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQMLDHPNIVALKH---CFFS  146 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------------~~E~~~l~~l~h~niv~~~~---~~~~  146 (403)
                      +|.+.+++-......|.+...  +|+.+++|..+......             .+++..+..+....+..+-+   +..-
T Consensus        32 ~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek  109 (229)
T PF06176_consen   32 NYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK  109 (229)
T ss_pred             CceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence            477888888777777766654  47889999765432111             23444444443333222222   2111


Q ss_pred             cCCCCceEEEEEeeccCCc-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee
Q 015672          147 TTDKEELYLNLVLEYVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY  225 (403)
Q Consensus       147 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~  225 (403)
                      ....-....+|+|||++|- +.++.        .+++.    +...|+.++.-||. .|+.|+|..|.|++++.++ +.+
T Consensus       110 k~~~~~~~~~ll~EYIeG~~l~d~~--------~i~e~----~~~ki~~~ikqlH~-~G~~HGD~hpgNFlv~~~~-i~i  175 (229)
T PF06176_consen  110 KIFRYTSSYVLLMEYIEGVELNDIE--------DIDED----LAEKIVEAIKQLHK-HGFYHGDPHPGNFLVSNNG-IRI  175 (229)
T ss_pred             eeccceeEEEEEEEEecCeecccch--------hcCHH----HHHHHHHHHHHHHH-cCCccCCCCcCcEEEECCc-EEE
Confidence            1112223356899999972 21111        12221    23467788999999 8999999999999998654 666


Q ss_pred             ecccc
Q 015672          226 ICSRY  230 (403)
Q Consensus       226 ~~t~~  230 (403)
                      +.|..
T Consensus       176 ID~~~  180 (229)
T PF06176_consen  176 IDTQG  180 (229)
T ss_pred             EECcc
Confidence            66543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.80  E-value=0.00025  Score=75.32  Aligned_cols=185  Identities=19%  Similarity=0.275  Sum_probs=112.4

Q ss_pred             HHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc
Q 015672          124 RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC  202 (403)
Q Consensus       124 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~  202 (403)
                      .|+..+.++.|+|++.++.+-+...... ..+.+..++|.. .+...+..    -...+...++.+..++++||.|+|+ 
T Consensus       231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~-  304 (1351)
T KOG1035|consen  231 IELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHS-  304 (1351)
T ss_pred             HHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHH-
Confidence            4677788899999999877654332222 112223355553 33333332    3567888889999999999999998 


Q ss_pred             CCccccccccc---cceecCCCCc--------------------eeeccccccchhhhhCCCCCCc--hhHHHHHHHHHH
Q 015672          203 IGICHRDIKPQ---NLLVKGEPNV--------------------SYICSRYYRAPELIFGATEYTT--AIDIWSTGCVMA  257 (403)
Q Consensus       203 ~~ivHrDlKp~---NILl~~~~~~--------------------~~~~t~~y~aPE~~~~~~~~~~--~~DiwSlGvil~  257 (403)
                      ....|.-+...   +-..+.++..                    ....+..+.|+|..... .+..  ..|+|.+|..+.
T Consensus       305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~-~~~~~r~~dL~~lgll~~  383 (1351)
T KOG1035|consen  305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKEN-TAKKSRLTDLWCLGLLLL  383 (1351)
T ss_pred             hccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccc-cchhhhhhHHHHHHHHHh
Confidence            54444333322   1111111111                    11235567788876432 2333  469999999999


Q ss_pred             HHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCC
Q 015672          258 ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR  337 (403)
Q Consensus       258 el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R  337 (403)
                      .+..|..+-...   ......                                   ++........+++.+|+.-|+++|
T Consensus       384 ~~~~~~~i~~~~---~~~~~~-----------------------------------l~~~~~~~~~d~~~~~~~~~~~~R  425 (1351)
T KOG1035|consen  384 QLSQGEDISEKS---AVPVSL-----------------------------------LDVLSTSELLDALPKCLDEDSEER  425 (1351)
T ss_pred             hhhhcCcccccc---cchhhh-----------------------------------hccccchhhhhhhhhhcchhhhhc
Confidence            988876432100   000000                                   001111267889999999999999


Q ss_pred             CCHHHHhcCCCcccCC
Q 015672          338 CTALEACVHPFFDELR  353 (403)
Q Consensus       338 pta~e~l~hp~f~~~~  353 (403)
                      +.+.+++.|+|.+--.
T Consensus       426 l~~~~ll~~~f~~~~~  441 (1351)
T KOG1035|consen  426 LSALELLTHPFLRFPT  441 (1351)
T ss_pred             cchhhhhhchhccccc
Confidence            9999999999987543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.72  E-value=0.00012  Score=73.32  Aligned_cols=122  Identities=21%  Similarity=0.347  Sum_probs=70.7

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEccccccc--------------------------------------------HH
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY--------------------------------------------KN  123 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------------------------------------------~~  123 (403)
                      ..|+.++-|.||+|+.+ +|+.||||+.+.+-..                                            ..
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            66999999999999985 5999999987432100                                            01


Q ss_pred             HHHHHHHhc----C-CCCccccceEEeecCCCCceEEEEEeeccCCc-HHHHHHHhhhhcCCCCH-----HHHHHHHHHH
Q 015672          124 RELQIMQML----D-HPNIVALKHCFFSTTDKEELYLNLVLEYVPET-VNRIARNYSRIHQRMPL-----IYVKLYTYQI  192 (403)
Q Consensus       124 ~E~~~l~~l----~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~-----~~~~~~~~qi  192 (403)
                      +|..-+.++    + .+++ .+-.+|......    -.|+|||++|. +.++....   ...++.     ..+..++.|+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~----~VLtmE~i~Gi~i~d~~~l~---~~g~d~k~ia~~~~~~f~~q~  281 (517)
T COG0661         210 REAANAERFRENFKDDPDV-YVPKVYWEYTTR----RVLTMEWIDGIKISDIAALK---SAGIDRKELAELLVRAFLRQL  281 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCe-EeceeehhccCC----cEEEEEeeCCEecccHHHHH---hcCCCHHHHHHHHHHHHHHHH
Confidence            344444443    2 2332 233333211111    45999999972 22221111   122332     2222333333


Q ss_pred             HHHHHHHHhcCCccccccccccceecCCCCceee
Q 015672          193 CRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI  226 (403)
Q Consensus       193 ~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~  226 (403)
                      +       . .|++|.|..|.||+++.++.+.++
T Consensus       282 ~-------~-dgffHaDpHpGNi~v~~~g~i~~l  307 (517)
T COG0661         282 L-------R-DGFFHADPHPGNILVRSDGRIVLL  307 (517)
T ss_pred             H-------h-cCccccCCCccceEEecCCcEEEE
Confidence            2       2 599999999999999998776554

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.62  E-value=0.00042  Score=61.95  Aligned_cols=124  Identities=16%  Similarity=0.177  Sum_probs=77.8

Q ss_pred             eecccCceEEEEEEECCCCcEEEEEEcccccc----------------------------cHHHHHHHHHhcCCCCc--c
Q 015672           89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR----------------------------YKNRELQIMQMLDHPNI--V  138 (403)
Q Consensus        89 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------------------------~~~~E~~~l~~l~h~ni--v  138 (403)
                      .|.+|--+.||+|.. .++..+|+|+.+....                            ...+|+.-|+++...+|  .
T Consensus        55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            677888889999986 5688999998742110                            11257777777754442  2


Q ss_pred             ccceEEeecCCCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceec
Q 015672          139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVK  218 (403)
Q Consensus       139 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~  218 (403)
                      +-+.+.     .    -.|||||++...   .....-....+....+..+..+++..+.-|-...++||+||..=|||+.
T Consensus       134 ~Pi~~~-----~----nVLvMEfIg~~g---~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~  201 (268)
T COG1718         134 EPIAFR-----N----NVLVMEFIGDDG---LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH  201 (268)
T ss_pred             Cceeec-----C----CeEEEEeccCCC---CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence            323222     1    348999998531   0000000122333357777788888888766436999999999999998


Q ss_pred             CCCCceee
Q 015672          219 GEPNVSYI  226 (403)
Q Consensus       219 ~~~~~~~~  226 (403)
                       ++.+.++
T Consensus       202 -~~~p~iI  208 (268)
T COG1718         202 -DGEPYII  208 (268)
T ss_pred             -CCeEEEE
Confidence             4444443

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.57  E-value=0.00014  Score=70.93  Aligned_cols=170  Identities=18%  Similarity=0.237  Sum_probs=105.9

Q ss_pred             HHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 015672          124 RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI  203 (403)
Q Consensus       124 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~  203 (403)
                      -..+.++.+.|+|...++++--    .......+|||++..++.+.+....     +..       .++.       . +
T Consensus        31 gr~~~lktl~~~~l~~yl~~~r----~~~~r~IVV~e~~~~Sled~~~~~~-----l~~-------~s~~-------~-~   86 (725)
T KOG1093|consen   31 GRFQYLKSLQHDNLCQYLDFSR----GKHERVIVVMEHYTMSLEDILKTGN-----LKD-------ESLL-------A-H   86 (725)
T ss_pred             hhhHHHHhhcCccceeeEeeec----CccceEEEEehhhccchHHHHHhcc-----cch-------hhhc-------c-c
Confidence            4567888999999998876542    1222377999999988887765421     110       0111       1 2


Q ss_pred             CccccccccccceecCCCCceeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 015672          204 GICHRDIKPQNLLVKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG  283 (403)
Q Consensus       204 ~ivHrDlKp~NILl~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~  283 (403)
                      ++.|-     ||+...+...+.     |  |-      ..++|+||||+|.++.++.-|...+......+.+..+.+...
T Consensus        87 ~~~~~-----~~~~~td~~~t~-----~--~~------~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~  148 (725)
T KOG1093|consen   87 GVLHL-----NIIYITDHFLTK-----Y--PS------PIGPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYT  148 (725)
T ss_pred             cccee-----hhhhcccccccc-----C--CC------CCCcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhcc
Confidence            33332     222222211111     1  11      133699999999999999999988876666666555544332


Q ss_pred             CCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          284 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                      .+.......+                 ...+...++....++..+|+-..|..||...++.+++-|.++
T Consensus       149 ~d~~~~~~a~-----------------e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  149 DDQELLSTAM-----------------EHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             CchhHHHHHH-----------------HHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            2222111000                 001223467788999999999999999999999999999875

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.35  E-value=0.00071  Score=67.66  Aligned_cols=30  Identities=30%  Similarity=0.392  Sum_probs=25.7

Q ss_pred             eeceecccCceEEEEEEECCCCcEEEEEEcc
Q 015672           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVL  116 (403)
Q Consensus        86 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~  116 (403)
                      -.+.||.-+.|.|++|+.+. |+.||||+-.
T Consensus       165 ~~~piaaASlaQVhrA~L~~-G~~VaVKVQ~  194 (538)
T KOG1235|consen  165 DEEPIAAASLAQVHRARLKN-GEDVAVKVQH  194 (538)
T ss_pred             CcchhhhcchhheEEEEecC-CCEEEEEecC
Confidence            34679999999999999865 9999999753

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.33  E-value=0.0017  Score=56.62  Aligned_cols=116  Identities=25%  Similarity=0.339  Sum_probs=79.7

Q ss_pred             ccEeeeceecccCc-eEEEEEEECCCCcEEEEEEccc--------------cc-----------ccHHHHHHHHHhc---
Q 015672           82 VSYIAEHVVGTGSF-GVVFQAKCRETGEIVAIKKVLQ--------------DK-----------RYKNRELQIMQML---  132 (403)
Q Consensus        82 ~~y~~~~~lG~G~~-g~V~~~~~~~~~~~vaiK~~~~--------------~~-----------~~~~~E~~~l~~l---  132 (403)
                      ..++.++.||.|.- |.||+++..  |+.||+|....              ..           .-+..|.+...+|   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            45899999999999 999999975  88999998311              00           0123566666555   


Q ss_pred             CCCCc--cccceEEeecC-------------CCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHH
Q 015672          133 DHPNI--VALKHCFFSTT-------------DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA  197 (403)
Q Consensus       133 ~h~ni--v~~~~~~~~~~-------------~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~  197 (403)
                      .+.++  |+.++++.-..             ........||.||++..-            .+....    +.+|..-|.
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~----~~~~~~dl~  178 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRD----IPQMLRDLK  178 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhH----HHHHHHHHH
Confidence            45566  88888774331             112234568888877421            122222    357888899


Q ss_pred             HHHhcCCccccccccccce
Q 015672          198 YIHNCIGICHRDIKPQNLL  216 (403)
Q Consensus       198 ~LH~~~~ivHrDlKp~NIL  216 (403)
                      .+|. .||+-+|+|+.|..
T Consensus       179 ~~~k-~gI~~~Dv~~~ny~  196 (207)
T PF13095_consen  179 ILHK-LGIVPRDVKPRNYR  196 (207)
T ss_pred             HHHH-CCeeeccCcccccc
Confidence            9999 89999999999974

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.33  E-value=0.0023  Score=56.08  Aligned_cols=115  Identities=20%  Similarity=0.301  Sum_probs=75.0

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEccccc--------------------ccHHHHHHHHHhcC------CCCccccc
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------------------RYKNRELQIMQMLD------HPNIVALK  141 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------------~~~~~E~~~l~~l~------h~niv~~~  141 (403)
                      ..||+|+.-.||.-   ......+||++....                    ....+|+.....+.      +.+|.+++
T Consensus         7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            56899999988853   334456789876544                    33346777666665      78888999


Q ss_pred             eEEeecCCCCceEEEEEeeccC---C----cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccccc
Q 015672          142 HCFFSTTDKEELYLNLVLEYVP---E----TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (403)
Q Consensus       142 ~~~~~~~~~~~~~~~lv~e~~~---~----~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~N  214 (403)
                      +...+..+     +.+|+|.+.   |    +|.+++.     .+.++. ....   .+-.-..||-. .+|+.+||+|.|
T Consensus        84 G~veT~~G-----~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~~~---~L~~f~~~l~~-~~Iv~~dl~~~N  148 (199)
T PF10707_consen   84 GFVETNLG-----LGLVVELIRDADGNISPTLEDYLK-----EGGLTE-ELRQ---ALDEFKRYLLD-HHIVIRDLNPHN  148 (199)
T ss_pred             EEEecCCc-----eEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HHHH---HHHHHHHHHHH-cCCeecCCCccc
Confidence            88754443     667777653   3    4444442     244554 3332   22333557777 799999999999


Q ss_pred             ceecCC
Q 015672          215 LLVKGE  220 (403)
Q Consensus       215 ILl~~~  220 (403)
                      |++...
T Consensus       149 Iv~~~~  154 (199)
T PF10707_consen  149 IVVQRR  154 (199)
T ss_pred             EEEEec
Confidence            999654

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.13  E-value=0.0017  Score=55.04  Aligned_cols=113  Identities=19%  Similarity=0.331  Sum_probs=72.0

Q ss_pred             eeeceecccCceEEEEEEECCCCcEEEEEEcccc--cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeecc
Q 015672           85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV  162 (403)
Q Consensus        85 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  162 (403)
                      .+.+.|++|.+|.||+|.+.  |..+|+|+-+.+  ......|+++|..+.-.++..=...+ .   .    .++.|||+
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~y-g---~----~~i~me~i   94 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY-G---E----DFIRMEYI   94 (201)
T ss_pred             hhhhhhhcccccEEEEeecc--CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEe-c---h----hhhhhhhh
Confidence            45688999999999999986  678999986544  34557899999999887776432222 1   1    23569999


Q ss_pred             CC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccc--ccceecC
Q 015672          163 PE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKP--QNLLVKG  219 (403)
Q Consensus       163 ~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp--~NILl~~  219 (403)
                      .| .|......       ..    +.-+..++++---|-. .||-|..|.-  .||++..
T Consensus        95 ~G~~L~~~~~~-------~~----rk~l~~vlE~a~~LD~-~GI~H~El~~~~k~vlv~~  142 (201)
T COG2112          95 DGRPLGKLEIG-------GD----RKHLLRVLEKAYKLDR-LGIEHGELSRPWKNVLVND  142 (201)
T ss_pred             cCcchhhhhhc-------cc----HHHHHHHHHHHHHHHH-hccchhhhcCCceeEEecC
Confidence            87 33222111       11    1122345555333444 7999998863  3555543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.04  E-value=0.0071  Score=54.35  Aligned_cols=69  Identities=14%  Similarity=0.073  Sum_probs=45.2

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEccccc--ccHHHHHHHHHhcCCCCc--cccceEEeecCCCCceEEEEEeeccC
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNI--VALKHCFFSTTDKEELYLNLVLEYVP  163 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~  163 (403)
                      ..||.|..+.||+.    .+..+++|......  ....+|.++++.+..-++  .+.+++.     .......+|||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence            46899999999984    24467889775422  235689999999865444  3333332     12222568999998


Q ss_pred             Cc
Q 015672          164 ET  165 (403)
Q Consensus       164 ~~  165 (403)
                      |.
T Consensus        78 G~   79 (226)
T TIGR02172        78 GK   79 (226)
T ss_pred             Cc
Confidence            73

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.38  E-value=0.0042  Score=68.16  Aligned_cols=196  Identities=15%  Similarity=-0.009  Sum_probs=117.0

Q ss_pred             HHHHHHhcCCCCccccceEEeecCCCCceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 015672          125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI  203 (403)
Q Consensus       125 E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~  203 (403)
                      |...++...|+++...+.-.   .+....-.+..++||. |.+..++-........+....+.....+.+.+..-+|+..
T Consensus      1279 e~de~~~~~h~~~~~~p~rI---~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRI---PPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhceeeecccccC---CCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            44455667899988764433   2222333557888887 4454444433332333444444444444467777777522


Q ss_pred             C----ccccccccccceecCCCCc-------------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHH
Q 015672          204 G----ICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL  260 (403)
Q Consensus       204 ~----ivHrDlKp~NILl~~~~~~-------------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~  260 (403)
                      +    .+|++||+-|.+|..+.++                   ..+|++.|++|++... -.++.++|+|..|+.+|+..
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHHh
Confidence            2    6899999999999766533                   1357889999998754 34788899999999999999


Q ss_pred             hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH
Q 015672          261 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA  340 (403)
Q Consensus       261 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta  340 (403)
                      .|..+|.     ..++.+.+.           .-.+...+..+.            ..|.++......+|-+.-..||.-
T Consensus      1435 ~~n~~fi-----~flq~~Lkg-----------iidn~tf~sIe~------------l~pgdaNve~~~~Ll~K~~~rp~q 1486 (2724)
T KOG1826|consen 1435 DGNAYFI-----FFLQPALKG-----------IIDNHTFFSIEK------------LKPGDANVEALHRLLWKYMERPGQ 1486 (2724)
T ss_pred             cccHHHH-----HHHHHHHcC-----------cccccccccccc------------cCCCcccHHHHHHHHHHhhhcchh
Confidence            9988772     222222221           111111111111            123333344445555566788988


Q ss_pred             HHHhcCCCcccC
Q 015672          341 LEACVHPFFDEL  352 (403)
Q Consensus       341 ~e~l~hp~f~~~  352 (403)
                      ...+.-+.|.-.
T Consensus      1487 ~isls~d~~a~~ 1498 (2724)
T KOG1826|consen 1487 YISLSRDHFAVG 1498 (2724)
T ss_pred             hhhccccccccc
Confidence            888887777543

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=96.18  E-value=0.062  Score=48.34  Aligned_cols=69  Identities=19%  Similarity=0.328  Sum_probs=44.4

Q ss_pred             eceecccCceEEEEEEECC-CCcEEEEEEccccc---ccHHHHHHHHHhcCCCCcc-ccceEEeecCCCCceEEEEEeec
Q 015672           87 EHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLNLVLEY  161 (403)
Q Consensus        87 ~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~  161 (403)
                      .+.|..|-...+|++.... .++.|++|+.....   ....+|+.+++.+...+++ +++..+     .+    .++|||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~~----~~l~e~   73 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF-----QN----GLIYEF   73 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe-----CC----cEEEEe
Confidence            3567888888999987543 35678899764322   2234799999999655554 332211     11    279999


Q ss_pred             cCC
Q 015672          162 VPE  164 (403)
Q Consensus       162 ~~~  164 (403)
                      ++|
T Consensus        74 i~G   76 (235)
T cd05157          74 IPG   76 (235)
T ss_pred             eCC
Confidence            875

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.12  E-value=0.028  Score=53.30  Aligned_cols=122  Identities=19%  Similarity=0.234  Sum_probs=80.5

Q ss_pred             eeceecccCceEEEEEEECCCCcEEEEEEccc------cc------------------------ccHHHHHHHHHhcCCC
Q 015672           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DK------------------------RYKNRELQIMQMLDHP  135 (403)
Q Consensus        86 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------~~------------------------~~~~~E~~~l~~l~h~  135 (403)
                      +-..|..|--+.||.|.. .+|..+|||+.+-      ++                        ....+|++-|++|+..
T Consensus       148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            445678888889999876 5788899997631      10                        1123688889998877


Q ss_pred             CccccceEEeecCCCCceEEEEEeeccCCcHH--HHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccc
Q 015672          136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVN--RIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ  213 (403)
Q Consensus       136 niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~--~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~  213 (403)
                      .|..---....      . -.|||++++..-+  -.+.     .-.++...+..+-.|++.-+.-|-+..++||.||.-=
T Consensus       227 GIP~PePIlLk------~-hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEf  294 (520)
T KOG2270|consen  227 GIPCPEPILLK------N-HVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEF  294 (520)
T ss_pred             CCCCCCceeee------c-ceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhh
Confidence            65432222211      1 3489999984211  1111     2346666777777788877776655468999999999


Q ss_pred             cceecCC
Q 015672          214 NLLVKGE  220 (403)
Q Consensus       214 NILl~~~  220 (403)
                      |+|+...
T Consensus       295 N~LyhdG  301 (520)
T KOG2270|consen  295 NLLYHDG  301 (520)
T ss_pred             hheEECC
Confidence            9998643

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=96.08  E-value=0.06  Score=48.78  Aligned_cols=68  Identities=15%  Similarity=0.093  Sum_probs=41.4

Q ss_pred             ecccCc-eEEEEEEECCCCcEEEEEEcccc-cccHHHHHHHHHhcCCC-CccccceEEeecCCCCceEEEEEeeccCC
Q 015672           90 VGTGSF-GVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLDHP-NIVALKHCFFSTTDKEELYLNLVLEYVPE  164 (403)
Q Consensus        90 lG~G~~-g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~~lv~e~~~~  164 (403)
                      |-.|.+ +.||++...  +..+.+|..... .....+|+++++.+... -+.+++++..     .....++||++++|
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~lv~e~i~G   76 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGS-----DDGRAWLLTSAVPG   76 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEe-----cCCccEEEEEeeCC
Confidence            444555 688998753  467888876432 12356799999988532 2334444331     11235689999886

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=95.87  E-value=0.066  Score=57.62  Aligned_cols=77  Identities=16%  Similarity=0.188  Sum_probs=49.7

Q ss_pred             eceecccCceEEEEEEECCCC--cEEEEEEcccc-----cccHHHHHHHHHhcC-CCCc--cccceEEeecCCCCceEEE
Q 015672           87 EHVVGTGSFGVVFQAKCRETG--EIVAIKKVLQD-----KRYKNRELQIMQMLD-HPNI--VALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        87 ~~~lG~G~~g~V~~~~~~~~~--~~vaiK~~~~~-----~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~~~~~~~~~~  156 (403)
                      .+.|+.|.++.+|+......+  ..+++|+....     .....+|+++|+.|. |.++  .+++.++.  +.......|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~--d~~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCT--DASVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEec--CCCcCCCce
Confidence            466899999999998764432  46778865332     234568999999996 6665  44443331  111122367


Q ss_pred             EEeeccCCc
Q 015672          157 LVLEYVPET  165 (403)
Q Consensus       157 lv~e~~~~~  165 (403)
                      +||||++|.
T Consensus       121 lVME~v~G~  129 (822)
T PLN02876        121 YIMEYLEGR  129 (822)
T ss_pred             EEEEecCCc
Confidence            999999874

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=95.58  E-value=0.09  Score=47.42  Aligned_cols=71  Identities=11%  Similarity=0.112  Sum_probs=38.6

Q ss_pred             ceecccCce-EEEEEEECCCCcEEEEEEcccc--cccHHHHHHHHHhcCCC-CccccceEEeecCCCC-ceEEEEEeecc
Q 015672           88 HVVGTGSFG-VVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHP-NIVALKHCFFSTTDKE-ELYLNLVLEYV  162 (403)
Q Consensus        88 ~~lG~G~~g-~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~-~~~~~lv~e~~  162 (403)
                      +.|+.|+.. .||+.     +..+++|.....  .....+|.+++..|... .+ ..-..+......+ ..+.+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v-~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPL-PVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCC-CCCceeecCCCccCCCcceEEEEee
Confidence            456766666 58875     234778865432  22456799999888642 11 1211221111111 12357889998


Q ss_pred             CC
Q 015672          163 PE  164 (403)
Q Consensus       163 ~~  164 (403)
                      +|
T Consensus        77 ~G   78 (235)
T cd05155          77 EG   78 (235)
T ss_pred             cC
Confidence            75

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=95.53  E-value=0.098  Score=46.51  Aligned_cols=74  Identities=18%  Similarity=0.205  Sum_probs=49.5

Q ss_pred             eceecccCceEEEEEEECCCCcEEEEEEcccc--cccHHHHHHHHHhcCCCCc--cccceEEeecCCCCceEEEEEeecc
Q 015672           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNI--VALKHCFFSTTDKEELYLNLVLEYV  162 (403)
Q Consensus        87 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~  162 (403)
                      ++.|+.|..+.||++....  ..+++|.....  .....+|..+++.|....+  .+++...  .........+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~--~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFD--TSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEE--EETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeec--ccccccccceEEEEEe
Confidence            4678999999999999754  58999987554  2344578899988865444  3444322  1122333478999999


Q ss_pred             CC
Q 015672          163 PE  164 (403)
Q Consensus       163 ~~  164 (403)
                      +|
T Consensus        78 ~g   79 (239)
T PF01636_consen   78 PG   79 (239)
T ss_dssp             SS
T ss_pred             cc
Confidence            86

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02721 ycfN_thiK thiamine kinase

Probab=95.10  E-value=0.14  Score=46.82  Aligned_cols=64  Identities=16%  Similarity=0.134  Sum_probs=40.8

Q ss_pred             ecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccc-cceEEeecCCCCceEEEEEeeccCC
Q 015672           90 VGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA-LKHCFFSTTDKEELYLNLVLEYVPE  164 (403)
Q Consensus        90 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~~~~~~lv~e~~~~  164 (403)
                      +..|-.+.+|+..  .+++.+++|......    ....+|..+++.+....++. ++...     .    -++||||++|
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~i~G   72 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEWLEG   72 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEeccC
Confidence            4567777888886  346678888754322    13467999999997554432 22211     1    2479999886

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=95.01  E-value=0.023  Score=52.97  Aligned_cols=128  Identities=16%  Similarity=0.148  Sum_probs=79.3

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcc----------ccc----------------ccHHHHHHHHHhcCCCC
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----------QDK----------------RYKNRELQIMQMLDHPN  136 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~----------~~~----------------~~~~~E~~~l~~l~h~n  136 (403)
                      -|.+++.||-|.-+.||.+.+ ..|.+.++|.-+          ..+                ....+|...|+.|....
T Consensus        93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            367888999999999999987 568888888431          110                11236899999985322


Q ss_pred             --ccccceEEeecCCCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccccc
Q 015672          137 --IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (403)
Q Consensus       137 --iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~N  214 (403)
                        +.+.++         ...-|+|||++.+-.   +.+.   ..-....   .+...+..-+.-|-. +|+||+|..-=|
T Consensus       172 fpVPkpiD---------~~RH~Vvmelv~g~P---l~~v---~~v~d~~---~ly~~lm~~Iv~la~-~GlIHgDFNEFN  232 (465)
T KOG2268|consen  172 FPVPKPID---------HNRHCVVMELVDGYP---LRQV---RHVEDPP---TLYDDLMGLIVRLAN-HGLIHGDFNEFN  232 (465)
T ss_pred             CCCCCccc---------ccceeeHHHhhcccc---eeee---eecCChH---HHHHHHHHHHHHHHH-cCceecccchhe
Confidence              222222         122568999887621   1110   1111122   222233333445555 799999999999


Q ss_pred             ceecCCCCceeecccc
Q 015672          215 LLVKGEPNVSYICSRY  230 (403)
Q Consensus       215 ILl~~~~~~~~~~t~~  230 (403)
                      |+++.+..+..+..|.
T Consensus       233 imv~dd~~i~vIDFPQ  248 (465)
T KOG2268|consen  233 IMVKDDDKIVVIDFPQ  248 (465)
T ss_pred             eEEecCCCEEEeechH
Confidence            9999888777765443

>PLN02756 S-methyl-5-thioribose kinase

Probab=94.99  E-value=1.2  Score=43.46  Aligned_cols=70  Identities=16%  Similarity=0.187  Sum_probs=43.4

Q ss_pred             eeceecccCceEEEEEEECCCCcEEEEEEccc-----------ccccHHHHHHHHHhcC---CCCccccceEEeecCCCC
Q 015672           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----------DKRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        86 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-----------~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~  151 (403)
                      ..+.||.|.-..||+....  +..++||.-..           .......|.+.|+.+.   ...+.+++.+.     .+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed  108 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RT  108 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CC
Confidence            3567899999999998863  45688997531           1122234666666653   23555665443     11


Q ss_pred             ceEEEEEeeccCC
Q 015672          152 ELYLNLVLEYVPE  164 (403)
Q Consensus       152 ~~~~~lv~e~~~~  164 (403)
                      .  -+++||++++
T Consensus       109 ~--~vlvME~L~~  119 (418)
T PLN02756        109 M--ALIGMRYLEP  119 (418)
T ss_pred             C--CEEEEeecCC
Confidence            1  4578999864

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=94.98  E-value=0.064  Score=46.66  Aligned_cols=95  Identities=21%  Similarity=0.191  Sum_probs=66.7

Q ss_pred             HHHHHHHHhcCC-CCccccceEEeecCCCCceEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH
Q 015672          123 NRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH  200 (403)
Q Consensus       123 ~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH  200 (403)
                      +.|.-+++.+.+ +++.+++|.+     .    -.++.||.+. .+......... -...++.....++.+++..+++|+
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~   76 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELD   76 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHh
Confidence            358889999977 6899999887     2    2468899873 33211000000 123567778899999999999998


Q ss_pred             hc--CCccccccccccceecCCCCceeec
Q 015672          201 NC--IGICHRDIKPQNLLVKGEPNVSYIC  227 (403)
Q Consensus       201 ~~--~~ivHrDlKp~NILl~~~~~~~~~~  227 (403)
                      ..  ..+.-.|++|+|+-++.++.++++.
T Consensus        77 ~~~~~~~~lcDv~~~nfgv~~~~~lk~iD  105 (188)
T PF12260_consen   77 HGPLGFFYLCDVSPDNFGVNDDGRLKLID  105 (188)
T ss_pred             cCCCCcEEEeecchHHeEEeCCCcEEEEe
Confidence            51  1366689999999999888877654

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=94.83  E-value=0.28  Score=45.83  Aligned_cols=73  Identities=5%  Similarity=-0.051  Sum_probs=44.4

Q ss_pred             eceecccCceEEEEEEECCCCcEEEEEEccc-ccccHHHHHHHHHhcCCCC--ccccceEEeecCC----CCceEEEEEe
Q 015672           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNRELQIMQMLDHPN--IVALKHCFFSTTD----KEELYLNLVL  159 (403)
Q Consensus        87 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~----~~~~~~~lv~  159 (403)
                      .+.|..|....+|++...  +..+++|+... .......|++++..|.+.+  +.+++..   ..+    ......++++
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~---~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIAD---RDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccC---CCCcEeeeeCCceEEEE
Confidence            456778888899988653  45688998753 2233457888888886543  3333221   000    0112357899


Q ss_pred             eccCC
Q 015672          160 EYVPE  164 (403)
Q Consensus       160 e~~~~  164 (403)
                      ++++|
T Consensus        94 ~~i~G   98 (296)
T cd05153          94 EFLAG   98 (296)
T ss_pred             EeCCC
Confidence            99875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=94.59  E-value=0.65  Score=43.88  Aligned_cols=72  Identities=10%  Similarity=-0.027  Sum_probs=40.5

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEccc-ccccHHHHHHHHHhcCCCCc--cccceEEeecCC----CCceEEEEEee
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYKNRELQIMQMLDHPNI--VALKHCFFSTTD----KEELYLNLVLE  160 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~----~~~~~~~lv~e  160 (403)
                      +.|+.|....+|.....  +..+++|+... .......|+.++..|...++  .+.+.   +..+    ......+++++
T Consensus        28 ~~l~~G~~n~~y~v~t~--~g~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~---~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         28 KGIAEGIENSNFFLTTT--QGEYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVA---RRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             chhccccccceEEEEeC--CCcEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCccee---CCCCCEeeeeCCEEEEEEE
Confidence            45777877889988753  33688997642 22233356777777743333  22221   1100    01223678999


Q ss_pred             ccCC
Q 015672          161 YVPE  164 (403)
Q Consensus       161 ~~~~  164 (403)
                      |++|
T Consensus       103 ~l~G  106 (319)
T PRK05231        103 FLEG  106 (319)
T ss_pred             ecCC
Confidence            9886

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=94.35  E-value=0.46  Score=44.70  Aligned_cols=77  Identities=5%  Similarity=-0.102  Sum_probs=43.6

Q ss_pred             eeceecccCceEEEEEEECCCCcEEEEEEcccc--cccHHHHHHHHHhcCCCC--ccccceEEeec-CCCCceEEEEEee
Q 015672           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPN--IVALKHCFFST-TDKEELYLNLVLE  160 (403)
Q Consensus        86 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~-~~~~~~~~~lv~e  160 (403)
                      ..+.++.|....+|++.. . +..+++|+....  ......|.+++..|...+  +.+++...-.. ........+++++
T Consensus        26 ~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             eccccCCccccceEEEEe-C-CCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            356678887789998864 2 335778976542  233446788888885433  23332210000 0011234678999


Q ss_pred             ccCC
Q 015672          161 YVPE  164 (403)
Q Consensus       161 ~~~~  164 (403)
                      |++|
T Consensus       104 ~i~G  107 (307)
T TIGR00938       104 FLQG  107 (307)
T ss_pred             eCCC
Confidence            9875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=94.33  E-value=0.8  Score=43.96  Aligned_cols=68  Identities=22%  Similarity=0.279  Sum_probs=41.3

Q ss_pred             eecccCceEEEEEEECCCCcEEEEEEcccc-----------cccHHHHHHHHHhcCC--C-CccccceEEeecCCCCceE
Q 015672           89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----------KRYKNRELQIMQMLDH--P-NIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        89 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~~~~~~~~  154 (403)
                      .||.|.-..||++.....++.|+||.-...           .....-|.+.|+...-  | .+.+++. | .    .. .
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~-D----~e-~   74 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH-F-D----TE-M   74 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE-E-c----cc-c
Confidence            479999999999997544468999964211           1122357777776632  3 3444433 2 1    11 1


Q ss_pred             EEEEeeccC
Q 015672          155 LNLVLEYVP  163 (403)
Q Consensus       155 ~~lv~e~~~  163 (403)
                      ..+|||+++
T Consensus        75 ~~~vMEdL~   83 (370)
T TIGR01767        75 AVTVMEDLS   83 (370)
T ss_pred             ceehHhhCc
Confidence            448999885

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=93.88  E-value=1.2  Score=41.71  Aligned_cols=65  Identities=12%  Similarity=0.077  Sum_probs=36.2

Q ss_pred             EEEEEEECCCCcEEEEEEcccccccHHHHHHHHHhcCCCCccccceEEeecCC----CCceEEEEEeeccCC
Q 015672           97 VVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD----KEELYLNLVLEYVPE  164 (403)
Q Consensus        97 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~~~~~~lv~e~~~~  164 (403)
                      .||++...  +..+++|...........|+.++..|...++ .+-..+.+..+    ......+++++|++|
T Consensus        11 ~v~~v~t~--~g~~~LK~~~~~~~~~~~~~~~~~~L~~~g~-~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G   79 (313)
T TIGR02906        11 NVYKVETD--SGNKCLKKINYPPERLLFILGAQEHLRKNGF-NIPKILKTKDGELYVKYNGDLYVLTEWIEG   79 (313)
T ss_pred             cEEEEEeC--CCCeEEEEcCCCHHHHHHHHHHHHHHHHcCC-CCCceeecCCCCEEEEECCEEEEEehhccC
Confidence            47887642  3358899875443344557777777754443 22222211111    012347899999875

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=93.46  E-value=5.1  Score=37.68  Aligned_cols=65  Identities=17%  Similarity=0.332  Sum_probs=36.1

Q ss_pred             ceEEEEEEECCCCcEEEEEEcccccccHHHHHHHHHhcCCCC---ccccceEEeecCCC----CceEEEEEeeccCC
Q 015672           95 FGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPN---IVALKHCFFSTTDK----EELYLNLVLEYVPE  164 (403)
Q Consensus        95 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~n---iv~~~~~~~~~~~~----~~~~~~lv~e~~~~  164 (403)
                      -|.||++.. . +..+++|.+..........+.++..|...+   ++++   +.+..+.    .+...+++|++++|
T Consensus        19 ~~~v~~v~T-~-~G~~~Lk~~~~~~~~l~~~~~~~~~L~~~G~~~~~~~---~~t~~G~~~~~~~~~~~~L~~wi~G   90 (309)
T TIGR02904        19 TGKLFKVYT-D-QGVFALKKLYADRNTIESFVSQIQVLSEKGFSRIVPV---YPTKDGSYYLFHGHFLYYLMPWLDI   90 (309)
T ss_pred             cCcEEEEEe-C-CCCEEEEEeccchHhHHHHHHHHHHHHHcCCCcCCce---eecCCCCeeeEECCEEEEEeCCccc
Confidence            558898865 3 346889988644433334566666665433   3443   2111111    12234789988775

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK10593 hypothetical protein; Provisional

Probab=93.31  E-value=1.1  Score=42.09  Aligned_cols=104  Identities=11%  Similarity=0.002  Sum_probs=63.1

Q ss_pred             eeceecccCceEEEEEEECCCCcEEEEEEccc--ccccHHHHHHHHHhcCCC---CccccceEEeecCCCCceEEEEEee
Q 015672           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDHP---NIVALKHCFFSTTDKEELYLNLVLE  160 (403)
Q Consensus        86 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~~~~~~lv~e  160 (403)
                      -.+.||.|..+.||..... ++ .+.+|..+.  .......|...|+.|...   .+.++++.+...  ......+||||
T Consensus        18 ~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~--~~~g~~~LVmE   93 (297)
T PRK10593         18 RVECISEQPYAALWALYDS-QG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE--QSPGPDVLLLE   93 (297)
T ss_pred             eeeecCCccceeEEEEEcC-CC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC--CcCCCeEEEEe
Confidence            3467999999999998643 23 466776543  134667899999998643   455555543211  11233679999


Q ss_pred             ccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 015672          161 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN  201 (403)
Q Consensus       161 ~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~  201 (403)
                      ++++...   ..     ..........+..+++.+|.-||+
T Consensus        94 ~i~G~~~---~~-----~~~~~~~~~~l~~~l~~~La~LH~  126 (297)
T PRK10593         94 RLRGVSV---EA-----PARTPERWEQLKDQIVEGLLAWHR  126 (297)
T ss_pred             ccCCEec---CC-----CCCCHHHHHHHHHHHHHHHHHHhC
Confidence            9986310   00     011222334455677788888886

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=92.34  E-value=2.2  Score=39.92  Aligned_cols=51  Identities=18%  Similarity=0.209  Sum_probs=33.9

Q ss_pred             ceecccCceEEEEEEECC------CCcEEEEEEccccc---ccHHHHHHHHHhcCCCCcc
Q 015672           88 HVVGTGSFGVVFQAKCRE------TGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIV  138 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~------~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv  138 (403)
                      +.|..|-...||++....      .++.+++|+.....   ....+|.+++..+...++.
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~   63 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLG   63 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCC
Confidence            445666677888887533      25788899865432   2346799999998655544

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=91.89  E-value=0.036  Score=54.48  Aligned_cols=71  Identities=25%  Similarity=0.490  Sum_probs=56.7

Q ss_pred             CCcccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccccc-----HHHHHHHHHhcCCCCccccceEEeec
Q 015672           77 NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-----KNRELQIMQMLDHPNIVALKHCFFST  147 (403)
Q Consensus        77 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~E~~~l~~l~h~niv~~~~~~~~~  147 (403)
                      ..+...++.....+|.|+||+|+.+..+.++..+|||.|......     ..+|+.-+.++.|++++.+.+.|...
T Consensus        44 ~sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~  119 (516)
T KOG1033|consen   44 TSREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYER  119 (516)
T ss_pred             hhhhhccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceecC
Confidence            456667789999999999999999999888889999988543222     23577778899999999998887543

>PLN02236 choline kinase

Probab=90.80  E-value=3.4  Score=39.62  Aligned_cols=52  Identities=13%  Similarity=0.109  Sum_probs=33.7

Q ss_pred             eceecccCceEEEEEEECC----CCcEEEEEEcccccc---cHHHHHHHHHhcCCCCcc
Q 015672           87 EHVVGTGSFGVVFQAKCRE----TGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIV  138 (403)
Q Consensus        87 ~~~lG~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~niv  138 (403)
                      ...|-.|-...+|++....    .++.|++|+......   ...+|..+++.+...++.
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~   99 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQG   99 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCC
Confidence            3445557777889886432    246788997643321   235799999998765554

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=90.65  E-value=0.69  Score=44.82  Aligned_cols=62  Identities=26%  Similarity=0.268  Sum_probs=35.1

Q ss_pred             EEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC
Q 015672          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP  221 (403)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~  221 (403)
                      ..|+-+|..| ++..++.     ....++...+.++.-.+.||.-+--..+.+|.|+.|.||++....
T Consensus       320 ~vl~E~~~~Gl~v~~~v~-----~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~  382 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVK-----WKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK  382 (565)
T ss_pred             ceeeeeccccccHHhhhh-----cccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence            3355556655 2322222     233455455555554455544332225899999999999996443

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=90.45  E-value=0.34  Score=45.77  Aligned_cols=63  Identities=24%  Similarity=0.470  Sum_probs=35.7

Q ss_pred             EEEeeccCCcHHHHHHH-hhhhcCCCCHHHHHHHHHHHHHHHHHHH-----hcCCccccccccccceecCC
Q 015672          156 NLVLEYVPETVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIH-----NCIGICHRDIKPQNLLVKGE  220 (403)
Q Consensus       156 ~lv~e~~~~~l~~~~~~-~~~~~~~l~~~~~~~~~~qi~~~L~~LH-----~~~~ivHrDlKp~NILl~~~  220 (403)
                      .+|++++-++-..+-.. ....+-..-...++.++.||+  |-|+-     .+.+.+|-||||+|||+-+.
T Consensus       247 IIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQia--LLyikIYelp~c~nF~H~DLKPdNILiFds  315 (434)
T PF05445_consen  247 IIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIA--LLYIKIYELPCCTNFLHVDLKPDNILIFDS  315 (434)
T ss_pred             EEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHH--HHHeeeecCCCcceeeecccCcCcEEEecC
Confidence            37887765433322111 111111122345777788884  45522     23578999999999998543

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PHA03111 Ser/Thr kinase; Provisional

Probab=89.04  E-value=0.58  Score=44.03  Aligned_cols=39  Identities=31%  Similarity=0.491  Sum_probs=26.8

Q ss_pred             HHHHHHHHHHHHHHHHHHHh---cCCccccccccccceecCC
Q 015672          182 LIYVKLYTYQICRALAYIHN---CIGICHRDIKPQNLLVKGE  220 (403)
Q Consensus       182 ~~~~~~~~~qi~~~L~~LH~---~~~ivHrDlKp~NILl~~~  220 (403)
                      ...++.++.||+.-.-.+-.   +.+.+|-||||+|||+-..
T Consensus       278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds  319 (444)
T PHA03111        278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS  319 (444)
T ss_pred             HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence            34577888898643322311   3478999999999998544

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=88.28  E-value=0.19  Score=40.15  Aligned_cols=45  Identities=24%  Similarity=0.343  Sum_probs=33.0

Q ss_pred             eceecccCceEEEEEEECCCCcEEEEEEccccc-ccHHHHHHHHHhc
Q 015672           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQML  132 (403)
Q Consensus        87 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l  132 (403)
                      ...||.|+.|.||+|+.+. |+.||||+.+..- ......+.+|+.+
T Consensus        16 ~~PlasASiaQVh~a~l~~-g~~VaVKV~rP~i~~~i~~Dl~~l~~~   61 (119)
T PF03109_consen   16 PEPLASASIAQVHRARLKD-GEEVAVKVQRPGIEEQIEADLRILRRL   61 (119)
T ss_pred             cchhhheehhhheeeeecc-cchhhhhhcchHHHHHHHHHHHHHHHH
Confidence            4579999999999999854 9999999876543 2334456665553

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=87.16  E-value=7.3  Score=38.15  Aligned_cols=71  Identities=18%  Similarity=0.262  Sum_probs=45.9

Q ss_pred             eceecccCceEEEEEEECCCCcEEEEEEccc-----------ccccHHHHHHHHHhcC---CCCccccceEEeecCCCCc
Q 015672           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----------DKRYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        87 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-----------~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~  152 (403)
                      .+.||.|.+..||++.....++.++||.-..           .......|.+.|+.+.   -.++.+++.+-     .  
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-----~--  103 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-----E--  103 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-----C--
Confidence            3569999999999999854436899997431           1112345778887763   23455554431     1  


Q ss_pred             eEEEEEeeccCC
Q 015672          153 LYLNLVLEYVPE  164 (403)
Q Consensus       153 ~~~~lv~e~~~~  164 (403)
                      ..-++||||+++
T Consensus       104 ~~~~lVME~L~~  115 (401)
T PRK09550        104 ELAVTVMEDLSD  115 (401)
T ss_pred             CCCEEEEecCCC
Confidence            114599999874

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=86.28  E-value=9.3  Score=36.36  Aligned_cols=51  Identities=16%  Similarity=0.256  Sum_probs=32.4

Q ss_pred             ceecccCceEEEEEEECCC---CcEEEEEEcccccc---cHHHHHHHHHhcCCCCcc
Q 015672           88 HVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIV  138 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~niv  138 (403)
                      +.|..|-...+|++.....   +..|++|+.-....   ...+|..+++.+...++.
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~   76 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFG   76 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCC
Confidence            3444477778888865432   23788887643222   235799999999766664

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=86.25  E-value=10  Score=35.04  Aligned_cols=42  Identities=14%  Similarity=0.061  Sum_probs=26.1

Q ss_pred             cccCceEEEEEEECCCCcEEEEEEcccc--cccHHHHHHHHHhcC
Q 015672           91 GTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLD  133 (403)
Q Consensus        91 G~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~  133 (403)
                      ++|-...|+.+.. .+|..+++|.-...  .....+|.++|+.|.
T Consensus        20 ~~g~~~~v~~i~~-~~g~~~VlR~p~~~~~~~~l~rE~~vL~~L~   63 (276)
T cd05152          20 ESGLDFQVVFAKD-TDGVPWVLRIPRRPDVSERAAAEKRVLALVR   63 (276)
T ss_pred             CCcceeEEEEEEc-CCCCeEEEEecCCHHHHHHHHHHHHHHHHHH
Confidence            4444445665532 35778888876432  223468999999985

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=84.09  E-value=9.7  Score=36.00  Aligned_cols=22  Identities=23%  Similarity=0.412  Sum_probs=18.4

Q ss_pred             CccccccccccceecCCCCcee
Q 015672          204 GICHRDIKPQNLLVKGEPNVSY  225 (403)
Q Consensus       204 ~ivHrDlKp~NILl~~~~~~~~  225 (403)
                      .++|+|+.+.||+++..+.+.+
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gV  220 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGV  220 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEE
Confidence            4899999999999998776443

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=81.20  E-value=5.4  Score=38.37  Aligned_cols=69  Identities=22%  Similarity=0.252  Sum_probs=47.3

Q ss_pred             CCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceeec
Q 015672          150 KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYIC  227 (403)
Q Consensus       150 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~~  227 (403)
                      .+..|.|++|++-++.+...        ......++..++.+.+.-+.-+......-|||+...||||+ +|+++++.
T Consensus       296 de~~y~yl~~kdhgt~is~i--------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLID  364 (488)
T COG5072         296 DETLYLYLHFKDHGTPISII--------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLID  364 (488)
T ss_pred             CCceEEEEEEecCCceeeee--------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEE
Confidence            45678999999987654221        11234456666666666555555445688999999999999 88887653

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	403
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-120
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-120
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-120
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-120
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-120
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-120
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-120
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-119
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-119
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-119
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-119
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-119
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-119
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-118
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-118
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-118
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-118
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-118
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-117
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-117
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-116
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-114
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		5e-76
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-69
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-38
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-38
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-38
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-37
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-37
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-37
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-37
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-37
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-37
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-37
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-37
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-37
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-37
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-37
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-37
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-37
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-37
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-37
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-37
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-37
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-37
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-37
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-37
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-37
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-37
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-37
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-37
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-37
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-37
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-37
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-37
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-37
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-37
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-37
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-37
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-37
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		8e-37
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-37
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-36
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-36
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-36
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-36
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		8e-36
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-36
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-35
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-35
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-35
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-35
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-35
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-35
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-34
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-34
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-34
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-34
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-34
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-34
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-34
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-34
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-34
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-34
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-34
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-34
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-34
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-34
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-34
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-34
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-34
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-34
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-34
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-34
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		8e-34
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-34
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		9e-34
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-33
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-33
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-33
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-33
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-33
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-33
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-33
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-33
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-33
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-33
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-33
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-33
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-33
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-33
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-33
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-33
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-33
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-33
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-33
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-33
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-33
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-33
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-33
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-33
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-33
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-33
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-33
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-33
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-33
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-33
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-33
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-33
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-33
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-33
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-33
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-33
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-33
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-33
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-33
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-33
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-33
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-33
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-33
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-33
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-33
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-33
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-33
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-33
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-33
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-33
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-33
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-33
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-33
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-33
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-33
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-33
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-33
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-33
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-33
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-33
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-32
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-32
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-32
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-32
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-32
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-32
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		8e-32
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-31
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-30
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-28
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-28
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-28
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-28
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-28
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-27
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-27
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-27
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-27
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-27
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-27
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-27
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-27
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-26
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-26
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-26
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-26
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-26
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-26
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-26
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-26
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-26
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-26
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-26
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-26
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		9e-26
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		9e-26
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-25
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-25
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-25
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-25
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-25
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-24
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-24
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-24
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-24
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-24
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-24
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		4e-24
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		4e-24
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-24
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-24
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		4e-24
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-24
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		5e-24
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		5e-24
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		5e-24
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		6e-24
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		6e-24
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		9e-24
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-23
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-23
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		4e-23
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		5e-23
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		6e-23
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		6e-23
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		6e-23
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		6e-23
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		6e-23
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		6e-23
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		6e-23
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		6e-23
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		6e-23
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		7e-23
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		9e-23
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-22
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-22
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-22
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-22
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-22
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-22
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-22
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-22
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-22
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-22
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		7e-22
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-21
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-20
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-20
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-20
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-19
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		7e-19
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-18
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-18
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-18
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-18
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-18
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-18
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-17
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		4e-17
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		5e-17
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-17
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-15
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-14
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-14
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-14
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		6e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-14
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		9e-14
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-13
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-13
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-13
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-13
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-13
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		3e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-13
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-13
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		9e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-12
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-12
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-12
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-12
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-12
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-12
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-12
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-12
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		8e-12
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		8e-12
4ae6_A	343	Structure And Function Of The Human Sperm-specific		8e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-12
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		9e-12
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		9e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-11
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-11
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-11
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-11
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-11
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-11
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-11
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-11
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-11
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-11
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-11
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-11
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-11
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-11
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-11
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-11
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-11
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		2e-11
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-11
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-11
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-11
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-11
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-11
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-11
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-11
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-11
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-11
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-11
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-11
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-11
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-11
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		4e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-11
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-11
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-11
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-11
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-11
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-11
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-11
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-11
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		7e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-11
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		8e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		9e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		9e-11
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		9e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-11
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		9e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-10
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		1e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-10
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		1e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-10
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		2e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-10
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-10
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		5e-10
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		5e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-10
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-10
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		8e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-09
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-09
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-09
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-09
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-09
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-09
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-09
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-09
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-09
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-09
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-09
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-09
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-09
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-09
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-09
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-09
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-09
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-09
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-09
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-09
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-09
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-09
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		7e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		7e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		8e-09
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		9e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-08
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-08
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-08
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-08
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-08
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-08
3soa_A	444	Full-Length Human Camkii Length = 444		4e-08
2oza_A	356	Structure Of P38alpha Complex Length = 356		4e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-08
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		5e-08
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		5e-08
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		5e-08
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-08
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		5e-08
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		5e-08
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		6e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-08
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		6e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-08
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		7e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		7e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		8e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		9e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		9e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-07
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		5e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		5e-07
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		5e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-07
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		7e-07
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-07
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-06
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-06
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-06
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-06
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-06
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-06
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-06
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-06
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-06
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-06
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-06
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-06
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-06
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-06
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-06
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-06
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		8e-06
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		8e-06
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-06
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-06
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-06
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		8e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-05
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-05
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		1e-05
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-05
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-05
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-05
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-05
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-05
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-05
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-05
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		2e-05
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		3e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-05
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-05
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-05
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-05
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-05
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-05
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-05
3gni_B	389	Structure Of Strad And Mo25 Length = 389		3e-05
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-05
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-05
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-05
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-05
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-05
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-05
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-05
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-05
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-05
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-05
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-05
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-05
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		8e-05
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		9e-05
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		9e-05
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		9e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-04
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-04
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-04
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-04
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-04
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-04
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-04
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-04
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-04
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-04
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-04
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-04
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-04
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-04
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-04
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-04
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-04
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-04
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-04
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-04
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-04
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-04
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-04
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-04
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-04
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-04
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-04
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-04
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-04
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-04
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-04
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-04
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-04
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-04
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-04
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-04
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-04
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-04
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-04
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-04
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-04
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-04
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		5e-04
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-04
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-04
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-04
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-04
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		6e-04
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-04
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-04
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-04
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		6e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		7e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		7e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-04
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-04
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		7e-04
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		7e-04
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		7e-04
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-04
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		8e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		8e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		8e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-04
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-04

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  429 bits (1102), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 221/360 (61%), Positives = 261/360 (72%), Gaps = 26/360 (7%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 25  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 82
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 83  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 142
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL------------------- 216
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL                   
Sbjct: 143 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 201
Query: 217 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 276
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 202 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 261
Query: 277 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 336
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 262 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 321
Query: 337 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 395
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 322 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 379

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  428 bits (1101), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 221/360 (61%), Positives = 261/360 (72%), Gaps = 26/360 (7%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 31  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 89  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL------------------- 216
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL                   
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 217 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 276
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 277 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 336
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327
Query: 337 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 395
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 328 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 385

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  428 bits (1101), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 221/360 (61%), Positives = 261/360 (72%), Gaps = 26/360 (7%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 35  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 92
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 93  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 152
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL------------------- 216
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL                   
Sbjct: 153 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 211
Query: 217 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 276
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 212 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 271
Query: 277 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 336
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 272 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 331
Query: 337 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 395
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 332 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 389

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  428 bits (1100), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 221/360 (61%), Positives = 261/360 (72%), Gaps = 26/360 (7%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 33  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 90
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 91  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 150
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL------------------- 216
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL                   
Sbjct: 151 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 209
Query: 217 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 276
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 210 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 269
Query: 277 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 336
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 270 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 329
Query: 337 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 395
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 330 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 387

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  428 bits (1100), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 221/360 (61%), Positives = 261/360 (72%), Gaps = 26/360 (7%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 76  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 133
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 134 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 193
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL------------------- 216
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL                   
Sbjct: 194 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 252
Query: 217 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 276
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 253 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 312
Query: 277 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 336
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 313 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 372
Query: 337 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 395
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 373 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 430

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  427 bits (1099), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 220/359 (61%), Positives = 260/359 (72%), Gaps = 26/359 (7%)
Query: 60  GAETGHVIRTTIG--GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ 117
           GA +   + T +   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQ
Sbjct: 1   GAMSLSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ 60
Query: 118 DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRI 176
           DKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR 
Sbjct: 61  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 120
Query: 177 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL-------------------V 217
            Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL                   V
Sbjct: 121 KQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 179
Query: 218 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 277
           +GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVE
Sbjct: 180 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 239
Query: 278 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 337
           IIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R
Sbjct: 240 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 299
Query: 338 CTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 395
            T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 300 LTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 356

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  427 bits (1098), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 221/360 (61%), Positives = 261/360 (72%), Gaps = 26/360 (7%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 10  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 67
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 68  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 127
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL------------------- 216
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL                   
Sbjct: 128 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186
Query: 217 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 276
           V+GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 187 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 246
Query: 277 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 336
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 247 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 306
Query: 337 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 395
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 307 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 364

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  426 bits (1094), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 220/360 (61%), Positives = 260/360 (72%), Gaps = 26/360 (7%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 31  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 89  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL------------------- 216
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL                   
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 217 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 276
           V+GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 208 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 277 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 336
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327
Query: 337 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 395
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 328 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 385

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  425 bits (1092), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 220/360 (61%), Positives = 260/360 (72%), Gaps = 26/360 (7%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 9   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 67  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 126
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL------------------- 216
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL                   
Sbjct: 127 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 217 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 276
           V+GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 277 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 336
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 305
Query: 337 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 395
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 306 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 363

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  424 bits (1090), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 220/360 (61%), Positives = 260/360 (72%), Gaps = 26/360 (7%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 16  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 73
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 74  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 133
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL------------------- 216
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL                   
Sbjct: 134 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192
Query: 217 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 276
           V+GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 193 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 252
Query: 277 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 336
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 253 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 312
Query: 337 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 395
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 313 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 370

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  424 bits (1090), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 220/360 (61%), Positives = 260/360 (72%), Gaps = 26/360 (7%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 9   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 67  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 126
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL------------------- 216
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL                   
Sbjct: 127 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 217 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 276
           V+GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 277 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 336
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 305
Query: 337 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 395
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 306 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 363

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  424 bits (1089), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 220/360 (61%), Positives = 260/360 (72%), Gaps = 26/360 (7%)
Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 5   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 62
Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR
Sbjct: 63  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 122
Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL------------------- 216
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL                   
Sbjct: 123 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181
Query: 217 VKGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 276
           V+GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 182 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 241
Query: 277 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 336
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 242 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 301
Query: 337 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 395
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 302 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 359

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  424 bits (1089), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 216/342 (63%), Positives = 253/342 (73%), Gaps = 24/342 (7%)
Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 ICRALAYIHNCIGICHRDIKPQNLL-------------------VKGEPNVSYICSRYYR 232
           + R+LAYIH+  GICHRDIKPQNLL                   V+GEPNVSYICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 353 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 393
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 349

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  422 bits (1085), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 218/357 (61%), Positives = 259/357 (72%), Gaps = 26/357 (7%)
Query: 58  GVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ 117
            +G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQ
Sbjct: 2   AMGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ 59
Query: 118 DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRI 176
           DKR+KNRELQIM+ LDH NIV L++ F+S+ +K               TV R+AR+YSR 
Sbjct: 60  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 119
Query: 177 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL-------------------V 217
            Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL                   V
Sbjct: 120 KQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 178
Query: 218 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 277
           +GEPNVS ICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVE
Sbjct: 179 RGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 238
Query: 278 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 337
           IIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R
Sbjct: 239 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 298
Query: 338 CTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 393
            T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 299 LTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 353

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  422 bits (1084), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 216/344 (62%), Positives = 253/344 (73%), Gaps = 24/344 (6%)
Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 ICRALAYIHNCIGICHRDIKPQNLL-------------------VKGEPNVSYICSRYYR 232
           + R+LAYIH+  GICHRDIKPQNLL                   V+GEPNVS ICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 353 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 395
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 351

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  421 bits (1081), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 215/342 (62%), Positives = 252/342 (73%), Gaps = 24/342 (7%)
Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 ICRALAYIHNCIGICHRDIKPQNLL-------------------VKGEPNVSYICSRYYR 232
           + R+LAYIH+  GICHRDIKPQNLL                   V+GEPNVS ICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 353 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 393
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 349

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  421 bits (1081), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 215/342 (62%), Positives = 252/342 (73%), Gaps = 24/342 (7%)
Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 12  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 71
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 72  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 131
Query: 192 ICRALAYIHNCIGICHRDIKPQNLL-------------------VKGEPNVSYICSRYYR 232
           + R+LAYIH+  GICHRDIKPQNLL                   V+GEPNVS ICSRYYR
Sbjct: 132 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 190
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 191 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 250
Query: 293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 251 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 310
Query: 353 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 393
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 311 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 350

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  421 bits (1081), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 215/342 (62%), Positives = 252/342 (73%), Gaps = 24/342 (7%)
Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 ICRALAYIHNCIGICHRDIKPQNLL-------------------VKGEPNVSYICSRYYR 232
           + R+LAYIH+  GICHRDIKPQNLL                   V+GEPNVS ICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 353 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 393
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 349

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  418 bits (1075), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 214/342 (62%), Positives = 251/342 (73%), Gaps = 24/342 (7%)
Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQ K +KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKL 70
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 ICRALAYIHNCIGICHRDIKPQNLL-------------------VKGEPNVSYICSRYYR 232
           + R+LAYIH+  GICHRDIKPQNLL                   V+GEPNVSYICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 353 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 393
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 349

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  417 bits (1073), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 214/344 (62%), Positives = 251/344 (72%), Gaps = 24/344 (6%)
Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQ K +KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKL 70
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 ICRALAYIHNCIGICHRDIKPQNLL-------------------VKGEPNVSYICSRYYR 232
           + R+LAYIH+  GICHRDIKPQNLL                   V+GEPNVSYICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
           MNPNYTEF FPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 353 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHARKQ 395
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR Q
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHARIQ 351

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  414 bits (1063), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 212/342 (61%), Positives = 249/342 (72%), Gaps = 24/342 (7%)
Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQ K +KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKL 70
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           DH NIV L++ F+S+ +K               TV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 192 ICRALAYIHNCIGICHRDIKPQNLL-------------------VKGEPNVSYICSRYYR 232
           + R+LAYIH+  GICHRDIKPQNLL                   V+GEPNVS ICSRYYR
Sbjct: 131 LFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYR 189
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
           MNPNYTEF FPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 353 RDPNTRLPNGRPLPPLFNFKPPELSGIPP-ETINRLIPEHAR 393
           RDPN +LPNGR  P LFNF   ELS  PP  TI  LIP HAR
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATI--LIPPHAR 349

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  408 bits (1049), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 205/352 (58%), Positives = 253/352 (71%), Gaps = 23/352 (6%)
Query: 66  VIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE 125
           VI+          +++++Y    V+G GSFGVVFQAK  E+ E VAIKKVLQDKR+KNRE
Sbjct: 24  VIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRE 82
Query: 126 LQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXX-XTVNRIARNYSRIHQRMPLIY 184
           LQIM+++ HPN+V LK  F+S  DK               TV R +R+Y+++ Q MP++ 
Sbjct: 83  LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLL 142
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNL-------------------LVKGEPNVSY 225
           +KLY YQ+ R+LAYIH+ IGICHRDIKPQNL                   L+ GEPNVS 
Sbjct: 143 IKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX 201
Query: 226 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 285
           ICSRYYRAPELIFGAT YTT IDIWSTGCVMAEL+ GQPLFPGESG+DQLVEIIKVLGTP
Sbjct: 202 ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261
Query: 286 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 345
           +RE+IK MNPNY E KFPQI+PHP+ KVF+ R PP+A+DL+ R  +Y+P+ R TA+EA  
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321
Query: 346 HPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNL 397
           HPFFDELR    R+PNGR LPPLFN+   ELS + P+ I+RL+P+HA  + L
Sbjct: 322 HPFFDELRTGEARMPNGRELPPLFNWTKEELS-VRPDLISRLVPQHAEAELL 372

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  281 bits (718), Expect = 5e-76,   Method: Compositional matrix adjust.
 Identities = 150/369 (40%), Positives = 215/369 (58%), Gaps = 62/369 (16%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHC 143
           Y     +GTGSFG+V +    E+G+  A+KKVLQD RYKNREL IM++LDH NI+ L   
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 144 FFSTTDK---------------------------------XXXXXXXXXXXXXXTVNRIA 170
           F++T D+                                               T++++ 
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 171 RNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKG----------- 219
           +++ R  + +P+  + +Y YQ+ RA+ +IH+ +GICHRDIKPQNLLV             
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 220 --------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 271
                   EP+V+ ICSR+YRAPEL+ GATEYT +ID+WS GCV  EL+LG+PLF GE+ 
Sbjct: 188 SAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETS 247
Query: 272 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 331
           +DQLV II+++GTPT+E++  MNP+YTE +FP +K   W K+  +  P  A+DL+ +  +
Sbjct: 248 IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307
Query: 332 YSPNLRCTALEACVHPFFDELRDP-------NTRLPNG--RPLPPLFNFKPPELSGIPPE 382
           Y P+LR    EA  HPFFD LR+        N+  P+G  + +P LFNF P ELS IP  
Sbjct: 308 YEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGN 367
Query: 383 TINRLIPEH 391
            +NR++P++
Sbjct: 368 VLNRILPKN 376

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  258 bits (660), Expect = 3e-69,   Method: Compositional matrix adjust.
 Identities = 142/339 (41%), Positives = 195/339 (57%), Gaps = 29/339 (8%)
Query: 79  KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQ---MLDHP 135
           K+   +  E + G G+FG V   K + TG  VAIKKV+QD R++NRELQIMQ   +L HP
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHP 79
Query: 136 NIVALKHCFFS--TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           NIV L+  F++    D+              T++R  RNY R     P I +K++ +Q+ 
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 194 RALAYIH-NCIGICHRDIKPQNLLVK-------------------GEPNVSYICSRYYRA 233
           R++  +H   + +CHRDIKP N+LV                     EPNV+YICSRYYRA
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRA 199
Query: 234 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 293
           PELIFG   YTTA+DIWS GC+ AE++LG+P+F G++   QL EI++VLG P+RE ++ +
Sbjct: 200 PELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259
Query: 294 NPNYTEFKFPQIKPHPWHKVFQK---RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
           NP++T+      K  PW  VF     +   EA DL+    QY P  R    EA  HP+FD
Sbjct: 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFD 319
Query: 351 ELRDPNTRLPNGRPLPP-LFNFKPPELSGIPPETINRLI 388
           EL DP T+LPN + LP  LF F P E+  +      +L+
Sbjct: 320 ELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLV 358

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  155 bits (391), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 102/318 (32%), Positives = 157/318 (49%), Gaps = 69/318 (21%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 75  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 115
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KPQNLL+                 G P  +Y   + + +YR
Sbjct: 116 LLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 174
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 175 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 230
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 231 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 288
Query: 347 PFFDELRDPNTRLPNGRP 364
           PFF ++  P   L   RP
Sbjct: 289 PFFQDVTKPVPHLRLERP 306

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  154 bits (389), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 99/309 (32%), Positives = 154/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQ 110
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KPQNLL+                 G P  +Y   + + +YR
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 169
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 225
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 226 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 284 PFFQDVTKP 292

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  154 bits (389), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 99/309 (32%), Positives = 154/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KPQNLL+                 G P  +Y   + + +YR
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 170
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 171 APEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 226
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 227 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 284
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 285 PFFQDVTKP 293

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 99/309 (32%), Positives = 154/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 78  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KPQNLL+                 G P  +Y   + + +YR
Sbjct: 119 LLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 177
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 178 APEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 233
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 234 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 291
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 292 PFFQDVTKP 300

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 99/309 (32%), Positives = 154/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 73  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KPQNLL+                 G P  +Y   + + +YR
Sbjct: 114 LLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 172
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 228
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 229 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 286
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 287 PFFQDVTKP 295

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 99/309 (32%), Positives = 154/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 74  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KPQNLL+                 G P  +Y   + + +YR
Sbjct: 115 LLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 173
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 229
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 230 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 287
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 288 PFFQDVTKP 296

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 99/309 (32%), Positives = 154/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KPQNLL+                 G P  +Y   + + +YR
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 170
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 226
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 227 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 284
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 285 PFFQDVTKP 293

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 99/309 (32%), Positives = 154/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 74  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KPQNLL+                 G P  +Y   + + +YR
Sbjct: 115 LLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 173
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 229
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 230 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 287
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 288 PFFQDVTKP 296

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 99/309 (32%), Positives = 154/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 73  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KPQNLL+                 G P  +Y   + + +YR
Sbjct: 114 LLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 172
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 228
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 229 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 286
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 287 PFFQDVTKP 295

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 99/309 (32%), Positives = 154/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KPQNLL+                 G P  +Y   + + +YR
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 169
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 225
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 226 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 284 PFFQDVTKP 292

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 99/309 (32%), Positives = 154/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KPQNLL+                 G P  +Y   + + +YR
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 170
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 226
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 227 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 284
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 285 PFFQDVTKP 293

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 99/309 (32%), Positives = 154/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KPQNLL+                 G P  +Y   + + +YR
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 169
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 225
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 226 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 284 PFFQDVTKP 292

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 99/309 (32%), Positives = 154/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 78  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KPQNLL+                 G P  +Y   + + +YR
Sbjct: 119 LLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 177
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 178 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 233
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 234 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 291
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 292 PFFQDVTKP 300

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 99/309 (32%), Positives = 154/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 74  I-------------------HTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQ 114
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KPQNLL+                 G P  +Y   + + +YR
Sbjct: 115 LLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 173
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 229
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 230 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 287
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 288 PFFQDVTKP 296

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 99/309 (32%), Positives = 154/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KPQNLL+                 G P  +Y   + + +YR
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 170
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 226
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 227 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 284
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 285 PFFQDVTKP 293

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 99/309 (32%), Positives = 154/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 72  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KPQNLL+                 G P  +Y   + + +YR
Sbjct: 113 LLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 171
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 227
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 228 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 285
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 286 PFFQDVTKP 294

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 99/309 (32%), Positives = 154/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 75  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 115
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KPQNLL+                 G P  +Y   + + +YR
Sbjct: 116 LLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 174
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 175 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 230
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 231 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 288
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 289 PFFQDVTKP 297

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 99/309 (32%), Positives = 154/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 72  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KPQNLL+                 G P  +Y   + + +YR
Sbjct: 113 LLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 171
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 227
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 228 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 285
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 286 PFFQDVTKP 294

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 99/309 (32%), Positives = 154/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KPQNLL+                 G P  +Y   + + +YR
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 169
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 225
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 226 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 284 PFFQDVTKP 292

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 99/309 (32%), Positives = 154/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KPQNLL+                 G P  +Y   + + +YR
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 169
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 225
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 226 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 284 PFFQDVTKP 292

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 99/309 (32%), Positives = 154/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KPQNLL+                 G P  +Y   + + +YR
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 170
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 226
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 227 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 284
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 285 PFFQDVTKP 293

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 99/309 (32%), Positives = 154/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 72  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KPQNLL+                 G P  +Y   + + +YR
Sbjct: 113 LLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 171
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 227
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 228 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 285
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 286 PFFQDVTKP 294

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 99/309 (32%), Positives = 154/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KPQNLL+                 G P  +Y   + + +YR
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 170
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 226
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 227 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 284
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 285 PFFQDVTKP 293

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 98/297 (32%), Positives = 152/297 (51%), Gaps = 45/297 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
              T +K               ++  A         +PL  +K Y +Q+ + LA+ H+  
Sbjct: 73  I-HTENKLYLVFEFLSMDLKDFMDASALT------GIPLPLIKSYLFQLLQGLAFCHSH- 124
Query: 204 GICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYRAPELIFGATEYT 244
            + HRD+KPQNLL+                 G P  +Y   + + +YRAPE++ G   Y+
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 245 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 304
           TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + + P  T    P 
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTS--MPD 238
Query: 305 IKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 355
            KP    W +  F K +PP   +   L+ +   Y PN R +A  A  HPFF ++  P
Sbjct: 239 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 98/297 (32%), Positives = 152/297 (51%), Gaps = 45/297 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
              T +K               ++  A         +PL  +K Y +Q+ + LA+ H+  
Sbjct: 74  I-HTENKLYLVFEFLSMDLKDFMDASALT------GIPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 204 GICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYRAPELIFGATEYT 244
            + HRD+KPQNLL+                 G P  +Y   + + +YRAPE++ G   Y+
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 245 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 304
           TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + + P  T    P 
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTS--MPD 239
Query: 305 IKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 355
            KP    W +  F K +PP   +   L+ +   Y PN R +A  A  HPFF ++  P
Sbjct: 240 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 98/297 (32%), Positives = 152/297 (51%), Gaps = 45/297 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
              T +K               ++  A         +PL  +K Y +Q+ + LA+ H+  
Sbjct: 74  I-HTENKLYLVFEHVDQDLKKFMDASALT------GIPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 204 GICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYRAPELIFGATEYT 244
            + HRD+KPQNLL+                 G P  +Y   + + +YRAPE++ G   Y+
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 245 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 304
           TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + + P  T    P 
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTS--MPD 239
Query: 305 IKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 355
            KP    W +  F K +PP   +   L+ +   Y PN R +A  A  HPFF ++  P
Sbjct: 240 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 98/309 (31%), Positives = 154/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 72  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KP+NLL+                 G P  +Y   + + +YR
Sbjct: 113 LLQGLAFCHSH-RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 171
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 227
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 228 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 285
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 286 PFFQDVTKP 294

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 98/309 (31%), Positives = 154/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 73  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KP+NLL+                 G P  +Y   + + +YR
Sbjct: 114 LLQGLAFCHSH-RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 172
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 228
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 229 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 286
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 287 PFFQDVTKP 295

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 98/309 (31%), Positives = 154/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + L++ H+   + HRD+KPQNLL+                 G P  +Y   + + +YR
Sbjct: 112 LLQGLSFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 170
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 226
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 227 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 284
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 285 PFFQDVTKP 293

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 98/309 (31%), Positives = 154/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KP+NLL+                 G P  +Y   + + +YR
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 170
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 226
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 227 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 284
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 285 PFFQDVTKP 293

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 97/323 (30%), Positives = 150/323 (46%), Gaps = 62/323 (19%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN---RELQIMQMLDHPN 136
           +Y++   VG+G++G V  A  + +GE VAIKK+    Q + +     REL +++ + H N
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--------- 187
           ++ L   F                    T     RN+   +  MP +   L         
Sbjct: 85  VIGLLDVF--------------------TPASSLRNFYDFYLVMPFMQTDLQKIMGLKFS 124
Query: 188 ------YTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV----------------SY 225
                   YQ+ + L YIH+  G+ HRD+KP NL V  +  +                 Y
Sbjct: 125 EEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY 183
Query: 226 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 285
           + +R+YRAPE+I     Y   +DIWS GC+MAE+L G+ LF G+  +DQL +I+KV G P
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 243
Query: 286 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALE 342
             E ++ +N    +  + Q  P    K F +  P   P+A DL+ +  +   + R TA +
Sbjct: 244 GTEFVQKLNDKAAK-SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ 302
Query: 343 ACVHPFFDELRDPNTRLPNGRPL 365
           A  HPFF+  RDP       +P 
Sbjct: 303 ALTHPFFEPFRDPEEETEAQQPF 325

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 98/305 (32%), Positives = 152/305 (49%), Gaps = 69/305 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KPQNLL+                 G P  +Y   + + +YR
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYR 170
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 226
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 227 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 284
Query: 347 PFFDE 351
           PFF +
Sbjct: 285 PFFQD 289

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 97/297 (32%), Positives = 152/297 (51%), Gaps = 45/297 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
              T +K               ++  A         +PL  +K Y +Q+ + LA+ H+  
Sbjct: 74  I-HTENKLYLVFEFLSMDLKKFMDASALT------GIPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 204 GICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYRAPELIFGATEYT 244
            + HRD+KP+NLL+                 G P  +Y   + + +YRAPE++ G   Y+
Sbjct: 126 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 245 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 304
           TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + + P  T    P 
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTS--MPD 239
Query: 305 IKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 355
            KP    W +  F K +PP   +   L+ +   Y PN R +A  A  HPFF ++  P
Sbjct: 240 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 97/323 (30%), Positives = 150/323 (46%), Gaps = 62/323 (19%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN---RELQIMQMLDHPN 136
           +Y++   VG+G++G V  A  + +GE VAIKK+    Q + +     REL +++ + H N
Sbjct: 43  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 102
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--------- 187
           ++ L   F                    T     RN+   +  MP +   L         
Sbjct: 103 VIGLLDVF--------------------TPASSLRNFYDFYLVMPFMQTDLQKIMGMEFS 142
Query: 188 ------YTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV----------------SY 225
                   YQ+ + L YIH+  G+ HRD+KP NL V  +  +                 Y
Sbjct: 143 EEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY 201
Query: 226 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 285
           + +R+YRAPE+I     Y   +DIWS GC+MAE+L G+ LF G+  +DQL +I+KV G P
Sbjct: 202 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 261
Query: 286 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLP---PEAVDLVCRFFQYSPNLRCTALE 342
             E ++ +N    +  + Q  P    K F +  P   P+A DL+ +  +   + R TA +
Sbjct: 262 GTEFVQKLNDKAAK-SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ 320
Query: 343 ACVHPFFDELRDPNTRLPNGRPL 365
           A  HPFF+  RDP       +P 
Sbjct: 321 ALTHPFFEPFRDPEEETEAQQPF 343

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 97/297 (32%), Positives = 152/297 (51%), Gaps = 45/297 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
              T +K               ++  A         +PL  +K Y +Q+ + LA+ H+  
Sbjct: 72  I-HTENKLYLVFEFLSMDLKKFMDASALT------GIPLPLIKSYLFQLLQGLAFCHSH- 123
Query: 204 GICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYRAPELIFGATEYT 244
            + HRD+KP+NLL+                 G P  +Y   + + +YRAPE++ G   Y+
Sbjct: 124 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 245 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 304
           TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + + P  T    P 
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EVVWPGVTS--MPD 237
Query: 305 IKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 355
            KP    W +  F K +PP   +   L+ +   Y PN R +A  A  HPFF ++  P
Sbjct: 238 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  151 bits (381), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 98/309 (31%), Positives = 153/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+ K+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 71  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KPQNLL+                 G P  +Y   + + +YR
Sbjct: 112 LLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 170
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 226
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 227 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 284
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 285 PFFQDVTKP 293

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  151 bits (381), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 98/309 (31%), Positives = 153/309 (49%), Gaps = 69/309 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+ + TGE+VA+ K+  D   +       RE+ +++ L+HPNIV L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM------------PLIYVKLYTYQ 191
                                T N++   +  +HQ +            PL  +K Y +Q
Sbjct: 70  I-------------------HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYR 232
           + + LA+ H+   + HRD+KPQNLL+                 G P  +Y   + + +YR
Sbjct: 111 LLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 169
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP     + 
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD----EV 225
Query: 293 MNPNYTEFKFPQIKPH--PWHKV-FQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVH 346
           + P  T    P  KP    W +  F K +PP   +   L+ +   Y PN R +A  A  H
Sbjct: 226 VWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283
Query: 347 PFFDELRDP 355
           PFF ++  P
Sbjct: 284 PFFQDVTKP 292

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  150 bits (380), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 97/291 (33%), Positives = 146/291 (50%), Gaps = 44/291 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVAL 140
           +G G F  V++A+ + T +IVAIKK+    R +          RE++++Q L HPNI+ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
              F   ++                +  I ++ S +   +   ++K Y     + L Y+H
Sbjct: 78  LDAFGHKSN-----ISLVFDFMETDLEVIIKDNSLV---LTPSHIKAYMLMTLQGLEYLH 129
Query: 201 NCIGICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYRAPELIFGAT 241
               I HRD+KP NLL+                 G PN +Y   + +R+YRAPEL+FGA 
Sbjct: 130 QH-WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGAR 188
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI--KCMNPNYTE 299
            Y   +D+W+ GC++AELLL  P  PG+S +DQL  I + LGTPT E+    C  P+Y  
Sbjct: 189 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 248
Query: 300 FK-FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           FK FP I   P H +F      + +DL+   F ++P  R TA +A    +F
Sbjct: 249 FKSFPGI---PLHHIFSAA-GDDLLDLIQGLFLFNPCARITATQALKMKYF 295

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 104/344 (30%), Positives = 164/344 (47%), Gaps = 43/344 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKK------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
            +G G++GVV  A+ R TG+ VAIKK      V+ + +   REL+I++   H NI+A+K 
Sbjct: 61  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 120
Query: 143 CFFSTTDKXXXXXXXXXXXXXXT-VNRIARNYSRIHQRMPLI--YVKLYTYQICRALAYI 199
               T                 + +++I      IH   PL   +V+ + YQ+ R L Y+
Sbjct: 121 ILRPTVPYGEFKSVYVVLDLMESDLHQI------IHSSQPLTLEHVRYFLYQLLRGLKYM 174
Query: 200 HNCIGICHRDIKPQNLLVK-------GEPNVS----------------YICSRYYRAPEL 236
           H+   + HRD+KP NLLV        G+  ++                Y+ +R+YRAPEL
Sbjct: 175 HSA-QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL 233
Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 296
           +    EYT AID+WS GC+  E+L  + LFPG++ V QL  I+ VLGTP+   I+ +   
Sbjct: 234 MLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAE 293
Query: 297 YTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 353
                    P  +P PW  V+      +A+ L+ R  ++ P+ R +A  A  HPF  +  
Sbjct: 294 RVRAYIQSLPPRQPVPWETVYPG-ADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352
Query: 354 DPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNL 397
           DP+       P    F+ +      I    +  +   HAR++ +
Sbjct: 353 DPDDEPDCAPPFDFAFDREALTRERIKEAIVAEIEDFHARREGI 396

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  150 bits (380), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 102/344 (29%), Positives = 167/344 (48%), Gaps = 45/344 (13%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIV 138
           Y     +G G++G+V  A        VAIKK+   + + Y  R   E+QI+    H N++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            ++    ++T +               + ++ ++     Q++   ++  + YQI R L Y
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKS-----QQLSNDHICYFLYQILRGLKY 159
Query: 199 IHNCIGICHRDIKPQNLLVK---------------GEPN-------VSYICSRYYRAPEL 236
           IH+   + HRD+KP NLL+                 +P           + +R+YRAPE+
Sbjct: 160 IHSA-NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEI 218
Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--- 293
           +  +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+   
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINM 278
Query: 294 -NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
              NY +   P      W K+F K    +A+DL+ R   ++PN R T  EA  HP+ ++ 
Sbjct: 279 KARNYLQ-SLPSKTKVAWAKLFPKS-DSKALDLLDRMLTFNPNKRITVEEALAHPYLEQY 336
Query: 353 RDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 395
            DP        P    F F   EL  +P E +  LI  E AR Q
Sbjct: 337 YDPTDEPVAEEP----FTFA-MELDDLPKERLKELIFQETARFQ 375

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 104/344 (30%), Positives = 164/344 (47%), Gaps = 43/344 (12%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKK------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
            +G G++GVV  A+ R TG+ VAIKK      V+ + +   REL+I++   H NI+A+K 
Sbjct: 62  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 121
Query: 143 CFFSTTDKXXXXXXXXXXXXXXT-VNRIARNYSRIHQRMPLI--YVKLYTYQICRALAYI 199
               T                 + +++I      IH   PL   +V+ + YQ+ R L Y+
Sbjct: 122 ILRPTVPYGEFKSVYVVLDLMESDLHQI------IHSSQPLTLEHVRYFLYQLLRGLKYM 175
Query: 200 HNCIGICHRDIKPQNLLVK-------GEPNVS----------------YICSRYYRAPEL 236
           H+   + HRD+KP NLLV        G+  ++                Y+ +R+YRAPEL
Sbjct: 176 HSA-QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL 234
Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 296
           +    EYT AID+WS GC+  E+L  + LFPG++ V QL  I+ VLGTP+   I+ +   
Sbjct: 235 MLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAE 294
Query: 297 YTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 353
                    P  +P PW  V+      +A+ L+ R  ++ P+ R +A  A  HPF  +  
Sbjct: 295 RVRAYIQSLPPRQPVPWETVYPG-ADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 353
Query: 354 DPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQNL 397
           DP+       P    F+ +      I    +  +   HAR++ +
Sbjct: 354 DPDDEPDCAPPFDFAFDREALTRERIKEAIVAEIEDFHARREGI 397

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 92/300 (30%), Positives = 143/300 (47%), Gaps = 32/300 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           VG+G++G V  A      + VA+KK+      L   R   REL++++ L H N++ L   
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 144 FF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           F  +T+ +               +N I ++     Q +   +V+   YQ+ R L YIH+ 
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKS-----QALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 203 IGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTTA 246
            GI HRD+KP N+ V                  E    Y+ +R+YRAPE++     Y   
Sbjct: 151 -GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 247 IDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 306
           +DIWS GC+MAELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +       + 
Sbjct: 210 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLP 269
Query: 307 PHPWHKVFQ--KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRP 364
           P P   +    +   P A+DL+ R      + R +A EA  H +F +  DP    P   P
Sbjct: 270 PMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDE-PEAEP 328

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  147 bits (372), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 95/319 (29%), Positives = 157/319 (49%), Gaps = 46/319 (14%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHC 143
           ++G G++GVV  A  + TGEIVAIKK+    +        RE++I++   H NI+ + + 
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
               + +               ++R+        Q +   +++ + YQ  RA+  +H   
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS- 131
Query: 204 GICHRDIKPQNLLVKG-----------------------EPN------VSYICSRYYRAP 234
            + HRD+KP NLL+                         EP       V ++ +R+YRAP
Sbjct: 132 NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAP 191
Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP-TREEIKCM 293
           E++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GTP +  +++C+
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCI 251
Query: 294 -NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
            +P   E+    P     P  K+F  R+ P+ +DL+ R   + P  R TA EA  HP+  
Sbjct: 252 ESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310
Query: 351 ELRDPNTRLPNGRPLPPLF 369
              DPN   P G P+PP F
Sbjct: 311 TYHDPNDE-PEGEPIPPSF 328

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  147 bits (372), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 95/319 (29%), Positives = 156/319 (48%), Gaps = 46/319 (14%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHC 143
           ++G G++GVV  A  + TGEIVAIKK+    +        RE++I++   H NI+ + + 
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
               + +               ++R+        Q +   +++ + YQ  RA+  +H   
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS- 131
Query: 204 GICHRDIKPQNLLVKG-----------------------EPN------VSYICSRYYRAP 234
            + HRD+KP NLL+                         EP         Y+ +R+YRAP
Sbjct: 132 NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAP 191
Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP-TREEIKCM 293
           E++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GTP +  +++C+
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCI 251
Query: 294 -NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
            +P   E+    P     P  K+F  R+ P+ +DL+ R   + P  R TA EA  HP+  
Sbjct: 252 ESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310
Query: 351 ELRDPNTRLPNGRPLPPLF 369
              DPN   P G P+PP F
Sbjct: 311 TYHDPNDE-PEGEPIPPSF 328

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 92/300 (30%), Positives = 142/300 (47%), Gaps = 32/300 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           VG+G++G V  A      + VA+KK+      L   R   REL++++ L H N++ L   
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 144 FF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           F  +T+ +               +N I +      Q +   +V+   YQ+ R L YIH+ 
Sbjct: 96  FTPATSIEDFSEVYLVTTLMGADLNNIVKC-----QALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 203 IGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTTA 246
            GI HRD+KP N+ V                  E    Y+ +R+YRAPE++     Y   
Sbjct: 151 -GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 247 IDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 306
           +DIWS GC+MAELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +       + 
Sbjct: 210 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLP 269
Query: 307 PHPWHKVFQ--KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRP 364
           P P   +    +   P A+DL+ R      + R +A EA  H +F +  DP    P   P
Sbjct: 270 PMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDE-PEAEP 328

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 92/300 (30%), Positives = 142/300 (47%), Gaps = 32/300 (10%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           VG+G++G V  A      + VA+KK+      L   R   REL++++ L H N++ L   
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 144 FF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           F  +T+ +               +N I +      Q +   +V+   YQ+ R L YIH+ 
Sbjct: 88  FTPATSIEDFSEVYLVTTLMGADLNNIVKC-----QALSDEHVQFLVYQLLRGLKYIHSA 142
Query: 203 IGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTTA 246
            GI HRD+KP N+ V                  E    Y+ +R+YRAPE++     Y   
Sbjct: 143 -GIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATRWYRAPEIMLNWMHYNQT 201
Query: 247 IDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 306
           +DIWS GC+MAELL G+ LFPG   +DQL  I++V+GTP+ E +  ++  +       + 
Sbjct: 202 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLP 261
Query: 307 PHPWHKVFQ--KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRP 364
           P P   +    +   P A+DL+ R      + R +A EA  H +F +  DP    P   P
Sbjct: 262 PMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDE-PEAEP 320

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 94/332 (28%), Positives = 156/332 (46%), Gaps = 74/332 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLD-HPNIVALKH 142
           +G G++G+V+++  R TGE+VA+KK+        D +   RE+ I+  L  H NIV L +
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              +  D+               V R A     +H++    YV    YQ+ + + Y+H+ 
Sbjct: 77  VLRADNDRDVYLVFDYMETDLHAVIR-ANILEPVHKQ----YV---VYQLIKVIKYLHSG 128
Query: 203 IGICHRDIKPQNLLVKGEPNV--------------------------------------- 223
            G+ HRD+KP N+L+  E +V                                       
Sbjct: 129 -GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 224 -SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 282
             Y+ +R+YRAPE++ G+T+YT  ID+WS GC++ E+L G+P+FPG S ++QL  II V+
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVI 247
Query: 283 GTPTREEIKCMNPNYTEFKFPQIKPH-------------PWHKVFQKRLPP-----EAVD 324
             P+ E+++ +   + +     +K                W  +  K  P      EA+D
Sbjct: 248 DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALD 307
Query: 325 LVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
           L+ +  Q++PN R +A +A  HPF     +PN
Sbjct: 308 LLDKLLQFNPNKRISANDALKHPFVSIFHNPN 339

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 94/319 (29%), Positives = 155/319 (48%), Gaps = 46/319 (14%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHC 143
           ++G G++GVV  A  + TGEIVAIKK+    +        RE++I++   H NI+ + + 
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
               + +               ++R+        Q +   +++ + YQ  RA+  +H   
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS- 131
Query: 204 GICHRDIKPQNLLVKG-----------------------EPN------VSYICSRYYRAP 234
            + HRD+KP NLL+                         EP          + +R+YRAP
Sbjct: 132 NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAP 191
Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP-TREEIKCM 293
           E++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GTP +  +++C+
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCI 251
Query: 294 -NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
            +P   E+    P     P  K+F  R+ P+ +DL+ R   + P  R TA EA  HP+  
Sbjct: 252 ESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310
Query: 351 ELRDPNTRLPNGRPLPPLF 369
              DPN   P G P+PP F
Sbjct: 311 TYHDPNDE-PEGEPIPPSF 328

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  144 bits (364), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 95/294 (32%), Positives = 151/294 (51%), Gaps = 39/294 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           VG G++GVV++AK  + G IVA+K++  D   +       RE+ +++ L HPNIV+L   
Sbjct: 29  VGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
             S  ++               V  +  N + +        +K+Y YQ+ R +A+ H   
Sbjct: 88  IHS--ERCLTLVFEFMEKDLKKV--LDENKTGLQDSQ----IKIYLYQLLRGVAHCHQH- 138
Query: 204 GICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYRAPELIFGATEYT 244
            I HRD+KPQNLL+                 G P  SY   + + +YRAP+++ G+ +Y+
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYS 198
Query: 245 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKF 302
           T++DIWS GC+ AE++ G+PLFPG +  DQL +I  +LGTP   E   +   P + +  F
Sbjct: 199 TSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF 258
Query: 303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
              +  PW  +       E +DL+     + PN R +A +A  HP+F +L DP 
Sbjct: 259 QVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL-DPQ 310

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  144 bits (363), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 95/294 (32%), Positives = 151/294 (51%), Gaps = 39/294 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           VG G++GVV++AK  + G IVA+K++  D   +       RE+ +++ L HPNIV+L   
Sbjct: 29  VGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
             S  ++               V  +  N + +        +K+Y YQ+ R +A+ H   
Sbjct: 88  IHS--ERCLTLVFEFMEKDLKKV--LDENKTGLQDSQ----IKIYLYQLLRGVAHCHQH- 138
Query: 204 GICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYRAPELIFGATEYT 244
            I HRD+KPQNLL+                 G P  SY   + + +YRAP+++ G+ +Y+
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYS 198
Query: 245 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKF 302
           T++DIWS GC+ AE++ G+PLFPG +  DQL +I  +LGTP   E   +   P + +  F
Sbjct: 199 TSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF 258
Query: 303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
              +  PW  +       E +DL+     + PN R +A +A  HP+F +L DP 
Sbjct: 259 QVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL-DPQ 310

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 97/338 (28%), Positives = 164/338 (48%), Gaps = 45/338 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 205 ICHRDIKPQNLLVK---------------GEPN-------VSYICSRYYRAPELIFGATE 242
           + HRD+KP NLL+                 +P+         Y+ +R+YRAPE++  +  
Sbjct: 149 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNYT 298
           YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY 
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 268
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
               P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+  
Sbjct: 269 -LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 326
Query: 359 LPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 395
                P    F F   EL  +P E +  LI  E AR Q
Sbjct: 327 PIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 359

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 97/338 (28%), Positives = 164/338 (48%), Gaps = 45/338 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 152
Query: 205 ICHRDIKPQNLLVK---------------GEPN-------VSYICSRYYRAPELIFGATE 242
           + HRD+KP NLL+                 +P+         Y+ +R+YRAPE++  +  
Sbjct: 153 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 212
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNYT 298
           YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY 
Sbjct: 213 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 272
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
               P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+  
Sbjct: 273 -LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 330
Query: 359 LPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 395
                P    F F   EL  +P E +  LI  E AR Q
Sbjct: 331 PIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 363

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 97/338 (28%), Positives = 164/338 (48%), Gaps = 45/338 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 205 ICHRDIKPQNLLVK---------------GEPN-------VSYICSRYYRAPELIFGATE 242
           + HRD+KP NLL+                 +P+         Y+ +R+YRAPE++  +  
Sbjct: 145 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNYT 298
           YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY 
Sbjct: 205 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 264
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
               P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+  
Sbjct: 265 -LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 322
Query: 359 LPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 395
                P    F F   EL  +P E +  LI  E AR Q
Sbjct: 323 PIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 355

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 97/338 (28%), Positives = 164/338 (48%), Gaps = 45/338 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 205 ICHRDIKPQNLLVK---------------GEPN-------VSYICSRYYRAPELIFGATE 242
           + HRD+KP NLL+                 +P+         Y+ +R+YRAPE++  +  
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNYT 298
           YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY 
Sbjct: 205 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 264
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
               P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+  
Sbjct: 265 -LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 322
Query: 359 LPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 395
                P    F F   EL  +P E +  LI  E AR Q
Sbjct: 323 PIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 355

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 97/338 (28%), Positives = 164/338 (48%), Gaps = 45/338 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 205 ICHRDIKPQNLLVK---------------GEPN-------VSYICSRYYRAPELIFGATE 242
           + HRD+KP NLL+                 +P+         Y+ +R+YRAPE++  +  
Sbjct: 149 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNYT 298
           YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY 
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 268
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
               P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+  
Sbjct: 269 -LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 326
Query: 359 LPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 395
                P    F F   EL  +P E +  LI  E AR Q
Sbjct: 327 PIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 359

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 97/338 (28%), Positives = 164/338 (48%), Gaps = 45/338 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 205 ICHRDIKPQNLLVK---------------GEPN-------VSYICSRYYRAPELIFGATE 242
           + HRD+KP NLL+                 +P+         Y+ +R+YRAPE++  +  
Sbjct: 145 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNYT 298
           YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY 
Sbjct: 205 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 264
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
               P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+  
Sbjct: 265 -LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 322
Query: 359 LPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 395
                P    F F   EL  +P E +  LI  E AR Q
Sbjct: 323 PIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 355

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 97/338 (28%), Positives = 164/338 (48%), Gaps = 45/338 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 205 ICHRDIKPQNLLVK---------------GEPN-------VSYICSRYYRAPELIFGATE 242
           + HRD+KP NLL+                 +P+         Y+ +R+YRAPE++  +  
Sbjct: 147 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNYT 298
           YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY 
Sbjct: 207 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 266
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
               P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+  
Sbjct: 267 -LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 324
Query: 359 LPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 395
                P    F F   EL  +P E +  LI  E AR Q
Sbjct: 325 PIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 357

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 97/338 (28%), Positives = 164/338 (48%), Gaps = 45/338 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 164
Query: 205 ICHRDIKPQNLLVK---------------GEPN-------VSYICSRYYRAPELIFGATE 242
           + HRD+KP NLL+                 +P+         Y+ +R+YRAPE++  +  
Sbjct: 165 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 224
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNYT 298
           YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY 
Sbjct: 225 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 284
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
               P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+  
Sbjct: 285 -LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 342
Query: 359 LPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 395
                P    F F   EL  +P E +  LI  E AR Q
Sbjct: 343 PIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 375

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 97/338 (28%), Positives = 164/338 (48%), Gaps = 45/338 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 164
Query: 205 ICHRDIKPQNLLVK---------------GEPN-------VSYICSRYYRAPELIFGATE 242
           + HRD+KP NLL+                 +P+         Y+ +R+YRAPE++  +  
Sbjct: 165 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 224
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNYT 298
           YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY 
Sbjct: 225 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 284
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
               P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+  
Sbjct: 285 -LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 342
Query: 359 LPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 395
                P    F F   EL  +P E +  LI  E AR Q
Sbjct: 343 PIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 375

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 97/338 (28%), Positives = 164/338 (48%), Gaps = 45/338 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 142
Query: 205 ICHRDIKPQNLLVK---------------GEPN-------VSYICSRYYRAPELIFGATE 242
           + HRD+KP NLL+                 +P+         Y+ +R+YRAPE++  +  
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 202
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNYT 298
           YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY 
Sbjct: 203 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 262
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
               P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+  
Sbjct: 263 -LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 320
Query: 359 LPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 395
                P    F F   EL  +P E +  LI  E AR Q
Sbjct: 321 PIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 353

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 97/338 (28%), Positives = 164/338 (48%), Gaps = 45/338 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 149
Query: 205 ICHRDIKPQNLLVK---------------GEPN-------VSYICSRYYRAPELIFGATE 242
           + HRD+KP NLL+                 +P+         Y+ +R+YRAPE++  +  
Sbjct: 150 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 209
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNYT 298
           YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY 
Sbjct: 210 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 269
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
               P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+  
Sbjct: 270 -LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 327
Query: 359 LPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 395
                P    F F   EL  +P E +  LI  E AR Q
Sbjct: 328 PIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 360

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 97/338 (28%), Positives = 164/338 (48%), Gaps = 45/338 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 150
Query: 205 ICHRDIKPQNLLVK---------------GEPN-------VSYICSRYYRAPELIFGATE 242
           + HRD+KP NLL+                 +P+         Y+ +R+YRAPE++  +  
Sbjct: 151 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 210
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNYT 298
           YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY 
Sbjct: 211 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 270
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
               P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+  
Sbjct: 271 -LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 328
Query: 359 LPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 395
                P    F F   EL  +P E +  LI  E AR Q
Sbjct: 329 PIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 361

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 97/338 (28%), Positives = 164/338 (48%), Gaps = 45/338 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 141
Query: 205 ICHRDIKPQNLLVK---------------GEPN-------VSYICSRYYRAPELIFGATE 242
           + HRD+KP NLL+                 +P+         Y+ +R+YRAPE++  +  
Sbjct: 142 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 201
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNYT 298
           YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY 
Sbjct: 202 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 261
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
               P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+  
Sbjct: 262 -LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 319
Query: 359 LPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 395
                P    F F   EL  +P E +  LI  E AR Q
Sbjct: 320 PIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 352

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 97/338 (28%), Positives = 164/338 (48%), Gaps = 45/338 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 205 ICHRDIKPQNLLVK---------------GEPN-------VSYICSRYYRAPELIFGATE 242
           + HRD+KP NLL+                 +P+         Y+ +R+YRAPE++  +  
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNYT 298
           YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY 
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 268
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
               P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+  
Sbjct: 269 -LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 326
Query: 359 LPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 395
                P    F F   EL  +P E +  LI  E AR Q
Sbjct: 327 PIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 359

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 147/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I ++     Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKS-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVKGEPNV----------------SYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V  +  +                 Y+ +R+YRAPE++     Y  
Sbjct: 144 A-DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 261
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 97/338 (28%), Positives = 163/338 (48%), Gaps = 45/338 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 205 ICHRDIKPQNLLVK---------------GEPN-------VSYICSRYYRAPELIFGATE 242
           + HRD+KP NLL+                 +P+         Y+ +R+YRAPE++  +  
Sbjct: 147 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNYT 298
           YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY 
Sbjct: 207 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 266
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
               P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+  +  DP+  
Sbjct: 267 -LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDPSDE 324
Query: 359 LPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 395
                P    F F   EL  +P E +  LI  E AR Q
Sbjct: 325 PIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 357

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  141 bits (356), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 93/304 (30%), Positives = 147/304 (48%), Gaps = 69/304 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+ I++ L H NIV L   
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP-----------LIYVKLYTYQI 192
                                T  R+   +  + Q +             +  K +  Q+
Sbjct: 69  I-------------------HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 193 CRALAYIHNCIGICHRDIKPQNLLV--KGEPNVS-----------------YICSRYYRA 233
              +AY H+   + HRD+KPQNLL+  +GE  ++                  I + +YRA
Sbjct: 110 LNGIAYCHDR-RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168
Query: 234 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE----- 288
           P+++ G+ +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +     
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 289 -EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 347
            E+   +PN+T +     +P PW   F K L    +DL+ +  +  PN R TA +A  H 
Sbjct: 229 TELPKYDPNFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282
Query: 348 FFDE 351
           +F E
Sbjct: 283 YFKE 286

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 95/337 (28%), Positives = 161/337 (47%), Gaps = 43/337 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 205 ICHRDIKPQNLLVK---------------GEPN-------VSYICSRYYRAPELIFGATE 242
           + HRD+KP NLL+                 +P+         Y+ +R+YRAPE++  +  
Sbjct: 147 VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC---MNPNYTE 299
           YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C   +      
Sbjct: 207 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKARNYL 266
Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 359
              P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+  +  DP+   
Sbjct: 267 LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDPSDEP 325
Query: 360 PNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 395
               P    F F   EL  +P E +  LI  E AR Q
Sbjct: 326 IAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 357

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 97/338 (28%), Positives = 163/338 (48%), Gaps = 45/338 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 142
Query: 205 ICHRDIKPQNLLVK---------------GEPN-------VSYICSRYYRAPELIFGATE 242
           + HRD+KP NLL+                 +P+         Y+ +R+YRAPE++  +  
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 202
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNYT 298
           YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P +E++ C+      NY 
Sbjct: 203 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKARNYL 262
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
               P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+  
Sbjct: 263 -LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 320
Query: 359 LPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 395
                P    F F   EL  +P E +  LI  E AR Q
Sbjct: 321 PIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 353

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  141 bits (355), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 96/338 (28%), Positives = 164/338 (48%), Gaps = 45/338 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAI+K+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 205 ICHRDIKPQNLLVK---------------GEPN-------VSYICSRYYRAPELIFGATE 242
           + HRD+KP NLL+                 +P+         Y+ +R+YRAPE++  +  
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNYT 298
           YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY 
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 268
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
               P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+  
Sbjct: 269 -LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 326
Query: 359 LPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 395
                P    F F   EL  +P E +  LI  E AR Q
Sbjct: 327 PIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 359

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  141 bits (355), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 97/315 (30%), Positives = 150/315 (47%), Gaps = 38/315 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  +   ++G  +A+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 117
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  +T+ +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 172
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 173 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNM 231
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   ++QL +I+++ GTP    I  M      NY    
Sbjct: 232 TVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNYIN-S 290
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPN 361
            PQ+    +  VF     P AVDL+ +      + R TA EA  HP+F +  DP+   P 
Sbjct: 291 LPQMPKRNFADVFIGA-NPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHDPDDE-PE 348
Query: 362 GRPLPPLFNFKPPEL 376
             P    F  +  E+
Sbjct: 349 SEPYDQSFESRQLEI 363

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  141 bits (355), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 94/295 (31%), Positives = 146/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++  A  Y  
Sbjct: 144 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNAMHYNQ 202
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 261
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  140 bits (354), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 92/304 (30%), Positives = 147/304 (48%), Gaps = 69/304 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+ I++ L H NIV L   
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP-----------LIYVKLYTYQI 192
                                T  R+   +  + Q +             +  K +  Q+
Sbjct: 69  I-------------------HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 193 CRALAYIHNCIGICHRDIKPQNLLV--KGEPNVS-----------------YICSRYYRA 233
              +AY H+   + HRD+KPQNLL+  +GE  ++                  + + +YRA
Sbjct: 110 LNGIAYCHDR-RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRA 168
Query: 234 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE----- 288
           P+++ G+ +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +     
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 289 -EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 347
            E+   +PN+T +     +P PW   F K L    +DL+ +  +  PN R TA +A  H 
Sbjct: 229 TELPKYDPNFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282
Query: 348 FFDE 351
           +F E
Sbjct: 283 YFKE 286

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 146/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKX-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVKGEPNV----------------SYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V  +  +                 Y+ +R+YRAPE++     Y  
Sbjct: 144 A-DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 261
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 92/304 (30%), Positives = 147/304 (48%), Gaps = 69/304 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+ I++ L H NIV L   
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP-----------LIYVKLYTYQI 192
                                T  R+   +  + Q +             +  K +  Q+
Sbjct: 69  I-------------------HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 193 CRALAYIHNCIGICHRDIKPQNLLV--KGEPNVS-----------------YICSRYYRA 233
              +AY H+   + HRD+KPQNLL+  +GE  ++                  + + +YRA
Sbjct: 110 LNGIAYCHDR-RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRA 168
Query: 234 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE----- 288
           P+++ G+ +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +     
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 289 -EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 347
            E+   +PN+T +     +P PW   F K L    +DL+ +  +  PN R TA +A  H 
Sbjct: 229 TELPKYDPNFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282
Query: 348 FFDE 351
           +F E
Sbjct: 283 YFKE 286

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 97/338 (28%), Positives = 164/338 (48%), Gaps = 45/338 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKC-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 205 ICHRDIKPQNLLVK---------------GEPN-------VSYICSRYYRAPELIFGATE 242
           + HRD+KP NLL+                 +P+         Y+ +R+YRAPE++  +  
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNYT 298
           YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY 
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 268
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
               P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+  
Sbjct: 269 -LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 326
Query: 359 LPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 395
                P    F F   EL  +P E +  LI  E AR Q
Sbjct: 327 PIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 359

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 146/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 145
Query: 202 CIGICHRDIKPQNLLVKGEPNV----------------SYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V  +  +                 Y+ +R+YRAPE++     Y  
Sbjct: 146 A-DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 204
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 205 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 263
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 264 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 146/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 149
Query: 202 CIGICHRDIKPQNLLVKGEPNV----------------SYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V  +  +                 Y+ +R+YRAPE++     Y  
Sbjct: 150 A-DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 208
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 209 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 267
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 268 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 107
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 162
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 163 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 221
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 222 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 280
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 281 LAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 334

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 144 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 261
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 LAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 163
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 164 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 222
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 223 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 281
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 282 LAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKX-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 144 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 261
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 149
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 150 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 208
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 209 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 267
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 268 LAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 146/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 99
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 154
Query: 202 CIGICHRDIKPQNLLVKGEPNV----------------SYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V  +  +                 Y+ +R+YRAPE++     Y  
Sbjct: 155 A-DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 213
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 214 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 272
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 273 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 326

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 97/338 (28%), Positives = 162/338 (47%), Gaps = 45/338 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 205 ICHRDIKPQNLLVK---------------GEPN-------VSYICSRYYRAPELIFGATE 242
           + HRD+KP NLL+                 +P+         Y+ +R+YRAPE++  +  
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMNPNYT 298
           YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E+    I     NY 
Sbjct: 205 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYL 264
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
               P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+  
Sbjct: 265 -LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 322
Query: 359 LPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 395
                P    F F   EL  +P E +  LI  E AR Q
Sbjct: 323 PIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 355

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 98
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 99  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 153
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 154 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 212
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 213 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 271
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 272 LAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 325

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 139
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 140 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 198
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 257
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 258 LAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 144 A-DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 261
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 97/338 (28%), Positives = 162/338 (47%), Gaps = 45/338 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 144
Query: 205 ICHRDIKPQNLLVK---------------GEPN-------VSYICSRYYRAPELIFGATE 242
           + HRD+KP NLL+                 +P+         Y+ +R+YRAPE++  +  
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMNPNYT 298
           YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E+    I     NY 
Sbjct: 205 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYL 264
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
               P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+  
Sbjct: 265 -LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 322
Query: 359 LPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 395
                P    F F   EL  +P E +  LI  E AR Q
Sbjct: 323 PIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 355

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 150
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 151 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQ 209
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 210 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 268
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 269 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 96/317 (30%), Positives = 151/317 (47%), Gaps = 42/317 (13%)
Query: 73  GRNGNSKQKVSYIAEHV---------VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKR 120
            R+G  +Q+V+  A  V         VG+G++G V  A    TG  VAIKK+    Q + 
Sbjct: 7   ARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL 66
Query: 121 YKNR---ELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH 177
           +  R   EL++++ + H N++ L   F  T D+                  + +     H
Sbjct: 67  FAKRAYRELRLLKHMRHENVIGLLDVF--TPDETLDDFTDFYLVMPFMGTDLGKLMK--H 122
Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-------------- 223
           +++    ++   YQ+ + L YIH   GI HRD+KP NL V  +  +              
Sbjct: 123 EKLGEDRIQFLVYQMLKGLRYIH-AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
Query: 224 --SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 281
               + +R+YRAPE+I     YT  +DIWS GC+MAE++ G+ LF G   +DQL EI+KV
Sbjct: 182 MXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 241
Query: 282 LGTPTREEIKCMNP----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 337
            GTP  E ++ +      NY +   P+++   +  +      P AV+L+ +        R
Sbjct: 242 TGTPPAEFVQRLQSDEAKNYMK-GLPELEKKDFASILTN-ASPLAVNLLEKMLVLDAEQR 299
Query: 338 CTALEACVHPFFDELRD 354
            TA EA  HP+F+ L D
Sbjct: 300 VTAGEALAHPYFESLHD 316

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 150
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 151 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQ 209
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 210 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 268
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 269 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 146/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 148
Query: 202 CIGICHRDIKPQNLLVKGEPNV----------------SYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V  +  +                 Y+ +R+YRAPE++     Y  
Sbjct: 149 A-DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 207
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 208 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 266
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 267 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 96/338 (28%), Positives = 164/338 (48%), Gaps = 45/338 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 148
Query: 205 ICHRDIKPQNLLVK---------------GEPNVSY-------ICSRYYRAPELIFGATE 242
           + HRD+KP NLL+                 +P+  +       + +R+YRAPE++  +  
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKG 208
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNYT 298
           YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY 
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 268
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
               P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+  
Sbjct: 269 -LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 326
Query: 359 LPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 395
                P    F F   EL  +P E +  LI  E AR Q
Sbjct: 327 PIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 359

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 150
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 151 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQ 209
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 210 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 268
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 269 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 96/338 (28%), Positives = 164/338 (48%), Gaps = 45/338 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNR---ELQIMQMLDHPNIVALKHCF 144
           +G G++G+V  A        VAIKK+   + + Y  R   E++I+    H NI+ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            + T +               + ++ +      Q +   ++  + YQI R L YIH+   
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-N 149
Query: 205 ICHRDIKPQNLLVK---------------GEPNVSY-------ICSRYYRAPELIFGATE 242
           + HRD+KP NLL+                 +P+  +       + +R+YRAPE++  +  
Sbjct: 150 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKG 209
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----NPNYT 298
           YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+      NY 
Sbjct: 210 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 269
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
               P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  DP+  
Sbjct: 270 -LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 327
Query: 359 LPNGRPLPPLFNFKPPELSGIPPETINRLI-PEHARKQ 395
                P    F F   EL  +P E +  LI  E AR Q
Sbjct: 328 PIAEAP----FKFD-MELDDLPKEKLKELIFEETARFQ 360

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 155
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 156 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 214
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 215 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 273
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 274 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 327

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 155
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 156 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 214
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 215 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 273
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 274 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 327

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 149
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 150 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 208
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 209 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 267
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 268 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 149
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 150 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 208
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 209 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 267
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 268 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 155
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 156 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 214
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 215 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 273
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 274 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 327

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 111
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 166
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 167 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 225
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 226 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 284
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 285 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 338

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 92/295 (31%), Positives = 146/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 148
Query: 202 CIGICHRDIKPQNLLVKGEPNV----------------SYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V  +  +                 Y+ +R+YRAPE++     Y  
Sbjct: 149 A-DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 207
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 208 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 266
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 267 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 144 A-DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 261
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 148
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 149 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 207
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 208 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 266
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 267 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 107
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 162
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 163 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 221
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 222 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 280
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 281 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 334

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 150
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 151 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 209
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 210 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 268
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 269 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 144 A-DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 261
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 145
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 146 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 204
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 205 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 263
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 264 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 144 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 261
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 99
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 154
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 155 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 213
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 214 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 272
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 273 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 326

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 144 A-DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 261
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 148
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 149 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 207
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 208 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 266
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 267 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 87
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 142
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 143 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 201
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 202 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 260
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 261 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 314

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 144 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 261
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 144 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 261
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 144 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 261
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 144 A-DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 261
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 144 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 261
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 144 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 261
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 146/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 111
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 166
Query: 202 CIGICHRDIKPQNLLVKGEPNV----------------SYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V  +  +                 Y+ +R+YRAPE++     Y  
Sbjct: 167 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATRWYRAPEIMLNWMHYNQ 225
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 226 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 284
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 285 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 338

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 163
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 164 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 222
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 223 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 281
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 282 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 144 A-DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 261
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 145
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 146 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 204
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 205 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 263
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 264 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 144 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 261
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 86
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 141
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 142 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 200
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 201 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 259
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 260 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 313

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 145
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 146 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 204
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 205 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 263
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 264 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 140
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 141 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 199
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 200 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 258
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 259 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 312

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 139
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 140 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 198
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 257
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 258 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 93/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 140
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 141 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 199
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 200 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 258
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 259 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 312

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 92/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    ++ +R+YRAPE++     Y  
Sbjct: 144 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWYRAPEIMLNWMHYNQ 202
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 261
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 LAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 92/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    ++ +R+YRAPE++     Y  
Sbjct: 144 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWYRAPEIMLNWMHYNQ 202
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 261
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  137 bits (346), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 92/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 139
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    ++ +R+YRAPE++     Y  
Sbjct: 140 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWYRAPEIMLNWMHYNQ 198
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 257
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 258 LAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 92/295 (31%), Positives = 144/295 (48%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +       ++   +V+   YQI R L YIH+
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----AKLTDDHVQFLIYQILRGLKYIHS 139
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +    Y+ +R+YRAPE++     Y  
Sbjct: 140 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 198
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 257
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 258 LAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 96/298 (32%), Positives = 144/298 (48%), Gaps = 47/298 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++G VF+AK RET EIVA+K+V  D   +       RE+ +++ L H NIV L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
             S  DK                  + + +   +  +    VK + +Q+ + L + H+  
Sbjct: 70  LHS--DKKLTLVFEFCD------QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS-R 120
Query: 204 GICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYRAPELIFGATEYT 244
            + HRD+KPQNLL+                 G P   Y   + + +YR P+++FGA  Y+
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 245 TAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 303
           T+ID+WS GC+ AEL   G+PLFPG    DQL  I ++LGTPT E+   M       K P
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------KLP 234
Query: 304 QIKPHPWHKVFQK------RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 355
             KP+P +           +L     DL+    + +P  R +A EA  HP+F +   P
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 92/295 (31%), Positives = 145/295 (49%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 163
Query: 202 CIGICHRDIKPQNLLVKGEPNV----------------SYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V  +  +                  + +R+YRAPE++     Y  
Sbjct: 164 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVATRWYRAPEIMLNWMHYNQ 222
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 223 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 281
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 282 LAQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 92/294 (31%), Positives = 146/294 (49%), Gaps = 40/294 (13%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHC 143
           +G GS+GVVF+ + R+TG+IVAIKK L+       K+   RE+++++ L HPN+V L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH--N 201
           F                      + +     R  + +P   VK  T+Q  +A+ + H  N
Sbjct: 71  F--------RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 202 CIGICHRDIKPQNLLVKGE----------------PNVSY---ICSRYYRAPELIFGATE 242
           CI   HRD+KP+N+L+                   P+  Y   + +R+YR+PEL+ G T+
Sbjct: 123 CI---HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQ 179
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNYTEF 300
           Y   +D+W+ GCV AELL G PL+PG+S VDQL  I K LG   P  +++   N  ++  
Sbjct: 180 YGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239
Query: 301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 354
           K P  +     ++    +   A+ L+       P  R T  +   HP+F+ +R+
Sbjct: 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 89/305 (29%), Positives = 147/305 (48%), Gaps = 36/305 (11%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
           +YI    +G G++  V++ K + T  +VA+K++  +          RE+ +++ L H NI
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L       T+K                     N   +H       VKL+ +Q+ R LA
Sbjct: 63  VTLHDIIH--TEKSLTLVFEYLDKDLKQYLDDCGNIINMHN------VKLFLFQLLRGLA 114
Query: 198 YIHNCIGICHRDIKPQNLLV--KGE--------------PNVSY---ICSRYYRAPELIF 238
           Y H    + HRD+KPQNLL+  +GE              P  +Y   + + +YR P+++ 
Sbjct: 115 YCHRQ-KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILL 173
Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NPN 296
           G+T+Y+T ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E    +  N  
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233
Query: 297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
           +  + +P+ +          RL  +  DL+ +  Q+    R +A +A  HPFF  L +  
Sbjct: 234 FKTYNYPKYRAEALLS-HAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI 292
Query: 357 TRLPN 361
            +LP+
Sbjct: 293 HKLPD 297

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 92/295 (31%), Positives = 144/295 (48%), Gaps = 37/295 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKK-------VLQDKRYKNRELQIMQMLDHPNIVALKH 142
           VG+G++G V  A   +TG  VA+KK       ++  KR   REL++++ + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 143 CFF-STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            F  + + +               +N I +      Q++   +V+   YQI R L YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS 143
Query: 202 CIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGATEYTT 245
              I HRD+KP NL V                  +     + +R+YRAPE++     Y  
Sbjct: 144 A-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVATRWYRAPEIMLNWMHYNQ 202
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTEFK 301
            +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++     NY +  
Sbjct: 203 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ-S 261
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+
Sbjct: 262 LTQMPKMNFANVFIGA-NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  134 bits (338), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 95/298 (31%), Positives = 143/298 (47%), Gaps = 47/298 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++G VF+AK RET EIVA+K+V  D   +       RE+ +++ L H NIV L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
             S  DK                  + + +   +  +    VK + +Q+ + L + H+  
Sbjct: 70  LHS--DKKLTLVFEFCD------QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS-R 120
Query: 204 GICHRDIKPQNLLVK----------------GEPNVSY---ICSRYYRAPELIFGATEYT 244
            + HRD+KPQNLL+                 G P   Y   + + +YR P+++FGA  Y+
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 245 TAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 303
           T+ID+WS GC+ AEL    +PLFPG    DQL  I ++LGTPT E+   M       K P
Sbjct: 181 TSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------KLP 234
Query: 304 QIKPHPWHKVFQK------RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 355
             KP+P +           +L     DL+    + +P  R +A EA  HP+F +   P
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 87/289 (30%), Positives = 142/289 (49%), Gaps = 38/289 (13%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKH 142
           +VG GS+G+V + + ++TG IVAIKK L+       K+   RE+++++ L H N+V L  
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNL-- 89
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
                  K               ++ +    + +  ++    V+ Y +QI   + + H+ 
Sbjct: 90  --LEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQV----VQKYLFQIINGIGFCHSH 143
Query: 203 IGICHRDIKPQNLLVK-------------------GEPNVSYICSRYYRAPELIFGATEY 243
             I HRDIKP+N+LV                    GE     + +R+YRAPEL+ G  +Y
Sbjct: 144 -NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEIKCMNPNYTEFK 301
             A+D+W+ GC++ E+ +G+PLFPG+S +DQL  I+  LG   P  +E+   NP +   +
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262
Query: 302 FPQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
            P+IK   P  + + K L    +DL  +     P+ R    E   H FF
Sbjct: 263 LPEIKEREPLERRYPK-LSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 87/296 (29%), Positives = 140/296 (47%), Gaps = 43/296 (14%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVALKHCF 144
           +G G++  V++   + TG  VA+K+V  D          RE+ +M+ L H NIV L    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            +                    +R   N  R    + L  VK + +Q+ + LA+ H    
Sbjct: 73  HTENKLTLVFEFMDNDLKKYMDSRTVGNTPR---GLELNLVKYFQWQLLQGLAFCHEN-K 128
Query: 205 ICHRDIKPQNLLV--KGEPNV-----------------SYICSRYYRAPELIFGATEYTT 245
           I HRD+KPQNLL+  +G+  +                 S + + +YRAP+++ G+  Y+T
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYST 188
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE------EIKCMNPNYTE 299
           +IDIWS GC++AE++ G+PLFPG +  +QL  I  ++GTP         ++   NPN   
Sbjct: 189 SIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPN--- 245
Query: 300 FKFPQIKPHPWHKVFQKR----LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 351
               Q  P    +V Q      L    +D +    Q +P++R +A +A  HP+F E
Sbjct: 246 --IQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 143/294 (48%), Gaps = 37/294 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 145
           +G G  G+VF A   +  + VAIKK++    Q  ++  RE++I++ LDH NIV +     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 146 STTDKXXXXXXXXXXXXXXTVNR--IARNYSRIHQRMPLI--YVKLYTYQICRALAYIHN 201
            +  +               + +  +  + + + ++ PL+  + +L+ YQ+ R L YIH+
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHS 138
Query: 202 CIGICHRDIKPQNLLVKGE----------------PNVSY-------ICSRYYRAPELIF 238
              + HRD+KP NL +  E                P+ S+       + +++YR+P L+ 
Sbjct: 139 A-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLL 197
Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL---VEIIKVLGTPTREEIKCMNP 295
               YT AID+W+ GC+ AE+L G+ LF G   ++Q+   +E I V+    R+E+  + P
Sbjct: 198 SPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIP 257
Query: 296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
            Y   +    +PH         +  EAVD + +   +SP  R TA EA  HP+ 
Sbjct: 258 VY--IRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 82/312 (26%), Positives = 141/312 (45%), Gaps = 49/312 (15%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN------------RELQI 128
           Y  +  + +GS+G V  A     G  VAIK+V   + D R  N            RE+++
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI---YV 185
           +    HPNI+ L+  F    +                + ++      IH +  +I   ++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQV------IHDQRIVISPQHI 136
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS------------------YIC 227
           + + Y I   L  +H   G+ HRD+ P N+L+    +++                  Y+ 
Sbjct: 137 QYFMYHILLGLHVLHEA-GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT 195
Query: 228 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 287
            R+YRAPEL+     +T  +D+WS GCVMAE+   + LF G +  +QL +I++V+GTP  
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 288 EEIKCMNP----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 343
           E++   +     +Y       +    W  V      P A+DL+ +  +++P  R +  +A
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTA-DPVALDLIAKMLEFNPQRRISTEQA 314
Query: 344 CVHPFFDELRDP 355
             HP+F+ L DP
Sbjct: 315 LRHPYFESLFDP 326

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 82/312 (26%), Positives = 141/312 (45%), Gaps = 49/312 (15%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN------------RELQI 128
           Y  +  + +GS+G V  A     G  VAIK+V   + D R  N            RE+++
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI---YV 185
           +    HPNI+ L+  F    +                + ++      IH +  +I   ++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQV------IHDQRIVISPQHI 136
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS------------------YIC 227
           + + Y I   L  +H   G+ HRD+ P N+L+    +++                  Y+ 
Sbjct: 137 QYFMYHILLGLHVLHEA-GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT 195
Query: 228 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 287
            R+YRAPEL+     +T  +D+WS GCVMAE+   + LF G +  +QL +I++V+GTP  
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 288 EEIKCMNP----NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 343
           E++   +     +Y       +    W  V      P A+DL+ +  +++P  R +  +A
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTA-DPVALDLIAKMLEFNPQRRISTEQA 314
Query: 344 CVHPFFDELRDP 355
             HP+F+ L DP
Sbjct: 315 LRHPYFESLFDP 326

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 91/311 (29%), Positives = 149/311 (47%), Gaps = 58/311 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M++++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 197
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLVGIK 140
Query: 198 YIHNCIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFG 239
           ++H+  GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---N 296
              Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P    
Sbjct: 200 MG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRT 258
Query: 297 YTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACV 345
           Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA  
Sbjct: 259 YVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317
Query: 346 HPFFDELRDPN 356
           HP+ +   DP+
Sbjct: 318 HPYINVWYDPS 328

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  120 bits (302), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 91/311 (29%), Positives = 149/311 (47%), Gaps = 58/311 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M++++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 197
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLCGIK 140
Query: 198 YIHNCIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFG 239
           ++H+  GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---N 296
              Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P    
Sbjct: 200 MG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRT 258
Query: 297 YTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACV 345
           Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA  
Sbjct: 259 YVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317
Query: 346 HPFFDELRDPN 356
           HP+ +   DP+
Sbjct: 318 HPYINVWYDPS 328

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 90/311 (28%), Positives = 148/311 (47%), Gaps = 58/311 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M++++H NI+ L + 
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 197
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLVGIK 140
Query: 198 YIHNCIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFG 239
           ++H+  GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---N 296
              Y   +DIWS G +M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P    
Sbjct: 200 MG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRT 258
Query: 297 YTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACV 345
           Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA  
Sbjct: 259 YVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317
Query: 346 HPFFDELRDPN 356
           HP+ +   DP+
Sbjct: 318 HPYINVWYDPS 328

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 89/305 (29%), Positives = 141/305 (46%), Gaps = 48/305 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD--HERMSYL-----LYQMLXGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFGATEY 243
             GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G   Y
Sbjct: 145 A-GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 299
              +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 262
Query: 300 ------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
                   FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ +
Sbjct: 263 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 322
Query: 351 ELRDP 355
              DP
Sbjct: 323 VWYDP 327

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 91/311 (29%), Positives = 148/311 (47%), Gaps = 58/311 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 197
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLCGIK 140
Query: 198 YIHNCIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFG 239
           ++H+  GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---N 296
              Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P    
Sbjct: 200 MG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRT 258
Query: 297 YTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACV 345
           Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA  
Sbjct: 259 YVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317
Query: 346 HPFFDELRDPN 356
           HP+ +   DP+
Sbjct: 318 HPYINVWYDPS 328

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 89/305 (29%), Positives = 141/305 (46%), Gaps = 48/305 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD--HERMSYL-----LYQMLXGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFGATEY 243
             GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G   Y
Sbjct: 145 A-GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 299
              +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 262
Query: 300 ------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
                   FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ +
Sbjct: 263 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 322
Query: 351 ELRDP 355
              DP
Sbjct: 323 VWYDP 327

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 89/305 (29%), Positives = 141/305 (46%), Gaps = 48/305 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD--HERMSYL-----LYQMLXGIKHLHS 137
Query: 202 CIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFGATEY 243
             GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G   Y
Sbjct: 138 A-GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 195
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 299
              +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 255
Query: 300 ------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
                   FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ +
Sbjct: 256 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315
Query: 351 ELRDP 355
              DP
Sbjct: 316 VWYDP 320

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 90/311 (28%), Positives = 148/311 (47%), Gaps = 58/311 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M++++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 197
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLVGIK 140
Query: 198 YIHNCIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFG 239
           ++H+  GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---N 296
              Y   +DIWS G +M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P    
Sbjct: 200 MG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRT 258
Query: 297 YTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACV 345
           Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA  
Sbjct: 259 YVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317
Query: 346 HPFFDELRDPN 356
           HP+ +   DP+
Sbjct: 318 HPYINVWYDPS 328

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/305 (29%), Positives = 141/305 (46%), Gaps = 48/305 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFGATEY 243
             GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G   Y
Sbjct: 145 A-GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 299
              +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 262
Query: 300 ------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
                   FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ +
Sbjct: 263 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 322
Query: 351 ELRDP 355
              DP
Sbjct: 323 VWYDP 327

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 91/311 (29%), Positives = 148/311 (47%), Gaps = 58/311 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI------HQRMPLIYVKLYTYQICRALA 197
           F  T  K               +  +  N S++      H+RM  +      YQ+   + 
Sbjct: 92  F--TPQKSLEEFQDVYI----VMELMDANLSQVIQMELDHERMSYL-----LYQMLCGIK 140
Query: 198 YIHNCIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFG 239
           ++H+  GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G
Sbjct: 141 HLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---N 296
              Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P    
Sbjct: 200 MG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRT 258
Query: 297 YTEFKFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACV 345
           Y E + P+   + + K+F   L P           +A DL+ +      + R +  EA  
Sbjct: 259 YVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317
Query: 346 HPFFDELRDPN 356
           HP+ +   DP+
Sbjct: 318 HPYINVWYDPS 328

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/305 (29%), Positives = 141/305 (46%), Gaps = 48/305 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFGATEY 243
             GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G   Y
Sbjct: 145 A-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 299
              +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 262
Query: 300 ------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
                   FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ +
Sbjct: 263 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 322
Query: 351 ELRDP 355
              DP
Sbjct: 323 VWYDP 327

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/305 (29%), Positives = 141/305 (46%), Gaps = 48/305 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 92
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 93  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 145
Query: 202 CIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFGATEY 243
             GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G   Y
Sbjct: 146 A-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 203
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 299
              +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 204 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 263
Query: 300 ------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
                   FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ +
Sbjct: 264 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 323
Query: 351 ELRDP 355
              DP
Sbjct: 324 VWYDP 328

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/305 (29%), Positives = 141/305 (46%), Gaps = 48/305 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 92
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 93  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 145
Query: 202 CIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFGATEY 243
             GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G   Y
Sbjct: 146 A-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 203
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 299
              +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 204 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 263
Query: 300 ------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
                   FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ +
Sbjct: 264 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 323
Query: 351 ELRDP 355
              DP
Sbjct: 324 VWYDP 328

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 89/305 (29%), Positives = 141/305 (46%), Gaps = 48/305 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFGATEY 243
             GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G   Y
Sbjct: 145 A-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 299
              +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 262
Query: 300 ------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
                   FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ +
Sbjct: 263 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 322
Query: 351 ELRDP 355
              DP
Sbjct: 323 VWYDP 327

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 89/305 (29%), Positives = 141/305 (46%), Gaps = 48/305 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 31  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 90
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 91  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 143
Query: 202 CIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFGATEY 243
             GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G   Y
Sbjct: 144 A-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 201
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 299
              +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 202 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 261
Query: 300 ------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
                   FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ +
Sbjct: 262 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 321
Query: 351 ELRDP 355
              DP
Sbjct: 322 VWYDP 326

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 89/305 (29%), Positives = 141/305 (46%), Gaps = 48/305 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 86  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 138
Query: 202 CIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFGATEY 243
             GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G   Y
Sbjct: 139 A-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 196
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 299
              +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 197 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 256
Query: 300 ------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
                   FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ +
Sbjct: 257 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 316
Query: 351 ELRDP 355
              DP
Sbjct: 317 VWYDP 321

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 89/305 (29%), Positives = 141/305 (46%), Gaps = 48/305 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 137
Query: 202 CIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFGATEY 243
             GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G   Y
Sbjct: 138 A-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 195
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 299
              +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 255
Query: 300 ------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
                   FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ +
Sbjct: 256 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315
Query: 351 ELRDP 355
              DP
Sbjct: 316 VWYDP 320

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 89/305 (29%), Positives = 141/305 (46%), Gaps = 48/305 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 182
Query: 202 CIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFGATEY 243
             GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G   Y
Sbjct: 183 A-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 240
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 299
              +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 241 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 300
Query: 300 ------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
                   FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ +
Sbjct: 301 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 360
Query: 351 ELRDP 355
              DP
Sbjct: 361 VWYDP 365

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 89/305 (29%), Positives = 141/305 (46%), Gaps = 48/305 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 86  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 138
Query: 202 CIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFGATEY 243
             GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G   Y
Sbjct: 139 A-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 196
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 299
              +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 197 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 256
Query: 300 ------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
                   FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ +
Sbjct: 257 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 316
Query: 351 ELRDP 355
              DP
Sbjct: 317 VWYDP 321

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 144/307 (46%), Gaps = 50/307 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 92  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFGATEY 243
             GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G   Y
Sbjct: 145 A-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 300
              +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P    Y E 
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVEN 262
Query: 301 KFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+ 
Sbjct: 263 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
Query: 350 DELRDPN 356
           +   DP+
Sbjct: 322 NVWYDPS 328

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 89/305 (29%), Positives = 141/305 (46%), Gaps = 48/305 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 182
Query: 202 CIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFGATEY 243
             GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G   Y
Sbjct: 183 A-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 240
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 299
              +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 241 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 300
Query: 300 ------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
                   FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ +
Sbjct: 301 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 360
Query: 351 ELRDP 355
              DP
Sbjct: 361 VWYDP 365

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 87/300 (29%), Positives = 139/300 (46%), Gaps = 48/300 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFGATEY 243
             GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G   Y
Sbjct: 145 A-GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 299
              +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P   NY E 
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 262
Query: 300 ------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
                   FP++ P    P      K    +A DL+ +     P  R +  +A  HP+ +
Sbjct: 263 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 322

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 143/307 (46%), Gaps = 50/307 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 93  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 145
Query: 202 CIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFGATEY 243
             GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G   Y
Sbjct: 146 A-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 203
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 300
              +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E 
Sbjct: 204 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 263
Query: 301 KFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+ 
Sbjct: 264 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322
Query: 350 DELRDPN 356
           +   DP+
Sbjct: 323 NVWYDPS 329

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 88/305 (28%), Positives = 141/305 (46%), Gaps = 48/305 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A     G  VA+KK+    Q++ +  R   EL +++ ++H NI++L + 
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 91
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIHMELD--HERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFGATEY 243
             GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G   Y
Sbjct: 145 A-GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 299
              +DIWS GC+M EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P   NY E 
Sbjct: 203 AANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVEN 262
Query: 300 ------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
                  KF ++ P    P      K    +A DL+ +     P+ R +  EA  HP+  
Sbjct: 263 RPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 322
Query: 351 ELRDP 355
              DP
Sbjct: 323 VWYDP 327

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 143/307 (46%), Gaps = 50/307 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 92  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFGATEY 243
             GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G   Y
Sbjct: 145 A-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 202
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 300
              +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E 
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 262
Query: 301 KFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+ 
Sbjct: 263 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
Query: 350 DELRDPN 356
           +   DP+
Sbjct: 322 NVWYDPS 328

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 143/307 (46%), Gaps = 50/307 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 34  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 93
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 94  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 146
Query: 202 CIGICHRDIKPQNLLVKGEPN------------------VSYICSRYYRAPELIFGATEY 243
             GI HRD+KP N++VK +                    V ++ +RYYRAPE+I G   Y
Sbjct: 147 A-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMG-Y 204
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 300
              +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E 
Sbjct: 205 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 264
Query: 301 KFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+ 
Sbjct: 265 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 323
Query: 350 DELRDPN 356
           +   DP+
Sbjct: 324 NVWYDPS 330

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 87/305 (28%), Positives = 140/305 (45%), Gaps = 48/305 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A     G  VA+KK+    Q++ +  R   EL +++ ++H NI++L + 
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 144 FF--STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    T ++                  I       H+RM  +      YQ+   + ++H+
Sbjct: 90  FTPQKTLEEFQDVYLVMELMDANLCQVIHMELD--HERMSYL-----LYQMLCGIKHLHS 142
Query: 202 CIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFGATEY 243
             GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G   Y
Sbjct: 143 A-GIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMG-Y 200
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTE- 299
              +DIWS GC+M EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P   NY E 
Sbjct: 201 KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVEN 260
Query: 300 ------FKFPQIKPH---PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
                   F ++ P    P      K    +A DL+ +     P+ R +  EA  HP+  
Sbjct: 261 RPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 320
Query: 351 ELRDP 355
              DP
Sbjct: 321 VWYDP 325

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 102/397 (25%), Positives = 156/397 (39%), Gaps = 96/397 (24%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNI 137
           Y   H++GTGS+G V +A  +    +VAIKK+L+      D +   RE+ I+  L+H ++
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V +         +                 ++ R    + +    +++K   Y +   + 
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTE----LHIKTLLYNLLVGVK 170
Query: 198 YIHNCIGICHRDIKPQNLLVKGEPNV---------------------------------- 223
           Y+H+  GI HRD+KP N LV  + +V                                  
Sbjct: 171 YVHSA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229
Query: 224 ------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL---------- 261
                        ++ +R+YRAPELI     YT AID+WS GC+ AELL           
Sbjct: 230 FPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289
Query: 262 -GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
              PLFPG S                      DQL  I  +LGTP+ E+I+ +     + 
Sbjct: 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAK- 348
Query: 301 KFPQIKPHPWHKVFQKRLPPEAVD---LVCRFFQYSPNLRCTALEACVHPFFDELR---- 353
           ++ +I P        +R P  + D   L+ R   ++PN R T  E   HPFF E+R    
Sbjct: 349 RYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEV 408
Query: 354 DPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPE 390
           + N       P     N   P+L     + I R  PE
Sbjct: 409 ETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYHPE 445

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 142/307 (46%), Gaps = 50/307 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 92  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVKGEPNVSY------------------ICSRYYRAPELIFGATEY 243
             GI HRD+KP N++VK +  +                    + +RYYRAPE+I G   Y
Sbjct: 145 A-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMG-Y 202
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 300
              +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P    Y E 
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 262
Query: 301 KFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+ 
Sbjct: 263 R-PKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
Query: 350 DELRDPN 356
           +   DP+
Sbjct: 322 NVWYDPS 328

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 143/307 (46%), Gaps = 50/307 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 37  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 96
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 97  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 149
Query: 202 CIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFGATEY 243
             GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G   Y
Sbjct: 150 A-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 207
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 300
              +D+WS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P    Y E 
Sbjct: 208 KENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 267
Query: 301 KFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+ 
Sbjct: 268 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 326
Query: 350 DELRDPN 356
           +   DP+
Sbjct: 327 NVWYDPS 333

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 133/291 (45%), Gaps = 42/291 (14%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-NRELQIMQML-DHPNIVALKHCFFST 147
           +G G +  VF+A      E V +K +   K+ K  RE++I++ L   PNI+ L       
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKREIKILENLRGGPNIITL------- 97
Query: 148 TDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH 207
            D                VN    ++ +++Q +    ++ Y Y+I +AL Y H  +GI H
Sbjct: 98  ADIVKDPVSRTPALVFEHVNNT--DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMH 154
Query: 208 RDIKPQNLLVKGE----------------PNVSY---ICSRYYRAPELIFGATEYTTAID 248
           RD+KP N+++  E                P   Y   + SRY++ PEL+     Y  ++D
Sbjct: 155 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 214
Query: 249 IWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKF 302
           +WS GC++A ++   +P F G    DQLV I KVLGT    +        ++P + +   
Sbjct: 215 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-L 273
Query: 303 PQIKPHPW----HKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
            +     W    H   Q  + PEA+D + +  +Y    R TA EA  HP+F
Sbjct: 274 GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 143/307 (46%), Gaps = 50/307 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 26  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 85
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 86  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 138
Query: 202 CIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFGATEY 243
             GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I G   Y
Sbjct: 139 A-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-Y 196
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 300
              +D+WS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P    Y E 
Sbjct: 197 KENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 256
Query: 301 KFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+ 
Sbjct: 257 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 315
Query: 350 DELRDPN 356
           +   DP+
Sbjct: 316 NVWYDPS 322

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 41/203 (20%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----------------PNVSY--- 225
           ++ Y Y++ +AL Y H+  GI HRD+KP N+++  E                P   Y   
Sbjct: 148 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 206
Query: 226 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 284
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 207 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 266
Query: 285 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 330
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 267 ------DGLNAYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 320
Query: 331 QYSPNLRCTALEACVHPFFDELR 353
           +Y    R TALEA  HP+F ++R
Sbjct: 321 RYDHQERLTALEAMTHPYFQQVR 343

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 139/303 (45%), Gaps = 65/303 (21%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALK-- 141
           +G G++G V++A    T E VAIK++  +   +       RE+ +++ L H NI+ LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 142 -------HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
                  H  F   +                     + Y   +  + +  +K + YQ+  
Sbjct: 102 IHHNHRLHLIFEYAENDL------------------KKYMDKNPDVSMRVIKSFLYQLIN 143
Query: 195 ALAYIHN--CIGICHRDIKPQNLLVK---------------------GEPNVSY---ICS 228
            + + H+  C+   HRD+KPQNLL+                      G P   +   I +
Sbjct: 144 GVNFCHSRRCL---HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIIT 200
Query: 229 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 288
            +YR PE++ G+  Y+T++DIWS  C+ AE+L+  PLFPG+S +DQL +I +VLG P   
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260
Query: 289 EIKCMN--PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 346
               +   P++ +  FP+ +     +V    L  E +DL+    +  P  R +A  A  H
Sbjct: 261 TWPGVTALPDWKQ-SFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319
Query: 347 PFF 349
           P+F
Sbjct: 320 PYF 322

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 141/304 (46%), Gaps = 38/304 (12%)
Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN------RELQIMQ 130
           + Q+   +AE  +G G++G VF+A+  +  G  VA+K+V      +       RE+ +++
Sbjct: 9   ADQQYECVAE--IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 131 ML---DHPNIVAL-KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK 186
            L   +HPN+V L   C  S TD+                  + +        +P   +K
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIK 123
Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV------------------SYICS 228
              +Q+ R L ++H+   + HRD+KPQN+LV     +                  S + +
Sbjct: 124 DMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT 182
Query: 229 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 288
            +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  E
Sbjct: 183 LWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241
Query: 289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
           +    +       F      P  K F   +     DL+ +   ++P  R +A  A  HP+
Sbjct: 242 DWP-RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299
Query: 349 FDEL 352
           F +L
Sbjct: 300 FQDL 303

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 41/203 (20%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----------------PNVSY--- 225
           ++ Y Y++ +AL Y H+  GI HRD+KP N+++  E                P   Y   
Sbjct: 128 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 186
Query: 226 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 284
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 187 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 246
Query: 285 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 330
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 247 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 300
Query: 331 QYSPNLRCTALEACVHPFFDELR 353
           +Y    R TALEA  HP+F ++R
Sbjct: 301 RYDHQERLTALEAMTHPYFQQVR 323

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 41/203 (20%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----------------PNVSY--- 225
           ++ Y Y++ +AL Y H+  GI HRD+KP N+++  E                P   Y   
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 226 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 284
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 285 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 330
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 331 QYSPNLRCTALEACVHPFFDELR 353
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 41/203 (20%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----------------PNVSY--- 225
           ++ Y Y++ +AL Y H+  GI HRD+KP N+++  E                P   Y   
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 226 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 284
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 285 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 330
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 331 QYSPNLRCTALEACVHPFFDELR 353
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 84/304 (27%), Positives = 141/304 (46%), Gaps = 38/304 (12%)
Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN------RELQIMQ 130
           + Q+   +AE  +G G++G VF+A+  +  G  VA+K+V      +       RE+ +++
Sbjct: 9   ADQQYECVAE--IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 131 ML---DHPNIVAL-KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK 186
            L   +HPN+V L   C  S TD+                  + +        +P   +K
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIK 123
Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV------------------SYICS 228
              +Q+ R L ++H+   + HRD+KPQN+LV     +                  S + +
Sbjct: 124 DMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT 182
Query: 229 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 288
            +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  E
Sbjct: 183 LWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241
Query: 289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
           +    +       F      P  K F   +     DL+ +   ++P  R +A  A  HP+
Sbjct: 242 DWP-RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299
Query: 349 FDEL 352
           F +L
Sbjct: 300 FQDL 303

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 41/203 (20%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----------------PNVSY--- 225
           ++ Y Y++ +AL Y H+  GI HRD+KP N+++  E                P   Y   
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 226 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 284
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 285 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 330
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 331 QYSPNLRCTALEACVHPFFDELR 353
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 41/203 (20%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----------------PNVSY--- 225
           ++ Y Y++ +AL Y H+  GI HRD+KP N+++  E                P   Y   
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 226 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 284
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 285 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 330
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 ------DGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 331 QYSPNLRCTALEACVHPFFDELR 353
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 41/203 (20%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----------------PNVSY--- 225
           ++ Y Y++ +AL Y H+  GI HRD+KP N+++  E                P   Y   
Sbjct: 128 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 186
Query: 226 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 284
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 187 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 246
Query: 285 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 330
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 247 DG------LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 300
Query: 331 QYSPNLRCTALEACVHPFFDELR 353
           +Y    R TALEA  HP+F ++R
Sbjct: 301 RYDHQERLTALEAMTHPYFQQVR 323

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 142/307 (46%), Gaps = 50/307 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 92  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVKGEPNVSY------------------ICSRYYRAPELIFGATEY 243
             GI HRD+KP N++VK +  +                    + +RYYRAPE+I G   Y
Sbjct: 145 A-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG-Y 202
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 300
              +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP    +K + P   NY E 
Sbjct: 203 KENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRNYVEN 262
Query: 301 KFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+ 
Sbjct: 263 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
Query: 350 DELRDPN 356
           +   DP+
Sbjct: 322 NVWYDPS 328

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 41/203 (20%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----------------PNVSY--- 225
           ++ Y Y++ +AL Y H+  GI HRD+KP N+++  E                P   Y   
Sbjct: 129 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 187
Query: 226 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 284
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 188 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 247
Query: 285 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 330
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 248 DG------LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 301
Query: 331 QYSPNLRCTALEACVHPFFDELR 353
           +Y    R TALEA  HP+F ++R
Sbjct: 302 RYDHQERLTALEAMTHPYFQQVR 324

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 41/203 (20%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----------------PNVSY--- 225
           ++ Y Y++ +AL Y H+  GI HRD+KP N+++  E                P   Y   
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 226 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 284
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 285 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 330
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 DG------LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 331 QYSPNLRCTALEACVHPFFDELR 353
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 41/203 (20%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----------------PNVSY--- 225
           ++ Y Y++ +AL Y H+  GI HRD+KP N+++  E                P   Y   
Sbjct: 127 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 185
Query: 226 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGT 284
           + SRY++ PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT
Sbjct: 186 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245
Query: 285 PTREEIKCMNPNYTEFKF---PQIKP-------HPWHKVF----QKRLPPEAVDLVCRFF 330
                   +N    +++    PQ++         PW K      Q  + PEA+D + +  
Sbjct: 246 DG------LNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 299
Query: 331 QYSPNLRCTALEACVHPFFDELR 353
           +Y    R TALEA  HP+F ++R
Sbjct: 300 RYDHQERLTALEAMTHPYFQQVR 322

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 142/307 (46%), Gaps = 50/307 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNR---ELQIMQMLDHPNIVALKHC 143
           +G+G+ G+V  A        VAIKK+    Q++ +  R   EL +M+ ++H NI+ L + 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F  T  K                  + +       H+RM  +      YQ+   + ++H+
Sbjct: 92  F--TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-----LYQMLCGIKHLHS 144
Query: 202 CIGICHRDIKPQNLLVKGEPNVSY------------------ICSRYYRAPELIFGATEY 243
             GI HRD+KP N++VK +  +                    + +RYYRAPE+I G   Y
Sbjct: 145 A-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG-Y 202
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP---NYTEF 300
              +D+WS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + P    Y E 
Sbjct: 203 KENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 262
Query: 301 KFPQIKPHPWHKVFQKRLPP-----------EAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           + P+   + + K+F   L P           +A DL+ +      + R +  EA  HP+ 
Sbjct: 263 R-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
Query: 350 DELRDPN 356
           +   DP+
Sbjct: 322 NVWYDPS 328

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 139/301 (46%), Gaps = 38/301 (12%)
Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN------RELQIMQ 130
           + Q+   +AE  +G G++G VF+A+  +  G  VA+K+V      +       RE+ +++
Sbjct: 9   ADQQYECVAE--IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 131 ML---DHPNIVAL-KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK 186
            L   +HPN+V L   C  S TD+                  + +        +P   +K
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIK 123
Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV------------------SYICS 228
              +Q+ R L ++H+   + HRD+KPQN+LV     +                  S + +
Sbjct: 124 DMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT 182
Query: 229 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 288
            +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  E
Sbjct: 183 LWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241
Query: 289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
           +    +       F      P  K F   +     DL+ +   ++P  R +A  A  HP+
Sbjct: 242 DWP-RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299
Query: 349 F 349
           F
Sbjct: 300 F 300

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 95/353 (26%), Positives = 150/353 (42%), Gaps = 92/353 (26%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPN 136
           +YI +H++G GS+G V+ A  + T + VAIKKV      L D +   RE+ I+  L    
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI----YVKLYTYQI 192
           I+ L                         V  IA +  +   + P+     ++K   Y +
Sbjct: 87  IIRLYDLIIPDD--------LLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNL 138
Query: 193 CRALAYIHNCIGICHRDIKPQNLLVKGEPNV----------------------------- 223
                +IH   GI HRD+KP N L+  + +V                             
Sbjct: 139 LLGENFIHES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 224 ------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQ------- 263
                       S++ +R+YRAPELI     YT +IDIWSTGC+ AELL + Q       
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257
Query: 264 ---PLFPG-----------------ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 303
              PLFPG                 +S  DQL  I  ++GTPT +++K +N      K+ 
Sbjct: 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEV-IKYI 316
Query: 304 QIKPHPWHKVFQKRLPP---EAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 353
           ++ PH      +++ P    + ++L+    +++PN R T  +A  HP+  ++R
Sbjct: 317 KLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 31/207 (14%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----------- 220
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N+L+  E           
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVLIDHEHRKLRLIDWGL 178
Query: 221 -----PNVSY---ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 271
                P   Y   + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 272 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 322
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 323 VDLVCRFFQYSPNLRCTALEACVHPFF 349
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 31/207 (14%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----------- 220
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N+++  E           
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 221 -----PNVSY---ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 271
                P   Y   + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 272 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 322
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 323 VDLVCRFFQYSPNLRCTALEACVHPFF 349
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 31/207 (14%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----------- 220
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N+++  E           
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 221 -----PNVSY---ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 271
                P   Y   + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 272 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 322
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 323 VDLVCRFFQYSPNLRCTALEACVHPFF 349
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 31/207 (14%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----------- 220
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N+++  E           
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 221 -----PNVSY---ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 271
                P   Y   + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 272 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 322
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 323 VDLVCRFFQYSPNLRCTALEACVHPFF 349
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 31/207 (14%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----------- 220
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N+++  E           
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 221 -----PNVSY---ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 271
                P   Y   + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 272 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 322
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 323 VDLVCRFFQYSPNLRCTALEACVHPFF 349
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 31/207 (14%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----------- 220
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N+++  E           
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 221 -----PNVSY---ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 271
                P   Y   + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 272 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 322
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 323 VDLVCRFFQYSPNLRCTALEACVHPFF 349
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 31/207 (14%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----------- 220
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N+++  E           
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 221 -----PNVSY---ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 271
                P   Y   + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 272 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 322
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 323 VDLVCRFFQYSPNLRCTALEACVHPFF 349
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 31/207 (14%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----------- 220
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N+++  E           
Sbjct: 119 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
Query: 221 -----PNVSY---ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 271
                P   Y   + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 178 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 237
Query: 272 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 322
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 238 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 296
Query: 323 VDLVCRFFQYSPNLRCTALEACVHPFF 349
           +D + +  +Y    R TA EA  HP+F
Sbjct: 297 LDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 31/207 (14%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----------- 220
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N+++  E           
Sbjct: 119 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
Query: 221 -----PNVSY---ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 271
                P   Y   + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 178 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 237
Query: 272 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 322
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 238 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 296
Query: 323 VDLVCRFFQYSPNLRCTALEACVHPFF 349
           +D + +  +Y    R TA EA  HP+F
Sbjct: 297 LDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 31/207 (14%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----------- 220
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N+++  E           
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 221 -----PNVSY---ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 271
                P   Y   + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 272 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 322
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 323 VDLVCRFFQYSPNLRCTALEACVHPFF 349
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 31/207 (14%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----------- 220
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N+++  E           
Sbjct: 125 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 183
Query: 221 -----PNVSY---ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 271
                P   Y   + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 184 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 243
Query: 272 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 322
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 244 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 302
Query: 323 VDLVCRFFQYSPNLRCTALEACVHPFF 349
           +D + +  +Y    R TA EA  HP+F
Sbjct: 303 LDFLDKLLRYDHQSRLTAREAMEHPYF 329

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 31/207 (14%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----------- 220
           ++ +++Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N+++  E           
Sbjct: 118 DFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 176
Query: 221 -----PNVSY---ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 271
                P   Y   + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 177 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 236
Query: 272 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 322
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 237 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 295
Query: 323 VDLVCRFFQYSPNLRCTALEACVHPFF 349
           +D + +  +Y    R TA EA  HP+F
Sbjct: 296 LDFLDKLLRYDHQSRLTAREAMEHPYF 322

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 31/207 (14%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----------- 220
           ++ +++Q +    ++ Y Y+I +AL Y H+ +GI HRD+KP N+++  E           
Sbjct: 120 DFKQLYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 221 -----PNVSY---ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 271
                P   Y   + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 272 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 322
            DQLV I KVLGT    +        ++P + +      +   W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKR-WERFVHSENQHLVSPEA 297
Query: 323 VDLVCRFFQYSPNLRCTALEACVHPFF 349
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 31/207 (14%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----------- 220
           ++ ++ Q +    ++ Y Y+I +AL Y H  +GI HRD+KP N+++  E           
Sbjct: 120 DFKQLRQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 178
Query: 221 -----PNVSY---ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 271
                P   Y   + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G   
Sbjct: 179 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 238
Query: 272 VDQLVEIIKVLGTPTREEIKC-----MNPNYTEFKFPQIKPHPW----HKVFQKRLPPEA 322
            DQLV I KVLGT    +        ++P + +    +     W    H   Q  + PEA
Sbjct: 239 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEA 297
Query: 323 VDLVCRFFQYSPNLRCTALEACVHPFF 349
           +D + +  +Y    R TA EA  HP+F
Sbjct: 298 LDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 37/210 (17%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----------- 220
           ++ +++Q +    ++ Y Y++ +AL Y H+  GI HRD+KP N+++  +           
Sbjct: 121 DFKQLYQILTDFDIRFYMYELLKALDYCHSK-GIMHRDVKPHNVMIDHQQKKLRLIDWGL 179
Query: 221 -----PNVSY---ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 271
                P   Y   + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G+  
Sbjct: 180 AEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDN 239
Query: 272 VDQLVEIIKVLGTPTREEIKC--------MNPNYTEFKFPQIKPHPW----HKVFQKRLP 319
            DQLV I KVLGT   EE+          ++P++ +    Q     W    H   +  + 
Sbjct: 240 YDQLVRIAKVLGT---EELYGYLKKYHIDLDPHFNDI-LGQHSRKRWENFIHSENRHLVS 295
Query: 320 PEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           PEA+DL+ +  +Y    R TA EA  HP+F
Sbjct: 296 PEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 132/295 (44%), Gaps = 49/295 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-------------LQIMQMLDHPN 136
           +G G++G V++A+   +G  VA+K V    R  N E             L+ ++  +HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 137 IVALKH-CFFSTTDKXXXXXXXXXXXXXXTVNRIARNY--SRIHQRMPLIYVKLYTYQIC 193
           +V L   C  S TD+               V++  R Y        +P   +K    Q  
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 194 RALAYIH-NCIGICHRDIKPQNLLVKGEPNV-----------SY-------ICSRYYRAP 234
           R L ++H NCI   HRD+KP+N+LV     V           SY       + + +YRAP
Sbjct: 123 RGLDFLHANCI--VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAP 180
Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
           E++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    +
Sbjct: 181 EVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RD 238
Query: 295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
            +     FP   P P   V  + +      L+     ++P+ R +A  A  H + 
Sbjct: 239 VSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 132/295 (44%), Gaps = 49/295 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-------------LQIMQMLDHPN 136
           +G G++G V++A+   +G  VA+K V    R  N E             L+ ++  +HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 137 IVALKH-CFFSTTDKXXXXXXXXXXXXXXTVNRIARNY--SRIHQRMPLIYVKLYTYQIC 193
           +V L   C  S TD+               V++  R Y        +P   +K    Q  
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 194 RALAYIH-NCIGICHRDIKPQNLLVKGEPNV-----------SY-------ICSRYYRAP 234
           R L ++H NCI   HRD+KP+N+LV     V           SY       + + +YRAP
Sbjct: 123 RGLDFLHANCI--VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAP 180
Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
           E++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    +
Sbjct: 181 EVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RD 238
Query: 295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
            +     FP   P P   V  + +      L+     ++P+ R +A  A  H + 
Sbjct: 239 VSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 132/295 (44%), Gaps = 49/295 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-------------LQIMQMLDHPN 136
           +G G++G V++A+   +G  VA+K V    R  N E             L+ ++  +HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 137 IVALKH-CFFSTTDKXXXXXXXXXXXXXXTVNRIARNY--SRIHQRMPLIYVKLYTYQIC 193
           +V L   C  S TD+               V++  R Y        +P   +K    Q  
Sbjct: 68  VVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 194 RALAYIH-NCIGICHRDIKPQNLLVKGEPNV-----------SY-------ICSRYYRAP 234
           R L ++H NCI   HRD+KP+N+LV     V           SY       + + +YRAP
Sbjct: 123 RGLDFLHANCI--VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAP 180
Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
           E++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++    +
Sbjct: 181 EVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RD 238
Query: 295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
            +     FP   P P   V  + +      L+     ++P+ R +A  A  H + 
Sbjct: 239 VSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 37/210 (17%)
Query: 172 NYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----------- 220
           ++ +++Q +    ++ Y Y++ +AL Y H+  GI HRD+KP N+++  +           
Sbjct: 126 DFKQLYQILTDFDIRFYMYELLKALDYCHSK-GIMHRDVKPHNVMIDHQQKKLRLIDWGL 184
Query: 221 -----PNVSY---ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG 271
                P   Y   + SRY++ PEL+     Y  ++D+WS GC++A ++   +P F G+  
Sbjct: 185 AEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDN 244
Query: 272 VDQLVEIIKVLGTPTREEIKC--------MNPNYTEFKFPQIKPHPW----HKVFQKRLP 319
            DQLV I KVLGT   EE+          ++P++ +    Q     W    H   +  + 
Sbjct: 245 YDQLVRIAKVLGT---EELYGYLKKYHIDLDPHFNDI-LGQHSRKRWENFIHSENRHLVS 300
Query: 320 PEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           PEA+DL+ +  +Y    R TA EA  HP+F
Sbjct: 301 PEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 132/294 (44%), Gaps = 37/294 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
             +                    + +A   S +  +  L  +K     +   L YIH   
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN- 144
Query: 204 GICHRDIKPQNLLV---------------------KGEPN--VSYICSRYYRAPELIFGA 240
            I HRD+K  N+L+                       +PN   + + + +YR PEL+ G 
Sbjct: 145 KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGE 204
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
            +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E    ++ NY  +
Sbjct: 205 RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-NYELY 263
Query: 301 KFPQIKPHPWHKVFQKRLP-----PEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           +  ++      KV + RL      P A+DL+ +     P  R  + +A  H FF
Sbjct: 264 EKLELVKGQKRKV-KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 132/294 (44%), Gaps = 37/294 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
             +                    + +A   S +  +  L  +K     +   L YIH   
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN- 144
Query: 204 GICHRDIKPQNLLV---------------------KGEPN--VSYICSRYYRAPELIFGA 240
            I HRD+K  N+L+                       +PN   + + + +YR PEL+ G 
Sbjct: 145 KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGE 204
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
            +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E    ++ NY  +
Sbjct: 205 RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-NYELY 263
Query: 301 KFPQIKPHPWHKVFQKRLP-----PEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           +  ++      KV + RL      P A+DL+ +     P  R  + +A  H FF
Sbjct: 264 EKLELVKGQKRKV-KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 132/294 (44%), Gaps = 37/294 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
             +                    + +A   S +  +  L  +K     +   L YIH   
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN- 144
Query: 204 GICHRDIKPQNLLV---------------------KGEPN--VSYICSRYYRAPELIFGA 240
            I HRD+K  N+L+                       +PN   + + + +YR PEL+ G 
Sbjct: 145 KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGE 204
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
            +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E    ++ NY  +
Sbjct: 205 RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-NYELY 263
Query: 301 KFPQIKPHPWHKVFQKRLP-----PEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           +  ++      KV + RL      P A+DL+ +     P  R  + +A  H FF
Sbjct: 264 EKLELVKGQKRKV-KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 132/294 (44%), Gaps = 37/294 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
             +                    + +A   S +  +  L  +K     +   L YIH   
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN- 143
Query: 204 GICHRDIKPQNLLV---------------------KGEPN--VSYICSRYYRAPELIFGA 240
            I HRD+K  N+L+                       +PN   + + + +YR PEL+ G 
Sbjct: 144 KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGE 203
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
            +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E    ++ NY  +
Sbjct: 204 RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-NYELY 262
Query: 301 KFPQIKPHPWHKVFQKRLP-----PEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           +  ++      KV + RL      P A+DL+ +     P  R  + +A  H FF
Sbjct: 263 EKLELVKGQKRKV-KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 134/298 (44%), Gaps = 52/298 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------------RELQIMQMLD--- 133
           +G G++G V++A+   +G  VA+K V    R  N             RE+ +++ L+   
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 134 HPNIVALKH-CFFSTTDKXXXXXXXXXXXXXXTVNRIARNY--SRIHQRMPLIYVKLYTY 190
           HPN+V L   C  S TD+               V++  R Y        +P   +K    
Sbjct: 73  HPNVVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKDLMR 127
Query: 191 QICRALAYIH-NCIGICHRDIKPQNLLVKGEPNV-----------SY-------ICSRYY 231
           Q  R L ++H NCI   HRD+KP+N+LV     V           SY       + + +Y
Sbjct: 128 QFLRGLDFLHANCI--VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWY 185
Query: 232 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 291
           RAPE++  +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++  
Sbjct: 186 RAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244
Query: 292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
             + +     FP   P P   V  + +      L+     ++P+ R +A  A  H + 
Sbjct: 245 -RDVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 99/370 (26%), Positives = 147/370 (39%), Gaps = 95/370 (25%)
Query: 72  GGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRE 125
           G    N K   +Y  +H++G GS+G V+ A  +   + VAIKKV      L D +   RE
Sbjct: 18  GAIIKNVKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILRE 77
Query: 126 LQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI-- 183
           + I+  L    I+ L H      D                V  IA +  +   + P+   
Sbjct: 78  ITILNRLKSDYIIRL-HDLIIPED-------LLKFDELYIVLEIADSDLKKLFKTPIFLT 129
Query: 184 --YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV------------------ 223
             +VK   Y +     +IH   GI HRD+KP N L+  + +V                  
Sbjct: 130 EQHVKTILYNLLLGEKFIHES-GIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIH 188
Query: 224 --------------------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMA 257
                                     S++ +R+YRAPELI     YT +IDIWSTGC+ A
Sbjct: 189 IVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFA 248
Query: 258 ELLLGQ-----------PLFPG-----------------ESGVDQLVEIIKVLGTPTREE 289
           ELL              PLFPG                 +S  DQL  I  V+GTP  E+
Sbjct: 249 ELLNMMKSHINNPTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEED 308
Query: 290 IKCMNPNYTEFKFPQIKPHPWHKVFQKR---LPPEAVDLVCRFFQYSPNLRCTALEACVH 346
           +KC+       K+ ++ P        K+   +  E +DL+    +++   R T  +A  H
Sbjct: 309 LKCITKQEV-IKYIKLFPTRDGIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKALSH 367
Query: 347 PFFDELRDPN 356
           P+  ++R  N
Sbjct: 368 PYLKDVRKEN 377

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 85/318 (26%), Positives = 141/318 (44%), Gaps = 66/318 (20%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDH------PNIVALKH 142
           V+G GSFG V +A   +  + VA+K V  +KR+  +  + +++L+H       N + + H
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              + T +              ++N          Q   L  V+ + + I + L  +H  
Sbjct: 164 MLENFTFRNHICMTFELL----SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 203 IGICHRDIKPQNLLVK--GEPNV----------------SYICSRYYRAPELIFGATEYT 244
             I H D+KP+N+L+K  G   +                + I SR+YRAPE+I GA  Y 
Sbjct: 220 -RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYRAPEVILGA-RYG 277
Query: 245 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 304
             ID+WS GC++AELL G PL PGE   DQL  +I++LG P++   K ++ +     F  
Sbjct: 278 MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ---KLLDASKRAKNFVS 334
Query: 305 IKPHPWH------------------KVFQKRLPPEA---------------VDLVCRFFQ 331
            K +P +                  +  + R PPE+               +D + +  +
Sbjct: 335 XKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLE 394
Query: 332 YSPNLRCTALEACVHPFF 349
           + P +R T  +A  HP+ 
Sbjct: 395 WDPAVRMTPGQALRHPWL 412

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 85/318 (26%), Positives = 141/318 (44%), Gaps = 66/318 (20%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDH------PNIVALKH 142
           V+G GSFG V +A   +  + VA+K V  +KR+  +  + +++L+H       N + + H
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              + T +              ++N          Q   L  V+ + + I + L  +H  
Sbjct: 164 MLENFTFRNHICMTFELL----SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 203 IGICHRDIKPQNLLVK--GEPNV----------------SYICSRYYRAPELIFGATEYT 244
             I H D+KP+N+L+K  G   +                + I SR+YRAPE+I GA  Y 
Sbjct: 220 -RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYRAPEVILGA-RYG 277
Query: 245 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 304
             ID+WS GC++AELL G PL PGE   DQL  +I++LG P++   K ++ +     F  
Sbjct: 278 MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ---KLLDASKRAKNFVS 334
Query: 305 IKPHPWH------------------KVFQKRLPPEA---------------VDLVCRFFQ 331
            K +P +                  +  + R PPE+               +D + +  +
Sbjct: 335 XKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLE 394
Query: 332 YSPNLRCTALEACVHPFF 349
           + P +R T  +A  HP+ 
Sbjct: 395 WDPAVRMTPGQALRHPWL 412

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 124/282 (43%), Gaps = 57/282 (20%)
Query: 124 RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQR---M 180
           RE+ +++ L HPN+++L+  F S  D+               + +  R  S+ +++   +
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRA-SKANKKPVQL 125
Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE---------PNVSY------ 225
           P   VK   YQI   + Y+H    + HRD+KP N+LV GE          ++ +      
Sbjct: 126 PRGMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 226 -----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF-------- 266
                      + + +YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F        
Sbjct: 185 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 244
Query: 267 -PGESGVDQLVEIIKVLGTPTR---EEIKCMNPNYTEFK---------FPQIKPHPWHKV 313
                  DQL  I  V+G P     E+IK M  + T  K            IK    HKV
Sbjct: 245 TSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV 304
Query: 314 FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 355
              +   +A  L+ +     P  R T+ +A   P+F  L DP
Sbjct: 305 ---KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF--LEDP 341

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/318 (26%), Positives = 139/318 (43%), Gaps = 66/318 (20%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDH------PNIVALKH 142
           V+G G FG V +A   +  + VA+K V  +KR+  +  + +++L+H       N + + H
Sbjct: 104 VIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              + T +              ++N          Q   L  V+ + + I + L  +H  
Sbjct: 164 MLENFTFRNHICMTFELL----SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 203 IGICHRDIKPQNLLVK--GEPNVSYI-----C-----------SRYYRAPELIFGATEYT 244
             I H D+KP+N+L+K  G   +  I     C           SR+YRAPE+I GA  Y 
Sbjct: 220 -RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYXXIQSRFYRAPEVILGA-RYG 277
Query: 245 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 304
             ID+WS GC++AELL G PL PGE   DQL  +I++LG P +   K ++ +     F  
Sbjct: 278 MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQ---KLLDASKRAKNFVS 334
Query: 305 IKPHPWH------------------KVFQKRLPPEA---------------VDLVCRFFQ 331
            K +P +                  +  + R PPE+               +D + +  +
Sbjct: 335 XKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLE 394
Query: 332 YSPNLRCTALEACVHPFF 349
           + P +R T  +A  HP+ 
Sbjct: 395 WDPAVRMTPGQALRHPWL 412

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 87/339 (25%), Positives = 136/339 (40%), Gaps = 75/339 (22%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---ELQIMQMLDHPN---- 136
           Y  + ++G GSFG V +A  R   E VAIK +   K + N+   E++++++++  +    
Sbjct: 37  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 96
Query: 137 --IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
             IV LK  F                      N   R  S       L   + +  Q+C 
Sbjct: 97  YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVS-------LNLTRKFAQQMCT 149
Query: 195 ALAYIHN-CIGICHRDIKPQNLLV------------------KGEPNVSYICSRYYRAPE 235
           AL ++    + I H D+KP+N+L+                   G+     I SR+YR+PE
Sbjct: 150 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQSRFYRSPE 209
Query: 236 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 295
           ++ G   Y  AID+WS GC++ E+  G+PLF G + VDQ+ +I++VLG P    I    P
Sbjct: 210 VLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP-AHILDQAP 267
Query: 296 NYTEFKFPQIKPHPWH----KVFQKRLPPEAV---------------------------- 323
              +F F ++    W+    K  ++   P                               
Sbjct: 268 KARKF-FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVAD 326
Query: 324 -----DLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 357
                DL+ R   Y P  R     A  H FF +  D  T
Sbjct: 327 YLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGT 365

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 122/293 (41%), Gaps = 64/293 (21%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-------KVLQDKRYKNRELQIMQMLDHPN 136
           Y  + V+G GSFG V   K + TG+  A+K       K   DK    RE+Q+++ LDHPN
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 110
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I+ L   F    DK                + I        +R   +       Q+   +
Sbjct: 111 IMKLYEFF---EDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGI 162
Query: 197 AYIHNCIGICHRDIKPQNLLVKG---EPNV------------------SYICSRYYRAPE 235
            Y+H    I HRD+KP+NLL++    + N+                    I + YY APE
Sbjct: 163 TYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 221
Query: 236 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 295
           ++ G   Y    D+WSTG ++  LL G P F G +  D L ++ K               
Sbjct: 222 VLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------G 265
Query: 296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
            YT F+ PQ     W KV        A DL+ +   Y P++R +A +A  H +
Sbjct: 266 KYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 307

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 122/293 (41%), Gaps = 64/293 (21%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-------KVLQDKRYKNRELQIMQMLDHPN 136
           Y  + V+G GSFG V   K + TG+  A+K       K   DK    RE+Q+++ LDHPN
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 111
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I+ L   F    DK                + I        +R   +       Q+   +
Sbjct: 112 IMKLYEFF---EDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGI 163
Query: 197 AYIHNCIGICHRDIKPQNLLVKG---EPNV------------------SYICSRYYRAPE 235
            Y+H    I HRD+KP+NLL++    + N+                    I + YY APE
Sbjct: 164 TYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 222
Query: 236 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 295
           ++ G   Y    D+WSTG ++  LL G P F G +  D L ++ K               
Sbjct: 223 VLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------G 266
Query: 296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
            YT F+ PQ     W KV        A DL+ +   Y P++R +A +A  H +
Sbjct: 267 KYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 308

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 123/293 (41%), Gaps = 64/293 (21%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPN 136
           Y  + V+G GSFG V   K + TG+  A+K + +       DK    RE+Q+++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I+ L   F    DK                + I        +R   +       Q+   +
Sbjct: 88  IMKLYEFF---EDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGI 139
Query: 197 AYIHNCIGICHRDIKPQNLLVKG---EPNV------------------SYICSRYYRAPE 235
            Y+H    I HRD+KP+NLL++    + N+                    I + YY APE
Sbjct: 140 TYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 198
Query: 236 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 295
           ++ G   Y    D+WSTG ++  LL G P F G +  D L ++ K               
Sbjct: 199 VLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------G 242
Query: 296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
            YT F+ PQ     W KV        A DL+ +   Y P++R +A +A  H +
Sbjct: 243 KYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 284

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 109/230 (47%), Gaps = 36/230 (15%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---ELQIMQMLDHPN---- 136
           Y  + ++G GSFG V +A  R   E VAIK +   K + N+   E++++++++  +    
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 137 --IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
             IV LK  F                      N   R  S       L   + +  Q+C 
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVS-------LNLTRKFAQQMCT 168
Query: 195 ALAYIHN-CIGICHRDIKPQNLLV------------------KGEPNVSYICSRYYRAPE 235
           AL ++    + I H D+KP+N+L+                   G+     I SR+YR+PE
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQSRFYRSPE 228
Query: 236 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 285
           ++ G   Y  AID+WS GC++ E+  G+PLF G + VDQ+ +I++VLG P
Sbjct: 229 VLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 109/230 (47%), Gaps = 36/230 (15%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR---ELQIMQMLDHPN---- 136
           Y  + ++G GSFG V +A  R   E VAIK +   K + N+   E++++++++  +    
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 137 --IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
             IV LK  F                      N   R  S       L   + +  Q+C 
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVS-------LNLTRKFAQQMCT 168
Query: 195 ALAYIHN-CIGICHRDIKPQNLLV------------------KGEPNVSYICSRYYRAPE 235
           AL ++    + I H D+KP+N+L+                   G+     I SR+YR+PE
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQXIQSRFYRSPE 228
Query: 236 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 285
           ++ G   Y  AID+WS GC++ E+  G+PLF G + VDQ+ +I++VLG P
Sbjct: 229 VLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 123/293 (41%), Gaps = 64/293 (21%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPN 136
           Y  + V+G GSFG V   K + TG+  A+K + +       DK    RE+Q+++ LDHPN
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 93
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I+ L   F    DK                + I        +R   +       Q+   +
Sbjct: 94  IMKLYEFF---EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLSGI 145
Query: 197 AYIHNCIGICHRDIKPQNLLVKG---EPNV------------------SYICSRYYRAPE 235
            Y+H    I HRD+KP+NLL++    + N+                    I + YY APE
Sbjct: 146 TYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 204
Query: 236 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 295
           ++ G   Y    D+WSTG ++  LL G P F G +  D L ++ K               
Sbjct: 205 VLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------G 248
Query: 296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
            YT F+ PQ     W KV        A DL+ +   Y P++R +A +A  H +
Sbjct: 249 KYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 290

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 119/293 (40%), Gaps = 64/293 (21%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-------KVLQDKRYKNRELQIMQMLDHPN 136
           Y  + V+G GSFG V   K + TG+  A+K       K   DK    RE+Q+++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I  L   F    DK                + I        +R   +       Q+   +
Sbjct: 88  IXKLYEFF---EDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGI 139
Query: 197 AYIHNCIGICHRDIKPQNLLVKG---EPNV------------------SYICSRYYRAPE 235
            Y H    I HRD+KP+NLL++    + N+                    I + YY APE
Sbjct: 140 TYXHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPE 198
Query: 236 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 295
           ++ G   Y    D+WSTG ++  LL G P F G +  D L ++ K               
Sbjct: 199 VLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--------------G 242
Query: 296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
            YT F+ PQ     W KV        A DL+ +   Y P+ R +A +A  H +
Sbjct: 243 KYT-FELPQ-----WKKV-----SESAKDLIRKXLTYVPSXRISARDALDHEW 284

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 93/356 (26%), Positives = 142/356 (39%), Gaps = 66/356 (18%)
Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY---KNRELQIMQML 132
           G   +   YI    +G G F  V+ AK       VA+K V  DK Y      E++++Q +
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 133 DHPN-----------IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP 181
           +  +           I+ L   F     K                N +A      H+ +P
Sbjct: 73  NDADNTKEDSMGANHILKLLDHF---NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129
Query: 182 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVK----------------------G 219
           LIYVK  + Q+   L Y+H   GI H DIKP+N+L++                       
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 189
Query: 220 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VD 273
           E   + I +R YR+PE++ GA  +    DIWST C++ EL+ G  LF  + G       D
Sbjct: 190 EHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248
Query: 274 QLVEIIKVLG------------TPTREEIKCMNPNYTEFKFPQIKPHPWHKV-FQKRLPP 320
            + +II++LG            T T    + +  N ++ KF  ++     K  F K    
Sbjct: 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAK 308
Query: 321 EAVDLVCRFFQYSPNLRCTALEACVHPFF------DELRDPNTRL-PNGRPLPPLF 369
           E  D +    Q  P  R  A     HP+       +E+R P+  L  +G  +P  F
Sbjct: 309 EISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 93/356 (26%), Positives = 142/356 (39%), Gaps = 66/356 (18%)
Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY---KNRELQIMQML 132
           G   +   YI    +G G F  V+ AK       VA+K V  DK Y      E++++Q +
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 133 DHPN-----------IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP 181
           +  +           I+ L   F     K                N +A      H+ +P
Sbjct: 73  NDADNTKEDSMGANHILKLLDHF---NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129
Query: 182 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVK----------------------G 219
           LIYVK  + Q+   L Y+H   GI H DIKP+N+L++                       
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 189
Query: 220 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VD 273
           E   + I +R YR+PE++ GA  +    DIWST C++ EL+ G  LF  + G       D
Sbjct: 190 EHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248
Query: 274 QLVEIIKVLG------------TPTREEIKCMNPNYTEFKFPQIKPHPWHKV-FQKRLPP 320
            + +II++LG            T T    + +  N ++ KF  ++     K  F K    
Sbjct: 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAK 308
Query: 321 EAVDLVCRFFQYSPNLRCTALEACVHPFF------DELRDPNTRL-PNGRPLPPLF 369
           E  D +    Q  P  R  A     HP+       +E+R P+  L  +G  +P  F
Sbjct: 309 EISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 124/296 (41%), Gaps = 67/296 (22%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----RELQIMQMLDHPNIV 138
           ++I   V+G+G+F  VF  K R TG++ A+K + +   +++     E+ +++ + H NIV
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIV 69
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK----LYTYQICR 194
            L+  + STT                        + RI +R   +Y +    L   Q+  
Sbjct: 70  TLEDIYESTTHYYLVMQLVSG----------GELFDRILERG--VYTEKDASLVIQQVLS 117
Query: 195 ALAYIHNCIGICHRDIKPQNLL-VKGEPNVSYICSRY-------------------YRAP 234
           A+ Y+H   GI HRD+KP+NLL +  E N   + + +                   Y AP
Sbjct: 118 AVKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAP 176
Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
           E +     Y+ A+D WS G +   LL G P F  E+   +L E IK              
Sbjct: 177 E-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-SKLFEKIK-------------- 220
Query: 295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
             Y EF+ P          F   +   A D +C   +  PN R T  +A  HP+ D
Sbjct: 221 EGYYEFESP----------FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 77/308 (25%), Positives = 124/308 (40%), Gaps = 68/308 (22%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 141
           ++G GSFG V + K R T +  A+K V+     KN       RE+++++ LDHPNI+ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                ++                 +  I R     H    +I       Q+   + Y+H 
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIK------QVFSGITYMHK 139
Query: 202 CIGICHRDIKPQNLLVKGEPN---------------------VSYICSRYYRAPELIFGA 240
              I HRD+KP+N+L++ +                          I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
             Y    D+WS G ++  LL G P F G++  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 360
             PQ     W     + +  +A DL+ +   + P+LR TA +   HP+   ++  ++  P
Sbjct: 242 DLPQ-----W-----RTISDDAKDLIRKMLTFHPSLRITATQCLEHPW---IQKYSSETP 288
Query: 361 NGRPLPPL 368
               LP L
Sbjct: 289 TISDLPSL 296

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 80/308 (25%), Positives = 129/308 (41%), Gaps = 71/308 (23%)
Query: 75  NGNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQI 128
            G++K  ++  Y  E+ +G GS+G V  A  + T    A KK+    ++D     +E++I
Sbjct: 17  QGSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEI 76
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTV--NRIAR--NYSRIHQRMPLIY 184
           M+ LDHPNI+ L   F   TD                V   R+ R  + +RI +      
Sbjct: 77  MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------ 130
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---------------------KGEPNV 223
                  +  A+AY H  + + HRD+KP+N L                       G+   
Sbjct: 131 ------DVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR 183
Query: 224 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 283
           + + + YY +P+++ G   Y    D WS G +M  LL G P F   +  + +++I +  G
Sbjct: 184 TKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--G 239
Query: 284 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 343
           T               F FP+     W  V      P+A  L+ R    SP  R T+L+A
Sbjct: 240 T---------------FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQA 276
Query: 344 CVHPFFDE 351
             H +F++
Sbjct: 277 LEHEWFEK 284

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 117/288 (40%), Gaps = 65/288 (22%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 141
           ++G GSFG V + K R T +  A+K V+     KN       RE+++++ LDHPNI+ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F    D                 + I +   R  +      +K    Q+   + Y+H 
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIK----QVFSGITYMHK 139
Query: 202 CIGICHRDIKPQNLLVKGEPN---------------------VSYICSRYYRAPELIFGA 240
              I HRD+KP+N+L++ +                          I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
             Y    D+WS G ++  LL G P F G++  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
             PQ     W     + +  +A DL+ +   + P+LR TA +   HP+
Sbjct: 242 DLPQ-----W-----RTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 117/288 (40%), Gaps = 65/288 (22%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 141
           ++G GSFG V + K R T +  A+K V+     KN       RE+++++ LDHPNI+ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F    D                 + I +   R  +      +K    Q+   + Y+H 
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIK----QVFSGITYMHK 139
Query: 202 CIGICHRDIKPQNLLVKGEPN---------------------VSYICSRYYRAPELIFGA 240
              I HRD+KP+N+L++ +                          I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
             Y    D+WS G ++  LL G P F G++  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
             PQ     W     + +  +A DL+ +   + P+LR TA +   HP+
Sbjct: 242 DLPQ-----W-----RTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 129/307 (42%), Gaps = 71/307 (23%)
Query: 76  GNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIM 129
           G++K  ++  Y  E+ +G GS+G V  A  + T    A KK+    ++D     +E++IM
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60
Query: 130 QMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTV--NRIAR--NYSRIHQRMPLIYV 185
           + LDHPNI+ L   F   TD                V   R+ R  + +RI +       
Sbjct: 61  KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------- 113
Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLV---------------------KGEPNVS 224
                 +  A+AY H  + + HRD+KP+N L                       G+   +
Sbjct: 114 -----DVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167
Query: 225 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 284
            + + YY +P+++ G   Y    D WS G +M  LL G P F   +  + +++I +  GT
Sbjct: 168 KVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--GT 223
Query: 285 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 344
                          F FP+     W  V      P+A  L+ R    SP  R T+L+A 
Sbjct: 224 ---------------FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQAL 260
Query: 345 VHPFFDE 351
            H +F++
Sbjct: 261 EHEWFEK 267

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 116/283 (40%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ R++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  SR  ++    Y+     ++  AL+Y H+ 
Sbjct: 80  YFHDAT----RVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYCHSK 131
Query: 203 IGICHRDIKPQNLLV--KGEPNV--------------SYICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  +              + +C    Y  PE+I G   +  
Sbjct: 132 -RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDE 189
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G P F   +  +    I +V                 EF FP  
Sbjct: 190 KVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------EFTFPDF 232
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++ + R T  E   HP+
Sbjct: 233 ------------VTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 116/283 (40%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ R++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  SR  ++    Y+     ++  AL+Y H+ 
Sbjct: 80  YFHDAT----RVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYCHSK 131
Query: 203 IGICHRDIKPQNLLV--KGEPNVS--------------YICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  ++               +C    Y  PE+I G   +  
Sbjct: 132 -RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRM-HDE 189
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G P F   +  +    I +V                 EF FP  
Sbjct: 190 KVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------EFTFPDF 232
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++ + R T  E   HP+
Sbjct: 233 ------------VTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 127/304 (41%), Gaps = 71/304 (23%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 130
           YI    +G+G+ G V  A  R+T + VAIK ++  +++                E++I++
Sbjct: 18  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 76
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L+HP I+ +K+ F    D                 +++  N     +R+     KLY Y
Sbjct: 77  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 127
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVK-------------------GEPNV-SYICSR- 229
           Q+  A+ Y+H   GI HRD+KP+N+L+                    GE ++   +C   
Sbjct: 128 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 186
Query: 230 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 287
            Y APE++   G   Y  A+D WS G ++   L G P F                 +  R
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHR 229
Query: 288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 347
            ++  +    T  K+  I P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 230 TQVS-LKDQITSGKYNFI-PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 282
Query: 348 FFDE 351
           +  +
Sbjct: 283 WLQD 286

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 127/304 (41%), Gaps = 71/304 (23%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 130
           YI    +G+G+ G V  A  R+T + VAIK ++  +++                E++I++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L+HP I+ +K+ F    D                 +++  N     +R+     KLY Y
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 121
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVK-------------------GEPNV-SYICSR- 229
           Q+  A+ Y+H   GI HRD+KP+N+L+                    GE ++   +C   
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 230 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 287
            Y APE++   G   Y  A+D WS G ++   L G P F                 +  R
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHR 223
Query: 288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 347
            ++  +    T  K+  I P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 224 TQVS-LKDQITSGKYNFI-PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 276
Query: 348 FFDE 351
           +  +
Sbjct: 277 WLQD 280

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 127/304 (41%), Gaps = 71/304 (23%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 130
           YI    +G+G+ G V  A  R+T + VAIK ++  +++                E++I++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L+HP I+ +K+ F    D                 +++  N     +R+     KLY Y
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 121
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVK-------------------GEPNV-SYICSR- 229
           Q+  A+ Y+H   GI HRD+KP+N+L+                    GE ++   +C   
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 230 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 287
            Y APE++   G   Y  A+D WS G ++   L G P F                 +  R
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHR 223
Query: 288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 347
            ++  +    T  K+  I P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 224 TQVS-LKDQITSGKYNFI-PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 276
Query: 348 FFDE 351
           +  +
Sbjct: 277 WLQD 280

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 125/304 (41%), Gaps = 71/304 (23%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 130
           YI    +G+G+ G V  A  R+T + VAIK ++  +++                E++I++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L+HP I+ +K+ F    D                 +++  N     +R+     KLY Y
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 121
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVKGEPN--------------------VSYICSR- 229
           Q+  A+ Y+H   GI HRD+KP+N+L+  +                      +  +C   
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 230 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 287
            Y APE++   G   Y  A+D WS G ++   L G P F                 +  R
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHR 223
Query: 288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 347
            ++  +    T  K+  I P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 224 TQVS-LKDQITSGKYNFI-PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 276
Query: 348 FFDE 351
           +  +
Sbjct: 277 WLQD 280

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 125/304 (41%), Gaps = 71/304 (23%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 130
           YI    +G+G+ G V  A  R+T + VAIK ++  +++                E++I++
Sbjct: 11  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 69
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L+HP I+ +K+ F    D                 +++  N     +R+     KLY Y
Sbjct: 70  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 120
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVKGEPN--------------------VSYICSR- 229
           Q+  A+ Y+H   GI HRD+KP+N+L+  +                      +  +C   
Sbjct: 121 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 179
Query: 230 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 287
            Y APE++   G   Y  A+D WS G ++   L G P F                 +  R
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHR 222
Query: 288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 347
            ++  +    T  K+  I P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 223 TQVS-LKDQITSGKYNFI-PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 275
Query: 348 FFDE 351
           +  +
Sbjct: 276 WLQD 279

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ + +  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F  +T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDST----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 203 IGICHRDIKPQNLLV--KGEPNVS--------------YICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  ++               +C    Y  PE+I G   +  
Sbjct: 128 -KVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRM-HDE 185
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  D    I +V                 EF FP  
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV-----------------EFTFPDF 228
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 229 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/318 (22%), Positives = 124/318 (38%), Gaps = 55/318 (17%)
Query: 89  VVGTGSFGVVFQA-KCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFST 147
            +G G+FG V +    +  G  VA+K V    RY       +Q+L+H N       F   
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCV 80
Query: 148 TDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP--LIYVKLYTYQICRALAYIHNCIGI 205
                             +     ++ + +  +P  L +++   YQIC+++ ++H+   +
Sbjct: 81  QMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN-KL 139
Query: 206 CHRDIKPQNLLV-----------------------------------KGEPNVSYICSRY 230
            H D+KP+N+L                                      E + + + +R+
Sbjct: 140 THTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRH 199
Query: 231 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG------- 283
           YRAPE+I  A  ++   D+WS GC++ E  LG  +FP     + L  + ++LG       
Sbjct: 200 YRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMI 258
Query: 284 --TPTREEIKCMNPNYTE------FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 335
             T  R+       ++ E      +     KP     + Q        DL+ +  +Y P 
Sbjct: 259 QKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318
Query: 336 LRCTALEACVHPFFDELR 353
            R T  EA  HPFFD L+
Sbjct: 319 KRITLREALKHPFFDLLK 336

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/318 (22%), Positives = 123/318 (38%), Gaps = 55/318 (17%)
Query: 89  VVGTGSFGVVFQA-KCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFST 147
            +G G+FG V +    +  G  VA+K V    RY       +Q+L+H N       F   
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCV 80
Query: 148 TDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP--LIYVKLYTYQICRALAYIHNCIGI 205
                             +     ++ + +  +P  L +++   YQIC+++ ++H+   +
Sbjct: 81  QMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN-KL 139
Query: 206 CHRDIKPQNLLV-----------------------------------KGEPNVSYICSRY 230
            H D+KP+N+L                                      E + + +  R+
Sbjct: 140 THTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVXXRH 199
Query: 231 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG------- 283
           YRAPE+I  A  ++   D+WS GC++ E  LG  +FP     + L  + ++LG       
Sbjct: 200 YRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMI 258
Query: 284 --TPTREEIKCMNPNYTE------FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 335
             T  R+       ++ E      +     KP     + Q        DL+ +  +Y P 
Sbjct: 259 QKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318
Query: 336 LRCTALEACVHPFFDELR 353
            R T  EA  HPFFD L+
Sbjct: 319 KRITLREALKHPFFDLLK 336

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 102 YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 153
Query: 203 IGICHRDIKPQNLLV--KGEPNV--------------SYICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  +              + +C    Y  PE+I G   +  
Sbjct: 154 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDE 211
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 212 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 254
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 255 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 119/283 (42%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 77  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 128
Query: 203 IGICHRDIKPQNLLV--KGEPNVS---YIC----SRY--------YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  ++   + C    SR         Y  PE+I G   +  
Sbjct: 129 -RVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSGTLDYLPPEMIEGRM-HDE 186
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 187 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 229
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 230 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 93  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 144
Query: 203 IGICHRDIKPQNLLV--KGEPNV--------------SYICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  +              + +C    Y  PE+I G   +  
Sbjct: 145 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDE 202
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 203 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 245
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 246 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 276

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 203 IGICHRDIKPQNLLV--KGEPNV--------------SYICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  +              + +C    Y  PE+I G   +  
Sbjct: 128 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCGTLDYLPPEMIEGRM-HDE 185
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 228
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 229 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 102 YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 153
Query: 203 IGICHRDIKPQNLLV--KGEPNVSY--------------ICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  ++               +C    Y  PE+I G   +  
Sbjct: 154 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMIEGRM-HDE 211
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 212 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 254
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 255 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 203 IGICHRDIKPQNLLV--KGEPNV--------------SYICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  +              + +C    Y  PE+I G   +  
Sbjct: 131 -RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDE 188
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 189 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 231
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 232 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 203 IGICHRDIKPQNLLV--KGEPNVS--------------YICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  ++               +C    Y  PE+I G   +  
Sbjct: 128 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRM-HDE 185
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 228
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 229 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 203 IGICHRDIKPQNLLV--KGEPNVS--------------YICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  ++               +C    Y  PE+I G   +  
Sbjct: 131 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRM-HDE 188
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 189 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 231
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 232 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 71/304 (23%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 130
           YI    +G+G+ G V  A  R+T + VAI+ ++  +++                E++I++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 195
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L+HP I+ +K+ F    D                 +++  N     +R+     KLY Y
Sbjct: 196 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 246
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVKGEPN--------------------VSYICSR- 229
           Q+  A+ Y+H   GI HRD+KP+N+L+  +                      +  +C   
Sbjct: 247 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 305
Query: 230 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 287
            Y APE++   G   Y  A+D WS G ++   L G P F        L           +
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----------K 354
Query: 288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 347
           ++I     N+         P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 355 DQITSGKYNFI--------PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 401
Query: 348 FFDE 351
           +  +
Sbjct: 402 WLQD 405

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 125/304 (41%), Gaps = 71/304 (23%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------------NRELQIMQ 130
           YI    +G+G+ G V  A  R+T + VAI+ ++  +++                E++I++
Sbjct: 151 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 209
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L+HP I+ +K+ F    D                 +++  N     +R+     KLY Y
Sbjct: 210 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFY 260
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVK-------------------GEPNV-SYICSR- 229
           Q+  A+ Y+H   GI HRD+KP+N+L+                    GE ++   +C   
Sbjct: 261 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 319
Query: 230 YYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 287
            Y APE++   G   Y  A+D WS G ++   L G P F        L           +
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----------K 368
Query: 288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 347
           ++I     N+         P  W +V +K     A+DLV +     P  R T  EA  HP
Sbjct: 369 DQITSGKYNFI--------PEVWAEVSEK-----ALDLVKKLLVVDPKARFTTEEALRHP 415
Query: 348 FFDE 351
           +  +
Sbjct: 416 WLQD 419

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 203 IGICHRDIKPQNLLV--KGEPNV--------------SYICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  +              + +C    Y  PE+I G   +  
Sbjct: 131 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDE 188
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 189 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 231
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 232 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 203 IGICHRDIKPQNLLV--KGEPNV--------------SYICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  +              + +C    Y  PE+I G   +  
Sbjct: 131 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDE 188
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 189 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 231
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 232 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 78  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 129
Query: 203 IGICHRDIKPQNLLV--KGEPNV--------------SYICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  +              + +C    Y  PE+I G   +  
Sbjct: 130 -RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDE 187
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 188 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 230
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 231 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 78  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 129
Query: 203 IGICHRDIKPQNLLV--KGEPNVS--------------YICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  ++               +C    Y  PE+I G   +  
Sbjct: 130 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRM-HDE 187
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 188 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 230
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 231 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 75  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 126
Query: 203 IGICHRDIKPQNLLV--KGEPNV--------------SYICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  +              + +C    Y  PE+I G   +  
Sbjct: 127 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDE 184
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 185 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 227
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 228 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 258

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 77  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 128
Query: 203 IGICHRDIKPQNLLV--KGEPNVS--------------YICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  ++               +C    Y  PE+I G   +  
Sbjct: 129 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRM-HDE 186
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 187 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 229
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 230 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 203 IGICHRDIKPQNLLV--KGEPNVS--------------YICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  ++               +C    Y  PE+I G   +  
Sbjct: 128 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRM-HDE 185
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 228
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 229 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 80  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 131
Query: 203 IGICHRDIKPQNLLV--KGEPNV--------------SYICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  +              + +C    Y  PE+I G   +  
Sbjct: 132 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDE 189
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 190 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 232
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 233 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 263

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 32/209 (15%)
Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN---RELQIMQMLDHPNIVA 139
           E  +G G F  V++A C   G  VA+KKV    L D + +    +E+ +++ L+HPN++ 
Sbjct: 37  EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 96
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
               ++++  +               ++R+ +++ +  + +P   V  Y  Q+C AL ++
Sbjct: 97  ----YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 200 HNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGA 240
           H+   + HRDIKP N+ +     V                   S + + YY +PE I   
Sbjct: 153 HS-RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH-E 210
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGE 269
             Y    DIWS GC++ E+   Q  F G+
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSPFYGD 239

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 203 IGICHRDIKPQNLLV--KGEPNV--------------SYICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  +              + +C    Y  PE+I G   +  
Sbjct: 128 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCGTLDYLPPEMIEGRM-HDE 185
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 228
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 229 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 81  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 132
Query: 203 IGICHRDIKPQNLLV--KGEPNV--------------SYICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  +              + +C    Y  PE+I G   +  
Sbjct: 133 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDE 190
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 191 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 233
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 234 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 203 IGICHRDIKPQNLLV--KGEPNV--------------SYICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  +              + +C    Y  PE+I G   +  
Sbjct: 128 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDE 185
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 228
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 229 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 203 IGICHRDIKPQNLLV--KGEPNVS--------------YICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  ++               +C    Y  PE+I G   +  
Sbjct: 131 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRM-HDE 188
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 189 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 231
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 232 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 81  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 132
Query: 203 IGICHRDIKPQNLLV--KGEPNV--------------SYICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  +              + +C    Y  PE+I G   +  
Sbjct: 133 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRM-HDE 190
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 191 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 233
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 234 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 79  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 130
Query: 203 IGICHRDIKPQNLLV--KGEPNVSY--------------ICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  ++               +C    Y  PE+I G   +  
Sbjct: 131 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMIEGRM-HDE 188
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 189 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 231
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 232 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 203 IGICHRDIKPQNLLV--KGEPNV--------------SYICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  +              + +C    Y  PE+I G   +  
Sbjct: 128 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRM-HDE 185
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 228
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 229 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 77  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 128
Query: 203 IGICHRDIKPQNLLV--KGEPNV--------------SYICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  +              + +C    Y  PE+I G   +  
Sbjct: 129 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRM-HDE 186
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 187 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 229
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 230 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 76  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 127
Query: 203 IGICHRDIKPQNLLV--KGEPNV--------------SYICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  +              + +C    Y  PE+I G   +  
Sbjct: 128 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRM-HDE 185
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 228
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 229 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 116/283 (40%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 81  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 132
Query: 203 IGICHRDIKPQNLLV--KGEPNV--------------SYICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  +              + +C    Y  PE I G   +  
Sbjct: 133 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEXIEGRX-HDE 190
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 191 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 233
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 234 ------------VTEGARDLISRLLKHNPSQRPXLREVLEHPW 264

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 116/283 (40%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ ++   I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                TV R  +  S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 73  YFHDAT----RVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYCHSK 124
Query: 203 IGICHRDIKPQNLLV--KGEPNV--------------SYICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  +              + +C    Y  PE+I G   +  
Sbjct: 125 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDE 182
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 183 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 225
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 226 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 256

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 114/287 (39%), Gaps = 64/287 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-------ELQIMQMLDHPNIVALKH 142
           +G+G++G V   K + TG   AIK + +              E+ +++ LDHPNI+ L  
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 71
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F    DK                + I      + Q+   +   +   Q+     Y+H  
Sbjct: 72  FF---EDKRNYYLVMEVYRGGELFDEII-----LRQKFSEVDAAVIMKQVLSGTTYLHKH 123
Query: 203 IGICHRDIKPQNLLVKGEPNVSYI---------------------CSRYYRAPELIFGAT 241
             I HRD+KP+NLL++ +   + I                      + YY APE++    
Sbjct: 124 -NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL--RK 180
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
           +Y    D+WS G ++  LL G P F G++  DQ  EI+K                  +F 
Sbjct: 181 KYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ--EILK-------------RVEKGKFS 223
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
           F    P  W +V       EA  LV     Y P+ R +A EA  HP+
Sbjct: 224 FD---PPDWTQV-----SDEAKQLVKLMLTYEPSKRISAEEALNHPW 262

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/304 (24%), Positives = 124/304 (40%), Gaps = 77/304 (25%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 202 CIGICHRDIKPQNLLVKGEPNV---------------------SYICSRYYRAPELIFGA 240
             GI HRD+KP+N+L+  + ++                     S++ +  Y +PEL+   
Sbjct: 151 K-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 209
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYT 298
           +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                 
Sbjct: 210 SASKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL----------------- 249
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDEL 352
           E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ +
Sbjct: 250 EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297
Query: 353 RDPN 356
              N
Sbjct: 298 TWEN 301

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 121/304 (39%), Gaps = 77/304 (25%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 44  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 103
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            CF                      N     Y R          + YT +I  AL Y+H 
Sbjct: 104 FCF--------QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 155
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------------YICSRYYRAPELIFGA 240
             GI HRD+KP+N+L+  + ++                      ++ +  Y +PEL+   
Sbjct: 156 K-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 214
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYT 298
           +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                 
Sbjct: 215 SACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL----------------- 254
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDEL 352
           E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ +
Sbjct: 255 EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 302
Query: 353 RDPN 356
              N
Sbjct: 303 TWEN 306

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 131/310 (42%), Gaps = 70/310 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G+G++G V   + + T    AIK + +     +       E+ ++++LDHPNI+ L + 
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL-YD 103
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIHN 201
           FF   DK                + I      IH RM    +   +   Q+   + Y+H 
Sbjct: 104 FFE--DKRNYYLVMECYKGGELFDEI------IH-RMKFNEVDAAVIIKQVLSGVTYLHK 154
Query: 202 CIGICHRDIKPQNLLVKGEPNVSYI---------------------CSRYYRAPELIFGA 240
              I HRD+KP+NLL++ +   + I                      + YY APE++   
Sbjct: 155 H-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL--R 211
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
            +Y    D+WS G ++  LL G P F G++  DQ  EI++          K     YT F
Sbjct: 212 KKYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EILR----------KVEKGKYT-F 256
Query: 301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 360
             P+     W     K +   A DL+ +  Q+    R +A +A  HP+  E+    ++  
Sbjct: 257 DSPE-----W-----KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM---CSKKE 303
Query: 361 NGRPLPPLFN 370
           +G  LP L N
Sbjct: 304 SGIELPSLAN 313

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 114/287 (39%), Gaps = 64/287 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-------ELQIMQMLDHPNIVALKH 142
           +G+G++G V   K + TG   AIK + +              E+ +++ LDHPNI+ L  
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 88
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F    DK                + I      + Q+   +   +   Q+     Y+H  
Sbjct: 89  FF---EDKRNYYLVMEVYRGGELFDEII-----LRQKFSEVDAAVIMKQVLSGTTYLHKH 140
Query: 203 IGICHRDIKPQNLLVKGEPNVSYI---------------------CSRYYRAPELIFGAT 241
             I HRD+KP+NLL++ +   + I                      + YY APE++    
Sbjct: 141 -NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL--RK 197
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
           +Y    D+WS G ++  LL G P F G++  DQ  EI+K                  +F 
Sbjct: 198 KYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ--EILK-------------RVEKGKFS 240
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
           F    P  W +V       EA  LV     Y P+ R +A EA  HP+
Sbjct: 241 FD---PPDWTQV-----SDEAKQLVKLMLTYEPSKRISAEEALNHPW 279

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 104/261 (39%), Gaps = 49/261 (18%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYK-NRELQIMQMLDHPNIVALKHC 143
           V+GTG+F  V  A+ + T ++VAIK    K L+ K      E+ ++  + HPNIVAL   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           + S                   +        R   R+         +Q+  A+ Y+H+ +
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--------IFQVLDAVKYLHD-L 135
Query: 204 GICHRDIKPQNLLVKG-EPNVSYICSRY--------------------YRAPELIFGATE 242
           GI HRD+KP+NLL    + +   + S +                    Y APE +     
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-VLAQKP 194
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV---LGTPTREEIKCMNPNY-- 297
           Y+ A+D WS G +   LL G P F  E+      +I+K      +P  ++I     ++  
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 254
Query: 298 --------TEFKFPQIKPHPW 310
                     F   Q   HPW
Sbjct: 255 HLMEKDPEKRFTCEQALQHPW 275

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 75/304 (24%), Positives = 124/304 (40%), Gaps = 77/304 (25%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 40  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 98
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 99  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 151
Query: 202 CIGICHRDIKPQNLLVKGEPNV---------------------SYICSRYYRAPELIFGA 240
             GI HRD+KP+N+L+  + ++                     S++ +  Y +PEL+   
Sbjct: 152 K-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 210
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYT 298
           +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                 
Sbjct: 211 SACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL----------------- 250
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDEL 352
           E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ +
Sbjct: 251 EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 298
Query: 353 RDPN 356
              N
Sbjct: 299 TWEN 302

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 75/304 (24%), Positives = 124/304 (40%), Gaps = 77/304 (25%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 36  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 94
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 95  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 147
Query: 202 CIGICHRDIKPQNLLVKGEPNV---------------------SYICSRYYRAPELIFGA 240
             GI HRD+KP+N+L+  + ++                     S++ +  Y +PEL+   
Sbjct: 148 K-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 206
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYT 298
           +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                 
Sbjct: 207 SACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL----------------- 246
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDEL 352
           E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ +
Sbjct: 247 EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 294
Query: 353 RDPN 356
              N
Sbjct: 295 TWEN 298

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 77/304 (25%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------------YICSRYYRAPELIFGA 240
             GI HRD+KP+N+L+  + ++                      ++ +  Y +PEL+   
Sbjct: 151 K-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYT 298
           +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                 
Sbjct: 210 SAXKSS-DLWALGCIIYQLVAGLP--PFRAGNEGLIFAKIIKL----------------- 249
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDEL 352
           E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ +
Sbjct: 250 EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297
Query: 353 RDPN 356
              N
Sbjct: 298 TWEN 301

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 116/283 (40%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                 + ++    S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKL----SKFDEQRTATYIT----ELANALSYCHSK 132
Query: 203 IGICHRDIKPQNLLV--KGEPNV--------------SYICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  +              + +C    Y  PE+I G   +  
Sbjct: 133 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM-HDE 190
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 191 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 233
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 234 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 124/304 (40%), Gaps = 77/304 (25%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 95
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 96  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 202 CIGICHRDIKPQNLLVKGEPNV---------------------SYICSRYYRAPELIFGA 240
             GI HRD+KP+N+L+  + ++                     +++ +  Y +PEL+   
Sbjct: 149 K-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEK 207
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYT 298
           +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                 
Sbjct: 208 SACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL----------------- 247
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDEL 352
           E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ +
Sbjct: 248 EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295
Query: 353 RDPN 356
              N
Sbjct: 296 TWEN 299

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 116/283 (40%), Gaps = 63/283 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPNI+ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   T                 + ++    S+  ++    Y+     ++  AL+Y H+ 
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKL----SKFDEQRTATYIT----ELANALSYCHSK 132
Query: 203 IGICHRDIKPQNLLV--KGEPNVSYI-------CSRY--------YRAPELIFGATEYTT 245
             + HRDIKP+NLL+   GE  ++          SR         Y  PE+I G   +  
Sbjct: 133 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXGTLDYLPPEMIEGRM-HDE 190
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
            +D+WS G +  E L+G+P F   +  +    I +V                 EF FP  
Sbjct: 191 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFPDF 233
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                       +   A DL+ R  +++P+ R    E   HP+
Sbjct: 234 ------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 91/214 (42%), Gaps = 37/214 (17%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDH 134
           +Y  +  +G G+F  V  A+   TG  VA+K +  DK   N        RE++IM++L+H
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKII--DKTQLNPTSLQKLFREVRIMKILNH 73
Query: 135 PNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           PNIV L    F   +                V     +Y   H RM     +    QI  
Sbjct: 74  PNIVKL----FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVS 125
Query: 195 ALAYIHNCIGICHRDIKPQNLLVKGEPNV------------------SYICSRYYRAPEL 236
           A+ Y H    I HRD+K +NLL+ G+ N+                  ++  S  Y APEL
Sbjct: 126 AVQYCHQKY-IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPEL 184
Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 270
             G       +D+WS G ++  L+ G   F G++
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 109/280 (38%), Gaps = 56/280 (20%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCFFST 147
           +G GS+G V++A  +ETG+IVAIK+V  +   +   +E+ IMQ  D P++V     +F  
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKN 96
Query: 148 TDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICH 207
           TD                +    RN +     +  I          + L Y+H    I H
Sbjct: 97  TDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATIL-----QSTLKGLEYLHFMRKI-H 148
Query: 208 RDIKPQNLLVKGEPNVSY-------------------ICSRYYRAPELIFGATEYTTAID 248
           RDIK  N+L+  E +                      I + ++ APE+I     Y    D
Sbjct: 149 RDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVI-QEIGYNCVAD 207
Query: 249 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH 308
           IWS G    E+  G+P +        +  +  +   PT       NP  T F+    KP 
Sbjct: 208 IWSLGITAIEMAEGKPPYA------DIHPMRAIFMIPT-------NPPPT-FR----KPE 249
Query: 309 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
            W   F         D V +    SP  R TA +   HPF
Sbjct: 250 LWSDNF--------TDFVKQCLVKSPEQRATATQLLQHPF 281

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 104/261 (39%), Gaps = 49/261 (18%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYK-NRELQIMQMLDHPNIVALKHC 143
           V+GTG+F  V  A+ + T ++VAIK    + L+ K      E+ ++  + HPNIVAL   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           + S                   +        R   R+         +Q+  A+ Y+H+ +
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--------IFQVLDAVKYLHD-L 135
Query: 204 GICHRDIKPQNLLVKG-EPNVSYICSRY--------------------YRAPELIFGATE 242
           GI HRD+KP+NLL    + +   + S +                    Y APE +     
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-VLAQKP 194
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV---LGTPTREEIKCMNPNY-- 297
           Y+ A+D WS G +   LL G P F  E+      +I+K      +P  ++I     ++  
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 254
Query: 298 --------TEFKFPQIKPHPW 310
                     F   Q   HPW
Sbjct: 255 HLMEKDPEKRFTCEQALQHPW 275

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 69  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 128
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 129 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 179
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 238
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 239 AVDWWALGVLIYEMAAGYPPF 259

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 218
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF 239

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 104/261 (39%), Gaps = 49/261 (18%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYK-NRELQIMQMLDHPNIVALKHC 143
           V+GTG+F  V  A+ + T ++VAIK    + L+ K      E+ ++  + HPNIVAL   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           + S                   +        R   R+         +Q+  A+ Y+H+ +
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--------IFQVLDAVKYLHD-L 135
Query: 204 GICHRDIKPQNLLVKG-EPNVSYICSRY--------------------YRAPELIFGATE 242
           GI HRD+KP+NLL    + +   + S +                    Y APE +     
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-VLAQKP 194
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV---LGTPTREEIKCMNPNY-- 297
           Y+ A+D WS G +   LL G P F  E+      +I+K      +P  ++I     ++  
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 254
Query: 298 --------TEFKFPQIKPHPW 310
                     F   Q   HPW
Sbjct: 255 HLMEKDPEKRFTCEQALQHPW 275

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 41  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 100
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 101 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 151
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 152 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 210
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 211 AVDWWALGVLIYEMAAGYPPF 231

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 104/261 (39%), Gaps = 49/261 (18%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYK-NRELQIMQMLDHPNIVALKHC 143
           V+GTG+F  V  A+ + T ++VAIK    + L+ K      E+ ++  + HPNIVAL   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           + S                   +        R   R+         +Q+  A+ Y+H+ +
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--------IFQVLDAVKYLHD-L 135
Query: 204 GICHRDIKPQNLLVKG-EPNVSYICSRY--------------------YRAPELIFGATE 242
           GI HRD+KP+NLL    + +   + S +                    Y APE +     
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-VLAQKP 194
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV---LGTPTREEIKCMNPNY-- 297
           Y+ A+D WS G +   LL G P F  E+      +I+K      +P  ++I     ++  
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 254
Query: 298 --------TEFKFPQIKPHPW 310
                     F   Q   HPW
Sbjct: 255 HLMEKDPEKRFTCEQALQHPW 275

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 218
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF 239

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 118/283 (41%), Gaps = 65/283 (22%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLDHPNIVALK 141
            +G GSFG V   +  +T ++ A+K     K ++    +N  +ELQIMQ L+HP +V L 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY----VKLYTYQICRALA 197
           + F    D                V+ +     R H +  + +    VKL+  ++  AL 
Sbjct: 82  YSFQDEED------------MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALD 129
Query: 198 YIHNCIGICHRDIKPQNLLVKGEPNV------------------SYICSRYYRAPELIFG 239
           Y+ N   I HRD+KP N+L+    +V                  +   ++ Y APE+   
Sbjct: 130 YLQNQ-RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
Query: 240 --ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP--------TREE 289
                Y+ A+D WS G    ELL G+  +   S      EI+    T         ++E 
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTFETTVVTYPSAWSQEM 247
Query: 290 I----KCMNPN----YTEFK----FPQIKPHPWHKVFQKRLPP 320
           +    K + PN    +++      FP +    W  VFQKRL P
Sbjct: 248 VSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIP 290

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 218
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF 239

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 31/196 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 144
           +G G+ GVV + + R +G I+A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 24  LGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 83
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +S  +               +++++ +   RI + +    +   +  + R LAY+     
Sbjct: 84  YSDGE----ISICMEHMDGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLAYLREKHQ 135
Query: 205 ICHRDIKPQNLLV--KGEPNV---------------SYICSRYYRAPELIFGATEYTTAI 247
           I HRD+KP N+LV  +GE  +               S++ +R Y APE + G T Y+   
Sbjct: 136 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAPERLQG-THYSVQS 194
Query: 248 DIWSTGCVMAELLLGQ 263
           DIWS G  + EL +G+
Sbjct: 195 DIWSMGLSLVELAVGR 210

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 120/294 (40%), Gaps = 59/294 (20%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIV 138
           +I +  +G+G+FG V   + R +G    IK + +D+          E+++++ LDHPNI+
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            +   F    D                + RI    +R  + +   YV     Q+  ALAY
Sbjct: 84  KIFEVF---EDYHNMYIVMETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAY 139
Query: 199 IHNCIGICHRDIKPQNLLVK---------------------GEPNVSYICSRYYRAPELI 237
            H+   + H+D+KP+N+L +                      E + +   +  Y APE+ 
Sbjct: 140 FHSQ-HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF 198
Query: 238 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 297
               + T   DIWS G VM  LL G   F G S    L E+        +++     PNY
Sbjct: 199 --KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTS----LEEV--------QQKATYKEPNY 244
Query: 298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 351
                 + +P          L P+AVDL+ +     P  R +A +   H +F +
Sbjct: 245 A----VECRP----------LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 77/304 (25%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------------YICSRYYRAPELIFGA 240
             GI HRD+KP+N+L+  + ++                      ++ +  Y +PEL+   
Sbjct: 151 K-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYT 298
           +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                 
Sbjct: 210 SACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL----------------- 249
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDEL 352
           E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ +
Sbjct: 250 EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297
Query: 353 RDPN 356
              N
Sbjct: 298 TWEN 301

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 77/304 (25%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 95
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 96  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------------YICSRYYRAPELIFGA 240
             GI HRD+KP+N+L+  + ++                      ++ +  Y +PEL+   
Sbjct: 149 K-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYT 298
           +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                 
Sbjct: 208 SACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL----------------- 247
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDEL 352
           E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ +
Sbjct: 248 EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295
Query: 353 RDPN 356
              N
Sbjct: 296 TWEN 299

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 77/304 (25%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------------YICSRYYRAPELIFGA 240
             GI HRD+KP+N+L+  + ++                      ++ +  Y +PEL+   
Sbjct: 151 K-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYT 298
           +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                 
Sbjct: 210 SACKSS-DLWALGCIIYQLVAGLP--PFRAGNEGLIFAKIIKL----------------- 249
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDEL 352
           E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ +
Sbjct: 250 EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297
Query: 353 RDPN 356
              N
Sbjct: 298 TWEN 301

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 77/304 (25%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 95
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 96  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------------YICSRYYRAPELIFGA 240
             GI HRD+KP+N+L+  + ++                      ++ +  Y +PEL+   
Sbjct: 149 K-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYT 298
           +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                 
Sbjct: 208 SACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL----------------- 247
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDEL 352
           E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ +
Sbjct: 248 EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295
Query: 353 RDPN 356
              N
Sbjct: 296 TWEN 299

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 77/304 (25%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------------YICSRYYRAPELIFGA 240
             GI HRD+KP+N+L+  + ++                      ++ +  Y +PEL+   
Sbjct: 151 K-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYT 298
           +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                 
Sbjct: 210 SACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL----------------- 249
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDEL 352
           E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ +
Sbjct: 250 EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297
Query: 353 RDPN 356
              N
Sbjct: 298 TWEN 301

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/304 (24%), Positives = 121/304 (39%), Gaps = 65/304 (21%)
Query: 83  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 135
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 31  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 88
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 89  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 139
Query: 196 LAYIHNCIGICHRDIKPQNLLVKGEPNVSY----ICSR---------------YYRAPEL 236
           L+ +H   G+ HRDIK  ++L+  +  V       C++               Y+ APEL
Sbjct: 140 LSVLH-AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPEL 198
Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 296
           I     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  N
Sbjct: 199 I-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDN 242
Query: 297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
                 P++K    HKV      P     + R     P  R TA E   HPF  +   P 
Sbjct: 243 LP----PRLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPA 291
Query: 357 TRLP 360
           + +P
Sbjct: 292 SIVP 295

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/307 (24%), Positives = 122/307 (39%), Gaps = 65/307 (21%)
Query: 83  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 135
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 20  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 77
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 78  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 128
Query: 196 LAYIHNCIGICHRDIKPQNLLVKGEPNVSY----ICSR---------------YYRAPEL 236
           L+ +H   G+ HRDIK  ++L+  +  V       C++               Y+ APEL
Sbjct: 129 LSVLH-AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPEL 187
Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 296
           I     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  N
Sbjct: 188 I-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDN 231
Query: 297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
                 P++K    HKV      P     + R     P  R TA E   HPF  +   P 
Sbjct: 232 LP----PRLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPA 280
Query: 357 TRLPNGR 363
           + +P  R
Sbjct: 281 SIVPLMR 287

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 77/304 (25%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 39  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 97
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 98  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------------YICSRYYRAPELIFGA 240
             GI HRD+KP+N+L+  + ++                      ++ +  Y +PEL+   
Sbjct: 151 K-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYT 298
           +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                 
Sbjct: 210 SACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL----------------- 249
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDEL 352
           E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ +
Sbjct: 250 EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297
Query: 353 RDPN 356
              N
Sbjct: 298 TWEN 301

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/304 (24%), Positives = 121/304 (39%), Gaps = 65/304 (21%)
Query: 83  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 135
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 24  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 81
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 82  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 132
Query: 196 LAYIHNCIGICHRDIKPQNLLVKGEPNVSY----ICSR---------------YYRAPEL 236
           L+ +H   G+ HRDIK  ++L+  +  V       C++               Y+ APEL
Sbjct: 133 LSVLH-AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPEL 191
Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 296
           I     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  N
Sbjct: 192 I-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDN 235
Query: 297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
                 P++K    HKV      P     + R     P  R TA E   HPF  +   P 
Sbjct: 236 LP----PRLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPA 284
Query: 357 TRLP 360
           + +P
Sbjct: 285 SIVP 288

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 69  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 128
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 129 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 179
Query: 202 CIGICHRDIKPQNLLVKGEPNVSY---------------ICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLCGTPEYLAPEIIL-SKGYNK 238
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 239 AVDWWALGVLIYEMAAGYPPF 259

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 77/304 (25%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 40  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 98
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 99  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 151
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------------YICSRYYRAPELIFGA 240
             GI HRD+KP+N+L+  + ++                      ++ +  Y +PEL+   
Sbjct: 152 K-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 210
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYT 298
           +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                 
Sbjct: 211 SACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL----------------- 250
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDEL 352
           E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ +
Sbjct: 251 EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 298
Query: 353 RDPN 356
              N
Sbjct: 299 TWEN 302

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K +E++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NL++  +  +                 +C    Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NL++  +  +                 +C    Y APE+I  +  Y  
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 218
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF 239

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 77/304 (25%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 21  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 79
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 80  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 132
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------------YICSRYYRAPELIFGA 240
             GI HRD+KP+N+L+  + ++                      ++ +  Y +PEL+   
Sbjct: 133 K-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 191
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYT 298
           +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                 
Sbjct: 192 SACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL----------------- 231
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDEL 352
           E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ +
Sbjct: 232 EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 279
Query: 353 RDPN 356
              N
Sbjct: 280 TWEN 283

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/304 (24%), Positives = 121/304 (39%), Gaps = 65/304 (21%)
Query: 83  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 135
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 74  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 131
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 132 NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 182
Query: 196 LAYIHNCIGICHRDIKPQNLLVKGEPNVSY----ICSR---------------YYRAPEL 236
           L+ +H   G+ HRDIK  ++L+  +  V       C++               Y+ APEL
Sbjct: 183 LSVLH-AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPEL 241
Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 296
           I     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  N
Sbjct: 242 I-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDN 285
Query: 297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
                 P++K    HKV      P     + R     P  R TA E   HPF  +   P 
Sbjct: 286 LP----PRLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPA 334
Query: 357 TRLP 360
           + +P
Sbjct: 335 SIVP 338

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K +E++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NL++  +  +                 +C    Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/304 (24%), Positives = 121/304 (39%), Gaps = 65/304 (21%)
Query: 83  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 135
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 29  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 86
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 87  NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 137
Query: 196 LAYIHNCIGICHRDIKPQNLLVKGEPNVSY----ICSR---------------YYRAPEL 236
           L+ +H   G+ HRDIK  ++L+  +  V       C++               Y+ APEL
Sbjct: 138 LSVLH-AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPEL 196
Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 296
           I     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  N
Sbjct: 197 I-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDN 240
Query: 297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
                 P++K    HKV      P     + R     P  R TA E   HPF  +   P 
Sbjct: 241 LP----PRLK--NLHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPA 289
Query: 357 TRLP 360
           + +P
Sbjct: 290 SIVP 293

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 77/304 (25%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 14  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 72
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 73  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 125
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------------YICSRYYRAPELIFGA 240
             GI HRD+KP+N+L+  + ++                      ++ +  Y +PEL+   
Sbjct: 126 K-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 184
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYT 298
           +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                 
Sbjct: 185 SACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL----------------- 224
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDEL 352
           E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ +
Sbjct: 225 EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 272
Query: 353 RDPN 356
              N
Sbjct: 273 TWEN 276

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 77/304 (25%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 16  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 74
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 75  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 127
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------------YICSRYYRAPELIFGA 240
             GI HRD+KP+N+L+  + ++                      ++ +  Y +PEL+   
Sbjct: 128 K-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 186
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYT 298
           +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                 
Sbjct: 187 SACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL----------------- 226
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDEL 352
           E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ +
Sbjct: 227 EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 274
Query: 353 RDPN 356
              N
Sbjct: 275 TWEN 278

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 218
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF 239

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVSYICSRY----------------YRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +      +                Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLAGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVSYICSRY----------------YRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +      +                Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLXGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 35  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 94
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H+
Sbjct: 95  FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLHS 146
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 147 -LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 204
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 205 AVDWWALGVLIYEMAAGYPPF 225

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 122/300 (40%), Gaps = 77/300 (25%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 17  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 75
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 76  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 128
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------------YICSRYYRAPELIFGA 240
             GI HRD+KP+N+L+  + ++                      ++ +  Y +PEL+   
Sbjct: 129 K-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 187
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYT 298
           +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                 
Sbjct: 188 SACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL----------------- 227
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDEL 352
           E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ +
Sbjct: 228 EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 275

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 77/304 (25%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 36  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 94
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 95  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 147
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------------YICSRYYRAPELIFGA 240
             GI HRD+KP+N+L+  + ++                      ++ +  Y +PEL+   
Sbjct: 148 K-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 206
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYT 298
           +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                 
Sbjct: 207 SACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL----------------- 246
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDEL 352
           E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ +
Sbjct: 247 EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 294
Query: 353 RDPN 356
              N
Sbjct: 295 TWEN 298

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 77/304 (25%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 15  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 73
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 74  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 126
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------------YICSRYYRAPELIFGA 240
             GI HRD+KP+N+L+  + ++                      ++ +  Y +PEL+   
Sbjct: 127 K-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 185
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYT 298
           +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                 
Sbjct: 186 SACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL----------------- 225
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDEL 352
           E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ +
Sbjct: 226 EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273
Query: 353 RDPN 356
              N
Sbjct: 274 TWEN 277

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/321 (22%), Positives = 126/321 (39%), Gaps = 61/321 (19%)
Query: 89  VVGTGSFGVVFQ-AKCRETGEIVAIKKVLQDKRYKNR---ELQIMQMLDH--PNIVALKH 142
            +G G+FG V Q    R  G  VA+K +   ++YK     E+ +++ ++   P+   L  
Sbjct: 40  TLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNLCV 99
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
             F   D               T + +  N    +   P+  V+   +Q+C+A+ ++H+ 
Sbjct: 100 QMFDWFDYHGHMCISFELLGLSTFDFLKDNN---YLPYPIHQVRHMAFQLCQAVKFLHDN 156
Query: 203 IGICHRDIKPQNLL-VKGEPNVSY----------------------------------IC 227
             + H D+KP+N+L V  +  ++Y                                  + 
Sbjct: 157 -KLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATFDHEHHSTIVS 215
Query: 228 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG-TPT 286
           +R+YRAPE+I     ++   D+WS GC++ E  +G  LF      + L  + ++LG  P+
Sbjct: 216 TRHYRAPEVILELG-WSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPIPS 274
Query: 287 REEIKCMNPNY--------------TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQY 332
           R   K     Y                +     KP   +   +     +  DL+    +Y
Sbjct: 275 RMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQLFDLIESMLEY 334
Query: 333 SPNLRCTALEACVHPFFDELR 353
            P  R T  EA  HPFF  LR
Sbjct: 335 EPAKRLTLGEALQHPFFARLR 355

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/323 (23%), Positives = 122/323 (37%), Gaps = 79/323 (24%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 145
           +GTG+FGVV +   R TG   A K V+     DK    +E+Q M +L HP +V L   F 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 223
Query: 146 STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
              D                  ++A  ++++ +   + Y++    Q+C+ L ++H     
Sbjct: 224 --EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLCHMHEN-NY 276
Query: 206 CHRDIKPQNLLVKG-----------------EPNVSY---ICSRYYRAPELIFGA-TEYT 244
            H D+KP+N++                    +P  S      +  + APE+  G    Y 
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 336
Query: 245 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 304
           T  D+WS G +   LL G   F GE+  + L              +K  + N  +  F  
Sbjct: 337 T--DMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMDDSAFSG 382
Query: 305 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP--NTRLPNG 362
           I               +  D + +     PN R T  +A  HP+      P  ++++P+ 
Sbjct: 383 IS-------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSS 429
Query: 363 R-----------------PLPPL 368
           R                 PLPPL
Sbjct: 430 RYTKIRDSIKTKYDAWPEPLPPL 452

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 120/304 (39%), Gaps = 65/304 (21%)
Query: 83  SYIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHP 135
           SY+   + +G GS G+V  A  R +G++VA+KK+  D R + R      E+ IM+   H 
Sbjct: 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 208
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           N+V + + +    +                V          H RM    +      + +A
Sbjct: 209 NVVEMYNSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIAAVCLAVLQA 259
Query: 196 LAYIHNCIGICHRDIKPQNLLVKGEPNVS-------------------YICSRYYRAPEL 236
           L+ +H   G+ HRDIK  ++L+  +  V                     + + Y+ APEL
Sbjct: 260 LSVLH-AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPEL 318
Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 296
           I     Y   +DIWS G ++ E++ G+P +  E               P  + +K +  N
Sbjct: 319 I-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDN 362
Query: 297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
                 P++K    HKV      P     + R     P  R TA E   HPF  +   P 
Sbjct: 363 LP----PRLK--NLHKVS-----PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPA 411
Query: 357 TRLP 360
           + +P
Sbjct: 412 SIVP 415

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/323 (23%), Positives = 122/323 (37%), Gaps = 79/323 (24%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 145
           +GTG+FGVV +   R TG   A K V+     DK    +E+Q M +L HP +V L   F 
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 117
Query: 146 STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
              D                  ++A  ++++ +   + Y++    Q+C+ L ++H     
Sbjct: 118 --EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLCHMHEN-NY 170
Query: 206 CHRDIKPQNLLVKG-----------------EPNVSY---ICSRYYRAPELIFGA-TEYT 244
            H D+KP+N++                    +P  S      +  + APE+  G    Y 
Sbjct: 171 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 230
Query: 245 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 304
           T  D+WS G +   LL G   F GE+  + L              +K  + N  +  F  
Sbjct: 231 T--DMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMDDSAFSG 276
Query: 305 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP--NTRLPNG 362
           I               +  D + +     PN R T  +A  HP+      P  ++++P+ 
Sbjct: 277 IS-------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSS 323
Query: 363 R-----------------PLPPL 368
           R                 PLPPL
Sbjct: 324 RYTKIRDSIKTKYDAWPEPLPPL 346

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 123/299 (41%), Gaps = 59/299 (19%)
Query: 75  NGNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYKNRELQIMQ 130
           +G+++  +S  +  E  +G G+  +V++ K + T +  A+K  K   DK+    E+ ++ 
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L HPNI+ LK  F + T+                 +RI        +R     VK    
Sbjct: 104 RLSHPNIIKLKEIFETPTE---ISLVLELVTGGELFDRIVEK-GYYSERDAADAVK---- 155
Query: 191 QICRALAYIHNCIGICHRDIKPQNLL--------------------VKGEPNVSYICSR- 229
           QI  A+AY+H   GI HRD+KP+NLL                    V+ +  +  +C   
Sbjct: 156 QILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTP 214
Query: 230 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 289
            Y APE++ G   Y   +D+WS G +   LL G   F  E G DQ +          R  
Sbjct: 215 GYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERG-DQFM---------FRRI 263
Query: 290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
           + C      E+ F      PW       +   A DLV +     P  R T  +A  HP+
Sbjct: 264 LNC------EYYFIS----PW----WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVLEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 218
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF 239

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 116/272 (42%), Gaps = 44/272 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ +++  IVA+K + + +  K        RE++I   L HPNI+ L +
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F+   D+                  + ++ +   QR   I  +L       AL Y H  
Sbjct: 91  YFY---DRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEEL-----ADALMYCHGK 142
Query: 203 IGICHRDIKPQNLLVKG--------------EPNV--SYICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+                 P++    +C    Y  PE+I G   +  
Sbjct: 143 -KVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCGTLDYLPPEMIEGRM-HNE 200
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-----LGTPTREE---IKCMNPNY 297
            +D+W  G +  ELL+G P F   S  +    I+KV        PT  +    K +  N 
Sbjct: 201 KVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISKLLRHNP 260
Query: 298 TE-FKFPQIKPHPWHKVFQKR-LPPEAVDLVC 327
           +E     Q+  HPW +   +R LPP A+  V 
Sbjct: 261 SERLPLAQVSAHPWVRANSRRVLPPSALQSVA 292

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 39/202 (19%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
           +G GSFG V+ A+     E+VAIKK+    +  N       +E++ +Q L HPN +  + 
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIH 200
           C+                         A +   +H++ PL  + +   T+   + LAY+H
Sbjct: 122 CYLREHTAWLVMEYCLGS---------ASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH 171
Query: 201 NCIGICHRDIKPQNLLVKGEPNV----------------SYICSRYYRAPELIFGATE-- 242
           +   + HRD+K  N+L+  EP +                 ++ + Y+ APE+I    E  
Sbjct: 172 SH-NMIHRDVKAGNILL-SEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQ 229
Query: 243 YTTAIDIWSTGCVMAELLLGQP 264
           Y   +D+WS G    EL   +P
Sbjct: 230 YDGKVDVWSLGITCIELAERKP 251

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 218
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF 239

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVKGEPNVSY---------------ICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIIL-SKGYNK 218
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF 239

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 34  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 93
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H+
Sbjct: 94  FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLHS 145
Query: 202 CIGICHRDIKPQNLLVKGEPNVSY---------------ICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 146 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIIL-SKGYNK 203
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 204 AVDWWALGVLIYEMAAGYPPF 224

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 43/228 (18%)
Query: 89  VVGTGSFGVVFQAK------CRETGEIVAIKKV---LQDKRYKNRELQIMQMLDHPNIVA 139
           V+G GSFG VF  K       R+   +  +KK    ++D+     E  I+  ++HP IV 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALA 197
           L H  F T  K                 R    ++R+ + +      VK Y  ++  AL 
Sbjct: 91  L-HYAFQTEGKLYLILDFL---------RGGDLFTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 198 YIHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIF 238
           ++H+ +GI +RD+KP+N+L+  E ++                   S+  +  Y APE++ 
Sbjct: 141 HLHS-LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV- 198
Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTP 285
               +T + D WS G +M E+L G   F G+   + +  I+K  LG P
Sbjct: 199 NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 39/202 (19%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
           +G GSFG V+ A+     E+VAIKK+    +  N       +E++ +Q L HPN +  + 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIH 200
           C+                         A +   +H++ PL  + +   T+   + LAY+H
Sbjct: 83  CYLREHTAWLVMEYCLGS---------ASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH 132
Query: 201 NCIGICHRDIKPQNLLVKGEPNV----------------SYICSRYYRAPELIFGATE-- 242
           +   + HRD+K  N+L+  EP +                 ++ + Y+ APE+I    E  
Sbjct: 133 SH-NMIHRDVKAGNILL-SEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQ 190
Query: 243 YTTAIDIWSTGCVMAELLLGQP 264
           Y   +D+WS G    EL   +P
Sbjct: 191 YDGKVDVWSLGITCIELAERKP 212

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 41  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 100
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 101 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 151
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 152 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 210
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 211 AVDWWALGVLIYEMAAGYPPF 231

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R ++  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FAEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 39/212 (18%)
Query: 84  YIAEHV-VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPN 136
           Y+A  + +G GS G+V  A  + TG+ VA+KK+  D R + R      E+ IM+   H N
Sbjct: 46  YLANFIKIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHDN 103
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           +V +   +    +                V          H RM    +      + RAL
Sbjct: 104 VVDMYSSYLVGDELWVVMEFLEGGALTDIVT---------HTRMNEEQIATVCLSVLRAL 154
Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNVSY----ICSR---------------YYRAPELI 237
           +Y+HN  G+ HRDIK  ++L+  +  +       C++               Y+ APE+I
Sbjct: 155 SYLHNQ-GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVI 213
Query: 238 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 269
                Y T +DIWS G ++ E++ G+P +  E
Sbjct: 214 -SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE 244

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 113/298 (37%), Gaps = 57/298 (19%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ----DKRYKNRELQIMQMLDHPNIVALKHCFF 145
           +G+G+FGVV +   + TG +   K +      DK     E+ IM  L HP ++ L   F 
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF- 117
Query: 146 STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
              DK                +RIA    ++ +   + Y++    Q C  L ++H    I
Sbjct: 118 --EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR----QACEGLKHMHEH-SI 170
Query: 206 CHRDIKPQNLLVKGEPNVSYICSRYYRA----PELIFGATEYTTAI-------------- 247
            H DIKP+N++ + +   S     +  A    P+ I   T  T                 
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFY 230
Query: 248 -DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 306
            D+W+ G +   LL G   F GE  ++ L            + +K  +  + E  F  + 
Sbjct: 231 TDMWAIGVLGYVLLSGLSPFAGEDDLETL------------QNVKRCDWEFDEDAFSSVS 278
Query: 307 PHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD-ELRDPNTRLPNGR 363
           P             EA D +    Q  P  R T  +A  HP+   +  +  +R+P+ R
Sbjct: 279 P-------------EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSR 323

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/304 (24%), Positives = 122/304 (40%), Gaps = 77/304 (25%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF     A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 37  ILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 95
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 96  --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------------YICSRYYRAPELIFGA 240
             GI HRD+KP+N+L+  + ++                      ++ +  Y +PEL+   
Sbjct: 149 K-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYT 298
           +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                 
Sbjct: 208 SACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL----------------- 247
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDEL 352
           E+ FP+            +  P+A DLV +      +  L C  +E       HPFF+ +
Sbjct: 248 EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295
Query: 353 RDPN 356
              N
Sbjct: 296 TWEN 299

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NL++  +  +                 +C    Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ ++  G P F
Sbjct: 218 AVDWWALGVLIYQMAAGYPPF 238

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NL++  +  +                 +C    Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NL++  +  +                 +C    Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIII-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 117/288 (40%), Gaps = 61/288 (21%)
Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYK-NRELQIMQMLDHPNIVALK 141
           +  +GTG+F  V  A+ + TG++ A+K    K L+ K      E+ +++ + H NIVAL+
Sbjct: 27  KETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALE 86
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             + S                   +  + + +        LI       Q+  A+ Y+H 
Sbjct: 87  DIYESPNHLYLVMQLVSGGELFDRI--VEKGFYTEKDASTLIR------QVLDAVYYLHR 138
Query: 202 CIGICHRDIKPQNLL-------------------VKGEPNV-SYICSR-YYRAPELIFGA 240
            +GI HRD+KP+NLL                   ++G+ +V S  C    Y APE +   
Sbjct: 139 -MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPE-VLAQ 196
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
             Y+ A+D WS G +   LL G P F  E+      +I+K                  E+
Sbjct: 197 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILK-----------------AEY 239
Query: 301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
           +F    P+ W  +        A D +    +  PN R T  +A  HP+
Sbjct: 240 EFDS--PY-WDDI-----SDSAKDFIRNLMEKDPNKRYTCEQAARHPW 279

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 43/228 (18%)
Query: 89  VVGTGSFGVVFQAK------CRETGEIVAIKKV---LQDKRYKNRELQIMQMLDHPNIVA 139
           V+G GSFG VF  K       R+   +  +KK    ++D+     E  I+  ++HP IV 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALA 197
           L H  F T  K                 R    ++R+ + +      VK Y  ++  AL 
Sbjct: 91  L-HYAFQTEGKLYLILDFL---------RGGDLFTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 198 YIHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIF 238
           ++H+ +GI +RD+KP+N+L+  E ++                   S+  +  Y APE++ 
Sbjct: 141 HLHS-LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV- 198
Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTP 285
               +T + D WS G +M E+L G   F G+   + +  I+K  LG P
Sbjct: 199 NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 69  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 128
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 129 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 179
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 238
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 239 AVDWWALGVLIYEMAAGYPPF 259

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 43/228 (18%)
Query: 89  VVGTGSFGVVFQAK------CRETGEIVAIKKV---LQDKRYKNRELQIMQMLDHPNIVA 139
           V+G GSFG VF  K       R+   +  +KK    ++D+     E  I+  ++HP IV 
Sbjct: 32  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 91
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALA 197
           L H  F T  K                 R    ++R+ + +      VK Y  ++  AL 
Sbjct: 92  L-HYAFQTEGKLYLILDFL---------RGGDLFTRLSKEVMFTEEDVKFYLAELALALD 141
Query: 198 YIHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIF 238
           ++H+ +GI +RD+KP+N+L+  E ++                   S+  +  Y APE++ 
Sbjct: 142 HLHS-LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV- 199
Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTP 285
               +T + D WS G +M E+L G   F G+   + +  I+K  LG P
Sbjct: 200 NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 247

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 134/309 (43%), Gaps = 75/309 (24%)
Query: 85  IAEHVVGTGSFG-VVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML----DHPNIVA 139
           ++E ++G GS G VVFQ   +  G  VA+K++L D  + +  L  +++L    DHPN++ 
Sbjct: 36  VSEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 90
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY-QICRALAY 198
            ++    TTD+               +   ++N S  + ++   Y  +    QI   +A+
Sbjct: 91  -RYYCSETTDRFLYIALELCNLNLQDLVE-SKNVSDENLKLQKEYNPISLLRQIASGVAH 148
Query: 199 IHNCIGICHRDIKPQNLLVK-----------GEPNVSYICSRY----------------- 230
           +H+ + I HRD+KPQN+LV            G  N+  + S +                 
Sbjct: 149 LHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 231 --------YRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 280
                   +RAPEL+  +T+   T +IDI+S GCV    +L +   P      +   II+
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRESNIIR 266
Query: 281 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 340
             G  + +E+KC++                     + L  EA DL+ +   + P  R TA
Sbjct: 267 --GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLKRPTA 304
Query: 341 LEACVHPFF 349
           ++   HP F
Sbjct: 305 MKVLRHPLF 313

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 118/301 (39%), Gaps = 78/301 (25%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKVLQDK-RYKN------------- 123
           SY     +G+G++G V    C+E        I  IKK   DK RY +             
Sbjct: 37  SYFKVRKLGSGAYGEVLL--CKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 124 RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI 183
            E+ +++ LDHPNI+ L   F    DK                 +I  N  +  +     
Sbjct: 95  NEISLLKSLDHPNIIKLFDVF---EDKKYFYLVTEFYEGGELFEQII-NRHKFDECDAAN 150
Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-------------------- 223
            +K    QI   + Y+H    I HRDIKP+N+L++ + ++                    
Sbjct: 151 IMK----QILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205
Query: 224 -SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 282
              + + YY APE++    +Y    D+WS G +M  LL G P F G++  D + ++ K  
Sbjct: 206 RDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK-- 261
Query: 283 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 342
                         Y +F       + W     K +  EA +L+     Y  N RCTA E
Sbjct: 262 -----------GKYYFDF-------NDW-----KNISDEAKELIKLMLTYDYNKRCTAEE 298
Query: 343 A 343
           A
Sbjct: 299 A 299

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 78/309 (25%), Positives = 134/309 (43%), Gaps = 75/309 (24%)
Query: 85  IAEHVVGTGSFG-VVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML----DHPNIVA 139
           ++E ++G GS G VVFQ   +  G  VA+K++L D  + +  L  +++L    DHPN++ 
Sbjct: 36  VSEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 90
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY-QICRALAY 198
            ++    TTD+               +   ++N S  + ++   Y  +    QI   +A+
Sbjct: 91  -RYYCSETTDRFLYIALELCNLNLQDLVE-SKNVSDENLKLQKEYNPISLLRQIASGVAH 148
Query: 199 IHNCIGICHRDIKPQNLLVK-----------GEPNVSYICSRY----------------- 230
           +H+ + I HRD+KPQN+LV            G  N+  + S +                 
Sbjct: 149 LHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 231 --------YRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 280
                   +RAPEL+  +T+   T +IDI+S GCV    +L +   P      +   II+
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRESNIIR 266
Query: 281 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA 340
             G  + +E+KC++                     + L  EA DL+ +   + P  R TA
Sbjct: 267 --GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLKRPTA 304
Query: 341 LEACVHPFF 349
           ++   HP F
Sbjct: 305 MKVLRHPLF 313

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 43  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 102
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 103 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 153
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 154 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 212
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 213 AVDWWALGVLIYEMAAGYPPF 233

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVSYICSRYYR----------------APELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +      + +                APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEALAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H+
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLHS 159
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 121/304 (39%), Gaps = 77/304 (25%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++ +  Y  RE  +M  LDHP  V L 
Sbjct: 42  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 100
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +F+  D                 N     Y R          + YT +I  AL Y+H 
Sbjct: 101 --YFTFQDDEKLYFGLSYAK-----NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 153
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------------YICSRYYRAPELIFGA 240
             GI HRD+KP+N+L+  + ++                      ++ +  Y +PEL+   
Sbjct: 154 K-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 212
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV--EIIKVLGTPTREEIKCMNPNYT 298
           +   ++ D+W+ GC++ +L+ G P  P  +G + L+  +IIK+                 
Sbjct: 213 SACKSS-DLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL----------------- 252
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRF--FQYSPNLRCTALEAC----VHPFFDEL 352
           E+ FP                P+A DLV +      +  L C  +E       HPFF+ +
Sbjct: 253 EYDFPAA------------FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 300
Query: 353 RDPN 356
              N
Sbjct: 301 TWEN 304

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 33/197 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALK 141
            +GTGSFG V   + R  G   A+K +       L+   + N E  ++ ++ HP I+ + 
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F    D                 + +     R  QR P    K Y  ++C AL Y+H+
Sbjct: 73  GTF---QDAQQIFMIMDYIEGGELFSLL-----RKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 202 CIGICHRDIKPQNLLV--------------KGEPNVSY-ICSR-YYRAPELIFGATEYTT 245
              I +RD+KP+N+L+              K  P+V+Y +C    Y APE++     Y  
Sbjct: 125 K-DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTPDYIAPEVV-STKPYNK 182
Query: 246 AIDIWSTGCVMAELLLG 262
           +ID WS G ++ E+L G
Sbjct: 183 SIDWWSFGILIYEMLAG 199

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 87/339 (25%), Positives = 127/339 (37%), Gaps = 95/339 (28%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLD 133
           Y  +  +G GS+GVV  A   +T  I AIK + ++K          R K  E+++M+ L 
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT-EVRLMKKLH 86
Query: 134 HPNIVALKHCFFS--------------------------TTDKXXXXXXXXXXXXXXTVN 167
           HPNI  L   +                            +T K                N
Sbjct: 87  HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 168 RIARNYSRIHQRMPLIYV---KLYT---YQICRALAYIHNCIGICHRDIKPQNLLVKGEP 221
             A N S    R  L +V   KL +    QI  AL Y+HN  GICHRDIKP+N L     
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN-QGICHRDIKPENFLFSTNK 205
Query: 222 N-----VSYICSR--------------------YYRAPELIFGATE-YTTAIDIWSTGCV 255
           +     V +  S+                    Y+ APE++    E Y    D WS G +
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 256 MAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQ 315
           +  LL+G   FPG +  D + +++        +++   NPNY                  
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLN-------KKLCFENPNYN----------------- 301
Query: 316 KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 354
             L P A DL+      + + R  A+ A  HP+  +  D
Sbjct: 302 -VLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y AP +I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPAIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 93/198 (46%), Gaps = 35/198 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVA-------IKKVLQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G G+ GVVF+   + +G ++A       IK  ++++    RELQ++   + P IV    
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 133
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F+S  +               +++++ +   RI +++    +   +  + + L Y+   
Sbjct: 134 AFYSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREK 185
Query: 203 IGICHRDIKPQNLLV--KGEPNV---------------SYICSRYYRAPELIFGATEYTT 245
             I HRD+KP N+LV  +GE  +               S++ +R Y +PE + G T Y+ 
Sbjct: 186 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQG-THYSV 244
Query: 246 AIDIWSTGCVMAELLLGQ 263
             DIWS G  + E+ +G+
Sbjct: 245 QSDIWSMGLSLVEMAVGR 262

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 88/208 (42%), Gaps = 37/208 (17%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVAL 140
            +G G+F  V  A+   TG+ VA+K +  DK   N        RE++IM++L+HPNIV L
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
               F   +                V     +Y   H RM     +    QI  A+ Y H
Sbjct: 79  ----FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 201 NCIGICHRDIKPQNLLVKGEPNV------------------SYICSRYYRAPELIFGATE 242
               I HRD+K +NLL+  + N+                  ++  S  Y APEL  G   
Sbjct: 131 QKF-IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGES 270
               +D+WS G ++  L+ G   F G++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 88/208 (42%), Gaps = 37/208 (17%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVAL 140
            +G G+F  V  A+   TG+ VA+K +  DK   N        RE++IM++L+HPNIV L
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
               F   +                V     +Y   H RM     +    QI  A+ Y H
Sbjct: 79  ----FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 201 NCIGICHRDIKPQNLLVKGEPNV------------------SYICSRYYRAPELIFGATE 242
               I HRD+K +NLL+  + N+                  ++  S  Y APEL  G   
Sbjct: 131 QKF-IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGES 270
               +D+WS G ++  L+ G   F G++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 87/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 87/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 87/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NLL+  +  +                 +C    Y APE+I  +  Y  
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 218
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF 239

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 105/251 (41%), Gaps = 36/251 (14%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
           +GTG FG V +   ++TGE VAIK+  Q+   KNR     E+QIM+ L+HPN+V+ +   
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE-V 81
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALAYIHNC 202
                K                  + +  ++      L    ++     I  AL Y+H  
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 141
Query: 203 IGICHRDIKPQNLLV---------------------KGEPNVSYICSRYYRAPELIFGAT 241
             I HRD+KP+N+++                     +GE    ++ +  Y APEL+    
Sbjct: 142 -RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL-EQK 199
Query: 242 EYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
           +YT  +D WS G +  E + G +P  P      Q V+    +   + E I   +      
Sbjct: 200 KYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQWHGKVREKSNEHIVVYDDLTGAV 255
Query: 301 KFPQIKPHPWH 311
           KF  + P P H
Sbjct: 256 KFSSVLPTPNH 266

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 105/251 (41%), Gaps = 36/251 (14%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
           +GTG FG V +   ++TGE VAIK+  Q+   KNR     E+QIM+ L+HPN+V+ +   
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE-V 80
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALAYIHNC 202
                K                  + +  ++      L    ++     I  AL Y+H  
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 203 IGICHRDIKPQNLLV---------------------KGEPNVSYICSRYYRAPELIFGAT 241
             I HRD+KP+N+++                     +GE    ++ +  Y APEL+    
Sbjct: 141 -RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL-EQK 198
Query: 242 EYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
           +YT  +D WS G +  E + G +P  P      Q V+    +   + E I   +      
Sbjct: 199 KYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQWHGKVREKSNEHIVVYDDLTGAV 254
Query: 301 KFPQIKPHPWH 311
           KF  + P P H
Sbjct: 255 KFSSVLPTPNH 265

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +  L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NL++  +  +                 +C    Y APE+I  +  Y  
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 218
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF 239

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 32/208 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 144
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 74  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 125
Query: 205 ICHRDIKPQNLLV--KGEPNV---------------SYICSRYYRAPELIFGATEYTTAI 247
           I HRD+KP N+LV  +GE  +               S++ +R Y +PE + G T Y+   
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQG-THYSVQS 184
Query: 248 DIWSTGCVMAELLLGQ-PLFPGESGVDQ 274
           DIWS G  + E+ +G+ P+ P ++  D 
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKEDS 212

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +  L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +S  H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FSEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NL++  +  +                 +C    Y APE+I  +  Y  
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 218
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF 239

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 93/196 (47%), Gaps = 31/196 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 144
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 101 YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 152
Query: 205 ICHRDIKPQNLLV--KGEPNV---------------SYICSRYYRAPELIFGATEYTTAI 247
           I HRD+KP N+LV  +GE  +               S++ +R Y +PE + G T Y+   
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQG-THYSVQS 211
Query: 248 DIWSTGCVMAELLLGQ 263
           DIWS G  + E+ +G+
Sbjct: 212 DIWSMGLSLVEMAVGR 227

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 99/212 (46%), Gaps = 31/212 (14%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 144
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 92
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 93  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 144
Query: 205 ICHRDIKPQNLLV--KGEPNV---------------SYICSRYYRAPELIFGATEYTTAI 247
           I HRD+KP N+LV  +GE  +               S++ +R Y +PE + G T Y+   
Sbjct: 145 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQG-THYSVQS 203
Query: 248 DIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
           DIWS G  + E+ +G+      SG   + E++
Sbjct: 204 DIWSMGLSLVEMAVGRYPIGSGSGSMAIFELL 235

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 120/296 (40%), Gaps = 64/296 (21%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 143
           +G GS G+V  A+ + +G  VA+K  + D R + R      E+ IM+   H N+V +   
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           +    +                V+++  N  +I               + +ALAY+H   
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVRLNEEQI---------ATVCEAVLQALAYLH-AQ 160
Query: 204 GICHRDIKPQNLLVKGEPNVSY----ICSR---------------YYRAPELIFGATEYT 244
           G+ HRDIK  ++L+  +  V       C++               Y+ APE+I   + Y 
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVI-SRSLYA 219
Query: 245 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 304
           T +DIWS G ++ E++ G+P +  +S V  +            + ++   P       P+
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------------KRLRDSPP-------PK 260
Query: 305 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 360
           +K    HKV      P   D + R     P  R TA E   HPF  +   P   +P
Sbjct: 261 LKNS--HKV-----SPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVP 309

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 158
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NL++  +  +                 +C    Y APE+I  +  Y  
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 217
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 218 AVDWWALGVLIYEMAAGYPPF 238

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 93/196 (47%), Gaps = 31/196 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 144
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 74  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 125
Query: 205 ICHRDIKPQNLLV--KGEPNV---------------SYICSRYYRAPELIFGATEYTTAI 247
           I HRD+KP N+LV  +GE  +               S++ +R Y +PE + G T Y+   
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQG-THYSVQS 184
Query: 248 DIWSTGCVMAELLLGQ 263
           DIWS G  + E+ +G+
Sbjct: 185 DIWSMGLSLVEMAVGR 200

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 110/265 (41%), Gaps = 44/265 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ ++   I+A+K + + +  K        RE++I   L HPNI+ + +
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F    D+                  + +     H R        +  ++  AL Y H  
Sbjct: 83  YFH---DRKRIYLMLEFAPRGELYKELQK-----HGRFDEQRSATFMEELADALHYCHER 134
Query: 203 IGICHRDIKPQNLLV--KGEPNVS--------------YICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+  KGE  ++               +C    Y  PE+I G T +  
Sbjct: 135 -KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTLDYLPPEMIEGKT-HDE 192
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-------LGTPTREEIKCMNPNYT 298
            +D+W  G +  E L+G P F   S  +    I+ V       L   +++ I  +   + 
Sbjct: 193 KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHP 252
Query: 299 EFKFP--QIKPHPWHKVFQKR-LPP 320
             + P   +  HPW K   +R LPP
Sbjct: 253 PQRLPLKGVMEHPWVKANSRRVLPP 277

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 93/196 (47%), Gaps = 31/196 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 144
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 74  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 125
Query: 205 ICHRDIKPQNLLV--KGEPNV---------------SYICSRYYRAPELIFGATEYTTAI 247
           I HRD+KP N+LV  +GE  +               S++ +R Y +PE + G T Y+   
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQG-THYSVQS 184
Query: 248 DIWSTGCVMAELLLGQ 263
           DIWS G  + E+ +G+
Sbjct: 185 DIWSMGLSLVEMAVGR 200

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 110/265 (41%), Gaps = 44/265 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKH 142
           +G G FG V+ A+ ++   I+A+K + + +  K        RE++I   L HPNI+ + +
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F    D+                  + +     H R        +  ++  AL Y H  
Sbjct: 82  YFH---DRKRIYLMLEFAPRGELYKELQK-----HGRFDEQRSATFMEELADALHYCHER 133
Query: 203 IGICHRDIKPQNLLV--KGEPNVS--------------YICSRY-YRAPELIFGATEYTT 245
             + HRDIKP+NLL+  KGE  ++               +C    Y  PE+I G T +  
Sbjct: 134 -KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTLDYLPPEMIEGKT-HDE 191
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-------LGTPTREEIKCMNPNYT 298
            +D+W  G +  E L+G P F   S  +    I+ V       L   +++ I  +   + 
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHP 251
Query: 299 EFKFP--QIKPHPWHKVFQKR-LPP 320
             + P   +  HPW K   +R LPP
Sbjct: 252 PQRLPLKGVMEHPWVKANSRRVLPP 276

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 37/208 (17%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVAL 140
            +G G+F  V  A+   TG+ VA++ +  DK   N        RE++IM++L+HPNIV L
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
               F   +                V     +Y   H RM     +    QI  A+ Y H
Sbjct: 79  ----FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 201 NCIGICHRDIKPQNLLVKGEPNV------------------SYICSRYYRAPELIFGATE 242
               I HRD+K +NLL+  + N+                  ++  S  Y APEL  G   
Sbjct: 131 QKF-IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKY 189
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGES 270
               +D+WS G ++  L+ G   F G++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 52/225 (23%)
Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL--------------------V 217
           Q  PL +V+   YQ+C AL ++H    + H D+KP+N+L                    V
Sbjct: 150 QPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 208
Query: 218 KG---------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 262
           K                E + + + +R+YR PE+I     +    D+WS GC++ E   G
Sbjct: 209 KNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRG 267
Query: 263 QPLFPGESGVDQLVEIIKVLG-------TPTREEIK------CMNPNYTEFKFPQIKPHP 309
             LF      + LV + K+LG         TR++          + N ++ ++ +    P
Sbjct: 268 FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKP 327
Query: 310 WHK-VFQKRLPP-EAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
               + Q  L   +  DL+ R  ++ P  R T  EA +HPFF  L
Sbjct: 328 LKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 372

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 93/196 (47%), Gaps = 31/196 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 144
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 74  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 125
Query: 205 ICHRDIKPQNLLV--KGEPNV---------------SYICSRYYRAPELIFGATEYTTAI 247
           I HRD+KP N+LV  +GE  +               S++ +R Y +PE + G T Y+   
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQG-THYSVQS 184
Query: 248 DIWSTGCVMAELLLGQ 263
           DIWS G  + E+ +G+
Sbjct: 185 DIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 93/196 (47%), Gaps = 31/196 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 144
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 74  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 125
Query: 205 ICHRDIKPQNLLV--KGEPNV---------------SYICSRYYRAPELIFGATEYTTAI 247
           I HRD+KP N+LV  +GE  +               S++ +R Y +PE + G T Y+   
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQG-THYSVQS 184
Query: 248 DIWSTGCVMAELLLGQ 263
           DIWS G  + E+ +G+
Sbjct: 185 DIWSMGLSLVEMAVGR 200

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 52/225 (23%)
Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL--------------------V 217
           Q  PL +V+   YQ+C AL ++H    + H D+KP+N+L                    V
Sbjct: 127 QPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 185
Query: 218 KG---------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 262
           K                E + + + +R+YR PE+I     +    D+WS GC++ E   G
Sbjct: 186 KNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRG 244
Query: 263 QPLFPGESGVDQLVEIIKVLG-------TPTREEIK------CMNPNYTEFKFPQIKPHP 309
             LF      + LV + K+LG         TR++          + N ++ ++ +    P
Sbjct: 245 FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKP 304
Query: 310 WHK-VFQKRLPP-EAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
               + Q  L   +  DL+ R  ++ P  R T  EA +HPFF  L
Sbjct: 305 LKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 349

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 37/208 (17%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVAL 140
            +G G+F  V  A+   TG+ VA+K +  DK   N        RE++IM++L+HPNIV L
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
               F   +                V     +Y   H RM     +    QI  A+ Y H
Sbjct: 79  ----FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 201 NCIGICHRDIKPQNLLVKGEPNV------------------SYICSRYYRAPELIFGATE 242
               I HRD+K +NLL+  + N+                  ++  +  Y APEL  G   
Sbjct: 131 QKF-IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKY 189
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGES 270
               +D+WS G ++  L+ G   F G++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 122/294 (41%), Gaps = 63/294 (21%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRET-------GEIVAIKKVLQDKRYKNRELQIMQMLDHPN 136
           Y+    +G G FG+V   +C ET        + V +K    D+    +E+ I+ +  H N
Sbjct: 7   YMIAEDLGRGEFGIVH--RCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRN 62
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I+ L   F S  +                  RI  +   +++R  + YV    +Q+C AL
Sbjct: 63  ILHLHESFESMEE---LVMIFEFISGLDIFERINTSAFELNEREIVSYV----HQVCEAL 115
Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNVSYICSRYYRAPEL--------IFGATEY----- 243
            ++H+   I H DI+P+N++ +   + +     + +A +L        +F A EY     
Sbjct: 116 QFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 244 ------TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 297
                 +TA D+WS G ++  LL G   F  E+   Q++E I             MN  Y
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENI-------------MNAEY 220
Query: 298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 351
           T   F +       + F K +  EA+D V R        R TA EA  HP+  +
Sbjct: 221 T---FDE-------EAF-KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/290 (23%), Positives = 111/290 (38%), Gaps = 65/290 (22%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYK---NRELQIMQMLDHPNIVALKHCF 144
           V+G G++G+V+  +       +AIK++ + D RY    + E+ + + L H NIV     +
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ----Y 84
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI----YVKLYTYQICRALAYIH 200
             +  +              +++ + R+     +  PL      +  YT QI   L Y+H
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRS-----KWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 201 NCIGICHRDIKPQNLLVKGEPNV--------------------SYICSRYYRAPELI-FG 239
           +   I HRDIK  N+L+     V                    ++  +  Y APE+I  G
Sbjct: 140 DN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG 198
Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 299
              Y  A DIWS GC + E+  G+P F                        +   P    
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPPF-----------------------YELGEPQAAM 235
Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           FK    K HP      + +  EA   + + F+  P+ R  A +  V  F 
Sbjct: 236 FKVGMFKVHP---EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 52/225 (23%)
Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL--------------------V 217
           Q  PL +V+   YQ+C AL ++H    + H D+KP+N+L                    V
Sbjct: 118 QPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176
Query: 218 KG---------------EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG 262
           K                E + + + +R+YR PE+I     +    D+WS GC++ E   G
Sbjct: 177 KNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRG 235
Query: 263 QPLFPGESGVDQLVEIIKVLG-------TPTREEIK------CMNPNYTEFKFPQIKPHP 309
             LF      + LV + K+LG         TR++          + N ++ ++ +    P
Sbjct: 236 FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKP 295
Query: 310 WHK-VFQKRLPP-EAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
               + Q  L   +  DL+ R  ++ P  R T  EA +HPFF  L
Sbjct: 296 LKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 87/208 (41%), Gaps = 37/208 (17%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVAL 140
            +G G+F  V  A+   TG  VAIK +  DK   N        RE++IM++L+HPNIV L
Sbjct: 19  TIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHPNIVKL 76
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
               F   +                V     +Y   H RM     +    QI  A+ Y H
Sbjct: 77  ----FEVIETEKTLYLIMEYASGGEVF----DYLVAHGRMKEKEARSKFRQIVSAVQYCH 128
Query: 201 NCIGICHRDIKPQNLLVKGEPNV------------------SYICSRYYRAPELIFGATE 242
               I HRD+K +NLL+  + N+                  ++  S  Y APEL  G   
Sbjct: 129 QK-RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKY 187
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGES 270
               +D+WS G ++  L+ G   F G++
Sbjct: 188 DGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/290 (23%), Positives = 111/290 (38%), Gaps = 65/290 (22%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQ-DKRYK---NRELQIMQMLDHPNIVALKHCF 144
           V+G G++G+V+  +       +AIK++ + D RY    + E+ + + L H NIV     +
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ----Y 70
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI----YVKLYTYQICRALAYIH 200
             +  +              +++ + R+     +  PL      +  YT QI   L Y+H
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRS-----KWGPLKDNEQTIGFYTKQILEGLKYLH 125
Query: 201 NCIGICHRDIKPQNLLVKGEPNV--------------------SYICSRYYRAPELI-FG 239
           +   I HRDIK  N+L+     V                    ++  +  Y APE+I  G
Sbjct: 126 DN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG 184
Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 299
              Y  A DIWS GC + E+  G+P F                        +   P    
Sbjct: 185 PRGYGKAADIWSLGCTIIEMATGKPPF-----------------------YELGEPQAAM 221
Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           FK    K HP      + +  EA   + + F+  P+ R  A +  V  F 
Sbjct: 222 FKVGMFKVHP---EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 268

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 87/208 (41%), Gaps = 37/208 (17%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVAL 140
            +G G+F  V  A+   TG+ VA++ +  DK   N        RE++IM++L+HPNIV L
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL 78
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
               F   +                V     +Y   H RM     +    QI  A+ Y H
Sbjct: 79  ----FEVIETEKTLYLVMEYASGGEV----FDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 201 NCIGICHRDIKPQNLLVKGEPNVS------------------YICSRYYRAPELIFGATE 242
               I HRD+K +NLL+  + N+                   +  S  Y APEL  G   
Sbjct: 131 QKF-IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKY 189
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGES 270
               +D+WS G ++  L+ G   F G++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/286 (22%), Positives = 111/286 (38%), Gaps = 56/286 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVALKHCF 144
           ++G G FG V + +   TG  +A K +    ++DK     E+ +M  LDH N++ L   F
Sbjct: 96  ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF 155
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
            S  D                 +RI      + +   ++++K    QIC  + ++H    
Sbjct: 156 ESKND---IVLVMEYVDGGELFDRIIDESYNLTELDTILFMK----QICEGIRHMHQMY- 207
Query: 205 ICHRDIKPQNLL-----VKGEPNVSYICSRYYRAPELI---FGATEY-----------TT 245
           I H D+KP+N+L      K    + +  +R Y+  E +   FG  E+           + 
Sbjct: 208 ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSF 267
Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
             D+WS G +   LL G   F G++  + L  I+        EE                
Sbjct: 268 PTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE---------------- 311
Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 351
                   FQ  +  EA + + +      + R +A EA  HP+  +
Sbjct: 312 --------FQD-ISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 33/201 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
            +GTGSFG V   K  ETG   A+K + + K  K ++++       I+Q ++ P +  L+
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE 108
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++                + RI R +   H R        Y  QI     Y+H 
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGR-FXEPHAR-------FYAAQIVLTFEYLH- 159
Query: 202 CIGICHRDIKPQNLLVKGEPNVS---------------YICSR-YYRAPELIFGATEYTT 245
            + + +RD+KP+NL++  +  +                 +C    Y APE+I  +  Y  
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIIL-SKGYNK 218
Query: 246 AIDIWSTGCVMAELLLGQPLF 266
           A+D W+ G ++ E+  G P F
Sbjct: 219 AVDWWALGVLIYEMAAGYPPF 239

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 87/207 (42%), Gaps = 37/207 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVALK 141
           +G G+F  V  A+   TG  VAIK +  DK   N        RE++IM++L+HPNIV L 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHPNIVKL- 79
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
              F   +                V     +Y   H RM     +    QI  A+ Y H 
Sbjct: 80  ---FEVIETEKTLYLIMEYASGGEVF----DYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 202 CIGICHRDIKPQNLLVKGEPNV------------------SYICSRYYRAPELIFGATEY 243
              I HRD+K +NLL+  + N+                  ++  +  Y APEL  G    
Sbjct: 133 K-RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYD 191
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGES 270
              +D+WS G ++  L+ G   F G++
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 88/211 (41%), Gaps = 35/211 (16%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
           YI    +G GSFG V  A   +T + VA+K + +    K+       RE+  +++L HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I+ L     + TD                V +         +RM     + +  QI  A+
Sbjct: 71  IIKLYDVITTPTDIVMVIEYAGGELFDYIVEK---------KRMTEDEGRRFFQQIICAI 121
Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV------------------SYICSRYYRAPELIF 238
            Y H    I HRD+KP+NLL+    NV                  +   S  Y APE+I 
Sbjct: 122 EYCHRH-KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN 180
Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGE 269
           G       +D+WS G V+  +L+G+  F  E
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 92/196 (46%), Gaps = 31/196 (15%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--YKN---RELQIMQMLDHPNIVALKHCF 144
           +G G+ GVVF+   + +G ++A K +  + +   +N   RELQ++   + P IV     F
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 76
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +S  +               +++++ +   RI +++    +   +  + + L Y+     
Sbjct: 77  YSDGE----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK 128
Query: 205 ICHRDIKPQNLLV--KGEPNV---------------SYICSRYYRAPELIFGATEYTTAI 247
           I HRD+KP N+LV  +GE  +                ++ +R Y +PE + G T Y+   
Sbjct: 129 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSPERLQG-THYSVQS 187
Query: 248 DIWSTGCVMAELLLGQ 263
           DIWS G  + E+ +G+
Sbjct: 188 DIWSMGLSLVEMAVGR 203

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 132/313 (42%), Gaps = 79/313 (25%)
Query: 85  IAEHVVGTGSFG-VVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML----DHPNIVA 139
           ++E ++G GS G VVFQ   +  G  VA+K++L D  + +  L  +++L    DHPN++ 
Sbjct: 18  VSEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 72
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY-QICRALAY 198
            ++    TTD+               +   ++N S  + ++   Y  +    QI   +A+
Sbjct: 73  -RYYCSETTDRFLYIALELCNLNLQDLVE-SKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 199 IHNCIGICHRDIKPQNLLVK-----------GEPNVSYICSRY----------------- 230
           +H+ + I HRD+KPQN+LV            G  N+  + S +                 
Sbjct: 131 LHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 231 --------YRAPELIFGATEYTT------AIDIWSTGCVMAELLLGQPLFPGESGVDQLV 276
                   +RAPEL+  +    T      +IDI+S GCV    +L +   P      +  
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRES 248
Query: 277 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 336
            II+  G  + +E+KC++                     + L  EA DL+ +   + P  
Sbjct: 249 NIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLK 286
Query: 337 RCTALEACVHPFF 349
           R TA++   HP F
Sbjct: 287 RPTAMKVLRHPLF 299

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 132/313 (42%), Gaps = 79/313 (25%)
Query: 85  IAEHVVGTGSFG-VVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML----DHPNIVA 139
           ++E ++G GS G VVFQ   +  G  VA+K++L D  + +  L  +++L    DHPN++ 
Sbjct: 18  VSEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 72
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY-QICRALAY 198
            ++    TTD+               +   ++N S  + ++   Y  +    QI   +A+
Sbjct: 73  -RYYCSETTDRFLYIALELCNLNLQDLVE-SKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 199 IHNCIGICHRDIKPQNLLVK-----------GEPNVSYICSRY----------------- 230
           +H+ + I HRD+KPQN+LV            G  N+  + S +                 
Sbjct: 131 LHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 189
Query: 231 --------YRAPELIFGATEYTT------AIDIWSTGCVMAELLLGQPLFPGESGVDQLV 276
                   +RAPEL+  +    T      +IDI+S GCV    +L +   P      +  
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRES 248
Query: 277 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 336
            II+  G  + +E+KC++                     + L  EA DL+ +   + P  
Sbjct: 249 NIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLK 286
Query: 337 RCTALEACVHPFF 349
           R TA++   HP F
Sbjct: 287 RPTAMKVLRHPLF 299

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 103/228 (45%), Gaps = 43/228 (18%)
Query: 89  VVGTGSFGVVFQAKCR---ETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNIVA 139
           V+G GSFG VF  +     ++G + A+K +      ++D+     E  I+  ++HP +V 
Sbjct: 35  VLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVK 94
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICRALA 197
           L H  F T  K                 R    ++R+ + +      VK Y  ++   L 
Sbjct: 95  L-HYAFQTEGKLYLILDFL---------RGGDLFTRLSKEVMFTEEDVKFYLAELALGLD 144
Query: 198 YIHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIF 238
           ++H+ +GI +RD+KP+N+L+  E ++                   S+  +  Y APE++ 
Sbjct: 145 HLHS-LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVV- 202
Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV-LGTP 285
               ++ + D WS G +M E+L G   F G+   + +  I+K  LG P
Sbjct: 203 NRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMP 250

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 38/218 (17%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQML-DHPNIVAL 140
           V+G GSFG V  A+ +ETG++ A+K + +D   ++ +++       I+ +  +HP +  L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             C F T D+                 + +R +     R        Y  +I  AL ++H
Sbjct: 90  -FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARAR-------FYAAEIISALMFLH 141
Query: 201 NCIGICHRDIKPQNLLV-------------------KGEPNVSYICSRYYRAPELIFGAT 241
           +  GI +RD+K  N+L+                    G    ++  +  Y APE I    
Sbjct: 142 D-KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPE-ILQEM 199
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
            Y  A+D W+ G ++ E+L G   F  E+  D L E I
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI 236

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 82/344 (23%), Positives = 122/344 (35%), Gaps = 80/344 (23%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVA 139
           V+G G+F VV +   RETG+  A+K V   K   +         RE  I  ML HP+IV 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L   +  ++D                   + R  +       +     Y  QI  AL Y 
Sbjct: 91  LLETY--SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV--ASHYMRQILEALRYC 146
Query: 200 HNCIGICHRDIKPQNLLVKGEPNVS----------------------YICSRYYRAPELI 237
           H+   I HRD+KP+N+L+  + N +                       + + ++ APE++
Sbjct: 147 HDN-NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 238 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 297
                Y   +D+W  G ++  LL G                +   GT  R     +   Y
Sbjct: 206 -KREPYGKPVDVWGCGVILFILLSG---------------CLPFYGTKERLFEGIIKGKY 249
Query: 298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE------ 351
                 ++ P  W  + +      A DLV R     P  R T  EA  HP+  E      
Sbjct: 250 ------KMNPRQWSHISES-----AKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAY 298
Query: 352 ----------LRDPNTRLP-NGRPLPPLFNFKPPELSGIPPETI 384
                     LR  N R    G  L  + + K     G PPE +
Sbjct: 299 KIHLPETVEQLRKFNARRKLKGAVLAAVSSHKFNSFYGDPPEEL 342

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 37/207 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVALK 141
           +G G+F  V  A+   TG+ VA+K +  DK   N        RE++IM++L+HPNIV L 
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKL- 71
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
              F   +                V     +Y   H  M     +    QI  A+ Y H 
Sbjct: 72  ---FEVIETEKTLYLVMEYASGGEV----FDYLVAHGWMKEKEARAKFRQIVSAVQYCHQ 124
Query: 202 CIGICHRDIKPQNLLVKGEPNV------------------SYICSRYYRAPELIFGATEY 243
              I HRD+K +NLL+  + N+                  ++  S  Y APEL  G    
Sbjct: 125 KF-IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 183
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGES 270
              +D+WS G ++  L+ G   F G++
Sbjct: 184 GPEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 47/221 (21%)
Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKN--RELQIMQMLDHPNIV 138
           E ++G G FG V++A     G+ VA+K    D      +  +N  +E ++  ML HPNI+
Sbjct: 12  EEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           AL+        K               +NR+        +R+P   +  +  QI R + Y
Sbjct: 70  ALRGVCL----KEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNY 120
Query: 199 IHN--CIGICHRDIKPQNLLV-----KGE--------------------PNVSYICSRYY 231
           +H+   + I HRD+K  N+L+      G+                      +S   +  +
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAW 180
Query: 232 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 272
            APE+I  A+ ++   D+WS G ++ ELL G+  F G  G+
Sbjct: 181 MAPEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 21/207 (10%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKH 142
            +I   ++G GSFG VF A+ ++T +  AIK + +D    + +++   +      +A +H
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F +                          + +   +  L     Y  +I   L ++H+ 
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 137
Query: 203 IGICHRDIKPQNLLVK------------------GEPNVSYICSR-YYRAPELIFGATEY 243
            GI +RD+K  N+L+                   G+   +  C    Y APE++ G  +Y
Sbjct: 138 -GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLG-QKY 195
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGES 270
             ++D WS G ++ E+L+GQ  F G+ 
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQSPFHGQD 222

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 88/221 (39%), Gaps = 33/221 (14%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y+    +G GSFG     K  E G    IK++       +++    RE+ ++  + HPNI
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V  +  F    +                  RI      + Q   ++    +  QIC AL 
Sbjct: 86  VQYRESF---EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD---WFVQICLALK 139
Query: 198 YIHNCIGICHRDIKPQNLLVKGEPNVSY-------------------ICSRYYRAPELIF 238
           ++H+   I HRDIK QN+ +  +  V                     I + YY +PE I 
Sbjct: 140 HVHDR-KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPE-IC 197
Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
               Y    DIW+ GCV+ EL   +  F   S  + +++II
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/284 (23%), Positives = 122/284 (42%), Gaps = 58/284 (20%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQ----IMQMLDHPNIVALKHC 143
           +G G++G V +   + +G+I+A+K++    D++ + + L     +M+  D P IV     
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   D               + ++  +  YS +   +P   +   T    +AL ++   
Sbjct: 90  LFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 203 IGICHRDIKPQNLLVKGEPNVSYICS-------------------RYYRAPELIFGATE- 242
           + I HRDIKP N+L+    N+  +C                    R Y APE I  +   
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIK-LCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASR 203
Query: 243 --YTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTP---TREEIKCMNPN 296
             Y    D+WS G  + EL  G+  +P  + V DQL +++K  G P   +  E +  +P+
Sbjct: 204 QGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDPPQLSNSEEREFSPS 261
Query: 297 YTEF-------------KFPQIKPHPWHKVFQKRLPPEAVDLVC 327
           +  F             K+ ++  HP+  ++++R    AV++ C
Sbjct: 262 FINFVNLCLTKDESKRPKYKELLKHPFILMYEER----AVEVAC 301

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 74/319 (23%), Positives = 116/319 (36%), Gaps = 77/319 (24%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPN 136
           Y+    +G G F   ++    +T E+ A K V +        K   + E+ I + LD+P+
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQ 191
           +V   H FF   D                V  I R  S   +H+R   +     + +  Q
Sbjct: 104 VVGF-HGFFEDDD------------FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 150
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVK-------------------GEPNVSYICSRYYR 232
             + + Y+HN   + HRD+K  NL +                    GE   +   +  Y 
Sbjct: 151 TIQGVQYLHNN-RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYI 209
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE +     ++  +DIWS GC++  LL+G+P F                      E  C
Sbjct: 210 APE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETSC 246
Query: 293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
           +   Y   K  +           + + P A  L+ R     P LR +  E     FF   
Sbjct: 247 LKETYIRIKKNEYS-------VPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTSG 299
Query: 353 RDPNTRLPNG-RPLPPLFN 370
             P  RLP     +PP F+
Sbjct: 300 YAP-MRLPTSCLTVPPRFS 317

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 97/226 (42%), Gaps = 48/226 (21%)
Query: 89  VVGTGSFGVVFQAK---CRETGEIVAIK--------KVLQDKRYKNRELQIMQMLDHPNI 137
           V+G G +G VFQ +      TG+I A+K        +  +D  +   E  I++ + HP I
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK----LYTYQIC 193
           V L + F +                   + R              I+++     Y  +I 
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREG------------IFMEDTACFYLAEIS 131
Query: 194 RALAYIHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAP 234
            AL ++H   GI +RD+KP+N+++  + +V                   ++  +  Y AP
Sbjct: 132 MALGHLHQK-GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190
Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 280
           E++   + +  A+D WS G +M ++L G P F GE+    + +I+K
Sbjct: 191 EILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/287 (22%), Positives = 113/287 (39%), Gaps = 58/287 (20%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQI-MQMLDHPNIVALKHC 143
           +G G++GVV + +   +G+I+A+K++      Q+++    +L I M+ +D P  V     
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
            F   D               ++++  +      Q +P   +      I +AL ++H+ +
Sbjct: 119 LFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 173
Query: 204 GICHRDIKPQNLLVKGEPNV---SYICSRY---------------YRAPELI---FGATE 242
            + HRD+KP N+L+     V    +  S Y               Y APE I        
Sbjct: 174 SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKG 233
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 302
           Y+   DIWS G  M EL + +  FP +S            GTP ++              
Sbjct: 234 YSVKSDIWSLGITMIELAILR--FPYDS-----------WGTPFQQ-------------L 267
Query: 303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
            Q+   P  ++   +   E VD   +  + +   R T  E   HPFF
Sbjct: 268 KQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/250 (22%), Positives = 104/250 (41%), Gaps = 45/250 (18%)
Query: 65  HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR 124
             + T   G+  +S     +    V+G GS+  V   + ++T  I A+K V ++    + 
Sbjct: 3   EAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE 62
Query: 125 ELQIMQM--------LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRI 176
           ++  +Q          +HP +V L  CF + +                 + R        
Sbjct: 63  DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-------- 114
Query: 177 HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV------------- 223
            +++P  + + Y+ +I  AL Y+H   GI +RD+K  N+L+  E ++             
Sbjct: 115 QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 173
Query: 224 -----SYICSR-YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF--------PGE 269
                S  C    Y APE++ G  +Y  ++D W+ G +M E++ G+  F        P +
Sbjct: 174 PGDTTSXFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 232
Query: 270 SGVDQLVEII 279
           +  D L ++I
Sbjct: 233 NTEDYLFQVI 242

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 140
           V+G GS+  V   + ++T  I A+K V ++    + ++  +Q          +HP +V L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             CF + +                 + R         +++P  + + Y+ +I  AL Y+H
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDLMFHMQR--------QRKLPEEHARFYSAEISLALNYLH 127
Query: 201 NCIGICHRDIKPQNLLVKGEPNV------------------SYICSR-YYRAPELIFGAT 241
              GI +RD+K  N+L+  E ++                  S  C    Y APE++ G  
Sbjct: 128 ER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE- 185
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLF--------PGESGVDQLVEII 279
           +Y  ++D W+ G +M E++ G+  F        P ++  D L ++I
Sbjct: 186 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/296 (22%), Positives = 117/296 (39%), Gaps = 66/296 (22%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALK 141
           ++G GSF  V++A+   TG  VAIK + +   YK         E++I   L HP+I+ L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F    +                +NR  +N  +          + + +QI   + Y+H+
Sbjct: 78  NYF----EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENE---ARHFMHQIITGMLYLHS 130
Query: 202 CIGICHRDIKPQNLLVKGEPNVSY------------------ICSR-YYRAPELIFGATE 242
             GI HRD+   NLL+    N+                    +C    Y +PE I   + 
Sbjct: 131 H-GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE-IATRSA 188
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 302
           +    D+WS GC+   LL+G+P F  ++  + L +++                   +++ 
Sbjct: 189 HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV-----------------LADYEM 231
Query: 303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
           P              L  EA DL+ +  + +P  R +      HPF    R+ +T+
Sbjct: 232 PSF------------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS--RNSSTK 273

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 96/226 (42%), Gaps = 48/226 (21%)
Query: 89  VVGTGSFGVVFQAK---CRETGEIVAIK--------KVLQDKRYKNRELQIMQMLDHPNI 137
           V+G G +G VFQ +      TG+I A+K        +  +D  +   E  I++ + HP I
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVK----LYTYQIC 193
           V L + F +                   + R              I+++     Y  +I 
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREG------------IFMEDTACFYLAEIS 131
Query: 194 RALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----ICSRY---------------YRAP 234
            AL ++H   GI +RD+KP+N+++  + +V      +C                  Y AP
Sbjct: 132 MALGHLHQK-GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAP 190
Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 280
           E++   + +  A+D WS G +M ++L G P F GE+    + +I+K
Sbjct: 191 EILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 37/224 (16%)
Query: 73  GRNGNSKQKVS-YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------- 123
           G   + + K+  Y+    +G G+FG V   + + TG  VA+K +L  ++ ++        
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIK 59
Query: 124 RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI 183
           RE+Q +++  HP+I+ L     + TD                      +Y   H R+  +
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELF--------DYICKHGRVEEM 111
Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV------------------SY 225
             +    QI  A+ Y H  + + HRD+KP+N+L+    N                   + 
Sbjct: 112 EARRLFQQILSAVDYCHRHM-VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS 170
Query: 226 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 269
             S  Y APE+I G       +DIWS G ++  LL G   F  E
Sbjct: 171 CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM--------LDHPNIVAL 140
           V+G GS+  V   + ++T  I A+K V ++    + ++  +Q          +HP +V L
Sbjct: 12  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 71
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             CF + +                 + R         +++P  + + Y+ +I  AL Y+H
Sbjct: 72  HSCFQTESRLFFVIEYVNGGDLMFHMQR--------QRKLPEEHARFYSAEISLALNYLH 123
Query: 201 NCIGICHRDIKPQNLLVKGEPNV------------------SYICSR-YYRAPELIFGAT 241
              GI +RD+K  N+L+  E ++                  S  C    Y APE++ G  
Sbjct: 124 ER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE- 181
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLF--------PGESGVDQLVEII 279
           +Y  ++D W+ G +M E++ G+  F        P ++  D L ++I
Sbjct: 182 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 227

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/287 (22%), Positives = 113/287 (39%), Gaps = 58/287 (20%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQI-MQMLDHPNIVALKHC 143
           +G G++GVV + +   +G+I+A+K++      Q+++    +L I M+ +D P  V     
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
            F   D               ++++  +      Q +P   +      I +AL ++H+ +
Sbjct: 75  LFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 204 GICHRDIKPQNLLVKGEPNV---SYICSRY---------------YRAPELI---FGATE 242
            + HRD+KP N+L+     V    +  S Y               Y APE I        
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKG 189
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 302
           Y+   DIWS G  M EL + +  FP +S            GTP ++              
Sbjct: 190 YSVKSDIWSLGITMIELAILR--FPYDS-----------WGTPFQQ-------------L 223
Query: 303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
            Q+   P  ++   +   E VD   +  + +   R T  E   HPFF
Sbjct: 224 KQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 92/224 (41%), Gaps = 37/224 (16%)
Query: 73  GRNGNSKQKVS-YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------- 123
           G   + + K+  Y+    +G G+FG V   + + TG  VA+K +L  ++ ++        
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIK 59
Query: 124 RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI 183
           RE+Q +++  HP+I+ L     + TD                      +Y   H R+  +
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELF--------DYICKHGRVEEM 111
Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----------------- 226
             +    QI  A+ Y H  + + HRD+KP+N+L+    N                     
Sbjct: 112 EARRLFQQILSAVDYCHRHM-VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS 170
Query: 227 -CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 269
             S  Y APE+I G       +DIWS G ++  LL G   F  E
Sbjct: 171 CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 40/219 (18%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
           V+G GSFG V  A  + T E+ AIK + +D   ++ +++       ++ +LD P  +   
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAYI 199
           H  F T D+               VN     Y  I Q  +        Y  +I   L ++
Sbjct: 86  HSCFQTVDRLYFVMEY--------VNGGDLMY-HIQQVGKFKEPQAVFYAAEISIGLFFL 136
Query: 200 HNCIGICHRDIKPQNLLVKGEPNVSY----ICSRY---------------YRAPELIFGA 240
           H   GI +RD+K  N+++  E ++      +C  +               Y APE+I   
Sbjct: 137 HKR-GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEII-AY 194
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
             Y  ++D W+ G ++ E+L GQP F GE   D+L + I
Sbjct: 195 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 232

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 75/319 (23%), Positives = 120/319 (37%), Gaps = 77/319 (24%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPN 136
           Y+    +G G F   ++    +T E+ A K V +        K   + E+ I + LD+P+
Sbjct: 28  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 87
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQ 191
           +V   H FF   D                V  I R  S   +H+R   +     + +  Q
Sbjct: 88  VVGF-HGFFEDDD------------FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 134
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------------------ICSR-YYR 232
             + + Y+HN   + HRD+K  NL +  + +V                    +C    Y 
Sbjct: 135 TIQGVQYLHNN-RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYI 193
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE +     ++  +DIWS GC++  LL+G+P F                      E  C
Sbjct: 194 APE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETSC 230
Query: 293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
           +   Y      +IK + +     + + P A  L+ R     P LR +  E     FF   
Sbjct: 231 LKETYI-----RIKKNEYS--VPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTSG 283
Query: 353 RDPNTRLPNG-RPLPPLFN 370
             P  RLP     +PP F+
Sbjct: 284 YAP-MRLPTSCLTVPPRFS 301

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/319 (23%), Positives = 117/319 (36%), Gaps = 77/319 (24%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPN 136
           Y+    +G G F   ++    +T E+ A K V +        K   + E+ I + LD+P+
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQ 191
           +V   H FF   D                V  I R  S   +H+R   +     + +  Q
Sbjct: 104 VVGF-HGFFEDDD------------FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 150
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------------------ICSR-YYR 232
             + + Y+HN   + HRD+K  NL +  + +V                    +C    Y 
Sbjct: 151 TIQGVQYLHNN-RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYI 209
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE +     ++  +DIWS GC++  LL+G+P F                      E  C
Sbjct: 210 APE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETSC 246
Query: 293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
           +   Y   K  +           + + P A  L+ R     P LR +  E     FF   
Sbjct: 247 LKETYIRIKKNEYS-------VPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTSG 299
Query: 353 RDPNTRLPNG-RPLPPLFN 370
             P  RLP     +PP F+
Sbjct: 300 YAP-MRLPTSCLTVPPRFS 317

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 43/204 (21%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 21  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQAHAERIDHIKLLQYTSQICKGMEY 132
Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV---SYICSR-------------------YYRAPEL 236
           +     I HRD+  +N+LV+ E  V    +  ++                   ++ APE 
Sbjct: 133 LGTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           +   ++++ A D+WS G V+ EL 
Sbjct: 192 L-TESKFSVASDVWSFGVVLYELF 214

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/319 (23%), Positives = 117/319 (36%), Gaps = 77/319 (24%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPN 136
           Y+    +G G F   ++    +T E+ A K V +        K   + E+ I + LD+P+
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQ 191
           +V   H FF   D                V  I R  S   +H+R   +     + +  Q
Sbjct: 104 VVGF-HGFFEDDD------------FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ 150
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS------------------YICSR-YYR 232
             + + Y+HN   + HRD+K  NL +  + +V                    +C    Y 
Sbjct: 151 TIQGVQYLHNN-RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYI 209
Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE +     ++  +DIWS GC++  LL+G+P F                      E  C
Sbjct: 210 APE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETSC 246
Query: 293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
           +   Y   K  +           + + P A  L+ R     P LR +  E     FF   
Sbjct: 247 LKETYIRIKKNEYS-------VPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTSG 299
Query: 353 RDPNTRLPNG-RPLPPLFN 370
             P  RLP     +PP F+
Sbjct: 300 YAP-MRLPTSCLTVPPRFS 317

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/253 (21%), Positives = 105/253 (41%), Gaps = 45/253 (17%)
Query: 62  ETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY 121
           E    + T   G+  +S     +    V+G GS+  V   + ++T  I A++ V ++   
Sbjct: 32  EEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN 91
Query: 122 KNRELQIMQM--------LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNY 173
            + ++  +Q          +HP +V L  CF + +                 + R     
Sbjct: 92  DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----- 146
Query: 174 SRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV---------- 223
               +++P  + + Y+ +I  AL Y+H   GI +RD+K  N+L+  E ++          
Sbjct: 147 ---QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202
Query: 224 --------SYICSR-YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF-------- 266
                   S  C    Y APE++ G  +Y  ++D W+ G +M E++ G+  F        
Sbjct: 203 GLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 261
Query: 267 PGESGVDQLVEII 279
           P ++  D L ++I
Sbjct: 262 PDQNTEDYLFQVI 274

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 43/204 (21%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 23  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 134
Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV---SYICSR-------------------YYRAPEL 236
           +     I HRD+  +N+LV+ E  V    +  ++                   ++ APE 
Sbjct: 135 LGTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 193
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           +   ++++ A D+WS G V+ EL 
Sbjct: 194 L-TESKFSVASDVWSFGVVLYELF 216

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 43/204 (21%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 24  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 135
Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV---SYICSR-------------------YYRAPEL 236
           +     I HRD+  +N+LV+ E  V    +  ++                   ++ APE 
Sbjct: 136 LGTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 194
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           +   ++++ A D+WS G V+ EL 
Sbjct: 195 L-TESKFSVASDVWSFGVVLYELF 217

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 43/204 (21%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 21  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 132
Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV---SYICSR-------------------YYRAPEL 236
           +     I HRD+  +N+LV+ E  V    +  ++                   ++ APE 
Sbjct: 133 LGTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           +   ++++ A D+WS G V+ EL 
Sbjct: 192 L-TESKFSVASDVWSFGVVLYELF 214

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 43/204 (21%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 18  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV---SYICSR-------------------YYRAPEL 236
           +     I HRD+  +N+LV+ E  V    +  ++                   ++ APE 
Sbjct: 130 LGTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           +   ++++ A D+WS G V+ EL 
Sbjct: 189 L-TESKFSVASDVWSFGVVLYELF 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 43/204 (21%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 22  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 133
Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV---SYICSR-------------------YYRAPEL 236
           +     I HRD+  +N+LV+ E  V    +  ++                   ++ APE 
Sbjct: 134 LGTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 192
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           +   ++++ A D+WS G V+ EL 
Sbjct: 193 L-TESKFSVASDVWSFGVVLYELF 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 43/204 (21%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 25  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 136
Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV---SYICSR-------------------YYRAPEL 236
           +     I HRD+  +N+LV+ E  V    +  ++                   ++ APE 
Sbjct: 137 LGTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 195
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           +   ++++ A D+WS G V+ EL 
Sbjct: 196 L-TESKFSVASDVWSFGVVLYELF 218

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 91/213 (42%), Gaps = 46/213 (21%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVAL 140
           I   V+G G FG   +   RETGE++ +K+++    + +R   +E+++M+ L+HPN++  
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK- 71
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
              F     K              T+  I ++   +  + P      +   I   +AY+H
Sbjct: 72  ---FIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 201 NCIGICHRDIKPQNLLVKGEPNV---------------------------------SYIC 227
           + + I HRD+   N LV+   NV                                 + + 
Sbjct: 126 S-MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 228 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 260
           + Y+ APE+I G + Y   +D++S G V+ E++
Sbjct: 185 NPYWMAPEMINGRS-YDEKVDVFSFGIVLCEII 216

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 43/204 (21%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 49  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 160
Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV---SYICSR-------------------YYRAPEL 236
           +     I HRD+  +N+LV+ E  V    +  ++                   ++ APE 
Sbjct: 161 LGTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 219
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           +   ++++ A D+WS G V+ EL 
Sbjct: 220 L-TESKFSVASDVWSFGVVLYELF 242

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 41/207 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY--KNRELQIM-------QMLDHPNIVA 139
           V+G GSFG V  A+  +  E+    KVLQ K    K  E  IM       + + HP +V 
Sbjct: 45  VIGKGSFGKVLLAR-HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLI-YVKLYTYQICRALAY 198
           L H  F T DK               +N     Y    +R  L    + Y  +I  AL Y
Sbjct: 104 L-HFSFQTADKLYFVLDY--------INGGELFYHLQRERCFLEPRARFYAAEIASALGY 154
Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFG 239
           +H+ + I +RD+KP+N+L+  + ++                   ++  +  Y APE +  
Sbjct: 155 LHS-LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE-VLH 212
Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLF 266
              Y   +D W  G V+ E+L G P F
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 43/204 (21%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 18  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV---SYICSR-------------------YYRAPEL 236
           +     I HRD+  +N+LV+ E  V    +  ++                   ++ APE 
Sbjct: 130 LGTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           +   ++++ A D+WS G V+ EL 
Sbjct: 189 L-TESKFSVASDVWSFGVVLYELF 211

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 43/204 (21%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 17  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 128
Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV---SYICSR-------------------YYRAPEL 236
           +     I HRD+  +N+LV+ E  V    +  ++                   ++ APE 
Sbjct: 129 LGTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 187
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           +   ++++ A D+WS G V+ EL 
Sbjct: 188 L-TESKFSVASDVWSFGVVLYELF 210

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 43/204 (21%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 36  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 147
Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV---SYICSR-------------------YYRAPEL 236
           +     I HRD+  +N+LV+ E  V    +  ++                   ++ APE 
Sbjct: 148 LGTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 206
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           +   ++++ A D+WS G V+ EL 
Sbjct: 207 L-TESKFSVASDVWSFGVVLYELF 229

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 43/204 (21%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 16  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 127
Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV---SYICSR-------------------YYRAPEL 236
           +     I HRD+  +N+LV+ E  V    +  ++                   ++ APE 
Sbjct: 128 LGTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 186
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           +   ++++ A D+WS G V+ EL 
Sbjct: 187 L-TESKFSVASDVWSFGVVLYELF 209

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 87/221 (39%), Gaps = 49/221 (22%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 139
           Y+    +G G F  V   +    G   A+K++L    QD+    RE  + ++ +HPNI+ 
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 140 L-KHCFFSTTDKXXXXXXXXXXXXXXTVNRIAR-----NYSRIHQRMPLIYVKLYTYQIC 193
           L  +C      K                N I R     N+    Q + L+        IC
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL------GIC 144
Query: 194 RALAYIHNCIGICHRDIKPQNLLV--KGEPNVSYI------------------------- 226
           R L  IH   G  HRD+KP N+L+  +G+P +  +                         
Sbjct: 145 RGLEAIH-AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 227 -CSRYYRAPELIFGATEYTTA---IDIWSTGCVMAELLLGQ 263
            C+  YRAPEL F    +       D+WS GCV+  ++ G+
Sbjct: 204 RCTISYRAPEL-FSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 43/204 (21%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 18  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 129
Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV---SYICSR-------------------YYRAPEL 236
           +     I HRD+  +N+LV+ E  V    +  ++                   ++ APE 
Sbjct: 130 LGTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           +   ++++ A D+WS G V+ EL 
Sbjct: 189 L-TESKFSVASDVWSFGVVLYELF 211

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 43/204 (21%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 36  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 147
Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV---SYICSR-------------------YYRAPEL 236
           +     I HRD+  +N+LV+ E  V    +  ++                   ++ APE 
Sbjct: 148 LGTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 206
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           +   ++++ A D+WS G V+ EL 
Sbjct: 207 L-TESKFSVASDVWSFGVVLYELF 229

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 41/200 (20%)
Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
           E VVG G+FGVV +AK R   + VAIK++  +   K    EL+ +  ++HPNIV L    
Sbjct: 14  EEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL-----YTYQICRALAYI 199
            +                          Y+ +H   PL Y        +  Q  + +AY+
Sbjct: 72  LNPV------------CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 200 HNC--IGICHRDIKPQNLLVKGEPNVSYIC-----------------SRYYRAPELIFGA 240
           H+     + HRD+KP NLL+     V  IC                 S  + APE +F  
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPE-VFEG 178
Query: 241 TEYTTAIDIWSTGCVMAELL 260
           + Y+   D++S G ++ E++
Sbjct: 179 SNYSEKCDVFSWGIILWEVI 198

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 41/200 (20%)
Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
           E VVG G+FGVV +AK R   + VAIK++  +   K    EL+ +  ++HPNIV L    
Sbjct: 13  EEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL-----YTYQICRALAYI 199
            +                          Y+ +H   PL Y        +  Q  + +AY+
Sbjct: 71  LNPV------------CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 200 HNC--IGICHRDIKPQNLLVKGEPNVSYIC-----------------SRYYRAPELIFGA 240
           H+     + HRD+KP NLL+     V  IC                 S  + APE +F  
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPE-VFEG 177
Query: 241 TEYTTAIDIWSTGCVMAELL 260
           + Y+   D++S G ++ E++
Sbjct: 178 SNYSEKCDVFSWGIILWEVI 197

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 87/208 (41%), Gaps = 37/208 (17%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIVAL 140
            +G G+F  V  A+   TG+ VA+K +  DK   N        RE++I ++L+HPNIV L
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIXKVLNHPNIVKL 78
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
               F   +                V     +Y   H R      +    QI  A+ Y H
Sbjct: 79  ----FEVIETEKTLYLVXEYASGGEV----FDYLVAHGRXKEKEARAKFRQIVSAVQYCH 130
Query: 201 NCIGICHRDIKPQNLLVKGEPNV------------------SYICSRYYRAPELIFGATE 242
               I HRD+K +NLL+  + N+                  ++  +  Y APEL  G   
Sbjct: 131 QKF-IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKY 189
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGES 270
               +D+WS G ++  L+ G   F G++
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 36/205 (17%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHP 135
           YI    +G G+FG V   K   TG  VA+K +L  ++ ++        RE+Q +++  HP
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           +I+ L     + +D                + +  R   +  +R+          QI   
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRL--------FQQILSG 128
Query: 196 LAYIHNCIGICHRDIKPQNLLVKGEPNVSYI------------------CSRYYRAPELI 237
           + Y H  + + HRD+KP+N+L+    N                       S  Y APE+I
Sbjct: 129 VDYCHRHM-VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVI 187
Query: 238 FGATEYTTAIDIWSTGCVMAELLLG 262
            G       +DIWS+G ++  LL G
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCG 212

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 85/203 (41%), Gaps = 37/203 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
           +G G+FG V++A+ +ET  ++A  KV+  K  +       E+ I+   DHPNIV L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +   +                +  + R  +          +++   Q   AL Y+H+   
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQ-------IQVVCKQTLDALNYLHDN-K 155
Query: 205 ICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGATE--- 242
           I HRD+K  N+L   + ++                   S+I + Y+ APE++   T    
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDR 215
Query: 243 -YTTAIDIWSTGCVMAELLLGQP 264
            Y    D+WS G  + E+   +P
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEP 238

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 43/204 (21%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 21  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R Y + H +R+  I +  YT QIC+ + Y
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGS------LREYLQKHKERIDHIKLLQYTSQICKGMEY 132
Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV---SYICSR-------------------YYRAPEL 236
           +     I HRD+  +N+LV+ E  V    +  ++                   ++ APE 
Sbjct: 133 LGTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           +   ++++ A D+WS G V+ EL 
Sbjct: 192 L-TESKFSVASDVWSFGVVLYELF 214

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 85/203 (41%), Gaps = 37/203 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
           +G G+FG V++A+ +ET  ++A  KV+  K  +       E+ I+   DHPNIV L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +   +                +  + R  +          +++   Q   AL Y+H+   
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQ-------IQVVCKQTLDALNYLHDN-K 155
Query: 205 ICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGATE--- 242
           I HRD+K  N+L   + ++                   S+I + Y+ APE++   T    
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 215
Query: 243 -YTTAIDIWSTGCVMAELLLGQP 264
            Y    D+WS G  + E+   +P
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEP 238

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 85/201 (42%), Gaps = 21/201 (10%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT 148
           ++G GSFG VF A+ ++T +  AIK + +D    + +++   +      +A +H F +  
Sbjct: 25  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 84
Query: 149 DKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHR 208
                                   + +   +  L     Y  +I   L ++H+  GI +R
Sbjct: 85  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK-GIVYR 143
Query: 209 DIKPQNLLVK------------------GEPNVSYICSR-YYRAPELIFGATEYTTAIDI 249
           D+K  N+L+                   G+   +  C    Y APE++ G  +Y  ++D 
Sbjct: 144 DLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG-QKYNHSVDW 202
Query: 250 WSTGCVMAELLLGQPLFPGES 270
           WS G ++ E+L+GQ  F G+ 
Sbjct: 203 WSFGVLLYEMLIGQSPFHGQD 223

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 98/252 (38%), Gaps = 56/252 (22%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKF-- 70
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 203 IGICHRDIKPQNLLVKGEPNVSY------ICSRY---------------YRAPELIFGAT 241
           IGI HRDIKP+NLL+    N+           RY               Y APEL+    
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 183
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            +   +D+WS G V+  +L G+   P +   D   E                   Y+++K
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWK 222
Query: 302 FPQIKPHPWHKV 313
             +   +PW K+
Sbjct: 223 EKKTYLNPWKKI 234

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 112/287 (39%), Gaps = 63/287 (21%)
Query: 90  VGTGSFGVVFQ-----AKCRETGEIVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           +G G+F VV +     A      +I+  KK+  +D +   RE +I ++L HPNIV L   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
                                 +  +AR Y         I       QI  A+ + H  +
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDI--VAREYYSEADASHCI------QQILEAVLHCHQ-M 140
Query: 204 GICHRDIKPQNLL--------------------VKGEPNV--SYICSRYYRAPELIFGAT 241
           G+ HRD+KP+NLL                    V+GE      +  +  Y +PE +    
Sbjct: 141 GVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE-VLRKD 199
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            Y   +D+W+ G ++  LL+G P F  E    +L + IK                   + 
Sbjct: 200 PYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GAYD 242
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
           FP  +   W  V      PEA DL+ +    +P+ R TA EA  HP+
Sbjct: 243 FPSPE---WDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPW 281

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 98/252 (38%), Gaps = 56/252 (22%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVKGEPNVSY------ICSRY---------------YRAPELIFGAT 241
           IGI HRDIKP+NLL+    N+           RY               Y APEL+    
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            +   +D+WS G V+  +L G+   P +   D   E                   Y+++K
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWK 221
Query: 302 FPQIKPHPWHKV 313
             +   +PW K+
Sbjct: 222 EKKTYLNPWKKI 233

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 98/252 (38%), Gaps = 56/252 (22%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVKGEPNVSY------ICSRY---------------YRAPELIFGAT 241
           IGI HRDIKP+NLL+    N+           RY               Y APEL+    
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            +   +D+WS G V+  +L G+   P +   D   E                   Y+++K
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWK 221
Query: 302 FPQIKPHPWHKV 313
             +   +PW K+
Sbjct: 222 EKKTYLNPWKKI 233

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 113/293 (38%), Gaps = 58/293 (19%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQI-MQMLDHPNIVALKH 142
           Y+ +  +G GS+    +   + T    A+K + + KR  + E++I ++   HPNI+ LK 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    D                +++I R      +    +      + I + + Y+H+ 
Sbjct: 89  VY---DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVL-----HTIGKTVEYLHSQ 140
Query: 203 IGICHRDIKPQNLLV---KGEPNVSYIC--------------------SRYYRAPELIFG 239
            G+ HRD+KP N+L     G P    IC                    +  + APE +  
Sbjct: 141 -GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPE-VLK 198
Query: 240 ATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 298
              Y    DIWS G ++  +L G  P   G S  D   EI+  +G+              
Sbjct: 199 RQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSG------------- 243
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 351
             KF  +    W+ V +      A DLV +     P+ R TA +   HP+  +
Sbjct: 244 --KF-TLSGGNWNTVSET-----AKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 87/203 (42%), Gaps = 37/203 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
           +G G+FG V++AK +ETG + A  KV++ K  +       E++I+   DHP IV L   +
Sbjct: 19  LGDGAFGKVYKAKNKETGALAA-AKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +                    +  + R  +          +++   Q+  AL ++H+   
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-------IQVVCRQMLEALNFLHSK-R 129
Query: 205 ICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELI----FGAT 241
           I HRD+K  N+L+  E ++                   S+I + Y+ APE++       T
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 189
Query: 242 EYTTAIDIWSTGCVMAELLLGQP 264
            Y    DIWS G  + E+   +P
Sbjct: 190 PYDYKADIWSLGITLIEMAQIEP 212

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 87/203 (42%), Gaps = 37/203 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
           +G G+FG V++AK +ETG + A  KV++ K  +       E++I+   DHP IV L   +
Sbjct: 27  LGDGAFGKVYKAKNKETGALAA-AKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +                    +  + R  +          +++   Q+  AL ++H+   
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-------IQVVCRQMLEALNFLHSK-R 137
Query: 205 ICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELI----FGAT 241
           I HRD+K  N+L+  E ++                   S+I + Y+ APE++       T
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 197
Query: 242 EYTTAIDIWSTGCVMAELLLGQP 264
            Y    DIWS G  + E+   +P
Sbjct: 198 PYDYKADIWSLGITLIEMAQIEP 220

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 43/204 (21%)
Query: 90  VGTGSFGVVFQAKCR------ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVA 139
           +G G+FG V    CR       TGE+VA+KK+        R   RE++I++ L H NIV 
Sbjct: 19  LGKGNFGSV--EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIH-QRMPLIYVKLYTYQICRALAY 198
            K   +S   +                    R+Y + H +R+  I +  YT QIC+ + Y
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGS------LRDYLQKHKERIDHIKLLQYTSQICKGMEY 130
Query: 199 IHNCIGICHRDIKPQNLLVKGEPNVSY----------ICSRYYR------------APEL 236
           +     I HR++  +N+LV+ E  V                YY+            APE 
Sbjct: 131 LGTKRYI-HRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 189
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           +   ++++ A D+WS G V+ EL 
Sbjct: 190 L-TESKFSVASDVWSFGVVLYELF 212

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 77/319 (24%), Positives = 115/319 (36%), Gaps = 77/319 (24%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 83
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 197
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 84  GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 131
Query: 198 YIHNCIGICHRDIKPQNLLVK-------------------GEPNVSYICSRYYRAPELIF 238
           Y+H    + HRD+K  NL +                    GE   +   +  Y APE + 
Sbjct: 132 YLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VL 189
Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 298
               ++  +D+WS GC+M  LL+G+P F                      E  C+   Y 
Sbjct: 190 SKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL 227
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
                +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  R
Sbjct: 228 -----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-AR 279
Query: 359 LP-NGRPLPPLFNFKPPEL 376
           LP     +PP F+  P  L
Sbjct: 280 LPITCLTIPPXFSIAPSSL 298

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 112/290 (38%), Gaps = 58/290 (20%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQI-MQMLDHPNIVALKH 142
           Y+ +  +G GS+    +   + T    A+K + + KR  + E++I ++   HPNI+ LK 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    D                +++I R      +    +      + I + + Y+H+ 
Sbjct: 89  VY---DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVL-----HTIGKTVEYLHSQ 140
Query: 203 IGICHRDIKPQNLLV---KGEPNVSYIC--------------------SRYYRAPELIFG 239
            G+ HRD+KP N+L     G P    IC                    +  + APE +  
Sbjct: 141 -GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPE-VLK 198
Query: 240 ATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 298
              Y    DIWS G ++  +L G  P   G S  D   EI+  +G+              
Sbjct: 199 RQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSG------------- 243
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
             KF  +    W+ V +      A DLV +     P+ R TA +   HP+
Sbjct: 244 --KFT-LSGGNWNTVSET-----AKDLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 98/252 (38%), Gaps = 56/252 (22%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVKGEPNVSY------ICSRY---------------YRAPELIFGAT 241
           IGI HRDIKP+NLL+    N+           RY               Y APEL+    
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            +   +D+WS G V+  +L G+   P +   D   E                   Y+++K
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSXQE-------------------YSDWK 221
Query: 302 FPQIKPHPWHKV 313
             +   +PW K+
Sbjct: 222 EKKTYLNPWKKI 233

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 98/252 (38%), Gaps = 56/252 (22%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 203 IGICHRDIKPQNLLVKGEPNVSY------ICSRY---------------YRAPELIFGAT 241
           IGI HRDIKP+NLL+    N+           RY               Y APEL+    
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            +   +D+WS G V+  +L G+   P +   D   E                   Y+++K
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWK 222
Query: 302 FPQIKPHPWHKV 313
             +   +PW K+
Sbjct: 223 EKKTYLNPWKKI 234

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 98/252 (38%), Gaps = 56/252 (22%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVKGEPNVSY------ICSRY---------------YRAPELIFGAT 241
           IGI HRDIKP+NLL+    N+           RY               Y APEL+    
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            +   +D+WS G V+  +L G+   P +   D   E                   Y+++K
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWK 221
Query: 302 FPQIKPHPWHKV 313
             +   +PW K+
Sbjct: 222 EKKTYLNPWKKI 233

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 98/252 (38%), Gaps = 56/252 (22%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 68
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 69  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 121
Query: 203 IGICHRDIKPQNLLVKGEPNVSY------ICSRY---------------YRAPELIFGAT 241
           IGI HRDIKP+NLL+    N+           RY               Y APEL+    
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            +   +D+WS G V+  +L G+   P +   D   E                   Y+++K
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWK 220
Query: 302 FPQIKPHPWHKV 313
             +   +PW K+
Sbjct: 221 EKKTYLNPWKKI 232

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 98/252 (38%), Gaps = 56/252 (22%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVKGEPNVSY------ICSRY---------------YRAPELIFGAT 241
           IGI HRDIKP+NLL+    N+           RY               Y APEL+    
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            +   +D+WS G V+  +L G+   P +   D   E                   Y+++K
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWK 221
Query: 302 FPQIKPHPWHKV 313
             +   +PW K+
Sbjct: 222 EKKTYLNPWKKI 233

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 98/252 (38%), Gaps = 56/252 (22%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 203 IGICHRDIKPQNLLVKGEPNVSY------ICSRY---------------YRAPELIFGAT 241
           IGI HRDIKP+NLL+    N+           RY               Y APEL+    
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            +   +D+WS G V+  +L G+   P +   D   E                   Y+++K
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWK 222
Query: 302 FPQIKPHPWHKV 313
             +   +PW K+
Sbjct: 223 EKKTYLNPWKKI 234

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 98/252 (38%), Gaps = 56/252 (22%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 203 IGICHRDIKPQNLLVKGEPNVSY------ICSRY---------------YRAPELIFGAT 241
           IGI HRDIKP+NLL+    N+           RY               Y APEL+    
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            +   +D+WS G V+  +L G+   P +   D   E                   Y+++K
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWK 222
Query: 302 FPQIKPHPWHKV 313
             +   +PW K+
Sbjct: 223 EKKTYLNPWKKI 234

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 98/252 (38%), Gaps = 56/252 (22%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVKGEPNVSY------ICSRY---------------YRAPELIFGAT 241
           IGI HRDIKP+NLL+    N+           RY               Y APEL+    
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            +   +D+WS G V+  +L G+   P +   D   E                   Y+++K
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWK 221
Query: 302 FPQIKPHPWHKV 313
             +   +PW K+
Sbjct: 222 EKKTYLNPWKKI 233

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 83/206 (40%), Gaps = 35/206 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNR---ELQIMQMLDHPNIVALKH 142
           +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +++L HP+I+ L  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              S  +                V R          +M     + +  QI  A+ Y H  
Sbjct: 72  VIKSKDEIIMVIEYAGNELFDYIVQR---------DKMSEQEARRFFQQIISAVEYCHRH 122
Query: 203 IGICHRDIKPQNLLVKGEPNV------------------SYICSRYYRAPELIFGATEYT 244
             I HRD+KP+NLL+    NV                  +   S  Y APE+I G     
Sbjct: 123 -KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 181
Query: 245 TAIDIWSTGCVMAELLLGQPLFPGES 270
             +D+WS G ++  +L  +  F  ES
Sbjct: 182 PEVDVWSCGVILYVMLCRRLPFDDES 207

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 98/252 (38%), Gaps = 56/252 (22%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 203 IGICHRDIKPQNLLVKGEPNVSY------ICSRY---------------YRAPELIFGAT 241
           IGI HRDIKP+NLL+    N+           RY               Y APEL+    
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            +   +D+WS G V+  +L G+   P +   D   E                   Y+++K
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWK 222
Query: 302 FPQIKPHPWHKV 313
             +   +PW K+
Sbjct: 223 EKKTYLNPWKKI 234

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 77/319 (24%), Positives = 115/319 (36%), Gaps = 77/319 (24%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 83
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 197
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 84  GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 131
Query: 198 YIHNCIGICHRDIKPQNLLVK-------------------GEPNVSYICSRYYRAPELIF 238
           Y+H    + HRD+K  NL +                    GE   +   +  Y APE + 
Sbjct: 132 YLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VL 189
Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 298
               ++  +D+WS GC+M  LL+G+P F                      E  C+   Y 
Sbjct: 190 SKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL 227
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
                +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  R
Sbjct: 228 -----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-AR 279
Query: 359 LP-NGRPLPPLFNFKPPEL 376
           LP     +PP F+  P  L
Sbjct: 280 LPITCLTIPPRFSIAPSSL 298

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 98/252 (38%), Gaps = 56/252 (22%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 203 IGICHRDIKPQNLLVKGEPNVSY------ICSRY---------------YRAPELIFGAT 241
           IGI HRDIKP+NLL+    N+           RY               Y APEL+    
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            +   +D+WS G V+  +L G+   P +   D   E                   Y+++K
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWK 222
Query: 302 FPQIKPHPWHKV 313
             +   +PW K+
Sbjct: 223 EKKTYLNPWKKI 234

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 98/252 (38%), Gaps = 56/252 (22%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVKGEPNVSY------ICSRY---------------YRAPELIFGAT 241
           IGI HRDIKP+NLL+    N+           RY               Y APEL+    
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            +   +D+WS G V+  +L G+   P +   D   E                   Y+++K
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWK 221
Query: 302 FPQIKPHPWHKV 313
             +   +PW K+
Sbjct: 222 EKKTYLNPWKKI 233

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 98/252 (38%), Gaps = 56/252 (22%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVKGEPNVSY------ICSRY---------------YRAPELIFGAT 241
           IGI HRDIKP+NLL+    N+           RY               Y APEL+    
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            +   +D+WS G V+  +L G+   P +   D   E                   Y+++K
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWK 221
Query: 302 FPQIKPHPWHKV 313
             +   +PW K+
Sbjct: 222 EKKTYLNPWKKI 233

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 83/206 (40%), Gaps = 35/206 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNR---ELQIMQMLDHPNIVALKH 142
           +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +++L HP+I+ L  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              S  +                V R          +M     + +  QI  A+ Y H  
Sbjct: 76  VIKSKDEIIMVIEYAGNELFDYIVQR---------DKMSEQEARRFFQQIISAVEYCHRH 126
Query: 203 IGICHRDIKPQNLLVKGEPNV------------------SYICSRYYRAPELIFGATEYT 244
             I HRD+KP+NLL+    NV                  +   S  Y APE+I G     
Sbjct: 127 -KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 185
Query: 245 TAIDIWSTGCVMAELLLGQPLFPGES 270
             +D+WS G ++  +L  +  F  ES
Sbjct: 186 PEVDVWSCGVILYVMLCRRLPFDDES 211

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 98/252 (38%), Gaps = 56/252 (22%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVKGEPNVSY------ICSRY---------------YRAPELIFGAT 241
           IGI HRDIKP+NLL+    N+           RY               Y APEL+    
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            +   +D+WS G V+  +L G+   P +   D   E                   Y+++K
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWK 221
Query: 302 FPQIKPHPWHKV 313
             +   +PW K+
Sbjct: 222 EKKTYLNPWKKI 233

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 98/252 (38%), Gaps = 56/252 (22%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 70
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 203 IGICHRDIKPQNLLVKGEPNVSY------ICSRY---------------YRAPELIFGAT 241
           IGI HRDIKP+NLL+    N+           RY               Y APEL+    
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            +   +D+WS G V+  +L G+   P +   D   E                   Y+++K
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWK 222
Query: 302 FPQIKPHPWHKV 313
             +   +PW K+
Sbjct: 223 EKKTYLNPWKKI 234

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 80/196 (40%), Gaps = 32/196 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLDHPNIVALKHCFFS 146
           +G+G+FGV    + +++ E+VA+K + + ++      RE+   + L HPNIV  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            T                 +    R +S    R        +  Q+   ++Y H  + +C
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGR-FSEDEAR-------FFFQQLISGVSYCH-AMQVC 137
Query: 207 HRDIKPQNLLVKGEPN--------------------VSYICSRYYRAPELIFGATEYTTA 246
           HRD+K +N L+ G P                      S + +  Y APE++         
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 197
Query: 247 IDIWSTGCVMAELLLG 262
            D+WS G  +  +L+G
Sbjct: 198 ADVWSCGVTLYVMLVG 213

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 98/252 (38%), Gaps = 56/252 (22%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVKGEPNVSY------ICSRY---------------YRAPELIFGAT 241
           IGI HRDIKP+NLL+    N+           RY               Y APEL+    
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            +   +D+WS G V+  +L G+   P +   D   E                   Y+++K
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWK 221
Query: 302 FPQIKPHPWHKV 313
             +   +PW K+
Sbjct: 222 EKKTYLNPWKKI 233

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 102/255 (40%), Gaps = 64/255 (25%)
Query: 124 RELQIMQMLD-HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL 182
           +E+ I++ +  HPNI+ LK  + + T                 + +    +  + +++ L
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNT----------FFFLVFDLMKKGELFDYLTEKVTL 121
Query: 183 IYVKLYTYQICRALAYI---HNCIGICHRDIKPQNLLVKGEPNVSY-------------- 225
              +  T +I RAL  +    + + I HRD+KP+N+L+  + N+                
Sbjct: 122 --SEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK 179
Query: 226 ---ICSR-YYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 276
              +C    Y APE+I  +       Y   +D+WSTG +M  LL G P F     +  L 
Sbjct: 180 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR 239
Query: 277 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 336
            I              M+ NY +F  P+   +               DLV RF    P  
Sbjct: 240 MI--------------MSGNY-QFGSPEWDDY----------SDTVKDLVSRFLVVQPQK 274
Query: 337 RCTALEACVHPFFDE 351
           R TA EA  HPFF +
Sbjct: 275 RYTAEEALAHPFFQQ 289

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 77/319 (24%), Positives = 115/319 (36%), Gaps = 77/319 (24%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 87
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 197
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 88  GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 135
Query: 198 YIHNCIGICHRDIKPQNLLVK-------------------GEPNVSYICSRYYRAPELIF 238
           Y+H    + HRD+K  NL +                    GE   +   +  Y APE + 
Sbjct: 136 YLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VL 193
Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 298
               ++  +D+WS GC+M  LL+G+P F                      E  C+   Y 
Sbjct: 194 SKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL 231
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
                +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  R
Sbjct: 232 -----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-AR 283
Query: 359 LP-NGRPLPPLFNFKPPEL 376
           LP     +PP F+  P  L
Sbjct: 284 LPITCLTIPPRFSIAPSSL 302

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 98/252 (38%), Gaps = 56/252 (22%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVKGEPNVSY------ICSRY---------------YRAPELIFGAT 241
           IGI HRDIKP+NLL+    N+           RY               Y APEL+    
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            +   +D+WS G V+  +L G+   P +   D   E                   Y+++K
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWK 221
Query: 302 FPQIKPHPWHKV 313
             +   +PW K+
Sbjct: 222 EKKTYLNPWKKI 233

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 80/196 (40%), Gaps = 32/196 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLDHPNIVALKHCFFS 146
           +G+G+FGV    + +++ E+VA+K + + ++      RE+   + L HPNIV  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILT 86
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            T                 +    R +S    R        +  Q+   ++Y H  + +C
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGR-FSEDEAR-------FFFQQLISGVSYCH-AMQVC 137
Query: 207 HRDIKPQNLLVKGEPN--------------------VSYICSRYYRAPELIFGATEYTTA 246
           HRD+K +N L+ G P                      S + +  Y APE++         
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 197
Query: 247 IDIWSTGCVMAELLLG 262
            D+WS G  +  +L+G
Sbjct: 198 ADVWSCGVTLYVMLVG 213

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 83/206 (40%), Gaps = 35/206 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNR---ELQIMQMLDHPNIVALKH 142
           +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +++L HP+I+ L  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              S  +                V R          +M     + +  QI  A+ Y H  
Sbjct: 82  VIKSKDEIIMVIEYAGNELFDYIVQR---------DKMSEQEARRFFQQIISAVEYCHRH 132
Query: 203 IGICHRDIKPQNLLVKGEPNV------------------SYICSRYYRAPELIFGATEYT 244
             I HRD+KP+NLL+    NV                  +   S  Y APE+I G     
Sbjct: 133 -KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 191
Query: 245 TAIDIWSTGCVMAELLLGQPLFPGES 270
             +D+WS G ++  +L  +  F  ES
Sbjct: 192 PEVDVWSCGVILYVMLCRRLPFDDES 217

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 106/285 (37%), Gaps = 59/285 (20%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLDHPNIVALKHCFFS 146
           +G+G+FGV    + + T E+VA+K + +         RE+   + L HPNIV  K    +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            T                 +    R +S    R        +  Q+   ++Y H+ + IC
Sbjct: 88  PTHLAIIMEYASGGELYERICNAGR-FSEDEAR-------FFFQQLLSGVSYCHS-MQIC 138
Query: 207 HRDIKPQNLLVKGEPN--------------------VSYICSRYYRAPELIFGATEYTTA 246
           HRD+K +N L+ G P                      S + +  Y APE++    EY   
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-RQEYDGK 197
Query: 247 I-DIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 304
           I D+WS G  +  +L+G  P    E   D    I ++L                ++  P 
Sbjct: 198 IADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS--------------VKYSIPD 243
Query: 305 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
                       R+ PE   L+ R F   P  R +  E   H +F
Sbjct: 244 ----------DIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 102/255 (40%), Gaps = 64/255 (25%)
Query: 124 RELQIMQMLD-HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL 182
           +E+ I++ +  HPNI+ LK  + + T                 + +    +  + +++ L
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNT----------FFFLVFDLMKKGELFDYLTEKVTL 121
Query: 183 IYVKLYTYQICRALAYI---HNCIGICHRDIKPQNLLVKGEPNVSY-------------- 225
              +  T +I RAL  +    + + I HRD+KP+N+L+  + N+                
Sbjct: 122 --SEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK 179
Query: 226 ---ICSR-YYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 276
              +C    Y APE+I  +       Y   +D+WSTG +M  LL G P F     +  L 
Sbjct: 180 LRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR 239
Query: 277 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 336
            I              M+ NY +F  P+   +               DLV RF    P  
Sbjct: 240 MI--------------MSGNY-QFGSPEWDDY----------SDTVKDLVSRFLVVQPQK 274
Query: 337 RCTALEACVHPFFDE 351
           R TA EA  HPFF +
Sbjct: 275 RYTAEEALAHPFFQQ 289

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 83/206 (40%), Gaps = 35/206 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNR---ELQIMQMLDHPNIVALKH 142
           +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +++L HP+I+ L  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              S  +                V R          +M     + +  QI  A+ Y H  
Sbjct: 81  VIKSKDEIIMVIEYAGNELFDYIVQR---------DKMSEQEARRFFQQIISAVEYCHRH 131
Query: 203 IGICHRDIKPQNLLVKGEPNV------------------SYICSRYYRAPELIFGATEYT 244
             I HRD+KP+NLL+    NV                  +   S  Y APE+I G     
Sbjct: 132 -KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 190
Query: 245 TAIDIWSTGCVMAELLLGQPLFPGES 270
             +D+WS G ++  +L  +  F  ES
Sbjct: 191 PEVDVWSCGVILYVMLCRRLPFDDES 216

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 102/255 (40%), Gaps = 64/255 (25%)
Query: 124 RELQIMQMLD-HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL 182
           +E+ I++ +  HPNI+ LK  + + T                 + +    +  + +++ L
Sbjct: 59  KEVDILRKVSGHPNIIQLKDTYETNT----------FFFLVFDLMKKGELFDYLTEKVTL 108
Query: 183 IYVKLYTYQICRALAYI---HNCIGICHRDIKPQNLLVKGEPNVSY-------------- 225
              +  T +I RAL  +    + + I HRD+KP+N+L+  + N+                
Sbjct: 109 --SEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK 166
Query: 226 ---ICSR-YYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 276
              +C    Y APE+I  +       Y   +D+WSTG +M  LL G P F     +  L 
Sbjct: 167 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR 226
Query: 277 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 336
            I              M+ NY +F  P+   +               DLV RF    P  
Sbjct: 227 MI--------------MSGNY-QFGSPEWDDY----------SDTVKDLVSRFLVVQPQK 261
Query: 337 RCTALEACVHPFFDE 351
           R TA EA  HPFF +
Sbjct: 262 RYTAEEALAHPFFQQ 276

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 37/203 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALKHCF 144
           +G G+FG V++A+ +ET  ++A  KV+  K  +       E+ I+   DHPNIV L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           +   +                +  + R  +          +++   Q   AL Y+H+   
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQ-------IQVVCKQTLDALNYLHDN-K 155
Query: 205 ICHRDIKPQNLLVKGEPNVS-------------------YICSRYYRAPELIFGATE--- 242
           I HRD+K  N+L   + ++                    +I + Y+ APE++   T    
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDR 215
Query: 243 -YTTAIDIWSTGCVMAELLLGQP 264
            Y    D+WS G  + E+   +P
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEP 238

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 80/196 (40%), Gaps = 32/196 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLDHPNIVALKHCFFS 146
           +G+G+FGV    + +++ E+VA+K + + ++      RE+   + L HPNIV  K    +
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            T                 +    R +S    R        +  Q+   ++Y H  + +C
Sbjct: 86  PTHLAIVMEYASGGELFERICNAGR-FSEDEAR-------FFFQQLISGVSYCH-AMQVC 136
Query: 207 HRDIKPQNLLVKGEPN--------------------VSYICSRYYRAPELIFGATEYTTA 246
           HRD+K +N L+ G P                      S + +  Y APE++         
Sbjct: 137 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 196
Query: 247 IDIWSTGCVMAELLLG 262
            D+WS G  +  +L+G
Sbjct: 197 ADVWSCGVTLYVMLVG 212

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 105/294 (35%), Gaps = 63/294 (21%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVA 139
           V+G G F VV +   RETG+  A+K V   K   +         RE  I  ML HP+IV 
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L   +  ++D                   + R  +       +     Y  QI  AL Y 
Sbjct: 93  LLETY--SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV--ASHYMRQILEALRYC 148
Query: 200 HNCIGICHRDIKPQNLLVKGEPNVS----------------------YICSRYYRAPELI 237
           H+   I HRD+KP  +L+  + N +                       + + ++ APE++
Sbjct: 149 HDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 207
Query: 238 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 297
                Y   +D+W  G ++  LL G                +   GT  R     +   Y
Sbjct: 208 -KREPYGKPVDVWGCGVILFILLSG---------------CLPFYGTKERLFEGIIKGKY 251
Query: 298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 351
                 ++ P  W  + +      A DLV R     P  R T  EA  HP+  E
Sbjct: 252 ------KMNPRQWSHISES-----AKDLVRRMLMLDPAERITVYEALNHPWLKE 294

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 97/252 (38%), Gaps = 56/252 (22%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G++G V  A  R T E VA+K V   +         +E+ I  ML+H N+V    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKF-- 70
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 71  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 123
Query: 203 IGICHRDIKPQNLLVKGEPNVSY------ICSRY---------------YRAPELIFGAT 241
           IGI HRDIKP+NLL+    N+           RY               Y APEL+    
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            +   +D+WS G V+  +L G+   P +   D   E                   Y+++K
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWK 222
Query: 302 FPQIKPHPWHKV 313
             +   +PW K+
Sbjct: 223 EKKTYLNPWKKI 234

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 110/260 (42%), Gaps = 60/260 (23%)
Query: 60  GAETGHVIRTTIGGRNGNSK-QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD 118
           G +TG++   TIGG+   ++   +  + E  +G+G+ G V++ + R+TG ++A+K++   
Sbjct: 7   GKQTGYL---TIGGQRYQAEINDLENLGE--MGSGTCGQVWKMRFRKTGHVIAVKQM--- 58
Query: 119 KRYKNRELQ---------IMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRI 169
           +R  N+E           +++  D P IV     F + TD                +  +
Sbjct: 59  RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD------------VFIAMELM 106
Query: 170 ARNYSRIHQRM----PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-- 223
                ++ +RM    P   +   T  I +AL Y+    G+ HRD+KP N+L+     +  
Sbjct: 107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKL 166
Query: 224 -----------------SYICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLG 262
                            S  C+ Y  APE I        +Y    D+WS G  + EL  G
Sbjct: 167 CDFGISGRLVDDKAKDRSAGCAAYM-APERIDPPDPTKPDYDIRADVWSLGISLVELATG 225
Query: 263 QPLFPGESGVDQLVEIIKVL 282
           Q  FP ++       + KVL
Sbjct: 226 Q--FPYKNCKTDFEVLTKVL 243

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 80/196 (40%), Gaps = 32/196 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLDHPNIVALKHCFFS 146
           +G+G+FGV    + +++ E+VA+K + + ++      RE+   + L HPNIV  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            T                 +    R +S    R        +  Q+   ++Y H  + +C
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGR-FSEDEAR-------FFFQQLISGVSYCH-AMQVC 137
Query: 207 HRDIKPQNLLVKGEPNVSY-ICSRYYR-------------------APELIFGATEYTTA 246
           HRD+K +N L+ G P     IC+  Y                    APE++         
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKV 197
Query: 247 IDIWSTGCVMAELLLG 262
            D+WS G  +  +L+G
Sbjct: 198 ADVWSCGVTLYVMLVG 213

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 77/319 (24%), Positives = 114/319 (35%), Gaps = 77/319 (24%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 105
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 197
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 106 GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 153
Query: 198 YIHNCIGICHRDIKPQNLLVK-------------------GEPNVSYICSRYYRAPELIF 238
           Y+H    + HRD+K  NL +                    GE       +  Y APE + 
Sbjct: 154 YLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VL 211
Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 298
               ++  +D+WS GC+M  LL+G+P F                      E  C+   Y 
Sbjct: 212 SKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL 249
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
                +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  R
Sbjct: 250 -----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-AR 301
Query: 359 LP-NGRPLPPLFNFKPPEL 376
           LP     +PP F+  P  L
Sbjct: 302 LPITCLTIPPRFSIAPSSL 320

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 81/344 (23%), Positives = 119/344 (34%), Gaps = 80/344 (23%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVA 139
           V+G G F VV +   RETG+  A+K V   K   +         RE  I  ML HP+IV 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 140 LKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L   +  ++D                   + R  +       +     Y  QI  AL Y 
Sbjct: 91  LLETY--SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV--ASHYMRQILEALRYC 146
Query: 200 HNCIGICHRDIKPQNLLVKGEPNVS----------------------YICSRYYRAPELI 237
           H+   I HRD+KP  +L+  + N +                       + + ++ APE++
Sbjct: 147 HDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 238 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 297
                Y   +D+W  G ++  LL G                +   GT  R     +   Y
Sbjct: 206 -KREPYGKPVDVWGCGVILFILLSG---------------CLPFYGTKERLFEGIIKGKY 249
Query: 298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE------ 351
                 ++ P  W  + +      A DLV R     P  R T  EA  HP+  E      
Sbjct: 250 ------KMNPRQWSHISES-----AKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAY 298
Query: 352 ----------LRDPNTRLP-NGRPLPPLFNFKPPELSGIPPETI 384
                     LR  N R    G  L  + + K     G PPE +
Sbjct: 299 KIHLPETVEQLRKFNARRKLKGAVLAAVSSHKFNSFYGDPPEEL 342

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 77/319 (24%), Positives = 114/319 (35%), Gaps = 77/319 (24%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 107
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 197
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 108 GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 155
Query: 198 YIHNCIGICHRDIKPQNLLVK-------------------GEPNVSYICSRYYRAPELIF 238
           Y+H    + HRD+K  NL +                    GE       +  Y APE + 
Sbjct: 156 YLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VL 213
Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 298
               ++  +D+WS GC+M  LL+G+P F                      E  C+   Y 
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL 251
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
                +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  R
Sbjct: 252 -----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-AR 303
Query: 359 LP-NGRPLPPLFNFKPPEL 376
           LP     +PP F+  P  L
Sbjct: 304 LPITCLTIPPRFSIAPSSL 322

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 94/227 (41%), Gaps = 40/227 (17%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHP 135
            Y    V+G G+FG V   + + T ++ A+K + +       D  +   E  IM   + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
            +V L   F++  D                VN ++ NY      +P  + + YT ++  A
Sbjct: 135 WVVQL---FYAFQDDRYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWARFYTAEVVLA 185
Query: 196 LAYIHNCIGICHRDIKPQNLLVKGEPNV--------------------SYICSRYYRAPE 235
           L  IH+ +G  HRD+KP N+L+    ++                    + + +  Y +PE
Sbjct: 186 LDAIHS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 244
Query: 236 LI---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
           ++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 245 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 79/318 (24%), Positives = 125/318 (39%), Gaps = 77/318 (24%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 124 YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 167
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVKGE-PN-------------------VSYIC-S 228
           +    A+ Y+H+ I I HRD+KP+NLL   + PN                   ++  C +
Sbjct: 168 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 226
Query: 229 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 288
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 227 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 279
Query: 289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 280 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 324
Query: 349 -FDELRDPNTRLPNGRPL 365
                + P T L   R L
Sbjct: 325 IMQSTKVPQTPLHTSRVL 342

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 94/227 (41%), Gaps = 40/227 (17%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHP 135
            Y    V+G G+FG V   + + T ++ A+K + +       D  +   E  IM   + P
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
            +V L   F++  D                VN ++ NY      +P  + + YT ++  A
Sbjct: 130 WVVQL---FYAFQDDRYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWARFYTAEVVLA 180
Query: 196 LAYIHNCIGICHRDIKPQNLLVKGEPNV--------------------SYICSRYYRAPE 235
           L  IH+ +G  HRD+KP N+L+    ++                    + + +  Y +PE
Sbjct: 181 LDAIHS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 239
Query: 236 LI---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
           ++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 112/289 (38%), Gaps = 63/289 (21%)
Query: 90  VGTGSFGVVFQAKCRETGE-----IVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           +G G+F VV +      G+     I+  KK+  +D +   RE +I ++L HPNIV L   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
                                 +  +AR Y         I       QI  A+ + H  +
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDI--VAREYYSEADASHCI------QQILEAVLHCHQ-M 129
Query: 204 GICHRDIKPQNLL--------------------VKGEPNV--SYICSRYYRAPELIFGAT 241
           G+ HR++KP+NLL                    V+GE      +  +  Y +PE +    
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE-VLRKD 188
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            Y   +D+W+ G ++  LL+G P F  E    +L + IK                   + 
Sbjct: 189 PYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GAYD 231
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
           FP  +   W  V      PEA DL+ +    +P+ R TA EA  HP+  
Sbjct: 232 FPSPE---WDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWIS 272

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 79/318 (24%), Positives = 125/318 (39%), Gaps = 77/318 (24%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 80  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 123
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVKGE-PN-------------------VSYIC-S 228
           +    A+ Y+H+ I I HRD+KP+NLL   + PN                   ++  C +
Sbjct: 124 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 182
Query: 229 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 288
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 183 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 235
Query: 289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 236 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 280
Query: 349 -FDELRDPNTRLPNGRPL 365
                + P T L   R L
Sbjct: 281 IMQSTKVPQTPLHTSRVL 298

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 97/252 (38%), Gaps = 56/252 (22%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-----NRELQIMQMLDHPNIVALKH 142
             +G G+ G V  A  R T E VA+K V   +         +E+ I +ML+H N+V    
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF-- 69
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            +    +                 +RI  +       MP    + + +Q+   + Y+H  
Sbjct: 70  -YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 122
Query: 203 IGICHRDIKPQNLLVKGEPNVSY------ICSRY---------------YRAPELIFGAT 241
           IGI HRDIKP+NLL+    N+           RY               Y APEL+    
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            +   +D+WS G V+  +L G+   P +   D   E                   Y+++K
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YSDWK 221
Query: 302 FPQIKPHPWHKV 313
             +   +PW K+
Sbjct: 222 EKKTYLNPWKKI 233

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 79/318 (24%), Positives = 125/318 (39%), Gaps = 77/318 (24%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 71  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 129
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 130 YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 173
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVKGE-PN-------------------VSYIC-S 228
           +    A+ Y+H+ I I HRD+KP+NLL   + PN                   ++  C +
Sbjct: 174 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 232
Query: 229 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 288
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 233 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 285
Query: 289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 286 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 330
Query: 349 -FDELRDPNTRLPNGRPL 365
                + P T L   R L
Sbjct: 331 IMQSTKVPQTPLHTSRVL 348

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 94/227 (41%), Gaps = 40/227 (17%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHP 135
            Y    V+G G+FG V   + + T ++ A+K + +       D  +   E  IM   + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
            +V L   F++  D                VN ++ NY      +P  + + YT ++  A
Sbjct: 135 WVVQL---FYAFQDDRYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWARFYTAEVVLA 185
Query: 196 LAYIHNCIGICHRDIKPQNLLVKGEPNV--------------------SYICSRYYRAPE 235
           L  IH+ +G  HRD+KP N+L+    ++                    + + +  Y +PE
Sbjct: 186 LDAIHS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 244
Query: 236 LI---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
           ++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 245 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 79/318 (24%), Positives = 125/318 (39%), Gaps = 77/318 (24%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 35  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 93
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 94  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 137
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVKGE-PN-------------------VSYIC-S 228
           +    A+ Y+H+ I I HRD+KP+NLL   + PN                   ++  C +
Sbjct: 138 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 196
Query: 229 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 288
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 197 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 249
Query: 289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 250 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 294
Query: 349 -FDELRDPNTRLPNGRPL 365
                + P T L   R L
Sbjct: 295 IMQSTKVPQTPLHTSRVL 312

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 79/318 (24%), Positives = 125/318 (39%), Gaps = 77/318 (24%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 25  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 83
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 84  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 127
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVKGE-PN-------------------VSYIC-S 228
           +    A+ Y+H+ I I HRD+KP+NLL   + PN                   ++  C +
Sbjct: 128 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 186
Query: 229 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 288
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 187 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 239
Query: 289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 240 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 284
Query: 349 -FDELRDPNTRLPNGRPL 365
                + P T L   R L
Sbjct: 285 IMQSTKVPQTPLHTSRVL 302

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 79/318 (24%), Positives = 125/318 (39%), Gaps = 77/318 (24%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 19  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 77
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 78  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 121
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVKGE-PN-------------------VSYIC-S 228
           +    A+ Y+H+ I I HRD+KP+NLL   + PN                   ++  C +
Sbjct: 122 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 180
Query: 229 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 288
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 181 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 233
Query: 289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 234 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 278
Query: 349 -FDELRDPNTRLPNGRPL 365
                + P T L   R L
Sbjct: 279 IMQSTKVPQTPLHTSRVL 296

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 79/318 (24%), Positives = 125/318 (39%), Gaps = 77/318 (24%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 26  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 84
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 85  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 128
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVKGE-PN-------------------VSYIC-S 228
           +    A+ Y+H+ I I HRD+KP+NLL   + PN                   ++  C +
Sbjct: 129 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 187
Query: 229 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 288
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 188 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 240
Query: 289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 241 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 285
Query: 349 -FDELRDPNTRLPNGRPL 365
                + P T L   R L
Sbjct: 286 IMQSTKVPQTPLHTSRVL 303

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 79/318 (24%), Positives = 125/318 (39%), Gaps = 77/318 (24%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 27  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 85
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 86  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 129
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVKGE-PN-------------------VSYIC-S 228
           +    A+ Y+H+ I I HRD+KP+NLL   + PN                   ++  C +
Sbjct: 130 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 188
Query: 229 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 288
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 189 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 241
Query: 289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 242 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 286
Query: 349 -FDELRDPNTRLPNGRPL 365
                + P T L   R L
Sbjct: 287 IMQSTKVPQTPLHTSRVL 304

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 79/318 (24%), Positives = 125/318 (39%), Gaps = 77/318 (24%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 20  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 78
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 79  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 122
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVKGE-PN-------------------VSYIC-S 228
           +    A+ Y+H+ I I HRD+KP+NLL   + PN                   ++  C +
Sbjct: 123 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 181
Query: 229 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 288
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 182 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 234
Query: 289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 235 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 279
Query: 349 -FDELRDPNTRLPNGRPL 365
                + P T L   R L
Sbjct: 280 IMQSTKVPQTPLHTSRVL 297

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 78/318 (24%), Positives = 122/318 (38%), Gaps = 77/318 (24%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 19  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 77
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 78  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 121
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVKGE-PNVSYICSR------------------- 229
           +    A+ Y+H+ I I HRD+KP+NLL   + PN     +                    
Sbjct: 122 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYT 180
Query: 230 -YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 288
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 181 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 233
Query: 289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 234 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 278
Query: 349 -FDELRDPNTRLPNGRPL 365
                + P T L   R L
Sbjct: 279 IMQSTKVPQTPLHTSRVL 296

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 76/316 (24%), Positives = 113/316 (35%), Gaps = 77/316 (24%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPNIVALKH 142
           +G G F   F+    +T E+ A K V +    K       + E+ I + L H ++V   H
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 81
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS--RIHQRMPLIY---VKLYTYQICRALA 197
            FF   D                V  + R  S   +H+R   +     + Y  QI     
Sbjct: 82  GFFEDND------------FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 129
Query: 198 YIHNCIGICHRDIKPQNLLVK-------------------GEPNVSYICSRYYRAPELIF 238
           Y+H    + HRD+K  NL +                    GE       +  Y APE + 
Sbjct: 130 YLHRN-RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VL 187
Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 298
               ++  +D+WS GC+M  LL+G+P F                      E  C+   Y 
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL 225
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
                +IK + +     K + P A  L+ +  Q  P  R T  E     FF     P  R
Sbjct: 226 -----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-AR 277
Query: 359 LP-NGRPLPPLFNFKP 373
           LP     +PP F+  P
Sbjct: 278 LPITCLTIPPRFSIAP 293

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 113/292 (38%), Gaps = 69/292 (23%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 158 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 217
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                    R +S    R        Y  +I  AL Y+H+
Sbjct: 218 YSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-------FYGAEIVSALDYLHS 269
Query: 202 CIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGATE 242
              + +RD+K +NL++  + ++                   ++  +  Y APE +    +
Sbjct: 270 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLEDND 328
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 302
           Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+           
Sbjct: 329 YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR----------- 370
Query: 303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 349
                      F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 371 -----------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 411

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 79/318 (24%), Positives = 125/318 (39%), Gaps = 77/318 (24%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 80  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 123
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVKGE-PN-------------------VSYIC-S 228
           +    A+ Y+H+ I I HRD+KP+NLL   + PN                   ++  C +
Sbjct: 124 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 182
Query: 229 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 288
            YY APE + G  +Y  + D+WS G +M  LL G P F    G      +    G  TR 
Sbjct: 183 PYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRI 235
Query: 289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
            +        +++FP  +   W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 236 RM-------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPW 280
Query: 349 -FDELRDPNTRLPNGRPL 365
                + P T L   R L
Sbjct: 281 IMQSTKVPQTPLHTSRVL 298

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 113/292 (38%), Gaps = 69/292 (23%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                    R +S    R        Y  +I  AL Y+H+
Sbjct: 215 YSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-------FYGAEIVSALDYLHS 266
Query: 202 CIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGATE 242
              + +RD+K +NL++  + ++                   ++  +  Y APE +    +
Sbjct: 267 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLEDND 325
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 302
           Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+           
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR----------- 367
Query: 303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 349
                      F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 368 -----------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 118/298 (39%), Gaps = 58/298 (19%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K +LQD     RE++          I++++D 
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 80  YENLYAGRKCLLIVMECLDG----------------GELFSRIQDRGDQAFTEREASEIM 123
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVKGE-PNVSYICSRYYRAPELIFGATEYTTAID 248
           +    A+ Y+H+ I I HRD+KP+NLL   + PN     + +  A E      +Y  + D
Sbjct: 124 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--GEKYDKSCD 180
Query: 249 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH 308
           +WS G +M  LL G P F    G      +    G  TR  +        +++FP  +  
Sbjct: 181 MWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM-------GQYEFPNPE-- 225
Query: 309 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF-FDELRDPNTRLPNGRPL 365
            W +V +     E   L+    +  P  R T  E   HP+     + P T L   R L
Sbjct: 226 -WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVL 277

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 36/203 (17%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCF---- 144
           ++G+G FG VF+AK R  G+   IK+V  +     RE++ +  LDH NIV    C+    
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 77
Query: 145 --------FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
                    S+  K              T+ +      R  +   ++ ++L+  QI + +
Sbjct: 78  YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEKLDKVLALELFE-QITKGV 135
Query: 197 AYIHNCIGICHRDIKPQNLLV-------------------KGEPNVSYICSRYYRAPELI 237
            YIH+   + +RD+KP N+ +                    G+   S    RY  +PE I
Sbjct: 136 DYIHSK-KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYM-SPEQI 193
Query: 238 FGATEYTTAIDIWSTGCVMAELL 260
             + +Y   +D+++ G ++AELL
Sbjct: 194 -SSQDYGKEVDLYALGLILAELL 215

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 113/288 (39%), Gaps = 63/288 (21%)
Query: 90  VGTGSFGVVFQAKCRETGE-----IVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           +G G+F VV +     TG+     I+  KK+  +D +   RE +I ++L HPNIV L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
              + +                 + +AR Y         I       QI  ++ + H   
Sbjct: 72  I--SEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCI------QQILESVNHCH-LN 122
Query: 204 GICHRDIKPQNLL--------------------VKGEPNV--SYICSRYYRAPELIFGAT 241
           GI HRD+KP+NLL                    V+G+      +  +  Y +PE +    
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPE-VLRKD 181
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            Y   +D+W+ G ++  LL+G P F  E    +L + IK                   + 
Sbjct: 182 PYGKPVDMWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GAYD 224
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           FP  +   W  V      PEA DL+ +    +P  R TA EA  HP+ 
Sbjct: 225 FPSPE---WDTV-----TPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 110/292 (37%), Gaps = 69/292 (23%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 17  LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 76
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                    R +S    R        Y  +I  AL Y+H+
Sbjct: 77  YSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-------FYGAEIVSALDYLHS 128
Query: 202 CIGICHRDIKPQNLL------------------VKGEPNVSYICSR-YYRAPELIFGATE 242
              + +RD+K +NL+                  +K    +   C    Y APE +    +
Sbjct: 129 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-VLEDND 187
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 302
           Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+           
Sbjct: 188 YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR----------- 229
Query: 303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 349
                      F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 230 -----------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 270

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 67/291 (23%), Positives = 107/291 (36%), Gaps = 56/291 (19%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQI-MQMLDHPNIVALK 141
            Y  +  +G GS+ V  +   + T    A+K + + KR    E++I ++   HPNI+ LK
Sbjct: 23  GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLK 82
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +    D                +++I R      +    +      + I + + Y+H 
Sbjct: 83  DVY---DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL-----FTITKTVEYLH- 133
Query: 202 CIGICHRDIKPQNLLV---KGEPNVSYIC--------------------SRYYRAPELIF 238
             G+ HRD+KP N+L     G P    IC                    +  + APE + 
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE-VL 192
Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 298
               Y  A DIWS G ++  +L G   F      D   EI+  +G+              
Sbjct: 193 ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSG------------- 238
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
             KF  +    W+ V        A DLV +     P+ R TA     HP+ 
Sbjct: 239 --KF-SLSGGYWNSV-----SDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 110/292 (37%), Gaps = 69/292 (23%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 15  LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 74
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                    R +S    R        Y  +I  AL Y+H+
Sbjct: 75  YSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-------FYGAEIVSALDYLHS 126
Query: 202 CIGICHRDIKPQNLL------------------VKGEPNVSYICSR-YYRAPELIFGATE 242
              + +RD+K +NL+                  +K    +   C    Y APE +    +
Sbjct: 127 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-VLEDND 185
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 302
           Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+           
Sbjct: 186 YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR----------- 227
Query: 303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 349
                      F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 228 -----------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 268

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 113/288 (39%), Gaps = 63/288 (21%)
Query: 90  VGTGSFGVVFQAKCRETGE-----IVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           +G G+F VV +     TG+     I+  KK+  +D +   RE +I ++L HPNIV L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
              + +                 + +AR Y         I       QI  ++ + H   
Sbjct: 72  I--SEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCI------QQILESVNHCH-LN 122
Query: 204 GICHRDIKPQNLL--------------------VKGEPNV--SYICSRYYRAPELIFGAT 241
           GI HRD+KP+NLL                    V+G+      +  +  Y +PE +    
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPE-VLRKD 181
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            Y   +D+W+ G ++  LL+G P F  E    +L + IK                   + 
Sbjct: 182 PYGKPVDMWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----------------GAYD 224
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           FP  +   W  V      PEA DL+ +    +P  R TA EA  HP+ 
Sbjct: 225 FPSPE---WDTV-----TPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 47/216 (21%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCF--F 145
            ++G+G FG VF+AK R  G+   I++V  +     RE++ +  LDH NIV    C+  F
Sbjct: 18  ELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGF 77
Query: 146 STTDKXXXXXXXXXXXXXXTVNRIARNYSR-----------------IHQRM-----PLI 183
               +                   +R+ ++                 I +R       ++
Sbjct: 78  DYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 137
Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV-------------------KGEPNVS 224
            ++L+  QI + + YIH+   + HRD+KP N+ +                    G+   S
Sbjct: 138 ALELFE-QITKGVDYIHSK-KLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS 195
Query: 225 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 260
               RY  +PE I  + +Y   +D+++ G ++AELL
Sbjct: 196 KGTLRYM-SPEQI-SSQDYGKEVDLYALGLILAELL 229

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 110/292 (37%), Gaps = 69/292 (23%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   K + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 16  LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 75
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F  T D+                    R +S    R        Y  +I  AL Y+H+
Sbjct: 76  YSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR-------FYGAEIVSALDYLHS 127
Query: 202 CIGICHRDIKPQNLL------------------VKGEPNVSYICSR-YYRAPELIFGATE 242
              + +RD+K +NL+                  +K    +   C    Y APE +    +
Sbjct: 128 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-VLEDND 186
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 302
           Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+           
Sbjct: 187 YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR----------- 228
Query: 303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFF 349
                      F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 229 -----------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 269

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/287 (22%), Positives = 112/287 (39%), Gaps = 58/287 (20%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQI-MQMLDHPNIVALKHC 143
           +G G++GVV + +   +G+I A+K++      Q+++    +L I  + +D P  V     
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
            F   D               ++++  +      Q +P   +      I +AL ++H+ +
Sbjct: 102 LFREGD-----VWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 156
Query: 204 GICHRDIKPQNLLVKGEPNV---SYICSRY---------------YRAPELI---FGATE 242
            + HRD+KP N+L+     V    +  S Y               Y APE I        
Sbjct: 157 SVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQKG 216
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 302
           Y+   DIWS G    EL + +  FP +S            GTP ++              
Sbjct: 217 YSVKSDIWSLGITXIELAILR--FPYDS-----------WGTPFQQ-------------L 250
Query: 303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
            Q+   P  ++   +   E VD   +  + +   R T  E   HPFF
Sbjct: 251 KQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 99/228 (43%), Gaps = 43/228 (18%)
Query: 70  TIGG-RNGNSKQKVSYIAEHVVGTGSFGVVFQA-KCRETGEI--VAIKKVLQDKRYKNRE 125
           ++GG + G +++ V  +   ++G G FG V++       GE   VA+K   +D    N+E
Sbjct: 1   SMGGPQYGIAREDV--VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE 58
Query: 126 -----LQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRM 180
                  IM+ LDHP+IV L        ++                + + RN       +
Sbjct: 59  KFMSEAVIMKNLDHPHIVKL----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSL 110
Query: 181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV---SYICSRY------- 230
            ++ + LY+ QIC+A+AY+ + I   HRDI  +N+LV     V    +  SRY       
Sbjct: 111 KVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY 169
Query: 231 ----------YRAPELIFGATEYTTAIDIWSTGCVMAELLL--GQPLF 266
                     + +PE I     +TTA D+W     M E+L    QP F
Sbjct: 170 KASVTRLPIKWMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFF 216

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 46/225 (20%)
Query: 89  VVGTGSFGVVF---QAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDH----PN 136
           V+GTG++G VF   +    +TG++ A+K      ++Q  +         Q+L+H    P 
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLYTYQICR 194
           +V L + F + T                 +N     ++ + QR       V++Y  +I  
Sbjct: 121 LVTLHYAFQTET---------KLHLILDYING-GELFTHLSQRERFTEHEVQIYVGEIVL 170
Query: 195 ALAYIHNCIGICHRDIKPQNLLVKGEPNV--------------------SYICSRYYRAP 234
           AL ++H  +GI +RDIK +N+L+    +V                     +  +  Y AP
Sbjct: 171 ALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 229
Query: 235 ELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEI 278
           +++ G  + +  A+D WS G +M ELL G   F  +   +   EI
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 274

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 94/227 (41%), Gaps = 40/227 (17%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHP 135
            Y    V+G G+FG V   + + + ++ A+K + +       D  +   E  IM   + P
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 135
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
            +V L   F +  D                VN ++ NY      +P  + K YT ++  A
Sbjct: 136 WVVQL---FCAFQDDKYLYMVMEYMPGGDLVNLMS-NYD-----VPEKWAKFYTAEVVLA 186
Query: 196 LAYIHNCIGICHRDIKPQNLLVKGEPNV--------------------SYICSRYYRAPE 235
           L  IH+ +G+ HRD+KP N+L+    ++                    + + +  Y +PE
Sbjct: 187 LDAIHS-MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPE 245
Query: 236 LI---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
           ++    G   Y    D WS G  + E+L+G   F  +S V    +I+
Sbjct: 246 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 292

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 90/220 (40%), Gaps = 43/220 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR----ELQIMQMLD-HPNIVALKHC 143
           V+  G F  V++A+   +G   A+K++L ++  KNR    E+  M+ L  HPNIV     
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL---IYVKLYTYQICRALAYIH 200
                ++                 ++     ++  R PL     +K++ YQ CRA+ ++H
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIF-YQTCRAVQHMH 153
Query: 201 NCIG-ICHRDIKPQNLLVKGE-----------------PNVSYICSR------------- 229
                I HRD+K +NLL+  +                 P+ S+   R             
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 230 -YYRAPELIFGATEYTTA--IDIWSTGCVMAELLLGQPLF 266
             YR PE+I   + +      DIW+ GC++  L   Q  F
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/196 (22%), Positives = 77/196 (39%), Gaps = 32/196 (16%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLDHPNIVALKHCFFS 146
           +G G+FGV    + ++  E+VA+K + + ++      RE+   + L HPNIV  K    +
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 147 TTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
            T                 +    R +S    R        +  Q+   ++Y H  + + 
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGR-FSEDEAR-------FFFQQLISGVSYAH-AMQVA 137
Query: 207 HRDIKPQNLLVKGEPN--------------------VSYICSRYYRAPELIFGATEYTTA 246
           HRD+K +N L+ G P                      S + +  Y APE++         
Sbjct: 138 HRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKV 197
Query: 247 IDIWSTGCVMAELLLG 262
            D+WS G  +  +L+G
Sbjct: 198 ADVWSCGVTLYVMLVG 213

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 40/212 (18%)
Query: 85  IAEHVVGTGSFGVVFQA-KCRETGEI--VAIKKVLQDKRYKNRE-----LQIMQMLDHPN 136
           +   ++G G FG V++       GE   VA+K   +D    N+E       IM+ LDHP+
Sbjct: 27  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 86
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV L        ++                + + RN       + ++ + LY+ QIC+A+
Sbjct: 87  IVKL----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAM 138
Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV---SYICSRY-----------------YRAPEL 236
           AY+ + I   HRDI  +N+LV     V    +  SRY                 + +PE 
Sbjct: 139 AYLES-INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 197
Query: 237 IFGATEYTTAIDIWSTGCVMAELLL--GQPLF 266
           I     +TTA D+W     M E+L    QP F
Sbjct: 198 I-NFRRFTTASDVWMFAVCMWEILSFGKQPFF 228

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 112/285 (39%), Gaps = 65/285 (22%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 137
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS-RIHQRMPLIYVKLYTYQICRAL 196
           V + + F  T DK               +N    +Y    H       ++ Y  +I   L
Sbjct: 255 VCMSYAF-HTPDKLSFILD--------LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 197 AYIHNCIGICHRDIKPQNLLV------------------KGEPNVSYICSRYYRAPELIF 238
            ++HN   + +RD+KP N+L+                  K +P+ S + +  Y APE++ 
Sbjct: 306 EHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 363
Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLF-----PGESGVDQLVEIIKV------------ 281
               Y ++ D +S GC++ +LL G   F       +  +D++   + V            
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 423
Query: 282 -----LGTPTREEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRLPP 320
                L       + C+     E K  P  +   W  VF ++ PP
Sbjct: 424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 121/303 (39%), Gaps = 64/303 (21%)
Query: 75  NGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKV-LQDKRYKNRELQI 128
           N ++K   +Y  +  +G G+F VV +   + TG     +I+  KK+  +D +   RE +I
Sbjct: 22  NASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARI 81
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLY 188
            + L HPNIV L       +                 +  +AR +         I     
Sbjct: 82  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCI----- 134
Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLV----KG------------EPNVS-----YIC 227
             QI  ++AY H+  GI HR++KP+NLL+    KG            E N S     +  
Sbjct: 135 -QQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 192
Query: 228 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 287
           +  Y +PE +     Y+  +DIW+ G ++  LL+G P F  E   DQ             
Sbjct: 193 TPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQ---------HRLY 239
Query: 288 EEIKCMNPNYTEFKFPQIKPHP-WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 346
            +IK    +Y         P P W  V      PEA  L+      +P  R TA +A   
Sbjct: 240 AQIKAGAYDY---------PSPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKV 285
Query: 347 PFF 349
           P+ 
Sbjct: 286 PWI 288

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 112/285 (39%), Gaps = 65/285 (22%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 137
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 195 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 253
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS-RIHQRMPLIYVKLYTYQICRAL 196
           V + + F  T DK               +N    +Y    H       ++ Y  +I   L
Sbjct: 254 VCMSYAF-HTPDKLSFILD--------LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 304
Query: 197 AYIHNCIGICHRDIKPQNLLV------------------KGEPNVSYICSRYYRAPELIF 238
            ++HN   + +RD+KP N+L+                  K +P+ S + +  Y APE++ 
Sbjct: 305 EHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 362
Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLF-----PGESGVDQLVEIIKV------------ 281
               Y ++ D +S GC++ +LL G   F       +  +D++   + V            
Sbjct: 363 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 422
Query: 282 -----LGTPTREEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRLPP 320
                L       + C+     E K  P  +   W  VF ++ PP
Sbjct: 423 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 467

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 107/291 (36%), Gaps = 56/291 (19%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQI-MQMLDHPNIVALK 141
            Y  +  +G GS+ V  +   + T    A+K + + KR    E++I ++   HPNI+ LK
Sbjct: 23  GYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLK 82
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +    D                +++I R      +    +      + I + + Y+H 
Sbjct: 83  DVY---DDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVL-----FTITKTVEYLH- 133
Query: 202 CIGICHRDIKPQNLLV---KGEPNVSYIC--------------------SRYYRAPELIF 238
             G+ HRD+KP N+L     G P    IC                    +  + APE + 
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPE-VL 192
Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 298
               Y  A DIWS G ++   L G   F      D   EI+  +G+              
Sbjct: 193 ERQGYDAACDIWSLGVLLYTXLTGYTPFANGPD-DTPEEILARIGSG------------- 238
Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
             KF  +    W+ V        A DLV +     P+ R TA     HP+ 
Sbjct: 239 --KF-SLSGGYWNSV-----SDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 40/216 (18%)
Query: 85  IAEHVVGTGSFGVVFQA-KCRETGEI--VAIKKVLQDKRYKNRE-----LQIMQMLDHPN 136
           +   ++G G FG V++       GE   VA+K   +D    N+E       IM+ LDHP+
Sbjct: 11  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 70
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV L        ++                + + RN       + ++ + LY+ QIC+A+
Sbjct: 71  IVKL----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAM 122
Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV---SYICSRY-----------------YRAPEL 236
           AY+ + I   HRDI  +N+LV     V    +  SRY                 + +PE 
Sbjct: 123 AYLES-INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 181
Query: 237 IFGATEYTTAIDIWSTGCVMAELLL--GQPLFPGES 270
           I     +TTA D+W     M E+L    QP F  E+
Sbjct: 182 I-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 216

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 109/277 (39%), Gaps = 62/277 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQMLD-HPNIVALKHCFF 145
           +G GSF +  +   +++ +  A+K +   KR +    +E+  +++ + HPNIV L   F 
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQKEITALKLCEGHPNIVKLHEVFH 76
Query: 146 STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
              D+                 RI +           I  KL +     A++++H+ +G+
Sbjct: 77  ---DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS-----AVSHMHD-VGV 127
Query: 206 CHRDIKPQNLLVKGEPN------VSYICSR----------------YYRAPELIFGATEY 243
            HRD+KP+NLL   E +      + +  +R                +Y APEL+     Y
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL-NQNGY 186
Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGES---GVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
             + D+WS G ++  +L GQ  F            VEI+K +                +F
Sbjct: 187 DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK-------------GDF 233
Query: 301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 337
            F   +   W  V Q     EA DL+       PN R
Sbjct: 234 SF---EGEAWKNVSQ-----EAKDLIQGLLTVDPNKR 262

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 112/285 (39%), Gaps = 65/285 (22%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 137
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS-RIHQRMPLIYVKLYTYQICRAL 196
           V + + F  T DK               +N    +Y    H       ++ Y  +I   L
Sbjct: 255 VCMSYAF-HTPDKLSFILD--------LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 197 AYIHNCIGICHRDIKPQNLLV------------------KGEPNVSYICSRYYRAPELIF 238
            ++HN   + +RD+KP N+L+                  K +P+ S + +  Y APE++ 
Sbjct: 306 EHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 363
Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLF-----PGESGVDQLVEIIKV------------ 281
               Y ++ D +S GC++ +LL G   F       +  +D++   + V            
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 423
Query: 282 -----LGTPTREEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRLPP 320
                L       + C+     E K  P  +   W  VF ++ PP
Sbjct: 424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 112/285 (39%), Gaps = 65/285 (22%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 137
           ++G G FG V+  +  +TG++ A+K  L  KR K ++           L ++   D P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYS-RIHQRMPLIYVKLYTYQICRAL 196
           V + + F  T DK               +N    +Y    H       ++ Y  +I   L
Sbjct: 255 VCMSYAF-HTPDKLSFILD--------LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 197 AYIHNCIGICHRDIKPQNLLV------------------KGEPNVSYICSRYYRAPELIF 238
            ++HN   + +RD+KP N+L+                  K +P+ S + +  Y APE++ 
Sbjct: 306 EHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 363
Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLF-----PGESGVDQLVEIIKV------------ 281
               Y ++ D +S GC++ +LL G   F       +  +D++   + V            
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 423
Query: 282 -----LGTPTREEIKCMNPNYTEFK-FPQIKPHPWHKVFQKRLPP 320
                L       + C+     E K  P  +   W  VF ++ PP
Sbjct: 424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/292 (22%), Positives = 115/292 (39%), Gaps = 70/292 (23%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 15  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 74
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           +  F T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 75  YA-FQTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 126
Query: 202 CIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGATE 242
              + +RDIK +NL++  + ++                   ++  +  Y APE +    +
Sbjct: 127 R-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDND 184
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 302
           Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+           
Sbjct: 185 YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR----------- 226
Query: 303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 349
                      F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 227 -----------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 267

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 93/243 (38%), Gaps = 77/243 (31%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLL---------------------------- 216
           V+ Y   + +AL  IH   GI HRD+KP N L                            
Sbjct: 119 VREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLK 177
Query: 217 -VKGEP-------NVSYIC-SRY-----------YRAPELIFGATEYTTAIDIWSTGCVM 256
            V+ E        N   IC SR            +RAPE++      TTAID+WS G + 
Sbjct: 178 FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIF 237
Query: 257 AELLLGQ-PLFPGESGVDQLVEIIKVLGT--------------------PTR------EE 289
             LL G+ P +     +  L +I+ + G+                    P +      E 
Sbjct: 238 LSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCER 297
Query: 290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           ++ M+ +  +     I+ H  +      +P EA DL+ +    +P  R TA EA +HPFF
Sbjct: 298 LRGMDSSTPKLT-SDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFF 356
Query: 350 DEL 352
            ++
Sbjct: 357 KDM 359

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/292 (22%), Positives = 115/292 (39%), Gaps = 70/292 (23%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           +  F T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 72  YA-FQTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 123
Query: 202 CIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGATE 242
              + +RDIK +NL++  + ++                   ++  +  Y APE +    +
Sbjct: 124 R-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDND 181
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 302
           Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+           
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR----------- 223
Query: 303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 349
                      F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 224 -----------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 66/292 (22%), Positives = 115/292 (39%), Gaps = 70/292 (23%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           +  F T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 72  YA-FQTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 123
Query: 202 CIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGATE 242
              + +RDIK +NL++  + ++                   ++  +  Y APE +    +
Sbjct: 124 R-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDND 181
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 302
           Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+           
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR----------- 223
Query: 303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 349
                      F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 224 -----------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 114/292 (39%), Gaps = 70/292 (23%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 17  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 76
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           +  F T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 77  YA-FQTHDR--LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 128
Query: 202 CIGICHRDIKPQNLLVKGEPNVSY----ICSR---------------YYRAPELIFGATE 242
              + +RDIK +NL++  + ++      +C                  Y APE +    +
Sbjct: 129 R-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDND 186
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 302
           Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+           
Sbjct: 187 YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR----------- 228
Query: 303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 349
                      F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 229 -----------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 269

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 114/292 (39%), Gaps = 70/292 (23%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           +  F T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 72  YA-FQTHDR--LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 123
Query: 202 CIGICHRDIKPQNLLVKGEPNVSY----ICSR---------------YYRAPELIFGATE 242
              + +RDIK +NL++  + ++      +C                  Y APE +    +
Sbjct: 124 R-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDND 181
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 302
           Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+           
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR----------- 223
Query: 303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 349
                      F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 224 -----------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 114/292 (39%), Gaps = 70/292 (23%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           +  F T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 72  YA-FQTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 123
Query: 202 CIGICHRDIKPQNLLVKGEPNVSY----ICSR---------------YYRAPELIFGATE 242
              + +RDIK +NL++  + ++      +C                  Y APE +    +
Sbjct: 124 R-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDND 181
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 302
           Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+           
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR----------- 223
Query: 303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 349
                      F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 224 -----------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/306 (21%), Positives = 120/306 (39%), Gaps = 54/306 (17%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCF 144
           +++ V+G G  G V +   R TG+  A+K +    + +       Q    P+IV +   +
Sbjct: 13  LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVY 72
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR----ALAYIH 200
            +                   +      +SRI +R    + +    +I R    A+ ++H
Sbjct: 73  ENMHHGKRCLLIIMECMEGGEL------FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 126
Query: 201 NCIGICHRDIKPQNLLVKGEPNVSYI-------------------C-SRYYRAPELIFGA 240
           +   I HRD+KP+NLL   +   + +                   C + YY APE + G 
Sbjct: 127 SH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPE-VLGP 184
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
            +Y  + D+WS G +M  LL G P F   +G        + +    +  I+       ++
Sbjct: 185 EKYDKSCDMWSLGVIMYILLCGFPPFYSNTG--------QAISPGMKRRIRL-----GQY 231
Query: 301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE-LRDPNTRL 359
            FP  +   W +V +     +A  L+    +  P  R T  +   HP+ ++ +  P T L
Sbjct: 232 GFPNPE---WSEVSE-----DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL 283
Query: 360 PNGRPL 365
              R L
Sbjct: 284 HTARVL 289

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/305 (21%), Positives = 114/305 (37%), Gaps = 74/305 (24%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK------------KVLQDKRYKNRELQIM-Q 130
           Y  + V+G G   VV +   R TG   A+K            ++ + +    RE  I+ Q
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIY--VKLY 188
           +  HP+I+ L   + S++                 + R    +  + +++ L     +  
Sbjct: 156 VAGHPHIITLIDSYESSS----------FMFLVFDLMRKGELFDYLTEKVALSEKETRSI 205
Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVK------------------GEPNVSYICSRY 230
              +  A++++H    I HRD+KP+N+L+                   GE       +  
Sbjct: 206 MRSLLEAVSFLH-ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPG 264
Query: 231 YRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 285
           Y APE++  + +     Y   +D+W+ G ++  LL G P F     +  L  I       
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI------- 317
Query: 286 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 345
                  M   Y +F  P+     W             DL+ R  Q  P  R TA +A  
Sbjct: 318 -------MEGQY-QFSSPE-----WDDR-----SSTVKDLISRLLQVDPEARLTAEQALQ 359
Query: 346 HPFFD 350
           HPFF+
Sbjct: 360 HPFFE 364

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 114/292 (39%), Gaps = 70/292 (23%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG   A+K + ++      E+       +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           +  F T D+                  ++R      +R      + Y  +I  AL Y+H+
Sbjct: 72  YA-FQTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-----ARFYGAEIVSALEYLHS 123
Query: 202 CIGICHRDIKPQNLLVKGEPNVSY----ICSR---------------YYRAPELIFGATE 242
              + +RDIK +NL++  + ++      +C                  Y APE +    +
Sbjct: 124 R-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VLEDND 181
Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 302
           Y  A+D W  G VM E++ G+  F  +   ++L E+I +      EEI+           
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR----------- 223
Query: 303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFF 349
                      F + L PEA  L+    +  P  R       A E   H FF
Sbjct: 224 -----------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 67/306 (21%), Positives = 120/306 (39%), Gaps = 54/306 (17%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCF 144
           +++ V+G G  G V +   R TG+  A+K +    + +       Q    P+IV +   +
Sbjct: 32  LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVY 91
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICR----ALAYIH 200
            +                   +      +SRI +R    + +    +I R    A+ ++H
Sbjct: 92  ENMHHGKRCLLIIMECMEGGEL------FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 201 NCIGICHRDIKPQNLLVKGEPNVSYI-------------------C-SRYYRAPELIFGA 240
           +   I HRD+KP+NLL   +   + +                   C + YY APE + G 
Sbjct: 146 SH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPE-VLGP 203
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
            +Y  + D+WS G +M  LL G P F   +G        + +    +  I+       ++
Sbjct: 204 EKYDKSCDMWSLGVIMYILLCGFPPFYSNTG--------QAISPGMKRRIRL-----GQY 250
Query: 301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE-LRDPNTRL 359
            FP  +   W +V +     +A  L+    +  P  R T  +   HP+ ++ +  P T L
Sbjct: 251 GFPNPE---WSEVSE-----DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL 302
Query: 360 PNGRPL 365
              R L
Sbjct: 303 HTARVL 308

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 79/318 (24%), Positives = 121/318 (38%), Gaps = 77/318 (24%)
Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ----------IMQMLD- 133
           +   V+G G  G V Q   + T E  A+K  LQD     RE++          I++++D 
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALK-XLQDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           + N+ A + C     +                       +SRI  R    + +    +I 
Sbjct: 124 YENLYAGRKCLLIVXECLDG----------------GELFSRIQDRGDQAFTEREASEIX 167
Query: 194 R----ALAYIHNCIGICHRDIKPQNLLVKGE-PN-------------------VSYIC-S 228
           +    A+ Y+H+ I I HRD+KP+NLL   + PN                   ++  C +
Sbjct: 168 KSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 226
Query: 229 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 288
            YY APE + G  +Y  + D WS G +   LL G P F    G      +    G  TR 
Sbjct: 227 PYYVAPE-VLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHG------LAISPGXKTR- 278
Query: 289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
               +     EF  P+     W +V +     E   L+    +  P  R T  E   HP+
Sbjct: 279 ----IRXGQYEFPNPE-----WSEVSE-----EVKXLIRNLLKTEPTQRXTITEFXNHPW 324
Query: 349 FDE-LRDPNTRLPNGRPL 365
             +  + P T L   R L
Sbjct: 325 IXQSTKVPQTPLHTSRVL 342

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 113/287 (39%), Gaps = 63/287 (21%)
Query: 90  VGTGSFGVVFQAKCRETG-----EIVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           +G G+F VV +     TG     +I+  KK+  +D +   RE +I ++L H NIV L   
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
              + +                 + +AR Y         I       QI  A+ + H  +
Sbjct: 72  I--SEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ------QILEAVLHCHQ-M 122
Query: 204 GICHRDIKPQNLL--------------------VKGEPNV--SYICSRYYRAPELIFGAT 241
           G+ HRD+KP+NLL                    V+G+      +  +  Y +PE +    
Sbjct: 123 GVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPE-VLRKE 181
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            Y   +DIW+ G ++  LL+G P F  E    +L + IK                   + 
Sbjct: 182 AYGKPVDIWACGVILYILLVGYPPFWDEDQ-HKLYQQIKA----------------GAYD 224
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
           FP  +   W  V      PEA +L+ +    +P  R TA EA  HP+
Sbjct: 225 FPSPE---WDTV-----TPEAKNLINQMLTINPAKRITAHEALKHPW 263

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 87/228 (38%), Gaps = 68/228 (29%)
Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLV--------------------------- 217
           +KLY  +I +AL Y+   + + H D+KP+N+L+                           
Sbjct: 139 IKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 218 --------------KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 263
                         K + + S I +R YRAPE+I     +  + D+WS GCV+AEL  G 
Sbjct: 198 STGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGS 256
Query: 264 PLFPGESGVDQLVEIIKVL----------GTPTREEIKCMNPNYTEFKFPQ--------- 304
            LF     ++ L  +  ++           T T    K +N +  +  +P+         
Sbjct: 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGS-KYVNKDELKLAWPENASSINSIK 315
Query: 305 --IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
              K  P +K+ +  L     D +    Q  P LR +  E   H F +
Sbjct: 316 HVKKCLPLYKIIKHEL---FCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 77/208 (37%), Gaps = 30/208 (14%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           Y  + V+G+G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPNIV
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           +    F    +                +  I          +    +     ++   L Y
Sbjct: 77  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV------------------------SYICSRYYRAP 234
           +H   G  HRD+K  N+L+  + +V                        +++ +  + AP
Sbjct: 137 LHKN-GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195
Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLG 262
           E++     Y    DIWS G    EL  G
Sbjct: 196 EVMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 113/287 (39%), Gaps = 63/287 (21%)
Query: 90  VGTGSFGVVFQAKCRE-----TGEIVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKHC 143
           +G G+F VV +   +        +I+  KK+  +D +   RE +I ++L HPNIV L   
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
              + +                 + +AR Y         I+      QI  ++ +IH   
Sbjct: 99  I--SEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIH------QILESVNHIHQH- 149
Query: 204 GICHRDIKPQNLL--------------------VKGEPNV--SYICSRYYRAPELIFGAT 241
            I HRD+KP+NLL                    V+GE      +  +  Y +PE +    
Sbjct: 150 DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPE-VLRKD 208
Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            Y   +DIW+ G ++  LL+G P F  E    +L + IK                   + 
Sbjct: 209 PYGKPVDIWACGVILYILLVGYPPFWDEDQ-HKLYQQIKA----------------GAYD 251
Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
           FP  +   W  V      PEA +L+ +    +P  R TA +A  HP+
Sbjct: 252 FPSPE---WDTV-----TPEAKNLINQMLTINPAKRITADQALKHPW 290

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 77/208 (37%), Gaps = 30/208 (14%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           Y  + V+G+G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPNIV
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 71
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           +    F    +                +  I          +    +     ++   L Y
Sbjct: 72  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 131
Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV------------------------SYICSRYYRAP 234
           +H   G  HRD+K  N+L+  + +V                        +++ +  + AP
Sbjct: 132 LHKN-GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 190
Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLG 262
           E++     Y    DIWS G    EL  G
Sbjct: 191 EVMEQVRGYDFKADIWSFGITAIELATG 218

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 83/215 (38%), Gaps = 39/215 (18%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 140
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 77
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 198
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 131
Query: 199 IHNCIGICHRDIKPQNLLVKGEPNVSYICSRYYRA----------PELIFGATEYTTA-- 246
            H   GI HRD+KP N+L+     V  +     RA             + G  +Y +   
Sbjct: 132 SHQN-GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQ 190
Query: 247 ---------IDIWSTGCVMAELLLGQPLFPGESGV 272
                     D++S GCV+ E+L G+P F G+S V
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 68/301 (22%), Positives = 109/301 (36%), Gaps = 67/301 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPNIV 138
           +G+G F +V + + + TG+  A  K ++ +R  +           RE+ I++ + HPNI+
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L   F + TD                 + +A   S             +  QI   + Y
Sbjct: 72  TLHDIFENKTD---VVLILELVSGGELFDFLAEKESLTEDE-----ATQFLKQILDGVHY 123
Query: 199 IHNCIGICHRDIKPQN--LLVKGEPN-----VSY-ICSRYYRAPEL--IFGATEYTT--- 245
           +H+   I H D+KP+N  LL K  PN     + + I  +     E   IFG  E+     
Sbjct: 124 LHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 182
Query: 246 --------AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 297
                     D+WS G +   LL G   F GE+  + L              I  +N ++
Sbjct: 183 VNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT------------NISAVNYDF 230
Query: 298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 357
            E  F                   A D + R     P  R T  ++  H +   +R  N 
Sbjct: 231 DEEYFSNTSEL-------------AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277
Query: 358 R 358
           R
Sbjct: 278 R 278

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/252 (23%), Positives = 106/252 (42%), Gaps = 45/252 (17%)
Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 16  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 132 LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
             +PNIV     +    +                V     +  +I               
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------------- 120
Query: 192 ICR----ALAYIHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICS 228
           +CR    AL ++H+   + HRDIK  N+L+  + +V                   + + +
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 179
Query: 229 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 288
            Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  +
Sbjct: 180 PYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQ 237
Query: 289 EIKCMNPNYTEF 300
             + ++  + +F
Sbjct: 238 NPEKLSAIFRDF 249

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/252 (23%), Positives = 106/252 (42%), Gaps = 45/252 (17%)
Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 16  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 132 LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
             +PNIV     +    +                V     +  +I               
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------------- 120
Query: 192 ICR----ALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----ICSR-------------- 229
           +CR    AL ++H+   + HRDIK  N+L+  + +V       C++              
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGT 179
Query: 230 -YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 288
            Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  +
Sbjct: 180 PYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQ 237
Query: 289 EIKCMNPNYTEF 300
             + ++  + +F
Sbjct: 238 NPEKLSAIFRDF 249

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/252 (23%), Positives = 106/252 (42%), Gaps = 45/252 (17%)
Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 16  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 132 LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
             +PNIV     +    +                V     +  +I               
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------------- 120
Query: 192 ICR----ALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----ICSR-------------- 229
           +CR    AL ++H+   + HRDIK  N+L+  + +V       C++              
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGT 179
Query: 230 -YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 288
            Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  +
Sbjct: 180 PYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQ 237
Query: 289 EIKCMNPNYTEF 300
             + ++  + +F
Sbjct: 238 NPEKLSAIFRDF 249

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/252 (23%), Positives = 106/252 (42%), Gaps = 45/252 (17%)
Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 17  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 132 LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
             +PNIV     +    +                V     +  +I               
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------------- 121
Query: 192 ICR----ALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----ICSR-------------- 229
           +CR    AL ++H+   + HRDIK  N+L+  + +V       C++              
Sbjct: 122 VCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGT 180
Query: 230 -YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 288
            Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  +
Sbjct: 181 PYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQ 238
Query: 289 EIKCMNPNYTEF 300
             + ++  + +F
Sbjct: 239 NPEKLSAIFRDF 250

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 85/216 (39%), Gaps = 41/216 (18%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 140
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 77
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 198
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 131
Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV----------------------SYICSRYYRAPEL 236
            H   GI HRD+KP N+++     V                      + I +  Y +PE 
Sbjct: 132 SHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 272
             G +    + D++S GCV+ E+L G+P F G+S V
Sbjct: 191 ARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 94/220 (42%), Gaps = 37/220 (16%)
Query: 77  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKV-LQDKRYKNRELQIMQ 130
           ++K   +Y  +  +G G+F VV +   + TG     +I+  KK+  +D +   RE +I +
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L HPNIV L       +                 +  +AR +         I       
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCI------Q 112
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLV----KG------------EPNVSYICSRY---- 230
           QI  ++AY H+  GI HR++KP+NLL+    KG            E N S     +    
Sbjct: 113 QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 171
Query: 231 -YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 269
            Y +PE +     Y+  +DIW+ G ++  LL+G P F  E
Sbjct: 172 GYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 210

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 84/214 (39%), Gaps = 41/214 (19%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 140
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 77
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 198
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 131
Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV----------------------SYICSRYYRAPEL 236
            H   GI HRD+KP N+++     V                      + I +  Y +PE 
Sbjct: 132 SHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 270
             G +    + D++S GCV+ E+L G+P F G+S
Sbjct: 191 ARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 94/220 (42%), Gaps = 37/220 (16%)
Query: 77  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKV-LQDKRYKNRELQIMQ 130
           ++K   +Y  +  +G G+F VV +   + TG     +I+  KK+  +D +   RE +I +
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 131 MLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY 190
            L HPNIV L       +                 +  +AR +         I       
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCI------Q 112
Query: 191 QICRALAYIHNCIGICHRDIKPQNLLV----KG------------EPNVSYICSRY---- 230
           QI  ++AY H+  GI HR++KP+NLL+    KG            E N S     +    
Sbjct: 113 QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 171
Query: 231 -YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 269
            Y +PE +     Y+  +DIW+ G ++  LL+G P F  E
Sbjct: 172 GYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 210

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 98/245 (40%), Gaps = 55/245 (22%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 145
           V+G G+FG V +A+        AIKK+   +   +    E+ ++  L+H  +V     + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 146 ---------STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
                    +   K              T+  +  + +   QR    Y +L+  QI  AL
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE--YWRLFR-QILEAL 129
Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV--------------------------------- 223
           +YIH+  GI HRD+KP N+ +    NV                                 
Sbjct: 130 SYIHSQ-GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 224 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 283
           S I +  Y A E++ G   Y   ID++S G +  E+     ++P  +G+++ V I+K L 
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER-VNILKKLR 242
Query: 284 TPTRE 288
           + + E
Sbjct: 243 SVSIE 247

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 86/216 (39%), Gaps = 32/216 (14%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y   + +GTGS+G   + + +  G+I+  K++        +K+    E+ +++ L HPNI
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V         T+                +  +    ++  Q +   +V     Q+  AL 
Sbjct: 68  VRYYDRIIDRTN--TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 198 YIH----NCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAP 234
             H        + HRD+KP N+ + G+ NV                   +++ + YY +P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185
Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 270
           E +     Y    DIWS GC++ EL    P F   S
Sbjct: 186 EQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 75/193 (38%), Gaps = 50/193 (25%)
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--YIC---------------------- 227
           +  AL ++H   GI HRD+KP+N+L +    VS   IC                      
Sbjct: 120 VAAALDFLHT-KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPEL 178
Query: 228 -----SRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD---QL 275
                S  Y APE++      AT Y    D+WS G V+  +L G P F G  G D     
Sbjct: 179 TTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDR 238
Query: 276 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 335
            E+ +V      E I+       +++FP      W       +  EA DL+ +       
Sbjct: 239 GEVCRVCQNKLFESIQ-----EGKYEFPD---KDW-----AHISSEAKDLISKLLVRDAK 285
Query: 336 LRCTALEACVHPF 348
            R +A +   HP+
Sbjct: 286 QRLSAAQVLQHPW 298

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 85/216 (39%), Gaps = 41/216 (18%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 140
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 77
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 198
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 131
Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV----------------------SYICSRYYRAPEL 236
            H   GI HRD+KP N+++     V                      + I +  Y +PE 
Sbjct: 132 SHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 272
             G +    + D++S GCV+ E+L G+P F G+S V
Sbjct: 191 ARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 86/216 (39%), Gaps = 32/216 (14%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y   + +GTGS+G   + + +  G+I+  K++        +K+    E+ +++ L HPNI
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V         T+                +  +    ++  Q +   +V     Q+  AL 
Sbjct: 68  VRYYDRIIDRTN--TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 198 YIH----NCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAP 234
             H        + HRD+KP N+ + G+ NV                   +++ + YY +P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 185
Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 270
           E +     Y    DIWS GC++ EL    P F   S
Sbjct: 186 EQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 98/245 (40%), Gaps = 55/245 (22%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 145
           V+G G+FG V +A+        AIKK+   +   +    E+ ++  L+H  +V     + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 146 ---------STTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
                    +   K              T+  +  + +   QR    Y +L+  QI  AL
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE--YWRLFR-QILEAL 129
Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV--------------------------------- 223
           +YIH+  GI HRD+KP N+ +    NV                                 
Sbjct: 130 SYIHSQ-GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 224 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 283
           S I +  Y A E++ G   Y   ID++S G +  E+     ++P  +G+++ V I+K L 
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER-VNILKKLR 242
Query: 284 TPTRE 288
           + + E
Sbjct: 243 SVSIE 247

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 37/214 (17%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETG-----EIVAIKKV-LQDKRYKNRELQIMQMLDHPN 136
           +Y  +  +G G+F VV +   + TG     +I+  KK+  +D +   RE +I + L HPN
Sbjct: 6   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 65
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV L       +                 +  +AR +         I       QI  ++
Sbjct: 66  IVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCI------QQILESI 117
Query: 197 AYIHNCIGICHRDIKPQNLLV----KG------------EPNVSYICSRY-----YRAPE 235
           AY H+  GI HR++KP+NLL+    KG            E N S     +     Y +PE
Sbjct: 118 AYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 176
Query: 236 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 269
            +     Y+  +DIW+ G ++  LL+G P F  E
Sbjct: 177 -VLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 209

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 85/216 (39%), Gaps = 41/216 (18%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 140
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 77
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 198
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 78  YATGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 131
Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV----------------------SYICSRYYRAPEL 236
            H   GI HRD+KP N+++     V                      + I +  Y +PE 
Sbjct: 132 SHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 272
             G +    + D++S GCV+ E+L G+P F G+S V
Sbjct: 191 ARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 39/164 (23%)
Query: 188 YTYQICRALAYIHN--CIGICHRDIKPQNLLVKGEPNVSYICS-----------RYYR-- 232
           Y++Q+ R + ++ +  CI   HRD+  +N+L+  E NV  IC             Y R  
Sbjct: 204 YSFQVARGMEFLSSRKCI---HRDLAARNILL-SENNVVKICDFGLARDIYKNPDYVRKG 259
Query: 233 ---------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVL 282
                    APE IF    Y+T  D+WS G ++ E+  LG   +PG       V++ +  
Sbjct: 260 DTRLPLKWMAPESIFDKI-YSTKSDVWSYGVLLWEIFSLGGSPYPG-------VQMDEDF 311
Query: 283 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLV 326
            +  RE ++   P Y+  +  QI    WH+  ++R  P   +LV
Sbjct: 312 CSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKER--PRFAELV 353

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/217 (22%), Positives = 85/217 (39%), Gaps = 32/217 (14%)
Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPN 136
            Y   + +GTGS+G   + + +  G+I+  K++        +K+    E+ +++ L HPN
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV         T+                +  +    ++  Q +   +V     Q+  AL
Sbjct: 67  IVRYYDRIIDRTN--TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 197 AYIH----NCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRA 233
              H        + HRD+KP N+ + G+ NV                    ++ + YY +
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMS 184
Query: 234 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 270
           PE +     Y    DIWS GC++ EL    P F   S
Sbjct: 185 PEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 85/216 (39%), Gaps = 41/216 (18%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVAL 140
           ++G G    V  A+       VA+K +  D         R++ RE Q    L+HP IVA+
Sbjct: 36  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAV 94
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAY 198
                + T                T+  I      +H   P+   +        C+AL +
Sbjct: 95  YDTGEAETPAGPLPYIVMEYVDGVTLRDI------VHTEGPMTPKRAIEVIADACQALNF 148
Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV----------------------SYICSRYYRAPEL 236
            H   GI HRD+KP N+++     V                      + I +  Y +PE 
Sbjct: 149 SHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 207
Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 272
             G +    + D++S GCV+ E+L G+P F G+S V
Sbjct: 208 ARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 242

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 24/106 (22%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------------------YIC 227
           +T QI   + + H+ + I HRDIKPQN+L+     +                      + 
Sbjct: 116 FTNQILDGIKHAHD-MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLG 174
Query: 228 SRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 272
           +  Y +PE   G AT+  T  DI+S G V+ E+L+G+P F GE+ V
Sbjct: 175 TVQYFSPEQAKGEATDECT--DIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 93/219 (42%), Gaps = 40/219 (18%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
           V+G GSFG V  ++ + T E+ A+K + +D   ++ +++       ++ +   P  +   
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAYI 199
           H  F T D+               VN     Y  I Q  R    +   Y  +I   L ++
Sbjct: 87  HSCFQTMDRLYFVMEY--------VNGGDLMY-HIQQVGRFKEPHAVFYAAEIAIGLFFL 137
Query: 200 HNCIGICHRDIKPQNLLVKGEPNVS-------------------YICSRYYRAPELIFGA 240
            +  GI +RD+K  N+++  E ++                    +  +  Y APE+I   
Sbjct: 138 QSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-AY 195
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
             Y  ++D W+ G ++ E+L GQ  F GE   D+L + I
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 233

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 93/219 (42%), Gaps = 40/219 (18%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ-------IMQMLDHPNIVALK 141
           V+G GSFG V  ++ + T E+ A+K + +D   ++ +++       ++ +   P  +   
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ--RMPLIYVKLYTYQICRALAYI 199
           H  F T D+               VN     Y  I Q  R    +   Y  +I   L ++
Sbjct: 408 HSCFQTMDRLYFVMEY--------VNGGDLMY-HIQQVGRFKEPHAVFYAAEIAIGLFFL 458
Query: 200 HNCIGICHRDIKPQNLLVKGEPNVS-------------------YICSRYYRAPELIFGA 240
            +  GI +RD+K  N+++  E ++                    +  +  Y APE+I   
Sbjct: 459 QS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-AY 516
Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
             Y  ++D W+ G ++ E+L GQ  F GE   D+L + I
Sbjct: 517 QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI 554

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/252 (22%), Positives = 106/252 (42%), Gaps = 45/252 (17%)
Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQM 131
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++ LQ +  K     E+ +M+ 
Sbjct: 17  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 132 LDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQ 191
             +PNIV     +    +                V     +  +I               
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------------- 121
Query: 192 ICR----ALAYIHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICS 228
           +CR    AL ++H+   + HR+IK  N+L+  + +V                   + + +
Sbjct: 122 VCRECLQALEFLHSN-QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 180
Query: 229 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 288
            Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  +
Sbjct: 181 PYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQ 238
Query: 289 EIKCMNPNYTEF 300
             + ++  + +F
Sbjct: 239 NPEKLSAIFRDF 250

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 67/301 (22%), Positives = 108/301 (35%), Gaps = 67/301 (22%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPNIV 138
           +G+G F +V + + + TG+  A  K ++ +R  +           RE+ I++ + HPNI+
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNII 92
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L   F + TD                 + +A   S             +  QI   + Y
Sbjct: 93  TLHDIFENKTD---VVLILELVSGGELFDFLAEKESLTEDE-----ATQFLKQILDGVHY 144
Query: 199 IHNCIGICHRDIKPQN--LLVKGEPN-----VSY-ICSRYYRAPEL--IFGATEYTT--- 245
           +H+   I H D+KP+N  LL K  PN     + + I  +     E   IFG  E+     
Sbjct: 145 LHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 203
Query: 246 --------AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 297
                     D+WS G +   LL G   F GE+  + L              I  +N ++
Sbjct: 204 VNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT------------NISAVNYDF 251
Query: 298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 357
            E  F                   A D + R     P  R    ++  H +   +R  N 
Sbjct: 252 DEEYFSNTSEL-------------AKDFIRRLLVKDPKRRMXIAQSLEHSWIKAIRRRNV 298
Query: 358 R 358
           R
Sbjct: 299 R 299

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 83/219 (37%), Gaps = 46/219 (21%)
Query: 174 SRIHQRMPL--IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--YIC-- 227
           S IH+R     +   +    +  AL ++HN  GI HRD+KP+N+L +    VS   IC  
Sbjct: 100 SHIHKRRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEHPNQVSPVKICDF 158
Query: 228 -------------------------SRYYRAPELIFGATE----YTTAIDIWSTGCVMAE 258
                                    S  Y APE++   +E    Y    D+WS G ++  
Sbjct: 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYI 218
Query: 259 LLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRL 318
           LL G P F G  G D   +  +    P  + +   +    +++FP      W       +
Sbjct: 219 LLSGYPPFVGRCGSDCGWD--RGEACPACQNMLFESIQEGKYEFPD---KDW-----AHI 268
Query: 319 PPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 357
              A DL+ +        R +A +   HP+       NT
Sbjct: 269 SCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENT 307

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 89/209 (42%), Gaps = 32/209 (15%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNR--ELQIMQMLDHPN 136
           ++   V+G G FG VF  + + TG++ A KK+ + +      Y+    E +I+  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV+L + F + TD                +  +  +     +   +     YT QI   L
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI----FYTAQIVSGL 302
Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELI 237
            ++H    I +RD+KP+N+L+  + NV                    Y  +  + APEL+
Sbjct: 303 EHLHQ-RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 238 FGATEYTTAIDIWSTGCVMAELLLGQPLF 266
            G  EY  ++D ++ G  + E++  +  F
Sbjct: 362 LG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 89/209 (42%), Gaps = 32/209 (15%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNR--ELQIMQMLDHPN 136
           ++   V+G G FG VF  + + TG++ A KK+ + +      Y+    E +I+  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV+L + F + TD                +  +  +     +   +     YT QI   L
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI----FYTAQIVSGL 302
Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELI 237
            ++H    I +RD+KP+N+L+  + NV                    Y  +  + APEL+
Sbjct: 303 EHLHQ-RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 238 FGATEYTTAIDIWSTGCVMAELLLGQPLF 266
            G  EY  ++D ++ G  + E++  +  F
Sbjct: 362 LG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 78/201 (38%), Gaps = 39/201 (19%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIVALKHCF 144
           +G GSFG V++     T E+VAIK +       +     +E+ ++   D P I      +
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPL--IYVKLYTYQICRALAYIHNC 202
             +T                 +           +  PL   Y+     +I + L Y+H+ 
Sbjct: 87  LKSTKLWIIMEYLGGGSALDLL-----------KPGPLEETYIATILREILKGLDYLHSE 135
Query: 203 IGICHRDIKPQNLLVKGEPNVS-------------------YICSRYYRAPELIFGATEY 243
             I HRDIK  N+L+  + +V                    ++ + ++ APE+I   + Y
Sbjct: 136 RKI-HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAY 193
Query: 244 TTAIDIWSTGCVMAELLLGQP 264
               DIWS G    EL  G+P
Sbjct: 194 DFKADIWSLGITAIELAKGEP 214

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 89/209 (42%), Gaps = 32/209 (15%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNR--ELQIMQMLDHPN 136
           ++   V+G G FG VF  + + TG++ A KK+ + +      Y+    E +I+  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV+L + F + TD                +  +  +     +   +     YT QI   L
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI----FYTAQIVSGL 302
Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELI 237
            ++H    I +RD+KP+N+L+  + NV                    Y  +  + APEL+
Sbjct: 303 EHLHQ-RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 238 FGATEYTTAIDIWSTGCVMAELLLGQPLF 266
            G  EY  ++D ++ G  + E++  +  F
Sbjct: 362 LG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 83/219 (37%), Gaps = 46/219 (21%)
Query: 174 SRIHQRMPL--IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--YIC-- 227
           S IH+R     +   +    +  AL ++HN  GI HRD+KP+N+L +    VS   IC  
Sbjct: 100 SHIHKRRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEHPNQVSPVKICDF 158
Query: 228 -------------------------SRYYRAPELIFGATE----YTTAIDIWSTGCVMAE 258
                                    S  Y APE++   +E    Y    D+WS G ++  
Sbjct: 159 GLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYI 218
Query: 259 LLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRL 318
           LL G P F G  G D   +  +    P  + +   +    +++FP      W       +
Sbjct: 219 LLSGYPPFVGRCGSDCGWD--RGEACPACQNMLFESIQEGKYEFPD---KDW-----AHI 268
Query: 319 PPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 357
              A DL+ +        R +A +   HP+       NT
Sbjct: 269 SCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENT 307

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 89/209 (42%), Gaps = 32/209 (15%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNR--ELQIMQMLDHPN 136
           ++   V+G G FG VF  + + TG++ A KK+ + +      Y+    E +I+  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV+L + F + TD                +  +  +     +   +     YT QI   L
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI----FYTAQIVSGL 302
Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELI 237
            ++H    I +RD+KP+N+L+  + NV                    Y  +  + APEL+
Sbjct: 303 EHLHQ-RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 238 FGATEYTTAIDIWSTGCVMAELLLGQPLF 266
            G  EY  ++D ++ G  + E++  +  F
Sbjct: 362 LG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 83/214 (38%), Gaps = 46/214 (21%)
Query: 180 MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------YICSRYY 231
           +P+  +K     +  + +YIHN   ICHRD+KP N+L+     V         Y+  +  
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 232 RA---------PELIFGATEYTTA-IDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 281
           +          PE     + Y  A +DIWS G  +  +      F  +     LVE+   
Sbjct: 208 KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS---LVELFNN 264
Query: 282 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR-------LPPEAVDLVCRFFQYSP 334
           + T   E             +P  + H  + +  K+       L  E +D +  F + +P
Sbjct: 265 IRTKNIE-------------YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNP 311
Query: 335 NLRCTALEACVHPFF-----DELRDPNTRLPNGR 363
             R T+ +A  H +      ++LR+ +  L   R
Sbjct: 312 AERITSEDALKHEWLADTNIEDLREFSKELYKKR 345

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 89/224 (39%), Gaps = 42/224 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPNIV 138
           +G+G F +V + + + TG+  A  K ++ +R  +           RE+ I++ + HPNI+
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L   F + TD                 + +A   S             +  QI   + Y
Sbjct: 79  TLHDIFENKTD---VVLILELVSGGELFDFLAEKESLTEDE-----ATQFLKQILDGVHY 130
Query: 199 IHNCIGICHRDIKPQN--LLVKGEPN-----VSY-ICSRYYRAPEL--IFGATEYTT--- 245
           +H+   I H D+KP+N  LL K  PN     + + I  +     E   IFG  E+     
Sbjct: 131 LHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 189
Query: 246 --------AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 281
                     D+WS G +   LL G   F GE+  + L  I  V
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 233

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 55/219 (25%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL---------QIMQMLDHPNIVAL 140
           +G G FGVVF+AK +      AIK++    R  NREL         + +  L+HP IV  
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKVMREVKALAKLEHPGIVRY 68
Query: 141 KHCFF--STTDKXXXXXXXXXXXXXXTVNR------IARNYSRIHQRMPLIYVKLYTYQI 192
            + +   +TT+K               + R             I +R   + + ++  QI
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF-LQI 127
Query: 193 CRALAYIHNCIGICHRDIKPQNLLVKGE-------------------------PNVSY-- 225
             A+ ++H+  G+ HRD+KP N+    +                         P  +Y  
Sbjct: 128 AEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 226 ----ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 260
               + ++ Y +PE I G + Y+  +DI+S G ++ ELL
Sbjct: 187 HTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELL 224

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 63/146 (43%), Gaps = 24/146 (16%)
Query: 226 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEII 279
           I +R YR+ E++ GA  Y+T  DIWST C+  EL  G  LF   SG       D +  II
Sbjct: 246 IQTRQYRSIEVLIGAG-YSTPADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHII 304
Query: 280 KVLGTPTREEIKCMNPNYTEFKF---------PQIKPHPWHKVFQKRL------PPEAVD 324
           ++LG+  R     ++  Y+   F          ++KP     V  ++         +  D
Sbjct: 305 ELLGSIPRH--FALSGKYSREFFNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQFTD 362
Query: 325 LVCRFFQYSPNLRCTALEACVHPFFD 350
            +    +  P  R +A E   HP+ +
Sbjct: 363 FLIPMLEMVPEKRASAGECLRHPWLN 388

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 76/323 (23%), Positives = 126/323 (39%), Gaps = 68/323 (21%)
Query: 81  KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLD 133
           K ++    V+G G FG V   + R TG++ A KK+ + +  K         E QI++ ++
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
              +V+L + + +                   +      Y       P      Y  +IC
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHI------YHMGQAGFPEARAVFYAAEIC 296
Query: 194 RALAYIHNCIGICHRDIKPQNLLV------------------KGEPNVSYICSRYYRAPE 235
             L  +H    I +RD+KP+N+L+                  +G+     + +  Y APE
Sbjct: 297 CGLEDLHR-ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPE 355
Query: 236 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 295
           ++     YT + D W+ GC++ E++ GQ  F       Q  + IK      REE++ +  
Sbjct: 356 VV-KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERL-- 400
Query: 296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFD 350
                    +K  P  + + +R  P+A  L  +     P  R      +A E   HP F 
Sbjct: 401 ---------VKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449
Query: 351 ELRDPNTRLPNGRPLPPLFNFKP 373
           +L     RL  G   PP   FKP
Sbjct: 450 KLN--FKRLGAGMLEPP---FKP 467

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 83/206 (40%), Gaps = 26/206 (12%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-KNRELQIMQMLDHPNIVALKHCFFSTT 148
           +G GS+G VF+ + +E G + A+K+ +   R  K+R  ++ ++  H  +     C     
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCV--RL 122
Query: 149 DKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHR 208
           ++                  + ++       +P   V  Y      ALA++H+  G+ H 
Sbjct: 123 EQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS-QGLVHL 181
Query: 209 DIKPQNLLV-------------------KGEPNVSYICSRYYRAPELIFGATEYTTAIDI 249
           D+KP N+ +                    G   V     RY  APEL+ G+  Y TA D+
Sbjct: 182 DVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYM-APELLQGS--YGTAADV 238
Query: 250 WSTGCVMAELLLGQPLFPGESGVDQL 275
           +S G  + E+     L  G  G  QL
Sbjct: 239 FSLGLTILEVACNMELPHGGEGWQQL 264

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 111/277 (40%), Gaps = 50/277 (18%)
Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK--------NRELQIMQMLDHP 135
           Y+   ++G GS+G V +    ET    A+K + + K  +         +E+Q+++ L H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 136 NIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           N++ L    ++   +               +       S   +R P+     Y  Q+   
Sbjct: 67  NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLD-----SVPEKRFPVCQAHGYFCQLIDG 121
Query: 196 LAYIHNCIGICHRDIKPQNLLVK--GEPNVSYI-------------------CSRYYRAP 234
           L Y+H+  GI H+DIKP NLL+   G   +S +                    S  ++ P
Sbjct: 122 LEYLHS-QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 235 ELIFGATEYTT-AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV--------LGTP 285
           E+  G   ++   +DIWS G  +  +  G   F G++ + +L E I           G P
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIGKGSYAIPGDCGPP 239
Query: 286 TREEIKCM--NPNYTEFKFPQIKPHPWHKVFQKRLPP 320
             + +K M        F   QI+ H W   F+K+ PP
Sbjct: 240 LSDLLKGMLEYEPAKRFSIRQIRQHSW---FRKKHPP 273

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 76/323 (23%), Positives = 126/323 (39%), Gaps = 68/323 (21%)
Query: 81  KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLD 133
           K ++    V+G G FG V   + R TG++ A KK+ + +  K         E QI++ ++
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242
Query: 134 HPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
              +V+L + + +                   +      Y       P      Y  +IC
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHI------YHMGQAGFPEARAVFYAAEIC 296
Query: 194 RALAYIHNCIGICHRDIKPQNLLV------------------KGEPNVSYICSRYYRAPE 235
             L  +H    I +RD+KP+N+L+                  +G+     + +  Y APE
Sbjct: 297 CGLEDLHR-ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPE 355
Query: 236 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 295
           ++     YT + D W+ GC++ E++ GQ  F       Q  + IK      REE++ +  
Sbjct: 356 VV-KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERL-- 400
Query: 296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFD 350
                    +K  P  + + +R  P+A  L  +     P  R      +A E   HP F 
Sbjct: 401 ---------VKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449
Query: 351 ELRDPNTRLPNGRPLPPLFNFKP 373
           +L     RL  G   PP   FKP
Sbjct: 450 KLN--FKRLGAGMLEPP---FKP 467

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 80/201 (39%), Gaps = 39/201 (19%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIVALKHCF 144
           +G GSFG VF+     T ++VAIK +       +     +E+ ++   D P +      +
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIHNC 202
              T                 +           +  PL   ++ T   +I + L Y+H+ 
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLL-----------EPGPLDETQIATILREILKGLDYLHSE 138
Query: 203 IGICHRDIKPQNLLVK--GEPNVS-----------------YICSRYYRAPELIFGATEY 243
             I HRDIK  N+L+   GE  ++                 ++ + ++ APE+I   + Y
Sbjct: 139 KKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAY 196
Query: 244 TTAIDIWSTGCVMAELLLGQP 264
            +  DIWS G    EL  G+P
Sbjct: 197 DSKADIWSLGITAIELARGEP 217

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/199 (22%), Positives = 77/199 (38%), Gaps = 35/199 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIVALKHCF 144
           +G GSFG VF+     T ++VAIK +       +     +E+ ++   D P +      +
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
              T                 +     + ++I   +          +I + L Y+H+   
Sbjct: 95  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATIL---------REILKGLDYLHSEKK 145
Query: 205 ICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGATEYTT 245
           I HRDIK  N+L+     V                   +++ + ++ APE+I   + Y +
Sbjct: 146 I-HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYDS 203
Query: 246 AIDIWSTGCVMAELLLGQP 264
             DIWS G    EL  G+P
Sbjct: 204 KADIWSLGITAIELARGEP 222

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 18/121 (14%)
Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP-------NVSYICSRY 230
           Q++P+     Y  +I  AL+Y+H+ IG+ + D+KP+N+++  E         VS I S  
Sbjct: 177 QKLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSFG 235
Query: 231 Y-------RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 283
           Y       +APE++   T  T A DI++ G  +A L L  P   G   VD L E   VL 
Sbjct: 236 YLYGTPGFQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRY-VDGLPEDDPVLK 292
Query: 284 T 284
           T
Sbjct: 293 T 293

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/199 (22%), Positives = 77/199 (38%), Gaps = 35/199 (17%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIVALKHCF 144
           +G GSFG VF+     T ++VAIK +       +     +E+ ++   D P +      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
              T                 +     + ++I   +          +I + L Y+H+   
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATIL---------REILKGLDYLHSEKK 125
Query: 205 ICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGATEYTT 245
           I HRDIK  N+L+     V                   +++ + ++ APE+I   + Y +
Sbjct: 126 I-HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYDS 183
Query: 246 AIDIWSTGCVMAELLLGQP 264
             DIWS G    EL  G+P
Sbjct: 184 KADIWSLGITAIELARGEP 202

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 80/201 (39%), Gaps = 39/201 (19%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPNIVALKHCF 144
           +G GSFG VF+     T ++VAIK +       +     +E+ ++   D P +      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIHNC 202
              T                 +           +  PL   ++ T   +I + L Y+H+ 
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLL-----------EPGPLDETQIATILREILKGLDYLHSE 123
Query: 203 IGICHRDIKPQNLLVK--GEPNVS-----------------YICSRYYRAPELIFGATEY 243
             I HRDIK  N+L+   GE  ++                 ++ + ++ APE+I   + Y
Sbjct: 124 KKI-HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAY 181
Query: 244 TTAIDIWSTGCVMAELLLGQP 264
            +  DIWS G    EL  G+P
Sbjct: 182 DSKADIWSLGITAIELARGEP 202

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 61/146 (41%), Gaps = 24/146 (16%)
Query: 226 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEII 279
           I +R YR+ E++ G+  Y T  DIWST C+  EL  G  LF   SG       D +  II
Sbjct: 254 IQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALII 312
Query: 280 KVLGTPTREEIKCMNPNYTEFKFPQ-------IKPHPWHKV--------FQKRLPPEAVD 324
           ++LG   R+ I  +   Y++  F +        K  PW           + +       D
Sbjct: 313 ELLGKVPRKLI--VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTD 370
Query: 325 LVCRFFQYSPNLRCTALEACVHPFFD 350
            +    +  P  R TA E   HP+ +
Sbjct: 371 FLLPMLELIPEKRATAAECLRHPWLN 396

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 61/146 (41%), Gaps = 24/146 (16%)
Query: 226 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEII 279
           I +R YR+ E++ G+  Y T  DIWST C+  EL  G  LF   SG       D +  II
Sbjct: 238 IQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALII 296
Query: 280 KVLGTPTREEIKCMNPNYTEFKFPQ-------IKPHPWHKV--------FQKRLPPEAVD 324
           ++LG   R+ I  +   Y++  F +        K  PW           + +       D
Sbjct: 297 ELLGKVPRKLI--VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTD 354
Query: 325 LVCRFFQYSPNLRCTALEACVHPFFD 350
            +    +  P  R TA E   HP+ +
Sbjct: 355 FLLPMLELIPEKRATAAECLRHPWLN 380

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 46/226 (20%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 18  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 75  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 126
Query: 197 AYIHNCIGICHRDIKPQNLLVKG----EPNVSYICSRYYRAPEL------IFGATEYTT- 245
            Y+H  + I H D+KP+N+++      +P +  I        +       IFG  E+   
Sbjct: 127 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185
Query: 246 ----------AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 281
                       D+WS G +   LL G   F G++  + L  +  V
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 46/226 (20%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 18  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 75  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 126
Query: 197 AYIHNCIGICHRDIKPQNLLVKG----EPNVSYICSRYYRAPEL------IFGATEYTT- 245
            Y+H  + I H D+KP+N+++      +P +  I        +       IFG  E+   
Sbjct: 127 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185
Query: 246 ----------AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 281
                       D+WS G +   LL G   F G++  + L  +  V
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 46/226 (20%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGKFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLVKG----EPNVSYICSRYYRAPEL------IFGATEYTT- 245
            Y+H  + I H D+KP+N+++      +P +  I        +       IFG  E+   
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 246 ----------AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 281
                       D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 46/226 (20%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLVKG----EPNVSYICSRYYRAPEL------IFGATEYTT- 245
            Y+H  + I H D+KP+N+++      +P +  I        +       IFG  E+   
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 246 ----------AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 281
                       D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 46/226 (20%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLVKG----EPNVSYICSRYYRAPEL------IFGATEYTT- 245
            Y+H  + I H D+KP+N+++      +P +  I        +       IFG  E+   
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 246 ----------AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 281
                       D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 46/226 (20%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLVKG----EPNVSYICSRYYRAPEL------IFGATEYTT- 245
            Y+H  + I H D+KP+N+++      +P +  I        +       IFG  E+   
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 246 ----------AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 281
                       D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 75/343 (21%), Positives = 134/343 (39%), Gaps = 71/343 (20%)
Query: 89  VVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVAL 140
           V+G G      V  A+ + TGE V ++++  +        +   EL + ++ +HPNIV  
Sbjct: 16  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 75
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           +  F +  +                 + I  ++      + + Y+      + +AL YIH
Sbjct: 76  RATFIADNELWVVTSFMAYGSAK---DLICTHFMDGMNELAIAYI---LQGVLKALDYIH 129
Query: 201 NCIGICHRDIKPQNLLVKGE---------PNVSYICS-----------RY------YRAP 234
           + +G  HR +K  ++L+  +          N+S I             +Y      + +P
Sbjct: 130 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 188
Query: 235 ELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK-----VLGTPT-- 286
           E++    + Y    DI+S G    EL  G   F        L+E +      +L T T  
Sbjct: 189 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 248
Query: 287 REEIKCMNPNYT--------EFKFPQIKP-------HPWHKVFQKRLPPEAVDLVCRFFQ 331
            EE+  M+P+ +               +P       HP+H+ F     P     V +  Q
Sbjct: 249 AEEL-TMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFS----PHFHHFVEQCLQ 303
Query: 332 YSPNLRCTALEACVHPFFDEL-RDPNTRLPN-GRPLPPLFNFK 372
            +P+ R +A     H FF ++ R  +  LP   RP+ P+ NF+
Sbjct: 304 RNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFE 346

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 46/226 (20%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILIGELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLVKG----EPNVSYICSRYYRAPEL------IFGATEYTT- 245
            Y+H  + I H D+KP+N+++      +P +  I        +       IFG  E+   
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 246 ----------AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 281
                       D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 46/226 (20%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLVKG----EPNVSYICSRYYRAPEL------IFGATEYTT- 245
            Y+H  + I H D+KP+N+++      +P +  I        +       IFG  E+   
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 246 ----------AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 281
                       D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 46/226 (20%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLVKG----EPNVSYICSRYYRAPEL------IFGATEYTT- 245
            Y+H  + I H D+KP+N+++      +P +  I        +       IFG  E+   
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 246 ----------AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 281
                       D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 75/343 (21%), Positives = 134/343 (39%), Gaps = 71/343 (20%)
Query: 89  VVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVAL 140
           V+G G      V  A+ + TGE V ++++  +        +   EL + ++ +HPNIV  
Sbjct: 32  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           +  F +  +                 + I  ++      + + Y+      + +AL YIH
Sbjct: 92  RATFIADNE---LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIH 145
Query: 201 NCIGICHRDIKPQNLLVKGE---------PNVSYICS-----------RY------YRAP 234
           + +G  HR +K  ++L+  +          N+S I             +Y      + +P
Sbjct: 146 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 235 ELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK-----VLGTPT-- 286
           E++    + Y    DI+S G    EL  G   F        L+E +      +L T T  
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264
Query: 287 REEIKCMNPNYT--------EFKFPQIKP-------HPWHKVFQKRLPPEAVDLVCRFFQ 331
            EE+  M+P+ +               +P       HP+H+ F     P     V +  Q
Sbjct: 265 AEEL-TMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFS----PHFHHFVEQCLQ 319
Query: 332 YSPNLRCTALEACVHPFFDEL-RDPNTRLPN-GRPLPPLFNFK 372
            +P+ R +A     H FF ++ R  +  LP   RP+ P+ NF+
Sbjct: 320 RNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFE 362

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 79  KQKVSYIAEHVVGTGSFGVVFQAKCR------ETGEIVAIKKVLQD----KRYKNRELQI 128
           ++ + YI++  +G G+FG V    CR       TG +VA+K++       +R   RE+QI
Sbjct: 9   ERHLKYISQ--LGKGNFGSV--ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 64
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKL 187
           ++ L    IV  +   +    +                +   R++ + H+ R+    + L
Sbjct: 65  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP------SGCLRDFLQRHRARLDASRLLL 118
Query: 188 YTYQICRALAYIHN--CIGICHRDIKPQNLLVKGEPNV---------------SYICSR- 229
           Y+ QIC+ + Y+ +  C+   HRD+  +N+LV+ E +V                Y   R 
Sbjct: 119 YSSQICKGMEYLGSRRCV---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE 175
Query: 230 ------YYRAPELIFGATEYTTAIDIWSTGCVMAELL 260
                 ++ APE +     ++   D+WS G V+ EL 
Sbjct: 176 PGQSPIFWYAPESL-SDNIFSRQSDVWSFGVVLYELF 211

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 46/226 (20%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLVKG----EPNVSYICSRYYRAPEL------IFGATEYTT- 245
            Y+H  + I H D+KP+N+++      +P +  I        +       IFG  E+   
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 246 ----------AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 281
                       D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 46/226 (20%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLVKG----EPNVSYICSRYYRAPEL------IFGATEYTT- 245
            Y+H  + I H D+KP+N+++      +P +  I        +       IFG  E+   
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 246 ----------AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 281
                       D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 79  KQKVSYIAEHVVGTGSFGVVFQAKCR------ETGEIVAIKKVLQD----KRYKNRELQI 128
           ++ + YI++  +G G+FG V    CR       TG +VA+K++       +R   RE+QI
Sbjct: 10  ERHLKYISQ--LGKGNFGSV--ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 65
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKL 187
           ++ L    IV  +   +    +                +   R++ + H+ R+    + L
Sbjct: 66  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP------SGCLRDFLQRHRARLDASRLLL 119
Query: 188 YTYQICRALAYIHN--CIGICHRDIKPQNLLVKGEPNV---------------SYICSR- 229
           Y+ QIC+ + Y+ +  C+   HRD+  +N+LV+ E +V                Y   R 
Sbjct: 120 YSSQICKGMEYLGSRRCV---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE 176
Query: 230 ------YYRAPELIFGATEYTTAIDIWSTGCVMAELL 260
                 ++ APE +     ++   D+WS G V+ EL 
Sbjct: 177 PGQSPIFWYAPESL-SDNIFSRQSDVWSFGVVLYELF 212

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/198 (21%), Positives = 82/198 (41%), Gaps = 36/198 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 149
           +G GSFG V + + ++TG   A+KKV + + ++  EL     L  P IV L    +    
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPL----YGAVR 155
Query: 150 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 209
           +              ++ ++ +    + +   L Y+     Q    L Y+H+   I H D
Sbjct: 156 EGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLHS-RRILHGD 210
Query: 210 IKPQNLLVKGEPNVSYIC-------------------------SRYYRAPELIFGATEYT 244
           +K  N+L+  + + + +C                         +  + APE++ G +   
Sbjct: 211 VKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS-CD 269
Query: 245 TAIDIWSTGCVMAELLLG 262
             +D+WS+ C+M  +L G
Sbjct: 270 AKVDVWSSCCMMLHMLNG 287

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 80/196 (40%), Gaps = 29/196 (14%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 149
           +G GSFG VF+     T ++VAIK +  D      E++ +Q      I  L  C  S   
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQ----EITVLSQCDSSYVT 84
Query: 150 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTY--QICRALAYIHNCIGICH 207
           K                     +   + +  P    ++ T   +I + L Y+H+   I H
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKI-H 143
Query: 208 RDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGATEYTTAID 248
           RDIK  N+L+  + +V                   +++ + ++ APE+I   + Y +  D
Sbjct: 144 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYDSKAD 202
Query: 249 IWSTGCVMAELLLGQP 264
           IWS G    EL  G+P
Sbjct: 203 IWSLGITAIELAKGEP 218

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 95/217 (43%), Gaps = 49/217 (22%)
Query: 79  KQKVSYIAEHVVGTGSFGVVFQAKCR------ETGEIVAIKKVLQD----KRYKNRELQI 128
           ++ + YI++  +G G+FG V    CR       TG +VA+K++       +R   RE+QI
Sbjct: 22  ERHLKYISQ--LGKGNFGSV--ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 77
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKL 187
           ++ L    IV  +   +    +                +   R++ + H+ R+    + L
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP------SGCLRDFLQRHRARLDASRLLL 131
Query: 188 YTYQICRALAYIHN--CIGICHRDIKPQNLLVKGEPNV---------------SYICSR- 229
           Y+ QIC+ + Y+ +  C+   HRD+  +N+LV+ E +V                Y   R 
Sbjct: 132 YSSQICKGMEYLGSRRCV---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE 188
Query: 230 ------YYRAPELIFGATEYTTAIDIWSTGCVMAELL 260
                 ++ APE +     ++   D+WS G V+ EL 
Sbjct: 189 PGQSPIFWYAPESL-SDNIFSRQSDVWSFGVVLYELF 224

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 46/226 (20%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGVFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLVKG----EPNVSYICSRYYRAPEL------IFGATEYTT- 245
            Y+H  + I H D+KP+N+++      +P +  I        +       IFG  E+   
Sbjct: 128 YYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 246 ----------AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 281
                       D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 85/204 (41%), Gaps = 39/204 (19%)
Query: 87  EHVVGTGSFGVVFQAKCRETGE------IVAIKKVLQDKRYKN--RELQIMQMLDHPNIV 138
           E ++G+G  G V   + R  G+      I A+K    +++ ++   E  IM   DHPNI+
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        +              +++   R +      M L+ +      +   + Y
Sbjct: 114 RLE----GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM---LRGVGAGMRY 166
Query: 199 IHNCIGICHRDIKPQNLLV-----------------KGEPNVSYICSR-----YYRAPEL 236
           + + +G  HRD+  +N+LV                 + +P+ +Y  +       + APE 
Sbjct: 167 LSD-LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           I   T +++A D+WS G VM E+L
Sbjct: 226 IAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 90/226 (39%), Gaps = 46/226 (20%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLVKG----EPNVSYICSRYYRAPEL------IFGATEYTT- 245
            Y+H+ + I H D+KP+N+++      +P +  I        +       IFG  E+   
Sbjct: 128 YYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 246 ----------AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 281
                       D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/198 (21%), Positives = 82/198 (41%), Gaps = 36/198 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 149
           +G GSFG V + + ++TG   A+KKV + + ++  EL     L  P IV L    +    
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPL----YGAVR 136
Query: 150 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 209
           +              ++ ++ +    + +   L Y+     Q    L Y+H+   I H D
Sbjct: 137 EGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLHS-RRILHGD 191
Query: 210 IKPQNLLVKGEPNVSYIC-------------------------SRYYRAPELIFGATEYT 244
           +K  N+L+  + + + +C                         +  + APE++ G +   
Sbjct: 192 VKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS-CD 250
Query: 245 TAIDIWSTGCVMAELLLG 262
             +D+WS+ C+M  +L G
Sbjct: 251 AKVDVWSSCCMMLHMLNG 268

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 80/198 (40%), Gaps = 36/198 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 149
           VG GSFG V + K ++TG   A+KKV + + ++  EL     L  P IV L    +    
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPL----YGAVR 136
Query: 150 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 209
           +              ++ ++ +    + +   L Y+     Q    L Y+H    I H D
Sbjct: 137 EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLHT-RRILHGD 191
Query: 210 IKPQNLLVKGEPNVSYIC-------------------------SRYYRAPELIFGATEYT 244
           +K  N+L+  + + + +C                         +  + APE++ G     
Sbjct: 192 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CD 250
Query: 245 TAIDIWSTGCVMAELLLG 262
             +DIWS+ C+M  +L G
Sbjct: 251 AKVDIWSSCCMMLHMLNG 268

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 79/204 (38%), Gaps = 39/204 (19%)
Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           E V+G G FG V   + +  G+    VAIK +      K R     E  IM   DHPNI+
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R   +   R  +I +      I   + Y
Sbjct: 94  HLE----GVVTKCKPVMIITEYMENGSLDAFLR---KNDGRFTVIQLVGMLRGIGSGMKY 146
Query: 199 IHNCIGICHRDIKPQNLLVKG-----------------EPNVSYICSR-----YYRAPEL 236
           + +   + HRD+  +N+LV                   +P  +Y          + APE 
Sbjct: 147 LSDMSAV-HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 205
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           I    ++T+A D+WS G VM E++
Sbjct: 206 I-AYRKFTSASDVWSYGIVMWEVM 228

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 80/198 (40%), Gaps = 36/198 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 149
           VG GSFG V + K ++TG   A+KKV + + ++  EL     L  P IV L    +    
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPL----YGAVR 120
Query: 150 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 209
           +              ++ ++ +    + +   L Y+     Q    L Y+H    I H D
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLHT-RRILHGD 175
Query: 210 IKPQNLLVKGEPNVSYIC-------------------------SRYYRAPELIFGATEYT 244
           +K  N+L+  + + + +C                         +  + APE++ G     
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CD 234
Query: 245 TAIDIWSTGCVMAELLLG 262
             +DIWS+ C+M  +L G
Sbjct: 235 AKVDIWSSCCMMLHMLNG 252

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 104/261 (39%), Gaps = 49/261 (18%)
Query: 90  VGTGSFGVVFQAKC-----RETGEIVAIKKVLQ-----DKRYKNRELQIM-QMLDHPNIV 138
           +G G+FG V +A         T   VA+K + +     + R    EL+I+  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARN----YSRIHQR-MPLIYVKLYTYQIC 193
            L                        T  R  RN    Y  +++  + L ++  Y++Q+ 
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 194 RALAYIHNCIGICHRDIKPQNLLVKGEPNVSYICS-----------RYYR---------- 232
           + + ++ +   I HRD+  +N+L+  E NV  IC             Y R          
Sbjct: 155 KGMEFLASRKXI-HRDLAARNILL-SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 212
Query: 233 -APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEI 290
            APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +      +E  
Sbjct: 213 MAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCRRLKEGT 264
Query: 291 KCMNPNYTEFKFPQIKPHPWH 311
           +   P+YT  +  Q     WH
Sbjct: 265 RMRAPDYTTPEMYQTMLDCWH 285

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 94/245 (38%), Gaps = 55/245 (22%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 145
           V+G G+FG V +A+        AIKK+   +   +    E+ ++  L+H  +V     + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAAWL 72
Query: 146 STTDKXXXXXXXXXXXXXXTVNRIARN---YSRIH------QRMPLIYVKLYTYQICRAL 196
              +                      N   Y  IH      QR    Y +L+  QI  AL
Sbjct: 73  ERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE--YWRLFR-QILEAL 129
Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV--------------------------------- 223
           +YIH+  GI HR++KP N+ +    NV                                 
Sbjct: 130 SYIHSQ-GIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 224 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 283
           S I +  Y A E++ G   Y   ID +S G +  E      ++P  +G ++ V I+K L 
Sbjct: 189 SAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE-----XIYPFSTGXER-VNILKKLR 242
Query: 284 TPTRE 288
           + + E
Sbjct: 243 SVSIE 247

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 86/206 (41%), Gaps = 34/206 (16%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYK-NRELQIMQMLDHPNIVALKHCFF 145
           +VG G++G V++ +  +TG++ AIK   V  D+  +  +E+ +++   H   +A  +  F
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 146 STTDKXXXXXXXXXXXX---XXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
              +                  +V  + +N       +   ++     +I R L+++H  
Sbjct: 91  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH 148
Query: 203 IGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIF----- 238
             + HRDIK QN+L+     V                   ++I + Y+ APE+I      
Sbjct: 149 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENP 207
Query: 239 GATEYTTAIDIWSTGCVMAELLLGQP 264
            AT Y    D+WS G    E+  G P
Sbjct: 208 DAT-YDFKSDLWSLGITAIEMAEGAP 232

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 45/207 (21%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 143
           +G GSFG V +A+    G  VA+K +++   +  R      E+ IM+ L HPNIV     
Sbjct: 45  IGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----L 98
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRI-----ARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           F     +              ++ R+     AR      +R+ +       Y + + + Y
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM------AYDVAKGMNY 152
Query: 199 IHN-CIGICHRDIKPQNLLVKGEPNVS-------------YICSRY------YRAPELIF 238
           +HN    I HRD+K  NLLV  +  V              ++ S+       + APE++ 
Sbjct: 153 LHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLR 212
Query: 239 GATEYTTAIDIWSTGCVMAEL-LLGQP 264
                  + D++S G ++ EL  L QP
Sbjct: 213 DEPSNEKS-DVYSFGVILWELATLQQP 238

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/220 (21%), Positives = 94/220 (42%), Gaps = 43/220 (19%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 20  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 71
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   + K                + +  + ++   +  +   +    Q  R + Y+H  
Sbjct: 72  LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR----QTARGMDYLH-A 126
Query: 203 IGICHRDIKPQNLLVK-------GEPNVSYICSRY--------------YRAPELIF--G 239
             I HRD+K  N+ +        G+  ++ + SR+              + APE+I    
Sbjct: 127 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 186
Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
           +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++E++
Sbjct: 187 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 226

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 67/157 (42%), Gaps = 37/157 (23%)
Query: 180 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYICS--------- 228
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L+  E NV  IC          
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILL-SEKNVVKICDFGLARDIYK 250
Query: 229 --RYYR-----------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 274
              Y R           APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 251 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 303
Query: 275 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 311
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 304 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 339

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 79/204 (38%), Gaps = 39/204 (19%)
Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           E V+G G FG V   + +  G+    VAIK +      K R     E  IM   DHPNI+
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R   +   R  +I +      I   + Y
Sbjct: 73  HLE----GVVTKCKPVMIITEYMENGSLDAFLR---KNDGRFTVIQLVGMLRGIGSGMKY 125
Query: 199 IHNCIGICHRDIKPQNLLVKG-----------------EPNVSYICSR-----YYRAPEL 236
           + + +   HRD+  +N+LV                   +P  +Y          + APE 
Sbjct: 126 LSD-MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 184
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           I    ++T+A D+WS G VM E++
Sbjct: 185 I-AYRKFTSASDVWSYGIVMWEVM 207

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 79/204 (38%), Gaps = 39/204 (19%)
Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           E V+G G FG V   + +  G+    VAIK +      K R     E  IM   DHPNI+
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R   +   R  +I +      I   + Y
Sbjct: 79  HLE----GVVTKCKPVMIITEYMENGSLDAFLR---KNDGRFTVIQLVGMLRGIGSGMKY 131
Query: 199 IHNCIGICHRDIKPQNLLVKG-----------------EPNVSYICSR-----YYRAPEL 236
           + + +   HRD+  +N+LV                   +P  +Y          + APE 
Sbjct: 132 LSD-MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 190
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           I    ++T+A D+WS G VM E++
Sbjct: 191 I-AYRKFTSASDVWSYGIVMWEVM 213

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 67/157 (42%), Gaps = 37/157 (23%)
Query: 180 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYICS--------- 228
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L+  E NV  IC          
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILL-SEKNVVKICDFGLARDIYK 252
Query: 229 --RYYR-----------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 274
              Y R           APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 253 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 305
Query: 275 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 311
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 306 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 341

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 67/157 (42%), Gaps = 37/157 (23%)
Query: 180 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYICS--------- 228
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L+  E NV  IC          
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILL-SEKNVVKICDFGLARDIYK 243
Query: 229 --RYYR-----------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 274
              Y R           APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 244 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 296
Query: 275 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 311
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 297 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 332

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 67/157 (42%), Gaps = 37/157 (23%)
Query: 180 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYICS--------- 228
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L+  E NV  IC          
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILL-SEKNVVKICDFGLARDIYK 245
Query: 229 --RYYR-----------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 274
              Y R           APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 246 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 298
Query: 275 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 311
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 299 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 334

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 80/204 (39%), Gaps = 39/204 (19%)
Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           E V+G G FG V   + +  G+    VAIK +      K R     E  IM   DHPN+V
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        +               ++   R +     +  +I +      I   + Y
Sbjct: 108 HLE----GVVTRGKPVMIVIEFMENGALDAFLRKHD---GQFTVIQLVGMLRGIAAGMRY 160
Query: 199 IHNCIGICHRDIKPQNLLV-----------------KGEPNVSYICSR-----YYRAPEL 236
           + + +G  HRD+  +N+LV                 + +P   Y  +       + APE 
Sbjct: 161 LAD-MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEA 219
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           I    ++T+A D+WS G VM E++
Sbjct: 220 I-QYRKFTSASDVWSYGIVMWEVM 242

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 80/204 (39%), Gaps = 39/204 (19%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 199 IHNCIGICHRDIKPQNLLVKG-----------------EPNVSYICSR-----YYRAPEL 236
           + + +G  HRD+  +N+L+                   +P  +Y          + +PE 
Sbjct: 163 LSD-MGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           I    ++T+A D+WS G V+ E++
Sbjct: 222 I-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/198 (22%), Positives = 80/198 (40%), Gaps = 36/198 (18%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD 149
           +G GSFG V + K ++TG   A+KKV + + ++  EL     L  P IV L    +    
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPL----YGAVR 134
Query: 150 KXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD 209
           +              ++ ++ +    + +   L Y+     Q    L Y+H    I H D
Sbjct: 135 EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLHT-RRILHGD 189
Query: 210 IKPQNLLVKGEPNVSYIC-------------------------SRYYRAPELIFGATEYT 244
           +K  N+L+  + + + +C                         +  + APE++ G     
Sbjct: 190 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CD 248
Query: 245 TAIDIWSTGCVMAELLLG 262
             +DIWS+ C+M  +L G
Sbjct: 249 AKVDIWSSCCMMLHMLNG 266

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 102/264 (38%), Gaps = 56/264 (21%)
Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-----DKRYKNRELQIM-QMLDHPNIVALK 141
            V+   +FG+   A CR     VA+K + +     + R    EL+I+  +  H N+V L 
Sbjct: 44  QVIEADAFGIDKTATCR----TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 99
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMP---------LIYVKLYTYQI 192
                                  T  R  RN    ++  P         L ++  Y++Q+
Sbjct: 100 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQV 159
Query: 193 CRALAYIHN--CIGICHRDIKPQNLLVKGEPNVSYICS-----------RYYR------- 232
            + + ++ +  CI   HRD+  +N+L+  E NV  IC             Y R       
Sbjct: 160 AKGMEFLASRKCI---HRDLAARNILL-SEKNVVKICDFGLARDIYKDPDYVRKGDARLP 215
Query: 233 ----APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTR 287
               APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +      +
Sbjct: 216 LKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCRRLK 267
Query: 288 EEIKCMNPNYTEFKFPQIKPHPWH 311
           E  +   P+YT  +  Q     WH
Sbjct: 268 EGTRMRAPDYTTPEMYQTMLDCWH 291

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 87/207 (42%), Gaps = 45/207 (21%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR------ELQIMQMLDHPNIVALKHC 143
           +G GSFG V +A+    G  VA+K +++   +  R      E+ IM+ L HPNIV     
Sbjct: 45  IGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----L 98
Query: 144 FFSTTDKXXXXXXXXXXXXXXTVNRI-----ARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           F     +              ++ R+     AR      +R+ +       Y + + + Y
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM------AYDVAKGMNY 152
Query: 199 IHN-CIGICHRDIKPQNLLVKGEPNV-------------SYICSRY------YRAPELIF 238
           +HN    I HR++K  NLLV  +  V             +++ S+       + APE++ 
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212
Query: 239 GATEYTTAIDIWSTGCVMAEL-LLGQP 264
                  + D++S G ++ EL  L QP
Sbjct: 213 DEPSNEKS-DVYSFGVILWELATLQQP 238

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 81/204 (39%), Gaps = 39/204 (19%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEXMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 199 IHNCIGICHRDIKPQNLLVKG-----------------EPNVSYICSR-----YYRAPEL 236
           + + +G  HRD+  +N+L+                   +P  +Y          + +PE 
Sbjct: 163 LSD-MGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           I    ++T+A D+WS G V+ E++
Sbjct: 222 I-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 68/157 (43%), Gaps = 37/157 (23%)
Query: 180 MPLIYVKLYTYQICRALAYIHN--CIGICHRDIKPQNLLVKGEPNVSYICS--------- 228
           + L ++  Y++Q+ + + ++ +  CI   HRD+  +N+L+  E NV  IC          
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILL-SEKNVVKICDFGLARDIYK 191
Query: 229 --RYYR-----------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 274
              Y R           APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 192 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 244
Query: 275 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 311
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 245 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 66/157 (42%), Gaps = 37/157 (23%)
Query: 180 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYICS--------- 228
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L+  E NV  IC          
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILL-SEKNVVKICDFGLARDIXK 191
Query: 229 -------------RYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 274
                          + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 192 DPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 244
Query: 275 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 311
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 245 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 66/157 (42%), Gaps = 37/157 (23%)
Query: 180 MPLIYVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYICS--------- 228
           + L ++  Y++Q+ + + ++    CI   HRD+  +N+L+  E NV  IC          
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILL-SEKNVVKICDFGLARDIXK 191
Query: 229 -------------RYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 274
                          + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 192 DPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 244
Query: 275 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 311
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 245 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 67/157 (42%), Gaps = 37/157 (23%)
Query: 180 MPLIYVKLYTYQICRALAYIHN--CIGICHRDIKPQNLLVKGEPNVSYICS--------- 228
           + L ++  Y++Q+ + + ++ +  CI   HRD+  +N+L+  E NV  IC          
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILL-SEKNVVKICDFGLARDIXK 200
Query: 229 -------------RYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 274
                          + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 201 DPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 253
Query: 275 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 311
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 254 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 68/157 (43%), Gaps = 37/157 (23%)
Query: 180 MPLIYVKLYTYQICRALAYIHN--CIGICHRDIKPQNLLVKGEPNVSYICS--------- 228
           + L ++  Y++Q+ + + ++ +  CI   HRD+  +N+L+  E NV  IC          
Sbjct: 182 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLS-EKNVVKICDFGLARDIYK 237
Query: 229 --RYYR-----------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 274
              Y R           APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 238 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 290
Query: 275 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 311
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 291 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 326

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 68/157 (43%), Gaps = 37/157 (23%)
Query: 180 MPLIYVKLYTYQICRALAYIHN--CIGICHRDIKPQNLLVKGEPNVSYICS--------- 228
           + L ++  Y++Q+ + + ++ +  CI   HRD+  +N+L+  E NV  IC          
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILL-SEKNVVKICDFGLARDIYK 200
Query: 229 --RYYR-----------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 274
              Y R           APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 201 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 253
Query: 275 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 311
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 254 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 66/155 (42%), Gaps = 33/155 (21%)
Query: 180 MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYICS----------- 228
           + L ++  Y++Q+ + + ++ +   I HRD+  +N+L+  E NV  IC            
Sbjct: 145 LTLEHLIXYSFQVAKGMEFLASRKXI-HRDLAARNILL-SEKNVVKICDFGLARDIXKDP 202
Query: 229 -----------RYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLV 276
                        + APE IF    YT   D+WS G ++ E+  LG   +PG       V
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 277 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 311
           +I +      +E  +   P+YT  +  Q     WH
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 68/157 (43%), Gaps = 37/157 (23%)
Query: 180 MPLIYVKLYTYQICRALAYIHN--CIGICHRDIKPQNLLVKGEPNVSYICS--------- 228
           + L ++  Y++Q+ + + ++ +  CI   HRD+  +N+L+  E NV  IC          
Sbjct: 136 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILL-SEKNVVKICDFGLARDIYK 191
Query: 229 --RYYR-----------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 274
              Y R           APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 192 DPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 244
Query: 275 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 311
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 245 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 83/202 (41%), Gaps = 40/202 (19%)
Query: 90  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVAL 140
           +G G FG V    +      TGE+VA+K +  D   ++R     E+ I++ L H +I+  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           K C     +K                    R+Y   H  + L  + L+  QIC  +AY+H
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSL------RDYLPRHS-IGLAQLLLFAQQICEGMAYLH 134
Query: 201 NCIGICHRDIKPQNLLVKGEPNVSY----------ICSRYYR------------APELIF 238
           +   I HR++  +N+L+  +  V                YYR            APE + 
Sbjct: 135 SQHYI-HRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL- 192
Query: 239 GATEYTTAIDIWSTGCVMAELL 260
              ++  A D+WS G  + ELL
Sbjct: 193 KEYKFYYASDVWSFGVTLYELL 214

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 80/204 (39%), Gaps = 39/204 (19%)
Query: 87  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           E V+G G FG V   + +  G+    VAIK +      K R     E  IM   DHPNI+
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   +   +   +  +I +      I   + Y
Sbjct: 87  HLE----GVVTKSKPVMIVTEYMENGSLDTFLK---KNDGQFTVIQLVGMLRGISAGMKY 139
Query: 199 IHNCIGICHRDIKPQNLLVKG-----------------EPNVSYICSR-----YYRAPEL 236
           + + +G  HRD+  +N+L+                   +P  +Y          + APE 
Sbjct: 140 LSD-MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 198
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           I    ++T+A D+WS G VM E++
Sbjct: 199 I-AFRKFTSASDVWSYGIVMWEVV 221

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 67/157 (42%), Gaps = 37/157 (23%)
Query: 180 MPLIYVKLYTYQICRALAYIHN--CIGICHRDIKPQNLLVKGEPNVSYICS--------- 228
           + L ++  Y++Q+ + + ++ +  CI   HRD+  +N+L+  E NV  IC          
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILL-SEKNVVKICDFGLARDIXK 200
Query: 229 -------------RYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 274
                          + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 201 DPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 253
Query: 275 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 311
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 254 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 67/157 (42%), Gaps = 37/157 (23%)
Query: 180 MPLIYVKLYTYQICRALAYIHN--CIGICHRDIKPQNLLVKGEPNVSYICS--------- 228
           + L ++  Y++Q+ + + ++ +  CI   HRD+  +N+L+  E NV  IC          
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILL-SEKNVVKICDFGLARDIYK 200
Query: 229 -------------RYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQ 274
                          + APE IF    YT   D+WS G ++ E+  LG   +PG      
Sbjct: 201 DPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 253
Query: 275 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 311
            V+I +      +E  +   P+YT  +  Q     WH
Sbjct: 254 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 80/204 (39%), Gaps = 39/204 (19%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 199 IHNCIGICHRDIKPQNLLVKG-----------------EPNVSYICSR-----YYRAPEL 236
           + + +G  HRD+  +N+L+                   +P  +Y          + +PE 
Sbjct: 163 LSD-MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           I    ++T+A D+WS G V+ E++
Sbjct: 222 I-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 80/204 (39%), Gaps = 39/204 (19%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 199 IHNCIGICHRDIKPQNLLVKG-----------------EPNVSYICSR-----YYRAPEL 236
           + + +G  HRD+  +N+L+                   +P  +Y          + +PE 
Sbjct: 163 LSD-MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           I    ++T+A D+WS G V+ E++
Sbjct: 222 I-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 80/204 (39%), Gaps = 39/204 (19%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 199 IHNCIGICHRDIKPQNLLVKG-----------------EPNVSYICSR-----YYRAPEL 236
           + + +G  HRD+  +N+L+                   +P  +Y          + +PE 
Sbjct: 163 LSD-MGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           I    ++T+A D+WS G V+ E++
Sbjct: 222 I-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 63/331 (19%), Positives = 109/331 (32%), Gaps = 94/331 (28%)
Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------- 123
           G +G+  Q   Y  +  +G GS+GVV  A         A+K + + K  +          
Sbjct: 4   GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63
Query: 124 ---------------------RELQIMQMLDHPNIVALKHCFFSTTDKXXXXXXXXX--- 159
                                +E+ I++ LDHPN+V L        +             
Sbjct: 64  RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123
Query: 160 -XXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVK 218
                 T+  ++ + +R            Y   + + + Y+H    I HRDIKP NLLV 
Sbjct: 124 PVMEVPTLKPLSEDQAR-----------FYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVG 171
Query: 219 GEPNV---SYICSRYYRAPELIFGATEYT------------------TAIDIWSTGCVMA 257
            + ++    +  S  ++  + +   T  T                   A+D+W+ G  + 
Sbjct: 172 EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231
Query: 258 ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 317
             + GQ  F                     E I C++         +IK        Q  
Sbjct: 232 CFVFGQCPF-------------------MDERIMCLH--------SKIKSQALEFPDQPD 264
Query: 318 LPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
           +  +  DL+ R    +P  R    E  +HP+
Sbjct: 265 IAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 81/204 (39%), Gaps = 39/204 (19%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEXMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 199 IHNCIGICHRDIKPQNLLVKG-----------------EPNVSYICSR-----YYRAPEL 236
           + + +G  HRD+  +N+L+                   +P  +Y          + +PE 
Sbjct: 163 LSD-MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           I    ++T+A D+WS G V+ E++
Sbjct: 222 I-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 89/226 (39%), Gaps = 46/226 (20%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHPN 136
           +G+G F VV   KCRE  TG   A  K ++ +R K+           RE+ I++ + HPN
Sbjct: 19  LGSGQFAVV--KKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 137 IVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++ L   + + TD                 + +A   S   +         +  QI   +
Sbjct: 76  VITLHEVYENKTD---VILILELVAGGELFDFLAEKESLTEEE-----ATEFLKQILNGV 127
Query: 197 AYIHNCIGICHRDIKPQNLLVKG----EPNVSYICSRYYRAPEL------IFGATEYTT- 245
            Y+H+ + I H D+KP+N+++      +P +  I        +       IFG   +   
Sbjct: 128 YYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAP 186
Query: 246 ----------AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 281
                       D+WS G +   LL G   F G++  + L  +  V
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 80/204 (39%), Gaps = 39/204 (19%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 199 IHNCIGICHRDIKPQNLLVKG-----------------EPNVSYICSR-----YYRAPEL 236
           + + +G  HRD+  +N+L+                   +P  +Y          + +PE 
Sbjct: 163 LSD-MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           I    ++T+A D+WS G V+ E++
Sbjct: 222 I-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 80/204 (39%), Gaps = 39/204 (19%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 199 IHNCIGICHRDIKPQNLLVKG-----------------EPNVSYICSR-----YYRAPEL 236
           + + +G  HRD+  +N+L+                   +P  +Y          + +PE 
Sbjct: 163 LSD-MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           I    ++T+A D+WS G V+ E++
Sbjct: 222 I-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 87/222 (39%), Gaps = 39/222 (17%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           V+G G+FG V   K + T  I A+K + + +  K  E         ++   D   I AL 
Sbjct: 81  VIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALH 140
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F    D+               +  +    S+   ++P    + Y  ++  A+  IH 
Sbjct: 141 YAF---QDENHLYLVMDYYVGGDLLTLL----SKFEDKLPEDMARFYIGEMVLAIDSIHQ 193
Query: 202 CIGICHRDIKPQNLL--VKGEPNVSYICSRY------------------YRAPELI---- 237
            +   HRDIKP N+L  V G   ++   S                    Y +PE++    
Sbjct: 194 -LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAME 252
Query: 238 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
            G  +Y    D WS G  M E+L G+  F  ES V+   +I+
Sbjct: 253 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 294

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 87/222 (39%), Gaps = 39/222 (17%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           V+G G+FG V   K + T  I A+K + + +  K  E         ++   D   I AL 
Sbjct: 97  VIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALH 156
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           + F    D+               +  +    S+   ++P    + Y  ++  A+  IH 
Sbjct: 157 YAF---QDENHLYLVMDYYVGGDLLTLL----SKFEDKLPEDMARFYIGEMVLAIDSIHQ 209
Query: 202 CIGICHRDIKPQNLL--VKGEPNVSYICSRY------------------YRAPELI---- 237
            +   HRDIKP N+L  V G   ++   S                    Y +PE++    
Sbjct: 210 -LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAME 268
Query: 238 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
            G  +Y    D WS G  M E+L G+  F  ES V+   +I+
Sbjct: 269 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 310

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 94/227 (41%), Gaps = 48/227 (21%)
Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIK--KVLQDKRYK--------NRELQIMQMLDHPNI 137
           +G+G F +V   KCRE  TG   A K  K  Q +  +         RE+ I++ + HPNI
Sbjct: 20  LGSGQFAIV--KKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 138 VALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           + L   + + TD                 + +A+  S + +     ++K    QI   + 
Sbjct: 78  ITLHDVYENRTD---VVLILELVSGGELFDFLAQKES-LSEEEATSFIK----QILDGVN 129
Query: 198 YIHNCIGICHRDIKPQNLLVKGE----PNVSYICSRYYRAPEL--------IFGATEYTT 245
           Y+H    I H D+KP+N+++  +    P++  I   +  A E+        IFG  E+  
Sbjct: 130 YLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLI--DFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 246 -----------AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 281
                        D+WS G +   LL G   F G++  + L  I  V
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 80/204 (39%), Gaps = 39/204 (19%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 110 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 162
Query: 199 IHNCIGICHRDIKPQNLLVKG-----------------EPNVSYICSR-----YYRAPEL 236
           + + +G  HRD+  +N+L+                   +P  +Y          + +PE 
Sbjct: 163 LSD-MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           I    ++T+A D+WS G V+ E++
Sbjct: 222 I-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 80/210 (38%), Gaps = 49/210 (23%)
Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           E V+G G FG V     +  G+    VAIK +      K R     E  IM   DHPN++
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R       +  +I +      I   + Y
Sbjct: 98  HLE----GVVTKSTPVMIITEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKY 150
Query: 199 IHNCIGICHRDIKPQNLLVKGEPNVSYIC-------SRY--------------------- 230
           + + +   HRD+  +N+LV    N + +C       SR+                     
Sbjct: 151 LAD-MNYVHRDLAARNILV----NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 205
Query: 231 YRAPELIFGATEYTTAIDIWSTGCVMAELL 260
           + APE I    ++T+A D+WS G VM E++
Sbjct: 206 WTAPEAI-QYRKFTSASDVWSYGIVMWEVM 234

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 80/204 (39%), Gaps = 39/204 (19%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 48  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 107
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 108 RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 160
Query: 199 IHNCIGICHRDIKPQNLLVKG-----------------EPNVSYICSR-----YYRAPEL 236
           + + +G  HRD+  +N+L+                   +P  +Y          + +PE 
Sbjct: 161 LSD-MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 219
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           I    ++T+A D+WS G V+ E++
Sbjct: 220 I-AYRKFTSASDVWSYGIVLWEVM 242

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 76/200 (38%), Gaps = 38/200 (19%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 78  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 129
Query: 202 CIGICHRDIKPQNLLVKGEPNV---SYICSRY-----------------YRAPELIFGAT 241
                HRDI  +N+LV     V    +  SRY                 + APE I    
Sbjct: 130 -KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFR 187
Query: 242 EYTTAIDIWSTGCVMAELLL 261
            +T+A D+W  G  M E+L+
Sbjct: 188 RFTSASDVWMFGVCMWEILM 207

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 86/203 (42%), Gaps = 40/203 (19%)
Query: 90  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVAL 140
           +G G FG V    +  +   TGE VA+K +  +    +     +E++I++ L H NIV  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNR-IARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           K     T D               ++   + +N ++I+ +  L Y      QIC+ + Y+
Sbjct: 89  KG--ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA----VQICKGMDYL 142
Query: 200 HNCIGICHRDIKPQNLLVKGEPNV---SYICSR-------------------YYRAPELI 237
                  HRD+  +N+LV+ E  V    +  ++                   ++ APE +
Sbjct: 143 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 201
Query: 238 FGATEYTTAIDIWSTGCVMAELL 260
              +++  A D+WS G  + ELL
Sbjct: 202 M-QSKFYIASDVWSFGVTLHELL 223

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 82/202 (40%), Gaps = 40/202 (19%)
Query: 90  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVAL 140
           +G G FG V    +      TGE+VA+K +  D   ++R     E+ I++ L H +I+  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           K C     +K                    R+Y   H  + L  + L+  QIC  +AY+H
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSL------RDYLPRHS-IGLAQLLLFAQQICEGMAYLH 134
Query: 201 NCIGICHRDIKPQNLLVKGEPNVSY----------ICSRYYR------------APELIF 238
               I HR++  +N+L+  +  V                YYR            APE + 
Sbjct: 135 AQHYI-HRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL- 192
Query: 239 GATEYTTAIDIWSTGCVMAELL 260
              ++  A D+WS G  + ELL
Sbjct: 193 KEYKFYYASDVWSFGVTLYELL 214

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 76/200 (38%), Gaps = 38/200 (19%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 80  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 131
Query: 202 CIGICHRDIKPQNLLVKGEPNV---SYICSRY-----------------YRAPELIFGAT 241
                HRDI  +N+LV     V    +  SRY                 + APE I    
Sbjct: 132 -KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFR 189
Query: 242 EYTTAIDIWSTGCVMAELLL 261
            +T+A D+W  G  M E+L+
Sbjct: 190 RFTSASDVWMFGVCMWEILM 209

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 86/203 (42%), Gaps = 40/203 (19%)
Query: 90  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVAL 140
           +G G FG V    +  +   TGE VA+K +  +    +     +E++I++ L H NIV  
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNR-IARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           K     T D               ++   + +N ++I+ +  L Y      QIC+ + Y+
Sbjct: 77  KG--ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA----VQICKGMDYL 130
Query: 200 HNCIGICHRDIKPQNLLVKGEPNV---SYICSR-------------------YYRAPELI 237
                  HRD+  +N+LV+ E  V    +  ++                   ++ APE +
Sbjct: 131 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 189
Query: 238 FGATEYTTAIDIWSTGCVMAELL 260
              +++  A D+WS G  + ELL
Sbjct: 190 M-QSKFYIASDVWSFGVTLHELL 211

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 80/204 (39%), Gaps = 39/204 (19%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 38  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 97
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 98  RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 150
Query: 199 IHNCIGICHRDIKPQNLLVKG-----------------EPNVSYICSR-----YYRAPEL 236
           + + +G  HRD+  +N+L+                   +P  +Y          + +PE 
Sbjct: 151 LSD-MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 209
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           I    ++T+A D+WS G V+ E++
Sbjct: 210 I-AYRKFTSASDVWSYGIVLWEVM 232

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 81/204 (39%), Gaps = 39/204 (19%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 81  RLE----GVVTKSKPVMIVTEXMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 133
Query: 199 IHNCIGICHRDIKPQNLLVKG-----------------EPNVSYICSR-----YYRAPEL 236
           + + +G  HRD+  +N+L+                   +P  +Y          + +PE 
Sbjct: 134 LSD-MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 192
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           I    ++T+A D+WS G V+ E++
Sbjct: 193 I-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 76/200 (38%), Gaps = 38/200 (19%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 81  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 132
Query: 202 CIGICHRDIKPQNLLVKGEPNV---SYICSRY-----------------YRAPELIFGAT 241
                HRDI  +N+LV     V    +  SRY                 + APE I    
Sbjct: 133 -KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFR 190
Query: 242 EYTTAIDIWSTGCVMAELLL 261
            +T+A D+W  G  M E+L+
Sbjct: 191 RFTSASDVWMFGVCMWEILM 210

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/204 (22%), Positives = 84/204 (41%), Gaps = 39/204 (19%)
Query: 87  EHVVGTGSFGVVFQAKCRETGE------IVAIKKVLQDKRYKN--RELQIMQMLDHPNIV 138
           E ++G+G  G V   + R  G+      I A+K    +++ ++   E  IM   DHPNI+
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        +              +++   R +      M L+ +      +   + Y
Sbjct: 114 RLE----GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM---LRGVGAGMRY 166
Query: 199 IHNCIGICHRDIKPQNLLV-----------------KGEPNVSYICSR-----YYRAPEL 236
           + + +G  HRD+  +N+LV                 + +P+ +   +       + APE 
Sbjct: 167 LSD-LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEA 225
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           I   T +++A D+WS G VM E+L
Sbjct: 226 IAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 76/200 (38%), Gaps = 38/200 (19%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 75  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 126
Query: 202 CIGICHRDIKPQNLLVKGEPNV---SYICSRY-----------------YRAPELIFGAT 241
                HRDI  +N+LV     V    +  SRY                 + APE I    
Sbjct: 127 -KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFR 184
Query: 242 EYTTAIDIWSTGCVMAELLL 261
            +T+A D+W  G  M E+L+
Sbjct: 185 RFTSASDVWMFGVCMWEILM 204

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 52/217 (23%)
Query: 82  VSYIA-EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQML 132
           VSY+  E V+G G FG V + + +  G+    VAIK +      + R     E  IM   
Sbjct: 15  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 74
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQ 191
           +HPNI+ L+    ++                   N    ++ R++  +  +I +      
Sbjct: 75  EHPNIIRLEGVVTNSM--------PVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRG 126
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYIC-------SRY-------------- 230
           I   + Y+   +   HRD+  +N+LV    N + +C       SR+              
Sbjct: 127 IASGMRYLAE-MSYVHRDLAARNILV----NSNLVCKVSDFGLSRFLEENSSDPTETSSL 181
Query: 231 -------YRAPELIFGATEYTTAIDIWSTGCVMAELL 260
                  + APE I    ++T+A D WS G VM E++
Sbjct: 182 GGKIPIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 217

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 76/200 (38%), Gaps = 38/200 (19%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 106 GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 157
Query: 202 CIGICHRDIKPQNLLVKGEPNV---SYICSRY-----------------YRAPELIFGAT 241
                HRDI  +N+LV     V    +  SRY                 + APE I    
Sbjct: 158 -KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFR 215
Query: 242 EYTTAIDIWSTGCVMAELLL 261
            +T+A D+W  G  M E+L+
Sbjct: 216 RFTSASDVWMFGVCMWEILM 235

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/222 (22%), Positives = 84/222 (37%), Gaps = 39/222 (17%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNREL-------QIMQMLDHPNIVALK 141
           V+G G+FG V   K +   ++ A+K + + +  K  E         ++   D   I  L 
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL- 139
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           H  F   +               T+       S+   R+P    + Y  ++  A+  +H 
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTL------LSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 202 CIGICHRDIKPQNLLVKGEPNVSY--------------------ICSRYYRAPELI---- 237
            +   HRDIKP N+L+    ++                      + +  Y +PE++    
Sbjct: 194 -LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 252
Query: 238 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
            G   Y    D WS G  M E+L G+  F  ES V+   +I+
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 294

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 80/204 (39%), Gaps = 39/204 (19%)
Query: 87  EHVVGTGSFGVVFQAKCR--ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +     EI VAIK +      K R     E  IM   DHPNI+
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L+        K              +++   R +     +  +I +      I   + Y
Sbjct: 81  RLE----GVVTKSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKY 133
Query: 199 IHNCIGICHRDIKPQNLLVKG-----------------EPNVSYICSR-----YYRAPEL 236
           + + +G  HRD+  +N+L+                   +P  +Y          + +PE 
Sbjct: 134 LSD-MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 192
Query: 237 IFGATEYTTAIDIWSTGCVMAELL 260
           I    ++T+A D+WS G V+ E++
Sbjct: 193 I-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 76/200 (38%), Gaps = 38/200 (19%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 78  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 129
Query: 202 CIGICHRDIKPQNLLVKGEPNV---SYICSRY-----------------YRAPELIFGAT 241
                HRDI  +N+LV     V    +  SRY                 + APE I    
Sbjct: 130 -KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFR 187
Query: 242 EYTTAIDIWSTGCVMAELLL 261
            +T+A D+W  G  M E+L+
Sbjct: 188 RFTSASDVWMFGVCMWEILM 207

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 92/217 (42%), Gaps = 49/217 (22%)
Query: 79  KQKVSYIAEHVVGTGSFGVVFQAKCR------ETGEIVAIKKVLQD----KRYKNRELQI 128
           ++ + YI++  +G G+FG V    CR       TG +VA+K++       +R   RE+QI
Sbjct: 6   ERHLKYISQ--LGKGNFGSV--ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 61
Query: 129 MQMLDHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKL 187
           ++ L    IV  +   +                     +   R++ + H+ R+    + L
Sbjct: 62  LKALHSDFIVKYRGVSYGPG------RPELRLVMEYLPSGCLRDFLQRHRARLDASRLLL 115
Query: 188 YTYQICRALAYIHN--CIGICHRDIKPQNLLVKGEPNVSYI------------------- 226
           Y+ QIC+ + Y+ +  C+   HRD+  +N+LV+ E +V                      
Sbjct: 116 YSSQICKGMEYLGSRRCV---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVRE 172
Query: 227 ---CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL 260
                 ++ APE +     ++   D+WS G V+ EL 
Sbjct: 173 PGQSPIFWYAPESL-SDNIFSRQSDVWSFGVVLYELF 208

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 76/200 (38%), Gaps = 38/200 (19%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 T+                     R YS     + L  + LY YQ+  ALAY+ +
Sbjct: 83  GVI---TENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLES 134
Query: 202 CIGICHRDIKPQNLLVKGEPNV---SYICSRY-----------------YRAPELIFGAT 241
                HRDI  +N+LV     V    +  SRY                 + APE I    
Sbjct: 135 -KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFR 192
Query: 242 EYTTAIDIWSTGCVMAELLL 261
            +T+A D+W  G  M E+L+
Sbjct: 193 RFTSASDVWMFGVCMWEILM 212

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/176 (23%), Positives = 78/176 (44%), Gaps = 25/176 (14%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLV---KGEPNV---------------SYICSR 229
           + +Q+  A+ + HNC G+ HRDIK +N+L+   +GE  +                +  +R
Sbjct: 120 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 178
Query: 230 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTRE 288
            Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  + 
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH 238
Query: 289 EIK-CMNPNYTEF-KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 342
            I+ C+    ++   F +I+ HPW +     LP E  ++        P+ +  ALE
Sbjct: 239 LIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQETAEIHLHSLSPGPS-KAAALE 291

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 94/220 (42%), Gaps = 43/220 (19%)
Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPNIVALKH 142
           +G+GSFG V++ K       VA+K +        Q + +KN E+ +++   H NI+    
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 83
Query: 143 CFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F   + K                + +  + ++   +  LI +     Q  R + Y+H  
Sbjct: 84  LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMK-KLIDI---ARQTARGMDYLH-A 138
Query: 203 IGICHRDIKPQNLLVK-------GEPNVSYICSRY--------------YRAPELIF--G 239
             I HRD+K  N+ +        G+  ++   SR+              + APE+I    
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
           +  Y+   D+++ G V+ EL+ GQ  +   +  DQ++E++
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 52/217 (23%)
Query: 82  VSYIA-EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQML 132
           VSY+  E V+G G FG V + + +  G+    VAIK +      + R     E  IM   
Sbjct: 13  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 72
Query: 133 DHPNIVALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQ 191
           +HPNI+ L+    ++                   N    ++ R++  +  +I +      
Sbjct: 73  EHPNIIRLEGVVTNSM--------PVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRG 124
Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYIC-------SRY-------------- 230
           I   + Y+   +   HRD+  +N+LV    N + +C       SR+              
Sbjct: 125 IASGMRYLAE-MSYVHRDLAARNILV----NSNLVCKVSDFGLSRFLEENSSDPTYTSSL 179
Query: 231 -------YRAPELIFGATEYTTAIDIWSTGCVMAELL 260
                  + APE I    ++T+A D WS G VM E++
Sbjct: 180 GGKIPIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 215

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 103/261 (39%), Gaps = 49/261 (18%)
Query: 90  VGTGSFGVVFQAKC-----RETGEIVAIKKVLQ-----DKRYKNRELQIM-QMLDHPNIV 138
           +G G+FG V +A         T   VA+K + +     + R    EL+I+  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 139 ALKHCFFSTTDKXXXXXXXXXXXXXXTVNRIARN----YSRIHQR-MPLIYVKLYTYQIC 193
            L                        T  R  RN    Y  +++  + L ++  Y++Q+ 
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 194 RALAYIHNCIGICHRDIKPQNLLVKGEPNVSYICS-----------RYYR---------- 232
           + + ++ +   I HRD+  +N+L+  E NV  I              Y R          
Sbjct: 155 KGMEFLASRKXI-HRDLAARNILL-SEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKW 212
Query: 233 -APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEI 290
            APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +      +E  
Sbjct: 213 MAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFXRRLKEGT 264
Query: 291 KCMNPNYTEFKFPQIKPHPWH 311
           +   P+YT  +  Q     WH
Sbjct: 265 RMRAPDYTTPEMYQTMLDCWH 285

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 80/201 (39%), Gaps = 40/201 (19%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYIH 200
                                  T+  + R++ ++ +  + L  + LY YQ+  ALAY+ 
Sbjct: 458 GVITENP--------VWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 201 NCIGICHRDIKPQNLLVKGEPNV---SYICSRY-----------------YRAPELIFGA 240
           +     HRDI  +N+LV     V    +  SRY                 + APE I   
Sbjct: 509 S-KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NF 566
Query: 241 TEYTTAIDIWSTGCVMAELLL 261
             +T+A D+W  G  M E+L+
Sbjct: 567 RRFTSASDVWMFGVCMWEILM 587

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/133 (23%), Positives = 60/133 (45%), Gaps = 9/133 (6%)
Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQ----MLDHPNIVALKHCF 144
           V+G G+F  V   K ++TG++ A+K + +    K  E+   +    +L + +   +    
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 145 FSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
           F+  D+               +  +    S+  +R+P    + Y  +I  A+  +H  +G
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLL----SKFGERIPAEMARFYLAEIVMAIDSVHR-LG 182
Query: 205 ICHRDIKPQNLLV 217
             HRDIKP N+L+
Sbjct: 183 YVHRDIKPDNILL 195

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 76/200 (38%), Gaps = 38/200 (19%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 T+                     R +S     + L  + LY YQ+  ALAY+ +
Sbjct: 78  GVI---TENPVWIIMELCTLGELRSFLQVRKFS-----LDLASLILYAYQLSTALAYLES 129
Query: 202 CIGICHRDIKPQNLLVKGEPNV---SYICSRY-----------------YRAPELIFGAT 241
                HRDI  +N+LV     V    +  SRY                 + APE I    
Sbjct: 130 -KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESI-NFR 187
Query: 242 EYTTAIDIWSTGCVMAELLL 261
            +T+A D+W  G  M E+L+
Sbjct: 188 RFTSASDVWMFGVCMWEILM 207

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 80/202 (39%), Gaps = 40/202 (19%)
Query: 90  VGTGSFGVV----FQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVAL 140
           +G G FG V    +      TGE+VA+K +  D   ++R     E+ I++ L H +I+  
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           K C                           R+Y   H  + L  + L+  QIC  +AY+H
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSL------RDYLPRHS-IGLAQLLLFAQQICEGMAYLH 151
Query: 201 NCIGICHRDIKPQNLLVKG----------------EPNVSYICSR------YYRAPELIF 238
               I HRD+  +N+L+                  E +  Y          ++ APE + 
Sbjct: 152 AQHYI-HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECL- 209
Query: 239 GATEYTTAIDIWSTGCVMAELL 260
              ++  A D+WS G  + ELL
Sbjct: 210 KEYKFYYASDVWSFGVTLYELL 231

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 80/201 (39%), Gaps = 40/201 (19%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALAYIH 200
                                  T+  + R++ ++ +  + L  + LY YQ+  ALAY+ 
Sbjct: 458 GVITENP--------VWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 201 NCIGICHRDIKPQNLLVKGEPNV---SYICSRY-----------------YRAPELIFGA 240
           +     HRDI  +N+LV     V    +  SRY                 + APE I   
Sbjct: 509 S-KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NF 566
Query: 241 TEYTTAIDIWSTGCVMAELLL 261
             +T+A D+W  G  M E+L+
Sbjct: 567 RRFTSASDVWMFGVCMWEILM 587

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 66/144 (45%), Gaps = 22/144 (15%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLV---KGEPNV---------------SYICSR 229
           + +Q+  A+ + HNC G+ HRDIK +N+L+   +GE  +                +  +R
Sbjct: 115 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 173
Query: 230 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTRE 288
            Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  + 
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQH 233
Query: 289 EIK-CMNPNYTEF-KFPQIKPHPW 310
            I+ C+    ++   F +I+ HPW
Sbjct: 234 LIRWCLALRPSDRPTFEEIQNHPW 257

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 66/144 (45%), Gaps = 22/144 (15%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLV---KGEPNV---------------SYICSR 229
           + +Q+  A+ + HNC G+ HRDIK +N+L+   +GE  +                +  +R
Sbjct: 147 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 205
Query: 230 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTRE 288
            Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  + 
Sbjct: 206 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQH 265
Query: 289 EIK-CMNPNYTEF-KFPQIKPHPW 310
            I+ C+    ++   F +I+ HPW
Sbjct: 266 LIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 66/144 (45%), Gaps = 22/144 (15%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLV---KGEPNV---------------SYICSR 229
           + +Q+  A+ + HNC G+ HRDIK +N+L+   +GE  +                +  +R
Sbjct: 147 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 205
Query: 230 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTRE 288
            Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  + 
Sbjct: 206 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQH 265
Query: 289 EIK-CMNPNYTEF-KFPQIKPHPW 310
            I+ C+    ++   F +I+ HPW
Sbjct: 266 LIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 66/144 (45%), Gaps = 22/144 (15%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLV---KGEPNV---------------SYICSR 229
           + +Q+  A+ + HNC G+ HRDIK +N+L+   +GE  +                +  +R
Sbjct: 148 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 206
Query: 230 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTRE 288
            Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  + 
Sbjct: 207 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQH 266
Query: 289 EIK-CMNPNYTEF-KFPQIKPHPW 310
            I+ C+    ++   F +I+ HPW
Sbjct: 267 LIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 66/144 (45%), Gaps = 22/144 (15%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLV---KGEPNV---------------SYICSR 229
           + +Q+  A+ + HNC G+ HRDIK +N+L+   +GE  +                +  +R
Sbjct: 148 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 206
Query: 230 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTRE 288
            Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  + 
Sbjct: 207 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQH 266
Query: 289 EIK-CMNPNYTEF-KFPQIKPHPW 310
            I+ C+    ++   F +I+ HPW
Sbjct: 267 LIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 66/144 (45%), Gaps = 22/144 (15%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLV---KGEPNV---------------SYICSR 229
           + +Q+  A+ + HNC G+ HRDIK +N+L+   +GE  +                +  +R
Sbjct: 162 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 220
Query: 230 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTRE 288
            Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  + 
Sbjct: 221 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH 280
Query: 289 EIK-CMNPNYTEF-KFPQIKPHPW 310
            I+ C+    ++   F +I+ HPW
Sbjct: 281 LIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 66/144 (45%), Gaps = 22/144 (15%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLV---KGEPNV---------------SYICSR 229
           + +Q+  A+ + HNC G+ HRDIK +N+L+   +GE  +                +  +R
Sbjct: 118 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 176
Query: 230 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTRE 288
            Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  + 
Sbjct: 177 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH 236
Query: 289 EIK-CMNPNYTEF-KFPQIKPHPW 310
            I+ C+    ++   F +I+ HPW
Sbjct: 237 LIRWCLALRPSDRPTFEEIQNHPW 260

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 66/144 (45%), Gaps = 22/144 (15%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLV---KGEPNV---------------SYICSR 229
           + +Q+  A+ + HNC G+ HRDIK +N+L+   +GE  +                +  +R
Sbjct: 119 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 177
Query: 230 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTRE 288
            Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  + 
Sbjct: 178 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH 237
Query: 289 EIK-CMNPNYTEF-KFPQIKPHPW 310
            I+ C+    ++   F +I+ HPW
Sbjct: 238 LIRWCLALRPSDRPTFEEIQNHPW 261

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 66/144 (45%), Gaps = 22/144 (15%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLV---KGEPNV---------------SYICSR 229
           + +Q+  A+ + HNC G+ HRDIK +N+L+   +GE  +                +  +R
Sbjct: 115 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 173
Query: 230 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTRE 288
            Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  + 
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH 233
Query: 289 EIK-CMNPNYTEF-KFPQIKPHPW 310
            I+ C+    ++   F +I+ HPW
Sbjct: 234 LIRWCLALRPSDRPTFEEIQNHPW 257

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 76/200 (38%), Gaps = 38/200 (19%)
Query: 90  VGTGSFGVVFQA---KCRETGEIVAIK--KVLQDKRYKNRELQ---IMQMLDHPNIVALK 141
           +G G FG V Q            VAIK  K       + + LQ    M+  DHP+IV L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 142 HCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                 T+                     R +S     + L  + LY YQ+  ALAY+ +
Sbjct: 78  GVI---TENPVWIIMELCTLGELRSFLQVRKFS-----LDLASLILYAYQLSTALAYLES 129
Query: 202 CIGICHRDIKPQNLLVKGEPNV---SYICSRY-----------------YRAPELIFGAT 241
                HRDI  +N+LV     V    +  SRY                 + APE I    
Sbjct: 130 -KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFR 187
Query: 242 EYTTAIDIWSTGCVMAELLL 261
            +T+A D+W  G  M E+L+
Sbjct: 188 RFTSASDVWMFGVCMWEILM 207

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 66/144 (45%), Gaps = 22/144 (15%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLV---KGEPNV---------------SYICSR 229
           + +Q+  A+ + HNC G+ HRDIK +N+L+   +GE  +                +  +R
Sbjct: 119 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 177
Query: 230 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTRE 288
            Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  + 
Sbjct: 178 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH 237
Query: 289 EIK-CMNPNYTEF-KFPQIKPHPW 310
            I+ C+    ++   F +I+ HPW
Sbjct: 238 LIRWCLALRPSDRPTFEEIQNHPW 261

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 66/144 (45%), Gaps = 22/144 (15%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLV---KGEPNV---------------SYICSR 229
           + +Q+  A+ + HNC G+ HRDIK +N+L+   +GE  +                +  +R
Sbjct: 120 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 178
Query: 230 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTRE 288
            Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  + 
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH 238
Query: 289 EIK-CMNPNYTEF-KFPQIKPHPW 310
            I+ C+    ++   F +I+ HPW
Sbjct: 239 LIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 66/144 (45%), Gaps = 22/144 (15%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLV---KGEPNV---------------SYICSR 229
           + +Q+  A+ + HNC G+ HRDIK +N+L+   +GE  +                +  +R
Sbjct: 147 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 205
Query: 230 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTRE 288
            Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  + 
Sbjct: 206 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH 265
Query: 289 EIK-CMNPNYTEF-KFPQIKPHPW 310
            I+ C+    ++   F +I+ HPW
Sbjct: 266 LIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 66/144 (45%), Gaps = 22/144 (15%)
Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLV---KGEPNV---------------SYICSR 229
           + +Q+  A+ + HNC G+ HRDIK +N+L+   +GE  +                +  +R
Sbjct: 162 FFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 220
Query: 230 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTRE 288
            Y  PE I     +  +  +WS G ++ +++ G  P    E  +   V   + + +  + 
Sbjct: 221 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH 280
Query: 289 EIK-CMNPNYTEF-KFPQIKPHPW 310
            I+ C+    ++   F +I+ HPW
Sbjct: 281 LIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 81/202 (40%), Gaps = 40/202 (19%)
Query: 90  VGTGSFGVV----FQAKCRETGEIVAIKKVL-----QDKRYKNRELQIMQMLDHPNIVAL 140
           +G G FG V    +      TGE+VA+K +      Q +    RE++I++ L H +IV  
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 141 KHCFFSTTDKXXXXXXXXXXXXXXTVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           K C     +K                    R+Y   H  + L  + L+  QIC  +AY+H
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSL------RDYLPRHC-VGLAQLLLFAQQICEGMAYLH 128
Query: 201 NCIGICHRDIKPQNLLVKGEPNVSY----------ICSRYYR------------APELIF 238
               I HR +  +N+L+  +  V                YYR            APE + 
Sbjct: 129 AQHYI-HRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL- 186
Query: 239 GATEYTTAIDIWSTGCVMAELL 260
              ++  A D+WS G  + ELL
Sbjct: 187 KECKFYYASDVWSFGVTLYELL 208

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	403
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	0.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	0.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	0.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	0.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-92
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-90
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-90
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-89
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-88
3niz_A	311	Rhodanese family protein; structural genomics, str	8e-87
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-86
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-85
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-84
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-84
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-84
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-83
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-83
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	8e-83
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-82
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-82
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-82
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-81
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-81
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-80
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-80
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-79
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-77
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	9e-76
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-75
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-74
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-72
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-54
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-52
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-51
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-51
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-51
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	8e-50
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	8e-50
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-49
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-48
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-48
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-48
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-47
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	9e-47
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-46
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	9e-46
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-45
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-45
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-45
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-45
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-45
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-45
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-44
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-44
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-44
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-44
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-44
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-44
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-44
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-44
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-43
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-43
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-43
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-43
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-43
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-43
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-42
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-42
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-42
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-42
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-42
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-42
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-42
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-41
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-41
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-41
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-41
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	8e-41
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-40
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-40
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-40
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-40
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-40
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-40
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-40
3bhy_A	283	Death-associated protein kinase 3; death associate	9e-40
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-39
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-39
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-39
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-39
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-39
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-39
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-38
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-38
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-38
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-37
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-37
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-36
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-36
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-36
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-36
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	9e-36
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-35
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-35
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-35
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-35
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-35
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-34
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-34
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-34
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-34
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	7e-34
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-33
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-33
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-33
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-33
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-32
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-32
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-32
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-32
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-32
3fme_A	290	Dual specificity mitogen-activated protein kinase;	9e-32
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-31
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-31
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-31
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-31
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	8e-31
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-30
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-30
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-30
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-30
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-30
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	8e-30
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	8e-30
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-29
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-29
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-29
3aln_A	327	Dual specificity mitogen-activated protein kinase;	9e-29
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-28
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-28
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-28
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-28
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-27
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-27
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-27
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-27
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-26
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-26
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-26
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-25
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-24
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-24
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-24
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-24
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-24
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-24
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-24
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	9e-24
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-24
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-23
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-23
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-23
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-23
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-23
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-22
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-22
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-21
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-21
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-21
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-21
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-21
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	8e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-20
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-20
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-20
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-20
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-20
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-19
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-19
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-19
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-19
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-18
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-18
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-18
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-18
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-18
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-18
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-18
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-18
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-18
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-18
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-18
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-18
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-17
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-17
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-17
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-17
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-17
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-17
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-17
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-17
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-17
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-17
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-16
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-16
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-16
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-16
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-16
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-16
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-16
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-16
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-16
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-15
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-15
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-15
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-15
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-15
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-15
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-15
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	7e-15
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-14
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-14
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-13
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-13
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-13
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-12
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	8e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-09
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	9e-09
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-08
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	6e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-06
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-04

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  572 bits (1476), Expect = 0.0
 Identities = 228/359 (63%), Positives = 272/359 (75%), Gaps = 24/359 (6%)

Query: 57  DGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL 116
           D  G++   V+ T   G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVL
Sbjct: 31  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88

Query: 117 QDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EELYLNLVLEYVPETVNRIARNYSR 175
           QDKR+KNRELQIM+ LDH NIV L++ F+S+ +K +E+YLNLVL+YVPETV R+AR+YSR
Sbjct: 89  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148

Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV------------------ 217
             Q +P+IYVKLY YQ+ R+LAYIH+  GICHRDIKPQNLL+                  
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

Query: 218 -KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 276
            +GEPNVSYICSRYYRAPELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLV
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267

Query: 277 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 336
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327

Query: 337 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQ 395
           R T LEAC H FFDELRDPN +LPNGR  P LFNF   ELS   P     LIP HAR Q
Sbjct: 328 RLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELS-SNPPLATILIPPHARIQ 385

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  570 bits (1470), Expect = 0.0
 Identities = 217/366 (59%), Positives = 271/366 (74%), Gaps = 24/366 (6%)

Query: 52  EPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVA 111
               ++ +      +      G+ G  ++ ++Y    V+G GSFGVVFQAK  E+ E VA
Sbjct: 11  NGVKLNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESDE-VA 68

Query: 112 IKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE-ELYLNLVLEYVPETVNRIA 170
           IKKVLQDKR+KNRELQIM+++ HPN+V LK  F+S  DK+ E++LNLVLEYVPETV R +
Sbjct: 69  IKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRAS 128

Query: 171 RNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV------------- 217
           R+Y+++ Q MP++ +KLY YQ+ R+LAYIH+ IGICHRDIKPQNLL+             
Sbjct: 129 RHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSGVLKLIDFG 187

Query: 218 ------KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 271
                  GEPNVSYICSRYYRAPELIFGAT YTT IDIWSTGCVMAEL+ GQPLFPGESG
Sbjct: 188 SAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG 247

Query: 272 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ 331
           +DQLVEIIKVLGTP+RE+IK MNPNY E KFPQI+PHP+ KVF+ R PP+A+DL+ R  +
Sbjct: 248 IDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLE 307

Query: 332 YSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEH 391
           Y+P+ R TA+EA  HPFFDELR    R+PNGR LPPLFN+   ELS + P+ I+RL+P+H
Sbjct: 308 YTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELS-VRPDLISRLVPQH 366

Query: 392 ARKQNL 397
           A  + L
Sbjct: 367 AEAELL 372

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  544 bits (1405), Expect = 0.0
 Identities = 151/358 (42%), Positives = 212/358 (59%), Gaps = 31/358 (8%)

Query: 64  GHVIRTTIGGRNG--NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY 121
           G ++           + K+   +  E + G G+FG V   K + TG  VAIKKV+QD R+
Sbjct: 3   GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62

Query: 122 KNRELQIMQML---DHPNIVALKHCFFSTT--DKEELYLNLVLEYVPETVNRIARNYSRI 176
           +NRELQIMQ L    HPNIV L+  F++    D+ ++YLN+V+EYVP+T++R  RNY R 
Sbjct: 63  RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122

Query: 177 HQRMPLIYVKLYTYQICRALAYIH-NCIGICHRDIKPQNLLV------------------ 217
               P I +K++ +Q+ R++  +H   + +CHRDIKP N+LV                  
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182

Query: 218 -KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 276
              EPNV+YICSRYYRAPELIFG   YTTA+DIWS GC+ AE++LG+P+F G++   QL 
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242

Query: 277 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK---RLPPEAVDLVCRFFQYS 333
           EI++VLG P+RE ++ +NP++T+      K  PW  VF     +   EA DL+    QY 
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302

Query: 334 PNLRCTALEACVHPFFDELRDPNTRLPNGRPLPP-LFNFKPPELSGIPPETINRLIPE 390
           P  R    EA  HP+FDEL DP T+LPN + LP  LF F P E+  +      +L+ +
Sbjct: 303 PEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  523 bits (1349), Expect = 0.0
 Identities = 159/382 (41%), Positives = 229/382 (59%), Gaps = 62/382 (16%)

Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHP 135
           G       Y     +GTGSFG+V +    E+G+  A+KKVLQD RYKNREL IM++LDH 
Sbjct: 1   GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60

Query: 136 NIVALKHCFFSTTDK---------------------------------EELYLNLVLEYV 162
           NI+ L   F++T D+                                 +  YLN+++EYV
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 163 PETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV----- 217
           P+T++++ +++ R  + +P+  + +Y YQ+ RA+ +IH+ +GICHRDIKPQNLLV     
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICHRDIKPQNLLVNSKDN 179

Query: 218 --------------KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 263
                           EP+V+YICSR+YRAPEL+ GATEYT +ID+WS GCV  EL+LG+
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

Query: 264 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAV 323
           PLF GE+ +DQLV II+++GTPT+E++  MNP+YTE +FP +K   W K+  +  P  A+
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299

Query: 324 DLVCRFFQYSPNLRCTALEACVHPFFDELRDP-------NTRLPNG--RPLPPLFNFKPP 374
           DL+ +  +Y P+LR    EA  HPFFD LR+        N+  P+G  + +P LFNF P 
Sbjct: 300 DLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPY 359

Query: 375 ELSGIPPETINRLIPEHARKQN 396
           ELS IP   +NR++P++     
Sbjct: 360 ELSIIPGNVLNRILPKNFSPNY 381

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  279 bits (716), Expect = 2e-92
 Identities = 99/311 (31%), Positives = 149/311 (47%), Gaps = 39/311 (12%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G GS+GVVF+ + R+TG+IVAIKK L+ +          RE+++++ L HPN+V L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
           F     K  L+L  V EY   TV      Y    + +P   VK  T+Q  +A+ + H   
Sbjct: 71  F---RRKRRLHL--VFEYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKH- 121

Query: 204 GICHRDIKPQNLLV----------------KGEPNVSY---ICSRYYRAPELIFGATEYT 244
              HRD+KP+N+L+                   P+  Y   + +R+YR+PEL+ G T+Y 
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYG 181

Query: 245 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NPNYTEFKF 302
             +D+W+ GCV AELL G PL+PG+S VDQL  I K LG       +    N  ++  K 
Sbjct: 182 PPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI 241

Query: 303 PQIKP-HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPN 361
           P  +   P    F   +   A+ L+       P  R T  +   HP+F+ +R+    L  
Sbjct: 242 PDPEDMEPLELKF-PNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI-EDLAK 299

Query: 362 GRPLPPLFNFK 372
               P    + 
Sbjct: 300 EHDKPAENLYF 310

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  275 bits (705), Expect = 2e-90
 Identities = 91/294 (30%), Positives = 142/294 (48%), Gaps = 38/294 (12%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           VG GS+G+V + + ++TG IVAIKK L+    K       RE+++++ L H N+V L   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
                 K+  YL  V E+V  T+      +      +    V+ Y +QI   + + H+  
Sbjct: 93  C---KKKKRWYL--VFEFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSH- 143

Query: 204 GICHRDIKPQNLLV----------------KGEPNVSY---ICSRYYRAPELIFGATEYT 244
            I HRDIKP+N+LV                   P   Y   + +R+YRAPEL+ G  +Y 
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYG 203

Query: 245 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--EIKCMNPNYTEFKF 302
            A+D+W+ GC++ E+ +G+PLFPG+S +DQL  I+  LG       E+   NP +   + 
Sbjct: 204 KAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRL 263

Query: 303 PQIKPH-PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 355
           P+IK   P  + +  +L    +DL  +     P+ R    E   H FF      
Sbjct: 264 PEIKEREPLERRY-PKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  274 bits (703), Expect = 3e-90
 Identities = 91/321 (28%), Positives = 157/321 (48%), Gaps = 46/321 (14%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLD 133
           +YI    +G G++  V++ K + T  +VA+K++    R ++         RE+ +++ L 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           H NIV L         ++ L L  V EY+ + + +   +       + +  VKL+ +Q+ 
Sbjct: 59  HANIVTLHDII---HTEKSLTL--VFEYLDKDLKQYLDDCG---NIINMHNVKLFLFQLL 110

Query: 194 RALAYIHNCIGICHRDIKPQNLLV----------------KGEPNVSY---ICSRYYRAP 234
           R LAY H    + HRD+KPQNLL+                K  P  +Y   + + +YR P
Sbjct: 111 RGLAYCHRQ-KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPP 169

Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIK 291
           +++ G+T+Y+T ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E    I 
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 229

Query: 292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 351
                +  + +P+ +          RL  +  DL+ +  Q+    R +A +A  HPFF  
Sbjct: 230 SN-EEFKTYNYPKYRAEALLSHA-PRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287

Query: 352 LRDPNTRLPNGRPLPPLFNFK 372
           L +   +LP+   +  L   +
Sbjct: 288 LGERIHKLPDTTSIFALKEIQ 308

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  272 bits (698), Expect = 3e-89
 Identities = 99/309 (32%), Positives = 149/309 (48%), Gaps = 46/309 (14%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVAL 140
           +G G F  V++A+ + T +IVAIKK+    R +          RE++++Q L HPNI+ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
               F         ++LV +++   +  I ++ S     +   ++K Y     + L Y+H
Sbjct: 78  -LDAFGHKSN----ISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLH 129

Query: 201 NCIGICHRDIKPQNLLV----------------KGEPNVSY---ICSRYYRAPELIFGAT 241
               I HRD+KP NLL+                 G PN +Y   + +R+YRAPEL+FGA 
Sbjct: 130 QH-WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 188

Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI---KCMNPNYT 298
            Y   +D+W+ GC++AELLL  P  PG+S +DQL  I + LGTPT EE     C  P+Y 
Sbjct: 189 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLPDYV 247

Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
              F      P H +F      + +DL+   F ++P  R TA +A    +F     P   
Sbjct: 248 T--FKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR--PGPT 302

Query: 359 LPNGRPLPP 367
                P P 
Sbjct: 303 PGCQLPRPN 311

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  265 bits (679), Expect = 8e-87
 Identities = 93/291 (31%), Positives = 154/291 (52%), Gaps = 40/291 (13%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           VG G++GVV++AK    G IVA+K++  D   +       RE+ +++ L HPNIV+L   
Sbjct: 29  VGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
                 +  L L  V E++ + + ++          +    +K+Y YQ+ R +A+ H   
Sbjct: 88  I---HSERCLTL--VFEFMEKDLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQH- 138

Query: 204 GICHRDIKPQNLLV----------------KGEPNVSY---ICSRYYRAPELIFGATEYT 244
            I HRD+KPQNLL+                 G P  SY   + + +YRAP+++ G+ +Y+
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYS 198

Query: 245 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYTEFK 301
           T++DIWS GC+ AE++ G+PLFPG +  DQL +I  +LGTP      +++ + P + +  
Sbjct: 199 TSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL-PLWKQRT 257

Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
           F   +  PW  +       E +DL+     + PN R +A +A  HP+F +L
Sbjct: 258 FQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  263 bits (674), Expect = 9e-86
 Identities = 84/311 (27%), Positives = 142/311 (45%), Gaps = 56/311 (18%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++G V++A    T E VAIK++  +   +       RE+ +++ L H NI+ LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
                    L+L  + EY    + +        +  + +  +K + YQ+   + + H+  
Sbjct: 102 I---HHNHRLHL--IFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR- 151

Query: 204 GICHRDIKPQNLLV---------------------KGEPNVSY---ICSRYYRAPELIFG 239
              HRD+KPQNLL+                      G P   +   I + +YR PE++ G
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPN 296
           +  Y+T++DIWS  C+ AE+L+  PLFPG+S +DQL +I +VLG P       +  + P+
Sbjct: 212 SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL-PD 270

Query: 297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
           + +  FP+ +     +V    L  E +DL+    +  P  R +A  A  HP+F       
Sbjct: 271 WKQS-FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN---- 325

Query: 357 TRLPNGRPLPP 367
                     P
Sbjct: 326 -------DFDP 329

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  260 bits (668), Expect = 2e-85
 Identities = 94/291 (32%), Positives = 148/291 (50%), Gaps = 41/291 (14%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++GVV++A+    GE  A+KK+  +K  +       RE+ I++ L H NIV L   
Sbjct: 10  IGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
                 K+ L L  V E++ + + ++          +  +  K +  Q+   +AY H+  
Sbjct: 69  I---HTKKRLVL--VFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR- 119

Query: 204 GICHRDIKPQNLLV----------------KGEPNVSY---ICSRYYRAPELIFGATEYT 244
            + HRD+KPQNLL+                 G P   Y   I + +YRAP+++ G+ +Y+
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179

Query: 245 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYTEFK 301
           T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +    +  + P Y +  
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKY-DPN 237

Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
           F   +P PW     K L    +DL+ +  +  PN R TA +A  H +F E 
Sbjct: 238 FTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  259 bits (665), Expect = 1e-84
 Identities = 88/315 (27%), Positives = 149/315 (47%), Gaps = 50/315 (15%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVAL 140
           +G G++  V++   + TG  VA+K+V    +  +         RE+ +M+ L H NIV L
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRI--ARNYSRIHQRMPLIYVKLYTYQICRALAY 198
                    + +L L  V E++   + +   +R      + + L  VK + +Q+ + LA+
Sbjct: 69  YDVI---HTENKLTL--VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 199 IHNCIGICHRDIKPQNLLV----------------KGEPNVSY---ICSRYYRAPELIFG 239
            H    I HRD+KPQNLL+                 G P  ++   + + +YRAP+++ G
Sbjct: 124 CHEN-KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG 182

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPN 296
           +  Y+T+IDIWS GC++AE++ G+PLFPG +  +QL  I  ++GTP       +  + P 
Sbjct: 183 SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL-PK 241

Query: 297 YTEFKFPQIKPHPWHKVFQK----RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
           Y      Q  P    +V Q      L    +D +    Q +P++R +A +A  HP+F E 
Sbjct: 242 Y-NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300

Query: 353 RDPNTRLPNGRPLPP 367
                 +   R    
Sbjct: 301 YHH-ASMGGSRSHHH 314

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  257 bits (660), Expect = 3e-84
 Identities = 94/295 (31%), Positives = 147/295 (49%), Gaps = 41/295 (13%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G++G VF+AK RET EIVA+K+V  D   +       RE+ +++ L H NIV L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
                  ++L L  V E+  + + +   + +     +    VK + +Q+ + L + H+  
Sbjct: 70  L---HSDKKLTL--VFEFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR- 120

Query: 204 GICHRDIKPQNLLV----------------KGEPNVSY---ICSRYYRAPELIFGATEYT 244
            + HRD+KPQNLL+                 G P   Y   + + +YR P+++FGA  Y+
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 245 TAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYTEF 300
           T+ID+WS GC+ AEL   G+PLFPG    DQL  I ++LGTPT E    +  + P+Y  +
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL-PDYKPY 239

Query: 301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 355
                       V   +L     DL+    + +P  R +A EA  HP+F +   P
Sbjct: 240 PMYP-ATTSLVNVV-PKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  258 bits (661), Expect = 5e-84
 Identities = 85/315 (26%), Positives = 140/315 (44%), Gaps = 53/315 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQD----KR-YKNRELQIMQMLDHPNI 137
           Y+    +G G  G+VF A   +  + VAIKK+ L D    K     RE++I++ LDH NI
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70

Query: 138 VALKHCF-----------FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVK 186
           V +                S T+   +Y+  V EY+   +  +          +   + +
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYI--VQEYMETDLANVLE-----QGPLLEEHAR 123

Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE----------------PNVS------ 224
           L+ YQ+ R L YIH+   + HRD+KP NL +  E                P+ S      
Sbjct: 124 LFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182

Query: 225 -YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 283
             + +++YR+P L+     YT AID+W+ GC+ AE+L G+ LF G   ++Q+  I++ + 
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242

Query: 284 TPTREEIKCMNPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 341
               E+ + +      +          P  ++    +  EAVD + +   +SP  R TA 
Sbjct: 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSPMDRLTAE 301

Query: 342 EACVHPFFDELRDPN 356
           EA  HP+      P 
Sbjct: 302 EALSHPYMSIYSFPM 316

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  257 bits (659), Expect = 2e-83
 Identities = 83/303 (27%), Positives = 135/303 (44%), Gaps = 42/303 (13%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKNRELQIMQML-DHPNIVAL 140
           Y     +G G +  VF+A      E V +K +  ++ K+ K RE++I++ L   PNI+ L
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK-REIKILENLRGGPNIITL 96

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
                    +       V E+V  T      ++ +++Q +    ++ Y Y+I +AL Y H
Sbjct: 97  ADIVKDPVSRTPAL---VFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDYCH 147

Query: 201 NCIGICHRDIKPQNLLVKGEPNVSYIC-------------------SRYYRAPELIFGAT 241
           +  GI HRD+KP N+++  E     +                    SRY++ PEL+    
Sbjct: 148 SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206

Query: 242 EYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEI--KCMNPNYT 298
            Y  ++D+WS GC++A ++   +P F G    DQLV I KVLGT    +   K       
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266

Query: 299 EFK--FPQIKPHPWHKVF----QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
            F     +     W +      Q  + PEA+D + +  +Y    R TA EA  HP+F  +
Sbjct: 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326

Query: 353 RDP 355
              
Sbjct: 327 VKD 329

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  256 bits (657), Expect = 6e-83
 Identities = 99/348 (28%), Positives = 167/348 (47%), Gaps = 56/348 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-----LQD-KR-YKNRELQIMQMLDHPN 136
           +  + ++G G++GVV  A  + TGEIVAIKK+          R    RE++I++   H N
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70

Query: 137 IVALKHCFFSTTDKE--ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           I+ + +     + +   E+Y+  + E +   ++R+        Q +   +++ + YQ  R
Sbjct: 71  IITIFNIQRPDSFENFNEVYI--IQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLR 123

Query: 195 ALAYIHNCIGICHRDIKPQNLLV-----------------------KGEPNVS------Y 225
           A+  +H    + HRD+KP NLL+                         EP         +
Sbjct: 124 AVKVLHGS-NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182

Query: 226 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 285
           + +R+YRAPE++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GTP
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242

Query: 286 TREEI--KCMNPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 341
             +       +P   E+    P     P  K+F + + P+ +DL+ R   + P  R TA 
Sbjct: 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITAK 301

Query: 342 EACVHPFFDELRDPNTRLPNGRPLPPL-FNFKPPELSGIPPETINRLI 388
           EA  HP+     DPN   P G P+PP  F F       +  + + +LI
Sbjct: 302 EALEHPYLQTYHDPN-DEPEGEPIPPSFFEFD-HYKEALTTKDLKKLI 347

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  256 bits (656), Expect = 8e-83
 Identities = 95/303 (31%), Positives = 155/303 (51%), Gaps = 42/303 (13%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQD----KR-YKNRELQIMQMLDHP 135
           Y++   VG+G++G V  A  + +GE VAIKK+    Q     KR Y  REL +++ + H 
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQHE 83

Query: 136 NIVALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 192
           N++ L   F   +      + YL  V+ ++   + +I      +  +     ++   YQ+
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYL--VMPFMQTDLQKI------MGLKFSEEKIQYLVYQM 135

Query: 193 CRALAYIHNCIGICHRDIKPQNLLVKG---------------EPNVS-YICSRYYRAPEL 236
            + L YIH+  G+ HRD+KP NL V                 +  ++ Y+ +R+YRAPE+
Sbjct: 136 LKGLKYIHSA-GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEV 194

Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-NP 295
           I     Y   +DIWS GC+MAE+L G+ LF G+  +DQL +I+KV G P  E ++ + + 
Sbjct: 195 ILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254

Query: 296 NYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 353
               +    PQ     + ++F  R  P+A DL+ +  +   + R TA +A  HPFF+  R
Sbjct: 255 AAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313

Query: 354 DPN 356
           DP 
Sbjct: 314 DPE 316

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  254 bits (650), Expect = 1e-82
 Identities = 78/300 (26%), Positives = 133/300 (44%), Gaps = 43/300 (14%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQML---DHPNI 137
           +G G++G V++A+   +G  VA+K V                 RE+ +++ L   +HPN+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L     ++    E+ + LV E+V + +             +P   +K    Q  R L 
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQFLRGLD 134

Query: 198 YIHNCIGICHRDIKPQNLLV--KGE-------------PNVSY---ICSRYYRAPELIFG 239
           ++H    I HRD+KP+N+LV   G                ++    + + +YRAPE++  
Sbjct: 135 FLHAN-CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQ 193

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 299
           +T Y T +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++     P    
Sbjct: 194 ST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW----PRDVS 248

Query: 300 ---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
                FP   P P   V    +      L+     ++P+ R +A  A  H +  +  + N
Sbjct: 249 LPRGAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD-EGN 306

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  254 bits (650), Expect = 3e-82
 Identities = 89/326 (27%), Positives = 149/326 (45%), Gaps = 44/326 (13%)

Query: 74  RNGNSKQKVSYIAEHVVGTGSFGVVFQAK-CRETGEIVAIKKVLQDKRYKN-------RE 125
           ++G  +    Y     +G G++G VF+A+  +  G  VA+K+V      +        RE
Sbjct: 3   KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIRE 61

Query: 126 LQIMQML---DHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL 182
           + +++ L   +HPN+V L      +    E  L LV E+V + +             +P 
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPT 119

Query: 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV--KGE-------------PNVSY-- 225
             +K   +Q+ R L ++H+   + HRD+KPQN+LV   G+               ++   
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 178

Query: 226 -ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 284
            + + +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G 
Sbjct: 179 VVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 237

Query: 285 PTREEIKCMNPNYTE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL 341
           P  E+     P         F      P  K     +     DL+ +   ++P  R +A 
Sbjct: 238 PGEEDW----PRDVALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAY 292

Query: 342 EACVHPFFDELRDPNTRLPNGRPLPP 367
            A  HP+F +L      L +   LPP
Sbjct: 293 SALSHPYFQDLERCKENLDS--HLPP 316

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  254 bits (652), Expect = 4e-82
 Identities = 89/335 (26%), Positives = 148/335 (44%), Gaps = 54/335 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------------RELQI 128
           Y  +  + +GS+G V        G  VAIK+V                       RE+++
Sbjct: 24  YTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82

Query: 129 MQMLDHPNIVALKHCF--FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IY 184
           +    HPNI+ L+  F  F      +LYL  V E +   + ++        QR+ +   +
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYL--VTELMRTDLAQVIH-----DQRIVISPQH 135

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKG-----------------EPNVS-YI 226
           ++ + Y I   L  +H   G+ HRD+ P N+L+                   + N + Y+
Sbjct: 136 IQYFMYHILLGLHVLHEA-GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYV 194

Query: 227 CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 286
             R+YRAPEL+     +T  +D+WS GCVMAE+   + LF G +  +QL +I++V+GTP 
Sbjct: 195 THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254

Query: 287 REEIKCM-NP---NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 342
            E++    +P   +Y       +    W  V      P A+DL+ +  +++P  R +  +
Sbjct: 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTEQ 313

Query: 343 ACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELS 377
           A  HP+F+ L DP   L  G      F+F      
Sbjct: 314 ALRHPYFESLFDPL-DLTEGLSER--FHFDESVTD 345

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  254 bits (650), Expect = 1e-81
 Identities = 90/301 (29%), Positives = 149/301 (49%), Gaps = 37/301 (12%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y     VG+G++G V  A    TG  VAIKK+          +   REL++++ + H N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86

Query: 138 VALKHCFF---STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           + L   F    +  D  + YL  V+ ++   + ++ ++     +++    ++   YQ+ +
Sbjct: 87  IGLLDVFTPDETLDDFTDFYL--VMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLK 139

Query: 195 ALAYIHNCIGICHRDIKPQNLLVKG---------------EPNVS-YICSRYYRAPELIF 238
            L YIH   GI HRD+KP NL V                 +  ++ Y+ +R+YRAPE+I 
Sbjct: 140 GLRYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVIL 198

Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-NPNY 297
               YT  +DIWS GC+MAE++ G+ LF G   +DQL EI+KV GTP  E ++ + +   
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258

Query: 298 TEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 355
             +    P+++   +  +      P AV+L+ +        R TA EA  HP+F+ L D 
Sbjct: 259 KNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 317

Query: 356 N 356
            
Sbjct: 318 E 318

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  252 bits (645), Expect = 5e-81
 Identities = 85/307 (27%), Positives = 156/307 (50%), Gaps = 45/307 (14%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--LQD----KR-YKNRELQIMQMLDHPN 136
           Y     +G G++G+V  A        VAIKK+   +     +R    RE++I+    H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86

Query: 137 IVALKHCFF--STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           I+ +       +    +++Y+  V + +   + ++ +      Q +   ++  + YQI R
Sbjct: 87  IIGINDIIRAPTIEQMKDVYI--VQDLMETDLYKLLKT-----QHLSNDHICYFLYQILR 139

Query: 195 ALAYIHNCIGICHRDIKPQNLLVKG---------------EPNVS-------YICSRYYR 232
            L YIH+   + HRD+KP NLL+                 +P+         Y+ +R+YR
Sbjct: 140 GLKYIHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198

Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++  +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258

Query: 293 M-NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           + N     +    P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ 
Sbjct: 259 IINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

Query: 350 DELRDPN 356
           ++  DP+
Sbjct: 318 EQYYDPS 324

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  250 bits (640), Expect = 2e-80
 Identities = 81/314 (25%), Positives = 130/314 (41%), Gaps = 43/314 (13%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKHC 143
           +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+V L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84

Query: 144 FFSTTDKEELYLN---LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             +             LV ++    +  +  N   +  +  L  +K     +   L YIH
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIH 141

Query: 201 NCIGICHRDIKPQNLLV--KGE-------------PNVSYICSRY--------YRAPELI 237
               I HRD+K  N+L+   G                 +   +RY        YR PEL+
Sbjct: 142 RN-KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 200

Query: 238 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMN 294
            G  +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E    +    
Sbjct: 201 LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY- 259

Query: 295 PNYTEFKFPQIKPHPWHKVFQK-RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 353
             Y + +  + +        +     P A+DL+ +     P  R  + +A  H FF    
Sbjct: 260 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS-- 317

Query: 354 DPNTRLPNGRPLPP 367
           DP      G     
Sbjct: 318 DPMPSDLKGMLSTH 331

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  249 bits (638), Expect = 5e-80
 Identities = 97/303 (32%), Positives = 151/303 (49%), Gaps = 41/303 (13%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 135
           Y     VG+G++G V  A   +TG  VA+KK+ +        KR Y  REL++++ + H 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88

Query: 136 NIVALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 192
           N++ L   F      E   ++YL  V   +   +N I +      Q++   +V+   YQI
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQI 141

Query: 193 CRALAYIHNCIGICHRDIKPQNLLVKGEPNV----------------SYICSRYYRAPEL 236
            R L YIH+   I HRD+KP NL V  +  +                 Y+ +R+YRAPE+
Sbjct: 142 LRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEI 200

Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-NP 295
           +     Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K + + 
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260

Query: 296 NYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 353
           +   +     Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  
Sbjct: 261 SARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319

Query: 354 DPN 356
           DP+
Sbjct: 320 DPD 322

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  249 bits (637), Expect = 1e-79
 Identities = 93/336 (27%), Positives = 151/336 (44%), Gaps = 55/336 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQD----KR-YKNRELQIMQMLDHP 135
           Y     +G+G+ G+V  A        VAIKK+    Q+    KR Y  REL +M+ ++H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 84

Query: 136 NIVALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 192
           NI+ L + F      E   ++Y+  V+E +   + ++      I   +    +    YQ+
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQV------IQMELDHERMSYLLYQM 136

Query: 193 CRALAYIHNCIGICHRDIKPQNLLVKG---------------EPNVS---YICSRYYRAP 234
              + ++H+  GI HRD+KP N++VK                  +     Y+ +RYYRAP
Sbjct: 137 LCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 195

Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
           E+I G   Y   +DIWS GC+M E++ G  LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 196 EVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254

Query: 295 PNYTEF--KFPQIKPHPWHKVFQ-----------KRLPPEAVDLVCRFFQYSPNLRCTAL 341
           P    +    P+   + + K+F            K    +A DL+ +      + R +  
Sbjct: 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 314

Query: 342 EACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELS 377
           EA  HP+ +   DP+       P  P       E +
Sbjct: 315 EALQHPYINVWYDPS-EAEAPPPKIPDKQLDEREHT 349

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  247 bits (631), Expect = 1e-77
 Identities = 89/315 (28%), Positives = 146/315 (46%), Gaps = 54/315 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 135
           Y     +G+G+ G+V  A        VAIKK+ +        KR Y  REL +M+ ++H 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121

Query: 136 NIVALKHCFFSTTDKE---ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQI 192
           NI++L + F      E   ++YL  V+E +   + ++      I   +    +    YQ+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQV------IQMELDHERMSYLLYQM 173

Query: 193 CRALAYIHNCIGICHRDIKPQNLLVKGEPNV------------------SYICSRYYRAP 234
              + ++H+  GI HRD+KP N++VK +  +                   Y+ +RYYRAP
Sbjct: 174 LCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 232

Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
           E+I G   Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K + 
Sbjct: 233 EVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291

Query: 295 PNYTEF--KFPQIKPHPWHKVF-----------QKRLPPEAVDLVCRFFQYSPNLRCTAL 341
           P    +    P+     + K+F            K    +A DL+ +     P  R +  
Sbjct: 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 351

Query: 342 EACVHPFFDELRDPN 356
           +A  HP+ +   DP 
Sbjct: 352 DALQHPYINVWYDPA 366

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  240 bits (615), Expect = 9e-76
 Identities = 98/357 (27%), Positives = 149/357 (41%), Gaps = 96/357 (26%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQD-KR-YKNRELQIMQMLDHP 135
           YI +H++G GS+G V+ A  + T + VAIKKV      L D KR    RE+ I+  L   
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85

Query: 136 NIVALKHCFF--STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQ 191
            I+ L            +ELY+  VLE     + ++          + L   ++K   Y 
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKL------FKTPIFLTEEHIKTILYN 137

Query: 192 ICRALAYIHNCIGICHRDIKPQNLLV---------------------------------- 217
           +     +IH   GI HRD+KP N L+                                  
Sbjct: 138 LLLGENFIHES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196

Query: 218 --KGEPNVS-----YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ------- 263
                 N+      ++ +R+YRAPELI     YT +IDIWSTGC+ AELL          
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256

Query: 264 ----PLFPGESG-----------------VDQLVEIIKVLGTPTREEIKCM-NPNYTEF- 300
               PLFPG S                   DQL  I  ++GTPT +++K +  P   ++ 
Sbjct: 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYI 316

Query: 301 -KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN 356
             FP  KP    + +   +  + ++L+    +++PN R T  +A  HP+  ++R   
Sbjct: 317 KLFPHRKPINLKQKY-PSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  238 bits (609), Expect = 2e-75
 Identities = 90/372 (24%), Positives = 166/372 (44%), Gaps = 82/372 (22%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL---QD----KR-YKNRELQIMQ-MLDH 134
           Y     +G G++G+V+++  R TGE+VA+KK+    Q+    +R +  RE+ I+  +  H
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68

Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
            NIV L +   +  D++ +YL  V +Y+   ++ + R        +  ++ +   YQ+ +
Sbjct: 69  ENIVNLLNVLRADNDRD-VYL--VFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIK 120

Query: 195 ALAYIHNCIGICHRDIKPQNLLV------------------------------------K 218
            + Y+H+  G+ HRD+KP N+L+                                     
Sbjct: 121 VIKYLHSG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179

Query: 219 GEPNVS----YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ 274
            + +      Y+ +R+YRAPE++ G+T+YT  ID+WS GC++ E+L G+P+FPG S ++Q
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239

Query: 275 LVEIIKVLGTPTREEIKCM-NPNYTEF--KFPQIKPHPWHKVFQKRLP------------ 319
           L  II V+  P+ E+++ + +P          +                           
Sbjct: 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKA 299

Query: 320 ---PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPEL 376
               EA+DL+ +  Q++PN R +A +A  HPF     +PN           +      + 
Sbjct: 300 DCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN----EEPNCDHIITIPINDN 355

Query: 377 SGIPPETINRLI 388
                +    L+
Sbjct: 356 VKHSIDDYRNLV 367

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  235 bits (602), Expect = 4e-74
 Identities = 86/360 (23%), Positives = 151/360 (41%), Gaps = 59/360 (16%)

Query: 90  VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCFF 145
           VG G++G V++AK ++    +  A+K++       +  RE+ +++ L HPN+++L+  F 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88

Query: 146 STTDKEELYLNLVLEYVPETVNRI-----ARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           S  D++   + L+ +Y    +  I     A   ++   ++P   VK   YQI   + Y+H
Sbjct: 89  SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 201 NCIGICHRDIKPQNLLVKGE--------------------PNVSY------ICSRYYRAP 234
               + HRD+KP N+LV GE                    P          + + +YRAP
Sbjct: 146 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204

Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES---------GVDQLVEIIKVLGTP 285
           EL+ GA  YT AIDIW+ GC+ AELL  +P+F               DQL  I  V+G P
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 264

Query: 286 TRE---------EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL 336
             +         E   +  ++    +       + +  + +   +A  L+ +     P  
Sbjct: 265 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIK 324

Query: 337 RCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARKQN 396
           R T+ +A   P+F E  DP             +  +       P +  ++   +  +  N
Sbjct: 325 RITSEQAMQDPYFLE--DPLPTSDVFAGCQIPYPKREFLTEEEPDDKGDKKNQQQQQGNN 382

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  231 bits (591), Expect = 7e-72
 Identities = 97/365 (26%), Positives = 143/365 (39%), Gaps = 104/365 (28%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KR-YKNRELQIMQMLDHP 135
           Y   H++GTGS+G V +A  +    +VAIKK+L+        KR    RE+ I+  L+H 
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112

Query: 136 NIVALKHCFF--STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPL--IYVKLYTYQ 191
           ++V +            +ELY  +VLE       ++          + L  +++K   Y 
Sbjct: 113 HVVKVLDIVIPKDVEKFDELY--VVLEIADSDFKKL------FRTPVYLTELHIKTLLYN 164

Query: 192 ICRALAYIHNCIGICHRDIKPQNLLV---------------------------------- 217
           +   + Y+H+  GI HRD+KP N LV                                  
Sbjct: 165 LLVGVKYVHSA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223

Query: 218 ---KGEPNVSYICSRYY---------RAPELIFGATEYTTAIDIWSTGCVMAELLL---- 261
                    +    R           RAPELI     YT AID+WS GC+ AELL     
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283

Query: 262 -------GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCM- 293
                    PLFPG S                      DQL  I  +LGTP+ E+I+ + 
Sbjct: 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALE 343

Query: 294 NPNYTEF--KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 351
             +   +   FP+ +     + F      +A+ L+ R   ++PN R T  E   HPFF E
Sbjct: 344 KEDAKRYIRIFPKREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402

Query: 352 LRDPN 356
           +R   
Sbjct: 403 VRIAE 407

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  184 bits (468), Expect = 5e-54
 Identities = 87/336 (25%), Positives = 143/336 (42%), Gaps = 88/336 (26%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQML------DH 134
           Y    V+G GSFG V +A   +  + VA+K V  +KR+      E++I++ L      + 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 135 PNIVALKHCF---------FSTTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPLI 183
            N++ +   F         F     E L +NL  +++      N+         Q   L 
Sbjct: 159 MNVIHMLENFTFRNHICMTF-----ELLSMNLYELIKK-----NK--------FQGFSLP 200

Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVK------------------GEPNVSY 225
            V+ + + I + L  +H    I H D+KP+N+L+K                   +   +Y
Sbjct: 201 LVRKFAHSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTY 259

Query: 226 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 285
           I SR+YRAPE+I GA  Y   ID+WS GC++AELL G PL PGE   DQL  +I++LG P
Sbjct: 260 IQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP 318

Query: 286 TREEIK-----------CMNPNYTEFKF---------------PQIKPHPWHKVFQKRLP 319
           +++ +               P Y                     +++  P  + +   L 
Sbjct: 319 SQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALK 378

Query: 320 PEA----VDLVCRFFQYSPNLRCTALEACVHPFFDE 351
                  +D + +  ++ P +R T  +A  HP+   
Sbjct: 379 GCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  178 bits (453), Expect = 2e-52
 Identities = 82/338 (24%), Positives = 131/338 (38%), Gaps = 59/338 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQML-----DHP 135
           YI    +G G F  V+ AK       VA+K V  DK Y      E++++Q +        
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 136 NIVALKHC-----FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 190
           + +   H       F+      +++ +V E + E +  + + Y   H+ +PLIYVK  + 
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 138

Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVK----------------------GEPNVSYICS 228
           Q+   L Y+H   GI H DIKP+N+L++                       E   + I +
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 198

Query: 229 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIKVL 282
           R YR+PE++ GA  +    DIWST C++ EL+ G  LF  + G       D + +II++L
Sbjct: 199 REYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 257

Query: 283 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP--------------EAVDLVCR 328
           G      ++        F   +       K+    L                E  D +  
Sbjct: 258 GELPSYLLR-NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 316

Query: 329 FFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLP 366
             Q  P  R  A     HP+  +           R L 
Sbjct: 317 MLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 354

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  174 bits (444), Expect = 3e-51
 Identities = 70/344 (20%), Positives = 119/344 (34%), Gaps = 97/344 (28%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQML-----DHP 135
           ++    +G G+FG V   +  +  +  A+K V   K+Y      E  I++ +     ++ 
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96

Query: 136 NIVALKHCF---------FSTTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPLIY 184
           NIV     F         F     E L  +L  ++            NY        +  
Sbjct: 97  NIVKYHGKFMYYDHMCLIF-----EPLGPSLYEIIT---------RNNY----NGFHIED 138

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV--------------------- 223
           +KLY  +I +AL Y+     + H D+KP+N+L+                           
Sbjct: 139 IKLYCIEILKALNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197

Query: 224 --------------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ 263
                               S I +R YRAPE+I     +  + D+WS GCV+AEL  G 
Sbjct: 198 STGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGS 256

Query: 264 PLFPGESGVDQLVEIIKVLGTPTREEI---------KCMNPNYTEFKFPQIKPHPWHKVF 314
            LF     ++ L  +  ++    +  +         K +N +  +  +P+          
Sbjct: 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKH 316

Query: 315 QKRLPPEA--------VDLVCRFFQYSPNLRCTALEACVHPFFD 350
            K+  P           D +    Q  P LR +  E   H F +
Sbjct: 317 VKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  174 bits (442), Expect = 6e-51
 Identities = 73/352 (20%), Positives = 119/352 (33%), Gaps = 91/352 (25%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDKRYKN---RELQIMQML------D 133
           Y     +G G+FG V +      G   VA+K +    +Y+     E+ +++ +      +
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80

Query: 134 HPNIVALKHCF---------FSTTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPL 182
               V +   F         F     E L  N    L+           N+    Q  PL
Sbjct: 81  KFLCVLMSDWFNFHGHMCIAF-----ELLGKNTFEFLK---------ENNF----QPYPL 122

Query: 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV------------------- 223
            +V+   YQ+C AL ++H    + H D+KP+N+L                          
Sbjct: 123 PHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181

Query: 224 ----------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFP 267
                           + + +R+YR PE+I     +    D+WS GC++ E   G  LF 
Sbjct: 182 RVADFGSATFDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQ 240

Query: 268 GESGVDQLVEIIKVLGTPTREEIKCM---------NPNYTEFKFPQIKPHPWHKVFQKRL 318
                + LV + K+LG      I               + E            K  +  +
Sbjct: 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYM 300

Query: 319 PPEA------VDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRP 364
             ++       DL+ R  ++ P  R T  EA +HPFF  L          R 
Sbjct: 301 LQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRN 352

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  174 bits (443), Expect = 6e-51
 Identities = 88/345 (25%), Positives = 134/345 (38%), Gaps = 93/345 (26%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQML------DH 134
           Y  + ++G GSFG V +A  R   E VAIK +   K + N    E+++++++        
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115

Query: 135 PNIVALKHCF---------FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQR--MPLI 183
             IV LK  F         F     E L  NL              +  R      + L 
Sbjct: 116 YYIVHLKRHFMFRNHLCLVF-----EMLSYNL-------------YDLLRNTNFRGVSLN 157

Query: 184 YVKLYTYQICRALAYIHNC-IGICHRDIKPQNLLVK------------------GEPNVS 224
             + +  Q+C AL ++    + I H D+KP+N+L+                   G+    
Sbjct: 158 LTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ 217

Query: 225 YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 284
           YI SR+YR+PE++ G   Y  AID+WS GC++ E+  G+PLF G + VDQ+ +I++VLG 
Sbjct: 218 YIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276

Query: 285 PTRE--------------------EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEA-- 322
           P                        +K       E+K P  +        +   P     
Sbjct: 277 PPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRA 336

Query: 323 -------------VDLVCRFFQYSPNLRCTALEACVHPFFDELRD 354
                         DL+ R   Y P  R     A  H FF +  D
Sbjct: 337 GESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  169 bits (431), Expect = 8e-50
 Identities = 67/342 (19%), Positives = 117/342 (34%), Gaps = 83/342 (24%)

Query: 59  VGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--- 115
           +G E  +    ++ GR         Y     +G+G    VFQ    E  +I AIK V   
Sbjct: 13  LGTENLYFQSMSVKGRI--------YSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLE 63

Query: 116 -LQDKRYKN--RELQIMQMLDHPN--IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIA 170
              ++   +   E+  +  L   +  I+ L          + +Y+  V+E     +N   
Sbjct: 64  EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE---ITDQYIYM--VMECGNIDLNSWL 118

Query: 171 RNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN-LLVKG---------- 219
           +      + +     K Y   +  A+  IH   GI H D+KP N L+V G          
Sbjct: 119 KK----KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGMLKLIDFGIA 173

Query: 220 ------EPNV---SYICSRYYRAPELIFGA----------TEYTTAIDIWSTGCVMAELL 260
                   +V   S + +  Y  PE I             ++ +   D+WS GC++  + 
Sbjct: 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233

Query: 261 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP 320
            G+  F         +  I             ++PN+ E +FP I               
Sbjct: 234 YGKTPFQQIINQISKLHAI-------------IDPNH-EIEFPDI------------PEK 267

Query: 321 EAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNG 362
           +  D++    +  P  R +  E   HP+      P  ++  G
Sbjct: 268 DLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 309

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  170 bits (433), Expect = 8e-50
 Identities = 72/343 (20%), Positives = 125/343 (36%), Gaps = 91/343 (26%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDKRYKN---RELQIMQML------D 133
           Y     +G G+FG V +    + G   VA+K V    RY      E+Q+++ L       
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 134 HPNIVALKHCF---------FSTTDKEELYLNL--VLEYVPETVNRIARNYSRIHQRMPL 182
               V +   F         F     E L L+    ++            +        L
Sbjct: 76  TFRCVQMLEWFEHHGHICIVF-----ELLGLSTYDFIK---------ENGF----LPFRL 117

Query: 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV------------------- 223
            +++   YQIC+++ ++H+   + H D+KP+N+L                          
Sbjct: 118 DHIRKMAYQICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176

Query: 224 ----------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFP 267
                           + + +R+YRAPE+I     ++   D+WS GC++ E  LG  +FP
Sbjct: 177 KVVDFGSATYDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFP 235

Query: 268 GESGVDQLVEIIKVLGTPTREEI-KCMNPNY---TEFKFPQIKP-----HPWHKVFQKRL 318
                + L  + ++LG   +  I K     Y       + +            K  ++ +
Sbjct: 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFM 295

Query: 319 PPE------AVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 355
             +        DL+ +  +Y P  R T  EA  HPFFD L+  
Sbjct: 296 LSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  170 bits (433), Expect = 5e-49
 Identities = 56/302 (18%), Positives = 107/302 (35%), Gaps = 70/302 (23%)

Query: 81  KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLD-HPNIV 138
           K+S+  + V+G G+ G +   +       VA+K++L +   + +RE+Q+++  D HPN++
Sbjct: 23  KISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVI 81

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
                      K+  +  + +E         + +         P+  ++    Q    LA
Sbjct: 82  RYFCTE-----KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLA 132

Query: 198 YIHNCIGICHRDIKPQNLLVKGEPNVSYIC---------------------------SRY 230
           ++H+   I HRD+KP N+L+        I                            +  
Sbjct: 133 HLHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191

Query: 231 YRAPELIFGATE--YTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR 287
           + APE++    +   T  +DI+S GCV   ++  G   F                G   +
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF----------------GKSLQ 235

Query: 288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 347
            +   +            + H             A +L+ +     P  R +A     HP
Sbjct: 236 RQANILLGAC-SLDCLHPEKH---------EDVIARELIEKMIAMDPQKRPSAKHVLKHP 285

Query: 348 FF 349
           FF
Sbjct: 286 FF 287

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  166 bits (423), Expect = 1e-48
 Identities = 48/304 (15%), Positives = 100/304 (32%), Gaps = 46/304 (15%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 138
           ++   ++G G+   VF+ + ++TG++ AIK       L+    + RE ++++ L+H NIV
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
            L      TT +    L  ++E+ P       +    +     +P     +    +   +
Sbjct: 71  KLFAIEEETTTRH-KVL--IMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125

Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNVSYI---------------------C-SRYYRAP 234
            ++    GI HR+IKP N++     +   +                       +  Y  P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 235 ELIFGAT-------EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK--VLGTP 285
           ++   A        +Y   +D+WS G        G   F    G  +  E++   + G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 286 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 345
           +               +    P        + L      ++    +          +   
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCS--LSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302

Query: 346 HPFF 349
               
Sbjct: 303 ETSD 306

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  167 bits (424), Expect = 1e-48
 Identities = 62/317 (19%), Positives = 107/317 (33%), Gaps = 75/317 (23%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN- 136
           Y     +G+G    VFQ    E  +I AIK V  ++           E+  +  L   + 
Sbjct: 11  YSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 137 -IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
            I+ L          + +Y+  V+E     +N   +      + +     K Y   +  A
Sbjct: 70  KIIRLYDYE---ITDQYIYM--VMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEA 120

Query: 196 LAYIHNCIGICHRDIKPQNLL-----VK------------GEPNV---SYICSRYYRAPE 235
           +  IH   GI H D+KP N L     +K               +V   S + +  Y  PE
Sbjct: 121 VHTIHQH-GIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179

Query: 236 LIFG----------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 285
            I             ++ +   D+WS GC++  +  G+  F         +  I      
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI------ 233

Query: 286 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 345
                  ++PN+ E +FP I               +  D++    +  P  R +  E   
Sbjct: 234 -------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPELLA 273

Query: 346 HPFFDELRDPNTRLPNG 362
           HP+      P  ++  G
Sbjct: 274 HPYVQIQTHPVNQMAKG 290

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  168 bits (427), Expect = 2e-48
 Identities = 63/323 (19%), Positives = 109/323 (33%), Gaps = 75/323 (23%)

Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQM 131
           S +   Y     +G+G    VFQ    E  +I AIK V  ++           E+  +  
Sbjct: 52  SVKGRIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110

Query: 132 LDHPN--IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYT 189
           L   +  I+ L          + +Y+  V+E     +N   +      + +     K Y 
Sbjct: 111 LQQHSDKIIRLYDYE---ITDQYIYM--VMECGNIDLNSWLKK----KKSIDPWERKSYW 161

Query: 190 YQICRALAYIHNCIGICHRDIKPQNLL-----VK------------GEPNV---SYICSR 229
             +  A+  IH   GI H D+KP N L     +K               +V   S + + 
Sbjct: 162 KNMLEAVHTIHQH-GIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAV 220

Query: 230 YYRAPELIFGA----------TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
            Y  PE I             ++ +   D+WS GC++  +  G+  F         +  I
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280

Query: 280 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT 339
                        ++PN+ E +FP I               +  D++    +  P  R +
Sbjct: 281 -------------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRIS 314

Query: 340 ALEACVHPFFDELRDPNTRLPNG 362
             E   HP+      P  ++  G
Sbjct: 315 IPELLAHPYVQIQTHPVNQMAKG 337

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  164 bits (415), Expect = 6e-47
 Identities = 53/392 (13%), Positives = 100/392 (25%), Gaps = 72/392 (18%)

Query: 22  SSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQK 81
           S   + D   R++L+          E+   EP  +      T           +  S+ +
Sbjct: 2   SHMEAGDSFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGE 61

Query: 82  VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDH 134
                   +  G   VVF  +  E  E  A+K                +        L  
Sbjct: 62  RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG 121

Query: 135 PNIVALKHCF---------------------FSTTDKEELYLNLVLEYVP---ETVNRIA 170
            +    +                            D       L++       E +    
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL 181

Query: 171 RNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYIC--- 227
                      ++ + + T Q+ R  A + +  G+ H    P NL +  +  +  +    
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHGHFTPDNLFIMPDGRL-MLGDVS 239

Query: 228 --------------SRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 272
                            Y   E +      +T A++ W  G  +  +      F   +  
Sbjct: 240 ALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299

Query: 273 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQY 332
            +       L  P  +                             LP     L+ RF  +
Sbjct: 300 IKGSWKRPSLRVPGTD--------------------SLAFGSCTPLPDFVKTLIGRFLNF 339

Query: 333 SPNLRCTALEACVHPFFDELRD-PNTRLPNGR 363
               R   LEA   P F +L++  ++ L  G+
Sbjct: 340 DRRRRLLPLEAMETPEFLQLQNEISSSLSTGQ 371

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  161 bits (409), Expect = 9e-47
 Identities = 64/319 (20%), Positives = 107/319 (33%), Gaps = 78/319 (24%)

Query: 77  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLD 133
           + +    +    V+G G+FG V +A+        AIKK+   +   +    E+ ++  L+
Sbjct: 1   SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN 60

Query: 134 HPNIVALKHCF--------FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLI 183
           H  +V     +          T  K++  L + +EY       + I        +     
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-------------------- 223
             +    QI  AL+YIH+  GI HRD+KP N+ +    NV                    
Sbjct: 121 LFR----QILEALSYIHSQ-GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175

Query: 224 -------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES 270
                        S I +  Y A E++ G   Y   ID++S G +  E++   P   G  
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGME 233

Query: 271 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 330
                V I+K L +                +FP     P    F          ++    
Sbjct: 234 ----RVNILKKLRSV-------------SIEFP-----PD---FDDNKMKVEKKIIRLLI 268

Query: 331 QYSPNLRCTALEACVHPFF 349
            + PN R  A       + 
Sbjct: 269 DHDPNKRPGARTLLNSGWL 287

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  164 bits (416), Expect = 2e-46
 Identities = 70/323 (21%), Positives = 116/323 (35%), Gaps = 79/323 (24%)

Query: 75  NGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLD 133
           N     K   ++E ++G GS G V   +    G  VA+K++L D       E++++   D
Sbjct: 8   NFEQSLKNLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESD 66

Query: 134 -HPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARN--YSRIHQRMPLIYVKLYT 189
            HPN++   +C  +      LY+   LE       + +          +           
Sbjct: 67  DHPNVIRY-YCSET--TDRFLYI--ALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121

Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLVKG----------------------------EP 221
            QI   +A++H+   I HRD+KPQN+LV                              + 
Sbjct: 122 RQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 222 NVSYICSR--------YYRAPELIFGATE------YTTAIDIWSTGCVMAELL-LGQPLF 266
             S   +          +RAPEL+  +         T +IDI+S GCV   +L  G+  F
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240

Query: 267 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLV 326
             +    +   II+                   F   ++K      +       EA DL+
Sbjct: 241 GDKY--SRESNIIR-----------------GIFSLDEMKCLHDRSL-----IAEATDLI 276

Query: 327 CRFFQYSPNLRCTALEACVHPFF 349
            +   + P  R TA++   HP F
Sbjct: 277 SQMIDHDPLKRPTAMKVLRHPLF 299

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  161 bits (408), Expect = 9e-46
 Identities = 53/313 (16%), Positives = 105/313 (33%), Gaps = 51/313 (16%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 138
           ++   ++G G+   VF+ + ++TG++ AIK       L+    + RE ++++ L+H NIV
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
            L      TT +      L++E+ P       +    +     +P     +    +   +
Sbjct: 71  KLFAIEEETTTR-HKV--LIMEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGM 125

Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNVSYI---------------------C-SRYYRAP 234
            ++    GI HR+IKP N++     +   +                       +  Y  P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 235 ELIFGAT-------EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK--VLGTP 285
           ++   A        +Y   +D+WS G        G   F    G  +  E++   + G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 286 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 345
           +               +    P        + L      ++    +          +   
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCS--LSRGLQVLLTPVLANILEADQEKCWGFDQ--- 299

Query: 346 HPFFDELRDPNTR 358
             FF E  D   R
Sbjct: 300 --FFAETSDILHR 310

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  157 bits (400), Expect = 1e-45
 Identities = 65/298 (21%), Positives = 112/298 (37%), Gaps = 62/298 (20%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y   + +GTGS+G   + + +  G+I+  K++        +K+    E+ +++ L HPNI
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           V          D+    L +V+EY     +  +    ++  Q +   +V     Q+  AL
Sbjct: 68  VRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 197 AYIH----NCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRA 233
              H        + HRD+KP N+ + G+ NV                   +++ + YY +
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184

Query: 234 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 293
           PE +     Y    DIWS GC++ EL    P F   S   +L   I+             
Sbjct: 185 PEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR------------- 229

Query: 294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 351
                E KF +I               E  +++ R        R +  E   +P   E
Sbjct: 230 -----EGKFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  161 bits (408), Expect = 2e-45
 Identities = 80/305 (26%), Positives = 128/305 (41%), Gaps = 73/305 (23%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------------RELQIMQM 131
           YI    +G+G+ G V  A  R+T + VAI+ + + K                 E++I++ 
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196

Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYT 189
           L+HP I+ +K+ F    D E+ Y  +VLE +   E  +++       ++R+     KLY 
Sbjct: 197 LNHPCIIKIKNFF----DAEDYY--IVLELMEGGELFDKVVG-----NKRLKEATCKLYF 245

Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI--------------------C-S 228
           YQ+  A+ Y+H   GI HRD+KP+N+L+  +     I                    C +
Sbjct: 246 YQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 304

Query: 229 RYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 286
             Y APE++       Y  A+D WS G ++   L G P F        L + I   G   
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG--- 360

Query: 287 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 346
                       ++ F    P  W +V       +A+DLV +     P  R T  EA  H
Sbjct: 361 ------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALRH 400

Query: 347 PFFDE 351
           P+  +
Sbjct: 401 PWLQD 405

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  165 bits (419), Expect = 2e-45
 Identities = 73/322 (22%), Positives = 120/322 (37%), Gaps = 48/322 (14%)

Query: 72  GGRNGNSKQKV--SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----R 124
           GGR+ +   +    +  +  +GTG FG V +   ++TGE VAIK+  Q+   KN      
Sbjct: 2   GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL 61

Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLN-LVLEYVP--ETVNRIARNYSRIHQRMP 181
           E+QIM+ L+HPN+V+ +             L  L +EY    +    + +        + 
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF--ENCCGLK 119

Query: 182 LIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI--------------- 226
              ++     I  AL Y+H    I HRD+KP+N++++  P                    
Sbjct: 120 EGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178

Query: 227 -----C-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK 280
                  +  Y APEL+    +YT  +D WS G +  E + G   F       Q    ++
Sbjct: 179 LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237

Query: 281 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQ----YSPNL 336
                + E I   +      KF  + P P        L       + R+ Q    +    
Sbjct: 238 ---EKSNEHIVVYDDLTGAVKFSSVLPTP------NHLSGILAGKLERWLQCMLMWHQRQ 288

Query: 337 RCTALEACVHPFFDELRDPNTR 358
           R T  +      F  L    + 
Sbjct: 289 RGTDPQNPNVGCFQALDSILSL 310

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  157 bits (400), Expect = 2e-45
 Identities = 60/286 (20%), Positives = 99/286 (34%), Gaps = 66/286 (23%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIM-QMLDHPNIVALK 141
            +G GS+G VF+ + +E G + A+K+ +      +D+  K  E+    ++  HP  V L+
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             +    +   LY  L  E    +   + ++       +P   V  Y      ALA++H+
Sbjct: 124 QAWE---EGGILY--LQTELCGPS---LQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175

Query: 202 CIGICHRDIKPQNLLVKGEPNV------------------SYICSRYYRAPELIFGATEY 243
             G+ H D+KP N+ +                               Y APEL+     Y
Sbjct: 176 Q-GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL--QGSY 232

Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 303
            TA D++S G  + E+     L  G  G  QL +                         P
Sbjct: 233 GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP---------------------P 271

Query: 304 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           +             L  E   ++    +  P LR TA      P  
Sbjct: 272 EFTAG---------LSSELRSVLVMMLEPDPKLRATAEALLALPVL 308

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  156 bits (397), Expect = 4e-45
 Identities = 71/326 (21%), Positives = 110/326 (33%), Gaps = 85/326 (26%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKN---RELQIMQMLDHPN 136
           Y+    +G G F   F+    +T E+ A K     +L     +     E+ I + L H +
Sbjct: 17  YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 76

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           +V     F    D + +++  VLE       +    R      + +     + Y  QI  
Sbjct: 77  VVGFHGFF---EDNDFVFV--VLELCRRRSLLELHKR-----RKALTEPEARYYLRQIVL 126

Query: 195 ALAYIHNCIGICHRDIKPQNLL------VK---------------------GEPNVSYIC 227
              Y+H    + HRD+K  NL       VK                     G PN     
Sbjct: 127 GCQYLHR-NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN----- 180

Query: 228 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 287
              Y APE++     ++  +D+WS GC+M  LL+G+P F      +  + I K       
Sbjct: 181 ---YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------ 230

Query: 288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 347
                      E+  P              + P A  L+ +  Q  P  R T  E     
Sbjct: 231 -----------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLNDE 267

Query: 348 FFDELRDPNTRLPNGRPLPPLFNFKP 373
           FF     P         +PP F+  P
Sbjct: 268 FFTSGYIPARLPITCLTIPPRFSIAP 293

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  161 bits (408), Expect = 7e-45
 Identities = 68/318 (21%), Positives = 119/318 (37%), Gaps = 71/318 (22%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDHPNI 137
           Y     +G+G++G V   + + T    AIK +               E+ ++++LDHPNI
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
           + L   F     +++    LV+E     E  + I     ++        +   +   Q+ 
Sbjct: 99  MKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFNE-------VDAAVIIKQVL 146

Query: 194 RALAYIHNCIGICHRDIKPQNLLV---------------------KGEPNVSYICSRYYR 232
             + Y+H    I HRD+KP+NLL+                       +     + + YY 
Sbjct: 147 SGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205

Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++    +Y    D+WS G ++  LL G P F G++  DQ  EI+         +++ 
Sbjct: 206 APEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EIL--------RKVEK 251

Query: 293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
               +            W  V        A DL+ +  Q+    R +A +A  HP+  E+
Sbjct: 252 GKYTFDS--------PEWKNV-----SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298

Query: 353 RDPNTRLPNGRPLPPLFN 370
                       L     
Sbjct: 299 CSKKESGIELPSLANAIE 316

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  155 bits (394), Expect = 1e-44
 Identities = 71/299 (23%), Positives = 117/299 (39%), Gaps = 61/299 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN---RELQIMQMLDHPNIVALKHCF 144
           V+G G++G+V+  +       +AIK++  +D RY      E+ + + L H NIV      
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ----- 83

Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
           +  +  E  ++ + +E VP  +++ + R+ +  +      I    YT QI   L Y+H+ 
Sbjct: 84  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--GFYTKQILEGLKYLHDN 141

Query: 203 IGICHRDIKPQNLLV--------------------KGEPNVSYICSRYYRAPELIFGATE 242
             I HRDIK  N+L+                          ++  +  Y APE+I     
Sbjct: 142 -QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 200

Query: 243 -YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            Y  A DIWS GC + E+  G+P F       +L E    +                 FK
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPFY------ELGEPQAAM-----------------FK 237

Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLP 360
               K HP      + +  EA   + + F+  P+ R  A +  V  F           P
Sbjct: 238 VGMFKVHP---EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQP 293

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  156 bits (397), Expect = 1e-44
 Identities = 74/340 (21%), Positives = 114/340 (33%), Gaps = 88/340 (25%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKN---RELQIMQMLDHPN 136
           Y+    +G G F   F+    +T E+ A K     +L     +     E+ I + L H +
Sbjct: 43  YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 102

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           +V     F    D + +++  VLE       +    R      + +     + Y  QI  
Sbjct: 103 VVGFHGFF---EDNDFVFV--VLELCRRRSLLELHKR-----RKALTEPEARYYLRQIVL 152

Query: 195 ALAYIHNCIGICHRDIKPQNLL------VK---------------------GEPNVSYIC 227
              Y+H    + HRD+K  NL       VK                     G PN     
Sbjct: 153 GCQYLHR-NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN----- 206

Query: 228 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 287
              Y APE++     ++  +D+WS GC+M  LL+G+P F      +  + I K       
Sbjct: 207 ---YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------ 256

Query: 288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 347
                      E+  P              + P A  L+ +  Q  P  R T  E     
Sbjct: 257 -----------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLNDE 293

Query: 348 FFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRL 387
           FF     P         +PP F+  P   S + P     L
Sbjct: 294 FFTSGYIPARLPITCLTIPPRFSIAP---SSLDPSNRKPL 330

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  160 bits (406), Expect = 1e-44
 Identities = 71/318 (22%), Positives = 122/318 (38%), Gaps = 71/318 (22%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDHPNI 137
           Y    ++G GSFG V + K R T +  A+K +       +D     RE+++++ LDHPNI
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
           + L        D    Y  +V E     E  + I +   +S                Q+ 
Sbjct: 84  MKLFEIL---EDSSSFY--IVGELYTGGELFDEIIKRKRFSE-------HDAARIIKQVF 131

Query: 194 RALAYIHNCIGICHRDIKPQNLLV---------------------KGEPNVSYICSRYYR 232
             + Y+H    I HRD+KP+N+L+                     +       I + YY 
Sbjct: 132 SGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190

Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y    D+WS G ++  LL G P F G++  +   +I+        + ++ 
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKN--EY--DIL--------KRVET 236

Query: 293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
               +            W  +       +A DL+ +   + P+LR TA +   HP+  + 
Sbjct: 237 GKYAFDL--------PQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283

Query: 353 RDPNTRLPNGRPLPPLFN 370
                 + +   L     
Sbjct: 284 SSETPTISDLPSLESAMT 301

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  159 bits (405), Expect = 1e-44
 Identities = 77/296 (26%), Positives = 125/296 (42%), Gaps = 68/296 (22%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN---RELQIMQMLDHPN 136
           Y  + V+G GSFG V   K + TG+  A+K +    ++ K  K    RE+Q+++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           I+ L   F     +++ Y  LV E     E  + I        +R   +       Q+  
Sbjct: 88  IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLS 137

Query: 195 ALAYIHNCIGICHRDIKPQNLLV---------------------KGEPNVSYICSRYYRA 233
            + Y+H    I HRD+KP+NLL+                       +     I + YY A
Sbjct: 138 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 196

Query: 234 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 293
           PE++ G   Y    D+WSTG ++  LL G P F G +  +   +I+        ++++  
Sbjct: 197 PEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGAN--EY--DIL--------KKVEKG 242

Query: 294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
              +            W KV        A DL+ +   Y P++R +A +A  H + 
Sbjct: 243 KYTFEL--------PQWKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEWI 285

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  155 bits (394), Expect = 3e-44
 Identities = 80/303 (26%), Positives = 126/303 (41%), Gaps = 73/303 (24%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKN--------RELQIMQM 131
           YI    +G+G+ G V  A  R+T + VAIK    +       +          E++I++ 
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71

Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYT 189
           L+HP I+ +K+ F    D E+ Y  +VLE +   E  +++       ++R+     KLY 
Sbjct: 72  LNHPCIIKIKNFF----DAEDYY--IVLELMEGGELFDKVVG-----NKRLKEATCKLYF 120

Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI--------------------C-S 228
           YQ+  A+ Y+H   GI HRD+KP+N+L+  +     I                    C +
Sbjct: 121 YQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179

Query: 229 RYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 286
             Y APE++       Y  A+D WS G ++   L G P F        L + I   G   
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG--- 235

Query: 287 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 346
                       ++ F    P  W +V       +A+DLV +     P  R T  EA  H
Sbjct: 236 ------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALRH 275

Query: 347 PFF 349
           P+ 
Sbjct: 276 PWL 278

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  155 bits (393), Expect = 3e-44
 Identities = 74/304 (24%), Positives = 124/304 (40%), Gaps = 67/304 (22%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----RELQIMQMLDHPNIVA 139
           +I   V+G+G+F  VF  K R TG++ A+K + +   +++     E+ +++ + H NIV 
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQICRA 195
           L+  +         Y  LV++ V   E  +RI     Y+   ++   + ++    Q+  A
Sbjct: 71  LEDIY---ESTTHYY--LVMQLVSGGELFDRILERGVYT---EKDASLVIQ----QVLSA 118

Query: 196 LAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-------------------C-SRYYRAPE 235
           + Y+H   GI HRD+KP+NLL       S I                   C +  Y APE
Sbjct: 119 VKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPE 177

Query: 236 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 295
            +     Y+ A+D WS G +   LL G P F  E+      +I +               
Sbjct: 178 -VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG-------------- 222

Query: 296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 355
               ++F       W  +        A D +C   +  PN R T  +A  HP+ D     
Sbjct: 223 ---YYEFE---SPFWDDI-----SESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTAL 271

Query: 356 NTRL 359
           +  +
Sbjct: 272 HRDI 275

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  154 bits (391), Expect = 3e-44
 Identities = 73/317 (23%), Positives = 120/317 (37%), Gaps = 65/317 (20%)

Query: 65  HVIRTTIGGRNGNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQ 117
           H    + G  N   +  +   +I +  +G+G+FG V   + R +G    IK     +   
Sbjct: 3   HHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV 62

Query: 118 DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSR 175
                  E+++++ LDHPNI+ +   F    D   +Y  +V+E     E + RI    +R
Sbjct: 63  PMEQIEAEIEVLKSLDHPNIIKIFEVF---EDYHNMY--IVMETCEGGELLERIVSAQAR 117

Query: 176 IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL------------------V 217
             + +   YV     Q+  ALAY H+   + H+D+KP+N+L                   
Sbjct: 118 -GKALSEGYVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175

Query: 218 KGEPNVSY--IC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ 274
             + +        +  Y APE+     + T   DIWS G VM  LL G   F G S  + 
Sbjct: 176 LFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV 233

Query: 275 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP 334
             +                     E  +               L P+AVDL+ +     P
Sbjct: 234 QQKATYK-----------------EPNYA---VECRP------LTPQAVDLLKQMLTKDP 267

Query: 335 NLRCTALEACVHPFFDE 351
             R +A +   H +F +
Sbjct: 268 ERRPSAAQVLHHEWFKQ 284

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  153 bits (389), Expect = 5e-44
 Identities = 73/297 (24%), Positives = 117/297 (39%), Gaps = 67/297 (22%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALKHC 143
           G G FG V+ A+ +++  I+A+K     ++ +        RE++I   L HPNI+ L   
Sbjct: 18  GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77

Query: 144 FFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    D   +Y  L+LEY P       + +       +        Y  ++  AL+Y H+
Sbjct: 78  FH---DATRVY--LILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS 127

Query: 202 CIGICHRDIKPQNLLVKGEPN---------VSYICSRY--------YRAPELIFGATEYT 244
              + HRDIKP+NLL+              V    SR         Y  PE+I G   + 
Sbjct: 128 K-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEG-RMHD 185

Query: 245 TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 304
             +D+WS G +  E L+G+P F   +  +    I +V                 EF FP 
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EFTFP- 227

Query: 305 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPN 361
                +       +   A DL+ R  +++P+ R    E   HP+        +   N
Sbjct: 228 ----DF-------VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQN 273

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  152 bits (387), Expect = 1e-43
 Identities = 54/331 (16%), Positives = 93/331 (28%), Gaps = 93/331 (28%)

Query: 72  GGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNRELQ- 127
           G     S+    +     +G+G FG VF+   R  G I AIK+    L     +   L+ 
Sbjct: 1   GAMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60

Query: 128 ---IMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLI 183
                 +  H ++V     +      E+ ++ +  EY    ++        RI       
Sbjct: 61  VYAHAVLGQHSHVVRYFSAWA-----EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEA 115

Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYICSR-------------- 229
            +K    Q+ R L YIH+   + H DIKP N+ +      +                   
Sbjct: 116 ELKDLLLQVGRGLRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174

Query: 230 --------------------YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE 269
                                + A E++     +    DI++    +      +PL    
Sbjct: 175 IGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234

Query: 270 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP-------EA 322
                                                   WH++ Q RLP        E 
Sbjct: 235 --------------------------------------DQWHEIRQGRLPRIPQVLSQEF 256

Query: 323 VDLVCRFFQYSPNLRCTALEACVHPFFDELR 353
            +L+       P  R +A+    H       
Sbjct: 257 TELLKVMIHPDPERRPSAMALVKHSVLLSAS 287

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  157 bits (400), Expect = 1e-43
 Identities = 75/306 (24%), Positives = 118/306 (38%), Gaps = 78/306 (25%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------------REL 126
           Y     +G+G++G V   K +      AIK + + +  K                   E+
Sbjct: 38  YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97

Query: 127 QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY 184
            +++ LDHPNI+ L   F    DK+  Y  LV E+    E   +I  N  +  +      
Sbjct: 98  SLLKSLDHPNIIKLFDVF---EDKKYFY--LVTEFYEGGELFEQII-NRHKFDEC----D 147

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---------------------KGEPNV 223
                 QI   + Y+H    I HRDIKP+N+L+                     K     
Sbjct: 148 AANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR 206

Query: 224 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 283
             + + YY APE++    +Y    D+WS G +M  LL G P F G++  DQ  +II    
Sbjct: 207 DRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQ--DII---- 256

Query: 284 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 343
               ++++     +          + W  +       EA +L+     Y  N RCTA EA
Sbjct: 257 ----KKVEKGKYYFDF--------NDWKNI-----SDEAKELIKLMLTYDYNKRCTAEEA 299

Query: 344 CVHPFF 349
               + 
Sbjct: 300 LNSRWI 305

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  151 bits (385), Expect = 1e-43
 Identities = 77/307 (25%), Positives = 123/307 (40%), Gaps = 71/307 (23%)

Query: 76  GNSKQKVS--YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNRELQIM 129
           G++K  ++  Y  E+ +G GS+G V  A  + T    A K      ++D     +E++IM
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60

Query: 130 QMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYV 185
           + LDHPNI+ L   F    D  ++Y  LV+E     E   R+     +            
Sbjct: 61  KSLDHPNIIRLYETF---EDNTDIY--LVMELCTGGELFERVVHKRVFRE-------SDA 108

Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI------CSR---------- 229
                 +  A+AY H    + HRD+KP+N L   +   S +       +           
Sbjct: 109 ARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167

Query: 230 -----YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 284
                YY +P+++ G   Y    D WS G +M  LL G P F   +  + +++I +    
Sbjct: 168 KVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG--- 222

Query: 285 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 344
                          F FP      W  V      P+A  L+ R    SP  R T+L+A 
Sbjct: 223 --------------TFTFP---EKDWLNV-----SPQAESLIRRLLTKSPKQRITSLQAL 260

Query: 345 VHPFFDE 351
            H +F++
Sbjct: 261 EHEWFEK 267

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  154 bits (390), Expect = 1e-43
 Identities = 57/322 (17%), Positives = 110/322 (34%), Gaps = 65/322 (20%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN----------------RELQIM 129
             G F  +      +  +  A+K      + + + +                   ELQI+
Sbjct: 40  NQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 130 QMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-----ETVNRIARNYSRIHQRMPLIY 184
             + +   +  +      T+ +E+Y+  + EY+      +               +P+  
Sbjct: 98  TDIKNEYCLTCEGII---TNYDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-------SYI---------C- 227
           +K     +  + +YIHN   ICHRD+KP N+L+     V       S             
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRG 212

Query: 228 SRYYRAPELIFGATEY-TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 286
           +  +  PE     + Y    +DIWS G  +  +      F  +  + +L   I+      
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR------ 266

Query: 287 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 346
            + I+   P      F     +         L  E +D +  F + +P  R T+ +A  H
Sbjct: 267 TKNIEY--PLDRN-HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323

Query: 347 PFF-----DELRDPNTRLPNGR 363
            +      ++LR+ +  L   R
Sbjct: 324 EWLADTNIEDLREFSKELYKKR 345

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  151 bits (384), Expect = 5e-43
 Identities = 67/293 (22%), Positives = 113/293 (38%), Gaps = 61/293 (20%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPN 136
           +  E  +G G F  V++A C   G  VA+KKV        + +    +E+ +++ L+HPN
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           ++     F      E+  LN+VLE      ++R+ +++ +  + +P   V  Y  Q+C A
Sbjct: 94  VIKYYASF-----IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 196 LAYIHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPEL 236
           L ++H+   + HRDIKP N+ +     V                   S + + YY +PE 
Sbjct: 149 LEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207

Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNP 295
           I     Y    DIWS GC++ E+   Q  F G+   +  L + I+               
Sbjct: 208 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE--------------- 251

Query: 296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
              +  +P +               E   LV       P  R           
Sbjct: 252 ---QCDYPPLPS--------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  150 bits (382), Expect = 5e-43
 Identities = 69/287 (24%), Positives = 116/287 (40%), Gaps = 67/287 (23%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYK--NRELQIMQMLDHPNIVALK 141
            +G G FG V+ A+ ++   I+A+K     ++ ++       RE++I   L HPNI+ + 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F    D++ +Y  L+LE+ P  E    + +     H R        +  ++  AL Y 
Sbjct: 81  NYFH---DRKRIY--LMLEFAPRGELYKELQK-----HGRFDEQRSATFMEELADALHYC 130

Query: 200 HNCIGICHRDIKPQNLLVKGEPNVSYI---CSRY--------------YRAPELIFGATE 242
           H    + HRDIKP+NLL+  +  +       S +              Y  PE+I G   
Sbjct: 131 HER-KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEG-KT 188

Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 302
           +   +D+W  G +  E L+G P F   S  +    I+ V                 + KF
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------DLKF 231

Query: 303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           P     P+       L   + DL+ +  +Y P  R        HP+ 
Sbjct: 232 P-----PF-------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  150 bits (381), Expect = 1e-42
 Identities = 58/289 (20%), Positives = 111/289 (38%), Gaps = 59/289 (20%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVALKH 142
            +G GSF  V++    ET   VA  ++   K  K+       E ++++ L HPNIV    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
            + ST   ++  + LV E +   T+    + Y +  + M +  ++ +  QI + L ++H 
Sbjct: 93  SWESTVKGKK-CIVLVTELMTSGTL----KTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147

Query: 202 C-IGICHRDIKPQNLLVKGEPNV------------------SYICSRYYRAPELIFGATE 242
               I HRD+K  N+ + G                      + I +  + APE+     +
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMY--EEK 205

Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 302
           Y  ++D+++ G  M E+   +  +       Q+   +                       
Sbjct: 206 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT---------------------- 243

Query: 303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 351
             +KP      F K   PE  +++    + + + R +  +   H FF E
Sbjct: 244 SGVKP----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  149 bits (379), Expect = 2e-42
 Identities = 71/299 (23%), Positives = 115/299 (38%), Gaps = 71/299 (23%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y    ++G GSFG V + K R T +  A+K + +            RE+++++ LDHPNI
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
           + L        D    Y  +V E     E  + I +   +S                Q+ 
Sbjct: 84  MKLFEIL---EDSSSFY--IVGELYTGGELFDEIIKRKRFSE-------HDAARIIKQVF 131

Query: 194 RALAYIHNCIGICHRDIKPQNLL------------------VKGEPNVSY--IC-SRYYR 232
             + Y+H    I HRD+KP+N+L                     + N        + YY 
Sbjct: 132 SGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190

Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++ G   Y    D+WS G ++  LL G P F G++  D L  +              
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET------------ 236

Query: 293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 351
                 ++ F       W  +       +A DL+ +   + P+LR TA +   HP+  +
Sbjct: 237 -----GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  150 bits (381), Expect = 4e-42
 Identities = 73/358 (20%), Positives = 121/358 (33%), Gaps = 85/358 (23%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y+    +G GSFG     K  E G    IK++       +++    RE+ ++  + HPNI
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           V  +  F     +E   L +V++Y    +   RI     +         +  +  QIC A
Sbjct: 86  VQYRESF-----EENGSLYIVMDYCEGGDLFKRINA---QKGVLFQEDQILDWFVQICLA 137

Query: 196 LAYIHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPEL 236
           L ++H+   I HRDIK QN+ +  +  V                   + I + YY +PE+
Sbjct: 138 LKHVHDR-KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI 196

Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 296
                 Y    DIW+ GCV+ EL   +  F   S +  LV  I             ++ +
Sbjct: 197 CEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLVLKII------SGSFPPVSLH 248

Query: 297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL---- 352
           Y                       +   LV + F+ +P  R +        F  +     
Sbjct: 249 Y---------------------SYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKF 287

Query: 353 ----------------RDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARK 394
                           +  +  +P  RP     +        I        IP   +K
Sbjct: 288 LSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAYKK 345

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  148 bits (376), Expect = 4e-42
 Identities = 70/304 (23%), Positives = 116/304 (38%), Gaps = 84/304 (27%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALKHC 143
           G GSF  V++A+   TG  VAIK + +   YK         E++I   L HP+I+ L + 
Sbjct: 20  GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79

Query: 144 FFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
           F    D   +YL  VLE     E    +        +       + + +QI   + Y+H+
Sbjct: 80  F---EDSNYVYL--VLEMCHNGEMNRYLKNR----VKPFSENEARHFMHQIITGMLYLHS 130

Query: 202 CIGICHRDIKPQNLL------VK---------------------GEPNVSYICSRYYRAP 234
             GI HRD+   NLL      +K                     G PN        Y +P
Sbjct: 131 H-GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN--------YISP 181

Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
           E+    + +    D+WS GC+   LL+G+P F  ++  + L +++               
Sbjct: 182 EIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA------------- 227

Query: 295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 354
               +++ P      +       L  EA DL+ +  + +P  R +      HPF      
Sbjct: 228 ----DYEMP-----SF-------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSS 271

Query: 355 PNTR 358
             ++
Sbjct: 272 TKSK 275

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  151 bits (382), Expect = 5e-42
 Identities = 81/360 (22%), Positives = 129/360 (35%), Gaps = 67/360 (18%)

Query: 41  DQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQ 100
            +V    D     D            +   +  + G+      Y     +G+G+FGVV +
Sbjct: 12  SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDY--YDILEELGSGAFGVVHR 69

Query: 101 AKCRETGEIVAIK----KVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN 156
              + TG +   K        DK     E+ IM  L HP ++ L   F    DK E+   
Sbjct: 70  CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF---EDKYEMV-- 124

Query: 157 LVLEYVP--ETVNRI-ARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ 213
           L+LE++   E  +RI A +Y      M    V  Y  Q C  L ++H    I H DIKP+
Sbjct: 125 LILEFLSGGELFDRIAAEDYK-----MSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPE 178

Query: 214 NLL-------------------VKGEPNVSYIC-SRYYRAPELIFGATEYTTAIDIWSTG 253
           N++                   +  +  V     +  + APE I          D+W+ G
Sbjct: 179 NIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-IVDREPVGFYTDMWAIG 237

Query: 254 CVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKV 313
            +   LL G   F GE  ++ L  + +                  +++F       +  V
Sbjct: 238 VLGYVLLSGLSPFAGEDDLETLQNVKRC-----------------DWEFD---EDAFSSV 277

Query: 314 FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF-DELRDPNTRLPNGRPLPPLFNFK 372
                 PEA D +    Q  P  R T  +A  HP+   +  +  +R+P+ R        K
Sbjct: 278 -----SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIK 332

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  149 bits (378), Expect = 8e-42
 Identities = 70/317 (22%), Positives = 120/317 (37%), Gaps = 60/317 (18%)

Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHC 143
           +++ V+G G  G V +   R TG+  A+K +L D     +E+         P+IV +   
Sbjct: 32  LSKQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILD- 89

Query: 144 FFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKLYTYQICRALA 197
            +      +  L +++E +   E        +SRI +R    +           I  A+ 
Sbjct: 90  VYENMHHGKRCLLIIMECMEGGEL-------FSRIQERGDQAFTEREAAEIMRDIGTAIQ 142

Query: 198 YIHNCIGICHRDIKPQNLLVKGEPNVSYI--------------------CSRYYRAPELI 237
           ++H+   I HRD+KP+NLL   +   + +                     + YY APE +
Sbjct: 143 FLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPE-V 200

Query: 238 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 297
            G  +Y  + D+WS G +M  LL G P F   +G      + +         I+      
Sbjct: 201 LGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR--------RIRLG---- 248

Query: 298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF-DELRDPN 356
            ++ FP      W +V       +A  L+    +  P  R T  +   HP+    +  P 
Sbjct: 249 -QYGFP---NPEWSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ 299

Query: 357 TRLPNGRPLPPLFNFKP 373
           T L   R L    +   
Sbjct: 300 TPLHTARVLQEDKDHWD 316

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  148 bits (376), Expect = 9e-42
 Identities = 61/327 (18%), Positives = 98/327 (29%), Gaps = 73/327 (22%)

Query: 70  TIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRE 125
            I  ++        Y+    +G G F  V   +    G   A+K++L    QD+    RE
Sbjct: 25  IIDNKH--------YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQRE 76

Query: 126 LQIMQMLDHPNIVALKHCFF-STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLI 183
             + ++ +HPNI+ L          K E +  L+L +    T+             +   
Sbjct: 77  ADMHRLFNHPNILRLVAYCLRERGAKHEAW--LLLPFFKRGTLWNEIERLKDKGNFLTED 134

Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV-------------------------- 217
            +      ICR L  IH   G  HRD+KP N+L+                          
Sbjct: 135 QILWLLLGICRGLEAIHAK-GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ 193

Query: 218 --KGEPNVSYICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD 273
               +   +  C+  YRAPEL             D+WS GCV+  ++ G+  +       
Sbjct: 194 ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253

Query: 274 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 333
             V +  V                 +   PQ            R       L+       
Sbjct: 254 DSVALA-VQN---------------QLSIPQ----------SPRHSSALWQLLNSMMTVD 287

Query: 334 PNLRCTALEACVHPFFDELRDPNTRLP 360
           P+ R             +   P     
Sbjct: 288 PHQRPHIPLLLSQLEALQPPAPGQHTT 314

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  146 bits (370), Expect = 2e-41
 Identities = 52/304 (17%), Positives = 102/304 (33%), Gaps = 69/304 (22%)

Query: 77  NSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPN 136
           + +  + +    ++G+G FG VF+AK R  G+   IK+V  +     RE++ +  LDH N
Sbjct: 6   DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVN 65

Query: 137 IVALKHCF-----------FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLI 183
           IV    C+            +++  +   L + +E+         I +   R  +++  +
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK---RRGEKLDKV 122

Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV------------------SY 225
                  QI + + YIH+   + +RD+KP N+ +     V                    
Sbjct: 123 LALELFEQITKGVDYIHSK-KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS 181

Query: 226 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 285
             +  Y +PE I    +Y   +D+++ G ++AELL                ++       
Sbjct: 182 KGTLRYMSPEQISS-QDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRD----- 233

Query: 286 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 345
                                      +       +   L+ +     P  R    E   
Sbjct: 234 --------------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILR 267

Query: 346 HPFF 349
               
Sbjct: 268 TLTV 271

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  148 bits (376), Expect = 3e-41
 Identities = 73/319 (22%), Positives = 113/319 (35%), Gaps = 70/319 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y  +  +G G+F VV +   + TG   A K +   K          RE +I + L HPNI
Sbjct: 31  YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
           V L        ++   Y  LV + V   E    I     YS                QI 
Sbjct: 91  VRLHDSI---QEESFHY--LVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL 138

Query: 194 RALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI------CSR---------------YYR 232
            ++AY H+  GI HR++KP+NLL+  +   + +       +                 Y 
Sbjct: 139 ESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYL 197

Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           +PE +     Y+  +DIW+ G ++  LL+G P F  E       +I              
Sbjct: 198 SPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG----------- 245

Query: 293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
                  + +P      W  V      PEA  L+      +P  R TA +A   P+    
Sbjct: 246 ------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291

Query: 353 RDPNTRLPNGRPLPPLFNF 371
               + +     +  L  F
Sbjct: 292 ERVASAIHRQDTVDCLKKF 310

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  147 bits (373), Expect = 3e-41
 Identities = 74/348 (21%), Positives = 124/348 (35%), Gaps = 103/348 (29%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL---------QDKRYKNRELQIMQMLDH 134
           Y  +  +G GS+GVV  A   +T  I AIK +          +D      E+++M+ L H
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87

Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKL----- 187
           PNI  L   +    D++ + L  V+E       ++++         +  +  VK      
Sbjct: 88  PNIARLYEVY---EDEQYICL--VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142

Query: 188 ------------------------------YTYQICRALAYIHNCIGICHRDIKPQNLLV 217
                                            QI  AL Y+HN  GICHRDIKP+N L 
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-GICHRDIKPENFLF 201

Query: 218 KGEPN------------------------VSYIC-SRYYRAPELIFGATE-YTTAIDIWS 251
               +                        ++    + Y+ APE++    E Y    D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 252 TGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWH 311
            G ++  LL+G   FPG +  D + +++                   +  F       ++
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLN-----------------KKLCFE---NPNYN 301

Query: 312 KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 359
            +      P A DL+      + + R  A+ A  HP+  +  D   ++
Sbjct: 302 VL-----SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKM 344

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  147 bits (373), Expect = 5e-41
 Identities = 79/325 (24%), Positives = 117/325 (36%), Gaps = 75/325 (23%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDH 134
           Y    V+G G F VV +   RETG+  A+K V   K   +         RE  I  ML H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKLY 188
           P+IV L   +   +    LY  +V E++   +    I +           +Y       Y
Sbjct: 86  PHIVELLETY---SSDGMLY--MVFEFMDGADLCFEIVK-----RADAGFVYSEAVASHY 135

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI------CSR------------- 229
             QI  AL Y H+   I HRD+KP  +L+  + N + +       +              
Sbjct: 136 MRQILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194

Query: 230 ---YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 286
              ++ APE +     Y   +D+W  G ++  LL G   F G    ++L E I       
Sbjct: 195 GTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGII------ 245

Query: 287 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 346
                       ++K     P  W  +        A DLV R     P  R T  EA  H
Sbjct: 246 ----------KGKYKMN---PRQWSHI-----SESAKDLVRRMLMLDPAERITVYEALNH 287

Query: 347 PFFDELRDPNTRLPNGRPLPPLFNF 371
           P+  E      ++     +  L  F
Sbjct: 288 PWLKERDRYAYKIHLPETVEQLRKF 312

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  147 bits (372), Expect = 8e-41
 Identities = 83/291 (28%), Positives = 115/291 (39%), Gaps = 65/291 (22%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALK 141
           +  E  +G G+  +V++ K + T +  A+K + +    K    E+ ++  L HPNI+ LK
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLK 114

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALA 197
             F       E+   LVLE V   E  +RI     YS   +R     VK    QI  A+A
Sbjct: 115 EIF---ETPTEIS--LVLELVTGGELFDRIVEKGYYS---ERDAADAVK----QILEAVA 162

Query: 198 YIHNCIGICHRDIKPQNLL------------------VKGEPNVSY--IC-SRYYRAPEL 236
           Y+H   GI HRD+KP+NLL                     E  V    +C +  Y APE 
Sbjct: 163 YLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPE- 220

Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 296
           I     Y   +D+WS G +   LL G   F  E G   +   I            C    
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL----------NC---- 266

Query: 297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 347
             E+ F       W +V        A DLV +     P  R T  +A  HP
Sbjct: 267 --EYYFI---SPWWDEV-----SLNAKDLVRKLIVLDPKKRLTTFQALQHP 307

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  146 bits (369), Expect = 1e-40
 Identities = 58/292 (19%), Positives = 98/292 (33%), Gaps = 66/292 (22%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNRELQIMQMLDHPNIVALKH 142
              +  VG GSFG V + K ++TG   A+KKV L+   ++  EL     L  P IV L  
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGLSSPRIVPLYG 117

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                  +E  ++N+ +E +   ++ ++ +        +P      Y  Q    L Y+H 
Sbjct: 118 AV-----REGPWVNIFMELLEGGSLGQLIKQMGC----LPEDRALYYLGQALEGLEYLHT 168

Query: 202 CIGICHRDIKPQNLLV-------------------------KGEPNVSYICSRYYRAPEL 236
              I H D+K  N+L+                                   +  + APE+
Sbjct: 169 R-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227

Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 296
           + G       +DIWS+ C+M  +L G   +         ++I      P           
Sbjct: 228 VMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-EPPPI---------- 275

Query: 297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                  +I P            P     +    +  P  R +A+E      
Sbjct: 276 ------REIPPS---------CAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  143 bits (364), Expect = 2e-40
 Identities = 71/297 (23%), Positives = 108/297 (36%), Gaps = 70/297 (23%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y  +  +G G+F VV +   + TG   A K +   K          RE +I + L HPNI
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
           V L        ++   Y  LV + V   E    I     YS                QI 
Sbjct: 68  VRLHDSI---QEESFHY--LVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL 115

Query: 194 RALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI------CSR---------------YYR 232
            ++AY H+  GI HR++KP+NLL+  +   + +       +                 Y 
Sbjct: 116 ESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYL 174

Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           +PE +     Y+  +DIW+ G ++  LL+G P F  E       +I              
Sbjct: 175 SPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG----------- 222

Query: 293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
                  + +P      W  V      PEA  L+      +P  R TA +A   P+ 
Sbjct: 223 ------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  143 bits (364), Expect = 3e-40
 Identities = 73/298 (24%), Positives = 114/298 (38%), Gaps = 35/298 (11%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQ-MLDHPNIVALKH 142
            +   V+G G  G V Q   + T E  A+ K+LQD     RE+++       P+IV +  
Sbjct: 20  KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 78

Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             +         L +V+E +   E  +RI     R  Q             I  A+ Y+H
Sbjct: 79  -VYENLYAGRKCLLIVMECLDGGELFSRIQ---DRGDQAFTEREASEIMKSIGEAIQYLH 134

Query: 201 NCIGICHRDIKPQNLLVKGE-PNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAEL 259
           +   I HRD+KP+NLL   + PN     + +  A E      +Y  + D+WS G +M  L
Sbjct: 135 SI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--GEKYDKSCDMWSLGVIMYIL 191

Query: 260 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLP 319
           L G P F    G+     +           I+       +++FP      W +V      
Sbjct: 192 LCGYPPFYSNHGLAISPGMK--------TRIR-----MGQYEFP---NPEWSEV-----S 230

Query: 320 PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD-PNTRLPNGRPLPPLFNFKPPEL 376
            E   L+    +  P  R T  E   HP+  +    P T L   R L      +  ++
Sbjct: 231 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVL-KEDKERWEDV 287

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  147 bits (372), Expect = 4e-40
 Identities = 71/320 (22%), Positives = 116/320 (36%), Gaps = 71/320 (22%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y     +G G+F VV +      G+  A   +   K          RE +I ++L HPNI
Sbjct: 13  YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQIC 193
           V L       +++   Y  L+ + V   E    I     YS   +      ++    QI 
Sbjct: 73  VRLHDSI---SEEGHHY--LIFDLVTGGELFEDIVAREYYS---EADASHCIQ----QIL 120

Query: 194 RALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI------CSR----------------YY 231
            A+ + H   G+ HR++KP+NLL+  +   + +       +                  Y
Sbjct: 121 EAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179

Query: 232 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 291
            +PE +     Y   +D+W+ G ++  LL+G P F  E       +I             
Sbjct: 180 LSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA----------- 227

Query: 292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 351
                   + FP      W  V      PEA DL+ +    +P+ R TA EA  HP+   
Sbjct: 228 ------GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWISH 273

Query: 352 LRDPNTRLPNGRPLPPLFNF 371
                + +     +  L  F
Sbjct: 274 RSTVASCMHRQETVDCLKKF 293

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  144 bits (365), Expect = 4e-40
 Identities = 70/294 (23%), Positives = 113/294 (38%), Gaps = 71/294 (24%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVA---IKKVLQDKRYKNRELQIMQMLDHPNIVAL 140
           Y+    +G G FG+V +     + +      +K    D+    +E+ I+ +  H NI+ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRI-ARNYSRIHQRMPLIY----VKLYTYQIC 193
              F      EEL   ++ E++   +   RI    +               +  Y +Q+C
Sbjct: 67  HESF---ESMEELV--MIFEFISGLDIFERINTSAFE---------LNEREIVSYVHQVC 112

Query: 194 RALAYIHNCIGICHRDIKPQNLL-------------------VKGEPNVSYIC-SRYYRA 233
            AL ++H+   I H DI+P+N++                   +K   N   +  +  Y A
Sbjct: 113 EALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171

Query: 234 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 293
           PE +      +TA D+WS G ++  LL G   F  E+  +Q  +II        E I   
Sbjct: 172 PE-VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQ--QII--------ENIMNA 218

Query: 294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 347
              + E  F +I               EA+D V R        R TA EA  HP
Sbjct: 219 EYTFDEEAFKEIS-------------IEAMDFVDRLLVKERKSRMTASEALQHP 259

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  142 bits (361), Expect = 7e-40
 Identities = 64/317 (20%), Positives = 112/317 (35%), Gaps = 77/317 (24%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-----QDKRYKNRELQIMQMLDHPNIV 138
           +     +G G FGVVF+AK +      AIK++        +    RE++ +  L+HP IV
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 139 ALKHCFF-------STTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTY 190
              + +              ++YL + ++    E +         I +R           
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHIFL 125

Query: 191 QICRALAYIHNCIGICHRDIKPQNLL------VK-------------------------G 219
           QI  A+ ++H+  G+ HRD+KP N+       VK                          
Sbjct: 126 QIAEAVEFLHSK-GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184

Query: 220 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
             +   + ++ Y +PE I G   Y+  +DI+S G ++ ELL   P F  +    + +  +
Sbjct: 185 ARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FSTQMERVRTLTDV 240

Query: 280 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT 339
           +                    KFP +              P    +V      SP  R  
Sbjct: 241 R------------------NLKFPPLFTQ---------KYPCEYVMVQDMLSPSPMERPE 273

Query: 340 ALEACVHPFFDELRDPN 356
           A+    +  F++L  P 
Sbjct: 274 AINIIENAVFEDLDFPG 290

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  145 bits (367), Expect = 8e-40
 Identities = 76/311 (24%), Positives = 117/311 (37%), Gaps = 61/311 (19%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKH 142
            +   V+G G  G V Q   + T E  A+ K+LQD     RE+++       P+IV +  
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRI-V 121

Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKLYTYQICRAL 196
             +         L +V+E +   E        +SRI  R    +           I  A+
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGEL-------FSRIQDRGDQAFTEREASEIMKSIGEAI 174

Query: 197 AYIHNCIGICHRDIKPQNLL--------------------VKGEPNVSYIC-SRYYRAPE 235
            Y+H+   I HRD+KP+NLL                         +++  C + YY APE
Sbjct: 175 QYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233

Query: 236 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 295
            + G  +Y  + D+WS G +M  LL G P F    G+     +           I+    
Sbjct: 234 -VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIR---- 280

Query: 296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD- 354
              +++FP      W +V       E   L+    +  P  R T  E   HP+  +    
Sbjct: 281 -MGQYEFPN---PEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 331

Query: 355 PNTRLPNGRPL 365
           P T L   R L
Sbjct: 332 PQTPLHTSRVL 342

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  142 bits (360), Expect = 9e-40
 Identities = 68/313 (21%), Positives = 110/313 (35%), Gaps = 79/313 (25%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 133
           Y     +G+G F +V + + + TG+  A K          +    +    RE+ I++ + 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKL 187
           HPNI+ L   F    +K ++   L+LE V   E  + +A   S                 
Sbjct: 67  HPNIITLHDIF---ENKTDVV--LILELVSGGELFDFLAEKES---------LTEDEATQ 112

Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLLV--KGEPN-------------------VSYI 226
           +  QI   + Y+H+   I H D+KP+N+++  K  PN                      I
Sbjct: 113 FLKQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI 171

Query: 227 C-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 285
             +  + APE I          D+WS G +   LL G   F GE+  + L  I  V    
Sbjct: 172 FGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV---- 226

Query: 286 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 345
                         + F       +           A D + R     P  R T  ++  
Sbjct: 227 -------------NYDFD---EEYFSNT-----SELAKDFIRRLLVKDPKRRMTIAQSLE 265

Query: 346 HPFFDELRDPNTR 358
           H +   +R  N R
Sbjct: 266 HSWIKAIRRRNVR 278

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  143 bits (362), Expect = 1e-39
 Identities = 64/325 (19%), Positives = 112/325 (34%), Gaps = 76/325 (23%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 133
           Y     +G+G F +V + + + TG   A K          +    +    RE+ I++ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYT 189
           H N++ L   +    ++ ++   L+LE V   E  + +A+  + S             + 
Sbjct: 74  HHNVITLHDVY---ENRTDVV--LILELVSGGELFDFLAQKESLSE-------EEATSFI 121

Query: 190 YQICRALAYIHNCIGICHRDIKPQNLL-------------------VKGEPNVSY--IC- 227
            QI   + Y+H    I H D+KP+N++                    + E  V +  I  
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG 180

Query: 228 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 287
           +  + APE I          D+WS G +   LL G   F G++  + L  I  V      
Sbjct: 181 TPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV------ 233

Query: 288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 347
                       + F       +           A D + +        R T  EA  HP
Sbjct: 234 -----------SYDFD---EEFFSHT-----SELAKDFIRKLLVKETRKRLTIQEALRHP 274

Query: 348 FFDELRDPNTRLPNGRPLPPLFNFK 372
           +     D    +     +  L NF+
Sbjct: 275 WITP-VDNQQAMVRRESVVNLENFR 298

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  148 bits (374), Expect = 1e-39
 Identities = 70/308 (22%), Positives = 123/308 (39%), Gaps = 64/308 (20%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVA 139
           Y     +GTG+FGVV +   R TG   A K V      DK    +E+Q M +L HP +V 
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           L   F    D  E+   ++ E++   E   ++A  ++++ +   + Y++    Q+C+ L 
Sbjct: 219 LHDAF---EDDNEMV--MIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLC 269

Query: 198 YIHNCIGICHRDIKPQNLL-------------------VKGEPNVSYIC-SRYYRAPELI 237
           ++H      H D+KP+N++                   +  + +V     +  + APE+ 
Sbjct: 270 HMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328

Query: 238 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 297
            G        D+WS G +   LL G   F GE+  +            T   +K  + N 
Sbjct: 329 EG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------------TLRNVKSCDWNM 375

Query: 298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF--DELRDP 355
            +  F  I               +  D + +     PN R T  +A  HP+         
Sbjct: 376 DDSAFSGIS-------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422

Query: 356 NTRLPNGR 363
           ++++P+ R
Sbjct: 423 DSQIPSSR 430

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  143 bits (362), Expect = 1e-39
 Identities = 65/327 (19%), Positives = 112/327 (34%), Gaps = 80/327 (24%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 133
           Y     +G+G F VV + + + TG   A K          +    +    RE+ I++ + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIY----VKL 187
           HPN++ L   +    +K ++   L+LE V   E  + +A   S                 
Sbjct: 73  HPNVITLHEVY---ENKTDVI--LILELVAGGELFDFLAEKES---------LTEEEATE 118

Query: 188 YTYQICRALAYIHNCIGICHRDIKPQNLL-------------------VKGEPNVSY--I 226
           +  QI   + Y+H+   I H D+KP+N++                    K +    +  I
Sbjct: 119 FLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177

Query: 227 C-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTP 285
             +  + APE I          D+WS G +   LL G   F G++  + L  +  V    
Sbjct: 178 FGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV---- 232

Query: 286 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 345
                         ++F       +           A D + R     P  R T  ++  
Sbjct: 233 -------------NYEFE---DEYFSNT-----SALAKDFIRRLLVKDPKKRMTIQDSLQ 271

Query: 346 HPFFDELRDPNTRLPNGRPLPPLFNFK 372
           HP+    +D    L        +  FK
Sbjct: 272 HPWIKP-KDTQQALSRKASAVNMEKFK 297

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  142 bits (361), Expect = 4e-39
 Identities = 65/304 (21%), Positives = 114/304 (37%), Gaps = 64/304 (21%)

Query: 71  IGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNREL 126
           +  + G      +     ++G G FG V + +   TG  +A K    + ++DK     E+
Sbjct: 78  VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137

Query: 127 QIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRI-ARNYSRIHQRMPLI 183
            +M  LDH N++ L   F     K ++   LV+EYV   E  +RI   +Y+     +  +
Sbjct: 138 SVMNQLDHANLIQLYDAF---ESKNDIV--LVMEYVDGGELFDRIIDESYN-----LTEL 187

Query: 184 YVKLYTYQICRALAYIHNCIGICHRDIKPQNLL-------------------VKGEPNVS 224
              L+  QIC  + ++H    I H D+KP+N+L                    K    + 
Sbjct: 188 DTILFMKQICEGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246

Query: 225 YIC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 283
               +  + APE +      +   D+WS G +   LL G   F G++  + L  I+    
Sbjct: 247 VNFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC-- 303

Query: 284 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA 343
                           +         +  +       EA + + +      + R +A EA
Sbjct: 304 ---------------RWDLE---DEEFQDI-----SEEAKEFISKLLIKEKSWRISASEA 340

Query: 344 CVHP 347
             HP
Sbjct: 341 LKHP 344

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  142 bits (360), Expect = 5e-39
 Identities = 65/328 (19%), Positives = 111/328 (33%), Gaps = 82/328 (25%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK----------KVLQDKRYKNRELQIMQMLD 133
           Y     +G+G F +V + + + TG   A K          +    +    RE+ I++ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRI-ARNYSRIHQRMPLIY----VK 186
           HPNI+ L   +    ++ ++   L+LE V   E  + +  +                   
Sbjct: 74  HPNIITLHDVY---ENRTDVV--LILELVSGGELFDFLAQKES----------LSEEEAT 118

Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLL-------------------VKGEPNVSY-- 225
            +  QI   + Y+H    I H D+KP+N++                    + E  V +  
Sbjct: 119 SFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177

Query: 226 IC-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 284
           I  +  + APE I          D+WS G +   LL G   F G++  + L  I  V   
Sbjct: 178 IFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV--- 233

Query: 285 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC 344
                          + F       + +         A D + +        R T  EA 
Sbjct: 234 --------------SYDFD---EEFFSQT-----SELAKDFIRKLLVKETRKRLTIQEAL 271

Query: 345 VHPFFDELRDPNTRLPNGRPLPPLFNFK 372
            HP+     D    +     +  L NFK
Sbjct: 272 RHPWITP-VDTQQAMVRRESVVNLENFK 298

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  140 bits (355), Expect = 6e-39
 Identities = 71/316 (22%), Positives = 114/316 (36%), Gaps = 79/316 (25%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK------------KVLQDKRYK-NRELQIMQ 130
           Y  + ++G G   VV +   + T +  A+K            + +Q+ R    +E+ I++
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78

Query: 131 MLD-HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYV 185
            +  HPNI+ LK  +         +  LV + +   E  + +      S    R      
Sbjct: 79  KVSGHPNIIQLKDTY---ETNTFFF--LVFDLMKKGELFDYLTEKVTLSEKETR------ 127

Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-----------------SYIC- 227
                 +   +  +H    I HRD+KP+N+L+  + N+                   +C 
Sbjct: 128 -KIMRALLEVICALHKL-NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCG 185

Query: 228 SRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 282
           +  Y APE+I  +       Y   +D+WSTG +M  LL G P F     +  L  I+   
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG- 244

Query: 283 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 342
                            ++F       W             DLV RF    P  R TA E
Sbjct: 245 ----------------NYQFG---SPEWDDY-----SDTVKDLVSRFLVVQPQKRYTAEE 280

Query: 343 ACVHPFFDELRDPNTR 358
           A  HPFF +      R
Sbjct: 281 ALAHPFFQQYVVEEVR 296

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  140 bits (355), Expect = 2e-38
 Identities = 70/319 (21%), Positives = 115/319 (36%), Gaps = 78/319 (24%)

Query: 65  HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR 124
           H I   +   +        Y  +  +G GS+ V  +   + T    A+K + + KR    
Sbjct: 7   HSIVQQLHRNSIQFTDG--YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE 64

Query: 125 ELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYS----- 174
           E++I+     HPNI+ LK  +    D + +Y  +V E +   E +++I R   +S     
Sbjct: 65  EIEILLRYGQHPNIITLKDVY---DDGKYVY--VVTELMKGGELLDKILRQKFFSEREAS 119

Query: 175 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE-PNVSYI------- 226
            +             + I + + Y+H   G+ HRD+KP N+L   E  N   I       
Sbjct: 120 AV------------LFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGF 166

Query: 227 --------------C-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG 271
                         C +  + APE +     Y  A DIWS G ++  +L G   F     
Sbjct: 167 AKQLRAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225

Query: 272 VDQLVEIIKVL-GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 330
                 + ++  G               +F         W+ V        A DLV +  
Sbjct: 226 DTPEEILARIGSG---------------KFSLS---GGYWNSV-----SDTAKDLVSKML 262

Query: 331 QYSPNLRCTALEACVHPFF 349
              P+ R TA     HP+ 
Sbjct: 263 HVDPHQRLTAALVLRHPWI 281

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  139 bits (353), Expect = 2e-38
 Identities = 63/306 (20%), Positives = 104/306 (33%), Gaps = 65/306 (21%)

Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDH-PNI 137
           +    +G G F VV Q   + TG+  A K + + +R ++       E+ ++++    P +
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           + L   +    +  E+   L+LEY    E  +        + + +    V     QI   
Sbjct: 92  INLHEVY---ENTSEII--LILEYAAGGEIFSLCL---PELAEMVSENDVIRLIKQILEG 143

Query: 196 LAYIHNCIGICHRDIKPQNLL------------------VKGEPNVSY--IC-SRYYRAP 234
           + Y+H    I H D+KPQN+L                   K         I  +  Y AP
Sbjct: 144 VYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAP 202

Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
           E I      TTA D+W+ G +   LL     F GE   +  + I +V             
Sbjct: 203 E-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV------------- 248

Query: 295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 354
                  +       +  V        A D +      +P  R TA     H +  +   
Sbjct: 249 ----NVDYS---EETFSSV-----SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296

Query: 355 PNTRLP 360
            N   P
Sbjct: 297 ENLFHP 302

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  139 bits (352), Expect = 3e-38
 Identities = 64/311 (20%), Positives = 121/311 (38%), Gaps = 61/311 (19%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-NRELQIMQMLD-HPNIVALK 141
            + +  +G GSF +  +   +++ +  A+K + +       +E+  +++ + HPNIV L 
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLH 72

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYSRIHQRMPLIYVKLYTYQICRALA 197
             F    D+   +  LV+E +   E   RI +  ++S   +            ++  A++
Sbjct: 73  EVF---HDQLHTF--LVMELLNGGELFERIKKKKHFS---ETE----ASYIMRKLVSAVS 120

Query: 198 YIHNCIGICHRDIKPQNLLVKGEPNVSYI---------------------C-SRYYRAPE 235
           ++H+  G+ HRD+KP+NLL   E +   I                     C + +Y APE
Sbjct: 121 HMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE 179

Query: 236 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 295
            +     Y  + D+WS G ++  +L GQ  F            ++++     ++IK    
Sbjct: 180 -LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-----KKIKKG-- 231

Query: 296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD- 354
              +F F       W  V       EA DL+       PN R        + +  +    
Sbjct: 232 ---DFSFE---GEAWKNV-----SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280

Query: 355 PNTRLPNGRPL 365
            +  L     L
Sbjct: 281 SSNPLMTPDIL 291

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  138 bits (348), Expect = 2e-37
 Identities = 49/334 (14%), Positives = 102/334 (30%), Gaps = 91/334 (27%)

Query: 78  SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQ 130
            ++  + +   V+G        +A  +ETGE   +      +R  +        E+  ++
Sbjct: 69  GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 128

Query: 131 ML-------------------------DHPNIVALKHCFFSTTDKEELYLNLVLEYVPET 165
           +L                             ++ ++            +L   ++   +T
Sbjct: 129 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 188

Query: 166 VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-- 223
              +  ++S  H+ +        T Q+ R LA +H+  G+ H  ++P ++++     V  
Sbjct: 189 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQRGGVFL 247

Query: 224 -------------SYICSRYYRAPELI----------FGATEYTTAIDIWSTGCVMAELL 260
                            SR +  PEL              T  T + D W+ G V+  + 
Sbjct: 248 TGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307

Query: 261 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPP 320
                   ++ +               E I         F+              K +P 
Sbjct: 308 CADLPITKDAALG------------GSEWI---------FRSC------------KNIPQ 334

Query: 321 EAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 354
               L+  F +Y    R   L+A   P +++LR 
Sbjct: 335 PVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  135 bits (343), Expect = 4e-37
 Identities = 69/325 (21%), Positives = 124/325 (38%), Gaps = 76/325 (23%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN---RELQIMQMLDHP 135
           Y+   ++G GS+G V +    ET    A+K     K+ +    +    +E+Q+++ L H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVP----ETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           N++ L    ++   K+++Y+  V+EY      E ++ +        +R P+     Y  Q
Sbjct: 67  NVIQLVDVLYNEE-KQKMYM--VMEYCVCGMQEMLDSVP------EKRFPVCQAHGYFCQ 117

Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-------SYICSRY-------------- 230
           +   L Y+H+  GI H+DIKP NLL+     +       +     +              
Sbjct: 118 LIDGLEYLHSQ-GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176

Query: 231 YRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 289
           ++ PE+  G   ++   +DIWS G  +  +  G   F G++        I  L     E 
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKL----FEN 224

Query: 290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           I         +  P                P   DL+    +Y P  R +  +   H +F
Sbjct: 225 IG-----KGSYAIP-----GD-------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267

Query: 350 DELRDPNTRLPNGRPLPPLFNFKPP 374
            +   P        P+PP  + K  
Sbjct: 268 RKKHPPAEAPV---PIPPSPDTKDR 289

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  134 bits (340), Expect = 2e-36
 Identities = 81/349 (23%), Positives = 134/349 (38%), Gaps = 77/349 (22%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHP 135
           Y     +G G+F  V  A+   TG  VAIK +  DK   N        RE++IM++L+HP
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHP 74

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           NIV L     +        L L++EY    E  + +       H RM     +    QI 
Sbjct: 75  NIVKLFEVIETEKT-----LYLIMEYASGGEVFDYLVA-----HGRMKEKEARSKFRQIV 124

Query: 194 RALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-----------------C-SRYYRAPE 235
            A+ Y H    I HRD+K +NLL+  + N+                    C +  Y APE
Sbjct: 125 SAVQYCHQ-KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPE 183

Query: 236 LIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
           L  G  +Y    +D+WS G ++  L+ G   F G++ + +L E +               
Sbjct: 184 LFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVL-------------- 227

Query: 295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 354
               +++ P      +       +  +  +L+ RF   +P  R T  +     + +   +
Sbjct: 228 --RGKYRIP-----FY-------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273

Query: 355 PNTRLPNGRPLPPLFNFKPPELS---GIPPETINRLIPEHARKQNLFMA 400
            +   P   P   + + K  ++    G   E I   +     K +   A
Sbjct: 274 EDELKPFVEPELDISDQKRIDIMVGMGYSQEEIQESL--SKMKYDEITA 320

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  135 bits (341), Expect = 3e-36
 Identities = 65/307 (21%), Positives = 115/307 (37%), Gaps = 80/307 (26%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----------KVLQDKRYK-NRELQIMQM 131
           Y  + V+G G   VV +   R TG   A+K           + L++ R    RE  I++ 
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155

Query: 132 L-DHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIAR--NYS-RIHQRMPLIYV 185
           +  HP+I+ L   +        ++  LV + +   E  + +      S +          
Sbjct: 156 VAGHPHIITLIDSY---ESSSFMF--LVFDLMRKGELFDYLTEKVALSEK--------ET 202

Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-----------------SYIC- 227
           +     +  A++++H    I HRD+KP+N+L+     +                   +C 
Sbjct: 203 RSIMRSLLEAVSFLHAN-NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCG 261

Query: 228 SRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 282
           +  Y APE++  + +     Y   +D+W+ G ++  LL G P F     +  L  I++  
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG- 320

Query: 283 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 342
                           +++F       W             DL+ R  Q  P  R TA +
Sbjct: 321 ----------------QYQFS---SPEWDDR-----SSTVKDLISRLLQVDPEARLTAEQ 356

Query: 343 ACVHPFF 349
           A  HPFF
Sbjct: 357 ALQHPFF 363

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  133 bits (337), Expect = 3e-36
 Identities = 72/300 (24%), Positives = 109/300 (36%), Gaps = 77/300 (25%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
           ++G GSF  V  A+   T    AIK      ++++    Y  RE  +M  LDHP  V L 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
             F    D E+LY    L Y    E +  I +              + YT +I  AL Y+
Sbjct: 97  FTF---QDDEKLY--FGLSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYL 146

Query: 200 HNCIGICHRDIKPQNLLV--------------KGEPNVSYICSRY-------YRAPELIF 238
           H   GI HRD+KP+N+L+              K     S             Y +PEL+ 
Sbjct: 147 HGK-GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 205

Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 298
                  + D+W+ GC++ +L+ G P F   +    + + I                   
Sbjct: 206 E-KSACKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQKII----------------KL 247

Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP------NLRCTALEACVHPFFDEL 352
           E+ FP            ++  P+A DLV +                       HPFF+ +
Sbjct: 248 EYDFP------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  134 bits (340), Expect = 4e-36
 Identities = 81/352 (23%), Positives = 129/352 (36%), Gaps = 77/352 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKNRELQIMQMLDHPNIV 138
           Y     +G+G+FGV    + + T E+VA+K       + +     RE+   + L HPNIV
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--REIINHRSLRHPNIV 79

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
             K    + T    L   +++EY    E   RI         R      + +  Q+   +
Sbjct: 80  RFKEVILTPTH---LA--IIMEYASGGELYERICN-----AGRFSEDEARFFFQQLLSGV 129

Query: 197 AYIHNCIGICHRDIKPQNLLV--KGEPNVSYIC-------------------SRYYRAPE 235
           +Y H+ + ICHRD+K +N L+     P +  IC                   +  Y APE
Sbjct: 130 SYCHS-MQICHRDLKLENTLLDGSPAPRLK-ICDFGYSKSSVLHSQPKSTVGTPAYIAPE 187

Query: 236 LIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
           ++    EY     D+WS G  +  +L+G   F                   T + I  + 
Sbjct: 188 VLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--------EPRDYRKTIQRILSV- 237

Query: 295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 354
               ++  P              + PE   L+ R F   P  R +  E   H +F  L++
Sbjct: 238 ----KYSIP---DDIR-------ISPECCHLISRIFVADPATRISIPEIKTHSWF--LKN 281

Query: 355 PNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHA------RKQNLFMA 400
               L N         F+ PE      +TI ++I E        R  + FM 
Sbjct: 282 LPADLMN--ESNTGSQFQEPEQPMQSLDTIMQIISEATIPAVRNRCLDDFMT 331

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  132 bits (334), Expect = 9e-36
 Identities = 73/332 (21%), Positives = 119/332 (35%), Gaps = 84/332 (25%)

Query: 85  IAEHVVGTGSFGVVFQAKCRETGEIVAIK----KVLQDKRYKNRELQIMQML-DHPNIVA 139
           + E V+G G+   V       T +  A+K    +    +    RE++++     H N++ 
Sbjct: 16  LQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLE 75

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYT-------- 189
           L   F    +++  Y  LV E +             S IH+R      + +         
Sbjct: 76  LIEFF---EEEDRFY--LVFEKMRGGSI-------LSHIHKR------RHFNELEASVVV 117

Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----------------------- 226
             +  AL ++HN  GI HRD+KP+N+L +    VS +                       
Sbjct: 118 QDVASALDFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176

Query: 227 -----C-SRYYRAPELI----FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV 276
                C S  Y APE++      A+ Y    D+WS G ++  LL G P F G  G D   
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236

Query: 277 EIIKVLGTPTR---EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYS 333
           +  +          E I+       +++FP      W  +        A DL+ +     
Sbjct: 237 DRGEACPACQNMLFESIQEG-----KYEFP---DKDWAHI-----SCAAKDLISKLLVRD 283

Query: 334 PNLRCTALEACVHPFFDELRDPNTRLPNGRPL 365
              R +A +   HP+      P   LP    L
Sbjct: 284 AKQRLSAAQVLQHPWVQG-CAPENTLPTPMVL 314

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  132 bits (335), Expect = 1e-35
 Identities = 66/339 (19%), Positives = 108/339 (31%), Gaps = 73/339 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQML-DHPNIV 138
                V+  G F  V++A+   +G   A+K++L    +  R   +E+  M+ L  HPNIV
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 139 ALKHCFFSTTD--KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
                     +         L+L  + +               +    V    YQ CRA+
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149

Query: 197 AYIHNC-IGICHRDIKPQNLL------VK-------------------------GEPNVS 224
            ++H     I HRD+K +NLL      +K                          E  ++
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209

Query: 225 YICSRYYRAPELI--FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 282
              +  YR PE+I  +         DIW+ GC++  L   Q  F   +     + I+   
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA----KLRIVNG- 264

Query: 283 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 342
                           ++  P   PH                L+    Q +P  R +  E
Sbjct: 265 ----------------KYSIP---PHD-------TQYTVFHSLIRAMLQVNPEERLSIAE 298

Query: 343 ACVHPF-FDELRDPNTRLPNGRPLPPLFNFKPPELSGIP 380
                      R+ N + P    L     +    LS  P
Sbjct: 299 VVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSRGP 337

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  134 bits (338), Expect = 1e-35
 Identities = 58/435 (13%), Positives = 121/435 (27%), Gaps = 106/435 (24%)

Query: 13  SSRSVNGFKSSSSSVDWLGREMLEMRLRDQVDNDEDRDSEPD--IIDGVGAETGHV-IRT 69
            +    GF+ +      +      +   +     E   S  D  +   +        + +
Sbjct: 12  ENLYFQGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVES 71

Query: 70  TIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------ 123
            +G R        + +   V+G        +A  +ETGE   +      +R  +      
Sbjct: 72  ELGER------PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQM 125

Query: 124 -RELQIMQML-------------------------DHPNIVALKHCFFSTTDKEELYLNL 157
             E+  +++L                             ++ ++            +L  
Sbjct: 126 KEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP 185

Query: 158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV 217
            ++   +T   +  ++S  H+ +        T Q+ R LA +H+  G+ H  ++P ++++
Sbjct: 186 RMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVL 244

Query: 218 KGEPNV---------------SYICSRYYRAPELI---------FGATEYTTAIDIWSTG 253
                V                    R +  PE              T  T A D W+ G
Sbjct: 245 DQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304

Query: 254 CVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKV 313
             +  +         ++ +                                        +
Sbjct: 305 LAIYWIWCADLPNTDDAALGGS-----------------------------------EWI 329

Query: 314 FQ--KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD---PNTRLPNGRPLPPL 368
           F+  K +P     L+  F +Y    R   L+A   P +++LR        L      P  
Sbjct: 330 FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTR 389

Query: 369 FNFKPPELSGIPPET 383
               PP  +  P E 
Sbjct: 390 EGGAPPSGTSQPDEA 404

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  130 bits (329), Expect = 2e-35
 Identities = 68/295 (23%), Positives = 113/295 (38%), Gaps = 67/295 (22%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           +     +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
                          YL   LEY    E  +RI          MP    + + +Q+   +
Sbjct: 69  KFYGHRREGNI---QYL--FLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGV 118

Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV-------SYI-------------C-SRYYRAPE 235
            Y+H  IGI HRDIKP+NLL+    N+       + +             C +  Y APE
Sbjct: 119 VYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

Query: 236 LIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
           L+    E+    +D+WS G V+  +L G+  +      DQ  +  +       ++     
Sbjct: 178 LLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN- 229

Query: 295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
                         PW K     +    + L+ +    +P+ R T  +     ++
Sbjct: 230 --------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  130 bits (330), Expect = 4e-35
 Identities = 69/312 (22%), Positives = 117/312 (37%), Gaps = 67/312 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           +     +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
                          YL   LEY    E  +RI          MP    + + +Q+   +
Sbjct: 69  KFYGHRREGNI---QYL--FLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGV 118

Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV-------SYI-------------C-SRYYRAPE 235
            Y+H  IGI HRDIKP+NLL+    N+       + +             C +  Y APE
Sbjct: 119 VYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

Query: 236 LIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
           L+    E+    +D+WS G V+  +L G+  +      DQ  +  +       ++     
Sbjct: 178 LLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN- 229

Query: 295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 354
                         PW K     +    + L+ +    +P+ R T  +     ++++   
Sbjct: 230 --------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270

Query: 355 PNTRLPNGRPLP 366
              + P      
Sbjct: 271 KGAKRPRVTSGG 282

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  129 bits (326), Expect = 5e-35
 Identities = 74/287 (25%), Positives = 117/287 (40%), Gaps = 55/287 (19%)

Query: 73  GRNGNSKQKV-SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------R 124
           G   + + K+  Y+    +G G+FG V   + + TG  VA+K + + K           R
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60

Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPL 182
           E+Q +++  HP+I+ L     + TD    +  +V+EYV   E  + I +     H R+  
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTD---FF--MVMEYVSGGELFDYICK-----HGRVEE 110

Query: 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI---------------- 226
           +  +    QI  A+ Y H    + HRD+KP+N+L+    N                    
Sbjct: 111 MEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 169

Query: 227 -C-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV--- 281
            C S  Y APE+I G       +DIWS G ++  LL G   F  E  V  L + I+    
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-VPTLFKKIRGGVF 228

Query: 282 -----LGTPTREEIKCM---NPNYTEFKFPQIKPHPWHKVFQKRLPP 320
                L       +  M   +P         I+ H W   F++ LP 
Sbjct: 229 YIPEYLNRSVATLLMHMLQVDPL-KRATIKDIREHEW---FKQDLPS 271

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  129 bits (326), Expect = 2e-34
 Identities = 61/314 (19%), Positives = 117/314 (37%), Gaps = 48/314 (15%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQIMQMLDHPNIV 138
           +     +G G+ GVVF+   + +G ++A K +   ++        RELQ++   + P IV
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
                F+S  +     +++ +E++   +++++ +   RI    P   +   +  + + L 
Sbjct: 95  GFYGAFYSDGE-----ISICMEHMDGGSLDQVLKKAGRI----PEQILGKVSIAVIKGLT 145

Query: 198 YIHNCIGICHRDIKPQNLLVKGEPNV-----------------SYICSRYYRAPELIFGA 240
           Y+     I HRD+KP N+LV     +                 S++ +R Y +PE + G 
Sbjct: 146 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 205

Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
             Y+   DIWS G  + E+ +G+   P     +  +     +     E            
Sbjct: 206 H-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264

Query: 301 KFPQIKPHPWHKVFQ----------KRLP-----PEAVDLVCRFFQYSPNLRCTALEACV 345
               +   P   +F+           +LP      E  D V +    +P  R    +  V
Sbjct: 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324

Query: 346 HPFFDELRDPNTRL 359
           H F           
Sbjct: 325 HAFIKRSDAEEVDF 338

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  130 bits (329), Expect = 3e-34
 Identities = 78/370 (21%), Positives = 121/370 (32%), Gaps = 105/370 (28%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKK-----VLQDKR--YKNRELQIMQMLDHPNIVALK 141
           V+G G+F  V   K ++TG++ A+K      +L+         E  ++   D   I  L 
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
             F    D+  LY  LV+EY    + +  +    S+  +R+P    + Y  +I  A+  +
Sbjct: 128 FAF---QDENYLY--LVMEYYVGGDLLTLL----SKFGERIPAEMARFYLAEIVMAIDSV 178

Query: 200 HNCIGICHRDIKPQNLLV---------------KGEPNVSYICSRY-----YRAPELI-- 237
           H  +G  HRDIKP N+L+               K   + +           Y +PE++  
Sbjct: 179 HR-LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237

Query: 238 ----FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 293
                G   Y    D W+ G    E+  GQ  F  +S   +    I             +
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-TAETYGKI-------------V 283

Query: 294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR---CTALEACVHPFF- 349
           +        P +            +P EA D + R     P  R     A +   HPFF 
Sbjct: 284 HYK-EHLSLPLVDEG---------VPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF 332

Query: 350 ----DELRDPNTRLPNGRPLPPLF-----------NF------KPPELSGIPPETINRLI 388
               D LRD            P F           NF          +SG      +   
Sbjct: 333 GLDWDGLRD----------SVPPFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSDIRE 382

Query: 389 PEHARKQNLF 398
                    F
Sbjct: 383 GAPLGVHLPF 392

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  128 bits (323), Expect = 6e-34
 Identities = 83/337 (24%), Positives = 129/337 (38%), Gaps = 78/337 (23%)

Query: 78  SKQKV-SYIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIM 129
           SK+ +  YI    +G GSFG V  A   +T + VA+K      + +   +    RE+  +
Sbjct: 4   SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL 63

Query: 130 QMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLY 188
           ++L HP+I+ L     + TD   +   +V+EY   E  + I        +RM     + +
Sbjct: 64  KLLRHPHIIKLYDVITTPTD---IV--MVIEYAGGELFDYIVE-----KKRMTEDEGRRF 113

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-----------------C-SRY 230
             QI  A+ Y H    I HRD+KP+NLL+    NV                    C S  
Sbjct: 114 FQQIICAIEYCH-RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN 172

Query: 231 YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 290
           Y APE+I G       +D+WS G V+  +L+G+  F  E  +  L + +           
Sbjct: 173 YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVN---------- 221

Query: 291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
                    +  P      +       L P A  L+ R     P  R T  E    P+F 
Sbjct: 222 ------SCVYVMP-----DF-------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF- 262

Query: 351 ELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRL 387
                N  LP       L   +  + S      +++L
Sbjct: 263 -----NVNLP-----DYLRPMEEVQGSYADSRIVSKL 289

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  128 bits (324), Expect = 6e-34
 Identities = 40/297 (13%), Positives = 84/297 (28%), Gaps = 55/297 (18%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIK----KVLQDKRYKNRELQIMQMLD 133
                H++G G+F  V++A        +  +   +K        +     + ++ ++   
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
               +           +    L  V E       +N I    +   + MP   V  +  +
Sbjct: 126 QHMFMKFYSAHL---FQNGSVL--VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYIC------------------------ 227
           +   +  +H+C  I H DIKP N ++                                  
Sbjct: 181 MLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239

Query: 228 --------SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF-PGESGVDQLVEI 278
                   +  ++  E++     +   ID +     +  +L G  +    E G  +   +
Sbjct: 240 TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298

Query: 279 IKVL-GTPTREEIKCMNPNYTEFKFPQIKP---HPWHKVFQKRLPPEAVDLVCRFFQ 331
            + L       E   +  N  +               KVFQ+    +   L  R   
Sbjct: 299 FRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIV 355

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  128 bits (325), Expect = 7e-34
 Identities = 73/319 (22%), Positives = 124/319 (38%), Gaps = 78/319 (24%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
            +G GSFG V   +  +T ++ A+K     K ++    R   +ELQIMQ L+HP +V L 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F    D+E++++  V++ +   +    + +N            VKL+  ++  AL Y+
Sbjct: 82  YSF---QDEEDMFM--VVDLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYL 131

Query: 200 HNCIGICHRDIKPQNLL------------------VKGEPNVSYICSRYYRAPELIF--G 239
            N   I HRD+KP N+L                   +     +   ++ Y APE+     
Sbjct: 132 QNQ-RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRK 190

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--VDQLVEIIKVLGTPTREEIKCMNPNY 297
              Y+ A+D WS G    ELL G+  +   S     ++V   +                 
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE----------------T 234

Query: 298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA-CVHPFFDELRDPN 356
           T   +P                 E V L+ +  + +P+ R + L      P+     D N
Sbjct: 235 TVVTYPS------------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM---NDIN 279

Query: 357 -TRLPNGRPLPPLFNFKPP 374
              +   R +P    F P 
Sbjct: 280 WDAVFQKRLIPG---FIPN 295

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  128 bits (324), Expect = 2e-33
 Identities = 70/306 (22%), Positives = 113/306 (36%), Gaps = 74/306 (24%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
           V+G G+FG V   K +   ++ A+K     ++L+         E  ++   D   I  L 
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F    D   LY  LV++Y    + +  +    S+   R+P    + Y  ++  A+  +
Sbjct: 141 YAF---QDDNNLY--LVMDYYVGGDLLTLL----SKFEDRLPEEMARFYLAEMVIAIDSV 191

Query: 200 HNCIGICHRDIKPQNLLV---------------KGEPNVSYICSRY-----YRAPELI-- 237
           H  +   HRDIKP N+L+               K   + +   S       Y +PE++  
Sbjct: 192 HQ-LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250

Query: 238 --FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 295
              G   Y    D WS G  M E+L G+  F  ES + +    I             MN 
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKI-------------MNH 296

Query: 296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN-LRCT-ALEACVHPFF---- 349
               F+FP              +   A DL+ R      + L      +   HPFF    
Sbjct: 297 K-ERFQFPTQVTD---------VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID 346

Query: 350 -DELRD 354
            D +R+
Sbjct: 347 WDNIRN 352

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  128 bits (324), Expect = 3e-33
 Identities = 79/373 (21%), Positives = 139/373 (37%), Gaps = 87/373 (23%)

Query: 41  DQVDNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVS-----YIAEHVVGTGSF 95
             V +   + +  ++    G+ + +     +       K +V+     Y+   ++G G+F
Sbjct: 104 QTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLK--LLGKGTF 161

Query: 96  GVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLDHPNIVALKHCFFSTT 148
           G V   K + TG   A+K      ++      +   E +++Q   HP + ALK+ F  T 
Sbjct: 162 GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-QTH 220

Query: 149 DKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
           D+  L    V+EY    E    ++R      +       + Y  +I  AL Y+H+   + 
Sbjct: 221 DR--LCF--VMEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSEKNVV 271

Query: 207 HRDIKPQNLLVKGE------------PNVSYICSRY-------YRAPELIFGATEYTTAI 247
           +RD+K +NL++  +              +    +         Y APE++    +Y  A+
Sbjct: 272 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAV 330

Query: 248 DIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKP 307
           D W  G VM E++ G+  F  +   ++L E+I                   E +FP    
Sbjct: 331 DWWGLGVVMYEMMCGRLPFYNQD-HEKLFELIL----------------MEEIRFP---- 369

Query: 308 HPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELRDPN-TRLPN 361
                   + L PEA  L+    +  P  R       A E   H FF          +  
Sbjct: 370 --------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF---AGIVWQHVYE 418

Query: 362 GRPLPPLFNFKPP 374
            +  PP   FKP 
Sbjct: 419 KKLSPP---FKPQ 428

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  125 bits (316), Expect = 5e-33
 Identities = 77/319 (24%), Positives = 125/319 (39%), Gaps = 81/319 (25%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLDHPNIVALK 141
           ++G G+FG V   + + TG   A+K      ++      +   E +++Q   HP + ALK
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           +  F T D+  L    V+EY    E    ++R      +       + Y  +I  AL Y+
Sbjct: 72  YA-FQTHDR--LC--FVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYL 121

Query: 200 HNCIGICHRDIKPQNLLVKGE------------PNVSYICSRY-------YRAPELIFGA 240
           H+   + +RDIK +NL++  +              +S   +         Y APE++   
Sbjct: 122 HS-RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED- 179

Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
            +Y  A+D W  G VM E++ G+  F  +   ++L E+I                   E 
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELIL----------------MEEI 222

Query: 301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELRDP 355
           +FP            + L PEA  L+    +  P  R       A E   H FF      
Sbjct: 223 RFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF---LSI 267

Query: 356 N-TRLPNGRPLPPLFNFKP 373
           N   +   + LPP   FKP
Sbjct: 268 NWQDVVQKKLLPP---FKP 283

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  124 bits (313), Expect = 1e-32
 Identities = 83/350 (23%), Positives = 142/350 (40%), Gaps = 87/350 (24%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
            +GTGSFG V   + R  G   A+K      V++ K   + N E  ++ ++ HP I+ + 
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
             F    D ++++  ++++Y+   E  + + ++     QR P    K Y  ++C AL Y+
Sbjct: 73  GTF---QDAQQIF--MIMDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYL 122

Query: 200 HNCIGICHRDIKPQNLLV--------------KGEPNVSY-IC-SRYYRAPELIFGATEY 243
           H+   I +RD+KP+N+L+              K  P+V+Y +C +  Y APE++     Y
Sbjct: 123 HSK-DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVST-KPY 180

Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 303
             +ID WS G ++ E+L G   F   +   +  E I                   E +FP
Sbjct: 181 NKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKIL----------------NAELRFP 223

Query: 304 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP-----NLRCTALEACVHPFFDELRDPN-T 357
                            +  DL+ R           NL+    +   HP+F E+      
Sbjct: 224 ------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV---VWE 268

Query: 358 RLPNGRPLPPLFNFKPPELSG---------IPPETINRLIPEHARKQNLF 398
           +L +     P   ++PP   G          P E IN  +       +LF
Sbjct: 269 KLLSRNIETP---YEPPIQQGQGDTSQFDKYPEEDINYGVQGEDPYADLF 315

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  126 bits (318), Expect = 5e-32
 Identities = 70/321 (21%), Positives = 111/321 (34%), Gaps = 75/321 (23%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 140
           V+G G FG VF  + + TG++ A  K L  KR K R        E +I+  +    IV+L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYAC-KKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            +  F T       L LV+  +   +    I       +          YT QI   L +
Sbjct: 251 AYA-FETKTD----LCLVMTIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEH 304

Query: 199 IHNCIGICHRDIKPQNLL------------------VKGEPNVSYIC-SRYYRAPELIFG 239
           +H    I +RD+KP+N+L                    G+        +  + APEL+ G
Sbjct: 305 LHQR-NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 299
             EY  ++D ++ G  + E++  +  F       +  E+         + +      Y +
Sbjct: 364 -EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK--------QRVLEQAVTYPD 414

Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELRD 354
                               P + D      Q  P  R      +      HP F   RD
Sbjct: 415 K-----------------FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF---RD 454

Query: 355 PN-TRLPNGRPLPPLFNFKPP 374
            +  +L  G   PP   F P 
Sbjct: 455 ISWRQLEAGMLTPP---FVPD 472

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  121 bits (307), Expect = 5e-32
 Identities = 64/312 (20%), Positives = 107/312 (34%), Gaps = 90/312 (28%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN---------------------- 123
           G GS+GVV  A         A+K     K+++   +                        
Sbjct: 22  GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81

Query: 124 ---RELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQ 178
              +E+ I++ LDHPN+V L        +++ LY+  V E V     +           +
Sbjct: 82  QVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLYM--VFELVNQGPVMEVPT------LK 132

Query: 179 RMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-------SYICSR-- 229
            +     + Y   + + + Y+H    I HRDIKP NLLV  + ++       S       
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHY-QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191

Query: 230 ----------YYRAPELIFGAT-EYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 277
                      + APE +      ++  A+D+W+ G  +   + GQ  F  E  +  L  
Sbjct: 192 ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER-IMCLHS 250

Query: 278 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 337
            IK                    +FP     P        +  +  DL+ R    +P  R
Sbjct: 251 KIK----------------SQALEFPD---QPD-------IAEDLKDLITRMLDKNPESR 284

Query: 338 CTALEACVHPFF 349
               E  +HP+ 
Sbjct: 285 IVVPEIKLHPWV 296

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  126 bits (319), Expect = 6e-32
 Identities = 67/322 (20%), Positives = 116/322 (36%), Gaps = 80/322 (24%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRE-----------LQIMQMLDHPNI 137
           ++G G FG V+  +  +TG++ A+ K L  KR K ++           L ++   D P I
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAM-KCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           V + + F      ++L    +L+ +   +    +++     H       ++ Y  +I   
Sbjct: 255 VCMSYAF---HTPDKLS--FILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILG 304

Query: 196 LAYIHNCIGICHRDIKPQNLLVKGEPNVSY----ICSRY-------------YRAPELIF 238
           L ++HN   + +RD+KP N+L+    +V      +   +             Y APE++ 
Sbjct: 305 LEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ 363

Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 298
               Y ++ D +S GC++ +LL G   F      D             + EI        
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------------KHEI-------- 402

Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR--CT---ALEACVHPFFDELR 353
                                PE   L+    Q   N R  C    A E    PFF  L 
Sbjct: 403 ---DRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL- 456

Query: 354 DPN-TRLPNGRPLPPLFNFKPP 374
             +   +   +  PP     PP
Sbjct: 457 --DWQMVFLQKYPPP---LIPP 473

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  124 bits (314), Expect = 8e-32
 Identities = 72/287 (25%), Positives = 115/287 (40%), Gaps = 55/287 (19%)

Query: 73  GRNGNSKQKV-SYIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--R 124
            +  + + K+  YI    +G G+FG V   K   TG  VA+K     K+          R
Sbjct: 6   KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR 65

Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPL 182
           E+Q +++  HP+I+ L     + +D   ++  +V+EYV   E  + I +     + R+  
Sbjct: 66  EIQNLKLFRHPHIIKLYQVISTPSD---IF--MVMEYVSGGELFDYICK-----NGRLDE 115

Query: 183 IYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI---------------- 226
              +    QI   + Y H    + HRD+KP+N+L+    N                    
Sbjct: 116 KESRRLFQQILSGVDYCH-RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 174

Query: 227 -C-SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV--- 281
            C S  Y APE+I G       +DIWS+G ++  LL G   F  +  V  L + I     
Sbjct: 175 SCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKICDGIF 233

Query: 282 -----LGTPTREEIKCM---NPNYTEFKFPQIKPHPWHKVFQKRLPP 320
                L       +K M   +P         I+ H W   F++ LP 
Sbjct: 234 YTPQYLNPSVISLLKHMLQVDPM-KRATIKDIREHEW---FKQDLPK 276

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  121 bits (305), Expect = 9e-32
 Identities = 62/298 (20%), Positives = 112/298 (37%), Gaps = 58/298 (19%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQI-MQMLDHPNIVALKH 142
            +G G++GVV + +   +G+I+A+K++   +  +  K    +L I M+ +D P  V    
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
             F   D     + + +E +  ++++  +      Q +P   +      I +AL ++H+ 
Sbjct: 74  ALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128

Query: 203 IGICHRDIKPQNLLVKGEPNV------------------SYICSRYYRAPELIFG---AT 241
           + + HRD+KP N+L+     V                       + Y APE I       
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQK 188

Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            Y+   DIWS G  M EL + +  +       Q ++ + V                    
Sbjct: 189 GYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPS---------------- 231

Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 359
            PQ+    +          E VD   +  + +   R T  E   HPFF       T +
Sbjct: 232 -PQLPADKF--------SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDV 280

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  120 bits (302), Expect = 3e-31
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 43/218 (19%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
           E VVG G+FGVV +AK R   + VAIK++  +   K    EL+ +  ++HPNIV L    
Sbjct: 13  EEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA- 69

Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYT-----YQICRALAY 198
               +     + LV+EY    ++      Y+ +H   PL Y           Q  + +AY
Sbjct: 70  --CLNP----VCLVMEYAEGGSL------YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117

Query: 199 IHNC--IGICHRDIKPQNLLVKGEPNVSYIC----SRY-------------YRAPELIFG 239
           +H+     + HRD+KP NLL+     V  IC    +               + APE+  G
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEG 177

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 277
            + Y+   D++S G ++ E++  +  F    G    + 
Sbjct: 178 -SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  123 bits (311), Expect = 4e-31
 Identities = 80/320 (25%), Positives = 124/320 (38%), Gaps = 76/320 (23%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQIMQMLDHPNIVAL 140
           V+G G FG V   + R TG++ A  K L+ KR K R        E QI++ ++   +V+L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYAC-KKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            +  + T D     L LVL  +   +    I   Y       P      Y  +IC  L  
Sbjct: 250 AYA-YETKDA----LCLVLTLMNGGDLKFHI---YHMGQAGFPEARAVFYAAEICCGLED 301

Query: 199 IHNCIGICHRDIKPQNLL------------------VKGEPNVSYICSRYYRAPELIFGA 240
           +H    I +RD+KP+N+L                   +G+     + +  Y APE++   
Sbjct: 302 LHRE-RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN- 359

Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
             YT + D W+ GC++ E++ GQ  F       +  E+ ++        +K +   Y+E 
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL--------VKEVPEEYSER 411

Query: 301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELRDP 355
                              P+A  L  +     P  R      +A E   HP F   +  
Sbjct: 412 -----------------FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF---KKL 451

Query: 356 N-TRLPNGRPLPPLFNFKPP 374
           N  RL  G   PP   FKP 
Sbjct: 452 NFKRLGAGMLEPP---FKPD 468

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  121 bits (305), Expect = 5e-31
 Identities = 73/299 (24%), Positives = 115/299 (38%), Gaps = 73/299 (24%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
           V+G G+FG V   + + T ++ A+K     ++++     +   E  IM   + P +V L 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           + F    D   LY  +V+EY+P  + VN ++         +P  + + YT ++  AL  I
Sbjct: 136 YAF---QDDRYLY--MVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAI 184

Query: 200 HNCIGICHRDIKPQNLLV---------------KGEPNVSYICSRY-----YRAPELIF- 238
           H+ +G  HRD+KP N+L+               K        C        Y +PE++  
Sbjct: 185 HS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243

Query: 239 --GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 296
             G   Y    D WS G  + E+L+G   F  +S    LV              K MN  
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS----LVGTYS----------KIMNHK 289

Query: 297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT---ALEACVHPFFDEL 352
                FP              +  EA +L+C F      +R       E   H FF   
Sbjct: 290 -NSLTFP---DDND-------ISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKND 336

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  119 bits (300), Expect = 8e-31
 Identities = 79/321 (24%), Positives = 128/321 (39%), Gaps = 83/321 (25%)

Query: 89  VVGTGSFGVVFQAK---CRETGEIVAIK-----KVLQDKRYKNR-ELQIMQMLDHPNIVA 139
           V+G GSFG VF  K     +  ++ A+K      +    R + + E  I+  ++HP IV 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90

Query: 140 LKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           L +  F T  K  LY  L+L+++   +   R+++             VK Y  ++  AL 
Sbjct: 91  LHYA-FQTEGK--LY--LILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALD 140

Query: 198 YIHNCIGICHRDIKPQNLLVKGE------------PNVSYICSRY-------YRAPELIF 238
           ++H+  GI +RD+KP+N+L+  E             ++ +    Y       Y APE++ 
Sbjct: 141 HLHSL-GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199

Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 298
               +T + D WS G +M E+L G   F G+    + + +I                   
Sbjct: 200 R-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMIL----------------KA 241

Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELR 353
           +   PQ             L PEA  L+   F+ +P  R         E   H FF    
Sbjct: 242 KLGMPQ------------FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF---S 286

Query: 354 DPN-TRLPNGRPLPPLFNFKP 373
             +  +L      PP   FKP
Sbjct: 287 TIDWNKLYRREIHPP---FKP 304

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  118 bits (299), Expect = 1e-30
 Identities = 60/319 (18%), Positives = 108/319 (33%), Gaps = 82/319 (25%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN-----RELQIMQMLD 133
           Y    ++G+G FG V+          VAIK     ++       N      E+ +++ + 
Sbjct: 45  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104

Query: 134 H--PNIVALKHCFFSTTDKEELYLNLVLEYVP---ETVNRIARNYSRIHQRMPLIYVKLY 188
                ++ L   +F   D       L+LE      +  + I          +     + +
Sbjct: 105 SGFSGVIRLLD-WFERPDS--FV--LILERPEPVQDLFDFITE-----RGALQEELARSF 154

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVKGEP-NVSYI----------------C-SRY 230
            +Q+  A+ + HNC G+ HRDIK +N+L+      +  I                  +R 
Sbjct: 155 FWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 213

Query: 231 YRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 289
           Y  PE I     Y   +  +WS G ++ +++ G   F  +       EII+         
Sbjct: 214 YSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR--------- 257

Query: 290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
                    +  F             +R+  E   L+       P+ R T  E   HP+ 
Sbjct: 258 --------GQVFFR------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297

Query: 350 DELRDPNTRLP-NGRPLPP 367
            ++  P      +   L P
Sbjct: 298 QDVLLPQETAEIHLHSLSP 316

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  118 bits (299), Expect = 1e-30
 Identities = 80/323 (24%), Positives = 129/323 (39%), Gaps = 85/323 (26%)

Query: 89  VVGTGSFGVVFQAK---CRETGEIVAIK-----KVLQDKRYKNR---ELQIMQMLDHPNI 137
           V+G G +G VFQ +      TG+I A+K      ++++ +       E  I++ + HP I
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           V L +  F T  K  LY  L+LEY+   E   ++ R                Y  +I  A
Sbjct: 84  VDLIYA-FQTGGK--LY--LILEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMA 133

Query: 196 LAYIHNCIGICHRDIKPQNLLVKGE------------PNVSYICSRY-------YRAPEL 236
           L ++H   GI +RD+KP+N+++  +             ++      +       Y APE+
Sbjct: 134 LGHLHQK-GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI 192

Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 296
           +   + +  A+D WS G +M ++L G P F GE+   + ++ I                 
Sbjct: 193 LMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTIDKIL---------------- 234

Query: 297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDE 351
             +   P              L  EA DL+ +  + +   R       A E   HPFF  
Sbjct: 235 KCKLNLP------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF-- 280

Query: 352 LRDPN-TRLPNGRPLPPLFNFKP 373
            R  N   L   +  PP   FKP
Sbjct: 281 -RHINWEELLARKVEPP---FKP 299

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  119 bits (299), Expect = 1e-30
 Identities = 64/326 (19%), Positives = 113/326 (34%), Gaps = 86/326 (26%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN-------RELQIMQM 131
           Y     +G+G+FG V+ A  +E  + V +K     KVL+D   ++        E+ I+  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVP---ETVNRIARNYSRIHQRMPLIYVKLY 188
           ++H NI+ +   F    ++      LV+E      +    I R     H R+        
Sbjct: 86  VEHANIIKVLDIF---ENQGFFQ--LVMEKHGSGLDLFAFIDR-----HPRLDEPLASYI 135

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-----------------C-SRY 230
             Q+  A+ Y+     I HRDIK +N+++  +  +  I                 C +  
Sbjct: 136 FRQLVSAVGYLRL-KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIE 194

Query: 231 YRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 289
           Y APE++ G   Y    +++WS G  +  L+  +  F       +L E ++         
Sbjct: 195 YCAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE--------- 238

Query: 290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
                        P              +  E + LV    Q  P  R T  +    P+ 
Sbjct: 239 --------AAIHPP-----YL-------VSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278

Query: 350 DELRDPNTRLPNGRPLPPLFNFKPPE 375
            +  +             +F    PE
Sbjct: 279 TQPVN-----LADYTWEEVFRVNKPE 299

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  118 bits (298), Expect = 2e-30
 Identities = 74/317 (23%), Positives = 123/317 (38%), Gaps = 78/317 (24%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K     KV++ K   +   E +I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 142 HCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
             F    D   LY+  V+EYV   E  + +     R   R    + + Y  QI     Y+
Sbjct: 108 FSF---KDNSNLYM--VMEYVAGGEMFSHL-----RRIGRFSEPHARFYAAQIVLTFEYL 157

Query: 200 HNCIGICHRDIKPQNLLV--------------KGEPNVSY-IC-SRYYRAPELIFGATEY 243
           H+   + +RD+KP+NLL+              K     ++ +C +    APE+I     Y
Sbjct: 158 HSL-DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILS-KGY 215

Query: 244 TTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 303
             A+D W+ G ++ E+  G P F  +    Q+ E I          +        + +FP
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKI----------VSG------KVRFP 258

Query: 304 QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSP-----NLRCTALEACVHPFFDELRDPN-T 357
                            +  DL+    Q        NL+    +   H +F      +  
Sbjct: 259 ------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT---DWI 303

Query: 358 RLPNGRPLPPLFNFKPP 374
            +   +   P   F P 
Sbjct: 304 AIYQRKVEAP---FIPK 317

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  117 bits (296), Expect = 5e-30
 Identities = 75/320 (23%), Positives = 121/320 (37%), Gaps = 82/320 (25%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQMLD-HPNIVAL 140
           V+G GSFG V  ++ + T E+ A+K      V+QD   +    E +++ +    P +  L
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
             C F T D+  LY   V+EYV   + +  I +       R    +   Y  +I   L +
Sbjct: 87  HSC-FQTMDR--LY--FVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFF 136

Query: 199 IHNCIGICHRDIKPQNLLVKGE------------PNVSYICSRY-------YRAPELIFG 239
           + +  GI +RD+K  N+++  E             N+    +         Y APE+I  
Sbjct: 137 LQS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY 195

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 299
              Y  ++D W+ G ++ E+L GQ  F GE   D+L + I                    
Sbjct: 196 -QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM----------------EHN 237

Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELRD 354
             +P            K +  EAV +        P  R         +   H FF   R 
Sbjct: 238 VAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF---RY 282

Query: 355 PN-TRLPNGRPLPPLFNFKP 373
            +  +L      PP   +KP
Sbjct: 283 IDWEKLERKEIQPP---YKP 299

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  116 bits (294), Expect = 8e-30
 Identities = 75/317 (23%), Positives = 125/317 (39%), Gaps = 78/317 (24%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQM-LDHPNIVAL 140
           ++G GSFG VF A+ ++T +  AIK      VL D   +    E +++ +  +HP +  +
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
               F T +   L+   V+EY+   + +  I         +  L     Y  +I   L +
Sbjct: 84  FCT-FQTKEN--LF--FVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQF 133

Query: 199 IHNCIGICHRDIKPQNLLVKGE------------PNVSYICSRY-------YRAPELIFG 239
           +H+  GI +RD+K  N+L+  +             N+              Y APE++ G
Sbjct: 134 LHS-KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG 192

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 299
             +Y  ++D WS G ++ E+L+GQ  F G+   ++L   I+                   
Sbjct: 193 -QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIR----------------MDN 234

Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA-CVHPFFDELRDPN-T 357
             +P            + L  EA DL+ + F   P  R         HP F   R+ N  
Sbjct: 235 PFYP------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF---REINWE 279

Query: 358 RLPNGRPLPPLFNFKPP 374
            L      PP   F+P 
Sbjct: 280 ELERKEIDPP---FRPK 293

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  116 bits (293), Expect = 8e-30
 Identities = 60/357 (16%), Positives = 110/357 (30%), Gaps = 120/357 (33%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           +     +G G FGVVF+AK +      AIK++    R        RE++ +  L+HP IV
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 139 ALKHCF----------------------------------------------------FS 146
              + +                                                      
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127

Query: 147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGIC 206
                ++YL + ++   +   +   N     +            QI  A+ ++H+  G+ 
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-GLM 186

Query: 207 HRDIKPQNLLVKGEPNV-------------------------------SYICSRYYRAPE 235
           HRD+KP N+    +  V                                 + ++ Y +PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246

Query: 236 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 295
            I G   Y+  +DI+S G ++ ELL     F  +    +++  ++               
Sbjct: 247 QIHG-NNYSHKVDIFSLGLILFELLYS---FSTQMERVRIITDVR--------------- 287

Query: 296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
                KFP +    +         P+   +V      SP  R  A +   +  F+ L
Sbjct: 288 ---NLKFPLLFTQKY---------PQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  116 bits (293), Expect = 1e-29
 Identities = 78/321 (24%), Positives = 131/321 (40%), Gaps = 83/321 (25%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN--RELQIMQM-LDHPNIVAL 140
           V+G GSFG V  A+ +ETG++ A+K      +LQD   +    E +I+ +  +HP +  L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
             C F T D+  L+   V+E+V   + +  I +      +R      + Y  +I  AL +
Sbjct: 90  FCC-FQTPDR--LF--FVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEIISALMF 139

Query: 199 IHNCIGICHRDIKPQNLLVKGE------------PNVSYICSRY-------YRAPELIFG 239
           +H+  GI +RD+K  N+L+  E              +    +         Y APE++  
Sbjct: 140 LHD-KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE 198

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 299
              Y  A+D W+ G ++ E+L G   F  E+  D L E I                   E
Sbjct: 199 -MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAIL----------------NDE 240

Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR------CTALEACVHPFFDELR 353
             +P              L  +A  ++  F   +P +R              HPFF   +
Sbjct: 241 VVYP------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF---K 285

Query: 354 DPN-TRLPNGRPLPPLFNFKP 373
           + +  +L + +  PP   F+P
Sbjct: 286 EIDWAQLNHRQIEPP---FRP 303

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  116 bits (293), Expect = 2e-29
 Identities = 72/319 (22%), Positives = 117/319 (36%), Gaps = 81/319 (25%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIM-QMLDHPNIVAL 140
           V+G GSFG V  A+ +      A+K      +L+ K  ++   E  ++ + + HP +V L
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
               F T DK  LY   VL+Y+   E    + R      +       + Y  +I  AL Y
Sbjct: 105 HFS-FQTADK--LY--FVLDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGY 154

Query: 199 IHNCIGICHRDIKPQNLLVKGE------------PNVSYICSRY-------YRAPELIFG 239
           +H+ + I +RD+KP+N+L+  +             N+ +  +         Y APE++  
Sbjct: 155 LHS-LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK 213

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 299
              Y   +D W  G V+ E+L G P F   +   ++ + I                    
Sbjct: 214 -QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNIL----------------NKP 255

Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR----CTALEACVHPFFDELRDP 355
            +                +   A  L+    Q     R       +E   H FF      
Sbjct: 256 LQLK------------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF---SLI 300

Query: 356 N-TRLPNGRPLPPLFNFKP 373
           N   L N +  PP   F P
Sbjct: 301 NWDDLINKKITPP---FNP 316

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  114 bits (286), Expect = 6e-29
 Identities = 56/300 (18%), Positives = 103/300 (34%), Gaps = 63/300 (21%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQI-MQMLDHPNIVALKH 142
            +G+G+ G V++ + R+TG ++A+K++      +  K    +L + ++  D P IV    
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
            F + TD     + + +E +     ++     R+   +P   +   T  I +AL Y+   
Sbjct: 92  TFITNTD-----VFIAMELMGTCAEKL---KKRMQGPIPERILGKMTVAIVKALYYLKEK 143

Query: 203 IGICHRDIKPQNLLVKGEPNV------------------SYICSRYYRAPELI----FGA 240
            G+ HRD+KP N+L+     +                         Y APE I       
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203

Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPNYTE 299
            +Y    D+WS G  + EL  GQ  +       + L ++++    P              
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP-------------- 247

Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 359
              P +  H            +    V          R    +   H F          +
Sbjct: 248 ---PLLPGH-------MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDV 297

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  113 bits (285), Expect = 9e-29
 Identities = 63/300 (21%), Positives = 113/300 (37%), Gaps = 58/300 (19%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKN--RELQI-MQMLDHPNIVALKH 142
            +G G++G V +   + +G+I+A+K++   + +K  K    +L + M+  D P IV    
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARN-YSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   D       + +E +  + ++  +  YS +   +P   +   T    +AL ++  
Sbjct: 89  ALFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143

Query: 202 CIGICHRDIKPQNLLVKGEPNVSYIC-------------------SRYYRAPELIFGATE 242
            + I HRDIKP N+L+    N+  +C                    R Y APE I  +  
Sbjct: 144 NLKIIHRDIKPSNILLDRSGNIK-LCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAS 202

Query: 243 ---YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 299
              Y    D+WS G  + EL  G+  +P  + V   +  + V G P         P    
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDP---------P---- 248

Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 359
            +    +   +         P  ++ V        + R    E   HPF     +    +
Sbjct: 249 -QLSNSEEREF--------SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEV 299

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  113 bits (284), Expect = 1e-28
 Identities = 61/321 (19%), Positives = 107/321 (33%), Gaps = 83/321 (25%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKRYKN-----RELQIMQMLD 133
           Y    ++G G FG VF          VAIK     +VL      +      E+ ++  + 
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92

Query: 134 ----HPNIVALKHCFFSTTDKEELYLNLVLEYVP---ETVNRIARNYSRIHQRMPLIYVK 186
               HP ++ L   +F T +       LVLE      +  + I          +     +
Sbjct: 93  AGGGHPGVIRL-LDWFETQEG--FM--LVLERPLPAQDLFDYITE-----KGPLGEGPSR 142

Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-----------------SYIC-S 228
            +  Q+  A+ + H+  G+ HRDIK +N+L+                       +    +
Sbjct: 143 CFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGT 201

Query: 229 RYYRAPELIFGATEYT-TAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 287
           R Y  PE I    +Y      +WS G ++ +++ G   F  +       EI++       
Sbjct: 202 RVYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA------ 248

Query: 288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP 347
                      E  FP              + P+   L+ R     P+ R +  E  + P
Sbjct: 249 -----------ELHFP------------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285

Query: 348 FFDELRDPNTRLPNGRPLPPL 368
           +     +     P+     PL
Sbjct: 286 WMQTPAEDVPLNPSKGGPAPL 306

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  113 bits (285), Expect = 1e-28
 Identities = 75/329 (22%), Positives = 128/329 (38%), Gaps = 90/329 (27%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQM-LDHPNIVAL 140
           V+G GS+  V   + ++T  I A+K      V  D+   +   E  + +   +HP +V L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
             C F T  +  L+   V+EYV   + +  + R      +++P  + + Y+ +I  AL Y
Sbjct: 76  HSC-FQTESR--LF--FVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNY 125

Query: 199 IHNCIGICHRDIKPQNLL------VK---------------------GEPNVSYICSRYY 231
           +H   GI +RD+K  N+L      +K                     G PN        Y
Sbjct: 126 LHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN--------Y 176

Query: 232 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 291
            APE++ G  +Y  ++D W+ G +M E++ G+  F      D   +        T + + 
Sbjct: 177 IAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL- 227

Query: 292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR------CTALEACV 345
                     F  I          + L  +A  ++  F    P  R          +   
Sbjct: 228 ----------FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275

Query: 346 HPFFDELRDPN-TRLPNGRPLPPLFNFKP 373
           HPFF   R+ +   +   + +PP   FKP
Sbjct: 276 HPFF---RNVDWDMMEQKQVVPP---FKP 298

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  111 bits (280), Expect = 2e-28
 Identities = 48/222 (21%), Positives = 82/222 (36%), Gaps = 45/222 (20%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----------RELQIMQMLDHP 135
           E  +G G FG+V + +  +   +VAIK ++                  RE+ IM  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           NIV L        +       +V+E+VP   +     + +     +           I  
Sbjct: 84  NIVKLYGL---MHNP----PRMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIAL 133

Query: 195 ALAYIHNC-IGICHRDIKPQNLLVKGEPNVSYIC--------SR-------------YYR 232
            + Y+ N    I HRD++  N+ ++     + +C        S+              + 
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWM 193

Query: 233 APELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVD 273
           APE I    E YT   D +S   ++  +L G+  F   S   
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  113 bits (286), Expect = 2e-28
 Identities = 76/371 (20%), Positives = 137/371 (36%), Gaps = 81/371 (21%)

Query: 44  DNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEH-----VVGTGSFGVV 98
           D D            +G+             +G +   +    +      V+G GS+  V
Sbjct: 11  DYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLG--LQDFDLLRVIGRGSYAKV 68

Query: 99  FQAKCRETGEIVAIK-----KVLQDKR--YKNRELQIMQM-LDHPNIVALKHCFFSTTDK 150
              + ++T  I A++      V  D+   +   E  + +   +HP +V L  C F T  +
Sbjct: 69  LLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC-FQTESR 127

Query: 151 EELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHR 208
             L+   V+EYV   + +  + R      +++P  + + Y+ +I  AL Y+H   GI +R
Sbjct: 128 --LF--FVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHE-RGIIYR 177

Query: 209 DIKPQNLLVKGE------------PNVSYICSRY-------YRAPELIFGATEYTTAIDI 249
           D+K  N+L+  E              +    +         Y APE++ G  +Y  ++D 
Sbjct: 178 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDW 236

Query: 250 WSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHP 309
           W+ G +M E++ G+  F      D   +        T + +           F  I    
Sbjct: 237 WALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL-----------FQVILEKQ 278

Query: 310 WHKVFQKRLPPEAVDLVCRFFQYSPNLR--CTALEAC----VHPFFDELRDPN-TRLPNG 362
                 + L  +A  ++  F    P  R  C           HPFF   R+ +   +   
Sbjct: 279 IR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF---RNVDWDMMEQK 333

Query: 363 RPLPPLFNFKP 373
           + +PP   FKP
Sbjct: 334 QVVPP---FKP 341

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  111 bits (279), Expect = 1e-27
 Identities = 82/327 (25%), Positives = 132/327 (40%), Gaps = 83/327 (25%)

Query: 89  VVGTGSFGVVFQAK---CRETGEIVAIK-----KVLQDKRYKNR---ELQIMQMLDH-PN 136
           V+GTG++G VF  +     +TG++ A+K      ++Q  +       E Q+++ +   P 
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           +V L +  F T  K  L+  L+L+Y+   E    +++      +R     V++Y  +I  
Sbjct: 121 LVTLHYA-FQTETK--LH--LILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVL 170

Query: 195 ALAYIHNCIGICHRDIKPQNLL------------------VKGEPNVSY-IC-SRYYRAP 234
           AL ++H  +GI +RDIK +N+L                  V  E   +Y  C +  Y AP
Sbjct: 171 ALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 229

Query: 235 ELIFGATE-YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 293
           +++ G    +  A+D WS G +M ELL G   F  +   +   EI           I   
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--------RRIL-- 279

Query: 294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPF 348
               +E  +PQ             +   A DL+ R     P  R       A E   H F
Sbjct: 280 ---KSEPPYPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

Query: 349 FDELRDPN-TRLPNGRPLPPLFNFKPP 374
           F   +  N   L   +   P   FKP 
Sbjct: 325 F---QKINWDDLAAKKVPAP---FKPV 345

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  109 bits (274), Expect = 1e-27
 Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 51/219 (23%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--------RELQIMQMLDHPNIV 138
           E ++G G FG V++A     G+ VA+K    D             +E ++  ML HPNI+
Sbjct: 12  EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 139 ALK-HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           AL+  C      +  L   LV+E+     +NR+        +R+P   +  +  QI R +
Sbjct: 70  ALRGVC----LKEPNLC--LVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGM 118

Query: 197 AYIHNC--IGICHRDIKPQNLLVKGEPNVSY-------IC----SRY------------- 230
            Y+H+   + I HRD+K  N+L+  +            I     +R              
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAY 178

Query: 231 -YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG 268
            + APE+I  +  ++   D+WS G ++ ELL G+  F G
Sbjct: 179 AWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  108 bits (273), Expect = 3e-27
 Identities = 68/308 (22%), Positives = 112/308 (36%), Gaps = 59/308 (19%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           Y  + V+G+G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPNIV
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 139 ALKHCFFSTTDKEELYLNLVLEY-----VPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           +    F     K+EL+L  V++      V + +  I          +    +     ++ 
Sbjct: 77  SYYTSFV---VKDELWL--VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 194 RALAYIHNCIGICHRDIKPQNLLVKGEPNV-----------------SYICSR------- 229
             L Y+H   G  HRD+K  N+L+  + +V                 +    R       
Sbjct: 132 EGLEYLHK-NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190

Query: 230 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 289
            + APE++     Y    DIWS G    EL  G   +     +  L+  ++         
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ--------- 241

Query: 290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
               N        P ++     K   K+       ++    Q  P  R TA E   H FF
Sbjct: 242 ----ND------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291

Query: 350 DELRDPNT 357
            + ++   
Sbjct: 292 QKAKNKEF 299

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  110 bits (276), Expect = 4e-27
 Identities = 56/345 (16%), Positives = 113/345 (32%), Gaps = 61/345 (17%)

Query: 91  GTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
           G      V  A+ + TGE V ++++      ++       EL + ++ +HPNIV  +  F
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 145 FSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI 203
            +  +     L +V  ++   +   +   +      M  + +      + +AL YIH+ +
Sbjct: 96  IADNE-----LWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHH-M 147

Query: 204 GICHRDIKPQNLLVKGEPNV--------------------------SYICSRYYRAPELI 237
           G  HR +K  ++L+  +  V                            +    + +PE++
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207

Query: 238 F-GATEYTTAIDIWSTGCVMAELLLGQP----------LF-------PGESGVDQLVEII 279
                 Y    DI+S G    EL  G            L        P       +    
Sbjct: 208 QQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEE 267

Query: 280 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT 339
             +          ++ + T               + +   P     V +  Q +P+ R +
Sbjct: 268 LTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS 327

Query: 340 ALEACVHPFFDELRDPNTRL--PNGRPLPPLFNFKPPELSGIPPE 382
           A     H FF +++   +       RP+ P+ NF+  +       
Sbjct: 328 ASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGI 372

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  112 bits (281), Expect = 5e-27
 Identities = 75/320 (23%), Positives = 120/320 (37%), Gaps = 82/320 (25%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIK-----KVLQDK--RYKNRELQIMQM-LDHPNIVAL 140
           V+G GSFG V  ++ + T E+ A+K      V+QD        E +++ +    P +  L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
             C F T D+  LY   V+EYV   + +  I +       R    +   Y  +I   L +
Sbjct: 408 HSC-FQTMDR--LY--FVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFF 457

Query: 199 IHNCIGICHRDIKPQNLLVKGE------------PNVSYICSRY-------YRAPELIFG 239
           + +  GI +RD+K  N+++  E             N+    +         Y APE+I  
Sbjct: 458 LQS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY 516

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 299
              Y  ++D W+ G ++ E+L GQ  F GE   D+L + I                    
Sbjct: 517 -QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM----------------EHN 558

Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHPFFDELRD 354
             +P            K +  EAV +        P  R         +   H FF   R 
Sbjct: 559 VAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF---RY 603

Query: 355 PN-TRLPNGRPLPPLFNFKP 373
            +  +L      PP   +KP
Sbjct: 604 IDWEKLERKEIQPP---YKP 620

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  106 bits (267), Expect = 4e-26
 Identities = 66/299 (22%), Positives = 115/299 (38%), Gaps = 62/299 (20%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
           +     +G GSFG V+ A+     E+VAIKK+    +  N       +E++ +Q L HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
            +  + C+            LV+EY   + + +   + +    +  + +   T+   + L
Sbjct: 116 TIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGL 167

Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV---------------SYICSRYYRAPELIFGAT 241
           AY+H+   + HRD+K  N+L+     V               S++ + Y+ APE+I    
Sbjct: 168 AYLHS-HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMD 226

Query: 242 E--YTTAIDIWSTGCVMA-ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 298
           E  Y   +D+WS G +   EL   +P     + +  L  I +                  
Sbjct: 227 EGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQ------------NES--- 270

Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 357
               P ++   W + F+        + V    Q  P  R T+     H F    R P  
Sbjct: 271 ----PALQSGHWSEYFR--------NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV 317

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  109 bits (273), Expect = 6e-26
 Identities = 54/255 (21%), Positives = 96/255 (37%), Gaps = 55/255 (21%)

Query: 49  RDSEPDIIDGVGAETGH--------VIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQ 100
                   +G     G              + G+         Y  +  +  G  G ++ 
Sbjct: 48  DSETKGASEGWCPYCGSPYSFLPQLNPGDIVAGQ---------YEVKGCIAHGGLGWIYL 98

Query: 101 AKCRE-TGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE 152
           A  R   G  V +K  L               E Q +  + HP+IV +   F   TD+  
Sbjct: 99  ALDRNVNGRPVVLK-GLVHSGDAEAQAMAM-AERQFLAEVVHPSIVQI-FNFVEHTDRHG 155

Query: 153 LYLN-LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDI 210
             +  +V+EYV  +++ R         Q++P+     Y  +I  AL+Y+H+ IG+ + D+
Sbjct: 156 DPVGYIVMEYVGGQSLKRS------KGQKLPVAEAIAYLLEILPALSYLHS-IGLVYNDL 208

Query: 211 KPQNLLVKGEPNV---------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCV 255
           KP+N+++  E  +                   +  ++APE++      T A DI++ G  
Sbjct: 209 KPENIMLTEE-QLKLIDLGAVSRINSFGYLYGTPGFQAPEIVRTGP--TVATDIYTVGRT 265

Query: 256 MAELLLGQPLFPGES 270
           +A L L  P   G  
Sbjct: 266 LAALTLDLPTRNGRY 280

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  105 bits (263), Expect = 6e-26
 Identities = 61/238 (25%), Positives = 95/238 (39%), Gaps = 52/238 (21%)

Query: 65  HVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------ 118
           H+I   I  R         Y     +G G    V+ A+       VAIK  +        
Sbjct: 3   HMIGKIINER---------YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKE 52

Query: 119 ---KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYS 174
              KR++ RE+     L H NIV++        + +  YL  V+EY+   T+      Y 
Sbjct: 53  ETLKRFE-REVHNSSQLSHQNIVSM---IDVDEEDDCYYL--VMEYIEGPTL----SEYI 102

Query: 175 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV----------- 223
             H  + +     +T QI   + + H+ + I HRDIKPQN+L+     +           
Sbjct: 103 ESHGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161

Query: 224 ---------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 272
                      + +  Y +PE   G        DI+S G V+ E+L+G+P F GE+ V
Sbjct: 162 SETSLTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAV 218

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  104 bits (262), Expect = 1e-25
 Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 38/210 (18%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 140
           +  +G GSFG V +A+    G  VA+K +++   +        RE+ IM+ L HPNIV  
Sbjct: 42  KEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
                + T    L   +V EY+   ++ R+    S   +++         Y + + + Y+
Sbjct: 100 MG---AVTQPPNLS--IVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYL 153

Query: 200 HNC-IGICHRDIKPQNLLVKGEPNVSYIC----SRY----------------YRAPELIF 238
           HN    I HR++K  NLLV  +  V  +C    SR                 + APE++ 
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKKYTVK-VCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212

Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPG 268
                    D++S G ++ EL   Q  +  
Sbjct: 213 D-EPSNEKSDVYSFGVILWELATLQQPWGN 241

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  103 bits (259), Expect = 3e-25
 Identities = 64/291 (21%), Positives = 114/291 (39%), Gaps = 64/291 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 139
           Y     +G G+ G V+ A    TG+ VAI+++       K     E+ +M+   +PNIV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
               +    +     L +V+EY+   ++  +          M    +     +  +AL +
Sbjct: 82  YLDSYLVGDE-----LWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEF 131

Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFG 239
           +H+   + HRDIK  N+L+  + +V                   + + + Y+ APE++  
Sbjct: 132 LHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190

Query: 240 ATEYTTAIDIWSTGCVMA-ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 298
              Y   +DIWS G +MA E++ G+P +  E+ +  L  I    GTP  +          
Sbjct: 191 -KAYGPKVDIWSLG-IMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQN--------- 238

Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
                   P     +F+        D + R  +     R +A E   H F 
Sbjct: 239 --------PEKLSAIFR--------DFLNRCLEMDVEKRGSAKELLQHQFL 273

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  102 bits (256), Expect = 8e-25
 Identities = 68/285 (23%), Positives = 115/285 (40%), Gaps = 64/285 (22%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVALKHCFF 145
           +G GS G+V  A+ + +G  VA+K +     Q +     E+ IM+   H N+V +   + 
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112

Query: 146 STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG 204
                EEL+  +++E++    +  I         R+    +      + +ALAY+H   G
Sbjct: 113 V---GEELW--VLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHA-QG 161

Query: 205 ICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGATEYTT 245
           + HRDIK  ++L+  +  V                   S + + Y+ APE+I   + Y T
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-SLYAT 220

Query: 246 AIDIWSTGCVMA-ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 304
            +DIWS G +M  E++ G+P +  +S V  +  +      P  +                
Sbjct: 221 EVDIWSLG-IMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKN--------------- 263

Query: 305 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
              H    V +        D + R     P  R TA E   HPF 
Sbjct: 264 --SHKVSPVLR--------DFLERMLVRDPQERATAQELLDHPFL 298

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  102 bits (255), Expect = 1e-24
 Identities = 61/301 (20%), Positives = 106/301 (35%), Gaps = 65/301 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           +     +G GSFG VF+     T ++VAIK +  ++         +E+ ++   D P + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
                +   T      L +++EY+   +   +          +    +     +I + L 
Sbjct: 84  KYYGSYLKDTK-----LWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLD 133

Query: 198 YIHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIF 238
           Y+H+     HRDIK  N+L+     V                   +++ + ++ APE+I 
Sbjct: 134 YLHS-EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK 192

Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 298
            +  Y +  DIWS G    EL  G+P                    P  E    ++P   
Sbjct: 193 QS-AYDSKADIWSLGITAIELARGEP--------------------PHSE----LHPMKV 227

Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
            F  P+  P P     +        + V       P+ R TA E   H F        + 
Sbjct: 228 LFLIPKNNP-P---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSY 283

Query: 359 L 359
           L
Sbjct: 284 L 284

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  101 bits (253), Expect = 1e-24
 Identities = 26/207 (12%), Positives = 70/207 (33%), Gaps = 33/207 (15%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVAL 140
              +     G +++ + +  G  + +K +          R  N E   +++  HPN++ +
Sbjct: 15  LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72

Query: 141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
                        +  L+  ++P  ++  +    +     +       +   + R +A++
Sbjct: 73  LGA---CQSPPAPHPTLITHWMPYGSLYNVLHEGTNF--VVDQSQAVKFALDMARGMAFL 127

Query: 200 HNC-IGICHRDIKPQNLLVKGEPNVSYIC----SRY-----------YRAPELIFG--AT 241
           H     I    +  +++++  E   + I                   + APE +      
Sbjct: 128 HTLEPLIPRHALNSRSVMI-DEDMTARISMADVKFSFQSPGRMYAPAWVAPEALQKKPED 186

Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPG 268
               + D+WS   ++ EL+  +  F  
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVPFAD 213

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  101 bits (254), Expect = 1e-24
 Identities = 49/220 (22%), Positives = 93/220 (42%), Gaps = 48/220 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKN--RELQIMQMLDHPNIVALKH 142
             V+G G FG   +   RETGE++ +K++++  ++  +   +E+++M+ L+HPN++    
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF-- 72

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                   + L    + EY+   T+  I ++      + P      +   I   +AY+H+
Sbjct: 73  -IGVLYKDKRLN--FITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHS 126

Query: 202 CIGICHRDIKPQNLLVKGEPNV---------------------------------SYICS 228
              I HRD+   N LV+   NV                                 + + +
Sbjct: 127 M-NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185

Query: 229 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPG 268
            Y+ APE+I G   Y   +D++S G V+ E++      P 
Sbjct: 186 PYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  101 bits (254), Expect = 2e-24
 Identities = 59/240 (24%), Positives = 90/240 (37%), Gaps = 54/240 (22%)

Query: 67  IRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL-----QDKRY 121
             + +  R         Y    ++G G    V  A+       VA+K VL     +D  +
Sbjct: 6   TPSHLSDR---------YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSF 55

Query: 122 KNR---ELQIMQMLDHPNIVALKHCFF---STTDKEELYLNLVLEYVP-ETVNRIARNYS 174
             R   E Q    L+HP IVA+    +              +V+EYV   T+    R+  
Sbjct: 56  YLRFRREAQNAAALNHPAIVAV----YDTGEAETPAGPLPYIVMEYVDGVTL----RDIV 107

Query: 175 RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV----------- 223
                M            C+AL + H   GI HRD+KP N+++     V           
Sbjct: 108 HTEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATNAVKVMDFGIARAI 166

Query: 224 -----------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV 272
                      + I +  Y +PE   G +      D++S GCV+ E+L G+P F G+S V
Sbjct: 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  101 bits (254), Expect = 2e-24
 Identities = 72/296 (24%), Positives = 116/296 (39%), Gaps = 58/296 (19%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALK 141
           +     +G GS+G V++A  +ETG+IVAIK+V  +   +   +E+ IMQ  D P++V   
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90

Query: 142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             +F  TD     L +V+EY    +V+ I       ++ +    +        + L Y+H
Sbjct: 91  GSYFKNTD-----LWIVMEYCGAGSVSDI---IRLRNKTLTEDEIATILQSTLKGLEYLH 142

Query: 201 NCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGAT 241
             +   HRDIK  N+L+  E +                    + I + ++ APE+I    
Sbjct: 143 F-MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI- 200

Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
            Y    DIWS G    E+  G+P +     +  +  I      PT  +            
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTFRK------------ 247

Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 357
                P  W   F         D V +    SP  R TA +   HPF    +  + 
Sbjct: 248 -----PELWSDNFT--------DFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSI 290

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  100 bits (252), Expect = 3e-24
 Identities = 51/256 (19%), Positives = 84/256 (32%), Gaps = 51/256 (19%)

Query: 44  DNDEDRDSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKC 103
            +             +         T  G           Y    +VG G  G V++A+ 
Sbjct: 6   HHHHHSSGLVPRGSHMDGTAESREGTQFGP----------YRLRRLVGRGGMGDVYEAED 55

Query: 104 RETGEIVAIKKVL-----QDKRYK---NRELQIMQMLDHPNIVALKHCFFSTTDKEELYL 155
                IVA+K ++      D  ++    RE +    L  P++V +           +LY+
Sbjct: 56  TVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI---HDFGEIDGQLYV 111

Query: 156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN 214
              +  +             R    +          QI  AL   H   G  HRD+KP+N
Sbjct: 112 --DMRLINGVD----LAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA-AGATHRDVKPEN 164

Query: 215 LLVKGEPNV--------------------SYICSRYYRAPELIFGATEYTTAIDIWSTGC 254
           +LV  +                       + + + YY APE    +   T   DI++  C
Sbjct: 165 ILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSES-HATYRADIYALTC 223

Query: 255 VMAELLLGQPLFPGES 270
           V+ E L G P + G+ 
Sbjct: 224 VLYECLTGSPPYQGDQ 239

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 99.7 bits (249), Expect = 7e-24
 Identities = 66/306 (21%), Positives = 118/306 (38%), Gaps = 71/306 (23%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 139
           +     +G G+FG V++AK +ETG + A K +     ++      E++I+   DHP IV 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 140 LKHCFFSTTDKEELYLNLVLEY-----VPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           L   ++         L +++E+     V   +  + R        +    +++   Q+  
Sbjct: 81  LLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDR-------GLTEPQIQVVCRQMLE 128

Query: 195 ALAYIHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPE 235
           AL ++H+   I HRD+K  N+L+  E ++                   S+I + Y+ APE
Sbjct: 129 ALNFLHSK-RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187

Query: 236 LIFGAT----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 291
           ++   T     Y    DIWS G  + E+   +P     + +  L++I K    PT     
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPPTLLT-- 244

Query: 292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 351
                          P  W   F+        D +      +P  R +A +   HPF   
Sbjct: 245 ---------------PSKWSVEFR--------DFLKIALDKNPETRPSAAQLLEHPFVSS 281

Query: 352 LRDPNT 357
           +     
Sbjct: 282 ITSNKA 287

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  100 bits (250), Expect = 9e-24
 Identities = 44/215 (20%), Positives = 81/215 (37%), Gaps = 51/215 (23%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 142
              +G G +G V+  K R  GE VA+K     ++    RE +I Q   + H NI+  +  
Sbjct: 42  VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYS-RIHQRMPLIYVKLYTYQICRALAYIH 200
               T    +LYL  + +Y    ++    ++ +      + L Y           L ++H
Sbjct: 100 DIKGTGSWTQLYL--ITDYHENGSLYDYLKSTTLDAKSMLKLAY------SSVSGLCHLH 151

Query: 201 NCI-------GICHRDIKPQNLLVKGEPNV-----------------------SYICSRY 230
             I        I HRD+K +N+LVK                            + + ++ 
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211

Query: 231 YRAPELIFGAT-----EYTTAIDIWSTGCVMAELL 260
           Y  PE++  +      +     D++S G ++ E+ 
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 99.4 bits (248), Expect = 9e-24
 Identities = 45/215 (20%), Positives = 82/215 (38%), Gaps = 51/215 (23%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 142
              VG G +G V++   +  GE VA+K    +D++   RE ++     L H NI+  +  
Sbjct: 13  LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYS-RIHQRMPLIYVKLYTYQICRALAYIH 200
              S     +L+L  +  Y    ++    +  +      + ++        I   LA++H
Sbjct: 71  DMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTTLDTVSCLRIVL------SIASGLAHLH 122

Query: 201 NCI-------GICHRDIKPQNLLVKGEPNV-----------------------SYICSRY 230
             I        I HRD+K +N+LVK                              + ++ 
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182

Query: 231 YRAPELI-----FGATEYTTAIDIWSTGCVMAELL 260
           Y APE++         +    +DIW+ G V+ E+ 
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 99.4 bits (248), Expect = 1e-23
 Identities = 53/243 (21%), Positives = 93/243 (38%), Gaps = 46/243 (18%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 142
             V   G FG V++A+     E VA+K    QDK+    E ++  +  + H NI+  +  
Sbjct: 29  LEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGA 86

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
               T+   +L+L  +  +          ++ + +         +    + R LAY+H  
Sbjct: 87  EKRGTSVDVDLWL--ITAFHE---KGSLSDFLKANVVSWNELCHIA-ETMARGLAYLHED 140

Query: 203 I---------GICHRDIKPQNLLVKG---------------EPNVSYICSRY------YR 232
           I          I HRDIK +N+L+K                E   S   +        Y 
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYM 200

Query: 233 APELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 288
           APE++ GA     +    ID+++ G V+ EL        G      L    ++   P+ E
Sbjct: 201 APEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLE 260

Query: 289 EIK 291
           +++
Sbjct: 261 DMQ 263

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 98.9 bits (247), Expect = 1e-23
 Identities = 44/224 (19%), Positives = 86/224 (38%), Gaps = 45/224 (20%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 140
              +G+GSFG V++ K       VA+K +               E+ +++   H NI+  
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84

Query: 141 KHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
              F   +   +L +  V ++    ++            +  +  +     Q  R + Y+
Sbjct: 85  ---FMGYSTAPQLAI--VTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYL 136

Query: 200 HNCIGICHRDIKPQNLLVKGEPNVSYIC----SRY------------------YRAPELI 237
           H    I HRD+K  N+ +  +  V  I     +                    + APE+I
Sbjct: 137 HAK-SIIHRDLKSNNIFLHEDNTVK-IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

Query: 238 FGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
                  Y+   D+++ G V+ EL+ GQ  +   +  DQ++E++
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 99.4 bits (248), Expect = 1e-23
 Identities = 62/306 (20%), Positives = 113/306 (36%), Gaps = 59/306 (19%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNRELQIMQML-DHPNIVA 139
           +    +VG G++G V++ +  +TG++ AIK +     ++    +E+ +++    H NI  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85

Query: 140 LKHCFF-STTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
               F        +  L LV+E+    +V  + +N       +   ++     +I R L+
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLS 143

Query: 198 YIHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELI- 237
           ++H    + HRDIK QN+L+     V                   ++I + Y+ APE+I 
Sbjct: 144 HLHQ-HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 202

Query: 238 ---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
                   Y    D+WS G    E+  G P       +  L  I +             N
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-------------N 249

Query: 295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD 354
           P       P++K   W K FQ          +      + + R    +   HPF  +  +
Sbjct: 250 P------APRLKSKKWSKKFQ--------SFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295

Query: 355 PNTRLP 360
                 
Sbjct: 296 ERQVRI 301

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 96.4 bits (240), Expect = 2e-22
 Identities = 53/215 (24%), Positives = 84/215 (39%), Gaps = 51/215 (23%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVL-QDKRYKNRELQIMQM--LDHPNIVA-LKH 142
           +  +G G FG V++ K R  GE VA+K    +++R   RE +I Q   L H NI+  +  
Sbjct: 47  QESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                    +L+L  V +Y    ++      Y+   + M    +KL        LA++H 
Sbjct: 105 DNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYTVTVEGM----IKL-ALSTASGLAHLHM 157

Query: 202 CI-------GICHRDIKPQNLLVKGEPNVSYIC----SRY-------------------- 230
            I        I HRD+K +N+LVK       I     +                      
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCC-IADLGLAVRHDSATDTIDIAPNHRVGTKR 216

Query: 231 YRAPELIFGAT-----EYTTAIDIWSTGCVMAELL 260
           Y APE++  +      E     DI++ G V  E+ 
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 95.7 bits (238), Expect = 3e-22
 Identities = 54/253 (21%), Positives = 97/253 (38%), Gaps = 56/253 (22%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKNRELQIMQM--LDHPNIVALKHC 143
             ++G G +G V++         VA+K     +++    E  I ++  ++H NI      
Sbjct: 18  LELIGRGRYGAVYKGSLD--ERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75

Query: 144 FFSTTDKEELYLNLVLEYVPET--VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
               T    +   LV+EY P       ++ + S       L +       + R LAY+H 
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH------SVTRGLAYLHT 129

Query: 202 CI--------GICHRDIKPQNLLVKGEPNV---------------------------SYI 226
            +         I HRD+  +N+LVK +                              S +
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189

Query: 227 CSRYYRAPELIFGA------TEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVD-QLVEI 278
            +  Y APE++ GA            +D+++ G +  E+ +    LFPGES  + Q+   
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249

Query: 279 IKVLGTPTREEIK 291
            +V   PT E+++
Sbjct: 250 TEVGNHPTFEDMQ 262

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 93.6 bits (233), Expect = 1e-21
 Identities = 36/221 (16%), Positives = 76/221 (34%), Gaps = 52/221 (23%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 140
             ++G G FG V+  +       VAI+ +  ++  ++      RE+   +   H N+V  
Sbjct: 38  GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 141 K-HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
              C         L   ++       T+  + R+       + +   +    +I + + Y
Sbjct: 95  MGAC----MSPPHLA--IITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGY 145

Query: 199 IHNCIGICHRDIKPQNLLV---------------KGEPNVSYICSRY--------YRAPE 235
           +H   GI H+D+K +N+                  G         +         + APE
Sbjct: 146 LHAK-GILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204

Query: 236 LIFGATE--------YTTAIDIWSTGCVMAELLLGQPLFPG 268
           +I   +         ++   D+++ G +  EL   +  F  
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 91.6 bits (228), Expect = 5e-21
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 49/210 (23%)

Query: 87  EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
              +G G+FG V   +       TGE+VA+KK LQ    ++     RE++I++ L H NI
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 138 VALKHCFFSTTDKEE-LYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
           V  K      +     L   L++EY+P       R+Y + H+ R+  I +  YT QIC+ 
Sbjct: 74  VKYKGV--CYSAGRRNLK--LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKG 126

Query: 196 LAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR-------YYR---------- 232
           + Y+     I   HRD+  +N+LV    N   I     ++       +++          
Sbjct: 127 MEYLGTKRYI---HRDLATRNILV-ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182

Query: 233 --APELIFGATEYTTAIDIWSTGCVMAELL 260
             APE +   ++++ A D+WS G V+ EL 
Sbjct: 183 WYAPESLT-ESKFSVASDVWSFGVVLYELF 211

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 90.7 bits (226), Expect = 6e-21
 Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 40/212 (18%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
              +G G FG V     R  G  VA+K +  D   +    E  +M  L H N+V L    
Sbjct: 26  LQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 82

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI--H 200
               +K  LY  +V EY+         +Y R   R  L    L  ++  +C A+ Y+  +
Sbjct: 83  -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136

Query: 201 NCIGICHRDIKPQNLLVKGEPNVSYIC----SR--YYR-----------APE-LIFGATE 242
           N +   HRD+  +N+LV  E NV+ +     ++                APE L     +
Sbjct: 137 NFV---HRDLAARNVLV-SEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREK--K 190

Query: 243 YTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 273
           ++T  D+WS G ++ E+   G+  +P     D
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 91.1 bits (227), Expect = 6e-21
 Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 44/212 (20%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
           +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN+V L   
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
               T +   Y  ++ E++         +Y R   R  +  V L     QI  A+ Y+  
Sbjct: 78  ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129

Query: 200 HNCIGICHRDIKPQNLLVKGEPNVSYIC----SRYYR-----------------APE-LI 237
            N I   HRD+  +N LV GE ++  +     SR                    APE L 
Sbjct: 130 KNFI---HRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 185

Query: 238 FGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 268
           +   +++   D+W+ G ++ E+   G   +PG
Sbjct: 186 YN--KFSIKSDVWAFGVLLWEIATYGMSPYPG 215

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 91.5 bits (228), Expect = 7e-21
 Identities = 50/230 (21%), Positives = 90/230 (39%), Gaps = 55/230 (23%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
             V+G+G+FG V++      GE     VAIK++ +    K       E  +M  +D+P++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 138 VALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
             L   C         +   L+ + +P        +Y R H+  +   Y+  +  QI + 
Sbjct: 80  CRLLGICL-----TSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 196 LAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR-------YYR---------- 232
           + Y+     +   HRD+  +N+LV   P    I     ++        Y           
Sbjct: 130 MNYLEDRRLV---HRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185

Query: 233 -APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 277
            A E ++     YT   D+WS G  + EL+  G   + G    +   ++E
Sbjct: 186 MALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 91.3 bits (227), Expect = 8e-21
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 47/209 (22%)

Query: 87  EHVVGTGSFGVVFQAKCR----ETGEIVAIK--KVLQDKRYKN--RELQIMQMLDHPNIV 138
              +G G+FG V   +       TGE+VA+K  +   ++  ++  RE++I++ L H NIV
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 139 ALKHCFFSTTDKEE-LYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
             K      +     L   L++EY+P       R+Y + H+ R+  I +  YT QIC+ +
Sbjct: 106 KYKGV--CYSAGRRNLK--LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158

Query: 197 AYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR-------YYR----------- 232
            Y+     I   HRD+  +N+LV    N   I     ++       YY+           
Sbjct: 159 EYLGTKRYI---HRDLATRNILV-ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFW 214

Query: 233 -APELIFGATEYTTAIDIWSTGCVMAELL 260
            APE +   ++++ A D+WS G V+ EL 
Sbjct: 215 YAPESLT-ESKFSVASDVWSFGVVLYELF 242

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 89.0 bits (221), Expect = 3e-20
 Identities = 31/244 (12%), Positives = 55/244 (22%), Gaps = 41/244 (16%)

Query: 50  DSEPDIIDGVGAETGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEI 109
                  D V    G  I     GR         Y      G       +QA        
Sbjct: 11  RESSAPPDDVQLVPGARI---ANGR---------YRLLIFHGGVPPLQFWQALDTALDRQ 58

Query: 110 VAIKKVL----QDKRYKNR---ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYV 162
           VA+  V                    +  +D P +  +         +    +  V E++
Sbjct: 59  VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV---LDVVHTRAGGLV--VAEWI 113

Query: 163 P-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP 221
              ++  +A            +        +  A    H   G+      P  + V  + 
Sbjct: 114 RGGSLQEVAD------TSPSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVSIDG 166

Query: 222 NVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKV 281
           +V  +                     DI   G  +  LL+ +   P       L    + 
Sbjct: 167 DV-VLAYPATMPDA--------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD 217

Query: 282 LGTP 285
               
Sbjct: 218 TAGQ 221

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 89.3 bits (222), Expect = 3e-20
 Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 47/227 (20%)

Query: 87  EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
              +G G FG V           TGE+VA+K +  D   ++     +E+ I++ L H +I
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           +  K C     D     L LV+EYVP       R+Y   H  + L  + L+  QIC  +A
Sbjct: 96  IKYKGC---CEDAGAASLQLVMEYVP---LGSLRDYLPRH-SIGLAQLLLFAQQICEGMA 148

Query: 198 YIH--NCIGICHRDIKPQNLLVKGEPNVSYIC----SR-------YYR------------ 232
           Y+H  + I   HRD+  +N+L+     +  I     ++       YYR            
Sbjct: 149 YLHAQHYI---HRDLAARNVLL-DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 204

Query: 233 APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 278
           APE +     +  A D+WS G  + ELL          +   +L+ I
Sbjct: 205 APECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 89.3 bits (222), Expect = 4e-20
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 47/209 (22%)

Query: 87  EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
              +G G+FG V   +       TG +VA+K  LQ           RE+QI++ L    I
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
           V  +        ++ L   LV+EY+P   +   R++ + H+ R+    + LY+ QIC+ +
Sbjct: 87  VKYRGV-SYGPGRQSLR--LVMEYLP---SGCLRDFLQRHRARLDASRLLLYSSQICKGM 140

Query: 197 AYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR-------YYR----------- 232
            Y+    C+   HRD+  +N+LV        I     ++       YY            
Sbjct: 141 EYLGSRRCV---HRDLAARNILV-ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 196

Query: 233 -APELIFGATEYTTAIDIWSTGCVMAELL 260
            APE +     ++   D+WS G V+ EL 
Sbjct: 197 YAPESLS-DNIFSRQSDVWSFGVVLYELF 224

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 90.0 bits (223), Expect = 6e-20
 Identities = 64/359 (17%), Positives = 109/359 (30%), Gaps = 93/359 (25%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK---NRELQIMQ---------- 130
           Y     +G G F  V+ +   +  + VA+K V   + Y      E+++++          
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98

Query: 131 -------MLDH-------------------PNIVALKHCFFSTTDKEEL----------- 153
                  +LD                     +++                          
Sbjct: 99  NREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158

Query: 154 --YLNLVLEYV-----PETV------NRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
             YL+     +     PE +        I R  +   +             +  A A   
Sbjct: 159 LDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218

Query: 201 NCIGICHRDIKPQNLLVK----------GEPNVSYICSRYYRAPELIFGATEYTTAIDIW 250
           N +         + L VK           +     I +R YR+ E++ G+  Y T  DIW
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGS-GYNTPADIW 277

Query: 251 STGCVMAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEI-------KCMNPNY 297
           ST C+  EL  G  LF   SG       D +  II++LG   R+ I       +      
Sbjct: 278 STACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG 337

Query: 298 TEFKFPQIKPHPWHKVFQKRLP------PEAVDLVCRFFQYSPNLRCTALEACVHPFFD 350
                 ++KP    +V  ++            D +    +  P  R TA E   HP+ +
Sbjct: 338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 89.7 bits (223), Expect = 8e-20
 Identities = 54/207 (26%), Positives = 85/207 (41%), Gaps = 40/207 (19%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCF 144
              +G G FG V     R  G  VA+K +  D   +    E  +M  L H N+V L    
Sbjct: 198 LQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 254

Query: 145 FSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI--H 200
               +K  LY  +V EY+         +Y R   R  L    L  ++  +C A+ Y+  +
Sbjct: 255 -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308

Query: 201 NCIGICHRDIKPQNLLVKGEPNV-----------SYICSRYYR------APE-LIFGATE 242
           N +   HRD+  +N+LV  E NV           +       +      APE L     +
Sbjct: 309 NFV---HRDLAARNVLV-SEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREK--K 362

Query: 243 YTTAIDIWSTGCVMAELL-LGQPLFPG 268
           ++T  D+WS G ++ E+   G+  +P 
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGRVPYPR 389

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 50/209 (23%), Positives = 87/209 (41%), Gaps = 46/209 (22%)

Query: 87  EHVVGTGSFGVVFQAKCR----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
              +G G FG V   +       TGE VA+K +  +    +     +E++I++ L H NI
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIH-QRMPLIYVKLYTYQICRAL 196
           V  K      T+     + L++E++P   +   + Y   +  ++ L     Y  QIC+ +
Sbjct: 86  VKYKGI---CTEDGGNGIKLIMEFLP---SGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139

Query: 197 AYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR-------YYR----------- 232
            Y+     +   HRD+  +N+LV    +   I     ++       YY            
Sbjct: 140 DYLGSRQYV---HRDLAARNVLV-ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195

Query: 233 -APELIFGATEYTTAIDIWSTGCVMAELL 260
            APE +  +  +  A D+WS G  + ELL
Sbjct: 196 YAPECLMQSK-FYIASDVWSFGVTLHELL 223

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 48/224 (21%), Positives = 92/224 (41%), Gaps = 50/224 (22%)

Query: 85  IAEHVVGTGSFGVVFQAKCRETGEI--VAIKKV---LQDKRYKN---RELQIMQMLDHPN 136
           + +  +G+G+FG V +   +    +  VA+K +     D   K+    E  +MQ LD+P 
Sbjct: 20  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV +        + E     LV+E            Y + ++ +    +    +Q+   +
Sbjct: 80  IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130

Query: 197 AYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR-------YYR----------- 232
            Y+   N +   HRD+  +N+L+    + + I     S+       YY+           
Sbjct: 131 KYLEESNFV---HRDLAARNVLL-VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 186

Query: 233 -APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 273
            APE + +   ++++  D+WS G +M E    GQ  + G  G +
Sbjct: 187 YAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 49/216 (22%), Positives = 88/216 (40%), Gaps = 42/216 (19%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
           +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN+V L   
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
               T +   Y  ++ E++         +Y R   R  +  V L     QI  A+ Y+  
Sbjct: 285 ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336

Query: 200 HNCIGICHRDIKPQNLLVKGEPNVSYIC----SRYYR-----------------APELIF 238
            N I   HR++  +N LV GE ++  +     SR                    APE + 
Sbjct: 337 KNFI---HRNLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 392

Query: 239 GATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 273
               ++   D+W+ G ++ E+   G   +PG     
Sbjct: 393 YNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 427

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 85.0 bits (211), Expect = 7e-19
 Identities = 43/226 (19%), Positives = 74/226 (32%), Gaps = 51/226 (22%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI-------VAIKKVLQDKRYKN----RELQIMQMLDHP 135
              +G G+F  +F+   RE G+        V +K + +  R  +        +M  L H 
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 136 NIVALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQIC 193
           ++V     C       +E    LV E+V          Y + ++    I  KL    Q+ 
Sbjct: 73  HLVLNYGVC----VCGDENI--LVQEFVK---FGSLDTYLKKNKNCINILWKLEVAKQLA 123

Query: 194 RALAYI--HNCIGICHRDIKPQNLLV-------KGEPNVSYIC----SR------YYR-- 232
            A+ ++  +  I   H ++  +N+L+        G P    +     S         +  
Sbjct: 124 AAMHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER 180

Query: 233 ----APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 273
                PE I        A D WS G  + E+   G           
Sbjct: 181 IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 84.2 bits (209), Expect = 1e-18
 Identities = 54/223 (24%), Positives = 90/223 (40%), Gaps = 48/223 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKH- 142
              +G+G FGVV   K +   + VA+K + +    ++   +E Q M  L HP +V     
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY-TYQICRALAYI-- 199
           C    + +  +Y  +V EY+    N    NY R H +       L   Y +C  +A++  
Sbjct: 72  C----SKEYPIY--IVTEYIS---NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES 122

Query: 200 HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YYR-----------APE-LI 237
           H  I   HRD+  +N LV        +     +R      Y             APE   
Sbjct: 123 HQFI---HRDLAARNCLV-DRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFH 178

Query: 238 FGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVE 277
           +   +Y++  D+W+ G +M E+  LG+  +   +   V   V 
Sbjct: 179 YF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 54/223 (24%), Positives = 93/223 (41%), Gaps = 48/223 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
              +G G FG V+        + VA+K + Q     +    E  +M+ L H  +V L   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
            ++   +E +Y  ++ EY+    N    ++ +    + L   KL     QI   +A+I  
Sbjct: 74  -YAVVTQEPIY--IITEYME---NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 200 HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YYR-----------APE-LI 237
            N I   HRD++  N+LV  +     I     +R      Y             APE + 
Sbjct: 128 RNYI---HRDLRAANILV-SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183

Query: 238 FGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVE 277
           +G   +T   D+WS G ++ E++  G+  +PG +   V Q +E
Sbjct: 184 YG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 84.2 bits (209), Expect = 1e-18
 Identities = 58/230 (25%), Positives = 91/230 (39%), Gaps = 52/230 (22%)

Query: 85  IAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQDKRYKNR-----ELQIMQMLDHPNI 137
           IA+  +G G+FG V Q   R   +   VAIK + Q     +      E QIM  LD+P I
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
           V L          E L   LV+E            +    +  +P+  V    +Q+   +
Sbjct: 73  VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123

Query: 197 AYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR-------YYR----------- 232
            Y+   N +   HRD+  +N+L+    + + I     S+       YY            
Sbjct: 124 KYLEEKNFV---HRDLAARNVLL-VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 179

Query: 233 -APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 277
            APE + F   ++++  D+WS G  M E L  GQ  +    G +    +E
Sbjct: 180 YAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 50/230 (21%), Positives = 84/230 (36%), Gaps = 53/230 (23%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
             ++G G FG V +A+ ++       VA+K +  D    +      RE   M+  DHP++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 138 VALKH-CFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYT 189
             L      S          ++L ++           +RI  N   +  +  L+    + 
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT-LVR---FM 143

Query: 190 YQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YYR----- 232
             I   + Y+   N I   HRD+  +N ++  E     +     SR      YYR     
Sbjct: 144 VDIACGMEYLSSRNFI---HRDLAARNCML-AEDMTVCVADFGLSRKIYSGDYYRQGCAS 199

Query: 233 -------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 273
                  A E L      YT   D+W+ G  M E++  GQ  + G    +
Sbjct: 200 KLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 84.3 bits (209), Expect = 3e-18
 Identities = 51/229 (22%), Positives = 89/229 (38%), Gaps = 53/229 (23%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
             V+G+G+FG V++      GE     VAIK++ +    K       E  +M  +D+P++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 138 VALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
             L   C         +   L+ + +P        +Y R H+  +   Y+  +  QI + 
Sbjct: 80  CRLLGICL-----TSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 196 LAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR-------YYR---------- 232
           + Y+     +   HRD+  +N+LV   P    I     ++        Y           
Sbjct: 130 MNYLEDRRLV---HRDLAARNVLV-KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185

Query: 233 -APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 277
            A E I     YT   D+WS G  + EL+  G   + G    +   ++E
Sbjct: 186 MALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 83.0 bits (206), Expect = 3e-18
 Identities = 50/217 (23%), Positives = 85/217 (39%), Gaps = 46/217 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKH- 142
              +G+G FG+V         + VAIK + +    +     E ++M  L HP +V L   
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY-TYQICRALAYI-- 199
           C     ++  +   LV E++    +    +Y R  + +      L     +C  +AY+  
Sbjct: 72  C----LEQAPIC--LVTEFME---HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122

Query: 200 HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YYR-----------APE-LI 237
              I   HRD+  +N LV GE  V  +     +R      Y             +PE   
Sbjct: 123 ACVI---HRDLAARNCLV-GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 178

Query: 238 FGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 273
           F    Y++  D+WS G +M E+   G+  +   S  +
Sbjct: 179 FS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 84.2 bits (207), Expect = 3e-18
 Identities = 46/316 (14%), Positives = 89/316 (28%), Gaps = 65/316 (20%)

Query: 90  VGTGSFGVVFQAKCRETGEIVAIKKV-LQDKRYKN-----------RELQIMQML----- 132
           +G G FG VF  +       VAIK + ++     N            E+ I + L     
Sbjct: 28  IGEGVFGEVF--QTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 133 ----DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIY-- 184
                    + L            L L     Y     + N     +      + L +  
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 185 -----------------VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-- 225
                             K   +Q+  +LA     +   HRD+   N+L+K         
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHY 205

Query: 226 -ICSRYYRAPE--LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL 282
            +  +    P   L     +YT +        V  ++ + + LF G+   D   +I +++
Sbjct: 206 TLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDG--DYQFDIYRLM 263

Query: 283 GTPTREEIKCMNP-------NYTEFKFPQIKPHPW--HKVFQKRLPPEAVDLVCRFFQYS 333
                      +P       +Y   K  +        +    K++  +  +       +S
Sbjct: 264 KKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS 323

Query: 334 PNLRCTALEACVHPFF 349
                +A +       
Sbjct: 324 -----SATDLLCQHSL 334

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 84.8 bits (210), Expect = 3e-18
 Identities = 56/222 (25%), Positives = 88/222 (39%), Gaps = 46/222 (20%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
           E  +G G FG V+      T   VAIK +           +E Q+M+ L H  +V L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
            ++   +E +Y  +V EY+         ++ +      L   +L     QI   +AY+  
Sbjct: 245 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298

Query: 200 HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YYR-----------APELIF 238
            N +   HRD++  N+LV GE  V  +     +R      Y             APE   
Sbjct: 299 MNYV---HRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 354

Query: 239 GATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 277
               +T   D+WS G ++ EL   G+  +PG    +    VE
Sbjct: 355 YGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 83.5 bits (207), Expect = 4e-18
 Identities = 48/228 (21%), Positives = 83/228 (36%), Gaps = 51/228 (22%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
             V+G+G FG V +      GE     V IK +      ++       +  +  LDH +I
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
           V L            L   LV +Y+P        ++ R H+  +    +  +  QI + +
Sbjct: 78  VRL----LGLCPGSSLQ--LVTQYLP---LGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128

Query: 197 AYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YYR------------ 232
            Y+  H  +   HR++  +N+L+   P+   +     +                      
Sbjct: 129 YYLEEHGMV---HRNLAARNVLL-KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184

Query: 233 APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 277
           A E I     YT   D+WS G  + EL+  G   + G    +   L+E
Sbjct: 185 ALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 82.6 bits (205), Expect = 4e-18
 Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 49/221 (22%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
             ++G G FG V++            VA+K   +D    N+     E  IM+ LDHP+IV
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 197
            L        ++E  +  +++E  P        +Y   ++  + ++ + LY+ QIC+A+A
Sbjct: 77  KL----IGIIEEEPTW--IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127

Query: 198 YI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YYR-----------AP 234
           Y+   NC+   HRDI  +N+LV   P    +     SR      YY+           +P
Sbjct: 128 YLESINCV---HRDIAVRNILV-ASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSP 183

Query: 235 E-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 273
           E + F    +TTA D+W     M E+L  G+  F      D
Sbjct: 184 ESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 84.4 bits (209), Expect = 5e-18
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 48/223 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
           E  +G G FG V+ A   +  + VA+K +            E  +M+ L H  +V L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
                 KE +Y  ++ E++         ++ +  +       KL  ++ QI   +A+I  
Sbjct: 252 VT----KEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302

Query: 200 HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YYR-----------APE-LI 237
            N I   HRD++  N+LV     V  I     +R      Y             APE + 
Sbjct: 303 RNYI---HRDLRAANILV-SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 358

Query: 238 FGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 277
           FG   +T   D+WS G ++ E++  G+  +PG S  +  + +E
Sbjct: 359 FG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 83.1 bits (206), Expect = 5e-18
 Identities = 57/241 (23%), Positives = 91/241 (37%), Gaps = 61/241 (25%)

Query: 91  GTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQML-DHPNIVA 139
           G G+FG V +A        +    VA+K +     L ++     EL+++  L +H NIV 
Sbjct: 32  GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVN 91

Query: 140 LKHCFFSTTDKEELYLNLVLEYV-------------PETVNRIARNYSRIHQRMPLIYVK 186
           L       T        ++ EY                 +             + L    
Sbjct: 92  LLGA---CTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 187 LYT--YQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YYR 232
           L +  YQ+ + +A++   NCI   HRD+  +N+L+     ++ IC    +R       Y 
Sbjct: 147 LLSFSYQVAKGMAFLASKNCI---HRDLAARNILL-THGRITKICDFGLARDIKNDSNYV 202

Query: 233 ------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEII 279
                       APE IF    YT   D+WS G  + EL  LG   +PG     +  ++I
Sbjct: 203 VKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261

Query: 280 K 280
           K
Sbjct: 262 K 262

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 83.8 bits (207), Expect = 1e-17
 Identities = 56/222 (25%), Positives = 88/222 (39%), Gaps = 46/222 (20%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHC 143
           E  +G G FG V+      T   VAIK +           +E Q+M+ L H  +V L   
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327

Query: 144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL--YTYQICRALAYI-- 199
            ++   +E +Y  +V EY+         ++ +      L   +L     QI   +AY+  
Sbjct: 328 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381

Query: 200 HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YYR-----------APELIF 238
            N +   HRD++  N+LV GE  V  +     +R      Y             APE   
Sbjct: 382 MNYV---HRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 437

Query: 239 GATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 277
               +T   D+WS G ++ EL   G+  +PG    +    VE
Sbjct: 438 YGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 83.8 bits (207), Expect = 1e-17
 Identities = 57/224 (25%), Positives = 90/224 (40%), Gaps = 50/224 (22%)

Query: 85  IAEHVVGTGSFGVVFQAKCR-ETGEI-VAIKKVLQDKRYKNR-----ELQIMQMLDHPNI 137
           IA+  +G G+FG V Q   R    +I VAIK + Q     +      E QIM  LD+P I
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
           V L          E L   LV+E            +    +  +P+  V    +Q+   +
Sbjct: 399 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 449

Query: 197 AYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR-------YYR----------- 232
            Y+   N +   HR++  +N+L+    + + I     S+       YY            
Sbjct: 450 KYLEEKNFV---HRNLAARNVLL-VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 505

Query: 233 -APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 273
            APE + F   ++++  D+WS G  M E L  GQ  +    G +
Sbjct: 506 YAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 43/229 (18%), Positives = 81/229 (35%), Gaps = 52/229 (22%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
             ++G G FG V +   ++       VA+K +  D   +        E   M+   HPN+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYTY 190
           + L       + +      ++L ++           +R+      I  +  L+    +  
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT-LLK---FMV 154

Query: 191 QICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YYR------ 232
            I   + Y+   N +   HRD+  +N ++  +     +     S+      YYR      
Sbjct: 155 DIALGMEYLSNRNFL---HRDLAARNCML-RDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210

Query: 233 ------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 273
                 A E L      YT+  D+W+ G  M E+   G   +PG    +
Sbjct: 211 MPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 81.1 bits (201), Expect = 1e-17
 Identities = 52/217 (23%), Positives = 89/217 (41%), Gaps = 46/217 (21%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKH- 142
              +GTG FGVV   K R   + VAIK + +    ++    E ++M  L H  +V L   
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 143 CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY-TYQICRALAYI-- 199
           C    T +  ++  ++ EY+    N    NY R  +        L     +C A+ Y+  
Sbjct: 88  C----TKQRPIF--IITEYMA---NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 138

Query: 200 HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YYR-----------APE-LI 237
              +   HRD+  +N LV  +  V  +     SR      Y              PE L+
Sbjct: 139 KQFL---HRDLAARNCLV-NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 194

Query: 238 FGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 273
           +   ++++  DIW+ G +M E+  LG+  +   +  +
Sbjct: 195 YS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 58/221 (26%), Positives = 85/221 (38%), Gaps = 50/221 (22%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALK 141
              +G G+FG VF  + R    +VA+K   +      +     E +I++   HPNIV L 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177

Query: 142 H--CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRALAY 198
              C    T K+ +Y  +V+E V          + R       +   L         + Y
Sbjct: 178 IGVC----TQKQPIY--IVMELVQ---GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEY 228

Query: 199 IH--NCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YYR------------AP 234
           +    CI   HRD+  +N LV  E NV  I     SR      Y              AP
Sbjct: 229 LESKCCI---HRDLAARNCLV-TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP 284

Query: 235 E-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 273
           E L +G   Y++  D+WS G ++ E   LG   +P  S   
Sbjct: 285 EALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 56/230 (24%), Positives = 86/230 (37%), Gaps = 54/230 (23%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           E ++G+G  G V   + R  G+    VAIK +      + R     E  IM   DHPNI+
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 139 ALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRAL 196
            L+       T        +V EY+    N     + R H     I   +     +   +
Sbjct: 114 RLEGVV----TRGRLAM--IVTEYME---NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164

Query: 197 AYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR-------YYR----------- 232
            Y+     +   HRD+  +N+LV     V  +     SR                     
Sbjct: 165 RYLSDLGYV---HRDLAARNVLV-DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRW 220

Query: 233 -APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 277
            APE + F    +++A D+WS G VM E+L  G+  +   +  D    VE
Sbjct: 221 TAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 80.0 bits (198), Expect = 4e-17
 Identities = 58/227 (25%), Positives = 88/227 (38%), Gaps = 51/227 (22%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
              +G G FG V Q            VAIK          R     E   M+  DHP+IV
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 197
            L         +  ++  +++E          R++ ++ +  + L  + LY YQ+  ALA
Sbjct: 80  KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKYSLDLASLILYAYQLSTALA 130

Query: 198 YI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YYR-----------AP 234
           Y+     +   HRDI  +N+LV    +   +     SR      YY+           AP
Sbjct: 131 YLESKRFV---HRDIAARNVLV-SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 186

Query: 235 E-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 277
           E + F    +T+A D+W  G  M E+L  G   F G    D    +E
Sbjct: 187 ESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 79.6 bits (197), Expect = 6e-17
 Identities = 52/231 (22%), Positives = 83/231 (35%), Gaps = 55/231 (23%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
              +G GSFGVV + +          VA+K +  D   +        RE+  M  LDH N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
           ++ L    +       +   +V E  P        +  R HQ    L  +  Y  Q+   
Sbjct: 83  LIRL----YGVVLTPPMK--MVTELAP---LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133

Query: 196 LAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR-------YYR---------- 232
           + Y+     I   HRD+  +NLL+    ++  I      R       +Y           
Sbjct: 134 MGYLESKRFI---HRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 189

Query: 233 --APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD--QLVE 277
             APE L      ++ A D W  G  + E+   GQ  + G +G      ++
Sbjct: 190 WCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 81.8 bits (202), Expect = 6e-17
 Identities = 58/227 (25%), Positives = 88/227 (38%), Gaps = 51/227 (22%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI---VAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
              +G G FG V Q            VAIK          R     E   M+  DHP+IV
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRALA 197
            L         +  ++  +++E          R++ ++ +  + L  + LY YQ+  ALA
Sbjct: 455 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKFSLDLASLILYAYQLSTALA 505

Query: 198 YI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YYR-----------AP 234
           Y+     +   HRDI  +N+LV    +   +     SR      YY+           AP
Sbjct: 506 YLESKRFV---HRDIAARNVLV-SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561

Query: 235 E-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESG--VDQLVE 277
           E + F    +T+A D+W  G  M E+L  G   F G     V   +E
Sbjct: 562 ESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 79.6 bits (197), Expect = 7e-17
 Identities = 57/242 (23%), Positives = 94/242 (38%), Gaps = 58/242 (23%)

Query: 88  HVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLD-HPN 136
             +G G+FG V +A         T   VA+K +       + R    EL+I+  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYV-------------PETVNRIARNYSRIHQRMPLI 183
           +V L      T     L   +++E+               E V             + L 
Sbjct: 93  VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 184 YVKLYTYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YY 231
           ++  Y++Q+ + + ++    CI   HRD+  +N+L+  E NV  IC    +R       Y
Sbjct: 149 HLICYSFQVAKGMEFLASRKCI---HRDLAARNILL-SEKNVVKICDFGLARDIYKDPDY 204

Query: 232 R------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEI 278
                        APE IF    YT   D+WS G ++ E+  LG   +PG    ++    
Sbjct: 205 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263

Query: 279 IK 280
           +K
Sbjct: 264 LK 265

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 78.8 bits (195), Expect = 1e-16
 Identities = 55/227 (24%), Positives = 90/227 (39%), Gaps = 56/227 (24%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIK--KVLQDKRYKN---RELQIMQMLDHPNIV 138
           + V+G G FGVV+  +  +  +     AIK    + + +      RE  +M+ L+HPN++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMP----LIYVKLYTYQICR 194
           AL          E L   ++L Y+    +     + R  QR P    LI    +  Q+ R
Sbjct: 86  ALIGI---MLPPEGLPH-VLLPYMC---HGDLLQFIRSPQRNPTVKDLIS---FGLQVAR 135

Query: 195 ALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YYR---------- 232
            + Y+     +   HRD+  +N ++  E     +     +R      YY           
Sbjct: 136 GMEYLAEQKFV---HRDLAARNCML-DESFTVKVADFGLARDILDREYYSVQQHRHARLP 191

Query: 233 ----APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 273
               A E L      +TT  D+WS G ++ ELL  G P +      D
Sbjct: 192 VKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 53/224 (23%), Positives = 89/224 (39%), Gaps = 52/224 (23%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIV 138
           + VVG G FG V   + +   +    VAIK +      K R     E  IM   DHPNI+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 139 ALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRAL 196
            L+       T  + +   +V EY+    N    ++ R H  +  +I +      I   +
Sbjct: 110 RLEGVV----TKSKPVM--IVTEYME---NGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160

Query: 197 AYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR--------YYR---------- 232
            Y+     +   HRD+  +N+L+     V  +      R         Y           
Sbjct: 161 KYLSDMGYV---HRDLAARNILI-NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW 216

Query: 233 -APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 273
            +PE + +   ++T+A D+WS G V+ E++  G+  +   S  D
Sbjct: 217 TSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 48/224 (21%), Positives = 85/224 (37%), Gaps = 50/224 (22%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI---VAIK--KVLQDKRYKN---RELQIMQMLDHPNIV 138
             V+G G FG V+     +        A+K    + D    +    E  IM+   HPN++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKL-YTYQICRALA 197
           +L         +      +VL Y+    +   RN+ R     P +   + +  Q+ + + 
Sbjct: 90  SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 142

Query: 198 YI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YYR------------- 232
           Y+     +   HRD+  +N ++  E     +     +R      YY              
Sbjct: 143 YLASKKFV---HRDLAARNCML-DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 198

Query: 233 -APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 273
            A E L     ++TT  D+WS G ++ EL+  G P +P  +  D
Sbjct: 199 MALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 56/239 (23%), Positives = 94/239 (39%), Gaps = 62/239 (25%)

Query: 91  GTGSFGVVFQAKCRETGE-----IVAIKKV----LQDKRYKNRELQIMQMLDHPNIVALK 141
           G G+FG VF A+C          +VA+K +    L  ++   RE +++  L H +IV   
Sbjct: 24  GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFY 83

Query: 142 HCFFSTTDKEELYLNLVLEYVP-----------ETVNRIARNYSRIHQRMPLIYVKLY-- 188
                  D + L   +V EY+                 I  +      +  L   ++   
Sbjct: 84  GV---CGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 189 TYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YYR---- 232
             QI   + Y+   + +   HRD+  +N LV G   +  I     SR      YYR    
Sbjct: 139 ASQIASGMVYLASQHFV---HRDLATRNCLV-GANLLVKIGDFGMSRDVYSTDYYRVGGH 194

Query: 233 --------APE-LIFGATEYTTAIDIWSTGCVMAELL-LG-QPLFPGESGVDQLVEIIK 280
                    PE +++   ++TT  D+WS G ++ E+   G QP +   S   +++E I 
Sbjct: 195 TMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQP-WFQLS-NTEVIECIT 249

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 57/251 (22%), Positives = 91/251 (36%), Gaps = 68/251 (27%)

Query: 87  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQML-DHP 135
             V+G+G+FG V  A             VA+K +       ++     EL++M  L  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVP------------------ETVNRIARNYSRIH 177
           NIV L       T    +Y  L+ EY                    E      +      
Sbjct: 110 NIVNLLGA---CTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 178 QRMPLIYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR 229
               L +  L  + YQ+ + + ++   +C+   HRD+  +N+LV     V  IC    +R
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCV---HRDLAARNVLV-THGKVVKICDFGLAR 220

Query: 230 ------YYR------------APELIFGATEYTTAIDIWSTGCVMAEL--LLGQPLFPGE 269
                  Y             APE +F    YT   D+WS G ++ E+  L   P +PG 
Sbjct: 221 DIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNP-YPGI 278

Query: 270 SGVDQLVEIIK 280
                  ++I+
Sbjct: 279 PVDANFYKLIQ 289

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 57/242 (23%), Positives = 94/242 (38%), Gaps = 59/242 (24%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE-----IVAIKKV-----LQDKRYKNRELQIMQMLD-HP 135
              +G G+FG V +A     G+      VA+K +       +K     EL+IM  L  H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVP---------ETVNRIARNYSRIHQRMPLIYVK 186
           NIV L       T    +   ++ EY                +  + +            
Sbjct: 111 NIVNLLGA---CTHGGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 187 L--YTYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YYR 232
           L  ++ Q+ + +A++   NCI   HRD+  +N+L+    +V+ I     +R       Y 
Sbjct: 166 LLHFSSQVAQGMAFLASKNCI---HRDVAARNVLL-TNGHVAKIGDFGLARDIMNDSNYI 221

Query: 233 ------------APELIFGATEYTTAIDIWSTGCVMAELL-LG-QPLFPGESGVDQLVEI 278
                       APE IF    YT   D+WS G ++ E+  LG  P +PG     +  ++
Sbjct: 222 VKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP-YPGILVNSKFYKL 279

Query: 279 IK 280
           +K
Sbjct: 280 VK 281

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 77.7 bits (192), Expect = 3e-16
 Identities = 52/251 (20%), Positives = 90/251 (35%), Gaps = 69/251 (27%)

Query: 87  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 136
              +G G FG V +A             VA+K +       + R    E  +++ ++HP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP-------------------ETVNRIARNYSRIH 177
           ++ L       +    L   L++EY                      +      +     
Sbjct: 88  VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 178 QRMPLIYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR 229
               L    L  + +QI + + Y+     +   HRD+  +N+LV  E     I     SR
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLV---HRDLAARNILV-AEGRKMKISDFGLSR 198

Query: 230 ------YYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LG-QPLFPGE 269
                  Y             A E +F    YTT  D+WS G ++ E++ LG  P +PG 
Sbjct: 199 DVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNP-YPGI 256

Query: 270 SGVDQLVEIIK 280
              ++L  ++K
Sbjct: 257 P-PERLFNLLK 266

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 77.8 bits (192), Expect = 4e-16
 Identities = 50/225 (22%), Positives = 86/225 (38%), Gaps = 53/225 (23%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI----VAIKKVLQDKRYKNR-----ELQIMQMLDHPNI 137
           + V+G G FG V++   + +       VAIK +      K R     E  IM    H NI
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 138 VALKH-CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQ-RMPLIYVKLYTYQICRA 195
           + L+       +  + +   ++ EY+    N     + R       ++ +      I   
Sbjct: 109 IRLEGVI----SKYKPMM--IITEYME---NGALDKFLREKDGEFSVLQLVGMLRGIAAG 159

Query: 196 LAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR--------YYR--------- 232
           + Y+   N +   HRD+  +N+LV     V  +     SR         Y          
Sbjct: 160 MKYLANMNYV---HRDLAARNILV-NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 215

Query: 233 --APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 273
             APE + +    +T+A D+WS G VM E++  G+  +   S  +
Sbjct: 216 WTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHE 258

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 77.3 bits (191), Expect = 6e-16
 Identities = 49/236 (20%), Positives = 93/236 (39%), Gaps = 55/236 (23%)

Query: 88  HVVGTGSFGVVFQAKCRETGE-----IVAIKKV-----LQDKRYKNRELQIMQMLDHPNI 137
             +G GSFG+V++   +   +      VAIK V     ++++     E  +M+  +  ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVKLYTY 190
           V L       +  +     +++E +            R A   + +     L  +     
Sbjct: 91  VRLLGV---VSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 191 QICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YYR------ 232
           +I   +AY+  +  +   HRD+  +N +V  E     I     +R      YYR      
Sbjct: 146 EIADGMAYLNANKFV---HRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201

Query: 233 ------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIK 280
                 +PE L  G   +TT  D+WS G V+ E+  L +  + G S  +Q++  + 
Sbjct: 202 LPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQVLRFVM 254

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 49/236 (20%), Positives = 90/236 (38%), Gaps = 53/236 (22%)

Query: 87  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 136
              +G G+FG V++ +        +   VA+K +      QD+     E  I+   +H N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQI 192
           IV        +      +  +++E +      +  R  R        + ++ +      I
Sbjct: 95  IVRCIGV---SLQSLPRF--ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 193 CRALAYI--HNCIGICHRDIKPQNLLV--KGEPNVSYIC----SR------YYR------ 232
                Y+  ++ I   HRDI  +N L+   G   V+ I     +R      YYR      
Sbjct: 150 ACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206

Query: 233 ------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIK 280
                  PE  + G   +T+  D WS G ++ E+  LG   +P +S   +++E + 
Sbjct: 207 LPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEVLEFVT 259

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 57/242 (23%), Positives = 95/242 (39%), Gaps = 61/242 (25%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE-----IVAIKKV----LQDKRYKNRELQIMQMLDHPNI 137
           +  +G G+FG VF A+C          +VA+K +       ++   RE +++ ML H +I
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP----------ETVNRIARNYSRIHQRMPLIYVKL 187
           V         T+   L   +V EY+              +             PL   +L
Sbjct: 106 VRFFGV---CTEGRPLL--MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 188 --YTYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YYR- 232
                Q+   + Y+   + +   HRD+  +N LV G+  V  I     SR      YYR 
Sbjct: 161 LAVASQVAAGMVYLAGLHFV---HRDLATRNCLV-GQGLVVKIGDFGMSRDIYSTDYYRV 216

Query: 233 -----------APE-LIFGATEYTTAIDIWSTGCVMAELL-LG-QPLFPGESGVDQLVEI 278
                       PE +++   ++TT  D+WS G V+ E+   G QP +   S   + ++ 
Sbjct: 217 GGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP-WYQLS-NTEAIDC 272

Query: 279 IK 280
           I 
Sbjct: 273 IT 274

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 59/226 (26%), Positives = 91/226 (40%), Gaps = 55/226 (24%)

Query: 87  EHVVGTGSFGVVFQAKCRETGE--IVAIKKV-----LQDKRYKNRELQIMQML-DHPNIV 138
           + V+G G+FG V +A+ ++ G     AIK++       D R    EL+++  L  HPNI+
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP-----------ETVNRIARNYSRIHQRMPLIYVKL 187
            L         +  LY  L +EY P             +               L   +L
Sbjct: 90  NLLGA---CEHRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 188 --YTYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR---YYR---- 232
             +   + R + Y+     I   HRD+  +N+LV GE  V+ I     SR    Y     
Sbjct: 145 LHFAADVARGMDYLSQKQFI---HRDLAARNILV-GENYVAKIADFGLSRGQEVYVKKTM 200

Query: 233 --------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPG 268
                   A E L +    YTT  D+WS G ++ E++ LG   + G
Sbjct: 201 GRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 50/236 (21%), Positives = 90/236 (38%), Gaps = 53/236 (22%)

Query: 87  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 136
              +G G+FG V++ +        +   VA+K +      QD+     E  I+   +H N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPE----TVNRIARNYSRIHQRMPLIYVKLYTYQI 192
           IV        +      +  ++LE +      +  R  R        + ++ +      I
Sbjct: 136 IVRCIGV---SLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 193 CRALAYI--HNCIGICHRDIKPQNLLV--KGEPNVSYIC----SR------YYR------ 232
                Y+  ++ I   HRDI  +N L+   G   V+ I     +R      YYR      
Sbjct: 191 ACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247

Query: 233 ------APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIK 280
                  PE  + G   +T+  D WS G ++ E+  LG   +P +S   +++E + 
Sbjct: 248 LPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEVLEFVT 300

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 58/252 (23%), Positives = 94/252 (37%), Gaps = 71/252 (28%)

Query: 87  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 136
              +G G+FG VFQA+       E   +VA+K +        +    RE  +M   D+PN
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP-------------------ETVNRIARNYSRIH 177
           IV L          + +   L+ EY+                       +   R      
Sbjct: 112 IVKLLGV---CAVGKPMC--LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 178 QRMPLIYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR 229
              PL   +      Q+   +AY+     +   HRD+  +N LV GE  V  I     SR
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFV---HRDLATRNCLV-GENMVVKIADFGLSR 222

Query: 230 ------YYR------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LG-QPLFPG 268
                 YY+             PE + +    YTT  D+W+ G V+ E+   G QP + G
Sbjct: 223 NIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQP-YYG 279

Query: 269 ESGVDQLVEIIK 280
            +  ++++  ++
Sbjct: 280 MA-HEEVIYYVR 290

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 75.2 bits (185), Expect = 4e-15
 Identities = 47/227 (20%), Positives = 84/227 (37%), Gaps = 56/227 (24%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI---VAIK--KVLQDKRYKN---RELQIMQMLDHPNIV 138
             V+G G FG V+     +        A+K    + D    +    E  IM+   HPN++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMP----LIYVKLYTYQICR 194
           +L         +      +VL Y+    +   RN+ R     P    LI    +  Q+ +
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIG---FGLQVAK 203

Query: 195 ALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YYR---------- 232
            + ++     +   HRD+  +N ++  E     +     +R      +            
Sbjct: 204 GMKFLASKKFV---HRDLAARNCML-DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 259

Query: 233 ----APE-LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVD 273
               A E L     ++TT  D+WS G ++ EL+  G P +P  +  D
Sbjct: 260 VKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 74.7 bits (184), Expect = 6e-15
 Identities = 61/245 (24%), Positives = 96/245 (39%), Gaps = 62/245 (25%)

Query: 87  EHVVGTGSFGVVFQAKCR-------ETGEIVAIKKV-----LQDKRYKNRELQIMQML-D 133
              +G G+FG V  A+              VA+K +      +D      E+++M+M+  
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVP-----------ETVNRIARNYSRIHQRMPL 182
           H NI+ L       T    LY  +++EY                          +    L
Sbjct: 134 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 183 IYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR----- 229
               L    YQ+ R + Y+    CI   HRD+  +N+LV  E NV  I     +R     
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLV-TEDNVMKIADFGLARDIHHI 244

Query: 230 -YYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQL 275
            YY+            APE +F    YT   D+WS G ++ E+  LG   +PG   V++L
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEEL 302

Query: 276 VEIIK 280
            +++K
Sbjct: 303 FKLLK 307

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 74.3 bits (183), Expect = 7e-15
 Identities = 62/245 (25%), Positives = 98/245 (40%), Gaps = 62/245 (25%)

Query: 87  EHVVGTGSFGVVFQAKCR-------ETGEIVAIKKV-----LQDKRYKNRELQIMQML-D 133
              +G G FG V  A+         +    VA+K +      +D      E+++M+M+  
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPE-----------TVNRIARNYSRIHQRMPL 182
           H NI+ L       T    LY  +++EY  +                            +
Sbjct: 146 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 183 IYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR----- 229
            +  L   TYQ+ R + Y+    CI   HRD+  +N+LV  E NV  I     +R     
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLV-TENNVMKIADFGLARDINNI 256

Query: 230 -YYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQL 275
            YY+            APE +F    YT   D+WS G +M E+  LG   +PG   V++L
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEEL 314

Query: 276 VEIIK 280
            +++K
Sbjct: 315 FKLLK 319

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 73.0 bits (180), Expect = 1e-14
 Identities = 52/244 (21%), Positives = 88/244 (36%), Gaps = 63/244 (25%)

Query: 87  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLDHPN 136
              +G   FG V++         E  + VAIK +        +     E  +   L HPN
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVP-----------ETVNRIARNYSRIHQRMPLIYV 185
           +V L       T  + L   ++  Y                + +         +  L   
Sbjct: 74  VVCLLGV---VTKDQPLS--MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 186 KL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YY 231
                  QI   + Y+  H+ +   H+D+  +N+LV  +     I      R      YY
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVV---HKDLATRNVLV-YDKLNVKISDLGLFREVYAADYY 184

Query: 232 R------------APE-LIFGATEYTTAIDIWSTGCVMAELL-LG-QPLFPGESGVDQLV 276
           +            APE +++G  +++   DIWS G V+ E+   G QP + G S    +V
Sbjct: 185 KLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP-YCGYS-NQDVV 240

Query: 277 EIIK 280
           E+I+
Sbjct: 241 EMIR 244

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 62/245 (25%), Positives = 99/245 (40%), Gaps = 62/245 (25%)

Query: 87  EHVVGTGSFGVVFQAKCR-------ETGEIVAIKKV-----LQDKRYKNRELQIMQML-D 133
              +G G+FG V  A+         +    VA+K +      +D      E+++M+M+  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPE-----------TVNRIARNYSRIHQRMPL 182
           H NI+ L       T    LY  +++EY  +                            +
Sbjct: 100 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 183 IYVKL--YTYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR----- 229
            +  L   TYQ+ R + Y+    CI   HRD+  +N+LV  E NV  I     +R     
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLV-TENNVMKIADFGLARDINNI 210

Query: 230 -YYR------------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQL 275
            YY+            APE +F    YT   D+WS G +M E+  LG   +PG   V++L
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEEL 268

Query: 276 VEIIK 280
            +++K
Sbjct: 269 FKLLK 273

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 35/163 (21%), Positives = 63/163 (38%), Gaps = 20/163 (12%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIK--KVLQDKRYKNRELQIMQMLDH-PNIVAL 140
           +     +G G+FG +   K   T E VAIK   +       + E +  + L     I  +
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            +           Y  +VLE +  ++  +     R      L  V +   Q+   + Y+H
Sbjct: 71  YYF-----GPCGKYNAMVLELLGPSLEDLFDLCDR---TFSLKTVLMIAIQLISRMEYVH 122

Query: 201 NCIGICHRDIKPQNLLV----KGEPNVSYI----CSRYYRAPE 235
           +   + +RD+KP+N L+         V +I     ++ Y  PE
Sbjct: 123 SK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 68.2 bits (167), Expect = 5e-13
 Identities = 31/137 (22%), Positives = 57/137 (41%), Gaps = 12/137 (8%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDH-PNIVAL 140
           Y     +G GSFGV+F+       + VAIK   +         E +  ++L     I  +
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            +       +E L+  LV++ +  ++  +     R   +  +  V +   Q+   +  IH
Sbjct: 72  YYF-----GQEGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIH 123

Query: 201 NCIGICHRDIKPQNLLV 217
               + +RDIKP N L+
Sbjct: 124 EK-SLVYRDIKPDNFLI 139

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 67.8 bits (166), Expect = 6e-13
 Identities = 42/161 (26%), Positives = 69/161 (42%), Gaps = 18/161 (11%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDH-PNIVAL 140
           Y     +G+GSFG ++       GE VAIK      ++     E +I +M+     I  +
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           + C       E  Y  +V+E +  ++  +    SR   +  L  V L   Q+   + YIH
Sbjct: 71  RWC-----GAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIH 122

Query: 201 NCIGICHRDIKPQNLLV--KGEPNVSYIC----SRYYRAPE 235
           +     HRD+KP N L+    + N+ YI     ++ YR   
Sbjct: 123 SK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 36/161 (22%), Positives = 69/161 (42%), Gaps = 18/161 (11%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQML-DHPNIVAL 140
           +     +G+GSFG ++     +T E VAIK      ++     E +I ++L     I  +
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
           +         E  Y  LV++ +  ++  +   ++   +++ L  V +   Q+   + ++H
Sbjct: 69  RWF-----GVEGDYNVLVMDLLGPSLEDL---FNFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 201 NCIGICHRDIKPQNLLV--KGEPNVSYI----CSRYYRAPE 235
           +     HRDIKP N L+      N  YI     ++ YR   
Sbjct: 121 SK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 36/195 (18%), Positives = 63/195 (32%), Gaps = 36/195 (18%)

Query: 63  TGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK 122
            G V+    G +         ++    +G+G FG+++ A      E  A   V  + +  
Sbjct: 27  EGKVLDDMEGNQ---------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN 77

Query: 123 N---RELQIMQMLDHPNIVALK--------------HCFFSTTDKEELYLNLVLEYVPET 165
                EL+  Q +   + +                 +    T  K   Y  +V+E +   
Sbjct: 78  GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID 137

Query: 166 VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV-KGEPNVS 224
           + +I    +          V     ++   L YIH      H DIK  NLL+    P+  
Sbjct: 138 LQKI-SGQNG---TFKKSTVLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNPDQV 192

Query: 225 YIC----SRYYRAPE 235
           Y+     S  Y    
Sbjct: 193 YLADYGLSYRYCPNG 207

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 63.3 bits (153), Expect = 7e-11
 Identities = 62/431 (14%), Positives = 134/431 (31%), Gaps = 116/431 (26%)

Query: 24  SSSVDWLGREMLEMRLRDQVDNDEDRDSEPDIIDGV--GAETGHVIRTTIGGRNGNSKQK 81
           +    +  +++L +     VDN + +D + D+   +    E  H+I +       ++   
Sbjct: 11  TGEHQYQYKDILSVFEDAFVDNFDCKDVQ-DMPKSILSKEEIDHIIMS------KDAVSG 63

Query: 82  VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALK 141
              +         F  +      +  E+V  +K +++    N +  +  +       ++ 
Sbjct: 64  TLRL---------FWTL----LSKQEEMV--QKFVEEVLRINYKFLMSPIKTEQRQPSMM 108

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRM----PLIYVKLY--------- 188
              +    ++ LY N    +    V+R+ + Y ++ Q +    P   V +          
Sbjct: 109 TRMYIEQ-RDRLY-NDNQVFAKYNVSRL-QPYLKLRQALLELRPAKNVLIDGVLGSGKTW 165

Query: 189 -TYQICRALA----------YIHNCIGICHRD---IKP-QNLLVKGEPNVSYICSRYYRA 233
               +C +            +++  +  C+     ++  Q LL + +PN +         
Sbjct: 166 VALDVCLSYKVQCKMDFKIFWLN--LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI 223

Query: 234 PELI----------FGATEYTTAI----DIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
              I            +  Y   +    ++ +     A        F             
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNA--------FNLSC--------- 266

Query: 280 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRL-PPEAVDLVCRFFQYSPNLRC 338
           K+L T TR          T+F       H         L P E   L+ ++     + R 
Sbjct: 267 KILLT-TR------FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYL----DCRP 315

Query: 339 TAL--EAC-VHPFF-----DELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPE 390
             L  E    +P       + +RD      N +      +    +L+ I   ++N L P 
Sbjct: 316 QDLPREVLTTNPRRLSIIAESIRDGLATWDNWK------HVNCDKLTTIIESSLNVLEPA 369

Query: 391 HARKQNLFMAL 401
             RK  +F  L
Sbjct: 370 EYRK--MFDRL 378

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 59.0 bits (143), Expect = 8e-10
 Identities = 33/197 (16%), Positives = 57/197 (28%), Gaps = 39/197 (19%)

Query: 64  GHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN 123
           G +I                +     +G G FG ++ A    + E V        K   +
Sbjct: 26  GEIITDMAAAA---------WKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPS 75

Query: 124 R------ELQIMQMLDHPNIVALK--------------HCFFSTTDKEELYLNLVLEYVP 163
                  EL+  Q    P  +                           + Y  ++++   
Sbjct: 76  DNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFG 135

Query: 164 ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV-KGEPN 222
             + +I    ++   R     V   + +I   L YIH      H DIK  NLL+    P+
Sbjct: 136 SDLQKIYEANAK---RFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKNPD 191

Query: 223 VSYI----CSRYYRAPE 235
             Y+     +  Y    
Sbjct: 192 QVYLVDYGLAYRYCPEG 208

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 23/197 (11%), Positives = 58/197 (29%), Gaps = 43/197 (21%)

Query: 63  TGHVIRTTIGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETG--------EIVAIK- 113
           TG V+    G +         +  +      + G++++A    T         +  ++K 
Sbjct: 32  TGTVLTDKSGRQ---------WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL 82

Query: 114 -----------KVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE 160
                         Q   K  +  + + +       I             ++ Y  LVL 
Sbjct: 83  DAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGV----HQDKYRFLVLP 138

Query: 161 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV-KG 219
            +  ++        +    +    V     ++  AL ++H      H ++  +N+ V   
Sbjct: 139 SLGRSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVDPE 195

Query: 220 EPNVSYI----CSRYYR 232
           + +   +     +  Y 
Sbjct: 196 DQSQVTLAGYGFAFRYC 212

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 55.3 bits (134), Expect = 9e-09
 Identities = 35/141 (24%), Positives = 62/141 (43%), Gaps = 24/141 (17%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR----ELQIMQMLDHPNIVAL-K 141
           + ++G G FG V++   R+ G  VA+K+   +          E++ +    HP++V+L  
Sbjct: 44  KFLIGHGVFGKVYKGVLRD-GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARN--YSRIHQRMPLIYVKLYTYQIC----RA 195
            C       E   + L+ +Y+    N   +   Y      M + + +    +IC    R 
Sbjct: 103 FC------DERNEMILIYKYME---NGNLKRHLYGSDLPTMSMSWEQ--RLEICIGAARG 151

Query: 196 LAYIHNCIGICHRDIKPQNLL 216
           L Y+H    I HRD+K  N+L
Sbjct: 152 LHYLHTR-AIIHRDVKSINIL 171

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 55.3 bits (134), Expect = 1e-08
 Identities = 55/229 (24%), Positives = 85/229 (37%), Gaps = 61/229 (26%)

Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR--------ELQ 127
            N  ++   +  + +G G FGVV+  K       VA+KK+                 E++
Sbjct: 25  NNFDERPISVGGNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIK 82

Query: 128 IMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYS------RIHQRMP 181
           +M    H N+V L     S+   +     LV  Y+P        N S       +    P
Sbjct: 83  VMAKCQHENLVELLGF--SSDGDDLC---LVYVYMP--------NGSLLDRLSCLDGTPP 129

Query: 182 LIYVKLYTYQIC----RALAYIH-NCIGICHRDIKPQNLL----------------VKGE 220
           L +      +I       + ++H N   I HRDIK  N+L                   +
Sbjct: 130 LSWHM--RCKIAQGAANGINFLHENHH-I-HRDIKSANILLDEAFTAKISDFGLARASEK 185

Query: 221 PNVSYICSR----Y-YRAPELIFGATEYTTAIDIWSTGCVMAELLLGQP 264
              + + SR      Y APE + G  E T   DI+S G V+ E++ G P
Sbjct: 186 FAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP 232

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 53.0 bits (128), Expect = 6e-08
 Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 59/217 (27%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNR-----ELQIMQMLDHPNIVALK 141
           ++++G G FG V++ +    G +VA+K++ +++          E++++ M  H N++ L+
Sbjct: 35  KNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYS-------RIHQRMPLIYVKLYTYQIC- 193
                 T  E L   LV  Y+         N S       R   + PL + K    +I  
Sbjct: 94  GF--CMTPTERL---LVYPYMA--------NGSVASCLRERPESQPPLDWPK--RQRIAL 138

Query: 194 ---RALAYIHN-C-IGICHRDIKPQNLLV--------------K-GEPNVSYICSRY--- 230
              R LAY+H+ C   I HRD+K  N+L+              K  +   +++ +     
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 198

Query: 231 --YRAPE-LIFG-ATEYTTAIDIWSTGCVMAELLLGQ 263
             + APE L  G ++E T   D++  G ++ EL+ GQ
Sbjct: 199 IGHIAPEYLSTGKSSEKT---DVFGYGVMLLELITGQ 232

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 46.5 bits (110), Expect = 9e-06
 Identities = 33/118 (27%), Positives = 53/118 (44%), Gaps = 30/118 (25%)

Query: 188 YTYQICRALAYI--HNCIGICHRDIKPQNLLVKGEPNVSYIC----SR------YYR--- 232
           Y++Q+ + + ++    CI   HRD+  +N+L+  E NV  IC    +R       Y    
Sbjct: 198 YSFQVAKGMEFLASRKCI---HRDLAARNILL-SEKNVVKICDFGLARDIYKDPDYVRKG 253

Query: 233 ---------APELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIK 280
                    APE IF    YT   D+WS G ++ E+  LG   +PG    ++    +K
Sbjct: 254 DARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 310

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 41.8 bits (98), Expect = 2e-04
 Identities = 21/88 (23%), Positives = 35/88 (39%), Gaps = 15/88 (17%)

Query: 87  EHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLD-HP 135
              +G G+FG V +A         T   VA+K +       + R    EL+I+  +  H 
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVP 163
           N+V L      T     L   +++E+  
Sbjct: 87  NVVNLLGA--CTKPGGPLM--VIVEFCK 110

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	403
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.89
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.84
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.73
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.64
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.93
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.72
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.59
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.41
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	97.92
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.75
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.57
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.53
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.27
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.23
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.21
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.17
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.1
3ats_A	357	Putative uncharacterized protein; hypothetical pro	96.88
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	95.62
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	95.33
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	94.9
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	94.35
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	94.01
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	93.59
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	93.33
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	92.17
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	91.94
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	90.8
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	86.9
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	81.39

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-60  Score=459.50  Aligned_cols=270  Identities=36%  Similarity=0.648  Sum_probs=224.3

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc------cHHHHHHHHHhcCCCCccccceEEeecC-CCCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTT-DKEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~  154 (403)
                      .+|++++.||+|+||+||+|+++.+|+.||||++.+...      ...+|+++|+.|+|||||++++++.... ..+..+
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            359999999999999999999999999999999864322      2347999999999999999999874332 123456


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc-----------
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-----------  223 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~-----------  223 (403)
                      +|||||||+|+|..++..    .+.+++..++.++.||+.||.|||+ +|||||||||+|||++.++.+           
T Consensus       134 ~~ivmE~~~g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          134 VYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHS-AQVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             EEEEEECCSEEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence            899999999988766543    4679999999999999999999999 899999999999999866543           


Q ss_pred             ------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015672          224 ------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       224 ------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  291 (403)
                                  .++||+.|||||++.+..+|+.++||||+||++|||++|++||.+.+..+++..|....+.|+...+.
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~  288 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ  288 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence                        24689999999999887778999999999999999999999999999999999999999999877654


Q ss_pred             hcCcCcc---ccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCC
Q 015672          292 CMNPNYT---EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  357 (403)
Q Consensus       292 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~  357 (403)
                      .......   ...++...+.+|...+ ..++++++|||.+||++||++||||+|+|+||||++..+|..
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~  356 (398)
T 4b99_A          289 AVGAERVRAYIQSLPPRQPVPWETVY-PGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDD  356 (398)
T ss_dssp             -----CHHHHHHSSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGG
T ss_pred             hhhhhhhhhhhhcCCCcCCCCHHHhC-CCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCcc
Confidence            3322111   1134444555565544 468999999999999999999999999999999999877654

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.8e-59  Score=436.73  Aligned_cols=234  Identities=30%  Similarity=0.507  Sum_probs=201.6

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      .+|++.+.||+|+||+||+|+++.+++.||||++.+.       .....+|+++|+.|+|||||+++++|.     +..+
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~  106 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DDEK  106 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence            4599999999999999999999999999999998532       123568999999999999999999983     3446


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc----------
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV----------  223 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~----------  223 (403)
                      +|||||||+ |+|.+++..    .+.+++..++.++.||+.||+|||+ +|||||||||+||||+.++.+          
T Consensus       107 ~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDlKPeNILl~~~g~vKl~DFGla~~  181 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKV  181 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEEcCCCCEEEEEcCCcee
Confidence            899999998 588777654    3679999999999999999999999 899999999999999876554          


Q ss_pred             -----------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          224 -----------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       224 -----------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                                 +++||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..|.+.           
T Consensus       182 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~-----------  249 (311)
T 4aw0_A          182 LSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL-----------  249 (311)
T ss_dssp             CCTTTTCCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-----------
T ss_pred             cCCCCCcccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------
Confidence                       24689999999999765 5899999999999999999999999998887777777652           


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHH------HhcCCCcccCCCC
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE------ACVHPFFDELRDP  355 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e------~l~hp~f~~~~~~  355 (403)
                            .+.            ++..+++++++||.+||+.||++|||++|      +++||||+++.+.
T Consensus       250 ------~~~------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~  300 (311)
T 4aw0_A          250 ------EYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE  300 (311)
T ss_dssp             ------CCC------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred             ------CCC------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHH
Confidence                  111            22468999999999999999999999987      5899999998643

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.1e-58  Score=438.92  Aligned_cols=236  Identities=27%  Similarity=0.425  Sum_probs=200.8

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc----cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ...|++.++||+|+||+||+|+++.+|+.||||++...    .....+|+++|+.++|||||+++++|..     ..++|
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~  147 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELW  147 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEE
Confidence            35699999999999999999999999999999998532    3345789999999999999999999854     33589


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-----------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-----------  224 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-----------  224 (403)
                      ||||||+ |+|.+++..     ..+++..++.++.||+.||+|||+ +|||||||||+||||+.++.++           
T Consensus       148 ivmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  221 (346)
T 4fih_A          148 VVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  221 (346)
T ss_dssp             EEECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEECCCCCEEEecCcCceecC
Confidence            9999998 477776643     579999999999999999999999 8999999999999998776553           


Q ss_pred             --------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          225 --------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       225 --------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                              .+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..+.......           
T Consensus       222 ~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-----------  289 (346)
T 4fih_A          222 KEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR-----------  289 (346)
T ss_dssp             SSSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-----------
T ss_pred             CCCCcccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-----------
Confidence                    4689999999998654 59999999999999999999999999988877776665421100           


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCC
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  354 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  354 (403)
                           +          ..+..+|+++++||.+||+.||++|||++|+|+||||++...
T Consensus       290 -----~----------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          290 -----L----------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             -----C----------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             -----C----------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence                 0          012458999999999999999999999999999999987543

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=6.7e-59  Score=428.23  Aligned_cols=232  Identities=28%  Similarity=0.387  Sum_probs=192.8

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+..       ....+|+++|+.++|||||++++++.     +..
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~   86 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK-----SKD   86 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECC
Confidence            346999999999999999999999999999999985432       23468999999999999999999983     344


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce---------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS---------  224 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~---------  224 (403)
                      ++|+|||||+|+|.+.+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.++         
T Consensus        87 ~~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDiKP~NILl~~~~~vkl~DFGla~~  161 (275)
T 3hyh_A           87 EIIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHR-HKIVHRDLKPENLLLDEHLNVKIADFGLSNI  161 (275)
T ss_dssp             EEEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECTTCCEEECCSSCC--
T ss_pred             EEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCChHHeEECCCCCEEEeecCCCee
Confidence            5899999999988776654    4679999999999999999999999 8999999999999998776653         


Q ss_pred             ---------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          225 ---------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       225 ---------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                               .+||+.|||||++.+..+++.++|||||||++|+|++|++||.+.+..+.+..+...              
T Consensus       162 ~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~--------------  227 (275)
T 3hyh_A          162 MTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG--------------  227 (275)
T ss_dssp             -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------------
T ss_pred             cCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--------------
Confidence                     458999999999987765678999999999999999999999988776666655442              


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                         ...            ++..+|+++++||.+||+.||++|||++|+++||||+.
T Consensus       228 ---~~~------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          228 ---VYT------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             ---CCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             ---CCC------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence               111            22468999999999999999999999999999999974

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.2e-58  Score=435.64  Aligned_cols=234  Identities=27%  Similarity=0.419  Sum_probs=195.1

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      -++|++++.||+|+||+||+|+++.+|+.||||++....      ....+|+++|+.|+|||||+++++|..     ...
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-----~~~   97 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-----NGS   97 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-----CCE
Confidence            357999999999999999999999999999999986432      234589999999999999999999843     345


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee--------
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY--------  225 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~--------  225 (403)
                      +|||||||+ |+|.+++....  ...+++..++.|+.||+.||+|||+ +|||||||||+||||+.++.+++        
T Consensus        98 ~yiVmEy~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~vKl~DFGla~~  174 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDGTVQLGDFGIARV  174 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-TTCEETTCCGGGEEECTTCCEEECSTTEESC
T ss_pred             EEEEEeCCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCCCEEEccccccee
Confidence            899999998 58877775422  3457899999999999999999999 89999999999999998877643        


Q ss_pred             -----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          226 -----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       226 -----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                 +||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..+...-            
T Consensus       175 ~~~~~~~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~------------  241 (350)
T 4b9d_A          175 LNSTVELARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS------------  241 (350)
T ss_dssp             CCHHHHHHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC------------
T ss_pred             ecCCcccccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC------------
Confidence                       489999999999764 59999999999999999999999999988888777776521            


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                             ++.         .+..+|+++++||.+||+.||++|||++|+|+||||++
T Consensus       242 -------~~~---------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          242 -------FPP---------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             -------CCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             -------CCC---------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence                   110         12468999999999999999999999999999999975

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2e-57  Score=440.54  Aligned_cols=235  Identities=27%  Similarity=0.427  Sum_probs=200.9

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc----cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ...|++.++||+|+||+||+|+++.+|+.||||++...    .....+|+.+|+.|+|||||+++++|...     .++|
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~  224 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELW  224 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-----CEEE
Confidence            45699999999999999999999999999999998532    34467899999999999999999998543     3589


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-----------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-----------  224 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-----------  224 (403)
                      ||||||+ |+|.+++..     ..+++..++.|+.||+.||+|||+ +|||||||||+||||+.++.++           
T Consensus       225 iVmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~-~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~  298 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  298 (423)
T ss_dssp             EEEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred             EEEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcCCCCEEEecCccceECC
Confidence            9999998 577776643     579999999999999999999999 8999999999999998776653           


Q ss_pred             --------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          225 --------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       225 --------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                              .+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..+.......           
T Consensus       299 ~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-----------  366 (423)
T 4fie_A          299 KEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR-----------  366 (423)
T ss_dssp             SSCCCBCCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-----------
T ss_pred             CCCccccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-----------
Confidence                    4689999999998654 59999999999999999999999999988877777665421100           


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                           +          .....+|+++++||.+||+.||++|||++|+|+||||++..
T Consensus       367 -----~----------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          367 -----L----------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             -----C----------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             -----C----------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence                 0          01246899999999999999999999999999999998754

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.6e-56  Score=415.71  Aligned_cols=234  Identities=24%  Similarity=0.369  Sum_probs=193.5

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      |.+.++||+|+||+||+|+++.+++.||+|++....      ..+.+|+++|+.|+|||||+++++|.... ....++||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence            578889999999999999999999999999985432      23458999999999999999999885432 34566899


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--ccccccccccceecC-CCCc----------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVKG-EPNV----------  223 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~--ivHrDlKp~NILl~~-~~~~----------  223 (403)
                      |||||+ |+|.+++..    ...+++..++.++.||+.||+|||+ +|  ||||||||+||||+. ++.+          
T Consensus       107 vmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~-~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~  181 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence            999998 588777654    4679999999999999999999998 78  999999999999975 4444          


Q ss_pred             -------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          224 -------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       224 -------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                             ..+||+.|||||++.+  .|+.++|||||||++|||+||++||.+.+....+...+.....|           
T Consensus       182 ~~~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~-----------  248 (290)
T 3fpq_A          182 KRASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP-----------  248 (290)
T ss_dssp             CCTTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-----------
T ss_pred             CCCCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC-----------
Confidence                   3468999999999854  49999999999999999999999998877665554433211000           


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                                     ..++...++++++||.+||+.||++|||++|+|+||||++
T Consensus       249 ---------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          249 ---------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ---------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ---------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                           0123557899999999999999999999999999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.4e-56  Score=423.39  Aligned_cols=237  Identities=24%  Similarity=0.361  Sum_probs=200.5

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEeec
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEY  161 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  161 (403)
                      ..|.+.++||+|+||+||+|+++.+|+.||||++..+. ...+|+.+|+.|+|||||+++++|..     ..++||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-~~~~E~~il~~l~HpnIV~l~~~~~~-----~~~~~ivmEy  131 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-FRVEELVACAGLSSPRIVPLYGAVRE-----GPWVNIFMEL  131 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCTHHHHTTTTCCCTTBCCEEEEEEE-----TTEEEEEECC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-hHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEEEEec
Confidence            45899999999999999999999999999999997643 33579999999999999999999843     3458999999


Q ss_pred             cC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC-ce---------------
Q 015672          162 VP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN-VS---------------  224 (403)
Q Consensus       162 ~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~-~~---------------  224 (403)
                      |+ |+|.+++..    .+.+++..++.|+.||+.||+|||+ +|||||||||+||||+.++. ++               
T Consensus       132 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          132 LEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHT-RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            98 588877764    3679999999999999999999999 89999999999999987653 32               


Q ss_pred             ---------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          225 ---------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       225 ---------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                               ++||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..+...  .++         
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~---------  274 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPP---------  274 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCG---------
T ss_pred             ccceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCC---------
Confidence                     3589999999999764 5999999999999999999999999887766666555441  110         


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHH-------------hcCCCcccCCCCC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA-------------CVHPFFDELRDPN  356 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~-------------l~hp~f~~~~~~~  356 (403)
                                     ...++..+++++.+||.+||+.||++|||+.|+             |+|||+.+..+|.
T Consensus       275 ---------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr  333 (336)
T 4g3f_A          275 ---------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR  333 (336)
T ss_dssp             ---------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred             ---------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence                           011335789999999999999999999999997             6799999887654

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=8.7e-57  Score=419.69  Aligned_cols=233  Identities=29%  Similarity=0.438  Sum_probs=194.8

Q ss_pred             ccEeeeceecccCceEEEEEEEC---CCCcEEEEEEcccc------cccHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      .+|++++.||+|+||+||+|++.   .+++.||||++.+.      .....+|+++|+.++|||||+++++|..     .
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~   98 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-----E   98 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-----T
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----C
Confidence            46999999999999999999874   46889999998542      2335679999999999999999999843     3


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-------
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-------  224 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-------  224 (403)
                      ..+|||||||+ |+|.+++..    .+.+++..++.++.||+.||+|||+ +|||||||||+|||++.++.++       
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~vKl~DFGla  173 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEGHIKLTDFGLS  173 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHeEEcCCCCEEecccccc
Confidence            45899999998 577776654    3679999999999999999999999 8999999999999998776653       


Q ss_pred             ------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          225 ------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       225 ------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                                  .+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..+.+.           
T Consensus       174 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-----------  241 (304)
T 3ubd_A          174 KESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA-----------  241 (304)
T ss_dssp             EC-----CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred             eeccCCCccccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC-----------
Confidence                        4589999999999765 5999999999999999999999999998888877777652           


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCcccCCC
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  354 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~e~l~hp~f~~~~~  354 (403)
                            ...            ++..+|+++++||.+||+.||++|||     ++|+++||||+++.+
T Consensus       242 ------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw  290 (304)
T 3ubd_A          242 ------KLG------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW  290 (304)
T ss_dssp             ------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             ------CCC------------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence                  111            22468999999999999999999998     479999999998853

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.9e-55  Score=432.35  Aligned_cols=313  Identities=69%  Similarity=1.186  Sum_probs=270.5

Q ss_pred             cccccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccccHHHHHHHHHhcCCCCccccceEEeecCC-CCceEEEE
Q 015672           79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYLNL  157 (403)
Q Consensus        79 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~l  157 (403)
                      .....|.+.+.||+|+||+||+|++..+++.||||++..+.....+|+++|+.++|+||++++++|+.... .+..++++
T Consensus        51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence            34557999999999999999999999999999999998776667789999999999999999998865432 45667889


Q ss_pred             EeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC-c-------------
Q 015672          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN-V-------------  223 (403)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~-~-------------  223 (403)
                      ||||+++++..++..+......+++..++.++.||+.||.|||+ +||+||||||+||||+.++. +             
T Consensus       131 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~  209 (420)
T 1j1b_A          131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  209 (420)
T ss_dssp             EEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             ehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence            99999998888777666666789999999999999999999999 89999999999999985432 2             


Q ss_pred             -----eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 015672          224 -----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  298 (403)
Q Consensus       224 -----~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  298 (403)
                           ..+||+.|+|||++.+...|+.++|||||||++|||++|++||.+.+..+++..+++.++.|..+.+..+++.+.
T Consensus       210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~  289 (420)
T 1j1b_A          210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT  289 (420)
T ss_dssp             TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCC
T ss_pred             CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence                 235789999999997766799999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 015672          299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSG  378 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  378 (403)
                      .+.++.+...+|...++..+++++.+||.+||++||.+|||+.|+++||||+++.++...++.+...+.++++....+..
T Consensus       290 ~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (420)
T 1j1b_A          290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSS  369 (420)
T ss_dssp             CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHTT
T ss_pred             hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccccCCCCCCCCccCCCCHHHhcc
Confidence            99999999999998888889999999999999999999999999999999999988887777777777777776544432


Q ss_pred             CChHHHhhcCcHHHH
Q 015672          379 IPPETINRLIPEHAR  393 (403)
Q Consensus       379 ~~~~~~~~~~~~~~~  393 (403)
                       .+.....++|.+.+
T Consensus       370 -~~~~~~~~~~~~~~  383 (420)
T 1j1b_A          370 -NPPLATILIPPHAR  383 (420)
T ss_dssp             -CGGGHHHHSCTTTT
T ss_pred             -ChhHHHhhCCHhhh
Confidence             33334444555443

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.7e-56  Score=431.69  Aligned_cols=311  Identities=50%  Similarity=0.970  Sum_probs=264.9

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccccHHHHHHHHHhcCCCCccccceEEeecCC------------
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD------------  149 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------------  149 (403)
                      .+|.+.+.||+|+||+||+|++..+++.||||++..+.....+|+++++.++|+||++++++|+....            
T Consensus         7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~   86 (383)
T 3eb0_A            7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDH   86 (383)
T ss_dssp             TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC--------------
T ss_pred             ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccccccc
Confidence            45999999999999999999999999999999998777667789999999999999999999866443            


Q ss_pred             ---------------------CCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 015672          150 ---------------------KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHR  208 (403)
Q Consensus       150 ---------------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHr  208 (403)
                                           ....++++||||++++|...+..+......+++..++.++.||+.||.|||+ .||+||
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~gi~H~  165 (383)
T 3eb0_A           87 NKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICHR  165 (383)
T ss_dssp             -----------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECS
T ss_pred             ccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CcCccC
Confidence                                 3456789999999999888887766667789999999999999999999999 899999


Q ss_pred             ccccccceecC-CCCc------------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 015672          209 DIKPQNLLVKG-EPNV------------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE  269 (403)
Q Consensus       209 DlKp~NILl~~-~~~~------------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~  269 (403)
                      ||||+|||++. ++.+                  ...||+.|+|||++.+...++.++|||||||++|+|++|++||.+.
T Consensus       166 Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  245 (383)
T 3eb0_A          166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGE  245 (383)
T ss_dssp             CCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCC
Confidence            99999999973 3333                  2357889999999977667999999999999999999999999999


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          270 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       270 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                      +..+++..+++.++.|+.+.+..+++.+....++......|...++..+++++.+||.+||++||++|||+.|+|+||||
T Consensus       246 ~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  325 (383)
T 3eb0_A          246 TSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF  325 (383)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred             ChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHH
Confidence            99999999999999999999999999999999999999999999989999999999999999999999999999999999


Q ss_pred             ccCCC-------CCCCCCCC--CCCCCCCCCCCCCCCCCChHHHhhcCcHHHH
Q 015672          350 DELRD-------PNTRLPNG--RPLPPLFNFKPPELSGIPPETINRLIPEHAR  393 (403)
Q Consensus       350 ~~~~~-------~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (403)
                      +++.+       +....+++  ..+|+++++.+..++.+++...++++|++.+
T Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  378 (383)
T 3eb0_A          326 DHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNRILPKNFS  378 (383)
T ss_dssp             HHHHHC------------------CCCCSCCCHHHHHHSCHHHHHHHSCC---
T ss_pred             HHHHhhccccccccccCCCcccCCCCCCCCCCHHHHhcCCHHHHhhcCchhhc
Confidence            88654       34445555  6678889998888877789999999998754

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.2e-55  Score=426.47  Aligned_cols=312  Identities=67%  Similarity=1.166  Sum_probs=274.2

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccccHHHHHHHHHhcCCCCccccceEEeecCC-CCceEEEEE
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYLNLV  158 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~lv  158 (403)
                      ...+|.+.++||+|+||+||+|++..+++ ||+|++..+.....+|+++++.++||||++++++++.... .+..++++|
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv  116 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV  116 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence            34569999999999999999999977665 8999887777677789999999999999999999876554 556778999


Q ss_pred             eeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceec-CCCCc--------------
Q 015672          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVK-GEPNV--------------  223 (403)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~-~~~~~--------------  223 (403)
                      |||+++++...+..+......+++..++.++.||+.||.|||+ .||+||||||+|||++ .++.+              
T Consensus       117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~  195 (394)
T 4e7w_A          117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG  195 (394)
T ss_dssp             EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence            9999988877776666667789999999999999999999999 8999999999999998 44433              


Q ss_pred             ----eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 015672          224 ----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  299 (403)
Q Consensus       224 ----~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  299 (403)
                          ..+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+.+.++.|..+.+..+++.+..
T Consensus       196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~  275 (394)
T 4e7w_A          196 EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYME  275 (394)
T ss_dssp             CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSS
T ss_pred             CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh
Confidence                2357889999999977667999999999999999999999999999999999999999999999999999999988


Q ss_pred             cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 015672          300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGI  379 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (403)
                      ..++.....+|...++..+++++.+||.+||++||.+|||+.|+++||||+++..+....+++..+|+++++....+. .
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  354 (394)
T 4e7w_A          276 HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELS-V  354 (394)
T ss_dssp             SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCCCTTSSCCCCSCCCCHHHHH-T
T ss_pred             hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccccCCCCCCCCCcCCCCHHHhh-c
Confidence            899999999998888888999999999999999999999999999999999999988888888888888888755543 3


Q ss_pred             ChHHHhhcCcHHHHh
Q 015672          380 PPETINRLIPEHARK  394 (403)
Q Consensus       380 ~~~~~~~~~~~~~~~  394 (403)
                      .+..+.+++|.+.+.
T Consensus       355 ~~~~~~~~~~~~~~~  369 (394)
T 4e7w_A          355 RPDLISRLVPQHAEA  369 (394)
T ss_dssp             CGGGHHHHSCGGGCS
T ss_pred             CHHHHHhhccHhhhh
Confidence            557778888877643

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6.2e-55  Score=418.78  Aligned_cols=260  Identities=27%  Similarity=0.456  Sum_probs=199.9

Q ss_pred             cccEeeeceecccCceEEEEEEEC---CCCcEEEEEEcccccc--cHHHHHHHHHhc-CCCCccccceEEeecCCCCceE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDKR--YKNRELQIMQML-DHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~--~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      .+.|++.++||+|+||+||+|+++   .+++.||||++.+...  ...+|+++|+.+ +|||||+++++|.     +..+
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~-----~~~~   94 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFR-----KNDH   94 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEE-----ETTE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEE-----ECCE
Confidence            345999999999999999999875   4678999998865432  345899999998 6999999999984     3446


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCC-CCc---------
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE-PNV---------  223 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~-~~~---------  223 (403)
                      +|||||||+ ++|.+++       ..+++..++.++.||+.||+|||+ +|||||||||+|||++.+ +.+         
T Consensus        95 ~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~-~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            999999998 5665554       358999999999999999999999 899999999999999754 222         


Q ss_pred             --------------------------------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 015672          224 --------------------------------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL  265 (403)
Q Consensus       224 --------------------------------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~p  265 (403)
                                                            ..+||+.|||||++.+...|+.++||||+||++|||++|++|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence                                                  135899999999998777799999999999999999999999


Q ss_pred             CC-CCCcHHHHHHHHHHhCCCCHHHHhhcCcC--c-------------------cccCCCCCC----CCCcccccccCCC
Q 015672          266 FP-GESGVDQLVEIIKVLGTPTREEIKCMNPN--Y-------------------TEFKFPQIK----PHPWHKVFQKRLP  319 (403)
Q Consensus       266 f~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~-------------------~~~~~~~~~----~~~~~~~~~~~~s  319 (403)
                      |. +.++.+++..|...+|.+...........  .                   .....|...    ...........+|
T Consensus       247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is  326 (361)
T 4f9c_A          247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP  326 (361)
T ss_dssp             SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred             CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence            85 55667888899888886544332211000  0                   000001000    0000011224689


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          320 PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       320 ~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                      ++++|||.+||++||++|+||+|+|+||||++++
T Consensus       327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             HHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            9999999999999999999999999999999874

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.1e-54  Score=404.59  Aligned_cols=244  Identities=25%  Similarity=0.409  Sum_probs=184.2

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCC-----
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTD-----  149 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----  149 (403)
                      ...+|++++.||+|+||+||+|+++.+|+.||||++....     ....+|+++|+.|+|||||+++++|.....     
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~   82 (299)
T 4g31_A            3 YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ   82 (299)
T ss_dssp             HHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred             cchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence            3456999999999999999999999999999999985432     234579999999999999999999865432     


Q ss_pred             --CCceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--
Q 015672          150 --KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--  224 (403)
Q Consensus       150 --~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--  224 (403)
                        ....++|||||||. ++|.+++..... ........++.++.||+.||+|||+ +|||||||||+||||+.++.++  
T Consensus        83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~-~~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           83 PSSPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ----CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             ccCCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHH-CcCccccCcHHHeEECCCCcEEEc
Confidence              23457899999998 578777654221 1224456688999999999999999 8999999999999998766542  


Q ss_pred             -----------------------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHH
Q 015672          225 -----------------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL  275 (403)
Q Consensus       225 -----------------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~  275 (403)
                                                   .+||+.|||||++.+. .|+.++|||||||++|||++   ||.+..  +..
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~~--~~~  234 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQM--ERV  234 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSHH--HHH
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCcc--HHH
Confidence                                         2589999999999764 59999999999999999996   775432  222


Q ss_pred             HHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          276 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       276 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                      ..+.......                +|.         .....++.+.+||.+||+.||++|||+.|+|+||||+++..|
T Consensus       235 ~~~~~~~~~~----------------~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p  289 (299)
T 4g31_A          235 RTLTDVRNLK----------------FPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP  289 (299)
T ss_dssp             HHHHHHHTTC----------------CCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred             HHHHHHhcCC----------------CCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence            2222211110                000         012346778999999999999999999999999999988654


Q ss_pred             C
Q 015672          356 N  356 (403)
Q Consensus       356 ~  356 (403)
                      .
T Consensus       290 ~  290 (299)
T 4g31_A          290 G  290 (299)
T ss_dssp             -
T ss_pred             C
Confidence            4

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=6.3e-53  Score=427.04  Aligned_cols=236  Identities=23%  Similarity=0.373  Sum_probs=193.8

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHH---HHHHHHhcCCCCccccceEEeecCC
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNR---ELQIMQMLDHPNIVALKHCFFSTTD  149 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~  149 (403)
                      ..++|+++++||+|+||+||+|+++.+|+.||||++.+..       ....+   ++.+++.++|||||+++++|.    
T Consensus       187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~----  262 (689)
T 3v5w_A          187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH----  262 (689)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE----
T ss_pred             chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE----
Confidence            3457999999999999999999999999999999985321       11223   356667779999999999983    


Q ss_pred             CCceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce----
Q 015672          150 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS----  224 (403)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~----  224 (403)
                       +..++|||||||. |+|..++..    .+.+++..++.|+.||+.||+|||+ +|||||||||+||||+.++.++    
T Consensus       263 -~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~-~gIiHRDLKPeNILld~~G~vKL~DF  336 (689)
T 3v5w_A          263 -TPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDL  336 (689)
T ss_dssp             -CSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             -ECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHeEEeCCCCEEeccc
Confidence             3446999999998 588777654    4679999999999999999999999 8999999999999999877653    


Q ss_pred             -------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCCHH
Q 015672          225 -------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---DQLVEIIKVLGTPTRE  288 (403)
Q Consensus       225 -------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~---~~~~~i~~~~~~~~~~  288 (403)
                                   .+||+.|||||++.+...|+.++|||||||++|||++|.+||.+.+..   +....+...       
T Consensus       337 GlA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~-------  409 (689)
T 3v5w_A          337 GLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-------  409 (689)
T ss_dssp             TTCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC-------
T ss_pred             ceeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC-------
Confidence                         468999999999965556999999999999999999999999764332   222222210       


Q ss_pred             HHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCcccCCC
Q 015672          289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  354 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~e~l~hp~f~~~~~  354 (403)
                                ...            ++..+|+++++||.+||+.||.+|++     ++|+++||||+++.+
T Consensus       410 ----------~~~------------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW  458 (689)
T 3v5w_A          410 ----------AVE------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW  458 (689)
T ss_dssp             ----------CCC------------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred             ----------CCC------------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence                      001            23568999999999999999999998     899999999999864

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7.8e-52  Score=420.04  Aligned_cols=241  Identities=25%  Similarity=0.389  Sum_probs=202.0

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ..+|++.+.||+|+||+||+|+++.+|+.||||++....    ....+|+++|+.|+|||||+++++|.     +..++|
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-----~~~~~~  230 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNEMV  230 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----CSSEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEE
Confidence            357999999999999999999999999999999986432    33457999999999999999999983     445699


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCC--CCc----------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE--PNV----------  223 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~--~~~----------  223 (403)
                      ||||||+ |+|.+.+..   ....+++..++.++.||+.||.|||+ +||+||||||+|||++.+  +.+          
T Consensus       231 iv~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          231 MIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  306 (573)
T ss_dssp             EEEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred             EEEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence            9999998 577555432   24579999999999999999999999 899999999999999754  333          


Q ss_pred             --------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          224 --------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       224 --------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                              ..+||+.|||||++.+. .|+.++|||||||++|+|++|.+||.+.+..+.+..+.......+         
T Consensus       307 ~~~~~~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~---------  376 (573)
T 3uto_A          307 LDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD---------  376 (573)
T ss_dssp             CCTTSEEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC---------
T ss_pred             ccCCCceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC---------
Confidence                    24689999999999765 589999999999999999999999999988888777654311111         


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  356 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~  356 (403)
                                      ......+|+++++||.+||++||.+|||+.|+|+||||+....+.
T Consensus       377 ----------------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~  421 (573)
T 3uto_A          377 ----------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  421 (573)
T ss_dssp             ----------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred             ----------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence                            012246899999999999999999999999999999999876543

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.3e-51  Score=385.35  Aligned_cols=236  Identities=23%  Similarity=0.350  Sum_probs=192.0

Q ss_pred             cccEeeeceecccCceEEEEEEEC-----CCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      ..+|++.+.||+|+||+||+|++.     .++..||||++....    ..+.+|+++|++|+|||||++++++..     
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----   86 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-----   86 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-----
Confidence            456999999999999999999875     357889999986432    234689999999999999999999843     


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhh---------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYS---------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP  221 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~---------~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~  221 (403)
                      ...++||||||+ |+|.+++....         .....+++..+..++.||+.||.|||+ ++||||||||+||||+.++
T Consensus        87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGG
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccCHhhEEECCCC
Confidence            233889999998 68888876532         123468999999999999999999999 8999999999999998766


Q ss_pred             Ccee---------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 015672          222 NVSY---------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEII  279 (403)
Q Consensus       222 ~~~~---------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~  279 (403)
                      .+++                     .||+.|||||++.+. .|+.++|||||||++|||+| |+.||.+.+..+.+..+.
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~  244 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  244 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            5432                     468899999999765 59999999999999999998 899999988777766665


Q ss_pred             HHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          280 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                      +....                            ..+..+++++.+||.+||+.||++|||+.++  |+|++++.
T Consensus       245 ~~~~~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~  288 (299)
T 4asz_A          245 QGRVL----------------------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA  288 (299)
T ss_dssp             HTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred             cCCCC----------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence            42100                            0235689999999999999999999999999  56787654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.9e-51  Score=386.38  Aligned_cols=234  Identities=24%  Similarity=0.360  Sum_probs=191.4

Q ss_pred             ccEeeeceecccCceEEEEEEEC-----CCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      .+|.+.++||+|+||+||+|+++     .+++.||||++....    ..+.+|+++|++|+|||||++++++..     .
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----~  115 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-----G  115 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----C
Confidence            46999999999999999999875     367899999986432    335689999999999999999999843     3


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhh-----------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCC
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSR-----------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE  220 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~-----------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~  220 (403)
                      ..++||||||+ |+|.+++.....           ....+++..+..++.||+.||.|||+ ++||||||||+||||+.+
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG-LHFVHRDLATRNCLVGQG  194 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHhhEEECCC
Confidence            34889999998 688887764321           12468999999999999999999999 899999999999999876


Q ss_pred             CCce---------------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 015672          221 PNVS---------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEI  278 (403)
Q Consensus       221 ~~~~---------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i  278 (403)
                      +.++                     .+||+.|||||++.+. .|+.++|||||||+||||+| |+.||.+.+..+.+..+
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  273 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI  273 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            5543                     2478899999999654 59999999999999999999 89999998877776665


Q ss_pred             HHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          279 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                      .+....                            ..+..+++++.+||.+||+.||++|||+.|++++  ++.+
T Consensus       274 ~~g~~~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~--L~~l  317 (329)
T 4aoj_A          274 TQGREL----------------------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR--LQAL  317 (329)
T ss_dssp             HHTCCC----------------------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH--HHHH
T ss_pred             HcCCCC----------------------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH--HHHH
Confidence            542100                            0235689999999999999999999999999874  5544

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-50  Score=377.23  Aligned_cols=229  Identities=20%  Similarity=0.286  Sum_probs=183.2

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      .++++.++||+|+||+||+|++.   ..||||+++...      ..+.+|+.+|++++|||||++++++. .   +  .+
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~---~--~~  106 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-K---D--NL  106 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-S---S--SC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-C---C--eE
Confidence            35889999999999999999864   359999985322      23458999999999999999999762 1   1  26


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce----------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS----------  224 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~----------  224 (403)
                      +||||||+ |+|.+++...   ...+++..+..++.||+.||+|||+ ++||||||||+||||+.++.++          
T Consensus       107 ~iVmEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~-~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  182 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHA-KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVK  182 (307)
T ss_dssp             EEEEECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred             EEEEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCccCHHHEEECCCCcEEEeeccCceec
Confidence            89999998 6887766532   3579999999999999999999999 8999999999999998664432          


Q ss_pred             -----------eeccccccchhhhhCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015672          225 -----------YICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       225 -----------~~~t~~y~aPE~~~~~--~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  291 (403)
                                 .+||+.|||||++.+.  ..|+.++|||||||+||||+||+.||.+.+....+..++.....       
T Consensus       183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~-------  255 (307)
T 3omv_A          183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA-------  255 (307)
T ss_dssp             -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC-------
T ss_pred             ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC-------
Confidence                       3589999999999643  35899999999999999999999999988777666555442111       


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                .|..      ...+..+++++.+||.+||+.||++|||+.|++++
T Consensus       256 ----------~p~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          256 ----------SPDL------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             ----------CCCS------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             ----------CCCc------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                      1110      01235689999999999999999999999987543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.2e-50  Score=380.40  Aligned_cols=230  Identities=22%  Similarity=0.284  Sum_probs=187.2

Q ss_pred             ccEeeeceecccCceEEEEEEEC-----CCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      ..+.+.++||+|+||+||+|++.     .+++.||||++....     ..+.+|+.+|++|+|||||++++++...    
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~----  101 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD----  101 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC----
Confidence            35888999999999999999864     367899999985432     3456899999999999999999998432    


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceec
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVK  218 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~------------~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~  218 (403)
                       ..++||||||+ |+|.+++....            .....+++..+..++.||+.||.|||+ ++||||||||+||||+
T Consensus       102 -~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          102 -QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-HHVVHKDLATRNVLVY  179 (308)
T ss_dssp             -SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC
T ss_pred             -CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCccccceEEC
Confidence             33789999998 68888875421            113468899999999999999999999 8999999999999998


Q ss_pred             CCCCce---------------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 015672          219 GEPNVS---------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLV  276 (403)
Q Consensus       219 ~~~~~~---------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~  276 (403)
                      .++.++                     .+||+.|||||++.+. .|+.++|||||||+||||+| |..||.+.+..+.+.
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~  258 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE  258 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            765443                     2468899999999765 59999999999999999998 899999988776665


Q ss_pred             HHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          277 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       277 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      .+......|                            .+..+++++.+||.+||+.||++|||+.||+++
T Consensus       259 ~i~~~~~~~----------------------------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          259 MIRNRQVLP----------------------------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCCC----------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            554311000                            235689999999999999999999999999875

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.9e-49  Score=394.18  Aligned_cols=271  Identities=35%  Similarity=0.576  Sum_probs=208.1

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      .+|.+.+.||+|+||+||+|+++.+++.||||++....      ....+|+.+|+.++|+||+++++++..........+
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            46999999999999999999999999999999985432      234579999999999999999998865543444568


Q ss_pred             EEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-----------
Q 015672          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-----------  224 (403)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-----------  224 (403)
                      |+||||++++|..++..    ...+++..++.++.||+.||.|||+ .|||||||||+||||+.++.++           
T Consensus       133 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          133 YVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHS-AGILHRDLKPANCLVNQDCSVKVCDFGLARTVD  207 (458)
T ss_dssp             EEEECCCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred             EEEEeccccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHh-CCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence            99999999988776653    4569999999999999999999999 8999999999999998665432           


Q ss_pred             -----------------------------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh--------
Q 015672          225 -----------------------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL--------  261 (403)
Q Consensus       225 -----------------------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t--------  261 (403)
                                                         .+||+.|+|||++.....|+.++|||||||++|||++        
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~  287 (458)
T 3rp9_A          208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY  287 (458)
T ss_dssp             SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred             CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence                                               2458889999988666679999999999999999998        


Q ss_pred             ---CCCCCCCCC--------------------cHHHHHHHHHHhCCCCHHHHhhcCcCcc---ccCCCCCCCCCcccccc
Q 015672          262 ---GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCMNPNYT---EFKFPQIKPHPWHKVFQ  315 (403)
Q Consensus       262 ---g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  315 (403)
                         |+++|.+.+                    ..+++..+...+|.|..+.+........   ...++.....++...+ 
T Consensus       288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  366 (458)
T 3rp9_A          288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF-  366 (458)
T ss_dssp             GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS-
T ss_pred             cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC-
Confidence               788887754                    2577888999999999887765432110   0122222233333333 


Q ss_pred             cCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCCC
Q 015672          316 KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  358 (403)
Q Consensus       316 ~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~~  358 (403)
                      ..+++++.+||.+||++||++|||++|+|+||||+++..+...
T Consensus       367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e  409 (458)
T 3rp9_A          367 PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVE  409 (458)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGC
T ss_pred             CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccC
Confidence            4579999999999999999999999999999999999876543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2e-49  Score=370.56  Aligned_cols=262  Identities=34%  Similarity=0.573  Sum_probs=210.3

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|++.+.||+|+||+||+|++..+++.||||++....      ....+|+.+++.++||||+++++++..     ...++
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   77 (292)
T 3o0g_A            3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKLT   77 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-----CCEEE
Confidence            5999999999999999999999999999999986432      233579999999999999999998843     34589


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      +||||+++++...+..   ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+++           
T Consensus        78 lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  153 (292)
T 3o0g_A           78 LVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             EEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred             EEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence            9999999887665443   24679999999999999999999999 89999999999999987765533           


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                              .+|+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+.++.+....+......
T Consensus       154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence                    3588899999997766689999999999999999987766 6677777888888888888877665433221


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                      ......+..............+++++.+||.+||+.||++|||++|+|+||||++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence            111112211111111222346899999999999999999999999999999999864

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.6e-49  Score=377.70  Aligned_cols=281  Identities=46%  Similarity=0.869  Sum_probs=224.8

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc---cHHHHHHHHHhcCCCCccccceEEeecCC--CCceEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVALKHCFFSTTD--KEELYL  155 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~~~~~  155 (403)
                      ..+|.+.+.||+|+||.||+|++..+++.||||++..+..   ...+|++.+..++||||+++++++.....  ....++
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  101 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL  101 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence            3469999999999999999999999999999998865433   33456777888899999999999865432  445678


Q ss_pred             EEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH--hcCCccccccccccceecC-CCCce--------
Q 015672          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH--NCIGICHRDIKPQNLLVKG-EPNVS--------  224 (403)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH--~~~~ivHrDlKp~NILl~~-~~~~~--------  224 (403)
                      ++||||+++++...+.........+++..++.++.||+.||.|||  + .||+||||||+|||++. ++.++        
T Consensus       102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~  180 (360)
T 3e3p_A          102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAK  180 (360)
T ss_dssp             EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT-TCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred             EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC-CCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence            999999999887776665555677899999999999999999999  8 89999999999999985 44432        


Q ss_pred             ----------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          225 ----------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       225 ----------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                ..||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+.+.++.++.+.+....
T Consensus       181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3e3p_A          181 KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLN  260 (360)
T ss_dssp             CCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             ecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcc
Confidence                      2468899999999776668999999999999999999999999999999999999999999999888777


Q ss_pred             cCccccCCCCCCCCCccccccc---CCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCCCCCCC
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQK---RLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNG  362 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~---~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~~~~~~  362 (403)
                      +......+......+|...+..   ..++++.+||.+||+.||.+|||+.|+|+||||+++.++....+..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~  331 (360)
T 3e3p_A          261 PSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNN  331 (360)
T ss_dssp             TTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTTS
T ss_pred             cchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCCC
Confidence            6655555555555555544432   3678999999999999999999999999999999998877655443

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.5e-49  Score=372.58  Aligned_cols=262  Identities=35%  Similarity=0.675  Sum_probs=212.3

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ..+|++.+.||+|+||+||+|++. +++.||+|++....      ....+|+++++.++||||+++++++.     ...+
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~   93 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH-----SERC   93 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CSSC
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc-----cCCE
Confidence            346999999999999999999985 58999999985432      23457999999999999999999883     3345


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      +++||||+++++...+..   ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+++         
T Consensus        94 ~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  169 (311)
T 3niz_A           94 LTLVFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQ-HRILHRDLKPQNLLINSDGALKLADFGLARAF  169 (311)
T ss_dssp             EEEEEECCSEEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred             EEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCchHhEEECCCCCEEEccCcCceec
Confidence            889999999988666543   23568999999999999999999999 89999999999999987765532         


Q ss_pred             ----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          226 ----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       226 ----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                .+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+....+.....
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  249 (311)
T 3niz_A          170 GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE  249 (311)
T ss_dssp             TSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred             CCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence                      4688899999997766789999999999999999999999999988889999999888877655443221


Q ss_pred             C--ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          296 N--YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       296 ~--~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                      .  +....+......+|.. ....+++++.+||.+||++||++|||+.|+|+||||+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          250 LPLWKQRTFQVFEKKPWSS-IIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             SHHHHSCCCCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             cchhhhcccccccCCcHHH-hCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence            1  1111222222333333 2356889999999999999999999999999999999874

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3e-49  Score=392.73  Aligned_cols=267  Identities=31%  Similarity=0.552  Sum_probs=214.2

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCC-CCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  153 (403)
                      ..+|++.+.||+|+||+||+|++..+++.||||++....      ....+|+.+|+.++||||+++++++..... .+..
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            356999999999999999999999999999999986431      223479999999999999999998854322 2335


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce---------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS---------  224 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~---------  224 (403)
                      .+|+||||+++++...+.      ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++.++         
T Consensus       141 ~~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          141 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             eEEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            689999999987755442      458899999999999999999999 8999999999999998776553         


Q ss_pred             ---------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          225 ---------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       225 ---------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                               .+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+++..+.+.++.|..+.+.....
T Consensus       214 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~  292 (464)
T 3ttj_A          214 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  292 (464)
T ss_dssp             ---CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred             cCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence                     3578999999999765 599999999999999999999999999999999999999999999887755432


Q ss_pred             Ccccc--CCCCCCCCCcccccccC-----------CCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          296 NYTEF--KFPQIKPHPWHKVFQKR-----------LPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       296 ~~~~~--~~~~~~~~~~~~~~~~~-----------~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                      ....+  ..+......+...++..           .++++.+||.+||++||++|||++|+|+||||+...++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~  365 (464)
T 3ttj_A          293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP  365 (464)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred             hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCc
Confidence            21111  11111222222222111           25679999999999999999999999999999976543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-48  Score=380.15  Aligned_cols=268  Identities=33%  Similarity=0.665  Sum_probs=208.7

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcC-CCCccccceEEeecCCCCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  154 (403)
                      .+|++.+.||+|+||.||+|.+..+++.||||++....      ....+|+.+++.+. |+||+++++++...   +...
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~~   85 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDRD   85 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TSSC
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CCCE
Confidence            46999999999999999999999999999999885421      22347999999997 99999999988542   2335


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce----------
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS----------  224 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~----------  224 (403)
                      +|+|||||+++|..++..     ..+++..++.++.||+.||+|||+ .||+||||||+|||++.++.++          
T Consensus        86 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           86 VYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHS-GGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            889999999988777654     468899999999999999999999 8999999999999998665432          


Q ss_pred             ------------------------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHH
Q 015672          225 ------------------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ  274 (403)
Q Consensus       225 ------------------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~  274 (403)
                                                    .+||+.|+|||++.+...|+.++|||||||++|||++|++||.+.+..++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  239 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ  239 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                                          35788999999997766799999999999999999999999999999999


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCccccC------CCCCCCCCccccc------------ccCCCHHHHHHHHHhcccCCCC
Q 015672          275 LVEIIKVLGTPTREEIKCMNPNYTEFK------FPQIKPHPWHKVF------------QKRLPPEAVDLVCRFFQYSPNL  336 (403)
Q Consensus       275 ~~~i~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~------------~~~~s~~~~~li~~~L~~dP~~  336 (403)
                      +..+...++.|..+.+......+....      ........+...+            ...+++++.+||.+||++||++
T Consensus       240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~  319 (388)
T 3oz6_A          240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK  319 (388)
T ss_dssp             HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred             HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence            999999999999887654332211000      0000000111101            1267899999999999999999


Q ss_pred             CCCHHHHhcCCCcccCCCCCCC
Q 015672          337 RCTALEACVHPFFDELRDPNTR  358 (403)
Q Consensus       337 Rpta~e~l~hp~f~~~~~~~~~  358 (403)
                      |||++|+|+||||+....+...
T Consensus       320 R~t~~e~l~Hp~~~~~~~~~~~  341 (388)
T 3oz6_A          320 RISANDALKHPFVSIFHNPNEE  341 (388)
T ss_dssp             SCCHHHHTTSTTTTTTCCGGGC
T ss_pred             CCCHHHHhCCHHHHHhcCCccC
Confidence            9999999999999988776543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.6e-49  Score=377.64  Aligned_cols=233  Identities=22%  Similarity=0.318  Sum_probs=188.2

Q ss_pred             cccEeeeceecccCceEEEEEEECCC-----CcEEEEEEccccc-----ccHHHHHHHHHhcCC-CCccccceEEeecCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDK-----RYKNRELQIMQMLDH-PNIVALKHCFFSTTD  149 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~  149 (403)
                      ..+|++.+.||+|+||+||+|++..+     ++.||||.+....     ..+.+|+++|.++.| ||||++++++...  
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~--  140 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--  140 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec--
Confidence            35699999999999999999997654     3679999986432     234579999999966 8999999987432  


Q ss_pred             CCceEEEEEeeccC-CcHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccce
Q 015672          150 KEELYLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL  216 (403)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NIL  216 (403)
                        ...++||||||+ |+|.+++.....            ....+++..+..++.||+.||+|||+ ++||||||||+|||
T Consensus       141 --~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~-~~iiHRDLK~~NIL  217 (353)
T 4ase_A          141 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL  217 (353)
T ss_dssp             --TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEE
T ss_pred             --CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh-CCeecCccCcccee
Confidence              223789999998 688888865432            12458899999999999999999999 89999999999999


Q ss_pred             ecCCCCce---------------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 015672          217 VKGEPNVS---------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQ  274 (403)
Q Consensus       217 l~~~~~~~---------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~  274 (403)
                      ++.++.++                     ..||+.|||||++.+. .|+.++|||||||+||||+| |+.||.+.+..+.
T Consensus       218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~  296 (353)
T 4ase_A          218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  296 (353)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            98665443                     2468899999999765 59999999999999999998 9999998775555


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          275 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       275 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      +..++..-..+                           ..+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       297 ~~~~i~~g~~~---------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          297 FCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCC---------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            54444321111                           0225678999999999999999999999999987

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.7e-49  Score=373.25  Aligned_cols=272  Identities=31%  Similarity=0.634  Sum_probs=218.9

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc-----cHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      +|.+.+.||+|+||+||+|++..+++.||||++.....     ...+|+.+++.++||||+++++++...     ..+++
T Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~l   77 (324)
T 3mtl_A            3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-----KSLTL   77 (324)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS-----SCEEE
T ss_pred             ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC-----CEEEE
Confidence            59999999999999999999999999999998854322     223699999999999999999988432     34889


Q ss_pred             EeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------------
Q 015672          158 VLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------------  225 (403)
Q Consensus       158 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------------  225 (403)
                      ||||+++++..++...   ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+++            
T Consensus        78 v~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  153 (324)
T 3mtl_A           78 VFEYLDKDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHR-QKVLHRDLKPQNLLINERGELKLADFGLARAKSIP  153 (324)
T ss_dssp             EEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred             EecccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence            9999999887766542   3568999999999999999999999 89999999999999987766533            


Q ss_pred             -------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc--C
Q 015672          226 -------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--N  296 (403)
Q Consensus       226 -------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~  296 (403)
                             .+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.|....+.....  .
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence                   3588999999997766789999999999999999999999999999999999999999887765543211  1


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCCCCCCCCC
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRP  364 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~~~~~~~~  364 (403)
                      +..+.++......+.. ....+++++.+||.+||++||++|||++|+|+||||.++.......+....
T Consensus       234 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~  300 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLS-HAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTS  300 (324)
T ss_dssp             HHHTCCCCCCCCCHHH-HCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTSC
T ss_pred             hcccccccccchhhhh-hcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCCc
Confidence            1122233322222222 235689999999999999999999999999999999998766555444433

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3e-48  Score=382.59  Aligned_cols=273  Identities=34%  Similarity=0.542  Sum_probs=218.9

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ...+|.+.+.||+|+||+||+|++..+++.||||++....      ....+|+.+|+.++|+||+++++++.........
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            3456999999999999999999999999999999986432      2345799999999999999999988544333335


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc----------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV----------  223 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~----------  223 (403)
                      .+|+||||++++|..++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+          
T Consensus       104 ~~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          104 ELYIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHE-SGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             CEEEEEECCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecCCcCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            5899999999988777653    4569999999999999999999999 899999999999999866433          


Q ss_pred             -------------------------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-----------
Q 015672          224 -------------------------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-----------  261 (403)
Q Consensus       224 -------------------------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-----------  261 (403)
                                                     ..+||+.|+|||++.....|+.++|||||||++|||++           
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence                                           23568899999998666679999999999999999998           


Q ss_pred             CCCCCCCCC-----------------cHHHHHHHHHHhCCCCHHHHhhcCcCccc---cCCCCCCCCCcccccccCCCHH
Q 015672          262 GQPLFPGES-----------------GVDQLVEIIKVLGTPTREEIKCMNPNYTE---FKFPQIKPHPWHKVFQKRLPPE  321 (403)
Q Consensus       262 g~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~  321 (403)
                      |.++|.+.+                 ..+++..+...+|.|+.+.+.........   ..++.....++...+ ..++++
T Consensus       259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~  337 (432)
T 3n9x_A          259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKY-PSISDD  337 (432)
T ss_dssp             CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHS-TTSCHH
T ss_pred             ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHC-CCCCHH
Confidence            556666654                 36788899999999999877654321100   012222233333322 468999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCCC
Q 015672          322 AVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  358 (403)
Q Consensus       322 ~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~~  358 (403)
                      +.+||.+||++||++|||++|+|+||||+++.++...
T Consensus       338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e  374 (432)
T 3n9x_A          338 GINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLE  374 (432)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccC
Confidence            9999999999999999999999999999999876544

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.7e-48  Score=362.31  Aligned_cols=259  Identities=35%  Similarity=0.649  Sum_probs=209.7

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|.+.+.||+|+||+||+|++ .+++.||+|++....      ....+|+++++.++||||+++++++...     .+++
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   76 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRLV   76 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCEE
T ss_pred             cchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-----CeEE
Confidence            599999999999999999998 679999999985432      2345899999999999999999988433     3488


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      +||||+++++..++...   ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+++           
T Consensus        77 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  152 (288)
T 1ob3_A           77 LVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINREGELKIADFGLARAFGI  152 (288)
T ss_dssp             EEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred             EEEEecCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence            99999999887766532   3568999999999999999999999 89999999999999987766543           


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                              .+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.+....+.......
T Consensus       153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T 1ob3_A          153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP  232 (288)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             cccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence                    368889999999766668999999999999999999999999999888888898888877655443221100


Q ss_pred             -cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          298 -TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       298 -~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                       ....+....+.+|.. +...+++++.+||.+||+.||++|||+.|+++||||++.
T Consensus       233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          233 KYDPNFTVYEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             TCCTTCCCCCCCCGGG-TCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccccccccCccHHH-HhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence             001122222333333 235689999999999999999999999999999999874

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.9e-48  Score=368.50  Aligned_cols=269  Identities=30%  Similarity=0.560  Sum_probs=202.2

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      .+|.+.+.||+|+||.||+|+++.+++.||+|++....     ....+|+.+++.++||||+++++++     .....++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~   79 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKLT   79 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEEE
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeEE
Confidence            35999999999999999999999999999999985432     2346899999999999999999988     3344589


Q ss_pred             EEeeccCCcHHHHHHHhhh--hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          157 LVLEYVPETVNRIARNYSR--IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      +||||++++|..++.....  ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+++         
T Consensus        80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-NKILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9999999998887765331  12458899999999999999999999 89999999999999987765432         


Q ss_pred             ----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          226 ----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       226 ----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                .+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+....+.....
T Consensus       159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (317)
T 2pmi_A          159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK  238 (317)
T ss_dssp             TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred             CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence                      4688899999997655689999999999999999999999999999999999999888877655443221


Q ss_pred             Ccc-ccCCCCCCCCCcc----cccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCC
Q 015672          296 NYT-EFKFPQIKPHPWH----KVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  356 (403)
Q Consensus       296 ~~~-~~~~~~~~~~~~~----~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~  356 (403)
                      ... ...++......+.    ......+++++.+||.+||+.||++|||+.|+|+||||++...+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~  304 (317)
T 2pmi_A          239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHA  304 (317)
T ss_dssp             CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC--
T ss_pred             hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchh
Confidence            000 0011111111111    112346789999999999999999999999999999999976554

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-48  Score=374.69  Aligned_cols=270  Identities=32%  Similarity=0.607  Sum_probs=214.2

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCC-CCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  153 (403)
                      ...|.+.+.||+|+||.||+|.+..+|+.||||++....      ....+|+++++.++||||+++++++..... .+..
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            345999999999999999999999999999999985422      223579999999999999999998854321 1223


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee--------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY--------  225 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~--------  225 (403)
                      .+|+||||++++|..++..     ..+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+++        
T Consensus       104 ~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            4689999998888877654     568999999999999999999999 89999999999999987765543        


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                              ++|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+.+..+.|+.+.+.......
T Consensus       178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~  257 (367)
T 1cm8_A          178 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE  257 (367)
T ss_dssp             CCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred             cccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHH
Confidence                    468899999999875679999999999999999999999999999999999999999999988765443211


Q ss_pred             cc---cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCC
Q 015672          298 TE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  357 (403)
Q Consensus       298 ~~---~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~  357 (403)
                      ..   ..++.....++...+ ..+++++.+||.+||+.||++|||++|+|+||||+++.++..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~  319 (367)
T 1cm8_A          258 AKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED  319 (367)
T ss_dssp             HHHHHHHSCCCCCCCGGGTC-TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred             HHHHHHhCCCCCCCCHHHHC-CCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCcc
Confidence            00   123333333443332 467999999999999999999999999999999999877654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.5e-48  Score=369.61  Aligned_cols=263  Identities=31%  Similarity=0.565  Sum_probs=213.6

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ..+|.+.+.||+|+||+||+|++..+++.||||++....      ....+|+.+++.++||||+++++++..     ...
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~  107 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-----NHR  107 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-----TTE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-----CCE
Confidence            446999999999999999999999999999999986432      223479999999999999999998843     345


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC-----ce-----
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN-----VS-----  224 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~-----~~-----  224 (403)
                      +++||||++++|..++..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.     ++     
T Consensus       108 ~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          108 LHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            889999999988777654    3568999999999999999999999 89999999999999953321     22     


Q ss_pred             --------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          225 --------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       225 --------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                    .++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....+
T Consensus       183 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          183 LARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             HHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             CccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence                          235889999999977666899999999999999999999999999999999999998888876554


Q ss_pred             hhcCcC-ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          291 KCMNPN-YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       291 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                      ...... .....++......+...+...+++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence            322110 011133444444445555566899999999999999999999999999999999864

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.4e-47  Score=364.17  Aligned_cols=236  Identities=28%  Similarity=0.390  Sum_probs=198.4

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc------cHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ..+|.+.+.||+|+||.||+|++..+|+.||||++.....      ...+|+++++.++||||+++++++.     ....
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~~   88 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-----TEKT   88 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCE
Confidence            3469999999999999999999999999999999864321      2347999999999999999999883     3345


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee--------
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY--------  225 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~--------  225 (403)
                      +++||||++ ++|.+++..    .+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+++        
T Consensus        89 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  163 (328)
T 3fe3_A           89 LYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQ-KRIVHRDLKAENLLLDADMNIKIADFGFSNE  163 (328)
T ss_dssp             EEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred             EEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence            899999996 577666644    3679999999999999999999999 89999999999999987765533        


Q ss_pred             ----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          226 ----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       226 ----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                +||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+...              
T Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--------------  229 (328)
T 3fe3_A          164 FTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG--------------  229 (328)
T ss_dssp             GSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------------
T ss_pred             cCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence                      47899999999987665568999999999999999999999988876666555431              


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                         .+.            ++..+++++.+||.+||+.||.+|||++|+++||||+.....
T Consensus       230 ---~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~  274 (328)
T 3fe3_A          230 ---KYR------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE  274 (328)
T ss_dssp             ---CCC------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTT
T ss_pred             ---CCC------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcc
Confidence               111            123578999999999999999999999999999999876543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=9.8e-48  Score=370.58  Aligned_cols=268  Identities=30%  Similarity=0.607  Sum_probs=221.5

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      .+|++.+.||+|+||.||+|++..+++.||||++....     ....+|+++++.++||||+++++++..........++
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            35999999999999999999999999999999986432     2335799999999999999999988654434445688


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce------------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS------------  224 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~------------  224 (403)
                      +||||++++|..++..     ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++            
T Consensus       107 iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  180 (364)
T 3qyz_A          107 IVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  180 (364)
T ss_dssp             EEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence            9999999988777653     569999999999999999999999 8999999999999998765542            


Q ss_pred             ----------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          225 ----------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       225 ----------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                .+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+..+.+.+..
T Consensus       181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  260 (364)
T 3qyz_A          181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  260 (364)
T ss_dssp             GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence                      2578899999998766668999999999999999999999999999999999999999999988765432


Q ss_pred             cCc---cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCC
Q 015672          295 PNY---TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  356 (403)
Q Consensus       295 ~~~---~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~  356 (403)
                      ...   .....+.....+|... ...+++++.+||.+||++||++|||+.|+|+||||++...+.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~  324 (364)
T 3qyz_A          261 NLKARNYLLSLPHKNKVPWNRL-FPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS  324 (364)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHH-CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             hhhHHHHHHhcCCccCCCHHHh-CCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcc
Confidence            110   0112222233333332 256899999999999999999999999999999999976554

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5e-48  Score=363.87  Aligned_cols=265  Identities=28%  Similarity=0.531  Sum_probs=212.7

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---------ccHHHHHHHHHhcC---CCCccccceEEeecCC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLD---HPNIVALKHCFFSTTD  149 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~  149 (403)
                      .+|++.+.||+|+||+||+|++..+++.||||++....         ....+|+.+++.++   ||||+++++++.....
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~   88 (308)
T 3g33_A            9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT   88 (308)
T ss_dssp             -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence            45999999999999999999999999999999985321         23457888877765   9999999999876665


Q ss_pred             CCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-----
Q 015672          150 KEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-----  224 (403)
Q Consensus       150 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-----  224 (403)
                      ....++++||||++++|..++....  ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.++     
T Consensus        89 ~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  165 (308)
T 3g33_A           89 DREIKVTLVFEHVDQDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGGTVKLADFG  165 (308)
T ss_dssp             SSEEEEEEEEECCCCBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred             CCceeEEEEehhhhcCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence            5666789999999998887766422  2348999999999999999999999 8999999999999998766543     


Q ss_pred             -------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015672          225 -------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       225 -------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  291 (403)
                                   ..||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+...++.++...+.
T Consensus       166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (308)
T 3g33_A          166 LARIYSYQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  244 (308)
T ss_dssp             CTTTSTTCCCSGGGGCCCSSCCHHHHHTS-CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred             cccccCCCcccCCccccccccCchHHcCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence                         2468899999999765 48999999999999999999999999999999999999988888765543


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                      .... .....++.....++.. ....+++++.+||.+||++||++|||+.|+|+||||++.
T Consensus       245 ~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          245 RDVS-LPRGAFPPRGPRPVQS-VVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             SSCS-SCGGGSCCCCCCCHHH-HSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             chhh-ccccccCCCCCCcHHH-hCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            2111 1111222222222222 335689999999999999999999999999999999874

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.2e-47  Score=367.26  Aligned_cols=238  Identities=24%  Similarity=0.357  Sum_probs=198.7

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----------ccHHHHHHHHHhcCCCCccccceEEeecCC
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLDHPNIVALKHCFFSTTD  149 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  149 (403)
                      ....|.+.+.||+|+||+||+|+++.+|+.||+|++....          ....+|+.+|+.++||||+++++++.    
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~----   85 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE----   85 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE----
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE----
Confidence            3456999999999999999999999999999999986432          23468999999999999999999883    


Q ss_pred             CCceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC----Cc-
Q 015672          150 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP----NV-  223 (403)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~----~~-  223 (403)
                       +...+++||||+. ++|.+++..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++    .+ 
T Consensus        86 -~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~~~vk  159 (361)
T 2yab_A           86 -NRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIK  159 (361)
T ss_dssp             -CSSEEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             -eCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeCCCCCccCEE
Confidence             3445899999996 677666543    4679999999999999999999999 8999999999999997654    23 


Q ss_pred             -----------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015672          224 -----------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  286 (403)
Q Consensus       224 -----------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~  286 (403)
                                       ..+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+.......+
T Consensus       160 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~  238 (361)
T 2yab_A          160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD  238 (361)
T ss_dssp             ECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred             EEecCCceEcCCCCccccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence                             23478999999998654 589999999999999999999999999887777766654321111


Q ss_pred             HHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          287 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                      ..                         ....+++++++||.+||+.||.+|||+.|+++||||+.+.
T Consensus       239 ~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          239 EE-------------------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             HH-------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             ch-------------------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence            11                         2246789999999999999999999999999999998653

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7.7e-48  Score=371.58  Aligned_cols=269  Identities=34%  Similarity=0.581  Sum_probs=214.1

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCC-CCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  154 (403)
                      .+|.+.+.||+|+||.||+|.+..+|+.||||++....      ....+|+.+++.++||||+++++++..... .....
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            46999999999999999999999999999999985432      223479999999999999999998853211 12234


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      +++||||++++|..++..     ..+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+++         
T Consensus       109 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~  182 (367)
T 2fst_X          109 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHT  182 (367)
T ss_dssp             CEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred             EEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence            789999998887666543     568999999999999999999999 89999999999999987765543         


Q ss_pred             -------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 015672          226 -------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  298 (403)
Q Consensus       226 -------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  298 (403)
                             +||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+.+.++.|..+.+........
T Consensus       183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~  262 (367)
T 2fst_X          183 ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  262 (367)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHH
T ss_pred             cccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence                   4689999999997756799999999999999999999999999999999999999999999887765432210


Q ss_pred             c---cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCC
Q 015672          299 E---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  357 (403)
Q Consensus       299 ~---~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~  357 (403)
                      .   ..++.....++...+ ...++++.+||.+||++||++|||+.|+|+||||++..++..
T Consensus       263 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~  323 (367)
T 2fst_X          263 RNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD  323 (367)
T ss_dssp             HHHHHTSCCCCCCCHHHHT-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred             HHHHhccCCCCCCCHHHHC-CCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCC
Confidence            0   122333333443333 467899999999999999999999999999999999877654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-47  Score=365.45  Aligned_cols=266  Identities=33%  Similarity=0.590  Sum_probs=212.4

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---------ccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      ..+|.+.+.||+|+||.||+|++..+|+.||||++....         ....+|+.+++.++||||+++++++..     
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----   83 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-----   83 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-----
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee-----
Confidence            345999999999999999999999999999999985321         234579999999999999999998833     


Q ss_pred             ceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------
Q 015672          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------  225 (403)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------  225 (403)
                      ...+++||||+++++...+..   ....+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++      
T Consensus        84 ~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           84 KSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             TTCCEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             CCceEEEEEcCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCHHHEEEcCCCCEEEEecccc
Confidence            334789999999887665543   23468888999999999999999999 89999999999999987765532      


Q ss_pred             -------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          226 -------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       226 -------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                                   .+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....|..
T Consensus       160 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  239 (346)
T 1ua2_A          160 KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD  239 (346)
T ss_dssp             STTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred             eeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence                         4688899999997666689999999999999999999999999999999999999888887766554


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCC
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  356 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~  356 (403)
                      .........+......++.. +...+++++.+||.+||+.||++|||+.|+|+||||++...+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~  302 (346)
T 1ua2_A          240 MCSLPDYVTFKSFPGIPLHH-IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT  302 (346)
T ss_dssp             TTSSTTCCCCCCCCCCCHHH-HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred             hccCcccccccccCCCChHH-hhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCC
Confidence            33222222222222233322 2256789999999999999999999999999999999875544

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.8e-47  Score=366.86  Aligned_cols=234  Identities=28%  Similarity=0.474  Sum_probs=197.1

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhc-CCCCccccceEEeecCCCCc
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  152 (403)
                      ..+|++.++||+|+||+||+|+++.+++.||||++.+..       ....+|+.+++.+ +||||+++++++.     ..
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-----~~   96 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ-----TP   96 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE-----eC
Confidence            346999999999999999999999999999999986431       2234789999988 7999999999883     33


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-------
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-------  224 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-------  224 (403)
                      .++|+|||||+ ++|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++       
T Consensus        97 ~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~g~ikL~DFG~a  171 (353)
T 3txo_A           97 DRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHD-KGIIYRDLKLDNVLLDHEGHCKLADFGMC  171 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCHHHEEECCCCCEEEccccce
Confidence            45899999998 477666554    3679999999999999999999999 8999999999999998776553       


Q ss_pred             ------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          225 ------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       225 ------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                                  .+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+.+..+...           
T Consensus       172 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-----------  239 (353)
T 3txo_A          172 KEGICNGVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-----------  239 (353)
T ss_dssp             BCSCC---------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred             eecccCCccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------
Confidence                        3479999999999654 4899999999999999999999999998888777776652           


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCCCcccCCC
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDELRD  354 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta------~e~l~hp~f~~~~~  354 (403)
                            ...            ++..+++++.+||.+||+.||.+||++      +++++||||+++.+
T Consensus       240 ------~~~------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w  289 (353)
T 3txo_A          240 ------EVV------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW  289 (353)
T ss_dssp             ------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred             ------CCC------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence                  111            124578999999999999999999998      89999999998753

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.8e-47  Score=374.19  Aligned_cols=263  Identities=31%  Similarity=0.552  Sum_probs=213.1

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc---cHHHHHHHHHhc------CCCCccccceEEeecCCCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQML------DHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~~  151 (403)
                      ..+|++.+.||+|+||+||+|++..+++.||||++.....   ...+|+.+++.+      +|+||+++++++..     
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-----  170 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-----  170 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-----
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-----
Confidence            3469999999999999999999999999999999875532   334688888887      57799999998843     


Q ss_pred             ceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC--ce-----
Q 015672          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN--VS-----  224 (403)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~--~~-----  224 (403)
                      ..++++||||++++|..++....  ...+++..++.++.||+.||.|||+ .|||||||||+|||++.++.  ++     
T Consensus       171 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          171 RNHICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             TTEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-HTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             CCeEEEEEeccCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEccCCCcceEEeecc
Confidence            34589999999998887776532  2458999999999999999999999 79999999999999987765  32     


Q ss_pred             -----------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015672          225 -----------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       225 -----------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  293 (403)
                                 .+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+.+..+.+.++.|+...+...
T Consensus       248 ~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~  326 (429)
T 3kvw_A          248 SSCYEHQRVYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS  326 (429)
T ss_dssp             TCEETTCCCCSSCSCGGGCCHHHHHTB-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTB
T ss_pred             cceecCCcccccCCCCCccChHHHhCC-CCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence                       3478999999999765 4899999999999999999999999999999999999999999998766432


Q ss_pred             CcCcccc---CCC---------------------------CCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 015672          294 NPNYTEF---KFP---------------------------QIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA  343 (403)
Q Consensus       294 ~~~~~~~---~~~---------------------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~  343 (403)
                      ......+   .++                           ......|...+....++++.+||.+||++||++|||+.|+
T Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~  406 (429)
T 3kvw_A          327 KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQA  406 (429)
T ss_dssp             TTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             hhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHH
Confidence            2110000   000                           0112234444455668999999999999999999999999


Q ss_pred             hcCCCcccC
Q 015672          344 CVHPFFDEL  352 (403)
Q Consensus       344 l~hp~f~~~  352 (403)
                      |+||||++.
T Consensus       407 L~Hpw~~~~  415 (429)
T 3kvw_A          407 LRHPWLRRR  415 (429)
T ss_dssp             HTSTTTC--
T ss_pred             hCChhhccC
Confidence            999999874

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=354.02  Aligned_cols=266  Identities=35%  Similarity=0.607  Sum_probs=208.3

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc------cHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      .+|++.+.||+|+||+||+|++..+++.||||++.....      ...+|+.+++.++||||+++++++..     ....
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-----KRRL   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-----CCeE
Confidence            359999999999999999999999999999998854322      23479999999999999999998843     3458


Q ss_pred             EEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------
Q 015672          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------  225 (403)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------  225 (403)
                      ++||||+++.....+   ......+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++          
T Consensus        78 ~lv~e~~~~~~l~~~---~~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  153 (311)
T 4agu_A           78 HLVFEYCDHTVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCHK-HNCIHRDVKPENILITKHSVIKLCDFGFARLLT  153 (311)
T ss_dssp             EEEEECCSEEHHHHH---HHTSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEeCCCchHHHH---HhhhcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence            899999996543222   2224678999999999999999999999 89999999999999987765432          


Q ss_pred             ---------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc--C
Q 015672          226 ---------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--N  294 (403)
Q Consensus       226 ---------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--~  294 (403)
                               .+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++..........  .
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          154 GPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred             CcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence                     46788999999977667899999999999999999999999999988888888888777665443221  1


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCC
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  356 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~  356 (403)
                      ..+.....+..............+++++.+||.+||+.||++|||++|+++||||+++.+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  295 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE  295 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence            11222222222211111122246899999999999999999999999999999999986543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.7e-46  Score=357.89  Aligned_cols=233  Identities=27%  Similarity=0.415  Sum_probs=196.5

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      .+|.+.+.||+|+||+||+|+++.+++.||||++.+.       .....+|+.+++.++||||+++++++.     ...+
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-----~~~~   79 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSSE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE-----eCCE
Confidence            4699999999999999999999999999999998542       123457999999999999999999883     3345


Q ss_pred             EEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce---------
Q 015672          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS---------  224 (403)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~---------  224 (403)
                      +|+||||+++ +|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++         
T Consensus        80 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  154 (337)
T 1o6l_A           80 LCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCCHHHEEECCCCCEEEeeccchhh
Confidence            8999999984 77665543    3678999999999999999999999 8999999999999998765543         


Q ss_pred             ----------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          225 ----------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       225 ----------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                .+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+.......+...             
T Consensus       155 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-------------  220 (337)
T 1o6l_A          155 GISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-------------  220 (337)
T ss_dssp             SCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------
T ss_pred             cccCCCcccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------
Confidence                      3578999999998654 5899999999999999999999999988766665555431             


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCCC
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  354 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~~  354 (403)
                          ...            ++..+++++.+||.+||+.||++||     ++.|+++||||+.+..
T Consensus       221 ----~~~------------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~  269 (337)
T 1o6l_A          221 ----EIR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             ----CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             ----CCC------------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence                111            2246899999999999999999999     9999999999998753

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=7.9e-47  Score=354.16  Aligned_cols=235  Identities=25%  Similarity=0.370  Sum_probs=196.5

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc----cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      ...+|++.+.||+|+||+||+|++..+++.||||++...    .....+|+.+++.++||||+++++++...     ..+
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~   92 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DEL   92 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----CEE
Confidence            345699999999999999999999999999999988532    23346899999999999999999988543     348


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce----------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS----------  224 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~----------  224 (403)
                      ++||||+. ++|.+++..     ..+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++          
T Consensus        93 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (297)
T ss_dssp             EEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence            89999996 677776653     468999999999999999999999 8999999999999998765543          


Q ss_pred             ---------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          225 ---------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       225 ---------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                               ..||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+........         
T Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---------  236 (297)
T 3fxz_A          167 TPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL---------  236 (297)
T ss_dssp             CSTTCCBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC---------
T ss_pred             CCcccccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------
Confidence                     2478899999999765 589999999999999999999999998887766655544211100         


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                                       ..+..+++.+.+||.+||+.||++|||+.|+++||||+..
T Consensus       237 -----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          237 -----------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             -----------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             -----------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence                             0124578999999999999999999999999999999875

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.8e-47  Score=366.16  Aligned_cols=267  Identities=31%  Similarity=0.548  Sum_probs=208.5

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCC-CCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  154 (403)
                      .+|.+.+.||+|+||.||+|++..+++.||||++....      ....+|+.+++.++||||+++++++..... .....
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            46999999999999999999999999999999986432      223479999999999999999998853321 22346


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      +++||||+++++...+.      ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+++         
T Consensus       105 ~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  177 (371)
T 2xrw_A          105 VYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  177 (371)
T ss_dssp             EEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred             eEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence            89999999988766553      458899999999999999999999 89999999999999987765532         


Q ss_pred             ---------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          226 ---------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       226 ---------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                               +||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+.++.+..+.+....+.
T Consensus       178 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  256 (371)
T 2xrw_A          178 GTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT  256 (371)
T ss_dssp             ------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred             ccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence                     468899999999764 5899999999999999999999999999999999999998888887766443221


Q ss_pred             cccc--CCCCCCCCCcccccc-----------cCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCC
Q 015672          297 YTEF--KFPQIKPHPWHKVFQ-----------KRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  356 (403)
Q Consensus       297 ~~~~--~~~~~~~~~~~~~~~-----------~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~  356 (403)
                      ...+  ..+......+...++           ...++++++||.+||+.||++|||++|+|+||||+...++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~  329 (371)
T 2xrw_A          257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPS  329 (371)
T ss_dssp             HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHH
T ss_pred             HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCcc
Confidence            1000  011111111111111           11257899999999999999999999999999998765543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.9e-46  Score=359.67  Aligned_cols=271  Identities=28%  Similarity=0.474  Sum_probs=211.2

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCC---CC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD---KE  151 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~  151 (403)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....      ....+|+.+++.++||||+++++++.....   ..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            456999999999999999999999999999999885432      234589999999999999999998855321   11


Q ss_pred             ceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------
Q 015672          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------  225 (403)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------  225 (403)
                      ...+++||||+++++...+...   ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+++      
T Consensus        96 ~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCSEEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            4468899999998876665432   3569999999999999999999999 89999999999999987655432      


Q ss_pred             -----------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015672          226 -----------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  288 (403)
Q Consensus       226 -----------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~  288 (403)
                                       .||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.++..
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence                             358889999999776668999999999999999999999999999999999998888877765


Q ss_pred             HHhhcCcC--ccccCCCCCCCCCccccc-ccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          289 EIKCMNPN--YTEFKFPQIKPHPWHKVF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       289 ~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                      .+......  +................+ ....++++.+||.+||+.||++|||++|+|+||||.....+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  321 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence            54332211  111111111111111100 01247889999999999999999999999999999875443

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.2e-46  Score=362.05  Aligned_cols=271  Identities=33%  Similarity=0.612  Sum_probs=218.3

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCC-Cce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~  153 (403)
                      ...|.+.+.||+|+||.||+|++..+++.||||++....      ....+|+.+++.++||||+++++++...... ...
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            346999999999999999999999999999999986432      2334799999999999999999988543321 112


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee--------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY--------  225 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~--------  225 (403)
                      .+++||||+.+++...+      ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+++        
T Consensus       121 ~~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCCEEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEccccccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence            34899999998775543      3458999999999999999999999 89999999999999988766543        


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                              ++|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+..+.+...+...
T Consensus       194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  273 (371)
T 4exu_A          194 ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA  273 (371)
T ss_dssp             ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred             cccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence                    468999999999765679999999999999999999999999999999999999999998877655433211


Q ss_pred             cc---cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCCCC
Q 015672          298 TE---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL  359 (403)
Q Consensus       298 ~~---~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~~~  359 (403)
                      ..   ...+......+.. ....+++++.+||.+||+.||++|||+.|+|+||||+.+..+....
T Consensus       274 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~  337 (371)
T 4exu_A          274 AKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEET  337 (371)
T ss_dssp             HHHHHHHSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCC
T ss_pred             hhhhhhccCCCcchhHHH-hccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCccccc
Confidence            00   0112222222222 2346799999999999999999999999999999999987765543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=367.94  Aligned_cols=272  Identities=29%  Similarity=0.498  Sum_probs=200.6

Q ss_pred             ccEee-eceecccCceEEEEEEEC--CCCcEEEEEEccccc--ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           82 VSYIA-EHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        82 ~~y~~-~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ..|.+ .++||+|+||+||+|+++  .+++.||||++....  ....+|+.+|+.++||||+++++++...   ...+++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~~~~~   96 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVW   96 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEET---TTTEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecC---CCCeEE
Confidence            34776 568999999999999976  578899999986543  2456899999999999999999998643   234588


Q ss_pred             EEeeccCCcHHHHHHHhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccccccee----cCCCCce---
Q 015672          157 LVLEYVPETVNRIARNYSRI-----HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV----KGEPNVS---  224 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl----~~~~~~~---  224 (403)
                      +||||+++++..++......     ...+++..++.++.||+.||.|||+ .||+||||||+||||    +..+.++   
T Consensus        97 lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A           97 LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             EEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             EEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            99999999888776543321     1248999999999999999999999 899999999999999    3333332   


Q ss_pred             -------------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc---------HHHHH
Q 015672          225 -------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---------VDQLV  276 (403)
Q Consensus       225 -------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~---------~~~~~  276 (403)
                                         .+||+.|+|||++.+...++.++|||||||++|+|++|++||.+...         .+++.
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~  255 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  255 (405)
T ss_dssp             TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred             CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence                               34688999999997766699999999999999999999999977654         47888


Q ss_pred             HHHHHhCCCCHHHHhhcCcCcc------ccCCCCCCCCC---cccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 015672          277 EIIKVLGTPTREEIKCMNPNYT------EFKFPQIKPHP---WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  347 (403)
Q Consensus       277 ~i~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~---~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp  347 (403)
                      .+...++.|....|........      .+.........   +........++++.+||.+||++||.+|||++|+|+||
T Consensus       256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp  335 (405)
T 3rgf_A          256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP  335 (405)
T ss_dssp             HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence            8999999887765543211000      00000000000   00111123478899999999999999999999999999


Q ss_pred             CcccCCCCCC
Q 015672          348 FFDELRDPNT  357 (403)
Q Consensus       348 ~f~~~~~~~~  357 (403)
                      ||.+...+..
T Consensus       336 ~f~~~~~~~~  345 (405)
T 3rgf_A          336 YFLEDPLPTS  345 (405)
T ss_dssp             GGTSSSCCCS
T ss_pred             hhccCCCCcc
Confidence            9998655543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.4e-46  Score=360.82  Aligned_cols=239  Identities=30%  Similarity=0.398  Sum_probs=193.9

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc---------cccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      ...|++.+.||+|+||+||+|+++.+++.||||++...         .....+|+.+++.++||||+++++++..     
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----   97 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS-----   97 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----
Confidence            34699999999999999999999999999999988431         2335689999999999999999998843     


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC---c----
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN---V----  223 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~---~----  223 (403)
                      ...+++|||||+ ++|...+.........+++..+..++.||+.||.|||+ +||+||||||+|||++.++.   +    
T Consensus        98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivHrDlkp~NIl~~~~~~~~~vkl~D  176 (351)
T 3c0i_A           98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLGG  176 (351)
T ss_dssp             TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChHHeEEecCCCCCcEEEec
Confidence            345899999998 57766665544434568999999999999999999999 89999999999999975433   2    


Q ss_pred             ---------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015672          224 ---------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  288 (403)
Q Consensus       224 ---------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~  288 (403)
                                     ..+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.. .+.+..+..........
T Consensus       177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~  254 (351)
T 3c0i_A          177 FGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPR  254 (351)
T ss_dssp             CTTCEECCTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHH
T ss_pred             CcceeEecCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcc
Confidence                           23478999999999654 58999999999999999999999998753 33333443321111111


Q ss_pred             HHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                                               ....+++++.+||.+||+.||++|||+.++|+||||++.
T Consensus       255 -------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          255 -------------------------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             -------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             -------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence                                     114578999999999999999999999999999999864

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-46  Score=354.71  Aligned_cols=238  Identities=22%  Similarity=0.360  Sum_probs=197.5

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----------ccHHHHHHHHHhcCCCCccccceEEeecCC
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLDHPNIVALKHCFFSTTD  149 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  149 (403)
                      ....|.+.+.||+|+||.||+|++..+++.||+|++....          ....+|+.+++.++||||+++++++.    
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----   84 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE----   84 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE----
Confidence            3456999999999999999999999999999999885422          23568999999999999999999883    


Q ss_pred             CCceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC----Cce
Q 015672          150 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP----NVS  224 (403)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~----~~~  224 (403)
                       ....+++||||++ ++|.+++..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++    .++
T Consensus        85 -~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~k  158 (326)
T 2y0a_A           85 -NKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIK  158 (326)
T ss_dssp             -CSSEEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCSSSSSCCEE
T ss_pred             -eCCEEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHH-CCeEcCCCCHHHEEEecCCCCCCCEE
Confidence             3345889999996 577666543    4678999999999999999999999 8999999999999997655    222


Q ss_pred             ------------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015672          225 ------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  286 (403)
Q Consensus       225 ------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~  286 (403)
                                        ..||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.......+
T Consensus       159 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  237 (326)
T 2y0a_A          159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE  237 (326)
T ss_dssp             ECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             EEECCCCeECCCCCccccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC
Confidence                              2478899999998654 589999999999999999999999998887776666554321111


Q ss_pred             HHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          287 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                      .                         .....+++.+.+||.+||+.||++|||+.|+|+||||+...
T Consensus       238 ~-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          238 D-------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             H-------------------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             c-------------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            1                         12245789999999999999999999999999999998653

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-46  Score=353.94  Aligned_cols=234  Identities=26%  Similarity=0.471  Sum_probs=198.9

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-------cccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..+|++.+.||+|+||+||+|+++.+|+.||+|++.+.       .....+|+.+++.++||||+++++++.     +..
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~   79 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQ   79 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE-----eCC
Confidence            35699999999999999999999999999999998542       123457999999999999999999883     344


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------  224 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------  224 (403)
                      .+|+||||++ ++|..++..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++        
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~  154 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNGHIKITDFGFAK  154 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChheEEEcCCCCEEEeecCcce
Confidence            5899999998 577776654    3578999999999999999999999 8999999999999998776653        


Q ss_pred             --------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          225 --------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       225 --------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                              .+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+.+..+...               
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---------------  218 (318)
T 1fot_A          155 YVPDVTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA---------------  218 (318)
T ss_dssp             ECSSCBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC---------------
T ss_pred             ecCCccccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------------
Confidence                    3579999999998654 5899999999999999999999999988877776666542               


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCCC
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  354 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~~  354 (403)
                        ...            ++..+++++.+||.+||+.||++||     +++++++||||+++..
T Consensus       219 --~~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~  267 (318)
T 1fot_A          219 --ELR------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW  267 (318)
T ss_dssp             --CCC------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             --CCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence              111            2245789999999999999999999     9999999999998753

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.9e-46  Score=358.89  Aligned_cols=270  Identities=29%  Similarity=0.582  Sum_probs=218.8

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---------------ccHHHHHHHHHhcCCCCccccceEEee
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------------RYKNRELQIMQMLDHPNIVALKHCFFS  146 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~E~~~l~~l~h~niv~~~~~~~~  146 (403)
                      .+|.+.+.||+|+||.||+|.+.. ++.||||++....               ....+|+++++.++||||+++++++..
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  100 (362)
T 3pg1_A           22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH  100 (362)
T ss_dssp             CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred             cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence            359999999999999999999854 9999999884321               234589999999999999999999877


Q ss_pred             cCCCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-
Q 015672          147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-  225 (403)
Q Consensus       147 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-  225 (403)
                      .......++++||||+++++...+..   ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+++ 
T Consensus       101 ~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl~  176 (362)
T 3pg1_A          101 FEEPAMHKLYLVTELMRTDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHE-AGVVHRDLHPGNILLADNNDITIC  176 (362)
T ss_dssp             CCTTTCCEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             ccCCCcceEEEEEccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CcCEecCCChHHEEEcCCCCEEEE
Confidence            66566678999999999988766553   23568999999999999999999999 89999999999999987766543 


Q ss_pred             -----------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015672          226 -----------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  288 (403)
Q Consensus       226 -----------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~  288 (403)
                                       .+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+...
T Consensus       177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  256 (362)
T 3pg1_A          177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE  256 (362)
T ss_dssp             CTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             ecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChH
Confidence                             467889999999765669999999999999999999999999999999999999999988876


Q ss_pred             HHhhcCcC----ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCC
Q 015672          289 EIKCMNPN----YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  357 (403)
Q Consensus       289 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~  357 (403)
                      .+......    +............|.. .....++.+.+||.+||+.||.+|||+.|+++||||+.+..+..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  328 (362)
T 3pg1_A          257 DVVMFSSPSARDYLRNSLSNVPARAWTA-VVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLD  328 (362)
T ss_dssp             HHHHTSCHHHHHHTTTCCCCCCCCCHHH-HSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred             HhhhccchhhhHHHHhhcccCChhhHHh-hCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccc
Confidence            54322110    0001111222223322 33567899999999999999999999999999999999876543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.5e-46  Score=355.97  Aligned_cols=269  Identities=32%  Similarity=0.564  Sum_probs=216.0

Q ss_pred             CCCCcccccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc------cHHHHHHHHHhcCCCCccccceEEeecC
Q 015672           75 NGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTT  148 (403)
Q Consensus        75 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~  148 (403)
                      +.......+|++.+.||+|+||.||+|++..+++.||||++.....      ...+|+.+++.++||||+++++++.   
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---   94 (331)
T 4aaa_A           18 NLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK---   94 (331)
T ss_dssp             -CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE---
T ss_pred             hhhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee---
Confidence            3344556679999999999999999999999999999998854322      2347999999999999999999884   


Q ss_pred             CCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---
Q 015672          149 DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---  225 (403)
Q Consensus       149 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---  225 (403)
                        ....+++||||+++.+...+   ......+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++   
T Consensus        95 --~~~~~~lv~e~~~~~~l~~~---~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nil~~~~~~~kl~Df  168 (331)
T 4aaa_A           95 --KKKRWYLVFEFVDHTILDDL---ELFPNGLDYQVVQKYLFQIINGIGFCHS-HNIIHRDIKPENILVSQSGVVKLCDF  168 (331)
T ss_dssp             --ETTEEEEEEECCSEEHHHHH---HHSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             --cCCEEEEEEecCCcchHHHH---HhhccCCCHHHHHHHHHHHHHHHHHHHH-CCEEccCcChheEEEcCCCcEEEEeC
Confidence              33458899999997553332   2224679999999999999999999999 89999999999999987765532   


Q ss_pred             ----------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          226 ----------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       226 ----------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                      .+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+......
T Consensus       169 g~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (331)
T 4aaa_A          169 GFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH  248 (331)
T ss_dssp             TTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             CCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Confidence                            3688899999997665689999999999999999999999999999998888888888776654


Q ss_pred             Hhh--cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          290 IKC--MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       290 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                      ...  ..+.+.....+..............+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             HHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             hhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            332  222333334444433333333335689999999999999999999999999999999864

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.3e-46  Score=365.59  Aligned_cols=239  Identities=28%  Similarity=0.484  Sum_probs=199.8

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccc-------ccccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ-------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..+|.+.++||+|+||+||+|+++.+++.||+|++.+       ......+|+.+++.++||||++++++|.     +..
T Consensus        68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~  142 (410)
T 3v8s_A           68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-----DDR  142 (410)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred             ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECC
Confidence            3469999999999999999999999999999999853       2234568999999999999999999883     345


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------  224 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------  224 (403)
                      ++|+|||||+ ++|..++..     ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++        
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence            6899999996 577776643     468999999999999999999999 8999999999999998766542        


Q ss_pred             ------------eeccccccchhhhhCCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          225 ------------YICSRYYRAPELIFGAT---EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       225 ------------~~~t~~y~aPE~~~~~~---~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                  .+||+.|+|||++.+..   .|+.++|||||||++|||++|++||.+.+..+.+..+.....      
T Consensus       217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~------  290 (410)
T 3v8s_A          217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN------  290 (410)
T ss_dssp             ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH------
T ss_pred             eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc------
Confidence                        35799999999996543   278899999999999999999999999888877777654210      


Q ss_pred             HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCcccCCCC
Q 015672          290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRDP  355 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpta~e~l~hp~f~~~~~~  355 (403)
                               ...+|.          ...+++++++||.+||+.+|.+  |++++|+++||||+.+.+.
T Consensus       291 ---------~~~~p~----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~  339 (410)
T 3v8s_A          291 ---------SLTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA  339 (410)
T ss_dssp             ---------HCCCCT----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred             ---------cccCCC----------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence                     011111          1358999999999999999988  9999999999999988643

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5.4e-47  Score=355.69  Aligned_cols=234  Identities=22%  Similarity=0.260  Sum_probs=173.3

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc-c--HHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-Y--KNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~--~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      +|++.++||+|+||+||+|++  +|+.||||++..... .  .+.|+..+..++|||||++++++.... .....+||||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV~   80 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVS   80 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEEe
Confidence            599999999999999999987  489999999864332 1  234566667889999999999886533 2334689999


Q ss_pred             eccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--------CccccccccccceecCCCCce------
Q 015672          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--------GICHRDIKPQNLLVKGEPNVS------  224 (403)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--------~ivHrDlKp~NILl~~~~~~~------  224 (403)
                      |||+ |+|.+++..     ..+++..+..++.|++.||.|||+ .        +||||||||+||||+.++.++      
T Consensus        81 Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~-~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl  154 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHM-EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             cCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-hhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence            9998 688877754     568899999999999999999997 5        899999999999998776542      


Q ss_pred             -----------------eeccccccchhhhhCCC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCCc-----------
Q 015672          225 -----------------YICSRYYRAPELIFGAT-----EYTTAIDIWSTGCVMAELLLGQPLFPGESG-----------  271 (403)
Q Consensus       225 -----------------~~~t~~y~aPE~~~~~~-----~~~~~~DiwSlGvil~el~tg~~pf~~~~~-----------  271 (403)
                                       .+||+.|||||++.+..     .|+.++|||||||+||||+||.+||.....           
T Consensus       155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~  234 (303)
T 3hmm_A          155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence                             25899999999996532     267799999999999999999887643321           


Q ss_pred             ---HHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          272 ---VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       272 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                         .+.+......-+                 ..|.++. .+   .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~-----------------~rp~~p~-~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          235 DPSVEEMRKVVCEQK-----------------LRPNIPN-RW---QSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SCCHHHHHHHHTTSC-----------------CCCCCCG-GG---GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cchHHHHHHHHhccc-----------------CCCCCCc-cc---cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence               111111110000                 0000000 00   001234578899999999999999999999864

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.7e-46  Score=356.84  Aligned_cols=270  Identities=31%  Similarity=0.617  Sum_probs=213.4

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc-----cHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      .+|.+.+.||+|+||.||+|++..+++.||||++.....     ...+|+.+++.++||||+++++++...........+
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   90 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY   90 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred             cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence            469999999999999999999999999999999854321     234799999999999999999877443333345688


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce------------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS------------  224 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~------------  224 (403)
                      +||||++++|..++..     ..+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++            
T Consensus        91 lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           91 IIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHG-SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE  164 (353)
T ss_dssp             EEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence            9999999988777653     568999999999999999999999 8999999999999998765442            


Q ss_pred             -----------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015672          225 -----------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  287 (403)
Q Consensus       225 -----------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~  287 (403)
                                       ..||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+..
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  244 (353)
T 2b9h_A          165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS  244 (353)
T ss_dssp             ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred             ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence                             245888999999876567999999999999999999999999999988888888888777653


Q ss_pred             HHH-hhcCcC-ccc--cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCCC
Q 015672          288 EEI-KCMNPN-YTE--FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  358 (403)
Q Consensus       288 ~~~-~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~~  358 (403)
                      ... .+.... ...  ..++.....++.. ....+++++.+||.+||+.||++|||+.|+++||||+....+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~  318 (353)
T 2b9h_A          245 DNDLRCIESPRAREYIKSLPMYPAAPLEK-MFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDE  318 (353)
T ss_dssp             TTTTTTCCCHHHHHHHHTSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSS
T ss_pred             hccccccccchhhHHhhcccCCCCcchhh-hcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccc
Confidence            211 100000 000  0112222222222 224689999999999999999999999999999999998766543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-46  Score=357.12  Aligned_cols=236  Identities=26%  Similarity=0.376  Sum_probs=196.9

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      .+|.+.+.||+|+||.||+|++..+++.||+|.+....   ....+|+.+++.++||||+++++++..     ...+++|
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~lv   79 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES-----MEELVMI   79 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEec-----CCEEEEE
Confidence            46999999999999999999999999999999886432   234589999999999999999998843     3358999


Q ss_pred             eeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecC--CCCce-----------
Q 015672          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKG--EPNVS-----------  224 (403)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~--~~~~~-----------  224 (403)
                      ||||++ +|.+.+..   ....+++..+..++.||+.||.|||+ +||+||||||+|||++.  ++.++           
T Consensus        80 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           80 FEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             ECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             EEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence            999984 77655432   23468999999999999999999999 89999999999999986  33332           


Q ss_pred             -------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          225 -------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       225 -------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                             ..||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.......+..         
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------  225 (321)
T 1tki_A          156 PGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE---------  225 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH---------
T ss_pred             CCCccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChh---------
Confidence                   3478999999999654 48999999999999999999999999988777777766543222221         


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                                      ....+++++.+||.+||..||.+|||+.|+|+||||++.
T Consensus       226 ----------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          226 ----------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             ----------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             ----------------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence                            114578999999999999999999999999999999874

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.8e-46  Score=360.99  Aligned_cols=235  Identities=26%  Similarity=0.484  Sum_probs=191.4

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhc-CCCCccccceEEeecCCCCc
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  152 (403)
                      ..+|.+.++||+|+||+||+|+++.+++.||||++.+..       ....+|..++..+ +||||++++++|.     ..
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-----~~  125 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TE  125 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE-----CS
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE-----EC
Confidence            456999999999999999999999999999999986432       2245789999887 8999999999883     34


Q ss_pred             eEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-------
Q 015672          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-------  224 (403)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-------  224 (403)
                      ..+++||||+++ +|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+||||+.++.++       
T Consensus       126 ~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~~g~ikL~DFGla  200 (396)
T 4dc2_A          126 SRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMC  200 (396)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEECCCCCEEEeeccee
Confidence            458999999984 77665543    3679999999999999999999999 8999999999999998776543       


Q ss_pred             ------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc--------HHHHHHHHHHhCC
Q 015672          225 ------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--------VDQLVEIIKVLGT  284 (403)
Q Consensus       225 ------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~--------~~~~~~i~~~~~~  284 (403)
                                  .+||+.|+|||++.+. .++.++|||||||++|||++|++||.+...        .+.+...+..   
T Consensus       201 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~---  276 (396)
T 4dc2_A          201 KEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE---  276 (396)
T ss_dssp             BCCCCTTCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH---
T ss_pred             eecccCCCccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc---
Confidence                        3579999999999764 589999999999999999999999965322        1112111111   


Q ss_pred             CCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCCCcccCCC
Q 015672          285 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDELRD  354 (403)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta------~e~l~hp~f~~~~~  354 (403)
                                   ....            ++..+++++++||.+||+.||.+||++      +|+++||||+.+.+
T Consensus       277 -------------~~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w  327 (396)
T 4dc2_A          277 -------------KQIR------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  327 (396)
T ss_dssp             -------------CCCC------------CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred             -------------cccC------------CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence                         0111            235689999999999999999999985      79999999998754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.9e-46  Score=368.78  Aligned_cols=237  Identities=27%  Similarity=0.388  Sum_probs=194.7

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ...+|.+.+.||+|+||+||+|.++.+|+.||+|++....      ....+|+.+++.++||||+++++++.     +..
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~~   83 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS-----EEG   83 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE-----CSS
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE-----ECC
Confidence            3457999999999999999999999999999999986533      23458999999999999999999883     444


Q ss_pred             EEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCC---CCc------
Q 015672          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE---PNV------  223 (403)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~---~~~------  223 (403)
                      +.++|||||.+ +|.+.+..    ...+++..+..++.||+.||.|||+ +||+||||||+|||++.+   +.+      
T Consensus        84 ~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~-~givHrDlKp~NIll~~~~~~~~vkL~DFG  158 (444)
T 3soa_A           84 HHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADFG  158 (444)
T ss_dssp             EEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred             EEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEeccCCCCcEEEccCc
Confidence            58899999974 77665543    4679999999999999999999999 899999999999999742   222      


Q ss_pred             -------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          224 -------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       224 -------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                   ...||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+.+..+.+..+......      
T Consensus       159 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~------  231 (444)
T 3soa_A          159 LAIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD------  231 (444)
T ss_dssp             SCBCCCTTCCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC------
T ss_pred             eeEEecCCCceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC------
Confidence                         23579999999998654 5899999999999999999999999988877777666542111      


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                                 ++.   .     ....+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       232 -----------~~~---~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          232 -----------FPS---P-----EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             -----------CCT---T-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             -----------CCc---c-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence                       110   0     114579999999999999999999999999999999763

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.6e-46  Score=367.03  Aligned_cols=243  Identities=25%  Similarity=0.405  Sum_probs=201.6

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-------cccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..+|.+.++||+|+||+||+|+++.+++.||+|++.+.       .....+|+.++..++||||++++++|.     +..
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~-----~~~  147 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ-----DDN  147 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE-----CSS
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----eCC
Confidence            34699999999999999999999999999999998531       233568999999999999999999883     344


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------  224 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------  224 (403)
                      .+|+|||||+ ++|..++...   ...+++..++.++.||+.||.|||+ +|||||||||+||||+.++.++        
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILl~~~g~vkL~DFGla~  223 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNGHIRLADFGSCL  223 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeeEcCCCCEEEcchhhhh
Confidence            5899999996 6887766542   3579999999999999999999999 8999999999999998766542        


Q ss_pred             ------------eeccccccchhhhh----CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015672          225 ------------YICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  288 (403)
Q Consensus       225 ------------~~~t~~y~aPE~~~----~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~  288 (403)
                                  .+||+.|+|||++.    +...|+.++|||||||++|||++|++||.+.+..+.+..+.....     
T Consensus       224 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----  298 (437)
T 4aw2_A          224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-----  298 (437)
T ss_dssp             ECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-----
T ss_pred             hcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc-----
Confidence                        35799999999986    234589999999999999999999999999888877777654210     


Q ss_pred             HHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCCCcccCCCCC
Q 015672          289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNL--RCTALEACVHPFFDELRDPN  356 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--Rpta~e~l~hp~f~~~~~~~  356 (403)
                                .+.+|.         ....+++++++||.+||+.+|++  |++++|+++||||+++.+..
T Consensus       299 ----------~~~~p~---------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~  349 (437)
T 4aw2_A          299 ----------RFQFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN  349 (437)
T ss_dssp             ----------HCCCCS---------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred             ----------cccCCc---------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence                      111111         01358999999999999999988  99999999999999886543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.7e-46  Score=362.72  Aligned_cols=269  Identities=21%  Similarity=0.359  Sum_probs=194.8

Q ss_pred             ccccEeeeceeccc--CceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           80 QKVSYIAEHVVGTG--SFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        80 ~~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      ...+|++.+.||+|  +||.||+|+++.+++.||||++....      ....+|+.+++.++||||+++++++..     
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----   97 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-----   97 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE-----
Confidence            45569999999999  99999999999999999999986432      233569999999999999999999853     


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----  225 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----  225 (403)
                      ...+++|||||+ ++|.+++....  ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+++     
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~kl~dfg~  174 (389)
T 3gni_B           98 DNELWVVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDGKVYLSGLRS  174 (389)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCGGG
T ss_pred             CCEEEEEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEccccc
Confidence            335899999998 57777765432  2568999999999999999999999 89999999999999987765432     


Q ss_pred             ---------------------eccccccchhhhhCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 015672          226 ---------------------ICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG  283 (403)
Q Consensus       226 ---------------------~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~  283 (403)
                                           +||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  254 (389)
T 3gni_B          175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV  254 (389)
T ss_dssp             CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred             ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence                                 457779999999653 4589999999999999999999999988776655544332111


Q ss_pred             C--------CCHHHHhhcCc-----Ccc-ccC--CCC-CCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          284 T--------PTREEIKCMNP-----NYT-EFK--FPQ-IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       284 ~--------~~~~~~~~~~~-----~~~-~~~--~~~-~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      .        +..........     ... ...  .+. ..........+..+++++.+||.+||++||++|||+.|+|+|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            0        00000000000     000 000  000 000001111335689999999999999999999999999999


Q ss_pred             CCcccCCCCC
Q 015672          347 PFFDELRDPN  356 (403)
Q Consensus       347 p~f~~~~~~~  356 (403)
                      |||+++....
T Consensus       335 p~f~~~~~~~  344 (389)
T 3gni_B          335 SFFKQIKRRA  344 (389)
T ss_dssp             GGGGGC---C
T ss_pred             HHHHHHhhcc
Confidence            9999886543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.7e-46  Score=362.57  Aligned_cols=242  Identities=26%  Similarity=0.437  Sum_probs=199.1

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-------cccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..+|++.++||+|+||+||+|+++.+++.||||++.+.       .....+|+.++..++|+||+++++++.     +..
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~-----~~~  134 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ-----DEN  134 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE-----CSS
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----eCC
Confidence            35699999999999999999999999999999998532       234568999999999999999999883     344


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------  224 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------  224 (403)
                      ++|+||||++ ++|..++...   ...+++..++.++.||+.||.|||+ +|||||||||+|||++.++.++        
T Consensus       135 ~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILld~~g~vkL~DFGla~  210 (412)
T 2vd5_A          135 YLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHR-LGYVHRDIKPDNILLDRCGHIRLADFGSCL  210 (412)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccCHHHeeecCCCCEEEeechhhe
Confidence            6899999996 6887776542   3479999999999999999999999 8999999999999998765542        


Q ss_pred             ------------eeccccccchhhhhC------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015672          225 ------------YICSRYYRAPELIFG------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  286 (403)
Q Consensus       225 ------------~~~t~~y~aPE~~~~------~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~  286 (403)
                                  .+||+.|+|||++..      ...|+.++|||||||++|||++|++||.+.+..+.+..+.....   
T Consensus       211 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---  287 (412)
T 2vd5_A          211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE---  287 (412)
T ss_dssp             ECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH---
T ss_pred             eccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---
Confidence                        357999999999863      24589999999999999999999999999888777776654210   


Q ss_pred             HHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCCCcccCCCCC
Q 015672          287 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR---CTALEACVHPFFDELRDPN  356 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R---pta~e~l~hp~f~~~~~~~  356 (403)
                                  ...+|.         .+..+++++++||.+||+ ||.+|   ++++|+++||||+.+.+..
T Consensus       288 ------------~~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~  338 (412)
T 2vd5_A          288 ------------HLSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDG  338 (412)
T ss_dssp             ------------HCCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTT
T ss_pred             ------------CcCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence                        001111         124689999999999999 99998   5999999999999986544

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.8e-46  Score=357.39  Aligned_cols=234  Identities=27%  Similarity=0.483  Sum_probs=196.5

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhc-CCCCccccceEEeecCCCCc
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  152 (403)
                      ..+|.+.+.||+|+||+||+|+++.+++.||||++.+..       .....|..++..+ +||||+++++++.     ..
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~-----~~   90 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-----TK   90 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-----CS
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE-----eC
Confidence            346999999999999999999999999999999986431       2235688888877 9999999999883     33


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-------
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-------  224 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-------  224 (403)
                      .++|+||||++ ++|..++..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++       
T Consensus        91 ~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g~vkL~DFG~a  165 (345)
T 1xjd_A           91 ENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDKDGHIKIADFGMC  165 (345)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCChhhEEECCCCCEEEeEChhh
Confidence            45899999997 577766654    3578999999999999999999999 8999999999999998765543       


Q ss_pred             ------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          225 ------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       225 ------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                                  .+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+.+..+...           
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-----------  233 (345)
T 1xjd_A          166 KENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-----------  233 (345)
T ss_dssp             BCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred             hhcccCCCcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC-----------
Confidence                        3578999999999654 5899999999999999999999999988877666665431           


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHH-HHhcCCCcccCCC
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELRD  354 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~-e~l~hp~f~~~~~  354 (403)
                            ...            ++..+++++.+||.+||+.||++||++. ++++||||+++.+
T Consensus       234 ------~~~------------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w  278 (345)
T 1xjd_A          234 ------NPF------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW  278 (345)
T ss_dssp             ------CCC------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             ------CCC------------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence                  001            2245789999999999999999999998 9999999998753

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.1e-47  Score=363.89  Aligned_cols=234  Identities=29%  Similarity=0.411  Sum_probs=192.2

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-------cccHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      ...+|.+.+.||+|+||+||+|++..+++.||||++...       .....+|+.+++.++||||+++++++..     .
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~   81 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-----P   81 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-----S
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----C
Confidence            345699999999999999999999999999999998532       2245689999999999999999998843     3


Q ss_pred             eEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------
Q 015672          153 LYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------  225 (403)
Q Consensus       153 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------  225 (403)
                      ..+++||||+++++.+.+..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+++       
T Consensus        82 ~~~~lv~E~~~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl~DFG~s~  156 (336)
T 3h4j_B           82 TDIVMVIEYAGGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHR-HKIVHRDLKPENLLLDDNLNVKIADFGLSN  156 (336)
T ss_dssp             SEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCSTTTEEECTTCCEEECCSSCTB
T ss_pred             CEEEEEEECCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCchhhEEEcCCCCEEEEEeccce
Confidence            35889999999888776654    3579999999999999999999999 79999999999999987765533       


Q ss_pred             -----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          226 -----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       226 -----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                 +||+.|+|||++.+...++.++|||||||++|+|++|..||.+........                  
T Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~------------------  218 (336)
T 3h4j_B          157 IMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK------------------  218 (336)
T ss_dssp             TTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC------------------
T ss_pred             eccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH------------------
Confidence                       478999999999766545889999999999999999999997654211100                  


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                               .+..  ....++..+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus       219 ---------~i~~--~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          219 ---------KVNS--CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             ---------CCCS--SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             ---------HHHc--CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence                     0000  0011235689999999999999999999999999999999863

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.7e-46  Score=358.03  Aligned_cols=260  Identities=24%  Similarity=0.418  Sum_probs=205.3

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcC-----CCCccccceEEeecCCCCce
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD-----HPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~~~~  153 (403)
                      .+|.+.++||+|+||+||+|++..+++.||||++....   .....|+.+++.+.     |+||+++++++...     .
T Consensus        35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~-----~  109 (360)
T 3llt_A           35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY-----D  109 (360)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET-----T
T ss_pred             CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC-----C
Confidence            45999999999999999999999999999999986432   23356999999996     99999999988443     3


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecC--------------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKG--------------  219 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~--------------  219 (403)
                      ++++||||++++|.+++....  ...+++..++.++.||+.||.|||+ .||+||||||+|||++.              
T Consensus       110 ~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~  186 (360)
T 3llt_A          110 HMCLIFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVT  186 (360)
T ss_dssp             EEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred             eeEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCcccEEEccccccccccchhccc
Confidence            589999999989988776532  2458999999999999999999999 89999999999999974              


Q ss_pred             -----------CCCce----------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcH
Q 015672          220 -----------EPNVS----------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV  272 (403)
Q Consensus       220 -----------~~~~~----------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~  272 (403)
                                 .+.++                ..||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..
T Consensus       187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~  265 (360)
T 3llt_A          187 DGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHM  265 (360)
T ss_dssp             TCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCCCCCCcHH
Confidence                       33332                3468999999999765 5899999999999999999999999999988


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCcc---------ccCCCCCCCCC--------cccccccCCCHHHHHHHHHhcccCCC
Q 015672          273 DQLVEIIKVLGTPTREEIKCMNPNYT---------EFKFPQIKPHP--------WHKVFQKRLPPEAVDLVCRFFQYSPN  335 (403)
Q Consensus       273 ~~~~~i~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~  335 (403)
                      +.+..+....+.++...+........         ...++......        ....+....++.+.+||.+||++||+
T Consensus       266 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  345 (360)
T 3llt_A          266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPT  345 (360)
T ss_dssp             HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChh
Confidence            88888888888877765533221100         00111100000        00011123457889999999999999


Q ss_pred             CCCCHHHHhcCCCcc
Q 015672          336 LRCTALEACVHPFFD  350 (403)
Q Consensus       336 ~Rpta~e~l~hp~f~  350 (403)
                      +|||+.|+|+||||+
T Consensus       346 ~Rpta~elL~hp~f~  360 (360)
T 3llt_A          346 LRPSPAELLKHKFLE  360 (360)
T ss_dssp             GSCCHHHHTTSGGGC
T ss_pred             hCCCHHHHhcCcccC
Confidence            999999999999995

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.2e-46  Score=359.68  Aligned_cols=236  Identities=28%  Similarity=0.407  Sum_probs=194.5

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ..+|.+.+.||+|+||.||+|.++.+++.||+|++....      ....+|+.+++.++||||+++++++.     +..+
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~  102 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF  102 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence            456999999999999999999999999999999986432      23457999999999999999999883     3445


Q ss_pred             EEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC---c-------
Q 015672          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN---V-------  223 (403)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~---~-------  223 (403)
                      .++||||+.+ +|.+.+..    ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.   +       
T Consensus       103 ~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~  177 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGL  177 (362)
T ss_dssp             EEEEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence            8899999985 66554432    4568999999999999999999999 89999999999999975432   2       


Q ss_pred             -----------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          224 -----------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       224 -----------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                                 ...||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+......        
T Consensus       178 a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--------  248 (362)
T 2bdw_A          178 AIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD--------  248 (362)
T ss_dssp             CBCCTTCCSCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--------
T ss_pred             ceEecCCcccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC--------
Confidence                       23578999999998654 5899999999999999999999999988877666665542111        


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                               ++.   .     ....+++++.+||.+||+.||++|||+.++|+||||...
T Consensus       249 ---------~~~---~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          249 ---------YPS---P-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             ---------CCT---T-----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             ---------CCc---c-----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence                     110   0     113578999999999999999999999999999999753

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.2e-45  Score=353.97  Aligned_cols=234  Identities=26%  Similarity=0.414  Sum_probs=198.5

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..+|.+.+.||+|+||.||+|+++.+++.||||++.+..       ....+|+.+++.++||||+++++++.     +..
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~  114 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DNS  114 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----cCC
Confidence            356999999999999999999999999999999985321       23457999999999999999999883     344


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------  224 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------  224 (403)
                      ++|+||||++ ++|..++..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++        
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g~~kL~DFg~a~  189 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCccceEEECCCCCEEEcccccce
Confidence            5899999996 677776654    3568999999999999999999999 8999999999999998776553        


Q ss_pred             --------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          225 --------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       225 --------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                              .+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+...               
T Consensus       190 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~---------------  253 (350)
T 1rdq_E          190 RVKGRTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG---------------  253 (350)
T ss_dssp             ECSSCBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------------
T ss_pred             eccCCcccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC---------------
Confidence                    3579999999999654 5899999999999999999999999988877766666542               


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCcccCCC
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  354 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~e~l~hp~f~~~~~  354 (403)
                        ...            ++..+++++.+||.+||+.||.+||+     ++++++||||+.+..
T Consensus       254 --~~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w  302 (350)
T 1rdq_E          254 --KVR------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             --CCC------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             --CCC------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence              111            22467999999999999999999998     999999999998653

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=352.00  Aligned_cols=235  Identities=27%  Similarity=0.423  Sum_probs=187.6

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------------------------------ccHHHHHHHHH
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------------------------RYKNRELQIMQ  130 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------------------------~~~~~E~~~l~  130 (403)
                      ..+|.+.+.||+|+||.||+|++..+++.||||++....                              ....+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            456999999999999999999999999999999985432                              23467999999


Q ss_pred             hcCCCCccccceEEeecCCCCceEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccc
Q 015672          131 MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD  209 (403)
Q Consensus       131 ~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrD  209 (403)
                      .++||||+++++++..   ....++++||||+++ ++..+     .....+++..++.++.||+.||.|||+ .||+|||
T Consensus        92 ~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~D  162 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEV-----PTLKPLSEDQARFYFQDLIKGIEYLHY-QKIIHRD  162 (298)
T ss_dssp             TCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCS-----SCSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCC
T ss_pred             hCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHH-----hhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccC
Confidence            9999999999998743   234568999999984 44322     123568999999999999999999999 8999999


Q ss_pred             cccccceecCCCCcee-------------------eccccccchhhhhCCCC--CCchhHHHHHHHHHHHHHhCCCCCCC
Q 015672          210 IKPQNLLVKGEPNVSY-------------------ICSRYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPG  268 (403)
Q Consensus       210 lKp~NILl~~~~~~~~-------------------~~t~~y~aPE~~~~~~~--~~~~~DiwSlGvil~el~tg~~pf~~  268 (403)
                      |||+|||++.++.+++                   .||+.|+|||++.+...  ++.++|||||||++|+|++|+.||.+
T Consensus       163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            9999999987665432                   46889999999865432  47899999999999999999999988


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 015672          269 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  348 (403)
Q Consensus       269 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~  348 (403)
                      .+.......+...                 ...++          ....+++++.+||.+||+.||++|||+.|+++|||
T Consensus       243 ~~~~~~~~~~~~~-----------------~~~~~----------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~  295 (298)
T 2zv2_A          243 ERIMCLHSKIKSQ-----------------ALEFP----------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW  295 (298)
T ss_dssp             SSHHHHHHHHHHC-----------------CCCCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred             ccHHHHHHHHhcc-----------------cCCCC----------CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence            7655444433321                 00111          01457899999999999999999999999999999


Q ss_pred             ccc
Q 015672          349 FDE  351 (403)
Q Consensus       349 f~~  351 (403)
                      |++
T Consensus       296 ~~~  298 (298)
T 2zv2_A          296 VTR  298 (298)
T ss_dssp             HHC
T ss_pred             ccC
Confidence            963

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1e-44  Score=343.67  Aligned_cols=272  Identities=30%  Similarity=0.552  Sum_probs=215.9

Q ss_pred             cccccEeeeceecccCceEEEEEEEC-CCCcEEEEEEcccc------cccHHHHHHHHHhc---CCCCccccceEEeecC
Q 015672           79 KQKVSYIAEHVVGTGSFGVVFQAKCR-ETGEIVAIKKVLQD------KRYKNRELQIMQML---DHPNIVALKHCFFSTT  148 (403)
Q Consensus        79 ~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~------~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~  148 (403)
                      +...+|.+.+.||+|+||.||+|++. .+++.||+|++...      .....+|+.+++.+   +||||+++++++....
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            34456999999999999999999995 67889999988532      22455788888777   8999999999886444


Q ss_pred             CCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---
Q 015672          149 DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---  225 (403)
Q Consensus       149 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---  225 (403)
                      ......+++||||++++|..++....  ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++   
T Consensus        88 ~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~-~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           88 TDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCCCceEEEEEecCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHHHeEEcCCCCEEEecC
Confidence            44567799999999999887776532  2458999999999999999999999 89999999999999987765533   


Q ss_pred             ---------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          226 ---------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       226 ---------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                     .+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....+
T Consensus       165 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (326)
T 1blx_A          165 GLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  243 (326)
T ss_dssp             CSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             cccccccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence                           357889999999654 5899999999999999999999999999988999999988888776654


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCC
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  356 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~  356 (403)
                      ...... ....+......+ ...+...+++++.+||.+||..||++|||+.++++||||+++....
T Consensus       244 ~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~  307 (326)
T 1blx_A          244 PRDVAL-PRQAFHSKSAQP-IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  307 (326)
T ss_dssp             CTTCSS-CGGGSCCCCCCC-GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             cccccc-chhhhcccCcch-hhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence            321110 001111111111 1223356899999999999999999999999999999999876443

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.7e-45  Score=350.86  Aligned_cols=234  Identities=26%  Similarity=0.481  Sum_probs=190.7

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhc-CCCCccccceEEeecCCCCc
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  152 (403)
                      ..+|.+.+.||+|+||.||+|+++.+++.||||++.+..       ....+|+.+++.+ +||||+++++++.     ..
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----~~   82 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TE   82 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE-----eC
Confidence            456999999999999999999999999999999986432       1235789999888 8999999999883     33


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-------
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-------  224 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-------  224 (403)
                      ..+|+||||++ ++|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++       
T Consensus        83 ~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g~~kL~DFG~a  157 (345)
T 3a8x_A           83 SRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMC  157 (345)
T ss_dssp             SEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCGGGC
T ss_pred             CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECCCCCEEEEecccc
Confidence            45899999997 577666553    3579999999999999999999999 8999999999999998766543       


Q ss_pred             ------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc--------HH-HHHHHHHHhC
Q 015672          225 ------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG--------VD-QLVEIIKVLG  283 (403)
Q Consensus       225 ------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~--------~~-~~~~i~~~~~  283 (403)
                                  .+||+.|+|||++.+. .++.++|||||||++|||++|++||.....        .. ....+...  
T Consensus       158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~--  234 (345)
T 3a8x_A          158 KEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--  234 (345)
T ss_dssp             BCSCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC--
T ss_pred             ccccCCCCcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC--
Confidence                        3578999999999654 589999999999999999999999975321        11 11222110  


Q ss_pred             CCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCCCcccCCC
Q 015672          284 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHPFFDELRD  354 (403)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta------~e~l~hp~f~~~~~  354 (403)
                                     ...            ++..+++++.+||.+||+.||.+||++      +++++||||+.+.+
T Consensus       235 ---------------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w  284 (345)
T 3a8x_A          235 ---------------QIR------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  284 (345)
T ss_dssp             ---------------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred             ---------------CCC------------CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence                           011            234689999999999999999999995      89999999998753

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.6e-45  Score=352.05  Aligned_cols=269  Identities=33%  Similarity=0.621  Sum_probs=214.9

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCC-CceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK-EELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~~  154 (403)
                      .+|.+.+.||+|+||.||+|++..+|+.||||++....      ....+|+.+++.++||||+++++++...... ....
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            46999999999999999999999999999999985432      2234799999999999999999988543211 1123


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      +++||||+.+++..++      ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+++         
T Consensus       104 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  176 (353)
T 3coi_A          104 FYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNEDCELKILDFGLARHA  176 (353)
T ss_dssp             CEEEEECCSEEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred             EEEEeccccCCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence            5899999998764432      3468999999999999999999999 89999999999999988766543         


Q ss_pred             -------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 015672          226 -------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  298 (403)
Q Consensus       226 -------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  298 (403)
                             .+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.++.+.+........
T Consensus       177 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  256 (353)
T 3coi_A          177 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA  256 (353)
T ss_dssp             -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHH
T ss_pred             CCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHH
Confidence                   4688999999997656689999999999999999999999999998899999999999888776544332110


Q ss_pred             c---cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCCC
Q 015672          299 E---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  358 (403)
Q Consensus       299 ~---~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~~  358 (403)
                      .   ..++......+.. ....+++++.+||.+||+.||++|||+.++++||||+....+...
T Consensus       257 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~  318 (353)
T 3coi_A          257 KSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEE  318 (353)
T ss_dssp             HHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGC
T ss_pred             HHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCcccc
Confidence            0   0111111111211 224679999999999999999999999999999999988766543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.1e-45  Score=350.50  Aligned_cols=238  Identities=27%  Similarity=0.340  Sum_probs=190.9

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-----cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      ..+|++.+.||+|+||+||+|++..+++.||||++...     .....+|+.+++.++||||+++++++.     .....
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~   80 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ   80 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCCeE
Confidence            34699999999999999999999999999999998533     234568999999999999999999873     34458


Q ss_pred             EEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce----------
Q 015672          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS----------  224 (403)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~----------  224 (403)
                      ++|||||++ +|.+++    .....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.++          
T Consensus        81 ~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  155 (323)
T 3tki_A           81 YLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVF  155 (323)
T ss_dssp             EEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccccchHHEEEeCCCCEEEEEeecccee
Confidence            899999975 554333    224568999999999999999999999 8999999999999998765543          


Q ss_pred             -----------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015672          225 -----------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       225 -----------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  293 (403)
                                 ..||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..............         
T Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------  226 (323)
T 3tki_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---------  226 (323)
T ss_dssp             EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT---------
T ss_pred             ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc---------
Confidence                       246889999999977665688999999999999999999999876543222221111000         


Q ss_pred             CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCC
Q 015672          294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  354 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  354 (403)
                                  ...+     ...+++++.+||.+||+.||++|||+.|+++||||++...
T Consensus       227 ------------~~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          227 ------------YLNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             ------------TSTT-----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             ------------cCCc-----cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence                        0001     1357899999999999999999999999999999987543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.2e-45  Score=354.20  Aligned_cols=234  Identities=25%  Similarity=0.401  Sum_probs=196.6

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhc-CCCCccccceEEeecCCCCc
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  152 (403)
                      ..+|.+.+.||+|+||+||+|+++.+++.||||++.+..       ....+|..++..+ +||||+++++++.     ..
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----~~   93 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----TM   93 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE-----CS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE-----cC
Confidence            346999999999999999999999999999999986431       2235788899887 8999999999883     33


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-------
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-------  224 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-------  224 (403)
                      .++|+||||++ ++|..++..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++       
T Consensus        94 ~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g~vkL~DFG~a  168 (353)
T 2i0e_A           94 DRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDSEGHIKIADFGMC  168 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence            46899999997 577766654    3579999999999999999999999 8999999999999998766543       


Q ss_pred             ------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          225 ------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       225 ------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                                  .+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..+...           
T Consensus       169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-----------  236 (353)
T 2i0e_A          169 KENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-----------  236 (353)
T ss_dssp             BCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred             cccccCCcccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-----------
Confidence                        3478999999999654 5899999999999999999999999988877776666542           


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCCC
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  354 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~~  354 (403)
                            ...            ++..+++++.+||.+||+.||.+||     +++++++||||+.+.+
T Consensus       237 ------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w  285 (353)
T 2i0e_A          237 ------NVA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  285 (353)
T ss_dssp             ------CCC------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred             ------CCC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCH
Confidence                  111            2246899999999999999999999     4799999999998754

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=9.6e-46  Score=359.89  Aligned_cols=265  Identities=27%  Similarity=0.398  Sum_probs=204.6

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcC--------CCCccccceEEeecCCC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD--------HPNIVALKHCFFSTTDK  150 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~--------h~niv~~~~~~~~~~~~  150 (403)
                      .+|.+.+.||+|+||+||+|++..+++.||||++....   ....+|+.+++.++        |+||+++++++.... .
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~-~  115 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG-V  115 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-T
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-C
Confidence            46999999999999999999999999999999986543   23457999999985        788999999875322 3


Q ss_pred             CceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-CccccccccccceecCCC--------
Q 015672          151 EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVKGEP--------  221 (403)
Q Consensus       151 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~-~ivHrDlKp~NILl~~~~--------  221 (403)
                      +..++|+||||+++++...+...  ....+++..++.++.||+.||.|||+ + ||+||||||+|||++.++        
T Consensus       116 ~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~givHrDikp~NIll~~~~~~~~~~~~  192 (397)
T 1wak_A          116 NGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLAA  192 (397)
T ss_dssp             TEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred             CCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHeeEeccchhhhhhhh
Confidence            45679999999998886665432  12568999999999999999999998 8 999999999999998653        


Q ss_pred             -----------------------------------------Cce----------------eeccccccchhhhhCCCCCC
Q 015672          222 -----------------------------------------NVS----------------YICSRYYRAPELIFGATEYT  244 (403)
Q Consensus       222 -----------------------------------------~~~----------------~~~t~~y~aPE~~~~~~~~~  244 (403)
                                                               .++                .+||+.|+|||++.+. .++
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~  271 (397)
T 1wak_A          193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGS-GYN  271 (397)
T ss_dssp             HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTS-CCC
T ss_pred             hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCC-CCC
Confidence                                                     222                2468999999999765 489


Q ss_pred             chhHHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHHHHHhCCCCHHHHhhcCcCcccc-------CCCCCCCCCcc
Q 015672          245 TAIDIWSTGCVMAELLLGQPLFPGES------GVDQLVEIIKVLGTPTREEIKCMNPNYTEF-------KFPQIKPHPWH  311 (403)
Q Consensus       245 ~~~DiwSlGvil~el~tg~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~  311 (403)
                      .++|||||||++|+|++|+.||.+.+      ..+.+..+.+.++.++...+.........+       .+....+....
T Consensus       272 ~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (397)
T 1wak_A          272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLF  351 (397)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHH
T ss_pred             cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchh
Confidence            99999999999999999999997655      456777888888888876653221110000       11111111110


Q ss_pred             cc------cccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          312 KV------FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       312 ~~------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                      ..      .+...++++.+||.+||+.||++|||+.|+|+||||++
T Consensus       352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          352 EVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             HHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             HhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            00      11233567899999999999999999999999999974

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.8e-46  Score=356.31  Aligned_cols=237  Identities=25%  Similarity=0.412  Sum_probs=191.9

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccccHHHHHHHHHhc-CCCCccccceEEeecCCCCceEEEEE
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      ...+|++.+.||+|+||+||+|+++.+++.||||++.+......+|++++.++ +||||+++++++     .+..++|+|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv   94 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVV   94 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEEEEE
Confidence            34569999999999999999999999999999999987766677899999888 799999999988     334568999


Q ss_pred             eeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCC-CC---c----------
Q 015672          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE-PN---V----------  223 (403)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~-~~---~----------  223 (403)
                      ||||. ++|.+.+..    ...+++..+..++.||+.||.|||+ +||+||||||+|||+... +.   +          
T Consensus        95 ~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~-~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           95 TELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             ECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            99997 477665543    3568999999999999999999999 899999999999998432 11   2          


Q ss_pred             ---------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC---CcHHHHHHHHHHhCCCCHHHHh
Q 015672          224 ---------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE---SGVDQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       224 ---------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~  291 (403)
                               ..+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+.   +..+.+..+...          
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~----------  238 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG----------  238 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC----------
T ss_pred             CcCCCCceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC----------
Confidence                     23468899999998654 4889999999999999999999999763   222333333221          


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                             .+.++.        ..+..+++++.+||.+||+.||++|||+.++++||||.+.
T Consensus       239 -------~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          239 -------KFSLSG--------GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             -------CCCCCS--------TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             -------CcccCc--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence                   111110        0124689999999999999999999999999999999764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.4e-45  Score=355.11  Aligned_cols=239  Identities=26%  Similarity=0.444  Sum_probs=187.1

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      ..+|.+.+.||+|+||+||+|++..+++.||||++....   ....+|+.+++.++||||+++++++..     ...+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~~l   93 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT-----PTHLAI   93 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEee-----CCEEEE
Confidence            446999999999999999999999999999999986532   345689999999999999999999843     345889


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC--ce----------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN--VS----------  224 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~--~~----------  224 (403)
                      ||||+. ++|..++..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.  ++          
T Consensus        94 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~-~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           94 IMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             EEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            999996 577666543    3579999999999999999999999 89999999999999976543  32          


Q ss_pred             --------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          225 --------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       225 --------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                              .+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+...+..            
T Consensus       169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~------------  236 (361)
T 3uc3_A          169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS------------  236 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT------------
T ss_pred             cccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc------------
Confidence                    347899999999977654455599999999999999999999875543222222221100            


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                       ..+.++.          ...+++++.+||.+||+.||++|||+.|+++||||.+.
T Consensus       237 -~~~~~~~----------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          237 -VKYSIPD----------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             -TCCCCCT----------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             -CCCCCCC----------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence             0011110          13578999999999999999999999999999999764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=357.15  Aligned_cols=236  Identities=27%  Similarity=0.418  Sum_probs=192.0

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..+|.+.+.||+|+||.||+|++..+++.||+|++.+..       ....+|+++|+.++||||++++++|.     ...
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~   88 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ-----DEE   88 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCC
Confidence            356999999999999999999999999999999985422       23457999999999999999999883     334


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------  224 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------  224 (403)
                      .+|+||||+. ++|..++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.++        
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g~vkL~DFG~a~  163 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQN-QRIIHRDMKPDNILLDEHGHVHITDFNIAA  163 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEECCCCCEEEeccceee
Confidence            5899999997 577665543    4579999999999999999999999 8999999999999998776553        


Q ss_pred             ----------eeccccccchhhhhC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCCHHHH
Q 015672          225 ----------YICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV--DQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       225 ----------~~~t~~y~aPE~~~~--~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~--~~~~~i~~~~~~~~~~~~  290 (403)
                                .+||+.|+|||++.+  ...|+.++|||||||++|+|++|..||...+..  ..+.......        
T Consensus       164 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~--------  235 (384)
T 4fr4_A          164 MLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT--------  235 (384)
T ss_dssp             ECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC--------
T ss_pred             eccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc--------
Confidence                      357899999999854  234899999999999999999999999754322  2222211110        


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCCCcccCCC
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-ALEACVHPFFDELRD  354 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-a~e~l~hp~f~~~~~  354 (403)
                              ...            ++..+++++.+||.+||+.||.+||+ ++++++||||+++.+
T Consensus       236 --------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w  280 (384)
T 4fr4_A          236 --------VVT------------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW  280 (384)
T ss_dssp             --------CCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred             --------ccC------------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence                    000            22467899999999999999999998 899999999998764

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.9e-45  Score=340.49  Aligned_cols=238  Identities=28%  Similarity=0.414  Sum_probs=193.7

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ....|.+.+.||+|+||.||+|++..+++.||+|++....     ....+|+++++.++||||+++++++.     ....
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~   94 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DYHN   94 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-----cCCe
Confidence            3456999999999999999999999999999999986433     33468999999999999999999883     3345


Q ss_pred             EEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCC---CCc-------
Q 015672          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE---PNV-------  223 (403)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~---~~~-------  223 (403)
                      +++||||+++ +|...+.........+++..+..++.||+.||.|||+ .||+||||||+|||++..   +.+       
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~  173 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHSPIKIIDFGL  173 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence            8899999984 7877776555455779999999999999999999999 899999999999999532   222       


Q ss_pred             -----------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          224 -----------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       224 -----------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                                 ...+|+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+..+....+....  +       
T Consensus       174 a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--~-------  242 (285)
T 3is5_A          174 AELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE--P-------  242 (285)
T ss_dssp             CCC----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C-------
T ss_pred             ceecCCcccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC--c-------
Confidence                       2346889999999843  48999999999999999999999998877655444333210  0       


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                              .+.         .....+++++.+||.+||+.||++|||+.|+|+||||++
T Consensus       243 --------~~~---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          243 --------NYA---------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             --------CCC---------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             --------ccc---------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence                    000         011347899999999999999999999999999999986

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5.5e-45  Score=338.76  Aligned_cols=241  Identities=28%  Similarity=0.385  Sum_probs=197.2

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|++....      ....+|+.+++.++||||+++++++.     ....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   79 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF   79 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE-----cCCE
Confidence            456999999999999999999999999999999985433      22357999999999999999999883     3445


Q ss_pred             EEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC---ce------
Q 015672          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN---VS------  224 (403)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~---~~------  224 (403)
                      .++||||+.+ ++...+..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.   ++      
T Consensus        80 ~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~  154 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGL  154 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence            8899999974 66555443    3568999999999999999999999 89999999999999975543   22      


Q ss_pred             ------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          225 ------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       225 ------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                                  ..||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+.......       
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------  226 (284)
T 3kk8_A          155 AIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY-------  226 (284)
T ss_dssp             CEECCSSCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-------
T ss_pred             eEEcccCccccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccC-------
Confidence                        3468899999998654 58999999999999999999999999887776666554421111       


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCC
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  357 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~  357 (403)
                                +.        .....+++++.+||.+||+.||++|||+.|+++||||++......
T Consensus       227 ----------~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~  273 (284)
T 3kk8_A          227 ----------PS--------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVAS  273 (284)
T ss_dssp             ----------CT--------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGG
T ss_pred             ----------Cc--------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHh
Confidence                      10        011357899999999999999999999999999999988655443

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.9e-45  Score=347.31  Aligned_cols=234  Identities=29%  Similarity=0.438  Sum_probs=193.3

Q ss_pred             cccEeeeceecccCceEEEEEEEC---CCCcEEEEEEccccc--------ccHHHHHHHHHhcCCCCccccceEEeecCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVALKHCFFSTTD  149 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  149 (403)
                      ..+|.+.+.||+|+||.||+|++.   .+++.||+|++.+..        ....+|+.+++.++||||+++++++..   
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---   92 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT---   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC---
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc---
Confidence            346999999999999999999985   689999999986431        223579999999999999999998843   


Q ss_pred             CCceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---
Q 015672          150 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---  225 (403)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---  225 (403)
                        ..++|+||||++ ++|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+++   
T Consensus        93 --~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~~~kl~Df  165 (327)
T 3a62_A           93 --GGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQ-KGIIYRDLKPENIMLNHQGHVKLTDF  165 (327)
T ss_dssp             --SSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECTTSCEEECCC
T ss_pred             --CCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEEcccCCHHHeEECCCCcEEEEeC
Confidence              334889999997 577666543    3568899999999999999999999 89999999999999987765432   


Q ss_pred             ----------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          226 ----------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       226 ----------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                      +||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....       
T Consensus       166 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-------  237 (327)
T 3a62_A          166 GLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-------  237 (327)
T ss_dssp             SCC----------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-------
T ss_pred             CcccccccCCccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-------
Confidence                            468899999998654 58999999999999999999999999888777666665421       


Q ss_pred             HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCCC
Q 015672          290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  354 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~~  354 (403)
                                ..            ++..+++++.+||.+||+.||++||     ++.++++||||+.+..
T Consensus       238 ----------~~------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~  285 (327)
T 3a62_A          238 ----------LN------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW  285 (327)
T ss_dssp             ----------CC------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred             ----------CC------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence                      11            1245789999999999999999999     8999999999998753

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=356.36  Aligned_cols=235  Identities=25%  Similarity=0.378  Sum_probs=187.2

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEcccc----cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      |...+.||+|+||.||+|++..+++.||+|++...    .....+|+++++.++||||+++++++..     ...+++||
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~lv~  165 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES-----KNDIVLVM  165 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEEEEEE
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEEEEE
Confidence            44477899999999999999999999999998653    2344689999999999999999998843     34588999


Q ss_pred             eccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceec--CCCCce------------
Q 015672          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVK--GEPNVS------------  224 (403)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~--~~~~~~------------  224 (403)
                      ||++ ++|.+.+...   ...+++..+..++.||+.||.|||+ .||+||||||+|||+.  ..+.++            
T Consensus       166 E~~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~  241 (373)
T 2x4f_A          166 EYVDGGELFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP  241 (373)
T ss_dssp             ECCTTCEEHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred             eCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence            9997 4665555432   3458899999999999999999999 8999999999999994  332222            


Q ss_pred             ------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 015672          225 ------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  298 (403)
Q Consensus       225 ------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  298 (403)
                            .+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.......+.           
T Consensus       242 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~-----------  309 (373)
T 2x4f_A          242 REKLKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED-----------  309 (373)
T ss_dssp             TCBCCCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS-----------
T ss_pred             ccccccccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh-----------
Confidence                  2478999999998644 5899999999999999999999999998888777777653211110           


Q ss_pred             ccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                                    .....+++++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus       310 --------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          310 --------------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             --------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             --------------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence                          01245789999999999999999999999999999998763

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1e-44  Score=343.35  Aligned_cols=238  Identities=22%  Similarity=0.335  Sum_probs=197.6

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----------ccHHHHHHHHHhcCCCCccccceEEeecCC
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLDHPNIVALKHCFFSTTD  149 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  149 (403)
                      ....|.+.+.||+|+||.||+|++..+++.||+|++....          ....+|+.+++.++||||+++++++.    
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----   85 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE----   85 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe----
Confidence            3456999999999999999999999999999999985422          23568999999999999999999883    


Q ss_pred             CCceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC----Cce
Q 015672          150 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP----NVS  224 (403)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~----~~~  224 (403)
                       ....+++||||++ ++|.+++..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++    .++
T Consensus        86 -~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivH~dikp~NIl~~~~~~~~~~~k  159 (321)
T 2a2a_A           86 -NRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIK  159 (321)
T ss_dssp             -CSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             -cCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChHHEEEecCCCCcCCEE
Confidence             3345889999996 588776653    4568999999999999999999999 8999999999999998765    232


Q ss_pred             ------------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015672          225 ------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  286 (403)
Q Consensus       225 ------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~  286 (403)
                                        ..||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.......+
T Consensus       160 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  238 (321)
T 2a2a_A          160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD  238 (321)
T ss_dssp             ECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred             EccCccceecCccccccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC
Confidence                              2468899999998654 589999999999999999999999998887776665544221111


Q ss_pred             HHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          287 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                      .                         .+...+++.+.+||.+||+.||++|||+.|+++||||+.+.
T Consensus       239 ~-------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          239 E-------------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             H-------------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             h-------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence            1                         12246789999999999999999999999999999998764

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.4e-45  Score=353.45  Aligned_cols=235  Identities=24%  Similarity=0.416  Sum_probs=191.8

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc-------cHHHHHHH-HHhcCCCCccccceEEeecCCCC
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQI-MQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      ...+|++.+.||+|+||+||+|+++.+++.||||++.+...       ...+|..+ ++.++||||+++++++.     .
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~-----~  110 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----T  110 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE-----C
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----e
Confidence            34569999999999999999999999999999999864321       12245554 56789999999999883     3


Q ss_pred             ceEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce------
Q 015672          152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS------  224 (403)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~------  224 (403)
                      ..++|+||||+++ +|..++..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++      
T Consensus       111 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g~ikL~DFG~  185 (373)
T 2r5t_A          111 ADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQGHIVLTDFGL  185 (373)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCCB
T ss_pred             CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECCCCCEEEeeCcc
Confidence            3468999999984 77666554    3578999999999999999999999 8999999999999998776543      


Q ss_pred             -------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015672          225 -------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       225 -------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  291 (403)
                                   .+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+.+..+...          
T Consensus       186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----------  254 (373)
T 2r5t_A          186 CKENIEHNSTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK----------  254 (373)
T ss_dssp             CGGGBCCCCCCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS----------
T ss_pred             ccccccCCCccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc----------
Confidence                         3578999999999654 5899999999999999999999999988877776666542          


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCCCcccCCC
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA----LEACVHPFFDELRD  354 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta----~e~l~hp~f~~~~~  354 (403)
                             ...            ++..+++++.+||.+||+.||.+||++    .++++||||+.+.+
T Consensus       255 -------~~~------------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w  302 (373)
T 2r5t_A          255 -------PLQ------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINW  302 (373)
T ss_dssp             -------CCC------------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred             -------ccC------------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCH
Confidence                   011            224688999999999999999999986    69999999998754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-45  Score=354.77  Aligned_cols=238  Identities=26%  Similarity=0.405  Sum_probs=195.2

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc----cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ...|.+.+.||+|+||.||+|.++.+++.||+|++...    .....+|+.+|+.++||||+++++++.     +...++
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~  124 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMV  124 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCEEE
Confidence            34699999999999999999999999999999998643    223467999999999999999999883     344589


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCC--CCce---------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE--PNVS---------  224 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~--~~~~---------  224 (403)
                      +||||+. ++|.+.+..   ....+++..+..++.||+.||.|||+ .||+||||||+|||++.+  +.++         
T Consensus       125 lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          125 LILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATK  200 (387)
T ss_dssp             EEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccchHHeEEecCCCCceEEEeccccee
Confidence            9999997 466554432   23468999999999999999999999 899999999999999743  2232         


Q ss_pred             ---------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          225 ---------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       225 ---------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                               ..||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.....            
T Consensus       201 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~------------  267 (387)
T 1kob_A          201 LNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW------------  267 (387)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC------------
T ss_pred             cCCCcceeeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------
Confidence                     2478999999998654 589999999999999999999999998887776666554211            


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                           .++.        .....+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus       268 -----~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          268 -----EFDE--------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             -----CCCS--------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             -----CCCc--------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence                 1100        01145799999999999999999999999999999998754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=5e-45  Score=339.90  Aligned_cols=240  Identities=24%  Similarity=0.347  Sum_probs=191.1

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccccc------HHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY------KNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++......      ..++...++.++||||+++++++....     .
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~-----~   80 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG-----D   80 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----S
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC-----C
Confidence            35699999999999999999999999999999998643221      123444577889999999999885332     3


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-CccccccccccceecCCCCcee--------
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVKGEPNVSY--------  225 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~-~ivHrDlKp~NILl~~~~~~~~--------  225 (403)
                      .++||||+++++..++.........+++..++.++.||+.||.|||+ + ||+||||||+|||++.++.+++        
T Consensus        81 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           81 VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISGY  159 (290)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred             EEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence            88999999999888777665556789999999999999999999998 7 9999999999999987765533        


Q ss_pred             ----------eccccccchhhh---hCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHHh
Q 015672          226 ----------ICSRYYRAPELI---FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       226 ----------~~t~~y~aPE~~---~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~  291 (403)
                                .||+.|+|||++   .....++.++|||||||++|+|++|..||...... ..+....... .+      
T Consensus       160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~------  232 (290)
T 3fme_A          160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-SP------  232 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC-CC------
T ss_pred             ccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC-CC------
Confidence                      468899999997   24455899999999999999999999999864433 3333332210 00      


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                                  .        .....+++++.+||.+||+.||++|||+.|+++||||+...
T Consensus       233 ------------~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          233 ------------Q--------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             ------------C--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             ------------C--------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence                        0        01135789999999999999999999999999999998643

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.5e-45  Score=345.46  Aligned_cols=268  Identities=29%  Similarity=0.507  Sum_probs=203.3

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecC--------
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTT--------  148 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------  148 (403)
                      ..+|.+.+.||+|+||.||+|++..+++.||||++....    ....+|+.+++.++||||+++++++....        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            345999999999999999999999999999999885432    23457999999999999999998873221        


Q ss_pred             -CCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCC-CCcee-
Q 015672          149 -DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE-PNVSY-  225 (403)
Q Consensus       149 -~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~-~~~~~-  225 (403)
                       ......+++||||++++|.+++.     ...+++..++.++.||+.||.|||+ .||+||||||+|||++.+ +.+++ 
T Consensus        90 ~~~~~~~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYMETDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccCCCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCeEEEc
Confidence             12345688999999998877654     2568999999999999999999999 899999999999999743 23221 


Q ss_pred             ---------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 015672          226 ---------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  284 (403)
Q Consensus       226 ---------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~  284 (403)
                                           .+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  243 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV  243 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence                                 24778999999876567899999999999999999999999999888888888877666


Q ss_pred             CCHHHHhhcCcCcccc---CCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCC
Q 015672          285 PTREEIKCMNPNYTEF---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  356 (403)
Q Consensus       285 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~  356 (403)
                      +..............+   .. .....++ ......+++++.+||.+||+.||++|||+.|+++||||+....|.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~  316 (320)
T 2i6l_A          244 VHEEDRQELLSVIPVYIRNDM-TEPHKPL-TQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM  316 (320)
T ss_dssp             CCHHHHHHHHTTSCHHHHHHT-TSCCCCH-HHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred             CchhhhhhhhhcCcccccccc-cCCCCCh-hHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence            6554433211100000   00 0001111 112356899999999999999999999999999999999876554

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5e-45  Score=349.49  Aligned_cols=235  Identities=25%  Similarity=0.381  Sum_probs=196.0

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ..|.+.+.||+|+||+||+|++..+++.||||++....       ....+|+++++.++||||+++++++...     ..
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~  128 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT  128 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----Ce
Confidence            45999999999999999999999999999999985432       2245799999999999999999988543     35


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce----------
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS----------  224 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~----------  224 (403)
                      .++||||+.+++.+++...   ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++          
T Consensus       129 ~~lv~e~~~g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  204 (348)
T 1u5q_A          129 AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM  204 (348)
T ss_dssp             EEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred             EEEEEecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence            8899999999887766432   3678999999999999999999999 8999999999999998766543          


Q ss_pred             -----eeccccccchhhhhC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          225 -----YICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       225 -----~~~t~~y~aPE~~~~--~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                           ..||+.|+|||++.+  ...++.++|||||||++|||++|++||.+.+....+..+.....              
T Consensus       205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~--------------  270 (348)
T 1u5q_A          205 APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--------------  270 (348)
T ss_dssp             SSBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--------------
T ss_pred             CCCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--------------
Confidence                 357899999999853  34589999999999999999999999988877666655543210              


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                           +.        .....+++.+.+||.+||+.||++|||++++++||||...
T Consensus       271 -----~~--------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          271 -----PA--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             -----CC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             -----CC--------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence                 00        0124578999999999999999999999999999999764

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4.8e-45  Score=365.05  Aligned_cols=238  Identities=28%  Similarity=0.454  Sum_probs=196.9

Q ss_pred             cccccEeeeceecccCceEEEEEEECCCCcEEEEEEccc------ccccHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ------DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        79 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      ....+|.+.+.||+|+||+||+|+++.+++.||||++..      ......+|+++++.++||||+++++++.     ..
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~   93 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DS   93 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-----cC
Confidence            345679999999999999999999999999999999843      2233568999999999999999999883     34


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC---Cc-----
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP---NV-----  223 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~---~~-----  223 (403)
                      ..+++|||||. ++|...+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++..+   .+     
T Consensus        94 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  168 (486)
T 3mwu_A           94 SSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDF  168 (486)
T ss_dssp             SEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEESSSSTTCCEEECSC
T ss_pred             CEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEEEC
Confidence            45899999997 467655543    3578999999999999999999999 8999999999999995432   22     


Q ss_pred             -------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          224 -------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       224 -------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                   ..+||+.|+|||++.+  .|+.++|||||||++|+|++|.+||.+.+..+.+..+.........   
T Consensus       169 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---  243 (486)
T 3mwu_A          169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL---  243 (486)
T ss_dssp             SCTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS---
T ss_pred             CcCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC---
Confidence                         2357999999999864  4899999999999999999999999998887777666542111110   


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                                  +          ....+++++++||.+||+.||.+|||+.++|+||||+...
T Consensus       244 ------------~----------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          244 ------------P----------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             ------------G----------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             ------------c----------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence                        0          1145789999999999999999999999999999998864

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=8.1e-45  Score=342.96  Aligned_cols=240  Identities=25%  Similarity=0.365  Sum_probs=187.4

Q ss_pred             cccccEeee-ceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhc-CCCCccccceEEeecCCCCc
Q 015672           79 KQKVSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        79 ~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  152 (403)
                      +....|.+. +.||+|+||.||+|++..+++.||||++....    ....+|++++.++ +||||+++++++..     .
T Consensus         9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-----~   83 (316)
T 2ac3_A            9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-----E   83 (316)
T ss_dssp             CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----T
T ss_pred             ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----C
Confidence            344569885 78999999999999999999999999986432    2345799999885 79999999998843     3


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC---ce----
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN---VS----  224 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~---~~----  224 (403)
                      ..+++||||++ ++|.+++..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.   ++    
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~~~kl~Df  158 (316)
T 2ac3_A           84 DRFYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEHPNQVSPVKICDF  158 (316)
T ss_dssp             TEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESCSSSSCSEEECCT
T ss_pred             CEEEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEEccCCCcCceEEEEc
Confidence            35899999997 677776654    3568999999999999999999999 89999999999999976543   21    


Q ss_pred             ----------------------eeccccccchhhhhCC----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcH------
Q 015672          225 ----------------------YICSRYYRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGV------  272 (403)
Q Consensus       225 ----------------------~~~t~~y~aPE~~~~~----~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~------  272 (403)
                                            .+||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||.+....      
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~  238 (316)
T 2ac3_A          159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR  238 (316)
T ss_dssp             TCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC--
T ss_pred             cCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc
Confidence                                  1378899999998541    24789999999999999999999999775421      


Q ss_pred             ---------HHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 015672          273 ---------DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA  343 (403)
Q Consensus       273 ---------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~  343 (403)
                               .....+....                 ..++        ......+++++.+||.+||+.||++|||+.|+
T Consensus       239 ~~~~~~~~~~~~~~i~~~~-----------------~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~  293 (316)
T 2ac3_A          239 GEACPACQNMLFESIQEGK-----------------YEFP--------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQV  293 (316)
T ss_dssp             --CCHHHHHHHHHHHHHCC-----------------CCCC--------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             cccchhHHHHHHHHHhccC-----------------cccC--------chhcccCCHHHHHHHHHHhhCChhhCCCHHHH
Confidence                     1122222110                 0010        00113578999999999999999999999999


Q ss_pred             hcCCCcccCC
Q 015672          344 CVHPFFDELR  353 (403)
Q Consensus       344 l~hp~f~~~~  353 (403)
                      ++||||++..
T Consensus       294 l~hp~~~~~~  303 (316)
T 2ac3_A          294 LQHPWVQGCA  303 (316)
T ss_dssp             HHSTTCC---
T ss_pred             hcChhhcCCC
Confidence            9999998764

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.4e-45  Score=364.69  Aligned_cols=233  Identities=28%  Similarity=0.401  Sum_probs=195.8

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ...|.+.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++..     ..
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-----~~   89 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST-----PS   89 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CC
Confidence            456999999999999999999999999999999985431       234689999999999999999998843     33


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------  224 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------  224 (403)
                      .+++||||++ ++|.+++.    ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.++        
T Consensus        90 ~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDLkp~NIll~~~~~vkL~DFG~a~  164 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLLDAHMNAKIADFGLSN  164 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcccccHHHEEEecCCCeEEEeccchh
Confidence            5899999996 57765543    24679999999999999999999999 8999999999999998776543        


Q ss_pred             ----------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          225 ----------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       225 ----------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                .+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..+....            
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------  232 (476)
T 2y94_A          165 MMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI------------  232 (476)
T ss_dssp             ECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC------------
T ss_pred             hccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC------------
Confidence                      3478999999999776555889999999999999999999999887776665554311            


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                           +.            .+..+++++.+||.+||+.||.+|||+.|+++||||++.
T Consensus       233 -----~~------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          233 -----FY------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             -----CC------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             -----cC------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence                 00            124578999999999999999999999999999999863

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.2e-45  Score=361.61  Aligned_cols=235  Identities=26%  Similarity=0.401  Sum_probs=191.9

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....       ....+|+.+++.++||||+++++++..     ..
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-----~~  221 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HD  221 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-----TT
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-----CC
Confidence            456999999999999999999999999999999985421       223468899999999999999998843     33


Q ss_pred             EEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------
Q 015672          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------  224 (403)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------  224 (403)
                      .+++||||+++ +|...+..    ...+++..++.++.||+.||+|||+..||+||||||+||||+.++.++        
T Consensus       222 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~  297 (446)
T 4ejn_A          222 RLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK  297 (446)
T ss_dssp             EEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred             EEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCce
Confidence            58999999984 77665543    357899999999999999999999525999999999999998766543        


Q ss_pred             -----------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015672          225 -----------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       225 -----------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  293 (403)
                                 .+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+...            
T Consensus       298 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------  364 (446)
T 4ejn_A          298 EGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------------  364 (446)
T ss_dssp             TTCC-----CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred             eccCCCcccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC------------
Confidence                       3478999999999654 5899999999999999999999999988876666555431            


Q ss_pred             CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCCC
Q 015672          294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  354 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~~  354 (403)
                           ...            ++..+++++.+||.+||+.||.+||     |+.|+++||||+.+..
T Consensus       365 -----~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~  413 (446)
T 4ejn_A          365 -----EIR------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW  413 (446)
T ss_dssp             -----CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             -----CCC------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence                 111            2245789999999999999999999     9999999999998754

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.2e-44  Score=363.88  Aligned_cols=237  Identities=29%  Similarity=0.439  Sum_probs=195.4

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----------------ccHHHHHHHHHhcCCCCccccce
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----------------RYKNRELQIMQMLDHPNIVALKH  142 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------~~~~~E~~~l~~l~h~niv~~~~  142 (403)
                      ....|.+.++||+|+||+||+|+++.+++.||||++....                 ....+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3456999999999999999999999999999999985432                 22457999999999999999999


Q ss_pred             EEeecCCCCceEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC
Q 015672          143 CFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP  221 (403)
Q Consensus       143 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~  221 (403)
                      ++.     +..++++|||||++ +|...+..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++
T Consensus       114 ~~~-----~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~  183 (504)
T 3q5i_A          114 VFE-----DKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHK-HNIVHRDIKPENILLENKN  183 (504)
T ss_dssp             EEE-----CSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESSTT
T ss_pred             EEE-----cCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCcHHHEEEecCC
Confidence            983     44568999999974 77665543    3579999999999999999999999 8999999999999998654


Q ss_pred             C---c------------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 015672          222 N---V------------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK  280 (403)
Q Consensus       222 ~---~------------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~  280 (403)
                      .   +                  ..+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+..
T Consensus       184 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  261 (504)
T 3q5i_A          184 SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK  261 (504)
T ss_dssp             CCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence            2   2                  2347899999999853  489999999999999999999999999888777776655


Q ss_pred             HhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          281 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                      .....+..                         ....+++++++||.+||++||.+|||+.|+|+||||++..
T Consensus       262 ~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          262 GKYYFDFN-------------------------DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             CCCCCCHH-------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             CCCCCCcc-------------------------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            32211111                         1146899999999999999999999999999999998754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.3e-44  Score=335.17  Aligned_cols=236  Identities=28%  Similarity=0.424  Sum_probs=195.7

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc----cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ...|.+.+.||+|+||.||+|++..++..||+|++...    .....+|+++++.++||||+++++++.     .....+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   82 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTDIY   82 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCeEE
Confidence            45699999999999999999999999999999998542    234568999999999999999999883     344588


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccccccee---cCCCCce--------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---KGEPNVS--------  224 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl---~~~~~~~--------  224 (403)
                      +||||++ ++|.+.+..    ...+++..+..++.||+.||.|||+ +||+||||||+|||+   +.++.++        
T Consensus        83 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~  157 (277)
T 3f3z_A           83 LVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA  157 (277)
T ss_dssp             EEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence            9999997 477665543    3568999999999999999999999 899999999999999   4444332        


Q ss_pred             ----------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          225 ----------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       225 ----------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                ..+|+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+....+.......+...     
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----  230 (277)
T 3f3z_A          158 RFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKD-----  230 (277)
T ss_dssp             ECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH-----
T ss_pred             eccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchh-----
Confidence                      346889999999854  389999999999999999999999998887777666655322222211     


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                                          ...+++++.+||.+||+.||++|||+.++|+||||++..
T Consensus       231 --------------------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          231 --------------------WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             --------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             --------------------hhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence                                135789999999999999999999999999999998753

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.2e-44  Score=343.89  Aligned_cols=264  Identities=30%  Similarity=0.524  Sum_probs=199.7

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-cccHHHHHHHHHhcC-CCCccccceEEeecCCCCceEEEE
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      ...+|++.+.||+|+||.||+|++..+++.||||++... .....+|+.+++.++ |+||+++++++..   ....+.++
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~~~l  110 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPAL  110 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCCEEE
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCceEE
Confidence            345699999999999999999999999999999998643 344568999999997 9999999998743   22345889


Q ss_pred             EeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC-Cce-----------
Q 015672          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP-NVS-----------  224 (403)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~-~~~-----------  224 (403)
                      ||||+.+ ++..++       ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .++           
T Consensus       111 v~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          111 VFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EEECCCCCCHHHHG-------GGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEeccCchhHHHHH-------HhCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            9999984 554433       248888999999999999999999 8999999999999998655 332           


Q ss_pred             -------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCC-CCCcHHHHHHHHHHhCCCCHHHH-hhcCc
Q 015672          225 -------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFP-GESGVDQLVEIIKVLGTPTREEI-KCMNP  295 (403)
Q Consensus       225 -------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~-~~~~~~~~~~i~~~~~~~~~~~~-~~~~~  295 (403)
                             ..+|+.|+|||++.+...++.++|||||||++|+|++|..||. +.+..+.+..+...++.+..... .....
T Consensus       183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  262 (330)
T 3nsz_A          183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  262 (330)
T ss_dssp             TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence                   2468889999999765679999999999999999999999985 44555666666666654332211 11100


Q ss_pred             Ccccc---CCCCCCCCCcccc----cccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCC
Q 015672          296 NYTEF---KFPQIKPHPWHKV----FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  354 (403)
Q Consensus       296 ~~~~~---~~~~~~~~~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  354 (403)
                      .....   .........|...    .+..+++++.+||.+||++||++|||++|+|+||||+++..
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence            00000   0000111112111    12347899999999999999999999999999999998753

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.8e-45  Score=365.64  Aligned_cols=236  Identities=33%  Similarity=0.508  Sum_probs=195.9

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-------cccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..+|.+.+.||+|+||.||+|+++.+++.||||++...       .....+|+.+++.++||||+++++++.     ...
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~   99 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE-----DKG   99 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCC
Confidence            45699999999999999999999999999999998532       223468999999999999999999883     344


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceec---CCCCce-----
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVK---GEPNVS-----  224 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~---~~~~~~-----  224 (403)
                      ++++|||||. ++|.+.+..    ...+++..+..++.||+.||.|||+ +||+||||||+|||++   .++.++     
T Consensus       100 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  174 (484)
T 3nyv_A          100 YFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHK-NKIVHRDLKPENLLLESKSKDANIRIIDFG  174 (484)
T ss_dssp             EEEEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred             EEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence            6899999997 566555443    4679999999999999999999999 8999999999999994   333332     


Q ss_pred             -------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015672          225 -------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       225 -------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  291 (403)
                                   .+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+.........    
T Consensus       175 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----  248 (484)
T 3nyv_A          175 LSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL----  248 (484)
T ss_dssp             HHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS----
T ss_pred             eeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC----
Confidence                         247899999999865  4899999999999999999999999998887777666542111110    


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                                 +          ....+++++++||.+||+.||.+|||+.|+|+||||+...
T Consensus       249 -----------~----------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          249 -----------P----------QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             -----------G----------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             -----------c----------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence                       0          1145789999999999999999999999999999998764

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=346.73  Aligned_cols=236  Identities=29%  Similarity=0.431  Sum_probs=186.1

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc--cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      ...|.+.+.||+|+||.||+|++..+++.||||++...  .....+|+++++.++||||+++++++..     ...+++|
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv  126 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFET-----PTEISLV  126 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEEC-----SSEEEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEec-----CCeEEEE
Confidence            34599999999999999999999999999999998653  2345679999999999999999998843     3458899


Q ss_pred             eeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecC---CCCce----------
Q 015672          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKG---EPNVS----------  224 (403)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~---~~~~~----------  224 (403)
                      |||++ ++|.+.+..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.   ++.++          
T Consensus       127 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          127 LELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             ECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             EEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            99997 577655432    4568999999999999999999999 89999999999999974   33332          


Q ss_pred             --------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHHHhCCCCHHHHhhcCc
Q 015672          225 --------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL-VEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       225 --------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~  295 (403)
                              ..||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....... ..+....             
T Consensus       202 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~-------------  267 (349)
T 2w4o_A          202 EHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE-------------  267 (349)
T ss_dssp             -----------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTC-------------
T ss_pred             CcccccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCC-------------
Confidence                    3478999999999654 5899999999999999999999999877665533 3332210             


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                          ..++    .+    ....++.++.+||.+||+.||++|||+.|+|+||||.+.
T Consensus       268 ----~~~~----~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  312 (349)
T 2w4o_A          268 ----YYFI----SP----WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK  312 (349)
T ss_dssp             ----CCCC----TT----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred             ----CccC----Cc----hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence                0000    00    124578999999999999999999999999999999874

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.5e-45  Score=346.59  Aligned_cols=235  Identities=24%  Similarity=0.423  Sum_probs=173.5

Q ss_pred             ccEeee---ceecccCceEEEEEEECCCCcEEEEEEccccc-ccHHHHHHHHHhcC-CCCccccceEEeecCCCCceEEE
Q 015672           82 VSYIAE---HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        82 ~~y~~~---~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      .+|.+.   +.||+|+||+||+|+++.+++.||||++.... ....+|+.+++.+. ||||+++++++.     +..+.|
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~-----~~~~~~   82 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFH-----DQLHTF   82 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEE-----cCCEEE
Confidence            457765   78999999999999999999999999986543 34568999999997 999999999883     344588


Q ss_pred             EEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC---Cc---------
Q 015672          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP---NV---------  223 (403)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~---~~---------  223 (403)
                      +||||+++ +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++   .+         
T Consensus        83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           83 LVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             EEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             EEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            99999974 77766654    4679999999999999999999999 8999999999999997543   22         


Q ss_pred             ----------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcH-------HHHHHHHHHhCCCC
Q 015672          224 ----------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-------DQLVEIIKVLGTPT  286 (403)
Q Consensus       224 ----------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~-------~~~~~i~~~~~~~~  286 (403)
                                ..++|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..       +.+..+...     
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~-----  231 (325)
T 3kn6_A          158 LKPPDNQPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG-----  231 (325)
T ss_dssp             ECCC----------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT-----
T ss_pred             ecCCCCCcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC-----
Confidence                      12358899999998654 5899999999999999999999999765432       122222110     


Q ss_pred             HHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          287 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                                  .+.        +.......+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus       232 ------------~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          232 ------------DFS--------FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             ------------CCC--------CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             ------------CCC--------CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence                        000        0001124579999999999999999999999999999999874

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.4e-45  Score=350.82  Aligned_cols=244  Identities=30%  Similarity=0.459  Sum_probs=193.8

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---------ccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      ..+|.+.+.||+|+||+||+|++..+++.||+|++....         ....+|+.+++.++||||+++++++.     +
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~   99 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE-----D   99 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc-----c
Confidence            456999999999999999999999999999999885321         23457999999999999999999883     3


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhhh------------------------------------cCCCCHHHHHHHHHHHHH
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSRI------------------------------------HQRMPLIYVKLYTYQICR  194 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~------------------------------------~~~l~~~~~~~~~~qi~~  194 (403)
                      ..+.++|||||+ ++|.+++..+...                                    ...+++..++.++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            445899999996 5776654311000                                    112356778889999999


Q ss_pred             HHHHHHhcCCccccccccccceecCCC--Cc-----------------------eeeccccccchhhhhCC-CCCCchhH
Q 015672          195 ALAYIHNCIGICHRDIKPQNLLVKGEP--NV-----------------------SYICSRYYRAPELIFGA-TEYTTAID  248 (403)
Q Consensus       195 ~L~~LH~~~~ivHrDlKp~NILl~~~~--~~-----------------------~~~~t~~y~aPE~~~~~-~~~~~~~D  248 (403)
                      ||.|||+ .||+||||||+|||++.++  .+                       ...||+.|+|||++.+. ..++.++|
T Consensus       180 ~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          180 ALHYLHN-QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHHH-TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHHH-CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            9999999 8999999999999997554  22                       22468889999998642 45899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHH
Q 015672          249 IWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCR  328 (403)
Q Consensus       249 iwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  328 (403)
                      ||||||++|+|++|+.||.+.+..+....+.........                         .....+++++.+||.+
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~  313 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN-------------------------PNYNVLSPLARDLLSN  313 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS-------------------------GGGGGSCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC-------------------------cccccCCHHHHHHHHH
Confidence            999999999999999999988877776666542111100                         0113478999999999


Q ss_pred             hcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          329 FFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       329 ~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                      ||+.||.+|||+.++|+||||++..+.
T Consensus       314 ~l~~~p~~Rps~~~~l~hp~~~~~~~~  340 (345)
T 3hko_A          314 LLNRNVDERFDAMRALQHPWISQFSDK  340 (345)
T ss_dssp             HSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred             HcCCChhHCCCHHHHhcChhhccChHh
Confidence            999999999999999999999987543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=341.85  Aligned_cols=230  Identities=27%  Similarity=0.384  Sum_probs=184.1

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccccc------HHHHHHHHHhc-CCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY------KNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..+|++.++||+|+||+||+|++..+++.||||++......      ...|+..+..+ +|+||+++++++.     +..
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~  130 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGG  130 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETT
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCC
Confidence            35699999999999999999999999999999987543221      12344444444 9999999999884     344


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee--------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY--------  225 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~--------  225 (403)
                      .+++||||+++++...+...   ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+++        
T Consensus       131 ~~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~  206 (311)
T 3p1a_A          131 ILYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFLGPRGRCKLGDFGLLVE  206 (311)
T ss_dssp             EEEEEEECCCCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred             EEEEEEeccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCCCEEEccceeeee
Confidence            58999999999887766543   4569999999999999999999999 89999999999999987655432        


Q ss_pred             ----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          226 ----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       226 ----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                .||+.|+|||++.+  .++.++|||||||++|||++|..||.+.....   .+..  +..          
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~--~~~----------  269 (311)
T 3p1a_A          207 LGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQ--GYL----------  269 (311)
T ss_dssp             CC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTT--TCC----------
T ss_pred             cccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhc--cCC----------
Confidence                      36889999999865  58999999999999999999987775433221   1111  000          


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                                     ...++..+++++.+||.+||+.||++|||+.|+|+||||++
T Consensus       270 ---------------~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          270 ---------------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             ---------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             ---------------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                           01123568999999999999999999999999999999976

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=8.9e-45  Score=352.17  Aligned_cols=265  Identities=31%  Similarity=0.557  Sum_probs=202.3

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc---cHHHHHHHHHhcC-CCC-----ccccceEEeecCCCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLD-HPN-----IVALKHCFFSTTDKE  151 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~-h~n-----iv~~~~~~~~~~~~~  151 (403)
                      ..+|.+.+.||+|+||+||+|++..+++.||||++.....   ...+|+.+++.+. |++     |+++++++..     
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-----  127 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-----  127 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE-----
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc-----
Confidence            3469999999999999999999999999999999875432   2346888888885 554     8888887743     


Q ss_pred             ceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCccccccccccceecC--CCCc-----
Q 015672          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN-CIGICHRDIKPQNLLVKG--EPNV-----  223 (403)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~~ivHrDlKp~NILl~~--~~~~-----  223 (403)
                      ..++|+||||++++|.+++....  ...+++..++.++.||+.||.|||. ..|||||||||+|||++.  ++.+     
T Consensus       128 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          128 RNHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             CCceEEEEecCCCCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            34589999999999888776532  2458999999999999999999994 168999999999999954  3333     


Q ss_pred             -----------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          224 -----------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       224 -----------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                                 ..++|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.++...+..
T Consensus       206 G~a~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  284 (382)
T 2vx3_A          206 GSSCQLGQRIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQ  284 (382)
T ss_dssp             TTCEETTCCCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             cCceecccccccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence                       23578999999999765 589999999999999999999999999999999999999999888776543


Q ss_pred             cCcCc--------cccC----------CCCCCCCCccccccc-----------------CCCHHHHHHHHHhcccCCCCC
Q 015672          293 MNPNY--------TEFK----------FPQIKPHPWHKVFQK-----------------RLPPEAVDLVCRFFQYSPNLR  337 (403)
Q Consensus       293 ~~~~~--------~~~~----------~~~~~~~~~~~~~~~-----------------~~s~~~~~li~~~L~~dP~~R  337 (403)
                      .....        ..+.          +.......+...+..                 ..++++.+||.+||++||++|
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R  364 (382)
T 2vx3_A          285 APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTR  364 (382)
T ss_dssp             CTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTS
T ss_pred             hHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhC
Confidence            21100        0000          000000000000000                 001478999999999999999


Q ss_pred             CCHHHHhcCCCcccCC
Q 015672          338 CTALEACVHPFFDELR  353 (403)
Q Consensus       338 pta~e~l~hp~f~~~~  353 (403)
                      ||+.|+|+||||++..
T Consensus       365 pta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          365 IQPYYALQHSFFKKTA  380 (382)
T ss_dssp             CCHHHHTTSGGGCC--
T ss_pred             CCHHHHhcCcccccCC
Confidence            9999999999998753

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.4e-44  Score=335.32  Aligned_cols=234  Identities=29%  Similarity=0.480  Sum_probs=196.2

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-------cccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..+|.+.+.||+|+||.||+|++..+++.||+|++...       .....+|+.+++.++||||+++++++.     +..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   82 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DAT   82 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----cCC
Confidence            45699999999999999999999999999999988532       223457999999999999999999883     334


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------  225 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------  225 (403)
                      ..++||||++ +++...+..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++       
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~  157 (279)
T 3fdn_A           83 RVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAGELKIADFGWSV  157 (279)
T ss_dssp             EEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTCEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred             EEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHhEEEcCCCCEEEEeccccc
Confidence            5889999998 577666554    3568999999999999999999999 89999999999999987765543       


Q ss_pred             ----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          226 ----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       226 ----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                .||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....             
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  223 (279)
T 3fdn_A          158 HAPSSRRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-------------  223 (279)
T ss_dssp             CC--------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-------------
T ss_pred             cCCcccccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC-------------
Confidence                      468899999998654 58999999999999999999999999887666665554321             


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  354 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  354 (403)
                          ..            ++..+++++.+||.+||+.||++|||+.|+++||||+....
T Consensus       224 ----~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~  266 (279)
T 3fdn_A          224 ----FT------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS  266 (279)
T ss_dssp             ----CC------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred             ----CC------------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence                01            12457899999999999999999999999999999988643

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.9e-44  Score=337.04  Aligned_cols=250  Identities=26%  Similarity=0.414  Sum_probs=200.7

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..+|.+.+.||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++|+||+++++++.     ...
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~   88 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND   88 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----cCC
Confidence            456999999999999999999999999999999885432       23357999999999999999999883     334


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------  225 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------  225 (403)
                      ..++||||++ ++|..++..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++       
T Consensus        89 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  163 (294)
T 2rku_A           89 FVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNEDLEVKIGDFGLAT  163 (294)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEcCCCCEEEEeccCce
Confidence            5889999998 577665543    3578999999999999999999999 89999999999999987765432       


Q ss_pred             ------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015672          226 ------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       226 ------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  293 (403)
                                  .||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+....+...            
T Consensus       164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------  230 (294)
T 2rku_A          164 KVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------------  230 (294)
T ss_dssp             ECCSTTCCBCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT------------
T ss_pred             ecccCccccccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc------------
Confidence                        367889999998654 5899999999999999999999999887766554443321            


Q ss_pred             CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCCCCCCCCCCCCCCC
Q 015672          294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFN  370 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~  370 (403)
                           ...            ++..+++.+.+||.+||+.||++|||+.++++||||.....|..........|+.+.
T Consensus       231 -----~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (294)
T 2rku_A          231 -----EYS------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFS  290 (294)
T ss_dssp             -----CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCCCGGGGTSCCCCC
T ss_pred             -----cCC------------CccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCCCCCccCCCCCCCcc
Confidence                 001            124578999999999999999999999999999999886555443333333344333

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.5e-44  Score=340.86  Aligned_cols=235  Identities=27%  Similarity=0.430  Sum_probs=192.9

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ...|...+.||+|+||.||+|++..+|+.||||++....    ....+|+.+++.++||||+++++++...     ...+
T Consensus        44 ~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~  118 (321)
T 2c30_A           44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG-----EELW  118 (321)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEE
T ss_pred             hhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEE
Confidence            345888899999999999999999999999999985432    2345899999999999999999988543     3488


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-----------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-----------  224 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-----------  224 (403)
                      +||||++ ++|.+++.     ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++           
T Consensus       119 lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  192 (321)
T 2c30_A          119 VLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHA-QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS  192 (321)
T ss_dssp             EEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCcEEEeeeeeeeecc
Confidence            9999997 56766543     2468999999999999999999999 8999999999999998765543           


Q ss_pred             --------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          225 --------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       225 --------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                              ..||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.... .+.          
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~~----------  260 (321)
T 2c30_A          193 KDVPKRKSLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPK----------  260 (321)
T ss_dssp             SSSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-CCC----------
T ss_pred             cCccccccccCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCC----------
Confidence                    2478899999998654 58999999999999999999999998877666555443311 000          


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                              .       .....+++++.+||.+||+.||++|||+.++++||||.+..
T Consensus       261 --------~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          261 --------L-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             --------C-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             --------c-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence                    0       01135789999999999999999999999999999998754

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.1e-44  Score=363.04  Aligned_cols=235  Identities=27%  Similarity=0.432  Sum_probs=192.0

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ...|.+.+.||+|+||+||+|+++.++..||+|++...      .....+|+.+++.++||||+++++++.     ....
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~  110 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKRN  110 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence            44699999999999999999999999999999998543      233468999999999999999999883     3445


Q ss_pred             EEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC---c-------
Q 015672          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN---V-------  223 (403)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~---~-------  223 (403)
                      +|+|||||.+ +|.+.+..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++..+.   +       
T Consensus       111 ~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~  185 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGL  185 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence            8899999984 66555543    3568999999999999999999999 89999999999999975322   2       


Q ss_pred             -----------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          224 -----------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       224 -----------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                                 ..+||+.|+|||++.+  .|+.++|||||||++|+|++|.+||.+.+..+.+..+.......+..    
T Consensus       186 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----  259 (494)
T 3lij_A          186 SAVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP----  259 (494)
T ss_dssp             CEECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSG----
T ss_pred             CeECCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCch----
Confidence                       2347999999999853  58999999999999999999999999988877776665532111100    


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                                           ....+++++++||.+||+.||.+|||+.++|+||||++.
T Consensus       260 ---------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          260 ---------------------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             ---------------------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             ---------------------hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence                                 114689999999999999999999999999999999875

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.2e-44  Score=336.38  Aligned_cols=238  Identities=21%  Similarity=0.272  Sum_probs=189.7

Q ss_pred             CcccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhc-CCCCccccceEEeecCCC
Q 015672           78 SKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  150 (403)
Q Consensus        78 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  150 (403)
                      .+...+|.+.+.||+|+||+||+|++..+++.||||++....      ....+|+..+..+ +||||+++++++..    
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~----   82 (289)
T 1x8b_A            7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE----   82 (289)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE----
T ss_pred             ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec----
Confidence            345567999999999999999999999999999999986431      2234688888888 99999999998843    


Q ss_pred             CceEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC--------
Q 015672          151 EELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP--------  221 (403)
Q Consensus       151 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~--------  221 (403)
                       ..++++||||+++ +|.+++.........+++..++.++.||+.||.|||+ +||+||||||+|||++.++        
T Consensus        83 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~~~~~~~  160 (289)
T 1x8b_A           83 -DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEE  160 (289)
T ss_dssp             -TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-----------
T ss_pred             -CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeecCCCHHHEEEcCCCCCcccccc
Confidence             3358899999974 8988887655555779999999999999999999999 8999999999999997433        


Q ss_pred             -----------Cce---------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHH
Q 015672          222 -----------NVS---------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL  275 (403)
Q Consensus       222 -----------~~~---------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~  275 (403)
                                 .++               ..||+.|+|||++.+...++.++|||||||++|+|++|.+|+.....   .
T Consensus       161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~  237 (289)
T 1x8b_A          161 GDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---W  237 (289)
T ss_dssp             ---------CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---H
T ss_pred             cccccccCCceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---H
Confidence                       222               23688999999997665677899999999999999999987754432   2


Q ss_pred             HHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          276 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       276 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                      ..+...                   ..+         .++..+++++.+||.+||+.||++|||+.++++||||.+.
T Consensus       238 ~~~~~~-------------------~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          238 HEIRQG-------------------RLP---------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HHHHTT-------------------CCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HHHHcC-------------------CCC---------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            222110                   001         1235689999999999999999999999999999999874

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4e-44  Score=345.47  Aligned_cols=235  Identities=25%  Similarity=0.399  Sum_probs=194.1

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------------ccHHHHHHHHHhc-CCCCccccceEEeecC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQML-DHPNIVALKHCFFSTT  148 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  148 (403)
                      .+|.+.+.||+|+||.||+|++..+|+.||||++....            ....+|+.+++.+ +||||+++++++.   
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~---  170 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE---  170 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE---
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe---
Confidence            46999999999999999999999999999999885432            2235799999999 8999999999873   


Q ss_pred             CCCceEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce---
Q 015672          149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS---  224 (403)
Q Consensus       149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~---  224 (403)
                        ...+.++||||+++ +|.+++..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++   
T Consensus       171 --~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~gi~H~Dlkp~NIl~~~~~~ikl~D  243 (365)
T 2y7j_A          171 --SSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHA-NNIVHRDLKPENILLDDNMQIRLSD  243 (365)
T ss_dssp             --BSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECC
T ss_pred             --eCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEEEe
Confidence              34458999999985 77766653    3578999999999999999999999 8999999999999998776553   


Q ss_pred             ---------------eeccccccchhhhhCC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 015672          225 ---------------YICSRYYRAPELIFGA-----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  284 (403)
Q Consensus       225 ---------------~~~t~~y~aPE~~~~~-----~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~  284 (403)
                                     ..||+.|+|||++.+.     ..++.++|||||||++|+|++|..||.+.+....+..+......
T Consensus       244 fG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  323 (365)
T 2y7j_A          244 FGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQ  323 (365)
T ss_dssp             CTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             cCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence                           2468899999998532     34789999999999999999999999887766666555543211


Q ss_pred             CCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          285 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                      ....                         ....+++++.+||.+||+.||++|||+.++++||||++
T Consensus       324 ~~~~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          324 FSSP-------------------------EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             CCHH-------------------------HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCCc-------------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            1111                         11357899999999999999999999999999999974

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3e-44  Score=342.31  Aligned_cols=238  Identities=26%  Similarity=0.414  Sum_probs=197.5

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..+|.+.+.||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++|+||+++++++.     +..
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~  114 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND  114 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCC
Confidence            456999999999999999999999999999999985432       23457999999999999999999883     334


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------  225 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------  225 (403)
                      ++++||||+. ++|.+++..    ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+++       
T Consensus       115 ~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  189 (335)
T 2owb_A          115 FVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNEDLEVKIGDFGLAT  189 (335)
T ss_dssp             EEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCchhEEEcCCCCEEEeeccCce
Confidence            5899999998 577665543    3578999999999999999999999 89999999999999987765432       


Q ss_pred             ------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015672          226 ------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       226 ------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  293 (403)
                                  .||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+...            
T Consensus       190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------------  256 (335)
T 2owb_A          190 KVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------------  256 (335)
T ss_dssp             ECCSTTCCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT------------
T ss_pred             ecccCcccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC------------
Confidence                        367889999999654 5899999999999999999999999887766655544331            


Q ss_pred             CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCCC
Q 015672          294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR  358 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~~  358 (403)
                           ...            ++..+++++.+||.+||+.||++|||+.|+++||||.....+...
T Consensus       257 -----~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~~~  304 (335)
T 2owb_A          257 -----EYS------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARL  304 (335)
T ss_dssp             -----CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCC
T ss_pred             -----CCC------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccccC
Confidence                 011            124578999999999999999999999999999999986655433

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.8e-45  Score=367.37  Aligned_cols=238  Identities=26%  Similarity=0.435  Sum_probs=193.9

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-------cccHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      ...+|.+.++||+|+||.||+|+++.+|+.||||++.+.       .....+|+++|+.++||||+++++++.     ..
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~  256 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TK  256 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe-----eC
Confidence            345699999999999999999999999999999998532       123457999999999999999999883     33


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-------
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-------  224 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-------  224 (403)
                      .++|+||||++ ++|...+....  ...+++..++.++.||+.||.|||+ +|||||||||+||||+.++.++       
T Consensus       257 ~~l~lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHrDLKPeNILld~~g~vKL~DFGla  333 (576)
T 2acx_A          257 DALCLVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHR-ERIVYRDLKPENILLDDHGHIRISDLGLA  333 (576)
T ss_dssp             SEEEEEECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCchheEEEeCCCCeEEEecccc
Confidence            45899999996 57766654321  2348999999999999999999999 8999999999999998776553       


Q ss_pred             -----------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCCHHHH
Q 015672          225 -----------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       225 -----------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~---~~~~~~i~~~~~~~~~~~~  290 (403)
                                 .+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+.   ...+...+...        
T Consensus       334 ~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~--------  404 (576)
T 2acx_A          334 VHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--------  404 (576)
T ss_dssp             EECCTTCCEECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC--------
T ss_pred             eecccCccccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc--------
Confidence                       3579999999999654 589999999999999999999999987643   22222222210        


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCCC
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  354 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~~  354 (403)
                              ..            .++..+++++++||.+||+.||.+||     +++|+++||||+.+.+
T Consensus       405 --------~~------------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w  453 (576)
T 2acx_A          405 --------PE------------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF  453 (576)
T ss_dssp             --------CC------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred             --------cc------------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence                    00            02246899999999999999999999     8999999999998754

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.2e-44  Score=334.49  Aligned_cols=239  Identities=24%  Similarity=0.373  Sum_probs=197.0

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc----------cccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      .+|.+.+.||+|+||.||+|++..+++.||+|++...          .....+|+.+++.++||||+++++++..     
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----   79 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN-----   79 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-----
Confidence            4699999999999999999999999999999988542          2234689999999999999999998843     


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC----Cce--
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP----NVS--  224 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~----~~~--  224 (403)
                      ....++||||++ ++|.+++..    ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++    .++  
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~~kl~  154 (283)
T 3bhy_A           80 KTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKLI  154 (283)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred             CCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChHHEEEecCCCCCCceEEE
Confidence            345889999996 688776654    3568999999999999999999999 8999999999999997655    232  


Q ss_pred             ----------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015672          225 ----------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  288 (403)
Q Consensus       225 ----------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~  288 (403)
                                      ..+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.......+. 
T Consensus       155 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-  232 (283)
T 3bhy_A          155 DFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE-  232 (283)
T ss_dssp             CCTTCEECC--------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH-
T ss_pred             ecccceeccCCCcccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc-
Confidence                            2368889999998654 5899999999999999999999999988776665554432111111 


Q ss_pred             HHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCC
Q 015672          289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  356 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~  356 (403)
                                              .....+++.+.+||.+||..||++|||+.++++||||+.+....
T Consensus       233 ------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          233 ------------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             ------------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred             ------------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence                                    12245789999999999999999999999999999999875443

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=5.3e-44  Score=345.01  Aligned_cols=269  Identities=30%  Similarity=0.479  Sum_probs=205.0

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcC-----------CCCccccceEEee
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD-----------HPNIVALKHCFFS  146 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----------h~niv~~~~~~~~  146 (403)
                      ..+|.+.+.||+|+||+||+|++..+++.||||++..+.   ....+|+.+++.+.           |+||+++++++..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            346999999999999999999999999999999986543   23457999998886           8999999998754


Q ss_pred             cCCCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-CccccccccccceecCCC----
Q 015672          147 TTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVKGEP----  221 (403)
Q Consensus       147 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~-~ivHrDlKp~NILl~~~~----  221 (403)
                      .. .+..++++||||++++|..++....  ...+++..+..++.||+.||.|||+ + ||+||||||+|||++.++    
T Consensus        98 ~~-~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~-~~~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           98 KG-PNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EE-TTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEEETTTT
T ss_pred             cC-CCCceEEEEEecCCCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChHHeEEeccCCCcC
Confidence            33 3455789999999888888776533  3458999999999999999999999 8 999999999999995321    


Q ss_pred             --Cc----------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC------cHHHHHH
Q 015672          222 --NV----------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES------GVDQLVE  277 (403)
Q Consensus       222 --~~----------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~------~~~~~~~  277 (403)
                        .+                ...+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+      ..+.+..
T Consensus       174 ~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  252 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  252 (373)
T ss_dssp             EEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             cceEEEcccccccccCCCCCCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHH
Confidence              11                23578999999999765 48999999999999999999999998654      4567778


Q ss_pred             HHHHhCCCCHHHHhhcCcCc-------cccCCCCCCCCCcccc------cccCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 015672          278 IIKVLGTPTREEIKCMNPNY-------TEFKFPQIKPHPWHKV------FQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  344 (403)
Q Consensus       278 i~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l  344 (403)
                      +...++.++...+.......       ...........+....      ++..+++++.+||.+||+.||++|||+.|+|
T Consensus       253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  332 (373)
T 1q8y_A          253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  332 (373)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHh
Confidence            88888888776553221100       0001111111111110      1223467899999999999999999999999


Q ss_pred             cCCCcccCCC
Q 015672          345 VHPFFDELRD  354 (403)
Q Consensus       345 ~hp~f~~~~~  354 (403)
                      +||||++...
T Consensus       333 ~hp~f~~~~~  342 (373)
T 1q8y_A          333 NHPWLKDTLG  342 (373)
T ss_dssp             TCGGGTTCTT
T ss_pred             hChhhhcccC
Confidence            9999998644

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=9.2e-44  Score=331.74  Aligned_cols=236  Identities=24%  Similarity=0.346  Sum_probs=192.3

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      ..|.+.+.||+|+||.||+|.+..++..||+|++....      ....+|+.+++.++||||+++++++.... .+..++
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceE
Confidence            34999999999999999999999999999999885432      22457999999999999999999875433 345678


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--ccccccccccceec-CCCCce-------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVK-GEPNVS-------  224 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~--ivHrDlKp~NILl~-~~~~~~-------  224 (403)
                      ++||||++ ++|..++..    ...+++..++.++.||+.||.|||+ .+  |+||||||+|||++ .++.++       
T Consensus       105 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            99999997 588777654    3568999999999999999999999 78  99999999999997 444442       


Q ss_pred             ----------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          225 ----------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       225 ----------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                ..||+.|+|||++.+  .++.++|||||||++|+|++|..||.+................+         
T Consensus       180 ~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------  248 (290)
T 1t4h_A          180 TLKRASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP---------  248 (290)
T ss_dssp             GGCCTTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC---------
T ss_pred             ccccccccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc---------
Confidence                      347889999998853  48999999999999999999999998866655544332211000         


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                                       ..++...++++.+||.+||+.||.+|||+.++++||||++
T Consensus       249 -----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          249 -----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             -----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             -----------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence                             1123457889999999999999999999999999999986

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=337.63  Aligned_cols=240  Identities=25%  Similarity=0.419  Sum_probs=195.4

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc--------cccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|++...        .....+|+++++.++|+||++++++++.   .+..
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~   81 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEKQ   81 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C---
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCCC
Confidence            4699999999999999999999999999999998542        1234589999999999999999998753   2234


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee--------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY--------  225 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~--------  225 (403)
                      .+++||||+++++..++....  ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+++        
T Consensus        82 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           82 KMYMVMEYCVCGMQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHS-QGIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             CEEEEEECCSEEHHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEehhccCCHHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            588999999988766665432  3568999999999999999999999 89999999999999987665432        


Q ss_pred             -------------eccccccchhhhhCCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015672          226 -------------ICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       226 -------------~~t~~y~aPE~~~~~~-~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  291 (403)
                                   .||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+....+...          
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~----------  228 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG----------  228 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC----------
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC----------
Confidence                         3688899999986532 2478999999999999999999999887766555544331          


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCC
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  356 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~  356 (403)
                             ...            ++..+++++.+||.+||..||.+|||+.++++||||++...+.
T Consensus       229 -------~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  274 (305)
T 2wtk_C          229 -------SYA------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA  274 (305)
T ss_dssp             -------CCC------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred             -------CCC------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence                   000            1245789999999999999999999999999999999865443

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.7e-44  Score=360.47  Aligned_cols=239  Identities=24%  Similarity=0.382  Sum_probs=195.2

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      ....|.+.++||+|+||+||+|+++.+|+.||||++.+..       ....+|+.+++.++||||+++++++.     ..
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~  257 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE-----TK  257 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----eC
Confidence            3457999999999999999999999999999999985421       23457999999999999999999883     33


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-------
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-------  224 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-------  224 (403)
                      ..+|+||||++ ++|...+.........+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++       
T Consensus       258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~gIvHrDLKP~NILl~~~g~vkL~DFGla  336 (543)
T 3c4z_A          258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-RNIIYRDLKPENVLLDDDGNVRISDLGLA  336 (543)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH-cCCcccCCChHHEEEeCCCCEEEeeccee
Confidence            45899999998 57776665443334569999999999999999999999 8999999999999998765542       


Q ss_pred             ------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCCHH
Q 015672          225 ------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG----VDQLVEIIKVLGTPTRE  288 (403)
Q Consensus       225 ------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~----~~~~~~i~~~~~~~~~~  288 (403)
                                  .+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+.    .+....+...       
T Consensus       337 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-------  408 (543)
T 3c4z_A          337 VELKAGQTKTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-------  408 (543)
T ss_dssp             EECCTTCCCBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-------
T ss_pred             eeccCCCcccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-------
Confidence                        3689999999999764 589999999999999999999999987642    2222222221       


Q ss_pred             HHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCcccCCC
Q 015672          289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELRD  354 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~e~l~hp~f~~~~~  354 (403)
                                ...            ++..+++++.+||.+||+.||.+||+     ++++++||||+.+.+
T Consensus       409 ----------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w  457 (543)
T 3c4z_A          409 ----------AVT------------YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW  457 (543)
T ss_dssp             ----------CCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred             ----------ccC------------CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence                      001            22468999999999999999999996     589999999998753

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.3e-44  Score=343.36  Aligned_cols=241  Identities=24%  Similarity=0.365  Sum_probs=184.5

Q ss_pred             cccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCC----
Q 015672           79 KQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTD----  149 (403)
Q Consensus        79 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----  149 (403)
                      +...+|++.+.||+|+||.||+|+++.+++.||||++....     ....+|+.+++.++||||+++++++.....    
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            34567999999999999999999999999999999986322     234589999999999999999998855332    


Q ss_pred             ------------------------------------------------CCceEEEEEeeccCC-cHHHHHHHhhhhcCCC
Q 015672          150 ------------------------------------------------KEELYLNLVLEYVPE-TVNRIARNYSRIHQRM  180 (403)
Q Consensus       150 ------------------------------------------------~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l  180 (403)
                                                                      ....++++|||||++ +|.+++..... ....
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~  161 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDR  161 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGS
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccch
Confidence                                                            123458999999984 77777654322 2234


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-------------------------------eeccc
Q 015672          181 PLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-------------------------------YICSR  229 (403)
Q Consensus       181 ~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-------------------------------~~~t~  229 (403)
                      ....+..++.||+.||.|||+ +||+||||||+|||++.++.++                               ..||+
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             hhHHHHHHHHHHHHHHHHHHh-CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            556688999999999999999 8999999999999998665442                               24788


Q ss_pred             cccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCC
Q 015672          230 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHP  309 (403)
Q Consensus       230 ~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (403)
                      .|+|||++.+. .++.++|||||||++|+|++|..|+.     +....+..........                     
T Consensus       241 ~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~~~~~---------------------  293 (332)
T 3qd2_B          241 LYMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLKFPL---------------------  293 (332)
T ss_dssp             GGSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTTCCCH---------------------
T ss_pred             CccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhccCCCc---------------------
Confidence            99999999765 58999999999999999999876652     1111111111000000                     


Q ss_pred             cccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          310 WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       310 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                          .....++++.+||.+||+.||++|||+.|+++||||+++
T Consensus       294 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          294 ----LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             ----HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             ----ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence                112356788999999999999999999999999999874

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.4e-44  Score=372.41  Aligned_cols=234  Identities=25%  Similarity=0.407  Sum_probs=197.9

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-------cccHHHHHHHHHhc-CCCCccccceEEeecCCCCc
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  152 (403)
                      ..+|.+.++||+|+||+||+|+++.+++.||||++.+.       ......|..++..+ +|+||+++++++     ...
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~~  414 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTM  414 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BCS
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----EeC
Confidence            45799999999999999999999999999999998642       12335688888887 799999998887     344


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-------
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-------  224 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-------  224 (403)
                      .++||||||++ ++|..++..    ...+++..++.|+.||+.||+|||+ +|||||||||+||||+.++.++       
T Consensus       415 ~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~gIiHrDLKp~NILl~~~g~ikL~DFGla  489 (674)
T 3pfq_A          415 DRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDSEGHIKIADFGMC  489 (674)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TSEECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred             CEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeccCChhhEEEcCCCcEEEeeccee
Confidence            56899999997 577666654    3579999999999999999999999 8999999999999998776543       


Q ss_pred             ------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          225 ------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       225 ------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                                  .+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..|...           
T Consensus       490 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~-----------  557 (674)
T 3pfq_A          490 KENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-----------  557 (674)
T ss_dssp             EECCCTTCCBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS-----------
T ss_pred             eccccCCcccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-----------
Confidence                        3579999999999654 5899999999999999999999999998887777766541           


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCCCcccCCC
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA-----LEACVHPFFDELRD  354 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta-----~e~l~hp~f~~~~~  354 (403)
                            ...            ++..+++++.+||.+||+.||++||++     +|+++||||+.+.+
T Consensus       558 ------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w  606 (674)
T 3pfq_A          558 ------NVA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  606 (674)
T ss_dssp             ------CCC------------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred             ------CCC------------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCH
Confidence                  111            235689999999999999999999997     99999999998754

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6.6e-44  Score=335.07  Aligned_cols=236  Identities=28%  Similarity=0.450  Sum_probs=194.1

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ..+|.+.+.||+|+||.||+|++..+++.||+|++....    ....+|+.+++.++||||+++++++.     ....++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   82 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTHYY   82 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEEE
Confidence            456999999999999999999999999999999986432    23468999999999999999999873     334588


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccccccee---cCCCCcee-------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---KGEPNVSY-------  225 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl---~~~~~~~~-------  225 (403)
                      +||||++ ++|.+.+..    ...+++..+..++.||+.||.|||+ .||+||||||+|||+   +.++.+++       
T Consensus        83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~  157 (304)
T 2jam_A           83 LVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHE-NGIVHRDLKPENLLYLTPEENSKIMITDFGLSK  157 (304)
T ss_dssp             EEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred             EEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence            9999997 577666543    3568999999999999999999999 899999999999999   44444332       


Q ss_pred             ----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          226 ----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       226 ----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                .||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+......           
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-----------  225 (304)
T 2jam_A          158 MEQNGIMSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE-----------  225 (304)
T ss_dssp             CCCCBTTHHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC-----------
T ss_pred             ecCCCccccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence                      368899999998654 5899999999999999999999999888776666555442110           


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                            ++        ......+++++.+||.+||..||++|||+.++++||||++.
T Consensus       226 ------~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          226 ------FE--------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             ------CC--------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             ------CC--------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence                  00        01224678999999999999999999999999999999874

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.1e-43  Score=332.39  Aligned_cols=240  Identities=26%  Similarity=0.394  Sum_probs=195.7

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------------ccHHHHHHHHHhcC-CCCccccceEEee
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------------RYKNRELQIMQMLD-HPNIVALKHCFFS  146 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~E~~~l~~l~-h~niv~~~~~~~~  146 (403)
                      ..+|.+.+.||+|+||.||+|+++.+++.||||++....             ....+|+++++++. ||||+++++++. 
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~-   94 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE-   94 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE-
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec-
Confidence            456999999999999999999999999999999985432             22347999999995 999999999883 


Q ss_pred             cCCCCceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee
Q 015672          147 TTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY  225 (403)
Q Consensus       147 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~  225 (403)
                          ...+.++||||++ ++|.+++..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++
T Consensus        95 ----~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl  165 (298)
T 1phk_A           95 ----TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDMNIKL  165 (298)
T ss_dssp             ----CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEE
T ss_pred             ----cCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEcCCCcEEE
Confidence                3456899999998 588777654    3578999999999999999999999 89999999999999987765533


Q ss_pred             ------------------eccccccchhhhh-----CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 015672          226 ------------------ICSRYYRAPELIF-----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL  282 (403)
Q Consensus       226 ------------------~~t~~y~aPE~~~-----~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~  282 (403)
                                        .+|+.|+|||++.     ....++.++|||||||++|+|++|..||.+.+.......+....
T Consensus       166 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  245 (298)
T 1phk_A          166 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN  245 (298)
T ss_dssp             CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             ecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCC
Confidence                              3688899999985     23458899999999999999999999998887666655554421


Q ss_pred             CCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          283 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                      ..                 ++.   .     ....++.++.+||.+||+.||++|||+.++++||||++....
T Consensus       246 ~~-----------------~~~---~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  293 (298)
T 1phk_A          246 YQ-----------------FGS---P-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE  293 (298)
T ss_dssp             CC-----------------CCT---T-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred             cc-----------------cCc---c-----cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence            11                 000   0     113578999999999999999999999999999999986543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.5e-44  Score=349.96  Aligned_cols=242  Identities=26%  Similarity=0.369  Sum_probs=186.7

Q ss_pred             ccccEeee-ceecccCceEEEEEEECCCCcEEEEEEcccccccHHHHHHHH-HhcCCCCccccceEEeecCCCCceEEEE
Q 015672           80 QKVSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIM-QMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        80 ~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      ...+|.+. ++||+|+||+||+|+++.+++.||||++... ....+|+.++ +..+||||++++++|.... .+..++|+
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~l  136 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI  136 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEE
Confidence            34568776 7899999999999999999999999998643 3456788887 4558999999999874322 33567899


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecC---CCCce---------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKG---EPNVS---------  224 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~---~~~~~---------  224 (403)
                      |||||. ++|.+++....  ...+++..++.++.||+.||.|||+ .||+||||||+|||++.   ++.++         
T Consensus       137 v~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~  213 (400)
T 1nxk_A          137 VMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  213 (400)
T ss_dssp             EEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence            999997 47877665321  2458999999999999999999999 89999999999999986   33332         


Q ss_pred             ---------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHHHhCCCCHHHHh
Q 015672          225 ---------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD----QLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       225 ---------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~  291 (403)
                               .+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+...    ....+..           
T Consensus       214 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~-----------  281 (400)
T 1nxk_A          214 TTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM-----------  281 (400)
T ss_dssp             CC-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH-----------
T ss_pred             cCCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc-----------
Confidence                     346899999999854 458999999999999999999999997654321    1122211           


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                            ..+.++.   .     ....+++++.+||.+||+.||++|||+.|+++||||.+.
T Consensus       282 ------~~~~~~~---~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          282 ------GQYEFPN---P-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             ------TCCCCCT---T-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             ------CcccCCC---c-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence                  0111111   0     114579999999999999999999999999999999864

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=6.7e-44  Score=339.18  Aligned_cols=264  Identities=26%  Similarity=0.492  Sum_probs=203.6

Q ss_pred             ccEeeeceecccCceEEEEEEE-CCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCC------ccccceEEeecCCCC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKC-RETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPN------IVALKHCFFSTTDKE  151 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~~~  151 (403)
                      .+|++.+.||+|+||.||+|.+ ..+++.||||++....   ....+|+++++.++|++      |+++++++..     
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~-----   88 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH-----   88 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE-----
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc-----
Confidence            4699999999999999999998 5678999999986533   23457999999987654      8888888733     


Q ss_pred             ceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCC-----------
Q 015672          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE-----------  220 (403)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~-----------  220 (403)
                      ..++++||||+++++.+++....  ...+++..++.++.||+.||.|||+ +||+||||||+|||++..           
T Consensus        89 ~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           89 HGHICIVFELLGLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeccccccccCCccc
Confidence            33589999999988887775432  2368899999999999999999999 899999999999999763           


Q ss_pred             --------CCce----------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 015672          221 --------PNVS----------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV  276 (403)
Q Consensus       221 --------~~~~----------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~  276 (403)
                              +.++                ..||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+.
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  244 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA  244 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred             cccccccCCCceEeeCcccccCccccccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence                    2222                3468899999999654 58999999999999999999999999998888888


Q ss_pred             HHHHHhCCCCHHHHhhcCcCcc----ccCCCCCC---------CCCccc--ccccCCCHHHHHHHHHhcccCCCCCCCHH
Q 015672          277 EIIKVLGTPTREEIKCMNPNYT----EFKFPQIK---------PHPWHK--VFQKRLPPEAVDLVCRFFQYSPNLRCTAL  341 (403)
Q Consensus       277 ~i~~~~~~~~~~~~~~~~~~~~----~~~~~~~~---------~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rpta~  341 (403)
                      .+.+..+..+...+........    ...+....         ..++..  ......++++.+||.+||+.||.+|||+.
T Consensus       245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  324 (339)
T 1z57_A          245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR  324 (339)
T ss_dssp             HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence            8888888777765543321100    00000000         000000  00122357799999999999999999999


Q ss_pred             HHhcCCCcccCCC
Q 015672          342 EACVHPFFDELRD  354 (403)
Q Consensus       342 e~l~hp~f~~~~~  354 (403)
                      |+++||||+.+..
T Consensus       325 ell~hp~f~~~~~  337 (339)
T 1z57_A          325 EALKHPFFDLLKK  337 (339)
T ss_dssp             HHTTSGGGGGGGC
T ss_pred             HHhcCHHHHHHhc
Confidence            9999999998753

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.6e-44  Score=353.03  Aligned_cols=237  Identities=30%  Similarity=0.453  Sum_probs=184.2

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------------ccHHHHHHHHHhcCCCCccccceEEeecC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTT  148 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  148 (403)
                      ..+|.+.+.||+|+||+||+|.+..+++.||||++....            ....+|+.+|++++||||+++++++.   
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~---  210 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD---  210 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE---
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence            457999999999999999999999999999999985432            13468999999999999999999862   


Q ss_pred             CCCceEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC---c-
Q 015672          149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN---V-  223 (403)
Q Consensus       149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~---~-  223 (403)
                        .. ..++||||+++ +|.+.+    .....+++..++.++.||+.||.|||+ +||+||||||+|||++..+.   + 
T Consensus       211 --~~-~~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~~~~k  282 (419)
T 3i6u_A          211 --AE-DYYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIK  282 (419)
T ss_dssp             --SS-EEEEEEECCTTCBGGGGT----SSSCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred             --cC-ceEEEEEcCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCCCcceEE
Confidence              11 26799999974 553332    234679999999999999999999999 89999999999999965432   2 


Q ss_pred             -----------------eeeccccccchhhhhC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 015672          224 -----------------SYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  284 (403)
Q Consensus       224 -----------------~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~  284 (403)
                                       ..+||+.|+|||++.+  ...++.++|||||||++|+|++|.+||.+......+...+.....
T Consensus       283 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~  362 (419)
T 3i6u_A          283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  362 (419)
T ss_dssp             ECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred             EeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence                             2357899999999853  345888999999999999999999999875543333222221100


Q ss_pred             CCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          285 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                      .                        +.......+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus       363 ~------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          363 N------------------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             C------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             C------------------------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            0                        0011124578999999999999999999999999999999864

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.3e-44  Score=347.96  Aligned_cols=250  Identities=16%  Similarity=0.140  Sum_probs=175.8

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc-------cHHHHHHHHHhc--CCCCccccc-------eEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQML--DHPNIVALK-------HCF  144 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l--~h~niv~~~-------~~~  144 (403)
                      ...|.+.+.||+|+||+||+|++..+++.||||++.....       ...+|+.+++.|  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            3459999999999999999999999999999999876432       223575545555  699988755       333


Q ss_pred             eecCCC------------CceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHH------HHHHHHHHHHHHHHHhcCCcc
Q 015672          145 FSTTDK------------EELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYV------KLYTYQICRALAYIHNCIGIC  206 (403)
Q Consensus       145 ~~~~~~------------~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~------~~~~~qi~~~L~~LH~~~~iv  206 (403)
                      ......            ....+|+||||++++|.+++.....   .+.....      ..++.||+.||.|||+ +||+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~-~~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQS-KGLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHH-TTEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHH-CCCc
Confidence            221110            1155899999999999888876422   2333333      4666999999999999 8999


Q ss_pred             ccccccccceecCCCCcee----------------eccccccchhhhhCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 015672          207 HRDIKPQNLLVKGEPNVSY----------------ICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGE  269 (403)
Q Consensus       207 HrDlKp~NILl~~~~~~~~----------------~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~tg~~pf~~~  269 (403)
                      ||||||+|||++.++.+++                .+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  296 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV  296 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence            9999999999998776643                357899999999641 35899999999999999999999999766


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          270 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       270 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                      .....                    ..+............+.......+++++.+||.+||+.||++|||+.++|+||||
T Consensus       297 ~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  356 (371)
T 3q60_A          297 TPGIK--------------------GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF  356 (371)
T ss_dssp             CTTCT--------------------TCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHH
T ss_pred             Ccccc--------------------cchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHH
Confidence            42100                    0001101111111111111124689999999999999999999999999999999


Q ss_pred             ccCCC
Q 015672          350 DELRD  354 (403)
Q Consensus       350 ~~~~~  354 (403)
                      +++.+
T Consensus       357 ~~~~~  361 (371)
T 3q60_A          357 LQLQN  361 (371)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            88643

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=343.02  Aligned_cols=228  Identities=22%  Similarity=0.361  Sum_probs=188.6

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------------ccHHHHHHHHHhcCCCCccccceEEeec
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFST  147 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~  147 (403)
                      ...+|.+.+.||+|+||.||+|++..+++.||||++....            ....+|+.+++.++||||+++++++.  
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~--   99 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE--   99 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE--
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence            4457999999999999999999999999999999986432            23347999999999999999999883  


Q ss_pred             CCCCceEEEEEeeccCC--cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-
Q 015672          148 TDKEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-  224 (403)
Q Consensus       148 ~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-  224 (403)
                         +..++++||||+.+  ++..++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.++ 
T Consensus       100 ---~~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kL  171 (335)
T 3dls_A          100 ---NQGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRL-KDIIHRDIKDENIVIAEDFTIKL  171 (335)
T ss_dssp             ---CSSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEE
T ss_pred             ---eCCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEeccCHHHEEEcCCCcEEE
Confidence               34458899999863  66655543    4579999999999999999999999 8999999999999998776543 


Q ss_pred             -----------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015672          225 -----------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  287 (403)
Q Consensus       225 -----------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~  287 (403)
                                       ..||+.|+|||++.+...++.++|||||||++|+|++|..||......      ..       
T Consensus       172 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~-------  238 (335)
T 3dls_A          172 IDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE-------  238 (335)
T ss_dssp             CCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT-------
T ss_pred             eecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh-------
Confidence                             347899999999977654588999999999999999999999652210      00       


Q ss_pred             HHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                                ...            ..+..+++++.+||.+||+.||++|||+.++++||||++.
T Consensus       239 ----------~~~------------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          239 ----------AAI------------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             ----------TCC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             ----------hcc------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence                      000            0123578999999999999999999999999999999874

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.2e-43  Score=329.73  Aligned_cols=238  Identities=26%  Similarity=0.405  Sum_probs=193.9

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ...|++.+.||+|+||.||+|++..+++.||+|++....    ....+|+.+++.++||||+++++++...     ..++
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   92 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-----GKLW   92 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------CEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-----CeEE
Confidence            456999999999999999999999999999999885432    2345799999999999999999988543     3488


Q ss_pred             EEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------
Q 015672          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------  225 (403)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------  225 (403)
                      +||||+++ ++..++...   ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++          
T Consensus        93 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  168 (302)
T 2j7t_A           93 IMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHS-KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL  168 (302)
T ss_dssp             EEEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred             EEEEeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence            99999974 666555432   3568999999999999999999999 89999999999999987766543          


Q ss_pred             ---------eccccccchhhhh----CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          226 ---------ICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       226 ---------~~t~~y~aPE~~~----~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                               .||+.|+|||++.    ....++.++|||||||++|+|++|..||...+....+..+.......       
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------  241 (302)
T 2j7t_A          169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT-------  241 (302)
T ss_dssp             HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-------
T ss_pred             ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc-------
Confidence                     3688899999984    34458999999999999999999999998887666555544321000       


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                                         ...+..++.++.+||.+||..||++|||+.++++||||+.+.
T Consensus       242 -------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          242 -------------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             -------------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             -------------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence                               001245789999999999999999999999999999998864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.4e-44  Score=331.36  Aligned_cols=233  Identities=27%  Similarity=0.479  Sum_probs=194.7

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-------cccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..+|.+.+.||+|+||.||+|++..+++.||+|++...       .....+|+++++.++|+||+++++++.     ...
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   87 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----DRK   87 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----cCC
Confidence            45699999999999999999999999999999998532       123467999999999999999999883     334


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------  225 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------  225 (403)
                      .+++||||++ ++|.+.+..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++       
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~  162 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHE-RKVIHRDIKPENLLMGYKGELKIADFGWSV  162 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEEcCCCCEEEecccccc
Confidence            5889999997 477766654    3568999999999999999999999 89999999999999987765533       


Q ss_pred             ----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          226 ----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       226 ----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                .||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+...              
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--------------  227 (284)
T 2vgo_A          163 HAPSLRRRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--------------  227 (284)
T ss_dssp             ECSSSCBCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--------------
T ss_pred             cCcccccccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc--------------
Confidence                      468889999998654 5899999999999999999999999887766555444321              


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                         ...            ++..++.++.+||.+||+.||.+|||+.++++||||+...
T Consensus       228 ---~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          228 ---DLK------------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             ---CCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             ---ccC------------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence               001            1245789999999999999999999999999999998753

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=339.74  Aligned_cols=235  Identities=24%  Similarity=0.357  Sum_probs=185.6

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCC--CCccccceEEeecCCCCce
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDH--PNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~  153 (403)
                      ..|.+.+.||+|+||.||+|.+ .+++.||||++....      ....+|+.+++.++|  +||+++++++.     ...
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~~   82 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQ   82 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred             CEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----eCC
Confidence            4599999999999999999988 468999999986432      233579999999987  99999999873     344


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc----------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV----------  223 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~----------  223 (403)
                      ++++|||+.+++|.+++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++.. .+          
T Consensus        83 ~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~iiHrDikp~NIll~~~-~~kl~DFG~a~~  156 (343)
T 3dbq_A           83 YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIVDG-MLKLIDFGIANQ  156 (343)
T ss_dssp             EEEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEETT-EEEECCCSSSCC
T ss_pred             EEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEECC-cEEEeecccccc
Confidence            6899999888888777664    4678999999999999999999999 899999999999999632 22          


Q ss_pred             -----------eeeccccccchhhhhC----------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHH
Q 015672          224 -----------SYICSRYYRAPELIFG----------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKV  281 (403)
Q Consensus       224 -----------~~~~t~~y~aPE~~~~----------~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~-~~~~~i~~~  281 (403)
                                 ..+||+.|+|||++.+          ...++.++|||||||++|+|++|+.||...... ..+..+.. 
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-  235 (343)
T 3dbq_A          157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-  235 (343)
T ss_dssp             C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC-
T ss_pred             cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc-
Confidence                       2357999999999854          245899999999999999999999999765443 22222211 


Q ss_pred             hCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          282 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                        ..            ...            .++...+.++.+||.+||+.||.+|||+.|+|+||||+....+
T Consensus       236 --~~------------~~~------------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  283 (343)
T 3dbq_A          236 --PN------------HEI------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  283 (343)
T ss_dssp             --TT------------SCC------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred             --CC------------ccc------------CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCc
Confidence              00            000            1224467899999999999999999999999999999865443

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.5e-43  Score=344.45  Aligned_cols=235  Identities=24%  Similarity=0.354  Sum_probs=185.3

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcC--CCCccccceEEeecCCCCce
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLD--HPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..|.+.+.||+|+||+||+|.+.. ++.||||++....      ....+|+.+|+.++  |+||+++++++..     ..
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-----~~  129 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----DQ  129 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-----CC
Confidence            359999999999999999999864 8999999985432      23457999999996  5999999998743     33


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc----------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV----------  223 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~----------  223 (403)
                      ++++|||+.+++|.+++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++. +.+          
T Consensus       130 ~~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~~-~~~kl~DFG~a~~  203 (390)
T 2zmd_A          130 YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIVD-GMLKLIDFGIANQ  203 (390)
T ss_dssp             EEEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCCGGGEEESS-SCEEECCCSSSCC
T ss_pred             EEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEEEC-CeEEEEecCcccc
Confidence            4899999877888777664    3578888999999999999999999 89999999999999953 222          


Q ss_pred             -----------eeeccccccchhhhhCC----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHH
Q 015672          224 -----------SYICSRYYRAPELIFGA----------TEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKV  281 (403)
Q Consensus       224 -----------~~~~t~~y~aPE~~~~~----------~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~-~~~~~i~~~  281 (403)
                                 ..+||+.|+|||++.+.          ..++.++|||||||++|+|++|++||.+.... ..+..+...
T Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~  283 (390)
T 2zmd_A          204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP  283 (390)
T ss_dssp             C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT
T ss_pred             ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc
Confidence                       23579999999998641          35899999999999999999999999876443 233222210


Q ss_pred             hCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          282 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                         .            ....            ++...+.++.+||.+||+.||++|||+.|+|+||||+....+
T Consensus       284 ---~------------~~~~------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~  330 (390)
T 2zmd_A          284 ---N------------HEIE------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  330 (390)
T ss_dssp             ---T------------SCCC------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC--
T ss_pred             ---c------------ccCC------------CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCcc
Confidence               0            0001            123457899999999999999999999999999999865443

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.7e-44  Score=338.06  Aligned_cols=242  Identities=26%  Similarity=0.336  Sum_probs=198.4

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....       ....+|+.+++.++||||+++++++.... ....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~   89 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   89 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence            446999999999999999999999999999999986532       12357899999999999999999875433 3344


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------  225 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------  225 (403)
                      +.|+||||++ ++|.+++..    ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+++       
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             ccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            6789999997 688777654    3578999999999999999999999 89999999999999987665432       


Q ss_pred             ---------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          226 ---------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       226 ---------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                     .||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+......++.   
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~---  240 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS---  240 (311)
T ss_dssp             -----------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH---
T ss_pred             cccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc---
Confidence                           368899999999765 5899999999999999999999999988877666555442211111   


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCC
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  354 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  354 (403)
                                            .....+++++.+||.+||+.||++||++.+++.|+|++....
T Consensus       241 ----------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          241 ----------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             ----------------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             ----------------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence                                  112458999999999999999999999999999999986543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=8.2e-44  Score=329.31  Aligned_cols=237  Identities=26%  Similarity=0.339  Sum_probs=189.6

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....     ....+|+.+++.++||||+++++++..     ....
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   80 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ   80 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-----CCEE
Confidence            346999999999999999999999999999999985432     234579999999999999999998743     3458


Q ss_pred             EEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      ++||||+++ +|.+++    .....+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+++         
T Consensus        81 ~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  155 (276)
T 2yex_A           81 YLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVF  155 (276)
T ss_dssp             EEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCCCcHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence            899999975 554433    223568999999999999999999999 89999999999999987665432         


Q ss_pred             ------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCHHHHhh
Q 015672          226 ------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       226 ------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~  292 (403)
                                  .||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.... +..+.... .        
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~--------  226 (276)
T 2yex_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-T--------  226 (276)
T ss_dssp             EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC-T--------
T ss_pred             CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc-c--------
Confidence                        3578899999997655457899999999999999999999987654322 22211100 0        


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCC
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  354 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  354 (403)
                              ..     .     ....+++++.+||.+||+.||++|||+.|+++||||++...
T Consensus       227 --------~~-----~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          227 --------YL-----N-----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             --------TS-----T-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             --------cc-----C-----chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence                    00     0     01357899999999999999999999999999999987643

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.3e-43  Score=335.80  Aligned_cols=237  Identities=30%  Similarity=0.471  Sum_probs=187.6

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------------ccHHHHHHHHHhcCCCCccccceEEeecC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTT  148 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  148 (403)
                      ..+|.+.+.||+|+||.||+|++..+++.||||++....            ....+|+++++.++||||+++++++.. .
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~   87 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E   87 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-C
Confidence            456999999999999999999999999999999885432            234689999999999999999988732 1


Q ss_pred             CCCceEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC---ce
Q 015672          149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN---VS  224 (403)
Q Consensus       149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~---~~  224 (403)
                         .  .++||||+++ +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.   ++
T Consensus        88 ---~--~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~k  157 (322)
T 2ycf_A           88 ---D--YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIK  157 (322)
T ss_dssp             ---S--EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSSSCCEE
T ss_pred             ---c--eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEecCCCCCeEE
Confidence               1  6899999974 66554432    4678999999999999999999999 89999999999999986543   32


Q ss_pred             e------------------eccccccchhhhh--CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 015672          225 Y------------------ICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  284 (403)
Q Consensus       225 ~------------------~~t~~y~aPE~~~--~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~  284 (403)
                      +                  .||+.|+|||++.  +...++.++|||||||++|+|++|..||........+...+.....
T Consensus       158 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  237 (322)
T 2ycf_A          158 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  237 (322)
T ss_dssp             ECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC
T ss_pred             EccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc
Confidence            2                  3688999999974  3445899999999999999999999999765543222222221100


Q ss_pred             CCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          285 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                      .                        +.......+++++.+||.+||..||++|||+.++++||||++.
T Consensus       238 ~------------------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          238 N------------------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             C------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             c------------------------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            0                        0011124578999999999999999999999999999999864

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.6e-44  Score=332.35  Aligned_cols=234  Identities=28%  Similarity=0.452  Sum_probs=172.9

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..+|.+.+.||+|+||.||+|++..+++.||||++....       ....+|+.+++.++||||+++++++.     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   84 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----DSN   84 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----CSS
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----cCC
Confidence            346999999999999999999999999999999985321       33467999999999999999999883     344


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------  225 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------  225 (403)
                      +.++||||++ ++|..++...   ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++       
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nili~~~~~~kl~dfg~~~  160 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHS-HGILHRDLTLSNLLLTRNMNIKIADFGLAT  160 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSSCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCCEEEEeeccee
Confidence            5889999997 4776665432   3568999999999999999999999 89999999999999987765432       


Q ss_pred             ------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015672          226 ------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       226 ------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  293 (403)
                                  .+|+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+..+..             
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------  226 (278)
T 3cok_A          161 QLKMPHEKHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL-------------  226 (278)
T ss_dssp             ECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS-------------
T ss_pred             eccCCCCcceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh-------------
Confidence                        367889999998654 588999999999999999999999977653332211100             


Q ss_pred             CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                          ...            ..+..++.++.+||.+||+.||++|||+.++++||||.+..
T Consensus       227 ----~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          227 ----ADY------------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             ----SCC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             ----ccc------------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence                000            02245789999999999999999999999999999998743

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.2e-43  Score=325.18  Aligned_cols=239  Identities=25%  Similarity=0.378  Sum_probs=197.1

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++....      ....+|+.+++.++||||+++++++...   ....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~   81 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT   81 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGTE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCce
Confidence            356999999999999999999999999999999986432      2345799999999999999999987542   2345


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC-----ccccccccccceecCCCCcee---
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-----ICHRDIKPQNLLVKGEPNVSY---  225 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~-----ivHrDlKp~NILl~~~~~~~~---  225 (403)
                      +++||||++ ++|.+++.........+++..+..++.||+.||.|||+ .+     |+||||||+|||++.++.+++   
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df  160 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  160 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred             EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc-ccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence            889999997 48888877655445569999999999999999999999 78     999999999999998776543   


Q ss_pred             ----------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          226 ----------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       226 ----------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                      .+|+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+....       
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-------  232 (279)
T 2w5a_A          161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-------  232 (279)
T ss_dssp             CHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-------
T ss_pred             chheeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc-------
Confidence                            357889999999765 58999999999999999999999998877655544443310       


Q ss_pred             HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                                  .+         .++..+++++.+||.+||+.||++|||+.|+++|+|+.+-
T Consensus       233 ------------~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          233 ------------FR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             ------------CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             ------------cc---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence                        00         0224578999999999999999999999999999999874

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=7.4e-44  Score=338.45  Aligned_cols=241  Identities=23%  Similarity=0.325  Sum_probs=194.2

Q ss_pred             cccEeee-ceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcC-CCCccccceEEeecCCCCc
Q 015672           81 KVSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        81 ~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~  152 (403)
                      ...|.+. +.||+|+||.||+|++..+++.||+|++....      ....+|+.+++.+. ||||+++++++.     ..
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~-----~~  101 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE-----NT  101 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE-----eC
Confidence            3458887 89999999999999999999999999986422      23457999999994 699999999883     34


Q ss_pred             eEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecC---CCCce----
Q 015672          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKG---EPNVS----  224 (403)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~---~~~~~----  224 (403)
                      ..+++||||+.+ +|..++..  .....+++..++.++.||+.||.|||+ .||+||||||+|||++.   .+.++    
T Consensus       102 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~-~givH~Dikp~NIl~~~~~~~~~~kL~Df  178 (327)
T 3lm5_A          102 SEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIVDF  178 (327)
T ss_dssp             SEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred             CeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence            458899999985 55443321  123568999999999999999999999 89999999999999986   33332    


Q ss_pred             --------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          225 --------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       225 --------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                    ..||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.........   
T Consensus       179 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---  254 (327)
T 3lm5_A          179 GMSRKIGHACELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE---  254 (327)
T ss_dssp             GGCEEC---------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT---
T ss_pred             ccccccCCccccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc---
Confidence                          2478999999998654 5899999999999999999999999988877776666543211111   


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                                            .....+++.+.+||.+||+.||++|||++++|+||||++....
T Consensus       255 ----------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~  297 (327)
T 3lm5_A          255 ----------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE  297 (327)
T ss_dssp             ----------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred             ----------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence                                  0114578999999999999999999999999999999987543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.4e-43  Score=327.86  Aligned_cols=233  Identities=28%  Similarity=0.402  Sum_probs=188.9

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..+|.+.+.||+|+||.||+|++..+++.||||++....       ....+|+.+++.++||||+++++++..     ..
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   84 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-----PT   84 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----CC
Confidence            346999999999999999999999999999999985321       234579999999999999999998733     34


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------  225 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------  225 (403)
                      ..++||||++ ++|.+++..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++       
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~  159 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDAHMNAKIADFGLSN  159 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HCSSCCCCCGGGEEECTTSCEEECCCCGGG
T ss_pred             eEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChhhEEECCCCCEEEeeccccc
Confidence            5889999997 588777654    3568999999999999999999999 79999999999999987765533       


Q ss_pred             -----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          226 -----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       226 -----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                 .+|+.|+|||++.+....+.++|||||||++|+|++|..||...+.......+....            
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------  227 (276)
T 2h6d_A          160 MMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV------------  227 (276)
T ss_dssp             CCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------------
T ss_pred             ccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc------------
Confidence                       357889999998765545789999999999999999999998776555544443210            


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                           ..            ++..++.++.+||.+||+.||++|||+.++++||||++.
T Consensus       228 -----~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          228 -----FY------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             -----CC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             -----cc------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence                 00            124578999999999999999999999999999999864

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.6e-43  Score=338.81  Aligned_cols=264  Identities=25%  Similarity=0.436  Sum_probs=202.0

Q ss_pred             ccEeeeceecccCceEEEEEEECCCC-cEEEEEEccccc---ccHHHHHHHHHhcCCCC------ccccceEEeecCCCC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETG-EIVAIKKVLQDK---RYKNRELQIMQMLDHPN------IVALKHCFFSTTDKE  151 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~~~~~~---~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~~~  151 (403)
                      .+|.+.+.||+|+||+||+|++..++ +.||+|++....   ....+|+.+++.++|++      ++.+++++..     
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~-----   93 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF-----   93 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE-----
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee-----
Confidence            46999999999999999999998777 689999986532   23457999999997766      7777777632     


Q ss_pred             ceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceec-------------
Q 015672          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVK-------------  218 (403)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~-------------  218 (403)
                      ..++++||||+++++...+....  ...+++..++.++.||+.||.|||+ +||+||||||+|||++             
T Consensus        94 ~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           94 HGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             CCeEEEEEeccCCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeccccccccccccc
Confidence            33589999999988876655421  2468999999999999999999999 8999999999999993             


Q ss_pred             ------CCCCc----------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 015672          219 ------GEPNV----------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLV  276 (403)
Q Consensus       219 ------~~~~~----------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~  276 (403)
                            ..+.+                ...||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+.
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  249 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV  249 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             ccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence                  23332                23578999999999654 58999999999999999999999999998888888


Q ss_pred             HHHHHhCCCCHHHHhhcCcCccc----cCCCCCC---------CCCccc--ccccCCCHHHHHHHHHhcccCCCCCCCHH
Q 015672          277 EIIKVLGTPTREEIKCMNPNYTE----FKFPQIK---------PHPWHK--VFQKRLPPEAVDLVCRFFQYSPNLRCTAL  341 (403)
Q Consensus       277 ~i~~~~~~~~~~~~~~~~~~~~~----~~~~~~~---------~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rpta~  341 (403)
                      .+.+..+..+...+.........    ..++...         ..++..  ......++++.+||.+||+.||++|||+.
T Consensus       250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  329 (355)
T 2eu9_A          250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA  329 (355)
T ss_dssp             HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence            88888888777655432211000    0000000         000000  00112246799999999999999999999


Q ss_pred             HHhcCCCcccCCC
Q 015672          342 EACVHPFFDELRD  354 (403)
Q Consensus       342 e~l~hp~f~~~~~  354 (403)
                      |+|+||||+++..
T Consensus       330 e~l~hp~f~~~~~  342 (355)
T 2eu9_A          330 EALLHPFFAGLTP  342 (355)
T ss_dssp             HHTTSGGGGGCCH
T ss_pred             HHhcChhhcCCCh
Confidence            9999999998754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.2e-44  Score=342.88  Aligned_cols=263  Identities=22%  Similarity=0.379  Sum_probs=194.2

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      ..+|.+.+.||+|+||.||+|++..+++.||+|++....     ....+|+.+++.++||||+++++++..     ...+
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~  106 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI  106 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TTEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CCEE
Confidence            346999999999999999999999999999999986542     234579999999999999999998843     3348


Q ss_pred             EEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-CccccccccccceecCCCCcee--------
Q 015672          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVKGEPNVSY--------  225 (403)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~-~ivHrDlKp~NILl~~~~~~~~--------  225 (403)
                      ++||||+++ +|.+++..    ...+++..+..++.||+.||.|||+ . ||+||||||+|||++.++.+++        
T Consensus       107 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  181 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  181 (360)
T ss_dssp             EEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             EEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-hCCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence            899999974 88777654    3568999999999999999999998 5 8999999999999988766543        


Q ss_pred             ---------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh-CCCCHHHHh--hc
Q 015672          226 ---------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL-GTPTREEIK--CM  293 (403)
Q Consensus       226 ---------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~--~~  293 (403)
                               .||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+.... +........  ..
T Consensus       182 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3eqc_A          182 LIDSMANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  260 (360)
T ss_dssp             HHHHC----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred             cccccccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence                     468899999999654 58999999999999999999999998876554332221111 110000000  00


Q ss_pred             CcCccccCCCCCCCC------------CcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCC
Q 015672          294 NPNYTEFKFPQIKPH------------PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  354 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  354 (403)
                      ......+........            .........++.++.+||.+||+.||++|||+.|+|+||||++...
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  333 (360)
T 3eqc_A          261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  333 (360)
T ss_dssp             -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence            000000000000000            0000112347889999999999999999999999999999987643

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.7e-45  Score=356.69  Aligned_cols=238  Identities=17%  Similarity=0.246  Sum_probs=180.0

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-------cccHHHHH---HHHHhcCCCCccccc-------eE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNREL---QIMQMLDHPNIVALK-------HC  143 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~---~~l~~l~h~niv~~~-------~~  143 (403)
                      ...|.+.+.||+|+||+||+|++..+|+.||||++...       .....+|+   ++++.++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            45699999999999999999999999999999998532       12345788   455556899999998       44


Q ss_pred             EeecC---------CCCce---EEEEEeeccCCcHHHHHHHhhhhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 015672          144 FFSTT---------DKEEL---YLNLVLEYVPETVNRIARNYSRIHQ---RMPLIYVKLYTYQICRALAYIHNCIGICHR  208 (403)
Q Consensus       144 ~~~~~---------~~~~~---~~~lv~e~~~~~l~~~~~~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~~ivHr  208 (403)
                      +....         +.+..   ..++||||++++|.+++........   .+++..+..++.||+.||.|||+ +||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence            32211         11111   2789999999999888775432111   23347777899999999999999 899999


Q ss_pred             ccccccceecCCCCcee----------------eccccccchhhhhCC----------CCCCchhHHHHHHHHHHHHHhC
Q 015672          209 DIKPQNLLVKGEPNVSY----------------ICSRYYRAPELIFGA----------TEYTTAIDIWSTGCVMAELLLG  262 (403)
Q Consensus       209 DlKp~NILl~~~~~~~~----------------~~t~~y~aPE~~~~~----------~~~~~~~DiwSlGvil~el~tg  262 (403)
                      ||||+|||++.++.+++                +| +.|+|||++.+.          ..++.++|||||||++|||++|
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg  309 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA  309 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHC
Confidence            99999999998776643                35 889999999765          2589999999999999999999


Q ss_pred             CCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHH
Q 015672          263 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE  342 (403)
Q Consensus       263 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e  342 (403)
                      +.||.+.+.......+.                       .          ....+++++.+||.+||+.||++|||+.+
T Consensus       310 ~~Pf~~~~~~~~~~~~~-----------------------~----------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e  356 (377)
T 3byv_A          310 DLPITKDAALGGSEWIF-----------------------R----------SCKNIPQPVRALLEGFLRYPKEDRLLPLQ  356 (377)
T ss_dssp             SCCC------CCSGGGG-----------------------S----------SCCCCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred             CCCCcccccccchhhhh-----------------------h----------hccCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence            99997654221110000                       0          11467899999999999999999999999


Q ss_pred             HhcCCCcccCC
Q 015672          343 ACVHPFFDELR  353 (403)
Q Consensus       343 ~l~hp~f~~~~  353 (403)
                      +++||||+++.
T Consensus       357 ~l~hp~f~~~~  367 (377)
T 3byv_A          357 AMETPEYEQLR  367 (377)
T ss_dssp             HHTSHHHHHHH
T ss_pred             HhhChHHHHHH
Confidence            99999998764

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-44  Score=342.72  Aligned_cols=239  Identities=28%  Similarity=0.448  Sum_probs=188.4

Q ss_pred             cccEeeeceecccCceEEEEEEEC---CCCcEEEEEEccccc--------ccHHHHHHHHHhc-CCCCccccceEEeecC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK--------RYKNRELQIMQML-DHPNIVALKHCFFSTT  148 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  148 (403)
                      ..+|.+.+.||+|+||.||+|++.   .+++.||||++....        ....+|+++++.+ +|+||+++++++..  
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--  130 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--  130 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence            356999999999999999999984   589999999885321        2334699999999 69999999998843  


Q ss_pred             CCCceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce---
Q 015672          149 DKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS---  224 (403)
Q Consensus       149 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~---  224 (403)
                         ...+++||||++ ++|..++..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++   
T Consensus       131 ---~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~D  202 (355)
T 1vzo_A          131 ---ETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNGHVVLTD  202 (355)
T ss_dssp             ---TTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEESC
T ss_pred             ---CceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCcEEEee
Confidence               335889999997 477776654    3578999999999999999999999 8999999999999998776543   


Q ss_pred             -----------------eeccccccchhhhhCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015672          225 -----------------YICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  286 (403)
Q Consensus       225 -----------------~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~  286 (403)
                                       .+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...........+.+....  
T Consensus       203 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--  280 (355)
T 1vzo_A          203 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--  280 (355)
T ss_dssp             SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--
T ss_pred             CCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc--
Confidence                             2478899999999653 34789999999999999999999999754332212222111000  


Q ss_pred             HHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCCC
Q 015672          287 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  354 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~~  354 (403)
                                 .   .+         .++..+++.+.+||.+||..||++||     |+.++++||||+++..
T Consensus       281 -----------~---~~---------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~  330 (355)
T 1vzo_A          281 -----------S---EP---------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  330 (355)
T ss_dssp             -----------C---CC---------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             -----------c---CC---------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence                       0   00         02246789999999999999999999     9999999999998753

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-43  Score=332.78  Aligned_cols=242  Identities=23%  Similarity=0.370  Sum_probs=194.9

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc---cccHHHHHHHHHhc-CCCCccccceEEeecCCC-CceEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQML-DHPNIVALKHCFFSTTDK-EELYL  155 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~-~~~~~  155 (403)
                      ...|.+.+.||+|+||.||+|++..+++.||||++...   .....+|+.+++.+ +||||+++++++...... ....+
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~  102 (326)
T 2x7f_A           23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL  102 (326)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceE
Confidence            34599999999999999999999999999999998543   33456899999999 899999999988653321 14568


Q ss_pred             EEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      ++||||+++ +|.+++....  ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++         
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  179 (326)
T 2x7f_A          103 WLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  179 (326)
T ss_dssp             EEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred             EEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence            899999985 8887776532  3568899999999999999999999 89999999999999987665432         


Q ss_pred             ----------eccccccchhhhhC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015672          226 ----------ICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       226 ----------~~t~~y~aPE~~~~----~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  291 (403)
                                .||+.|+|||++..    ...++.++|||||||++|+|++|..||.+.+....+..+.... .       
T Consensus       180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~-------  251 (326)
T 2x7f_A          180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-A-------  251 (326)
T ss_dssp             -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-C-------
T ss_pred             CcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-c-------
Confidence                      36888999999852    3358899999999999999999999998877665554443210 0       


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                                 +.        .....+++.+.+||.+||..||.+|||+.++++||||++.
T Consensus       252 -----------~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          252 -----------PR--------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             -----------CC--------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             -----------cc--------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence                       00        0124578999999999999999999999999999999875

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.2e-43  Score=332.59  Aligned_cols=249  Identities=26%  Similarity=0.364  Sum_probs=179.1

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      ..+|.+.+.||+|+||.||+|++..+++.||||++....     ....+|+.+++.++||||+++++++....     ..
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~   88 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-----EL   88 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS-----CE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-----Cc
Confidence            345999999999999999999998899999999885432     23357899999999999999999885433     38


Q ss_pred             EEEeeccC-CcHHHHHHHhhh----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----
Q 015672          156 NLVLEYVP-ETVNRIARNYSR----IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----  225 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~----~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----  225 (403)
                      ++||||++ ++|.+++.....    ....+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++     
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-NGQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            89999996 588777664322    13458999999999999999999999 89999999999999987765432     


Q ss_pred             -------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015672          226 -------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  286 (403)
Q Consensus       226 -------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~  286 (403)
                                         .||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+............. +.
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~  246 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP-PS  246 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC-CC
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC-Cc
Confidence                               3678899999986544589999999999999999999999988766554433222100 00


Q ss_pred             HHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCC
Q 015672          287 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  354 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  354 (403)
                                        .............+++++.+||.+||+.||.+|||+.++++||||++...
T Consensus       247 ------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          247 ------------------LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             ------------------TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             ------------------cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence                              00000001122467899999999999999999999999999999988653

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=328.15  Aligned_cols=237  Identities=29%  Similarity=0.433  Sum_probs=190.1

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc--ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      ...|.+.+.||+|+||.||+|.+..+++.||||++....  ....+|+.+++.++||||+++++++..     ...+++|
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv  102 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTDLWIV  102 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEEEE
Confidence            345999999999999999999999999999999986543  345689999999999999999998854     2348899


Q ss_pred             eeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------------
Q 015672          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------------  225 (403)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------------  225 (403)
                      |||+++ +|.+++..   ....+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++            
T Consensus       103 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          103 MEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHF-MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             EECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             eecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            999985 77776653   24678999999999999999999999 89999999999999987765532            


Q ss_pred             -------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 015672          226 -------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  298 (403)
Q Consensus       226 -------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  298 (403)
                             .||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.... .+             
T Consensus       179 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~-------------  243 (314)
T 3com_A          179 MAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP-PP-------------  243 (314)
T ss_dssp             BSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CC-------------
T ss_pred             ccccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC-Cc-------------
Confidence                   367889999998654 58999999999999999999999998877655444332210 00             


Q ss_pred             ccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                      .  +          ..+..++.++.+||.+||..||.+|||+.++++||||+...
T Consensus       244 ~--~----------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          244 T--F----------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             C--C----------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             c--c----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence            0  0          01234689999999999999999999999999999998753

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=6.1e-43  Score=325.78  Aligned_cols=238  Identities=28%  Similarity=0.455  Sum_probs=192.9

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc------cccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ...+|.+.+.||+|+||.||+|++..+++.||||++...      .....+|+++++.++||||+++++++.     ...
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   94 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSS   94 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----CCC
Confidence            345699999999999999999999999999999998532      223457999999999999999999873     334


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC---Ccee----
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP---NVSY----  225 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~---~~~~----  225 (403)
                      .+++||||+. ++|.+.+..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++   .+++    
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg  169 (287)
T 2wei_A           95 SFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFG  169 (287)
T ss_dssp             EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred             eEEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChhhEEEecCCCcccEEEeccC
Confidence            5889999997 567655543    3568999999999999999999999 8999999999999997543   2222    


Q ss_pred             --------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015672          226 --------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       226 --------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  291 (403)
                                    .+|+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+....+.......      
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------  241 (287)
T 2wei_A          170 LSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF------  241 (287)
T ss_dssp             GGGTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------
T ss_pred             cceeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC------
Confidence                          35778999999854  38999999999999999999999999887666555544321000      


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCC
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  354 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  354 (403)
                               ..+          ....+++++.+||.+||..||++|||+.++++||||++..+
T Consensus       242 ---------~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          242 ---------DLP----------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             ---------CSG----------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             ---------Cch----------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence                     000          11457899999999999999999999999999999987643

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=9.4e-43  Score=326.95  Aligned_cols=232  Identities=24%  Similarity=0.367  Sum_probs=192.5

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      ...|.+.+.||+|+||.||+|++..+++.||||++....     ....+|+.+++.++||||+++++++..     ...+
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   95 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKL   95 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeE
Confidence            345999999999999999999999999999999985432     334689999999999999999998843     3348


Q ss_pred             EEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      ++||||+++ +|.+++.     ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++         
T Consensus        96 ~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  169 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHGEVKLADFGVAGQL  169 (303)
T ss_dssp             EEEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChheEEECCCCCEEEeecccceec
Confidence            899999985 7766553     2578999999999999999999999 89999999999999987665432         


Q ss_pred             ----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          226 ----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       226 ----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                .||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+....  +          
T Consensus       170 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~----------  236 (303)
T 3a7i_A          170 TDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN--P----------  236 (303)
T ss_dssp             BTTBCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--C----------
T ss_pred             CccccccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC--C----------
Confidence                      367889999998654 58999999999999999999999998777655544433210  0          


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                                      ..++..++.++.+||.+||..||++|||+.++++||||...
T Consensus       237 ----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          237 ----------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             ----------------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             ----------------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence                            00224678999999999999999999999999999999764

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.5e-44  Score=337.09  Aligned_cols=258  Identities=19%  Similarity=0.296  Sum_probs=188.6

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      ...|.+.+.||+|+||+||+|++..+++.||||++....     ....+|+++++.++||||+++++++...   ...++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~   84 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK   84 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CCceE
Confidence            345999999999999999999999999999999985422     2345899999999999999999987432   23357


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccccccee----cCCCCc-------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV----KGEPNV-------  223 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl----~~~~~~-------  223 (403)
                      ++||||++ ++|..++..... ...+++..++.++.||+.||.|||+ .||+||||||+|||+    +..+.+       
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             EEEEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            89999997 688777765322 2348999999999999999999999 899999999999998    443222       


Q ss_pred             -----------eeeccccccchhhhhC-------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHH
Q 015672          224 -----------SYICSRYYRAPELIFG-------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESG----VDQLVEIIKV  281 (403)
Q Consensus       224 -----------~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~----~~~~~~i~~~  281 (403)
                                 ...||+.|+|||++..       ...++.++|||||||++|+|++|+.||.....    .+.+..+...
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence                       2347899999999852       34589999999999999999999999975433    3334443332


Q ss_pred             hCCCCHHHHhhc-CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 015672          282 LGTPTREEIKCM-NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF  348 (403)
Q Consensus       282 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~  348 (403)
                        .|. ..+... ......+.+...  .+....+...+++.+.+||.+||++||++|||++|+|+||=
T Consensus       243 --~p~-~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          243 --KPS-GAISGVQKAENGPIDWSGD--MPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             --CCT-TCCEEEECSTTCCEEEESS--CCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             --CCc-ccchhhhcccCCccccCcc--CCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence              111 111000 000000000000  00001122345678999999999999999999999999974

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=9.9e-43  Score=325.79  Aligned_cols=238  Identities=26%  Similarity=0.377  Sum_probs=190.4

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++     ....
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~   84 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDD   84 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSS
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCC
Confidence            346999999999999999999999999999999884321       2345799999999999999999987     3344


Q ss_pred             EEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------
Q 015672          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------  224 (403)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------  224 (403)
                      .+++||||+++ +|.+++..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++        
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~  159 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDSNKTLKIFDFGIAK  159 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCSSST
T ss_pred             eEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEEeCCCcc
Confidence            58899999974 88777654    3578999999999999999999999 8999999999999998776543        


Q ss_pred             ------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          225 ------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       225 ------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                                  ..||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+............ .+.      
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~------  231 (294)
T 4eqm_A          160 ALSETSLTQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS-VPN------  231 (294)
T ss_dssp             TC-------------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC-CCC------
T ss_pred             ccccccccccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc-CCC------
Confidence                        2478999999999765 48999999999999999999999999887665544333210 010      


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                                       ........+++.+.++|.+||..||.+||+..+.+.+.|..-+.
T Consensus       232 -----------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          232 -----------------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             -----------------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             -----------------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence                             01112356889999999999999999999766666676665443

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5e-43  Score=334.06  Aligned_cols=247  Identities=23%  Similarity=0.354  Sum_probs=172.9

Q ss_pred             ccccEeeec-eecccCceEEEEEEECCCCcEEEEEEcccccccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           80 QKVSYIAEH-VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        80 ~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      ...+|.+.+ +||+|+||+||+|+++.+++.||||++.............++.++|+||+++++++.... ....++++|
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv  104 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCLLII  104 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceEEEE
Confidence            445699955 699999999999999999999999998765544444455677889999999999875432 335668999


Q ss_pred             eeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC---ce----------
Q 015672          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN---VS----------  224 (403)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~---~~----------  224 (403)
                      |||+++ +|.+++....  ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.   ++          
T Consensus       105 ~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~  181 (336)
T 3fhr_A          105 MECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET  181 (336)
T ss_dssp             EECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence            999985 8877765421  2468999999999999999999999 89999999999999975332   32          


Q ss_pred             -------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          225 -------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       225 -------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                             ..+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.............+..             
T Consensus       182 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------  247 (336)
T 3fhr_A          182 TQNALQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL-------------  247 (336)
T ss_dssp             ----------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC-------------------------------
T ss_pred             cccccccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc-------------
Confidence                   2358889999998544 5889999999999999999999999766543322111111000             


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                      ....++.        .....+++++.+||.+||+.||++|||+.|+++||||++.
T Consensus       248 ~~~~~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          248 GQYGFPN--------PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             ---CCCT--------TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             cccccCc--------hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            0000110        0114579999999999999999999999999999999874

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.5e-42  Score=323.22  Aligned_cols=241  Identities=23%  Similarity=0.343  Sum_probs=185.9

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCC--------
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTD--------  149 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--------  149 (403)
                      ..+|.+.+.||+|+||.||+|++..+++.||||++....   ....+|+.+++.++||||+++++++.....        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            456999999999999999999999999999999986432   234579999999999999999998754321        


Q ss_pred             CCceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---
Q 015672          150 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---  225 (403)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---  225 (403)
                      .....+++||||++ ++|.+++...   ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++   
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHS-QGIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHh-CCeecccCCHHhEEEcCCCCEEEeeC
Confidence            23567899999997 5888777642   2457778889999999999999999 89999999999999986654422   


Q ss_pred             ------------------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHH
Q 015672          226 ------------------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQL  275 (403)
Q Consensus       226 ------------------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~  275 (403)
                                                    .||+.|+|||++.+...++.++|||||||++|+|++   ||.........
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~  237 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI  237 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence                                          367789999999766568999999999999999998   55432222221


Q ss_pred             HHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          276 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       276 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                      .......                ...++        ..+....++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus       238 ~~~~~~~----------------~~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          238 LKKLRSV----------------SIEFP--------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHHST----------------TCCCC--------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             HHhcccc----------------ccccC--------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            1111110                00111        11234567889999999999999999999999999999764

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.4e-43  Score=332.85  Aligned_cols=229  Identities=23%  Similarity=0.374  Sum_probs=188.0

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----------ccHHHHHHHHHhcC--CCCccccceEEeecC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLD--HPNIVALKHCFFSTT  148 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~--h~niv~~~~~~~~~~  148 (403)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....          ....+|+.+++.+.  |+||+++++++.   
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~---  118 (320)
T 3a99_A           42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE---  118 (320)
T ss_dssp             TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE---
T ss_pred             cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe---
Confidence            345999999999999999999999999999999985432          23457999999996  599999999884   


Q ss_pred             CCCceEEEEEeeccC--CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceec-CCCCce-
Q 015672          149 DKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVK-GEPNVS-  224 (403)
Q Consensus       149 ~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~-~~~~~~-  224 (403)
                        .....++|||++.  ++|.+++..    ...+++..++.++.||+.||.|||+ .||+||||||+|||++ .++.++ 
T Consensus       119 --~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~kL  191 (320)
T 3a99_A          119 --RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKL  191 (320)
T ss_dssp             --CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEE
T ss_pred             --cCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeCCCCHHHEEEeCCCCCEEE
Confidence              3345889999997  677776654    3578999999999999999999999 8999999999999998 444432 


Q ss_pred             ----------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015672          225 ----------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  288 (403)
Q Consensus       225 ----------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~  288 (403)
                                      ..||+.|+|||++.+...++.++|||||||++|+|++|+.||...+      .+...       
T Consensus       192 ~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~-------  258 (320)
T 3a99_A          192 IDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-------  258 (320)
T ss_dssp             CCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-------
T ss_pred             eeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcc-------
Confidence                            2468899999998766555789999999999999999999996432      11110       


Q ss_pred             HHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCC
Q 015672          289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  354 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  354 (403)
                                ..            .++..+++++.+||.+||+.||++|||+.++++||||++...
T Consensus       259 ----------~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  302 (320)
T 3a99_A          259 ----------QV------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  302 (320)
T ss_dssp             ----------CC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             ----------cc------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence                      00            022467899999999999999999999999999999998754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.2e-42  Score=322.71  Aligned_cols=234  Identities=23%  Similarity=0.321  Sum_probs=186.6

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc------cHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ..+|.+.+.||+|+||+||+|++  +++.||||++.....      ...+|++++++++||||+++++++..     ...
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~  108 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ-----PPN  108 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----TTC
T ss_pred             hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCc
Confidence            34699999999999999999987  488999999864331      23479999999999999999998833     333


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--ccccccccccceecCCCCcee------
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVKGEPNVSY------  225 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~--ivHrDlKp~NILl~~~~~~~~------  225 (403)
                      +++||||++ ++|.+++..... ...+++..+..++.||+.||.|||+ .|  |+||||||+|||++.++.+++      
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  186 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS  186 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHT-SSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred             eEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence            789999997 488777654221 1248899999999999999999999 79  999999999999987765532      


Q ss_pred             -------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          226 -------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       226 -------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                                   .||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.......       
T Consensus       187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~-------  258 (309)
T 3p86_A          187 RLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL-------  258 (309)
T ss_dssp             ---------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC-------
T ss_pred             ccccccccccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-------
Confidence                         468899999999654 58999999999999999999999998887666554443211000       


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc--CCCccc
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV--HPFFDE  351 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~--hp~f~~  351 (403)
                                          .++..+++++.+||.+||+.||.+|||+.++++  +++++.
T Consensus       259 --------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          259 --------------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             --------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                                123568899999999999999999999999987  445443

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=333.97  Aligned_cols=236  Identities=18%  Similarity=0.214  Sum_probs=188.7

Q ss_pred             cccEeeeceecccCceEEEEEEE-----CCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  150 (403)
                      ..+|.+.+.||+|+||+||+|+.     ..+++.||||++....     ....+|+.+++.++||||+++++++..    
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----  145 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ----  145 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence            45699999999999999999994     4567899999985432     234579999999999999999998843    


Q ss_pred             CceEEEEEeeccC-CcHHHHHHHhhh---hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC---c
Q 015672          151 EELYLNLVLEYVP-ETVNRIARNYSR---IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN---V  223 (403)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~---~  223 (403)
                       ....++|||||. ++|.+++.....   ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.   +
T Consensus       146 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          146 -SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             -CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEEecCCCCceE
Confidence             233689999996 588887765432   12458889999999999999999999 89999999999999985443   3


Q ss_pred             ee---------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 015672          224 SY---------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKV  281 (403)
Q Consensus       224 ~~---------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~  281 (403)
                      ++                     .+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+.+..+...
T Consensus       224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~  302 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  302 (367)
T ss_dssp             EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             EECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            22                     247789999998655 58999999999999999998 99999988776665554432


Q ss_pred             hCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          282 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                      ...+                            .+..+++++.+||.+||+.||++|||+.++++|.++-.
T Consensus       303 ~~~~----------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          303 GRMD----------------------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             CCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCC----------------------------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            1000                            12457899999999999999999999999999977643

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.6e-42  Score=320.61  Aligned_cols=236  Identities=25%  Similarity=0.405  Sum_probs=184.6

Q ss_pred             eeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEee
Q 015672           85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLE  160 (403)
Q Consensus        85 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  160 (403)
                      ....+||+|+||.||+|++..+++.||||.+....    ....+|+.+++.++||||+++++++..     ...+++|||
T Consensus        25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e   99 (295)
T 2clq_A           25 GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKIFME   99 (295)
T ss_dssp             SSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEEEE
T ss_pred             CCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEEEEE
Confidence            33458999999999999999999999999886432    234579999999999999999998843     335889999


Q ss_pred             ccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecC-CCCce--------------
Q 015672          161 YVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKG-EPNVS--------------  224 (403)
Q Consensus       161 ~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~-~~~~~--------------  224 (403)
                      |++ ++|..++.... ....+++..+..++.||+.||.|||+ .||+||||||+|||++. ++.++              
T Consensus       100 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          100 QVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             CCSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             eCCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHh-CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            996 67877765421 12346688888999999999999999 89999999999999986 44432              


Q ss_pred             -----eeccccccchhhhhCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 015672          225 -----YICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  298 (403)
Q Consensus       225 -----~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  298 (403)
                           ..||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...................             
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------------  244 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH-------------  244 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC-------------
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc-------------
Confidence                 2467889999998643 237899999999999999999999997654443222111111100             


Q ss_pred             ccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                                   ..++..+++++.+||.+||+.||++|||+.++++||||+...
T Consensus       245 -------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          245 -------------PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             -------------CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             -------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence                         012346789999999999999999999999999999998754

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=8.5e-42  Score=322.26  Aligned_cols=239  Identities=21%  Similarity=0.334  Sum_probs=180.3

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccccc------HHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY------KNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ...+|.+.+.||+|+||.||+|++..+++.||||++......      ...+..+++.++||||+++++++..     ..
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-----~~   97 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-----NT   97 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-----CC
Confidence            345699999999999999999999999999999998643221      1234456888899999999998843     33


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-CccccccccccceecCCCCcee-------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVKGEPNVSY-------  225 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~-~ivHrDlKp~NILl~~~~~~~~-------  225 (403)
                      .+++||||+++.+..+...   ....+++..+..++.||+.||.|||+ . ||+||||||+|||++.++.+++       
T Consensus        98 ~~~lv~e~~~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  173 (318)
T 2dyl_A           98 DVFIAMELMGTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGQIKLCDFGISG  173 (318)
T ss_dssp             EEEEEECCCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-HHCCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred             cEEEEEeccCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh-hCCEEeCCCCHHHEEECCCCCEEEEECCCch
Confidence            5889999997666555432   24678999999999999999999998 5 9999999999999987765533       


Q ss_pred             -----------eccccccchhhhh----CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHH
Q 015672          226 -----------ICSRYYRAPELIF----GATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       226 -----------~~t~~y~aPE~~~----~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~-~~~~~~i~~~~~~~~~~~  289 (403)
                                 .+|+.|+|||++.    ....++.++|||||||++|+|++|+.||..... .+.+..+....  ++   
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~---  248 (318)
T 2dyl_A          174 RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE--PP---  248 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC--CC---
T ss_pred             hccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC--CC---
Confidence                       3688899999984    234588999999999999999999999987443 34444433310  00   


Q ss_pred             HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                                 .++          ....+++++.+||.+||..||.+|||+.++++||||++..
T Consensus       249 -----------~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          249 -----------LLP----------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             -----------CCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             -----------CCC----------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence                       000          0135789999999999999999999999999999998753

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.5e-42  Score=331.87  Aligned_cols=256  Identities=20%  Similarity=0.312  Sum_probs=190.6

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---------------------ccHHHHHHHHHhcCCCCccc
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------------------RYKNRELQIMQMLDHPNIVA  139 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------------~~~~~E~~~l~~l~h~niv~  139 (403)
                      ..+|.+.+.||+|+||.||+|++  +++.||||++....                     ....+|+.+++.++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            45699999999999999999998  89999999985321                     44568999999999999999


Q ss_pred             cceEEeecCCCCceEEEEEeeccCC-cHHHHHHHh--hh--hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccccc
Q 015672          140 LKHCFFSTTDKEELYLNLVLEYVPE-TVNRIARNY--SR--IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (403)
Q Consensus       140 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~N  214 (403)
                      +++++..     ...+++||||+++ +|.+++...  ..  ....+++..+..++.||+.||.|||+..||+||||||+|
T Consensus       108 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N  182 (348)
T 2pml_X          108 CEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN  182 (348)
T ss_dssp             CSEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred             EEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence            9998843     3458999999985 664431100  11  146789999999999999999999962599999999999


Q ss_pred             ceecCCCCcee-----------------eccccccchhhhhCCCCCCc-hhHHHHHHHHHHHHHhCCCCCCCCCc-HHHH
Q 015672          215 LLVKGEPNVSY-----------------ICSRYYRAPELIFGATEYTT-AIDIWSTGCVMAELLLGQPLFPGESG-VDQL  275 (403)
Q Consensus       215 ILl~~~~~~~~-----------------~~t~~y~aPE~~~~~~~~~~-~~DiwSlGvil~el~tg~~pf~~~~~-~~~~  275 (403)
                      ||++.++.+++                 .+|+.|+|||++.+...++. ++|||||||++|+|++|..||.+.+. .+..
T Consensus       183 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  262 (348)
T 2pml_X          183 ILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF  262 (348)
T ss_dssp             EEECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred             EEEcCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence            99987765543                 36788999999976534666 99999999999999999999988776 4444


Q ss_pred             HHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          276 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       276 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                      ..+.......+.        ....+..+ ... .........+++++.+||.+||+.||.+|||+.|+++||||++..
T Consensus       263 ~~i~~~~~~~~~--------~~~~~~~~-~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          263 NNIRTKNIEYPL--------DRNHFLYP-LTN-KKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             HHHTSCCCCCCC--------SSSSSTTT-TCC---------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             HHHhccCcCCcc--------chhhhhcc-ccc-cccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            333221000000        00000000 000 000112256899999999999999999999999999999998753

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=7.9e-42  Score=324.80  Aligned_cols=229  Identities=19%  Similarity=0.186  Sum_probs=184.0

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc--cccHHHHHHHHHhc-CCCCccccceEEeecCCCCceEEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      .+|.+.+.||+|+||.||+|++..+++.||||++...  .....+|+.+++.+ +|+||+++++++..     ..+.++|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~~lv   83 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYNAMV   83 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEEEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCccEEE
Confidence            4599999999999999999999999999999988533  34567899999999 99999999998743     3458899


Q ss_pred             eeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC-----c----------
Q 015672          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN-----V----------  223 (403)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~-----~----------  223 (403)
                      |||++++|.+++...   ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.     +          
T Consensus        84 ~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           84 LELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHS-KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             EEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            999988898877653   3579999999999999999999999 89999999999999976543     2          


Q ss_pred             ----------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCC
Q 015672          224 ----------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---DQLVEIIKVLGT  284 (403)
Q Consensus       224 ----------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~---~~~~~i~~~~~~  284 (403)
                                      ...||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..   +.+..+......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  238 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA  238 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence                            23478899999999664 5899999999999999999999999875432   333333222111


Q ss_pred             CCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          285 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      .+.+.                        ....++ ++.+||.+||..||.+||+++++++
T Consensus       239 ~~~~~------------------------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          239 TPIEV------------------------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             SCHHH------------------------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CCHHH------------------------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            11110                        112244 9999999999999999999998876

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=6.4e-42  Score=324.89  Aligned_cols=233  Identities=23%  Similarity=0.327  Sum_probs=189.2

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCc---EEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      ...+|.+.+.||+|+||.||+|++..+++   .||||++....     ....+|+.+++.++||||+++++++     ..
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~  121 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----TR  121 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CG
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence            34569999999999999999999986655   49999986432     2345799999999999999999988     33


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----  226 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----  226 (403)
                      ...+++||||++ ++|..++...   ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++++    
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  197 (325)
T 3kul_A          122 GRLAMIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSD-LGYVHRDLAARNVLVDSNLVCKVSDFGL  197 (325)
T ss_dssp             GGCCEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred             CCccEEEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEECCCCCEEECCCCc
Confidence            445889999997 4887776432   3578999999999999999999999 899999999999999877665432    


Q ss_pred             ------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015672          227 ------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  287 (403)
Q Consensus       227 ------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~  287 (403)
                                        +|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......+  
T Consensus       198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~--  274 (325)
T 3kul_A          198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP--  274 (325)
T ss_dssp             CEECC----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC--
T ss_pred             ccccccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC--
Confidence                              25579999999654 48999999999999999999 999998887766655554321110  


Q ss_pred             HHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                                                .+..+++++.+||.+||..||++|||+.++++.  ++.+
T Consensus       275 --------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~--L~~l  311 (325)
T 3kul_A          275 --------------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV--LDAL  311 (325)
T ss_dssp             --------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHH
T ss_pred             --------------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHH--HHHH
Confidence                                      124678999999999999999999999999863  4443

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=5.2e-42  Score=325.47  Aligned_cols=242  Identities=24%  Similarity=0.350  Sum_probs=173.9

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc-----cHHHHHH-HHHhcCCCCccccceEEeecCCCCceEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQ-IMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      .+|.+.+.||+|+||.||+|.+..+++.||||++.....     ...+|+. +++.++||||+++++++..     ....
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-----~~~~   96 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-----EGDC   96 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-----SSEE
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-----CCce
Confidence            459999999999999999999999999999999865321     1223444 6777899999999998843     3358


Q ss_pred             EEEeeccCCcHHHHHHHhh-hhcCCCCHHHHHHHHHHHHHHHHHHHhcC-CccccccccccceecCCCCcee--------
Q 015672          156 NLVLEYVPETVNRIARNYS-RIHQRMPLIYVKLYTYQICRALAYIHNCI-GICHRDIKPQNLLVKGEPNVSY--------  225 (403)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~L~~LH~~~-~ivHrDlKp~NILl~~~~~~~~--------  225 (403)
                      ++||||+++++..++.... .....+++..+..++.|++.||.|||+ . ||+||||||+|||++.++.+++        
T Consensus        97 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  175 (327)
T 3aln_A           97 WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ  175 (327)
T ss_dssp             EEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH-HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred             EEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc-cCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence            8999999998877765432 225678999999999999999999998 7 9999999999999987665433        


Q ss_pred             ----------eccccccchhhhh---CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHHh
Q 015672          226 ----------ICSRYYRAPELIF---GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       226 ----------~~t~~y~aPE~~~---~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~  291 (403)
                                .||+.|+|||++.   ....++.++|||||||++|+|++|..||.+.+.. +.+..+.            
T Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------------  243 (327)
T 3aln_A          176 LVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV------------  243 (327)
T ss_dssp             ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC------------
T ss_pred             cccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh------------
Confidence                      4688899999983   2335899999999999999999999999765421 1110000            


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                             ....+     .+.......+++++.+||.+||+.||++|||+.++++||||....
T Consensus       244 -------~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          244 -------KGDPP-----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             -------CSCCC-----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             -------cCCCC-----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence                   00000     011111245789999999999999999999999999999998654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.7e-41  Score=319.89  Aligned_cols=235  Identities=23%  Similarity=0.340  Sum_probs=184.1

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcC--CCCccccceEEeecCCCCce
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLD--HPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..|.+.+.||+|+||.||+|++. +++.||||++....      ....+|+++++.++  |+||+++++++..     ..
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-----~~  101 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----DQ  101 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC-----SS
T ss_pred             ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec-----CC
Confidence            45999999999999999999985 58999999985432      23357999999997  5999999998743     34


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce---------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS---------  224 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~---------  224 (403)
                      ++++|||+.+++|.+++..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++. +.++         
T Consensus       102 ~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~  175 (313)
T 3cek_A          102 YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIVD-GMLKLIDFGIANQ  175 (313)
T ss_dssp             EEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred             EEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEEEC-CeEEEeecccccc
Confidence            5889999888888877664    3578899999999999999999999 89999999999999964 2221         


Q ss_pred             ------------eeccccccchhhhhCC----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHH
Q 015672          225 ------------YICSRYYRAPELIFGA----------TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD-QLVEIIKV  281 (403)
Q Consensus       225 ------------~~~t~~y~aPE~~~~~----------~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~-~~~~i~~~  281 (403)
                                  ..||+.|+|||++.+.          ..++.++|||||||++|+|++|..||....... .+..+...
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  255 (313)
T 3cek_A          176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP  255 (313)
T ss_dssp             --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred             ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhc
Confidence                        2468899999998541          358889999999999999999999997654432 22222110


Q ss_pred             hCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          282 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                         .            ...            .++...+.++.+||.+||+.||++|||+.|+++||||+....+
T Consensus       256 ---~------------~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  302 (313)
T 3cek_A          256 ---N------------HEI------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  302 (313)
T ss_dssp             ---T------------SCC------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred             ---c------------ccc------------CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence               0            000            0123467899999999999999999999999999999875443

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.7e-41  Score=312.93  Aligned_cols=227  Identities=19%  Similarity=0.293  Sum_probs=186.1

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      ..+|++.+.||+|+||.||+|++. +++.||+|++....   ....+|++++++++||||+++++++..     ....++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   82 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICL   82 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSEEE
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCceEE
Confidence            356999999999999999999986 57789999986543   335689999999999999999998833     334889


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----------  226 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----------  226 (403)
                      ||||++ ++|.+++...   ...+++..+..++.|++.||.|||+ .||+||||||+|||++.++.++++          
T Consensus        83 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           83 VFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             EEECCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             EEEeCCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHh-CCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence            999997 4777666432   3468999999999999999999999 899999999999999876655432          


Q ss_pred             ----------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          227 ----------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       227 ----------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                +|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......           
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~-----------  226 (269)
T 4hcu_A          159 DQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-----------  226 (269)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-----------
T ss_pred             cccccccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC-----------
Confidence                      35579999998654 48999999999999999999 99999888776665554431100           


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                       ..+...++++.+||.+||+.||++|||+.++++|
T Consensus       227 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          227 -----------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             -----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                             0124578999999999999999999999999976

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1e-41  Score=329.18  Aligned_cols=231  Identities=23%  Similarity=0.320  Sum_probs=185.3

Q ss_pred             cccEeeeceecccCceEEEEEEEC-------CCCcEEEEEEccccc-----ccHHHHHHHHHhc-CCCCccccceEEeec
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCR-------ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFST  147 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~  147 (403)
                      ..+|.+.+.||+|+||.||+|++.       .++..||||++....     ....+|+.+++.+ +||||+++++++.. 
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-  158 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-  158 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS-
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc-
Confidence            457999999999999999999875       345679999986542     2245799999999 89999999998833 


Q ss_pred             CCCCceEEEEEeeccC-CcHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccccc
Q 015672          148 TDKEELYLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (403)
Q Consensus       148 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~N  214 (403)
                          ...+|+||||++ ++|.+++.....            ....++...+..++.||+.||.|||+ +||+||||||+|
T Consensus       159 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~N  233 (370)
T 2psq_A          159 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARN  233 (370)
T ss_dssp             ----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGG
T ss_pred             ----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchhh
Confidence                334889999998 488887765321            12357888999999999999999999 899999999999


Q ss_pred             ceecCCCCceee---------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcH
Q 015672          215 LLVKGEPNVSYI---------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGV  272 (403)
Q Consensus       215 ILl~~~~~~~~~---------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~  272 (403)
                      ||++.++.++++                     +|+.|+|||++.+. .++.++|||||||++|||++ |..||.+.+..
T Consensus       234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~~~  312 (370)
T 2psq_A          234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  312 (370)
T ss_dssp             EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            999877665432                     35679999999764 58999999999999999999 99999887765


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          273 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       273 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      +....+.....                            ...+..+++++.+||.+||+.||.+|||+.|++++
T Consensus       313 ~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          313 ELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             GHHHHHHTTCC----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            54443322100                            00224678999999999999999999999999874

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.3e-41  Score=322.10  Aligned_cols=241  Identities=20%  Similarity=0.251  Sum_probs=179.8

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCc---EEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCC-
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE-  151 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~-  151 (403)
                      .+|.+.+.||+|+||.||+|++..++.   .||||++....      ....+|+++++.++||||+++++++....... 
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR  102 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence            459999999999999999999877665   89999986431      23457999999999999999999885433211 


Q ss_pred             ceEEEEEeeccCC-cHHHHHHHhhh--hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee--
Q 015672          152 ELYLNLVLEYVPE-TVNRIARNYSR--IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI--  226 (403)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~--  226 (403)
                      ....++||||+.+ +|..++.....  ....+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++++  
T Consensus       103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dikp~NIli~~~~~~kl~Df  181 (323)
T 3qup_A          103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS-RNFIHRDLAARNCMLAEDMTVCVADF  181 (323)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred             CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc-CCcccCCCCcceEEEcCCCCEEEeec
Confidence            1224899999984 88777654321  11258899999999999999999999 899999999999999887665432  


Q ss_pred             -------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 015672          227 -------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  286 (403)
Q Consensus       227 -------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~  286 (403)
                                         +|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......  
T Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~--  258 (323)
T 3qup_A          182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL--  258 (323)
T ss_dssp             CC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--
T ss_pred             cccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCC--
Confidence                               35679999998664 58999999999999999999 99999887766655544331100  


Q ss_pred             HHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-------HHHHhcCCCcccC
Q 015672          287 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-------ALEACVHPFFDEL  352 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-------a~e~l~hp~f~~~  352 (403)
                                                ..+..+++++.+||.+||+.||++|||       .+++++|||+...
T Consensus       259 --------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          259 --------------------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             --------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             --------------------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence                                      012457899999999999999999999       7788899999774

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.6e-41  Score=314.29  Aligned_cols=231  Identities=19%  Similarity=0.174  Sum_probs=186.9

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc--cccHHHHHHHHHhc-CCCCccccceEEeecCCCCceEEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      .+|.+.+.||+|+||.||+|++..+++.||||++...  .....+|+.+++.+ +|+||+++++++.     ...+.++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~~lv   84 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHNVLV   84 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecC-----CCceeEEE
Confidence            4599999999999999999999999999999988543  34567899999999 7999999998773     34458899


Q ss_pred             eeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC-----ce---------
Q 015672          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN-----VS---------  224 (403)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~-----~~---------  224 (403)
                      |||++++|.+++...   ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.     ++         
T Consensus        85 ~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           85 IDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEecCCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            999988998877643   3468999999999999999999999 89999999999999976543     21         


Q ss_pred             -----------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHHhCC
Q 015672          225 -----------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES---GVDQLVEIIKVLGT  284 (403)
Q Consensus       225 -----------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~---~~~~~~~i~~~~~~  284 (403)
                                       ..||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+   ....+..+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence                             2367889999998654 58999999999999999999999998743   23333333332111


Q ss_pred             CCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          285 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      ++..                        .....+++++.+||.+||+.||++|||+.++++.
T Consensus       240 ~~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          240 TPLR------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             SCHH------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             ccHH------------------------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            1111                        1124678999999999999999999999999764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.3e-41  Score=326.81  Aligned_cols=233  Identities=23%  Similarity=0.323  Sum_probs=185.8

Q ss_pred             cccEeeeceecccCceEEEEEE-----ECCCCcEEEEEEccccc-----ccHHHHHHHHHhc-CCCCccccceEEeecCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAK-----CRETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  149 (403)
                      ..+|.+.+.||+|+||.||+|+     ...+++.||||++....     ....+|+++++.+ +||||+++++++...  
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~--   98 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--   98 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC--
Confidence            4569999999999999999999     45567899999986532     2345799999999 789999999987432  


Q ss_pred             CCceEEEEEeeccC-CcHHHHHHHhhhh----------------------------------------------------
Q 015672          150 KEELYLNLVLEYVP-ETVNRIARNYSRI----------------------------------------------------  176 (403)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~----------------------------------------------------  176 (403)
                        ...+++|||||+ ++|.+++......                                                    
T Consensus        99 --~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (359)
T 3vhe_A           99 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV  176 (359)
T ss_dssp             --TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred             --CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence              233789999998 4887777643210                                                    


Q ss_pred             ----------cCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------------------
Q 015672          177 ----------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------------------  225 (403)
Q Consensus       177 ----------~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------------------  225 (403)
                                ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+++                     
T Consensus       177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~-~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  255 (359)
T 3vhe_A          177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA  255 (359)
T ss_dssp             -------CTTTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred             hhcccccchhccccCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence                      1228889999999999999999999 89999999999999986654432                     


Q ss_pred             eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCC
Q 015672          226 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ  304 (403)
Q Consensus       226 ~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (403)
                      .+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+.........+                   
T Consensus       256 ~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-------------------  315 (359)
T 3vhe_A          256 RLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-------------------  315 (359)
T ss_dssp             EECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-------------------
T ss_pred             CCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-------------------
Confidence            357789999998754 58999999999999999998 999998877555544444321110                   


Q ss_pred             CCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          305 IKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       305 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                              ..+..+++++.+||.+||+.||.+|||+.|+++|
T Consensus       316 --------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          316 --------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                    0124578999999999999999999999999986

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.6e-41  Score=328.80  Aligned_cols=228  Identities=21%  Similarity=0.309  Sum_probs=186.1

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ...+|.+.+.||+|+||.||+|++..+++.||||++....     ....+|+++|+.++||||+++++++..     ...
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~  186 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQP  186 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-----SSS
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-----CCC
Confidence            3457999999999999999999999899999999986432     234579999999999999999998833     233


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee-------
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-------  226 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~-------  226 (403)
                      +++||||++ ++|.+++...   ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.++++       
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~  262 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLES-KCCIHRDLAARNCLVTEKNVLKISDFGMSRE  262 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             cEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence            789999997 6887776542   3458899999999999999999999 899999999999999877665432       


Q ss_pred             --------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015672          227 --------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       227 --------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  291 (403)
                                    +++.|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+....+.....        
T Consensus       263 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~--------  333 (377)
T 3cbl_A          263 EADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR--------  333 (377)
T ss_dssp             CTTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC--------
T ss_pred             cCCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------
Confidence                          24569999998654 48999999999999999998 9999988776554433322100        


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                .+          .+..+++++.+||.+||+.||++|||+.++++
T Consensus       334 ----------~~----------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          334 ----------LP----------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             ----------CC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------CC----------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                      00          12457899999999999999999999999975

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.1e-41  Score=310.07  Aligned_cols=231  Identities=20%  Similarity=0.286  Sum_probs=187.7

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      ..+|++.+.||+|+||.||+|++. ++..||+|++....   ....+|+++++.++||||+++++++     ......++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   80 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIYI   80 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceEE
Confidence            456999999999999999999875 57789999986543   3346899999999999999999987     33334889


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----------  226 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----------  226 (403)
                      ||||++ ++|.+++...   ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++++          
T Consensus        81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           81 VTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLES-HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             EEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred             EEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence            999997 5687776543   3458999999999999999999999 899999999999999887765432          


Q ss_pred             ----------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          227 ----------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       227 ----------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                +|+.|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+......           
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----------  224 (268)
T 3sxs_A          157 DQYVSSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL-----------  224 (268)
T ss_dssp             TCEEECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-----------
T ss_pred             hhhhcccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC-----------
Confidence                      34569999999654 48999999999999999999 99999887766655544321100           


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                                       ..+...++++.+||.+||+.||.+|||+.++++|  ++.+
T Consensus       225 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~--L~~l  262 (268)
T 3sxs_A          225 -----------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS--IEPL  262 (268)
T ss_dssp             -----------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH--HGGG
T ss_pred             -----------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHh
Confidence                             0124468899999999999999999999999986  5544

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.3e-41  Score=311.81  Aligned_cols=227  Identities=20%  Similarity=0.264  Sum_probs=184.1

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      ..+|.+.+.||+|+||.||+|.+. ++..||+|++....   ....+|+++++.++|+||+++++++.     ....+++
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   96 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIFI   96 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEe-----cCCCeEE
Confidence            346999999999999999999885 67789999986543   33468999999999999999999883     3334889


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----------  226 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----------  226 (403)
                      ||||++ ++|.+++...   ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.++++          
T Consensus        97 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           97 ITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             EECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             EEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            999996 6777766542   3568999999999999999999999 899999999999999887766442          


Q ss_pred             ----------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          227 ----------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       227 ----------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                +|+.|+|||++.+. .++.++|||||||++|+|++ |+.||...+..+....+......           
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-----------  240 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-----------  240 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-----------
T ss_pred             cccccccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC-----------
Confidence                      35679999999755 48999999999999999998 99999888766665554432110           


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                       ..+...++.+.+||.+||+.||.+|||+.++++|
T Consensus       241 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          241 -----------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             -----------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                             0124568999999999999999999999999976

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.5e-42  Score=325.47  Aligned_cols=251  Identities=22%  Similarity=0.252  Sum_probs=182.9

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc---cHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ...+|++.++||+|+||+||+|++.  ++.||||++.....   ...+|+.+++.++||||+++++++.... .....++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~   98 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDLW   98 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceEE
Confidence            3456999999999999999999875  78999999864332   2345888899999999999999885533 2345688


Q ss_pred             EEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC----------CccccccccccceecCCCCce-
Q 015672          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI----------GICHRDIKPQNLLVKGEPNVS-  224 (403)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~----------~ivHrDlKp~NILl~~~~~~~-  224 (403)
                      +||||+++ +|.+++..     ..+++..+..++.||+.||.|||+ .          ||+||||||+|||++.++.++ 
T Consensus        99 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL  172 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI  172 (322)
T ss_dssp             EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred             EEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHh-hccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence            99999974 88877754     468999999999999999999998 8          999999999999998765543 


Q ss_pred             --------------------eeccccccchhhhhCC----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 015672          225 --------------------YICSRYYRAPELIFGA----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIK  280 (403)
Q Consensus       225 --------------------~~~t~~y~aPE~~~~~----~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~  280 (403)
                                          ..||+.|+|||++.+.    ..++.++|||||||++|||++|+.||.+............
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence                                2468899999998653    2356688999999999999999999987543221111112


Q ss_pred             HhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          281 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      ....+....+.....  .....+.. ...+   .....++++.+||.+||+.||++|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~--~~~~~~~~-~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          253 IGQHPSLEDMQEVVV--HKKKRPVL-RDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HCSSCCHHHHHHHHT--TSCCCCCC-CGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hccCCchhhhhhhhh--cccCCCCc-cccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            222222222211000  00000000 0000   01123456999999999999999999999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.5e-41  Score=314.82  Aligned_cols=235  Identities=17%  Similarity=0.250  Sum_probs=184.2

Q ss_pred             cccEeeeceecccCceEEEEEEECCCC-------cEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETG-------EIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTD  149 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  149 (403)
                      ..+|.+.+.||+|+||+||+|++..++       ..||+|++....    ....+|+.+++.++||||+++++++...  
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--   84 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG--   84 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT--
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC--
Confidence            456999999999999999999998777       479999885432    2345799999999999999999988432  


Q ss_pred             CCceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC------
Q 015672          150 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN------  222 (403)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~------  222 (403)
                         ...++||||++ ++|.+++...   ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.      
T Consensus        85 ---~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~  157 (289)
T 4fvq_A           85 ---DENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEE-NTLIHGNVCAKNILLIREEDRKTGNP  157 (289)
T ss_dssp             ---TCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred             ---CCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhh-CCeECCCcCcceEEEecCCccccccc
Confidence               23679999998 6888777653   2348899999999999999999999 89999999999999987765      


Q ss_pred             --cee---------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHHhCC
Q 015672          223 --VSY---------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGT  284 (403)
Q Consensus       223 --~~~---------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~-~pf~~~~~~~~~~~i~~~~~~  284 (403)
                        +++               .+|+.|+|||++.+...++.++|||||||++|+|++|. +||...+... ........  
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~~--  234 (289)
T 4fvq_A          158 PFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYEDR--  234 (289)
T ss_dssp             CEEEECCCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHTT--
T ss_pred             ceeeeccCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhcc--
Confidence              332               25788999999976456899999999999999999955 5554444333 22222210  


Q ss_pred             CCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCC
Q 015672          285 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  356 (403)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~  356 (403)
                                     ..            ++...++++.+||.+||+.||++|||+.++++|  ++++..|.
T Consensus       235 ---------------~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~l~~p~  277 (289)
T 4fvq_A          235 ---------------HQ------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD--LNSLFTPD  277 (289)
T ss_dssp             ---------------CC------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH--HHTCC---
T ss_pred             ---------------CC------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHhcCCC
Confidence                           00            123457789999999999999999999999987  77776544

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.4e-41  Score=311.52  Aligned_cols=230  Identities=14%  Similarity=0.221  Sum_probs=185.6

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ..+|.+.+.||+|+||.||+|++.  ++.||||++....      ....+|+.+++.++||||+++++++...   ...+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~   83 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAPH   83 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSSS
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCCC
Confidence            456999999999999999999985  8899999986432      2345799999999999999999987432   2244


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--ccccccccccceecCCCCcee------
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVKGEPNVSY------  225 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~--ivHrDlKp~NILl~~~~~~~~------  225 (403)
                      .++||||++ ++|.+++....  ...+++..+..++.||+.||.|||+ .|  |+||||||+|||++.++..++      
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVK  160 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTT-SSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred             eEeeecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhc-CCCceecCCCccceEEEcCCcceeEEeccce
Confidence            789999998 58887775421  2258999999999999999999998 79  999999999999998766533      


Q ss_pred             --------eccccccchhhhhCCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          226 --------ICSRYYRAPELIFGATE--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~--~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                              .+|+.|+|||++.+...  ++.++|||||||++|+|++|+.||.+.+..+....+......+          
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------  230 (271)
T 3kmu_A          161 FSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP----------  230 (271)
T ss_dssp             CTTSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC----------
T ss_pred             eeecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC----------
Confidence                    46889999999975432  3348999999999999999999998887766655544321110          


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                       .++..+++++.+||.+||+.||++|||+.++++
T Consensus       231 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          231 -----------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             -----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                             122568999999999999999999999999986

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.5e-41  Score=317.36  Aligned_cols=230  Identities=26%  Similarity=0.481  Sum_probs=186.4

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ..+|.+.+.||+|+||+||+|++..+++.||+|++....    ....+|+++++.++||||+++++++..     ....+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DKRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CCeeE
Confidence            346999999999999999999999999999999875422    234579999999999999999998853     33488


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-----------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-----------  224 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-----------  224 (403)
                      +||||++ ++|.+++...   ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++           
T Consensus        84 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  159 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHS-MNIIHRDLNSHNCLVRENKNVVVADFGLARLMV  159 (310)
T ss_dssp             EEEECCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence            9999997 4887776542   3568999999999999999999999 8999999999999998765442           


Q ss_pred             ----------------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHH-----HHH
Q 015672          225 ----------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-----LVE  277 (403)
Q Consensus       225 ----------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~-----~~~  277 (403)
                                            .+||+.|+|||++.+ ..++.++|||||||++|+|++|..||........     ...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~  238 (310)
T 3s95_A          160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG  238 (310)
T ss_dssp             --------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH
T ss_pred             cccccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc
Confidence                                  247888999999965 4589999999999999999999999865422100     000


Q ss_pred             HHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          278 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       278 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                      ..                               ....+..+++++.+||.+||+.||++|||+.++++  |++.+.
T Consensus       239 ~~-------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~  281 (310)
T 3s95_A          239 FL-------------------------------DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLR  281 (310)
T ss_dssp             HH-------------------------------HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred             cc-------------------------------cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHH
Confidence            00                               00123567889999999999999999999999987  676653

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-41  Score=322.64  Aligned_cols=236  Identities=24%  Similarity=0.302  Sum_probs=189.6

Q ss_pred             cccEeeeceecccCceEEEEEEEC-----CCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  150 (403)
                      ..+|.+.+.||+|+||.||+|++.     .+++.||||++....     ....+|+.+++.++||||+++++++..    
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----  121 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV----  121 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc----
Confidence            456999999999999999999987     345899999986542     234579999999999999999998833    


Q ss_pred             CceEEEEEeeccC-CcHHHHHHHhhhh--------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCccccc
Q 015672          151 EELYLNLVLEYVP-ETVNRIARNYSRI--------------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRD  209 (403)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~--------------------~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrD  209 (403)
                       ...+++||||++ ++|.+++......                    ...+++..+..++.||+.||.|||+ +||+|||
T Consensus       122 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~D  199 (343)
T 1luf_A          122 -GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRD  199 (343)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSC
T ss_pred             -CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCC
Confidence             334789999998 4888877653211                    1568899999999999999999999 8999999


Q ss_pred             cccccceecCCCCcee---------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 015672          210 IKPQNLLVKGEPNVSY---------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFP  267 (403)
Q Consensus       210 lKp~NILl~~~~~~~~---------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~  267 (403)
                      |||+|||++.++.+++                     .+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCcCC
Confidence            9999999987655433                     346779999998755 48999999999999999999 999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 015672          268 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  347 (403)
Q Consensus       268 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp  347 (403)
                      +.+..+....+....                   .+         ..+..+++++.+||.+||+.||++|||+.+++++ 
T Consensus       279 ~~~~~~~~~~~~~~~-------------------~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~-  329 (343)
T 1luf_A          279 GMAHEEVIYYVRDGN-------------------IL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI-  329 (343)
T ss_dssp             TSCHHHHHHHHHTTC-------------------CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH-
T ss_pred             CCChHHHHHHHhCCC-------------------cC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH-
Confidence            887666554443210                   00         0124678999999999999999999999999874 


Q ss_pred             CcccCC
Q 015672          348 FFDELR  353 (403)
Q Consensus       348 ~f~~~~  353 (403)
                       |+++.
T Consensus       330 -L~~~~  334 (343)
T 1luf_A          330 -LQRMC  334 (343)
T ss_dssp             -HHHTT
T ss_pred             -HHHHH
Confidence             65543

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=320.53  Aligned_cols=229  Identities=23%  Similarity=0.388  Sum_probs=181.2

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----------ccHHHHHHHHHhc----CCCCccccceEEee
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQML----DHPNIVALKHCFFS  146 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l----~h~niv~~~~~~~~  146 (403)
                      ..+|.+.+.||+|+||.||+|++..+++.||||++....          ....+|+.+++++    +|+||+++++++..
T Consensus        30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~  109 (312)
T 2iwi_A           30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET  109 (312)
T ss_dssp             ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred             hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence            345999999999999999999999999999999985432          2234699999999    89999999998733


Q ss_pred             cCCCCceEEEEEeec-cC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceec-CCCCc
Q 015672          147 TTDKEELYLNLVLEY-VP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVK-GEPNV  223 (403)
Q Consensus       147 ~~~~~~~~~~lv~e~-~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~-~~~~~  223 (403)
                           ....++|||| +. ++|.+++..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++ .++.+
T Consensus       110 -----~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          110 -----QEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             --------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTEECCCCSGGGEEEETTTTEE
T ss_pred             -----CCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChhhEEEeCCCCeE
Confidence                 3347899998 44 677776654    3568999999999999999999999 7999999999999998 55443


Q ss_pred             e-----------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 015672          224 S-----------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT  286 (403)
Q Consensus       224 ~-----------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~  286 (403)
                      +                 ..||+.|+|||++.+...++.++|||||||++|+|++|+.||....      .+...     
T Consensus       180 kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~-----  248 (312)
T 2iwi_A          180 KLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA-----  248 (312)
T ss_dssp             EECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT-----
T ss_pred             EEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh-----
Confidence            2                 2368889999998765545669999999999999999999996432      11110     


Q ss_pred             HHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCC
Q 015672          287 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  354 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  354 (403)
                                  ...            ++..+++++.+||.+||+.||++|||+.|+++||||+....
T Consensus       249 ------------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          249 ------------ELH------------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             ------------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             ------------ccC------------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence                        000            22457899999999999999999999999999999987543

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.1e-41  Score=335.78  Aligned_cols=238  Identities=28%  Similarity=0.414  Sum_probs=175.6

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-ccHHHHHHHHHhc-CCCCccccceEEeecCCCCceEEEEEee
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVLE  160 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e  160 (403)
                      .|.+.++||+|+||+||.+. ..+|+.||||++..+. ....+|+.+++.+ +||||+++++++     ....++++|||
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv~E   89 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIALE   89 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEEEC
T ss_pred             eeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEEEe
Confidence            48888999999999998754 4679999999886543 3346899999876 899999999887     33456899999


Q ss_pred             ccCCcHHHHHHHhhhhcCC---CCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC-------------Cc-
Q 015672          161 YVPETVNRIARNYSRIHQR---MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP-------------NV-  223 (403)
Q Consensus       161 ~~~~~l~~~~~~~~~~~~~---l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~-------------~~-  223 (403)
                      ||+++|.+++.........   ..+..+..++.||+.||.|||+ +||+||||||+|||++..+             .+ 
T Consensus        90 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           90 LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             CCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             cCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence            9999988877653221111   1223456789999999999999 8999999999999996432             11 


Q ss_pred             ----------------------eeeccccccchhhhhC------CCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 015672          224 ----------------------SYICSRYYRAPELIFG------ATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQ  274 (403)
Q Consensus       224 ----------------------~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~  274 (403)
                                            ...||+.|+|||++.+      ...++.++|||||||++|||++ |..||.+....+ 
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-  247 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-  247 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence                                  1247889999999864      2458999999999999999999 999997655433 


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          275 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       275 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                       ..+....                 ...+....     .....+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       248 -~~i~~~~-----------------~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          248 -SNIIRGI-----------------FSLDEMKC-----LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             -HHHHHTC-----------------CCCCCCTT-----CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             -HHHhcCC-----------------CCcccccc-----cccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence             2222211                 11111100     011235688999999999999999999999999999964

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.3e-41  Score=315.71  Aligned_cols=235  Identities=22%  Similarity=0.337  Sum_probs=191.1

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccccHHHHHHHHHhcCCCCccccceEEeecC-----------
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTT-----------  148 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----------  148 (403)
                      ...+|.+.+.||+|+||.||+|++..+++.||+|++........+|+++++.++||||+++++++....           
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~   88 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS   88 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence            445799999999999999999999999999999999877777889999999999999999999874311           


Q ss_pred             CCCceEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce---
Q 015672          149 DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS---  224 (403)
Q Consensus       149 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~---  224 (403)
                      ......+++||||+++ +|.+++....  ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++   
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~D  165 (284)
T 2a19_B           89 RSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHS-KKLINRDLKPSNIFLVDTKQVKIGD  165 (284)
T ss_dssp             CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECC
T ss_pred             ccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHEEEcCCCCEEECc
Confidence            1234568999999985 8888776532  3578999999999999999999999 8999999999999998665443   


Q ss_pred             ---------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          225 ---------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       225 ---------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                     ..+|+.|+|||++.+. .++.++|||||||++|+|++|..||....  .....+..         
T Consensus       166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~---------  233 (284)
T 2a19_B          166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD---------  233 (284)
T ss_dssp             CTTCEESSCCSCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT---------
T ss_pred             chhheeccccccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc---------
Confidence                           2468899999999754 58999999999999999999998874211  11111100         


Q ss_pred             HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                                .            .++..+++++.+||.+||..||.+|||+.|+++|.+.-.
T Consensus       234 ----------~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          234 ----------G------------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             ----------T------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             ----------c------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                      0            012457889999999999999999999999999977543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.3e-42  Score=336.59  Aligned_cols=235  Identities=23%  Similarity=0.366  Sum_probs=176.9

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-cccHHHHHHHHHhc-CCCCccccceEEeecCCCCceEEEEEe
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      .+|.+.++||+|+||+||. ....+++.||||++... .....+|+++|+.+ +|||||++++++.     +..++|+||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~-----~~~~~~lv~   97 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEK-----DRQFQYIAI   97 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEE-----ETTEEEEEE
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCEEEEEE
Confidence            3599999999999999764 33467999999998543 34457899999999 7999999998873     344589999


Q ss_pred             eccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCC---CCc-------------
Q 015672          160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE---PNV-------------  223 (403)
Q Consensus       160 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~---~~~-------------  223 (403)
                      |||+++|.+++...   ...+....+..++.||+.||.|||+ .||+||||||+|||++.+   +..             
T Consensus        98 E~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           98 ELCAATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             ECCSEEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHH-TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             ECCCCCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHH-CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            99999887776542   2234444567889999999999999 899999999999999532   111             


Q ss_pred             -----------eeeccccccchhhhhC--CCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          224 -----------SYICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       224 -----------~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                 ...||+.|+|||++.+  ...++.++|||||||++|||++ |..||......... .+.   +...   
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~~---~~~~---  246 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-ILL---GACS---  246 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HHT---TCCC---
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HHh---ccCC---
Confidence                       1347999999999864  3347889999999999999999 99999655433221 111   1100   


Q ss_pred             HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                                  ......       ....+..+.+||.+||+.||.+|||+.++++||||..+
T Consensus       247 ------------~~~~~~-------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          247 ------------LDCLHP-------EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             ------------CTTSCT-------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             ------------ccccCc-------cccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence                        000000       01235668999999999999999999999999999764

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.3e-41  Score=319.39  Aligned_cols=241  Identities=23%  Similarity=0.372  Sum_probs=187.5

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc----cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      .+|.+.+.||+|+||.||+|++..+++.||||++...    .....+|+.+++.++||||+++++++.... ......++
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~l  107 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAWL  107 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeEE
Confidence            4699999999999999999999999999999988532    223457999999999999999999885432 34456889


Q ss_pred             EeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----------
Q 015672          158 VLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----------  226 (403)
Q Consensus       158 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----------  226 (403)
                      ||||+.+ +|..++.........+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++++          
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  186 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI  186 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence            9999985 8888877655555779999999999999999999999 899999999999999877655332          


Q ss_pred             ------------------ccccccchhhhhCCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCC
Q 015672          227 ------------------CSRYYRAPELIFGAT--EYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTP  285 (403)
Q Consensus       227 ------------------~t~~y~aPE~~~~~~--~~~~~~DiwSlGvil~el~tg~~pf~~~~~~-~~~~~i~~~~~~~  285 (403)
                                        ||+.|+|||++.+..  .++.++|||||||++|+|++|+.||...... ..+......    
T Consensus       187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~----  262 (317)
T 2buj_A          187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN----  262 (317)
T ss_dssp             EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC----
T ss_pred             ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc----
Confidence                              378899999985432  2688999999999999999999999431100 001111110    


Q ss_pred             CHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          286 TREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                                   ...++          ....+++++.+||.+||+.||.+|||+.+++++  +..+.
T Consensus       263 -------------~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~  305 (317)
T 2buj_A          263 -------------QLSIP----------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ--LEALQ  305 (317)
T ss_dssp             -------------C--CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHTC
T ss_pred             -------------cCCCC----------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH--hhhcC
Confidence                         00011          113578999999999999999999999999986  66654

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.1e-40  Score=310.34  Aligned_cols=228  Identities=22%  Similarity=0.333  Sum_probs=180.7

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----------ccHHHHHHHHHhcCCCCccccceEEeecCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----------RYKNRELQIMQMLDHPNIVALKHCFFSTTD  149 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  149 (403)
                      ..+|.+.+.||+|+||.||+|++..+++.||+|++....           ....+|+.+++.++||||+++++++.    
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----   93 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH----   93 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET----
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec----
Confidence            346999999999999999999999999999999985321           33457999999999999999999872    


Q ss_pred             CCceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--ccccccccccceecCCCC----
Q 015672          150 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVKGEPN----  222 (403)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~--ivHrDlKp~NILl~~~~~----  222 (403)
                       +..  ++||||++ ++|.+.+..   ....+++..+..++.||+.||.|||+ .|  |+||||||+|||++.++.    
T Consensus        94 -~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~ivH~dikp~Nil~~~~~~~~~~  166 (287)
T 4f0f_A           94 -NPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPV  166 (287)
T ss_dssp             -TTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCSCCSGGGEEESCCCTTCSC
T ss_pred             -CCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHh-CCCCeecCCCCcceEEEeccCCCCce
Confidence             222  48999998 677555433   23578999999999999999999999 79  999999999999976554    


Q ss_pred             -ce----------------eeccccccchhhhhC-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhC
Q 015672          223 -VS----------------YICSRYYRAPELIFG-ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLG  283 (403)
Q Consensus       223 -~~----------------~~~t~~y~aPE~~~~-~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~-~~~i~~~~~  283 (403)
                       ++                ..||+.|+|||++.+ ...++.++|||||||++|+|++|+.||...+.... ........+
T Consensus       167 ~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  246 (287)
T 4f0f_A          167 CAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG  246 (287)
T ss_dssp             CEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred             eEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence             32                346889999999832 23478999999999999999999999987654332 111111111


Q ss_pred             CCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          284 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      .                          ...++..+++++.+||.+||+.||++|||+.++++
T Consensus       247 ~--------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          247 L--------------------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             C--------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C--------------------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            0                          00123567899999999999999999999999986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.6e-41  Score=318.32  Aligned_cols=231  Identities=20%  Similarity=0.328  Sum_probs=184.6

Q ss_pred             cccEeeeceecccCceEEEEEEEC-----CCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  150 (403)
                      ..+|.+.+.||+|+||.||+|++.     .+++.||+|++....     ....+|+++++.++||||+++++++..    
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----   97 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ----   97 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec----
Confidence            456999999999999999999973     455889999986432     233579999999999999999998733    


Q ss_pred             CceEEEEEeeccC-CcHHHHHHHhhh--------------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccc
Q 015672          151 EELYLNLVLEYVP-ETVNRIARNYSR--------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD  209 (403)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~--------------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrD  209 (403)
                       ....++||||++ ++|.+++.....                    ....+++..+..++.||+.||.|||+ +||+|||
T Consensus        98 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~d  175 (314)
T 2ivs_A           98 -DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE-MKLVHRD  175 (314)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH-TTEECCC
T ss_pred             -CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH-CCCcccc
Confidence             334789999998 688887765432                    11347889999999999999999999 8999999


Q ss_pred             cccccceecCCCCcee---------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 015672          210 IKPQNLLVKGEPNVSY---------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFP  267 (403)
Q Consensus       210 lKp~NILl~~~~~~~~---------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~  267 (403)
                      |||+|||++.++.+++                     .+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.
T Consensus       176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~  254 (314)
T 2ivs_A          176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYP  254 (314)
T ss_dssp             CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999987665433                     245679999999754 48999999999999999999 999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          268 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       268 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      +.+.......+.... .                           ...+..+++++.+||.+||+.||++|||+.+++++
T Consensus       255 ~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          255 GIPPERLFNLLKTGH-R---------------------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             TCCGGGHHHHHHTTC-C---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHhhcCC-c---------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            877654443332210 0                           00124678999999999999999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=5.6e-41  Score=318.92  Aligned_cols=231  Identities=23%  Similarity=0.355  Sum_probs=171.4

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcC-CCCccccceEEeecCC---CCceE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLD-HPNIVALKHCFFSTTD---KEELY  154 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~---~~~~~  154 (403)
                      +|.+.++||+|+||.||+|++..+++.||||++....    ....+|+.+++.+. ||||+++++++.....   .....
T Consensus        29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~  108 (337)
T 3ll6_A           29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE  108 (337)
T ss_dssp             EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred             eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence            5999999999999999999999999999999885432    23357999999996 9999999998854322   45567


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--ccccccccccceecCCCCcee-------
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVKGEPNVSY-------  225 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~--ivHrDlKp~NILl~~~~~~~~-------  225 (403)
                      ++++|||+.++|.+++..... ...+++..+..++.||+.||.|||+ .|  |+||||||+|||++.++.+++       
T Consensus       109 ~~lv~e~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  186 (337)
T 3ll6_A          109 FLLLTELCKGQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT  186 (337)
T ss_dssp             EEEEEECCSEEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCCCCCGGGCEECTTSCEEBCCCTTCB
T ss_pred             EEEEEEecCCCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEEccCCcccEEECCCCCEEEecCccce
Confidence            899999999998887765332 3569999999999999999999999 79  999999999999987655432       


Q ss_pred             ------------------------eccccccchhhhh--CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 015672          226 ------------------------ICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII  279 (403)
Q Consensus       226 ------------------------~~t~~y~aPE~~~--~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~  279 (403)
                                              .+|+.|+|||++.  ....++.++|||||||++|+|++|+.||.+.........  
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~--  264 (337)
T 3ll6_A          187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG--  264 (337)
T ss_dssp             CCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------------
T ss_pred             eccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC--
Confidence                                    3678899999983  234578999999999999999999999975443221110  


Q ss_pred             HHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          280 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                         ....+          .....+..+.+||.+||+.||.+|||+.|+++|
T Consensus       265 -------------------~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  302 (337)
T 3ll6_A          265 -------------------KYSIP----------PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ  302 (337)
T ss_dssp             --------------------CCCC----------TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             -------------------cccCC----------cccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                               00000          113467789999999999999999999999987

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.4e-40  Score=320.55  Aligned_cols=238  Identities=16%  Similarity=0.135  Sum_probs=181.4

Q ss_pred             ccEeeeceecccCceEEEEEEECCC-----CcEEEEEEcccccccHHHH---------------HHHHHhcCCCCccccc
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRET-----GEIVAIKKVLQDKRYKNRE---------------LQIMQMLDHPNIVALK  141 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~E---------------~~~l~~l~h~niv~~~  141 (403)
                      .+|.+.+.||+|+||.||+|.+..+     ++.||||++........+|               +..+..++|+||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            3599999999999999999998764     5789999986654333334               3445566799999999


Q ss_pred             eEEeecCCCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceec--C
Q 015672          142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVK--G  219 (403)
Q Consensus       142 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~--~  219 (403)
                      +++.... ....+++|||||++++|..++...   ...+++..+..++.||+.||.|||+ +||+||||||+|||++  .
T Consensus       115 ~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~-~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          115 GSGLHDK-NGKSYRFMIMDRFGSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHE-HEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEE-TTEEEEEEEEECEEEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEESSC
T ss_pred             eeeeecc-CCcceEEEEEeCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEEecCCHHHEEEecCC
Confidence            9886533 345678999999988888777542   3679999999999999999999999 8999999999999998  4


Q ss_pred             CCCce--------------------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHH
Q 015672          220 EPNVS--------------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVD  273 (403)
Q Consensus       220 ~~~~~--------------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~  273 (403)
                      ++.++                          ..||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.....
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            44432                          1278899999999654 48999999999999999999999998643332


Q ss_pred             HHHHHHH-HhCCCCHHHH-hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          274 QLVEIIK-VLGTPTREEI-KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       274 ~~~~i~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      ....... .........+ .+.                    ....+++++.+||..||..||.+||++.++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          269 KYVRDSKIRYRENIASLMDKCF--------------------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHS--------------------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHhhhhHHHHHHHhc--------------------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            2222211 1111111111 010                    01457899999999999999999999999876

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=8.4e-41  Score=308.37  Aligned_cols=224  Identities=27%  Similarity=0.433  Sum_probs=178.4

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc--------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      .+|.+.+.||+|+||.||+|++.  ++.||||++....        ....+|+.+++.++||||+++++++.     ...
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   79 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-----KEP   79 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CC-
T ss_pred             hheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----cCC
Confidence            45999999999999999999975  8899999885421        23457999999999999999999883     334


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---ccccccccccceecC--------CC
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG---ICHRDIKPQNLLVKG--------EP  221 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~---ivHrDlKp~NILl~~--------~~  221 (403)
                      ..++||||++ ++|..++.     ...+++..+..++.||+.||.|||+ .|   |+||||||+|||++.        ++
T Consensus        80 ~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~i~H~dikp~Nil~~~~~~~~~~~~~  153 (271)
T 3dtc_A           80 NLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHD-EAIVPIIHRDLKSSNILILQKVENGDLSNK  153 (271)
T ss_dssp             -CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHH-SSSSCCCCSCCSGGGEEESSCCSSSCCSSC
T ss_pred             ceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCchHHEEEecccccccccCc
Confidence            5889999997 56655543     3578999999999999999999999 78   899999999999975        22


Q ss_pred             Cce-----------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 015672          222 NVS-----------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT  284 (403)
Q Consensus       222 ~~~-----------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~  284 (403)
                      .++                 ..||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+..... 
T Consensus       154 ~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-  231 (271)
T 3dtc_A          154 ILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL-  231 (271)
T ss_dssp             CEEECCCCC-------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCC-
T ss_pred             ceEEccCCcccccccccccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCC-
Confidence            222                 2468899999998654 489999999999999999999999988776555443332100 


Q ss_pred             CCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          285 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                                ....+..+++++.+||.+||+.||.+|||+.|+++|
T Consensus       232 --------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          232 --------------------------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             --------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence                                      000224678999999999999999999999999875

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=322.91  Aligned_cols=232  Identities=21%  Similarity=0.299  Sum_probs=186.6

Q ss_pred             ccccEeeeceecccCceEEEEEEECCC-------CcEEEEEEccccc-----ccHHHHHHHHHhc-CCCCccccceEEee
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRET-------GEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFS  146 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~  146 (403)
                      ...+|.+.+.||+|+||.||+|++..+       +..||||++....     ....+|+++++.+ +||||+++++++..
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            345799999999999999999997543       3579999986542     2245799999999 99999999998843


Q ss_pred             cCCCCceEEEEEeeccC-CcHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccc
Q 015672          147 TTDKEELYLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQ  213 (403)
Q Consensus       147 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~  213 (403)
                           ...+++||||++ ++|.+++.....            ....+++..++.++.||+.||.|||+ .||+||||||+
T Consensus       147 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~  220 (382)
T 3tt0_A          147 -----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAAR  220 (382)
T ss_dssp             -----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGG
T ss_pred             -----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCcc
Confidence                 333789999997 488887765321            12358999999999999999999999 89999999999


Q ss_pred             cceecCCCCceee---------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCc
Q 015672          214 NLLVKGEPNVSYI---------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESG  271 (403)
Q Consensus       214 NILl~~~~~~~~~---------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~  271 (403)
                      |||++.++.++++                     +|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+.
T Consensus       221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~~~  299 (382)
T 3tt0_A          221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  299 (382)
T ss_dssp             GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999877655432                     45679999999764 58999999999999999999 9999988776


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          272 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       272 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      .+....+......                            ..+..+++++.+||.+||+.||++|||+.+++++
T Consensus       300 ~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          300 EELFKLLKEGHRM----------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHHHTTCCC----------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCC----------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5554443321000                            0124578999999999999999999999999986

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.6e-41  Score=311.86  Aligned_cols=229  Identities=21%  Similarity=0.331  Sum_probs=187.2

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ...+|.+.+.||+|+||.||+|.+..+++.||+|++..+.   ....+|+.+++.++||||+++++++.     ....++
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   85 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFY   85 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCEE
Confidence            3456999999999999999999999999999999986543   23457999999999999999999873     333488


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------  225 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------  225 (403)
                      +||||+. ++|.+++....  ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++          
T Consensus        86 ~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHH-HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             EEEEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHH-CCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            9999998 68877765422  3458999999999999999999999 79999999999999987665533          


Q ss_pred             ----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          226 ----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       226 ----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                .+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+.......+......          
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~----------  231 (288)
T 3kfa_A          163 GDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM----------  231 (288)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC----------
T ss_pred             CCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC----------
Confidence                      235679999998655 48999999999999999999 99999887655444333221000          


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                        ..+..+++++.+||.+||..||.+|||+.++++
T Consensus       232 ------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          232 ------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             ------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence                              012467899999999999999999999999976

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=8.9e-41  Score=317.24  Aligned_cols=228  Identities=21%  Similarity=0.340  Sum_probs=178.0

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEE----EEEEcccc-----cccHHHHHHHHHhcCCCCccccceEEeecCCC
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIV----AIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v----aiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  150 (403)
                      ...+|.+.+.||+|+||+||+|++..+++.+    |+|.+...     .....+|+.+++.++||||+++++++...   
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---   89 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---   89 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS---
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---
Confidence            3456999999999999999999998877754    77776432     22345799999999999999999988531   


Q ss_pred             CceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee---
Q 015672          151 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI---  226 (403)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~---  226 (403)
                        . .++|+||+. ++|..++...   ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++++   
T Consensus        90 --~-~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIll~~~~~~kl~Dfg  162 (327)
T 3poz_A           90 --T-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDFG  162 (327)
T ss_dssp             --S-EEEEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETTEEEECCTT
T ss_pred             --C-eEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCChheEEECCCCCEEEccCc
Confidence              1 567888887 6776665542   3568999999999999999999999 899999999999999877655432   


Q ss_pred             ------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015672          227 ------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  287 (403)
Q Consensus       227 ------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~  287 (403)
                                        +|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......   
T Consensus       163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---  238 (327)
T 3poz_A          163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---  238 (327)
T ss_dssp             HHHHHTTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---
T ss_pred             ceeEccCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC---
Confidence                              36689999999764 58999999999999999999 99999887655443333221000   


Q ss_pred             HHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                     +          .+..++.++.+||.+||+.||++|||+.+++++
T Consensus       239 ---------------~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          239 ---------------P----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             ---------------C----------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             ---------------C----------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                           0          124578899999999999999999999999976

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.1e-40  Score=314.05  Aligned_cols=232  Identities=23%  Similarity=0.302  Sum_probs=185.7

Q ss_pred             cccEeeeceecccCceEEEEEEE-----CCCCcEEEEEEccccc-----ccHHHHHHHHHhc-CCCCccccceEEeecCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  149 (403)
                      ..+|.+.+.||+|+||.||+|++     ..+++.||||++....     ....+|+.+++.+ +||||+++++++..   
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~---   98 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI---   98 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec---
Confidence            34699999999999999999985     4567899999986442     2345799999999 99999999998843   


Q ss_pred             CCceEEEEEeeccCC-cHHHHHHHhhh--------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccccc
Q 015672          150 KEELYLNLVLEYVPE-TVNRIARNYSR--------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (403)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~--------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~N  214 (403)
                        ....++||||+++ +|.+++.....              ....+++..+..++.||+.||.|||+ +||+||||||+|
T Consensus        99 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~N  175 (313)
T 1t46_A           99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARN  175 (313)
T ss_dssp             --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred             --CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccce
Confidence              2337899999974 88877765321              12248899999999999999999999 899999999999


Q ss_pred             ceecCCCCcee---------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcH
Q 015672          215 LLVKGEPNVSY---------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGV  272 (403)
Q Consensus       215 ILl~~~~~~~~---------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~  272 (403)
                      ||++.++.+++                     .+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  254 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence            99987665433                     245679999998654 58999999999999999999 99999887665


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          273 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       273 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      ..+.........+                           ..+..+++++.+||.+||..||.+|||+.+++++
T Consensus       255 ~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          255 SKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHhccCCCC---------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            5554444321110                           0124578999999999999999999999999875

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=7e-41  Score=313.01  Aligned_cols=239  Identities=26%  Similarity=0.431  Sum_probs=181.4

Q ss_pred             cccEeeeceecccCceEEEEEE----ECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      ..+|++.+.||+|+||+||+|+    +..+++.||||++....    ....+|+++++.++||||+++++++...   +.
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~   85 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GR   85 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH---HH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CC
Confidence            4569999999999999999998    56689999999986533    2345799999999999999999987432   12


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee-----
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-----  226 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~-----  226 (403)
                      .++++||||++ ++|.+++...   ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++++     
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             CceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence            23789999996 5887777653   2458899999999999999999999 899999999999999876654332     


Q ss_pred             -----------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          227 -----------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       227 -----------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                       +|..|+|||++.+. .++.++|||||||++|+|++|..||.....  ..   ....+......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~~---~~~~~~~~~~~  235 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPA--EF---MRMIGNDKQGQ  235 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHH--HH---HHHHCTTCCTH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChH--HH---HhhhcCccccc
Confidence                             35569999999765 489999999999999999999999864321  11   11111111000


Q ss_pred             ------HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          290 ------IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       290 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                            ......   ....          ..+..+++++.+||.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~---~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          236 MIVFHLIELLKN---NGRL----------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHHHHHHT---TCCC----------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhHHHHHHHHhc---cCcC----------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                  000000   0000          012568899999999999999999999999986

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.9e-40  Score=312.68  Aligned_cols=236  Identities=19%  Similarity=0.267  Sum_probs=183.6

Q ss_pred             cccEeeeceecccCceEEEEEEECC---CCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      ..+|.+.+.||+|+||.||+|++..   +++.||+|++....      ....+|+.+++.++||||+++++++.......
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  112 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG  112 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred             HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence            3469999999999999999998765   45689999986432      22457999999999999999999986544433


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhh--hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee--
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYS--RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI--  226 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~--  226 (403)
                      ..+.++||||+. ++|..++....  .....+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++++  
T Consensus       113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~~~~~kl~Df  191 (313)
T 3brb_A          113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN-RNFLHRDLAARNCMLRDDMTVCVADF  191 (313)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred             CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCCcEEEeec
Confidence            345789999998 58877764432  223568999999999999999999999 899999999999999877655432  


Q ss_pred             -------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 015672          227 -------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  286 (403)
Q Consensus       227 -------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~  286 (403)
                                         +++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......  
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~--  268 (313)
T 3brb_A          192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL--  268 (313)
T ss_dssp             SCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC--
T ss_pred             CcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC--
Confidence                               35679999999654 58999999999999999999 89999887766554444321000  


Q ss_pred             HHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          287 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                                ..+..+++++.+||.+||..||.+|||+.+++++
T Consensus       269 --------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          269 --------------------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             --------------------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             --------------------------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                      0224678999999999999999999999999875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-41  Score=319.46  Aligned_cols=232  Identities=21%  Similarity=0.275  Sum_probs=184.3

Q ss_pred             cccEeeeceecccCceEEEEEEEC-----CCCcEEEEEEcccc-----cccHHHHHHHHHhc-CCCCccccceEEeecCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  149 (403)
                      ..+|.+.+.||+|+||.||+|++.     .++..||||++...     .....+|+.+++.+ +||||+++++++..   
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~---  120 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL---  120 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee---
Confidence            356999999999999999999973     45678999998643     22345899999999 99999999998843   


Q ss_pred             CCceEEEEEeeccC-CcHHHHHHHhhhh-------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCccccc
Q 015672          150 KEELYLNLVLEYVP-ETVNRIARNYSRI-------------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRD  209 (403)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~-------------------~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrD  209 (403)
                        ...+++||||++ ++|.+++......                   ...+++..+..++.||+.||.|||+ .||+|||
T Consensus       121 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~D  197 (344)
T 1rjb_A          121 --SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRD  197 (344)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETT
T ss_pred             --CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCcccCC
Confidence              233789999997 5888777643210                   1237888999999999999999999 8999999


Q ss_pred             cccccceecCCCCcee---------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 015672          210 IKPQNLLVKGEPNVSY---------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFP  267 (403)
Q Consensus       210 lKp~NILl~~~~~~~~---------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~  267 (403)
                      |||+|||++.++.+++                     .+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999987765433                     246679999998654 48999999999999999998 999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          268 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       268 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      +......+..+......+                           ..+..+++++.+||.+||+.||.+|||+.++++|
T Consensus       277 ~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          277 GIPVDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             TCCCSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCcHHHHHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            877655554444321000                           0124578999999999999999999999999986

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1e-40  Score=315.69  Aligned_cols=238  Identities=22%  Similarity=0.298  Sum_probs=190.2

Q ss_pred             cccEeeeceecccCceEEEEEEEC-----CCCcEEEEEEcccccc-----cHHHHHHHHHhcCCCCccccceEEeecCCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  150 (403)
                      ..+|.+.+.||+|+||.||+|++.     .+++.||||++.....     ...+|+.+++.++|+||+++++++..    
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----   99 (322)
T 1p4o_A           24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ----   99 (322)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS----
T ss_pred             hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc----
Confidence            346999999999999999999876     3578899999864322     23579999999999999999998833    


Q ss_pred             CceEEEEEeeccC-CcHHHHHHHhhhh------cCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc
Q 015672          151 EELYLNLVLEYVP-ETVNRIARNYSRI------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV  223 (403)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~------~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~  223 (403)
                       ....++||||++ ++|.+++......      ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+
T Consensus       100 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~~~~  177 (322)
T 1p4o_A          100 -GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDFTV  177 (322)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECTTCCE
T ss_pred             -CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCCccCCCccceEEEcCCCeE
Confidence             334789999997 5888877654321      1456888999999999999999999 899999999999999887665


Q ss_pred             ee---------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 015672          224 SY---------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKV  281 (403)
Q Consensus       224 ~~---------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~  281 (403)
                      ++                     .+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  256 (322)
T 1p4o_A          178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG  256 (322)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred             EECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC
Confidence            43                     236779999998654 48999999999999999999 89999887765554444321


Q ss_pred             hCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC------CCcccCC
Q 015672          282 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH------PFFDELR  353 (403)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h------p~f~~~~  353 (403)
                      .                   .+         ..+..+++++.+||.+||+.||.+|||+.++++|      ++|+++.
T Consensus       257 ~-------------------~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~  306 (322)
T 1p4o_A          257 G-------------------LL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS  306 (322)
T ss_dssp             C-------------------CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred             C-------------------cC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccc
Confidence            0                   00         0124678999999999999999999999999986      6666553

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.3e-40  Score=309.05  Aligned_cols=227  Identities=26%  Similarity=0.347  Sum_probs=182.5

Q ss_pred             cccEeeeceecccCceEEEEEEECCC---CcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      ..+|++.+.||+|+||.||+|++..+   +..||+|++....     ....+|+.+++.++||||+++++++. .   + 
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~---~-   88 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E---N-   88 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S---S-
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c---C-
Confidence            45699999999999999999998654   4579999875432     23457999999999999999998862 1   1 


Q ss_pred             eEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee-----
Q 015672          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-----  226 (403)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~-----  226 (403)
                       ..++||||+++ +|.+++...   ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++++     
T Consensus        89 -~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  163 (281)
T 1mp8_A           89 -PVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSNDCVKLGDFGLS  163 (281)
T ss_dssp             -SCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred             -ccEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHEEECCCCCEEECccccc
Confidence             26799999984 787766542   3468899999999999999999999 899999999999999876654332     


Q ss_pred             ---------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          227 ---------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       227 ---------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                     +|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......      
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~------  236 (281)
T 1mp8_A          164 RYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------  236 (281)
T ss_dssp             ---------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC------
T ss_pred             cccCcccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC------
Confidence                           35679999998654 58999999999999999996 99999887766655444321000      


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                            ..+..+++++.+||.+||..||++|||+.+++++
T Consensus       237 ----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          237 ----------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                  0224688999999999999999999999999864

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.5e-40  Score=308.00  Aligned_cols=232  Identities=22%  Similarity=0.213  Sum_probs=184.3

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc--cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      ..+|.+.+.||+|+||.||+|++..+++.||||++...  .....+|+.+++.++|++++..+..+..    ...+.++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~lv   83 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMV   83 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccC----CCCceEEE
Confidence            34699999999999999999999999999999987543  3446789999999999998877766543    23357899


Q ss_pred             eeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceec---CCCCc------------
Q 015672          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVK---GEPNV------------  223 (403)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~---~~~~~------------  223 (403)
                      |||++++|.+++...   ...+++..+..++.||+.||.|||+ +||+||||||+|||++   .++.+            
T Consensus        84 ~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           84 MELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEecCCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            999988988877542   3569999999999999999999999 8999999999999994   33322            


Q ss_pred             --------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCC
Q 015672          224 --------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLGTPT  286 (403)
Q Consensus       224 --------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~---~~~~~~i~~~~~~~~  286 (403)
                                    ...||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.   ...+..+.......+
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             ccccccccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence                          23468889999998654 489999999999999999999999986432   223333322111111


Q ss_pred             HHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          287 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      ..                        .+...+++++.+||.+||+.||++|||+.++++
T Consensus       239 ~~------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          239 IE------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HH------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hH------------------------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            10                        112457899999999999999999999999986

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.5e-40  Score=310.14  Aligned_cols=245  Identities=23%  Similarity=0.308  Sum_probs=181.9

Q ss_pred             cccccEeee-ceecccCceEEEEEEECCCCcEEEEEEcccccccHHHHHHHH-HhcCCCCccccceEEeecCCCCceEEE
Q 015672           79 KQKVSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIM-QMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        79 ~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ....+|.+. +.||+|+||.||+|.+..+++.||+|++... ....+|+.++ +.++||||+++++++.... .+..+++
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~   91 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLL   91 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEE
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-HHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEE
Confidence            344558777 8899999999999999999999999998643 3456788887 6669999999999874322 3356789


Q ss_pred             EEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecC---CCCceeecccccc
Q 015672          157 LVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKG---EPNVSYICSRYYR  232 (403)
Q Consensus       157 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~---~~~~~~~~t~~y~  232 (403)
                      +||||+++ +|.+++....  ...+++..+..++.||+.||.|||+ .||+||||||+|||++.   ++.++++.  +-.
T Consensus        92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~~~kl~D--fg~  166 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTD--FGF  166 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTCCEEECC--CTT
T ss_pred             EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEecCCCCCcEEEec--ccc
Confidence            99999974 8877776522  2468999999999999999999999 89999999999999987   44444432  122


Q ss_pred             chhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCccc
Q 015672          233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHK  312 (403)
Q Consensus       233 aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (403)
                      |.+..  ...++.++|||||||++|+|++|..||.+.+.......+.                  ....   .....+..
T Consensus       167 a~~~~--~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~------------------~~~~---~~~~~~~~  223 (299)
T 3m2w_A          167 AKETT--GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK------------------TRIR---MGQYEFPN  223 (299)
T ss_dssp             CEECT--TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC------------------CSSC---TTCCSSCH
T ss_pred             ccccc--cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH------------------HHHh---hccccCCc
Confidence            33322  2358899999999999999999999997655332110000                  0000   00011111


Q ss_pred             ccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          313 VFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       313 ~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                      .....+++++.+||.+||+.||++|||+.|+++||||.+..
T Consensus       224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             hhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence            11246899999999999999999999999999999998753

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.5e-40  Score=309.66  Aligned_cols=238  Identities=27%  Similarity=0.443  Sum_probs=186.2

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++....       ....+|+.+++.++|+||+++++++...     .
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~  105 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----N  105 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----T
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----C
Confidence            446999999999999999999999999999999886421       2235799999999999999999988542     3


Q ss_pred             EEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------
Q 015672          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------  225 (403)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------  225 (403)
                      ..++||||+.+ +|..++.........+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++       
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~  184 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATGVVKLGDLGLGR  184 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCC----
T ss_pred             cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCcHHHEEEcCCCCEEEEecccee
Confidence            48899999985 8888877655556678999999999999999999999 89999999999999987765533       


Q ss_pred             ------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHhh
Q 015672          226 ------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       226 ------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~  292 (403)
                                  .+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+... ...+........         
T Consensus       185 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------  254 (310)
T 2wqm_A          185 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD---------  254 (310)
T ss_dssp             --------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC---------
T ss_pred             eecCCCccccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc---------
Confidence                        367889999998654 589999999999999999999999976532 222222211110         


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                               ++..        ....+++++.+||.+||..||++|||+.+++++  ++++.
T Consensus       255 ---------~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~--l~~l~  296 (310)
T 2wqm_A          255 ---------YPPL--------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV--AKRMH  296 (310)
T ss_dssp             ---------SCCC--------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred             ---------CCCC--------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHH--HHHHH
Confidence                     1100        114578999999999999999999999999874  55543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.5e-40  Score=307.85  Aligned_cols=232  Identities=22%  Similarity=0.222  Sum_probs=182.7

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccc--ccccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      ..+|.+.+.||+|+||.||+|++..+++.||||++..  ......+|+.+++.++|++++..+..+..    ...+.++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~lv   83 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMV   83 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecC----CCCceEEE
Confidence            3459999999999999999999999999999998643  33456789999999999998888776643    23457899


Q ss_pred             eeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccccccee---cCCCCc------------
Q 015672          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV---KGEPNV------------  223 (403)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl---~~~~~~------------  223 (403)
                      |||++++|.+++...   ...+++..+..++.||+.||.|||+ +||+||||||+|||+   +.++.+            
T Consensus        84 ~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           84 MELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EECCCCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            999988988876542   3569999999999999999999999 899999999999999   444332            


Q ss_pred             --------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCC
Q 015672          224 --------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---DQLVEIIKVLGTPT  286 (403)
Q Consensus       224 --------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~---~~~~~i~~~~~~~~  286 (403)
                                    ...||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..   ..+..+.......+
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence                          23578899999998654 5899999999999999999999999865432   22222222111111


Q ss_pred             HHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          287 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      ..                        .....+++++.+||.+||+.||++|||+.++++
T Consensus       239 ~~------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          239 IE------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HH------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hh------------------------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            10                        112457899999999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.2e-40  Score=316.24  Aligned_cols=236  Identities=18%  Similarity=0.202  Sum_probs=183.6

Q ss_pred             cccEeeeceecccCceEEEEEE-----ECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAK-----CRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  150 (403)
                      ..+|.+.+.||+|+||.||+|+     +..+++.||||++....     ....+|+.+++.++||||+++++++..    
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----  104 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ----  104 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC----
Confidence            3469999999999999999999     55678899999985332     234579999999999999999998843    


Q ss_pred             CceEEEEEeeccC-CcHHHHHHHhhhh---cCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC---Cc
Q 015672          151 EELYLNLVLEYVP-ETVNRIARNYSRI---HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP---NV  223 (403)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~---~~  223 (403)
                       ....++||||++ ++|.+++......   ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++   .+
T Consensus       105 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dlkp~NIli~~~~~~~~~  182 (327)
T 2yfx_A          105 -SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRVA  182 (327)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             -CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeecCcCCHhHEEEecCCCcceE
Confidence             233689999995 6888877654211   1348888999999999999999999 8999999999999998433   23


Q ss_pred             ee---------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 015672          224 SY---------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKV  281 (403)
Q Consensus       224 ~~---------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~  281 (403)
                      ++                     .+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  261 (327)
T 2yfx_A          183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  261 (327)
T ss_dssp             EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             EECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC
Confidence            22                     246789999998654 58999999999999999998 99999887765554444321


Q ss_pred             hCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          282 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                      . .+                           ..+..+++.+.+||.+||+.||.+|||+.++++|.|+-.
T Consensus       262 ~-~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          262 G-RM---------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             C-CC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C-CC---------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            0 00                           012457899999999999999999999999999988643

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.3e-40  Score=316.74  Aligned_cols=242  Identities=15%  Similarity=0.121  Sum_probs=179.6

Q ss_pred             ccEeeeceecccCceEEEEEEECC---CCcEEEEEEccccccc---------------HHHHHHHHHhcCCCCccccceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDKRY---------------KNRELQIMQMLDHPNIVALKHC  143 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~---------------~~~E~~~l~~l~h~niv~~~~~  143 (403)
                      .+|.+.+.||+|+||.||+|++..   ++..||||++......               ..+|+.+++.++|+||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            469999999999999999999987   7889999988654322               2356777888899999999998


Q ss_pred             EeecCCCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC--
Q 015672          144 FFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP--  221 (403)
Q Consensus       144 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~--  221 (403)
                      +.... .+..++++||||++++|.+++..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++  
T Consensus       117 ~~~~~-~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          117 GLTEF-KGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEES-SSCEEEEEEEECEEEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEESSSTT
T ss_pred             ccccc-CCCcEEEEEEeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCcCHHHEEEccCCCC
Confidence            86532 34567899999998788666543    2378999999999999999999999 8999999999999997654  


Q ss_pred             Cce--------------------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-CcHHH
Q 015672          222 NVS--------------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE-SGVDQ  274 (403)
Q Consensus       222 ~~~--------------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~-~~~~~  274 (403)
                      .++                          ..||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+. .....
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence            332                          2468899999999764 5899999999999999999999999653 22222


Q ss_pred             HHHHH-HHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          275 LVEII-KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       275 ~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                      ..... ......+.....+.                    -...+++++.+||.+||..||++|||+.++++.  |++.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~--L~~~  326 (345)
T 2v62_A          270 VQTAKTNLLDELPQSVLKWA--------------------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI--LNPH  326 (345)
T ss_dssp             HHHHHHHHHHTTTHHHHHHS--------------------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH--HCTT
T ss_pred             HHHHHHhhcccccHHHHhhc--------------------cccccHHHHHHHHHHHhhcCcccCCCHHHHHHH--Hhcc
Confidence            22222 21111111111110                    012578999999999999999999999999873  4443

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.7e-40  Score=315.83  Aligned_cols=232  Identities=23%  Similarity=0.314  Sum_probs=185.4

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCc-----EEEEEEccccc-----ccHHHHHHHHHhc-CCCCccccceEEeecCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGE-----IVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  149 (403)
                      ..+|.+.+.||+|+||.||+|.+..+++     .||+|.+....     ....+|+.+++.+ +||||+++++++..   
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~---  121 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH---  121 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec---
Confidence            3469999999999999999999877664     79999986532     2345799999999 89999999998833   


Q ss_pred             CCceEEEEEeeccCC-cHHHHHHHhhhh----------cCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceec
Q 015672          150 KEELYLNLVLEYVPE-TVNRIARNYSRI----------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVK  218 (403)
Q Consensus       150 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~----------~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~  218 (403)
                        ...+++||||+++ +|.+++......          ...+++..+..++.||+.||.|||+ .||+||||||+|||++
T Consensus       122 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 --GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLLT  198 (333)
T ss_dssp             --SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGCEEE
T ss_pred             --CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCcccceEEEC
Confidence              2337899999974 888877654321          3457899999999999999999999 8999999999999998


Q ss_pred             CCCCcee---------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 015672          219 GEPNVSY---------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLV  276 (403)
Q Consensus       219 ~~~~~~~---------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~  276 (403)
                      .++.+++                     .+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+......+.
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  277 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY  277 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence            6654422                     245679999998754 48999999999999999998 999998876655555


Q ss_pred             HHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          277 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       277 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      .+......+                           ..+...++++.+||.+||+.||.+|||+.+++++
T Consensus       278 ~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          278 KLVKDGYQM---------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            444321110                           0123468899999999999999999999999873

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=7.1e-41  Score=317.75  Aligned_cols=231  Identities=23%  Similarity=0.329  Sum_probs=186.3

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEE--EEEEcccc-----cccHHHHHHHHHhc-CCCCccccceEEeecCCCCc
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIV--AIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v--aiK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  152 (403)
                      ..+|.+.+.||+|+||.||+|++..++..+  |+|.+...     .....+|+++++.+ +||||+++++++..     .
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~   98 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----R   98 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----T
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee-----C
Confidence            356999999999999999999998888865  99987532     23356799999999 99999999998843     3


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecC
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKG  219 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~------------~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~  219 (403)
                      .++++||||++ ++|.+++....            .....+++..++.++.||+.||.|||+ +||+||||||+|||++.
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~  177 (327)
T 1fvr_A           99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE  177 (327)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECG
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCccceEEEcC
Confidence            45889999997 58887776432            122468999999999999999999999 89999999999999987


Q ss_pred             CCCceee------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 015672          220 EPNVSYI------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIK  280 (403)
Q Consensus       220 ~~~~~~~------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~  280 (403)
                      ++.++++                  +|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus       178 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~  256 (327)
T 1fvr_A          178 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  256 (327)
T ss_dssp             GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred             CCeEEEcccCcCccccccccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc
Confidence            6655432                  46779999998654 48999999999999999998 9999988776554433321


Q ss_pred             HhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          281 VLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      ..                  ..          ..+..+++++.+||.+||..||.+|||+.+++++
T Consensus       257 ~~------------------~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          257 GY------------------RL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             TC------------------CC----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CC------------------CC----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            10                  00          0124578999999999999999999999999986

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.2e-40  Score=316.05  Aligned_cols=228  Identities=22%  Similarity=0.287  Sum_probs=180.9

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcE----EEEEEcccc-----cccHHHHHHHHHhcCCCCccccceEEeecCCC
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEI----VAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~----vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  150 (403)
                      ...+|++.+.||+|+||+||+|++..+++.    ||+|.+...     .....+|+.+++.++||||+++++++.     
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----   85 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-----   85 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----
Confidence            345699999999999999999999888876    677766322     123457999999999999999999762     


Q ss_pred             CceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----
Q 015672          151 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----  225 (403)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----  225 (403)
                      + ...++||||+. ++|.+.+...   ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++    
T Consensus        86 ~-~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~kl~Dfg  160 (325)
T 3kex_A           86 G-SSLQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEE-HGMVHRNLAARNVLLKSPSQVQVADFG  160 (325)
T ss_dssp             B-SSEEEEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHH-TTCCCSCCSSTTEEESSSSCEEECSCS
T ss_pred             C-CccEEEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHh-CCCCCCccchheEEECCCCeEEECCCC
Confidence            1 12779999998 5776665432   3468888999999999999999999 89999999999999987665533    


Q ss_pred             -----------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015672          226 -----------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  287 (403)
Q Consensus       226 -----------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~  287 (403)
                                       .+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+....     
T Consensus       161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-----  234 (325)
T 3kex_A          161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE-----  234 (325)
T ss_dssp             GGGGSCCCTTCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC-----
T ss_pred             cccccCcccccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC-----
Confidence                             245689999999654 48999999999999999999 999998876555443332210     


Q ss_pred             HHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                 ..            ..+..++.++.+||.+||..||.+|||+.++++|
T Consensus       235 -----------~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          235 -----------RL------------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             -----------BC------------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             -----------CC------------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                       00            0123467789999999999999999999999987

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.7e-40  Score=303.23  Aligned_cols=227  Identities=19%  Similarity=0.288  Sum_probs=185.2

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      ..+|.+.+.||+|+||.||+|++. +++.||+|++....   ....+|+++++.++||||+++++++..     ....++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   80 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICL   80 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSCEE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCeEE
Confidence            346999999999999999999986 67889999986543   345689999999999999999998843     233789


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----------  226 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----------  226 (403)
                      ||||++ ++|.+++...   ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++.++++          
T Consensus        81 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             EECCCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             EEeCCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEECCCCCEEEccccccccccc
Confidence            999997 5787776542   3468899999999999999999999 899999999999999876655332          


Q ss_pred             ----------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          227 ----------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       227 ----------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                +|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......           
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~-----------  224 (267)
T 3t9t_A          157 DQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-----------  224 (267)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-----------
T ss_pred             ccccccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC-----------
Confidence                      35679999998654 48999999999999999999 89999887766655544321000           


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                       ..+...++++.+||.+||+.||++|||+.+++++
T Consensus       225 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          225 -----------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             -----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                             0124578999999999999999999999999875

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.4e-40  Score=310.73  Aligned_cols=228  Identities=24%  Similarity=0.313  Sum_probs=180.8

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..+|.+.+.||+|+||.||+|++..+++.||+|++....       ....+|+.+++.++||||+++++++..     ..
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~  107 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----DG  107 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TT
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----CC
Confidence            456999999999999999999999999999999986432       234579999999999999999998843     33


Q ss_pred             EEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------
Q 015672          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------  225 (403)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------  225 (403)
                      .+++||||+++ +|.+++..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++       
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~  182 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHA-AGATHRDVKPENILVSADDFAYLVDFGIAS  182 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECSCCC--
T ss_pred             eEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCCcCCCChHHEEEcCCCCEEEecCccCc
Confidence            58899999985 88777654    3568999999999999999999999 89999999999999987665432       


Q ss_pred             -------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          226 -------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       226 -------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                                   .+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.. .+....... .+       
T Consensus       183 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~-~~-------  252 (309)
T 2h34_A          183 ATTDEKLTQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQA-IP-------  252 (309)
T ss_dssp             --------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSC-CC-------
T ss_pred             cccccccccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccC-CC-------
Confidence                         367889999998654 5899999999999999999999999876543 222222210 00       


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-CHHHHhc
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-TALEACV  345 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-ta~e~l~  345 (403)
                                       .....+..+++++.+||.+||..||++|| +++++++
T Consensus       253 -----------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          253 -----------------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             -----------------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             -----------------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence                             01112356889999999999999999999 7887775

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=315.04  Aligned_cols=227  Identities=22%  Similarity=0.336  Sum_probs=180.9

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEE----EEEEcccc-----cccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIV----AIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v----aiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      ..+|.+.+.||+|+||.||+|++..+++.+    |+|.+...     .....+|+.+++.++||||+++++++...    
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----   89 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----   89 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS----
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC----
Confidence            346999999999999999999998888765    66655321     23345799999999999999999988532    


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----  226 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----  226 (403)
                       . .++|++|+. ++|.+++...   ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.++++    
T Consensus        90 -~-~~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~~~kL~DfG~  163 (327)
T 3lzb_A           90 -T-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDFGL  163 (327)
T ss_dssp             -S-EEEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred             -C-ceEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhh-CCCcCCCCCHHHEEEcCCCCEEEccCcc
Confidence             1 567888887 5776665542   3568999999999999999999999 899999999999999876655332    


Q ss_pred             -----------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015672          227 -----------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  288 (403)
Q Consensus       227 -----------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~  288 (403)
                                       +|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......+   
T Consensus       164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---  239 (327)
T 3lzb_A          164 AKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---  239 (327)
T ss_dssp             ----------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---
T ss_pred             eeEccCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---
Confidence                             36679999999764 58999999999999999999 999998877655443332211000   


Q ss_pred             HHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                               .+..++.++.+||.+||..||.+|||+.|+++.
T Consensus       240 -------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          240 -------------------------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             -------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                     124578899999999999999999999999873

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=9.7e-41  Score=322.69  Aligned_cols=227  Identities=24%  Similarity=0.331  Sum_probs=181.9

Q ss_pred             cccEeeeceecccCceEEEEEEEC---CCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      ..+|.+.+.||+|+||.||+|++.   .++..||||++....     ....+|+.+++.++||||+++++++..     .
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~  118 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK-----S  118 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----C
Confidence            346999999999999999999986   467789999986432     234579999999999999999998833     3


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee-----
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-----  226 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~-----  226 (403)
                      ..+++||||++ ++|.+++...   ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++++     
T Consensus       119 ~~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  194 (373)
T 2qol_A          119 KPVMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILINSNLVCKVSDFGLG  194 (373)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             CceEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEEcCCCCEEECcCccc
Confidence            34789999996 6887776532   3468999999999999999999999 899999999999999887665432     


Q ss_pred             -----------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015672          227 -----------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  288 (403)
Q Consensus       227 -----------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~  288 (403)
                                       +|+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+......+   
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~---  270 (373)
T 2qol_A          195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP---  270 (373)
T ss_dssp             -------------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC---
T ss_pred             cccccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---
Confidence                             24579999999654 58999999999999999998 999998887665554443211100   


Q ss_pred             HHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                               .+..++.++.+||.+||+.||++||++.++++
T Consensus       271 -------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          271 -------------------------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             -------------------------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                                     11357889999999999999999999999876

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=6e-41  Score=317.94  Aligned_cols=246  Identities=21%  Similarity=0.281  Sum_probs=183.4

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      .+|.+.+.||+|+||.||+|++ .+++.||||++....     ....+|+.+++.++||||+++++++..     ....+
T Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~  103 (326)
T 3uim_A           30 DNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-----PTERL  103 (326)
T ss_dssp             TSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC-----SSCCE
T ss_pred             hccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec-----CCceE
Confidence            4599999999999999999985 468999999986432     245689999999999999999998843     23377


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CccccccccccceecCCCCcee-------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI---GICHRDIKPQNLLVKGEPNVSY-------  225 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---~ivHrDlKp~NILl~~~~~~~~-------  225 (403)
                      +||||+. ++|..++.........+++..+..++.||+.||.|||+ .   ||+||||||+|||++.++.+++       
T Consensus       104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~  182 (326)
T 3uim_A          104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK  182 (326)
T ss_dssp             EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH-SSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence            9999997 48888776544444568999999999999999999999 8   9999999999999987765432       


Q ss_pred             -------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC----CcHHHHHHHHHHhCCCCHH
Q 015672          226 -------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGE----SGVDQLVEIIKVLGTPTRE  288 (403)
Q Consensus       226 -------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~----~~~~~~~~i~~~~~~~~~~  288 (403)
                                   .||+.|+|||++.+. .++.++|||||||++|+|++|..||...    .............      
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------  255 (326)
T 3uim_A          183 LMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL------  255 (326)
T ss_dssp             ECCSSSSCEECCCCSCGGGCCHHHHHHS-EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT------
T ss_pred             ccCcccccccccccCCcCccCHHHhccC-CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH------
Confidence                         368899999998655 4899999999999999999999999521    1000011111100      


Q ss_pred             HHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                              ......................++++.+|+.+||+.||.+|||+.++++|-.-
T Consensus       256 --------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          256 --------LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             --------TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             --------hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence                    00001111111111111122345789999999999999999999999988543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.5e-40  Score=311.25  Aligned_cols=235  Identities=23%  Similarity=0.324  Sum_probs=177.9

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-ccHHHHHHHHHh--cCCCCccccceEEeecCCCCceEEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQM--LDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      ..+|.+.+.||+|+||+||+|++  +++.||||++.... ....+|.+++..  ++||||+++++++.... .....+++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~~l   83 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQLWL   83 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCceeEE
Confidence            34699999999999999999987  58999999986443 233457777776  79999999999875433 34566889


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCCccccccccccceecCCCCcee---
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH--------NCIGICHRDIKPQNLLVKGEPNVSY---  225 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH--------~~~~ivHrDlKp~NILl~~~~~~~~---  225 (403)
                      ||||++ ++|.+++.     ...+++..+..++.||+.||.|||        + .||+||||||+|||++.++.+++   
T Consensus        84 v~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           84 ITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK-PAIAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             EECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB-CEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             ehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC-CCeecCCCChHhEEEcCCCCEEEeeC
Confidence            999998 48877663     357899999999999999999999        8 79999999999999987655422   


Q ss_pred             --------------------eccccccchhhhhCCC-----CCCchhHHHHHHHHHHHHHhC----------CCCCCCCC
Q 015672          226 --------------------ICSRYYRAPELIFGAT-----EYTTAIDIWSTGCVMAELLLG----------QPLFPGES  270 (403)
Q Consensus       226 --------------------~~t~~y~aPE~~~~~~-----~~~~~~DiwSlGvil~el~tg----------~~pf~~~~  270 (403)
                                          .||+.|+|||++.+..     .++.++|||||||++|||++|          ..||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence                                5788999999996543     234799999999999999999          88886532


Q ss_pred             c----HHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          271 G----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       271 ~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      .    ...+.........                 .+..    .........++++.+||.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~-----------------~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          238 PNDPSFEDMRKVVCVDQQ-----------------RPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             CSSCCHHHHHHHHTTSCC-----------------CCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCCcchhhhhHHHhccCC-----------------CCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            2    2222222111000                 0000    001112335678999999999999999999999986

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.3e-40  Score=333.43  Aligned_cols=229  Identities=21%  Similarity=0.337  Sum_probs=187.3

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ...+|.+.+.||+|+||.||+|+++.++..||||++..+.   ..+.+|+.+|+.++||||+++++++..     ...++
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~~~  292 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFY  292 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEec-----CCcEE
Confidence            3457999999999999999999999889999999986543   334589999999999999999998833     23378


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee---------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI---------  226 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~---------  226 (403)
                      +||||+. ++|.+++....  ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.++++         
T Consensus       293 lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEK-KNFIHRNLAARNCLVGENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred             EEEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence            9999998 68887776432  2458889999999999999999999 899999999999999876554332         


Q ss_pred             -----------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          227 -----------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       227 -----------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                 +++.|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+....+....            
T Consensus       370 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------------  436 (495)
T 1opk_A          370 GDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY------------  436 (495)
T ss_dssp             TCCEECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC------------
T ss_pred             CCceeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------------
Confidence                       24679999998654 48999999999999999999 999998877655443332210            


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                            ..          ..+..+++++.+||.+||+.||++|||+.++++
T Consensus       437 ------~~----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          437 ------RM----------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             ------CC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------CC----------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                  00          022467899999999999999999999999986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.7e-40  Score=313.10  Aligned_cols=231  Identities=23%  Similarity=0.322  Sum_probs=183.7

Q ss_pred             cccEeeeceecccCceEEEEEEEC-------CCCcEEEEEEccccc-----ccHHHHHHHHHhc-CCCCccccceEEeec
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCR-------ETGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFST  147 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~  147 (403)
                      ..+|.+.+.||+|+||.||+|++.       .+++.||||++....     ....+|+.+++.+ +||||+++++++.. 
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-  112 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-  112 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc-
Confidence            456999999999999999999975       356789999986532     2235799999999 89999999998833 


Q ss_pred             CCCCceEEEEEeeccC-CcHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccccc
Q 015672          148 TDKEELYLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (403)
Q Consensus       148 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~N  214 (403)
                          ...+++||||++ ++|.+++.....            ....+++..+..++.||+.||.|||+ .||+||||||+|
T Consensus       113 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~N  187 (334)
T 2pvf_A          113 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARN  187 (334)
T ss_dssp             ----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGG
T ss_pred             ----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCccce
Confidence                334789999997 488887765321            12348889999999999999999999 899999999999


Q ss_pred             ceecCCCCceee---------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcH
Q 015672          215 LLVKGEPNVSYI---------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGV  272 (403)
Q Consensus       215 ILl~~~~~~~~~---------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~  272 (403)
                      ||++.++.++++                     +|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  266 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  266 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence            999877665432                     35679999998654 48999999999999999999 99999887766


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          273 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       273 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      +....+......                            ..+..+++++.+||.+||..||.+|||+.+++++
T Consensus       267 ~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          267 ELFKLLKEGHRM----------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCCCC----------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            555444331100                            0124578999999999999999999999999875

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.2e-40  Score=326.44  Aligned_cols=227  Identities=22%  Similarity=0.340  Sum_probs=186.1

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ...+|.+.+.||+|+||+||+|.+. ++..||||++....   ..+.+|+.+|+.++||||+++++++. .     ..++
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~-----~~~~  258 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-K-----EPIY  258 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-S-----SSCE
T ss_pred             chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-C-----CccE
Confidence            3457999999999999999999985 47789999986543   33468999999999999999998862 1     1277


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee---------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI---------  226 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~---------  226 (403)
                      +||||+. ++|.+++....  ...++...+..++.||+.||.|||+ ++|+||||||+|||++.++.++++         
T Consensus       259 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            9999997 58887775432  2357888899999999999999999 899999999999999987766442         


Q ss_pred             -----------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          227 -----------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       227 -----------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                 +|..|+|||++... .++.++|||||||++|||++ |+.||.+.+..+.+..+......+         
T Consensus       336 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~---------  405 (454)
T 1qcf_A          336 DNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP---------  405 (454)
T ss_dssp             CHHHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC---------
T ss_pred             CCceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence                       24579999999654 58999999999999999999 999999888776665554421111         


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                         .+..+++++.+||.+||..||++|||+.++++
T Consensus       406 -------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          406 -------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             -------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                               12457899999999999999999999999975

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=8.2e-40  Score=323.93  Aligned_cols=228  Identities=22%  Similarity=0.327  Sum_probs=186.1

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc--ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      ...+|.+.+.||+|+||.||+|.+.  ++.||||++..+.  ..+.+|+.+|++++||||+++++++....    ..+++
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~i  264 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYI  264 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SCEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----CceEE
Confidence            3457999999999999999999985  7799999986543  34568999999999999999999875432    23789


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----------  226 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----------  226 (403)
                      ||||++ ++|.+++....  ...++...+..++.||+.||.|||+ +||+||||||+|||++.++.++++          
T Consensus       265 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EEECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            999997 58888776532  2347888999999999999999999 899999999999999887765442          


Q ss_pred             ------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 015672          227 ------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  299 (403)
Q Consensus       227 ------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  299 (403)
                            +++.|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+....+.....                
T Consensus       342 ~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~----------------  404 (450)
T 1k9a_A          342 TQDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK----------------  404 (450)
T ss_dssp             -----CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC----------------
T ss_pred             cccCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence                  46789999999754 59999999999999999998 9999988776555544432110                


Q ss_pred             cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                        .          ..+..+++++.+||.+||..||++|||+.++++
T Consensus       405 --~----------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          405 --M----------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             --C----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --C----------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence              0          022468899999999999999999999999875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.5e-40  Score=311.86  Aligned_cols=233  Identities=22%  Similarity=0.320  Sum_probs=184.1

Q ss_pred             cccEeeeceecccCceEEEEEEE-----CCCCcEEEEEEcccccc-----cHHHHHHHHHhc-CCCCccccceEEeecCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKC-----RETGEIVAIKKVLQDKR-----YKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  149 (403)
                      ..+|.+.+.||+|+||.||+|++     ..+++.||||++.....     ...+|+.+++.+ +||||+++++++...  
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--  103 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--  103 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC--
Confidence            35699999999999999999985     35678999999865322     345799999999 789999999987432  


Q ss_pred             CCceEEEEEeeccC-CcHHHHHHHhhhh------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccce
Q 015672          150 KEELYLNLVLEYVP-ETVNRIARNYSRI------------HQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL  216 (403)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~------------~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NIL  216 (403)
                        ...+++||||++ ++|.+++......            ...+++..+..++.||+.||.|||+ .||+||||||+|||
T Consensus       104 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil  180 (316)
T 2xir_A          104 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL  180 (316)
T ss_dssp             --TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEE
T ss_pred             --CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEE
Confidence              234789999998 5887777643211            1227889999999999999999999 89999999999999


Q ss_pred             ecCCCCcee---------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 015672          217 VKGEPNVSY---------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQ  274 (403)
Q Consensus       217 l~~~~~~~~---------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~  274 (403)
                      ++.++.+++                     .+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.
T Consensus       181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~  259 (316)
T 2xir_A          181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  259 (316)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence            986654432                     346789999998754 48999999999999999998 9999988765544


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          275 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       275 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      +.........+                           ..+..+++++.+||.+||+.||.+|||+.++++|
T Consensus       260 ~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          260 FCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhccCccC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            44333321100                           0124578999999999999999999999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.2e-40  Score=314.38  Aligned_cols=254  Identities=23%  Similarity=0.319  Sum_probs=187.8

Q ss_pred             CCCCcccccEeeeceecccCceEEEEEE----ECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEee
Q 015672           75 NGNSKQKVSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFS  146 (403)
Q Consensus        75 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~  146 (403)
                      ....-...+|.+.+.||+|+||.||+|+    +..+++.||||++....    ....+|+++++.++|+||++++++++.
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   95 (327)
T 3lxl_A           16 DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG   95 (327)
T ss_dssp             -CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence            3344456679999999999999999999    46788999999986543    224689999999999999999998753


Q ss_pred             cCCCCceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee
Q 015672          147 TTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY  225 (403)
Q Consensus       147 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~  225 (403)
                         .+...+++||||++ ++|.+++...   ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++
T Consensus        96 ---~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~kl  168 (327)
T 3lxl_A           96 ---PGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGS-RRCVHRDLAARNILVESEAHVKI  168 (327)
T ss_dssp             ---SSSCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEE
T ss_pred             ---CCCceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChhhEEECCCCCEEE
Confidence               34456889999995 6887776643   2458999999999999999999999 89999999999999987665433


Q ss_pred             ----------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 015672          226 ----------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG  283 (403)
Q Consensus       226 ----------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~  283 (403)
                                            .+|+.|+|||++.+. .++.++|||||||++|+|++|..||......... .......
T Consensus       169 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~  246 (327)
T 3lxl_A          169 ADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGCERD  246 (327)
T ss_dssp             CCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HCC----
T ss_pred             cccccceecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-hcccccc
Confidence                                  246669999998654 4899999999999999999999999654321110 0000000


Q ss_pred             CCCHHH-HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          284 TPTREE-IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       284 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                      .+.... .......   ..          ...+..+++++.+||.+||+.||++|||+.+++++  ++.+
T Consensus       247 ~~~~~~~~~~~~~~---~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~--L~~~  301 (327)
T 3lxl_A          247 VPALSRLLELLEEG---QR----------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ--LDML  301 (327)
T ss_dssp             CCHHHHHHHHHHTT---CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHC
T ss_pred             cccHHHHHHHhhcc---cC----------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH--HHHH
Confidence            000000 0000000   00          00125688999999999999999999999999765  4444

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.5e-40  Score=304.76  Aligned_cols=228  Identities=28%  Similarity=0.377  Sum_probs=182.1

Q ss_pred             ccccEeeeceecccCceEEEEEEECC---CCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      ...+|.+.+.||+|+||+||+|++..   ++..||+|.+....     ....+|+.+++.++||||+++++++..     
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----   84 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-----   84 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-----
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----
Confidence            34569999999999999999998654   34469999986542     234579999999999999999998621     


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----  225 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----  225 (403)
                      . ..++||||++ ++|.+++...   ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+++     
T Consensus        85 ~-~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  159 (281)
T 3cc6_A           85 E-PTWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILVASPECVKLGDFGL  159 (281)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred             C-CCEEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEECCCCcEEeCccCC
Confidence            1 1479999998 5787776542   3568999999999999999999999 89999999999999987665432     


Q ss_pred             ---------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          226 ---------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       226 ---------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                     .+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||...+..+....+......+    
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~----  234 (281)
T 3cc6_A          160 SRYIEDEDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP----  234 (281)
T ss_dssp             GGCC---------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC----
T ss_pred             CcccccccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC----
Confidence                           235679999998654 58999999999999999998 999998776655544443311000    


Q ss_pred             HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                              .+..+++.+.+||.+||..||++|||+.+++++
T Consensus       235 ------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          235 ------------------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             ------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                                    124578999999999999999999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-40  Score=311.10  Aligned_cols=228  Identities=22%  Similarity=0.303  Sum_probs=183.5

Q ss_pred             cccEeeeceecccCceEEEEEEECCCC----cEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETG----EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      ...|.+.+.||+|+||.||+|++..++    ..||||++....     ....+|+.+++.++||||+++++++.     .
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~  117 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----K  117 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----S
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe-----c
Confidence            346999999999999999999986543    359999986432     22357999999999999999999873     3


Q ss_pred             ceEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----
Q 015672          152 ELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----  226 (403)
Q Consensus       152 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----  226 (403)
                      ....++||||+++ +|.+++...   ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++++    
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  193 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNLVCKVSDFGL  193 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChheEEECCCCcEEECCCCc
Confidence            3348899999985 887776542   3568999999999999999999999 899999999999999877665432    


Q ss_pred             ------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015672          227 ------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  287 (403)
Q Consensus       227 ------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~  287 (403)
                                        +|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......   
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~---  269 (333)
T 1mqb_A          194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL---  269 (333)
T ss_dssp             -----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---
T ss_pred             chhhccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC---
Confidence                              25679999998654 58999999999999999999 99999887766555444321100   


Q ss_pred             HHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                     +          .+..+++++.+||.+||+.||++||++.+++++
T Consensus       270 ---------------~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          270 ---------------P----------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             ---------------C----------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ---------------C----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                           0          124578999999999999999999999999875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=318.77  Aligned_cols=236  Identities=14%  Similarity=0.104  Sum_probs=182.8

Q ss_pred             ccEeeeceecccCceEEEEEEECCC--------CcEEEEEEcccccccHHHHHHHHHhcCCCCcccc-------------
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRET--------GEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVAL-------------  140 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~-------------  140 (403)
                      .+|.+.+.||+|+||.||+|++..+        ++.||||++... ....+|+++++.++||||+++             
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~  120 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP  120 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence            4699999999999999999999874        889999998654 456789999999999999984             


Q ss_pred             --ceEEeecCCCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceec
Q 015672          141 --KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVK  218 (403)
Q Consensus       141 --~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~  218 (403)
                        ++++..    ...+.++||||++++|.+++....  ...+++..+..++.||+.||.|||+ +||+||||||+|||++
T Consensus       121 ~~~~~~~~----~~~~~~lv~e~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIl~~  193 (352)
T 2jii_A          121 TCMGFGVH----QDKYRFLVLPSLGRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHE-NEYVHGNVTAENIFVD  193 (352)
T ss_dssp             CCCEEEEE----TTTEEEEEEECCCEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCGGGEEEE
T ss_pred             chhhcccc----CCcEEEEEecCCCcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEEc
Confidence              444322    234688999999889988876532  3579999999999999999999999 8999999999999998


Q ss_pred             CCC--Cce--------------------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 015672          219 GEP--NVS--------------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES  270 (403)
Q Consensus       219 ~~~--~~~--------------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~  270 (403)
                      .++  .++                          ..||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+..
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            765  332                          1468899999998654 58999999999999999999999998764


Q ss_pred             -cHHHHHHHHHHh-CCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          271 -GVDQLVEIIKVL-GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       271 -~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                       ....+....... ..+..              +.   .   .......+++++.+||.+||..||++|||+.++++.
T Consensus       273 ~~~~~~~~~~~~~~~~~~~--------------~~---~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          273 PNTEDIMKQKQKFVDKPGP--------------FV---G---PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             TCHHHHHHHHHHHHHSCCC--------------EE---C---TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             cCHHHHHHHHHhccCChhh--------------hh---h---hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence             333333332211 11000              00   0   000113578999999999999999999999999863

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=330.89  Aligned_cols=254  Identities=20%  Similarity=0.311  Sum_probs=183.3

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ..|.+.++||+|+||+||+|++..+++.||||++....     ....+|+++++.++||||+++++++...   ...+.+
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~~~~   85 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHKV   85 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC---CCCeeE
Confidence            45999999999999999999999999999999986422     2345899999999999999999987432   233578


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccccccee----cCCCCc--------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV----KGEPNV--------  223 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl----~~~~~~--------  223 (403)
                      +|||||+ ++|..++..... ...+++..++.++.||+.||.|||+ .||+||||||+|||+    +..+.+        
T Consensus        86 lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EEEecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            9999997 577776654321 2348999999999999999999999 899999999999998    443322        


Q ss_pred             ----------eeeccccccchhhhhCC-------CCCCchhHHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHHHh
Q 015672          224 ----------SYICSRYYRAPELIFGA-------TEYTTAIDIWSTGCVMAELLLGQPLFPGES----GVDQLVEIIKVL  282 (403)
Q Consensus       224 ----------~~~~t~~y~aPE~~~~~-------~~~~~~~DiwSlGvil~el~tg~~pf~~~~----~~~~~~~i~~~~  282 (403)
                                ...||+.|+|||++.+.       ..++.++|||||||++|+|++|+.||....    ..+.+..+..  
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~--  241 (396)
T 4eut_A          164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--  241 (396)
T ss_dssp             EECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH--
T ss_pred             eEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc--
Confidence                      23478999999998541       347889999999999999999999996532    2344433333  


Q ss_pred             CCCCHHHHhhc-CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          283 GTPTREEIKCM-NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       283 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      +.|.. .+... ......+.+...  .+....+...+++.+.+||.+||++||++|||+.++++
T Consensus       242 ~~p~~-~~~~~~~~~~~~~~~~~~--~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          242 GKPSG-AISGVQKAENGPIDWSGD--MPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             SCCTT-CCEEEECSTTCCEEEESS--CCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             CCCcc-cchhheeccCCCcccCcc--CCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            22221 11000 000000000000  00001112335678899999999999999999999854

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=8.8e-40  Score=305.04  Aligned_cols=225  Identities=22%  Similarity=0.283  Sum_probs=180.2

Q ss_pred             cccEeeec-eecccCceEEEEEEE--CCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           81 KVSYIAEH-VVGTGSFGVVFQAKC--RETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        81 ~~~y~~~~-~lG~G~~g~V~~~~~--~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      ...|.+.+ .||+|+||.||+|.+  ..+++.||||++....      ....+|+++++.++||||+++++++ ...   
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~---   90 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE---   90 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS---
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC---
Confidence            34599988 999999999999954  5667899999986432      2345799999999999999999987 221   


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----  226 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----  226 (403)
                        ..++||||++ ++|.+++..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++++    
T Consensus        91 --~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~  163 (291)
T 1xbb_A           91 --SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQHYAKISDFGL  163 (291)
T ss_dssp             --SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             --CcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHh-CCeEcCCCCcceEEEeCCCcEEEccCCc
Confidence              2779999998 577776654    3568999999999999999999999 899999999999999876544322    


Q ss_pred             ------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015672          227 ------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  287 (403)
Q Consensus       227 ------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~  287 (403)
                                        +|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.... .   
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~---  238 (291)
T 1xbb_A          164 SKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-R---  238 (291)
T ss_dssp             CEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-C---
T ss_pred             ceeeccCCCcccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-C---
Confidence                              34679999999654 48899999999999999999 999998877655444332210 0   


Q ss_pred             HHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                     +         ..+..+++++.+||.+||+.||++|||+.++++
T Consensus       239 ---------------~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          239 ---------------M---------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             ---------------C---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---------------C---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                           0         012467899999999999999999999999975

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.4e-41  Score=320.15  Aligned_cols=242  Identities=19%  Similarity=0.220  Sum_probs=180.0

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      .+|.+.+.||+|+||.||+|++ .+++.||||++....    ....+|+.+++.++||||+++++++.     .....++
T Consensus        39 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~l  112 (321)
T 2qkw_B           39 NNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD-----ERNEMIL  112 (321)
T ss_dssp             CCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC-----CTTCCEE
T ss_pred             hccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCeEEE
Confidence            3599999999999999999996 468999999886432    23457999999999999999999873     2334789


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      ||||++ ++|.+++.........+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+++           
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-RAIIHRDVKSINILLDENFVPKITDFGISKKGTE  191 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC-CCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            999997 46655443222222358899999999999999999999 89999999999999987655432           


Q ss_pred             ----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH---HHHhCCCCHHHHhh
Q 015672          226 ----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEI---IKVLGTPTREEIKC  292 (403)
Q Consensus       226 ----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~~  292 (403)
                                .||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+....+   .....         
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---------  261 (321)
T 2qkw_B          192 LDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN---------  261 (321)
T ss_dssp             SSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT---------
T ss_pred             ccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc---------
Confidence                      368889999998655 4899999999999999999999999765432111000   00000         


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                       .     ..+................+..+.+|+.+||+.||++|||+.|+++|
T Consensus       262 -~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          262 -N-----GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             -T-----TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -c-----ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             0     00111111111111223356789999999999999999999999976

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=7.5e-40  Score=306.81  Aligned_cols=239  Identities=23%  Similarity=0.367  Sum_probs=178.8

Q ss_pred             cccEeeeceecccCceEEEEEE----ECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      ...|++.+.||+|+||.||+|+    +..+++.||+|++....     ....+|+++++.++|+||+++++++...   .
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~   96 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---G   96 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---C
Confidence            3459999999999999999999    56789999999986432     3346899999999999999999988542   2


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----  225 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----  225 (403)
                      ...+++||||++ ++|.+++...   ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++     
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~  172 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEHQVKIGDFGL  172 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             CceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCchheEEEcCCCCEEECcccc
Confidence            234789999997 4887776442   3568999999999999999999999 89999999999999986654432     


Q ss_pred             -----------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015672          226 -----------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  288 (403)
Q Consensus       226 -----------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~  288 (403)
                                       .+|..|+|||++.+. .++.++|||||||++|+|++|..|+....  .   ......+.....
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~--~---~~~~~~~~~~~~  246 (302)
T 4e5w_A          173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSPM--A---LFLKMIGPTHGQ  246 (302)
T ss_dssp             CEECCTTCCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHH--H---HHHHHHCSCCGG
T ss_pred             cccccCCCcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcchh--h---HHhhccCCcccc
Confidence                             246669999998665 48899999999999999999998864221  1   111111111110


Q ss_pred             H-----HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          289 E-----IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       289 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      .     ......   ...          ...+..+++++.+||.+||+.||.+|||+.++++
T Consensus       247 ~~~~~~~~~~~~---~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          247 MTVTRLVNTLKE---GKR----------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             GHHHHHHHHHHT---TCC----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             cCHHHHHHHHhc---cCC----------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            0     000000   000          0022568899999999999999999999999985

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.2e-41  Score=329.57  Aligned_cols=237  Identities=20%  Similarity=0.240  Sum_probs=178.4

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCC-CCccccc---------eEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDH-PNIVALK---------HCF  144 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h-~niv~~~---------~~~  144 (403)
                      ..|...+.||+|+||+||+|++..+|+.||||++....       ....+|+.+++.+.| .|+..+.         +..
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            45899999999999999999999999999999886322       234589999999987 3322111         111


Q ss_pred             ee------------cCCCCceEEEEEeeccCCcHHHHHHHhh---hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccc
Q 015672          145 FS------------TTDKEELYLNLVLEYVPETVNRIARNYS---RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD  209 (403)
Q Consensus       145 ~~------------~~~~~~~~~~lv~e~~~~~l~~~~~~~~---~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrD  209 (403)
                      ..            .........+++|+++.++|.+++....   .....+++..+..++.||+.||.|||+ +||||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~iiHrD  236 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHTY  236 (413)
T ss_dssp             ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEECSC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCC
Confidence            00            0001122367889999899888775432   123346677888888999999999999 8999999


Q ss_pred             cccccceecCCCCcee----------------eccccccchhhhh---------CCCCCCchhHHHHHHHHHHHHHhCCC
Q 015672          210 IKPQNLLVKGEPNVSY----------------ICSRYYRAPELIF---------GATEYTTAIDIWSTGCVMAELLLGQP  264 (403)
Q Consensus       210 lKp~NILl~~~~~~~~----------------~~t~~y~aPE~~~---------~~~~~~~~~DiwSlGvil~el~tg~~  264 (403)
                      |||+||||+.++.+++                +| +.|+|||++.         ....++.++|||||||++|+|++|+.
T Consensus       237 iKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~  315 (413)
T 3dzo_A          237 LRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL  315 (413)
T ss_dssp             CCGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSC
T ss_pred             cccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCC
Confidence            9999999998876643                35 8899999983         33347889999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 015672          265 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEAC  344 (403)
Q Consensus       265 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l  344 (403)
                      ||.+.+..+....+                       +.          ....+++++.+||.+||+.||++|||+.+++
T Consensus       316 Pf~~~~~~~~~~~~-----------------------~~----------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          316 PNTDDAALGGSEWI-----------------------FR----------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             CCCTTGGGSCSGGG-----------------------GS----------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             CCCCcchhhhHHHH-----------------------Hh----------hcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            99765422111000                       00          0135789999999999999999999999999


Q ss_pred             cCCCcccCC
Q 015672          345 VHPFFDELR  353 (403)
Q Consensus       345 ~hp~f~~~~  353 (403)
                      +||||+++.
T Consensus       363 ~~~~~~~~~  371 (413)
T 3dzo_A          363 ETPEYEQLR  371 (413)
T ss_dssp             TSHHHHHHH
T ss_pred             hCHHHHHHH
Confidence            999998764

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-39  Score=303.99  Aligned_cols=227  Identities=26%  Similarity=0.307  Sum_probs=181.2

Q ss_pred             ccEeeec-eecccCceEEEEEEEC--CCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           82 VSYIAEH-VVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        82 ~~y~~~~-~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      .+|.+.+ .||+|+||.||+|.+.  .++..||||++....     ....+|+++++.++||||+++++++ ...     
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~-----   82 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE-----   82 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS-----
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC-----
Confidence            3466665 9999999999999864  467889999986532     2245799999999999999999987 222     


Q ss_pred             EEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------
Q 015672          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------  225 (403)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------  225 (403)
                      ..++||||+++ +|..++..   ....+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++       
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~  158 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRHYAKISDFGLSK  158 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             CcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCchheEEEcCCCCEEECccccee
Confidence            27899999985 77665532   23568999999999999999999999 89999999999999986654432       


Q ss_pred             ---------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          226 ---------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       226 ---------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                     .+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+.... .     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~-~-----  231 (287)
T 1u59_A          159 ALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-R-----  231 (287)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-C-----
T ss_pred             eeccCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC-c-----
Confidence                           236779999998654 48999999999999999998 999998877666554443210 0     


Q ss_pred             HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 015672          290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  347 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp  347 (403)
                                   +         .++..+++++.+||.+||..||++||++.++++|.
T Consensus       232 -------------~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          232 -------------M---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             -------------C---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             -------------C---------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence                         0         02246789999999999999999999999999873

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.2e-39  Score=303.19  Aligned_cols=228  Identities=20%  Similarity=0.301  Sum_probs=179.4

Q ss_pred             cccEeeeceecccCceEEEEEEECCCC---cEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      ...|.+.+.||+|+||.||+|++..++   ..||+|.+....     ....+|+.+++.++||||++++++++..    .
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~   99 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----E   99 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----S
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC----C
Confidence            445999999999999999999975433   468999886432     2345799999999999999999986432    2


Q ss_pred             eEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee-----
Q 015672          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-----  226 (403)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~-----  226 (403)
                      ...++||||+++ +|.+++..   ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.++++     
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~a  175 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLAS-KKFVHRDLAARNCMLDEKFTVKVADFGLA  175 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred             CceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEECCCCCEEECccccc
Confidence            347799999985 88777653   23568889999999999999999999 899999999999999877655432     


Q ss_pred             ------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015672          227 ------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  287 (403)
Q Consensus       227 ------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~  287 (403)
                                        +|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+....+......   
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---  251 (298)
T 3f66_A          176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL---  251 (298)
T ss_dssp             CCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC---
T ss_pred             ccccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC---
Confidence                              35679999999654 58999999999999999999 67778776655544443321100   


Q ss_pred             HHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                               ..+..+++++.+||.+||..||++|||+.++++
T Consensus       252 -------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          252 -------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                     012457899999999999999999999999986

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=7.6e-40  Score=305.04  Aligned_cols=225  Identities=13%  Similarity=0.046  Sum_probs=176.3

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      .+|++.+.||+|+||.||+|++..+++.||||++....       ....+|+.++..++|+||+++++++..     ...
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~~  105 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----RAG  105 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----CCc
Confidence            45999999999999999999999999999999986542       234579999999999999999998843     345


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceeeccccccc
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYICSRYYRA  233 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~~t~~y~a  233 (403)
                      .|+||||++ ++|.+++..      ......+..++.||+.||.|||+ +||+||||||+|||++.++.+++ +++.|++
T Consensus       106 ~~lv~e~~~g~~L~~~l~~------~~~~~~~~~i~~ql~~aL~~lH~-~givH~Dikp~NIll~~~g~~kl-~~~~~~~  177 (286)
T 3uqc_A          106 GLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVSIDGDVVL-AYPATMP  177 (286)
T ss_dssp             EEEEEECCCEEEHHHHHTT------CCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEETTSCEEE-CSCCCCT
T ss_pred             EEEEEEecCCCCHHHHHhc------CCChHHHHHHHHHHHHHHHHHHH-CCCccCCCCcccEEEcCCCCEEE-EeccccC
Confidence            889999997 577666532      24555788899999999999999 89999999999999998887754 5777876


Q ss_pred             hhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccc
Q 015672          234 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKV  313 (403)
Q Consensus       234 PE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (403)
                      |        ++.++|||||||++|+|++|+.||.+.+..+.+...                     ..... ...+....
T Consensus       178 ~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---------------------~~~~~-~~~~~~~~  227 (286)
T 3uqc_A          178 D--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---------------------ERDTA-GQPIEPAD  227 (286)
T ss_dssp             T--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---------------------CBCTT-SCBCCHHH
T ss_pred             C--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---------------------HHHhc-cCCCChhh
Confidence            4        789999999999999999999999876532111000                     00000 00011112


Q ss_pred             cccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          314 FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       314 ~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                      ....+++++.+||.+||+.||++| |+.|+++.  ++++
T Consensus       228 ~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~--L~~~  263 (286)
T 3uqc_A          228 IDRDIPFQISAVAARSVQGDGGIR-SASTLLNL--MQQA  263 (286)
T ss_dssp             HCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH--HHHH
T ss_pred             cccCCCHHHHHHHHHHcccCCccC-CHHHHHHH--HHHH
Confidence            335689999999999999999999 99999874  5544

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.1e-39  Score=323.14  Aligned_cols=227  Identities=24%  Similarity=0.339  Sum_probs=184.8

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ...+|.+.+.||+|+||.||+|.+.. +..||||++....   ..+.+|+++|+.++||||+++++++..      ..++
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~~  254 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY  254 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------CceE
Confidence            34569999999999999999999864 4679999986533   345689999999999999999988732      1267


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee---------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI---------  226 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~---------  226 (403)
                      +||||++ ++|.+++....  ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.++++         
T Consensus       255 iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             EEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             EEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            9999997 58877765322  3468899999999999999999999 899999999999999876554332         


Q ss_pred             -----------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          227 -----------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       227 -----------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                 +|..|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+.+..+......+         
T Consensus       332 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~---------  401 (452)
T 1fmk_A          332 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP---------  401 (452)
T ss_dssp             -----------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---------
T ss_pred             CCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---------
Confidence                       35679999998654 58999999999999999999 999999887766655543311100         


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                         .+..+++.+.+||.+||+.||++|||++++++
T Consensus       402 -------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          402 -------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             -------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                               12467899999999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.5e-39  Score=301.28  Aligned_cols=227  Identities=22%  Similarity=0.331  Sum_probs=182.7

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc--ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      ..+|.+.+.||+|+||.||+|++.  ++.||||++..+.  ....+|+.+++.++||||+++++++...    ...+++|
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv   93 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYIV   93 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEEE
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCceEEE
Confidence            456999999999999999999874  8899999986543  3345799999999999999999986432    2247899


Q ss_pred             eeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee-----------
Q 015672          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-----------  226 (403)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~-----------  226 (403)
                      |||+++ +|.+++....  ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++++           
T Consensus        94 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           94 TEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             ECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            999985 8887775432  1237888899999999999999999 899999999999999877665432           


Q ss_pred             -----ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccc
Q 015672          227 -----CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  300 (403)
Q Consensus       227 -----~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  300 (403)
                           +++.|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+....                  
T Consensus       171 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~------------------  231 (278)
T 1byg_A          171 QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY------------------  231 (278)
T ss_dssp             -----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC------------------
T ss_pred             ccCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC------------------
Confidence                 46789999998654 58999999999999999998 999998776544443332110                  


Q ss_pred             CCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                ....+..+++++.+||.+||..||++|||+.++++
T Consensus       232 ----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          232 ----------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                      00122467899999999999999999999999976

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.3e-39  Score=302.04  Aligned_cols=228  Identities=20%  Similarity=0.303  Sum_probs=178.1

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      .+|.+.+.||+|+||.||+|++.   ..||+|++....      ....+|+.+++.++|+||++++++. ..     ..+
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~-----~~~   94 (289)
T 3og7_A           24 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA-----PQL   94 (289)
T ss_dssp             TSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS-----SSC
T ss_pred             cceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC-----Ccc
Confidence            45999999999999999999864   359999885432      2345799999999999999998854 11     126


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      ++||||+. ++|...+..   ....+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++         
T Consensus        95 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  170 (289)
T 3og7_A           95 AIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHA-KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK  170 (289)
T ss_dssp             EEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             EEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEEECCCCCEEEccceecccc
Confidence            79999998 566555432   23568899999999999999999999 89999999999999987665432         


Q ss_pred             ------------eccccccchhhhh--CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015672          226 ------------ICSRYYRAPELIF--GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       226 ------------~~t~~y~aPE~~~--~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  291 (403)
                                  .||+.|+|||++.  ....++.++|||||||++|+|++|+.||.+....+.+..+......++.    
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----  246 (289)
T 3og7_A          171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD----  246 (289)
T ss_dssp             -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC----
T ss_pred             ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc----
Confidence                        3688999999985  2345788999999999999999999999987777666655543211110    


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                         .......+++++.+||.+||..||.+|||+.++++
T Consensus       247 -------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          247 -------------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             -------------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                               00112467899999999999999999999999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.1e-39  Score=300.39  Aligned_cols=226  Identities=22%  Similarity=0.300  Sum_probs=182.3

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      ..+|.+.+.||+|+||.||+|++. ++..||+|++....   ....+|+++++.++||||+++++++..    +  ..++
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~--~~~~   84 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ----E--PIYI   84 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----S--SCEE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC----C--CcEE
Confidence            346999999999999999999975 56789999986533   334689999999999999999987621    1  2679


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----------  226 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----------  226 (403)
                      ||||++ ++|.+++....  ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.++++          
T Consensus        85 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             EEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence            999996 67776654321  2368899999999999999999999 899999999999999877655432          


Q ss_pred             ----------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          227 ----------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       227 ----------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                +|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....            
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------------  228 (279)
T 1qpc_A          162 NEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR------------  228 (279)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC------------
T ss_pred             cccccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC------------
Confidence                      35679999998654 48999999999999999999 9999988776665544432100            


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                      ...+..+++++.+||.+||..||++|||+.++++
T Consensus       229 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          229 ----------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                            0012467899999999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.7e-39  Score=300.07  Aligned_cols=230  Identities=21%  Similarity=0.292  Sum_probs=178.9

Q ss_pred             ccccEeeeceecccCceEEEEEEECCCCc---EEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      ....|.+.++||+|+||+||+|++..+++   .||+|++....     ....+|+.+++.++||||+++++++....   
T Consensus        19 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---   95 (298)
T 3pls_A           19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE---   95 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS---
T ss_pred             cceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC---
Confidence            34458899999999999999999765554   79999886432     23357999999999999999999884322   


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----  226 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----  226 (403)
                       ...++||||+. ++|.+++..   ....+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++++    
T Consensus        96 -~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nili~~~~~~kl~Dfg~  170 (298)
T 3pls_A           96 -GLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAE-QKFVHRDLAARNCMLDESFTVKVADFGL  170 (298)
T ss_dssp             -SCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred             -CCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCCcEEeCcCCC
Confidence             22478999986 677766643   23568899999999999999999999 899999999999999877655432    


Q ss_pred             -------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCC
Q 015672          227 -------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPT  286 (403)
Q Consensus       227 -------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg-~~pf~~~~~~~~~~~i~~~~~~~~  286 (403)
                                         +|+.|+|||++.+. .++.++|||||||++|+|++| .+||...+..+....+......  
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--  247 (298)
T 3pls_A          171 ARDILDREYYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL--  247 (298)
T ss_dssp             SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC--
T ss_pred             cccccCCcccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC--
Confidence                               46789999999654 589999999999999999995 5555555544433333221100  


Q ss_pred             HHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          287 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                                ..+..+++++.+||.+||+.||.+|||+.++++.
T Consensus       248 --------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          248 --------------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                      0124578999999999999999999999999863

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-39  Score=314.12  Aligned_cols=229  Identities=19%  Similarity=0.289  Sum_probs=180.6

Q ss_pred             cccEeeeceecccCceEEEEEEECCCC---cEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      ...|.+.+.||+|+||+||+|++..++   ..||+|.+....     ....+|+.+++.++||||++++++++...    
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~----  163 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----  163 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS----
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC----
Confidence            445999999999999999999875433   468999885432     23457999999999999999999864322    


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee-----
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-----  226 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~-----  226 (403)
                      ...++||||++ ++|.+++...   ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.++++     
T Consensus       164 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kL~DFG~a  239 (373)
T 3c1x_A          164 GSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKFTVKVADFGLA  239 (373)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             CCeEEEEECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCccchheEEECCCCCEEEeecccc
Confidence            23679999998 4887776532   3457888899999999999999999 899999999999999877665432     


Q ss_pred             ------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015672          227 ------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  287 (403)
Q Consensus       227 ------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~  287 (403)
                                        +|+.|+|||++.+. .++.++|||||||++|||++ |.+||.+.+..+....+....  .  
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~--~--  314 (373)
T 3c1x_A          240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--R--  314 (373)
T ss_dssp             ------------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC--C--
T ss_pred             ccccccccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC--C--
Confidence                              35679999998654 58999999999999999999 788887766554443332210  0  


Q ss_pred             HHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                              ...+..+++++.+||.+||..||++|||+.+++++
T Consensus       315 ------------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          315 ------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                    00124578999999999999999999999999875

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=299.80  Aligned_cols=228  Identities=28%  Similarity=0.400  Sum_probs=177.8

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc--ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      ..+|.+.+.||+|+||+||+|++.  ++.||||++....  ....+|+++++.++||||+++++++.     +.  .++|
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~--~~lv   77 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-----NP--VCLV   77 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TT--TEEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC--cEEE
Confidence            346999999999999999999975  7889999986543  33468999999999999999988762     22  5799


Q ss_pred             eeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhc--CCccccccccccceecCCCC-cee---------
Q 015672          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC--IGICHRDIKPQNLLVKGEPN-VSY---------  225 (403)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~--~~ivHrDlKp~NILl~~~~~-~~~---------  225 (403)
                      |||++ ++|.+++..... ...++...+..++.||+.||.|||+.  +||+||||||+|||++.++. +++         
T Consensus        78 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~  156 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI  156 (307)
T ss_dssp             EECCTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred             EEcCCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence            99997 588777654221 12467888899999999999999972  38999999999999987665 222         


Q ss_pred             -------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCHHHHhhcCcCc
Q 015672          226 -------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       226 -------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                             .||+.|+|||++.+. .++.++|||||||++|+|++|+.||........ ....... +..            
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~------------  222 (307)
T 2eva_A          157 QTHMTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN-GTR------------  222 (307)
T ss_dssp             --------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT-TCC------------
T ss_pred             ccccccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc-CCC------------
Confidence                   368899999998654 589999999999999999999999976443221 1111110 000            


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                           +         .....+++.+.+||.+||+.||++|||+.+++++
T Consensus       223 -----~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          223 -----P---------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             -----C---------CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----C---------CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                 0         0124678999999999999999999999999873

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=9.3e-39  Score=317.91  Aligned_cols=232  Identities=20%  Similarity=0.212  Sum_probs=182.6

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccc--ccccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      ..+|.+.++||+|+||.||+|++..+++.||||++..  ......+|+++++.|+|.+++..+..+..    ...+.+||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~~~lv   81 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV----EGDYNVLV   81 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCEEEEE
Confidence            3469999999999999999999999999999998753  33456789999999998666655555432    23457899


Q ss_pred             eeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceec---CCCCc------------
Q 015672          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVK---GEPNV------------  223 (403)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~---~~~~~------------  223 (403)
                      |||++++|.+++...   ...+++..++.++.||+.||.|||+ +|||||||||+||||+   ..+.+            
T Consensus        82 me~~g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           82 MDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EECCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            999998998877642   3579999999999999999999999 8999999999999993   33322            


Q ss_pred             --------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCC
Q 015672          224 --------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG---VDQLVEIIKVLGTPT  286 (403)
Q Consensus       224 --------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~---~~~~~~i~~~~~~~~  286 (403)
                                    ...||+.|+|||++.+. .++.++|||||||+||||++|+.||.+...   ...+..+........
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             CCccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence                          23578899999999654 589999999999999999999999987544   223333322111111


Q ss_pred             HHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          287 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      .+                        .+...+++++.+||.+||..||++||++.++++
T Consensus       237 ~~------------------------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          237 IE------------------------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HH------------------------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HH------------------------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            11                        122467899999999999999999999988754

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=5.8e-41  Score=341.82  Aligned_cols=264  Identities=24%  Similarity=0.316  Sum_probs=187.6

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecC-CCCceEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTT-DKEELYL  155 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~  155 (403)
                      .+|.+.+.||+|+||.||+|.+..+|+.||||++....     ....+|+++++.++||||+++++++.... .......
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            45999999999999999999999999999999886432     23457999999999999999988763211 1124457


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC---c--------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN---V--------  223 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~---~--------  223 (403)
                      ++|||||+ ++|..++..... ...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.   +        
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs-~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHH-TTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             EEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            89999996 588777664321 2358888999999999999999999 89999999999999986543   1        


Q ss_pred             ----------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015672          224 ----------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       224 ----------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  293 (403)
                                ...||+.|+|||++.+. .++.++|||||||++|+|++|..||.+......+...   ........+...
T Consensus       172 ~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~---i~~~~~~~~~~~  247 (676)
T 3qa8_A          172 KELDQGELCTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK---VREKSNEHIVVY  247 (676)
T ss_dssp             CBTTSCCCCCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTT---CC------CCSC
T ss_pred             cccccccccccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhh---hhcccchhhhhh
Confidence                      23578899999998654 5899999999999999999999999775433221110   000000000000


Q ss_pred             CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                      ........+....  +....+...+++.+.+||.+||.+||++|||+.++++||||+.+.
T Consensus       248 ~~l~g~~~~~~~l--p~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~  305 (676)
T 3qa8_A          248 DDLTGAVKFSSVL--PTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD  305 (676)
T ss_dssp             CCCSSSCCCCSSS--CCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred             hhhcccccccccc--CCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence            0011111121111  111122344678999999999999999999999999999998764

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-39  Score=308.29  Aligned_cols=234  Identities=22%  Similarity=0.292  Sum_probs=174.1

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc-cHHHHHHHHHhc--CCCCccccceEEeecCCCCceEEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-YKNRELQIMQML--DHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      .+|++.+.||+|+||.||+|++.  ++.||||++..... ...+|.+++..+  +|+||+++++++.... .....+++|
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv  113 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWTQLYLI  113 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGGCEEEEE
T ss_pred             cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCCCceEEE
Confidence            46999999999999999999985  89999999854332 223556665554  9999999999875432 223568999


Q ss_pred             eeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--------CccccccccccceecCCCCce-----
Q 015672          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI--------GICHRDIKPQNLLVKGEPNVS-----  224 (403)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--------~ivHrDlKp~NILl~~~~~~~-----  224 (403)
                      |||+++ +|.+++..     ..+++..+..++.|++.||.|||+ .        ||+||||||+|||++.++.++     
T Consensus       114 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg  187 (337)
T 3mdy_A          114 TDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHT-EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  187 (337)
T ss_dssp             ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHS-CBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH-hhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence            999974 88877753     468999999999999999999998 7        999999999999998765442     


Q ss_pred             ------------------eeccccccchhhhhCCCCCCc------hhHHHHHHHHHHHHHhC----------CCCCCCCC
Q 015672          225 ------------------YICSRYYRAPELIFGATEYTT------AIDIWSTGCVMAELLLG----------QPLFPGES  270 (403)
Q Consensus       225 ------------------~~~t~~y~aPE~~~~~~~~~~------~~DiwSlGvil~el~tg----------~~pf~~~~  270 (403)
                                        ..||+.|+|||++.+.. ++.      ++|||||||++|||++|          ..||....
T Consensus       188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~  266 (337)
T 3mdy_A          188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV  266 (337)
T ss_dssp             TCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence                              24788999999996543 333      49999999999999999          66665432


Q ss_pred             ----cHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          271 ----GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       271 ----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                          .............                     ..+..........+++++.+||.+||+.||++|||+.++++|
T Consensus       267 ~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          267 PSDPSYEDMREIVCIKK---------------------LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             CSSCCHHHHHHHHTTSC---------------------CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCCCchhhhHHHHhhhc---------------------cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence                1122222211000                     000000000112456789999999999999999999999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.1e-39  Score=326.34  Aligned_cols=227  Identities=24%  Similarity=0.339  Sum_probs=184.8

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      ..+|.+.+.||+|+||.||+|++.. +..||||++....   ..+.+|+++|+.++|+||+++++++..      ..+++
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~l  338 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYI  338 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEE
T ss_pred             hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccceE
Confidence            4569999999999999999999864 4679999986533   345689999999999999999988732      22779


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----------  226 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----------  226 (403)
                      ||||+. ++|.+++....  ...+++..+..++.||+.||.|||+ +|||||||||+|||++.++.++++          
T Consensus       339 v~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          339 VTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLARLIED  415 (535)
T ss_dssp             EECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred             eeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence            999997 48877765322  3458899999999999999999999 899999999999999876655432          


Q ss_pred             ----------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          227 ----------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       227 ----------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                                ++..|+|||++.+. .++.++|||||||++|||++ |+.||.+....+.+..+......           
T Consensus       416 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-----------  483 (535)
T 2h8h_A          416 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------  483 (535)
T ss_dssp             HHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC-----------
T ss_pred             CceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence                      34679999998654 58999999999999999999 99999988776665554331110           


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                             +          .+..+++++.+||.+||+.||++|||+.++++.
T Consensus       484 -------~----------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~  517 (535)
T 2h8h_A          484 -------P----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAF  517 (535)
T ss_dssp             -------C----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------C----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                   0          124678999999999999999999999999863

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=8.2e-40  Score=311.29  Aligned_cols=258  Identities=21%  Similarity=0.293  Sum_probs=178.0

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc-cHHHHHHH--HHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-YKNRELQI--MQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      ..+|++.+.||+|+||.||+|++  +++.||||++..... ....|.++  +..++|+||+++++.+..........+++
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l   89 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL   89 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence            34699999999999999999976  589999999864332 22234444  45589999999998765555556667899


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---------CccccccccccceecCCCCcee--
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCI---------GICHRDIKPQNLLVKGEPNVSY--  225 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---------~ivHrDlKp~NILl~~~~~~~~--  225 (403)
                      ||||++ ++|.+++..     ...++..+..++.||+.||.|||+ .         ||+||||||+|||++.++.+++  
T Consensus        90 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           90 VMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHT-ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred             EEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHh-hhccccccccceeecccccceEEEcCCCcEEEee
Confidence            999996 588777754     456888899999999999999998 8         9999999999999987655432  


Q ss_pred             -------------------------eccccccchhhhhCC------CCCCchhHHHHHHHHHHHHHhCCCCCCC-CCcHH
Q 015672          226 -------------------------ICSRYYRAPELIFGA------TEYTTAIDIWSTGCVMAELLLGQPLFPG-ESGVD  273 (403)
Q Consensus       226 -------------------------~~t~~y~aPE~~~~~------~~~~~~~DiwSlGvil~el~tg~~pf~~-~~~~~  273 (403)
                                               .||+.|+|||++.+.      ..++.++|||||||++|||++|..||.. ....+
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  243 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE  243 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence                                     378899999998652      2356789999999999999999766533 22111


Q ss_pred             HHHHHH-HHhCCCCHHHHhhc-CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc------
Q 015672          274 QLVEII-KVLGTPTREEIKCM-NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV------  345 (403)
Q Consensus       274 ~~~~i~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~------  345 (403)
                      ....+. .....+....+... ........++.    .|..  ...+++++.+||.+||+.||++|||+.|+++      
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE----AWKE--NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT----TCCC--CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhhhcccCCCchHHHHHhhhcccccCCCCCc----cccc--ccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            100111 11122222221110 00000001111    0000  0124568999999999999999999999954      


Q ss_pred             CCCcccC
Q 015672          346 HPFFDEL  352 (403)
Q Consensus       346 hp~f~~~  352 (403)
                      ++|-++-
T Consensus       318 ~~~~~~~  324 (336)
T 3g2f_A          318 MIWERNK  324 (336)
T ss_dssp             HCCCC--
T ss_pred             HHHHhcc
Confidence            5665543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.1e-39  Score=306.42  Aligned_cols=239  Identities=21%  Similarity=0.268  Sum_probs=179.0

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccc--------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      .|...+.||+|+||.||+|++  +++.||+|++...        .....+|+.+++.++||||+++++++..     ...
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~  104 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD-----GDD  104 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSS
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec-----CCc
Confidence            366779999999999999986  5889999988532        1234579999999999999999998833     234


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce---------
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS---------  224 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~---------  224 (403)
                      .++||||++ ++|.+++.... ....+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++         
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  182 (307)
T 2nru_A          105 LCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHE-NHHIHRDIKSANILLDEAFTAKISDFGLARA  182 (307)
T ss_dssp             CEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEcCCCcEEEeecccccc
Confidence            789999996 68877765432 23568999999999999999999999 8999999999999998765442         


Q ss_pred             ------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          225 ------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       225 ------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                                  ..||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+......+..+..............
T Consensus       183 ~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (307)
T 2nru_A          183 SEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY  260 (307)
T ss_dssp             CCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH
T ss_pred             cccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh
Confidence                        246889999999854  378999999999999999999999987654333333322211110000000


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      ..        +....      .+...++.+.+||.+||..||.+|||+.+++++
T Consensus       261 ~~--------~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          261 ID--------KKMND------ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             SC--------SSCSC------CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cc--------ccccc------cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            00        00000      112345779999999999999999999999874

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3e-39  Score=300.94  Aligned_cols=232  Identities=25%  Similarity=0.341  Sum_probs=177.1

Q ss_pred             cccEeeeceecccCceEEEEEEECC-CCc--EEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRE-TGE--IVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~--~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  150 (403)
                      ..+|++.+.||+|+||+||+|++.. +++  .||||++....       ....+|+++++.++||||+++++++...   
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   93 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---   93 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence            3469999999999999999998643 333  68999885431       2335799999999999999999987421   


Q ss_pred             CceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----
Q 015672          151 EELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----  225 (403)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----  225 (403)
                        . .++||||+. ++|.+.+...   ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+++    
T Consensus        94 --~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nili~~~~~~kl~Dfg  166 (291)
T 1u46_A           94 --P-MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRDLVKIGDFG  166 (291)
T ss_dssp             --S-CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             --C-ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEEcCCCCEEEcccc
Confidence              1 679999997 5777766543   3468899999999999999999999 89999999999999986654432    


Q ss_pred             ------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 015672          226 ------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  286 (403)
Q Consensus       226 ------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~  286 (403)
                                        .+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+.+..+......  
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--  243 (291)
T 1u46_A          167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER--  243 (291)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC--
T ss_pred             ccccccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCC--
Confidence                              235579999998654 48899999999999999999 99999888766655544321000  


Q ss_pred             HHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          287 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                                     .+          .+..+++++.+||.+||..||.+|||+.++++  +++++
T Consensus       244 ---------------~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~l~~~  282 (291)
T 1u46_A          244 ---------------LP----------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEA  282 (291)
T ss_dssp             ---------------CC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             ---------------CC----------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHH--HHHHh
Confidence                           00          12457899999999999999999999999997  35554

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.1e-38  Score=327.86  Aligned_cols=222  Identities=22%  Similarity=0.283  Sum_probs=179.1

Q ss_pred             Eee-eceecccCceEEEEEEE--CCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           84 YIA-EHVVGTGSFGVVFQAKC--RETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        84 y~~-~~~lG~G~~g~V~~~~~--~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      +.+ .+.||+|+||.||+|.+  +.+++.||||++....      ....+|+++|+.++|||||++++++. ..     .
T Consensus       370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~-----~  443 (635)
T 4fl3_A          370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AE-----S  443 (635)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SS-----S
T ss_pred             ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC-----C
Confidence            444 45899999999999954  4567899999986432      23458999999999999999999772 11     1


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee-------
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-------  226 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~-------  226 (403)
                      +++||||+. ++|.+++..    ...+++..+..++.||+.||.|||+ +|||||||||+||||+.++.++++       
T Consensus       444 ~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDLkp~NILl~~~~~~kL~DFGla~~  518 (635)
T 4fl3_A          444 WMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQHYAKISDFGLSKA  518 (635)
T ss_dssp             EEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred             EEEEEEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHH-CCEeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence            679999998 577776653    4568999999999999999999999 899999999999999877655332       


Q ss_pred             ---------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          227 ---------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       227 ---------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                     +|+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+......      
T Consensus       519 ~~~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~------  591 (635)
T 4fl3_A          519 LRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM------  591 (635)
T ss_dssp             TTC-------------CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC------
T ss_pred             cccCccccccccCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------
Confidence                           35679999999654 58999999999999999998 99999988876655554432100      


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                            ..+..+++++.+||.+||+.||++|||+.++++
T Consensus       592 ----------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          592 ----------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             ----------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                                  012468899999999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=326.82  Aligned_cols=224  Identities=25%  Similarity=0.312  Sum_probs=179.5

Q ss_pred             cEeeec-eecccCceEEEEEEEC--CCCcEEEEEEcccc-----cccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           83 SYIAEH-VVGTGSFGVVFQAKCR--ETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        83 ~y~~~~-~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      .|.+.+ .||+|+||.||+|.++  .++..||||++...     ...+.+|+++|+.++|||||++++++.. .     .
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~-----~  409 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E-----A  409 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S-----S
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C-----C
Confidence            355555 8999999999999875  35667999998643     2334689999999999999999998732 1     2


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee-------
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI-------  226 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~-------  226 (403)
                      +++|||||+ ++|.+++..   ....+++..+..++.||+.||.|||+ +||+||||||+||||+.++.++++       
T Consensus       410 ~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~vkL~DFGla~~  485 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRNLAARNVLLVNRHYAKISDFGLSKA  485 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred             eEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence            789999998 477666532   23568999999999999999999999 899999999999999876654332       


Q ss_pred             ---------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          227 ---------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       227 ---------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                     +|+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+......      
T Consensus       486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~------  558 (613)
T 2ozo_A          486 LGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM------  558 (613)
T ss_dssp             CC--------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC------
T ss_pred             ccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC------
Confidence                           24679999999654 58999999999999999998 99999988877766555431100      


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                            ..+..+++++.+||.+||..||++|||+.++++
T Consensus       559 ----------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          559 ----------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             ----------------------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             ----------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                  022468899999999999999999999999853

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.7e-39  Score=304.13  Aligned_cols=234  Identities=24%  Similarity=0.365  Sum_probs=176.8

Q ss_pred             EeeeceecccCceEEEEEEE----CCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           84 YIAEHVVGTGSFGVVFQAKC----RETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      |++.+.||+|+||+||+|.+    ..+++.||||++....     ....+|+++++.++||||+++++++...   +...
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~  109 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---GAAS  109 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TTTE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---CCce
Confidence            59999999999999988764    3478899999986542     2345799999999999999999988542   2345


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee--------
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY--------  225 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~--------  225 (403)
                      +++||||++ ++|.+++..     ..+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+++        
T Consensus       110 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~-~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHA-QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEEcCCCCEEECCcccccc
Confidence            889999997 477666542     458999999999999999999999 89999999999999988765533        


Q ss_pred             --------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH--
Q 015672          226 --------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE--  289 (403)
Q Consensus       226 --------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~--  289 (403)
                                    .+|+.|+|||++.+. .++.++|||||||++|+|++|..||.......     ...........  
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-----~~~~~~~~~~~~~  257 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-----LELIGIAQGQMTV  257 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-----HHHHCSCCHHHHH
T ss_pred             ccccccccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchhh-----hhhhcccccchhH
Confidence                          246679999999754 48899999999999999999999996532110     00000000000  


Q ss_pred             ---HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          290 ---IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       290 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                         ....... .  .          ...+..+++++.+||.+||+.||++|||+.++++
T Consensus       258 ~~~~~~~~~~-~--~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          258 LRLTELLERG-E--R----------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHHHHTT-C--C----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcc-c--C----------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence               0000000 0  0          0022567899999999999999999999999985

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=307.21  Aligned_cols=225  Identities=16%  Similarity=0.172  Sum_probs=173.9

Q ss_pred             ccEeeeceecccCceEEEEE-----EECCCCcEEEEEEccccc-ccHHHHHHHHHhcC---CCCccccceEEeecCCCCc
Q 015672           82 VSYIAEHVVGTGSFGVVFQA-----KCRETGEIVAIKKVLQDK-RYKNRELQIMQMLD---HPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~-----~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~  152 (403)
                      ..|.+.+.||+|+||+||+|     .+..+++.||||++.... ....+|+++++.++   |+||+++++++....    
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~----  140 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN----  140 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS----
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC----
Confidence            45999999999999999999     466789999999986543 34457888888887   899999999885433    


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhh-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecC-----------
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSR-IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKG-----------  219 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~-----------  219 (403)
                       ..++|||||+ ++|.+++..... ....+++..++.++.||+.||+|||+ +|||||||||+|||++.           
T Consensus       141 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~ivHrDiKp~NIll~~~~~~~~~~~~~  218 (365)
T 3e7e_A          141 -GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDEDDL  218 (365)
T ss_dssp             -CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECGGGTCC------
T ss_pred             -CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEecccccCccccccc
Confidence             3789999997 688888765433 24569999999999999999999999 89999999999999977           


Q ss_pred             CCCce---------------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Q 015672          220 EPNVS---------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEI  278 (403)
Q Consensus       220 ~~~~~---------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i  278 (403)
                      ++.++                     .+||+.|+|||++.+. .++.++|||||||++|||++|+.||......      
T Consensus       219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~------  291 (365)
T 3e7e_A          219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCMLFGTYMKVKNEGG------  291 (365)
T ss_dssp             CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCCCEEEETT------
T ss_pred             cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC-CCCccccHHHHHHHHHHHHhCCCccccCCCC------
Confidence            44432                     2378999999999765 4899999999999999999999999543210      


Q ss_pred             HHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          279 IKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                          .+........       ...++...+++.+||..+|.+|++..+.+.+
T Consensus       292 --------------------~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          292 --------------------ECKPEGLFRR-------LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             --------------------EEEECSCCTT-------CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             --------------------ceeechhccc-------cCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence                                0000000000       1235678999999999999999765555544

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-38  Score=300.46  Aligned_cols=240  Identities=25%  Similarity=0.430  Sum_probs=179.5

Q ss_pred             ccccEeeeceecccCceEEEEEE----ECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAK----CRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      ....|.+.+.||+|+||.||+|+    +..+++.||||++....    ....+|+.+++.++|+||+++++++...   +
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~  115 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---G  115 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-----
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec---C
Confidence            44569999999999999999998    45689999999986532    2345899999999999999999987432   2


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceee----
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYI----  226 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~----  226 (403)
                      ...+++||||++ ++|.+++...   ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++++    
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENENRVKIGDFGL  191 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             CCceEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEEcCCCcEEEecCcc
Confidence            234789999997 5887776542   2458999999999999999999999 899999999999999876554322    


Q ss_pred             ------------------ccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015672          227 ------------------CSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  288 (403)
Q Consensus       227 ------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~  288 (403)
                                        ++..|+|||++.+. .++.++|||||||++|+|++|..||....  ..   ..+..+.....
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~--~~---~~~~~~~~~~~  265 (326)
T 2w1i_A          192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPP--AE---FMRMIGNDKQG  265 (326)
T ss_dssp             CEECCSSCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHH--HH---HHHHHCTTCCT
T ss_pred             hhhccccccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCH--HH---HHHhhccccch
Confidence                              35569999998654 48899999999999999999999885321  11   11111111100


Q ss_pred             H------HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          289 E------IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       289 ~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      .      ......   ....          ..+..+++++.+||.+||..||++|||+.++++
T Consensus       266 ~~~~~~~~~~~~~---~~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          266 QMIVFHLIELLKN---NGRL----------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHHHHHHHT---TCCC----------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhhHHHHHHHhhc---CCCC----------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            0      000000   0000          012467899999999999999999999999975

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=299.34  Aligned_cols=232  Identities=19%  Similarity=0.264  Sum_probs=180.1

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      .+|.+.+.||+|+||.||+|++..   .+|+|++...      .....+|+.+++.++|+||+++++++...     ..+
T Consensus        33 ~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~  104 (319)
T 2y4i_B           33 EQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP-----PHL  104 (319)
T ss_dssp             SCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS-----SCE
T ss_pred             HHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----Cce
Confidence            359999999999999999999853   4999988532      12345799999999999999999988543     238


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce----------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS----------  224 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~----------  224 (403)
                      ++||||++ ++|.+++..   ....+++..+..++.||+.||.|||+ .||+||||||+|||++. +.++          
T Consensus       105 ~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~NIl~~~-~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHA-KGILHKDLKSKNVFYDN-GKVVITDFGLFSIS  179 (319)
T ss_dssp             EEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             EEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChhhEEEeC-CCEEEeecCCcccc
Confidence            89999997 577665532   23468899999999999999999999 89999999999999973 2322          


Q ss_pred             --------------eeccccccchhhhhC--------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 015672          225 --------------YICSRYYRAPELIFG--------ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL  282 (403)
Q Consensus       225 --------------~~~t~~y~aPE~~~~--------~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~  282 (403)
                                    ..||+.|+|||++.+        ...++.++|||||||++|+|++|..||.+.+.......+....
T Consensus       180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  259 (319)
T 2y4i_B          180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM  259 (319)
T ss_dssp             --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC
T ss_pred             ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC
Confidence                          136788999999864        2347899999999999999999999998877665544433210


Q ss_pred             CCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          283 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                      .                   +.        .....++.++.+||.+||..||++|||+.++++.  ++.+...
T Consensus       260 ~-------------------~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~--l~~l~~~  303 (319)
T 2y4i_B          260 K-------------------PN--------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM--LEKLPKR  303 (319)
T ss_dssp             C-------------------CC--------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH--HTTC---
T ss_pred             C-------------------CC--------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH--HHHHHHh
Confidence            0                   00        0113478899999999999999999999999873  6665443

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=8.4e-38  Score=322.48  Aligned_cols=228  Identities=27%  Similarity=0.370  Sum_probs=184.3

Q ss_pred             ccccEeeeceecccCceEEEEEEECCC---CcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           80 QKVSYIAEHVVGTGSFGVVFQAKCRET---GEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        80 ~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      ...+|.+.+.||+|+||.||+|++..+   +..||+|.+....     ....+|+.+++.++||||+++++++. .   +
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~---~  463 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E---N  463 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S---S
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c---C
Confidence            345699999999999999999998653   4579999876432     23457999999999999999999862 1   1


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----  225 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----  225 (403)
                        .+++||||++ ++|.+++...   ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+++     
T Consensus       464 --~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDikp~NILl~~~~~vkL~DFG~  537 (656)
T 2j0j_A          464 --PVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSNDCVKLGDFGL  537 (656)
T ss_dssp             --SCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred             --ceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchHhEEEeCCCCEEEEecCC
Confidence              2679999998 6887776542   2458899999999999999999999 89999999999999987655433     


Q ss_pred             ---------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          226 ---------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       226 ---------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                     .+|+.|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+.+..+......+    
T Consensus       538 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~----  612 (656)
T 2j0j_A          538 SRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP----  612 (656)
T ss_dssp             CCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC----
T ss_pred             CeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC----
Confidence                           235689999999654 58999999999999999997 999999888777665554421100    


Q ss_pred             HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                              .+..+++++.+||.+||..||++|||+.++++.
T Consensus       613 ------------------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          613 ------------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             ------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                    124678999999999999999999999999863

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.9e-38  Score=300.37  Aligned_cols=235  Identities=23%  Similarity=0.288  Sum_probs=177.1

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-ccHHHHHHHHHh--cCCCCccccceEEeecCCCCceEEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQM--LDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      .+|.+.+.||+|+||.||+|++  +++.||||++.... ....+|++++..  ++||||+++++++.... .....+++|
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~~~~lv  118 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV  118 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCCCEEEE
T ss_pred             ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-CccceeEEE
Confidence            4699999999999999999998  48999999986432 334578888888  79999999999875432 222358899


Q ss_pred             eeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCCccccccccccceecCCCCcee----
Q 015672          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH--------NCIGICHRDIKPQNLLVKGEPNVSY----  225 (403)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH--------~~~~ivHrDlKp~NILl~~~~~~~~----  225 (403)
                      |||+++ +|.+++..     ..+++..+..++.||+.||.|||        + .||+||||||+|||++.++.+++    
T Consensus       119 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~NIll~~~~~~kL~Dfg  192 (342)
T 1b6c_B          119 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK-PAIAHRDLKSKNILVKKNGTCCIADLG  192 (342)
T ss_dssp             ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB-CEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc-CCeeeCCCCHHHEEECCCCCEEEEECC
Confidence            999985 88877753     46899999999999999999999        7 79999999999999987655432    


Q ss_pred             -------------------eccccccchhhhhCCCC-----CCchhHHHHHHHHHHHHHhC----------CCCCCCCCc
Q 015672          226 -------------------ICSRYYRAPELIFGATE-----YTTAIDIWSTGCVMAELLLG----------QPLFPGESG  271 (403)
Q Consensus       226 -------------------~~t~~y~aPE~~~~~~~-----~~~~~DiwSlGvil~el~tg----------~~pf~~~~~  271 (403)
                                         .||+.|+|||++.+...     ++.++|||||||++|+|++|          ..||.....
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~  272 (342)
T 1b6c_B          193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  272 (342)
T ss_dssp             TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence                               46889999999865432     23689999999999999999          778865422


Q ss_pred             ----HHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          272 ----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       272 ----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                          .+.+.........                 .+.+ +..+   .....+..+.+||.+||+.||++|||+.++++|
T Consensus       273 ~~~~~~~~~~~~~~~~~-----------------~~~~-~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          273 SDPSVEEMRKVVCEQKL-----------------RPNI-PNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             SSCCHHHHHHHHTTSCC-----------------CCCC-CGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             CcccHHHHHHHHHHHHh-----------------CCCC-cccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence                2222222110000                 0000 0000   112345679999999999999999999999986

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.9e-40  Score=316.10  Aligned_cols=233  Identities=18%  Similarity=0.158  Sum_probs=169.1

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------------ccHHHHHHHHHhcC---------CCCccc
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLD---------HPNIVA  139 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~---------h~niv~  139 (403)
                      ..+|++.+.||+|+||+||+|++  +++.||||++....            ....+|+.+++.++         |+||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            34699999999999999999998  68999999986442            34568999999886         666666


Q ss_pred             cceEEeecC-------------------------CCCceEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHH
Q 015672          140 LKHCFFSTT-------------------------DKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQIC  193 (403)
Q Consensus       140 ~~~~~~~~~-------------------------~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~  193 (403)
                      +.+++....                         .....++|+|||||.+ ++...+     ....+++..++.++.||+
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~-----~~~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQM-----RTKLSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGG-----TTTCCCHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHH-----HhcCCCHHHHHHHHHHHH
Confidence            665543110                         0013458999999874 232222     125689999999999999


Q ss_pred             HHHHHHH-hcCCccccccccccceecCCC--------------------Cce--------------eeccccccchhhhh
Q 015672          194 RALAYIH-NCIGICHRDIKPQNLLVKGEP--------------------NVS--------------YICSRYYRAPELIF  238 (403)
Q Consensus       194 ~~L~~LH-~~~~ivHrDlKp~NILl~~~~--------------------~~~--------------~~~t~~y~aPE~~~  238 (403)
                      .||.||| + +||+||||||+|||++.++                    .++              .+||+.|+|||++.
T Consensus       172 ~aL~~lH~~-~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~  250 (336)
T 2vuw_A          172 ASLAVAEAS-LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFT  250 (336)
T ss_dssp             HHHHHHHHH-HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGC
T ss_pred             HHHHHHHHh-CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhhc
Confidence            9999999 8 7999999999999998775                    332              25799999999996


Q ss_pred             CCCCCCchhHHHHHHHH-HHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCccccccc
Q 015672          239 GATEYTTAIDIWSTGCV-MAELLLGQPLFPGESGVD-QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQK  316 (403)
Q Consensus       239 ~~~~~~~~~DiwSlGvi-l~el~tg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (403)
                      +..  +.++||||||++ .+++++|..||.+..... ....+.....                  +...   + ......
T Consensus       251 g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~------------------~~~~---~-~~~~~~  306 (336)
T 2vuw_A          251 GDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT------------------FKTK---C-NTPAMK  306 (336)
T ss_dssp             CCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCC------------------CSSC---C-CSHHHH
T ss_pred             CCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhc------------------cCcc---c-chhhhh
Confidence            543  889999998777 788889999994321101 1111111100                  0000   0 001123


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHh-cCCCcc
Q 015672          317 RLPPEAVDLVCRFFQYSPNLRCTALEAC-VHPFFD  350 (403)
Q Consensus       317 ~~s~~~~~li~~~L~~dP~~Rpta~e~l-~hp~f~  350 (403)
                      .+++++.+||.+||++|     ||+|+| +||||+
T Consensus       307 ~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          307 QIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             hcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            57889999999999987     999999 999995

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.7e-38  Score=326.05  Aligned_cols=226  Identities=25%  Similarity=0.371  Sum_probs=180.2

Q ss_pred             ccEeeeceecccCceEEEEEEECC-CCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRE-TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      .+|.+.+.||+|+||+||+|++.. +++.||||++....     ....+|+++++.++||||+++++++...........
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            569999999999999999999976 78999999885432     223579999999999999999998876554445567


Q ss_pred             EEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc-----------
Q 015672          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-----------  223 (403)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~-----------  223 (403)
                      ||||||+++ +|...+      ...+++..+..++.||+.||.|||+ +|||||||||+|||++.+ .+           
T Consensus       160 ~lv~E~~~g~~L~~~~------~~~l~~~~~~~~~~qi~~aL~~lH~-~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSK------GQKLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             EEEEEeCCCCcHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            999999984 553332      2368999999999999999999999 899999999999999864 33           


Q ss_pred             ----eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 015672          224 ----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE  299 (403)
Q Consensus       224 ----~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  299 (403)
                          ..+||+.|+|||++.+.  ++.++|||||||++|+|++|.+||.+....                           
T Consensus       232 ~~~~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------------------------  282 (681)
T 2pzi_A          232 NSFGYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD---------------------------  282 (681)
T ss_dssp             TCCSCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS---------------------------
T ss_pred             ccCCccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc---------------------------
Confidence                23479999999998653  589999999999999999999988642100                           


Q ss_pred             cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                       ..+.  ..+     ....++.+.+||.+||+.||++||++.+++.|+|+.-+
T Consensus       283 -~~~~--~~~-----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          283 -GLPE--DDP-----VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             -SCCT--TCH-----HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -cccc--ccc-----ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence             0000  000     01246789999999999999999999999999998643

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=9.6e-29  Score=250.61  Aligned_cols=163  Identities=15%  Similarity=0.035  Sum_probs=109.9

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEccccc--------------ccHHHHHHHHHhc-CCCCccccceEEeecCCCCc
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--------------RYKNRELQIMQML-DHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  152 (403)
                      ..++.|++|.+..++....|+.||+|++.++.              ..+.+|+++|+++ .|+||+++++++     .+.
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~  314 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENA  314 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECS
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EEC
Confidence            34678888888888877789999999985431              2245799999999 799999999988     445


Q ss_pred             eEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------
Q 015672          153 LYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------  225 (403)
Q Consensus       153 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------  225 (403)
                      ..+|||||||+| +|.+.+..    .+.+++.   .|+.||+.||+|||+ +|||||||||+||||+.++.+++      
T Consensus       315 ~~~yLVMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~-~GIIHRDIKPeNILL~~dg~vKL~DFGlA  386 (569)
T 4azs_A          315 QSGWLVMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEK-QGFWHDDVRPWNVMVDARQHARLIDFGSI  386 (569)
T ss_dssp             SEEEEEEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHH-TTCEESCCCGGGEEECTTSCEEECCCTTE
T ss_pred             CEEEEEEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHH-CCceeccCchHhEEECCCCCEEEeecccC
Confidence            569999999985 77776654    3556553   578999999999999 89999999999999998877643      


Q ss_pred             -------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 015672          226 -------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL  265 (403)
Q Consensus       226 -------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~p  265 (403)
                                   +||+.|||||++.+  .+..++|+||+|+++|++.++..+
T Consensus       387 r~~~~~~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          387 VTTPQDCSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred             eeCCCCCccccCceechhhccHHHhCC--CCCCcccccccccchhhhccccch
Confidence                         47899999999865  367889999999998887665433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.89  E-value=6.6e-24  Score=213.94  Aligned_cols=160  Identities=14%  Similarity=0.224  Sum_probs=117.1

Q ss_pred             eeeceecccCceEEEEEEECCCCcEEEEEEccccc------------ccHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           85 IAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        85 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      ...+.||+|+||+||+|.  ..++.+|+|+.....            ....+|++++++++||||+++..++.....   
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~---  413 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN---  413 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT---
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc---
Confidence            456789999999999995  457889999764321            123589999999999999965544433222   


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc--------
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV--------  223 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~--------  223 (403)
                        .|+||||++ ++|.+++..            +..++.||+.||.|||+ +||+||||||+|||++.  .+        
T Consensus       414 --~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~-~gIiHrDiKp~NILl~~--~~kL~DFGla  476 (540)
T 3en9_A          414 --KRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK-NDVIHNDLTTSNFIFDK--DLYIIDFGLG  476 (540)
T ss_dssp             --TEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH-TTEECTTCCTTSEEESS--SEEECCCTTC
T ss_pred             --cEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH-CcCccCCCCHHHEEECC--eEEEEECccC
Confidence              579999997 677655432            45788999999999999 89999999999999986  33        


Q ss_pred             ------------------eeeccccccchhhhhCC-CCCCchhHHHHHHHHHHHHHhCCCCC
Q 015672          224 ------------------SYICSRYYRAPELIFGA-TEYTTAIDIWSTGCVMAELLLGQPLF  266 (403)
Q Consensus       224 ------------------~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~tg~~pf  266 (403)
                                        .+.||+.|||||++.+. ..|+..+|+||..+-..+.+.++.+|
T Consensus       477 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          477 KISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             EECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             EECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence                              23478999999998541 23788899999998888888877666

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.84  E-value=3.1e-21  Score=178.68  Aligned_cols=132  Identities=19%  Similarity=0.160  Sum_probs=102.7

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEccccc----------------------ccHHHHHHHHHhcCCCCccccc
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------------------RYKNRELQIMQMLDHPNIVALK  141 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------------~~~~~E~~~l~~l~h~niv~~~  141 (403)
                      |.+.+.||+|+||.||+|++ .+|+.||||++....                      ....+|+++|+.++  | +++.
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            55669999999999999999 889999999985321                      12458999999999  5 6776


Q ss_pred             eEEeecCCCCceEEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCC
Q 015672          142 HCFFSTTDKEELYLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE  220 (403)
Q Consensus       142 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~  220 (403)
                      +++..      ...|+||||+++ +|.+ +          .......++.||+.||.|||+ .||+||||||+|||++ +
T Consensus       168 ~~~~~------~~~~lvmE~~~g~~L~~-l----------~~~~~~~i~~qi~~~l~~lH~-~giiHrDlkp~NILl~-~  228 (282)
T 1zar_A          168 KVYAW------EGNAVLMELIDAKELYR-V----------RVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVS-E  228 (282)
T ss_dssp             CEEEE------ETTEEEEECCCCEEGGG-C----------CCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEE-T
T ss_pred             eEEec------cceEEEEEecCCCcHHH-c----------chhhHHHHHHHHHHHHHHHHH-CCCEeCCCCHHHEEEE-C
Confidence            65421      225799999975 5533 1          112345688999999999999 8999999999999999 7


Q ss_pred             CCceee------ccccccchhhhh
Q 015672          221 PNVSYI------CSRYYRAPELIF  238 (403)
Q Consensus       221 ~~~~~~------~t~~y~aPE~~~  238 (403)
                      +.++++      .+..|+|||++.
T Consensus       229 ~~vkl~DFG~a~~~~~~~a~e~l~  252 (282)
T 1zar_A          229 EGIWIIDFPQSVEVGEEGWREILE  252 (282)
T ss_dssp             TEEEECCCTTCEETTSTTHHHHHH
T ss_pred             CcEEEEECCCCeECCCCCHHHHHH
Confidence            776654      366799999873

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.73  E-value=6.9e-18  Score=154.13  Aligned_cols=126  Identities=16%  Similarity=0.218  Sum_probs=93.5

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcE--EEEEEccccc----------------------------ccHHHHHHHHHhc
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQDK----------------------------RYKNRELQIMQML  132 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~~~~~~----------------------------~~~~~E~~~l~~l  132 (403)
                      -|.+.+.||+|+||.||+|.+..+|+.  ||||++....                            ....+|+.+|..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            388999999999999999998778999  9999864321                            1346799999999


Q ss_pred             CCCCccccceEEeecCCCCceEEEEEeeccCC------cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHH-hcCCc
Q 015672          133 DHPNIVALKHCFFSTTDKEELYLNLVLEYVPE------TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH-NCIGI  205 (403)
Q Consensus       133 ~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~------~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH-~~~~i  205 (403)
                      .|+++.... .+.. .     ..+|||||+++      .|.+...       ..++..+..++.||+.||.||| + .||
T Consensus       128 ~~~~i~~p~-~~~~-~-----~~~lVmE~~g~~g~~~~~L~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~-~gi  192 (258)
T 1zth_A          128 KEAGVSVPQ-PYTY-M-----KNVLLMEFIGEDELPAPTLVELGR-------ELKELDVEGIFNDVVENVKRLYQE-AEL  192 (258)
T ss_dssp             HHTTCCCCC-EEEE-E-----TTEEEEECCEETTEECCBHHHHGG-------GGGGSCHHHHHHHHHHHHHHHHHT-SCE
T ss_pred             HhCCCCCCe-EEEc-C-----CCEEEEEecCCCCCccccHHHHhh-------ccChHHHHHHHHHHHHHHHHHHHH-CCE
Confidence            988753221 1211 1     15699999952      4443321       1224457788999999999999 8 899


Q ss_pred             cccccccccceecCCCCcee
Q 015672          206 CHRDIKPQNLLVKGEPNVSY  225 (403)
Q Consensus       206 vHrDlKp~NILl~~~~~~~~  225 (403)
                      |||||||+|||++.  .+.+
T Consensus       193 vHrDlkp~NILl~~--~~~l  210 (258)
T 1zth_A          193 VHADLSEYNIMYID--KVYF  210 (258)
T ss_dssp             ECSSCSTTSEEESS--SEEE
T ss_pred             EeCCCCHHHEEEcC--cEEE
Confidence            99999999999987  4444

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.64  E-value=3.3e-16  Score=149.37  Aligned_cols=121  Identities=15%  Similarity=0.165  Sum_probs=83.3

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc--------------------------cHHHHHHHHHhcCCCC
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR--------------------------YKNRELQIMQMLDHPN  136 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------------------~~~~E~~~l~~l~h~n  136 (403)
                      -|.+...||+|+||.||+|.+ .+|+.||||+++....                          ...+|...|.++.+.+
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            389999999999999999998 4699999998642110                          0123556666665444


Q ss_pred             ccccceEEeecCCCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccce
Q 015672          137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLL  216 (403)
Q Consensus       137 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NIL  216 (403)
                      +... ..+.. . .    .+|||||++|..   +..      ......+..++.||+.+|.|||+ .|||||||||.|||
T Consensus       175 v~vp-~p~~~-~-~----~~LVME~i~G~~---L~~------l~~~~~~~~l~~qll~~l~~lH~-~gIVHrDLKp~NIL  237 (397)
T 4gyi_A          175 FPVP-EPIAQ-S-R----HTIVMSLVDALP---MRQ------VSSVPDPASLYADLIALILRLAK-HGLIHGDFNEFNIL  237 (397)
T ss_dssp             CSCC-CEEEE-E-T----TEEEEECCSCEE---GGG------CCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEE
T ss_pred             CCCC-eeeec-c-C----ceEEEEecCCcc---Hhh------hcccHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEE
Confidence            3221 11111 0 1    259999998632   111      11122356678999999999999 89999999999999


Q ss_pred             ecCCC
Q 015672          217 VKGEP  221 (403)
Q Consensus       217 l~~~~  221 (403)
                      ++.++
T Consensus       238 l~~dg  242 (397)
T 4gyi_A          238 IREEK  242 (397)
T ss_dssp             EEEEE
T ss_pred             EeCCC
Confidence            98765

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.93  E-value=3.7e-09  Score=95.93  Aligned_cols=103  Identities=14%  Similarity=0.062  Sum_probs=73.7

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccc----ccccHHHHHHHHHhcC-CCCccccceEEeecCCCCceEEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ----DKRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      .|.+...++.|+.+.||++...  +..+++|....    ......+|+.+++.+. +..+.+++++..     .....|+
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~l   87 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGWSNL   87 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEE
T ss_pred             cceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCceEE
Confidence            4888999999999999999753  68899998753    3345778999999995 566667776652     2334789


Q ss_pred             EeeccCCc-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 015672          158 VLEYVPET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN  201 (403)
Q Consensus       158 v~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~  201 (403)
                      ||||++|. +...   .      .+......++.+++.+|..||+
T Consensus        88 v~e~i~G~~l~~~---~------~~~~~~~~~~~~l~~~l~~LH~  123 (263)
T 3tm0_A           88 LMSEADGVLCSEE---Y------EDEQSPEKIIELYAECIRLFHS  123 (263)
T ss_dssp             EEECCSSEEHHHH---C------CTTTCHHHHHHHHHHHHHHHHH
T ss_pred             EEEecCCeehhhc---c------CCcccHHHHHHHHHHHHHHHhC
Confidence            99999973 3221   1      0111233567788999999997

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.72  E-value=3.8e-08  Score=88.78  Aligned_cols=101  Identities=15%  Similarity=0.053  Sum_probs=63.1

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEcccc-cccHHHHHHHHHhcCCCCc--cccceEEeecCCCCceEEEEEee
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLDHPNI--VALKHCFFSTTDKEELYLNLVLE  160 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e  160 (403)
                      |.+..+.+.|..+.||++.. .+|..+++|..... .....+|+.+++.+.+.++  .+++.+...     ....++|||
T Consensus        22 ~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~~~~~v~e   95 (264)
T 1nd4_A           22 YDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLLG   95 (264)
T ss_dssp             CEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEEE
T ss_pred             CceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CCCCEEEEE
Confidence            55555555677799999964 56778999987543 2345789999999965554  346554421     123779999


Q ss_pred             ccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 015672          161 YVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN  201 (403)
Q Consensus       161 ~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~  201 (403)
                      |++|....    .    ....   ...++.+++..|..||+
T Consensus        96 ~i~G~~l~----~----~~~~---~~~~~~~l~~~l~~lh~  125 (264)
T 1nd4_A           96 EVPGQDLL----S----SHLA---PAEKVSIMADAMRRLHT  125 (264)
T ss_dssp             CCSSEETT----T----SCCC---HHHHHHHHHHHHHHHTT
T ss_pred             ecCCcccC----c----CcCC---HhHHHHHHHHHHHHHhC
Confidence            99863211    0    0111   12345566777777775

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.59  E-value=1.6e-07  Score=89.24  Aligned_cols=107  Identities=13%  Similarity=0.098  Sum_probs=70.0

Q ss_pred             eeceecccCceEEEEEEECCCCcEEEEEEcc--cc-----cccHHHHHHHHHhcCC--CCccccceEEeecCCCCceEEE
Q 015672           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVL--QD-----KRYKNRELQIMQMLDH--PNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        86 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~--~~-----~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      ..+.|+.|.++.||++...  +..+++|+..  ..     .....+|+.+++.|..  ..+.+++..+...  ......+
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSCE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCeE
Confidence            4567899999999998864  4678899775  22     2356789999999974  4456666554221  1112356


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN  201 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~  201 (403)
                      +||||++|...   .  ......++......++.+++..|..||+
T Consensus       118 ~vme~v~G~~l---~--~~~~~~l~~~~~~~~~~~l~~~La~LH~  157 (359)
T 3dxp_A          118 YIMEFVSGRVL---W--DQSLPGMSPAERTAIYDEMNRVIAAMHT  157 (359)
T ss_dssp             EEEECCCCBCC---C--CTTCTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEecCCeec---C--CCccccCCHHHHHHHHHHHHHHHHHHhC
Confidence            89999987321   0  0111235667777788899999999996

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.41  E-value=2.7e-07  Score=85.58  Aligned_cols=167  Identities=11%  Similarity=0.128  Sum_probs=96.4

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEcccc--cccHHHHHHHHHhcC-CCCccccceEEeecCC-CCceEEEEEeeccC
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLD-HPNIVALKHCFFSTTD-KEELYLNLVLEYVP  163 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~-~~~~~~~lv~e~~~  163 (403)
                      +.++.|....||++.     ..+++|+....  .....+|.++|+.+. +..+ .+-..+..... ......|+||++++
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v-~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPL-PIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSS-CCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCC-CCCceEeecCCCCCCCcceEEEcccC
Confidence            458999999999863     45889976433  234568999999884 3333 22222222111 11123468999998


Q ss_pred             Cc-HHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 015672          164 ET-VNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN-----------------------------------------  201 (403)
Q Consensus       164 ~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~-----------------------------------------  201 (403)
                      |. +.....      ..++......++.|++..|..||+                                         
T Consensus       100 G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A          100 GVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            62 111100      124444455555566666665553                                         


Q ss_pred             ----------------cCCccccccccccceecCC-CC-ceee-------ccc--------cc---cchhhhh----CCC
Q 015672          202 ----------------CIGICHRDIKPQNLLVKGE-PN-VSYI-------CSR--------YY---RAPELIF----GAT  241 (403)
Q Consensus       202 ----------------~~~ivHrDlKp~NILl~~~-~~-~~~~-------~t~--------~y---~aPE~~~----~~~  241 (403)
                                      ...++|+|++|.|||++.+ +. +.++       |.+        .+   ..|+...    ...
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                            0247999999999999874 22 2222       111        11   2343221    111


Q ss_pred             CCC---------chhHHHHHHHHHHHHHhCCCCC
Q 015672          242 EYT---------TAIDIWSTGCVMAELLLGQPLF  266 (403)
Q Consensus       242 ~~~---------~~~DiwSlGvil~el~tg~~pf  266 (403)
                      ..+         .-.+.|++|.++|.+.+|..+|
T Consensus       254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            111         1268999999999999998776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.75  E-value=0.00022  Score=65.93  Aligned_cols=68  Identities=12%  Similarity=-0.046  Sum_probs=43.8

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEcccc--cccHHHHHHHHHhcCCCC---ccccceEEeecCCCCceEEEEEeecc
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPN---IVALKHCFFSTTDKEELYLNLVLEYV  162 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~n---iv~~~~~~~~~~~~~~~~~~lv~e~~  162 (403)
                      +.++.|....||+.     +..+++|+....  .....+|.++|+.|.+..   +.+.+.+..  .  .....++||+++
T Consensus        25 ~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~--~--~~g~~~~v~e~i   95 (306)
T 3tdw_A           25 ESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK--R--SDGNPFVGYRKV   95 (306)
T ss_dssp             EEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE--C--TTSCEEEEEECC
T ss_pred             eecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc--c--CCCceEEEEecc
Confidence            45788888899987     566888975322  133468999999997632   223333221  1  122356999999


Q ss_pred             CC
Q 015672          163 PE  164 (403)
Q Consensus       163 ~~  164 (403)
                      +|
T Consensus        96 ~G   97 (306)
T 3tdw_A           96 QG   97 (306)
T ss_dssp             CS
T ss_pred             CC
Confidence            86

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.57  E-value=0.0015  Score=56.47  Aligned_cols=92  Identities=20%  Similarity=0.116  Sum_probs=63.4

Q ss_pred             cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCceeecc------ccccchhhhh
Q 015672          165 TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSYICS------RYYRAPELIF  238 (403)
Q Consensus       165 ~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~~~t------~~y~aPE~~~  238 (403)
                      +|..++..+   +.++++.+++.++.|.+.+|.-+-....-..+=+-|..|+|..+|.+.+...      ..+.|||...
T Consensus        34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~~~s~~~~~~~~~pe~~~  110 (229)
T 2yle_A           34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAPAADDAGEPPPVAGKLGY  110 (229)
T ss_dssp             EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECCC------------CCSS
T ss_pred             cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceecccccccccccCCCChhhcc
Confidence            677777654   5889999999999999999876621011112334578999999999877643      2478898752


Q ss_pred             CCCCCCchhHHHHHHHHHHHHHh
Q 015672          239 GATEYTTAIDIWSTGCVMAELLL  261 (403)
Q Consensus       239 ~~~~~~~~~DiwSlGvil~el~t  261 (403)
                        ...+.+.=|||||+++|..+-
T Consensus       111 --~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A          111 --SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             --SSSCHHHHHHHHHHHHHHHHT
T ss_pred             --ccchHHHHHHHHHHHHHHHhh
Confidence              335788999999999999874

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.27  E-value=0.00094  Score=62.19  Aligned_cols=72  Identities=14%  Similarity=0.291  Sum_probs=39.4

Q ss_pred             ceecccCceEEEEEEECCCCcEEEEEEcccccccHHHHHHHHHhcCCC--CccccceE----EeecCCCCceEEEEEeec
Q 015672           88 HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHP--NIVALKHC----FFSTTDKEELYLNLVLEY  161 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~----~~~~~~~~~~~~~lv~e~  161 (403)
                      +.|+.|..+.||++...  +..+++|+..........|..+++.|...  .+.+++..    ++.   ......+++|+|
T Consensus        38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~---~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRPEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYS---KHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEET--TEEEEEEEECSCHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCE---EETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeC--CCCEEEEecCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEE---EECCEEEEEEEe
Confidence            45666778899998763  34589998865433344567777766421  22333221    000   012346799999


Q ss_pred             cCC
Q 015672          162 VPE  164 (403)
Q Consensus       162 ~~~  164 (403)
                      ++|
T Consensus       113 i~G  115 (346)
T 2q83_A          113 IEG  115 (346)
T ss_dssp             CCC
T ss_pred             ecC
Confidence            986

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.23  E-value=0.0018  Score=61.96  Aligned_cols=71  Identities=20%  Similarity=0.218  Sum_probs=44.3

Q ss_pred             eceecccCceEEEEEEECCCCcEEEEEEcccc-----------cccHHHHHHHHHhcCC--CCcc-ccceEEeecCCCCc
Q 015672           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----------KRYKNRELQIMQMLDH--PNIV-ALKHCFFSTTDKEE  152 (403)
Q Consensus        87 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~E~~~l~~l~h--~niv-~~~~~~~~~~~~~~  152 (403)
                      .+.||.|..+.||++....+++.++||.....           ......|.++++.+..  +..+ +++.+  ..   +.
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~---~~  109 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT---EM  109 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET---TT
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cC---Cc
Confidence            46789999999999976556788999975321           1123579999988743  3333 33321  21   11


Q ss_pred             eEEEEEeeccCC
Q 015672          153 LYLNLVLEYVPE  164 (403)
Q Consensus       153 ~~~~lv~e~~~~  164 (403)
                        .++|||++++
T Consensus       110 --~~lvmE~l~g  119 (397)
T 2olc_A          110 --AVTVMEDLSH  119 (397)
T ss_dssp             --TEEEECCCTT
T ss_pred             --cEEEEEeCCC
Confidence              3589999975

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.17  E-value=0.0022  Score=57.66  Aligned_cols=69  Identities=13%  Similarity=0.131  Sum_probs=44.2

Q ss_pred             cccCce-EEEEEEECCCCcEEEEEEcccc-cccHHHHHHHHHhcCC-CCccccceEEeecCCCCceEEEEEeeccCC
Q 015672           91 GTGSFG-VVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNLVLEYVPE  164 (403)
Q Consensus        91 G~G~~g-~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv~e~~~~  164 (403)
                      ..|..| .||+......+..+.+|+-... .....+|...|+.|.. --+.+++.+..     +....++|||+++|
T Consensus        33 ~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~-----~~~~~~lvme~l~G  104 (272)
T 4gkh_A           33 NVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIR-----TPDDAWLLTTAIPG  104 (272)
T ss_dssp             ECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEEEEECCCS
T ss_pred             cCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEE-----ECCeEEEEEEeeCC
Confidence            334444 7898887777778999976432 2234679999998853 22334444432     12346799999986

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.10  E-value=0.012  Score=53.50  Aligned_cols=73  Identities=14%  Similarity=0.056  Sum_probs=48.9

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      ..-.+.+|.|..+.||+.+. .+|+.|.+|+.....    ..+..|...|+.|.-..-|.+-.++....      -++||
T Consensus        17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~------~~lv~   89 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDD------RTLAM   89 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEET------TEEEE
T ss_pred             eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccC------ceEEE
Confidence            55678899999999999986 578899999864322    34578999999985332222222221111      24789


Q ss_pred             eccC
Q 015672          160 EYVP  163 (403)
Q Consensus       160 e~~~  163 (403)
                      ||+.
T Consensus        90 e~l~   93 (288)
T 3f7w_A           90 EWVD   93 (288)
T ss_dssp             ECCC
T ss_pred             Eeec
Confidence            9876

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=96.88  E-value=0.0038  Score=58.64  Aligned_cols=78  Identities=9%  Similarity=0.106  Sum_probs=48.9

Q ss_pred             eeecee-cccCceEEEEEEEC--C----CCcEEEEEEccccc-------ccHHHHHHHHHhcCC---CCccccceEEeec
Q 015672           85 IAEHVV-GTGSFGVVFQAKCR--E----TGEIVAIKKVLQDK-------RYKNRELQIMQMLDH---PNIVALKHCFFST  147 (403)
Q Consensus        85 ~~~~~l-G~G~~g~V~~~~~~--~----~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h---~niv~~~~~~~~~  147 (403)
                      ...+.| +.|..+.+|++...  .    ++..+++|......       ....+|+.+++.|..   -.+.+++..... 
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~-  101 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT-  101 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS-
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC-
Confidence            345677 88889999988653  0    15678899765432       356789999998853   234555544311 


Q ss_pred             CCCCceEEEEEeeccCC
Q 015672          148 TDKEELYLNLVLEYVPE  164 (403)
Q Consensus       148 ~~~~~~~~~lv~e~~~~  164 (403)
                       .......++||||++|
T Consensus       102 -~~~~g~~~~v~e~l~G  117 (357)
T 3ats_A          102 -GDVLGTPFFLMDYVEG  117 (357)
T ss_dssp             -STTTSSCEEEEECCCC
T ss_pred             -CCccCCceEEEEecCC
Confidence             1111224689999875

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=95.62  E-value=0.058  Score=49.17  Aligned_cols=65  Identities=12%  Similarity=0.063  Sum_probs=40.8

Q ss_pred             eceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCcc-ccceEEeecCCCCceEEEEEeecc
Q 015672           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLNLVLEYV  162 (403)
Q Consensus        87 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~~  162 (403)
                      .+.|+.|....+|++      ..+++|+.....   ....+|+.+++.+...++. +++...     .+.  -++++||+
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~~~--~~~v~e~i   89 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD-----PAT--GVMVTRYI   89 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC-----TTT--CCEEEECC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE-----CCC--CEEEEeec
Confidence            567888999999998      457888764321   2345788888888544444 333221     111  24789999


Q ss_pred             -CC
Q 015672          163 -PE  164 (403)
Q Consensus       163 -~~  164 (403)
                       ++
T Consensus        90 ~~g   92 (301)
T 3dxq_A           90 AGA   92 (301)
T ss_dssp             TTC
T ss_pred             CCC
Confidence             54

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=95.33  E-value=0.063  Score=51.57  Aligned_cols=26  Identities=27%  Similarity=0.396  Sum_probs=21.0

Q ss_pred             eceecccCceEEEEEEECCCCcEEEEEE
Q 015672           87 EHVVGTGSFGVVFQAKCRETGEIVAIKK  114 (403)
Q Consensus        87 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~  114 (403)
                      .+.||.|..+.||++..  +++.++||.
T Consensus        39 i~~l~~G~~n~vyrv~~--~~~~~vvK~   64 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG--SSGSLVIKQ   64 (420)
T ss_dssp             EEECCCSSSCEEEEEEC--SSCEEEEEE
T ss_pred             EEEccCCCcEEEEEEEc--CCceEEEEE
Confidence            46689999999999964  467899993

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=94.90  E-value=0.085  Score=48.38  Aligned_cols=74  Identities=9%  Similarity=-0.006  Sum_probs=42.5

Q ss_pred             eeceecccCceEEEEEEECCCCcEEEEEEccc--ccccHHHHHHHHHhcCCCCc--cccceEEeecCCC----CceEEEE
Q 015672           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDHPNI--VALKHCFFSTTDK----EELYLNL  157 (403)
Q Consensus        86 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~----~~~~~~l  157 (403)
                      -.+.|+.|....+|++... ++ .+++|....  .......|+.+++.|...++  .+++..   ..+.    .....++
T Consensus        26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~---~~g~~~~~~~g~~~~  100 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR---KDGELLGELSGRPAA  100 (322)
T ss_dssp             EEEEECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB---TTCCSCEEETTEEEE
T ss_pred             EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCC---CCCCEEEEECCEEEE
Confidence            3466788888999998763 33 688998765  33455678888888853332  232211   0000    0123578


Q ss_pred             EeeccCC
Q 015672          158 VLEYVPE  164 (403)
Q Consensus       158 v~e~~~~  164 (403)
                      +|+|++|
T Consensus       101 l~~~l~G  107 (322)
T 2ppq_A          101 LISFLEG  107 (322)
T ss_dssp             EEECCCC
T ss_pred             EEEeCCC
Confidence            9999875

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=94.35  E-value=0.4  Score=46.11  Aligned_cols=70  Identities=17%  Similarity=0.248  Sum_probs=46.5

Q ss_pred             eeceecccCceEEEEEEECC-------CCcEEEEEEccc-cc-ccHHHHHHHHHhcCCCCc-cccceEEeecCCCCceEE
Q 015672           86 AEHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQ-DK-RYKNRELQIMQMLDHPNI-VALKHCFFSTTDKEELYL  155 (403)
Q Consensus        86 ~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~-~~-~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~  155 (403)
                      -.+.|+.|....||++....       .+..+++|+... .. ....+|..+++.|...++ .++++.+     .+    
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~----  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----
Confidence            34568888889999998643       257899998743 22 334479999998865455 3444433     22    


Q ss_pred             EEEeeccCC
Q 015672          156 NLVLEYVPE  164 (403)
Q Consensus       156 ~lv~e~~~~  164 (403)
                      .+|+||++|
T Consensus       148 g~v~e~l~G  156 (429)
T 1nw1_A          148 GRLEEYIPS  156 (429)
T ss_dssp             EEEECCCCE
T ss_pred             CEEEEEeCC
Confidence            278999874

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=94.01  E-value=0.58  Score=45.39  Aligned_cols=70  Identities=16%  Similarity=0.186  Sum_probs=45.7

Q ss_pred             eeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCcc-ccceEEeecCCCCceEEEEEeec
Q 015672           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLNLVLEY  161 (403)
Q Consensus        86 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~  161 (403)
                      -.+.|+.|-...+|++.....+..+++|+.....   ....+|..+++.|...++. ++++.+     .+    .+||||
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~e~  182 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----TN----GRIEEF  182 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEEEC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEEEe
Confidence            3456888989999999875445788899764321   1236899999999766664 444443     22    149999


Q ss_pred             cCC
Q 015672          162 VPE  164 (403)
Q Consensus       162 ~~~  164 (403)
                      ++|
T Consensus       183 I~G  185 (458)
T 2qg7_A          183 MDG  185 (458)
T ss_dssp             CCS
T ss_pred             eCC
Confidence            874

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=93.59  E-value=0.33  Score=44.46  Aligned_cols=72  Identities=14%  Similarity=0.022  Sum_probs=42.4

Q ss_pred             eecccCceEEEEEEECCCCcEEEEEEcccc---cccHHHHHHHHHhcCCCC--ccccceEEeecCC--CCceEEEEEeec
Q 015672           89 VVGTGSFGVVFQAKCRETGEIVAIKKVLQD---KRYKNRELQIMQMLDHPN--IVALKHCFFSTTD--KEELYLNLVLEY  161 (403)
Q Consensus        89 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~--~~~~~~~lv~e~  161 (403)
                      .|+ |....||++.. .+|+.+++|.....   ......|..+++.|....  +.+++..  ....  ......+++|++
T Consensus        33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEEC
T ss_pred             eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEEe
Confidence            456 77788998764 34667899987532   234456888888875323  3333321  0000  012245789999


Q ss_pred             cCC
Q 015672          162 VPE  164 (403)
Q Consensus       162 ~~~  164 (403)
                      ++|
T Consensus       109 i~G  111 (328)
T 1zyl_A          109 VGG  111 (328)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            875

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=93.33  E-value=0.47  Score=44.78  Aligned_cols=68  Identities=16%  Similarity=0.179  Sum_probs=38.7

Q ss_pred             ceecccCceEEEEEEECC-------CCcEEEEEEccc---ccccHHHHHHHHHhcCCCCcc-ccceEEeecCCCCceEEE
Q 015672           88 HVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQ---DKRYKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~---~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~  156 (403)
                      +.|..|-...+|++....       +++.+++|+.-.   ......+|..+++.|...++. ++++.+     .+.    
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~g----  126 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PEG----  126 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TTE----
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CCc----
Confidence            456667777888887632       357888987532   122345799999888544443 444433     221    


Q ss_pred             EEeeccCC
Q 015672          157 LVLEYVPE  164 (403)
Q Consensus       157 lv~e~~~~  164 (403)
                      +||||++|
T Consensus       127 ~v~e~i~G  134 (379)
T 3feg_A          127 RLEQYIPS  134 (379)
T ss_dssp             EEEECCSE
T ss_pred             cEEEEecC
Confidence            79999874

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=92.17  E-value=0.91  Score=41.62  Aligned_cols=68  Identities=10%  Similarity=0.058  Sum_probs=34.5

Q ss_pred             eecccCceE-EEEEEECCCCcEEEEEEccccc-ccHHHHHHHHHhcCCCCc--cccceEEeecCCCCceEEEEEeeccCC
Q 015672           89 VVGTGSFGV-VFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLDHPNI--VALKHCFFSTTDKEELYLNLVLEYVPE  164 (403)
Q Consensus        89 ~lG~G~~g~-V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~  164 (403)
                      .|+.|.... +|+... .++..+++|...... .....|+.+++.|...++  .+++..  . . .. .  +++||++++
T Consensus        25 ~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~--d-~-~~-g--~ll~e~l~~   96 (333)
T 3csv_A           25 PLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAE--E-H-AR-G--LLLIEDLGD   96 (333)
T ss_dssp             C--------CCEEEEC-TTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEE--E-T-TT-T--EEEECCCCS
T ss_pred             ECCCCCCCceEEEEEc-CCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeee--c-C-CC-C--EEEEeeCCC
Confidence            454454443 666653 235677788654433 455678998888854333  344332  1 1 22 2  478998864

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=91.94  E-value=0.56  Score=42.98  Aligned_cols=92  Identities=12%  Similarity=0.040  Sum_probs=61.9

Q ss_pred             eeceecccCceEEEEEEECCCCcEEEEEEcccc-cccHHHHHHHHHhcCC---CCccccceEEeecCCCCceEEEEEeec
Q 015672           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-KRYKNRELQIMQMLDH---PNIVALKHCFFSTTDKEELYLNLVLEY  161 (403)
Q Consensus        86 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~~~~~~lv~e~  161 (403)
                      -.+.|+.|....+|+...  ++..+++|+.... ......|...|+.|..   ..+.+++....     .....++||||
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~~~lvme~  112 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGHSFLLLEA  112 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSEEEEEEEC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCceEEEEEe
Confidence            346689999999999875  4678889976543 2345689999988843   34555554431     12347899999


Q ss_pred             cCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 015672          162 VPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN  201 (403)
Q Consensus       162 ~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~  201 (403)
                      +++.-             ...    ....++...|.-||.
T Consensus       113 l~G~~-------------~~~----~~~~~lG~~LA~LH~  135 (312)
T 3jr1_A          113 LNKSK-------------NKQ----SSFTIFAEKIAQLHQ  135 (312)
T ss_dssp             CCCCC-------------CCT----THHHHHHHHHHHHHH
T ss_pred             ccCCC-------------CCc----hhHHHHHHHHHHHHc
Confidence            98631             111    123578888999998

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=90.80  E-value=1.3  Score=40.93  Aligned_cols=70  Identities=14%  Similarity=0.217  Sum_probs=40.0

Q ss_pred             cccCceEEEEEEECCCCcEEEEEEcccccccHHHHHHHHHhcCCCC---ccccceEEeec-CCCCceEEEEEeeccCC
Q 015672           91 GTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPN---IVALKHCFFST-TDKEELYLNLVLEYVPE  164 (403)
Q Consensus        91 G~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~n---iv~~~~~~~~~-~~~~~~~~~lv~e~~~~  164 (403)
                      |.|....||++... +| .+++|+.....  ...|+.+++.|....   +.+.+...... ........+++|+|++|
T Consensus        32 G~g~~N~vy~v~~~-~g-~~vLK~~~~~~--~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G  105 (339)
T 3i1a_A           32 GADTNAFAYQADSE-SK-SYFIKLKYGYH--DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA  105 (339)
T ss_dssp             TSCSSCEEEEEECS-SC-EEEEEEEECSS--CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred             cCccccceEEEEeC-CC-CEEEEEecCcc--chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence            44446789998753 34 89999765443  256888888774322   33333210000 00112457899999875

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=81.39  E-value=0.16  Score=49.54  Aligned_cols=56  Identities=13%  Similarity=0.034  Sum_probs=16.9

Q ss_pred             eeceecccCceEEEEEEECCCCcEEEE------EEccccc------ccHHHHHHHHHhcCCCCccccceEE
Q 015672           86 AEHVVGTGSFGVVFQAKCRETGEIVAI------KKVLQDK------RYKNRELQIMQMLDHPNIVALKHCF  144 (403)
Q Consensus        86 ~~~~lG~G~~g~V~~~~~~~~~~~vai------K~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~  144 (403)
                      +.+.||   ||.||++........||+      |......      ....+|..+++.++|+|+++.+.+.
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            345676   999999998765668888      6553211      1234677888889999999988765

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	403
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-115
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-67
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	9e-64
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-62
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	9e-62
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-61
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-61
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-58
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-58
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-58
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-56
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-56
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-55
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-54
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-54
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-54
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-54
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-52
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-52
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-51
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-51
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-51
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-50
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-50
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-49
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-49
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-48
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-45
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-45
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	9e-45
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-44
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-43
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	6e-43
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-40
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-40
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-39
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-39
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-39
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-36
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-36
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-35
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-34
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-33
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-33
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-33
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-33
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-32
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-32
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-32
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-31
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-31
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	8e-31
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-30
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-29
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-28
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-28
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	9e-28
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	9e-28
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-27
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-27
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-27
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-14

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  337 bits (864), Expect = e-115
 Identities = 225/341 (65%), Positives = 264/341 (77%), Gaps = 22/341 (6%)

Query: 73  GRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQML 132
           G+  +  Q+VSY    V+G GSFGVV+QAK  ++GE+VAIKKVLQDKR+KNRELQIM+ L
Sbjct: 11  GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL 70

Query: 133 DHPNIVALKHCFFST-TDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
           DH NIV L++ F+S+   K+E+YLNLVL+YVPETV R+AR+YSR  Q +P+IYVKLY YQ
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130

Query: 192 ICRALAYIHNCIGICHRDIKPQNL-------------------LVKGEPNVSYICSRYYR 232
           + R+LAYIH+  GICHRDIKPQNL                   LV+GEPNVSYICSRYYR
Sbjct: 131 LFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189

Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APELIFGAT+YT++ID+WS GCV+AELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249

Query: 293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
           MNPNYTEFKFPQIK HPW KVF+ R PPEA+ L  R  +Y+P  R T LEAC H FFDEL
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309

Query: 353 RDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHAR 393
           RDPN +LPNGR  P LFNF   ELS  PP     LIP HAR
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQELSSNPPLA-TILIPPHAR 349

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 2e-67
 Identities = 92/341 (26%), Positives = 164/341 (48%), Gaps = 42/341 (12%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV--LQDKRYKN---RELQIMQMLDHPNIV 138
           Y     +G G++G+V  A        VAIKK+   + + Y     RE++I+    H NI+
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            +     + T ++   + LV   +   + ++ +      Q +   ++  + YQI R L Y
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKY 124

Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV----------------------SYICSRYYRAPEL 236
           IH+   + HRD+KP NLL+    ++                       Y+ +R+YRAPE+
Sbjct: 125 IHSA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--- 293
           +  +  YT +IDIWS GC++AE+L  +P+FPG+  +DQL  I+ +LG+P++E++ C+   
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243

Query: 294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 353
                    P     PW+++F      +A+DL+ +   ++P+ R    +A  HP+ ++  
Sbjct: 244 KARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302

Query: 354 DPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLIPEHARK 394
           DP+       P+         EL  +P E +  LI E   +
Sbjct: 303 DPSD-----EPIAEAPFKFDMELDDLPKEKLKELIFEETAR 338

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 9e-64
 Identities = 91/302 (30%), Positives = 139/302 (46%), Gaps = 40/302 (13%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---------RELQIMQMLDHPNIVA 139
            +G G F  V++A+ + T +IVAIKK+    R +          RE++++Q L HPNI+ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L   F     K  + L  V +++      +          +   ++K Y     + L Y+
Sbjct: 65  LLDAF---GHKSNISL--VFDFME---TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 116

Query: 200 HNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGA 240
           H    I HRD+KP NLL+     +                     + +R+YRAPEL+FGA
Sbjct: 117 HQHW-ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGA 175

Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
             Y   +D+W+ GC++AELLL  P  PG+S +DQL  I + LGTPT E+   M       
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP--NTR 358
            F      P H +F      + +DL+   F ++P  R TA +A    +F     P    +
Sbjct: 236 TFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQ 294

Query: 359 LP 360
           LP
Sbjct: 295 LP 296

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 2e-62
 Identities = 94/332 (28%), Positives = 151/332 (45%), Gaps = 37/332 (11%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV------LQDKRYKNRELQIMQMLDHPNI 137
           Y     VG+G++G V  A   +TG  VA+KK+      +   +   REL++++ + H N+
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           + L   F      EE     ++ ++         N     Q++   +V+   YQI R L 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADL----NNIVKCQKLTDDHVQFLIYQILRGLK 135

Query: 198 YIHNCIGICHRDIKPQNLLVK----------------GEPNVSYICSRYYRAPELIFGAT 241
           YIH+   I HRD+KP NL V                  +    Y+ +R+YRAPE++    
Sbjct: 136 YIHSA-DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 194

Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF- 300
            Y   +DIWS GC+MAELL G+ LFPG   +DQL  I++++GTP  E +K ++       
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254

Query: 301 --KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTR 358
                Q+    +  VF     P AVDL+ +      + R TA +A  H +F +  DP+  
Sbjct: 255 IQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD- 312

Query: 359 LPNGRPLPPLFNFKPPELSGIPPETINRLIPE 390
                P+   ++    E   +  +    L  +
Sbjct: 313 ----EPVADPYDQ-SFESRDLLIDEWKSLTYD 339

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 9e-62
 Identities = 63/303 (20%), Positives = 111/303 (36%), Gaps = 46/303 (15%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           +     +G G+ GVVF+   + +G ++A K +  + +        RELQ++   + P IV
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
                F       E+ +   +E++            +   R+P   +   +  + + L Y
Sbjct: 68  GFYGAF---YSDGEISI--CMEHMD---GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119

Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV-----------------SYICSRYYRAPELIFGAT 241
           +     I HRD+KP N+LV     +                 S++ +R Y +PE + G T
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQG-T 178

Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
            Y+   DIWS G  + E+ +G+   P       +L+   +V G       +   P     
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238

Query: 301 KF--------------PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 346
            +                I   P  K+       E  D V +    +P  R    +  VH
Sbjct: 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298

Query: 347 PFF 349
            F 
Sbjct: 299 AFI 301

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (508), Expect = 2e-61
 Identities = 91/313 (29%), Positives = 152/313 (48%), Gaps = 34/313 (10%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y     VG+G++G V  A    TG  VAIKK+ +  + +       REL++++ + H N+
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79

Query: 138 VALKHCFFSTTDKEELY-LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           + L   F      ++     LV+ ++   + ++ +     H+++    ++   YQ+ + L
Sbjct: 80  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLKGL 134

Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV----------------SYICSRYYRAPELIFGA 240
            YIH   GI HRD+KP NL V  +  +                 Y+ +R+YRAPE+I   
Sbjct: 135 RYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNW 193

Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
             YT  +DIWS GC+MAE++ G+ LF G   +DQL EI+KV GTP  E ++ +  +  + 
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253

Query: 301 ---KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 357
                P+++   +  +      P AV+L+ +        R TA EA  HP+F+ L D   
Sbjct: 254 YMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE- 311

Query: 358 RLPNGRPLPPLFN 370
             P  +     F+
Sbjct: 312 DEPQVQKYDDSFD 324

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 2e-61
 Identities = 95/306 (31%), Positives = 157/306 (51%), Gaps = 38/306 (12%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           +     +G G++GVV++A+ + TGE+VA+KK+  D   +       RE+ +++ L+HPNI
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L         + +LYL  V E++ + + +     +     +PL  +K Y +Q+ + LA
Sbjct: 64  VKLLDVI---HTENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLA 116

Query: 198 YIHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIF 238
           + H+   + HRD+KPQNLL+  E  +                     + + +YRAPE++ 
Sbjct: 117 FCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175

Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK-CMNPNY 297
           G   Y+TA+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP         +   
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235

Query: 298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 357
            +  FP+     + KV    L  +   L+ +   Y PN R +A  A  HPFF ++  P  
Sbjct: 236 YKPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP-- 292

Query: 358 RLPNGR 363
            +P+ R
Sbjct: 293 -VPHLR 297

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 1e-58
 Identities = 83/298 (27%), Positives = 137/298 (45%), Gaps = 34/298 (11%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRET-GEIVAIKKVLQDKRYKN------RELQIMQML---D 133
           Y     +G G++G VF+A+  +  G  VA+K+V      +       RE+ +++ L   +
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           HPN+V L      +    E  L LV E+V +  +            +P   +K   +Q+ 
Sbjct: 69  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ--DLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 194 RALAYIHNCIGICHRDIKPQNLLVKGEPNV------------------SYICSRYYRAPE 235
           R L ++H+   + HRD+KPQN+LV     +                  S + + +YRAPE
Sbjct: 127 RGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 185

Query: 236 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 295
           ++   + Y T +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  E+    + 
Sbjct: 186 VLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RDV 243

Query: 296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 353
                 F      P  K     +     DL+ +   ++P  R +A  A  HP+F +L 
Sbjct: 244 ALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 2e-58
 Identities = 79/308 (25%), Positives = 136/308 (44%), Gaps = 39/308 (12%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y     +G G+FG VF+A+ R+TG+ VA+KKVL +   +       RE++I+Q+L H N+
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 138 VALKHCFFSTT---DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           V L     +     ++ +  + LV ++     + +A   S +  +  L  +K     +  
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 195 ALAYIHNCIGICHRDIKPQNLLVKGEPNV-----------------------SYICSRYY 231
            L YIH    I HRD+K  N+L+  +  +                       + + + +Y
Sbjct: 129 GLYYIHRN-KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187

Query: 232 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 291
           R PEL+ G  +Y   ID+W  GC+MAE+    P+  G +   QL  I ++ G+ T E   
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247

Query: 292 CMNPNYTEFKFPQIKPHP---WHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
            ++      K   +K        ++      P A+DL+ +     P  R  + +A  H F
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307

Query: 349 FDELRDPN 356
           F     P+
Sbjct: 308 FWSDPMPS 315

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (479), Expect = 8e-58
 Identities = 90/298 (30%), Positives = 140/298 (46%), Gaps = 35/298 (11%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y     +G G++G VF+AK RET EIVA+K+V  D   +       RE+ +++ L H NI
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L           +  L LV E+       + + +   +  +    VK + +Q+ + L 
Sbjct: 64  VRLHDVL-----HSDKKLTLVFEFCD---QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 198 YIHNCIGICHRDIKPQNLLV-------------------KGEPNVSYICSRYYRAPELIF 238
           + H+   + HRD+KPQNLL+                         + + + +YR P+++F
Sbjct: 116 FCHSR-NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174

Query: 239 GATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 297
           GA  Y+T+ID+WS GC+ AEL    +PLFPG    DQL  I ++LGTPT E+   M    
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234

Query: 298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP 355
               +P             +L     DL+    + +P  R +A EA  HP+F +   P
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  187 bits (475), Expect = 2e-56
 Identities = 66/309 (21%), Positives = 111/309 (35%), Gaps = 60/309 (19%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL----QDKRYKNRELQIMQMLDHPNIVA 139
           Y     +GTG+FGVV +   R TG   A K V+     DK    +E+Q M +L HP +V 
Sbjct: 28  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L   F    D  E+ +  + E++      +    +  H +M       Y  Q+C+ L ++
Sbjct: 88  LHDAF---EDDNEMVM--IYEFMSG--GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140

Query: 200 HNCIGICHRDIKPQNLLVKGEPN--------------------VSYICSRYYRAPELIFG 239
           H      H D+KP+N++   + +                         +  + APE+  G
Sbjct: 141 HEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 299
                   D+WS G +   LL G   F GE+  + L  +                     
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF--------- 249

Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP--NT 357
                             +  +  D + +     PN R T  +A  HP+      P  ++
Sbjct: 250 ----------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293

Query: 358 RLPNGRPLP 366
           ++P+ R   
Sbjct: 294 QIPSSRYTK 302

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  186 bits (472), Expect = 2e-56
 Identities = 84/300 (28%), Positives = 137/300 (45%), Gaps = 40/300 (13%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-NRELQIMQML-DHPNIVALK 141
           Y     +G G +  VF+A      E V +K +   K+ K  RE++I++ L   PNI+ L 
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
                  D       LV E+V  T      ++ +++Q +    ++ Y Y+I +AL Y H+
Sbjct: 97  DIV---KDPVSRTPALVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDYCHS 147

Query: 202 CIGICHRDIKPQNLLV-------------------KGEPNVSYICSRYYRAPELIFGATE 242
             GI HRD+KP N+++                    G+     + SRY++ PEL+     
Sbjct: 148 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206

Query: 243 YTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
           Y  ++D+WS GC++A ++  + P F G    DQLV I KVLGT    +         + +
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266

Query: 302 FPQIKPHPWHKVFQKRLP--------PEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 353
           F  I      K +++ +         PEA+D + +  +Y    R TA EA  HP+F  + 
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  183 bits (464), Expect = 1e-55
 Identities = 90/294 (30%), Positives = 142/294 (48%), Gaps = 37/294 (12%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y     +G G++GVV++A+    GE  A+KK+  +K  +       RE+ I++ L H NI
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L           +  L LV E++      + +        +  +  K +  Q+   +A
Sbjct: 63  VKLYDVIH-----TKKRLVLVFEHLD---QDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114

Query: 198 YIHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIF 238
           Y H+   + HRD+KPQNLL+  E  +                     I + +YRAP+++ 
Sbjct: 115 YCHDR-RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173

Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-Y 297
           G+ +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +    +     
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233

Query: 298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 351
            +  F   +P PW     K L    +DL+ +  +  PN R TA +A  H +F E
Sbjct: 234 YDPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  182 bits (463), Expect = 1e-54
 Identities = 90/347 (25%), Positives = 143/347 (41%), Gaps = 64/347 (18%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 140
           YI    +G G F  V+ AK       VA+K V  DK Y      E++++Q ++  +    
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 141 KH----------CFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 190
                         F+      +++ +V E + E +  + + Y   H+ +PLIYVK  + 
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 132

Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVK----------------------GEPNVSYICS 228
           Q+   L Y+H   GI H DIKP+N+L++                       E   + I +
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192

Query: 229 RYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESG------VDQLVEIIKVL 282
           R YR+PE++ GA  +    DIWST C++ EL+ G  LF  + G       D + +II++L
Sbjct: 193 REYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251

Query: 283 GTPTREEIKCMNPNYTEF-------KFPQIKPHPWHKV------FQKRLPPEAVDLVCRF 329
           G      ++      T F          ++K  P   V      F K    E  D +   
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311

Query: 330 FQYSPNLRCTALEACVHPFF------DELRDPNTRL-PNGRPLPPLF 369
            Q  P  R  A     HP+       +E+R P+  L  +G  +P  F
Sbjct: 312 LQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 358

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 2e-54
 Identities = 62/294 (21%), Positives = 105/294 (35%), Gaps = 61/294 (20%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           +     +G G++G V  A  R T E VA+K V   +         +E+ I +ML+H N+V
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
                             L LEY          +       MP    + + +Q+   + Y
Sbjct: 67  KFYGHRREGN-----IQYLFLEYCS---GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118

Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV---------------------SYICSRYYRAPELI 237
           +H   GI HRDIKP+NLL+    N+                         +  Y APEL+
Sbjct: 119 LHGI-GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

Query: 238 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 297
                +   +D+WS G V+  +L G+  +   S   Q                       
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW------------------ 219

Query: 298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 351
              K  +   +PW K+         + L+ +    +P+ R T  +     ++++
Sbjct: 220 ---KEKKTYLNPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNK 265

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 3e-54
 Identities = 71/309 (22%), Positives = 114/309 (36%), Gaps = 53/309 (17%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIM-QMLDHPNIVALKH 142
            +   V+G G  G V Q   + T E  A+ K+LQD     RE+++  +    P+IV +  
Sbjct: 14  KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 72

Query: 143 CFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            + +     +  L +V+E +   E  +RI     R  Q             I  A+ Y+H
Sbjct: 73  VYENLYAGRK-CLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLH 128

Query: 201 NCIGICHRDIKPQNLLV---------------------KGEPNVSYICSRYYRAPELIFG 239
           +   I HRD+KP+NLL                            +   + YY APE++  
Sbjct: 129 SI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 187

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 299
             +Y  + D+WS G +M  LL G P F    G+     +   +                +
Sbjct: 188 -EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-------------Q 233

Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF-DELRDPNTR 358
           ++FP  +           +  E   L+    +  P  R T  E   HP+     + P T 
Sbjct: 234 YEFPNPEW--------SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 285

Query: 359 LPNGRPLPP 367
           L   R L  
Sbjct: 286 LHTSRVLKE 294

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 4e-54
 Identities = 95/343 (27%), Positives = 152/343 (44%), Gaps = 50/343 (14%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNI 137
           Y     +G+G+ G+V  A        VAIKK+ +  + +       REL +M+ ++H NI
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 138 VALKHCFFSTTDKEEL-YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           ++L + F      EE   + LV+E +       A     I   +    +    YQ+   +
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMD------ANLCQVIQMELDHERMSYLLYQMLCGI 132

Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV------------------SYICSRYYRAPELIF 238
            ++H+  GI HRD+KP N++VK +  +                   Y+ +RYYRAPE+I 
Sbjct: 133 KHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191

Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM----- 293
           G   Y   +DIWS GC+M E++  + LFPG   +DQ  ++I+ LGTP  E +K +     
Sbjct: 192 G-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250

Query: 294 -----NPNYTEFKFPQIKP---HPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV 345
                 P Y    FP++ P    P      K    +A DL+ +     P  R +  +A  
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310

Query: 346 HPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIPPETINRLI 388
           HP+ +   DP        P P +++ +  E      E    LI
Sbjct: 311 HPYINVWYDPAEVEA---PPPQIYDKQLDERE-HTIEEWKELI 349

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  176 bits (447), Expect = 2e-52
 Identities = 74/335 (22%), Positives = 119/335 (35%), Gaps = 63/335 (18%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVALKHCF 144
            +G+G+FGVV +   + TG +   K +      DK     E+ IM  L HP ++ L   F
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 145 FSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNC 202
               DK E+ L  +LE++   E  +RIA        +M    V  Y  Q C  L ++H  
Sbjct: 96  ---EDKYEMVL--ILEFLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEH 146

Query: 203 IGICHRDIKPQNLLV--------------------KGEPNVSYICSRYYRAPELIFGATE 242
             I H DIKP+N++                       E       +  + APE++     
Sbjct: 147 -SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EP 204

Query: 243 YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 302
                D+W+ G +   LL G   F GE  ++ L  + +       +              
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF------------ 252

Query: 303 PQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF-DELRDPNTRLPN 361
                          + PEA D +    Q  P  R T  +A  HP+   +  +  +R+P+
Sbjct: 253 -------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPS 299

Query: 362 GRPLPPLFNFKPPELSGIPPETINRLIPEHARKQN 396
            R        K        P+     I   +  + 
Sbjct: 300 SRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRK 334

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  174 bits (443), Expect = 4e-52
 Identities = 65/301 (21%), Positives = 112/301 (37%), Gaps = 60/301 (19%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
           +     +G GSFG V+ A+     E+VAIKK+    +  N       +E++ +Q L HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
            +  + C+     +   +  LV+EY        +       + +  + +   T+   + L
Sbjct: 77  TIQYRGCY---LREHTAW--LVMEYCL---GSASDLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV---------------SYICSRYYRAPELIFGAT 241
           AY+H+   + HRD+K  N+L+     V               S++ + Y+ APE+I    
Sbjct: 129 AYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMD 187

Query: 242 E--YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 299
           E  Y   +D+WS G    EL   +P     + +  L  I +                   
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------------- 228

Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRL 359
            + P ++   W             + V    Q  P  R T+     H F    R P   +
Sbjct: 229 NESPALQSGHW--------SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIM 280

Query: 360 P 360
            
Sbjct: 281 D 281

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 1e-51
 Identities = 63/295 (21%), Positives = 110/295 (37%), Gaps = 62/295 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVL------QDKRYKNRELQIMQMLDHPNI 137
           Y   + +GTGS+G   + + +  G+I+  K++        +K+    E+ +++ L HPNI
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           V         T+     L +V+EY     +  +    ++  Q +   +V     Q+  AL
Sbjct: 66  VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 197 AYIH----NCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRA 233
              H        + HRD+KP N+ + G+ NV                   +++ + YY +
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182

Query: 234 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 293
           PE +     Y    DIWS GC++ EL    P F   S  +   +I               
Sbjct: 183 PEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-------------- 227

Query: 294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                E KF +I               E  +++ R        R +  E   +P 
Sbjct: 228 -----EGKFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 2e-51
 Identities = 70/290 (24%), Positives = 116/290 (40%), Gaps = 63/290 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
           +     +G G FG V+ A+ +++  I+A+K + + +  K        RE++I   L HPN
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I+ L   F    D   +YL  +LEY P           +   +        Y  ++  AL
Sbjct: 68  ILRLYGYF---HDATRVYL--ILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 119

Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV-----------------SYICSRYYRAPELIFG 239
           +Y H+   + HRDIKP+NLL+     +                 +   +  Y  PE+I G
Sbjct: 120 SYCHSK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEG 178

Query: 240 ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 299
              +   +D+WS G +  E L+G+P F   +  +    I +V                 E
Sbjct: 179 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 220

Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
           F FP              +   A DL+ R  +++P+ R    E   HP+ 
Sbjct: 221 FTFP------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 4e-51
 Identities = 59/293 (20%), Positives = 111/293 (37%), Gaps = 61/293 (20%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQMLDHPNIVA 139
           +     +G G+FG V++A+ +ET  + A K +     ++      E+ I+   DHPNIV 
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L   F     +  L++  ++E+       +      + + +    +++   Q   AL Y+
Sbjct: 74  LLDAF---YYENNLWI--LIEFCAG--GAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126

Query: 200 HNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYRAPELIFGA 240
           H+   I HRD+K  N+L   + ++                   S+I + Y+ APE++   
Sbjct: 127 HDN-KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 185

Query: 241 T----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 296
           T     Y    D+WS G  + E+   +P     + +  L++I K                
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS--------------E 231

Query: 297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
                 P             R      D + +  + + + R T  +   HPF 
Sbjct: 232 PPTLAQP------------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 5e-51
 Identities = 68/308 (22%), Positives = 120/308 (38%), Gaps = 62/308 (20%)

Query: 76  GNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV----LQDKRYKNRELQIMQM 131
           G+ K+K  Y     +G G+ G V+ A    TG+ VAI+++       K     E+ +M+ 
Sbjct: 16  GDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 132 LDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
             +PNIV     +      +EL++  V+EY+                 M    +     +
Sbjct: 74  NKNPNIVNYLDSY---LVGDELWV--VMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124

Query: 192 ICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-------------------SYICSRYYR 232
             +AL ++H+   + HRDIK  N+L+  + +V                   + + + Y+ 
Sbjct: 125 CLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 183

Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
           APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  I    GTP       
Sbjct: 184 APEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP------- 234

Query: 293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
                 E + P            ++L     D + R        R +A E   H F    
Sbjct: 235 ------ELQNP------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276

Query: 353 RDPNTRLP 360
           +  ++  P
Sbjct: 277 KPLSSLTP 284

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 1e-50
 Identities = 80/328 (24%), Positives = 122/328 (37%), Gaps = 84/328 (25%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYK-------NRELQIMQMLDHPN 136
           +    ++G GSF  V  A+   T    AIK + +    K        RE  +M  LDHP 
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
            V L   F    D E+LY    L Y     N     Y R          + YT +I  AL
Sbjct: 70  FVKLYFTF---QDDEKLYF--GLSYAK---NGELLKYIRKIGSFDETCTRFYTAEIVSAL 121

Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV---------------------SYICSRYYRAPE 235
            Y+H    I HRD+KP+N+L+  + ++                     S++ +  Y +PE
Sbjct: 122 EYLHGKG-IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180

Query: 236 LIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 295
           L+        + D+W+ GC++ +L+ G P F   +      +IIK+              
Sbjct: 181 LLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-------------- 225

Query: 296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV------HPFF 349
              E+ FP+            +  P+A DLV +        R    E         HPFF
Sbjct: 226 ---EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 270

Query: 350 DELRDPNTRLPNGRPLPPLFNFKPPELS 377
           + +   N           L    PP+L+
Sbjct: 271 ESVTWEN-----------LHQQTPPKLT 287

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 2e-50
 Identities = 55/288 (19%), Positives = 108/288 (37%), Gaps = 57/288 (19%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPNIVAL 140
           +  +G GSF  V++    ET   VA  ++   K  K+       E ++++ L HPNIV  
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
            +  + +T K +  + LV E +    +   + Y +  + M +  ++ +  QI + L ++H
Sbjct: 74  -YDSWESTVKGKKCIVLVTELMT---SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 201 -NCIGICHRDIKPQNLLVKGEPNVSYIC------------------SRYYRAPELIFGAT 241
                I HRD+K  N+ + G      I                   +  + APE+     
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-- 187

Query: 242 EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 301
           +Y  ++D+++ G  M E+   +  +       Q+   +     P                
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS-------------- 233

Query: 302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
                       F K   PE  +++    + + + R +  +   H FF
Sbjct: 234 ------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  165 bits (420), Expect = 8e-49
 Identities = 65/303 (21%), Positives = 107/303 (35%), Gaps = 61/303 (20%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
           Y    V+GTG+F  V  A+ + T ++VAIK + +            E+ ++  + HPNIV
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           AL   +        LYL  +++ V         +                 +Q+  A+ Y
Sbjct: 71  ALDDIY---ESGGHLYL--IMQLVS---GGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122

Query: 199 IHNCIGICHRDIKPQNLLV---------------------KGEPNVSYICSRYYRAPELI 237
           +H+   I HRD+KP+NLL                       G    +   +  Y APE++
Sbjct: 123 LHDLG-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 181

Query: 238 FGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 297
                Y+ A+D WS G +   LL G P F  E+      +I+K                 
Sbjct: 182 AQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP--------- 231

Query: 298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 357
                           +   +   A D +    +  P  R T  +A  HP+       + 
Sbjct: 232 ----------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDK 275

Query: 358 RLP 360
            + 
Sbjct: 276 NIH 278

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 8e-49
 Identities = 67/293 (22%), Positives = 112/293 (38%), Gaps = 61/293 (20%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV---LQDKRYKNRELQIMQMLDHPNIVAL 140
           Y+    +G G FG+V +     + +    K V     D+    +E+ I+ +  H NI+ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 141 KHCFFSTTDKEELYLNLVLEYVP--ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
              F      EEL +  + E++   +   RI  +   +++R     +  Y +Q+C AL +
Sbjct: 67  HESF---ESMEELVM--IFEFISGLDIFERINTSAFELNERE----IVSYVHQVCEALQF 117

Query: 199 IHNCIGICHRDIKPQNLLV--------------------KGEPNVSYICSRYYRAPELIF 238
           +H+   I H DI+P+N++                      G+       +  Y APE+  
Sbjct: 118 LHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176

Query: 239 GATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 298
                +TA D+WS G ++  LL G   F  E+    +  I+    T   E          
Sbjct: 177 H-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF-------- 227

Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 351
                            K +  EA+D V R        R TA EA  HP+  +
Sbjct: 228 -----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  163 bits (413), Expect = 3e-48
 Identities = 68/305 (22%), Positives = 112/305 (36%), Gaps = 71/305 (23%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-------------LQDKRYKNRELQIMQ 130
           Y  + ++G G   VV +   + T +  A+K +              + +    +E+ I++
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 131 ML-DHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYT 189
            +  HPNI+ LK  +     +   +  LV + +         +Y      +     +   
Sbjct: 65  KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMK---KGELFDYLTEKVTLSEKETRKIM 116

Query: 190 YQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV------------------SYICSRYY 231
             +   +  +H    I HRD+KP+N+L+  + N+                      +  Y
Sbjct: 117 RALLEVICALHKL-NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSY 175

Query: 232 RAPELIFGATE-----YTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPT 286
            APE+I  +       Y   +D+WSTG +M  LL G P F     +  L  I        
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI-------- 227

Query: 287 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 346
                 M+ NY +F  P+                   DLV RF    P  R TA EA  H
Sbjct: 228 ------MSGNY-QFGSPEW----------DDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270

Query: 347 PFFDE 351
           PFF +
Sbjct: 271 PFFQQ 275

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  157 bits (398), Expect = 2e-45
 Identities = 74/352 (21%), Positives = 132/352 (37%), Gaps = 81/352 (23%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKV-------LQDKRYKNRELQIMQMLDHPN 136
           +     +GTGSFG V   + R  G   A+K +       L+   + N E  ++ ++ HP 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I+ +   F     ++   + ++++Y+         +  R  QR P    K Y  ++C AL
Sbjct: 66  IIRMWGTF-----QDAQQIFMIMDYIE---GGELFSLLRKSQRFPNPVAKFYAAEVCLAL 117

Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV----------------SYICSRYYRAPELIFGA 240
            Y+H+   I +RD+KP+N+L+    ++                +   +  Y APE++   
Sbjct: 118 EYLHSK-DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVST- 175

Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
             Y  +ID WS G ++ E+L G   F   + +    +I+                   E 
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-----------------AEL 218

Query: 301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRDP 355
           +FP                 +  DL+ R      + R         +   HP+F E+   
Sbjct: 219 RFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV--V 264

Query: 356 NTRLPNGRPLPPLFNFKPPELSGI---------PPETINRLIPEHARKQNLF 398
             +L +     P   ++PP   G          P E IN  +       +LF
Sbjct: 265 WEKLLSRNIETP---YEPPIQQGQGDTSQFDKYPEEDINYGVQGEDPYADLF 313

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 4e-45
 Identities = 76/353 (21%), Positives = 131/353 (37%), Gaps = 79/353 (22%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQ--------IMQMLDHP 135
           +I   ++G GSFG VF A+ ++T +  AIK + +D    + +++        +    +HP
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
            +  +   F     KE L+    +EY+          + +   +  L     Y  +I   
Sbjct: 64  FLTHMFCTF---QTKENLFFV--MEYLN---GGDLMYHIQSCHKFDLSRATFYAAEIILG 115

Query: 196 LAYIHNCIGICHRDIKPQNLL-------------------VKGEPNVSYICSRYYRAPEL 236
           L ++H+  GI +RD+K  N+L                   +      ++  +  Y APE+
Sbjct: 116 LQFLHSK-GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 174

Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 296
           + G  +Y  ++D WS G ++ E+L+GQ  F G+   +                I+  NP 
Sbjct: 175 LLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNPF 221

Query: 297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV-HPFFDELRDP 355
           Y  +                 L  EA DL+ + F   P  R         HP F E+   
Sbjct: 222 YPRW-----------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN-- 262

Query: 356 NTRLPNGRPLPP----------LFNFKPPELSGIPPETINRLIPEHARKQNLF 398
              L      PP            NF    L+  P  +       ++  QN+F
Sbjct: 263 WEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMF 315

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  154 bits (389), Expect = 9e-45
 Identities = 60/294 (20%), Positives = 94/294 (31%), Gaps = 60/294 (20%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPN 136
           Y    ++G G    V  A+       VA+K +  D            RE Q    L+HP 
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IVA+ +              +V+EYV        R+       M            C+AL
Sbjct: 69  IVAV-YDTGEAETPAGPLPYIVMEYVD---GVTLRDIVHTEGPMTPKRAIEVIADACQAL 124

Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV----------------------SYICSRYYRAP 234
            + H   GI HRD+KP N+++     V                      + I +  Y +P
Sbjct: 125 NFSHQN-GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183

Query: 235 ELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
           E   G        D++S GCV+ E+L G+P F G+S V    + ++    P         
Sbjct: 184 EQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA------ 236

Query: 295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPF 348
                                + L  +   +V +    +P  R           
Sbjct: 237 -------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 5e-44
 Identities = 59/317 (18%), Positives = 110/317 (34%), Gaps = 68/317 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLD 133
           Y     +G+G F VV + + + TG   A K + + +   +          RE+ I++ + 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           HPN++ L   +    +K ++ L  +LE V         ++    + +       +  QI 
Sbjct: 72  HPNVITLHEVY---ENKTDVIL--ILELVA---GGELFDFLAEKESLTEEEATEFLKQIL 123

Query: 194 RALAYIHNCIGICHRDIKPQNLLV----------------------KGEPNVSYICSRYY 231
             + Y+H+   I H D+KP+N+++                       G    +   +  +
Sbjct: 124 NGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182

Query: 232 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 291
            APE++          D+WS G +   LL G   F G++  + L  +  V      E   
Sbjct: 183 VAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE--- 238

Query: 292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE 351
                                 +       A D + R     P  R T  ++  HP+   
Sbjct: 239 ----------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276

Query: 352 LRDPNTRLPNGRPLPPL 368
            +D    L +    P  
Sbjct: 277 -KDTQQALSSAWSHPQF 292

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  152 bits (386), Expect = 2e-43
 Identities = 62/323 (19%), Positives = 112/323 (34%), Gaps = 72/323 (22%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLD 133
           +    ++G G FG V+  +  +TG++ A+K + + +            +   L ++   D
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
            P IV + + F      ++L    +L+ +          +   H       ++ Y  +I 
Sbjct: 66  CPFIVCMSYAF---HTPDKLSF--ILDLMN---GGDLHYHLSQHGVFSEADMRFYAAEII 117

Query: 194 RALAYIHNCIGICHRDIKPQNLLVKGEPNV-----------------SYICSRYYRAPEL 236
             L ++HN   + +RD+KP N+L+    +V                 + + +  Y APE+
Sbjct: 118 LGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEV 176

Query: 237 IFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 296
           +     Y ++ D +S GC++ +LL G   F      D+  EI +                
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDR---------------- 219

Query: 297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDE 351
                                  PE   L+    Q   N R       A E    PFF  
Sbjct: 220 ---------MTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270

Query: 352 LRDPNTRLPNGRPLPPLFNFKPP 374
           L      +   +  PP     PP
Sbjct: 271 L--DWQMVFLQKYPPP---LIPP 288

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 6e-43
 Identities = 56/302 (18%), Positives = 104/302 (34%), Gaps = 73/302 (24%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN----------RELQIMQMLD 133
           Y    ++G+G FG V+          VAIK V +D+               E+ +++ + 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 134 --HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQ 191
                ++ L   F            L+LE       +   ++      +     + + +Q
Sbjct: 66  SGFSGVIRLLDWFE-----RPDSFVLILERPEP--VQDLFDFITERGALQEELARSFFWQ 118

Query: 192 ICRALAYIHNCIGICHRDIKPQNLLV------------------KGEPNVSYICSRYYRA 233
           +  A+ + HNC G+ HRDIK +N+L+                  K      +  +R Y  
Sbjct: 119 VLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSP 177

Query: 234 PELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 293
           PE I     +  +  +WS G ++ +++ G   F  +       EII+             
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------------- 218

Query: 294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 353
                               F++R+  E   L+       P+ R T  E   HP+  ++ 
Sbjct: 219 ----------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262

Query: 354 DP 355
            P
Sbjct: 263 LP 264

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  143 bits (360), Expect = 3e-40
 Identities = 52/315 (16%), Positives = 97/315 (30%), Gaps = 73/315 (23%)

Query: 71  IGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQI 128
           +G R         Y     +G+GSFG ++       GE VAIK      ++     E +I
Sbjct: 5   VGNR---------YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI 55

Query: 129 MQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY 188
            +M+     +       +  D    Y  +V+E +  ++  +   ++   ++  L  V L 
Sbjct: 56  YKMMQGGVGIPTIRWCGAEGD----YNVMVMELLGPSLEDL---FNFCSRKFSLKTVLLL 108

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLL-----------------------------VKG 219
             Q+   + YIH+     HRD+KP N L                             +  
Sbjct: 109 ADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167

Query: 220 EPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEII 279
             N +   +  Y +     G  E +   D+ S G V+    LG   + G     +  +  
Sbjct: 168 RENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY- 225

Query: 280 KVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT 339
                                +  + K     +V  K  P E    +        + +  
Sbjct: 226 --------------------ERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPD 265

Query: 340 A---LEACVHPFFDE 351
                +   + F  +
Sbjct: 266 YSYLRQLFRNLFHRQ 280

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 6e-40
 Identities = 65/327 (19%), Positives = 112/327 (34%), Gaps = 76/327 (23%)

Query: 81  KVS---YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQ 130
           KV+   +    ++G G+FG V   + + TG   A+K + ++             E +++Q
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 131 MLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTY 190
              HP + ALK+ F      + L        +          +    +       + Y  
Sbjct: 61  NTRHPFLTALKYAF---QTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGA 112

Query: 191 QICRALAYIHNCIGICHRDIKPQNLLVKGEPNV------------------SYICSRYYR 232
           +I  AL Y+H+   + +RDIK +NL++  + ++                     C     
Sbjct: 113 EIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 171

Query: 233 APELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 292
               +    +Y  A+D W  G VM E++ G+  F  +        I+             
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM------------ 219

Query: 293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----CTALEACVHP 347
                 E +FP            + L PEA  L+    +  P  R       A E   H 
Sbjct: 220 -----EEIRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262

Query: 348 FFDELRDPNTRLPNGRPLPPLFNFKPP 374
           FF  +      +   + LPP   FKP 
Sbjct: 263 FFLSIN--WQDVVQKKLLPP---FKPQ 284

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  142 bits (358), Expect = 1e-39
 Identities = 59/309 (19%), Positives = 106/309 (34%), Gaps = 70/309 (22%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIVALK 141
            +GTGSFG V   K +E+G   A+K + + K  K         E +I+Q ++ P +V L+
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN 201
             F   ++   +   +    +   + R          R    + + Y  QI     Y+H+
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRR--------IGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 202 CIGICHRDIKPQNLLVKGEPNV----------------SYICSRYYRAPELIFGATEYTT 245
              + +RD+KP+NLL+  +  +                +   +    APE+I     Y  
Sbjct: 160 L-DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILS-KGYNK 217

Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
           A+D W+ G ++ E+  G P F  +  +    +I                           
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--------------------------- 250

Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSP-----NLRCTALEACVHPFFDELRDPNTRLP 360
                   F      +  DL+    Q        NL+    +   H +F      +    
Sbjct: 251 --VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF---ATTDWIAI 305

Query: 361 NGRPLPPLF 369
             R +   F
Sbjct: 306 YQRKVEAPF 314

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 2e-39
 Identities = 49/278 (17%), Positives = 93/278 (33%), Gaps = 56/278 (20%)

Query: 88  HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQIMQMLDHPNIVALKHCFF 145
             +G G FG V        G  VA+K +  D   +    E  +M  L H N+V L     
Sbjct: 13  QTIGKGEFGDVM--LGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70

Query: 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
                    L +V EY+ +  + +    SR    +    +  ++  +C A+ Y+      
Sbjct: 71  EEKG----GLYIVTEYMAKG-SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NF 124

Query: 206 CHRDIKPQNLLVKGEPNV----------------SYICSRYYRAPELIFGATEYTTAIDI 249
            HRD+  +N+LV  +                   +      + APE +    +++T  D+
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALRE-KKFSTKSDV 183

Query: 250 WSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPH 308
           WS G ++ E+   G+  +P     D +  + K                            
Sbjct: 184 WSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---------------------------- 215

Query: 309 PWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 346
            +        PP   +++   +     +R + L+    
Sbjct: 216 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (350), Expect = 6e-39
 Identities = 47/293 (16%), Positives = 96/293 (32%), Gaps = 64/293 (21%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN 136
                  +G+GSFG V++ K       VA+K +               E+ +++   H N
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           I+                L +V ++   +   +  +   I  +  +I +     Q  + +
Sbjct: 66  ILLFMGYS------TAPQLAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGM 117

Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV---------------------SYICSRYYRAPE 235
            Y+H    I HRD+K  N+ +  +  V                         S  + APE
Sbjct: 118 DYLH-AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176

Query: 236 LIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 293
           +I       Y+   D+++ G V+ EL+ GQ  +   +  DQ++ ++              
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR------------ 224

Query: 294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 346
              Y      +++ +          P     L+    +   + R    +    
Sbjct: 225 --GYLSPDLSKVRSN---------CPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 1e-36
 Identities = 68/336 (20%), Positives = 120/336 (35%), Gaps = 78/336 (23%)

Query: 79  KQKVS---YIAEHVVGTGSFGVVFQAKC---RETGEIVAIKKV--------LQDKRYKNR 124
            +KV    +    V+GTG++G VF  +     +TG++ A+K +         +   +   
Sbjct: 18  AEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT 77

Query: 125 ELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIY 184
           E Q+++ +     +   H  F    + +L+L L      E    +++      +R     
Sbjct: 78  ERQVLEHIRQSPFLVTLHYAF--QTETKLHLILDYINGGELFTHLSQ-----RERFTEHE 130

Query: 185 VKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV--------------------- 223
           V++Y  +I  AL ++H   GI +RDIK +N+L+    +V                     
Sbjct: 131 VQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 189

Query: 224 SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG 283
                 Y     +  G + +  A+D WS G +M ELL G   F  +   +   EI +   
Sbjct: 190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--- 246

Query: 284 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR-----C 338
                                 +       + + +   A DL+ R     P  R      
Sbjct: 247 ----------------------RILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPR 284

Query: 339 TALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPP 374
            A E   H FF ++   +  L   +   P   FKP 
Sbjct: 285 DADEIKEHLFFQKINWDD--LAAKKVPAP---FKPV 315

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  133 bits (334), Expect = 2e-36
 Identities = 44/280 (15%), Positives = 88/280 (31%), Gaps = 52/280 (18%)

Query: 71  IGGRNGNSKQKVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN--RELQI 128
           +G           Y     +G GSFGV+F+       + VAIK   +         E + 
Sbjct: 3   VGVH---------YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT 53

Query: 129 MQMLDHPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLY 188
            ++L     +   + F      E L+  LV++ +  ++  +     R   +  +  V + 
Sbjct: 54  YKLLAGCTGIPNVYYFGQ----EGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMA 106

Query: 189 TYQICRALAYIHNCIGICHRDIKPQNLLV------------------------------- 217
             Q+   +  IH    + +RDIKP N L+                               
Sbjct: 107 AKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165

Query: 218 KGEPNVSYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVE 277
                 +   +  Y +     G  E +   D+ + G V    L G   + G        +
Sbjct: 166 PYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224

Query: 278 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKR 317
             ++        ++ +   + E +F +   +  +  F   
Sbjct: 225 YERIGEKKQSTPLRELCAGFPE-EFYKYMHYARNLAFDAT 263

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 3e-35
 Identities = 56/298 (18%), Positives = 106/298 (35%), Gaps = 52/298 (17%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVA 139
           + + +  +G G FG V+  + +  GE VA+K     +    ++  E+    ML H NI+ 
Sbjct: 4   TIVLQESIGKGRFGEVW--RGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
                 +  +     L LV +Y     +    +Y      + +  +          LA++
Sbjct: 62  F-IAADNKDNGTWTQLWLVSDYHE---HGSLFDYLN-RYTVTVEGMIKLALSTASGLAHL 116

Query: 200 HNCI-------GICHRDIKPQNLLVKGEPNV-----------------------SYICSR 229
           H  I        I HRD+K +N+LVK                              + ++
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176

Query: 230 YYRAPELIFGA-----TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGT 284
            Y APE++  +      E     DI++ G V  E+     +  G     QL     V   
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVPSD 235

Query: 285 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 342
           P+ EE++ +          +++P+  ++            ++   +  +   R TAL 
Sbjct: 236 PSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 4e-34
 Identities = 61/299 (20%), Positives = 99/299 (33%), Gaps = 64/299 (21%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVA 139
           S   E  +G G FG V+      T   VAIK +           +E Q+M+ L H  +V 
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L         +E +Y+  V EY+ +             + + L  +     QI   +AY+
Sbjct: 77  LYAVV----SEEPIYI--VTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYV 129

Query: 200 HNCIGICHRDIKPQNLLVKGEPNV--------------------SYICSRYYRAPELIFG 239
                  HRD++  N+LV                                 + APE    
Sbjct: 130 ERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188

Query: 240 ATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 298
              +T   D+WS G ++ EL   G+  +PG    + L ++ +    P   E         
Sbjct: 189 -GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC-------- 239

Query: 299 EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA--LEACVHPFFDELRDP 355
                               P    DL+C+ ++  P  R T   L+A +  +F      
Sbjct: 240 --------------------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 2e-33
 Identities = 51/292 (17%), Positives = 97/292 (33%), Gaps = 64/292 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 140
                 +G G FG V+          VA+K + Q     +    E  +M+ L H  +V L
Sbjct: 15  LKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
                    +E +Y+  + EY+    + +    +    ++ +  +     QI   +A+I 
Sbjct: 74  YAVV----TQEPIYI--ITEYMENG-SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 201 NCIGICHRDIKPQNLLVKGEPNV--------------------SYICSRYYRAPELIFGA 240
                 HRD++  N+LV    +                            + APE I   
Sbjct: 127 ER-NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185

Query: 241 TEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 299
             +T   D+WS G ++ E++  G+  +PG +  + +  + +                   
Sbjct: 186 -TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------------- 225

Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE--ACVHPFF 349
                     +  V     P E   L+   ++  P  R T     + +  FF
Sbjct: 226 ---------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 5e-33
 Identities = 62/299 (20%), Positives = 99/299 (33%), Gaps = 71/299 (23%)

Query: 85  IAEHVVGTGSFGVVFQAKCRETGE--IVAIKKVLQDKRYKN-----RELQIMQMLDHPNI 137
           IA+  +G G+FG V Q   R   +   VAIK + Q     +     RE QIM  LD+P I
Sbjct: 12  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 71

Query: 138 VALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALA 197
           V L          +   L LV+E        + +      + +P+  V    +Q+   + 
Sbjct: 72  VRLIGVC------QAEALMLVMEMAGGGP--LHKFLVGKREEIPVSNVAELLHQVSMGMK 123

Query: 198 YIHNCIGICHRDIKPQNLLVKGEPNVSYIC----------------------SRYYRAPE 235
           Y+       HRD+  +N+L+                                   + APE
Sbjct: 124 YLE-EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182

Query: 236 LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
            I    ++++  D+WS G  M E L  GQ  +    G + +  I +              
Sbjct: 183 CINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG------------- 228

Query: 295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV---HPFFD 350
                 K  +  P           PPE   L+   + Y    R   L         ++ 
Sbjct: 229 ------KRMECPPE---------CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 8e-33
 Identities = 42/281 (14%), Positives = 85/281 (30%), Gaps = 60/281 (21%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVALKHCFF 145
            +G+G FG+V         + VAIK + +    +     E ++M  L HP +V L     
Sbjct: 12  EIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC- 69

Query: 146 STTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGI 205
              ++  +   LV E++      ++              +      +C  +AY+     +
Sbjct: 70  --LEQAPIC--LVFEFMEH--GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-CV 122

Query: 206 CHRDIKPQNLLVKGEPNV--------------------SYICSRYYRAPELIFGATEYTT 245
            HRD+  +N LV     +                           + +PE+    + Y++
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSS 181

Query: 246 AIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 305
             D+WS G +M E+     +        ++VE I                          
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS------------------------- 216

Query: 306 KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 346
               +     +        ++   ++  P  R         
Sbjct: 217 --TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 9e-33
 Identities = 53/297 (17%), Positives = 93/297 (31%), Gaps = 70/297 (23%)

Query: 89  VVGTGSFGVVFQAKCRET---GEIVAIKKVLQDKRYKN-------RELQIMQMLDHPNIV 138
            +G GSFGVV + +          VA+K +  D   +        RE+  M  LDH N++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
            L              + +V E  P     +     +      L  +  Y  Q+   + Y
Sbjct: 75  RLYGVV------LTPPMKMVTELAPL--GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV---------------------SYICSRYYRAPELI 237
           + +     HRD+  +NLL+     V                      +    +       
Sbjct: 127 LESK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185

Query: 238 FGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 296
                ++ A D W  G  + E+   GQ  + G +G   L +I K      R E       
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE------- 238

Query: 297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR 353
                                 P +  +++ + + + P  R T +   +  F  E +
Sbjct: 239 --------------------DCPQDIYNVMVQCWAHKPEDRPTFVA--LRDFLLEAQ 273

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  121 bits (305), Expect = 2e-32
 Identities = 49/292 (16%), Positives = 103/292 (35%), Gaps = 60/292 (20%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 140
              +H +G G +G V++   ++    VA+K + +D        +E  +M+ + HPN+V L
Sbjct: 19  ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL 78

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
                  T +   Y+    E++               Q +  + +     QI  A+ Y+ 
Sbjct: 79  LGVC---TREPPFYIIT--EFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLE 132

Query: 201 NCIGICHRDIKPQNLLVKGEPNV--------------------SYICSRYYRAPELIFGA 240
                 HRD+  +N LV     V                           + APE +   
Sbjct: 133 KK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY- 190

Query: 241 TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 300
            +++   D+W+ G ++ E+            + Q+ E+++                    
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---------------KDYRM 235

Query: 301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL 352
           + P            +  P +  +L+   +Q++P+ R +  E  +H  F+ +
Sbjct: 236 ERP------------EGCPEKVYELMRACWQWNPSDRPSFAE--IHQAFETM 273

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  121 bits (305), Expect = 2e-32
 Identities = 58/308 (18%), Positives = 103/308 (33%), Gaps = 71/308 (23%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVL-----QDKRYKNRELQIMQMLDH 134
               E V+G G FG V     +  G+    VAIK +      + +R    E  IM   DH
Sbjct: 27  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86

Query: 135 PNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICR 194
           PN++ L+      T    +   ++ E++      +     +   +  +I +      I  
Sbjct: 87  PNVIHLEGVV---TKSTPVM--IITEFMEN--GSLDSFLRQNDGQFTVIQLVGMLRGIAA 139

Query: 195 ALAYIHNCIGICHRDIKPQNLLVKGEPNV------------------------SYICSRY 230
            + Y+   +   HRD+  +N+LV                                     
Sbjct: 140 GMKYLA-DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 198

Query: 231 YRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREE 289
           + APE I    ++T+A D+WS G VM E++  G+  +   +  D +  I +    P   +
Sbjct: 199 WTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMD 257

Query: 290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF 349
                                        P     L+   +Q   N R    +  V+   
Sbjct: 258 C----------------------------PSALHQLMLDCWQKDRNHRPKFGQ-IVNTLD 288

Query: 350 DELRDPNT 357
             +R+PN+
Sbjct: 289 KMIRNPNS 296

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 2e-32
 Identities = 50/300 (16%), Positives = 97/300 (32%), Gaps = 73/300 (24%)

Query: 85  IAEHVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDKRYKN------RELQIMQMLDHPN 136
           + +  +G+G+FG V +   +  +  + VA+K +  +            E  +MQ LD+P 
Sbjct: 10  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 69

Query: 137 IVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRAL 196
           IV +        + E   L  V+E            Y + ++ +    +    +Q+   +
Sbjct: 70  IVRMIGIC----EAESWML--VMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 120

Query: 197 AYIHNCIGICHRDIKPQNLLVKGEPNV----------------------SYICSRYYRAP 234
            Y+       HRD+  +N+L+  +                                + AP
Sbjct: 121 KYLEES-NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179

Query: 235 ELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 293
           E I    ++++  D+WS G +M E    GQ  + G  G +    + K             
Sbjct: 180 ECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC--- 235

Query: 294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV---HPFFD 350
                                    P E  DL+   + Y    R       +   + ++D
Sbjct: 236 -------------------------PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 2e-31
 Identities = 55/316 (17%), Positives = 95/316 (30%), Gaps = 87/316 (27%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGE-----IVAIKKVLQDKRYKN-----RELQIMQML- 132
                V+G+G+FG V  A      +      VA+K + +            EL++M  L 
Sbjct: 39  LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98

Query: 133 DHPNIVALKHCFFSTTDKEELYLNLVLEYVP--------------------ETVNRIARN 172
            H NIV L       T    +Y  L+ EY                      E  N+    
Sbjct: 99  SHENIVNLLGAC---TLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 173 YSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV--------- 223
                  +    +  + YQ+ + + ++       HRD+  +N+LV     V         
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTHGKVVKICDFGLAR 212

Query: 224 ------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGES 270
                       +      + APE +F    YT   D+WS G ++ E+  LG   +PG  
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271

Query: 271 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFF 330
                 ++I+               N  +   P                 E   ++   +
Sbjct: 272 VDANFYKLIQ---------------NGFKMDQP------------FYATEEIYIIMQSCW 304

Query: 331 QYSPNLRCTALEACVH 346
            +    R +       
Sbjct: 305 AFDSRKRPSFPNLTSF 320

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 3e-31
 Identities = 48/287 (16%), Positives = 94/287 (32%), Gaps = 62/287 (21%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKN---RELQIMQMLDHPNIVAL 140
                 +GTG FGVV   K R     VAIK + +    ++    E ++M  L H  +V L
Sbjct: 6   LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL 64

Query: 141 KHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIH 200
                  T +  ++  ++ EY+      +      +  R     +      +C A+ Y+ 
Sbjct: 65  YGVC---TKQRPIF--IITEYMAN--GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117

Query: 201 NCIGICHRDIKPQNLLVKGEPNV--------------------SYICSRYYRAPELIFGA 240
                 HRD+  +N LV  +  V                           +  PE++   
Sbjct: 118 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY- 175

Query: 241 TEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 299
           +++++  DIW+ G +M E+  LG+  +   +  +    I + L                 
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL----------------R 219

Query: 300 FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 346
              P +               +   ++   +    + R T      +
Sbjct: 220 LYRPHL------------ASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 8e-31
 Identities = 57/328 (17%), Positives = 109/328 (33%), Gaps = 72/328 (21%)

Query: 89  VVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLDHPNIVA 139
           V+G+G+FG V++      GE     VAIK++ +    K       E  +M  +D+P++  
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75

Query: 140 LKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYI 199
           L     ++T      + L+ + +P     +          +   Y+  +  QI + + Y+
Sbjct: 76  LLGICLTST------VQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127

Query: 200 HNCIGICHRDIKPQNLLVKGEPNV---------------------SYICSRYYRAPELIF 238
            +   + HRD+  +N+LVK   +V                            + A E I 
Sbjct: 128 EDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186

Query: 239 GATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 297
               YT   D+WS G  + EL+  G   + G     ++  I++      +  I       
Sbjct: 187 H-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSILEKGERLPQPPI------- 237

Query: 298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT 357
                                  +   ++ + +    + R    E  +  F    RDP  
Sbjct: 238 --------------------CTIDVYMIMVKCWMIDADSRPKFRELIIE-FSKMARDPQR 276

Query: 358 RLPNGRPLPPLFNFKPPELSGIPPETIN 385
            L          +   P  S      ++
Sbjct: 277 YLV--IQGDERMHLPSPTDSNFYRALMD 302

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 4e-30
 Identities = 54/307 (17%), Positives = 95/307 (30%), Gaps = 82/307 (26%)

Query: 84  YIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDKRYKN-----RELQIMQML- 132
                 +G G+FG V +A        +    VA+K +              EL+++  L 
Sbjct: 25  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84

Query: 133 DHPNIVALKHCFFSTTDKEELYLNLVLEYVP---------------ETVNRIARNYSRIH 177
           +H NIV L       T        ++ EY                               
Sbjct: 85  NHMNIVNLLGAC---TIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-------------- 223
             + L  +  ++YQ+ + +A++ +     HRD+  +N+L+                    
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRITKICDFGLARDIKND 198

Query: 224 -------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQL 275
                  +      + APE IF    YT   D+WS G  + EL  LG   +PG     + 
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257

Query: 276 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 335
            ++IK                             +  +  +  P E  D++   +   P 
Sbjct: 258 YKMIK---------------------------EGFRMLSPEHAPAEMYDIMKTCWDADPL 290

Query: 336 LRCTALE 342
            R T  +
Sbjct: 291 KRPTFKQ 297

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (282), Expect = 3e-29
 Identities = 62/292 (21%), Positives = 89/292 (30%), Gaps = 67/292 (22%)

Query: 84  YIAEHVVGTGSFGVVFQAKCR---ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHP 135
                 +G G FG V Q            VAIK               +E   M+  DHP
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68

Query: 136 NIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRA 195
           +IV L           E  + +++E        +          + L  + LY YQ+  A
Sbjct: 69  HIVKLIGVI------TENPVWIIMELCTL--GELRSFLQVRKYSLDLASLILYAYQLSTA 120

Query: 196 LAYIHNCIGICHRDIKPQNLLVKGEPNVSYIC--------------------SRYYRAPE 235
           LAY+ +     HRDI  +N+LV     V                           + APE
Sbjct: 121 LAYLESK-RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179

Query: 236 LIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
            I     +T+A D+W  G  M E+L+ G   F G    D +  I      P         
Sbjct: 180 SINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC---- 234

Query: 295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 346
                                   PP    L+ + + Y P+ R    E    
Sbjct: 235 ------------------------PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 1e-28
 Identities = 47/303 (15%), Positives = 94/303 (31%), Gaps = 74/303 (24%)

Query: 87  EHVVGTGSFGVVFQAKCRE---TGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
             V+G G FG V+     +        A+K + +            E  IM+   HPN++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAY 198
           +L      +    E    +VL Y+     R             +  +  +  Q+ + + +
Sbjct: 92  SLLGICLRS----EGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKF 145

Query: 199 IHNCIGICHRDIKPQNLLVKGEPNV-----------------------SYICSRYYRAPE 235
           +       HRD+  +N ++  +  V                              + A E
Sbjct: 146 LA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204

Query: 236 LIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 294
            +    ++TT  D+WS G ++ EL+  G P +P  +  D  V +++       E      
Sbjct: 205 SLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC---- 259

Query: 295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA------LEACVHPF 348
                                   P    +++ + +     +R +       + A    F
Sbjct: 260 ------------------------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295

Query: 349 FDE 351
             E
Sbjct: 296 IGE 298

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 2e-28
 Identities = 56/308 (18%), Positives = 108/308 (35%), Gaps = 83/308 (26%)

Query: 84  YIAEHVVGTGSFGVVFQAKCRETGE-------IVAIKKVLQDKRYKN-----RELQIMQM 131
            +    +G G+FG V  A+     +        VA+K +  D   K+      E+++M+M
Sbjct: 15  LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74

Query: 132 L-DHPNIVALKHCFFSTTDKEELYLNLVLEYV-------------PETVNRIARNYSRIH 177
           +  H NI+   +   + T    LY+  ++EY              P  +           
Sbjct: 75  IGKHKNII---NLLGACTQDGPLYV--IVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-------------- 223
           +++    +    YQ+ R + Y+ +     HRD+  +N+LV  +  +              
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188

Query: 224 -------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQL 275
                  +      + APE +F    YT   D+WS G ++ E+  LG   +PG   V++L
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEEL 246

Query: 276 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 335
            +++K                  E        +            E   ++   +   P+
Sbjct: 247 FKLLK------------------EGHRMDKPSN---------CTNELYMMMRDCWHAVPS 279

Query: 336 LRCTALEA 343
            R T  + 
Sbjct: 280 QRPTFKQL 287

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  109 bits (272), Expect = 9e-28
 Identities = 58/317 (18%), Positives = 98/317 (30%), Gaps = 90/317 (28%)

Query: 89  VVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDKRYKN-----RELQIMQMLDHPNIV 138
            +G G+FG VFQA+       E   +VA+K + ++          RE  +M   D+PNIV
Sbjct: 20  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 79

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP---------------------ETVNRIARNYSRIH 177
                       + + L  + EY+                        ++  AR  S   
Sbjct: 80  ---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 134

Query: 178 QRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV-------------- 223
             +          Q+   +AY+       HRD+  +N LV     V              
Sbjct: 135 PPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193

Query: 224 -------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQL 275
                  +      +  PE IF    YTT  D+W+ G V+ E+   G   + G +  + +
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI 252

Query: 276 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPN 335
             +                          I   P      +  P E  +L+   +   P 
Sbjct: 253 YYVRD----------------------GNILACP------ENCPLELYNLMRLCWSKLPA 284

Query: 336 LRCTALEACVHPFFDEL 352
            R +     +H     +
Sbjct: 285 DRPSFCS--IHRILQRM 299

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 9e-28
 Identities = 48/291 (16%), Positives = 87/291 (29%), Gaps = 67/291 (23%)

Query: 83  SYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQDKRYKN-----RELQIMQMLD 133
               + V+G G FG V++   + +       VAIK +      K       E  IM    
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
           H NI+ L+         +   + ++ EY+        +          ++ +      I 
Sbjct: 68  HHNIIRLEGVIS-----KYKPMMIITEYMENGALD--KFLREKDGEFSVLQLVGMLRGIA 120

Query: 194 RALAYIHNCIGICHRDIKPQNLLVKGEPNV----------------------SYICSRYY 231
             + Y+ N     HRD+  +N+LV                                   +
Sbjct: 121 AGMKYLANM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179

Query: 232 RAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 291
            APE I    ++T+A D+WS G VM E++        E    ++++ I            
Sbjct: 180 TAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN----------- 227

Query: 292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE 342
                             +        P     L+ + +Q     R    +
Sbjct: 228 ----------------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFAD 262

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 2e-27
 Identities = 54/299 (18%), Positives = 96/299 (32%), Gaps = 73/299 (24%)

Query: 87  EHVVGTGSFGVVFQAKCRETGEI--VAIKKV-----LQDKRYKNRELQIMQML-DHPNIV 138
           + V+G G+FG V +A+ ++ G     AIK++       D R    EL+++  L  HPNI+
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74

Query: 139 ALKHCFFSTTDKEELYLNLVLEYVP-------------ETVNRIARNYSRIHQRMPLIYV 185
            L             YL L +EY P                +      +     +    +
Sbjct: 75  NLLGACEHRG-----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 186 KLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV------------------SYIC 227
             +   + R + Y+       HRD+  +N+LV                            
Sbjct: 130 LHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 188

Query: 228 SRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 287
              + A E +   + YTT  D+WS G ++ E++             +L E +        
Sbjct: 189 PVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP------- 240

Query: 288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH 346
                        + P                 E  DL+ + ++  P  R +  +  V 
Sbjct: 241 --------QGYRLEKP------------LNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (269), Expect = 3e-27
 Identities = 52/314 (16%), Positives = 107/314 (34%), Gaps = 80/314 (25%)

Query: 84  YIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKV-----LQDKRYKNRELQIMQMLD 133
                 +G GSFG+V++   +     E    VAIK V     ++++     E  +M+  +
Sbjct: 22  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81

Query: 134 HPNIVALKHCFFSTTDKEELYLNLVLEYVPE-------TVNRIARNYSRIHQRMPLIYVK 186
             ++V         +  +     +++E +            R A   + +     L  + 
Sbjct: 82  CHHVV---RLLGVVSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 187 LYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV---------------------SY 225
               +I   +AY++      HRD+  +N +V  +  V                       
Sbjct: 137 QMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195

Query: 226 ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELL-LGQPLFPGESGVDQLVEIIKVLGT 284
           +    + +PE +     +TT  D+WS G V+ E+  L +  + G S    L  +++    
Sbjct: 196 LLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME---- 250

Query: 285 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTA---- 340
                               +   P         P    +L+   +QY+P +R +     
Sbjct: 251 ------------------GGLLDKP------DNCPDMLFELMRMCWQYNPKMRPSFLEII 286

Query: 341 --LEACVHPFFDEL 352
             ++  + P F E+
Sbjct: 287 SSIKEEMEPGFREV 300

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 3e-27
 Identities = 51/309 (16%), Positives = 96/309 (31%), Gaps = 79/309 (25%)

Query: 84  YIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQD------KRYKNRELQIMQML 132
                 +G G+FG V +A         T   VA+K + +       +   +    ++ + 
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 133 DHPNIVALKHCFFSTTDKEELYLNLVLEYVP-------------ETVNRIARNYSRIHQR 179
            H N+V L              L +++E+               E V             
Sbjct: 75  HHLNVVNLLGACTKPGG----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 180 MPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV---------------- 223
           + L ++  Y++Q+ + + ++ +     HRD+  +N+L+  +  V                
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 224 -----SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVE 277
                       + APE IF    YT   D+WS G ++ E+       +PG    ++   
Sbjct: 190 YVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248

Query: 278 IIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLR 337
            +K                 T  + P                PE    +   +   P+ R
Sbjct: 249 RLK---------------EGTRMRAPDY------------TTPEMYQTMLDCWHGEPSQR 281

Query: 338 CTALEACVH 346
            T  E   H
Sbjct: 282 PTFSELVEH 290

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 69.4 bits (169), Expect = 1e-14
 Identities = 25/199 (12%), Positives = 52/199 (26%), Gaps = 43/199 (21%)

Query: 89  VVGTGSFGVVFQAKCRETGEIVAIKKV--------------LQDKRYKNRELQIMQMLDH 134
           ++G G    VF     E      +K                     + +         + 
Sbjct: 7   LMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 135 PNIVALKHCFFSTT-DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQIC 193
             +  L+          E     +++E             ++   R+ +         I 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNA--VLMEL----------IDAKELYRVRVENPDEVLDMIL 113

Query: 194 RALAYIHNCIGICHRDIKPQNLLVKGEPNV-----SYICSRYYRAPELI---------FG 239
             +A  ++   I H D+   N+LV  E          +        E++         + 
Sbjct: 114 EEVAKFYHRG-IVHGDLSQYNVLVSEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172

Query: 240 ATEYTTAIDIWSTGCVMAE 258
           +  Y T  DI S    + +
Sbjct: 173 SRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	403
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.85
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.03
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.56
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	95.97
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	92.55
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	91.89

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-60  Score=455.79  Aligned_cols=311  Identities=69%  Similarity=1.189  Sum_probs=268.4

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccccHHHHHHHHHhcCCCCccccceEEeecCC-CCceEEEEEe
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELYLNLVL  159 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~lv~  159 (403)
                      ..+|...++||+|+||+||+|+++.+|+.||||++..+.....+|+++|++++|+||++++++|+.... .+..++||||
T Consensus        19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~   98 (350)
T d1q5ka_          19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL   98 (350)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred             cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence            446999999999999999999999999999999998877777799999999999999999999865432 4567899999


Q ss_pred             eccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC-Cc---------------
Q 015672          160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP-NV---------------  223 (403)
Q Consensus       160 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~-~~---------------  223 (403)
                      |||++++...+.........+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+               
T Consensus        99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~  177 (350)
T d1q5ka_          99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE  177 (350)
T ss_dssp             ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred             eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence            999988777666655556789999999999999999999999 8999999999999998654 33               


Q ss_pred             ---eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcccc
Q 015672          224 ---SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  300 (403)
Q Consensus       224 ---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  300 (403)
                         ..+||+.|+|||++.+...|+.++|||||||++|||++|++||.+.+..+++..+.+.++.+..+.+....+.+...
T Consensus       178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~  257 (350)
T d1q5ka_         178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF  257 (350)
T ss_dssp             CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CC
T ss_pred             ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhc
Confidence               23578999999998777779999999999999999999999999999999999999999999999998888888888


Q ss_pred             CCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 015672          301 KFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNTRLPNGRPLPPLFNFKPPELSGIP  380 (403)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (403)
                      .++.....++.......+++++.+||.+||++||++||||.|+|+||||+++.++...+++....+..+++...+++. .
T Consensus       258 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~  336 (350)
T d1q5ka_         258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSS-N  336 (350)
T ss_dssp             CCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHTT-C
T ss_pred             cccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCCCCCCCCCCCccCCCCHhhccC-C
Confidence            888888888888777889999999999999999999999999999999999998888888877777777776555543 4


Q ss_pred             hHHHhhcCcHHHH
Q 015672          381 PETINRLIPEHAR  393 (403)
Q Consensus       381 ~~~~~~~~~~~~~  393 (403)
                      +.....++|+|+|
T Consensus       337 ~~~~~~~~p~~~r  349 (350)
T d1q5ka_         337 PPLATILIPPHAR  349 (350)
T ss_dssp             GGGHHHHSCTTTT
T ss_pred             ccccccCCCcccc
Confidence            4555667776654

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-57  Score=419.65  Aligned_cols=260  Identities=34%  Similarity=0.594  Sum_probs=212.3

Q ss_pred             eeceecccCceEEEEEEECCCCcEEEEEEccccc---------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           86 AEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        86 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      .+++||+|+||+||+|+++.+|+.||||++....         ....+|+.+|+.++|||||++++++..     ..++|
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-----~~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-----KSNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-----TTCCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-----CCcee
Confidence            4678999999999999999999999999985322         234589999999999999999999843     33488


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce------------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS------------  224 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~------------  224 (403)
                      +|||||.+++...+   ......+++..++.++.||+.||+|||+ +||+||||||+|||++.++.++            
T Consensus        77 ivmE~~~~~~~~~~---~~~~~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~  152 (299)
T d1ua2a_          77 LVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS  152 (299)
T ss_dssp             EEEECCSEEHHHHH---TTCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred             ehhhhhcchHHhhh---hhcccCCCHHHHHHHHHHHHHHHHHhhc-cceecccCCcceEEecCCCccccccCccccccCC
Confidence            99999997654333   2334678999999999999999999999 8999999999999998776553            


Q ss_pred             -------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          225 -------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       225 -------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                             .+||+.|+|||++.+...|+.++|||||||++|||++|.+||.+.++.+++..+.+.++.|..+.+.......
T Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~  232 (299)
T d1ua2a_         153 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP  232 (299)
T ss_dssp             CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred             CcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence                   3479999999999776678999999999999999999999999999999999999999998877654433322


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                      ....+......++... ...+++++.+||.+||++||++||||.|+|+||||++...|
T Consensus       233 ~~~~~~~~~~~~~~~~-~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p  289 (299)
T d1ua2a_         233 DYVTFKSFPGIPLHHI-FSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  289 (299)
T ss_dssp             TCCCCCCCCCCCHHHH-CTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             hhhhhccCCCCChHHh-cccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence            2223333333333332 24679999999999999999999999999999999876544

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-56  Score=408.50  Aligned_cols=230  Identities=30%  Similarity=0.505  Sum_probs=196.7

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      .+|++.+.||+|+||+||+|+++.+++.||+|++.+.       .....+|+++++.++|||||++++++.     +...
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~   80 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DATR   80 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-----ECCE
Confidence            4699999999999999999999999999999998532       123457999999999999999999984     3445


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee--------
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY--------  225 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~--------  225 (403)
                      +|+|||||+ ++|..++..    ...+++..++.++.||+.||+|||+ +|||||||||+|||++.++.+++        
T Consensus        81 ~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~-~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~  155 (263)
T d2j4za1          81 VYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAGELKIADFGWSVH  155 (263)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred             EEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeeeeccccceecCCCCEeecccceeee
Confidence            899999998 577766654    3679999999999999999999999 89999999999999987766543        


Q ss_pred             ---------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          226 ---------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       226 ---------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                               .||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+..+.+.               
T Consensus       156 ~~~~~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~---------------  219 (263)
T d2j4za1         156 APSSRRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------  219 (263)
T ss_dssp             CCCCCCEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT---------------
T ss_pred             cCCCcccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC---------------
Confidence                     479999999999764 5899999999999999999999999988877666655431               


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                        ...            ++..+++++++||.+||+.||++|||++|+|+||||+.
T Consensus       220 --~~~------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         220 --EFT------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             --CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             --CCC------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence              111            22458999999999999999999999999999999975

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-56  Score=412.01  Aligned_cols=232  Identities=25%  Similarity=0.384  Sum_probs=196.5

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++....    ....+|+++|+.++|||||+++++|..     ..++|+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----CCEEEE
Confidence            35999999999999999999999999999999985332    335689999999999999999999854     335899


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce------------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS------------  224 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~------------  224 (403)
                      |||||+ ++|..+..     ...+++..++.++.||+.||.|||+ +|||||||||+|||++.++.++            
T Consensus        95 vmEy~~gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~  168 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (293)
T ss_dssp             EEECCTTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEecCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence            999998 47765543     2579999999999999999999999 8999999999999998776553            


Q ss_pred             -------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          225 -------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       225 -------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                             .+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..+..... +.           
T Consensus       169 ~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~-----------  235 (293)
T d1yhwa1         169 EQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PE-----------  235 (293)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CC-----------
T ss_pred             ccccccccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CC-----------
Confidence                   3479999999999654 589999999999999999999999998887777766654311 10           


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                          +          ..+..+++++++||.+||+.||++|||++|+|+||||+.
T Consensus       236 ----~----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         236 ----L----------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             ----C----------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             ----C----------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence                0          012458999999999999999999999999999999975

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-55  Score=410.58  Aligned_cols=265  Identities=35%  Similarity=0.653  Sum_probs=215.7

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      ++|++++.||+|+||+||+|+++.+|+.||||++...      .....+|+++|++++|||||++++++..     ...+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-----~~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-----ccce
Confidence            3599999999999999999999999999999998532      2234589999999999999999999844     3458


Q ss_pred             EEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-----------
Q 015672          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-----------  224 (403)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-----------  224 (403)
                      |+|||||.+++..++...  ....+++..++.++.||+.||+|||+ +|||||||||+|||++.++.++           
T Consensus        77 ~iv~e~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~-~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~  153 (298)
T d1gz8a_          77 YLVFEFLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG  153 (298)
T ss_dssp             EEEEECCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred             eEEEeecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhc-CCEEccccCchheeecccCcceeccCCcceecc
Confidence            999999998766554432  24679999999999999999999999 8999999999999998776543           


Q ss_pred             --------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          225 --------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       225 --------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                              .+||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+....+......
T Consensus       154 ~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (298)
T d1gz8a_         154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM  233 (298)
T ss_dssp             CCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             CCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence                    357899999999877777799999999999999999999999999999999999998888776554322111


Q ss_pred             c-cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          297 Y-TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       297 ~-~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                      . ....++.....++.. ....+++++++||.+||+.||++|||+.|+|+||||+++.+|
T Consensus       234 ~~~~~~~~~~~~~~~~~-~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         234 PDYKPSFPKWARQDFSK-VVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             TTCCTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             cccccccccccccchhh-hccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            0 111222222222222 224688999999999999999999999999999999998765

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-55  Score=409.21  Aligned_cols=270  Identities=30%  Similarity=0.551  Sum_probs=217.4

Q ss_pred             cccccEeeeceecccCceEEEEEEECCC-CcEEEEEEcccc------cccHHHHHHHHHhc---CCCCccccceEEeecC
Q 015672           79 KQKVSYIAEHVVGTGSFGVVFQAKCRET-GEIVAIKKVLQD------KRYKNRELQIMQML---DHPNIVALKHCFFSTT  148 (403)
Q Consensus        79 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vaiK~~~~~------~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~  148 (403)
                      +...+|++++.||+|+||+||+|++..+ ++.||||++...      .....+|+.+|+.|   +||||++++++|....
T Consensus         4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence            3456799999999999999999999766 567999998532      22345788888776   7999999999987665


Q ss_pred             CCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce----
Q 015672          149 DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS----  224 (403)
Q Consensus       149 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~----  224 (403)
                      .....+++++||||.+++..+...  .....+++..++.++.||+.||+|||+ +|||||||||+|||++..+..+    
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cccCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecCCCccEEEEcCCCCeeecch
Confidence            566778999999999876544433  224678999999999999999999999 8999999999999998776543    


Q ss_pred             --------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          225 --------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       225 --------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                    ..||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+++..+.+.++.+....+
T Consensus       161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         161 GLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  239 (305)
T ss_dssp             CSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             hhhhhhcccccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence                          3579999999999764 5999999999999999999999999999999999999999998887665


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCC
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRD  354 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  354 (403)
                      ....... ...+......++. .+...+++.+++||.+||++||++||||.|+|+||||+++..
T Consensus       240 ~~~~~~~-~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         240 PRDVALP-RQAFHSKSAQPIE-KFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             CTTCSSC-GGGSCCCCCCCGG-GTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cccccch-hhhhccccccchh-hccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence            4322111 1111111222222 234578999999999999999999999999999999998753

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-56  Score=409.47  Aligned_cols=235  Identities=27%  Similarity=0.343  Sum_probs=192.2

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-----cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      ..+|++.+.||+|+||+||+|+++.+|+.||||++...     .....+|+++|+.++|||||++++++..     ...+
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-----~~~~   78 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ   78 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----Ccee
Confidence            34699999999999999999999999999999998543     2345689999999999999999999844     3458


Q ss_pred             EEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce----------
Q 015672          156 NLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS----------  224 (403)
Q Consensus       156 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~----------  224 (403)
                      |||||||++ +|.+++.    ....+++..++.++.||+.||+|||+ +|||||||||+|||++.++.++          
T Consensus        79 ~ivmEy~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~-~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~  153 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVF  153 (271)
T ss_dssp             EEEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccCcccHHHEEECCCCCEEEccchhheee
Confidence            999999984 6654432    24679999999999999999999999 8999999999999998766543          


Q ss_pred             -----------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015672          225 -----------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       225 -----------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  293 (403)
                                 .+||+.|||||++.+...++.++|||||||++|||++|++||...+...............        
T Consensus       154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~--------  225 (271)
T d1nvra_         154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------  225 (271)
T ss_dssp             EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT--------
T ss_pred             ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------
Confidence                       3579999999999776656789999999999999999999998765443333222210000        


Q ss_pred             CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                                   ..+     ...+++++.+||.+||+.||++|||++|+|+||||++
T Consensus       226 -------------~~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         226 -------------LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             -------------STT-----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             -------------CCc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence                         001     1457899999999999999999999999999999975

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-55  Score=408.26  Aligned_cols=233  Identities=30%  Similarity=0.508  Sum_probs=198.1

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      .+|++.+.||+|+||+||+|+++.+++.||||++.+.       .....+|+++|++++|||||+++++|.     +...
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~   82 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DDEK   82 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE-----CSSE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE-----ECCE
Confidence            4699999999999999999999999999999998532       123468999999999999999999883     3445


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce---------
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS---------  224 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~---------  224 (403)
                      +|+|||||+ ++|.+++..    .+.+++..++.++.||+.||+|||+ +|||||||||+|||++.++.++         
T Consensus        83 ~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~  157 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKV  157 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcc-ccEEcCcCCccccccCCCceEEeccccccee
Confidence            899999998 477665543    4679999999999999999999999 8999999999999998776542         


Q ss_pred             ------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh
Q 015672          225 ------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC  292 (403)
Q Consensus       225 ------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  292 (403)
                                  .+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+..+.+.           
T Consensus       158 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-----------  225 (288)
T d1uu3a_         158 LSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-----------  225 (288)
T ss_dssp             CC----------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT-----------
T ss_pred             cccCCcccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC-----------
Confidence                        3589999999999765 5899999999999999999999999988877776666531           


Q ss_pred             cCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHH------HhcCCCcccCCC
Q 015672          293 MNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALE------ACVHPFFDELRD  354 (403)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e------~l~hp~f~~~~~  354 (403)
                            ...            ++..+++++++||.+||+.||++|||++|      +++||||+++..
T Consensus       226 ------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w  275 (288)
T d1uu3a_         226 ------EYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW  275 (288)
T ss_dssp             ------CCC------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred             ------CCC------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCH
Confidence                  111            22468999999999999999999999987      588999998854

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-55  Score=402.77  Aligned_cols=235  Identities=25%  Similarity=0.395  Sum_probs=192.4

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++....      ....+|+++|++++|||||++++++...   ....+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~~   80 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTTL   80 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCEE
Confidence            56999999999999999999999999999999985432      2245799999999999999999988532   23347


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC-----ccccccccccceecCCCCce-----
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG-----ICHRDIKPQNLLVKGEPNVS-----  224 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~-----ivHrDlKp~NILl~~~~~~~-----  224 (403)
                      |+|||||+ |+|.+++.........+++..++.++.||+.||+|||+ .|     ||||||||+||||+.++.++     
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG  159 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  159 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-HCC---------CCGGGEEECTTSCEEECCHH
T ss_pred             EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-hcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence            89999998 58888887666666789999999999999999999998 55     99999999999999877654     


Q ss_pred             --------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH
Q 015672          225 --------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       225 --------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  290 (403)
                                    .+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+..+....+...-        
T Consensus       160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~--------  230 (269)
T d2java1         160 LARILNHDTSFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK--------  230 (269)
T ss_dssp             HHHHC-----------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--------
T ss_pred             ceeecccCCCccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--------
Confidence                          3479999999999654 58999999999999999999999999888776666554420        


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCc
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFF  349 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  349 (403)
                                 ++         .++..+|+++.+||.+||+.||++|||++|+|+|||+
T Consensus       231 -----------~~---------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         231 -----------FR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             -----------CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             -----------CC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                       00         0224689999999999999999999999999999995

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-55  Score=405.08  Aligned_cols=235  Identities=25%  Similarity=0.386  Sum_probs=197.0

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc----cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      ..|++++.||+|+||+||+|+++.+++.||||++...    .....+|+++|+.++|||||++++++..     ...+++
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCeEEE
Confidence            3599999999999999999999999999999998542    2345689999999999999999999844     334889


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      |||||+ ++|..++...   ...+++..++.++.||+.||.|||+ +|||||||||+|||++.++.+++           
T Consensus        87 vmEy~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~-~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             EEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred             EEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence            999998 5676654432   3579999999999999999999999 89999999999999998776533           


Q ss_pred             --------eccccccchhhhhC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015672          226 --------ICSRYYRAPELIFG----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~----~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  293 (403)
                              .||+.|+|||++..    ...|+.++|||||||++|||++|++||.+.+..+.+..+..... +        
T Consensus       163 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~-~--------  233 (288)
T d2jfla1         163 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP-P--------  233 (288)
T ss_dssp             HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC-C--------
T ss_pred             CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-C--------
Confidence                    47999999999842    34589999999999999999999999998887777766654210 0        


Q ss_pred             CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                                .       ...+..+++++++||.+||+.||++|||++|+|+||||+.
T Consensus       234 ----------~-------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         234 ----------T-------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             ----------C-------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             ----------C-------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                      0       0012468999999999999999999999999999999974

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=397.68  Aligned_cols=233  Identities=24%  Similarity=0.372  Sum_probs=191.8

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      |.+.++||+|+||+||+|+++.+++.||+|++....      ....+|+++|++++|||||++++++.... .+...+|+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEE
Confidence            578889999999999999999999999999985432      23458999999999999999999875433 34566899


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--ccccccccccceecC-CCCce---------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIG--ICHRDIKPQNLLVKG-EPNVS---------  224 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~--ivHrDlKp~NILl~~-~~~~~---------  224 (403)
                      |||||+ ++|.+++..    ...+++..++.++.||+.||+|||+ ++  ||||||||+|||++. ++.++         
T Consensus        90 vmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHH-CCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            999998 577776654    3679999999999999999999998 78  999999999999964 44442         


Q ss_pred             --------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          225 --------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       225 --------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                              .+||+.|||||++.+  .|+.++|||||||++|||++|+.||.+......+...+.. +.++          
T Consensus       165 ~~~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~----------  231 (270)
T d1t4ha_         165 KRASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKP----------  231 (270)
T ss_dssp             CCTTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCC----------
T ss_pred             ccCCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCC----------
Confidence                    358999999999854  4899999999999999999999999877666554433321 1110          


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  350 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~  350 (403)
                                     ..++...++++++||.+||+.||++|||++|+|+||||+
T Consensus       232 ---------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         232 ---------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             ---------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             ---------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                           112356789999999999999999999999999999996

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.9e-55  Score=408.74  Aligned_cols=234  Identities=25%  Similarity=0.384  Sum_probs=195.6

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc-------cHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-------YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ..|++++.||+|+||+||+|+++.+++.||||++.....       ...+|+++|+.++|||||++++++..     ..+
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~   89 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT   89 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCE
Confidence            349999999999999999999999999999999864321       23579999999999999999999844     334


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce----------
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS----------  224 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~----------  224 (403)
                      +|+|||||.++......   .....+++..++.++.||+.||.|||+ +|||||||||+||||+.++.++          
T Consensus        90 ~~iv~E~~~~g~l~~~~---~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~  165 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (309)
T ss_dssp             EEEEEECCSEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred             EEEEEEecCCCchHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEECCCCCEEEeeccccccc
Confidence            89999999965533322   224679999999999999999999999 8999999999999998776553          


Q ss_pred             -----eeccccccchhhhhC--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          225 -----YICSRYYRAPELIFG--ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       225 -----~~~t~~y~aPE~~~~--~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                           ..||+.|||||++.+  ...|+.++|||||||++|||++|..||.+.+..+.+..+......             
T Consensus       166 ~~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~-------------  232 (309)
T d1u5ra_         166 APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP-------------  232 (309)
T ss_dssp             SSBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-------------
T ss_pred             CCCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-------------
Confidence                 358999999999854  235899999999999999999999999988877777666542100             


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                            .        ..+..+|+++++||.+||+.||++|||++|+|+||||..
T Consensus       233 ------~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         233 ------A--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             ------C--------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             ------C--------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence                  0        012457899999999999999999999999999999976

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-54  Score=402.29  Aligned_cols=236  Identities=22%  Similarity=0.364  Sum_probs=198.0

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc----------cccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      +.|++.+.||+|+||+||+|+++.+|+.||||++.+.          .....+|+.+|++++|||||+++++|.     +
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~   84 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE-----N   84 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----E
Confidence            4599999999999999999999999999999998532          123468999999999999999999983     3


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC----c---
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN----V---  223 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~----~---  223 (403)
                      ..++|||||||+ ++|.+++..    ...+++..++.++.||+.||+|||+ +|||||||||+|||++.++.    +   
T Consensus        85 ~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~-~~ivHrDiKp~Nill~~~~~~~~~vkl~  159 (293)
T d1jksa_          85 KTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKII  159 (293)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred             CCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhh-cceeecccccceEEEecCCCcccceEec
Confidence            455899999998 588777654    3579999999999999999999999 89999999999999976542    2   


Q ss_pred             ---------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015672          224 ---------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  288 (403)
Q Consensus       224 ---------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~  288 (403)
                                     ...||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+...-...+  
T Consensus       160 DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~--  236 (293)
T d1jksa_         160 DFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE--  236 (293)
T ss_dssp             CCTTCEECTTSCBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC--
T ss_pred             chhhhhhcCCCccccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--
Confidence                           23478899999999654 589999999999999999999999999888777766654311111  


Q ss_pred             HHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                                             ...+..+|+++++||.+||+.||++|||++|+|+||||+...
T Consensus       237 -----------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  278 (293)
T d1jksa_         237 -----------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  278 (293)
T ss_dssp             -----------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred             -----------------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                                   112356899999999999999999999999999999998754

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-54  Score=405.96  Aligned_cols=234  Identities=28%  Similarity=0.440  Sum_probs=191.8

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +.|++.+.||+|+||+||+|+++.+++.||||++....     ....+|+.+|+.++|||||++++++.     +..++|
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~~~   83 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE-----SGGHLY   83 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEE
Confidence            45999999999999999999999999999999986432     23347999999999999999999883     344589


Q ss_pred             EEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecC---CCCc---------
Q 015672          157 LVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKG---EPNV---------  223 (403)
Q Consensus       157 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~---~~~~---------  223 (403)
                      ||||||+ ++|.+++..    ...+++..++.++.||+.||+|||+ +|||||||||+|||+..   ++.+         
T Consensus        84 lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_          84 LIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             EEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             EEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhh-ceeeeEEecccceeecccCCCceEEEeccceeE
Confidence            9999998 688776653    4679999999999999999999999 89999999999999953   3333         


Q ss_pred             ---------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          224 ---------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       224 ---------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                               ..+||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..+....+.+....          
T Consensus       159 ~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~----------  227 (307)
T d1a06a_         159 MEDPGSVLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE----------  227 (307)
T ss_dssp             --------------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCC----------
T ss_pred             EccCCCeeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC----------
Confidence                     23589999999999654 5899999999999999999999999988877766666542111          


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                             ++        ......+|+++.+||.+||+.||++|||++|+++||||++
T Consensus       228 -------~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         228 -------FD--------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             -------CC--------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             -------CC--------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence                   10        0122568999999999999999999999999999999976

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-54  Score=405.61  Aligned_cols=232  Identities=27%  Similarity=0.430  Sum_probs=198.5

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      .+|++++.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.+|+.++||||++++++|     .+..+
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~~   79 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSSE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----ccccc
Confidence            4699999999999999999999999999999998542       12345799999999999999999998     34456


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce---------
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS---------  224 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~---------  224 (403)
                      +|+|||||+ |+|..++..    ...+++..++.++.||+.||+|||+ +|||||||||+|||++.++.++         
T Consensus        80 ~~iv~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~  154 (337)
T d1o6la_          80 LCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             cccceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhh-cCccccccCHHHeEecCCCCEEEeecccccc
Confidence            999999998 566555543    4679999999999999999999999 8999999999999998776553         


Q ss_pred             ----------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          225 ----------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       225 ----------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                .+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..+...             
T Consensus       155 ~~~~~~~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~-------------  220 (337)
T d1o6la_         155 GISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-------------  220 (337)
T ss_dssp             SCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------
T ss_pred             cccCCcccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC-------------
Confidence                      4589999999999665 5899999999999999999999999998877766665542             


Q ss_pred             cCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCC
Q 015672          295 PNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  353 (403)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~  353 (403)
                          ...            ++..+|+++++||.+||++||.+|+     ++.|+++||||+++.
T Consensus       221 ----~~~------------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~  268 (337)
T d1o6la_         221 ----EIR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             ----CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             ----CCC------------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCC
Confidence                111            2356899999999999999999999     499999999998874

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=6.4e-54  Score=398.03  Aligned_cols=259  Identities=35%  Similarity=0.655  Sum_probs=211.9

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      ++|++.++||+|+||+||+|+++ +|+.||||++....      ....+|+.+|++++|||||++++++....     ..
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-----RL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-----CE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC-----ce
Confidence            35999999999999999999985 78999999985432      23468999999999999999999985433     38


Q ss_pred             EEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee----------
Q 015672          156 NLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY----------  225 (403)
Q Consensus       156 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~----------  225 (403)
                      +++|||+.+++...+.   .....+++..++.++.||+.||+|||+ .|||||||||+|||++.++.++.          
T Consensus        76 ~i~~e~~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~  151 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINREGELKIADFGLARAFG  151 (286)
T ss_dssp             EEEEECCSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred             eEEEEeehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhcc-CcEEecCCCCceeeEcCCCCEEecccccceecc
Confidence            8999999987654443   234779999999999999999999999 89999999999999988776643          


Q ss_pred             ---------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          226 ---------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       226 ---------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                               ++|+.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++..+.+.++.+....+......
T Consensus       152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (286)
T d1ob3a_         152 IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL  231 (286)
T ss_dssp             C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             cCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence                     36888999999987777899999999999999999999999999999999999998888876655432211


Q ss_pred             cc-ccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          297 YT-EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       297 ~~-~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                      .. ...+......++.. ....+++++.|||.+||++||++|||+.|+|+||||++
T Consensus       232 ~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         232 PKYDPNFTVYEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TTCCTTCCCCCCCCGGG-TCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hhcccccccccCcchhh-hcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            10 11122222233322 33678999999999999999999999999999999985

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-54  Score=407.97  Aligned_cols=270  Identities=33%  Similarity=0.615  Sum_probs=214.9

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCC-CCce
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEEL  153 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~  153 (403)
                      ...|++++.||+|+||+||+|+++.+|+.||||++....      ....+|+++|+.++|||||+++++|..... ....
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            456999999999999999999999999999999986432      123579999999999999999999854332 2334


Q ss_pred             EEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce---------
Q 015672          154 YLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS---------  224 (403)
Q Consensus       154 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~---------  224 (403)
                      ++|+|||||+.++..+..     ...+++..++.++.||+.||.|||+ +|||||||||+|||++.++.++         
T Consensus        97 ~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~-~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECCSEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecccccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCcchhhcccccccccccccceec
Confidence            578999999887766554     3679999999999999999999999 8999999999999998776553         


Q ss_pred             -------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          225 -------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       225 -------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                             .+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.++.+.+.......
T Consensus       171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (346)
T d1cm8a_         171 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE  250 (346)
T ss_dssp             CCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred             cCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence                   3579999999999877778999999999999999999999999999999999999999999887765433211


Q ss_pred             c---ccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCC
Q 015672          298 T---EFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  357 (403)
Q Consensus       298 ~---~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~  357 (403)
                      .   ...++.....++... ...+++++.|||.+||++||++||||.|+|+||||+++.++..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~  312 (346)
T d1cm8a_         251 AKNYMKGLPELEKKDFASI-LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED  312 (346)
T ss_dssp             HHHHHHHSCCCCCCCGGGT-CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred             hhhhhccCCcccccchHHh-ccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccc
Confidence            0   112333333444332 2568999999999999999999999999999999999876543

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.9e-54  Score=410.16  Aligned_cols=240  Identities=25%  Similarity=0.390  Sum_probs=200.3

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++....    ....+|+.+|+.++|||||++++++..     ..++||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~i  100 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMVM  100 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence            46999999999999999999999999999999986432    234579999999999999999998843     345899


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCC--CCc-----------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE--PNV-----------  223 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~--~~~-----------  223 (403)
                      |||||+ ++|.+++..   ....+++..++.++.||+.||.|||+ +|||||||||+|||++.+  +.+           
T Consensus       101 vmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         101 IYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             EECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            999998 577655432   24579999999999999999999999 899999999999999643  333           


Q ss_pred             -------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          224 -------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       224 -------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                             ...||+.|||||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+..+.......+.         
T Consensus       177 ~~~~~~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~---------  246 (350)
T d1koaa2         177 DPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD---------  246 (350)
T ss_dssp             CTTSCEEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC---------
T ss_pred             ccccccceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc---------
Confidence                   23579999999999765 5899999999999999999999999998888887777653211110         


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCC
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  356 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~  356 (403)
                                      .....+|+++++||.+||+.||++|||++|+|+||||+....+.
T Consensus       247 ----------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~  290 (350)
T d1koaa2         247 ----------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  290 (350)
T ss_dssp             ----------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCS
T ss_pred             ----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCC
Confidence                            11245899999999999999999999999999999999876543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-55  Score=410.16  Aligned_cols=263  Identities=24%  Similarity=0.393  Sum_probs=193.8

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++..+.     ....+|+.+|+.++|||||+++++|..     ..++
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~~   79 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI   79 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-----SSEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEE
Confidence            356999999999999999999999999999999986432     234579999999999999999999843     3458


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce----------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS----------  224 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~----------  224 (403)
                      |+|||||+ ++|..++..    .+.+++..++.++.||+.||.|||+.+||+||||||+||||+.++.++          
T Consensus        80 ~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             EEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence            99999998 478776654    357999999999999999999999624899999999999998877654          


Q ss_pred             -------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCHHHHhhcCc-
Q 015672          225 -------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMNP-  295 (403)
Q Consensus       225 -------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~-  295 (403)
                             .+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+. ...+....+.+.......... 
T Consensus       156 ~~~~~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         156 IDSMANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             HHHTC---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             CCCccccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence                   4589999999999765 599999999999999999999999987664432 222222222211110000000 


Q ss_pred             ----CccccCCCCC---------CCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          296 ----NYTEFKFPQI---------KPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       296 ----~~~~~~~~~~---------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                          .+.....+..         ...+........+|.+++|||.+||++||++||||+|+|+||||++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence                0000000000         000000111134689999999999999999999999999999998753

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.7e-54  Score=408.99  Aligned_cols=237  Identities=25%  Similarity=0.386  Sum_probs=197.5

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      ..|++.+.||+|+||+||+|+++.+|+.||||++....    ....+|+.+|++|+|||||+++++|.     +..++||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~i  103 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMVL  103 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence            45999999999999999999999999999999986432    23457999999999999999999983     3455899


Q ss_pred             EeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecC--CCCce----------
Q 015672          158 VLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKG--EPNVS----------  224 (403)
Q Consensus       158 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~--~~~~~----------  224 (403)
                      |||||+ ++|.+.+   ......+++..++.++.||+.||.|||+ +|||||||||+||||+.  ++.++          
T Consensus       104 vmE~~~gg~L~~~~---~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~  179 (352)
T d1koba_         104 ILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL  179 (352)
T ss_dssp             EEECCCCCBHHHHT---TCTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEEcCCCChHHHHH---HhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccccccccccccCCCeEEEeecccceec
Confidence            999998 5664432   2234569999999999999999999999 89999999999999973  33332          


Q ss_pred             --------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          225 --------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       225 --------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                              ..||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..+.+....++          
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~----------  248 (352)
T d1koba_         180 NPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD----------  248 (352)
T ss_dssp             CTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC----------
T ss_pred             CCCCceeeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----------
Confidence                    3478999999999654 599999999999999999999999999888887777765321111          


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                                     ......+++++++||.+||+.||.+|||+.|+|+||||++..
T Consensus       249 ---------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         249 ---------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             ---------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             ---------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence                           011246899999999999999999999999999999998753

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-53  Score=400.48  Aligned_cols=233  Identities=26%  Similarity=0.476  Sum_probs=198.1

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      .+|++++.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.+|+.++|||||++++++.     +..+
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe-----eCCe
Confidence            4699999999999999999999999999999998532       123458999999999999999999984     3446


Q ss_pred             EEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce---------
Q 015672          155 LNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS---------  224 (403)
Q Consensus       155 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~---------  224 (403)
                      +|+|||||.+ ++..++..    ...+++..++.++.||+.||.|||+ +|||||||||+||||+.++.++         
T Consensus        79 ~~ivmE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~  153 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNGHIKITDFGFAKY  153 (316)
T ss_dssp             EEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             eeeEeeecCCccccccccc----cccccccHHHHHHHHHHHhhhhhcc-CcEEccccCchheeEcCCCCEEEecCccceE
Confidence            8999999985 55444433    4678899999999999999999999 8999999999999999877664         


Q ss_pred             -------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          225 -------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       225 -------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                             .+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+..+...                
T Consensus       154 ~~~~~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~----------------  216 (316)
T d1fota_         154 VPDVTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA----------------  216 (316)
T ss_dssp             CSSCBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC----------------
T ss_pred             eccccccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC----------------
Confidence                   3589999999999654 5899999999999999999999999998877777766542                


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCCC
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  354 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~~  354 (403)
                       ...            ++..+++++.+||.+||+.||.+|+     |++++++||||+++..
T Consensus       217 -~~~------------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~  265 (316)
T d1fota_         217 -ELR------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW  265 (316)
T ss_dssp             -CCC------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             -CCC------------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence             111            2246899999999999999999996     9999999999998753

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5.9e-53  Score=388.72  Aligned_cols=236  Identities=27%  Similarity=0.405  Sum_probs=198.3

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------------ccHHHHHHHHHhcC-CCCccccceEEeec
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------------RYKNRELQIMQMLD-HPNIVALKHCFFST  147 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~E~~~l~~l~-h~niv~~~~~~~~~  147 (403)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++.+..             ....+|+.+|++++ ||||+++++++.  
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--   80 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE--   80 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE--
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc--
Confidence            46999999999999999999999999999999985432             12447999999997 999999999983  


Q ss_pred             CCCCceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--
Q 015672          148 TDKEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--  224 (403)
Q Consensus       148 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--  224 (403)
                         +..++|||||||+ ++|.+++..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.++  
T Consensus        81 ---~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~~~kl~  152 (277)
T d1phka_          81 ---TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDMNIKLT  152 (277)
T ss_dssp             ---CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEEC
T ss_pred             ---cCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEcCCCCeEEc
Confidence               4456899999997 588777754    4679999999999999999999999 8999999999999998776553  


Q ss_pred             ----------------eeccccccchhhhhC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 015672          225 ----------------YICSRYYRAPELIFG-----ATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG  283 (403)
Q Consensus       225 ----------------~~~t~~y~aPE~~~~-----~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~  283 (403)
                                      ..||+.|+|||++.+     ...++.++||||+||++|+|++|+.||.+.+..+....+...-.
T Consensus       153 DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~  232 (277)
T d1phka_         153 DFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY  232 (277)
T ss_dssp             CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             cchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCC
Confidence                            347899999999852     34578899999999999999999999999887777766655211


Q ss_pred             CCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          284 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                      .                 ++        ......+|+++++||.+||+.||++|||++|+|+||||++.
T Consensus       233 ~-----------------~~--------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         233 Q-----------------FG--------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             C-----------------CC--------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             C-----------------CC--------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            1                 00        00124689999999999999999999999999999999863

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.1e-53  Score=401.78  Aligned_cols=233  Identities=25%  Similarity=0.405  Sum_probs=197.9

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc-------cccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-------KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.+|+.++|||||++++++.     ....
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~  115 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DNSN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc-----cccc
Confidence            4699999999999999999999999999999998532       123458999999999999999999883     3445


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee--------
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY--------  225 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~--------  225 (403)
                      +++||||+. +++...+..    ...+++..++.++.||+.||.|||+ +|||||||||+||||+.++.+++        
T Consensus       116 ~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~  190 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR  190 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             cccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCcCCHHHcccCCCCCEEeeeceeeee
Confidence            889999998 466555443    3579999999999999999999999 89999999999999988776643        


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                              .||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+....+..+....               
T Consensus       191 ~~~~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~---------------  254 (350)
T d1rdqe_         191 VKGRTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK---------------  254 (350)
T ss_dssp             CSSCBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------------
T ss_pred             cccccccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC---------------
Confidence                    479999999999764 58999999999999999999999999888777776665421               


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCCC
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELRD  354 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~~  354 (403)
                        ..            ++..+++++.+||.+||+.||.+|+     |++++++||||+++.+
T Consensus       255 --~~------------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~  302 (350)
T d1rdqe_         255 --VR------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             --CC------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             --CC------------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence              00            1246899999999999999999995     9999999999998753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.1e-53  Score=405.35  Aligned_cols=236  Identities=25%  Similarity=0.383  Sum_probs=191.4

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHH---HHHHHHhcCCCCccccceEEeecCCCC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNR---ELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      ++|++.++||+|+||+||+|+++.+|+.||||++.+..       ....+   |+++++.++|||||+++++|.     .
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~-----~   78 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----T   78 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-----C
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE-----E
Confidence            45999999999999999999999999999999985321       11223   466677778999999999884     3


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce------
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS------  224 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~------  224 (403)
                      ...+|+|||||+ ++|..++..    ...+++..++.++.||+.||.|||+ +|||||||||+|||++.++.++      
T Consensus        79 ~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~-~~iiHrDlKP~NILl~~~g~iKl~DFGl  153 (364)
T d1omwa3          79 PDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGL  153 (364)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSSSCEEECCCTT
T ss_pred             CCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHH-CCccceeeccceeEEcCCCcEEEeeece
Confidence            345899999998 677776654    4678999999999999999999999 8999999999999998776654      


Q ss_pred             -----------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015672          225 -----------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       225 -----------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  293 (403)
                                 .+||+.|+|||++.....|+.++|||||||++|||+||+.||.+.+..+... +.+......       
T Consensus       154 a~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~~-------  225 (364)
T d1omwa3         154 ACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMA-------  225 (364)
T ss_dssp             CEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSCC-------
T ss_pred             eeecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccCC-------
Confidence                       3489999999999766669999999999999999999999998765433222 222110000       


Q ss_pred             CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCCCcccCC
Q 015672          294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCT-----ALEACVHPFFDELR  353 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-----a~e~l~hp~f~~~~  353 (403)
                                        ..++..+|+++++||.+||+.||++|||     |+|+++||||+++.
T Consensus       226 ------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~  272 (364)
T d1omwa3         226 ------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  272 (364)
T ss_dssp             ------------------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence                              0123568999999999999999999999     89999999999875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-53  Score=400.00  Aligned_cols=235  Identities=26%  Similarity=0.378  Sum_probs=198.0

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc---cHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR---YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      ++|++.+.||+|+||+||+|+++.+++.||||++.....   ...+|+++|+.++|||||+++++|..     ..++|||
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~~lv   79 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES-----MEELVMI   79 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEEEE
Confidence            459999999999999999999999999999999865432   34589999999999999999999843     3458999


Q ss_pred             eeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC--Cc------------
Q 015672          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP--NV------------  223 (403)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~--~~------------  223 (403)
                      ||||++ +|.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++  .+            
T Consensus        80 mE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~-~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          80 FEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             ECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence            999984 77665532   23468999999999999999999999 8999999999999997543  22            


Q ss_pred             ------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          224 ------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       224 ------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                            ...+|+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+.+..+.+..+.+.....+..         
T Consensus       156 ~~~~~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~---------  225 (321)
T d1tkia_         156 PGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE---------  225 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH---------
T ss_pred             cCCcccccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChh---------
Confidence                  23468999999998654 58999999999999999999999999998888877776642222221         


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                                      ....+|+++++||.+||+.||.+|||++|+|+||||++
T Consensus       226 ----------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         226 ----------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             ----------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             ----------------hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence                            12468999999999999999999999999999999976

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-52  Score=395.75  Aligned_cols=268  Identities=31%  Similarity=0.607  Sum_probs=216.5

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc-----cHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      .+|++++.||+|+||+||+|+++.+|+.||||++.+...     ...+|+++|+.++||||+++++++.........+++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            359999999999999999999999999999999864322     234799999999999999999998655544555677


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      ++|++++++|.+++..     ..+++..++.++.||+.||+|||+ +|||||||||+|||++.++.+++           
T Consensus        88 l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~-~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          88 LVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            8888888898887753     579999999999999999999999 89999999999999987765432           


Q ss_pred             -----------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC
Q 015672          226 -----------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN  294 (403)
Q Consensus       226 -----------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  294 (403)
                                 +||+.|+|||++.....++.++||||+||++|+|++|++||.+.+..+....+...+..+.........
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  241 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence                       468899999998666678999999999999999999999999999888888888888887766443211


Q ss_pred             cC---ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCC
Q 015672          295 PN---YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPN  356 (403)
Q Consensus       295 ~~---~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~  356 (403)
                      ..   ......+.....+|...+ ..+++++++||.+||++||.+||||.|+|+||||++...+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~  305 (345)
T d1pmea_         242 NLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS  305 (345)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHC-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             hhhhhcccccCCccCCCCHHHhC-CCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCc
Confidence            10   011123333444444433 46899999999999999999999999999999999876654

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-52  Score=393.57  Aligned_cols=268  Identities=28%  Similarity=0.452  Sum_probs=206.8

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCC---CC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD---KE  151 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~  151 (403)
                      ..+|.+.++||+|+||+||+|+++.+|+.||||++....      ....+|+++|+.++|+||+++++++.....   ..
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            456999999999999999999999999999999985331      234589999999999999999998754321   12


Q ss_pred             ceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce-------
Q 015672          152 ELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS-------  224 (403)
Q Consensus       152 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~-------  224 (403)
                      ..++|+|||||.+.+....   ......+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++       
T Consensus        89 ~~~~~iv~e~~~~~~~~~~---~~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLL---SNVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             --CEEEEEECCCEEHHHHH---TCTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCccchh---hhcccccccHHHHHHHHHHHHHHHHhcc-CCEEecCcCchheeecCCCcEEeeeccee
Confidence            3458999999997664432   2335678999999999999999999999 8999999999999998765442       


Q ss_pred             ----------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015672          225 ----------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE  288 (403)
Q Consensus       225 ----------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~  288 (403)
                                      .+||+.|+|||++.+...|+.++|||||||++|||++|++||.+.++.+.+..+.+.++.+..+
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  244 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence                            3479999999999877679999999999999999999999999999999999999988887765


Q ss_pred             HHhhcCcCccccCC--CCCCCCCccccc-ccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          289 EIKCMNPNYTEFKF--PQIKPHPWHKVF-QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       289 ~~~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                      .+...........+  ......+....+ ....++++.|||.+||++||++||||.|+|+||||+.-
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            44332211111111  111111111111 12347889999999999999999999999999999863

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=394.85  Aligned_cols=232  Identities=28%  Similarity=0.509  Sum_probs=194.8

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHH-hcCCCCccccceEEeecCCCCce
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQ-MLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      .+|++++.||+|+||+||+|+++.+++.||||++.++.       ....+|+.++. .++|||||++++++.     +..
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~-----~~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-----TKE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-----CSS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc-----cCC
Confidence            35999999999999999999999999999999985421       12335666654 689999999999983     344


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------  224 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------  224 (403)
                      ++|||||||+ |+|..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++..+.++        
T Consensus        77 ~~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~-~~iiHrDikp~NiL~~~~~~~kl~DFG~a~  151 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDKDGHIKIADFGMCK  151 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             ceeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCcccceeecCCCceeccccchhh
Confidence            5899999998 577776654    4678999999999999999999999 8999999999999998776553        


Q ss_pred             -----------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhc
Q 015672          225 -----------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM  293 (403)
Q Consensus       225 -----------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  293 (403)
                                 ..||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+..+...  .+        
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~--------  220 (320)
T d1xjda_         152 ENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP--------  220 (320)
T ss_dssp             CCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC--------
T ss_pred             hcccccccccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC--------
Confidence                       3579999999999754 5899999999999999999999999998877766665431  11        


Q ss_pred             CcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHH-HHhcCCCcccCC
Q 015672          294 NPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL-EACVHPFFDELR  353 (403)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~-e~l~hp~f~~~~  353 (403)
                             .            ++..+|+++++||.+||+.||++|||+. ++++||||+++.
T Consensus       221 -------~------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~  262 (320)
T d1xjda_         221 -------F------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  262 (320)
T ss_dssp             -------C------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             -------C------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence                   1            2246899999999999999999999995 899999999874

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-52  Score=386.68  Aligned_cols=264  Identities=33%  Similarity=0.568  Sum_probs=207.8

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  156 (403)
                      +|+++++||+|+||+||+|+++.+++.||||++....      ....+|+.+|+.++||||+++++++.     ...+.+
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-----~~~~~~   77 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKLT   77 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc-----ccccee
Confidence            5999999999999999999999999999999985432      23358999999999999999999884     334588


Q ss_pred             EEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----------
Q 015672          157 LVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----------  225 (403)
Q Consensus       157 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----------  225 (403)
                      ++++++.+.....+.   ...+.+++..++.++.|++.||+|||+ +|||||||||+|||++.++.++.           
T Consensus        78 iv~~~~~~~~l~~~~---~~~~~~~~~~~~~~~~q~~~aL~~lH~-~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~  153 (292)
T d1unla_          78 LVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             EEEECCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEeeecccccccccc---ccccccchhHHHHHHHHHHHHHHHhhc-CCEeeecccCcccccccCCceeeeecchhhcccC
Confidence            999999875533322   235678999999999999999999999 89999999999999987665533           


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLF-PGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                              .+++.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+.+..+....+.+....+......
T Consensus       154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             CCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence                    35788999999977766899999999999999999998875 556666777778887777766544332211


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                      ......+..............+++++.+||.+||++||++||||+|+|+||||+++..|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~~  292 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP  292 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSCC
T ss_pred             ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCCC
Confidence            11111111111112222335689999999999999999999999999999999987543

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-52  Score=397.05  Aligned_cols=269  Identities=34%  Similarity=0.569  Sum_probs=217.4

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccccc------cHHHHHHHHHhcCCCCccccceEEeecCC-CCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKR------YKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  154 (403)
                      .+|++++.||+|+||+||+|+++.+|+.||||++.+...      ...+|+++|+.++|+|||++++++..... .+..+
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            459999999999999999999999999999999864322      23579999999999999999998854332 23334


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      +++++++++++|.+++.     .+++++..++.++.||+.||+|||+ +||+||||||+|||++.++.++.         
T Consensus        98 ~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~-~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             EEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCCccccccccccccccccchhccc
Confidence            55666666678877653     3579999999999999999999999 89999999999999998776543         


Q ss_pred             -------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 015672          226 -------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT  298 (403)
Q Consensus       226 -------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  298 (403)
                             .||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+.+..+.+..+..........
T Consensus       172 ~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  251 (348)
T d2gfsa1         172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  251 (348)
T ss_dssp             TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred             CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence                   4688899999987777789999999999999999999999999999999999999888888766543321110


Q ss_pred             c---cCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCCCC
Q 015672          299 E---FKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDPNT  357 (403)
Q Consensus       299 ~---~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~~~  357 (403)
                      .   ...+......+... ...++++++|||.+||++||++||||.|+|+||||++..++..
T Consensus       252 ~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~  312 (348)
T d2gfsa1         252 RNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD  312 (348)
T ss_dssp             HHHHTTSCCCCCCCHHHH-STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS
T ss_pred             hhhhhhcccCCCcchhhh-cCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCcc
Confidence            0   11222223333322 2468999999999999999999999999999999999876543

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-52  Score=396.33  Aligned_cols=266  Identities=31%  Similarity=0.534  Sum_probs=211.4

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCC-CCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTD-KEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  154 (403)
                      .+|+++++||+|+||+||+|+++.+|+.||||++....      ....+|+.+|+.++|||||+++++|..... ....+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            35999999999999999999999999999999986432      124579999999999999999999854332 24568


Q ss_pred             EEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          155 LNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       155 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      +|+|||||.+++....      ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.++.         
T Consensus        97 ~~iv~Ey~~~~l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~-~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          97 VYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEECCSEEHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEeccchHHHHhh------hcCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCccccccccccceeeechhhhhcc
Confidence            9999999998765433      3578999999999999999999999 89999999999999987765532         


Q ss_pred             ---------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          226 ---------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       226 ---------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                               ++|+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+.......+...++.+..+.+......
T Consensus       170 ~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  248 (355)
T d2b1pa1         170 GTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_dssp             -----------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred             ccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence                     478999999999764 5899999999999999999999999999999999999999999888877544322


Q ss_pred             cccc--CCCCCCCCCccc-----------ccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCCCC
Q 015672          297 YTEF--KFPQIKPHPWHK-----------VFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELRDP  355 (403)
Q Consensus       297 ~~~~--~~~~~~~~~~~~-----------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  355 (403)
                      ...+  ..+......+..           ......++++.+||++||++||++||||+|+|+||||++..++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~  320 (355)
T d2b1pa1         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP  320 (355)
T ss_dssp             HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred             HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCc
Confidence            1111  001111111111           1112346789999999999999999999999999999986543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=386.72  Aligned_cols=227  Identities=23%  Similarity=0.367  Sum_probs=187.6

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc----------ccHHHHHHHHHhcC--CCCccccceEEeecCC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------RYKNRELQIMQMLD--HPNIVALKHCFFSTTD  149 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~  149 (403)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++.+..          ....+|+.+|++++  |||||++++++.    
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~----   79 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE----   79 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE----
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe----
Confidence            45999999999999999999999999999999985421          22358999999997  899999999884    


Q ss_pred             CCceEEEEEeeccCC--cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCC-CCc---
Q 015672          150 KEELYLNLVLEYVPE--TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE-PNV---  223 (403)
Q Consensus       150 ~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~-~~~---  223 (403)
                       +...+++||||+.+  ++..++..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.+ +.+   
T Consensus        80 -~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NIll~~~~~~vkl~  153 (273)
T d1xwsa_          80 -RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLI  153 (273)
T ss_dssp             -CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             -eCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCcccceEEecCCCeEEEC
Confidence             33458899999974  55444443    4679999999999999999999999 899999999999999754 333   


Q ss_pred             --------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          224 --------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       224 --------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                    ...||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+      .+.+.        
T Consensus       154 DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~--------  219 (273)
T d1xwsa_         154 DFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG--------  219 (273)
T ss_dssp             CCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC--------
T ss_pred             ccccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc--------
Confidence                          23579999999999776666788999999999999999999997532      12211        


Q ss_pred             HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                               ...            ++..+|+++++||.+||+.||++|||++|+|+||||+++.
T Consensus       220 ---------~~~------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         220 ---------QVF------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             ---------CCC------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ---------ccC------------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence                     000            2356899999999999999999999999999999998864

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2e-51  Score=388.59  Aligned_cols=262  Identities=30%  Similarity=0.512  Sum_probs=202.3

Q ss_pred             cccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-ccHHHHHHHHHhcC-CCCccccceEEeecCCCCceEEEEE
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      .++|+++++||+|+||+||+|+++.+|+.||||++.... ....+|+++|+.+. ||||++++++|...   ...++++|
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~~v  110 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPALV  110 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCceeEE
Confidence            457999999999999999999999999999999986543 34568999999995 99999999987532   33458899


Q ss_pred             eeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC-ce------------
Q 015672          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN-VS------------  224 (403)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~-~~------------  224 (403)
                      ||||.+ +|..       ..+.+++..++.++.||+.||+|||+ +|||||||||+|||++.++. ++            
T Consensus       111 ~e~~~~~~L~~-------~~~~l~e~~i~~i~~qil~aL~~LH~-~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         111 FEHVNNTDFKQ-------LYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             EECCCSCBGGG-------TTTSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             EeecCCCcHHH-------HhcCCCHHHHHHHHHHHHHHHHHHhh-cccccccccccceEEcCCCCeeeecccccceeccC
Confidence            999985 3321       23579999999999999999999999 89999999999999986543 32            


Q ss_pred             ------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          225 ------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       225 ------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                            .++|+.|+|||++.+...++.++||||+||++|+|++|+.||.... ..++...+...++.+....+.......
T Consensus       183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence                  2468899999999877778999999999999999999999997654 445666677777655443332111000


Q ss_pred             cc--c--CCCCCCCCCcccc----cccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccCC
Q 015672          298 TE--F--KFPQIKPHPWHKV----FQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDELR  353 (403)
Q Consensus       298 ~~--~--~~~~~~~~~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  353 (403)
                      ..  +  .........+...    ....+++++.|||.+||++||++|||++|+|+||||+.+.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            00  0  0011111111111    1245789999999999999999999999999999999875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-52  Score=393.71  Aligned_cols=244  Identities=25%  Similarity=0.352  Sum_probs=189.9

Q ss_pred             cccEeee-ceecccCceEEEEEEECCCCcEEEEEEcccccccHHHHHHHHHh-cCCCCccccceEEeecCCCCceEEEEE
Q 015672           81 KVSYIAE-HVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRYKNRELQIMQM-LDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        81 ~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      ..+|.+. ++||+|+||+||+|+++.+++.||||++.. .....+|+.++.+ ++|||||+++++|.... ....++|+|
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~iv   87 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIV   87 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEEEE
Confidence            3469876 469999999999999999999999999864 3456689998765 48999999999874322 345678999


Q ss_pred             eeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC---Cc-----------
Q 015672          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP---NV-----------  223 (403)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~---~~-----------  223 (403)
                      ||||+ |+|.+++...  ....+++..++.++.||+.||+|||+ +||+||||||+|||++...   .+           
T Consensus        88 mEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~-~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~  164 (335)
T d2ozaa1          88 MECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  164 (335)
T ss_dssp             EECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHH-cCCccccccccccccccccccccccccccceeeec
Confidence            99998 5887776532  13469999999999999999999999 8999999999999997532   22           


Q ss_pred             -------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          224 -------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       224 -------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                             ..+||+.|+|||++.+. .|+.++|||||||++|+|+||++||.+.+.......+...+..            
T Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~------------  231 (335)
T d2ozaa1         165 TSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM------------  231 (335)
T ss_dssp             CCCCCCCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS------------
T ss_pred             cCCCccccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc------------
Confidence                   23589999999998654 5999999999999999999999999877654443333221100            


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCccc
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDE  351 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  351 (403)
                       ..+.+|.        .....+|+++++||.+||++||++|||+.|+++||||.+
T Consensus       232 -~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         232 -GQYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             -CSSSCCT--------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             -CCCCCCC--------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence             1111111        112357999999999999999999999999999999975

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.7e-51  Score=379.76  Aligned_cols=237  Identities=26%  Similarity=0.348  Sum_probs=189.1

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELY  154 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  154 (403)
                      ++|++.+.||+|+||+||+|++..+|+.||||++..+.       ....+|+++|+.++|||||++++++.... .....
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~~   85 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGPL   85 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCce
Confidence            45999999999999999999999999999999985432       12457999999999999999999886543 34556


Q ss_pred             EEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCc----------
Q 015672          155 LNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNV----------  223 (403)
Q Consensus       155 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~----------  223 (403)
                      +|+|||||+ ++|...+..    .+.+++..++.++.||+.||+|||+ +|||||||||+|||++.++..          
T Consensus        86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~-~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCccccCcccccCccccceeehhhhhhh
Confidence            889999998 466554433    4679999999999999999999999 899999999999999765543          


Q ss_pred             ------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015672          224 ------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       224 ------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  291 (403)
                                  ..+||+.|+|||++.+. .|+.++|||||||++|+|+||++||.+.+..+.+..+...-..++     
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~-----  234 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP-----  234 (277)
T ss_dssp             CC----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG-----
T ss_pred             hccccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC-----
Confidence                        23579999999999654 589999999999999999999999998887777766654211111     


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcc
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFD  350 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~  350 (403)
                                          ......+|+++.+||.+||+.||++||+..+.+.|+|.+
T Consensus       235 --------------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         235 --------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             --------------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             --------------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence                                112256899999999999999999999544455566654

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-49  Score=368.00  Aligned_cols=233  Identities=20%  Similarity=0.292  Sum_probs=187.9

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      .+|++.+.||+|+||+||+|+++.+++.||||++..+.   ..+.+|+++|+.++|||||++++++..     ...+++|
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~iv   91 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFYII   91 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEEE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEee-----CCeeEEE
Confidence            46999999999999999999999999999999986543   334689999999999999999998843     2337899


Q ss_pred             eeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------------
Q 015672          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------------  225 (403)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------------  225 (403)
                      ||||+ |++..++...  ....+++..+..++.||+.||+|||+ +|||||||||+||||+.++.+++            
T Consensus        92 ~E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          92 TEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             EECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             eecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHH-CCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence            99998 5777666442  23568999999999999999999999 89999999999999987665543            


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                              .||+.|+|||++.+. .|+.++|||||||++|||++|..||........+..++..-..             
T Consensus       169 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~-------------  234 (287)
T d1opja_         169 TYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-------------  234 (287)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC-------------
T ss_pred             CceeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCC-------------
Confidence                    257789999998765 5899999999999999999976665555545444444331100             


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCCCcccC
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVHPFFDEL  352 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  352 (403)
                                    ...+..+++++.+||.+||+.||++|||++|+++  +|+.+
T Consensus       235 --------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~  273 (287)
T d1opja_         235 --------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM  273 (287)
T ss_dssp             --------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             --------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence                          0123568999999999999999999999999976  45544

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=364.66  Aligned_cols=229  Identities=20%  Similarity=0.273  Sum_probs=184.7

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      .+|++.+.||+|+||+||+|+.+   ..||||++....      ..+.+|+.+|++++|||||++++++..    .  .+
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~----~--~~   78 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA----P--QL   78 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S--SC
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec----c--EE
Confidence            45999999999999999999864   469999985321      234579999999999999999987521    1  26


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce----------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS----------  224 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~----------  224 (403)
                      ++|||||+ ++|.+++..   ....+++..+..++.||+.||+|||+ ++||||||||+||||+.++.++          
T Consensus        79 ~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~  154 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHA-KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK  154 (276)
T ss_dssp             EEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred             EEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhc-CCEeccccCHHHEEEcCCCCEEEccccceeec
Confidence            79999998 688776643   23568999999999999999999999 8999999999999998776553          


Q ss_pred             -----------eeccccccchhhhhCC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015672          225 -----------YICSRYYRAPELIFGA--TEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       225 -----------~~~t~~y~aPE~~~~~--~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  291 (403)
                                 ..||+.|||||++.+.  ..|+.++|||||||++|||+||+.||.+.+....+.........++     
T Consensus       155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p-----  229 (276)
T d1uwha_         155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP-----  229 (276)
T ss_dssp             -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC-----
T ss_pred             cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC-----
Confidence                       2478999999998643  3489999999999999999999999998887766655554321111     


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                        .....+..+++++.+||.+||..||++|||+.|++++
T Consensus       230 ------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         230 ------------------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             ------------------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                              0011235689999999999999999999999999986

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-49  Score=359.49  Aligned_cols=225  Identities=19%  Similarity=0.295  Sum_probs=183.0

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      +|++.+.||+|+||+||+|+++ +++.||||++..+.   ..+.+|++++++++|||||++++++...     ..+++||
T Consensus         6 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~~~lv~   79 (263)
T d1sm2a_           6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICLVF   79 (263)
T ss_dssp             CEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEE
T ss_pred             HcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccC-----CceEEEE
Confidence            5999999999999999999985 57789999986543   3346899999999999999999998433     2378999


Q ss_pred             eccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------------
Q 015672          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------------  225 (403)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------------  225 (403)
                      |||+ |+|.+++...   ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+++             
T Consensus        80 E~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~-~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          80 EFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             ECCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred             EecCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhc-cceeecccchhheeecCCCCeEecccchheeccCCC
Confidence            9998 6776665432   3568889999999999999999999 89999999999999987665532             


Q ss_pred             -------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 015672          226 -------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY  297 (403)
Q Consensus       226 -------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  297 (403)
                             .||+.|+|||++.+. .|+.++|||||||++|||+| |.+||...+..+.+..+......             
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~-------------  221 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-------------  221 (263)
T ss_dssp             ---------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC-------------
T ss_pred             ceeecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC-------------
Confidence                   367889999999654 59999999999999999999 56777666655555555432110             


Q ss_pred             cccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          298 TEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                     ..+..+++++.+||.+||+.||++|||++|+++|
T Consensus       222 ---------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         222 ---------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             ---------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                           0124578999999999999999999999999987

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.3e-49  Score=365.13  Aligned_cols=227  Identities=24%  Similarity=0.332  Sum_probs=183.2

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCc---EEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGE---IVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      ..|.+.++||+|+||+||+|+++.+++   .||||.+....     ..+.+|+++|++++|||||++++++...     .
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----~  100 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS-----T  100 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----S
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----C
Confidence            459999999999999999999987665   58999875432     2346899999999999999999988433     2


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------  225 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------  225 (403)
                      .+++|||||+ |+|..++..   ....+++..+..++.||+.||.|||+ ++||||||||+||||+.++.+++       
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHrDlKp~NILl~~~~~~Kl~DFGla~  176 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLAD-MNYVHRDLAARNILVNSNLVCKVSDFGLSR  176 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             EEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhh-CCCccCccccceEEECCCCcEEECCcccce
Confidence            3789999998 467665543   23568999999999999999999999 89999999999999988766533       


Q ss_pred             -----------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015672          226 -----------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  287 (403)
Q Consensus       226 -----------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~  287 (403)
                                       .+|+.|+|||++.+. .|+.++|||||||++|||+| |++||.+.+..+.+..+.+....+  
T Consensus       177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~--  253 (299)
T d1jpaa_         177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP--  253 (299)
T ss_dssp             -------------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC--
T ss_pred             EccCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--
Confidence                             247789999998654 59999999999999999998 899999888776665554321111  


Q ss_pred             HHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                                .+..+++++.+||.+||+.||++|||+.|++++
T Consensus       254 --------------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         254 --------------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             --------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             --------------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                      124578999999999999999999999999875

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-49  Score=371.86  Aligned_cols=231  Identities=21%  Similarity=0.275  Sum_probs=186.1

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCc-----EEEEEEcccc-----cccHHHHHHHHHhc-CCCCccccceEEeecCCC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGE-----IVAIKKVLQD-----KRYKNRELQIMQML-DHPNIVALKHCFFSTTDK  150 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  150 (403)
                      .+|++.++||+|+||+||+|++..+++     .||+|.+...     .....+|+.+|.++ +|||||++++++..    
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~----  112 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL----  112 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee----
Confidence            569999999999999999999876554     6999988532     22345799999998 89999999999843    


Q ss_pred             CceEEEEEeeccC-CcHHHHHHHhhh-------------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccc
Q 015672          151 EELYLNLVLEYVP-ETVNRIARNYSR-------------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDI  210 (403)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~-------------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDl  210 (403)
                       ...+++|||||+ |+|.+++.....                   ....+++..++.++.||+.||+|||+ ++||||||
T Consensus       113 -~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~-~~IiHRDl  190 (325)
T d1rjba_         113 -SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDL  190 (325)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETTC
T ss_pred             -CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccC
Confidence             334889999998 688877754321                   12358889999999999999999999 89999999


Q ss_pred             ccccceecCCCCcee---------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 015672          211 KPQNLLVKGEPNVSY---------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPG  268 (403)
Q Consensus       211 Kp~NILl~~~~~~~~---------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~  268 (403)
                      ||+|||++.++.+++                     .||+.|||||++.+. .|+.++|||||||++|||+| |.+||.+
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            999999987765432                     358899999998755 58999999999999999997 8999998


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          269 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       269 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      .+..+.+..+++.-..+                           ..+..+++++++||.+||+.||++|||++||++|
T Consensus       270 ~~~~~~~~~~~~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         270 IPVDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CCCSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHhcCCCC---------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            77766666665421110                           0225689999999999999999999999999876

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-49  Score=363.70  Aligned_cols=231  Identities=21%  Similarity=0.286  Sum_probs=185.0

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      .+|++.+.||+|+||+||+|+++ +++.||||++....   ..+.+|+++|++++|||||++++++. ..     .+++|
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~-----~~~iv   85 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QE-----PIYII   85 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS-----SCEEE
T ss_pred             HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cC-----CeEEE
Confidence            46999999999999999999985 67889999986543   33568999999999999999999762 11     15799


Q ss_pred             eeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------------
Q 015672          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------------  225 (403)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------------  225 (403)
                      ||||+ |+|.+++...  ....+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+++            
T Consensus        86 ~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~-~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          86 TEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             EECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccchhheeeecccceeeccccceEEccCC
Confidence            99998 5666544322  23468999999999999999999999 89999999999999998766543            


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                              .||+.|+|||++.+. .++.++|||||||++|||+|| .+||...+..+.+..+......            
T Consensus       163 ~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~------------  229 (272)
T d1qpca_         163 EYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM------------  229 (272)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC------------
T ss_pred             ccccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC------------
Confidence                    357889999998654 489999999999999999995 5556655555554444321100            


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc--CCCccc
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV--HPFFDE  351 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~--hp~f~~  351 (403)
                                      ..+..+++++.+||.+||+.||++|||++++++  |+||..
T Consensus       230 ----------------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         230 ----------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                            022568899999999999999999999999998  788864

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-49  Score=371.15  Aligned_cols=237  Identities=28%  Similarity=0.454  Sum_probs=190.5

Q ss_pred             ccEeeeceecccCceEEEEEEE---CCCCcEEEEEEcccc--------cccHHHHHHHHHhcCC-CCccccceEEeecCC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKC---RETGEIVAIKKVLQD--------KRYKNRELQIMQMLDH-PNIVALKHCFFSTTD  149 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~---~~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~  149 (403)
                      .+|++.+.||+|+||+||+|++   +.+|+.||||++.+.        .....+|+++|++++| |||+++++++..   
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~---  100 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT---  100 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE---
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc---
Confidence            5699999999999999999987   347899999988532        1234579999999977 799999988833   


Q ss_pred             CCceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---
Q 015672          150 KEELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---  225 (403)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---  225 (403)
                        ...++++|||+. ++|...+..    ...+++..++.++.||+.||+|||+ +|||||||||+|||++.++.+++   
T Consensus       101 --~~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~-~~ivHrDiKp~Nill~~~~~vkL~DF  173 (322)
T d1vzoa_         101 --ETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDF  173 (322)
T ss_dssp             --TTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEESCS
T ss_pred             --CCceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhc-CCEEeccCCccceeecCCCCEEEeec
Confidence              345889999998 577665544    3568899999999999999999999 89999999999999998776533   


Q ss_pred             -----------------eccccccchhhhhCCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015672          226 -----------------ICSRYYRAPELIFGAT-EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTR  287 (403)
Q Consensus       226 -----------------~~t~~y~aPE~~~~~~-~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~~~~~  287 (403)
                                       .||+.|+|||.+.+.. .++.++|||||||+||+|++|+.||.+.+..+....+.+.....  
T Consensus       174 G~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~--  251 (322)
T d1vzoa_         174 GLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--  251 (322)
T ss_dssp             SEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC--
T ss_pred             cchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC--
Confidence                             3688999999996543 47889999999999999999999998876554444443321000  


Q ss_pred             HHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCCCcccCC
Q 015672          288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRC-----TALEACVHPFFDELR  353 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~  353 (403)
                                 .            ..++..+++++.+||.+||++||++||     |++|+++||||++++
T Consensus       252 -----------~------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         252 -----------E------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             -----------C------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             -----------C------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence                       0            002356899999999999999999999     589999999999875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-49  Score=357.31  Aligned_cols=226  Identities=20%  Similarity=0.263  Sum_probs=186.6

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      .+|++.++||+|+||+||+|+++ +++.||||++..+.   ..+.+|+.++++++||||+++++++...     ..+++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-----~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCS-----SSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----CceEEE
Confidence            35899999999999999999984 78899999986533   3456899999999999999999988432     238899


Q ss_pred             eeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------------
Q 015672          159 LEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------------  225 (403)
Q Consensus       159 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------------  225 (403)
                      |||++ |++..++..   ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+++            
T Consensus        78 ~Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~-~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  153 (258)
T d1k2pa_          78 TEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  153 (258)
T ss_dssp             EECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHH-TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred             EEccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhh-cCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence            99998 566555332   23568889999999999999999999 89999999999999987765532            


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                              .||+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+....+.+....+           
T Consensus       154 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~-----------  221 (258)
T d1k2pa_         154 EYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-----------  221 (258)
T ss_dssp             SCCCCCCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC-----------
T ss_pred             CceeecccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC-----------
Confidence                    367889999999755 48999999999999999998 899999888776665554321100           


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                       .+...++++.+||.+||+.||++|||+.++++|
T Consensus       222 -----------------~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         222 -----------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             -----------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                             124578999999999999999999999999987

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-49  Score=363.10  Aligned_cols=223  Identities=22%  Similarity=0.291  Sum_probs=178.6

Q ss_pred             ceecccCceEEEEEEEC--CCCcEEEEEEccccc------ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           88 HVVGTGSFGVVFQAKCR--ETGEIVAIKKVLQDK------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        88 ~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      ++||+|+||+||+|.+.  .+++.||||++....      ..+.+|+++|++++|||||++++++.. .   .  .+|||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~---~--~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-E---S--WMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-S---S--EEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-C---C--EEEEE
Confidence            57999999999999864  356789999985432      234589999999999999999998732 1   1  57999


Q ss_pred             eccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce--------------
Q 015672          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS--------------  224 (403)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~--------------  224 (403)
                      |||+ |+|.+++..    ...+++..+..++.||+.||.|||+ ++||||||||+|||++.++.++              
T Consensus        87 E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~-~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~  161 (277)
T d1xbba_          87 EMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  161 (277)
T ss_dssp             ECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             EcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHh-CCcccCCCcchhhcccccCcccccchhhhhhccccc
Confidence            9998 577776554    4679999999999999999999999 8999999999999998665442              


Q ss_pred             --------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCc
Q 015672          225 --------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP  295 (403)
Q Consensus       225 --------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  295 (403)
                              ..||+.|+|||++.+. .++.++|||||||++|||++ |++||.+.+..+....+.+.. .+          
T Consensus       162 ~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~-~~----------  229 (277)
T d1xbba_         162 NYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RM----------  229 (277)
T ss_dssp             SEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-CC----------
T ss_pred             cccccccccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC-CC----------
Confidence                    2367889999999755 48999999999999999998 899999887665554443210 00          


Q ss_pred             CccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHH---hcCCCcc
Q 015672          296 NYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA---CVHPFFD  350 (403)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~---l~hp~f~  350 (403)
                                       ..+..+++++.+||.+||+.||++|||++++   |+|+|++
T Consensus       230 -----------------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         230 -----------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             -----------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             -----------------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence                             0235689999999999999999999999998   4666654

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-49  Score=362.17  Aligned_cols=232  Identities=25%  Similarity=0.313  Sum_probs=185.8

Q ss_pred             cccEeeece-ecccCceEEEEEEECC--CCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           81 KVSYIAEHV-VGTGSFGVVFQAKCRE--TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        81 ~~~y~~~~~-lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      ..+|.+.+. ||+|+||+||+|.++.  ++..||||++....     ..+.+|+++|++++|||||++++++.. .    
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~----   81 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E----   81 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S----
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C----
Confidence            346888885 9999999999998764  34579999986432     234579999999999999999998732 1    


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------  225 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------  225 (403)
                       .+|+|||||+ |+|.+++..   ....+++..+..++.||+.||.|||+ +|||||||||+|||++.++.+++      
T Consensus        82 -~~~lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~Nill~~~~~~Kl~DFGla  156 (285)
T d1u59a_          82 -ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRHYAKISDFGLS  156 (285)
T ss_dssp             -SEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred             -eEEEEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCcCchhheeeccCCceeeccchhh
Confidence             1789999998 577665432   23569999999999999999999999 89999999999999987655432      


Q ss_pred             ----------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHH
Q 015672          226 ----------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE  288 (403)
Q Consensus       226 ----------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~  288 (403)
                                      .||+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+.+..+.+...     
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~-----  230 (285)
T d1u59a_         157 KALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-----  230 (285)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC-----
T ss_pred             hcccccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence                            357889999998655 58999999999999999998 9999998887766555443110     


Q ss_pred             HHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHH---hcCCCccc
Q 015672          289 EIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEA---CVHPFFDE  351 (403)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~---l~hp~f~~  351 (403)
                                    +         ..+..+++++.+||.+||+.||++|||+.++   |+|+|+.-
T Consensus       231 --------------~---------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         231 --------------M---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             --------------C---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --------------C---------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence                          0         0235689999999999999999999999887   67888753

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=352.69  Aligned_cols=232  Identities=24%  Similarity=0.339  Sum_probs=185.6

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      .+|++.+.||+|+||+||+|+++.+ +.||||++....   ..+.+|+.+|++++|+|||++++++. ..   .  +++|
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~---~--~~lv   89 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EE---P--IYIV   89 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS---S--CEEE
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cC---C--eEEE
Confidence            4699999999999999999998654 579999986543   34568999999999999999999862 11   1  5799


Q ss_pred             eeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------------
Q 015672          159 LEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------------  225 (403)
Q Consensus       159 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------------  225 (403)
                      ||||++ ++..++...  ....+++..+..++.||+.||+|||+ +||+||||||+||||+.++.+++            
T Consensus        90 ~Ey~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~-~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          90 TEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             ECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             EEecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhh-hheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence            999984 565554332  23568999999999999999999999 89999999999999987665533            


Q ss_pred             --------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcC
Q 015672          226 --------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN  296 (403)
Q Consensus       226 --------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  296 (403)
                              .||+.|+|||++... .++.++|||||||++|||++|. +||.+....+.+..+.+....+           
T Consensus       167 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~-----------  234 (285)
T d1fmka3         167 EYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-----------  234 (285)
T ss_dssp             ---------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-----------
T ss_pred             CceeeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-----------
Confidence                    357889999999654 5899999999999999999964 5555555555554443311100           


Q ss_pred             ccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc--CCCcccC
Q 015672          297 YTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV--HPFFDEL  352 (403)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~--hp~f~~~  352 (403)
                                       .+..+++++++||.+||+.||++|||++++++  |+||...
T Consensus       235 -----------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         235 -----------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             -----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             -----------------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence                             22568999999999999999999999999988  8899764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=351.49  Aligned_cols=226  Identities=27%  Similarity=0.343  Sum_probs=183.3

Q ss_pred             ccEeeeceecccCceEEEEEEECCCC---cEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      .+|++.+.||+|+||+||+|++..++   ..||||.+....     ..+.+|+++|++++|||||++++++. .     .
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~-----~   80 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E-----N   80 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S-----S
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c-----C
Confidence            46999999999999999999986543   468999885322     23457999999999999999999872 1     1


Q ss_pred             EEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------
Q 015672          154 YLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------  225 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------  225 (403)
                      .+++|||||+ +++..++..   ....+++..++.++.||+.||.|||+ ++||||||||+|||++.++.+++       
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~  156 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSNDCVKLGDFGLSR  156 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             eEEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcc-cCeeccccchhheeecCCCcEEEccchhhe
Confidence            2789999998 566554433   24568999999999999999999999 89999999999999987665533       


Q ss_pred             -------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 015672          226 -------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK  291 (403)
Q Consensus       226 -------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  291 (403)
                                   .||+.|+|||++.+. .|+.++|||||||++|||++ |.+||.+.+..+.+..+......       
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~-------  228 (273)
T d1mp8a_         157 YMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-------  228 (273)
T ss_dssp             --------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-------
T ss_pred             eccCCcceeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence                         357899999999654 58999999999999999998 89999988877666555431100       


Q ss_pred             hcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          292 CMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                           .++..+|+++.+||.+||+.||++|||+.|+++|
T Consensus       229 ---------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         229 ---------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             ---------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                 0235689999999999999999999999999876

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-47  Score=357.13  Aligned_cols=226  Identities=22%  Similarity=0.336  Sum_probs=179.3

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCc----EEEEEEcccc-----cccHHHHHHHHHhcCCCCccccceEEeecCCCCc
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGE----IVAIKKVLQD-----KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEE  152 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  152 (403)
                      .+|+++++||+|+||+||+|++..+|+    .||+|++...     ...+.+|+.+|++++|||||++++++...     
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence            459999999999999999999988876    5788877432     22356899999999999999999988432     


Q ss_pred             eEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee------
Q 015672          153 LYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY------  225 (403)
Q Consensus       153 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~------  225 (403)
                      . .++++||+. +++...+..   ....+++..++.++.||+.||.|||+ +|||||||||+||||+.++.+++      
T Consensus        84 ~-~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlKp~NIll~~~~~~kl~DFGla  158 (317)
T d1xkka_          84 T-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDFGLA  158 (317)
T ss_dssp             S-EEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETTEEEECCCSHH
T ss_pred             C-eeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHH-cCcccCcchhhcceeCCCCCeEeeccccc
Confidence            1 456677765 666555443   24678999999999999999999999 89999999999999987665432      


Q ss_pred             ---------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          226 ---------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       226 ---------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                     .||+.|+|||++.+. .|+.++|||||||++|||+| |.+||.+.+..+....+.+....+    
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~----  233 (317)
T d1xkka_         159 KLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP----  233 (317)
T ss_dssp             HHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC----
T ss_pred             eecccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC----
Confidence                           368899999999765 59999999999999999998 899998877655444443311000    


Q ss_pred             HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                              .+..+++++.+||.+||+.||.+|||+.|+++|
T Consensus       234 ------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         234 ------------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             ------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence                                    124678999999999999999999999999988

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=348.02  Aligned_cols=225  Identities=21%  Similarity=0.279  Sum_probs=176.5

Q ss_pred             cEeeeceecccCceEEEEEEECCCC----cEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCce
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETG----EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  153 (403)
                      .|.+.++||+|+||+||+|.++.++    ..||||++....     ..+.+|+++|++++|||||++++++...     .
T Consensus         8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~-----~   82 (283)
T d1mqba_           8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-----K   82 (283)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----S
T ss_pred             HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC-----C
Confidence            4999999999999999999987654    469999985432     2345899999999999999999988432     3


Q ss_pred             EEEEEeeccCC-cHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------
Q 015672          154 YLNLVLEYVPE-TVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------  225 (403)
Q Consensus       154 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------  225 (403)
                      .+++|||||.+ ++......   ....+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+++       
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~-~~iiHrDlKp~NILl~~~~~~Kl~DFGla~  158 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNLVCKVSDFGLSR  158 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             ceEEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccc-cccccCccccceEEECCCCeEEEcccchhh
Confidence            37899999985 44443332   23578999999999999999999999 89999999999999998766543       


Q ss_pred             ---------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCHHH
Q 015672          226 ---------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREE  289 (403)
Q Consensus       226 ---------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~p-f~~~~~~~~~~~i~~~~~~~~~~~  289 (403)
                                     .||+.|+|||++.+. .++.++|||||||++|||++|..| |.+.+..+.+..+.... .+    
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-~~----  232 (283)
T d1mqba_         159 VLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-RL----  232 (283)
T ss_dssp             ---------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CC----
T ss_pred             cccCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC-CC----
Confidence                           257889999998654 599999999999999999996554 54444444433332211 00    


Q ss_pred             HhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          290 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                             ..+..++.++.+||.+||+.||++|||+.|+++
T Consensus       233 -----------------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         233 -----------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             -----------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----------------------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                                   022457899999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-47  Score=347.91  Aligned_cols=227  Identities=22%  Similarity=0.326  Sum_probs=185.0

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccccc--ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      .+|++.+.||+|+||.||+|+++  |..||||++..+.  +.+.+|++++++++||||+++++++...    ...+++||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~lv~   80 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYIVT   80 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEEEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEec----CCcEEEEE
Confidence            35999999999999999999984  7789999996543  3456899999999999999999987432    22378999


Q ss_pred             eccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-------------
Q 015672          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-------------  225 (403)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-------------  225 (403)
                      ||++ |+|.+++....  ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+++             
T Consensus        81 ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~-~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~  157 (262)
T d1byga_          81 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  157 (262)
T ss_dssp             CCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             eccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhcccccc-CceeccccchHhheecCCCCEeecccccceecCCCC
Confidence            9997 57877765432  2358899999999999999999999 89999999999999998876543             


Q ss_pred             ---eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccC
Q 015672          226 ---ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  301 (403)
Q Consensus       226 ---~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  301 (403)
                         .+|+.|+|||++.+. .++.++|||||||++|||+| |++||...+..+....+.+..                   
T Consensus       158 ~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~-------------------  217 (262)
T d1byga_         158 DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-------------------  217 (262)
T ss_dssp             ----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC-------------------
T ss_pred             ccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-------------------
Confidence               357789999999765 58999999999999999998 788888776665554442210                   


Q ss_pred             CCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          302 FPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       302 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      .         ..++..+++++.+||.+||+.||++|||+.+++++
T Consensus       218 ~---------~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         218 K---------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C---------CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            0         01235678999999999999999999999999874

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8e-47  Score=361.60  Aligned_cols=268  Identities=29%  Similarity=0.454  Sum_probs=194.3

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcC-----------CCCccccceEEeecC
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLD-----------HPNIVALKHCFFSTT  148 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----------h~niv~~~~~~~~~~  148 (403)
                      +|+++++||+|+||+||+|+++.+|+.||||++.++.   ....+|+.+++.++           |+||+++++++....
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~   93 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   93 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence            3999999999999999999999999999999997653   23357899888875           578999998874422


Q ss_pred             CCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCC------
Q 015672          149 DKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPN------  222 (403)
Q Consensus       149 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~------  222 (403)
                       ....+.++.++++.++......  ......+++..++.++.||+.||+|||+..||+||||||+||||+.++.      
T Consensus        94 -~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          94 -PNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             -TTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             -ccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence             2233333334444444333322  2335678999999999999999999996468999999999999964322      


Q ss_pred             c----------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHHHH
Q 015672          223 V----------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGES------GVDQLVEIIK  280 (403)
Q Consensus       223 ~----------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~------~~~~~~~i~~  280 (403)
                      +                ..+||+.|+|||++.+. .++.++||||+||++++|++|+.||...+      ..+.+.....
T Consensus       171 ~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~  249 (362)
T d1q8ya_         171 IKIADLGNACWYDEHYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE  249 (362)
T ss_dssp             EEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred             eeEeecccccccccccccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH
Confidence            1                23579999999999765 58999999999999999999999997543      2456677778


Q ss_pred             HhCCCCHHHHhhcCcC-------ccccCCCCCCCCCccccc------ccCCCHHHHHHHHHhcccCCCCCCCHHHHhcCC
Q 015672          281 VLGTPTREEIKCMNPN-------YTEFKFPQIKPHPWHKVF------QKRLPPEAVDLVCRFFQYSPNLRCTALEACVHP  347 (403)
Q Consensus       281 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~------~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~hp  347 (403)
                      .+|.++.+.+......       ............++....      ....++++.|||.+||++||.+||||+|+|+||
T Consensus       250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp  329 (362)
T d1q8ya_         250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHP  329 (362)
T ss_dssp             HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCG
T ss_pred             HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            8888877765432211       011112222222221111      123467899999999999999999999999999


Q ss_pred             CcccCCC
Q 015672          348 FFDELRD  354 (403)
Q Consensus       348 ~f~~~~~  354 (403)
                      ||++...
T Consensus       330 ~f~~~~~  336 (362)
T d1q8ya_         330 WLKDTLG  336 (362)
T ss_dssp             GGTTCTT
T ss_pred             ccCCCCC
Confidence            9997643

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-46  Score=350.14  Aligned_cols=232  Identities=22%  Similarity=0.304  Sum_probs=180.4

Q ss_pred             ccEeeeceecccCceEEEEEEECC-----CCcEEEEEEccccc-----ccHHHHHHHHHhc-CCCCccccceEEeecCCC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQML-DHPNIVALKHCFFSTTDK  150 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  150 (403)
                      .+|++.+.||+|+||+||+|++..     +++.||||++....     ....+|..++.++ +|+||+.+++++...   
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~---   89 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---   89 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST---
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC---
Confidence            569999999999999999999754     44689999986432     1233566667666 689999998876432   


Q ss_pred             CceEEEEEeeccC-CcHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccccccee
Q 015672          151 EELYLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLV  217 (403)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl  217 (403)
                       ...+++|||||+ |+|..++.....            ....+++..++.++.||+.||.|||+ +|||||||||+||||
T Consensus        90 -~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~ivHrDlKp~NILl  167 (299)
T d1ywna1          90 -GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILL  167 (299)
T ss_dssp             -TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             -CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh-CCCcCCcCCccceeE
Confidence             234789999998 688887765322            12458899999999999999999999 899999999999999


Q ss_pred             cCCCCce---------------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCcHHHH
Q 015672          218 KGEPNVS---------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQL  275 (403)
Q Consensus       218 ~~~~~~~---------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg-~~pf~~~~~~~~~  275 (403)
                      +.++.++                     ..||+.|+|||++.+. .++.++|||||||++|||++| .+||.+.+..+.+
T Consensus       168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~  246 (299)
T d1ywna1         168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  246 (299)
T ss_dssp             CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            8665443                     3478999999999764 589999999999999999986 5788877666655


Q ss_pred             HHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          276 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       276 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      ..+......+                           ..+..+++++.+||.+||+.||++|||++|+++|
T Consensus       247 ~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         247 CRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            5554421111                           0224678999999999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-46  Score=348.07  Aligned_cols=230  Identities=21%  Similarity=0.298  Sum_probs=178.0

Q ss_pred             cccEeeeceecccCceEEEEEEECCCC-------cEEEEEEcccccc-----cHHHHHHHHHhc-CCCCccccceEEeec
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRETG-------EIVAIKKVLQDKR-----YKNRELQIMQML-DHPNIVALKHCFFST  147 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~-----~~~~E~~~l~~l-~h~niv~~~~~~~~~  147 (403)
                      ..+|++.+.||+|+||.||+|++..++       ..||||++..+..     ...+|...+.++ +|||||++++++.. 
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~-   90 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-   90 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-
Confidence            346999999999999999999976554       3799999865432     233588888888 89999999999843 


Q ss_pred             CCCCceEEEEEeeccC-CcHHHHHHHhhh------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccccc
Q 015672          148 TDKEELYLNLVLEYVP-ETVNRIARNYSR------------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (403)
Q Consensus       148 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~N  214 (403)
                          ...+++|||||. |++.+++.....            ....+++..++.++.||+.||+|||+ .+||||||||+|
T Consensus        91 ----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~-~~ivHrDiKp~N  165 (299)
T d1fgka_          91 ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN  165 (299)
T ss_dssp             ----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred             ----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh-CCEEeeeecccc
Confidence                334889999998 678777654321            12468999999999999999999999 899999999999


Q ss_pred             ceecCCCCce---------------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcH
Q 015672          215 LLVKGEPNVS---------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGV  272 (403)
Q Consensus       215 ILl~~~~~~~---------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~  272 (403)
                      ||++.++..+                     ..+|+.|+|||++.+. .|+.++|||||||++|||++ |.+||.+.+..
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~  244 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  244 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence            9998776543                     2467889999999764 59999999999999999998 78899877765


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          273 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       273 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      +....+... ..+                           ..+..+++++.+||.+||+.||++|||+.|+++
T Consensus       245 ~~~~~i~~~-~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         245 ELFKLLKEG-HRM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHHTT-CCC---------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcC-CCC---------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            544333221 000                           022568899999999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-46  Score=345.30  Aligned_cols=226  Identities=24%  Similarity=0.309  Sum_probs=175.6

Q ss_pred             ccEeeeceecccCceEEEEEEECCC-C--cEEEEEEccccc-------ccHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRET-G--EIVAIKKVLQDK-------RYKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~-~--~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      .+|++.+.||+|+||+||+|++..+ +  ..||||++.++.       ..+.+|+.+|++++|||||++++++..     
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-----   82 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-----   82 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence            4599999999999999999986533 3  368999885421       234589999999999999999998832     


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee-----
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY-----  225 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~-----  225 (403)
                      . .+++|||||+ +++.+.+...   ...+++..+..++.||+.||.|||+ +||+||||||+||||+.++.++.     
T Consensus        83 ~-~~~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDikp~NIll~~~~~vkl~DfGl  157 (273)
T d1u46a_          83 P-PMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRDLVKIGDFGL  157 (273)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             c-chheeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhh-CCEeeeeecHHHhccccccceeeccchh
Confidence            1 2679999998 5665544432   3569999999999999999999999 89999999999999987654432     


Q ss_pred             -----------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 015672          226 -----------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  287 (403)
Q Consensus       226 -----------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~~~~~~i~~~~~~~~~  287 (403)
                                       .+|..|+|||++.+. .++.++|||||||++|||+| |.+||.+.+..+.+..+.+....+  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~--  234 (273)
T d1u46a_         158 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL--  234 (273)
T ss_dssp             CEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC--
T ss_pred             hhhcccCCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC--
Confidence                             246789999999764 58999999999999999998 899999988887776665421000  


Q ss_pred             HHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          288 EEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                                               ..+..+++++.+||.+||..||++|||+.++++
T Consensus       235 -------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         235 -------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                     022568899999999999999999999999863

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.1e-46  Score=346.40  Aligned_cols=230  Identities=23%  Similarity=0.283  Sum_probs=185.3

Q ss_pred             cccEeeeceecccCceEEEEEEECC-----CCcEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDK  150 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  150 (403)
                      .++|++.+.||+|+||+||+|+++.     +++.||||++....     ..+.+|+++|+.++||||+++++++...   
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~---   88 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG---   88 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS---
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC---
Confidence            3569999999999999999999753     56789999986432     2346899999999999999999988433   


Q ss_pred             CceEEEEEeeccC-CcHHHHHHHhh--------------------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccc
Q 015672          151 EELYLNLVLEYVP-ETVNRIARNYS--------------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRD  209 (403)
Q Consensus       151 ~~~~~~lv~e~~~-~~l~~~~~~~~--------------------~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrD  209 (403)
                        ..++++|||++ ++|.+++....                    .....++...+..++.||+.||+|||+ ++|||||
T Consensus        89 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~ivHrD  165 (301)
T d1lufa_          89 --KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRD  165 (301)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSC
T ss_pred             --CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc-CCeEeeE
Confidence              33789999998 67877765321                    112347888999999999999999999 8999999


Q ss_pred             cccccceecCCCCcee---------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCC-CCCC
Q 015672          210 IKPQNLLVKGEPNVSY---------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFP  267 (403)
Q Consensus       210 lKp~NILl~~~~~~~~---------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~-~pf~  267 (403)
                      |||+||||+.++.+++                     .+|+.|+|||++.+. .|+.++|||||||++|||++|. +||.
T Consensus       166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCCCC
Confidence            9999999987765533                     357889999999765 5999999999999999999985 7888


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          268 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       268 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      +.+..+.+..+....                   .+         ..+..+++++.+||.+||+.||++|||+.||++
T Consensus       245 ~~~~~e~~~~v~~~~-------------------~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         245 GMAHEEVIYYVRDGN-------------------IL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             TSCHHHHHHHHHTTC-------------------CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHcCC-------------------CC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            887777665544310                   00         023568899999999999999999999999965

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-46  Score=349.54  Aligned_cols=230  Identities=23%  Similarity=0.314  Sum_probs=185.1

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcE--EEEEEccc-----ccccHHHHHHHHHhc-CCCCccccceEEeecCCCCce
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEI--VAIKKVLQ-----DKRYKNRELQIMQML-DHPNIVALKHCFFSTTDKEEL  153 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~~~~-----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  153 (403)
                      .+|++.++||+|+||+||+|+++.++..  ||||++..     ....+.+|+++|+++ +|||||++++++...     .
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-----~   84 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----G   84 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----T
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-----C
Confidence            4699999999999999999999888764  67787642     223456899999999 799999999998543     3


Q ss_pred             EEEEEeeccC-CcHHHHHHHhh------------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCC
Q 015672          154 YLNLVLEYVP-ETVNRIARNYS------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE  220 (403)
Q Consensus       154 ~~~lv~e~~~-~~l~~~~~~~~------------~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~  220 (403)
                      .+++|||||+ |+|.+++....            .....+++..+..++.||+.||.|||+ ++||||||||+|||++.+
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~-~~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGEN  163 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGG
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCccccccccceEEEcCC
Confidence            4899999998 68887765421            224678999999999999999999999 899999999999999876


Q ss_pred             CCcee------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHH
Q 015672          221 PNVSY------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQ-PLFPGESGVDQLVEIIKV  281 (403)
Q Consensus       221 ~~~~~------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~-~pf~~~~~~~~~~~i~~~  281 (403)
                      +.+++                  .||..|+|||.+.+. .|+.++|||||||++|||++|. +||.+.+..+.+..+.+.
T Consensus       164 ~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~  242 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  242 (309)
T ss_dssp             GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             CceEEccccccccccccccccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence            55432                  368899999999665 5899999999999999999965 678777765555443321


Q ss_pred             hCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          282 LGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      . .                  +         ..+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       243 ~-~------------------~---------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         243 Y-R------------------L---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             C-C------------------C---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C-C------------------C---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            0 0                  0         0224678999999999999999999999999987

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-45  Score=345.50  Aligned_cols=231  Identities=23%  Similarity=0.305  Sum_probs=184.9

Q ss_pred             cccEeeeceecccCceEEEEEEEC-----CCCcEEEEEEcccccc-----cHHHHHHHHHhc-CCCCccccceEEeecCC
Q 015672           81 KVSYIAEHVVGTGSFGVVFQAKCR-----ETGEIVAIKKVLQDKR-----YKNRELQIMQML-DHPNIVALKHCFFSTTD  149 (403)
Q Consensus        81 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  149 (403)
                      ..+|++.++||+|+||.||+|++.     .+++.||||++.....     .+.+|+.+++.+ +|||||++++++..   
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~---   98 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI---   98 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee---
Confidence            357999999999999999999863     4567899999865432     235799999999 69999999999843   


Q ss_pred             CCceEEEEEeeccC-CcHHHHHHHhh--------------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCcccccccccc
Q 015672          150 KEELYLNLVLEYVP-ETVNRIARNYS--------------RIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQN  214 (403)
Q Consensus       150 ~~~~~~~lv~e~~~-~~l~~~~~~~~--------------~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~N  214 (403)
                        ...+++|||||+ +++..++....              .....+++..+..++.||+.||+|||+ ++||||||||+|
T Consensus        99 --~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~-~~ivHrDLKp~N  175 (311)
T d1t46a_          99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARN  175 (311)
T ss_dssp             --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred             --CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccccccc
Confidence              333789999998 57777665432              122358899999999999999999999 899999999999


Q ss_pred             ceecCCCCce---------------------eeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCcH
Q 015672          215 LLVKGEPNVS---------------------YICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLL-GQPLFPGESGV  272 (403)
Q Consensus       215 ILl~~~~~~~---------------------~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~t-g~~pf~~~~~~  272 (403)
                      ||++..+.++                     ..||+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+..
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            9998665442                     2468899999999654 58999999999999999998 67778777776


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          273 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       273 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      +.+..+++.-..+                           ..+..+++++.+||.+||+.||++|||++++++
T Consensus       255 ~~~~~~i~~~~~~---------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         255 SKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcCCCC---------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            6666665431111                           022457899999999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-45  Score=342.55  Aligned_cols=236  Identities=21%  Similarity=0.236  Sum_probs=182.7

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEcccc--cccHHHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD--KRYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      ++|++.+.||+|+||+||+|++..+|+.||||++...  .....+|+++++.++|+|++..+..+...    ....++||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~----~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEE----TTEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEec----CCEEEEEE
Confidence            3599999999999999999999999999999987542  34567899999999988877766655432    33478999


Q ss_pred             eccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC---Cc-------------
Q 015672          160 EYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP---NV-------------  223 (403)
Q Consensus       160 e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~---~~-------------  223 (403)
                      ||+++++...+..   ....+++..+..++.|++.||+|||+ +|||||||||+|||++..+   .+             
T Consensus        83 e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          83 ELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             ECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EEcCCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            9999887665443   24679999999999999999999999 8999999999999874211   11             


Q ss_pred             -------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh----CCCC
Q 015672          224 -------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVL----GTPT  286 (403)
Q Consensus       224 -------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~----~~~~  286 (403)
                                   ...||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+.+..    ..+.
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence                         23589999999999764 58999999999999999999999998766544333322211    1111


Q ss_pred             HHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHH---HHhcCCCccc
Q 015672          287 REEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTAL---EACVHPFFDE  351 (403)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~---e~l~hp~f~~  351 (403)
                                               ......+|+++.+||.+||+.||++||++.   ++|+|+|.+.
T Consensus       238 -------------------------~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         238 -------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             -------------------------HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             -------------------------hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence                                     112246899999999999999999999987   4567877644

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-45  Score=342.61  Aligned_cols=236  Identities=22%  Similarity=0.280  Sum_probs=189.5

Q ss_pred             ccEeeeceecccCceEEEEEEECC-----CCcEEEEEEcccccc-----cHHHHHHHHHhcCCCCccccceEEeecCCCC
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRE-----TGEIVAIKKVLQDKR-----YKNRELQIMQMLDHPNIVALKHCFFSTTDKE  151 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  151 (403)
                      .+|++.+.||+|+||+||+|.++.     ++..||||++.....     .+.+|++++++++|||||++++++...    
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~----   95 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG----   95 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS----
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC----
Confidence            469999999999999999998753     357899999864322     245899999999999999999988432    


Q ss_pred             ceEEEEEeeccC-CcHHHHHHHhhh------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCce
Q 015672          152 ELYLNLVLEYVP-ETVNRIARNYSR------IHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVS  224 (403)
Q Consensus       152 ~~~~~lv~e~~~-~~l~~~~~~~~~------~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~  224 (403)
                       ..+++|||||. |++..++.....      ....++...+..++.|++.||.|||+ ++|+||||||+|||++.++.++
T Consensus        96 -~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~-~~ivHrDlk~~NiLld~~~~~K  173 (308)
T d1p4oa_          96 -QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDFTVK  173 (308)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECTTCCEE
T ss_pred             -CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeceEcCCceeecCCceEE
Confidence             23789999998 677776654321      11346788899999999999999999 8999999999999999877664


Q ss_pred             e---------------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHh
Q 015672          225 Y---------------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLG-QPLFPGESGVDQLVEIIKVL  282 (403)
Q Consensus       225 ~---------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg-~~pf~~~~~~~~~~~i~~~~  282 (403)
                      +                     .+|+.|+|||.+.+. .++.++|||||||++|||+|| .+||.+.+..+.+..+.+..
T Consensus       174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~  252 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG  252 (308)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred             EeecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC
Confidence            3                     367889999999755 589999999999999999998 58888887777666554311


Q ss_pred             CCCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc------CCCcccC
Q 015672          283 GTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV------HPFFDEL  352 (403)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~------hp~f~~~  352 (403)
                      .                   +         ..+..+++.+.+||.+||+.||++|||+.++++      +|+|+++
T Consensus       253 ~-------------------~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~  300 (308)
T d1p4oa_         253 L-------------------L---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV  300 (308)
T ss_dssp             C-------------------C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred             C-------------------C---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence            0                   0         012467899999999999999999999999997      7777654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-44  Score=334.75  Aligned_cols=226  Identities=18%  Similarity=0.245  Sum_probs=173.3

Q ss_pred             EeeeceecccCceEEEEEEECCCC---cEEEEEEccccc-----ccHHHHHHHHHhcCCCCccccceEEeecCCCCceEE
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETG---EIVAIKKVLQDK-----RYKNRELQIMQMLDHPNIVALKHCFFSTTDKEELYL  155 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  155 (403)
                      +...++||+|+||+||+|++..++   ..||||++....     ..+.+|+++|++++|||||++++++....    ..+
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~  104 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSP  104 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TEE
T ss_pred             eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----Cce
Confidence            444688999999999999986643   368999885321     23468999999999999999999875432    247


Q ss_pred             EEEeeccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCCCcee---------
Q 015672          156 NLVLEYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEPNVSY---------  225 (403)
Q Consensus       156 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~~~~~---------  225 (403)
                      ++|||||+ +++.+++..   ....++...+..++.|++.||.|||+ .+|+||||||+||||+.++.+++         
T Consensus       105 ~lv~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~-~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~  180 (311)
T d1r0pa_         105 LVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKFTVKVADFGLARDM  180 (311)
T ss_dssp             EEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred             EEEEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcc-cCcccCCccHHhEeECCCCCEEEecccchhhc
Confidence            89999998 566555442   23457788889999999999999999 89999999999999987665433         


Q ss_pred             --------------eccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHH
Q 015672          226 --------------ICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEI  290 (403)
Q Consensus       226 --------------~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~  290 (403)
                                    .||+.|+|||++... .++.++|||||||++|||++|..||...... +....+...  ..     
T Consensus       181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g--~~-----  252 (311)
T d1r0pa_         181 YDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--RR-----  252 (311)
T ss_dssp             TTTTCCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT--CC-----
T ss_pred             cccccccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--CC-----
Confidence                          357889999998654 5899999999999999999977777554332 222222211  00     


Q ss_pred             hhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          291 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                                  +         ..+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       253 ------------~---------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         253 ------------L---------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             ------------C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------C---------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                        0         0224578999999999999999999999999988

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2e-43  Score=327.97  Aligned_cols=230  Identities=19%  Similarity=0.187  Sum_probs=182.5

Q ss_pred             ccEeeeceecccCceEEEEEEECCCCcEEEEEEccc--ccccHHHHHHHHHhcCC-CCccccceEEeecCCCCceEEEEE
Q 015672           82 VSYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQ--DKRYKNRELQIMQMLDH-PNIVALKHCFFSTTDKEELYLNLV  158 (403)
Q Consensus        82 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv  158 (403)
                      .+|++.+.||+|+||+||+|++..+|+.||||++..  +.....+|+++++.|.| +||+.+++++.     ...+.++|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~~~v   79 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHNVLV   79 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEee-----cCCccEEE
Confidence            359999999999999999999999999999998754  33456789999999976 88888888763     34458899


Q ss_pred             eeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCC-----CCc----------
Q 015672          159 LEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGE-----PNV----------  223 (403)
Q Consensus       159 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~-----~~~----------  223 (403)
                      |||++++|..++...   ...++...+..++.|++.||+|||+ +|||||||||+|||++..     +.+          
T Consensus        80 me~~~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~-~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          80 IDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEecCCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            999999987776542   3568999999999999999999999 899999999999999632     111          


Q ss_pred             ----------------eeeccccccchhhhhCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCC
Q 015672          224 ----------------SYICSRYYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGV---DQLVEIIKVLGT  284 (403)
Q Consensus       224 ----------------~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~tg~~pf~~~~~~---~~~~~i~~~~~~  284 (403)
                                      ..+||+.|||||++.+. .++.++|||||||++|||++|+.||.+....   .....+......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence                            23589999999999754 5999999999999999999999999865432   222222221111


Q ss_pred             CCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 015672          285 PTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACV  345 (403)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~  345 (403)
                      ++..                        .+...+|+++.+++..|+..+|++||+...+.+
T Consensus       235 ~~~~------------------------~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         235 TPLR------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             SCHH------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CChH------------------------HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            1111                        122467899999999999999999999877654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-43  Score=331.34  Aligned_cols=249  Identities=21%  Similarity=0.209  Sum_probs=173.9

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEccccccc-H--HHHHHHHHhcCCCCccccceEEeecCCCCceEEEEEe
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDKRY-K--NRELQIMQMLDHPNIVALKHCFFSTTDKEELYLNLVL  159 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~--~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  159 (403)
                      .|++.+.||+|+||.||+|++  +|+.||||++..+... .  +.|+..+..++|||||++++++.... .....+|+||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv~   80 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVS   80 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEEE
Confidence            599999999999999999986  5889999998544322 2  23455556789999999999886543 4445689999


Q ss_pred             eccC-CcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHh-------cCCccccccccccceecCCCCcee------
Q 015672          160 EYVP-ETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHN-------CIGICHRDIKPQNLLVKGEPNVSY------  225 (403)
Q Consensus       160 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~-------~~~ivHrDlKp~NILl~~~~~~~~------  225 (403)
                      |||. ++|..++..     ..+++.....++.|++.||.|||+       .+|||||||||+||||+.++.+++      
T Consensus        81 Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            9997 588877754     468899999999999999999995       158999999999999987766533      


Q ss_pred             -----------------eccccccchhhhhCCC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 015672          226 -----------------ICSRYYRAPELIFGAT-----EYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLG  283 (403)
Q Consensus       226 -----------------~~t~~y~aPE~~~~~~-----~~~~~~DiwSlGvil~el~tg~~pf~~~~~~~~~~~i~~~~~  283 (403)
                                       +||+.|+|||++.+..     .++.++|||||||+||||+||.+||............ ....
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~-~~~~  234 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-LVPS  234 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-TSCS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh-cccc
Confidence                             4789999999986432     2567899999999999999999887432211000000 0000


Q ss_pred             CCCHHHHhhcCcCccccCCCCCCCCCcccccccCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 015672          284 TPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLVCRFFQYSPNLRCTALEACVH  346 (403)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~l~h  346 (403)
                      .+....+...      .......+..............+.+|+.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~------~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         235 DPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SCCHHHHHHH------HTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cchHHHHHHH------HhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            0010000000      00000000000000111233568999999999999999999999864

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.85  E-value=3.4e-22  Score=172.28  Aligned_cols=149  Identities=19%  Similarity=0.117  Sum_probs=106.0

Q ss_pred             EeeeceecccCceEEEEEEECCCCcEEEEEEccccc----------------------ccHHHHHHHHHhcCCCCccccc
Q 015672           84 YIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQDK----------------------RYKNRELQIMQMLDHPNIVALK  141 (403)
Q Consensus        84 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------------~~~~~E~~~l~~l~h~niv~~~  141 (403)
                      |.+.++||+|+||+||+|++. +|+.||||+++...                      ....+|...+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            567899999999999999984 78999999864211                      0112578889999999998876


Q ss_pred             eEEeecCCCCceEEEEEeeccCCcHHHHHHHhhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCccccccccccceecCCC
Q 015672          142 HCFFSTTDKEELYLNLVLEYVPETVNRIARNYSRIHQRMPLIYVKLYTYQICRALAYIHNCIGICHRDIKPQNLLVKGEP  221 (403)
Q Consensus       142 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~~ivHrDlKp~NILl~~~~  221 (403)
                      ++.     .    .+++|||+++..          ...++...+..++.|++.||.|||+ +||+||||||+|||++.++
T Consensus        81 ~~~-----~----~~lvme~~~~~~----------~~~l~~~~~~~i~~ql~~~l~~lH~-~giiHrDiKP~NILv~~~~  140 (191)
T d1zara2          81 AWE-----G----NAVLMELIDAKE----------LYRVRVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVSEEG  140 (191)
T ss_dssp             EEE-----T----TEEEEECCCCEE----------GGGCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEETTE
T ss_pred             Eec-----C----CEEEEEeecccc----------ccchhhHHHHHHHHHHHHHHHHHhh-CCEEEccCChhheeeeCCC
Confidence            543     1    258999998632          1124445567889999999999999 8999999999999998654


Q ss_pred             Cceee--c----cccccchhhhhC---------CCCCCchhHHHHHHH
Q 015672          222 NVSYI--C----SRYYRAPELIFG---------ATEYTTAIDIWSTGC  254 (403)
Q Consensus       222 ~~~~~--~----t~~y~aPE~~~~---------~~~~~~~~DiwSlGv  254 (403)
                       +.++  |    +....+.+.+..         ...|+.++|+||+.-
T Consensus       141 -~~liDFG~a~~~~~~~~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~  187 (191)
T d1zara2         141 -IWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTYRTEKDINSAID  187 (191)
T ss_dssp             -EEECCCTTCEETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHHHH
T ss_pred             -EEEEECCCcccCCCCCcHHHHHHHHHHHHHHHcCCCCCcccHHHHHH
Confidence             3333  1    112233332210         124788999999753

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.03  E-value=0.0017  Score=55.95  Aligned_cols=75  Identities=16%  Similarity=0.113  Sum_probs=47.5

Q ss_pred             cEeeeceecccCceEEEEEEECCCCcEEEEEEcccc----cccHHHHHHHHHhcC-CCCccccceEEeecCCCCceEEEE
Q 015672           83 SYIAEHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD----KRYKNRELQIMQMLD-HPNIVALKHCFFSTTDKEELYLNL  157 (403)
Q Consensus        83 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  157 (403)
                      .|...+..+-++.+.||+..  ..++.+.+|.....    .....+|...+..|. +--+.+++...     .+....++
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~~~l   87 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSNL   87 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEE
T ss_pred             ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCceEE
Confidence            46666665555667899876  35667888876432    234568999988874 22234444433     12234679


Q ss_pred             EeeccCC
Q 015672          158 VLEYVPE  164 (403)
Q Consensus       158 v~e~~~~  164 (403)
                      ||++++|
T Consensus        88 v~~~l~G   94 (263)
T d1j7la_          88 LMSEADG   94 (263)
T ss_dssp             EEECCSS
T ss_pred             EEEeccc
Confidence            9999986

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.56  E-value=0.0072  Score=55.45  Aligned_cols=71  Identities=18%  Similarity=0.170  Sum_probs=42.2

Q ss_pred             eceecccCceEEEEEEECCCCcEEEEEEcccc-----------cccHHHHHHHHHhcC-C-C-CccccceEEeecCCCCc
Q 015672           87 EHVVGTGSFGVVFQAKCRETGEIVAIKKVLQD-----------KRYKNRELQIMQMLD-H-P-NIVALKHCFFSTTDKEE  152 (403)
Q Consensus        87 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~E~~~l~~l~-h-~-niv~~~~~~~~~~~~~~  152 (403)
                      .+.||.|....||++....+++.++||.-...           ......|.+.|+.+. + | .+.+++.  +...   .
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~---~  105 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTE---M  105 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETT---T
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCC---C
Confidence            45689999999999988777889999964211           112346888888773 2 2 2334332  2211   1


Q ss_pred             eEEEEEeeccCC
Q 015672          153 LYLNLVLEYVPE  164 (403)
Q Consensus       153 ~~~~lv~e~~~~  164 (403)
                        .++|||++++
T Consensus       106 --~~lvmE~L~~  115 (392)
T d2pula1         106 --AVTVMEDLSH  115 (392)
T ss_dssp             --TEEEECCCTT
T ss_pred             --CEEEEeccCC
Confidence              3479999864

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=95.97  E-value=0.016  Score=49.18  Aligned_cols=68  Identities=19%  Similarity=0.164  Sum_probs=42.4

Q ss_pred             cccC-ceEEEEEEECCCCcEEEEEEccccc-ccHHHHHHHHHhcCCCCc--cccceEEeecCCCCceEEEEEeeccCC
Q 015672           91 GTGS-FGVVFQAKCRETGEIVAIKKVLQDK-RYKNRELQIMQMLDHPNI--VALKHCFFSTTDKEELYLNLVLEYVPE  164 (403)
Q Consensus        91 G~G~-~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~  164 (403)
                      ..|. .+.||+... ..+..+++|...... .....|...++.|....+  .+++.+..     +....++||++++|
T Consensus        19 ~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~-----~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          19 TIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLLGEVPG   90 (255)
T ss_dssp             SCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEEECCSS
T ss_pred             CCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecc-----cccceEEEEEeeec
Confidence            3443 467898875 456668889765432 345689999988855444  34444331     12236789999974

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=92.55  E-value=0.21  Score=43.78  Aligned_cols=68  Identities=15%  Similarity=0.060  Sum_probs=39.1

Q ss_pred             eEEEEEEECCCCcEEEEEEccccc---ccHHHHHHHHHhcCCCCccccceEEeecC--CCCceEEEEEeeccCC
Q 015672           96 GVVFQAKCRETGEIVAIKKVLQDK---RYKNRELQIMQMLDHPNIVALKHCFFSTT--DKEELYLNLVLEYVPE  164 (403)
Q Consensus        96 g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~~~~~~lv~e~~~~  164 (403)
                      -.||+++. .+|..|++|+.+...   .....|...+..|...+|....-......  .....+.+.++++++|
T Consensus        36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            48999986 568889999876532   33557888888885433321100000000  0122346778888764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=91.89  E-value=0.35  Score=43.51  Aligned_cols=69  Identities=17%  Similarity=0.236  Sum_probs=44.5

Q ss_pred             eceecccCceEEEEEEECC-------CCcEEEEEEccccc--ccHHHHHHHHHhcCCCCcc-ccceEEeecCCCCceEEE
Q 015672           87 EHVVGTGSFGVVFQAKCRE-------TGEIVAIKKVLQDK--RYKNRELQIMQMLDHPNIV-ALKHCFFSTTDKEELYLN  156 (403)
Q Consensus        87 ~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~  156 (403)
                      ++.|+-|-.-.+|++....       ..+.|.+++.-...  ....+|..+++.+.-.+++ ++++++     .+    .
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~----g  117 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G  117 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC----c
Confidence            3568888888999998653       23567777654222  2235789999988655555 555544     22    3


Q ss_pred             EEeeccCC
Q 015672          157 LVLEYVPE  164 (403)
Q Consensus       157 lv~e~~~~  164 (403)
                      +|+||++|
T Consensus       118 ~I~efi~g  125 (395)
T d1nw1a_         118 RLEEYIPS  125 (395)
T ss_dssp             EEECCCCE
T ss_pred             eEEEEecc
Confidence            68898874